PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FP	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	DL	D2	EA	PG	WC	WE	SC	GA	PM	OA	HC	HP	DA	UT
J	Meng, ZQ; Liu, C; Hu, XT; Ma, YY				Meng, Zhiqiang; Liu, Chang; Hu, Xintian; Ma, Yuanye			Somatosensory Cortices Are Required for the Acquisition of Morphine-Induced Conditioned Place Preference	PLOS ONE			English	Article							COCAINE-SEEKING; CORTEX; ADDICTION; REWARD; RAT; REPRESENTATIONS; PLASTICITY; BEHAVIOR; INSULA; PROJECTIONS	Background: Sensory system information is thought to play an important role in drug addiction related responses. However, how somatic sensory information participates in the drug related behaviors is still unclear. Many studies demonstrated that drug addiction represents a pathological usurpation of neural mechanisms of learning and memory that normally relate to the pursuit of rewards. Thus, elucidate the role of somatic sensory in drug related learning and memory is of particular importance to understand the neurobiological mechanisms of drug addiction. Principal Findings: In the present study, we investigated the role of somatosensory system in reward-related associative learning using the conditioned place preference model. Lesions were made in somatosensory cortices either before or after conditioning training. We found that lesion of somatosensory cortices before, rather than after morphine conditioning impaired the acquisition of place preference. Conclusion: These results demonstrate that somatosensory cortices are necessary for the acquisition but not retention of morphine induced place preference.			Meng, ZQ (corresponding author), Chinese Acad Sci, Lab Sensory Motor Integrat Res, Kunming, Yunnan, Peoples R China.	xthu@mail.kiz.ac.cn; yuanma0716@vip.sina.com						Accolla R, 2008, P NATL ACAD SCI USA, V105, P4010, DOI 10.1073/pnas.0708927105; Bardo MT, 2000, PSYCHOPHARMACOLOGY, V153, P31, DOI 10.1007/s002130000569; Breiter HC, 1997, NEURON, V19, P591, DOI 10.1016/S0896-6273(00)80374-8; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Cardinal RN, 2002, NEUROSCI BIOBEHAV R, V26, P321, DOI 10.1016/S0149-7634(02)00007-6; Contreras M, 2007, SCIENCE, V318, P655, DOI 10.1126/science.1145590; Devonshire IM, 2007, NEUROSCIENCE, V146, P841, DOI 10.1016/j.neuroscience.2007.01.070; DI CG, 1999, EUR J PHARMACOL, V375, P13; Drouin C, 2004, EUR J NEUROSCI, V19, P1016, DOI 10.1111/j.0953-816X.2004.03186.x; EIKELBOOM R, 1982, PSYCHOL REV, V89, P507, DOI 10.1037/0033-295X.89.5.507; Everitt BJ, 2001, BRAIN RES REV, V36, P129, DOI 10.1016/S0165-0173(01)00088-1; Everitt BJ, 2005, NAT NEUROSCI, V8, P1481, DOI 10.1038/nn1579; Finnerty GT, 1999, NATURE, V400, P367, DOI 10.1038/22553; Fitzgerald PJ, 2004, J NEUROSCI, V24, P11193, DOI 10.1523/JNEUROSCI.3481-04.2004; Frances H, 2004, NEUROREPORT, V15, P2245, DOI 10.1097/00001756-200410050-00021; Golmayo L, 2003, NEUROSCIENCE, V119, P597, DOI 10.1016/S0306-4522(03)00031-9; Grant S, 1996, P NATL ACAD SCI USA, V93, P12040, DOI 10.1073/pnas.93.21.12040; Hearing MC, 2008, BRAIN STRUCT FUNCT, V213, P215, DOI 10.1007/s00429-008-0182-4; Hoffer ZS, 2001, J COMP NEUROL, V439, P87, DOI 10.1002/cne.1337; Hollander JA, 2008, P NATL ACAD SCI USA, V105, P19480, DOI 10.1073/pnas.0808023105; Hyman SE, 2005, AM J PSYCHIAT, V162, P1414, DOI 10.1176/appi.ajp.162.8.1414; JOHNSON SW, 1992, J NEUROSCI, V12, P483; Kalivas PW, 2003, PSYCHOPHARMACOLOGY, V168, P44, DOI 10.1007/s00213-003-1393-2; Koob GF, 2004, NEUROSCI BIOBEHAV R, V27, P739, DOI 10.1016/j.neubiorev.2003.11.007; Koob GF, 1997, SCIENCE, V278, P52, DOI 10.1126/science.278.5335.52; KOOB GF, 2009, NEUROPSYCHOPHAR 0826; Lei YL, 2005, NEUROSCI LETT, V390, P72, DOI 10.1016/j.neulet.2005.08.001; Menzel RR, 2005, CEREB CORTEX, V15, P1690, DOI 10.1093/cercor/bhi045; Naqvi NH, 2007, SCIENCE, V315, P531, DOI 10.1126/science.1135926; Naqvi NH, 2009, TRENDS NEUROSCI, V32, P56, DOI 10.1016/j.tins.2008.09.009; Paxinos G., 1998, RAT BRAIN STEROTAXIC; Shi CJ, 1998, J COMP NEUROL, V399, P469, DOI 10.1002/(SICI)1096-9861(19981005)399:4<469::AID-CNE3>3.0.CO;2-#; Siucinska E, 1996, CEREB CORTEX, V6, P506, DOI 10.1093/cercor/6.3.506; Spanagel R, 1999, TRENDS NEUROSCI, V22, P521, DOI 10.1016/S0166-2236(99)01447-2; Tzschentke TM, 2007, ADDICT BIOL, V12, P227, DOI 10.1111/j.1369-1600.2007.00070.x; Verdejo-Garcia A, 2009, NEUROPHARMACOLOGY, V56, P48, DOI 10.1016/j.neuropharm.2008.07.035; Vorel SR, 2001, SCIENCE, V292, P1175, DOI 10.1126/science.1058043; Wallace MT, 2004, P NATL ACAD SCI USA, V101, P2167, DOI 10.1073/pnas.0305697101; WEINBERGER NM, 1993, P NATL ACAD SCI USA, V90, P2394, DOI 10.1073/pnas.90.6.2394; Xiang Y, 2006, NEUROCHEM RES, V31, P1255, DOI 10.1007/s11064-006-9158-z	40	14	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2009	4	11							e7742	10.1371/journal.pone.0007742	http://dx.doi.org/10.1371/journal.pone.0007742			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RY	19888465	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414500011
J	Muller, IB; Bergmann, B; Groves, MR; Couto, I; Amaral, L; Begley, TP; Walter, RD; Wrenger, C				Mueller, Ingrid B.; Bergmann, Baerbel; Groves, Matthew R.; Couto, Isabel; Amaral, Leonard; Begley, Tadhg P.; Walter, Rolf D.; Wrenger, Carsten			The Vitamin B1 Metabolism of Staphylococcus aureus Is Controlled at Enzymatic and Transcriptional Levels	PLOS ONE			English	Article							PARASITE PLASMODIUM-FALCIPARUM; THIAMIN PHOSPHATE SYNTHASE; THI-BOX RIBOSWITCH; BACILLUS-SUBTILIS; CRYSTAL-STRUCTURE; MALARIA PARASITE; ANGSTROM RESOLUTION; SACCHAROMYCES-CEREVISIAE; PYROPHOSPHOKINASE CDNA; BIOSYNTHESIS	Vitamin B1 is in its active form thiamine pyrophosphate (TPP), an essential cofactor for several key enzymes in the carbohydrate metabolism. Mammals must salvage this crucial nutrient from their diet in order to complement the deficiency of de novo synthesis. In the human pathogenic bacterium Staphylococcus aureus, two operons were identified which are involved in vitamin B1 metabolism. The first operon encodes for the thiaminase type II (TenA), 4-amino-5-hydroxymethyl-2-methylpyrimidine kinase (ThiD), 5-(2-hydroxyethyl)-4-methylthiazole kinase (ThiM) and thiamine phosphate synthase (ThiE). The second operon encodes a phosphatase, an epimerase and the thiamine pyrophosphokinase (TPK). The open reading frames of the individual operons were cloned, their corresponding proteins were recombinantly expressed and biochemically analysed. The kinetic properties of the enzymes as well as the binding of TPP to the in vitro transcribed RNA of the proposed operons suggest that the vitamin B1 homeostasis in S. aureus is strongly regulated at transcriptional as well as enzymatic levels.			Muller, IB (corresponding author), Bernhard Nocht Inst Trop Med, Dept Biochem, Hamburg, Germany.	wrenger@bni-hamburg.de	Wrenger, Carsten/E-4110-2013; Amaral, Leonard/I-2112-2012; Begley, Tadhg/B-5801-2015; Couto, Isabel/I-2640-2012	Wrenger, Carsten/0000-0001-5987-1749; Amaral, Leonard/0000-0003-3127-1295; Couto, Isabel/0000-0003-3536-2733; Groves, Matthew/0000-0001-9859-5177				ACAR JF, 1978, J CLIN MICROBIOL, V8, P142; Baker LJ, 2001, STRUCTURE, V9, P539, DOI 10.1016/S0969-2126(01)00615-3; Batifoulier F, 2005, J CHROMATOGR B, V816, P67, DOI 10.1016/j.jchromb.2004.11.004; Begley TP, 1999, ARCH MICROBIOL, V171, P293, DOI 10.1007/s002030050713; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Campobasso N, 2000, BIOCHEMISTRY-US, V39, P7868, DOI 10.1021/bi0000061; Campobasso N, 1998, BIOCHEMISTRY-US, V37, P15981, DOI 10.1021/bi981673l; Cheng G, 2002, STRUCTURE, V10, P225, DOI 10.1016/S0969-2126(02)00708-6; Chiu HJ, 1999, BIOCHEMISTRY-US, V38, P6460, DOI 10.1021/bi982903z; Downs DM, 2006, ANNU REV MICROBIOL, V60, P533, DOI 10.1146/annurev.micro.60.080805.142308; Edwards TE, 2006, STRUCTURE, V14, P1459, DOI 10.1016/j.str.2006.07.008; Eschbach ML, 2006, BIOL CHEM, V387, P1583, DOI 10.1515/BC.2006.197; Fey PD, 2003, ANTIMICROB AGENTS CH, V47, P196, DOI 10.1128/AAC.47.1.196-203.2003; Grundy FJ, 2002, NUCLEIC ACIDS RES, V30, P1646, DOI 10.1093/nar/30.7.1646; Hohmann S, 1998, BBA-PROTEIN STRUCT M, V1385, P201, DOI 10.1016/S0167-4838(98)00069-7; Jenkins AH, 2007, NAT CHEM BIOL, V3, P492, DOI 10.1038/nchembio.2007.13; Jurgenson CT, 2009, ANNU REV BIOCHEM, V78, P569, DOI 10.1146/annurev.biochem.78.072407.102340; KAUFFMAN CA, 1993, AM J MED, V94, P371, DOI 10.1016/0002-9343(93)90147-H; Knockel J, 2008, MOL BIOCHEM PARASIT, V157, P241, DOI 10.1016/j.molbiopara.2007.10.010; Lawhorn BG, 2004, J BIOL CHEM, V279, P43555, DOI 10.1074/jbc.M404284200; Lee JM, 2001, J BACTERIOL, V183, P7371, DOI 10.1128/JB.183.24.7371-7380.2001; Liu JY, 2006, J BIOL CHEM, V281, P6601, DOI 10.1074/jbc.M510951200; Lowy FD, 1998, NEW ENGL J MED, V339, P520, DOI 10.1056/NEJM199808203390806; Melnick J, 2004, J BACTERIOL, V186, P3660, DOI 10.1128/JB.186.11.3660-3662.2004; Miranda-Rios J, 2001, P NATL ACAD SCI USA, V98, P9736, DOI 10.1073/pnas.161168098; MIZOTE T, 1989, BIOCHIM BIOPHYS ACTA, V991, P109, DOI 10.1016/0304-4165(89)90035-4; MOTOMIZU S, 1983, TALANTA, V30, P333, DOI 10.1016/0039-9140(83)80076-9; Muller IB, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004406; Muller IB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001815; Muller IB, 2005, BIOL CHEM, V386, P117, DOI 10.1515/BC.2005.015; Nettleship Joanne E., 2008, V426, P299, DOI 10.1007/978-1-60327-058-8_19; NOSAKA K, 1993, J BIOL CHEM, V268, P17440; Nosaka K, 1999, J BIOL CHEM, V274, P34129, DOI 10.1074/jbc.274.48.34129; Nosaka K, 2001, BBA-GENE STRUCT EXPR, V1517, P293, DOI 10.1016/S0167-4781(00)00247-5; Ontiveros-Palacios N, 2008, MOL MICROBIOL, V67, P793, DOI 10.1111/j.1365-2958.2007.06088.x; Park JH, 2004, J BACTERIOL, V186, P1571, DOI 10.1128/JB.186.5.1571-1573.2004; Perkins JB, 2002, BACILLUS SUBTILIS IT, P271, DOI DOI 10.1128/9781555817992.CH20; Pohl M, 2004, CURR OPIN BIOTECH, V15, P335, DOI 10.1016/j.copbio.2004.06.002; Reddick JJ, 2001, BIOORG MED CHEM LETT, V11, P2245, DOI 10.1016/S0960-894X(01)00373-0; Reddick JJ, 2001, BIOCHEMISTRY-US, V40, P10095, DOI 10.1021/bi010267q; Rodionov DA, 2002, J BIOL CHEM, V277, P48949, DOI 10.1074/jbc.M208965200; Sambrook J., 2002, MOL CLONING LAB MANU; SAUBERLICH HE, 1984, ANNU REV NUTR, V4, P377, DOI 10.1146/annurev.nu.04.070184.002113; Shin PK, 2005, AM J PHYSIOL-CELL PH, V289, pC727, DOI 10.1152/ajpcell.00034.2005; Toms AV, 2005, BIOCHEMISTRY-US, V44, P2319, DOI 10.1021/bi0478648; VOSKOBOYEV AI, 1982, ANN NY ACAD SCI, V378, P161, DOI 10.1111/j.1749-6632.1982.tb31195.x; Wrenger C, 2008, BRAZ J MED BIOL RES, V41, P82, DOI 10.1590/S0100-879X2008005000006; Wrenger C, 2006, BIOL CHEM, V387, P41, DOI 10.1515/BC.2006.007; Zhang Y, 1997, J BACTERIOL, V179, P3030, DOI 10.1128/jb.179.9.3030-3035.1997	49	20	20	3	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2009	4	11							e7656	10.1371/journal.pone.0007656	http://dx.doi.org/10.1371/journal.pone.0007656			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RY	19888457	gold, Green Submitted, Green Published			2022-12-27	WOS:000271414500002
J	Hladik, W; Stover, J; Esiru, G; Harper, M; Tappero, J				Hladik, Wolfgang; Stover, John; Esiru, Godfrey; Harper, Malayah; Tappero, Jordan			The Contribution of Family Planning towards the Prevention of Vertical HIV Transmission in Uganda	PLOS ONE			English	Article							SINGLE-DOSE NEVIRAPINE; TO-CHILD TRANSMISSION; ZIDOVUDINE; INTRAPARTUM; LAMIVUDINE	Background: Uganda has one of the highest total fertility rates (TFR) worldwide. We compared the effects of antiretroviral (ARV) prophylaxis for the prevention of mother-to-child HIV transmission (PMTCT) to that of existing family planning (FP) use and estimated the burden of pediatric HIV disease due to unwanted fertility. Methodology/Principal Findings: Using the demographic software Spectrum, a baseline mathematical projection to estimate the current pediatric HIV burden in Uganda was compared to three hypothetical projections: 1) without ARV-PMTCT (to estimate the effect of ARV-PMTCT), 2) without contraception (effect of existing FP use), 3) without unwanted fertility (effect of unmet FP needs). Key input parameters included HIV prevalence, ARV-PMTCT uptake, MTCT probabilities, and TFR. We estimate that in 2007, an estimated 25,000 vertical infections and 17,000 pediatric AIDS deaths occurred (baseline projection). Existing ARV-PMTCT likely averted 8.1% of infections and 8.5% of deaths. FP use likely averted 19.7% of infections and 13.1% of deaths. Unwanted fertility accounted for 21.3% of infections and 13.4% of deaths. During 20082012, an estimated 131,000 vertical infections and 71,000 pediatric AIDS deaths will occur. The projected scale up of ARV-PMTCT (from 39%-57%) may avert 18.1% of infections and 24.5% of deaths. Projected FP use may avert 21.6% of infections and 18.5% of deaths. Unwanted fertility will account for 24.5% of infections and 19.8% of deaths. Conclusions: Existing FP use contributes as much or more than ARV-PMTCT in mitigating pediatric HIV in Uganda. Expanding FP services can substantially contribute towards PMTCT.			Hladik, W (corresponding author), Ctr Dis Control & Prevent, Global AIDS Program, Natl Ctr HIV Hepatitis STD & TB Prevent, Entebbe, Uganda.	wfh3@cdc.gov						[Anonymous], EP FACT SHEETS HIV A; [Anonymous], WORLD POP PROSP 2008; Brown T., 2008, SEX TRANSM INFECT S1, V84, P5; Cohen S., 2008, GUTTMACHER POLICY RE, V11, P2; Dabis F, 2005, AIDS, V19, P309; Feeney G, 2001, POPUL DEV REV, V27, P771, DOI 10.1111/j.1728-4457.2001.00771.x; Ghys PD, 2008, SEX TRANSM INFECT, V84, pI1, DOI 10.1136/sti.2008.032573; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Jackson JB, 2003, LANCET, V362, P859, DOI 10.1016/S0140-6736(03)14341-3; KIRUNGI W, 2009, COMMUNICATION; *MIN HLTH, 2008, SIT AN REP JOINT REV; *MOH UG ORC MACRO, 2006, UG HIV AIDS SER SURV; Moodley D, 2003, J INFECT DIS, V187, P725, DOI 10.1086/367898; Musinguzi J, 2009, JAIDS-J ACQ IMM DEF, V51, P78, DOI 10.1097/QAI.0b013e3181990713; Prata N, 2008, J FAM PLAN REPROD H, V34, P219, DOI 10.1783/147118908786000406; Reynolds HW, 2006, SEX TRANSM DIS, V33, P350, DOI 10.1097/01.olq.0000194602.01058.e1; REYOLDS HW, 2008, SEX TRANSM INFECT S2, V84, P49; Robertson L, 2008, SEX TRANSM INFECT, V84, pI57, DOI 10.1136/sti.2008.029926; Singh S, 2005, INT FAM PLAN PERSPEC, V31, P183, DOI 10.1363/3118305; Stover J, 2008, SEX TRANSM INFECT, V84, pI24, DOI 10.1136/sti.2008.029868; STOVER J, 2009, AIM MANUAL COMPUTER; Sweat MD, 2004, AIDS, V18, P1661, DOI 10.1097/01.aids.0000131353.06784.8f; *UBOS MACRO INT IN, 2006, UG DEM HLTH SURV 200; *UG AIDS COMM, 2007, MOV UN ACC NAT HIV A; *UN POP FUND, 2007, PEOPL POV POSS; UNAIDS, 2008, REP GLOB AIDS EP; *UNFPA, 2004, NEW YORK CELL COMM L; *WHO INT AG TASK T, 2007, GUID GLOB SCAL UP PR; Wilcher R, 2008, SEX TRANSM INFECT, V84, pII54, DOI 10.1136/sti.2008.030098; World Health Organization, 2007, MAT MORT 2005 EST DE; World Health Organization, 2002, STRAT APPR PREV HIV; World Health Organization, 2008, UN ACC SCAL PRIOR HI	32	52	52	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2009	4	11							e7691	10.1371/journal.pone.0007691	http://dx.doi.org/10.1371/journal.pone.0007691			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RX	19888347	Green Published, gold			2022-12-27	WOS:000271414400008
J	Emerson, GL; Li, Y; Frace, MA; Olsen-Rasmussen, MA; Khristova, ML; Govil, D; Sammons, SA; Regnery, RL; Karem, KL; Damon, IK; Carroll, DS				Emerson, Ginny L.; Li, Yu; Frace, Michael A.; Olsen-Rasmussen, Melissa A.; Khristova, Marina L.; Govil, Dhwani; Sammons, Scott A.; Regnery, Russell L.; Karem, Kevin L.; Damon, Inger K.; Carroll, Darin S.			The Phylogenetics and Ecology of the Orthopoxviruses Endemic to North America	PLOS ONE			English	Article							MONKEYPOX VIRUS; POXVIRUS GENOME; AVIAN POX; SEQUENCE; COWPOX; INFECTION; TRANSMISSION; EVOLUTION; INFERENCE; ALIGNMENT	The data presented herein support the North American orthopoxviruses (NA OPXV) in a sister relationship to all other currently described Orthopoxvirus (OPXV) species. This phylogenetic analysis reaffirms the identification of the NA OPXV as close relatives of "Old World'' (Eurasian and African) OPXV and presents high support for deeper nodes within the Chordopoxvirinae family. The natural reservoir host(s) for many of the described OPXV species remains unknown although a clear virus-host association exists between the genus OPXV and several mammalian taxa. The hypothesized host associations and the deep divergence of the OPXV/NA OPXV clades depicted in this study may reflect the divergence patterns of the mammalian faunas of the Old and New World and reflect a more ancient presence of OPXV on what are now the American continents. Genes from the central region of the poxvirus genome are generally more conserved than genes from either end of the linear genome due to functional constraints imposed on viral replication abilities. The relatively slower evolution of these genes may more accurately reflect the deeper history among the poxvirus group, allowing for robust placement of the NA OPXV within Chordopoxvirinae. Sequence data for nine genes were compiled from three NA OPXV strains plus an additional 50 genomes collected from Genbank. The current, gene sequence based phylogenetic analysis reaffirms the identification of the NA OPXV as the nearest relatives of "Old World'' OPXV and presents high support for deeper nodes within the Chordopoxvirinae family. Additionally, the substantial genetic distances that separate the currently described NA OPXV species indicate that it is likely that many more undescribed OPXV/NA OPXV species may be circulating among wild animals in North America.			Emerson, GL (corresponding author), Ctr Dis Control & Prevent, Coordinating Ctr Infect Dis, CCID, CDC, Atlanta, GA 30333 USA.	DCarroll@cdc.gov						Afonso CL, 2006, J VIROL, V80, P4978, DOI 10.1128/JVI.80.10.4978-4991.2006; Afonso CL, 2005, J VIROL, V79, P966, DOI 10.1128/JVI.79.2.966-977.2005; Alexander A.D., 1972, Journal Wildl Dis, V8, P119; Babkin IV, 2006, MOL BIOL+, V40, P20; Baxby D., 1981, TRENDS IMMUNOL, V3, P26; Begon M, 1999, P ROY SOC B-BIOL SCI, V266, P1939, DOI 10.1098/rspb.1999.0870; Bratke KA, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-67; Cameron C, 1999, VIROLOGY, V264, P298, DOI 10.1006/viro.1999.0001; Chantrey J, 1999, EPIDEMIOL INFECT, V122, P455, DOI 10.1017/S0950268899002423; Delhon G, 2004, J VIROL, V78, P168, DOI 10.1128/JVI.78.1.168-177.2004; Do CB, 2005, GENOME RES, V15, P330, DOI 10.1101/gr.2821705; Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365; Gubser C, 2004, J GEN VIROL, V85, P105, DOI 10.1099/vir.0.19565-0; Hazel SM, 2000, EPIDEMIOL INFECT, V124, P551, DOI 10.1017/S0950268899003799; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes AL, 2005, MOL PHYLOGENET EVOL, V35, P186, DOI 10.1016/j.ympev.2004.12.008; KHODAKEVICH L, 1987, TROP GEOGR MED, V39, P56; KHODAKEVICH L, 1986, LANCET, V1, P98; KHODAKEVICH L, 1987, TROP GEOGR MED, V39, P115; KNIGHT JC, 1992, VIROLOGY, V190, P423, DOI 10.1016/0042-6822(92)91228-M; LADNYJ ID, 1972, B WORLD HEALTH ORGAN, V46, P593; Lefkowitz EJ, 2006, VIRUS RES, V117, P105, DOI 10.1016/j.virusres.2006.01.016; Li Y, 2007, P NATL ACAD SCI USA, V104, P15787, DOI 10.1073/pnas.0609268104; LOURIE B, 1975, J INFECT DIS, V132, P677, DOI 10.1093/infdis/132.6.677; Marchal J, 1930, J PATHOL BACTERIOL, V33, P713, DOI 10.1002/path.1700330317; McInnes CJ, 2006, J GEN VIROL, V87, P2115, DOI 10.1099/vir.0.81966-0; NITSCHE A, 2007, EUROSURVEILLANCE, V12, P3178; OSTERHAUS ADME, 1981, LAB ANIM SCI, V31, P704; REGNERY DC, 1987, ARCH VIROL, V94, P159, DOI 10.1007/BF01313734; Rocke TE, 2004, VACCINE, V22, P2757, DOI 10.1016/j.vaccine.2004.01.030; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; Senkevich TG, 1997, VIROLOGY, V233, P19, DOI 10.1006/viro.1997.8607; Shchelkunov SN, 1998, VIROLOGY, V243, P432, DOI 10.1006/viro.1998.9039; Smits JE, 2005, VET PATHOL, V42, P59, DOI 10.1354/vp.42-1-59; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Thiel T, 2005, J WILDLIFE DIS, V41, P342, DOI 10.7589/0090-3558-41.2.342; Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404; Upton C, 2003, J VIROL, V77, P7590, DOI 10.1128/JVI.77.13.7590-7600.2003; Van Riper C, 2002, AUK, V119, P929, DOI 10.1642/0004-8038(2002)119[0929:EAEOAP]2.0.CO;2; von Magnus P., 1959, Acta Pathologica et Microbiologica Scandinavica, V46, P156; Vorou RM, 2008, CURR OPIN INFECT DIS, V21, P153, DOI 10.1097/QCO.0b013e3282f44c74; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Willer DO, 1999, VIROLOGY, V264, P319, DOI 10.1006/viro.1999.0002; Woodall J., 1967, ATAS SIMP SIO BIOTA, V6, P31; Yager JA, 2006, VET DERMATOL, V17, P443, DOI 10.1111/j.1365-3164.2006.00553.x	45	43	45	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7666	10.1371/journal.pone.0007666	http://dx.doi.org/10.1371/journal.pone.0007666			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19865479	Green Submitted, Green Published, gold			2022-12-27	WOS:000271232000017
J	Bullock, AN; Russo, S; Amos, A; Pagano, N; Bregman, H; Debreczeni, JE; Lee, WH; von Delft, F; Meggers, E; Knapp, S				Bullock, Alex N.; Russo, Santina; Amos, Ann; Pagano, Nicholas; Bregman, Howard; Debreczeni, Judit E.; Lee, Wen Hwa; von Delft, Frank; Meggers, Eric; Knapp, Stefan			Crystal Structure of the PIM2 Kinase in Complex with an Organoruthenium Inhibitor	PLOS ONE			English	Article							HALF-SANDWICH COMPLEXES; PROVIRAL INSERTION SITE; MYC; PHOSPHORYLATION; TRANSFORMATION; SPECIFICITY; ACTIVATION; EXPRESSION; LEUKEMIA; GROWTH	Background: The serine/threonine kinase PIM2 is highly expressed in human leukemia and lymphomas and has been shown to positively regulate survival and proliferation of tumor cells. Its diverse ATP site makes PIM2 a promising target for the development of anticancer agents. To date our knowledge of catalytic domain structures of the PIM kinase family is limited to PIM1 which has been extensively studied and which shares about 50% sequence identity with PIM2. Principal Findings: Here we determined the crystal structure of PIM2 in complex with an organoruthenium complex (inhibition in sub-nanomolar level). Due to its extraordinary shape complementarity this stable organometallic compound is a highly potent inhibitor of PIM kinases. Significance: The structure of PIM2 revealed several differences to PIM1 which may be explored further to generate isoform selective inhibitors. It has also demonstrated how an organometallic inhibitor can be adapted to the binding site of protein kinases to generate highly potent inhibitors.			Bullock, AN (corresponding author), Univ Oxford, Struct Genom Consortium, Oxford, England.	stefan.knapp@sgc.ox.ac.uk	Lee, Wen Hwa/GZA-8183-2022; Knapp, Stefan/AAG-2347-2019; Lee, Wen Hwa/G-1250-2013; Meggers, Eric/B-8541-2014	Lee, Wen Hwa/0000-0002-4098-5225; Knapp, Stefan/0000-0001-5995-6494; Lee, Wen Hwa/0000-0002-4098-5225; Meggers, Eric/0000-0002-8851-7623; von Delft, Frank/0000-0003-0378-0017	CIHR Funding Source: Medline; Wellcome Trust Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)		Adam M, 2006, CANCER RES, V66, P3828, DOI 10.1158/0008-5472.CAN-05-2309; Agrawal S, 2008, LEUKEMIA, V22, P78, DOI 10.1038/sj.leu.2404988; Allen JD, 1997, ONCOGENE, V15, P1133, DOI 10.1038/sj.onc.1201288; Atilla-Gokcumen GE, 2006, CHEMBIOCHEM, V7, P1443, DOI 10.1002/cbic.200600117; Bregman H, 2004, J AM CHEM SOC, V126, P13594, DOI 10.1021/ja046049c; BREUER ML, 1989, EMBO J, V8, P743, DOI 10.1002/j.1460-2075.1989.tb03434.x; Bullock AN, 2005, J MED CHEM, V48, P7604, DOI 10.1021/jm0504858; Bullock AN, 2005, J BIOL CHEM, V280, P41675, DOI 10.1074/jbc.M510711200; Chen JL, 2008, BLOOD, V111, P1677, DOI 10.1182/blood-2007-04-083808; Cohen AM, 2004, LEUKEMIA LYMPHOMA, V45, P951, DOI 10.1080/10428190310001641251; Debreczeni JE, 2006, ANGEW CHEM INT EDIT, V45, P1580, DOI 10.1002/anie.200503468; Fedorov O, 2007, P NATL ACAD SCI USA, V104, P20523, DOI 10.1073/pnas.0708800104; Fox CJ, 2003, GENE DEV, V17, P1841, DOI 10.1101/gad.1105003; Giles F, 2005, BLOOD, V105, P4158, DOI 10.1182/blood-2005-03-1150; Hammerman PS, 2005, BLOOD, V105, P4477, DOI 10.1182/blood-2004-09-3706; Jacobs MD, 2005, J BIOL CHEM, V280, P13728, DOI 10.1074/jbc.M413155200; Kumar A, 2005, J MOL BIOL, V348, P183, DOI 10.1016/j.jmb.2005.02.039; Meggers E, 2007, CURR OPIN CHEM BIOL, V11, P287, DOI 10.1016/j.cbpa.2007.05.013; Mikkers H, 2004, MOL CELL BIOL, V24, P6104, DOI 10.1128/MCB.24.13.6104-6115.2004; Mikkers H, 2002, NAT GENET, V32, P459, DOI 10.1038/ng1102-459b; Mochizuki T, 1999, J BIOL CHEM, V274, P18659, DOI 10.1074/jbc.274.26.18659; Pagano N, 2007, ORG BIOMOL CHEM, V5, P1218, DOI 10.1039/b700433h; Pogacic V, 2007, CANCER RES, V67, P6916, DOI 10.1158/0008-5472.CAN-07-0320; Qian KC, 2005, J BIOL CHEM, V280, P6130, DOI 10.1074/jbc.M409123200; Wernig G, 2008, BLOOD, V111, P3751, DOI 10.1182/blood-2007-07-102186; Williams DS, 2005, ANGEW CHEM INT EDIT, V44, P1984, DOI 10.1002/anie.200462501; Xie Y, 2008, J BIOL CHEM, V283, P3349, DOI 10.1074/jbc.M707773200; Yan B, 2003, J BIOL CHEM, V278, P45358, DOI 10.1074/jbc.M307933200; Zhang YD, 2007, MOL CANCER RES, V5, P909, DOI 10.1158/1541-7786.MCR-06-0388; Zippo A, 2007, NAT CELL BIOL, V9, P932, DOI 10.1038/ncb1618	30	70	74	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7112	10.1371/journal.pone.0007112	http://dx.doi.org/10.1371/journal.pone.0007112			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841674	Green Published, gold			2022-12-27	WOS:000271012900002
J	Autiero, I; Costantini, S; Colonna, G				Autiero, Ida; Costantini, Susan; Colonna, Giovanni			Human Sirt-1: Molecular Modeling and Structure-Function Relationships of an Unordered Protein	PLOS ONE			English	Article								Background: Sirt-1 is a NAD+-dependent nuclear deacetylase of 747 residues that in mammals is involved in various important metabolic pathways, such as glucose metabolism and insulin secretion, and often works on many different metabolic substrates as a multifunctional protein. Sirt-1 down-regulates p53 activity, rising lifespan, and cell survival; it also deacetylases peroxisome proliferator-activated receptor-gamma (PPAR-gamma) and its coactivator 1 alpha (PGC-1 alpha), promoting lipid mobilization, positively regulating insulin secretion, and increasing mitochondrial dimension and number. Therefore, it has been implicated in diseases such as diabetes and the metabolic syndrome and, also, in the mechanisms of longevity induced by calorie restriction. Its whole structure is not yet experimentally determined and the structural features of its allosteric site are unknown, and no information is known about the structural changes determined by the binding of its allosteric effectors. Methodology: In this study, we modelled the whole three-dimensional structure of Sirt-1 and that of its endogenous activator, the nuclear protein AROS. Moreover, we modelled the Sirt-1/AROS complex in order to study the structural basis of its activation and regulation. Conclusions: Amazingly, the structural data show that Sirt-1 is an unordered protein with a globular core and two large unordered structural regions at both termini, which play an important role in the protein-protein interaction. Moreover, we have found on Sirt-1 a conserved pharmacophore pocket of which we have discussed the implication.	[Autiero, Ida; Costantini, Susan; Colonna, Giovanni] Univ Naples 2, CRISCEB Interdepartmental Res Ctr Computat & Biot, Naples, Italy; [Costantini, Susan] CROM Oncol Res Ctr Mercogliano Fiorentino Lo Vuol, Mercogliano, Italy; [Costantini, Susan; Colonna, Giovanni] Univ Naples 2, Dept Biochem & Biophys, Naples, Italy	Universita della Campania Vanvitelli; Universita della Campania Vanvitelli	Autiero, I (corresponding author), Univ Naples 2, CRISCEB Interdepartmental Res Ctr Computat & Biot, Naples, Italy.	susan.costantini@unina2.it	Costantini, Susan/J-9914-2018; Colonna, Giovanni/AAY-3568-2021; Autiero, Ida/HCI-1827-2022; Autiero, Ida/P-7002-2018	Autiero, Ida/0000-0001-8886-8063; Autiero, Ida/0000-0001-8886-8063; Colonna, Giovanni/0000-0002-0473-1455; Costantini, Susan/0000-0002-7538-4657	CRISCEB, Second University of Naples, Naples, Italy	CRISCEB, Second University of Naples, Naples, Italy	The funding is from the Institute in which this project was carried out. Funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. IA is supported by Doctorate in Computational Biology, CRISCEB, Second University of Naples, Naples, Italy.	Chang JH, 2002, J BIOL CHEM, V277, P34489, DOI 10.1074/jbc.M205460200; COFF JA, 2000, FUNCTION GENOMICS, V302, P511; Dalton JAR, 2007, BIOINFORMATICS, V23, P1901, DOI 10.1093/bioinformatics/btm262; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; Ghosh HS, 2007, BIOCHEM J, V408, P105, DOI 10.1042/BJ20070817; Jones S, 1996, P NATL ACAD SCI USA, V93, P13, DOI 10.1073/pnas.93.1.13; Kaeberlein M, 1999, GENE DEV, V13, P2570, DOI 10.1101/gad.13.19.2570; Kim EJ, 2007, MOL CELL, V28, P277, DOI 10.1016/j.molcel.2007.08.030; Mattagajasingh I, 2007, P NATL ACAD SCI USA, V104, P14855, DOI 10.1073/pnas.0704329104; Nishimasu H, 2007, J BIOL CHEM, V282, P9923, DOI 10.1074/jbc.M610678200; Picard F, 2004, NATURE, V429, P771, DOI 10.1038/nature02583; Rajendrasozhan S, 2008, AM J RESP CRIT CARE, V177, P861, DOI 10.1164/rccm.200708-1269OC; Rodgers JT, 2005, NATURE, V434, P113, DOI 10.1038/nature03354; Shi JY, 2001, J MOL BIOL, V310, P243, DOI 10.1006/jmbi.2001.4762; Tanno M, 2007, J BIOL CHEM, V282, P6823, DOI 10.1074/jbc.M609554200; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Vaziri H, 2001, CELL, V107, P149, DOI 10.1016/S0092-8674(01)00527-X; Zhao KH, 2004, J MOL BIOL, V337, P731, DOI 10.1016/j.jmb.2004.01.060	18	52	54	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7350	10.1371/journal.pone.0007350	http://dx.doi.org/10.1371/journal.pone.0007350			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YN	19806227	gold, Green Published, Green Submitted			2022-12-27	WOS:000207567000002
J	McWalter, TA; Welte, A				McWalter, Thomas A.; Welte, Alex			A Comparison of Biomarker Based Incidence Estimators	PLOS ONE			English	Article							RECENT INFECTION; HIV	Background: Cross-sectional surveys utilizing biomarkers that test for recent infection provide a convenient and cost effective way to estimate HIV incidence. In particular, the BED assay has been developed for this purpose. Controversy surrounding the way in which false positive results from the biomarker should be handled has lead to a number of different estimators that account for imperfect specificity. We compare the estimators proposed by McDougal et al., Hargrove et al. and McWalter & Welte. Methodology/Principal Findings: The three estimators are analyzed and compared. An identity showing a relationship between the calibration parameters in the McDougal methodology is shown. When the three estimators are tested under a steady state epidemic, which includes individuals who fail to progress on the biomarker, only the McWalter/Welte method recovers an unbiased result. Conclusions/Significance: Our analysis shows that the McDougal estimator can be reduced to a formula that only requires calibration of a mean window period and a long-term specificity. This allows simpler calibration techniques to be used and shows that all three estimators can be expressed using the same set of parameters. The McWalter/Welte method is applicable under the least restrictive assumptions and is the least prone to bias of the methods reviewed.			McWalter, TA (corresponding author), Univ Witwatersrand, Sch Computat & Appl Math, Johannesburg, South Africa.	mcwalter@cam.wits.ac.za		McWalter, Thomas/0000-0002-2163-4112				BARNIGHAUSEN T, 2009, INT J EPIDEMIO UNPUB; BROOKMEYER R, 1995, AM J EPIDEMIOL, V141, P166, DOI 10.1093/oxfordjournals.aje.a117404; Brookmeyer R, 2009, AIDS, V23, P485, DOI 10.1097/QAD.0b013e3283269e28; Dobbs T, 2004, J CLIN MICROBIOL, V42, P2623, DOI 10.1128/JCM.42.6.2623-2628.2004; Hargrove JW, 2008, AIDS, V22, P511, DOI 10.1097/QAD.0b013e3282f2a960; Hu DJ, 2003, AIDS RES HUM RETROV, V19, P727, DOI 10.1089/088922203769232511; Janssen RS, 1998, JAMA-J AM MED ASSOC, V280, P42, DOI 10.1001/jama.280.1.42; KASSANJEE R, 2009, 5 IAS C HIV PATH TRE; McDougal JS, 2006, AIDS RES HUM RETROV, V22, P945, DOI 10.1089/aid.2006.22.945; MCWALTER TA, 2009, J MATH BIOL IN PRESS; Parekh BS, 2002, AIDS RES HUM RETROV, V18, P295, DOI 10.1089/088922202753472874; VanDenBos A, 2007, PARAMETER ESTIMATION FOR SCIENTISTS AND ENGINEERS, P1, DOI 10.1002/9780470173862; WANG R, 2009, USE ADJUSTED CROSS S; Welte A, 2008, S AFR J SCI, V104, P199	14	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7368	10.1371/journal.pone.0007368	http://dx.doi.org/10.1371/journal.pone.0007368			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809505	Green Published, gold			2022-12-27	WOS:000270594000018
J	Raoust, E; Balloy, V; Garcia-Verdugo, I; Touqui, L; Ramphal, R; Chignard, M				Raoust, Eloise; Balloy, Viviane; Garcia-Verdugo, Ignacio; Touqui, Lhousseine; Ramphal, Reuben; Chignard, Michel			Pseudomonas aeruginosa LPS or Flagellin Are Sufficient to Activate TLR-Dependent Signaling in Murine Alveolar Macrophages and Airway Epithelial Cells	PLOS ONE			English	Article								Background: The human lung is exposed to a large number of airborne pathogens as a result of the daily inhalation of 10,000 liters of air. Innate immunity is thus essential to defend the lungs against these pathogens. This defense is mediated in part through the recognition of specific microbial ligands by Toll-like receptors (TLR) of which there are at least 10 in humans. Pseudomonas aeruginosa is the main pathogen that infects the lungs of cystic fibrosis patients. Based on whole animal experiments, using TLR knockout mice, the control of this bacterium is believed to occur by the recognition of LPS and flagellin by TLRs 2,4 and 5, respectively. Methodology/Principal Findings: In the present study, we investigated in vitro the role of these same TLR and ligands, in alveolar macrophage (AM) and epithelial cell (EC) activation. Cellular responses to P. aeruginosa was evaluated by measuring KC, TNF-alpha, IL-6 and G-CSF secretion, four different markers of the innate immune response. AM and EC from WT and TLR2, 4, 5 and MyD88 knockout mice for were stimulated with the wild-type P. aeruginosa or with a mutant devoid of flagellin production. Conclusions/Significance: The results clearly demonstrate that only two ligand/receptor pairs are necessary for the induction of KC, TNF-alpha, and IL-6 synthesis by P. aeruginosa-activated cells, i.e. TLR2,4/LPS and TLR5/flagellin. Either ligand/ receptor pair is sufficient to sense the bacterium and to trigger cell activation, and when both are missing lung EC and AM are unable to produce such a response as were cells from MyD88(-/-) mice.			Raoust, E (corresponding author), Inst Pasteur, Unite Def Innee & Inflammat, Paris, France.	chignard@pasteur.fr	Balloy, Viviane/B-8551-2014; Garcia-Verdugo, Ignacio/J-3584-2017; Chignard, Michel/B-4351-2008	Balloy, Viviane/0000-0001-9093-9676; Garcia-Verdugo, Ignacio/0000-0003-4535-8316; Chignard, Michel/0000-0003-3810-6575	NIAID NIH HHS [AI 45014, R01 AI045014] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI045014] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balloy V, 2005, INFECT IMMUN, V73, P5420, DOI 10.1128/IAI.73.9.5420-5425.2005; Balloy V, 2007, J INFECT DIS, V196, P289, DOI 10.1086/518610; Blohmke CJ, 2008, J IMMUNOL, V180, P7764, DOI 10.4049/jimmunol.180.11.7764; Bortnick AE, 2003, AM J PHYSIOL-LUNG C, V285, pL869, DOI 10.1152/ajplung.00077.2003; Carnpodonico VL, 2008, TRENDS MOL MED, V14, P120, DOI 10.1016/j.molmed.2008.01.002; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Cooper MA, 2001, BLOOD, V97, P3146, DOI 10.1182/blood.V97.10.3146; Corti M, 1996, AM J RESP CELL MOL, V14, P309, DOI 10.1165/ajrcmb.14.4.8600933; Dasgupta N, 2003, MOL MICROBIOL, V50, P809, DOI 10.1046/j.1365-2958.2003.03740.x; de Diego J L, 2007, Ernst Schering Found Symp Proc, P83; DOBBS LG, 1990, AM J PHYSIOL, V258, pL134, DOI 10.1152/ajplung.1990.258.4.L134; Dunstan SJ, 2005, J INFECT DIS, V191, P1068, DOI 10.1086/428593; Elizur A, 2007, AM J PHYSIOL-LUNG C, V293, pL383, DOI 10.1152/ajplung.00024.2007; Erridge C, 2004, J MED MICROBIOL, V53, P735, DOI 10.1099/jmm.0.45598-0; FEGAN M, 1990, J CLIN MICROBIOL, V28, P1143, DOI 10.1128/JCM.28.6.1143-1146.1990; Feuillet V, 2006, P NATL ACAD SCI USA, V103, P12487, DOI 10.1073/pnas.0605200103; Franchi L, 2007, EUR J IMMUNOL, V37, P3030, DOI 10.1002/eji.200737532; Fuchs S, 2003, CELL TISSUE RES, V311, P31, DOI 10.1007/s00441-002-0653-5; Goldberg JB, 2000, TRENDS MICROBIOL, V8, P514, DOI 10.1016/S0966-842X(00)01872-2; Gordon SB, 2002, BRIT MED BULL, V61, P45, DOI 10.1093/bmb/61.1.45; Govan JR, 2007, FUTURE MICROBIOL, V2, P153, DOI 10.2217/17460913.2.2.153; Hajjar AM, 2005, AM J RESP CELL MOL, V33, P470, DOI 10.1165/rcmb.2005-0199OC; Hajjar AM, 2002, NAT IMMUNOL, V3, P354, DOI 10.1038/ni777; Harder J, 2000, AM J RESP CELL MOL, V22, P714, DOI 10.1165/ajrcmb.22.6.4023; Hawn TR, 2007, J IMMUNOL, V179, P6981, DOI 10.4049/jimmunol.179.10.6981; Hawn TR, 2003, J EXP MED, V198, P1563, DOI 10.1084/jem.20031220; Hayashi F, 2001, NATURE, V410, P1099, DOI 10.1038/35074106; Hernandez JM, 2003, CLIN CANCER RES, V9, P1906; Hippenstiel S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-97; Honko AN, 2005, IMMUNOL RES, V33, P83, DOI 10.1385/IR:33:1:083; Hoshino K, 1999, J IMMUNOL, V162, P3749; Hybiske K, 2004, CELL MICROBIOL, V6, P49, DOI 10.1046/j.1462-5822.2003.00342.x; Kaisho T, 2002, BBA-MOL CELL RES, V1589, P1, DOI 10.1016/S0167-4889(01)00182-3; Kipnis E, 2006, MED MALADIES INFECT, V36, P78, DOI 10.1016/j.medmal.2005.10.007; Lau GW, 2005, TRENDS MICROBIOL, V13, P389, DOI 10.1016/j.tim.2005.05.011; Liu L, 1996, AM J PHYSIOL-LUNG C, V270, pL668, DOI 10.1152/ajplung.1996.270.4.L668; Lopez-Boado YS, 2005, INFECT IMMUN, V73, P7525, DOI 10.1128/IAI.73.11.7525-7534.2005; Marriott HM, 2007, EXP LUNG RES, V33, P493, DOI 10.1080/01902140701756562; Mayer AK, 2007, J IMMUNOL, V178, P3134, DOI 10.4049/jimmunol.178.5.3134; McDermott PF, 2000, INFECT IMMUN, V68, P5525, DOI 10.1128/IAI.68.10.5525-5529.2000; Medzhitov R, 1997, CELL, V91, P295, DOI 10.1016/S0092-8674(00)80412-2; Miao EA, 2008, P NATL ACAD SCI USA, V105, P2562, DOI 10.1073/pnas.0712183105; Moravec R., 1994, PROMEGA NOTES, V45, P11; Murray TS, 2007, CURR OPIN PEDIATR, V19, P83, DOI 10.1097/MOP.0b013e3280123a5d; OREFFO VIC, 1990, ENVIRON HEALTH PERSP, V85, P51, DOI 10.2307/3430665; Pier GB, 1996, SCIENCE, V271, P64, DOI 10.1126/science.271.5245.64; Pier GB, 2007, INT J MED MICROBIOL, V297, P277, DOI 10.1016/j.ijmm.2007.03.012; Prince A, 2006, AM J RESP CELL MOL, V34, P548, DOI 10.1165/rcmb.2006-0022SF; Ramphal R, 2005, J IMMUNOL, V175, P3927, DOI 10.4049/jimmunol.175.6.3927; Ramphal R, 2008, J IMMUNOL, V181, P586, DOI 10.4049/jimmunol.181.1.586; Reiniger N, 2007, INFECT IMMUN, V75, P1598, DOI 10.1128/IAI.01980-06; RIETSCHEL ET, 1994, FASEB J, V8, P217, DOI 10.1096/fasebj.8.2.8119492; Rivas-Santiago B, 2007, REV INVEST CLIN, V59, P481; Sadikot RT, 2005, AM J RESP CRIT CARE, V171, P1209, DOI 10.1164/rccm.200408-1044SO; Sadikot RT, 2006, J IMMUNOL, V176, P4923, DOI 10.4049/jimmunol.176.8.4923; Schroeder TH, 2001, J IMMUNOL, V166, P7410, DOI 10.4049/jimmunol.166.12.7410; Sha Q, 2004, AM J RESP CELL MOL, V31, P358, DOI 10.1165/rcmb.2003-0388OC; SIMPSON DA, 1992, INFECT IMMUN, V60, P3771, DOI 10.1128/IAI.60.9.3771-3779.1992; Skerrett SJ, 2007, AM J PHYSIOL-LUNG C, V292, pL312, DOI 10.1152/ajplung.00250.2006; Smith EE, 2006, P NATL ACAD SCI USA, V103, P8487, DOI 10.1073/pnas.0602138103; Sutterwala FS, 2007, J EXP MED, V204, P3235, DOI 10.1084/jem.20071239; TAKEDA K, 2007, CURR PROTOC IMMUNOL, pCH14, DOI DOI 10.1002/0471142735.IM1412S77; Taylor PR, 2005, ANNU REV IMMUNOL, V23, P901, DOI 10.1146/annurev.immunol.23.021704.115816; Uematsu S, 2006, NAT IMMUNOL, V7, P868, DOI 10.1038/ni1362; Verma A, 2005, INFECT IMMUN, V73, P8237, DOI 10.1128/IAI.73.12.8237-8246.2005; von Bernuth H, 2008, SCIENCE, V321, P691, DOI 10.1126/science.1158298; WALKER SR, 1989, EXP LUNG RES, V15, P553, DOI 10.3109/01902148909069618; Warshamana GS, 2001, EXP MOL PATHOL, V71, P13, DOI 10.1006/exmp.2001.2376; Zhang Z, 2005, INFECT IMMUN, V73, P7151, DOI 10.1128/IAI.73.11.7151-7160.2005	70	118	122	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7259	10.1371/journal.pone.0007259	http://dx.doi.org/10.1371/journal.pone.0007259			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806220	Green Published, Green Submitted, gold			2022-12-27	WOS:000270593800005
J	Khasnatinov, MA; Ustanikova, K; Frolova, TV; Pogodina, VV; Bochkova, NG; Levina, LS; Slovak, M; Kazimirova, M; Labuda, M; Klempa, B; Eleckova, E; Gould, EA; Gritsun, TS				Khasnatinov, Maxim A.; Ustanikova, Katarina; Frolova, Tatiana V.; Pogodina, Vanda V.; Bochkova, Nadezshda G.; Levina, Ludmila S.; Slovak, Mirko; Kazimirova, Maria; Labuda, Milan; Klempa, Boris; Eleckova, Elena; Gould, Ernest A.; Gritsun, Tamara S.			Non-Hemagglutinating Flaviviruses: Molecular Mechanisms for the Emergence of New Strains via Adaptation to European Ticks	PLOS ONE			English	Article							BORNE ENCEPHALITIS-VIRUS; ENVELOPE GLYCOPROTEIN; ACID; TRANSMISSION; NUCLEOTIDE; EVOLUTION; SEQUENCE	Tick-borne encephalitis virus (TBEV) causes human epidemics across Eurasia. Clinical manifestations range from inapparent infections and fevers to fatal encephalitis but the factors that determine disease severity are currently undefined. TBEV is characteristically a hemagglutinating (HA) virus; the ability to agglutinate erythrocytes tentatively reflects virion receptor/fusion activity. However, for the past few years many atypical HA-deficient strains have been isolated from patients and also from the natural European host tick, Ixodes persulcatus. By analysing the sequences of HA-deficient strains we have identified 3 unique amino acid substitutions (D67G, E122G or D277A) in the envelope protein, each of which increases the net charge and hydrophobicity of the virion surface. Therefore, we genetically engineered virus mutants each containing one of these 3 substitutions; they all exhibited HA-deficiency. Unexpectedly, each genetically modified non-HA virus demonstrated increased TBEV reproduction in feeding Ixodes ricinus, not the recognised tick host for these strains. Moreover, virus transmission efficiency between infected and uninfected ticks co-feeding on mice was also intensified by each substitution. Retrospectively, the mutation D67G was identified in viruses isolated from patients with encephalitis. We propose that the emergence of atypical Siberian HA-deficient TBEV strains in Europe is linked to their molecular adaptation to local ticks. This process appears to be driven by the selection of single mutations that change the virion surface thus enhancing receptor/fusion function essential for TBEV entry into the unfamiliar tick species. As the consequence of this adaptive mutagenesis, some of these mutations also appear to enhance the ability of TBEV to cross the human blood-brain barrier, a likely explanation for fatal encephalitis. Future research will reveal if these emerging Siberian TBEV strains continue to disperse westwards across Europe by adaptation to the indigenous tick species and if they are associated with severe forms of TBE.			Khasnatinov, MA (corresponding author), Univ Reading, Sch Biol Sci, Reading, Berks, England.	t.s.gritsun@reading.ac.uk	Bochkova, Nadezhda/E-2592-2014; Khasnatinov, Maxim/F-2153-2011; Kazimirova, Maria/U-8222-2017; Klempa, Boris/N-3096-2019; Pogodina, Vanda/D-9553-2014; Khasnatinov, Maxim/S-7266-2016; Klempa, Boris/J-8876-2012	Kazimirova, Maria/0000-0001-6904-8342; Klempa, Boris/0000-0002-6931-1224; Khasnatinov, Maxim/0000-0002-8441-3640; Klempa, Boris/0000-0002-6931-1224	Biotechnology and Biological Sciences Research Council [BBS/B/00697] Funding Source: researchfish; Natural Environment Research Council [CEH010021] Funding Source: researchfish	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ADELSHIN PV, 2006, EPIDEMIOLOGY VACCINO, V2, P27; Bressanelli S, 2004, EMBO J, V23, P728, DOI 10.1038/sj.emboj.7600064; CLARKE DH, 1958, AM J TROP MED HYG, V7, P561, DOI 10.4269/ajtmh.1958.7.561; DALRYMPLE JM, 1976, VIROLOGY, V69, P93, DOI 10.1016/0042-6822(76)90197-5; Ecker M, 1999, J GEN VIROL, V80, P179, DOI 10.1099/0022-1317-80-1-179; GOLOVLJOVA I, 2008, INT J MED MICROBIOL; Gould EA, 2008, LANCET, V371, P500, DOI 10.1016/S0140-6736(08)60238-X; GOULD EA, 1985, J GEN VIROL, V66, P1369, DOI 10.1099/0022-1317-66-7-1369; Grard G, 2007, VIROLOGY, V361, P80, DOI 10.1016/j.virol.2006.09.015; Gritsun TS, 2003, ANTIVIR RES, V57, P129, DOI 10.1016/S0166-3542(02)00206-1; Gritsun TS, 2003, J VIROL, V77, P25, DOI 10.1128/JVI.77.1.25-36.2003; Gritsun TS, 1998, J VIROL METHODS, V76, P109, DOI 10.1016/S0166-0934(98)00130-X; Gritsun TS, 1995, VIROLOGY, V214, P611, DOI 10.1006/viro.1995.0072; Gritsun TS, 2001, J GEN VIROL, V82, P1667, DOI 10.1099/0022-1317-82-7-1667; GRITSUN TS, 1993, VIRUS RES, V27, P201, DOI 10.1016/0168-1702(93)90082-X; GRITSUN TS, 1995, VIRUS RES, V35, P307, DOI 10.1016/0168-1702(94)00090-Y; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hayasaka D, 2001, J GEN VIROL, V82, P1319, DOI 10.1099/0022-1317-82-6-1319; Heinz FX, 2004, ARCH VIROL, P133; HEINZ FX, 2000, VIRUS TAXONOMY, P859; HERRLER G, 1985, VIROLOGY, V141, P144, DOI 10.1016/0042-6822(85)90190-4; Jaaskelainen AE, 2006, EMERG INFECT DIS, V12, P1568, DOI 10.3201/eid1210.060320; Jones LD, 1997, MED VET ENTOMOL, V11, P172, DOI 10.1111/j.1365-2915.1997.tb00309.x; KARAN LS, 2006, B SIBERIAN MED, V15, P24; LABUDA M, 1994, VIRUS RES, V31, P305, DOI 10.1016/0168-1702(94)90024-8; Labuda M, 1997, VIROLOGY, V235, P138, DOI 10.1006/viro.1997.8622; Labuda M, 1996, VIROLOGY, V219, P357, DOI 10.1006/viro.1996.0261; LaSala PR, 2010, CLIN LAB MED, V30, P221, DOI 10.1016/j.cll.2010.01.002; Leveque N, 2007, VIRUS RES, V130, P1, DOI 10.1016/j.virusres.2007.05.006; Lundkvist A, 2001, J MED VIROL, V65, P730, DOI 10.1002/jmv.2097; Perez K, 2006, J VIROL METHODS, V135, P254, DOI 10.1016/j.jviromet.2006.03.020; Pogodina V V, 2004, Vopr Virusol, V49, P24; Pogodina V. V., 2004, Voprosy Virusologii, V49, P20; Pogodina V. V., 2005, Voprosy Virusologii, V50, P7; Anonymous, 2007, Voprosy Virusologii, V52, P17; POGODINA VV, 1981, VOP VIRUSOL+, P741; POGODINA VV, 1992, VOP VIRUSOL+, V37, P103; REY FA, 1995, NATURE, V375, P291, DOI 10.1038/375291a0; Romanova LI, 2007, VIROLOGY, V362, P75, DOI 10.1016/j.virol.2006.12.013; Stiasny K, 2006, J VIROL, V80, P9557, DOI 10.1128/JVI.00080-06; Suss J, 2008, Euro Surveill, V13; TAMURA K, 1993, MOL BIOL EVOL, V10, P512, DOI 10.1093/oxfordjournals.molbev.a040023; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VLASAK R, 1988, P NATL ACAD SCI USA, V85, P4526, DOI 10.1073/pnas.85.12.4526; Votyakov V.I., 2002, TICK BORNE ENCEPHALI; Wengler G, 1999, VIROLOGY, V257, P472, DOI 10.1006/viro.1999.9661; ZANOTTO PMD, 1995, VIROLOGY, V210, P152, DOI 10.1006/viro.1995.1326	47	27	31	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7295	10.1371/journal.pone.0007295	http://dx.doi.org/10.1371/journal.pone.0007295			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802385	Green Accepted, gold, Green Published, Green Submitted			2022-12-27	WOS:000270593600006
J	Liu, HW; Luo, YC; Ho, CL; Yang, JY; Lin, CH				Liu, Hong-Wen; Luo, Yun-Cin; Ho, Chia-Lin; Yang, Jung-Yen; Lin, Chi-Hung			Locomotion Guidance by Extracellular Matrix Is Adaptive and Can be Restored by a Transient Change in Ca2+ Level	PLOS ONE			English	Article								Navigation of cell locomotion by gradients of soluble factors can be desensitized if the concentration of the chemoattractant stays unchanged. It remains obscure if the guidance by immobilized extracellular matrix (ECM) as the substrate is also adaptive and if so, how can the desensitized ECM guidance be resensitized. When first interacting with a substrate containing micron-scale fibronectin (FBN) trails, highly motile fish keratocytes selectively adhere and migrate along the FBN paths. However, such guided motion become adaptive after about 10 min and the cells start to migrate out of the ECM trails. We found that a burst increase of intracellular calcium created by an uncaging technique immediately halts the undirected migration by disrupting the ECM-cytoskeleton coupling, as evidenced by the appearance of retrograde F-actin flow. When the motility later resumes, the activated integrin receptors render the cell selectively binding to the FBN path and reinitiates signaling events, including tyrosine phosphorylation of paxillin, that couple retrograde F-actin flow to the substrate. Thus, the calcium-resensitized cell can undergo a period of ECM-navigated movement, which later becomes desensitized. Our results also suggest that endogenous calcium transients as occur during spontaneous calcium oscillations may exert a cycling resensitization-desensitization control over cell's sensing of substrate guiding cues.			Liu, HW (corresponding author), Natl Yang Ming Univ, Inst Microbiol & Immunol, Taipei 112, Taiwan.	linch@ym.edu.tw						Anderson KI, 2000, CURR BIOL, V10, P253, DOI 10.1016/S0960-9822(00)00357-2; Bolsover S, 2001, BIOCHEM J, V356, P345, DOI 10.1042/0264-6021:3560345; BURRIDGE K, 1992, J CELL BIOL, V119, P893, DOI 10.1083/jcb.119.4.893; Chen Y, 2006, SCIENCE, V314, P1792, DOI 10.1126/science.1132559; Csucs G, 2003, BIOMATERIALS, V24, P1713, DOI 10.1016/S0142-9612(02)00568-9; DAVIS GE, 1993, J IMMUNOL, V151, P7138; Doyle AD, 2005, J CELL SCI, V118, P369, DOI 10.1242/jcs.01590; Duong L, 2000, MATRIX BIOL, V19, P97, DOI 10.1016/S0945-053X(00)00051-2; Galbraith CG, 1999, J CELL BIOL, V147, P1313, DOI 10.1083/jcb.147.6.1313; Glading A, 2002, TRENDS CELL BIOL, V12, P46, DOI 10.1016/S0962-8924(01)02179-1; Guan CB, 2007, CELL, V129, P385, DOI 10.1016/j.cell.2007.01.051; Hegerfeldt Y, 2002, CANCER RES, V62, P2125; Henley JR, 2004, NEURON, V44, P909, DOI 10.1016/j.neuron.2004.11.030; Hsieh CF, 2006, J BIOL CHEM, V281, P25466, DOI 10.1074/jbc.M601793200; Huttenlocher A, 1997, J BIOL CHEM, V272, P32719, DOI 10.1074/jbc.272.52.32719; Jung DR, 2001, CRIT REV BIOTECHNOL, V21, P111, DOI 10.1080/20013891081700; Jurado C, 2005, MOL BIOL CELL, V16, P507, DOI 10.1091/mbc.E04-10-0860; Kane RS, 1999, BIOMATERIALS, V20, P2363, DOI 10.1016/S0142-9612(99)00165-9; LEE J, 1993, NATURE, V362, P167, DOI 10.1038/362167a0; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; LIN CH, 1995, NEURON, V14, P763, DOI 10.1016/0896-6273(95)90220-1; MAHER PA, 1985, P NATL ACAD SCI USA, V82, P6576, DOI 10.1073/pnas.82.19.6576; Scotchford CA, 2002, J BIOMED MATER RES, V59, P84, DOI 10.1002/jbm.1220; Servant G, 1999, MOL BIOL CELL, V10, P1163, DOI 10.1091/mbc.10.4.1163; Shitashiro M, 2003, J BIOTECHNOL, V101, P11, DOI 10.1016/S0168-1656(02)00285-7; VERSCHUEREN H, 1985, J CELL SCI, V75, P279; Vogt AK, 2004, J NEUROSCI METH, V134, P191, DOI 10.1016/j.jneumeth.2003.11.004; Zheng JQ, 2007, ANNU REV CELL DEV BI, V23, P375, DOI 10.1146/annurev.cellbio.23.090506.123221; ZIGMOND SH, 1977, J CELL BIOL, V75, P606, DOI 10.1083/jcb.75.2.606	29	6	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7330	10.1371/journal.pone.0007330	http://dx.doi.org/10.1371/journal.pone.0007330			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802394	Green Published, Green Submitted, gold			2022-12-27	WOS:000270593600009
J	Perrard, MH; Chassaing, E; Montillet, G; Sabido, O; Durand, P				Perrard, Marie-Helene; Chassaing, Emeric; Montillet, Guillaume; Sabido, Odile; Durand, Philippe			Cytostatic Factor Proteins Are Present in Male Meiotic Cells and beta-Nerve Growth Factor Increases Mos Levels in Rat Late Spermatocytes	PLOS ONE			English	Article								Background: In co-cultures of pachytene spermatocytes with Sertoli cells, beta-NGF regulates the second meiotic division by blocking secondary spermatocytes in metaphase (metaphase II), and thereby lowers round spermatid formation. In vertebrates, mature oocytes are arrested at metaphase II until fertilization, because of the presence of cytostatic factor (CSF) in their cytoplasm. By analogy, we hypothesized the presence of CSF in male germ cells. Methodology/Principal Findings: We show here, that Mos, Emi2, cyclin E and Cdk2, the four proteins of CSF, and their respective mRNAs, are present in male rat meiotic cells; this was assessed by using Western blotting, immunocytochemistry and reverse transcriptase PCR. We measured the relative cellular levels of Mos, Emi2, Cyclin E and Cdk2 in the meiotic cells by flow cytometry and found that the four proteins increased throughout the first meiotic prophase, reaching their highest levels in middle to late pachytene spermatocytes, then decreased following the meiotic divisions. In co-cultures of pachytene spermatocytes with Sertoli cells, beta-NGF increased the number of metaphases II, while enhancing Mos and Emi2 levels in middle to late pachytene spermatocytes, pachytene spermatocytes in division and secondary spermatocytes. Conclusion/Significance: Our results suggest that CSF is not restricted to the oocyte. In addition, they reinforce the view that NGF, by enhancing Mos in late spermatocytes, is one of the intra-testicular factors which adjusts the number of round spermatids that can be supported by Sertoli cells.	[Perrard, Marie-Helene; Chassaing, Emeric; Montillet, Guillaume; Durand, Philippe] Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, INRA,UMR 1288,CNRS,UMR 5242, F-69365 Lyon, France; [Sabido, Odile] Univ St Etienne, Fac Med, Ctr Commun Cytometrie Flux, St Etienne, France	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute for Biology (INSB); INRAE; UDICE-French Research Universities; Universite Claude Bernard Lyon 1; CHU Lyon; Ecole Normale Superieure de Lyon (ENS de LYON); Universite Jean Monnet	Perrard, MH (corresponding author), Univ Lyon 1, Ecole Normale Super Lyon, Inst Genom Fonct Lyon, INRA,UMR 1288,CNRS,UMR 5242, F-69365 Lyon, France.	marie-helene.durand@ens-lyon.fr	Perrard, Marie-Hélène/R-7864-2017; Perrard, marie-Hélène/L-2132-2014					Ashley T, 2001, J CELL SCI, V114, P685; Damestoy A, 2005, REPROD BIOL ENDOCRIN, V3, DOI 10.1186/1477-7827-3-22; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ferrara D, 2004, BIOL REPROD, V70, P1782, DOI 10.1095/biolreprod.103.026666; Fouchecourt S, 2006, J ENDOCRINOL, V190, P59, DOI 10.1677/joe.1.06699; Furuno N, 1997, EMBO J, V16, P3860, DOI 10.1093/emboj/16.13.3860; GABRIELLI BG, 1993, SCIENCE, V259, P1766, DOI 10.1126/science.8456304; Godet M, 2000, EUR J CELL BIOL, V79, P816, DOI 10.1078/0171-9335-00107; Godet M, 2008, DEV BIOL, V315, P173, DOI 10.1016/j.ydbio.2007.12.019; GOLDMAN DS, 1987, P NATL ACAD SCI USA, V84, P4509, DOI 10.1073/pnas.84.13.4509; HAKOVIRTA H, 1993, ENDOCRINOLOGY, V133, P1664, DOI 10.1210/en.133.4.1664; HERZOG NK, 1988, ONCOGENE, V3, P225; Hikim APS, 1999, REV REPROD, V4, P38; Inoue D, 2007, NATURE, V446, P1100, DOI 10.1038/nature05688; KIERSZENBAUM AL, 1994, ENDOCR REV, V15, P116, DOI 10.1210/er.15.1.116; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Madgwick S, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-4; MASUI Y, 1971, J EXP ZOOL, V177, P129, DOI 10.1002/jez.1401770202; Musa FRM, 1998, J ANDROL, V19, P657; MUTTER GL, 1987, P NATL ACAD SCI USA, V84, P5301, DOI 10.1073/pnas.84.15.5301; Nagao Y, 2002, CELL BIOL INT, V26, P193, DOI 10.1006/cbir.2001.0834; NAGAO Y, 1995, BBA-GEN SUBJECTS, V1245, P130, DOI 10.1016/0304-4165(94)00185-Z; Nebreda AR, 2000, CURR OPIN CELL BIOL, V12, P666, DOI 10.1016/S0955-0674(00)00150-2; Nishiyama T, 2007, NATURE, V446, P1096, DOI 10.1038/nature05696; Ohe M, 2007, DEV BIOL, V303, P157, DOI 10.1016/j.ydbio.2006.10.044; ONODA M, 1991, MOL CELL ENDOCRINOL, V77, P207, DOI 10.1016/0303-7207(91)90076-5; PARVINEN M, 1982, ENDOCR REV, V3, P404, DOI 10.1210/edrv-3-4-404; Patapoutian A, 2001, CURR OPIN NEUROBIOL, V11, P272, DOI 10.1016/S0959-4388(00)00208-7; PAULES RS, 1989, P NATL ACAD SCI USA, V86, P5395, DOI 10.1073/pnas.86.14.5395; Perrard MH, 2007, J CELL PHYSIOL, V210, P51, DOI 10.1002/jcp.20805; Perrard MH, 2009, MICROSC RES TECHNIQ, V72, P596, DOI 10.1002/jemt.20706; Perrard MH, 2003, MOL REPROD DEV, V65, P86, DOI 10.1002/mrd.10259; PROPST F, 1987, MOL CELL BIOL, V7, P1629, DOI 10.1128/MCB.7.5.1629; Ravnik SE, 1999, DEV BIOL, V207, P408, DOI 10.1006/dbio.1998.9156; Roederer M, 2008, CYTOM PART A, V73A, P384, DOI 10.1002/cyto.a.20549; ROSENBERG MP, 1995, CELL GROWTH DIFFER, V6, P325; RUSSELL LD, 1984, J REPROD FERTIL, V70, P635, DOI 10.1530/jrf.0.0700635; SAGATA N, 1989, NATURE, V342, P512, DOI 10.1038/342512a0; SAGATA N, 1988, NATURE, V335, P519, DOI 10.1038/335519a0; Secker GA, 2008, EXP CELL RES, V314, P131, DOI 10.1016/j.yexcr.2007.09.001; Shiratsuchi A, 1999, J BIOL CHEM, V274, P5901, DOI 10.1074/jbc.274.9.5901; Shoji S, 2006, EMBO J, V25, P834, DOI 10.1038/sj.emboj.7600953; Spruck C, 2006, CANCER RES, V66, P7355, DOI 10.1158/0008-5472.CAN-05-3240; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; VANDERHOORN FA, 1991, ONCOGENE, V6, P929; Vigier M, 2004, J MOL ENDOCRINOL, V33, P729, DOI 10.1677/jme.1.01493; Weiss M, 1997, BIOL REPROD, V57, P68, DOI 10.1095/biolreprod57.1.68; Wu B, 1997, BIOL REPROD, V56, P260, DOI 10.1095/biolreprod56.1.260; ZHENGWEI Y, 1990, BIOL REPROD, V43, P629, DOI 10.1095/biolreprod43.4.629	49	16	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7237	10.1371/journal.pone.0007237	http://dx.doi.org/10.1371/journal.pone.0007237			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802389	Green Submitted, Green Published, gold			2022-12-27	WOS:000270593600002
J	Englitz, B; Tolnai, S; Typlt, M; Jost, J; Rubsamen, R				Englitz, Bernhard; Tolnai, Sandra; Typlt, Marei; Jost, Juergen; Ruebsamen, Rudolf			Reliability of Synaptic Transmission at the Synapses of Held In Vivo under Acoustic Stimulation	PLOS ONE			English	Article								Background: The giant synapses of Held play an important role in high-fidelity auditory processing and provide a model system for synaptic transmission at central synapses. Whether transmission of action potentials can fail at these synapses has been investigated in recent studies. At the endbulbs of Held in the anteroventral cochlear nucleus (AVCN) a consistent picture emerged, whereas at the calyx of Held in the medial nucleus of the trapezoid body (MNTB) results on the reliability of transmission remain inconsistent. In vivo this discrepancy could be due to the difficulty in identifying failures of transmission. Methods/Findings: We introduce a novel method for detecting unreliable transmission in vivo. Based on the temporal relationship between a cells' waveform and other potentials in the recordings, a statistical test is developed that provides a balanced decision between the presence and the absence of failures. Its performance is quantified using simulated voltage recordings and found to exhibit a high level of accuracy. The method was applied to extracellular recordings from the synapses of Held in vivo. At the calyces of Held failures of transmission were found only rarely. By contrast, at the endbulbs of Held in the AVCN failures were found under spontaneous, excited, and suppressed conditions. In accordance with previous studies, failures occurred most abundantly in the suppressed condition, suggesting a role for inhibition. Conclusions/Significance: Under the investigated activity conditions/anesthesia, transmission seems to remain largely unimpeded in the MNTB, whereas in the AVCN the occurrence of failures is related to inhibition and could be the basis/result of computational mechanisms for temporal processing. More generally, our approach provides a formal tool for studying the reliability of transmission with high statistical accuracy under typical in vivo recording conditions.			Englitz, B (corresponding author), Max Planck Inst Math Sci, Leipzig, Germany.	rueb@uni-leipzig.de	Englitz, Bernhard/K-7636-2018	Englitz, Bernhard/0000-0001-9106-0356; Typlt, Marei/0000-0002-1627-7560; Jost, Juergen/0000-0001-5258-6590				Awatramani GB, 2005, NEURON, V48, P109, DOI 10.1016/j.neuron.2005.08.038; Awatramani GB, 2004, J NEUROSCI, V24, P2643, DOI 10.1523/JNEUROSCI.5144-03.2004; BANKS MI, 1992, J NEUROSCI, V12, P2819; BARNESDAVIES M, 1995, J PHYSIOL-LONDON, V488, P387, DOI 10.1113/jphysiol.1995.sp020974; Borst JGG, 1995, J PHYSIOL-LONDON, V489, P825, DOI 10.1113/jphysiol.1995.sp021095; CANT NB, 1979, NEUROSCIENCE, V4, P1925, DOI 10.1016/0306-4522(79)90066-6; CASPARY DM, 1994, J NEUROPHYSIOL, V72, P2124, DOI 10.1152/jn.1994.72.5.2124; Chuhma N, 1998, J NEUROSCI, V18, P512; EBERT U, 1995, EXP BRAIN RES, V104, P310; ENGLITZ B, 2009, THESIS U LEIPZIG; FORSYTHE ID, 1994, J PHYSIOL-LONDON, V479, P381, DOI 10.1113/jphysiol.1994.sp020303; Futai K, 2001, J NEUROSCI, V21, P3342, DOI 10.1523/JNEUROSCI.21-10-03342.2001; GUINAN JJ, 1972, INT J NEUROSCI, V4, P101, DOI 10.3109/00207457209147165; GUINAN JJ, 1990, HEARING RES, V49, P321, DOI 10.1016/0378-5955(90)90111-2; Haustein MD, 2008, J NEUROSCI METH, V174, P227, DOI 10.1016/j.jneumeth.2008.07.015; Held H., 1893, ARCH ANAT PHYSIOL, V17, P201; Hermann J, 2007, J NEUROPHYSIOL, V98, P807, DOI 10.1152/jn.00355.2007; HODGKIN AL, 1952, J PHYSIOL-LONDON, V117, P500, DOI 10.1113/jphysiol.1952.sp004764; JORIS PX, 1994, J NEUROPHYSIOL, V71, P1037, DOI 10.1152/jn.1994.71.3.1037; JORIS PX, 1994, J NEUROPHYSIOL, V71, P1022, DOI 10.1152/jn.1994.71.3.1022; Juiz JM, 1996, J COMP NEUROL, V373, P11, DOI 10.1002/(SICI)1096-9861(19960909)373:1<11::AID-CNE2>3.0.CO;2-G; KOLSTON J, 1992, ANAT EMBRYOL, V186, P443; Kopp-Scheinpflug C, 2008, NEUROSCIENCE, V154, P160, DOI 10.1016/j.neuroscience.2008.01.088; Kopp-Scheinpflug C, 2003, JARO-J ASSOC RES OTO, V4, P1, DOI 10.1007/s10162-002-2010-5; Kopp-Scheinpflug C, 2002, J NEUROSCI, V22, P11004; KUWABARA N, 1991, J COMP NEUROL, V314, P684, DOI 10.1002/cne.903140405; KUWABARA N, 1991, J COMP NEUROL, V314, P707, DOI 10.1002/cne.903140406; Mahendrasingam S, 2004, EUR J NEUROSCI, V19, P993, DOI 10.1111/j.1460-9568.2004.03193.x; Mc Laughlin M, 2008, J NEUROSCI, V28, P10206, DOI 10.1523/JNEUROSCI.2735-08.2008; MOORE JK, 1987, J COMP NEUROL, V260, P157, DOI 10.1002/cne.902600202; MOREST D K, 1968, Zeitschrift fuer Anatomie und Entwicklungsgeschichte, V127, P201, DOI 10.1007/BF00526129; Paolini AG, 2001, HEARING RES, V159, P101, DOI 10.1016/S0378-5955(01)00327-6; PFEIFFER RR, 1966, SCIENCE, V154, P667, DOI 10.1126/science.154.3749.667; ROTHMAN JS, 1993, J NEUROPHYSIOL, V70, P2562, DOI 10.1152/jn.1993.70.6.2562; Rothman JS, 1996, AUDIT NEUROSCI, V2, P47; RYUGO DK, 1982, J COMP NEUROL, V210, P239, DOI 10.1002/cne.902100304; SAINTMARIE RL, 1991, HEARING RES, V51, P11, DOI 10.1016/0378-5955(91)90003-R; Satzler K, 2002, J NEUROSCI, V22, P10567; Schneggenburger R, 2006, CELL TISSUE RES, V326, P311, DOI 10.1007/s00441-006-0272-7; SENTO S, 1989, J COMP NEUROL, V280, P553, DOI 10.1002/cne.902800406; SIVARAMAKRISHNAN S, 1995, J NEUROSCI, V15, P6576; SMITH PH, 1991, J COMP NEUROL, V304, P387, DOI 10.1002/cne.903040305; Steinert JR, 2008, NEURON, V60, P642, DOI 10.1016/j.neuron.2008.08.025; Takahashi T, 1996, SCIENCE, V274, P594, DOI 10.1126/science.274.5287.594; Taschenberger H, 2000, J NEUROSCI, V20, P9162; Tollin DJ, 2005, J NEUROSCI, V25, P10648, DOI 10.1523/JNEUROSCI.1609-05.2005; Tolnai S, 2008, EUR J NEUROSCI, V27, P3191, DOI 10.1111/j.1460-9568.2008.06292.x; Tsuchitani C, 1997, HEARING RES, V105, P211, DOI 10.1016/S0378-5955(96)00212-2; Turecek R, 2001, NATURE, V411, P587, DOI 10.1038/35079084; Wang Y, 2006, JARO-J ASSOC RES OTO, V7, P412, DOI 10.1007/s10162-006-0052-9; WICKESBERG RE, 1990, J NEUROSCI, V10, P1762; WU SH, 1992, J NEUROSCI, V12, P3084, DOI 10.1523/JNEUROSCI.12-08-03084.1992; WU SH, 1986, J NEUROSCI, V6, P2691; Zhang XD, 2001, J ACOUST SOC AM, V109, P648, DOI 10.1121/1.1336503	54	48	48	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7014	10.1371/journal.pone.0007014	http://dx.doi.org/10.1371/journal.pone.0007014			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19798414	gold, Green Published, Green Submitted			2022-12-27	WOS:000270593300001
J	Schweitzer, AD; Howell, RC; Jiang, ZW; Bryan, RA; Gerfen, G; Chen, CC; Mah, D; Cahill, S; Casadevall, A; Dadachova, E				Schweitzer, Andrew D.; Howell, Robertha C.; Jiang, Zewei; Bryan, Ruth A.; Gerfen, Gary; Chen, Chin-Cheng; Mah, Dennis; Cahill, Sean; Casadevall, Arturo; Dadachova, Ekaterina			Physico-Chemical Evaluation of Rationally Designed Melanins as Novel Nature-Inspired Radioprotectors	PLOS ONE			English	Article								Background: Melanin, a high-molecular weight pigment that is ubiquitous in nature, protects melanized microorganisms against high doses of ionizing radiation. However, the physics of melanin interaction with ionizing radiation is unknown. Methodology/Principal Findings: We rationally designed melanins from either 5-S-cysteinyl-DOPA, L-cysteine/L-DOPA, or L-DOPA with diverse structures as shown by elemental analysis and HPLC. Sulfur-containing melanins had higher predicted attenuation coefficients than non-sulfur-containing melanins. All synthetic melanins displayed strong electron paramagnetic resonance (2.14. 10(18), 7.09. 10(18), and 9.05. 10(17) spins/g, respectively), with sulfur-containing melanins demonstrating more complex spectra and higher numbers of stable free radicals. There was no change in the quality or quantity of the stable free radicals after high-dose (30,000 cGy), high-energy (Cs-137, 661.6 keV) irradiation, indicating a high degree of radical stability as well as a robust resistance to the ionizing effects of gamma irradiation. The rationally designed melanins protected mammalian cells against ionizing radiation of different energies. Conclusions/Significance: We propose that due to melanin's numerous aromatic oligomers containing multiple pi-electron system, a generated Compton recoil electron gradually loses energy while passing through the pigment, until its energy is sufficiently low that it can be trapped by stable free radicals present in the pigment. Controlled dissipation of high-energy recoil electrons by melanin prevents secondary ionizations and the generation of damaging free radical species.			Schweitzer, AD (corresponding author), Albert Einstein Coll Med, Dept Nucl Med, New York, NY USA.	edadacho@aecom.yu.edu	Dadachova, Ekaterina/I-7838-2013; Schweitzer, Andrew/M-3702-2013	Schweitzer, Andrew/0000-0001-9538-8076	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [R01 AI060507, R56 AI060507, R01 AI052733, AI52733, AI60507] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI060507, R01AI060507, R01AI052733] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bomford CK., 2002, WALTER MILLERS TXB R; Dadachova E, 2008, PIGM CELL MELANOMA R, V21, P192, DOI 10.1111/j.1755-148X.2007.00430.x; Dadachova E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000457; ENOCHS WS, 1993, PIGM CELL RES, V6, P91, DOI 10.1111/j.1600-0749.1993.tb00587.x; Franken NAP, 2006, NAT PROTOC, V1, P2315, DOI 10.1038/nprot.2006.339; GALLAS JM, 1992, Patent No. 5112883; HILL HZ, 1992, BIOESSAYS, V14, P49, DOI 10.1002/bies.950140111; Hirayama H, 1985, SLAC265; International Commission on Radiation Units and Measurements, 1984, 37 ICRU; Ito S, 1998, PIGM CELL RES, V11, P120, DOI 10.1111/j.1600-0749.1998.tb00721.x; ITO S, 1985, ANAL BIOCHEM, V144, P527, DOI 10.1016/0003-2697(85)90150-2; Kawrakow I, 2006, PIRS701 NAT RES COUN; Kaxiras E, 2006, PHYS REV LETT, V97, DOI 10.1103/PhysRevLett.97.218102; Khan FM, 2014, PHYS RAD THERAPY, V5th; Klevenhagen SC, 1996, PHYS MED BIOL, V41, P2605, DOI 10.1088/0031-9155/41/12/002; La Russa DJ, 2007, MED PHYS, V34, P4690, DOI 10.1118/1.2799580; MA CM, 1995, PHYS MED BIOL, V40, P63, DOI 10.1088/0031-9155/40/1/006; Ma CM, 2001, MED PHYS, V28, P868, DOI 10.1118/1.1374247; Meredith P, 2006, PIGM CELL RES, V19, P572, DOI 10.1111/j.1600-0749.2006.00345.x; MIRCHINK TG, 1972, MIKROBIOLOGIYA, V41, P83; Mironenko NV, 2000, ECOTOX ENVIRON SAFE, V45, P177, DOI 10.1006/eesa.1999.1848; Mosse I, 2000, RADIAT ENVIRON BIOPH, V39, P47, DOI 10.1007/PL00007685; Nosanchuk JD, 2003, CELL MICROBIOL, V5, P203, DOI 10.1046/j.1462-5814.2003.00268.x; SEALY RC, 1982, SCIENCE, V217, P545, DOI 10.1126/science.6283638; SEALY RC, 1982, P NATL ACAD SCI-BIOL, V79, P2885, DOI 10.1073/pnas.79.9.2885; SINILOVA N G, 1969, Zhurnal Mikrobiologii Epidemiologii i Immunobiologii, V46, P94; Steenbergen JN, 2001, P NATL ACAD SCI USA, V98, P15245, DOI 10.1073/pnas.261418798; Wakamatsu K, 2002, PIGM CELL RES, V15, P174, DOI 10.1034/j.1600-0749.2002.02017.x; Wang YL, 1996, INFECT IMMUN, V64, P2420, DOI 10.1128/IAI.64.7.2420-2424.1996; Zhong JY, 2008, BIOCHEMISTRY-US, V47, P4701, DOI 10.1021/bi702093r	30	57	60	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7229	10.1371/journal.pone.0007229	http://dx.doi.org/10.1371/journal.pone.0007229			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789711	Green Submitted, gold, Green Published			2022-12-27	WOS:000270354100003
J	Vebo, HC; Snipen, L; Nes, IF; Brede, DA				Vebo, Heidi C.; Snipen, Lars; Nes, Ingolf F.; Brede, Dag A.			The Transcriptome of the Nosocomial Pathogen Enterococcus faecalis V583 Reveals Adaptive Responses to Growth in Blood	PLOS ONE			English	Article							OXIDATIVE-STRESS-RESPONSE; GLUCOSE STARVATION RESPONSE; URINARY-TRACT-INFECTION; GROUP-A STREPTOCOCCUS; GROUP-B STREPTOCOCCUS; STAPHYLOCOCCUS-AUREUS; IN-VIVO; BIOFILM FORMATION; SERINE-PROTEASE; POLYSACCHARIDE BIOSYNTHESIS	Background: Enterococcus faecalis plays a dual role in human ecology, predominantly existing as a commensal in the alimentary canal, but also as an opportunistic pathogen that frequently causes nosocomial infections like bacteremia. A number of virulence factors that contribute to the pathogenic potential of E. faecalis have been established. However, the process in which E. faecalis gains access to the bloodstream and establishes a persistent infection is not well understood. Methodology/Principal Findings: To enhance our understanding of how this commensal bacterium adapts during a bloodstream infection and to examine the interplay between genes we designed an in vitro experiment using genome-wide microarrays to investigate what effects the presence of and growth in blood have on the transcriptome of E. faecalis strain V583. We showed that growth in both 2xYT supplemented with 10% blood and in 100% blood had a great impact on the transcription of many genes in the V583 genome. We identified several immediate changes signifying cellular processes that might contribute to adaptation and growth in blood. These include modulation of membrane fatty acid composition, oxidative and lytic stress protection, acquisition of new available substrates, transport functions including heme/iron transporters and genes associated with virulence in E. faecalis. Conclusions/Significance: The results presented here reveal that cultivation of E. faecalis in blood in vitro has a profound impact on its transcriptome, which includes a number of virulence traits. Observed regulation of genes and pathways revealed new insight into physiological features and metabolic capacities which enable E. faecalis to adapt and grow in blood. A number of the regulated genes might potentially be useful candidates for development of new therapeutic approaches for treatment of E. faecalis infections.			Vebo, HC (corresponding author), Norwegian Univ Life Sci, Lab Microbial Gene Technol & Food Microbiol Biote, As, Norway.	heidi.vebo@umb.no						Aakra A, 2005, ANTIMICROB AGENTS CH, V49, P2246, DOI 10.1128/AAC.49.6.2246-2259.2005; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Benachour A, 2005, J BACTERIOL, V187, P1022, DOI 10.1128/JB.187.3.1022-1035.2005; Bourgogne A, 2006, J BACTERIOL, V188, P2875, DOI 10.1128/JB.188.8.2875-2884.2006; Bourgogne A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-7-r110; Brinster S, 2009, NATURE, V458, P83, DOI 10.1038/nature07772; Brooijmans R, 2009, MICROB CELL FACT, V8, DOI 10.1186/1475-2859-8-28; Brunskill EW, 1996, J BACTERIOL, V178, P5810, DOI 10.1128/jb.178.19.5810-5812.1996; Capiaux H, 2000, INT J FOOD MICROBIOL, V55, P99, DOI 10.1016/S0168-1605(00)00183-5; CHAKRABORTY T, 1992, J BACTERIOL, V174, P568, DOI 10.1128/jb.174.2.568-574.1992; Chandler JR, 2005, P NATL ACAD SCI USA, V102, P15617, DOI 10.1073/pnas.0505545102; CHOW JW, 1993, ANTIMICROB AGENTS CH, V37, P2474, DOI 10.1128/AAC.37.11.2474; Coburn PS, 2004, SCIENCE, V306, P2270, DOI 10.1126/science.1103996; Corbin BD, 2008, SCIENCE, V319, P962, DOI 10.1126/science.1152449; Deutscher J, 2006, MICROBIOL MOL BIOL R, V70, P939, DOI 10.1128/MMBR.00024-06; Diggle PJ, 2002, ANAL LONGITUDINAL DA; Duwat P, 2001, J BACTERIOL, V183, P4509, DOI 10.1128/JB.183.15.4509-4516.2001; Fabretti F, 2006, INFECT IMMUN, V74, P4164, DOI 10.1128/IAI.00111-06; Flahaut S, 1998, LETT APPL MICROBIOL, V26, P259; Gentry-Weeks C, 2003, INFECT IMMUN, V71, P1434, DOI 10.1128/IAI.71.3.1434-1441.2003; Giard JC, 2006, FEMS IMMUNOL MED MIC, V46, P410, DOI 10.1111/j.1574-695X.2005.00049.x; Giard JC, 1997, RES MICROBIOL, V148, P27, DOI 10.1016/S0923-2508(97)81897-9; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Groicher KH, 2000, J BACTERIOL, V182, P1794, DOI 10.1128/JB.182.7.1794-1801.2000; GUZMAN CA, 1989, INFECT IMMUN, V57, P1834; GUZMAN CA, 1991, MICROB PATHOGENESIS, V11, P399, DOI 10.1016/0882-4010(91)90036-A; Hancock LE, 2004, J BACTERIOL, V186, P7951, DOI 10.1128/JB.186.23.7951-7958.2004; Hancock LE, 2003, J BACTERIOL, V185, P4393, DOI 10.1128/JB.185.15.4393-4401.2003; Hancock LE, 2002, P NATL ACAD SCI USA, V99, P1574, DOI 10.1073/pnas.032448299; Hechard Y, 2001, MICROBIOL-SGM, V147, P1575, DOI 10.1099/00221287-147-6-1575; Hirt H, 2002, INFECT IMMUN, V70, P716, DOI 10.1128/IAI.70.2.716-723.2002; Huebner J, 1999, INFECT IMMUN, V67, P1213, DOI 10.1128/IAI.67.3.1213-1219.1999; Hufnagel M, 2004, J INFECT DIS, V189, P420, DOI 10.1086/381150; Hutchings MI, 2009, TRENDS MICROBIOL, V17, P13, DOI 10.1016/j.tim.2008.10.001; Huycke MM, 2002, CARCINOGENESIS, V23, P529, DOI 10.1093/carcin/23.3.529; Huycke MM, 1998, EMERG INFECT DIS, V4, P239, DOI 10.3201/eid0402.980211; IKE Y, 1984, INFECT IMMUN, V45, P528, DOI 10.1128/IAI.45.2.528-530.1984; JAEGER KE, 1994, FEMS MICROBIOL REV, V15, P29, DOI 10.1016/0168-6445(94)90025-6; Jordan S, 2008, FEMS MICROBIOL REV, V32, P107, DOI 10.1111/j.1574-6976.2007.00091.x; KLEBANOFF SJ, 1980, ANN INTERN MED, V93, P480, DOI 10.7326/0003-4819-93-3-480; KREFT B, 1992, INFECT IMMUN, V60, P25, DOI 10.1128/IAI.60.1.25-30.1992; La Carbona S, 2007, MOL MICROBIOL, V66, P1148, DOI 10.1111/j.1365-2958.2007.05987.x; Le Breton Y, 2005, J APPL MICROBIOL, V98, P806, DOI 10.1111/j.1365-2672.2004.02468.x; Low YL, 2003, J MED MICROBIOL, V52, P113, DOI 10.1099/jmm.0.05039-0; LOWE AM, 1995, INFECT IMMUN, V63, P703, DOI 10.1128/IAI.63.2.703-706.1995; MACLEOD RA, 1947, J BIOL CHEM, V170, P351; MACLEOD RA, 1951, J BACTERIOL, V62, P337, DOI 10.1128/JB.62.3.337-345.1951; Mereghetti L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003143; Mohamed JA, 2006, J INFECT DIS, V193, P231, DOI 10.1086/498871; Mohamed JA, 2004, INFECT IMMUN, V72, P3658, DOI 10.1128/IAI.72.6.3658-3663.2004; Mundy LM, 2000, CLIN MICROBIOL REV, V13, P513, DOI 10.1128/CMR.13.4.513-522.2000; MURRAY BE, 1993, J BACTERIOL, V175, P5216, DOI 10.1128/JB.175.16.5216-5223.1993; Nallapareddy SR, 2008, J INFECT DIS, V197, P1728, DOI 10.1086/588143; Nannini EC, 2005, INFECT IMMUN, V73, P7772, DOI 10.1128/IAI.73.11.7772-7774.2005; NOBLE CJ, 1978, J CLIN PATHOL, V31, P1182, DOI 10.1136/jcp.31.12.1182; Orihuela CJ, 2004, INFECT IMMUN, V72, P5582, DOI 10.1128/IAI.72.10.5582-5596.2004; Paulsen IT, 2003, SCIENCE, V299, P2071, DOI 10.1126/science.1080613; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Portenier I, 2003, ENDOD TOP, V6, P135, DOI DOI 10.1111/j.1601-1546.2003.00040.x; Posey JE, 2000, SCIENCE, V288, P1651, DOI 10.1126/science.288.5471.1651; Qin X, 2000, INFECT IMMUN, V68, P2579, DOI 10.1128/IAI.68.5.2579-2586.2000; Qin X, 2001, J BACTERIOL, V183, P3372, DOI 10.1128/JB.183.11.3372-3382.2001; RECSEI P, 1986, MOL GEN GENET, V202, P58, DOI 10.1007/BF00330517; Riboulet E, 2007, J MOL MICROB BIOTECH, V13, P140, DOI 10.1159/000103605; Rice KC, 2005, J BACTERIOL, V187, P813, DOI 10.1128/JB.187.3.813-821.2005; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Rince A, 2001, J BACTERIOL, V183, P1482, DOI 10.1128/JB.183.4.1482-1488.2001; Rince A, 2000, INT J FOOD MICROBIOL, V55, P87, DOI 10.1016/S0168-1605(00)00180-X; Roberts JC, 2004, J CLIN MICROBIOL, V42, P2317, DOI 10.1128/JCM.42.5.2317-2320.2004; Rowley G, 2006, NAT REV MICROBIOL, V4, P383, DOI 10.1038/nrmicro1394; Ruiz-Garbajosa P, 2006, J CLIN MICROBIOL, V44, P2220, DOI 10.1128/JCM.02596-05; SAHM DF, 1989, ANTIMICROB AGENTS CH, V33, P1588, DOI 10.1128/AAC.33.9.1588; Schlievert PM, 1998, INFECT IMMUN, V66, P218, DOI 10.1128/IAI.66.1.218-223.1998; Shankar N, 2002, NATURE, V417, P746, DOI 10.1038/nature00802; Shepard BD, 2002, INFECT IMMUN, V70, P4344, DOI 10.1128/IAI.70.8.4344-4352.2002; Sherman JM, 1937, J BACTERIOL, V33, P275, DOI 10.1128/JB.33.3.275-282.1937; Sifri CD, 2002, INFECT IMMUN, V70, P5647, DOI 10.1128/IAI.70.10.5647-5650.2002; Singh KV, 2009, J INFECT DIS, V200, P417, DOI 10.1086/600124; Singh KV, 1998, FEMS IMMUNOL MED MIC, V21, P323, DOI 10.1016/S0928-8244(98)00087-X; Solheim M, 2007, APPL ENVIRON MICROB, V73, P5767, DOI 10.1128/AEM.00651-07; Teng F, 2005, J INFECT DIS, V191, P472, DOI 10.1086/427191; Teng F, 2002, INFECT IMMUN, V70, P2010, DOI 10.1128/IAI.70.4.2010-2015.2002; Teng F, 2002, INFECT IMMUN, V70, P1991, DOI 10.1128/IAI.70.4.1991-1996.2002; Teng F, 2009, INFECT IMMUN, V77, P3759, DOI 10.1128/IAI.00149-09; THOMAS EL, 1988, REV INFECT DIS, V10, pS450; Torres VJ, 2007, CELL HOST MICROBE, V1, P109, DOI 10.1016/j.chom.2007.03.001; Verneuil N, 2005, MICROBIOL-SGM, V151, P3997, DOI 10.1099/mic.0.28325-0; Verneuil N, 2006, MICROBIOL-SGM, V152, P2579, DOI 10.1099/mic.0.28922-0; von Wallbrunn A, 2002, APPL MICROBIOL BIOT, V60, P179, DOI 10.1007/s00253-002-1080-y; Walecka E, 2009, LETT APPL MICROBIOL, V49, P79, DOI 10.1111/j.1472-765X.2009.02629.x; WEISER JN, 1994, INFECT IMMUN, V62, P2582, DOI 10.1128/IAI.62.6.2582-2589.1994; WELLS CL, 1990, J INFECT DIS, V162, P82, DOI 10.1093/infdis/162.1.82; Wernisch L, 2003, BIOINFORMATICS, V19, P53, DOI 10.1093/bioinformatics/19.1.53; Xu Y, 1998, INFECT IMMUN, V66, P4313; Xu Y, 1997, INFECT IMMUN, V65, P4207, DOI 10.1128/IAI.65.10.4207-4215.1997; Xu Y, 2000, INFECT IMMUN, V68, P815, DOI 10.1128/IAI.68.2.815-823.2000; Yamamoto Y, 2005, MOL MICROBIOL, V56, P525, DOI 10.1111/j.1365-2958.2005.04555.x	98	67	67	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2009	4	11							e7660	10.1371/journal.pone.0007660	http://dx.doi.org/10.1371/journal.pone.0007660			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RZ	19888459	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414600003
J	Hardy, RD; Coalson, JJ; Peters, J; Chaparro, A; Techasaensiri, C; Cantwell, AM; Kannan, TR; Baseman, JB; Dube, PH				Hardy, R. Doug; Coalson, Jacqueline J.; Peters, Jay; Chaparro, Adriana; Techasaensiri, Chonnamet; Cantwell, Angelene M.; Kannan, T. R.; Baseman, Joel B.; Dube, Peter H.			Analysis of Pulmonary Inflammation and Function in the Mouse and Baboon after Exposure to Mycoplasma pneumoniae CARDS Toxin	PLOS ONE			English	Article							AIRWAY HYPERRESPONSIVENESS; BRONCHIAL-ASTHMA; ALLERGIC MICE; INFECTION; MODEL; ADULTS; HYPERREACTIVITY; EXACERBATION; LIPOPEPTIDE; OBSTRUCTION	Mycoplasma pneumoniae produces an ADP-ribosylating and vacuolating toxin known as the CARDS (Community Acquired Respiratory Distress Syndrome) toxin that has been shown to be cytotoxic to mammalian cells in tissue and organ culture. In this study we tested the ability of recombinant CARDS (rCARDS) toxin to elicit changes within the pulmonary compartment in both mice and baboons. Animals responded to a respiratory exposure to rCARDS toxin in a dose and activity-dependent manner by increasing the expression of the pro-inflammatory cytokines IL-1 alpha, 1 beta, 6, 12, 17, TNF-alpha and IFN-gamma. There was also a dose-dependent increase in several growth factors and chemokines following toxin exposure including KC, IL-8, RANTES, and G-CSF. Increased expression of IFN-gamma was observed only in the baboon; otherwise, mice and baboons responded to CARDS toxin in a very similar manner. Introduction of rCARDS toxin to the airways of mice or baboons resulted in a cellular inflammatory response characterized by a dose-dependent early vacuolization and cytotoxicity of the bronchiolar epithelium followed by a robust peribronchial and perivascular lymphocytic infiltration. In mice, rCARDS toxin caused airway hyper-reactivity two days after toxin exposure as well as prolonged airway obstruction. The changes in airway function, cytokine expression, and cellular inflammation correlate temporally and are consistent with what has been reported for M. pneumoniae infection. Altogether, these data suggest that the CARDS toxin interacts extensively with the pulmonary compartment and that the CARDS toxin is sufficient to cause prolonged inflammatory responses and airway dysfunction.			Hardy, RD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Internal Med & Pediat Infect Dis, San Antonio, TX 78229 USA.	Dube@UTHSCSA.EDU		Hardy, MD, Robert Doug/0000-0003-0632-6610	NIAID NIH HHS [U19 AI070412, AI 070412] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI070412] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Balasubramanian S, 2008, INFECT IMMUN, V76, P3116, DOI 10.1128/IAI.00173-08; Baseman J B, 1993, Subcell Biochem, V20, P243; Baseman JB, 1997, EMERG INFECT DIS, V3, P21, DOI 10.3201/eid0301.970103; Baseman JB, 1996, AM J RESP CRIT CARE, V154, pS137, DOI 10.1164/ajrccm/154.4_Pt_2.S137; Bubeck SS, 2007, INFECT IMMUN, V75, P697, DOI 10.1128/IAI.00403-06; Chu HW, 2005, J IMMUNOL, V174, P5713, DOI 10.4049/jimmunol.174.9.5713; Chu HW, 2003, CHEST, V123, p390S, DOI 10.1378/chest.123.3_suppl.390S; CHU HW, 2005, AM J PHYSL LUNG CELL; CIMOLAI N, 1992, MICROBIOL IMMUNOL, V36, P465, DOI 10.1111/j.1348-0421.1992.tb02045.x; COUCH RB, 1964, JAMA-J AM MED ASSOC, V187, P442; Dube PH, 2004, INFECT IMMUN, V72, P3561, DOI 10.1128/IAI.72.6.3561-3570.2004; FEIZI T, 1967, IMMUNOLOGY, V13, P405; Fonseca-Aten M, 2005, AM J RESP CELL MOL, V32, P201, DOI 10.1165/rcmb.2004-0197OC; Galanos C, 2000, J ENDOTOXIN RES, V6, P471, DOI 10.1179/096805100101532441; Giavedoni LD, 2005, J IMMUNOL METHODS, V301, P89, DOI 10.1016/j.jim.2005.03.015; Gonzalo JA, 1998, J EXP MED, V188, P157, DOI 10.1084/jem.188.1.157; Hamelmann E, 1997, AM J RESP CRIT CARE, V156, P766, DOI 10.1164/ajrccm.156.3.9606031; Hardy RD, 2002, INFECT IMMUN, V70, P649, DOI 10.1128/IAI.70.2.649-654.2002; Hardy RD, 2001, INFECT IMMUN, V69, P3869, DOI 10.1128/IAI.69.6.3869-3876.2001; Into T, 2002, MICROBIOL IMMUNOL, V46, P265, DOI 10.1111/j.1348-0421.2002.tb02695.x; Johnston SL, 2005, AM J RESP CRIT CARE; Kannan TR, 2006, P NATL ACAD SCI USA, V103, P6724, DOI 10.1073/pnas.0510644103; Kannan TR, 2005, INFECT IMMUN, V73, P2828, DOI 10.1128/IAI.73.5.2828-2834.2005; Kraft M, 2008, EUR RESPIR J, V31, P43, DOI 10.1183/09031936.00103307; Kraft M, 1998, AM J RESP CRIT CARE, V158, P998, DOI 10.1164/ajrccm.158.3.9711092; Kraft M, 2002, CHEST, V121, P1782, DOI 10.1378/chest.121.6.1782; KRUEGER KM, 1995, CLIN MICROBIOL REV, V8, P34, DOI 10.1128/CMR.8.1.34; Lieberman D, 2003, AM J RESP CRIT CARE, V167, P406, DOI 10.1164/rccm.200209-996OC; Liu J, 1998, J Tongji Med Univ, V18, P216; Martin RJ, 2001, J ALLERGY CLIN IMMUN, V107, P595, DOI 10.1067/mai.2001.113563; McCurnin D, 2008, PEDIATRICS, V122, pE1262, DOI 10.1542/peds.2008-2045; SABATO AR, 1984, ARCH DIS CHILD, V59, P1034, DOI 10.1136/adc.59.11.1034; Salvatore CM, 2008, INFECT IMMUN, V76, P732, DOI 10.1128/IAI.00878-07; Salvatore CM, 2007, INFECT IMMUN, V75, P236, DOI 10.1128/IAI.01249-06; Schwarze J, 1997, J CLIN INVEST, V100, P226, DOI 10.1172/JCI119516; SEGGEV JS, 1986, ANN ALLERGY, V57, P263; Takeuchi O, 2000, J IMMUNOL, V164, P554, DOI 10.4049/jimmunol.164.2.554; Talkington DF, 2004, CLIN DIAGN LAB IMMUN, V11, P862, DOI 10.1128/CDLI.11.5.862-867.2004; Thomson MA, 2006, PEDIATRICS, V118, P2038, DOI 10.1542/peds.2006-0622; van Schaik SM, 1998, J INFECT DIS, V177, P269, DOI 10.1086/514208; Waites KB, 2004, CLIN MICROBIOL REV, V17, P697, DOI 10.1128/CMR.17.4.697-728.2004; Waites KB, 2003, PEDIATR PULM, V36, P267, DOI 10.1002/ppul.10346; Woolard MD, 2004, J ALLERGY CLIN IMMUN, V114, P645, DOI 10.1016/j.jaci.2004.06.019; Wu Q, 2007, AM J PHYSIOL-LUNG C, V292, pL1064, DOI 10.1152/ajplung.00301.2006	44	72	85	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7562	10.1371/journal.pone.0007562	http://dx.doi.org/10.1371/journal.pone.0007562			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859545	Green Submitted, Green Published, gold			2022-12-27	WOS:000271147400001
J	Qureshi, AH; Chaoji, V; Maiguel, D; Faridi, MH; Barth, CJ; Salem, SM; Singhal, M; Stoub, D; Krastins, B; Ogihara, M; Zaki, MJ; Gupta, V				Qureshi, Amir H.; Chaoji, Vineet; Maiguel, Dony; Faridi, Mohd Hafeez; Barth, Constantinos J.; Salem, Saeed M.; Singhal, Mudita; Stoub, Darren; Krastins, Bryan; Ogihara, Mitsunori; Zaki, Mohammed J.; Gupta, Vineet			Proteomic and Phospho-Proteomic Profile of Human Platelets in Basal, Resting State: Insights into Integrin Signaling	PLOS ONE			English	Article							2-DIMENSIONAL GEL-ELECTROPHORESIS; FLOW-CYTOMETRIC ANALYSIS; ACTIVATED PLATELETS; MASS-SPECTROMETRY; THREONINE PHOSPHORYLATION; AFFINITY-CHROMATOGRAPHY; PROTEIN INTERACTIONS; INTERACTION NETWORKS; IDENTIFICATION; INTERACTOME	During atherogenesis and vascular inflammation quiescent platelets are activated to increase the surface expression and ligand affinity of the integrin alpha IIb beta 3 via inside-out signaling. Diverse signals such as thrombin, ADP and epinephrine transduce signals through their respective GPCRs to activate protein kinases that ultimately lead to the phosphorylation of the cytoplasmic tail of the integrin alpha IIb beta 3 and augment its function. The signaling pathways that transmit signals from the GPCR to the cytosolic domain of the integrin are not well defined. In an effort to better understand these pathways, we employed a combination of proteomic profiling and computational analyses of isolated human platelets. We analyzed ten independent human samples and identified a total of 1507 unique proteins in platelets. This is the most comprehensive platelet proteome assembled to date and includes 190 membrane-associated and 262 phosphorylated proteins, which were identified via independent proteomic and phospho-proteomic profiling. We used this proteomic dataset to create a platelet protein-protein interaction (PPI) network and applied novel contextual information about the phosphorylation step to introduce limited directionality in the PPI graph. This newly developed contextual PPI network computationally recapitulated an integrin signaling pathway. Most importantly, our approach not only provided insights into the mechanism of integrin alpha IIb beta 3 activation in resting platelets but also provides an improved model for analysis and discovery of PPI dynamics and signaling pathways in the future.			Qureshi, AH (corresponding author), Harvard Univ, Massachusetts Gen Hosp, Sch Med, Div Nephrol, Boston, MA 02115 USA.	vgupta2@med.miami.edu	Ogihara, Mitsunori/AAB-8275-2020	Ogihara, Mitsunori/0000-0002-5690-7854; Zaki, Mohammed/0000-0003-4711-0234; Gupta, Vineet/0000-0001-6987-2550	Direct For Computer & Info Scie & Enginr [0958490] Funding Source: National Science Foundation; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [K01DK068253] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R03NS053659] Funding Source: NIH RePORTER; NIBIB NIH HHS [1R01EB0080161] Funding Source: Medline; NIDDK NIH HHS [K01DK068253, K01 DK068253] Funding Source: Medline; NINDS NIH HHS [R03NS053659, R03 NS053659] Funding Source: Medline	Direct For Computer & Info Scie & Enginr(National Science Foundation (NSF)NSF - Directorate for Computer & Information Science & Engineering (CISE)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Amanchy R, 2007, NAT BIOTECHNOL, V25, P285, DOI 10.1038/nbt0307-285; ANAGLI J, 1991, BIOCHEM J, V274, P497, DOI 10.1042/bj2740497; Bader GD, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-2; Bagamery K, 2005, CLIN LAB HAEMATOL, V27, P75, DOI 10.1111/j.1365-2257.2004.00662.x; BENNETT JS, 1979, J CLIN INVEST, V64, P1393, DOI 10.1172/JCI109597; Braun P, 2009, NAT METHODS, V6, P91, DOI [10.1038/NMETH.1281, 10.1038/nmeth.1281]; Cagney G, 2008, ARTERIOSCL THROM VAS, V28, P1214, DOI 10.1161/ATVBAHA.108.167452; Calderwood DA, 1999, J BIOL CHEM, V274, P28071, DOI 10.1074/jbc.274.40.28071; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Cardigan R, 2005, VOX SANG, V88, P153, DOI 10.1111/j.1423-0410.2005.00618.x; CARRELL NA, 1985, J BIOL CHEM, V260, P1743; Claeys D, 2005, ELECTROPHORESIS, V26, P1189, DOI 10.1002/elps.200406196; Coller BS, 2008, BLOOD, V112, P3011, DOI 10.1182/blood-2008-06-077891; Coppinger JA, 2004, BLOOD, V103, P2096, DOI 10.1182/blood-2003-08-2804; Cowan KJ, 2000, J BIOL CHEM, V275, P36423, DOI 10.1074/jbc.M004068200; Crooks GE, 2004, GENOME RES, V14, P1188, DOI 10.1101/gr.849004; Curvers J, 2008, TRANSFUSION, V48, P1439, DOI 10.1111/j.1537-2995.2008.01738.x; Cusick ME, 2005, HUM MOL GENET, V14, pR171, DOI 10.1093/hmg/ddi335; Dittrich M, 2008, ARTERIOSCL THROM VAS, V28, P1326, DOI 10.1161/ATVBAHA.107.161000; Furie B, 2008, NEW ENGL J MED, V359, P938, DOI 10.1056/NEJMra0801082; Garcia A, 2004, PROTEOMICS, V4, P656, DOI 10.1002/pmic.200300665; Garcia A, 2004, BLOOD, V103, P2088, DOI 10.1182/blood-2003-07-2392; Garcia A, 2006, PROTEOMICS, V6, P5332, DOI 10.1002/pmic.200600299; Garcia BA, 2005, J PROTEOME RES, V4, P1516, DOI 10.1021/pr0500760; Gawaz M, 2005, J CLIN INVEST, V115, P3378, DOI 10.1172/JCI27196; Gnatenko DV, 2006, BLOOD, V108, P3983, DOI 10.1182/blood-2006-06-026518; Goh KI, 2007, P NATL ACAD SCI USA, V104, P8685, DOI 10.1073/pnas.0701361104; Greening DW, 2008, PROTEOM CLIN APPL, V2, P63, DOI 10.1002/prca.200780067; Greening David W., 2009, V528, P245, DOI 10.1007/978-1-60327-310-7_17; Hayashi M, 1999, ARCH BIOCHEM BIOPHYS, V371, P133, DOI 10.1006/abbi.1999.1427; Immler D, 1998, ELECTROPHORESIS, V19, P1015, DOI 10.1002/elps.1150190617; Kirk RI, 2000, J BIOL CHEM, V275, P30901, DOI 10.1074/jbc.M001908200; Lerea KM, 2007, BBA-MOL CELL RES, V1773, P185, DOI 10.1016/j.bbamcr.2006.08.053; Lerea KM, 1999, J BIOL CHEM, V274, P1914, DOI 10.1074/jbc.274.4.1914; MacDonald JA, 2002, MOL CELL PROTEOMICS, V1, P314, DOI 10.1074/mcp.M200002-MCP200; Maguire PB, 2002, PROTEOMICS, V2, P642, DOI 10.1002/1615-9861(200206)2:6<642::AID-PROT642>3.0.CO;2-I; Marcus K, 2003, ANAL BIOANAL CHEM, V376, P973, DOI 10.1007/s00216-003-2021-z; Marcus K, 2000, ELECTROPHORESIS, V21, P2622, DOI 10.1002/1522-2683(20000701)21:13<2622::AID-ELPS2622>3.0.CO;2-3; Martens L, 2005, PROTEOMICS, V5, P3193, DOI 10.1002/pmic.200401142; Moebius J, 2005, MOL CELL PROTEOMICS, V4, P1754, DOI 10.1074/mcp.M500209-MCP200; Moore RE, 2002, J AM SOC MASS SPECTR, V13, P378, DOI 10.1016/S1044-0305(02)00352-5; Murakami T, 1996, EUR J CLIN INVEST, V26, P996, DOI 10.1046/j.1365-2362.1996.2360585.x; MUSZYNSKA G, 1992, J CHROMATOGR, V604, P19, DOI 10.1016/0021-9673(92)85524-W; O'Neill EE, 2002, PROTEOMICS, V2, P288, DOI 10.1002/1615-9861(200203)2:3<288::AID-PROT288>3.0.CO;2-0; Obergfell A, 2002, J CELL BIOL, V157, P265, DOI 10.1083/jcb.200112113; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Palmer-Toy DE, 2005, J PROTEOME RES, V4, P2404, DOI 10.1021/pr050208p; Phipps RP, 2001, LANCET, V357, P2023, DOI 10.1016/S0140-6736(00)05108-4; Posewitz MC, 1999, ANAL CHEM, V71, P2883, DOI 10.1021/ac981409y; Prasad TSK, 2009, NUCLEIC ACIDS RES, V37, pD767, DOI 10.1093/nar/gkn892; Pruitt KD, 2005, NUCLEIC ACIDS RES, V33, pD501, DOI 10.1093/nar/gki025; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Sato K, 2002, J BIOL CHEM, V277, P29568, DOI 10.1074/jbc.M203179200; Schwartz D, 2005, NAT BIOTECHNOL, V23, P1391, DOI 10.1038/nbt1146; Senis YA, 2007, MOL CELL PROTEOMICS, V6, P548, DOI 10.1074/mcp.D600007-MCP200; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shattil SJ, 2004, BLOOD, V104, P1606, DOI 10.1182/blood-2004-04-1257; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; VERHALLEN PFJ, 1987, BIOCHIM BIOPHYS ACTA, V903, P206, DOI 10.1016/0005-2736(87)90170-2; Vijayan KV, 2004, J BIOL CHEM, V279, P33039, DOI 10.1074/jbc.C400239200; Villen J, 2007, P NATL ACAD SCI USA, V104, P1488, DOI 10.1073/pnas.0609836104; Wagner CL, 1996, BLOOD, V88, P907; Winkler W, 2008, MOL CELL PROTEOMICS, V7, P193, DOI 10.1074/mcp.M700137-MCP200; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Zahedi RP, 2008, J PROTEOME RES, V7, P526, DOI 10.1021/pr0704130; Zahedi RP, 2006, BBA-PROTEINS PROTEOM, V1764, P1963, DOI 10.1016/j.bbapap.2006.08.017; Zaidel-Bar R, 2007, NAT CELL BIOL, V9, P858, DOI 10.1038/ncb0807-858	67	102	106	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7627	10.1371/journal.pone.0007627	http://dx.doi.org/10.1371/journal.pone.0007627			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859549	Green Submitted, Green Published, gold			2022-12-27	WOS:000271147400019
J	Ben Arous, J; Laffont, S; Chatenay, D				Ben Arous, Juliette; Laffont, Sophie; Chatenay, Didier			Molecular and Sensory Basis of a Food Related Two-State Behavior in C. elegans	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CAENORHABDITIS-ELEGANS; CGMP; MODULATION; MECHANISMS; EXPERIENCE; FAT	Most animals display multiple behavioral states and control the time allocation to each of their activity phases depending on their environment. Here we develop a new quantitative method to analyze Caenorhabditis elegans behavioral states. We show that the dwelling and roaming two-state behavior of C. elegans is tightly controlled by the concentration of food in the environment of the animal. Sensory perception through the amphid neurons is necessary to extend roaming phases while internal metabolic perception of food nutritional value is needed to induce dwelling. Our analysis also shows that the proportion of time spent in each state is modulated by past nutritional experiences of the animal. This two-state behavior is regulated through serotonin as well as insulin and TGF-beta signaling pathways. We propose a model where food nutritional value is assessed through internal metabolic signaling. Biogenic amines signaling could allow the worm to adapt to fast changes in the environment when peptide transcriptional pathways may mediate slower adaptive changes.			Ben Arous, J (corresponding author), Univ Paris 06, CNRS, Ecole Normale Super, Lab Phys Stat, Paris, France.	juliette.benarous@lps.ens.fr						BARGMANN CI, 1993, ANNU REV NEUROSCI, V16, P47, DOI 10.1146/annurev.ne.16.030193.000403; Cheung BHH, 2005, CURR BIOL, V15, P905, DOI 10.1016/j.cub.2005.04.017; Colbert HA, 1997, LEARN MEMORY, V4, P179, DOI 10.1101/lm.4.2.179; de Bono M, 2005, ANNU REV NEUROSCI, V28, P451, DOI 10.1146/annurev.neuro.27.070203.144259; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Fujiwara M, 2002, NEURON, V36, P1091, DOI 10.1016/S0896-6273(02)01093-0; Gems D, 1998, GENETICS, V150, P129; Goulding EH, 2008, P NATL ACAD SCI USA, V105, P20575, DOI 10.1073/pnas.0809053106; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Gruninger TR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000117; Hapiak VM, 2009, GENETICS, V181, P153, DOI 10.1534/genetics.108.096891; HERBERS JM, 1981, OECOLOGIA, V49, P252, DOI 10.1007/BF00349198; Hobert O, 2008, P NATL ACAD SCI USA, V105, P20067, DOI 10.1073/pnas.0806070105; Kang CH, 2009, GENE DEV, V23, P12, DOI 10.1101/gad.1723409; Kaun KR, 2007, J EXP BIOL, V210, P3547, DOI 10.1242/jeb.006924; Kindt KS, 2007, NEURON, V55, P662, DOI 10.1016/j.neuron.2007.07.023; Ranganathan R, 2000, NATURE, V408, P470, DOI 10.1038/35044083; Riddle DL, 1997, C ELEGANS, P739; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schafer WR, 2005, CURR BIOL, V15, pR723, DOI 10.1016/j.cub.2005.08.020; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Srinivasan S, 2008, CELL METAB, V7, P533, DOI 10.1016/j.cmet.2008.04.012; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005	24	73	86	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7584	10.1371/journal.pone.0007584	http://dx.doi.org/10.1371/journal.pone.0007584			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851507	Green Published, gold, Green Submitted			2022-12-27	WOS:000271022300015
J	Terrien, J; Zahariev, A; Blanc, S; Aujard, F				Terrien, Jeremy; Zahariev, Alexandre; Blanc, Stephane; Aujard, Fabienne			Impaired Control of Body Cooling during Heterothermia Represents the Major Energetic Constraint in an Aging Non-Human Primate Exposed to Cold	PLOS ONE			English	Article							BROWN ADIPOSE-TISSUE; LESSER MOUSE LEMUR; DOUBLY LABELED WATER; DAILY TORPOR; AMBIENT-TEMPERATURE; MICROCEBUS-MURINUS; THERMOREGULATORY RESPONSES; REPRODUCTIVE FUNCTION; PROSIMIAN PRIMATE; GENE-EXPRESSION	Daily heterothermia is used by small mammals for energy and water savings, and seems to be preferentially exhibited during winter rather than during summer. This feature induces a trade-off between the energy saved during daily heterothermia and the energy cost of arousal, which can impact energy balance and survival under harsh environmental conditions. Especially, aging may significantly affect such trade off during cold-induced energy stress, but direct evidences are still lacking. We hypothesized that aging could alter the energetics of daily heterothermia, and that the effects could differ according to season. In the gray mouse lemur (Microcebus murinus), a non-human primate species which exhibits daily heterothermia, we investigated the effects of exposures to 25 and 12 degrees C on body composition, energy balance, patterns of heterothermia and water turnover in adult (N = 8) and aged animals (N = 7) acclimated to winter-like or summer-like photoperiods. Acclimation to summer prevented animals from deep heterothermia, even during aging. During winter, adult animals at 12 degrees C and aged animals at 25 degrees C exhibited low levels of energy expenditure with minor modulations of heterothermia. The major effects of cold were observed during winter, and were particularly pronounced in aged mouse lemurs which exhibited deep heterothermia phases. Body composition was not significantly affected by age and could not explain the age-related differences in heterothermia patterns. However, aging was associated with increased levels of energy expenditure during cold exposure, in concomitance with impaired energy balance. Interestingly, increased energy expenditure and depth of heterothermia phases were strongly correlated. In conclusion, it appeared that the exhibition of shallow heterothermia allowed energy savings during winter in adult animals only. Aged animals exhibited deep heterothermia and increased levels of energy expenditure, impairing energy balance. Thus, an impaired control of the heterothermic process induced high energy costs in the aging mouse lemur exposed to cold.			Terrien, J (corresponding author), MNHN, CNRS, UMR 7179, Brunoy, France.	jeremy.terrien@hotmail.fr	Jeremy, TERRIEN/J-7359-2013; TERRIEN, Jeremy/F-6538-2010	Terrien, Jeremy/0000-0001-8530-4481				Anderson GS, 1999, INT J BIOMETEOROL, V43, P99, DOI 10.1007/s004840050123; Aujard F, 2001, NEUROSCIENCE, V105, P403, DOI 10.1016/S0306-4522(01)00202-0; Aujard F, 1998, J COMP PHYSIOL B, V168, P540, DOI 10.1007/s003600050175; Aujard F, 1998, PHYSIOL BEHAV, V64, P513, DOI 10.1016/S0031-9384(98)00087-0; Bolker BM, 2009, TRENDS ECOL EVOL, V24, P127, DOI 10.1016/j.tree.2008.10.008; Cannon B, 2004, PHYSIOL REV, V84, P277, DOI 10.1152/physrev.00015.2003; DeGroot DW, 2007, AM J PHYSIOL-REG I, V292, pR103, DOI 10.1152/ajpregu.00074.2006; DIEM K, 1963, VITAMINES LIPOSOLUBL, P459; Duchamp C, 1997, AM J PHYSIOL-ENDOC M, V272, pE453, DOI 10.1152/ajpendo.1997.272.3.E453; ELLISON GTH, 1992, J THERM BIOL, V17, P25, DOI 10.1016/0306-4565(92)90016-9; Frank SM, 2000, AM J PHYSIOL-REG I, V279, pR349, DOI 10.1152/ajpregu.2000.279.1.R349; Geiser F, 2004, ANNU REV PHYSIOL, V66, P239, DOI 10.1146/annurev.physiol.66.032102.115105; Geiser F, 2003, J COMP PHYSIOL B, V173, P55, DOI 10.1007/s00360-002-0311-y; Genin F, 2000, PHYSIOL BEHAV, V71, P315, DOI 10.1016/S0031-9384(00)00335-8; Genin F, 2003, AM J PHYSIOL-REG I, V284, pR811, DOI 10.1152/ajpregu.00525.2002; Giroud S, 2008, AM J PHYSIOL-REG I, V294, pR1958, DOI 10.1152/ajpregu.00794.2007; Giroud S, 2009, J COMP PHYSIOL B, V179, P99, DOI 10.1007/s00360-008-0294-4; Granneman JG, 2003, AM J PHYSIOL-ENDOC M, V285, pE1230, DOI 10.1152/ajpendo.00197.2003; Hampl R, 2006, PHYSIOL RES, V55, P123, DOI 10.33549/physiolres.930758; Heldmaier G, 2004, RESP PHYSIOL NEUROBI, V141, P317, DOI 10.1016/j.resp.2004.03.014; HELDMAIER G, 1992, J COMP PHYSIOL B, V162, P696, DOI 10.1007/BF00301619; Kenney WL, 1996, J APPL PHYSIOL, V80, P512, DOI 10.1152/jappl.1996.80.2.512; Lovegrove BG, 1999, J COMP PHYSIOL B, V169, P11, DOI 10.1007/s003600050188; Perret M, 2006, M S-MED SCI, V22, P279, DOI 10.1051/medsci/2006223279; Perret M, 2005, EXP GERONTOL, V40, P582, DOI 10.1016/j.exger.2005.05.002; Perret M, 1997, J BIOL RHYTHM, V12, P136, DOI 10.1177/074873049701200205; Perret M, 2001, AM J PHYSIOL-REG I, V281, pR1925, DOI 10.1152/ajpregu.2001.281.6.R1925; Perret M, 2001, INT J PRIMATOL, V22, P5, DOI 10.1023/A:1026457813626; PERRET M, 1992, FOLIA PRIMATOL, V59, P1; Perret M, 1998, J MAMMAL, V79, P1093, DOI 10.2307/1383001; Pinheiro J. C., 2005, NLME LINEAR NONLINEA; PROTHERO J, 1986, J THEOR BIOL, V121, P403, DOI 10.1016/S0022-5193(86)80099-6; *R DEV COR T, 2004, R LANG ENV STAT COMP; Ricquier D, 2006, CR BIOL, V329, P578, DOI 10.1016/j.crvi.2005.10.010; Schmid J, 2009, NATURWISSENSCHAFTEN, V96, P737, DOI 10.1007/s00114-009-0523-z; Schmid J, 2009, NATURWISSENSCHAFTEN, V96, P609, DOI 10.1007/s00114-009-0515-z; Schmid J, 2000, J COMP PHYSIOL B, V170, P633, DOI 10.1007/s003600000146; SCHOELLER DA, 1986, AM J PHYSIOL, V250, pR823, DOI 10.1152/ajpregu.1986.250.5.R823; SCHOELLER DA, 1982, J APPL PHYSIOL, V53, P955, DOI 10.1152/jappl.1982.53.4.955; Seguy M, 2005, J COMP PHYSIOL B, V175, P107, DOI 10.1007/s00360-004-0467-8; Sell H, 2004, INT J BIOCHEM CELL B, V36, P2098, DOI 10.1016/j.biocel.2004.04.003; Shefer VI, 1997, EXP GERONTOL, V32, P325, DOI 10.1016/S0531-5565(96)00131-3; Speakman J.R., 1997, DOUBLY LABELLED WATE; Terrien J, 2008, AM J PHYSIOL-REG I, V295, pR696, DOI 10.1152/ajpregu.00629.2007; Terrien J, 2009, CHRONOBIOL INT, V26, P838, DOI 10.1080/07420520903044281; Tiraby C, 2003, TRENDS ENDOCRIN MET, V14, P439, DOI 10.1016/j.tem.2003.10.001; TUCKER VA, 1965, J CELL COMPAR PHYSL, V65, P393, DOI 10.1002/jcp.1030650313; WEIR JBD, 1949, J PHYSIOL-LONDON, V109, P1, DOI 10.1113/jphysiol.1949.sp004363; WONG WW, 1987, AM J CLIN NUTR, V45, P905, DOI 10.1093/ajcn/45.5.905; YAMASHITA H, 1994, LIFE SCI, V55, P141, DOI 10.1016/0024-3205(94)90105-8	50	11	12	2	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7587	10.1371/journal.pone.0007587	http://dx.doi.org/10.1371/journal.pone.0007587			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851464	Green Published, gold, Green Submitted			2022-12-27	WOS:000271022300018
J	Galli, S; Jahn, O; Hitt, R; Hesse, D; Opitz, L; Plessmann, U; Urlaub, H; Poderoso, JJ; Jares-Erijman, EA; Jovin, TM				Galli, Soledad; Jahn, Olaf; Hitt, Reiner; Hesse, Doerte; Opitz, Lennart; Plessmann, Uwe; Urlaub, Henning; Poderoso, Juan Jose; Jares-Erijman, Elizabeth A.; Jovin, Thomas M.			A New Paradigm for MAPK: Structural Interactions of hERK1 with Mitochondria in HeLa Cells	PLOS ONE			English	Article							DEPENDENT ANION CHANNEL; ACTIVATED PROTEIN-KINASES; SIGNAL-REGULATED KINASE; FACTOR-A TFAM; HISTONE H1.2; PKC-EPSILON; ERK; PHOSPHORYLATION; IDENTIFICATION; VDAC	Extracellular signal-regulated protein kinase 1 and 2 (ERK1/2) are members of the MAPK family and participate in the transduction of stimuli in cellular responses. Their long-term actions are accomplished by promoting the expression of specific genes whereas faster responses are achieved by direct phosphorylation of downstream effectors located throughout the cell. In this study we determined that hERK1 translocates to the mitochondria of HeLa cells upon a proliferative stimulus. In the mitochondrial environment, hERK1 physically associates with (i) at least 5 mitochondrial proteins with functions related to transport (i.e. VDAC1), signalling, and metabolism; (ii) histones H2A and H4; and (iii) other cytosolic proteins. This work indicates for the first time the presence of diverse ERK-complexes in mitochondria and thus provides a new perspective for assessing the functions of ERK1 in the regulation of cellular signalling and trafficking in HeLa cells.			Galli, S (corresponding author), Max Planck Inst Biophys Chem, Lab Cellular Dynam, Gottingen, Germany.	sgalli@qo.fcen.uba.ar; tjovin@gwdg.de	Jahn, Olaf/AAD-8212-2020	Jahn, Olaf/0000-0002-3397-8924				Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Ando R, 2004, SCIENCE, V306, P1370, DOI 10.1126/science.1102506; ATTARDI G, 1988, ANNU REV CELL BIOL, V4, P289, DOI 10.1146/annurev.cellbio.4.1.289; Baines CP, 2002, CIRC RES, V90, P390, DOI 10.1161/01.RES.0000012702.90501.8D; Bastiaens PIH, 1996, EMBO J, V15, P4246, DOI 10.1002/j.1460-2075.1996.tb00799.x; Bernardi P, 1999, PHYSIOL REV, V79, P1127, DOI 10.1152/physrev.1999.79.4.1127; Bretz F, 2005, METHOD INFORM MED, V44, P431; Canagarajah BJ, 1997, CELL, V90, P859, DOI 10.1016/S0092-8674(00)80351-7; Carreras MC, 2004, HEPATOLOGY, V40, P157, DOI 10.1002/hep.20255; Casar B, 2008, MOL CELL, V31, P708, DOI 10.1016/j.molcel.2008.07.024; CHEN RH, 1992, MOL CELL BIOL, V12, P915, DOI 10.1128/MCB.12.3.915; CLEVELAND WS, 1979, J AM STAT ASSOC, V74, P829, DOI 10.2307/2286407; Cobb MH, 2000, TRENDS BIOCHEM SCI, V25, P7, DOI 10.1016/S0968-0004(99)01508-X; Colombini M, 2004, MOL CELL BIOCHEM, V256, P107, DOI 10.1023/B:MCBI.0000009862.17396.8d; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; CREWS CM, 1991, P NATL ACAD SCI USA, V88, P8845, DOI 10.1073/pnas.88.19.8845; Crompton M, 1999, BIOCHEM J, V341, P233, DOI 10.1042/0264-6021:3410233; DAVIS RJ, 1993, J BIOL CHEM, V268, P14553; English J, 1999, EXP CELL RES, V253, P255, DOI 10.1006/excr.1999.4687; Enriquez JA, 1996, EUR J BIOCHEM, V237, P601, DOI 10.1111/j.1432-1033.1996.0601p.x; Fink M, 2007, MOL CELL BIOL, V27, P3589, DOI 10.1128/MCB.02077-06; Furuno T, 2001, J IMMUNOL, V166, P4416, DOI 10.4049/jimmunol.166.7.4416; Galli S, 2003, CANCER RES, V63, P6370; Galli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002379; Garstka HL, 2003, NUCLEIC ACIDS RES, V31, P5039, DOI 10.1093/nar/gkg717; Jahn O, 2006, ANAL BIOANAL CHEM, V386, P92, DOI 10.1007/s00216-006-0592-1; Jimenez C, 2007, J EXP BOT, V58, P1001, DOI 10.1093/jxb/erl260; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Karlsson M, 2006, BIOCHEM SOC T, V34, P842, DOI 10.1042/BST0340842; Khokhlatchev AV, 1998, CELL, V93, P605, DOI 10.1016/S0092-8674(00)81189-7; Klemke RL, 1997, J CELL BIOL, V137, P481, DOI 10.1083/jcb.137.2.481; Komiya T, 1996, J BIOL CHEM, V271, P22105, DOI 10.1074/jbc.271.36.22105; Konishi A, 2003, CELL, V114, P673, DOI 10.1016/S0092-8674(03)00719-0; Landgrebe J, 2006, COMPUT STAT DATA AN, V50, P499, DOI 10.1016/j.csda.2004.08.014; LENORMAND P, 1993, J CELL BIOL, V122, P1079, DOI 10.1083/jcb.122.5.1079; Levin-Salomon V, 2009, BIOCHEM J, V417, P331, DOI 10.1042/BJ20081335; LINDEN M, 1983, BIOCHIM BIOPHYS ACTA, V736, P125, DOI 10.1016/0005-2736(83)90177-3; Lloyd Alison C, 2006, J Biol, V5, P13, DOI 10.1186/jbiol46; Maniura-Weber K, 2004, NUCLEIC ACIDS RES, V32, P6015, DOI 10.1093/nar/gkh921; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Manning G, 2008, P NATL ACAD SCI USA, V105, P9674, DOI 10.1073/pnas.0801314105; Okamura H, 2008, J CELL BIOCHEM, V103, P1488, DOI 10.1002/jcb.21537; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Philipova R, 2005, J CELL SCI, V118, P5767, DOI 10.1242/jcs.02683; Ping PP, 2002, J CLIN INVEST, V109, P499, DOI 10.1172/JCI200213200; Poderoso C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001443; Ray D, 2005, GENE, V346, P41, DOI 10.1016/j.gene.2004.10.026; Reumann S, 2007, PLANT CELL, V19, P3170, DOI 10.1105/tpc.107.050989; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rostovtseva TK, 2000, P NATL ACAD SCI USA, V97, P7819, DOI 10.1073/pnas.140115397; Roth SY, 2001, ANNU REV BIOCHEM, V70, P81, DOI 10.1146/annurev.biochem.70.1.81; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Schwertz H, 2007, PROTEOMICS, V7, P4579, DOI 10.1002/pmic.200700734; Shadel GS, 1997, ANNU REV BIOCHEM, V66, P409, DOI 10.1146/annurev.biochem.66.1.409; Shaul YD, 2006, J CELL BIOL, V172, P885, DOI 10.1083/jcb.200509063; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Shi Y, 2003, BIOCHEM BIOPH RES CO, V303, P475, DOI 10.1016/S0006-291X(03)00359-0; Shoshan-Barmatz V, 2006, CURR PHARM DESIGN, V12, P2249, DOI 10.2174/138161206777585111; Shoshan-Barmatz V, 2003, CELL BIOCHEM BIOPHYS, V39, P279, DOI 10.1385/CBB:39:3:279; Song CX, 2002, AM J PHYSIOL-HEART C, V282, pH1166, DOI 10.1152/ajpheart.00830.2001; Tanoue T, 2001, EMBO J, V20, P466, DOI 10.1093/emboj/20.3.466; Tanoue T, 2000, NAT CELL BIOL, V2, P110, DOI 10.1038/35000065; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yoon S, 2006, GROWTH FACTORS, V24, P21, DOI 10.1080/02699050500284218; Zalk R, 2005, BIOCHEM J, V386, P73, DOI 10.1042/BJ20041356; Zhou TJ, 2006, STRUCTURE, V14, P1011, DOI 10.1016/j.str.2006.04.006; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	68	34	34	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7541	10.1371/journal.pone.0007541	http://dx.doi.org/10.1371/journal.pone.0007541			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847302	Green Published, gold, Green Submitted			2022-12-27	WOS:000271022000012
J	Ramachandran, V; Arumugam, T; Langley, R; Hwang, RF; Vivas-Mejia, P; Sood, AK; Lopez-Berestein, G; Logsdon, CD				Ramachandran, Vijaya; Arumugam, Thiruvengadam; Langley, Robert; Hwang, Rosa F.; Vivas-Mejia, Pablo; Sood, Anil K.; Lopez-Berestein, Gabriel; Logsdon, Craig D.			The ADMR Receptor Mediates the Effects of Adrenomedullin on Pancreatic Cancer Cells and on Cells of the Tumor Microenvironment	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; GENE-RELATED PEPTIDE; HYDROPS-FETALIS; MICE LACKING; EXPRESSION; PROLIFERATION; ANGIOGENESIS; INVOLVEMENT; SURVIVAL; LINES	Background: Adrenomedullin (AM) is highly expressed in pancreatic cancer and stimulates pancreatic cancer cells leading to increased tumor growth and metastasis. The current study examines the role of specific AM receptors on tumor and cells resembling the tumor microenvironment (human pancreatic stellate - HPSC, human umbilical vein - HUVEC and mouse lung endothelial cells - MLEC). Methods and Findings: AM receptors ADMR and CRLR were present in HPSC, HUVEC and MLECs while PDAC cells possessed only ADMR receptors as assessed by RT-PCR and western blotting. All cell lines expressed and secreted AM as indicated by ELISA. The growth of each of the cell lines was stimulated by exogenous AM and inhibited by the antagonist AMA. AM also stimulated in vitro angiogenesis assessed by polygon formation of endothelial cell lines. SiRNA-mediated silencing of ADMR, but not CRLR, reduced basal growth of all cells examined and reduced polygon formation of endothelial cells in vitro. Orthotopic tumors developed with shADMR bearing cancer cells had dramatically reduced primary tumor volume (>90%) and lung and liver metastasis compared to shControl bearing cells. To validate ADMR as a potential therapeutic target, in vivo studies were conducted using neutral nanoliposomes to systemically deliver human siRNA to ADMR to silence human cancer cells and mouse siRNA to ADMR to silence mouse tumor stromal cells. Systemic silencing of both human and mouse ADMR had no obvious adverse effects but strongly reduced tumor development. Conclusion: ADMR mediates the stimulatory effects of AM on cancer cells and on endothelial and stellate cells within the tumor microenvironment. These data support the further development of ADMR as a useful target treatment of pancreatic cancer.			Ramachandran, V (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, Houston, TX 77030 USA.	clogsdon@mdanderson.org			NCI NIH HHS [P30 CA016672, P20 CA101936, CA16672] Funding Source: Medline; NIDDK NIH HHS [R01 DK052067, DK052067] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA016672, P20CA101936] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052067] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Albertin G, 2001, INT J MOL MED, V8, P423; Arumugam T, 2005, CLIN CANCER RES, V11, P5356, DOI 10.1158/1078-0432.CCR-05-0092; Caron KM, 2001, P NATL ACAD SCI USA, V98, P615, DOI 10.1073/pnas.021548898; Cormier-Regard S, 1998, J BIOL CHEM, V273, P17787, DOI 10.1074/jbc.273.28.17787; Dackor RT, 2006, MOL CELL BIOL, V26, P2511, DOI 10.1128/MCB.26.7.2511-2518.2006; Fernandez-Sauze S, 2004, INT J CANCER, V108, P797, DOI 10.1002/ijc.11663; Fritz-Six KL, 2008, J CLIN INVEST, V118, P40, DOI 10.1172/JCI33302; Gorbig MN, 2001, J HEPATOL, V34, P222; Guidolin D, 2008, PEPTIDES, V29, P2013, DOI 10.1016/j.peptides.2008.07.009; Hayakawa H, 1999, HYPERTENSION, V33, P689, DOI 10.1161/01.HYP.33.2.689; Hinson JP, 2000, ENDOCR REV, V21, P138, DOI 10.1210/er.21.2.138; Hwang RF, 2008, CANCER RES, V68, P918, DOI 10.1158/0008-5472.CAN-07-5714; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Kato H, 1997, ENDOCRINOLOGY, V138, P2615, DOI 10.1210/en.138.6.2615; KITAMURA K, 1993, BIOCHEM BIOPH RES CO, V192, P553, DOI 10.1006/bbrc.1993.1451; Landen CN, 2005, CANCER RES, V65, P6910, DOI 10.1158/0008-5472.CAN-05-0530; Langley RR, 2003, CANCER RES, V63, P2971; Martinez A, 1996, ENDOCRINOLOGY, V137, P2626, DOI 10.1210/en.137.6.2626; Martinez A, 2000, ENDOCRINOLOGY, V141, P406, DOI 10.1210/en.141.1.406; Miller MJ, 1996, J BIOL CHEM, V271, P23345; Miyashita K, 2003, HYPERTENS RES, V26, pS93, DOI 10.1291/hypres.26.S93; Nakayama M, 1998, BIOCHEM BIOPH RES CO, V243, P514, DOI 10.1006/bbrc.1998.8131; NUKI C, 1993, BIOCHEM BIOPH RES CO, V196, P245, DOI 10.1006/bbrc.1993.2241; Oehler MK, 2001, ONCOGENE, V20, P2937, DOI 10.1038/sj.onc.1204422; Peiper M, 1997, INT J CANCER, V71, P993, DOI 10.1002/(SICI)1097-0215(19970611)71:6<993::AID-IJC15>3.0.CO;2-7; Pio R, 2001, J BIOL CHEM, V276, P12292, DOI 10.1074/jbc.M007822200; PLIARCHOPOULOU K, 2009, CANC TREAT IN PRESS; Ramachandran V, 2007, CANCER RES, V67, P2666, DOI 10.1158/0008-5472.CAN-06-3362; Rocchi P, 2001, CANCER RES, V61, P1196; Shibata Y, 2006, UROLOGY, V68, P1127, DOI 10.1016/j.urology.2006.06.025; Sumanas S, 2005, BLOOD, V106, P534, DOI 10.1182/blood-2004-12-4653; ZHAO L, 1996, AM J PHYSIOL, V271, P622	32	23	25	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7502	10.1371/journal.pone.0007502	http://dx.doi.org/10.1371/journal.pone.0007502			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847298	Green Published, Green Submitted, gold			2022-12-27	WOS:000271022000010
J	Karlberg, T; van den Berg, S; Hammarstrom, M; Sagemark, J; Johansson, I; Holmberg-Schiavone, L; Schuler, H				Karlberg, Tobias; van den Berg, Susanne; Hammarstrom, Martin; Sagemark, Johanna; Johansson, Ida; Holmberg-Schiavone, Lovisa; Schuler, Herwig			Crystal Structure of the ATPase Domain of the Human AAA plus Protein Paraplegin/SPG7	PLOS ONE			English	Article							SPASTIC PARAPLEGIA; SPG7 MUTATIONS; MITOCHONDRIA; RESIDUES; BINDING; FAMILY; REGION; FTSH	Paraplegin is an m-AAA protease of the mitochondrial inner membrane that is linked to hereditary spastic paraplegias. The gene encodes an FtsH-homology protease domain in tandem with an AAA+ homology ATPase domain. The protein is believed to form a hexamer that uses ATPase-driven conformational changes in its AAA-domain to deliver substrate peptides to its protease domain. We present the crystal structure of the AAA-domain of human paraplegin bound to ADP at 2.2 angstrom. This enables assignment of the roles of specific side chains within the catalytic cycle, and provides the structural basis for understanding the mechanism of disease mutations.			Karlberg, T (corresponding author), Karolinska Inst, Dept Med Biochem & Biophys, Struct Genom Consortium, Stockholm, Sweden.	herwig.schuler@ki.se	Schuler, Herwig/E-5751-2011	Schuler, Herwig/0000-0003-4059-3501	CIHR Funding Source: Medline; Wellcome Trust Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ammelburg M, 2006, J STRUCT BIOL, V156, P2, DOI 10.1016/j.jsb.2006.05.002; Arnoldi A, 2008, HUM MUTAT, V29, P522, DOI 10.1002/humu.20682; Atorino L, 2003, J CELL BIOL, V163, P777, DOI 10.1083/jcb.200304112; Bieniossek C, 2006, P NATL ACAD SCI USA, V103, P3066, DOI 10.1073/pnas.0600031103; Briggs LC, 2008, J BIOL CHEM, V283, P13745, DOI 10.1074/jbc.M709632200; Brugman F, 2008, NEUROLOGY, V71, P1500, DOI 10.1212/01.wnl.0000319700.11606.21; Casari G, 1998, CELL, V93, P973, DOI 10.1016/S0092-8674(00)81203-9; Elleuch N, 2006, NEUROLOGY, V66, P654, DOI 10.1212/01.wnl.0000201185.91110.15; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Erzberger JP, 2006, ANNU REV BIOPH BIOM, V35, P93, DOI 10.1146/annurev.biophys.35.040405.101933; Ferreirinha F, 2001, AM J HUM GENET, V69, P196; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; Hanson PI, 2005, NAT REV MOL CELL BIO, V6, P519, DOI 10.1038/nrm1684; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; Juhola MK, 2000, FEBS LETT, V481, P91, DOI 10.1016/S0014-5793(00)01989-X; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Karata K, 1999, J BIOL CHEM, V274, P26225, DOI 10.1074/jbc.274.37.26225; Koppen M, 2007, MOL CELL BIOL, V27, P758, DOI 10.1128/MCB.01470-06; Lovell SC, 2003, PROTEINS, V50, P437, DOI 10.1002/prot.10286; Martin A, 2008, NAT STRUCT MOL BIOL, V15, P1147, DOI 10.1038/nsmb.1503; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Niwa H, 2002, STRUCTURE, V10, P1415, DOI 10.1016/S0969-2126(02)00855-9; Nolden M, 2005, CELL, V123, P277, DOI 10.1016/j.cell.2005.08.003; Ogura T, 2004, J STRUCT BIOL, V146, P106, DOI 10.1016/j.jsb.2003.11.008; Painter J, 2006, J APPL CRYSTALLOGR, V39, P109, DOI 10.1107/S0021889805038987; Rugarli EI, 2006, TRENDS MOL MED, V12, P262, DOI 10.1016/j.molmed.2006.04.002; Salinas S, 2008, LANCET NEUROL, V7, P1127, DOI 10.1016/S1474-4422(08)70258-8; Snider J, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-4-216; Suno R, 2006, MOL CELL, V22, P575, DOI 10.1016/j.molcel.2006.04.020; Vagin A, 2000, ACTA CRYSTALLOGR D, V56, P1622, DOI 10.1107/S0907444900013780; White SR, 2007, TRAFFIC, V8, P1657, DOI 10.1111/j.1600-0854.2007.00642.x; Wilkinson PA, 2004, BRAIN, V127, P973, DOI 10.1093/brain/awh125; Yamada-Inagawa T, 2003, J BIOL CHEM, V278, P50182, DOI 10.1074/jbc.M308327200; Zhang XD, 2008, NAT STRUCT MOL BIOL, V15, P1223, DOI 10.1038/nsmb.1501	34	30	31	2	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e6975	10.1371/journal.pone.0006975	http://dx.doi.org/10.1371/journal.pone.0006975			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841671	Green Published, Green Submitted, gold			2022-12-27	WOS:000271012900001
J	Pilling, D; Fan, T; Huang, D; Kaul, B; Gomer, RH				Pilling, Darrell; Fan, Ted; Huang, Donna; Kaul, Bhavika; Gomer, Richard H.			Identification of Markers that Distinguish Monocyte-Derived Fibrocytes from Monocytes, Macrophages, and Fibroblasts	PLOS ONE			English	Article							PERIPHERAL-BLOOD FIBROCYTES; COLONY-STIMULATING FACTOR; T-CELL APOPTOSIS; CIRCULATING FIBROCYTES; MONOCLONAL-ANTIBODY; GENE-EXPRESSION; LUNG FIBROBLASTS; DENDRITIC CELLS; STROMAL CELLS; BURN PATIENTS	Background: The processes that drive fibrotic diseases are complex and include an influx of peripheral blood monocytes that can differentiate into fibroblast-like cells called fibrocytes. Monocytes can also differentiate into other cell types, such as tissue macrophages. The ability to discriminate between monocytes, macrophages, fibrocytes, and fibroblasts in fibrotic lesions could be beneficial in identifying therapies that target either stromal fibroblasts or fibrocytes. Methodology/Principal Findings: We have identified markers that discriminate between human peripheral blood monocytes, tissue macrophages, fibrocytes, and fibroblasts. Amongst these four cell types, only peripheral blood monocytes express the combination of CD45RO, CD93, and S100A8/A9; only macrophages express the combination of CD45RO, 25F9, S100A8/A9, and PM-2K; only fibrocytes express the combination of CD45RO, 25F9, and S100A8/A9, but not PM-2K; and only fibroblasts express the combination of CD90, cellular fibronectin, hyaluronan, and TE-7. These markers are effective both in vitro and in sections from human lung. We found that markers such as CD34, CD68, and collagen do not effectively discriminate between the four cell types. In addition, IL-4, IL-12, IL-13, IFN-gamma, and SAP differentially regulate the expression of CD32, CD163, CD172a, and CD206 on both macrophages and fibrocytes. Finally, CD49c (alpha 3 integrin) expression identifies a subset of fibrocytes, and this subset increases with time in culture. Conclusions/Significance: These results suggest that discrimination of monocytes, macrophages, fibrocytes, and fibroblasts in fibrotic lesions is possible, and this may allow for an assessment of fibrocytes in fibrotic diseases.			Pilling, D (corresponding author), Rice Univ, Dept Biochem & Cell Biol, POB 1892, Houston, TX 77251 USA.	dpilling@rice.edu		Gomer, Richard/0000-0003-2361-4307; Huang, Donna/0000-0001-8620-639X; Pilling, Darrell/0000-0002-7413-2773	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL083029] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL083029, R01 HL083029] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Abe R, 2001, J IMMUNOL, V166, P7556, DOI 10.4049/jimmunol.166.12.7556; Akbar AN, 1996, EUR J IMMUNOL, V26, P294, DOI 10.1002/eji.1830260204; Andersson-Sjoland A, 2008, INT J BIOCHEM CELL B, V40, P2129, DOI 10.1016/j.biocel.2008.02.012; Balciunaite G, 2005, EUR J IMMUNOL, V35, P2019, DOI 10.1002/eji.200526318; BECKER S, 1987, J IMMUNOL, V139, P3703; Bellini A, 2007, LAB INVEST, V87, P858, DOI 10.1038/labinvest.3700654; Bohlson SS, 2005, J IMMUNOL, V175, P1239, DOI 10.4049/jimmunol.175.2.1239; BRUGGER W, 1991, J LEUKOCYTE BIOL, V49, P483, DOI 10.1002/jlb.49.5.483; Bucala, 2007, FIBROCYTES NEW INSIG, P37, DOI DOI 10.1142/9789812706690_0003; BUCALA R, 1994, MOL MED, V1, P71, DOI 10.1007/bf03403533; Buckley CD, 2001, TRENDS IMMUNOL, V22, P199, DOI 10.1016/S1471-4906(01)01863-4; Buckley CD, 2000, J IMMUNOL, V165, P3423, DOI 10.4049/jimmunol.165.6.3423; Cabezon T, 2007, INT J CANCER, V121, P1433, DOI 10.1002/ijc.22850; Chang HY, 2002, P NATL ACAD SCI USA, V99, P12877, DOI 10.1073/pnas.162488599; Dewald O, 2004, AM J PATHOL, V164, P665, DOI 10.1016/S0002-9440(10)63154-9; Duffield JS, 2003, CLIN SCI, V104, P27, DOI 10.1042/CS20020240; EPSTEIN AL, 1987, BLOOD, V70, P1124; Erdag G, 2008, J CUTAN PATHOL, V35, P752, DOI 10.1111/j.1600-0560.2007.00895.x; Faint JM, 1999, J IMMUNOL METHODS, V225, P53, DOI 10.1016/S0022-1759(99)00027-7; Faust J, 1999, J CELL BIOCHEM, V72, P67, DOI 10.1002/(SICI)1097-4644(19990101)72:1<67::AID-JCB8>3.0.CO;2-A; FIRESTEIN GS, 1987, CELL IMMUNOL, V104, P343, DOI 10.1016/0008-8749(87)90036-0; FLAVELL DJ, 1987, J HISTOCHEM CYTOCHEM, V35, P1217, DOI 10.1177/35.11.3309045; Fonseca JE, 2002, ARTHRITIS RHEUM-US, V46, P1210, DOI 10.1002/art.10207; Garcia-Vicuna R, 2004, ARTHRITIS RHEUM-US, V50, P3866, DOI 10.1002/art.20615; Gomperts BN, 2007, J LEUKOCYTE BIOL, V82, P449, DOI 10.1189/jlb.0906587; Gordon S, 2005, NAT REV IMMUNOL, V5, P953, DOI 10.1038/nri1733; Gottfried E, 2008, SCAND J IMMUNOL, V67, P453, DOI 10.1111/j.1365-3083.2008.02091.x; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Gratchev A, 2001, SCAND J IMMUNOL, V53, P386, DOI 10.1046/j.1365-3083.2001.00885.x; Halder S, 2005, CELL RES, V15, P739, DOI 10.1038/sj.cr.7290344; Hashimoto N, 2004, J CLIN INVEST, V113, P243, DOI 10.1172/JCI200418847; Haudek SB, 2008, P NATL ACAD SCI USA, V105, P10179, DOI 10.1073/pnas.0804910105; Haudek SB, 2006, P NATL ACAD SCI USA, V103, P18284, DOI 10.1073/pnas.0608799103; Henderson NC, 2008, AM J PATHOL, V172, P288, DOI 10.2353/ajpath.2008.070726; Hosokawa Y, 2005, CLIN EXP IMMUNOL, V141, P467, DOI 10.1111/j.1365-2249.2005.02852.x; Hume DA, 2002, J LEUKOCYTE BIOL, V72, P621; Inoue T, 2005, KIDNEY INT, V67, P2488, DOI 10.1111/j.1523-1755.2005.00358.x; Kalluri R, 2003, J CLIN INVEST, V112, P1776, DOI 10.1172/JCI200320530; KO SD, 1977, P NATL ACAD SCI USA, V74, P3429, DOI 10.1073/pnas.74.8.3429; Kunisch E, 2004, ANN RHEUM DIS, V63, P774, DOI 10.1136/ard.2003.013029; Lax S, 2007, FEBS LETT, V581, P3550, DOI 10.1016/j.febslet.2007.06.063; LIPTAY MJ, 1993, J CLIN INVEST, V91, P588, DOI 10.1172/JCI116238; Lucattelli M, 2003, EUR RESPIR J, V22, P728, DOI 10.1183/09031936.03.00047603; MacFadyen JR, 2005, FEBS LETT, V579, P2569, DOI 10.1016/j.febslet.2005.03.071; Mantovani A, 2004, TRENDS IMMUNOL, V25, P677, DOI 10.1016/j.it.2004.09.015; Martin P, 1997, SCIENCE, V276, P75, DOI 10.1126/science.276.5309.75; Martinez FO, 2008, FRONT BIOSCI-LANDMRK, V13, P453, DOI 10.2741/2692; Moore BB, 2005, AM J PATHOL, V166, P675, DOI 10.1016/S0002-9440(10)62289-4; Moore BB, 2006, AM J RESP CELL MOL, V35, P175, DOI 10.1165/rcmb.2005-0239OC; Mosser DM, 2003, J LEUKOCYTE BIOL, V73, P209, DOI 10.1189/jlb.0602325; Naik-Mathuria B, 2008, WOUND REPAIR REGEN, V16, P266, DOI 10.1111/j.1524-475X.2008.00366.x; NICKOLOFF BJ, 1991, ARCH DERMATOL, V127, P523, DOI 10.1001/archderm.127.4.523; Olert J, 2001, PATHOL RES PRACT, V197, P823, DOI 10.1078/0344-0338-00166; Olson MC, 1995, IMMUNITY, V3, P703, DOI 10.1016/1074-7613(95)90060-8; Parsonage G, 2003, THROMB HAEMOSTASIS, V90, P688, DOI 10.1160/TH03-04-0208; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Peduto L, 2009, J IMMUNOL, V182, P5789, DOI 10.4049/jimmunol.0803974; Phillips RJ, 2004, J CLIN INVEST, V114, P438, DOI 10.1172/jci200420997; Phinney DG, 2007, STEM CELLS, V25, P2896, DOI 10.1634/stemcells.2007-0637; PHIPPS RP, 1989, AM J RESP CELL MOL, V1, P65, DOI 10.1165/ajrcmb/1.1.65; Pilling D, 1999, EUR J IMMUNOL, V29, P1041, DOI 10.1002/(SICI)1521-4141(199903)29:03<1041::AID-IMMU1041>3.0.CO;2-#; Pilling D, 2003, J IMMUNOL, V171, P5537, DOI 10.4049/jimmunol.171.10.5537; Pilling D, 2007, J IMMUNOL, V179, P4035, DOI 10.4049/jimmunol.179.6.4035; Pilling D, 2006, J LEUKOCYTE BIOL, V79, P1242, DOI 10.1189/jlb.0805456; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Rosseau S, 2000, AM J PHYSIOL-LUNG C, V279, pL25, DOI 10.1152/ajplung.2000.279.1.L25; Salmon M, 1997, J CLIN INVEST, V99, P439, DOI 10.1172/JCI119178; SALMON M, 1994, EUR J IMMUNOL, V24, P892, DOI 10.1002/eji.1830240417; Schmidt M, 2003, J IMMUNOL, V171, P380, DOI 10.4049/jimmunol.171.1.380; Schnoor M, 2008, J IMMUNOL, V180, P5707, DOI 10.4049/jimmunol.180.8.5707; Shao DD, 2008, J LEUKOCYTE BIOL, V83, P1323, DOI 10.1189/jlb.1107782; SIMMONS DL, 1992, J IMMUNOL, V148, P267; Singer AJ, 1999, NEW ENGL J MED, V341, P738, DOI 10.1056/NEJM199909023411006; STRUTZ F, 1995, J CELL BIOL, V130, P393, DOI 10.1083/jcb.130.2.393; Su YP, 2005, J BIOL CHEM, V280, P32811, DOI 10.1074/jbc.M503457200; TAKEYA M, 1991, J PATHOL, V163, P315, DOI 10.1002/path.1711630408; TERSTAPPEN LWMM, 1990, J LEUKOCYTE BIOL, V48, P138, DOI 10.1002/jlb.48.2.138; VAAGE J, 1990, J LEUKOCYTE BIOL, V48, P274, DOI 10.1002/jlb.48.3.274; Wang JF, 2007, WOUND REPAIR REGEN, V15, P113, DOI 10.1111/j.1524-475X.2006.00192.x; Wang JF, 2007, J LEUKOCYTE BIOL, V82, P1554, DOI 10.1189/0507306; Way KJ, 2009, J LEUKOCYTE BIOL, V85, P766, DOI 10.1189/jlb.1108689; Yang LJ, 2005, WOUND REPAIR REGEN, V13, P398, DOI 10.1111/j.1067-1927.2005.130407.x; Yang LJ, 2002, LAB INVEST, V82, P1183, DOI 10.1097/01.LAB.0000027841.50269.61; Zeng L, 1996, J HISTOCHEM CYTOCHEM, V44, P845, DOI 10.1177/44.8.8756757; Zhao HJ, 2009, PROSTATE, V69, P991, DOI 10.1002/pros.20946; Zola H., 2007, LEUKOCYTE STROMAL CE; ZWADLO G, 1985, J IMMUNOL, V134, P1487	87	368	381	2	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7475	10.1371/journal.pone.0007475	http://dx.doi.org/10.1371/journal.pone.0007475			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834619	Green Submitted, Green Published, gold			2022-12-27	WOS:000270880700006
J	Venkatachari, NJ; Alber, S; Watkins, SC; Ayyavoo, V				Venkatachari, Narasimhan J.; Alber, Sean; Watkins, Simon C.; Ayyavoo, Velpandi			HIV-1 Infection of DC: Evidence for the Acquisition of Virus Particles from Infected T Cells by Antigen Uptake Mechanism	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; MONOCYTE-DERIVED MACROPHAGES; PLASMACYTOID DENDRITIC CELLS; TYPE-1 INFECTION; IN-VIVO; IMMUNOLOGICAL SYNAPSE; VIROLOGICAL SYNAPSE; TRANSMISSION; MUCOSA; TROGOCYTOSIS	Dendritic cells (DC) play a pivotal role in transmission and dissemination of HIV-1. Earlier studies reported that DC present at the site of infection trap virus particles via DC-SIGN and transfer the virus to the interacting naive T cells. This prompted us to ask the question whether DC could acquire virus from infected T cells during DC-T cell interaction. To address this, we investigated the likely transfer of virus from HIV-1 infected T cells to DC and the underlying mechanisms involved. Results indicate that DC acquire virus from infected T cells via antigen uptake mechanism and this results in infection of DC with expression of proteins directed by viral DNA. Further studies with HIV-1 lacking the Env protein also resulted in infection of DC. The use of antibodies against DC-SIGN and DC-SIGN-R ruled out a role for receptor in the infection of DC. Additional data show that DC infection is directly correlated with the ability of DC to take up antigen from infected T cells. Overall, these studies provide evidence to suggest that HIV-1, besides infecting immune cells, also utilizes immunological mechanism(s) to acquire and disseminate virus.			Venkatachari, NJ (corresponding author), Univ Pittsburgh, Grad Sch Publ Hlth, Dept Infect Dis & Microbiol, Pittsburgh, PA 15261 USA.	velpandi@pitt.edu	Watkins, Simon/ABG-2590-2021	Watkins, Simon/0000-0003-4092-1552; Ayyavoo, Velpandi/0000-0002-9043-0885	NIAID NIH HHS [R56 AI050463, R01 AI050463, R56 AI-50463] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI050463, R01AI050463] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Aziz S, 2005, JAIDS-J ACQ IMM DEF, V38, P23, DOI 10.1097/00126334-200501010-00005; Bhoopat L, 2001, MODERN PATHOL, V14, P1263, DOI 10.1038/modpathol.3880472; Bounou S, 2004, FASEB J, V18, P1294, DOI 10.1096/fj.04-1755fje; Bromley SK, 2002, IMMUNOLOGY, V106, P289, DOI 10.1046/j.1365-2567.2002.01441.x; Burleigh L, 2006, J VIROL, V80, P2949, DOI 10.1128/JVI.80.6.2949-2957.2006; Butler SL, 2001, NAT MED, V7, P631, DOI 10.1038/87979; Carr JM, 1999, VIROLOGY, V265, P319, DOI 10.1006/viro.1999.0047; Caumartin J, 2006, TRANSPL IMMUNOL, V17, P20, DOI 10.1016/j.trim.2006.09.032; Choi YK, 2003, J PATHOL, V201, P616, DOI 10.1002/path.1482; Chow YH, 2002, J ACQ IMMUN DEF SYND, V30, P1, DOI 10.1097/00126334-200205010-00001; DIMITROV DS, 1993, J VIROL, V67, P2182, DOI 10.1128/JVI.67.4.2182-2190.1993; Dustin ML, 2008, IMMUNOL REV, V221, P77, DOI 10.1111/j.1600-065X.2008.00589.x; Dustin ML, 2002, ARTHRITIS RES THER, V4, pS119, DOI 10.1186/ar559; Fackler OT, 2007, NAT REV IMMUNOL, V7, P310, DOI 10.1038/nri2041; Frankel SS, 1996, SCIENCE, V272, P115, DOI 10.1126/science.272.5258.115; Geijtenbeek TBH, 2003, CURR TOP MICROBIOL, V276, P31; Groot F, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-75; Grossman Z, 2006, NAT MED, V12, P289, DOI 10.1038/nm1380; Gummuluru S, 2002, J VIROL, V76, P10692, DOI 10.1128/JVI.76.21.10692-10701.2002; GUPTA P, 1989, J VIROL, V63, P2361, DOI 10.1128/JVI.63.5.2361-2365.1989; Gurney KB, 2005, J VIROL, V79, P5762, DOI 10.1128/JVI.79.9.5762-5773.2005; Haase AT, 1999, ANNU REV IMMUNOL, V17, P625, DOI 10.1146/annurev.immunol.17.1.625; Harshyne LA, 2001, J IMMUNOL, V166, P3717, DOI 10.4049/jimmunol.166.6.3717; Hioe CE, 2001, J VIROL, V75, P1077, DOI 10.1128/JVI.75.2.1077-1082.2001; Hu JJ, 1999, AIDS RES HUM RETROV, V15, P1305, DOI 10.1089/088922299310205; Ignatius R, 2002, J VIROL, V76, P9787, DOI 10.1128/JVI.76.19.9787-9797.2002; Ji X, 2005, MOL IMMUNOL, V42, P145, DOI 10.1016/j.molimm.2004.06.015; Ji X, 2006, CURR PROTEIN PEPT SC, V7, P317, DOI 10.2174/138920306778017990; Joly E, 2003, NAT IMMUNOL, V4, P815, DOI 10.1038/ni0903-815; Lekkerkerker AN, 2006, CURR HIV RES, V4, P169, DOI 10.2174/157016206776055020; Levine BL, 1998, J HEMATOTHER, V7, P437, DOI 10.1089/scd.1.1998.7.437; Lore K, 2005, J EXP MED, V201, P2023, DOI 10.1084/jem.20042413; Majumder B, 2005, J VIROL, V79, P7990, DOI 10.1128/JVI.79.13.7990-8003.2005; MASSO M, 2003, MEDGENMED, V2, P1; McDonald D, 2003, SCIENCE, V300, P1295, DOI 10.1126/science.1084238; Morrow Gavin, 2007, Curr HIV/AIDS Rep, V4, P29, DOI 10.1007/s11904-007-0005-x; Nobile C, 2005, J VIROL, V79, P5386, DOI 10.1128/JVI.79.9.5386-5399.2005; Piguet V, 2004, J CLIN INVEST, V114, P605, DOI 10.1172/JCI200422812; Piguet V, 2007, TRENDS IMMUNOL, V28, P503, DOI 10.1016/j.it.2007.07.010; Riond J, 2007, SCAND J IMMUNOL, V66, P441, DOI 10.1111/j.1365-3083.2007.01996.x; Russo V, 2000, BLOOD, V95, P3473, DOI 10.1182/blood.V95.11.3473.011k06_3473_3477; Sabado RL, 2007, EUR J IMMUNOL, V37, P1752, DOI 10.1002/eji.200636981; Salter RD, 2006, IMMUNOL RES, V36, P211, DOI 10.1385/IR:36:1:211; Smed-Sorensen A, 2005, J VIROL, V79, P8861, DOI 10.1128/JVI.79.14.8861-8869.2005; Sol-Foulon N, 2007, EMBO J, V26, P516, DOI 10.1038/sj.emboj.7601509; Steinman RM, 1999, HUM IMMUNOL, V60, P562, DOI 10.1016/S0198-8859(99)00030-0; STLUCE S, 1993, J MED VIROL, V41, P71, DOI 10.1002/jmv.1890410115; Trapp S, 2006, J LEUKOCYTE BIOL, V80, P1076, DOI 10.1189/jlb.0206121; Turville SG, 2008, NAT METHODS, V5, P75, DOI 10.1038/NMETH1137; Venkatachari NJ, 2007, VIROLOGY, V358, P347, DOI 10.1016/j.virol.2006.08.030; WANG JH, 2007, J VIROL; Watkins SC, 2005, IMMUNITY, V23, P309, DOI 10.1016/j.immuni.2005.08.009; Wu L, 2006, NAT REV IMMUNOL, V6, P859, DOI 10.1038/nri1960; Zhang ZQ, 2004, P NATL ACAD SCI USA, V101, P5640, DOI 10.1073/pnas.0308425101; Zheng JY, 2006, JAIDS-J ACQ IMM DEF, V43, P127, DOI 10.1097/01.qai.0000228149.17669.08	55	8	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7470	10.1371/journal.pone.0007470	http://dx.doi.org/10.1371/journal.pone.0007470			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829715	Green Accepted, gold, Green Published			2022-12-27	WOS:000270847800009
J	Craven, RR; Gao, X; Allen, IC; Gris, D; Wardenburg, JB; McElvania-TeKippe, E; Ting, JP; Duncan, JA				Craven, Robin R.; Gao, Xi; Allen, Irving C.; Gris, Denis; Wardenburg, Juliane Bubeck; McElvania-TeKippe, Erin; Ting, Jenny P.; Duncan, Joseph A.			Staphylococcus aureus alpha-Hemolysin Activates the NLRP3-Inflammasome in Human and Mouse Monocytic Cells	PLOS ONE			English	Article							PANTON-VALENTINE LEUKOCIDIN; COMMUNITY-ASSOCIATED MRSA; CASPASE ACTIVATION; ENDOTHELIAL-CELLS; CIAS1 MUTATIONS; WALL COMPONENTS; DEATH PATHWAY; CUTTING EDGE; RECEPTOR 2; TOXIN	Community Acquired Methicillin Resistant Staphylococcus aureus (CA-MRSA) causes severe necrotizing infections of the skin, soft tissues, and lungs. Staphylococcal alpha-hemolysin is an essential virulence factor in mouse models of CA-MRSA necrotizing pneumonia. S. aureus alpha-hemolysin has long been known to induce inflammatory signaling and cell death in host organisms, however the mechanism underlying these signaling events were not well understood. Using highly purified recombinant alpha-hemolysin, we now demonstrate that alpha-hemolysin activates the Nucleotide-binding domain and leucine-rich repeat containing gene family, pyrin domain containing 3 protein (NLRP3) inflammasome, a host inflammatory signaling complex involved in responses to pathogens and endogenous danger signals. Non-cytolytic mutant alpha-hemolysin molecules fail to elicit NLRP3-inflammasome signaling, demonstrating that the responses are not due to non-specific activation of this innate immune signaling system by bacterially derived proteins. In monocyte-derived cells from humans and mice, inflammasome assembly in response to alpha-hemolysin results in activation of the cysteine proteinase, caspase-1. We also show that inflammasome activation by alpha-hemolysin works in conjunction with signaling by other CA-MRSA-derived Pathogen Associated Molecular Patterns (PAMPs) to induce secretion of pro-inflammatory cytokines IL-1 beta and IL-18. Additionally, alpha-hemolysin induces cell death in these cells through an NLRP3-dependent program of cellular necrosis, resulting in the release of endogenous pro-inflammatory molecules, like the chromatin-associated protein, High-mobility group box 1 (HMGB1). These studies link the activity of a major S. aureus virulence factor to a specific host signaling pathway. The cellular events linked to inflammasome activity have clear relevance to the disease processes associated with CA-MRSA including tissue necrosis and inflammation.			Craven, RR (corresponding author), Univ N Carolina, Dept Med, Div Infect Dis, Chapel Hill, NC 27515 USA.	jaduncan@med.unc.edu	Ariel, Pablo/AGJ-4118-2022; Gris, Denis/ABE-5229-2021; Gris, Denis/AGA-1192-2022	Gris, Denis/0000-0003-1215-2434; Gris, Denis/0000-0003-1215-2434	NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025746] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U54AI057153, U54AI057157, U19AI067798] Funding Source: NIH RePORTER; NCRR NIH HHS [RR025746, KL2 RR025746] Funding Source: Medline; NIAID NIH HHS [U54 AI057157, U19-AI067798, AI057157, U19 AI067798, U54 AI057153, AI057153] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agostini L, 2004, IMMUNITY, V20, P319, DOI 10.1016/S1074-7613(04)00046-9; Aksentijevich I, 2002, ARTHRITIS RHEUM-US, V46, P3340, DOI 10.1002/art.10688; Bantel H, 2001, J CELL BIOL, V155, P637, DOI 10.1083/jcb.200105081; BHAKDI S, 1989, INFECT IMMUN, V57, P3512, DOI 10.1128/IAI.57.11.3512-3519.1989; BRAMLEY AJ, 1989, INFECT IMMUN, V57, P2489, DOI 10.1128/IAI.57.8.2489-2494.1989; Chambers HF, 2005, NEW ENGL J MED, V352, P1485, DOI 10.1056/NEJMe058023; Diep BA, 2008, TRENDS MICROBIOL, V16, P361, DOI 10.1016/j.tim.2008.05.002; Dowds TA, 2004, J BIOL CHEM, V279, P21924, DOI 10.1074/jbc.M401178200; Duncan JA, 2009, J IMMUNOL, V182, P6460, DOI 10.4049/jimmunol.0802696; Ellis MW, 2004, CLIN INFECT DIS, V39, P971, DOI 10.1086/423965; Essmann F, 2003, CELL DEATH DIFFER, V10, P1260, DOI 10.1038/sj.cdd.4401301; Franchi L, 2009, NAT IMMUNOL, V10, P241, DOI 10.1038/ni.1703; Francis JS, 2005, CLIN INFECT DIS, V40, P100, DOI 10.1086/427148; FUJISAWA A, 2006, BLOOD; Grimminger F, 1997, J IMMUNOL, V159, P1909; Haslinger B, 2003, CELL MICROBIOL, V5, P729, DOI 10.1046/j.1462-5822.2003.00317.x; Hoffman HM, 2001, NAT GENET, V29, P301, DOI 10.1038/ng756; Kanneganti TD, 2006, NATURE, V440, P233, DOI 10.1038/nature04517; Kanneganti TD, 2006, J BIOL CHEM, V281, P36560, DOI 10.1074/jbc.M607594200; KUIDA K, 1995, SCIENCE, V267, P2000, DOI 10.1126/science.7535475; Labandeira-Rey M, 2007, SCIENCE, V315, P1130, DOI 10.1126/science.1137165; Mariathasan S, 2006, NATURE, V440, P228, DOI 10.1038/nature04515; Martinon F, 2006, NATURE, V440, P237, DOI 10.1038/nature04516; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Martinon F, 2009, ANNU REV IMMUNOL, V27, P229, DOI 10.1146/annurev.immunol.021908.132715; McElroy MC, 1999, INFECT IMMUN, V67, P5541, DOI 10.1128/IAI.67.10.5541-5544.1999; MENZIES BE, 1994, INFECT IMMUN, V62, P1843, DOI 10.1128/IAI.62.5.1843-1847.1994; Miller LG, 2005, NEW ENGL J MED, V352, P1445, DOI 10.1056/NEJMoa042683; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Nilsson IM, 1999, INFECT IMMUN, V67, P1045, DOI 10.1128/IAI.67.3.1045-1049.1999; Onogawa T, 2002, FEMS IMMUNOL MED MIC, V33, P15, DOI 10.1111/j.1574-695X.2002.tb00566.x; PATEL AH, 1987, INFECT IMMUN, V55, P3103, DOI 10.1128/IAI.55.12.3103-3110.1987; Ragle BE, 2009, INFECT IMMUN, V77, P2712, DOI 10.1128/IAI.00115-09; Rose F, 2002, AM J PHYSIOL-LUNG C, V282, pL207, DOI 10.1152/ajplung.00156.2001; Saito M, 2008, BLOOD, V111, P2132, DOI 10.1182/blood-2007-06-094201; Schwandner R, 1999, J BIOL CHEM, V274, P17406, DOI 10.1074/jbc.274.25.17406; SEEGER W, 1990, LAB INVEST, V63, P341; Siqueira JA, 1997, J MED MICROBIOL, V46, P486, DOI 10.1099/00222615-46-6-486; Srivastava SS, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006293; Sutterwala FS, 2006, IMMUNITY, V24, P317, DOI 10.1016/j.immuni.2006.02.004; SUTTORP N, 1992, THROMB RES, V67, P243, DOI 10.1016/0049-3848(92)90143-X; SUTTORP N, 1993, J EXP MED, V178, P337, DOI 10.1084/jem.178.1.337; Takeuchi O, 1999, IMMUNITY, V11, P443, DOI 10.1016/S1074-7613(00)80119-3; Tao M, 1999, FEMS IMMUNOL MED MIC, V23, P135; Taxman DJ, 2006, J IMMUNOL, V177, P4252, DOI 10.4049/jimmunol.177.7.4252; Ting JPY, 2008, IMMUNITY, V28, P285, DOI 10.1016/j.immuni.2008.02.005; Ting JPY, 2006, NAT REV IMMUNOL, V6, P183, DOI 10.1038/nri1788; Wardenburg JB, 2008, J EXP MED, V205, P287, DOI 10.1084/jem.20072208; Wardenburg JB, 2007, NAT MED, V13, P1405, DOI 10.1038/nm1207-1405; Wardenburg JB, 2007, INFECT IMMUN, V75, P1040, DOI 10.1128/IAI.01313-06; Willingham SB, 2007, CELL HOST MICROBE, V2, P147, DOI 10.1016/j.chom.2007.07.009; Yoshimura A, 1999, J IMMUNOL, V163, P1	52	299	310	0	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7446	10.1371/journal.pone.0007446	http://dx.doi.org/10.1371/journal.pone.0007446			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826485	Green Submitted, Green Published, gold			2022-12-27	WOS:000270808700009
J	Hayakawa, T; Arisue, N; Udono, T; Hirai, H; Sattabongkot, J; Toyama, T; Tsuboi, T; Horii, T; Tanabe, K				Hayakawa, Toshiyuki; Arisue, Nobuko; Udono, Toshifumi; Hirai, Hirohisa; Sattabongkot, Jetsumon; Toyama, Tomoko; Tsuboi, Takafumi; Horii, Toshihiro; Tanabe, Kazuyuki			Identification of Plasmodium malariae, a Human Malaria Parasite, in Imported Chimpanzees	PLOS ONE			English	Article								It is widely believed that human malaria parasites infect only man as a natural host. However, earlier morphological observations suggest that great apes are likely to be natural reservoirs as well. To identify malaria parasites in great apes, we screened 60 chimpanzees imported into Japan. Using the sequences of small subunit rRNA and the mitochondrial genome, we identified infection of Plasmodium malariae, a human malaria parasite, in two chimpanzees that were imported about thirty years ago. The chimpanzees have been asymptomatic to the present. In Japan, indigenous malaria disappeared more than fifty years ago; and thus, it is most likely inferred that the chimpanzees were infected in Africa, and P. malariae isolates were brought into Japan from Africa with their hosts, suggesting persistence of parasites at low level for thirty years. Such a long term latent infection is a unique feature of P. malariae infection in humans. To our knowledge, this is the first to report P. malariae infection in chimpanzees and a human malaria parasite from nonhuman primates imported to a nonendemic country.			Hayakawa, T (corresponding author), Osaka Univ, Microbial Dis Res Inst, Int Res Ctr Infect Dis, Lab Malariol, Osaka, Japan.	hayakawa@biken.osaka-u.ac.jp; kztanabe@biken.osaka-u.ac.jp	Prachumsri, Jetsumon/AAZ-7732-2021; Tsuboi, Takafumi/AAK-6145-2021	Sattabongkot, Jetsumon/0000-0002-3938-4588; Horii, Toshihiro/0000-0002-3000-2045; Tsuboi, Takafumi/0000-0002-7415-1325				[Anonymous], 2003, PRIMATE MALARIAS; Collins WE, 2007, CLIN MICROBIOL REV, V20, P579, DOI 10.1128/CMR.00027-07; Duval L, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005520; ESCALANTE AA, 1995, MOL BIOL EVOL, V12, P616; ESCALANTE AA, 1994, P NATL ACAD SCI USA, V91, P11373, DOI 10.1073/pnas.91.24.11373; Hayakawa T, 2008, MOL BIOL EVOL, V25, P2233, DOI 10.1093/molbev/msn171; Jongwutiwes S, 2004, EMERG INFECT DIS, V10, P2211, DOI 10.3201/eid1012.040293; Jotty A, 2005, SCIENCE, V309, P1457, DOI 10.1126/science.1111873; Kano S, 2004, ACTA TROP, V89, P271, DOI 10.1016/j.actatropica.2003.10.003; Kantele A, 2008, EMERG INFECT DIS, V14, P1434, DOI 10.3201/eid1409.080170; Levine ND, 1988, PROTOZOAN PHYLUM API, V2; Mu JB, 2005, MOL BIOL EVOL, V22, P1686, DOI 10.1093/molbev/msi160; Nishimoto Y, 2008, MOL PHYLOGENET EVOL, V47, P45, DOI 10.1016/j.ympev.2008.01.031; Ollomo B, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000446; Reichenow E., 1920, CENTRALBL F BAKT I A, V85, P207; Singh B, 2004, LANCET, V363, P1017, DOI 10.1016/S0140-6736(04)15836-4; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Vinetz JM, 1998, NEW ENGL J MED, V338, P367, DOI 10.1056/NEJM199802053380605; Vythilingam I, 2006, T ROY SOC TROP MED H, V100, P1087, DOI 10.1016/j.trstmh.2006.02.006	19	45	45	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7412	10.1371/journal.pone.0007412	http://dx.doi.org/10.1371/journal.pone.0007412			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823579	gold, Green Published, Green Submitted			2022-12-27	WOS:000270728500012
J	Koshiol, J; Rotunno, M; Consonni, D; Pesatori, AC; De Matteis, S; Goldstein, AM; Chaturvedi, AK; Wacholder, S; Landi, MT; Lubin, JH; Caporaso, NE				Koshiol, Jill; Rotunno, Melissa; Consonni, Dario; Pesatori, Angela Cecilia; De Matteis, Sara; Goldstein, Alisa M.; Chaturvedi, Anil K.; Wacholder, Sholom; Landi, Maria Teresa; Lubin, Jay H.; Caporaso, Neil E.			Chronic Obstructive Pulmonary Disease and Altered Risk of Lung Cancer in a Population-Based Case-Control Study	PLOS ONE			English	Article							CIGARETTE-SMOKING; FAMILY-HISTORY; SUSCEPTIBILITY LOCUS; CHRONIC-BRONCHITIS; NEVER SMOKERS; WOMEN; INFLAMMATION; ASTHMA; EXACERBATIONS; EPIDEMIOLOGY	Background: Chronic obstructive pulmonary disease ( COPD) has been consistently associated with increased risk of lung cancer. However, previous studies have had limited ability to determine whether the association is due to smoking. Methodology/Principal Findings: The Environment And Genetics in Lung cancer Etiology ( EAGLE) population-based case-control study recruited 2100 cases and 2120 controls, of whom 1934 cases and 2108 controls reported about diagnosis of chronic bronchitis, emphysema, COPD (chronic bronchitis and/or emphysema), or asthma more than 1 year before enrollment. We estimated odds ratios (OR) and 95% confidence intervals (CI) using logistic regression. After adjustment for smoking, other previous lung diseases, and study design variables, lung cancer risk was elevated among individuals with a history of chronic bronchitis (OR = 2.0, 95% CI = 1.5-2.5), emphysema (OR = 1.9, 95% CI = 1.4-2.8), or COPD (OR = 2.5, 95% CI = 2.0-3.1). Among current smokers, association between chronic bronchitis and lung cancer was strongest among lighter smokers. Asthma was associated with a decreased risk of lung cancer in males (OR = 0.48, 95% CI = 0.30-0.78). Conclusions/Significance: These results suggest that the associations of personal history of chronic bronchitis, emphysema, and COPD with increased risk of lung cancer are not entirely due to smoking. Inflammatory processes may both contribute to COPD and be important for lung carcinogenesis.			Koshiol, J (corresponding author), NCI, Div Canc Epidemiol & Genet, NIH, Dept Hlth & Human Serv, Bethesda, MD 20892 USA.	koshiolj@mail.nih.gov	De Matteis, Sara/AFW-0443-2022; Consonni, Dario/AAM-2947-2020; koshiol, Jill/L-8686-2014; pesatori, angela/K-5742-2016	De Matteis, Sara/0000-0001-8256-2661; Consonni, Dario/0000-0002-8935-3843; koshiol, Jill/0000-0002-3832-6204; pesatori, angela/0000-0002-0261-3252	Intramural NIH HHS Funding Source: Medline	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA)		Alberg AJ, 2003, CHEST, V123, p21S, DOI 10.1378/chest.123.1_suppl.21S; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Barr RG, 2002, AM J EPIDEMIOL, V155, P965, DOI 10.1093/aje/155.10.965; Boutin-Forzano S, 2007, INT J TUBERC LUNG D, V11, P695; Brenner AV, 2001, INT J EPIDEMIOL, V30, P118, DOI 10.1093/ije/30.1.118; Brownson RC, 2000, CANCER CAUSE CONTROL, V11, P853, DOI 10.1023/A:1008999202040; Castaing M, 2005, AM J EPIDEMIOL, V162, P542, DOI 10.1093/aje/kwi241; COHEN BH, 1977, LANCET, V2, P523; Dubey S, 2008, AM J RESP CRIT CARE, V177, P941, DOI 10.1164/rccm.200801-107UP; Engels EA, 2008, EXPERT REV ANTICANC, V8, P605, DOI 10.1586/14737140.8.4.605; Gao Y, 2009, INT J CANCER, V125, P146, DOI 10.1002/ijc.24283; Garber ME, 2001, P NATL ACAD SCI USA, V98, P13784, DOI 10.1073/pnas.241500798; Global Initiative for Chronic Obstructive Lung Disease, 2008, GLOB STRAT DIAGN MAN; Halbert RJ, 2006, EUR RESPIR J, V28, P523, DOI 10.1183/09031936.06.00124605; Holtzman Michael J, 2005, Proc Am Thorac Soc, V2, P132, DOI 10.1513/pats.200502-015AW; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Landi MT, 2008, BMC PUBLIC HEALTH, V8, DOI 10.1186/1471-2458-8-203; Littman AJ, 2005, CANCER EPIDEM BIOMAR, V14, P773, DOI 10.1158/1055-9965.EPI-04-0599; Lubin JH, 2008, AM J EPIDEMIOL, V167, P970, DOI 10.1093/aje/kwm392; Lubin JH, 2007, INT J EPIDEMIOL, V36, P236, DOI 10.1093/ije/dym043; Lubin JH, 2006, CANCER EPIDEM BIOMAR, V15, P517, DOI 10.1158/1055-9965.EPI-05-0863; Lugogo NL, 2006, CLIN CHEST MED, V27, P1, DOI 10.1016/j.ccm.2005.10.006; Mallia P, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-116; Mattison Sue, 2006, Intensive Crit Care Nurs, V22, P329, DOI 10.1016/j.iccn.2006.03.003; McCallister JW, 2008, J ASTHMA, V45, P853, DOI 10.1080/02770900802444187; OSANN KE, 1991, CANCER RES, V51, P4893; Papi A, 2007, CURR OPIN PHARMACOL, V7, P259, DOI 10.1016/j.coph.2006.11.015; Papi A, 2006, AM J RESP CRIT CARE, V173, P1114, DOI 10.1164/rccm.200506-859OC; Parkin DM, 2005, CA-CANCER J CLIN, V55, P74, DOI 10.3322/canjclin.55.2.74; Pelkonen M, 2008, CURR OPIN PULM MED, V14, P105, DOI 10.1097/MCP.0b013e3282f379e9; Petty Thomas L, 2006, Int J Chron Obstruct Pulmon Dis, V1, P3, DOI 10.2147/copd.2006.1.1.3; SAMET JM, 1986, AM REV RESPIR DIS, V134, P466; Santillan AA, 2003, CANCER CAUSE CONTROL, V14, P327, DOI 10.1023/A:1023982402137; Schabath MB, 2006, AM J EPIDEMIOL, V163, DOI 10.1093/aje/kwj065; Schabath MB, 2005, AM J EPIDEMIOL, V161, P412, DOI 10.1093/aje/kwi063; Schottenfeld D, 2006, CA-CANCER J CLIN, V56, P69, DOI 10.3322/canjclin.56.2.69; Subramanian J, 2007, J CLIN ONCOL, V25, P561, DOI 10.1200/JCO.2006.06.8015; Sun S, 2007, NAT REV CANCER, V7, P778, DOI 10.1038/nrc2190; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; Thun MJ, 2006, JNCI-J NATL CANCER I, V98, P691, DOI 10.1093/jnci/djj187; Turner MC, 2005, AM J EPIDEMIOL, V162, P212, DOI 10.1093/aje/kwi193; Turner MC, 2007, AM J RESP CRIT CARE, V176, P285, DOI 10.1164/rccm.200612-1792OC; VENA JE, 1985, AM J EPIDEMIOL, V122, P66, DOI 10.1093/oxfordjournals.aje.a114087; Viegi G, 1994, Monaldi Arch Chest Dis, V49, P191; Wang SY, 1996, LUNG CANCER-J IASLC, V14, pS99, DOI 10.1016/S0169-5002(96)90215-9; WU AH, 1995, AM J EPIDEMIOL, V141, P1023, DOI 10.1093/oxfordjournals.aje.a117366; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yang P, 2008, ARCH INTERN MED, V168, P1097, DOI 10.1001/archinte.168.10.1097	48	107	112	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7380	10.1371/journal.pone.0007380	http://dx.doi.org/10.1371/journal.pone.0007380			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812684	Green Submitted, Green Published, gold			2022-12-27	WOS:000270594200006
J	Sene, A; Tadayoni, R; Pannicke, T; Wurm, A; El Mathari, B; Benard, R; Roux, MJ; Yaffe, D; Mornet, D; Reichenbach, A; Sahel, JA; Rendon, A				Sene, Abdoulaye; Tadayoni, Ramin; Pannicke, Thomas; Wurm, Antje; El Mathari, Brahim; Benard, Romain; Roux, Michel Joseph; Yaffe, David; Mornet, Dominique; Reichenbach, Andreas; Sahel, Jose-Alain; Rendon, Alvaro			Functional Implication of Dp71 in Osmoregulation and Vascular Permeability of the Retina	PLOS ONE			English	Article								Functional alterations of Muller cells, the principal glia of the retina, are an early hallmark of most retina diseases and contribute to their further progression. The molecular mechanisms of these reactive Muller cell alterations, resulting in disturbed retinal homeostasis, remain largely unknown. Here we show that experimental detachment of mouse retina induces mislocation of the inwardly rectifying potassium channels (Kir4.1) and a downregulation of the water channel protein (AQP4) in Muller cells. These alterations are associated with a strong decrease of Dp71, a cytoskeleton protein responsible for the localization and the clustering of Kir4.1 and AQP4. Partial (in detached retinas) or total depletion of Dp71 in Muller cells (in Dp71-null mice) impairs the capability of volume regulation of Muller cells under osmotic stress. The abnormal swelling of Muller cells In Dp71-null mice involves the action of inflammatory mediators. Moreover, we investigated whether the alterations in Muller cells of Dp71-null mice may interfere with their regulatory effect on the blood-retina barrier. In the absence of Dp71, the retinal vascular permeability was increased as compared to the controls. Our results reveal that Dp71 is crucially implicated in the maintenance of potassium homeostasis, in transmembraneous water transport, and in the Muller cell-mediated regulation of retinal vascular permeability. Furthermore, our data provide novel insights into the mechanisms of retinal homeostasis provided by Muller cells under normal and pathological conditions.			Sene, A (corresponding author), INSERM, UMR S 968, Inst Vis, Paris, France.	alvaro.rendon@inserm.fr	Rendon, Alvaro/A-1127-2012; Grosche, Antje/N-1978-2014; Sahel, Jose-Alain/F-3172-2017; Reichenbach, Andreas/B-2510-2017; Roux, Michel J/A-3213-2009; Pannicke, Thomas/A-5078-2017; Sene, Abdoulaye/D-3342-2015	Grosche, Antje/0000-0003-0338-7530; Sahel, Jose-Alain/0000-0002-4831-1153; Roux, Michel J/0000-0002-5812-5215; Pannicke, Thomas/0000-0001-7435-9540; Sene, Abdoulaye/0000-0001-9194-7264				Amiry-Moghaddam M, 2003, P NATL ACAD SCI USA, V100, P13615, DOI 10.1073/pnas.2336064100; Barnett NL, 2000, GLIA, V30, P64, DOI 10.1002/(SICI)1098-1136(200003)30:1<64::AID-GLIA7>3.0.CO;2-I; Barnett NL, 2001, NEUROCHEM INT, V39, P291, DOI 10.1016/S0197-0186(01)00033-X; Bordais A, 2005, NEUROMUSCULAR DISORD, V15, P476, DOI 10.1016/j.nmd.2005.03.011; BRESNICK GH, 1983, OPHTHALMOLOGY, V90, P1301; BREW H, 1987, NATURE, V327, P707, DOI 10.1038/327707a0; Bringmann A, 2000, GLIA, V29, P35, DOI 10.1002/(SICI)1098-1136(20000101)29:1<35::AID-GLIA4>3.0.CO;2-A; Bringmann A, 2004, OPHTHALMIC RES, V36, P241, DOI 10.1159/000081203; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Bringmann A, 2009, NEUROCHEM INT, V54, P143, DOI 10.1016/j.neuint.2008.10.014; Connors NC, 2002, J NEUROSCI, V22, P4321, DOI 10.1523/JNEUROSCI.22-11-04321.2002; CUNHAVAZ JG, 1984, SURV OPHTHALMOL, V28, P485, DOI 10.1016/0039-6257(84)90230-3; Dalloz C, 2003, HUM MOL GENET, V12, P1543, DOI 10.1093/hmg/ddg170; Distler C, 1996, VISION RES, V36, P2381, DOI 10.1016/0042-6989(96)00005-3; EHINGER B, 1977, EXP EYE RES, V25, P221, DOI 10.1016/0014-4835(77)90089-6; Eichler W, 2000, NEUROREPORT, V11, P3533, DOI 10.1097/00001756-200011090-00026; Faude F, 2001, INVEST OPHTH VIS SCI, V42, P1328; Fletcher Erica L, 2005, Clin Exp Optom, V88, P132; Fort PE, 2008, GLIA, V56, P597, DOI 10.1002/glia.20633; Francke M, 2001, INVEST OPHTH VIS SCI, V42, P1072; Iandiev I, 2006, INVEST OPHTH VIS SCI, V47, P2161, DOI 10.1167/iovs.05-0595; Ishikawa A, 1996, CURR EYE RES, V15, P63, DOI 10.3109/02713689609017612; Ishikawa A, 1996, CURR EYE RES, V15, P958, DOI 10.3109/02713689609017641; Kaur C, 2006, INVEST OPHTH VIS SCI, V47, P1126, DOI 10.1167/iovs.05-0518; Kofuji P, 2002, GLIA, V39, P292, DOI 10.1002/glia.10112; Kofuji P, 2000, J NEUROSCI, V20, P5733, DOI 10.1523/JNEUROSCI.20-15-05733.2000; Lewis GP, 2003, INT REV CYTOL, V230, P263, DOI 10.1016/S0074-7696(03)30005-1; LEWIS GP, 1995, INVEST OPHTH VIS SCI, V36, P2404; Nagelhus EA, 1999, GLIA, V26, P47, DOI 10.1002/(SICI)1098-1136(199903)26:1<47::AID-GLIA5>3.0.CO;2-5; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Newman E, 1996, TRENDS NEUROSCI, V19, P307, DOI 10.1016/0166-2236(96)10040-0; Pannicke T, 2006, DIABETES, V55, P633, DOI 10.2337/diabetes.55.03.06.db05-1349; Pannicke T, 2005, GLIA, V50, P1, DOI 10.1002/glia.20151; Pannicke T, 2004, MOL CELL NEUROSCI, V26, P493, DOI 10.1016/j.mcn.2004.04.005; REHAK M, 2008, INVEST OPHTHALMOL VI; Rivier F, 1999, HISTOCHEM J, V31, P425, DOI 10.1023/A:1003805905456; Rozen S, 2000, Methods Mol Biol, V132, P365; Sarig R, 1999, HUM MOL GENET, V8, P1, DOI 10.1093/hmg/8.1.1; TOUT S, 1993, NEUROSCIENCE, V55, P291, DOI 10.1016/0306-4522(93)90473-S; Tretiach M, 2005, NEUROSCI LETT, V378, P160, DOI 10.1016/j.neulet.2004.12.026; Uckermann O, 2004, GLIA, V45, P59, DOI 10.1002/glia.10305; Wurm A, 2006, AM J PATHOL, V169, P1990, DOI 10.2353/ajpath.2006.060628; Xu QW, 2001, INVEST OPHTH VIS SCI, V42, P789; Yang L, 2004, INVEST OPHTH VIS SCI, V45, P648, DOI 10.1167/iovs.03-0827	44	28	29	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7329	10.1371/journal.pone.0007329	http://dx.doi.org/10.1371/journal.pone.0007329			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809515	gold, Green Submitted, Green Published			2022-12-27	WOS:000270594000008
J	Caldwell, KA; Tucci, ML; Armagost, J; Hodges, TW; Chen, J; Memon, SB; Blalock, JE; DeLeon, SM; Findlay, RH; Ruan, QM; Webber, PJ; Standaert, DG; Olson, JB; Caldwell, GA				Caldwell, Kim A.; Tucci, Michelle L.; Armagost, Jafa; Hodges, Tyler W.; Chen, Jue; Memon, Shermeen B.; Blalock, Jeana E.; DeLeon, Susan M.; Findlay, Robert H.; Ruan, Qingmin; Webber, Philip J.; Standaert, David G.; Olson, Julie B.; Caldwell, Guy A.			Investigating Bacterial Sources of Toxicity as an Environmental Contributor to Dopaminergic Neurodegeneration	PLOS ONE			English	Article							UBIQUITIN-PROTEASOME SYSTEM; 16S RIBOSOMAL-RNA; CAENORHABDITIS-ELEGANS; PARKINSONS-DISEASE; NOCARDIA-ASTEROIDES; ENDOTOXIN EXPOSURE; C-ELEGANS; NEURONS; CULTURE; STRESS	Parkinson disease (PD) involves progressive neurodegeneration, including loss of dopamine (DA) neurons from the substantia nigra. Select genes associated with rare familial forms of PD function in cellular pathways, such as the ubiquitin-proteasome system (UPS), involved in protein degradation. The misfolding and accumulation of proteins, such as alpha-synuclein, into inclusions termed Lewy Bodies represents a clinical hallmark of PD. Given the predominance of sporadic PD among patient populations, environmental toxins may induce the disease, although their nature is largely unknown. Thus, an unmet challenge surrounds the discovery of causal or contributory neurotoxic factors that could account for the prevalence of sporadic PD. Bacteria within the order Actinomycetales are renowned for their robust production of secondary metabolites and might represent unidentified sources of environmental exposures. Among these, the aerobic genera, Streptomyces, produce natural proteasome inhibitors that block protein degradation and may potentially damage DA neurons. Here we demonstrate that a metabolite produced by a common soil bacterium, S. venezuelae, caused DA neurodegeneration in the nematode, Caenorhabditis elegans, which increased as animals aged. This metabolite, which disrupts UPS function, caused gradual degeneration of all neuronal classes examined, however DA neurons were particularly vulnerable to exposure. The presence of DA exacerbated toxicity because neurodegeneration was attenuated in mutant nematodes depleted for tyrosine hydroxylase (TH), the rate-limiting enzyme in DA production. Strikingly, this factor caused dose-dependent death of human SH-SY5Y neuroblastoma cells, a dopaminergic line. Efforts to purify the toxic activity revealed that it is a highly stable, lipophilic, and chemically unique small molecule. Evidence of a robust neurotoxic factor that selectively impacts neuronal survival in a progressive yet moderate manner is consistent with the etiology of age-associated neurodegenerative diseases. Collectively, these data suggest the potential for exposures to the metabolites of specific common soil bacteria to possibly represent a contributory environmental component to PD.			Caldwell, KA (corresponding author), Univ Alabama, Dept Biol Sci, Tuscaloosa, AL USA.	kcaldwel@bama.ua.edu; gcaldwel@bama.ua.edu	Findlay, Robert H/G-4223-2011	Thompson, Michelle/0000-0001-8134-9017; Standaert, David/0000-0003-2921-8348; DeLeon, Susan/0000-0002-9716-9026; Caldwell, Kim/0000-0003-1580-6122	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [R21ES014426] Funding Source: NIH RePORTER; NIEHS NIH HHS [R21ES01442, R21 ES014426] Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Barry DP, 2006, APOPTOSIS, V11, P1695, DOI 10.1007/s10495-006-9236-3; Bedford L, 2008, J NEUROSCI, V28, P8189, DOI 10.1523/JNEUROSCI.2218-08.2008; Bence NF, 2001, SCIENCE, V292, P1552, DOI 10.1126/science.292.5521.1552; BRENNER S, 1974, GENETICS, V77, P71; Bush KT, 1997, J BIOL CHEM, V272, P9086; CALDWELL GA, 2006, INTEGRATED GENOMICS, P17; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Cao SS, 2005, J NEUROSCI, V25, P3801, DOI 10.1523/JNEUROSCI.5157-04.2005; Carvelli L, 2004, P NATL ACAD SCI USA, V101, P16046, DOI 10.1073/pnas.0403299101; Chapman G, 2003, EXP NEUROL, V184, P715, DOI 10.1016/S0014-4886(03)00337-6; Cook C, 2009, BBA-MOL BASIS DIS, V1792, P664, DOI 10.1016/j.bbadis.2009.01.012; Costello S, 2009, AM J EPIDEMIOL, V169, P919, DOI 10.1093/aje/kwp006; Dawson TM, 2003, SCIENCE, V302, P819, DOI 10.1126/science.1087753; DECKER T, 1988, J IMMUNOL METHODS, V115, P61, DOI 10.1016/0022-1759(88)90310-9; DEIMAIN AL, 2000, ADV BIOCHEM ENG BIOT, P1; Diaz-Corrales FJ, 2004, BRAZ J MED BIOL RES, V37, P539, DOI 10.1590/S0100-879X2004000400011; Firestone JA, 2005, ARCH NEUROL-CHICAGO, V62, P91, DOI 10.1001/archneur.62.1.91; Gailliot FP, 1998, METH BIOTEC, V4, P53; Gorell JM, 1998, NEUROLOGY, V50, P1346, DOI 10.1212/WNL.50.5.1346; Janssen PH, 2006, APPL ENVIRON MICROB, V72, P1719, DOI 10.1128/AEM.72.3.1719-1728.2006; Jones D, 1996, TOXICOLOGY, V109, P119, DOI 10.1016/0300-483X(96)03316-1; KOHBATA S, 1991, INFECT IMMUN, V59, P181, DOI 10.1128/IAI.59.1.181-191.1991; Kordower JH, 2006, ANN NEUROL, V60, P264, DOI 10.1002/ana.20935; Lee RYN, 1999, J NEUROSCI, V19, P159, DOI 10.1523/JNEUROSCI.19-01-00159.1999; Li XP, 2008, J NEUROPATH EXP NEUR, V67, P933, DOI 10.1097/NEN.0b013e318186de64; Lickteig KM, 2001, J NEUROSCI, V21, P2001, DOI 10.1523/JNEUROSCI.21-06-02001.2001; Ling ZD, 2004, NEUROSCIENCE, V124, P619, DOI 10.1016/j.neuroscience.2003.12.017; Ling ZD, 2002, MOVEMENT DISORD, V17, P116, DOI 10.1002/mds.10078; Loeffler DA, 2004, MICROB PATHOGENESIS, V37, P73, DOI 10.1016/j.micpath.2004.05.001; MADURO M, 1995, GENETICS, V141, P977; Manning-Bog AB, 2006, ANN NEUROL, V60, P256, DOI 10.1002/ana.20938; McIntire SL, 1997, NATURE, V389, P870, DOI 10.1038/39908; McNaught KSP, 2004, ANN NEUROL, V56, P149, DOI 10.1002/ana.20186; Mosharov EV, 2009, NEURON, V62, P218, DOI 10.1016/j.neuron.2009.01.033; Nass R, 2002, P NATL ACAD SCI USA, V99, P3264, DOI 10.1073/pnas.042497999; Nedelsky NB, 2008, BBA-MOL BASIS DIS, V1782, P691, DOI 10.1016/j.bbadis.2008.10.002; OGATA SA, 1992, INFECT IMMUN, V60, P1800, DOI 10.1128/IAI.60.5.1800-1805.1992; OGATA SA, 1992, INFECT IMMUN, V60, P3262, DOI 10.1128/IAI.60.8.3262-3267.1992; Pandey UB, 2007, NATURE, V447, P859, DOI 10.1038/nature05853; Park YC, 2006, J NAT PROD, V69, P580, DOI 10.1021/np058113p; Praitis V, 2001, GENETICS, V157, P1217; Priyadarshi A, 2001, ENVIRON RES, V86, P122, DOI 10.1006/enrs.2001.4264; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Sanyal S, 2004, EMBO J, V23, P473, DOI 10.1038/sj.emboj.7600057; Sawin ER, 2000, NEURON, V26, P619, DOI 10.1016/S0896-6273(00)81199-X; Schapira AHV, 2006, ANN NEUROL, V60, P253, DOI 10.1002/ana.20934; Strange K, 2007, NAT PROTOC, V2, P1003, DOI 10.1038/nprot.2007.143; STRINGHAM EG, 1994, ENVIRON TOXICOL CHEM, V13, P1211, DOI 10.1897/1552-8618(1994)13[1211:THLSOT]2.0.CO;2; SULSTON J, 1975, J COMP NEUROL, V163, P215, DOI 10.1002/cne.901630207; Sun F, 2006, NEUROTOXICOLOGY, V27, P807, DOI 10.1016/j.neuro.2006.06.006; Sze JY, 2000, NATURE, V403, P560, DOI 10.1038/35000609; Tam S, 2002, EXP NEUROL, V177, P453, DOI 10.1006/exnr.2002.8012; TANNER CM, 1992, OCCUP MED, V7, P503; Tanner CM, 2003, ADV NEUROL, V91, P133; Zeng BY, 2006, ANN NEUROL, V60, P248, DOI 10.1002/ana.20932; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	56	39	40	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7227	10.1371/journal.pone.0007227	http://dx.doi.org/10.1371/journal.pone.0007227			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806188	gold, Green Submitted, Green Published			2022-12-27	WOS:000270593800004
J	Gallo, V; Schwarzer, E; Rahlfs, S; Schirmer, RH; van Zwieten, R; Roos, D; Arese, P; Becker, K				Gallo, Valentina; Schwarzer, Evelin; Rahlfs, Stefan; Schirmer, R. Heiner; van Zwieten, Rob; Roos, Dirk; Arese, Paolo; Becker, Katja			Inherited Glutathione Reductase Deficiency and Plasmodium falciparum Malaria-A Case Study	PLOS ONE			English	Article							PYRIDOXINE PHOSPHATE OXIDASE; CELL FLAVIN ENZYMES; INFECTED ERYTHROCYTES; RIBOFLAVIN DEFICIENCY; GLUCOSE-6-PHOSPHATE-DEHYDROGENASE DEFICIENCY; POPULATION-GENETICS; HUMAN MONOCYTES; SICKLE-CELL; PHAGOCYTOSIS; PIGMENT	In Plasmodium falciparum-infected red blood cells (RBCs), the flavoenzyme glutathione reductase (GR) regenerates reduced glutathione, which is essential for antioxidant defense. GR utilizes NADPH produced in the pentose phosphate shunt by glucose-6-phosphate dehydrogenase (G6PD). Thus, conditions affecting host G6PD or GR induce increased sensitivity to oxidants. Hereditary G6PD deficiency is frequent in malaria endemic areas and provides protection against severe malaria. Furthermore, GR deficiency resulting from insufficient saturation of the enzyme with its prosthetic group FAD is common. Based on these naturally occurring phenomena, GR of malaria parasites and their host cells represent attractive antimalarial drug targets. Recently we were given the opportunity to examine invasion, growth, and drug sensitivity of three P. falciparum strains (3D7, K1, and Palo Alto) in the RBCs from three homozygous individuals with total GR deficiency resulting from mutations in the apoprotein. Invasion or growth in the GR-deficient RBCs was not impaired for any of the parasite strains tested. Drug sensitivity to chloroquine, artemisinin, and methylene blue was comparable to parasites grown in GR-sufficient RBCs and sensitivity towards paraquat and sodium nitroprusside was only slightly enhanced. In contrast, membrane deposition of hemichromes as well as the opsonizing complement C3b fragments and phagocytosis were strongly increased in ring-infected RBCs of the GR-deficient individuals compared to ring-infected normal RBCs. Also, in one of the individuals, membrane-bound autologous IgGs were significantly enhanced. Thus, based on our in vitro data, GR deficiency and drug-induced GR inhibition may protect from malaria by inducing enhanced ring stage phagocytosis rather than by impairing parasite growth directly.			Gallo, V (corresponding author), Univ Turin, Dipartimento Genet Biol & Biochim, Turin, Italy.	katja.becker@ernaehrung.uni-giessen.de	Gallo, Valentina/E-1132-2011	Gallo, Valentina/0000-0002-1621-5829; Schwarzer, Evelin/0000-0003-2791-1894				Ahmed F, 2008, EUR J CLIN NUTR, V62, P365, DOI 10.1038/sj.ejcn.1602697; Akoachere M, 2005, BIOL CHEM, V386, P41, DOI 10.1515/BC.2005.006; ANDERSON BB, 1989, EUR J HAEMATOL, V42, P354; ANDERSON BB, 1995, AM J HUM GENET, V57, P674; ANDERSON BB, 1993, AM J CLIN NUTR, V57, P666, DOI 10.1093/ajcn/57.5.666; ANDERSON BB, 1994, AM J HUM GENET, V55, P975; Arese P, 2005, CELL PHYSIOL BIOCHEM, V16, P133, DOI 10.1159/000089839; ARESE P, 1990, SEMIN HEMATOL, V27, P1; Arie T, 2005, J STRUCT BIOL, V150, P163, DOI 10.1016/j.jsb.2005.02.008; ATAMNA H, 1995, J BIOL CHEM, V270, P24876, DOI 10.1074/jbc.270.42.24876; Ayi K, 2004, BLOOD, V104, P3364, DOI 10.1182/blood-2003-11-3820; Ayi K, 2008, NEW ENGL J MED, V358, P1805, DOI 10.1056/NEJMoa072464; Becker K, 2005, MOLECULAR APPROACHES TO MALARIA, P365; Becker K, 2004, INT J PARASITOL, V34, P163, DOI 10.1016/j.ijpara.2003.09.011; Becker K, 2003, BIOL CHEM, V384, P551, DOI 10.1515/BC.2003.063; BECKER K, 1994, HISTOCHEMISTRY, V102, P389, DOI 10.1007/BF00268910; Beutler E, 1996, BLOOD REV, V10, P45, DOI 10.1016/S0268-960X(96)90019-3; BEUTLER E, 2001, WILLIAMS HEMATOLOGY, P289; BEUTLER E, 2001, WILLIAMS HEMATOLOGY, P527; BUCHHOLZ K, 2007, FRONTIERS DRUG DESIG, V3, P225; Cappadoro M, 1998, BLOOD, V92, P2527, DOI 10.1182/blood.V92.7.2527.2527_2527_2534; Chakravorty SJ, 2008, BIOCHEM SOC T, V36, P221, DOI 10.1042/BST0360221; Cholera R, 2008, P NATL ACAD SCI USA, V105, P991, DOI 10.1073/pnas.0711401105; Chotivanich K, 2002, BLOOD, V100, P1172, DOI 10.1182/blood.V100.4.1172.h81602001172_1172_1176; CLEMENTS JE, 1981, BIOMEDICINE, V34, P119; DAS BS, 1988, EUR J CLIN NUTR, V42, P277; DESJARDINS RE, 1979, ANTIMICROB AGENTS CH, V16, P710, DOI 10.1128/AAC.16.6.710; ELHAZMI MAF, 1985, HUM HERED, V35, P326, DOI 10.1159/000153571; Fairhurst RM, 2006, CURR OPIN HEMATOL, V13, P124, DOI 10.1097/01.moh.0000219655.73162.42; Fairhurst RM, 2005, NATURE, V435, P1117, DOI 10.1038/nature03631; FIORI PL, 1993, PARASITE IMMUNOL, V15, P647, DOI 10.1111/j.1365-3024.1993.tb00579.x; Fivelman QL, 2004, ANTIMICROB AGENTS CH, V48, P4097, DOI 10.1128/AAC.48.11.4097-4102.2004; FRISCHER H, 1977, J LAB CLIN MED, V89, P1080; GREENE L, 1993, YB PHYS ANTHR, V36, P26; Hanscheid T, 2007, LANCET INFECT DIS, V7, P675, DOI 10.1016/S1473-3099(07)70238-4; Hiller N, 2006, PROTEIN SCI, V15, P281, DOI 10.1110/ps.051891106; KAIKAI P, 1983, T ROY SOC TROP MED H, V77, P680, DOI 10.1016/0035-9203(83)90204-3; Kamerbeek NM, 2007, BLOOD, V109, P3560, DOI 10.1182/blood-2006-08-042531; Komaki-Yasuda K, 2003, FEBS LETT, V547, P140, DOI 10.1016/S0014-5793(03)00694-X; Krauth-Siegel RL, 2005, ANGEW CHEM INT EDIT, V44, P690, DOI 10.1002/anie.200300639; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; LOOS H, 1976, BLOOD, V48, P53; Lutz HU, 2004, CELL MOL BIOL, V50, P107; Min-Oo G, 2005, CELL MICROBIOL, V7, P753, DOI 10.1111/j.1462-5822.2005.00524.x; NKHOMA ET, 2009, BLOOD CELLS MOL DIS; NORDHOFF A, 1993, BIOCHEMISTRY-US, V32, P4060, DOI 10.1021/bi00066a029; Rahlfs S, 2006, MINI-REV MED CHEM, V6, P163, DOI 10.2174/138955706775475911; Roberts DJ, 2004, SUSCEPTIBILITY INFEC, P139; Rohner F, 2007, BRIT J NUTR, V97, P970, DOI 10.1017/S0007114507665180; Ruwende C, 1998, J MOL MED, V76, P581, DOI 10.1007/s001090050253; SCHULZ GE, 1982, J MOL BIOL, V160, P287, DOI 10.1016/0022-2836(82)90177-2; SCHWARZER E, 1992, J EXP MED, V176, P1033, DOI 10.1084/jem.176.4.1033; SCHWARZER E, 1994, BRIT J HAEMATOL, V88, P740, DOI 10.1111/j.1365-2141.1994.tb05112.x; Schwarzer E, 1998, INFECT IMMUN, V66, P1601, DOI 10.1128/IAI.66.4.1601-1606.1998; Scorza T, 1999, PARASITE IMMUNOL, V21, P545, DOI 10.1046/j.1365-3024.1999.00254.x; SINISCALCO M, 1966, B WORLD HEALTH ORGAN, V34, P379; Skorokhod OA, 2004, J IMMUNOL, V173, P4066, DOI 10.4049/jimmunol.173.6.4066; Skorokhod OA, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-73; STECK TL, 1970, SCIENCE, V168, P255, DOI 10.1126/science.168.3928.255; Tokumasu F, 2005, J CELL SCI, V118, P1091, DOI 10.1242/jcs.01662; TRAGER W, 1976, SCIENCE, V193, P673, DOI 10.1126/science.781840; TURRINI F, 1992, BLOOD, V80, P801; VARMA RN, 1983, AM J CLIN NUTR, V38, P884, DOI 10.1093/ajcn/38.6.884; Williams TN, 2006, CURR OPIN MICROBIOL, V9, P388, DOI 10.1016/j.mib.2006.06.009; ZHANG Y, 1988, BIOCHEM PHARMACOL, V37, P861, DOI 10.1016/0006-2952(88)90173-6; [No title captured]	66	21	21	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7303	10.1371/journal.pone.0007303	http://dx.doi.org/10.1371/journal.pone.0007303			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806191	Green Published, Green Submitted, gold			2022-12-27	WOS:000270593800013
J	Glover, WA; Yang, YQ; Zhang, Y				Glover, William A.; Yang, Yanqin; Zhang, Ying			Insights into the Molecular Basis of L-Form Formation and Survival in Escherichia coli	PLOS ONE			English	Article								L-forms have been shown to occur among many species of bacteria and are suspected to be involved in persistent infections. Since their discovery in 1935, numerous studies characterizing L-form morphology, growth, and pathogenic potential have been conducted. However, the molecular mechanisms underlying the formation and survival of L-forms remain unknown. Using unstable L-form colonies of Escherichia coli as a model, we performed genome-wide transcriptome analysis and screened a deletion mutant library to study the molecular mechanisms involved in formation and survival of L-forms. Microarray analysis of L-form versus classical colonies revealed many up-regulated genes of unknown function as well as multiple over-expressed stress pathways shared in common with persister cells and biofilms. Mutant screens identified three groups of mutants which displayed varying degrees of defects in L-form colony formation. Group 1 mutants, which showed the strongest defect in L-form colony formation, belonged to pathways involved in cell envelope stress, DNA repair, iron homeostasis, outer membrane biogenesis, and drug efflux/ABC transporters. Four (Group 1) mutants, rcsB, a positive response regulator of colanic acid capsule synthesis, ruvA, a recombinational junction binding protein, fur, a ferric uptake regulator and smpA a small membrane lipoprotein were selected for complementation. Complementation of the mutants using a high-copy overexpression vector failed, while utilization of a low-copy inducible vector successfully restored L-form formation. This work represents the first systematic genetic evaluation of genes and pathways involved in the formation and survival of unstable L-form bacteria. Our findings provide new insights into the molecular mechanisms underlying L-form formation and survival and have implications for understanding the emergence of antibiotic resistance, bacterial persistence and latent infections and designing novel drugs and vaccines.			Glover, WA (corresponding author), Johns Hopkins Univ, Bloomberg Sch Publ Hlth, Dept Mol Microbiol & Immunol, Baltimore, MD 21218 USA.	yzhang@jhsph.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI044063, T32AI007417] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI044063, T32 AI007417, R01 AI44063] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALLAN EJ, 2009, ADV APPL MICROBIOL, P1; Andrews SC, 2003, FEMS MICROBIOL REV, V27, P215, DOI 10.1016/S0168-6445(03)00055-X; Baba T, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100050; Beloin C, 2004, MOL MICROBIOL, V51, P659, DOI 10.1046/j.1365-2958.2003.03865.x; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boulanger A, 2005, J BACTERIOL, V187, P3282, DOI 10.1128/JB.187.9.3282-3286.2005; Carballes F, 1999, MOL MICROBIOL, V34, P442, DOI 10.1046/j.1365-2958.1999.01605.x; CLASENER H, 1972, ANNU REV MICROBIOL, V26, P55, DOI 10.1146/annurev.mi.26.100172.000415; Dell'Era S, 2009, MOL MICROBIOL, V73, P306, DOI 10.1111/j.1365-2958.2009.06774.x; DIENES L, 1951, BACTERIOL REV, V15, P245, DOI 10.1128/MMBR.15.4.245-288.1951; DIENES L, 1947, J BACTERIOL, V54, P231, DOI 10.1128/JB.54.2.231-237.1947; Domingue GJ, 1997, CLIN MICROBIOL REV, V10, P320, DOI 10.1128/CMR.10.2.320; Domka J, 2007, ENVIRON MICROBIOL, V9, P332, DOI 10.1111/j.1462-2920.2006.01143.x; Francez-Charlot A, 2005, J BACTERIOL, V187, P3873, DOI 10.1128/JB.187.11.3873-3877.2005; Francez-Charlot A, 2003, MOL MICROBIOL, V49, P823, DOI 10.1046/j.1365-2958.2003.03601.x; Fuller E, 2005, ANTIMICROB AGENTS CH, V49, P5075, DOI 10.1128/AAC.49.12.5075-5080.2005; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grove JI, 2008, DNA REPAIR, V7, P1517, DOI 10.1016/j.dnarep.2008.05.010; GUTMAN LT, 1965, J CLIN INVEST, V44, P1945, DOI 10.1172/JCI105300; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; HUBER TW, 1977, J CLIN MICROBIOL, V6, P166; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Joseleau-Petit D, 2007, J BACTERIOL, V189, P6512, DOI 10.1128/JB.00273-07; Keren I, 2004, J BACTERIOL, V186, P8172, DOI 10.1128/JB.186.24.8172-8180.2004; Klieneberger E, 1935, J PATHOL BACTERIOL, V40, P93, DOI 10.1002/path.1700400108; Kohanski MA, 2007, CELL, V130, P797, DOI 10.1016/j.cell.2007.06.049; Kvist M, 2008, APPL ENVIRON MICROB, V74, P7376, DOI 10.1128/AEM.01310-08; Laubacher ME, 2008, J BACTERIOL, V190, P2065, DOI 10.1128/JB.01740-07; Leaver M, 2009, NATURE, V457, P849, DOI 10.1038/nature07742; LEDERBERG J, 1958, J BACTERIOL, V75, P143, DOI 10.1128/JB.75.2.143-160.1958; LEDERBERG J, 1956, P NATL ACAD SCI USA, V42, P574, DOI 10.1073/pnas.42.9.574; Majdalani N, 2005, ANNU REV MICROBIOL, V59, P379, DOI 10.1146/annurev.micro.59.050405.101230; Mattman L., 2001, CELL WALL DEFICIENT; Miller C, 2004, SCIENCE, V305, P1629, DOI 10.1126/science.1101630; OWENS WE, 1987, J CLIN MICROBIOL, V25, P1956, DOI 10.1128/JCM.25.10.1956-1961.1987; Schmidt AJ, 2005, J BACTERIOL, V187, P4774, DOI 10.1128/JB.187.14.4774-4781.2005; Schmidtke LM, 1999, VET MICROBIOL, V69, P287, DOI 10.1016/S0378-1135(99)00120-0; Shah D, 2006, BMC MICROBIOL, V6, DOI 10.1186/1471-2180-6-53; Shingaki R, 2003, MICROBIOL-SGM, V149, P2501, DOI 10.1099/mic.0.26259-0; Siddiqui RA, 2006, FEMS MICROBIOL LETT, V258, P305, DOI 10.1111/j.1574-6968.2006.00237.x; Sklar JG, 2007, P NATL ACAD SCI USA, V104, P6400, DOI 10.1073/pnas.0701579104; Tamae C, 2008, J BACTERIOL, V190, P5981, DOI 10.1128/JB.01982-07; Zhang XS, 2007, J BACTERIOL, V189, P3051, DOI 10.1128/JB.01832-06	43	49	54	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7316	10.1371/journal.pone.0007316	http://dx.doi.org/10.1371/journal.pone.0007316			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806199	Green Published, Green Submitted, gold			2022-12-27	WOS:000270593800019
J	Krishna, ADS; Mandraju, RK; Kishore, G; Kondapi, AK				Krishna, Athuluri Divakar Sai; Mandraju, Raj Kumar; Kishore, Golla; Kondapi, Anand Kumar			An Efficient Targeted Drug Delivery through Apotransferrin Loaded Nanoparticles	PLOS ONE			English	Article								Background: Cancerous state is a highly stimulated environment of metabolically active cells. The cells under these conditions over express selective receptors for assimilation of factors essential for growth and transformation. Such receptors would serve as potential targets for the specific ligand mediated transport of pharmaceutically active molecules. The present study demonstrates the specificity and efficacy of protein nanoparticle of apotransferrin for targeted delivery of doxorubicin. Methodology/Principal Findings: Apotransferrin nanoparticles were developed by sol-oil chemistry. A comparative analysis of efficiency of drug delivery in conjugated and non-conjugated forms of doxorubicin to apotransferrin nanoparticle is presented. The spherical shaped apotransferrin nanoparticles (nano) have diameters of 25-50 eta m, which increase to 60-80 eta m upon direct loading of drug (direct-nano), and showed further increase in dimension (75-95 eta m) in conjugated nanoparticles (conj-nano). The competitive experiments with the transferrin receptor specific antibody showed the entry of both conj-nano and direct-nano into the cells through transferrin receptor mediated endocytosis. Results of various studies conducted clearly establish the superiority of the direct-nano over conj-nano viz. ( a) localization studies showed complete release of drug very early, even as early as 30 min after treatment, with the drug localizing in the target organelle ( nucleus) (b) pharmacokinetic studies showed enhanced drug concentrations, in circulation with sustainable half-life ( c) the studies also demonstrated efficient drug delivery, and an enhanced inhibition of proliferation in cancer cells. Tissue distribution analysis showed intravenous administration of direct nano lead to higher drug localization in liver, and blood as compared to relatively lesser localization in heart, kidney and spleen. Experiments using rat cancer model confirmed the efficacy of the formulation in regression of hepatocellular carcinoma with negligible toxicity to kidney and liver. Conclusions: The present study thus demonstrates that the direct-nano is highly efficacious in delivery of drug in a target specific manner with lower toxicity to heart, liver and kidney.			Krishna, ADS (corresponding author), Univ Hyderabad, Dept Biochem, Hyderabad 500134, Andhra Pradesh, India.	akondapi@yahoo.com		A. DIVAKAR, SAI KRISHNA/0000-0003-0232-4052				Ali SA, 1999, J BIOL CHEM, V274, P24066, DOI 10.1074/jbc.274.34.24066; Anhorn MG, 2008, BIOCONJUGATE CHEM, V19, P2321, DOI 10.1021/bc8002452; Aravalli RN, 2008, HEPATOLOGY, V48, P2047, DOI 10.1002/hep.22580; Baalousha M, 2005, MICROSC RES TECHNIQ, V66, P299, DOI 10.1002/jemt.20173; BABSON AL, 1973, CLIN CHEM, V19, P766; Berthelot MPE., 1859, REPORT CHIM APPL, V384, P2884; Beyer U, 1998, J MED CHEM, V41, P2701, DOI 10.1021/jm9704661; Bills CE, 1926, J BIOL CHEM, V67, P279; Bowers GN, 1972, CLIN CHEM, V18, P97; BOWERS LD, 1980, CLIN CHEM, V26, P555; BRASLAWSKY GR, 1991, CANCER IMMUNOL IMMUN, V33, P367, DOI 10.1007/BF01741596; Brigger I, 2002, ADV DRUG DELIVER REV, V54, P631, DOI 10.1016/S0169-409X(02)00044-3; Chen BA, 2008, INT J NANOMED, V3, P277; COHN EJ, 1946, J AM CHEM SOC, V68, P459, DOI 10.1021/ja01207a034; ENNS CA, 1982, P NATL ACAD SCI-BIOL, V79, P3241, DOI 10.1073/pnas.79.10.3241; Erickson B, 2008, LANGMUIR, V24, P11003, DOI 10.1021/la801497d; GATTER KC, 1983, J CLIN PATHOL, V36, P539, DOI 10.1136/jcp.36.5.539; Gaur U, 2000, INT J PHARM, V202, P1, DOI 10.1016/S0378-5173(99)00447-0; Grayson SM, 2008, J DRUG TARGET, V16, P329, DOI [10.1080/10611860801969616, 10.1080/10611860801969616 ]; Hait W. N., 2009, CANCER RES, V69, P1267; Hait WN, 2009, CANCER RES, V69, P1263, DOI 10.1158/0008-5472.CAN-08-3836; Hamad I, 2008, EXPERT OPIN DRUG DEL, V5, P205, DOI 10.1517/17425247.5.2.205; Holmstrom P, 2006, LIVER INT, V26, P976, DOI 10.1111/j.1478-3231.2006.01316.x; Hsieh MF, 2008, J NANOSCI NANOTECHNO, V8, P2362, DOI 10.1166/jnn.2008.322; Iankov ID, 2007, MOL THER, V15, P114, DOI 10.1038/sj.mt.6300020; Jain RK, 1999, ANNU REV BIOMED ENG, V1, P241, DOI 10.1146/annurev.bioeng.1.1.241; Kircheis R, 2001, GENE THER, V8, P28, DOI 10.1038/sj.gt.3301351; KONDAPI AK, 2007, Patent No. 14433; Kondapi AK, 2006, ARCH BIOCHEM BIOPHYS, V450, P123, DOI 10.1016/j.abb.2006.04.003; Kono K, 2008, BIOMATERIALS, V29, P1664, DOI 10.1016/j.biomaterials.2007.12.017; Li HY, 2002, TRENDS PHARMACOL SCI, V23, P206, DOI 10.1016/S0165-6147(02)01989-2; Lochmann D, 2005, EUR J PHARM BIOPHARM, V59, P419, DOI 10.1016/j.ejpb.2004.04.001; Lopez-Tarruella S, 2009, BREAST CANCER RES, V11, DOI 10.1186/bcr2226; Mier W, 2005, BIOCONJUGATE CHEM, V16, P237, DOI 10.1021/bc034216c; Minguez B, 2009, CURR OPIN GASTROEN, V25, P186, DOI 10.1097/MOG.0b013e32832962a1; Misra S, 2009, J BIOL CHEM, V284, P12432, DOI 10.1074/jbc.M806772200; Munnier E, 2008, INT J PHARMACEUT, V363, P170, DOI 10.1016/j.ijpharm.2008.07.006; PANDE G, 1986, CANCER RES, V46, P1673; Papagiannaros A, 2005, INT J PHARMACEUT, V302, P29, DOI 10.1016/j.ijpharm.2005.05.039; PLOSKER GL, 1993, DRUGS, V45, P788, DOI 10.2165/00003495-199345050-00011; Qian ZM, 2002, PHARMACOL REV, V54, P561, DOI 10.1124/pr.54.4.561; Reddy Lakkireddy Harivardhan, 2005, Acta Pharmaceutica (Zagreb), V55, P81; Romberg B, 2008, PHARM RES, V25, P55, DOI 10.1007/s11095-007-9348-7; Singh M, 1999, CURR PHARM DESIGN, V5, P443; STEIN BS, 1984, J BIOL CHEM, V259, P4762; STORM G, 1995, ADV DRUG DELIVER REV, V17, P31, DOI 10.1016/0169-409X(95)00039-A; THORSTENSEN K, 1993, SCAND J CLIN LAB INV, V53, P113, DOI 10.3109/00365519309090703; Tian Z, 2008, BIOMED MATER, V3, DOI 10.1088/1748-6041/3/4/044116; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; TSENG HH, 2009, J CANC RES CLIN 0423; Udhrain A, 2007, INT J NANOMED, V2, P345; VINCENT A, 2009, ACS NANO; Wei JS, 2005, FRONT BIOSCI-LANDMRK, V10, P3058; Wong HL, 2006, J CONTROL RELEASE, V116, P275, DOI 10.1016/j.jconrel.2006.09.007; Xu JP, 2005, J CONTROL RELEASE, V107, P502, DOI 10.1016/j.jconrel.2005.06.013; Xu PS, 2009, MOL PHARMACEUT, V6, P190, DOI 10.1021/mp800137z; Yadav AK, 2008, J DRUG TARGET, V16, P464, DOI [10.1080/10611860802095494, 10.1080/10611860802095494 ]; Yadav AK, 2007, NANOMED-NANOTECHNOL, V3, P246, DOI 10.1016/j.nano.2007.09.004; Ying XY, 2008, PHARMAZIE, V63, P878, DOI 10.1691/ph.2008.8162; Yuen MF, 2009, J GASTROEN HEPATOL, V24, P346, DOI 10.1111/j.1440-1746.2009.05784.x; Zamboni WC, 2008, ONCOLOGIST, V13, P248, DOI 10.1634/theoncologist.2007-0180	61	55	56	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7240	10.1371/journal.pone.0007240	http://dx.doi.org/10.1371/journal.pone.0007240			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19806207	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593300005
J	Hudson, NJ; Reverter, A; Wang, YH; Greenwood, PL; Dalrymple, BP				Hudson, Nicholas J.; Reverter, Antonio; Wang, YongHong; Greenwood, Paul L.; Dalrymple, Brian P.			Inferring the Transcriptional Landscape of Bovine Skeletal Muscle by Integrating Co-Expression Networks	PLOS ONE			English	Article								Background: Despite modern technologies and novel computational approaches, decoding causal transcriptional regulation remains challenging. This is particularly true for less well studied organisms and when only gene expression data is available. In muscle a small number of well characterised transcription factors are proposed to regulate development. Therefore, muscle appears to be a tractable system for proposing new computational approaches. Methodology/Principal Findings: Here we report a simple algorithm that asks "which transcriptional regulator has the highest average absolute co-expression correlation to the genes in a co-expression module?'' It correctly infers a number of known causal regulators of fundamental biological processes, including cell cycle activity (E2F1), glycolysis (HLF), mitochondrial transcription (TFB2M), adipogenesis (PIAS1), neuronal development (TLX3), immune function (IRF1) and vasculogenesis (SOX17), within a skeletal muscle context. However, none of the canonical pro-myogenic transcription factors (MYOD1, MYOG, MYF5, MYF6 and MEF2C) were linked to muscle structural gene expression modules. Co-expression values were computed using developing bovine muscle from 60 days post conception (early foetal) to 30 months post natal (adulthood) for two breeds of cattle, in addition to a nutritional comparison with a third breed. A number of transcriptional landscapes were constructed and integrated into an always correlated landscape. One notable feature was a 'metabolic axis' formed from glycolysis genes at one end, nuclear-encoded mitochondrial protein genes at the other, and centrally tethered by mitochondrially-encoded mitochondrial protein genes. Conclusions/Significance: The new module-to-regulator algorithm complements our recently described Regulatory Impact Factor analysis. Together with a simple examination of a co-expression module's contents, these three gene expression approaches are starting to illuminate the in vivo transcriptional regulation of skeletal muscle development.			Hudson, NJ (corresponding author), CSIRO, Brisbane, Qld, Australia.	Brian.Dalrymple@csiro.au	Hudson, Nick/C-1201-2008; Hudson, Nicholas J/D-1606-2011; Dalrymple, Brian P/F-8721-2010; Hudson, Nick/AAF-5644-2020; Greenwood, Paul L/G-9747-2013; Reverter, Antonio/C-9699-2013	Hudson, Nicholas J/0000-0002-3549-9396; Dalrymple, Brian P/0000-0003-3891-5233; Hudson, Nick/0000-0002-3549-9396; Greenwood, Paul L/0000-0002-7719-8233; Reverter, Antonio/0000-0002-4681-9404				AKAZAWA C, 1992, J BIOL CHEM, V267, P21879; Almenar-Queralt A, 1999, J BIOL CHEM, V274, P28466, DOI 10.1074/jbc.274.40.28466; Badis G, 2009, SCIENCE, V324, P1720, DOI 10.1126/science.1162327; Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; BARNES JD, 1994, DEV BIOL, V161, P168, DOI 10.1006/dbio.1994.1018; Basso K, 2005, NAT GENET, V37, P382, DOI 10.1038/ng1532; Berger MF, 2008, CELL, V133, P1266, DOI 10.1016/j.cell.2008.05.024; Berry C, 2002, AM J PHYSIOL-CELL PH, V283, pC135, DOI 10.1152/ajpcell.00458.2001; Bicer S, 2004, J MUSCLE RES CELL M, V25, P623, DOI 10.1007/s10974-004-5070-9; Blais A, 2005, GENE DEV, V19, P1499, DOI 10.1101/gad.1325605; Blais A, 2005, GENE DEV, V19, P553, DOI 10.1101/gad.1281105; Bottinelli R, 2000, PROG BIOPHYS MOL BIO, V73, P195, DOI 10.1016/S0079-6107(00)00006-7; BRAND MD, 1991, BIOCHEM J, V275, P81, DOI 10.1042/bj2750081; Cao Y, 2006, EMBO J, V25, P502, DOI 10.1038/sj.emboj.7600958; Carter SL, 2004, BIOINFORMATICS, V20, P2242, DOI 10.1093/bioinformatics/bth234; Cartharius K, 2005, BIOINFORMATICS, V21, P2933, DOI 10.1093/bioinformatics/bti473; Chen L, 2002, P NATL ACAD SCI USA, V99, P14320, DOI 10.1073/pnas.212532399; Chen Q, 2000, INVEST OPHTH VIS SCI, V41, P4223; Chin CH, 2004, GENE DEV, V18, P1970, DOI 10.1101/gad.1213104; Christensen J, 2005, NUCLEIC ACIDS RES, V33, P5458, DOI 10.1093/nar/gki855; Cohen DR, 2000, MECH DEVELOP, V91, P317, DOI 10.1016/S0925-4773(99)00263-4; D'haeseleer P, 2000, BIOINFORMATICS, V16, P707, DOI 10.1093/bioinformatics/16.8.707; Dal Rhee S, 2008, MOL CELL ENDOCRINOL, V294, P61, DOI 10.1016/j.mce.2008.08.018; de la Cruz CC, 1999, DEV BIOL, V216, P595, DOI 10.1006/dbio.1999.9528; De la Fuente R, 2006, NAT CELL BIOL, V8, P1448, DOI 10.1038/ncb1513; Eden E, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-48; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; Falkenberg M, 2002, NAT GENET, V31, P289, DOI 10.1038/ng909; Farrall M, 2004, HUM MOL GENET, V13, pR1, DOI 10.1093/hmg/ddh084; Finocchietto P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001749; Fuller TF, 2007, MAMM GENOME, V18, P463, DOI 10.1007/s00335-007-9043-3; Gradin K, 2002, J BIOL CHEM, V277, P23508, DOI 10.1074/jbc.M201307200; Grifone R, 2004, MOL CELL BIOL, V24, P6253, DOI 10.1128/MCB.24.14.6253-6267.2004; Hartemink AJ, 2005, NAT BIOTECHNOL, V23, P554, DOI 10.1038/nbt0505-554; Hawley JA, 2007, SPORTS MED, V37, P328, DOI 10.2165/00007256-200737040-00014; Hayashi R, 2006, J BIOL CHEM, V281, P35633, DOI 10.1074/jbc.M603800200; Hofmann WE, 2001, J BIOL CHEM, V276, P12460, DOI 10.1074/jbc.M100466200; HOLLAND PWH, 1992, DEVELOPMENT, V116, P653; Hong SK, 1999, BIOCHEM BIOPH RES CO, V255, P116, DOI 10.1006/bbrc.1999.0158; Hudson NJ, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000382; HUDSON NJ, 2009, PLOS COMPUT IN PRESS; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; Issa LL, 2006, DEV BIOL, V293, P104, DOI 10.1016/j.ydbio.2006.01.019; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; JOHNSON DG, 1994, GENE DEV, V8, P1514, DOI 10.1101/gad.8.13.1514; Lee HK, 2004, GENOME RES, V14, P1085, DOI 10.1101/gr.1910904; Lee SI, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000358; Lehnert SA, 2006, J ANIM SCI, V84, P3239, DOI 10.2527/jas.2006-192; Lehnert SA, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213x-7-95; Leid M, 2004, GENE EXPR PATTERNS, V4, P733, DOI 10.1016/j.modgep.2004.03.009; Lin J, 2002, NATURE, V418, P797, DOI 10.1038/nature00904; Liu B, 1998, P NATL ACAD SCI USA, V95, P10626, DOI 10.1073/pnas.95.18.10626; Liu Li, 2007, Chinese Journal of Pathology, V36, P390; MacIntosh B.R., 2006, SKELETAL MUSCLE FORM; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Matsui T, 2006, J CELL SCI, V119, P3513, DOI 10.1242/jcs.03081; McCleland ML, 2003, GENE DEV, V17, P101, DOI 10.1101/gad.1040903; McPherron AC, 1997, NATURE, V387, P83, DOI 10.1038/387083a0; Michoel T, 2009, ANN NY ACAD SCI, V1158, P36, DOI 10.1111/j.1749-6632.2008.03943.x; Ong VH, 2009, EXP CELL RES, V315, P151, DOI 10.1016/j.yexcr.2008.11.001; Passos JF, 2005, EXP GERONTOL, V40, P466, DOI 10.1016/j.exger.2005.04.006; Petrovic V, 2008, J BIOL CHEM, V283, P453, DOI 10.1074/jbc.M705792200; PINE R, 1992, J VIROL, V66, P4470, DOI 10.1128/JVI.66.7.4470-4478.1992; Presson AP, 2009, BMC SYST BIOL, V2, DOI 10.1186/1752-0509-2-95; Prieto C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003911; Qian Y, 2001, GENE DEV, V15, P2533, DOI 10.1101/gad.921501; Qin XQ, 1997, ONCOGENE, V14, P53, DOI 10.1038/sj.onc.1200809; Reverter A, 2008, BIOINFORMATICS, V24, P2491, DOI 10.1093/bioinformatics/btn482; Reverter A, 2006, PHYSIOL GENOMICS, V28, P76, DOI 10.1152/physiolgenomics.00105.2006; SAGE EH, 1991, J BIOL CHEM, V266, P14831; Sander EE, 1998, J CELL BIOL, V143, P1385, DOI 10.1083/jcb.143.5.1385; Scherf M, 2005, BRIEF BIOINFORM, V6, P287, DOI 10.1093/bib/6.3.287; Setoyama C, 1995, Nihon Rinsho, V53, P1081; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Sheng HZ, 1997, DEV DYNAM, V208, P266, DOI 10.1002/(SICI)1097-0177(199702)208:2<266::AID-AJA13>3.0.CO;2-1; Stolovitzky G, 2009, ANN NY ACAD SCI, V1158, P159, DOI 10.1111/j.1749-6632.2009.04497.x; Sun XK, 2004, J BIOL CHEM, V279, P2394, DOI 10.1074/jbc.M311324200; Suthram S, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.4; Takebe A, 2006, DEV BIOL, V293, P25, DOI 10.1016/j.ydbio.2005.12.016; Toresson H, 1999, DEVELOPMENT, V126, P1317; Tuch BB, 2008, SCIENCE, V319, P1797, DOI 10.1126/science.1152398; Vaquerizas JM, 2009, NAT REV GENET, V10, P252, DOI 10.1038/nrg2538; Villena JA, 2007, P NATL ACAD SCI USA, V104, P1418, DOI 10.1073/pnas.0607696104; Wang YH, 2009, J ANIM SCI, V87, P119, DOI 10.2527/jas.2008-1082; Wang YX, 2004, PLOS BIOL, V2, P1532, DOI 10.1371/journal.pbio.0020294; Watkinson J, 2009, ANN NY ACAD SCI, V1158, P302, DOI 10.1111/j.1749-6632.2008.03757.x; WATT PM, 1994, BIOCHEM J, V303, P681, DOI 10.1042/bj3030681; Xu Y, 2004, J BIOL CHEM, V279, P41179, DOI 10.1074/jbc.M400292200; Zampieri M, 2008, BIOINFORMATICS, V24, P1510, DOI 10.1093/bioinformatics/btn220; Zhang B, 2005, STAT APPL GENET MOL, V4, DOI 10.2202/1544-6115.1128	90	46	48	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2009	4	10							e7249	10.1371/journal.pone.0007249	http://dx.doi.org/10.1371/journal.pone.0007249			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BP	19794913	gold, Green Published, Green Submitted			2022-12-27	WOS:000270354200004
J	Jaworski, T; Dewachter, I; Lechat, B; Croes, S; Termont, A; Demedts, D; Borghgraef, P; Devijver, H; Filipkowski, RK; Kaczmarek, L; Kugler, S; Van Leuven, F				Jaworski, Tomasz; Dewachter, Ilse; Lechat, Benoit; Croes, Sophie; Termont, Annelies; Demedts, David; Borghgraef, Peter; Devijver, Herman; Filipkowski, Robert K.; Kaczmarek, Leszek; Kuegler, Sebastian; Van Leuven, Fred			AAV-Tau Mediates Pyramidal Neurodegeneration by Cell-Cycle Re-Entry without Neurofibrillary Tangle Formation in Wild-Type Mice	PLOS ONE			English	Article								In Alzheimer's disease tauopathy is considered secondary to amyloid, and the duality obscures their relation and the definition of their respective contributions. Transgenic mouse models do not resolve this problem conclusively, i.e. the relative hierarchy of amyloid and tau pathology depends on the actual model and the genes expressed or inactivated. Here, we approached the problem in non-transgenic models by intracerebral injection of adeno-associated viral vectors to express protein tau or amyloid precursor protein in the hippocampus in vivo. AAV-APP mutant caused neuronal accumulation of amyloid peptides, and eventually amyloid plaques at 6 months post-injection, but with only marginal hippocampal cell-death. In contrast, AAV-Tau, either wild-type or mutant P301L, provoked dramatic degeneration of pyramidal neurons in CA1/2 and cortex within weeks. Tau-mediated neurodegeneration proceeded without formation of large fibrillar tau-aggregates or tangles, but with increased expression of cell-cycle markers. We present novel AAV-based models, which demonstrate that protein tau mediates pyramidal neurodegeneration in vivo. The data firmly support the unifying hypothesis that post-mitotic neurons are forced to re-enter the cell-cycle in primary and secondary tauopathies, including Alzheimer's disease.			Jaworski, T (corresponding author), Katholieke Univ Leuven VIB, Dept Human Genet, Expt Genet Grp, KULeuven Campus, B-3000 Leuven, Belgium.	fred.vanleuven@med.kuleuven.be	Kaczmarek, Leszek/AHA-0076-2022; Kaczmarek, Leszek/B-6171-2008; Dewachter, Ilse/AAZ-5661-2020	Kaczmarek, Leszek/0000-0002-7207-3490; Kaczmarek, Leszek/0000-0002-7207-3490; Dewachter, Ilse/0000-0001-7202-515X; Jaworski, Tomasz/0000-0002-6387-9249				Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Arnaud L, 2006, NEURODEGENER DIS, V3, P313, DOI 10.1159/000095638; Bard F, 2003, P NATL ACAD SCI USA, V100, P2023, DOI 10.1073/pnas.0436286100; BRAAK H, 1991, ACTA NEUROPATHOL, V82, P239, DOI 10.1007/BF00308809; CITRON M, 1992, NATURE, V360, P672, DOI 10.1038/360672a0; CLAVAGUERA F, 2009, NAT CELL BI IN PRESS; Dewachter I, 2002, LANCET NEUROL, V1, P409, DOI 10.1016/S1474-4422(02)00188-6; DUYCKAERTS C, 2009, ACTA NEUROP IN PRESS; Frank S, 2008, ACTA NEUROPATHOL, V115, P39, DOI 10.1007/s00401-007-0291-9; FRANKLIN KBJ, 1997, MOUSE BRAIN STEREOTA, P360; Geschwind DH, 2003, NEURON, V40, P457, DOI 10.1016/S0896-6273(03)00681-0; GOATE A, 1991, NATURE, V349, P704, DOI 10.1038/349704a0; GOEDERT M, 1989, NEURON, V3, P519, DOI 10.1016/0896-6273(89)90210-9; Gotz J, 2008, NAT REV NEUROSCI, V9, P532, DOI 10.1038/nrn2420; GRUNDKEIQBAL I, 1986, P NATL ACAD SCI USA, V83, P4913, DOI 10.1073/pnas.83.13.4913; Hasan S, 2001, NATURE, V410, P387, DOI 10.1038/35066610; Herrup K, 2007, NAT REV NEUROSCI, V8, P368, DOI 10.1038/nrn2124; Hoozemans JJM, 2002, J NEUROPATH EXP NEUR, V61, P678, DOI 10.1093/jnen/61.8.678; Husseman JW, 2000, NEUROBIOL AGING, V21, P815, DOI 10.1016/S0197-4580(00)00221-9; Hutton M, 1998, NATURE, V393, P702, DOI 10.1038/31508; Khurana V, 2006, CURR BIOL, V16, P230, DOI 10.1016/j.cub.2005.12.042; Kim K., 1988, NEUROSCI RES COMMUN, V2, P121; KLEIN RL, 2009, NEUROBIOL AGING; Kowalczyk A, 2004, J CELL BIOL, V167, P209, DOI 10.1083/jcb.200404181; Kugler S, 2007, AM J HUM GENET, V80, P291, DOI 10.1086/511281; Kumar-Singh S, 2000, HUM MOL GENET, V9, P2589, DOI 10.1093/hmg/9.18.2589; Lee VMY, 2001, ANNU REV NEUROSCI, V24, P1121, DOI 10.1146/annurev.neuro.24.1.1121; Mandelkow EM, 1998, TRENDS CELL BIOL, V8, P425, DOI 10.1016/S0962-8924(98)01368-3; Melino G, 2005, CELL DEATH DIFFER, V12, P1457, DOI 10.1038/sj.cdd.4401781; Moechars D, 1999, J BIOL CHEM, V274, P6483, DOI 10.1074/jbc.274.10.6483; Morrissette DA, 2009, J BIOL CHEM, V284, P6033, DOI 10.1074/jbc.R800030200; Muyllaert D, 2008, AM J PATHOL, V172, P470, DOI 10.2353/ajpath.2008.070693; Nixon RA, 2006, TRENDS NEUROSCI, V29, P528, DOI 10.1016/j.tins.2006.07.003; Roberson ED, 2007, SCIENCE, V316, P750, DOI 10.1126/science.1141736; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; SantaCruz K, 2005, SCIENCE, V309, P476, DOI 10.1126/science.1113694; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shevtsova Z, 2005, EXP PHYSIOL, V90, P53, DOI 10.1113/expphysiol.2004.028159; Sicinski P, 1996, NATURE, V384, P470, DOI 10.1038/384470a0; Spillantini MG, 1998, AM J PATHOL, V153, P1359, DOI 10.1016/S0002-9440(10)65721-5; Spittaels K, 1999, AM J PATHOL, V155, P2153, DOI 10.1016/S0002-9440(10)65533-2; Spittaels K, 2000, J BIOL CHEM, V275, P41340, DOI 10.1074/jbc.M006219200; Styren SC, 2000, J HISTOCHEM CYTOCHEM, V48, P1223, DOI 10.1177/002215540004800906; Takashima A, 2008, J ALZHEIMERS DIS, V14, P371; Terwel D, 2005, J BIOL CHEM, V280, P3963, DOI 10.1074/jbc.M409876200; TERWEL D, 2002, NEUROMOL MED, V2, P161; Terwel D, 2008, AM J PATHOL, V172, P786, DOI 10.2353/ajpath.2008.070904; van Leuven F, 2000, PROG NEUROBIOL, V61, P305, DOI 10.1016/S0301-0082(99)00055-6; Vincent I, 1997, J NEUROSCI, V17, P3588	49	59	62	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2009	4	10							e7280	10.1371/journal.pone.0007280	http://dx.doi.org/10.1371/journal.pone.0007280			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BP	19794916	Green Published, Green Submitted, gold			2022-12-27	WOS:000270354200007
J	Clay, BS; Shilling, RA; Bandukwala, HS; Moore, TV; Cannon, JL; Welcher, AA; Weinstock, JV; Sperling, AI				Clay, Bryan S.; Shilling, Rebecca A.; Bandukwala, Hozefa S.; Moore, Tamson V.; Cannon, Judy L.; Welcher, Andrew A.; Weinstock, Joel V.; Sperling, Anne I.			Inducible Costimulator Expression Regulates the Magnitude of Th2-Mediated Airway Inflammation by Regulating the Number of Th2 Cells	PLOS ONE			English	Article							CD4(+) T-CELLS; B-CELL; IMMUNE-RESPONSES; MOLECULE ICOS; CHROMOSOME 2Q; CUTTING EDGE; DIFFERENTIATION; IL-4; RECEPTOR; ASTHMA	Background: Inducible Costimulator (ICOS) is an important regulator of Th2 lymphocyte function and a potential immunotherapeutic target for allergy and asthma. A SNP in the ICOS 5' promoter in humans is associated with increased atopy and serum IgE in a founder population and increased ICOS surface expression and Th2 cytokine production from peripheral blood mononuclear cells. However, it is unknown if increased ICOS expression contributes to disease progression or is a result of disease pathology. Methodology/Principal Findings: We developed a mouse model in which ICOS surface expression levels are genetically predetermined to test our hypothesis that genetic regulation of ICOS expression controls the severity of Th2 responses in vivo. Using ICOS(+/+) and ICOS(+/-) mice in a Th2 model of airway inflammation, we found that T cells from the ICOS(+/-) mice had reduced ICOS expression and decreased Th2-mediated inflammation in vivo. Although the activation status of the T cells did not differ, T cells isolated from the lungs and draining lymph nodes of ICOS(+/-) mice at the peak of inflammation produced less Th2 cytokines upon stimulation ex vivo. Using 4get mice, which express GFP upon IL-4 transcription, we determined that the decreased Th2 cytokines in ICOS(+/-) is due to reduced percentage of Th2 cells and not a defect in their ability to produce IL-4. Conclusion: These data suggest that in both mice and humans, the level of ICOS surface expression regulates the magnitude of the in vivo Th2 response, perhaps by influencing Th2 differentiation.			Clay, BS (corresponding author), Univ Chicago, Comm Immunol, Chicago, IL 60637 USA.	asperlin@uchicago.edu	Sperling, Anne/ACZ-2351-2022	Sperling, Anne I./0000-0002-4265-9212; Cannon, Judy/0000-0003-0069-8106	NIAID NIH HHS [T32 AI007090, K08 AI059105, R01 AI50180, P01-AI56352, P01 AI056352, 5T32AI07090, R01 AI050180] Funding Source: Medline; PHS HHS [P01 A156352] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [K08AI059105, R01AI050180, T32AI007090, P01AI056352] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Beier KC, 2004, J ALLERGY CLIN IMMUN, V114, P775, DOI 10.1016/j.jaci.2004.06.024; Chen LQ, 2004, J IMMUNOL, V172, P2059, DOI 10.4049/jimmunol.172.4.2059; Cookson W, 1999, NATURE, V402, pB5, DOI 10.1038/35037002; Coyle AJ, 2000, IMMUNITY, V13, P95, DOI 10.1016/S1074-7613(00)00011-X; Ding HL, 2006, CLIN IMMUNOL, V118, P258, DOI 10.1016/j.clim.2005.10.017; Dong C, 2001, J IMMUNOL, V166, P3659, DOI 10.4049/jimmunol.166.6.3659; Dong C, 2001, NATURE, V409, P97, DOI 10.1038/35051100; Evans DM, 2004, J ALLERGY CLIN IMMUN, V114, P826, DOI 10.1016/j.jaci.2004.05.060; Gonzalo JA, 2001, NAT IMMUNOL, V2, P597, DOI 10.1038/89739; Grimbacher B, 2003, NAT IMMUNOL, V4, P261, DOI 10.1038/ni902; Hoeck J, 2001, J IMMUNOL, V166, P4507, DOI 10.4049/jimmunol.166.7.4507; Howard TD, 2002, J ALLERGY CLIN IMMUN, V110, P743, DOI 10.1067/mai.2002.128723; Hutloff A, 2004, ARTHRITIS RHEUM-US, V50, P3211, DOI 10.1002/art.20519; Koppelman GH, 2002, J ALLERGY CLIN IMMUN, V109, P498, DOI 10.1067/mai.2002.122235; Liang L, 2002, J EXP MED, V196, P97, DOI 10.1084/jem.20020298; Logue EC, 2006, J IMMUNOL, V177, P2356, DOI 10.4049/jimmunol.177.4.2356; Lohning M, 2003, J EXP MED, V197, P181, DOI 10.1084/jem.20020632; McAdam AJ, 2000, J IMMUNOL, V165, P5035, DOI 10.4049/jimmunol.165.9.5035; McAdam AJ, 2001, NATURE, V409, P102, DOI 10.1038/35051107; Mohrs K, 2005, J IMMUNOL, V175, P5306, DOI 10.4049/jimmunol.175.8.5306; Monick MM, 2007, J IMMUNOL, V179, P1648, DOI 10.4049/jimmunol.179.3.1648; Nurieva RI, 2003, IMMUNITY, V18, P801, DOI 10.1016/S1074-7613(03)00144-4; O'Connell EJ, 2004, ALLERGY, V59, P7, DOI 10.1111/j.1398-9995.2004.00563.x; Okamoto T, 2003, J RHEUMATOL, V30, P1157; ROTHENBERG ME, 1995, P NATL ACAD SCI USA, V92, P8960, DOI 10.1073/pnas.92.19.8960; Scott BG, 2004, J NEUROIMMUNOL, V153, P16, DOI 10.1016/j.jneuroim.2004.04.019; Shilling RA, 2005, J IMMUNOL, V175, P2061, DOI 10.4049/jimmunol.175.4.2061; Tafuri A, 2001, NATURE, V409, P105, DOI 10.1038/35051113; Terada N, 2001, CLIN EXP ALLERGY, V31, P1923, DOI 10.1046/j.1365-2222.2001.01152.x; Tesciuba AG, 2001, J IMMUNOL, V167, P1996, DOI 10.4049/jimmunol.167.4.1996; Venter JC, 2001, SCIENCE, V291, P1304, DOI 10.1126/science.1058040; Vinuesa CG, 2005, NATURE, V435, P452, DOI 10.1038/nature03555; Watanabe M, 2005, J IMMUNOL, V174, P1989, DOI 10.4049/jimmunol.174.4.1989; Watanabe M, 2008, J IMMUNOL, V180, P5222, DOI 10.4049/jimmunol.180.8.5222; Yagi J, 2003, J IMMUNOL, V171, P783, DOI 10.4049/jimmunol.171.2.783; Zheng Y, 2005, J IMMUNOL, V174, P3117, DOI 10.4049/jimmunol.174.5.3117; Zhou ZP, 2005, EUR J IMMUNOL, V35, P1918, DOI 10.1002/eji.200525971	37	16	16	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2009	4	11							e7525	10.1371/journal.pone.0007525	http://dx.doi.org/10.1371/journal.pone.0007525			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RZ	19888475	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414600001
J	Abrajano, JJ; Qureshi, IA; Gokhan, S; Zheng, DY; Bergman, A; Mehler, MF				Abrajano, Joseph J.; Qureshi, Irfan A.; Gokhan, Solen; Zheng, Deyou; Bergman, Aviv; Mehler, Mark F.			Differential Deployment of REST and CoREST Promotes Glial Subtype Specification and Oligodendrocyte Lineage Maturation	PLOS ONE			English	Article							PROGENITOR-CELL RESPONSIVENESS; EMBRYONIC STEM-CELLS; SILENCER FACTOR NRSF; TARGET GENES; TRANSCRIPTION FACTORS; IN-VITRO; DEVELOPMENTAL-CHANGES; TUMOR-SUPPRESSOR; RAT-BRAIN; FATE SPECIFICATION	Background: The repressor element-1 (RE1) silencing transcription factor/neuron-restrictive silencer factor (REST/NRSF) is a master transcriptional regulator that binds to numerous genomic RE1 sites where it acts as a molecular scaffold for dynamic recruitment of modulatory and epigenetic cofactors, including corepressor for element-1-silencing transcription factor (CoREST). CoREST also acts as a hub for various cofactors that play important roles in epigenetic remodeling and transcriptional regulation. While REST can recruit CoREST to its macromolecular complex, CoREST complexes also function at genomic sites independently of REST. REST and CoREST perform a broad array of context-specific functions, which include repression of neuronal differentiation genes in neural stem cells (NSCs) and other non-neuronal cells as well as promotion of neurogenesis. Despite their involvement in multiple aspects of neuronal development, REST and CoREST are not believed to have any direct modulatory roles in glial cell maturation. Methodology/Principal Findings: We challenged this view by performing the first study of REST and CoREST in NSC-mediated glial lineage specification and differentiation. Utilizing ChIP on chip (ChIP-chip) assays, we identified distinct but overlapping developmental stage-specific profiles for REST and CoREST target genes during astrocyte (AS) and oligodendrocyte (OL) lineage specification and OL lineage maturation and myelination, including many genes not previously implicated in glial cell biology or linked to REST and CoREST regulation. Amongst these factors are those implicated in macroglial (AS and OL) cell identity, maturation, and maintenance, such as members of key developmental signaling pathways and combinatorial transcription factor codes. Conclusions/Significance: Our results imply that REST and CoREST modulate not only neuronal but also glial lineage elaboration. These factors may therefore mediate critical developmental processes including the coupling of neurogenesis and gliogenesis and neuronal-glial interactions that underlie synaptic and neural network plasticity and homeostasis in health and in specific neurological disease states.			Abrajano, JJ (corresponding author), Albert Einstein Coll Med, Inst Brain Disorders & Neural Regenerat, Bronx, NY 10467 USA.	mehler@aecom.yu.edu		Zheng, Deyou/0000-0003-4354-5337	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066290] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS038902] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG028872, P01AG027734] Funding Source: NIH RePORTER; NIA NIH HHS [AG027734, P01 AG027734, AG028872, R01 AG028872] Funding Source: Medline; NIMH NIH HHS [R01 MH066290, MH66290] Funding Source: Medline; NINDS NIH HHS [R01 NS038902, NS38902] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Ahn M, 2008, J NEUROSCI RES, V86, P992, DOI 10.1002/jnr.21561; Andres ME, 1999, P NATL ACAD SCI USA, V96, P9873, DOI 10.1073/pnas.96.17.9873; Archange C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002475; Ballas N, 2005, CELL, V121, P645, DOI 10.1016/j.cell.2005.03.013; Ballas N, 2005, CURR OPIN NEUROBIOL, V15, P500, DOI 10.1016/j.conb.2005.08.015; BANCK M, 2009, EPIGENETICS, V4; Bao DS, 2005, J NEUROCHEM, V95, P618, DOI 10.1111/j.1471-4159.2005.03385.x; Blais A, 2007, J CELL BIOL, V179, P1399, DOI 10.1083/jcb.200705051; Broide RS, 2007, J MOL NEUROSCI, V31, P47, DOI 10.1007/BF02686117; Bruce AW, 2004, P NATL ACAD SCI USA, V101, P10458, DOI 10.1073/pnas.0401827101; BRUCE AW, 2009, GENOME RES; Butzkueven H, 2002, NAT MED, V8, P613, DOI 10.1038/nm0602-613; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; Camelo S, 2005, J NEUROIMMUNOL, V164, P10, DOI 10.1016/j.jneuroim.2005.02.022; Campuzano O, 2008, J NEUROSCI RES, V86, P3170, DOI 10.1002/jnr.21751; Canzonetta C, 2008, AM J HUM GENET, V83, P388, DOI 10.1016/j.ajhg.2008.08.012; Chakrabarti SK, 2002, J BIOL CHEM, V277, P13286, DOI 10.1074/jbc.M111857200; Chen ZF, 1998, NAT GENET, V20, P136, DOI 10.1038/2431; Cheng LC, 2009, NAT NEUROSCI, V12, P399, DOI 10.1038/nn.2294; Chinnadurai G, 2009, CANCER RES, V69, P731, DOI 10.1158/0008-5472.CAN-08-3349; CHONG JHA, 1995, CELL, V80, P949, DOI 10.1016/0092-8674(95)90298-8; Cohen RI, 1996, J NEUROSCI, V16, P6433; Conaco C, 2006, P NATL ACAD SCI USA, V103, P2422, DOI 10.1073/pnas.0511041103; COPRAY S, 2009, GLIA; Cowger JJM, 2007, ONCOGENE, V26, P3378, DOI 10.1038/sj.onc.1210126; Cui XY, 2004, J BIOL CHEM, V279, P25858, DOI 10.1074/jbc.M313505200; D'Alessandro R, 2009, ANN NY ACAD SCI, V1152, P194, DOI 10.1111/j.1749-6632.2008.03988.x; Dietrich Joerg, 2006, J Biol, V5, P22, DOI 10.1186/jbiol50; Dugas JC, 2006, J NEUROSCI, V26, P10967, DOI 10.1523/JNEUROSCI.2572-06.2006; Fancy SPJ, 2009, GENE DEV, V23, P1571, DOI 10.1101/gad.1806309; Fu H, 2009, J NEUROSCI, V29, P11399, DOI 10.1523/JNEUROSCI.0160-09.2009; Gokhan S, 2005, J NEUROSCI, V25, P8311, DOI 10.1523/JNEUROSCI.1850-05.2005; Greenway DJ, 2007, STEM CELLS, V25, P354, DOI 10.1634/stemcells.2006-0207; Guan JS, 2009, NATURE, V459, P55, DOI 10.1038/nature07925; Guillemot F, 2007, PROG NEUROBIOL, V83, P37, DOI 10.1016/j.pneurobio.2007.02.009; He Y, 2007, NEURON, V55, P217, DOI 10.1016/j.neuron.2007.06.029; Hu QD, 2006, DEV NEUROSCI-BASEL, V28, P25, DOI 10.1159/000090750; Hu QD, 2003, CELL, V115, P163, DOI 10.1016/S0092-8674(03)00810-9; Huang YF, 2002, J NEUROSCI, V22, P8422; Ivkovic S, 1999, J NEUROSCI, V19, P5409; Izrael M, 2007, MOL CELL NEUROSCI, V34, P310, DOI 10.1016/j.mcn.2006.11.008; Jensen LB, 2009, CANCER BIOMARK, V5, P41, DOI 10.3233/CBM-2009-0570; Johnson DS, 2007, SCIENCE, V316, P1497, DOI 10.1126/science.1141319; Johnson R, 2009, RNA, V15, P85, DOI 10.1261/rna.1127009; Johnson R, 2008, PLOS BIOL, V6, P2205, DOI 10.1371/journal.pbio.0060256; JUNG M, 1995, EUR J NEUROSCI, V7, P1245, DOI 10.1111/j.1460-9568.1995.tb01115.x; Kalsi AS, 2004, J ANAT, V204, P475, DOI 10.1111/j.0021-8782.2004.00288.x; Kiefer JC, 2007, DEV DYNAM, V236, P2356, DOI 10.1002/dvdy.21218; Kim CS, 2008, BBA-MOL CELL RES, V1783, P1835, DOI 10.1016/j.bbamcr.2008.06.019; Kim DK, 2008, NEUROSCI LETT, V433, P259, DOI 10.1016/j.neulet.2008.01.016; KOLLER KJ, 1985, J NEUROSCI, V5, P2882; Kondo T, 2000, SCIENCE, V289, P1754, DOI 10.1126/science.289.5485.1754; Kordes U, 2005, DEV BRAIN RES, V157, P209, DOI 10.1016/j.devbrainres.2005.03.009; Koyama Y, 1999, J NEUROCHEM, V73, P1004, DOI 10.1046/j.1471-4159.1999.0731004.x; Lakowski B, 2006, J MOL NEUROSCI, V29, P227, DOI 10.1385/JMN:29:3:227; Leeds P, 2005, NEUROCHEM INT, V46, P61, DOI 10.1016/j.neuint.2004.07.001; Lin WS, 2009, NAT NEUROSCI, V12, P379, DOI 10.1038/nn.2273; Liu AX, 2003, GLIA, V44, P264, DOI 10.1002/glia.10290; Liu H, 2009, GLIA, V57, P1, DOI 10.1002/glia.20729; Liu J, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-261; Magin A, 2002, NEUROCHEM INT, V40, P195, DOI 10.1016/S0197-0186(01)00091-2; Majumder S, 2006, CELL CYCLE, V5, P1929, DOI 10.4161/cc.5.17.2982; Marin-Husstege M, 2002, J NEUROSCI, V22, P10333; Marin-Husstege M, 2006, GLIA, V54, P285, DOI 10.1002/glia.20385; Marmur R, 1998, J NEUROSCI, V18, P9800; Marmur R, 1998, DEV BIOL, V204, P577, DOI 10.1006/dbio.1998.9099; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Miller RH, 2002, PROG NEUROBIOL, V67, P451, DOI 10.1016/S0301-0082(02)00058-8; Miller RH, 2007, NAT NEUROSCI, V10, P1351, DOI 10.1038/nn1995; Mortazavi A, 2006, GENOME RES, V16, P1208, DOI 10.1101/gr.4997306; Namihira M, 2008, PHILOS T R SOC B, V363, P2099, DOI 10.1098/rstb.2008.2262; Nicoilay DJ, 2007, GLIA, V55, P1287, DOI 10.1002/glia.20540; Nicolis SK, 2007, NEUROBIOL DIS, V25, P217, DOI 10.1016/j.nbd.2006.08.022; Nielsen JA, 2004, MOL CELL NEUROSCI, V25, P111, DOI 10.1016/j.mcn.2003.10.001; North BJ, 2003, MOL CELL, V11, P437, DOI 10.1016/S1097-2765(03)00038-8; Oberley MJ, 2004, METHOD ENZYMOL, V376, P315; Ohsawa R, 2005, J NEUROSCI, V25, P5857, DOI 10.1523/JNEUROSCI.4621-04.2005; Ooi L, 2007, NAT REV GENET, V8, P544, DOI 10.1038/nrg2100; Otto SJ, 2007, J NEUROSCI, V27, P6729, DOI 10.1523/JNEUROSCI.0091-07.2007; Packer AN, 2008, J NEUROSCI, V28, P14341, DOI 10.1523/JNEUROSCI.2390-08.2008; Polo JM, 2007, P NATL ACAD SCI USA, V104, P3207, DOI 10.1073/pnas.0611399104; Potzner MR, 2007, MOL CELL BIOL, V27, P5316, DOI 10.1128/MCB.00339-07; Raff M, 2001, NOVART FDN SYMP, V237, P100, DOI 10.1002/0470846666.ch9; Raff M., 2001, NOVART FDN SYMP, V237, P158; Reilly JO, 2002, MOL CELL NEUROSCI, V19, P88, DOI 10.1006/mcne.2001.1063; Relvas JB, 2001, CURR BIOL, V11, P1039, DOI 10.1016/S0960-9822(01)00292-5; Rosenbaum T, 1999, ANN NY ACAD SCI, V883, P203, DOI 10.1111/j.1749-6632.1999.tb08583.x; Saijo K, 2009, CELL, V137, P47, DOI 10.1016/j.cell.2009.01.038; Sandoval J, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh091; SCHOENHERR CJ, 1995, SCIENCE, V267, P1360, DOI 10.1126/science.7871435; Shannon C, 2007, J ANAT, V210, P684, DOI 10.1111/j.1469-7580.2007.00731.x; Sorrentino E, 2007, GENE EXPR PATTERNS, V7, P714, DOI 10.1016/j.modgep.2007.02.002; Southwood CM, 2007, NEUROCHEM RES, V32, P187, DOI 10.1007/s11064-006-9127-6; Stankoff B, 2002, J NEUROSCI, V22, P9221; Stolt CC, 2004, DEVELOPMENT, V131, P2349, DOI 10.1242/dev.01114; Sun YM, 2005, MOL BIOL CELL, V16, P5630, DOI 10.1091/mbc.E05-07-0687; Sun YM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003656; Terada N, 2002, GLIA, V40, P350, DOI 10.1002/glia.10134; Thillainadesan G, 2008, MOL CELL BIOL, V28, P6066, DOI 10.1128/MCB.00246-08; Wang SZ, 2006, DEVELOPMENT, V133, P3389, DOI 10.1242/dev.02522; Wegner M, 2008, J MOL NEUROSCI, V35, P3, DOI 10.1007/s12031-007-9008-8; Weinmann AS, 2002, METHODS, V26, P37, DOI 10.1016/S1046-2023(02)00006-3; Wen S, 2009, PROG NEUROBIOL, V87, P98, DOI 10.1016/j.pneurobio.2008.10.002; Wenning GK, 2008, ANN NEUROL, V64, P239, DOI 10.1002/ana.21465; Williams A, 2007, BRAIN, V130, P2554, DOI 10.1093/brain/awm202; Wu J, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-9-r85; Wynder C, 2005, NAT CELL BIOL, V7, P1113, DOI 10.1038/ncb1312; Xu J, 2008, J NEUROSCI, V28, P4521, DOI 10.1523/JNEUROSCI.5382-07.2008; Ye F, 2009, NAT NEUROSCI, V12, P829, DOI 10.1038/nn.2333; Yokoyama A, 2008, MOL CELL BIOL, V28, P3995, DOI 10.1128/MCB.02030-07; Yung SY, 2002, P NATL ACAD SCI USA, V99, P16273, DOI 10.1073/pnas.232586699; Zheng DY, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-1-r9; Zhou Y, 2006, LIFE SCI, V79, P1645, DOI 10.1016/j.lfs.2006.05.022; Zhu G, 2000, J NEUROSCI RES, V59, P312, DOI 10.1002/(SICI)1097-4547(20000201)59:3<312::AID-JNR4>3.0.CO;2-A; Zhu G, 1999, J NEUROSCI RES, V56, P131, DOI 10.1002/(SICI)1097-4547(19990415)56:2<131::AID-JNR3>3.0.CO;2-I; Zuccato C, 2007, J NEUROSCI, V27, P6972, DOI 10.1523/JNEUROSCI.4278-06.2007	117	63	64	2	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2009	4	11							e7665	10.1371/journal.pone.0007665	http://dx.doi.org/10.1371/journal.pone.0007665			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RY	19888342	Green Published, Green Submitted, gold			2022-12-27	WOS:000271414500004
J	Steele, RE; Dana, CE				Steele, Robert E.; Dana, Catherine E.			Evolutionary History of the HAP2/GCS1 Gene and Sexual Reproduction in Metazoans	PLOS ONE			English	Article							CLASS-LEVEL RELATIONSHIPS; PHYLUM CNIDARIA; GENOME; GCS1	The HAP2/GCS1 gene first appeared in the common ancestor of plants, animals, and protists, and is required in the male gamete for fusion to the female gamete in the unicellular organisms Chlamydomonas and Plasmodium. We have identified a HAP2/GCS1 gene in the genome sequence of the sponge Amphimedon queenslandica. This finding provides a continuous evolutionary history of HAP2/GCS1 from unicellular organisms into the metazoan lineage. Divergent versions of the HAP2/GCS1 gene are also present in the genomes of some but not all arthropods. By examining the expression of the HAP2/GCS1 gene in the cnidarian Hydra, we have found the first evidence supporting the hypothesis that HAP2/GCS1 was used for male gamete fusion in the ancestor of extant metazoans and that it retains that function in modern cnidarians.			Steele, RE (corresponding author), Univ Calif Irvine, Dept Biol Chem, Irvine, CA 92717 USA.	resteele@uci.edu		Dana, Catherine/0000-0003-3788-7955	NIGMS NIH HHS [R24 GM080537, 1R24GM080537-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R24GM080537] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Besansky NJ, 1997, MOL BIOL EVOL, V14, P442, DOI 10.1093/oxfordjournals.molbev.a025780; Bode Hans, 2008, V469, P69, DOI 10.1007/978-1-60327-469-2_7; BOGUSKI MS, 1993, NAT GENET, V4, P332, DOI 10.1038/ng0893-332; Borges F, 2008, PLANT PHYSIOL, V148, P1168, DOI 10.1104/pp.108.125229; BRIDGE D, 1995, MOL BIOL EVOL, V12, P679; BRIDGE D, 1992, P NATL ACAD SCI USA, V89, P8750, DOI 10.1073/pnas.89.18.8750; Goodman CD, 2008, CURR BIOL, V18, pR571, DOI 10.1016/j.cub.2008.05.007; Grell K.G., 1991, MICROSCOPIC ANATOMY; Hemmrich G, 2008, BIOESSAYS, V30, P1010, DOI 10.1002/bies.20813; Hirai M, 2008, CURR BIOL, V18, P607, DOI 10.1016/j.cub.2008.03.045; King N, 2005, CURR BIOL, V15, pR113, DOI 10.1016/j.cub.2005.02.004; Liu YJ, 2008, GENE DEV, V22, P1051, DOI 10.1101/gad.1656508; Miller MA, 2000, DEV BIOL, V224, P326, DOI 10.1006/dbio.2000.9790; Mori T, 2006, NAT CELL BIOL, V8, P64, DOI 10.1038/ncb1345; Notredame C, 2000, J MOL BIOL, V302, P205, DOI 10.1006/jmbi.2000.4042; Schierwater B, 2009, PLOS BIOL, V7, P36, DOI 10.1371/journal.pbio.1000020; Signorovitch AY, 2005, P NATL ACAD SCI USA, V102, P15518, DOI 10.1073/pnas.0504031102; Srivastava M, 2008, NATURE, V454, P955, DOI 10.1038/nature07191; von Besser K, 2006, DEVELOPMENT, V133, P4761, DOI 10.1242/dev.02683; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260	20	37	37	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2009	4	11							e7680	10.1371/journal.pone.0007680	http://dx.doi.org/10.1371/journal.pone.0007680			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RY	19888453	Green Submitted, Green Published, gold			2022-12-27	WOS:000271414500006
J	Tan, KS; Armugam, A; Sepramaniam, S; Lim, KY; Setyowati, KD; Wang, CW; Jeyaseelan, K				Tan, Kay Sin; Armugam, Arunmozhiarasi; Sepramaniam, Sugunavathi; Lim, Kai Ying; Setyowati, Karolina Dwi; Wang, Chee Woon; Jeyaseelan, Kandiah			Expression Profile of MicroRNAs in Young Stroke Patients	PLOS ONE			English	Article							TRANSIENT FOCAL ISCHEMIA; GENE-EXPRESSION; BLOOD; BIOMARKERS; BRAIN; HEART; RATS	Background: The methods currently available for diagnosis and prognosis of cerebral ischaemia still require further improvements. Micro-RNAs (small non-coding RNAs) have been recently reported as useful biomarkers in diseases such as cancer and diabetes. We therefore carried out microRNA (miRNA) profiling from peripheral blood to detect and identify characteristic patterns in ischaemic stroke. Methods/Principal Findings: The ischaemic stroke patients aged between 18-49 years, characterized based on World Health Organization clinical criteria were further classified according to TOAST classification, a) Large-vessel atherosclerosis [n = 8] b) Small- vessel disease [n = 3] c) Cardioembolism [n = 5] d) Undetermined cause [n = 3]. The patients' functional status at the time of blood sampling (at the outpatient clinics) was evaluated with the modified Rankin Scale (mRS). Blood samples from normal (n = 5) individuals were used as controls. Total RNA extracted from whole blood was subjected to miroRNA profiling and real-time PCR analysis. miRNAs that are implicated in the endothelial/vascular function, erythropoiesis, angiogenesis and neural function showed differential expression profile as compared to the normal control. Interestingly, miRNAs that are involved in hypoxic conditions have also been found in our miRNA profiles. Conclusion: We demonstrate that the peripheral blood miRNAs and their profiles can be developed as biomarkers in diagnosis and prognosis of cerebral ischaemic stroke. The dysregulated miRNAs have been detectable even after several months from the onset of stroke in what is usually regarded as neurologically stable patients.			Tan, KS (corresponding author), Univ Malaya, Dept Med, Kuala Lumpur, Malaysia.	bchjeya@nus.edu.sg	WANG, CHEE WOON/C-1033-2010; Wang, Chee/GQZ-3436-2022; WANG, CHEE WOON/GQZ-3715-2022; WOON, WANG CHEE/H-7458-2019; TAN, KAY SIN/B-9911-2010	Armugam, Arunmozhiarasi/0000-0002-6064-1980				Aumiller V, 2008, BBA-GENE REGUL MECH, V1779, P692, DOI 10.1016/j.bbagrm.2008.04.008; Bartel DP, 2009, CELL, V136, P215, DOI 10.1016/j.cell.2009.01.002; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bushati N, 2008, CURR OPIN NEUROBIOL, V18, P292, DOI 10.1016/j.conb.2008.07.001; CARISSIMI C, 2009, AUTOIMMUN REV   0203; Chen L, 2009, J HEPATOL, V50, P358, DOI 10.1016/j.jhep.2008.09.015; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Couzin J, 2008, SCIENCE, V319, P1782, DOI 10.1126/science.319.5871.1782; Dharap A, 2009, J CEREBR BLOOD F MET, V29, P675, DOI 10.1038/jcbfm.2008.157; Divakaran V, 2008, CIRC RES, V103, P1072, DOI 10.1161/CIRCRESAHA.108.183087; Felli N, 2005, P NATL ACAD SCI USA, V102, P18081, DOI 10.1073/pnas.0506216102; Grond-Ginsbach C, 2008, J NEUROL, V255, P723, DOI 10.1007/s00415-008-0784-z; He AB, 2007, MOL ENDOCRINOL, V21, P2785, DOI 10.1210/me.2007-0167; Jeyaseelan K, 2008, STROKE, V39, P959, DOI 10.1161/STROKEAHA.107.500736; Johnnidis JB, 2008, NATURE, V451, P1125, DOI 10.1038/nature06607; Kasner SE, 2006, LANCET NEUROL, V5, P603, DOI 10.1016/S1474-4422(06)70495-1; Kulshreshtha R, 2008, CELL DEATH DIFFER, V15, P667, DOI 10.1038/sj.cdd.4402310; Lawrie CH, 2007, INT J CANCER, V121, P1156, DOI 10.1002/ijc.22800; Li LC, 2008, RNA BIOL, V5, P61, DOI 10.4161/rna.5.2.5989; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mocellin S, 2009, MINI-REV MED CHEM, V9, P70, DOI 10.2174/138955709787001802; Nelson PT, 2008, BRAIN PATHOL, V18, P130, DOI 10.1111/j.1750-3639.2007.00120.x; Papadopoulos GL, 2009, BIOINFORMATICS, V25, P1991, DOI 10.1093/bioinformatics/btp299; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Saeed AI, 2003, BIOTECHNIQUES, V34, P374, DOI 10.2144/03342mt01; Sucharov C, 2008, J MOL CELL CARDIOL, V45, P185, DOI 10.1016/j.yjmcc.2008.04.014; Urbich C, 2008, CARDIOVASC RES, V79, P581, DOI 10.1093/cvr/cvn156; van Rooij E, 2008, P NATL ACAD SCI USA, V105, P13027, DOI 10.1073/pnas.0805038105; Wang XH, 2009, CLIN EXP PHARMACOL P, V36, P181, DOI 10.1111/j.1440-1681.2008.05057.x; Xu HC, 2008, J CEREBR BLOOD F MET, V28, P1320, DOI 10.1038/jcbfm.2008.22	30	334	356	2	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2009	4	11							e7689	10.1371/journal.pone.0007689	http://dx.doi.org/10.1371/journal.pone.0007689			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RX	19888324	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414400007
J	Gershenson, C; Pineda, LA				Gershenson, Carlos; Pineda, Luis A.			Why Does Public Transport Not Arrive on Time? The Pervasiveness of Equal Headway Instability	PLOS ONE			English	Article							CAR-FOLLOWING MODEL; BUS-ROUTE; TRANSITIONS; SYSTEM; STATES	Background: The equal headway instability phenomenon is pervasive in public transport systems. This instability is characterized by an aggregation of vehicles that causes inefficient service. While equal headway instability is common, it has not been studied independently of a particular scenario. However, the phenomenon is apparent in many transport systems and can be modeled and rectified in abstraction. Methodology: We present a multi-agent simulation where a default method with no restrictions always leads to unstable headways. We discuss two methods that attempt to achieve equal headways, called minimum and maximum. Since one parameter of the methods depends on the passenger density, adaptive versions-where the relevant parameter is adjusted automatically-are also put forward. Our results show that the adaptive maximum method improves significantly over the default method. The model and simulation give insights of the interplay between transport design and passenger behavior. Finally, we provide technological and social suggestions for engineers and passengers to help achieve equal headways and thus reduce delays. Conclusions: The equal headway instability phenomenon can be avoided with the suggested technological and social measures.			Gershenson, C (corresponding author), Univ Nacl Autonoma Mexico, Dept Comp Sci, Inst Invest Matemat Aplicadas & Sistemas, Ciudad Univ, Mexico City 04510, DF, Mexico.	cgg@unam.mx	Gershenson, Carlos/F-2241-2010; Pineda Cortés, Luis Alberto/GLR-3816-2022	Gershenson, Carlos/0000-0003-0193-3067; Pineda Cortés, Luis Alberto/0000-0001-7081-7524				[Anonymous], 1980, TRANSP RES REC; Chopard B, 1996, J PHYS A-MATH GEN, V29, P2325, DOI 10.1088/0305-4470/29/10/012; Chowdhury D, 2000, EUR PHYS J B, V15, P375, DOI 10.1007/s100510051139; Chowdhury D, 2000, PHYS REP, V329, P199, DOI 10.1016/S0370-1573(99)00117-9; Gershenson C, 2005, COMPLEX SYST, V16, P29; Gill DC, 1998, INTERNATIONAL CONFERENCE ON DEVELOPMENTS IN MASS TRANSIT SYSTEMS, P235, DOI 10.1049/cp:19980122; Helbing D, 1998, NATURE, V396, P738, DOI 10.1038/25499; Helbing D, 1997, VERKEHRSDYNAMIK; Helbing D., 2000, TRAFFIC GRANULAR FLO; Huijberts HJC, 2002, PHYSICA A, V308, P489, DOI 10.1016/S0378-4371(02)00622-2; LEVINSON HS, 2003, 1841 TRANSP RES; Ling K, 2003, J ADV TRANSPORT, V38, P45; Nagatani T, 2004, PHYSICA A, V333, P441, DOI 10.1016/j.physa.2003.10.001; Nagatani T, 2003, PHYSICA A, V326, P556, DOI 10.1016/S0378-4371(03)00278-4; Nagatani T, 2004, PHYSICA A, V331, P279, DOI 10.1016/j.physa.2003.07.007; Nagatani T, 2002, PHYSICA A, V305, P629, DOI 10.1016/S0378-4371(01)00577-5; Nagatani T, 2001, PHYSICA A, V296, P320, DOI 10.1016/S0378-4371(01)00151-0; Nagatani T, 2000, PHYSICA A, V287, P302, DOI 10.1016/S0378-4371(00)00455-6; Newell GF, 1998, TRANSPORT RES B-METH, V32, P583, DOI 10.1016/S0191-2615(98)00019-8; O'Loan OJ, 1998, PHYS REV E, V58, P1404, DOI 10.1103/PhysRevE.58.1404; Prigogine I., 1971, KINETIC THEORY VEHIC; Schreckenberg M., 1998, TRAFFIC GRANULAR FLO; Strathman J. G, 2003, PR126 CTR URB STUD; WELDING PI, 1957, OPER RES QUART, V8, P133, DOI 10.2307/3007157; Wilensky U., 1999, NETLOGO; Wolf D., 1996, TRAFFIC GRANULAR FLO; WOLFRAM S, 1986, THEORY APPL CELLULAR; Wolfram S., 2002, NEW KIND SCI; YUKAWA S, 1994, J PHYS SOC JPN, V63, P3609, DOI 10.1143/JPSJ.63.3609; [No title captured]	30	48	49	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7292	10.1371/journal.pone.0007292	http://dx.doi.org/10.1371/journal.pone.0007292			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862321	gold, Green Published			2022-12-27	WOS:000271194600002
J	Grover, D; Ford, D; Brown, C; Hoe, N; Erdem, A; Tavare, S; Tower, J				Grover, Dhruv; Ford, Daniel; Brown, Christopher; Hoe, Nicholas; Erdem, Aysen; Tavare, Simon; Tower, John			Hydrogen Peroxide Stimulates Activity and Alters Behavior in Drosophila melanogaster	PLOS ONE			English	Article							GENE-EXPRESSION; LIFE-SPAN; SUPEROXIDE-DISMUTASE; CIRCADIAN REGULATION; OXIDATIVE STRESS; METABOLISM; FLY; MITOCHONDRIA; RESISTANCE; TRANSGENES	Circadian rhythms in animals are regulated at the level of individual cells and by systemic signaling to coordinate the activities of multiple tissues. The circadian pacemakers have several physiological outputs, including daily locomotor rhythms. Several redox-active compounds have been found to function in regulation of circadian rhythms in cells, however, how particular compounds might be involved in regulating specific animal behaviors remains largely unknown. Here the effects of hydrogen peroxide on Drosophila movement were analyzed using a recently developed three-dimensional real-time multiple fly tracking assay. Both hydrogen peroxide feeding and direct injection of hydrogen peroxide caused increased adult fly locomotor activity. Continuous treatment with hydrogen peroxide also suppressed daily locomotor rhythms. Conditional over-expression of the hydrogen peroxide-producing enzyme superoxide dismutase ( SOD) also increased fly activity and altered the patterns of locomotor activity across days and weeks. The real-time fly tracking system allowed for detailed analysis of the effects of these manipulations on behavior. For example, both hydrogen peroxide feeding and SOD over-expression increased all fly motion parameters, however, hydrogen peroxide feeding caused relatively more erratic movement, whereas SOD over-expression produced relatively faster-moving flies. Taken together, the data demonstrate that hydrogen peroxide has dramatic effects on fly movement and daily locomotor rhythms, and implicate hydrogen peroxide in the normal control of these processes.			Grover, D (corresponding author), Howard Hughes Med Inst, Ashburn, VA USA.	jtower@usc.edu			NATIONAL HUMAN GENOME RESEARCH INSTITUTE [P50HG002790] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG011833] Funding Source: NIH RePORTER; NHGRI NIH HHS [P50 HG002790] Funding Source: Medline; NIA NIH HHS [AG011833, R01 AG011833] Funding Source: Medline	NATIONAL HUMAN GENOME RESEARCH INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NHGRI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Human Genome Research Institute (NHGRI)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Allegra M, 2003, J PINEAL RES, V34, P1, DOI 10.1034/j.1600-079X.2003.02112.x; Allikian MJ, 2002, GENOME BIOL, V3; [Anonymous], 2007, TSERIES TIME SERIES; Balaban RS, 2005, CELL, V120, P483, DOI 10.1016/j.cell.2005.02.001; Besson M, 2005, J NEUROBIOL, V62, P386, DOI 10.1002/neu.20111; Bieschke ET, 1998, MOL GEN GENET, V258, P571, DOI 10.1007/s004380050770; Bjornberg O, 2006, ANTIOXID REDOX SIGN, V8, P354, DOI 10.1089/ars.2006.8.354; Boothroyd CE, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030054; Branson K, 2009, NAT METHODS, V6, P451, DOI [10.1038/nmeth.1328, 10.1038/NMETH.1328]; Brockwell P, 1993, TIME SERIES THEORY M; Budick SA, 2006, J EXP BIOL, V209, P3001, DOI 10.1242/jeb.02305; CHANCE B, 1979, PHYSIOL REV, V59, P527, DOI 10.1152/physrev.1979.59.3.527; Chen Z, 2007, SCIENCE, V316, P1916, DOI 10.1126/science.1140958; Cleveland R.B., 1990, J OFF STAT, V6, P3; Curtis C, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-12-r262; Davis RA, 2006, J AM STAT ASSOC, V101, P223, DOI 10.1198/016214505000000745; DEGOOIJER JG, 1985, INT STAT REV, V53, P301, DOI 10.2307/1402894; Dooley CT, 2004, J BIOL CHEM, V279, P22284, DOI 10.1074/jbc.M312847200; Driver C, 2004, BIOGERONTOLOGY, V5, P185, DOI 10.1023/B:BGEN.0000031156.75376.e3; Feldman A, 2004, ADAPT BEHAV, V12, P241, DOI 10.1177/105971230401200309; Ford D, 2007, EXP GERONTOL, V42, P483, DOI 10.1016/j.exger.2007.01.004; FRIDOVICH I, 1995, ANNU REV BIOCHEM, V64, P97, DOI 10.1146/annurev.bi.64.070195.000525; Fridovich I, 2004, AGING CELL, V3, P13, DOI 10.1046/j.1474-9728.2003.00075.x; Gems D, 2005, MECH AGEING DEV, V126, P381, DOI 10.1016/j.mad.2004.09.001; Goncharova ND, 2006, EXP GERONTOL, V41, P778, DOI 10.1016/j.exger.2006.04.006; Green CB, 2006, CELL METAB, V4, P3, DOI 10.1016/j.cmet.2006.06.002; Grover D, 2008, J R SOC INTERFACE, V5, P1181, DOI 10.1098/rsif.2007.1333; Grover Dhruv, 2009, BMC Res Notes, V2, P58, DOI 10.1186/1756-0500-2-58; Grover D, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-93; Grzelak A, 2004, FREE RADICAL RES, V38, P1155, DOI 10.1080/10715760412331272486; Hanson GT, 2004, J BIOL CHEM, V279, P13044, DOI 10.1074/jbc.M312846200; Howlader G, 2006, J INSECT PHYSIOL, V52, P779, DOI 10.1016/j.jinsphys.2006.05.001; Kadener S, 2006, P NATL ACAD SCI USA, V103, P13537, DOI 10.1073/pnas.0605962103; Kaneuchi T, 2003, BIOGERONTOLOGY, V4, P157, DOI 10.1023/A:1024145822785; King-Jones K, 2006, CELL METAB, V4, P37, DOI 10.1016/j.cmet.2006.06.006; Koh K, 2006, P NATL ACAD SCI USA, V103, P13843, DOI 10.1073/pnas.0605903103; Kondratov RV, 2007, AGEING RES REV, V6, P12, DOI 10.1016/j.arr.2007.02.003; Krishnan N, 2008, BIOCHEM BIOPH RES CO, V374, P299, DOI 10.1016/j.bbrc.2008.07.011; Landis GN, 2004, P NATL ACAD SCI USA, V101, P7663, DOI 10.1073/pnas.0307605101; Landis GN, 2005, MECH AGEING DEV, V126, P365, DOI 10.1016/j.mad.2004.08.012; Lee CC, 2006, CANCER CAUSE CONTROL, V17, P525, DOI 10.1007/s10552-005-9003-8; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; Liochev SI, 2007, FREE RADICAL BIO MED, V42, P1465, DOI 10.1016/j.freeradbiomed.2007.02.015; MARGOLIASH E, 1958, BIOCHEM J, V68, P468, DOI 10.1042/bj0680468; Martin JR, 2004, BEHAV PROCESS, V67, P207, DOI 10.1016/j.beproc.2004.04.003; Meunier N, 2007, J EXP BIOL, V210, P1424, DOI 10.1242/jeb.02755; Meyer AJ, 2007, PLANT J, V52, P973, DOI 10.1111/j.1365-313X.2007.03280.x; Montell C, 1999, ANNU REV CELL DEV BI, V15, P231, DOI 10.1146/annurev.cellbio.15.1.231; Niethammer P, 2009, NATURE, V459, P996, DOI 10.1038/nature08119; Nishinokubi Izumi, 2006, J Circadian Rhythms, V4, P4, DOI 10.1186/1740-3391-4-4; Pletcher SD, 2002, CURR BIOL, V12, P712, DOI 10.1016/S0960-9822(02)00808-4; R Development Core Team, 2006, R LANG ENV STAT COMP; Rutter J, 2002, ANNU REV BIOCHEM, V71, P307, DOI 10.1146/annurev.biochem.71.090501.142857; Rutter J, 2001, SCIENCE, V293, P510, DOI 10.1126/science.1060698; Schibler U, 2005, CURR OPIN CELL BIOL, V17, P223, DOI 10.1016/j.ceb.2005.01.007; Shaw PJ, 2002, NATURE, V417, P287, DOI 10.1038/417287a; Sun JT, 2002, GENETICS, V161, P661; SZEBENYI AL, 1969, ANIM BEHAV, V17, P641, DOI 10.1016/S0003-3472(69)80006-0; Tammero LF, 2002, J EXP BIOL, V205, P327; Tan Dun-Xian, 2002, Current Topics in Medicinal Chemistry, V2, P181, DOI 10.2174/1568026023394443; Thomson SL, 2002, HEREDITY, V88, P52, DOI 10.1038/sj.hdy.6800008; Tu BP, 2006, NAT REV MOL CELL BIO, V7, P696, DOI 10.1038/nrm1980; Valente D, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001083; Vrontou E, 2006, NAT NEUROSCI, V9, P1469, DOI 10.1038/nn1809; Wijnen H, 2006, ANNU REV GENET, V40, P409, DOI 10.1146/annurev.genet.40.110405.090603; Williams AE, 2004, PHYSIOL BIOCHEM ZOOL, V77, P10, DOI 10.1086/381467; Yang JS, 2009, J GERONTOL A-BIOL, V64, P828, DOI 10.1093/gerona/glp054	67	22	24	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7580	10.1371/journal.pone.0007580	http://dx.doi.org/10.1371/journal.pone.0007580			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862323	Green Published, gold, Green Submitted			2022-12-27	WOS:000271194600006
J	Tan, M; Jones, G; Zhu, GJ; Ye, JP; Hong, TY; Zhou, SY; Zhang, SY; Zhang, LB				Tan, Min; Jones, Gareth; Zhu, Guangjian; Ye, Jianping; Hong, Tiyu; Zhou, Shanyi; Zhang, Shuyi; Zhang, Libiao			Fellatio by Fruit Bats Prolongs Copulation Time	PLOS ONE			English	Article							SEXUALLY-TRANSMITTED-DISEASES; CYNOPTERUS-SPHINX; MATING-BEHAVIOR; CHIROPTERA; SYSTEM	Oral sex is widely used in human foreplay, but rarely documented in other animals. Fellatio has been recorded in bonobos Pan paniscus, but even then functions largely as play behaviour among juvenile males. The short-nosed fruit bat Cynopterus sphinx exhibits resource defence polygyny and one sexually active male often roosts with groups of females in tents made from leaves. Female bats often lick their mate's penis during dorsoventral copulation. The female lowers her head to lick the shaft or the base of the male's penis but does not lick the glans penis which has already penetrated the vagina. Males never withdrew their penis when it was licked by the mating partner. A positive relationship exists between the length of time that the female licked the male's penis during copulation and the duration of copulation. Furthermore, mating pairs spent significantly more time in copulation if the female licked her mate's penis than if fellatio was absent. Males also show postcopulatory genital grooming after intromission. At present, we do not know why genital licking occurs, and we present four non-mutually exclusive hypotheses that may explain the function of fellatio in C. sphinx.			Tan, M (corresponding author), Guangdong Entomol Inst, Guangzhou, Guangdong, Peoples R China.	zhanglb@gdei.gd.cn	Zhang, Shuyi/B-5117-2011	Jones, Gareth/0000-0002-1904-3735	CSRD VA [I01 CX002007] Funding Source: Medline	CSRD VA		Bagemihl B., 1999, BIOL EXUBERANCE ANIM; BALASINGH J, 1995, ETHOLOGY, V100, P210; Baron S, 2000, ANTIVIR RES, V48, P71, DOI 10.1016/S0166-3542(00)00126-1; Bates PJJ, 1997, BATS INDIAN SUBCONTI; BRADBURY JW, 1977, Z TIERPSYCHOL, V45, P225; CANFIELD PJ, 1991, AUST VET J, V68, P167, DOI 10.1111/j.1751-0813.1991.tb03171.x; CHAN CSM, 2006, HK BIODIVERS, V11, P8; Corlett Richard T., 2005, Urban Ecosystems, V8, P275, DOI 10.1007/s11252-005-3260-x; DEWAAL FBM, 1995, SCI AM, V272, P82, DOI 10.1038/scientificamerican0395-82; Eberhard W. G., 1996, FEMALE CONTROL SEXUA; French B, 1998, SOUTHWEST NAT, V43, P484; Gopukumar N, 2005, J MAMMAL, V86, P281, DOI 10.1644/BFW-031.1; GOPUKUMAR N, 2002, J SCI ED, V6, P63; HART BL, 1987, PHYSIOL BEHAV, V41, P321, DOI 10.1016/0031-9384(87)90395-7; Jia Zhiyun, 2000, Acta Theriologica Sinica, V20, P108; Karuppudurai T, 2008, MAMM BIOL, V73, P138, DOI 10.1016/j.mambio.2007.02.006; Keeley ATH, 2004, J MAMMAL, V85, P113, DOI 10.1644/BME-004; Koilraj BJ, 2001, CURR SCI INDIA, V80, P15; KOYAMA N, 1988, PRIMATES, V29, P163, DOI 10.1007/BF02381120; Lockhart AB, 1996, BIOL REV, V71, P415, DOI 10.1111/j.1469-185X.1996.tb01281.x; MANDEL ID, 1993, CRIT REV ORAL BIOL M, V4, P599, DOI 10.1177/10454411930040034701; Martin P., 2007, MEASURING BEHAV INTR, DOI 10.1017/CBO9780511810893; Mayer F, 2007, HEREDITY, V99, P257, DOI 10.1038/sj.hdy.6800989; McCracken Gary F., 2000, P321, DOI 10.1016/B978-012195670-7/50009-6; Morga Francisco J., 2001, Veterinaria Mexico, V32, P301; Nathan PT, 2005, CURR SCI INDIA, V88, P1679; Neuweiler G., 2000, BIOL BATS; NIE YG, 2006, J CHINA W NOR U, V27, P86; Palagi E, 2004, AM J PRIMATOL, V62, P15, DOI 10.1002/ajp.20000; REEDER DM, 2003, SEXUAL SELECTION REP, P255; Schurmann C, 1982, ORANGUTAN ITS BIOL C, P269; Simmons N., 2005, MAMMAL SPECIES WORLD, P312, DOI DOI 10.1007/S10914-006-9022-6; Smith Stephanie J., 2006, Mammalian Species, P1; THOMAS DW, 1979, BEHAV ECOL SOCIOBIOL, V6, P129, DOI 10.1007/BF00292559; Thrall PH, 2000, P ROY SOC B-BIOL SCI, V267, P1555, DOI 10.1098/rspb.2000.1178; WANG S, 2004, CHINA SPECIES RES LI, V1; WEDEKIND C, 1995, P ROY SOC B-BIOL SCI, V260, P245, DOI 10.1098/rspb.1995.0087; WILKINSON GS, 1985, BEHAV ECOL SOCIOBIOL, V17, P123; Zhang Wei, 2008, Shengtaixue Zazhi, V27, P286	39	18	20	0	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7595	10.1371/journal.pone.0007595	http://dx.doi.org/10.1371/journal.pone.0007595			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862320	Green Submitted, Green Published, gold			2022-12-27	WOS:000271194600007
J	Bhattacharyya, S; Wei, J; Melichian, DS; Milbrandt, J; Takehara, K; Varga, J				Bhattacharyya, Swati; Wei, Jun; Melichian, Denisa S.; Milbrandt, Jeffrey; Takehara, Kazuhiko; Varga, John			The Transcriptional Cofactor Nab2 Is Induced by TGF-beta and Suppresses Fibroblast Activation: Physiological Roles and Impaired Expression in Scleroderma	PLOS ONE			English	Article							GROWTH-FACTOR-BETA; SMOOTH-MUSCLE-CELLS; COREPRESSOR NAB2; GENE-EXPRESSION; COLLAGEN GENE; A EGR-1; RESPONSES; PROTEINS; NURD; MODULATION	By stimulating collagen synthesis and myofibroblasts differentiation, transforming growth factor-beta (TGF-beta) plays a pivotal role in tissue repair and fibrosis. The early growth response-1 (Egr-1) transcription factor mediates profibrotic TGF-beta responses, and its expression is elevated in biopsies from patients with scleroderma. NGF1-A-binding protein 2 (Nab2) is a conserved transcriptional cofactor that directly binds to Egr-1 and positively or negatively modulates Egr-1 target gene transcription. Despite the recognized importance of Nab2 in governing the intensity of Egr-1-dependent responses, the regulation and function of Nab2 in the context of fibrotic TGF-beta signaling is unknown. Here we show that TGF-beta caused a time-dependent stimulation of Nab2 protein and mRNA in normal fibroblasts. Ectopic expression of Nab2 in these cells blocked Egr-1-dependent transcriptional responses, and abrogated TGF-beta-induced stimulation of collagen synthesis and myofibroblasts differentiation. These inhibitory effects of Nab2 involved recruitment of the NuRD chromatin remodeling complex to the COL1A2 promoter and were accompanied by reduced histone H4 acetylation. Mice with targeted deletion of Nab2 displayed increased collagen accumulation in the dermis, and genetic or siRNA-mediated loss of Nab2 in fibroblasts was associated with constitutively elevated collagen synthesis and accentuation of Egr-1-dependent TGF-beta responses in vitro. Expression of Nab2 was markedly up-regulated in skin biopsies from patients with scleroderma, and was localized primarily to epidermal keratinocytes. In contrast, little Nab2 could be detected in dermal fibroblasts. These results identify Nab2 as a novel endogenous negative regulator of Egr-1-dependent TGF-beta signaling responsible for setting the intensity of fibrotic responses. Defective Nab2 expression or function in dermal fibroblasts might play a role in persistent fibrotic responses in scleroderma.			Bhattacharyya, S (corresponding author), Northwestern Univ, Div Rheumatol, Feinberg Sch Med, Chicago, IL 60611 USA.	j-varga@northwestern.edu	Wei, Jun/G-3295-2012; Bhattacharyya, Swati/W-8145-2019; Varga, John/AAK-6472-2021	Milbrandt, Jeffrey/0000-0002-5477-7689	NIAMS NIH HHS [AR-04239] Funding Source: Medline	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Abraham DJ, 2005, TRENDS IMMUNOL, V26, P587, DOI 10.1016/j.it.2005.09.004; Baloh RH, 2009, J NEUROSCI, V29, P2312, DOI 10.1523/JNEUROSCI.2168-08.2009; Becker PB, 2002, ANNU REV BIOCHEM, V71, P247, DOI 10.1146/annurev.biochem.71.110601.135400; Bhattacharyya S, 2009, ONCOGENE, V28, P1285, DOI 10.1038/onc.2008.479; Bhattacharyya S, 2008, AM J PATHOL, V173, P1085, DOI 10.2353/ajpath.2008.080382; Bowen NJ, 2004, BBA-GENE STRUCT EXPR, V1677, P52, DOI 10.1016/j.bbaexp.2003.10.010; Chen SJ, 2006, J BIOL CHEM, V281, P21183, DOI 10.1074/jbc.M603270200; Chen SJ, 2000, J CELL PHYSIOL, V183, P381, DOI 10.1002/(SICI)1097-4652(200006)183:3<381::AID-JCP11>3.0.CO;2-O; Derynck R, 2007, NAT CELL BIOL, V9, P1000, DOI 10.1038/ncb434; Desmazieres A, 2008, J NEUROSCI, V28, P5891, DOI 10.1523/JNEUROSCI.5187-07.2008; Ehrengruber MU, 2000, GENE, V258, P63, DOI 10.1016/S0378-1119(00)00445-5; Fu MG, 2003, GENE, V315, P33, DOI 10.1016/S0378-1119(03)00730-3; Fukuda T, 2007, BIOCHEM BIOPH RES CO, V353, P147, DOI 10.1016/j.bbrc.2006.12.011; GASHLER A, 1995, PROG NUCLEIC ACID RE, V50, P191, DOI 10.1016/S0079-6603(08)60815-6; GASHLER AL, 1993, MOL CELL BIOL, V13, P4556, DOI 10.1128/MCB.13.8.4556; Ghosh A, 2009, FASEB J, V23; Houston P, 2001, BIOCHEM BIOPH RES CO, V283, P480, DOI 10.1006/bbrc.2001.4810; Ihn H, 1997, J BIOL CHEM, V272, P24666, DOI 10.1074/jbc.272.39.24666; Jimenez SA, 2004, ANN INTERN MED, V140, P37, DOI 10.7326/0003-4819-140-1-200401060-00010; Kamimura M, 2004, HYPERTENSION, V44, P944, DOI 10.1161/01.HYP.0000146908.75091.99; Khachigian LM, 1998, J MOL MED-JMM, V76, P613, DOI 10.1007/s001090050258; Le N, 2005, NAT NEUROSCI, V8, P932, DOI 10.1038/nn1490; Lucerna M, 2003, J BIOL CHEM, V278, P11433, DOI 10.1074/jbc.M204937200; Mauviel A, 2005, METH MOLEC MED, V117, P69; MILBRANDT J, 1987, SCIENCE, V238, P797, DOI 10.1126/science.3672127; Mori Y, 2004, ARTHRITIS RHEUM-US, V50, P4008, DOI 10.1002/art.20658; Okano K, 2006, J BIOL CHEM, V281, P26196, DOI 10.1074/jbc.M606710200; RUSSO MW, 1995, P NATL ACAD SCI USA, V92, P6873, DOI 10.1073/pnas.92.15.6873; Schweighofer B, 2007, CLIN HEMORHEOL MICRO, V37, P57; Sevetson BR, 2000, J BIOL CHEM, V275, P9749, DOI 10.1074/jbc.275.13.9749; Silverman ES, 1999, AM J PATHOL, V155, P1311, DOI 10.1016/S0002-9440(10)65233-9; Srinivasan R, 2006, J BIOL CHEM, V281, P15129, DOI 10.1074/jbc.M600775200; Svaren J, 1996, MOL CELL BIOL, V16, P3545; Svaren J, 1998, EMBO J, V17, P6010, DOI 10.1093/emboj/17.20.6010; Swirnoff AH, 1998, MOL CELL BIOL, V18, P512, DOI 10.1128/MCB.18.1.512; Thiel G, 2002, J CELL PHYSIOL, V193, P287, DOI 10.1002/jcp.10178; Thiel G, 2000, BBA-GENE STRUCT EXPR, V1493, P289, DOI 10.1016/S0167-4781(00)00207-4; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; VARGA J, 1987, BIOCHEM J, V247, P597, DOI 10.1042/bj2470597; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Wu MH, 2009, AM J PATHOL, V175, P1041, DOI 10.2353/ajpath.2009.090241; Wu MH, 2009, AM J PATHOL, V174, P519, DOI 10.2353/ajpath.2009.080574; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhu XJ, 2007, CARDIOVASC RES, V76, P141, DOI 10.1016/j.cardiores.2007.06.015	45	18	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7620	10.1371/journal.pone.0007620	http://dx.doi.org/10.1371/journal.pone.0007620			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19888474	Green Published, Green Submitted, gold			2022-12-27	WOS:000271147200018
J	Arciuch, VGA; Galli, S; Franco, MC; Lam, PY; Cadenas, E; Carreras, MC; Poderoso, JJ				Antico Arciuch, Valeria Gabriela; Galli, Soledad; Franco, Maria Clara; Lam, Philip Y.; Cadenas, Enrique; Cecilia Carreras, Maria; Jose Poderoso, Juan			Akt1 Intramitochondrial Cycling Is a Crucial Step in the Redox Modulation of Cell Cycle Progression	PLOS ONE			English	Article							MITOCHONDRIAL NITRIC-OXIDE; KINASE; ACTIVATION; PHOSPHORYLATION; PHENOTYPE; APOPTOSIS; OXIDATION; ONCOGENE; PROTEINS; AKT/PKB	Akt is a serine/threonine kinase involved in cell proliferation, apoptosis, and glucose metabolism. Akt is differentially activated by growth factors and oxidative stress by sequential phosphorylation of Ser(473) by mTORC2 and Thr(308) by PDK1. On these bases, we investigated the mechanistic connection of H2O2 yield, mitochondrial activation of Akt1 and cell cycle progression in NIH/3T3 cell line with confocal microscopy, in vivo imaging, and directed mutagenesis. We demonstrate that modulation by H2O2 entails the entrance of cytosolic P-Akt1 Ser(473) to mitochondria, where it is further phosphorylated at Thr(308) by constitutive PDK1. Phosphorylation of Thr(308) in mitochondria determines Akt1 passage to nuclei and triggers genomic post-translational mechanisms for cell proliferation. At high H2O2, Akt1-PDK1 association is disrupted and P-Akt1 Ser(473) accumulates in mitochondria in detriment to nuclear translocation; accordingly, Akt1 T308A is retained in mitochondria. Low Akt1 activity increases cytochrome c release to cytosol leading to apoptosis. As assessed by mass spectra, differential H2O2 effects on Akt1-PDK interaction depend on the selective oxidation of Cys(310) to sulfenic or cysteic acids. These results indicate that Akt1 intramitochondrial-cycling is central for redox modulation of cell fate.			Arciuch, VGA (corresponding author), Univ Buenos Aires, Univ Hosp, Lab Oxygen Metab, Buenos Aires, DF, Argentina.	vantico@hospitaldeclinicas.uba.ar; jpoderos@fmed.uba.ar	Franco, Maria/O-7862-2015		NIA NIH HHS [AG016718, R01 AG016718] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Alessi DR, 2009, SCI SIGNAL, V2, DOI 10.1126/scisignal.267pe27; Alonso M, 2004, J NEUROCHEM, V89, P248, DOI 10.1111/j.1471-4159.2004.02323.x; Aran M, 2008, FEBS J, V275, P1450, DOI 10.1111/j.1742-4658.2008.06299.x; Bayascas JR, 2008, MOL CELL BIOL, V28, P3258, DOI 10.1128/MCB.02032-07; BELLACOSA A, 1993, ONCOGENE, V8, P745; BELLACOSA A, 1991, SCIENCE, V254, P274, DOI 10.1126/science.1833819; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brazil DP, 2002, CELL, V111, P293, DOI 10.1016/S0092-8674(02)01083-8; Calleja V, 2007, PLOS BIOL, V5, P780, DOI 10.1371/journal.pbio.0050095; Carreras Maria C., 2004, Molecular Aspects of Medicine, V25, P125, DOI 10.1016/j.mam.2004.02.014; Carreras MC, 2007, AM J PHYSIOL-CELL PH, V292, pC1569, DOI 10.1152/ajpcell.00248.2006; Cefaratti C, 2000, J BIOL CHEM, V275, P3772, DOI 10.1074/jbc.275.6.3772; Chan TO, 1999, ANNU REV BIOCHEM, V68, P965, DOI 10.1146/annurev.biochem.68.1.965; Connor KM, 2005, J BIOL CHEM, V280, P16916, DOI 10.1074/jbc.M410690200; Cory S, 2003, ONCOGENE, V22, P8590, DOI 10.1038/sj.onc.1207102; Costes SV, 2004, BIOPHYS J, V86, P3993, DOI [10.1529/biophysj.103.038422, 10.1529/biophysi.103.038422]; Filippa N, 2000, MOL CELL BIOL, V20, P5712, DOI 10.1128/MCB.20.15.5712-5721.2000; Finocchietto P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001749; FRANKE TF, 1995, CELL, V81, P727, DOI 10.1016/0092-8674(95)90534-0; Frodin M, 2002, EMBO J, V21, P5396, DOI 10.1093/emboj/cdf551; Galli S, 2003, CANCER RES, V63, P6370; Galli S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002379; Green DR, 1998, SCIENCE, V281, P1309, DOI 10.1126/science.281.5381.1309; Heiden MGV, 2009, SCIENCE, V324, P1029, DOI 10.1126/science.1160809; Ikenoue T, 2008, EMBO J, V27, P1919, DOI 10.1038/emboj.2008.119; Jacinto E, 2006, CELL, V127, P125, DOI 10.1016/j.cell.2006.08.033; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Liu XS, 2004, ANTICANCER RES, V24, P2697; NICOLETTI I, 1991, J IMMUNOL METHODS, V139, P271, DOI 10.1016/0022-1759(91)90198-O; Nogueira V, 2008, CANCER CELL, V14, P458, DOI 10.1016/j.ccr.2008.11.003; Ohori K, 2008, AM J PHYSIOL-HEART C, V295, pH2079, DOI 10.1152/ajpheart.00092.2008; ROBEY RB, 2005, SEMINARS CANC BIOL, V19, P25; Sarbassov DD, 2005, SCIENCE, V307, P1098, DOI 10.1126/science.1106148; Shevchenko A, 2006, NAT PROTOC, V1, P2856, DOI 10.1038/nprot.2006.468; STAAL SP, 1987, P NATL ACAD SCI USA, V84, P5034, DOI 10.1073/pnas.84.14.5034; Toker A, 2000, CELL, V103, P185, DOI 10.1016/S0092-8674(00)00110-0; Toral-Barza L, 2007, MOL CANCER THER, V6, P3028, DOI 10.1158/1535-7163.MCT-07-0211; Wang Y, 2008, J CELL PHYSIOL, V215, P676, DOI 10.1002/jcp.21350	39	59	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7523	10.1371/journal.pone.0007523	http://dx.doi.org/10.1371/journal.pone.0007523			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844585	Green Published, gold, Green Submitted			2022-12-27	WOS:000271013000009
J	Doeschl-Wilson, AB; Brindle, W; Emmans, G; Kyriazakis, I				Doeschl-Wilson, Andrea B.; Brindle, Will; Emmans, Gerry; Kyriazakis, Ilias			Unravelling the Relationship between Animal Growth and Immune Response during Micro-Parasitic Infections	PLOS ONE			English	Article							DISEASE RESISTANCE; HOST NUTRITION; TRADE-OFFS; GASTROINTESTINAL PARASITISM; GROWING PIG; FEED-INTAKE; SELECTION; MODEL; CONSEQUENCES; ENERGY	Background: Both host genetic potentials for growth and disease resistance, as well as nutrition are known to affect responses of individuals challenged with micro-parasites, but their interactive effects are difficult to predict from experimental studies alone. Methodology/Principal Findings: Here, a mathematical model is proposed to explore the hypothesis that a host's response to pathogen challenge largely depends on the interaction between a host's genetic capacities for growth or disease resistance and the nutritional environment. As might be expected, the model predicts that if nutritional availability is high, hosts with higher growth capacities will also grow faster under micro-parasitic challenge, and more resistant animals will exhibit a more effective immune response. Growth capacity has little effect on immune response and resistance capacity has little effect on achieved growth. However, the influence of host genetics on phenotypic performance changes drastically if nutrient availability is scarce. In this case achieved growth and immune response depend simultaneously on both capacities for growth and disease resistance. A higher growth capacity (achieved e. g. through genetic selection) would be detrimental for the animal's ability to cope with pathogens and greater resistance may reduce growth in the short-term. Significance: Our model can thus explain contradicting outcomes of genetic selection observed in experimental studies and provides the necessary biological background for understanding the influence of selection and/or changes in the nutritional environment on phenotypic growth and immune response.			Doeschl-Wilson, AB (corresponding author), Scottish Agr Coll, Edinburgh, Midlothian, Scotland.	andrea.wilson@sac.ac.uk		Wilson, Andrea/0000-0002-2658-6973				ANDERSON R M, 1991; Antia R, 1996, P ROY SOC B-BIOL SCI, V263, P257, DOI 10.1098/rspb.1996.0040; BEILHARZ RG, 1993, J ANIM BREED GENET, V110, P161, DOI 10.1111/j.1439-0388.1993.tb00728.x; BHARGAVA K K, 1970, Journal of Nutrition, V100, P241; Bishop SC, 2007, SMALL RUMINANT RES, V70, P48, DOI 10.1016/j.smallrumres.2007.01.006; Bishop SC, 1999, ANIM SCI, V69, P515, DOI 10.1017/S1357729800051365; BLACK JL, 1986, RES DEV AGRIC, V3, P121; Bryant JR, 2007, ANIMAL, V1, P175, DOI 10.1017/S1751731107657747; Coop RL, 2001, TRENDS PARASITOL, V17, P325, DOI 10.1016/S1471-4922(01)01900-6; Datta FU, 1998, INT J PARASITOL, V28, P1269, DOI 10.1016/S0020-7519(98)00104-0; DEJONG G, 1992, AM NAT, V139, P749, DOI 10.1086/285356; Doeschl-Wilson AB, 2008, GENET SEL EVOL, V40, P241, DOI 10.1051/gse:2008001; Exton MS, 1997, APPETITE, V29, P369, DOI 10.1006/appe.1997.0116; FERGUSON NS, 2007, MECH MODELING PIG PO, P22; Frank JW, 2005, VET IMMUNOL IMMUNOP, V107, P179, DOI 10.1016/j.vetimm.2005.04.014; Friggens NC, 2007, ANIMAL, V1, P87, DOI 10.1017/S1751731107657772; Green DM, 2003, ANIM SCI, V77, P113, DOI 10.1017/S1357729800053716; Greiner LL, 2000, J ANIM SCI, V78, P2690; Gross WB, 2002, AVIAN DIS, V46, P1007, DOI 10.1637/0005-2086(2002)046[1007:EOGSFH]2.0.CO;2; Houdijk JGM, 2006, P NUTR SOC, V65, p68A; Houston AI, 2007, P ROY SOC B-BIOL SCI, V274, P2835, DOI 10.1098/rspb.2007.0934; Hutchings MR, 2001, ECOLOGY, V82, P1138, DOI 10.1890/0012-9658(2001)082[1138:HPSAFT]2.0.CO;2; Imsland AK, 2002, AQUACULTURE, V204, P167, DOI 10.1016/S0044-8486(01)00656-1; Knap PW, 2000, ANIM SCI, V70, P39, DOI 10.1017/S1357729800051584; Kyriazakis I, 1998, ANIM BEHAV, V56, P265, DOI 10.1006/anbe.1998.0761; Kyriazakis I, 1996, VET PARASITOL, V61, P297, DOI 10.1016/0304-4017(95)00824-1; Kyriazakis I, 2009, VOLUNTARY FEED INTAKE IN PIGS, P307; Lochmiller RL, 2000, OIKOS, V88, P87, DOI 10.1034/j.1600-0706.2000.880110.x; Mallard B. A., 1998, Proceedings of the 6th World Congress on Genetics Applied to Livestock Production, Armidale, Australia, January 11-16, 1998. Volume 27: Reproduction; fish breeding; genetics and the environment; genetics in agricultural systems; disease resistance; animal welfare; computing and information technology; tree breeding., P257; Mangel M, 2001, EVOL ECOL RES, V3, P583; McNamara JP, 2000, J DAIRY SCI, V83, P128, DOI 10.3168/jds.S0022-0302(00)74864-8; Medley GF, 2002, PARASITOLOGY, V125, pS61, DOI 10.1017/S0031182002002354; Morris CA, 2000, ANIM SCI, V70, P17, DOI 10.1017/S1357729800051560; Rauw WM, 2003, J ANIM SCI, V81, P939; Rauw WM, 1998, LIVEST PROD SCI, V56, P15, DOI 10.1016/S0301-6226(98)00147-X; REZNICK D, 1985, OIKOS, V44, P257, DOI 10.2307/3544698; Ritz BW, 2006, J NUTR, V136, P1141, DOI 10.1093/jn/136.5.1141; Roff Derek A., 1992; Sandberg FB, 2006, J ANIM SCI, V84, P1552, DOI 10.2527/2006.8461552x; Sandberg FB, 2005, BRIT J NUTR, V93, P213, DOI 10.1079/BJN20041322; SCRIMSHAW NS, 1968, WHO MONOGRAPH SERIES, V57; Sheldon BC, 1996, TRENDS ECOL EVOL, V11, P317, DOI 10.1016/0169-5347(96)10039-2; Shudo E, 2001, J THEOR BIOL, V209, P233, DOI 10.1006/jtbi.2000.2259; Soler JJ, 2003, P ROY SOC B-BIOL SCI, V270, P241, DOI 10.1098/rspb.2002.2217; Stearns S.C., 1992, pi; TSIAGBE VK, 1987, POULTRY SCI, V66, P1147, DOI 10.3382/ps.0661147; Vagenas D, 2007, PARASITOLOGY, V134, P1263, DOI 10.1017/S0031182007002570; Vagenas D, 2007, PARASITOLOGY, V134, P1279, DOI 10.1017/S0031182007002624; van der Waaij EH, 2000, J ANIM SCI, V78, P2809; van der Waaij EH, 2004, J ANIM SCI, V82, P973; Wellock IJ, 2003, ANIM SCI, V77, P255, DOI 10.1017/S1357729800058999	51	21	24	1	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7508	10.1371/journal.pone.0007508	http://dx.doi.org/10.1371/journal.pone.0007508			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838306	Green Published, Green Submitted, gold			2022-12-27	WOS:000270880900011
J	Ernst, J; Ghanem, L; Bar-Joseph, Z; McNamara, M; Brown, J; Steinman, RA				Ernst, Jason; Ghanem, Louis; Bar-Joseph, Ziv; McNamara, Michael; Brown, Jason; Steinman, Richard A.			IL-3 and Oncogenic Abl Regulate the Myeloblast Transcriptome by Altering mRNA Stability	PLOS ONE			English	Article							COLONY-STIMULATING FACTOR; AU-RICH ELEMENTS; CELL-PROLIFERATION; C-MYB; GRANULOCYTIC DIFFERENTIATION; MYELOID DIFFERENTIATION; GENE-TRANSCRIPTION; P110-DELTA ISOFORM; UP-REGULATION; G-CSF	The growth factor interleukin-3 (IL-3) promotes the survival and growth of multipotent hematopoietic progenitors and stimulates myelopoiesis. It has also been reported to oppose terminal granulopoiesis and to support leukemic cell growth through autocrine or paracrine mechanisms. The degree to which IL-3 acts at the posttranscriptional level is largely unknown. We have conducted global mRNA decay profiling and bioinformatic analyses in 32Dcl3 myeloblasts indicating that IL-3 caused immediate early stabilization of hundreds of transcripts in pathways relevant to myeloblast function. Stabilized transcripts were enriched for AU-Response elements (AREs), and an ARE-containing domain from the interleukin-6 (IL-6) 39-UTR rendered a heterologous gene responsive to IL-3-mediated transcript stabilization. Many IL-3-stabilized transcripts had been associated with leukemic transformation. Deregulated Abl kinase shared with IL-3 the ability to delay turnover of transcripts involved in proliferation or differentiation blockade, relying, in part, on signaling through the Mek/Erk pathway. These findings support a model of IL-3 action through mRNA stability control and suggest that aberrant stabilization of an mRNA network linked to IL-3 contributes to leukemic cell growth.			Ernst, J (corresponding author), MIT, Comp Sci & Artificial Intelligence Lab, Boston, MA USA.	steinman@pitt.edu	Ghanem, Louis/R-3733-2016; Bar-Joseph, Ziv/GWN-2754-2022	Ghanem, Louis/0000-0002-7723-5241; Bar-Joseph, Ziv/0000-0003-3430-6051				Amit I, 2007, NAT GENET, V39, P503, DOI 10.1038/ng1987; Bakheet T, 2006, NUCLEIC ACIDS RES, V34, pD111, DOI 10.1093/nar/gkj052; BIES J, 1995, CELL GROWTH DIFFER, V6, P59; Billottet C, 2006, ONCOGENE, V25, P6648, DOI 10.1038/sj.onc.1209670; CALABRETTA B, 1993, CANCER INVEST, V11, P191, DOI 10.3109/07357909309024839; CHEN CYA, 1995, TRENDS BIOCHEM SCI, V20, P465, DOI 10.1016/S0968-0004(00)89102-1; Chen Y, 2007, BLOOD, V110, P2889, DOI 10.1182/blood-2007-01-066316; Corradini F, 2007, BLOOD CELL MOL DIS, V39, P292, DOI 10.1016/j.bcmd.2007.06.002; Deleault KM, 2008, MOL IMMUNOL, V45, P13, DOI 10.1016/j.molimm.2007.05.017; Ernst J, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-191; Ernst J, 2005, BIOINFORMATICS, V21, pI159, DOI 10.1093/bioinformatics/bti1022; Esnault S, 2002, BLOOD, V99, P4048, DOI 10.1182/blood.V99.11.4048; Figueroa A, 2003, MOL CELL BIOL, V23, P4991, DOI 10.1128/MCB.23.14.4991-5004.2003; Frevel MAE, 2003, MOL CELL BIOL, V23, P425, DOI 10.1128/MCB.23.2.425-436.2003; Gaines Peter, 2005, Curr Protoc Immunol, VChapter 22, DOI 10.1002/0471142735.im22f05s67; Ghanem L, 2005, LEUKEMIA RES, V29, P1315, DOI 10.1016/j.leukres.2005.03.018; Ghanem L, 2006, LEUKEMIA RES, V30, P1285, DOI 10.1016/j.leukres.2005.12.023; Guchhait P, 2003, J IMMUNOL METHODS, V283, P195, DOI 10.1016/j.jim.2003.09.013; Hevehan DL, 2000, EXP HEMATOL, V28, P1016, DOI 10.1016/S0301-472X(00)00505-1; Hevehan DL, 2002, BLOOD, V99, P1627, DOI 10.1182/blood.V99.5.1627; Huang TS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-31; Hudson BP, 2004, NAT STRUCT MOL BIOL, V11, P257, DOI 10.1038/nsmb738; *ING SYST INC, 2005, IPA NETW GEN ALG; Ino T, 1995, ONCOGENE, V11, P2705; Jaramillo M, 2002, J IMMUNOL, V169, P7026, DOI 10.4049/jimmunol.169.12.7026; Jijon HB, 2002, AM J PHYSIOL-CELL PH, V283, pC31, DOI 10.1152/ajpcell.00113.2001; Khanna-Gupta A, 2001, P NATL ACAD SCI USA, V98, P8000, DOI 10.1073/pnas.141229598; Kim KT, 2005, BLOOD, V105, P1759, DOI 10.1182/blood-2004-05-2006; Lam LT, 2001, GENOME BIOL, V2; Li SG, 2001, BLOOD, V97, P1442, DOI 10.1182/blood.V97.5.1442; Liu J, 2008, LEUKEMIA, V22, P791, DOI 10.1038/leu.2008.3; Martinez-Moczygemba M, 2003, J ALLERGY CLIN IMMUN, V112, P653, DOI 10.1067/mai.2003.1796; Matsui H, 2007, MOL CELL, V25, P99, DOI 10.1016/j.molcel.2006.12.007; MATULONIS U, 1993, EXP HEMATOL, V21, P1460; Mondal K, 2000, J LEUKOCYTE BIOL, V67, P216, DOI 10.1002/jlb.67.2.216; Munoz L, 2001, HAEMATOLOGICA, V86, P1261; Nowak R, 1999, CYTOKINE, V11, P435, DOI 10.1006/cyto.1998.0445; Numata A, 2005, J BIOL CHEM, V280, P12621, DOI 10.1074/jbc.M408442200; Raghavan A, 2004, GENOMICS, V84, P1002, DOI 10.1016/j.ygeno.2004.08.007; Raghavan A, 2002, NUCLEIC ACIDS RES, V30, P5529, DOI 10.1093/nar/gkf682; Shimada H, 2000, BLOOD, V96, P655; Steinman RA, 2007, LEUKEMIA, V21, P1158, DOI 10.1038/sj.leu.2404656; Steinman RA, 1999, LEUKEMIA, V13, P54, DOI 10.1038/sj.leu.2401253; STEINMAN RA, 1994, BLOOD, V83, P119; Stoecklin G, 2003, ONCOGENE, V22, P3554, DOI 10.1038/sj.onc.1206418; Stoecklin G, 2002, EMBO J, V21, P4709, DOI 10.1093/emboj/cdf444; Sugiura R, 2004, CELL CYCLE, V3, P286; Sugiyama H, 1996, LEUKEMIA LYMPHOMA, V21, P49, DOI 10.3109/10428199609067579; Sujobert P, 2005, BLOOD, V106, P1063, DOI 10.1182/blood-2004-08-3225; Sun DX, 2006, NAT IMMUNOL, V7, P375, DOI 10.1038/ni1308; Tamura M, 2002, J CLIN ENDOCR METAB, V87, P3263, DOI 10.1210/jc.87.7.3263; Tenenbaum SA, 2000, P NATL ACAD SCI USA, V97, P14085, DOI 10.1073/pnas.97.26.14085; Testa U, 2002, BLOOD, V100, P2980, DOI 10.1182/blood-2002-03-0852; VALTIERI M, 1987, J IMMUNOL, V138, P3829; VELLENGA E, 1987, LEUKEMIA, V1, P584; Wang P, 1998, J IMMUNOL, V160, P4427; Wang YL, 2002, P NATL ACAD SCI USA, V99, P5860, DOI 10.1073/pnas.092538799; Xu NH, 1997, MOL CELL BIOL, V17, P4611, DOI 10.1128/MCB.17.8.4611; Yang E, 2003, GENOME RES, V13, P1863, DOI 10.1101/gr.1272403; Yang XL, 2004, J BIOL CHEM, V279, P49298, DOI 10.1074/jbc.M407535200; Yen JJY, 2006, VITAM HORM, V74, P147, DOI 10.1016/S0083-6729(06)74006-7; Zhang W, 1995, CLIN CANCER RES, V1, P1051; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	63	9	9	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7469	10.1371/journal.pone.0007469	http://dx.doi.org/10.1371/journal.pone.0007469			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829692	Green Published, gold, Green Accepted			2022-12-27	WOS:000270847800008
J	Shin, DH; Chun, YS; Lee, KH; Shin, HW; Park, JW				Shin, Dong Hoon; Chun, Yang-Sook; Lee, Kyoung-Hwa; Shin, Hyun-Woo; Park, Jong-Wan			Arrest Defective-1 Controls Tumor Cell Behavior by Acetylating Myosin Light Chain Kinase	PLOS ONE			English	Article							SMOOTH-MUSCLE; ARD1 GENE; PHOSPHORYLATION; PHOSPHATASE; PROTEIN; DESTABILIZATION; IDENTIFICATION; HIF-1-ALPHA; METASTASIS; INHIBITORS	Background: The enhancement of cell motility is a critical event during tumor cell spreading. Since myosin light chain kinase (MLCK) regulates cell behavior, it is regarded as a promising target in terms of preventing tumor invasion and metastasis. Since MLCK was identified to be associated with human arrest defective-1 (hARD1) through yeast two-hybrid screening, we here tested the possibility that hARD1 acts as a regulator of MLCK and by so doing controls tumor cell motility. Methodology/ Principal Findings: The physical interaction between MLCK and hARD1 was confirmed both in vivo and in vitro by immunoprecipitation assay and affinity chromatography. hARD1, which is known to have the activity of protein lysine epsilon-acetylation, bound to and acetylated MLCK activated by Ca2+ signaling, and by so doing deactivated MLCK, which led to a reduction in the phosphorylation of MLC. Furthermore, hARD1 inhibited tumor cell migration and invasion MLCK-dependently. Our mutation study revealed that hARD1 associated with an IgG motif of MLCK and acetylated the Lys608 residue in this motif. The K608A-mutated MLCK was neither acetylated nor inactivated by hARD1, and its stimulatory effect on cell motility was not inhibited by hARD1. Conclusion/Significance: These results indicate that hARD1 is a bona fide regulator of MLCK, and that hARD1 plays a crucial role in the balance between tumor cell migration and stasis. Thus, hARD1 could be a therapeutic target in the context of preventing tumor invasion and metastasis.			Shin, DH (corresponding author), Seoul Natl Univ, Coll Med, Dept Pharmacol, Ischem Hypox Dis Inst, Seoul, South Korea.	parkjw@snu.ac.kr	Park, Jong-Wan/J-2758-2012; Shin, Dong Hoon/J-5520-2012; Chun, Yang Sook/J-2789-2012; Song, Young Goo/AGV-5104-2022	Song, Young Goo/0000-0002-0733-4156				ADELSTEIN RS, 1980, ANNU REV BIOCHEM, V921, P956; ALESSI D, 1992, EUR J BIOCHEM, V210, P1023, DOI 10.1111/j.1432-1033.1992.tb17508.x; Amano M, 1996, J BIOL CHEM, V271, P20246, DOI 10.1074/jbc.271.34.20246; Arnesen T, 2005, FEBS LETT, V579, P6428, DOI 10.1016/j.febslet.2005.10.036; Arnesen T, 2005, BIOCHEM J, V386, P433, DOI 10.1042/BJ20041071; ChrzanowskaWodnicka M, 1996, J CELL BIOL, V133, P1403, DOI 10.1083/jcb.133.6.1403; Chun YS, 2003, CANCER RES, V63, P8700; Dulyaninova NG, 2004, EXP CELL RES, V299, P303, DOI 10.1016/j.yexcr.2004.06.015; EINHEBER S, 1990, P NATL ACAD SCI USA, V87, P2157, DOI 10.1073/pnas.87.6.2157; Fajmut A, 2005, FEBS LETT, V579, P4361, DOI 10.1016/j.febslet.2005.06.076; GALLAGHER PJ, 1991, J BIOL CHEM, V266, P23936; Gallagher PJ, 1997, J MUSCLE RES CELL M, V18, P1, DOI 10.1023/A:1018616814417; Gillespie GY, 1999, CANCER RES, V59, P2076; Herring BP, 2000, AM J PHYSIOL-CELL PH, V279, pC1656, DOI 10.1152/ajpcell.2000.279.5.C1656; Jeong JW, 2002, CELL, V111, P709, DOI 10.1016/S0092-8674(02)01085-1; KAMM KE, 1985, ANNU REV PHARMACOL, V25, P593, DOI 10.1146/annurev.pharmtox.25.1.593; Kamm KE, 2001, J BIOL CHEM, V276, P4527, DOI 10.1074/jbc.R000028200; Kaneko K, 2002, PANCREAS, V24, P34, DOI 10.1097/00006676-200201000-00005; Kim SH, 2006, BIOCHEM BIOPH RES CO, V340, P422, DOI 10.1016/j.bbrc.2005.12.018; Kimura K, 1996, SCIENCE, V273, P245, DOI 10.1126/science.273.5272.245; Lazar V, 1999, GENOMICS, V57, P256, DOI 10.1006/geno.1999.5774; LEE FJS, 1989, J BACTERIOL, V171, P5795, DOI 10.1128/jb.171.11.5795-5802.1989; Lee J, 1999, NATURE, V400, P382, DOI 10.1038/22578; Lim JH, 2006, CANCER RES, V66, P10677, DOI 10.1158/0008-5472.CAN-06-3171; Matsumura F, 1998, J CELL BIOL, V140, P119, DOI 10.1083/jcb.140.1.119; Minamiya Y, 2005, TUMOR BIOL, V26, P153, DOI 10.1159/000086487; PARK EC, 1992, EMBO J, V11, P2087, DOI 10.1002/j.1460-2075.1992.tb05267.x; Polevoda B, 2000, J BIOL CHEM, V275, P36479, DOI 10.1074/jbc.R000023200; Sanders LC, 1999, SCIENCE, V283, P2083, DOI 10.1126/science.283.5410.2083; SHIRAZI A, 1994, J BIOL CHEM, V269, P31598; Smith L, 1999, J BIOL CHEM, V274, P29433, DOI 10.1074/jbc.274.41.29433; Smith L, 2000, FEBS LETT, V480, P298, DOI 10.1016/S0014-5793(00)01931-1; Steeg PS, 2006, NAT MED, V12, P895, DOI 10.1038/nm1469; Tohtong R, 2003, PROSTATE CANCER P D, V6, P212, DOI 10.1038/sj.pcan.4500663; WHITEWAY M, 1987, MOL CELL BIOL, V7, P3713, DOI 10.1128/MCB.7.10.3713; WHITEWAY M, 1985, CELL, V43, P483, DOI 10.1016/0092-8674(85)90178-3; WILLIAMS AF, 1988, ANNU REV IMMUNOL, V6, P381, DOI 10.1146/annurev.iy.06.040188.002121; Yamazaki D, 2005, CANCER SCI, V96, P379, DOI 10.1111/j.1349-7006.2005.00062.x	38	60	67	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7451	10.1371/journal.pone.0007451	http://dx.doi.org/10.1371/journal.pone.0007451			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826488	Green Published, gold, Green Submitted			2022-12-27	WOS:000270808700012
J	Renner, O; Harsch, S; Schaeffeler, E; Winter, S; Schwab, M; Krawczyk, M; Rosendahl, J; Wittenburg, H; Lammert, F; Stange, EF				Renner, Olga; Harsch, Simone; Schaeffeler, Elke; Winter, Stefan; Schwab, Matthias; Krawczyk, Marcin; Rosendahl, Jonas; Wittenburg, Henning; Lammert, Frank; Stange, Eduard F.			A Variant of the SLC10A2 Gene Encoding the Apical Sodium-Dependent Bile Acid Transporter Is a Risk Factor for Gallstone Disease	PLOS ONE			English	Article							SUSCEPTIBILITY FACTOR; DIETARY-CHOLESTEROL; GALLBLADDER-DISEASE; RECEPTOR GENES; POLYMORPHISMS; EXPRESSION; MUTATION; PLASMA; CHOLELITHIASIS; COTRANSPORTER	Background: Cholelithiasis is a multifactorial process and several mechanisms of gallstone formation have been postulated. As one of these mechanisms, a decreased expression of the ileal apical sodium-dependent bile acid transporter gene SLC10A2 in gallstone carriers was described previously. In this study the SLC10A2 gene was investigated to identify novel genetic variants and their association with gallstone formation. Methodology/Principal Findings: Study subjects were selected with the presence or absence of gallstones confirmed by ultrasound and medical history. Genomic DNA was obtained from blood leukocytes. Sequence analysis was performed of all six exonic and flanking regions as well as of 2,400 base pairs of the SLC10A2 promoter in a cohort of gallstone carriers and control subjects from Stuttgart, Germany. Genotype frequencies of newly identified genetic variants (n = 6) and known single nucleotide polymorphisms (n = 24) were established using MALDI-TOF mass spectrometry. Six new genetic variants were found within the SLC10A2 gene. Although none of the variants was linked to gallstone disease in the Stuttgart cohort overall, the minor allele of SNP rs9514089 was more prevalent in male non-obese gallstone carriers (p = 0.06680, OR = 11.00). In a separate population from Aachen, Germany, the occurrence of rs9514089 was two-fold higher in gallstone patients (22%) than in corresponding controls (11%) ( p = 0.00995, OR = 2.19). In the pooled Aachen/Stuttgart cohort rs9514089 was highly significantly linked to cholelithiasis (p = 0.00767, OR = 2.04). A more frequent occurrence was observed for male gallstone carriers (22%) compared to controls (9%) (p = 0.01017, OR = 2.99), for the total normal weight group (p = 0.00754, OR = 2.90), and for male non-obese gallstone patients (p = 0.01410, OR = 6.85). Moreover, for the minor allele of rs9514089 an association with low plasma cholesterol levels was found especially in gallstone carriers (p = 0.05). Conclusions/Significance: We have identified SLC10A2 as a novel susceptibility gene for cholelithiasis in humans. Comprehensive statistical analysis provides strong evidence that rs9514089 is a genetic determinant especially in male non-obese gallstone carriers. The minor allele of rs9514089 is related to differences in plasma cholesterol levels among the subjects.			Renner, O (corresponding author), Dr Margarete Fischer Bosch Inst Clin Pharmacol, Auerbachstr 112, D-7000 Stuttgart, Germany.	eduard.stange@rbk.de	Schwab, Matthias/ABH-7449-2020; Krawczyk, Marcin/AAG-4356-2020	Krawczyk, Marcin/0000-0002-0113-0777; Renner, Olga/0000-0003-0985-4515				ACALOVSCHI M, 2009, LIPIDS; Acalovschi M, 2006, EUR J INTERN MED, V17, P490, DOI 10.1016/j.ejim.2006.04.012; Berge KE, 2002, J LIPID RES, V43, P486; Bergheim I, 2006, J LIPID RES, V47, P42, DOI 10.1194/jlr.M500215-JLR200; BERR F, 1992, J CLIN INVEST, V90, P859, DOI 10.1172/JCI115961; Buch S, 2007, NAT GENET, V39, P995, DOI 10.1038/ng2101; den Dunnen JT, 2000, HUM MUTAT, V15, P7; Dowling RH, 2000, ALIMENT PHARM THER, V14, P39, DOI 10.1046/j.1365-2036.2000.014s2039.x; Duane WC, 2000, J LIPID RES, V41, P1384; Everhart JE, 1999, GASTROENTEROLOGY, V117, P632, DOI 10.1016/S0016-5085(99)70456-7; Gonzalez JR, 2007, BIOINFORMATICS, V23, P644, DOI 10.1093/bioinformatics/btm025; Grunhage F, 2007, HEPATOLOGY, V46, P793, DOI 10.1002/hep.21847; Gylling H, 2004, J LIPID RES, V45, P1660, DOI 10.1194/jlr.M300522-JLR200; Hofmann AF, 1999, NEWS PHYSIOL SCI, V14, P24, DOI 10.1152/physiologyonline.1999.14.1.24; Holzer A, 2008, DIGESTION, V78, P52, DOI 10.1159/000159379; Jiang ZY, 2004, WORLD J GASTROENTERO, V10, P1508; Johnson AD, 2009, HUM MOL GENET, V18, P2700, DOI 10.1093/hmg/ddp202; Katsika D, 2005, HEPATOLOGY, V41, P1138, DOI 10.1002/hep.20654; KERN F, 1994, J CLIN INVEST, V93, P1186, DOI 10.1172/JCI117072; Klass DM, 2007, AM J GASTROENTEROL, V102, P2482, DOI 10.1111/j.1572-0241.2007.01430.x; Klass DM, 2006, ALIMENT PHARM THER, V23, P895, DOI 10.1111/j.1365-2036.2006.02836.x; Kovacs P, 2008, J HEPATOL, V48, P116, DOI 10.1016/j.jhep.2007.07.027; Kullak-Ublick GA, 2004, GASTROENTEROLOGY, V126, P322, DOI 10.1053/j.gastro.2003.06.005; Lammert F, 2004, HEPATOLOGY, V39, P117, DOI 10.1002/hep.20022; Lamont J T, 1992, Prog Liver Dis, V10, P165; Love MW, 2001, ARTERIOSCL THROM VAS, V21, P2039, DOI 10.1161/hq1201.100262; Mella JG, 2007, J LIPID RES, V48, P1378, DOI 10.1194/jlr.M700059-JLR200; Montagnani M, 2001, SCAND J GASTROENTERO, V36, P1077, DOI 10.1080/003655201750422693; Montagnani M, 2006, WORLD J GASTROENTERO, V12, P7710, DOI 10.3748/wjg.v12.i47.7710; Nakken KE, 2009, LIVER INT, V29, P743, DOI 10.1111/j.1478-3231.2008.01914.x; Oelkers P, 1997, J CLIN INVEST, V99, P1880, DOI 10.1172/JCI119355; Portincasa P, 2006, LANCET, V368, P230, DOI 10.1016/S0140-6736(06)69044-2; Poupon Raoul, 2007, Rev Prat, V57, P2115; Puppala S, 2006, AM J HUM GENET, V78, P377, DOI 10.1086/500274; Renner O, 2008, J LIPID RES, V49, P2045, DOI 10.1194/jlr.M800162-JLR200; Renner O, 2009, HUM GENET, V125, P381, DOI 10.1007/s00439-009-0630-0; Rosmorduc O, 2003, GASTROENTEROLOGY, V125, P452, DOI 10.1016/S0016-5085(03)00898-9; Sandler RS, 2002, GASTROENTEROLOGY, V122, P1500, DOI 10.1053/gast.2002.32978; Wigginton JE, 2005, AM J HUM GENET, V76, P887, DOI 10.1086/429864; Wittenburg H, 2003, GASTROENTEROLOGY, V125, P868, DOI 10.1016/S0016-5085(03)01053-9; Wittenburg H, 2003, DIGEST LIVER DIS, V35, pS2, DOI 10.1016/S1590-8658(03)00085-9; Wittenburg H, 2007, SEMIN LIVER DIS, V27, P109, DOI 10.1055/s-2006-960174; WONG MH, 1995, J BIOL CHEM, V270, P27228, DOI 10.1074/jbc.270.45.27228; Zanlungo S, 2004, CURR OPIN LIPIDOL, V15, P279, DOI 10.1097/00041433-200406000-00007; Zanlungo S, 2003, FRONT BIOSCI-LANDMRK, V8, pS1166, DOI 10.2741/1193	45	32	33	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7321	10.1371/journal.pone.0007321	http://dx.doi.org/10.1371/journal.pone.0007321			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823678	Green Published, gold, Green Submitted			2022-12-27	WOS:000270808300003
J	Niemann, S; Koser, CU; Gagneux, S; Plinke, C; Homolka, S; Bignell, H; Carter, RJ; Cheetham, RK; Cox, A; Gormley, NA; Kokko-Gonzales, P; Murray, LJ; Rigatti, R; Smith, VP; Arends, FPM; Cox, HS; Smith, G; Archer, JAC				Niemann, Stefan; Koeser, Claudio U.; Gagneux, Sebastien; Plinke, Claudia; Homolka, Susanne; Bignell, Helen; Carter, Richard J.; Cheetham, R. Keira; Cox, Anthony; Gormley, Niall A.; Kokko-Gonzales, Paula; Murray, Lisa J.; Rigatti, Roberto; Smith, Vincent P.; Arends, Felix P. M.; Cox, Helen S.; Smith, Geoff; Archer, John A. C.			Genomic Diversity among Drug Sensitive and Multidrug Resistant Isolates of Mycobacterium tuberculosis with Identical DNA Fingerprints	PLOS ONE			English	Article							BEIJING/W STRAINS; GENE; MUTATIONS; SUSCEPTIBILITY; PYRAZINAMIDE; EMERGENCE; SEQUENCE; SYSTEM; PHYLOGEOGRAPHY; GENOTYPE	Background: Mycobacterium tuberculosis complex (MTBC), the causative agent of tuberculosis (TB), is characterized by low sequence diversity making this bacterium one of the classical examples of a genetically monomorphic pathogen. Because of this limited DNA sequence variation, routine genotyping of clinical MTBC isolates for epidemiological purposes relies on highly discriminatory DNA fingerprinting methods based on mobile and repetitive genetic elements. According to the standard view, isolates exhibiting the same fingerprinting pattern are considered direct progeny of the same bacterial clone, and most likely reflect ongoing transmission or disease relapse within individual patients. Methodology/Principal Findings: Here we further investigated this assumption and used massively parallel whole-genome sequencing to compare one drug-susceptible (K-1) and one multidrug resistant (MDR) isolate (K-2) of a rapidly spreading M. tuberculosis Beijing genotype clone from a high incidence region (Karakalpakstan, Uzbekistan). Both isolates shared the same IS6110 RFLP pattern and the same allele at 23 out of 24 MIRU-VNTR loci. We generated 23.9 million (K-1) and 33.0 million (K-2) paired 50 bp purity filtered reads corresponding to a mean coverage of 483.5 fold and 656.1 fold respectively. Compared with the laboratory strain H37Rv both Beijing isolates shared 1,209 SNPs. The two Beijing isolates differed by 130 SNPs and one large deletion. The susceptible isolate had 55 specific SNPs, while the MDR variant had 75 specific SNPs, including the five known resistance-conferring mutations. Conclusions: Our results suggest that M. tuberculosis isolates exhibiting identical DNA fingerprinting patterns can harbour substantial genomic diversity. Because this heterogeneity is not captured by traditional genotyping of MTBC, some aspects of the transmission dynamics of tuberculosis could be missed or misinterpreted. Furthermore, a valid differentiation between disease relapse and exogenous reinfection might be impossible using standard genotyping tools if the overall diversity of circulating clones is limited. These findings have important implications for clinical trials of new anti-tuberculosis drugs.			Niemann, S (corresponding author), Res Ctr Borstel, Borstel, Germany.	sniemann@fz-borstel.de	Niemann, Stefan/C-9327-2011; Gagneux, Sebastien/ABE-7909-2020; Archer, John/D-5200-2012; Archer, John/AAW-1990-2021; Köser, Claudio/I-3740-2013	Archer, John/0000-0002-3302-3933; Köser, Claudio/0000-0002-0232-846X; Niemann, Stefan/0000-0002-6604-0684; Cox, Anthony/0000-0002-6534-749X; Cox, Helen/0000-0002-6538-7192; Gagneux, Sebastien/0000-0001-7783-9048	Medical Research Council [MC_U117588500] Funding Source: Medline; NIAID NIH HHS [R01 AI034238] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI034238] Funding Source: NIH RePORTER; MRC [MC_U117588500] Funding Source: UKRI	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abe C, 2008, J CLIN MICROBIOL, V46, P2263, DOI 10.1128/JCM.00561-08; Achtman M, 2008, ANNU REV MICROBIOL, V62, P53, DOI 10.1146/annurev.micro.62.081307.162832; [Anonymous], 2008, 4 WHO; Bemer P, 2002, J CLIN MICROBIOL, V40, P150, DOI 10.1128/JCM.40.1.150-154.2002; Bentley DR, 2008, NATURE, V456, P53, DOI 10.1038/nature07517; Bousquet J., 2007, GLOBAL SURVEILLANCE, P146; Carver T, 2009, BIOINFORMATICS, V25, P119, DOI 10.1093/bioinformatics/btn578; Caws M, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000034; Chan RCY, 2007, J ANTIMICROB CHEMOTH, V59, P866, DOI 10.1093/jac/dkm054; Cole ST, 1999, FEBS LETT, V452, P7, DOI 10.1016/S0014-5793(99)00536-0; Cole ST, 1998, NOVART FDN SYMP, V217, P160, DOI 10.1002/0470846526.ch12; Cowley D, 2008, CLIN INFECT DIS, V47, P1252, DOI 10.1086/592575; Cox HS, 2008, NEW ENGL J MED, V359, P2398, DOI 10.1056/NEJMc0805644; Cox HS, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-134; Cox HS, 2004, EMERG INFECT DIS, V10, P865, DOI 10.3201/eid1005.030718; de Jong BC, 2008, J INFECT DIS, V198, P1037, DOI 10.1086/591504; Farmer PE, 2006, PLOS MED, V3, P1686, DOI 10.1371/journal.pmed.0030449; Fleischmann RD, 2002, J BACTERIOL, V184, P5479, DOI 10.1128/JB.184.19.5479-5490.2002; Frigui W, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040033; Gagneux S, 2006, P NATL ACAD SCI USA, V103, P2869, DOI 10.1073/pnas.0511240103; Gagneux S, 2007, LANCET INFECT DIS, V7, P328, DOI 10.1016/S1473-3099(07)70108-1; Gagneux S, 2006, SCIENCE, V312, P1944, DOI 10.1126/science.1124410; Garnier T, 2003, P NATL ACAD SCI USA, V100, P7877, DOI 10.1073/pnas.1130426100; Glynn JR, 2002, EMERG INFECT DIS, V8, P843; Hershberg R, 2008, PLOS BIOL, V6, P2658, DOI 10.1371/journal.pbio.0060311; Hill AVS, 2006, ANNU REV GENET, V40, P469, DOI 10.1146/annurev.genet.40.110405.090546; Jassal M, 2009, LANCET INFECT DIS, V9, P19, DOI 10.1016/S1473-3099(08)70260-3; Kamerbeek J, 1997, J CLIN MICROBIOL, V35, P907, DOI 10.1128/JCM.35.4.907-914.1997; Keshavjee S, 2008, ANN NY ACAD SCI, V1136, P1, DOI 10.1196/annals.1425.009; Koenig R, 2007, SCIENCE, V318, P901; Lee JS, 2008, CELL HOST MICROBE, V3, P97, DOI 10.1016/j.chom.2008.01.002; Lee KW, 2001, J KOREAN MED SCI, V16, P537, DOI 10.3346/jkms.2001.16.5.537; Maisnier-Patin S, 2004, RES MICROBIOL, V155, P360, DOI 10.1016/j.resmic.2004.01.019; Musser JM, 2000, GENETICS, V155, P7; NAIR J, 1993, MOL MICROBIOL, V10, P521, DOI 10.1111/j.1365-2958.1993.tb00924.x; Oelemann MC, 2007, J CLIN MICROBIOL, V45, P691, DOI 10.1128/JCM.01393-06; Pardini M, 2009, TUBERCULOSIS, V89, P317, DOI 10.1016/j.tube.2009.04.002; Pfyffer GE, 2002, J CLIN MICROBIOL, V40, P1670, DOI 10.1128/JCM.40.5.1670-1674.2002; Ramaswamy SV, 2000, ANTIMICROB AGENTS CH, V44, P326, DOI 10.1128/AAC.44.2.326-336.2000; Reed MB, 2004, NATURE, V431, P84, DOI 10.1038/nature02837; Rutherford K, 2000, BIOINFORMATICS, V16, P944, DOI 10.1093/bioinformatics/16.10.944; Scorpio A, 1996, NAT MED, V2, P662, DOI 10.1038/nm0696-662; Service RF, 2006, SCIENCE, V311, P1544, DOI 10.1126/science.311.5767.1544; Shah NS, 2007, EMERG INFECT DIS, V13, P380, DOI 10.3201/eid1303.061400; Sreevatsan S, 1997, P NATL ACAD SCI USA, V94, P9869, DOI 10.1073/pnas.94.18.9869; Supply P, 2006, J CLIN MICROBIOL, V44, P4498, DOI 10.1128/JCM.01392-06; TELENTI A, 1993, LANCET, V341, P647, DOI 10.1016/0140-6736(93)90417-F; Telenti A, 1997, NAT MED, V3, P567, DOI 10.1038/nm0597-567; Thwaites G, 2008, J CLIN MICROBIOL, V46, P1363, DOI 10.1128/JCM.02180-07; Tsolaki AG, 2005, J CLIN MICROBIOL, V43, P3185, DOI 10.1128/JCM.43.7.3185-3191.2005; Van Soolingen Dick, 2003, VVolume 2, P17; VANEMBDEN JDA, 1993, J CLIN MICROBIOL, V31, P406, DOI 10.1128/JCM.31.2.406-409.1993; Wirth T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000160; ZHANG Y, 1992, NATURE, V358, P591, DOI 10.1038/358591a0; ZHANG Y, 2008, HDB TUBERCULOSIS; Zheng HJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002375; Zignol M, 2006, J INFECT DIS, V194, P479, DOI 10.1086/505877	57	114	114	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7407	10.1371/journal.pone.0007407	http://dx.doi.org/10.1371/journal.pone.0007407			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823582	Green Submitted, gold, Green Published			2022-12-27	WOS:000270728500008
J	Zhou, CX; Tiberi, M; Liang, BH; Alper, SL; Baltz, JM				Zhou, Chenxi; Tiberi, Mario; Liang, Binhui; Alper, Seth L.; Baltz, Jay M.			HCO3-/Cl- Exchange Inactivation and Reactivation during Mouse Oocyte Meiosis Correlates with MEK/MAPK-Regulated Ae2 Plasma Membrane Localization	PLOS ONE			English	Article								Background: Germinal Vesicle (GV) stage mouse oocytes in first meiotic prophase exhibit highly active HCO3-/Cl- exchange-a class of transport nearly ubiquitously involved in regulation of intracellular pH and cell volume. During meiosis, however, oocyte HCO3-/Cl- exchange becomes inactivated during first metaphase (MI), remains inactive in second metaphase (MII), and is reactivated only after egg activation. Previous work using pharmacological manipulations had indicated that activity of the MEK/MAPK signaling pathway was negatively correlated with HCO3-/Cl- exchange activity during meiosis. However, the mechanism by which the exchanger is inactivated during meiotic progression had not been determined, nor had the role of MEK/MAPK been directly established. Methodology/Principal Findings: Expression of a constitutively active form of MEK (MAP kinase kinase), which prevented the normal downregulation of MAPK after egg activation, also prevented reactivation of HCO3-/Cl- exchange. Conversely, suppression of endogenous MAPK activity with dominant negative MEK activated the normally quiescent HCO3-/Cl- exchange in mature MII eggs. A GFP-tagged form of the HCO3-/Cl- exchanger isoform Ae2 (Slc4a2) was strongly expressed at the GV oocyte plasma membrane, but membrane localization decreased markedly during meiotic progression. A similar pattern for endogenous Ae2 was confirmed by immunocytochemistry. The loss of membrane-localized Ae2 appeared selective, since membrane localization of a GFP-tagged human dopamine D1 receptor did not change during meiotic maturation. Conclusions: Direct manipulation of MAPK activity indicated that GFP-tagged Ae2 localization depended upon MAPK activity. Inactivation of HCO3-/Cl- exchange during the meiotic cell cycle may therefore reflect the loss of Ae2 from the oocyte plasma membrane, downstream of MEK/MAPK signaling. This identifies a novel role for MEK/MAPK-mediated cytostatic factor (CSF) activity during meiosis in membrane protein trafficking in mouse oocytes, and shows for the first time that selective retrieval of membrane proteins is a feature of meiosis in mammalian oocytes.			Zhou, CX (corresponding author), Ottawa Hosp, Res Inst, Ottawa, ON, Canada.	jmbaltz@ohri.ca		Baltz, Jay/0000-0002-9749-2480	NIDDK NIH HHS [DK43495, R37 DK043495] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK043495, R37DK043495] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Alper SL, 2006, EXP PHYSIOL, V91, P153, DOI 10.1113/expphysiol.2005.031765; ALPER SL, 1991, ANNU REV PHYSIOL, V53, P549, DOI 10.1146/annurev.physiol.53.1.549; Baltz JM, 2003, SODIUM-HYDROGEN EXCHANGER: FROM MOLECULE TO ITS ROLE IN DISEASE, P123; BALTZ JM, 1991, MOL REPROD DEV, V28, P351, DOI 10.1002/mrd.1080280407; BALTZ JM, 1991, J BIOL CHEM, V266, P17212; BIGGERS JD, 1967, P NATL ACAD SCI USA, V58, P560, DOI 10.1073/pnas.58.2.560; BORON WF, 1986, ANNU REV PHYSIOL, V48, P377; BOSMIKICH A, 1995, MOL REPROD DEV, V41, P84, DOI 10.1002/mrd.1080410113; Cetinkaya A, 2008, J REPROD DEVELOP, V54, P492, DOI 10.1262/jrd.20029; Chiariello M, 2000, MOL CELL BIOL, V20, P1747, DOI 10.1128/MCB.20.5.1747-1758.2000; COSO OA, 1995, CELL, V81, P1137, DOI 10.1016/S0092-8674(05)80018-2; El-Jouni W, 2007, DEVELOPMENT, V134, P3307, DOI 10.1242/dev.005454; El-Jouni W, 2008, DEV BIOL, V324, P99, DOI 10.1016/j.ydbio.2008.09.007; Erdogan S, 2005, DEV BIOL, V286, P352, DOI 10.1016/j.ydbio.2005.08.009; Fan HY, 2004, BIOL REPROD, V70, P535, DOI 10.1095/biolreprod.103.022830; FitzHarris G, 2006, DEVELOPMENT, V133, P591, DOI 10.1242/dev.02246; FitzHarris G, 2007, DEVELOPMENT, V134, P4283, DOI 10.1242/dev.005272; FRASER LR, 1987, GAMETE RES, V18, P363, DOI 10.1002/mrd.1120180410; GRINSTEIN S, 1989, BIOCHIM BIOPHYS ACTA, V988, P73, DOI 10.1016/0304-4157(89)90004-X; HAGHIGHAT N, 1990, J EXP ZOOL, V253, P71, DOI 10.1002/jez.1402530110; Hang JS, 2008, CURR BIOL, V18, pR416, DOI 10.1016/j.cub.2008.03.033; Jensen LJ, 1999, BIOL REPROD, V61, P973, DOI 10.1095/biolreprod61.4.973; JIANG LW, 1994, AM J PHYSIOL, V267, pC845, DOI 10.1152/ajpcell.1994.267.3.C845; Jiang LW, 1997, AM J PHYSIOL-CELL PH, V272, pC191, DOI 10.1152/ajpcell.1997.272.1.C191; JOHNSON JD, 1976, NATURE, V262, P661, DOI 10.1038/262661a0; Kline D, 1995, ZYGOTE, V3, P305, DOI 10.1017/S0967199400002732; Lane M, 1999, BIOL REPROD, V61, P452, DOI 10.1095/biolreprod61.2.452; Madgwick S, 2007, CELL DIV, V2, DOI 10.1186/1747-1028-2-4; Mehlmann LM, 2004, SCIENCE, V306, P1947, DOI 10.1126/science.1103974; Moos J, 1996, DEV BIOL, V175, P358, DOI 10.1006/dbio.1996.0121; MOOS J, 1995, BIOL REPROD, V53, P692, DOI 10.1095/biolreprod53.3.692; Mount DB, 2004, PFLUG ARCH EUR J PHY, V447, P710, DOI 10.1007/s00424-003-1090-3; MULLER HAJ, 1995, DEV DYNAM, V202, P405; Muller HAJ, 2001, DEV GROWTH DIFFER, V43, P327, DOI 10.1046/j.1440-169x.2001.00587.x; NORD EP, 1988, J BIOL CHEM, V263, P5599; Pelland AMD, 2009, BIOL REPROD, V81, P1041, DOI 10.1095/biolreprod.109.079046; PETRUNEWICH MA, 2008, J REPROD DEV; Phillips KP, 1999, DEV BIOL, V208, P392, DOI 10.1006/dbio.1999.9199; Phillips KP, 1996, MOL REPROD DEV, V45, P52, DOI 10.1002/(SICI)1098-2795(199609)45:1&lt;52::AID-MRD8&gt;3.0.CO;2-R; Phillips KP, 2000, HUM REPROD, V15, P896, DOI 10.1093/humrep/15.4.896; Phillips KP, 2002, DEV BIOL, V247, P210, DOI 10.1006/dbio.2002.0680; Phillips KP, 2002, MOL BIOL CELL, V13, P3800, DOI 10.1091/mbc.E02-04-0242; Putney LK, 2002, ANNU REV PHARMACOL, V42, P527, DOI 10.1146/annurev.pharmtox.42.092001.143801; Romero MF, 2004, PFLUG ARCH EUR J PHY, V447, P495, DOI 10.1007/s00424-003-1180-2; SCHMALZING G, 1990, AM J PHYSIOL, V258, pC179, DOI 10.1152/ajpcell.1990.258.1.C179; Schmidt A, 2006, J CELL SCI, V119, P1213, DOI 10.1242/jcs.02919; SCHULTZ RM, 1995, CURR TOP DEV BIOL, V30, P21, DOI 10.1016/S0070-2153(08)60563-3; Sedaghat K, 2006, MOL BIOTECHNOL, V34, P1, DOI 10.1385/MB:34:1:1; Sheng YL, 2001, CURR BIOL, V11, P405, DOI 10.1016/S0960-9822(01)00123-3; Simon AM, 1997, NATURE, V385, P525, DOI 10.1038/385525a0; Steeves CL, 2005, J CELL PHYSIOL, V204, P273, DOI 10.1002/jcp.20284; Steeves CL, 2003, P NATL ACAD SCI USA, V100, P13982, DOI 10.1073/pnas.2334537100; Stewart AK, 2007, AM J PHYSIOL-CELL PH, V292, pC909, DOI 10.1152/ajpcell.00265.2006; STUARTTILLEY A, 1994, AM J PHYSIOL, V266, pC559, DOI 10.1152/ajpcell.1994.266.2.C559; Su YQ, 2008, DEVELOPMENT, V135, P111, DOI 10.1242/dev.009068; Su YQ, 2009, SEMIN REPROD MED, V27, P32, DOI 10.1055/s-0028-1108008; Takakura I, 2005, J REPROD DEVELOP, V51, P617, DOI 10.1262/jrd.17034; Tartia AP, 2009, DEVELOPMENT, V136, P2247, DOI 10.1242/dev.036756; Tumova K, 2003, J BIOL CHEM, V278, P8146, DOI 10.1074/jbc.M208059200; VERLHAC MH, 1994, DEVELOPMENT, V120, P1017; Zhao YY, 1996, AM J PHYSIOL-CELL PH, V271, pC1512, DOI 10.1152/ajpcell.1996.271.5.C1512; ZHAO YY, 1995, J BIOL CHEM, V270, P24428, DOI 10.1074/jbc.270.41.24428; Zhao YY, 1997, DEV BIOL, V189, P148, DOI 10.1006/dbio.1997.8651	63	17	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7417	10.1371/journal.pone.0007417	http://dx.doi.org/10.1371/journal.pone.0007417			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823673	Green Published, gold, Green Submitted			2022-12-27	WOS:000270728500015
J	Meinke, D; Sweeney, C; Muralla, R				Meinke, David; Sweeney, Colleen; Muralla, Rosanna			Integrating the Genetic and Physical Maps of Arabidopsis thaliana: Identification of Mapped Alleles of Cloned Essential (EMB) Genes	PLOS ONE			English	Article							LETHAL MUTANTS; INSERTIONAL MUTAGENESIS; CELL FATE; ARRESTED EMBRYOS; PROTEIN; GENOME; PLANT; BIOSYNTHESIS; REVEALS; INVITRO	The classical genetic map of Arabidopsis includes more than 130 genes with an embryo-defective (emb) mutant phenotype. Many of these essential genes remain to be cloned. Hundreds of additional EMB genes have been cloned and catalogued (www.seedgenes.org) but not mapped. To facilitate EMB gene identification and assess the current level of saturation, we updated the classical map, compared the physical and genetic locations of mapped loci, and performed allelism tests between mapped ( but not cloned) and cloned (but not mapped) emb mutants with similar chromosome locations. Two hundred pairwise combinations of genes located on chromosomes 1 and 5 were tested and more than 1100 total crosses were screened. Sixteen of 51 mapped emb mutants examined were found to be disrupted in a known EMB gene. Alleles of a wide range of published EMB genes (YDA, GLA1, TIL1, AtASP38, AtDEK1, EMB506, DG1, OEP80) were discovered. Two EMS mutants isolated 30 years ago, T-DNA mutants with complex insertion sites, and a mutant with an atypical, embryo-specific phenotype were resolved. The frequency of allelism encountered was consistent with past estimates of 500 to 1000 EMB loci. New EMB genes identified among mapped T-DNA insertion mutants included CHC1, which is required for chromatin remodeling, and SHS1/AtBT1, which encodes a plastidial nucleotide transporter similar to the maize Brittle1 protein required for normal endosperm development. Two classical genetic markers (PY, ALB1) were identified based on similar map locations of known genes required for thiamine (THIC) and chlorophyll (PDE166) biosynthesis. The alignment of genetic and physical maps presented here should facilitate the continued analysis of essential genes in Arabidopsis and further characterization of a broad spectrum of mutant phenotypes in a model plant.			Meinke, D (corresponding author), Oklahoma State Univ, Dept Bot, Stillwater, OK 74078 USA.	david.meinke@okstate.edu						Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BAUS AD, 1986, THEOR APPL GENET, V72, P577, DOI 10.1007/BF00288994; Bayer M, 2009, SCIENCE, V323, P1485, DOI 10.1126/science.1167784; Berg M, 2005, PLANT J, V44, P866, DOI 10.1111/j.1365-313X.2005.02580.x; CASTLE LA, 1993, MOL GEN GENET, V241, P504, DOI 10.1007/BF00279892; Chi W, 2008, PLANT PHYSIOL, V147, P573, DOI 10.1104/pp.108.116194; Crane YM, 2007, P NATL ACAD SCI USA, V104, P15156, DOI 10.1073/pnas.0706986104; Cushing DA, 2005, PLANTA, V221, P424, DOI 10.1007/s00425-004-1452-x; ERRAMPALLI D, 1991, PLANT CELL, V3, P149, DOI 10.1105/tpc.3.2.149; FEENSTRA WJ, 1964, GENETICA, V35, P259, DOI 10.1007/BF01804894; FRANZMANN L, 1989, THEOR APPL GENET, V77, P609, DOI 10.1007/BF00261231; FRANZMANN LH, 1995, PLANT J, V7, P341, DOI 10.1046/j.1365-313X.1995.7020341.x; FURNER IJ, 1992, DEVELOPMENT, V115, P755; Furner IJ, 1996, DEVELOPMENT, V122, P1041; Garcion C, 2006, PLANT J, V48, P895, DOI 10.1111/j.1365-313X.2006.02922.x; Ge XC, 2005, EMBO REP, V6, P282, DOI 10.1038/sj.embor.7400357; Inan G, 2007, PLANT MOL BIOL, V65, P295, DOI 10.1007/s11103-007-9219-y; Ishikawa T, 2003, PLANT J, V33, P235, DOI 10.1046/j.1365-313X.2003.01621.x; Jenik PD, 2005, PLANT CELL, V17, P3362, DOI 10.1105/tpc.105.036889; Johnson KL, 2008, PLANT CELL, V20, P2619, DOI 10.1105/tpc.108.059964; JURGENS G, 1991, DEVELOPMENT, P27; Kirchberger S, 2008, PLANT J, V56, P51, DOI 10.1111/j.1365-313X.2008.03583.x; Kobayashi K, 2008, PHOTOCH PHOTOBIO SCI, V7, P1188, DOI 10.1039/b802604c; Kong DY, 2008, CELL RES, V18, P566, DOI 10.1038/cr.2008.35; KOORNNEEF M, 1983, J HERED, V74, P265, DOI 10.1093/oxfordjournals.jhered.a109781; Lampard GR, 2008, SCIENCE, V322, P1113, DOI 10.1126/science.1162263; LI SL, 1969, BIOCHEM GENET, V3, P163, DOI 10.1007/BF00520351; Lid SE, 2002, P NATL ACAD SCI USA, V99, P5460, DOI 10.1073/pnas.042098799; LISTER C, 1993, PLANT J, V4, P745, DOI 10.1046/j.1365-313X.1993.04040745.x; Liu CM, 2002, PLANT J, V29, P405, DOI 10.1046/j.1365-313x.2002.01224.x; Lukowitz W, 2004, CELL, V116, P109, DOI 10.1016/S0092-8674(03)01067-5; Lukowitz W, 2000, PLANT PHYSIOL, V123, P795, DOI 10.1104/pp.123.3.795; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; McElver J, 2001, GENETICS, V159, P1751; MEINKE D, 1989, MOL BASIS PLANT DEV, P121; Meinke D, 2008, TRENDS PLANT SCI, V13, P483, DOI 10.1016/j.tplants.2008.06.003; MEINKE DW, 1985, THEOR APPL GENET, V69, P543, DOI 10.1007/BF00251102; Meinke DW, 2003, PLANT PHYSIOL, V131, P409, DOI 10.1104/pp.014134; MEINKE DW, 1979, DEV BIOL, V72, P62, DOI 10.1016/0012-1606(79)90098-8; Meinke DW, 1998, SCIENCE, V282, P662, DOI 10.1126/science.282.5389.662; MEINKE DW, 1982, THEOR APPL GENET, V63, P381, DOI 10.1007/BF00303912; Meinke DW, 1994, ARABIDOPSIS THALIANA, P253; MULLER A. J., 1963, BIOL ZENTRALBL, V82, P133; Nachman MW, 2002, CURR OPIN GENET DEV, V12, P657, DOI 10.1016/S0959-437X(02)00358-1; Patel R, 2008, PLANT PHYSIOL, V148, P235, DOI 10.1104/pp.108.122754; PATTON DA, 1991, MOL GEN GENET, V227, P337, DOI 10.1007/BF00273921; Preuss SB, 2003, GENETICS, V164, P323; Raschke M, 2007, P NATL ACAD SCI USA, V104, P19637, DOI 10.1073/pnas.0709597104; REDEI GP, 1975, ANNU REV GENET, V9, P111, DOI 10.1146/annurev.ge.09.120175.000551; ROBBELEN G, 1957, Z INDUKT ABSTAMM VER, V88, P189, DOI 10.1007/BF00308341; ROBBELEN G, 1972, ARAB INF SERV, V9, P21; Ronceret A, 2005, PLANT J, V44, P223, DOI 10.1111/j.1365-313X.2005.02521.x; Rosso MG, 2003, PLANT MOL BIOL, V53, P247, DOI 10.1023/B:PLAN.0000009297.37235.4a; Sessions A, 2002, PLANT CELL, V14, P2985, DOI 10.1105/tpc.004630; Singer T, 2006, PLOS GENET, V2, P1352, DOI 10.1371/journal.pgen.0020144; Stephenson PG, 2008, PHOTOCH PHOTOBIO SCI, V7, P1243, DOI 10.1039/b802596g; Tax FE, 2001, PLANT PHYSIOL, V126, P1527, DOI 10.1104/pp.126.4.1527; Terauchi R, 2000, MOL GEN GENET, V263, P554, DOI 10.1007/s004380051201; Tzafrir I, 2004, PLANT PHYSIOL, V135, P1206, DOI 10.1104/pp.104.045179; VANDERVEEN JH, 1973, ARABID INF SERV, V10, P11; VERNON DM, 1995, DEV GENET, V16, P311, DOI 10.1002/dvg.1020160404; Winkler RG, 1998, METH MOL B, V82, P129; Yu A, 2001, NATURE, V409, P951, DOI 10.1038/35057185	63	39	42	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7386	10.1371/journal.pone.0007386	http://dx.doi.org/10.1371/journal.pone.0007386			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812694	Green Published, gold, Green Submitted			2022-12-27	WOS:000270594200011
J	Wen, J; Zhang, H; Li, G; Mao, GP; Chen, XF; Wang, JW; Guo, M; Mu, XY; Ouyang, H; Zhang, MJ; Xia, GL				Wen, Jing; Zhang, Hua; Li, Ge; Mao, Guanping; Chen, Xiufen; Wang, Jianwei; Guo, Meng; Mu, Xinyi; Ouyang, Hong; Zhang, Meijia; Xia, Guoliang			PAR6, A Potential Marker for the Germ Cells Selected to Form Primordial Follicles in Mouse Ovary	PLOS ONE			English	Article							JUNCTIONAL COMMUNICATION; AXIS FORMATION; STEM-CELLS; DROSOPHILA; OOCYTE; POLARITY; DIFFERENTIATION; POLARIZATION; MAINTENANCE; INHIBITION	Partitioning-defective proteins (PAR) are detected to express mainly in the cytoplast, and play an important role in cell polarity. However, we showed here that PAR6, one kind of PAR protein, was localized in the nuclei of mouse oocytes that formed primordial follicles during the perinatal period, suggesting a new role of PAR protein. It is the first time we found that, in mouse fetal ovaries, PAR6 appeared in somatic cell cytoplasm and fell weak when somatic cells invaded germ cell cysts at 17.5 days post coitus (dpc). Meanwhile, the expression of PAR6 was observed in cysts, and became strong in the nuclei of some germ cells at 19.5 dpc and all primordial follicular oocytes at 3 day post parturition (dpp), and then obviously declined when the primordial follicles entered the folliculogenic growth phase. During the primordial follicle pool foundation, the number of PAR6 positive germ cells remained steady and was consistent with that of formed follicles at 3 dpp. There were no TUNEL (apoptosis examination) positive germ cells stained with PAR6 at any time studied. The number of follicles significantly declined when 15.5 dpc ovaries were treated with the anti-PAR6 antibody and PAR6 RNA interference. Carbenoxolone (CBX, a known blocker of gap junctions) inhibited the expression of PAR6 in germ cells and the formation of follicles. Our results suggest that PAR6 could be used as a potential marker of germ cells for the primordial follicle formation, and the expression of PAR6 by a gap junction-dependent process may contribute to the formation of primordial follicles and the maintenance of oocytes at the diplotene stage.			Wen, J (corresponding author), Univ Agr, Coll Biol Sci, State Key Lab Agrobiotechnol, Beijing, Peoples R China.	zmeijia@cau.edu.cn; glxiachina@sohu.com		Xia, Guoliang/0000-0003-3674-0142; Ouyang, Hong/0000-0002-7622-7733				Albertini DF, 2004, REPRODUCTION, V127, P513, DOI 10.1530/rep.1.00247; Benton R, 2002, DEV CELL, V3, P659, DOI 10.1016/S1534-5807(02)00320-9; Bruzzone R, 1996, BIOESSAYS, V18, P709, DOI 10.1002/bies.950180906; Bruzzone R, 1996, EUR J BIOCHEM, V238, P1, DOI 10.1111/j.1432-1033.1996.0001q.x; BYSKOV AG, 1986, PHYSIOL REV, V66, P71, DOI 10.1152/physrev.1986.66.1.71; Cheutin T, 2003, SCIENCE, V299, P721, DOI 10.1126/science.1078572; Cox DN, 2001, P NATL ACAD SCI USA, V98, P14475, DOI 10.1073/pnas.261565198; DAVIDSON JS, 1988, J PHARMACOL EXP THER, V246, P1104; DAVIDSON JS, 1986, BIOCHEM BIOPH RES CO, V134, P29, DOI 10.1016/0006-291X(86)90522-X; Deng W, 2001, INT REV CYTOL, V203, P93; Duncan FE, 2005, DEV BIOL, V280, P38, DOI 10.1016/j.ydbio.2004.12.034; ENDERS GC, 1994, DEV BIOL, V163, P331, DOI 10.1006/dbio.1994.1152; Etienne-Manneville S, 2003, CURR OPIN CELL BIOL, V15, P67, DOI 10.1016/S0955-0674(02)00005-4; Goldberg GS, 1996, EXP CELL RES, V222, P48, DOI 10.1006/excr.1996.0006; Greenfeld C, 2004, BIOESSAYS, V26, P829, DOI 10.1002/bies.20094; Hong A, 2003, DEVELOPMENT, V130, P1235, DOI 10.1242/dev.00352; Hurov JB, 2004, CURR BIOL, V14, P736, DOI 10.1016/j.cub.2004.04.007; Huynh JR, 2004, CURR BIOL, V14, pR438, DOI 10.1016/j.cub.2004.05.040; Huynh JR, 2001, DEVELOPMENT, V128, P1201; Johnson J, 2004, NATURE, V428, P145, DOI 10.1038/nature02316; Lei L, 2006, J CELL PHYSIOL, V208, P640, DOI 10.1002/jcp.20702; Lyczak R, 2002, DEV CELL, V3, P157, DOI 10.1016/S1534-5807(02)00226-5; Macara AG, 2004, CURR BIOL, V14, pR160, DOI 10.1016/j.cub.2004.01.048; MACKAY S, 1989, CELL DIFFER DEV, V27, P19, DOI 10.1016/0922-3371(89)90041-5; Martin SG, 2003, NATURE, V421, P379, DOI 10.1038/nature01296; McClellan KA, 2003, DEV BIOL, V258, P334, DOI 10.1016/S0012-1606(03)00132-5; Pellettieri J, 2002, SCIENCE, V298, P1946, DOI 10.1126/science.1072162; Pepling ME, 1998, DEVELOPMENT, V125, P3323; Pepling ME, 2001, DEV BIOL, V234, P339, DOI 10.1006/dbio.2001.0269; Pepling ME, 2006, GENESIS, V44, P622, DOI 10.1002/dvg.20258; Perez-Armendariz EM, 2003, ANAT REC PART A, V271A, P360, DOI 10.1002/ar.a.10040; RAJAH R, 1992, DEV DYNAM, V194, P177, DOI 10.1002/aja.1001940303; Soyal SM, 2000, DEVELOPMENT, V127, P4645; Telfer W. H., 1975, Advances Insect Physiol, V11, P223, DOI 10.1016/S0065-2806(08)60164-2; Tilly Jonathan L, 2003, Reprod Biol Endocrinol, V1, P11, DOI 10.1186/1477-7827-1-11; Vaccari T, 2002, CURR BIOL, V12, P1524, DOI 10.1016/S0960-9822(02)01079-5; Vinot S, 2005, DEV BIOL, V282, P307, DOI 10.1016/j.ydbio.2005.03.001; Vinot S, 2004, CURR BIOL, V14, P520, DOI 10.1016/j.cub.2004.02.061; Wang DH, 1997, MOL REPROD DEV, V48, P154, DOI 10.1002/(SICI)1098-2795(199710)48:2&lt;154::AID-MRD2&gt;3.0.CO;2-R; Wang HB, 2001, CHINESE SCI BULL, V46, P672, DOI 10.1007/BF03182833	40	15	16	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7372	10.1371/journal.pone.0007372	http://dx.doi.org/10.1371/journal.pone.0007372			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809506	Green Published, Green Submitted, gold			2022-12-27	WOS:000270594000020
J	Zaradic, PA; Pergams, ORW; Kareiva, P				Zaradic, Patricia A.; Pergams, Oliver R. W.; Kareiva, Peter			The Impact of Nature Experience on Willingness to Support Conservation	PLOS ONE			English	Article							RECREATION; TRENDS	We hypothesized that willingness to financially support conservation depends on one's experience with nature. In order to test this hypothesis, we used a novel time-lagged correlation analysis to look at times series data concerning nature participation, and evaluate its relationship with future conservation support (measured as contributions to conservation NGOs). Our results suggest that the type and timing of nature experience may determine future conservation investment. Time spent hiking or backpacking is correlated with increased conservation contributions 11-12 years later. On the other hand, contributions are negatively correlated with past time spent on activities such as public lands visitation or fishing. Our results suggest that each hiker or backpacker translates to $200-$300 annually in future NGO contributions. We project that the recent decline in popularity of hiking and backpacking will negatively impact conservation NGO contributions from approximately 2010-2011 through at least 2018.			Zaradic, PA (corresponding author), Red Rock Inst Inc, Bryn Mawr, PA USA.	pzaradic@redrockinstitute.org						*AM ENV, 2005, ROADM NEW EC MAJ; BUTLER RA, 2009, EC CRISIS HITS CONSE; Cordell HK, 2005, FREE TIME AND LEISURE PARTICIPATION: INTERNATIONAL PERSPECTIVES, P245, DOI 10.1079/9780851996202.0245; *ECH MED, 2009, MARK REP FIELD STREA; Kareiva P, 2008, P NATL ACAD SCI USA, V105, P2757, DOI 10.1073/pnas.0800474105; Loomis J., 2005, General Technical Report - Pacific Northwest Research Station, USDA Forest Service; MANNI MF, 2007, 178 U ID PARK STUD U; *NAT PARK SERV, 2001, NAT PARK SERV COMPR; Nordhaus T., 2007, BREAK DEATH ENV POLI; Pergams ORW, 2008, P NATL ACAD SCI USA, V105, P2295, DOI 10.1073/pnas.0709893105; Pergams ORW, 2004, CONSERV BIOL, V18, P1617, DOI 10.1111/j.1523-1739.2004.00411.x; *S CAR DEP PARKS R, 2001, NAT STAT PARKS S CAR; Shellenberger Michael, 2004, DEATH ENV GLOBAL WAR; *STAT VIRG, 2007, OUTD RECR ISS TRENDS	14	62	65	1	32	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7367	10.1371/journal.pone.0007367	http://dx.doi.org/10.1371/journal.pone.0007367			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809511	Green Published, gold			2022-12-27	WOS:000270594000017
J	Zerbib, J; Seddon, JM; Richard, F; Reynolds, R; Leveziel, N; Benlian, P; Borel, P; Feingold, J; Munnich, A; Soubrane, G; Kaplan, J; Rozet, JM; Souied, EH				Zerbib, Jennyfer; Seddon, Johanna M.; Richard, Florence; Reynolds, Robyn; Leveziel, Nicolas; Benlian, Pascale; Borel, Patrick; Feingold, Josue; Munnich, Arnold; Soubrane, Gisele; Kaplan, Josseline; Rozet, Jean-Michel; Souied, Eric H.			rs5888 Variant of SCARB1 Gene Is a Possible Susceptibility Factor for Age-Related Macular Degeneration	PLOS ONE			English	Article							B TYPE-I; COMPLEMENT FACTOR-H; SCAVENGER RECEPTOR; SR-BI; CIGARETTE-SMOKING; APOLIPOPROTEIN-E; RISK-FACTORS; VITAMIN-E; CARDIOVASCULAR-DISEASE; POOLED FINDINGS	Major genetic factors for age-related macular degeneration (AMD) have recently been identified as susceptibility risk factors, including variants in the CFH gene and the ARMS2 LOC387715/HTRA1locus. Our purpose was to perform a case-control study in two populations among individuals who did not carry risk variants for CFHY402H and LOC387715 A69S (ARMS2), called "study'' individuals, in order to identify new genetic risk factors. Based on a candidate gene approach, we analyzed SNP rs5888 of the SCARB1 gene, coding for SRBI, which is involved in the lipid and lutein pathways. This study was conducted in a French series of 1241 AMD patients and 297 controls, and in a North American series of 1257 patients with advanced AMD and 1732 controls. Among these individuals, we identified 61 French patients, 77 French controls, 85 North American patients and 338 North American controls who did not carry the CFH nor ARMS2 polymorphisms. An association between AMD and the SCARB1 gene was seen among the study subjects. The genotypic distribution of the rs5888 polymorphism was significantly different between cases and controls in the French population (p<0.006). Heterozygosity at the rs5888 SNP increased risk of AMD compared to the CC genotypes in the French study population (odds ratio (OR) = 3.5, CI95%: 1.4-8.9, p<0.01) and after pooling the 2 populations (OR = 2.9, 95% CI: 1.6-5.3, p<0.002). Subgroup analysis in exudative forms of AMD revealed a pooled OR of 3.6 for individuals heterozygous for rs5888 (95% CI: 1.7-7.6, p<0.0015). These results suggest the possible contribution of SCARB1, a new genetic factor in AMD, and implicate a role for cholesterol and antioxidant micronutrient (lutein and vitamin E) metabolism in AMD.			Zerbib, J (corresponding author), Creteil Univ, Eye Clin, Fac Med Henri Mondor, Creteil, France.	eric.souied@chicreteil.fr	Borel, Patrick/A-4057-2015; ROZET, Jean-Michel/E-5737-2016; Benlian, Pascale/I-7964-2016; KAPLAN, Josseline/I-2622-2017	Borel, Patrick/0000-0001-9977-3238; ROZET, Jean-Michel/0000-0001-7951-7886; Nicolas, Leveziel/0000-0001-8533-9457; Benlian, Pascale/0000-0002-3423-8979; KAPLAN, Josseline/0000-0002-1849-8658				Acton S, 1996, SCIENCE, V271, P518, DOI 10.1126/science.271.5248.518; Acton S, 1999, ARTERIOSCL THROM VAS, V19, P1734, DOI 10.1161/01.ATV.19.7.1734; Allikmets R, 2000, AM J HUM GENET, V67, P487, DOI 10.1086/303018; Allikmets R, 1997, SCIENCE, V277, P1805, DOI 10.1126/science.277.5333.1805; Anand R, 2000, OPHTHALMOLOGY, V107, P2224; Borel P, 2007, J NUTR, V137, P2653, DOI 10.1093/jn/137.12.2653; Delcourt C, 1999, ARCH OPHTHALMOL-CHIC, V117, P1384, DOI 10.1001/archopht.117.10.1384; Duncan KG, 2002, BIOCHEM BIOPH RES CO, V292, P1017, DOI 10.1006/bbrc.2002.6756; During A, 2008, J LIPID RES, V49, P1715, DOI 10.1194/jlr.M700580-JLR200; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Fagerness JA, 2009, EUR J HUM GENET, V17, P100, DOI 10.1038/ejhg.2008.140; Fazio S, 2005, CIRCULATION, V111, P3349, DOI 10.1161/CIRCULATIONAHA.105.545996; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Gold B, 2006, NAT GENET, V38, P458, DOI 10.1038/ng1750; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Hsu Chin-Chun, 2003, MULTINATIONAL BUSINE, V11, P23, DOI DOI 10.1108/1525383X200300015; Huang ZH, 2002, J LIPID RES, V43, P375; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Ji Y, 1997, J BIOL CHEM, V272, P20982, DOI 10.1074/jbc.272.34.20982; Jian B, 1998, J BIOL CHEM, V273, P5599, DOI 10.1074/jbc.273.10.5599; Kassoff A, 2001, ARCH OPHTHALMOL-CHIC, V119, P1417, DOI 10.1001/archopht.119.10.1417; Khan JC, 2006, BRIT J OPHTHALMOL, V90, P75, DOI 10.1136/bjo.2005.073643; Klaver CCW, 1998, AM J HUM GENET, V63, P200, DOI 10.1086/301901; Klein ML, 1998, ARCH OPHTHALMOL-CHIC, V116, P1082, DOI 10.1001/archopht.116.8.1082; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2007, AM J OPHTHALMOL, V143, P473, DOI 10.1016/j.ajo.2006.11.058; Leveziel N, 2007, MOL VIS, V13, P2153; Maller J, 2006, NAT GENET, V38, P1055, DOI 10.1038/ng1873; Morabia A, 2004, ATHEROSCLEROSIS, V175, P159, DOI 10.1016/j.atherosclerosis.2004.03.014; Reboul E, 2005, BIOCHEM J, V387, P455, DOI 10.1042/BJ20040554; Reboul E, 2006, J BIOL CHEM, V281, P4739, DOI 10.1074/jbc.M509042200; Rigotti A, 2003, ENDOCR REV, V24, P357, DOI 10.1210/er.2001-0037; Ritsch A, 2007, METABOLISM, V56, P1135, DOI 10.1016/j.metabol.2007.04.009; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Roberts CGP, 2007, HUM HERED, V64, P107, DOI 10.1159/000101962; Rodriguez-Esparragon F, 2005, ARTERIOSCL THROM VAS, V25, P854, DOI 10.1161/01.ATV.0000157581.88838.03; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P1225, DOI 10.1001/archopht.125.9.1225; SanGiovanni JP, 2007, ARCH OPHTHALMOL-CHIC, V125, P671, DOI 10.1001/archopht.125.5.671; Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P55, DOI 10.1001/archopht.125.1.55; Schick JH, 2003, AM J HUM GENET, V72, P1412, DOI 10.1086/375500; Seddon J, 2007, PRINCIPLES PRACTICE, P413; Seddon JM, 2005, ARCH OPHTHALMOL-CHIC, V123, P321, DOI 10.1001/archopht.123.3.321; Seddon JM, 2003, ARCH OPHTHALMOL-CHIC, V121, P1728, DOI 10.1001/archopht.121.12.1728; Seddon JM, 2003, AM J HUM GENET, V73, P780, DOI 10.1086/378505; Seddon JM, 1996, JAMA-J AM MED ASSOC, V276, P1141, DOI 10.1001/jama.276.14.1141; Seddon JM, 1997, AM J OPHTHALMOL, V123, P199, DOI 10.1016/S0002-9394(14)71036-0; SEDDON JM, 1994, JAMA-J AM MED ASSOC, V272, P1413, DOI 10.1001/jama.272.18.1413; Seddon JM, 2001, ARCH OPHTHALMOL-CHIC, V119, P1191, DOI 10.1001/archopht.119.8.1191; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Seddon JM, 2006, ARCH OPHTHALMOL-CHIC, V124, P995, DOI 10.1001/archopht.124.7.995; Shuler RK, 2007, ARCH OPHTHALMOL-CHIC, V125, P63, DOI 10.1001/archopht.125.1.63; Smith W, 2001, OPHTHALMOLOGY, V108, P697, DOI 10.1016/S0161-6420(00)00580-7; Snow K K, 1999, Ophthalmic Epidemiol, V6, P125, DOI 10.1076/opep.6.2.125.1558; Souied EH, 1998, AM J OPHTHALMOL, V125, P353, DOI 10.1016/S0002-9394(99)80146-9; Souied EH, 2005, MOL VIS, V11, P1135; Swaroop A, 2007, HUM MOL GENET, V16, pR174, DOI 10.1093/hmg/ddm212; Tan JSL, 2008, BRIT J OPHTHALMOL, V92, P509, DOI 10.1136/bjo.2007.131706; Tanaka T, 2007, J NUTR, V137, P578, DOI 10.1093/jn/137.3.578; Tomany SC, 2004, OPHTHALMOLOGY, V111, P1280, DOI 10.1016/j.ophtha.2003.11.010; van Leeuwen R, 2005, JAMA-J AM MED ASSOC, V294, P3101, DOI 10.1001/jama.294.24.3101; VINGERLING JR, 1995, OPHTHALMOLOGY, V102, P205; Zareparsi S, 2005, AM J HUM GENET, V77, P149, DOI 10.1086/431426	64	51	55	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7341	10.1371/journal.pone.0007341	http://dx.doi.org/10.1371/journal.pone.0007341			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19806217	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593600014
J	Lacomble, S; Portman, N; Gull, K				Lacomble, Sylvain; Portman, Neil; Gull, Keith			A Protein-Protein Interaction Map of the Trypanosoma brucei Paraflagellar Rod	PLOS ONE			English	Article							INDUCIBLE EXPRESSION SYSTEM; RNA INTERFERENCE; AFRICAN TRYPANOSOME; INTERACTION NETWORK; GENE-FUNCTION; CHLAMYDOMONAS; PREDICTION; FLAGELLUM; TRANSPORT; MOTILITY	We have conducted a protein interaction study of components within a specific sub-compartment of a eukaryotic flagellum. The trypanosome flagellum contains a para-crystalline extra-axonemal structure termed the paraflagellar rod (PFR) with around forty identified components. We have used a Gateway cloning approach coupled with yeast two-hybrid, RNAi and 2D DiGE to define a protein-protein interaction network taking place in this structure. We define two clusters of interactions; the first being characterised by two proteins with a shared domain which is not sufficient for maintaining the interaction. The other cohort is populated by eight proteins, a number of which possess a PFR domain and sub-populations of this network exhibit dependency relationships. Finally, we provide clues as to the structural organisation of the PFR at the molecular level. This multi-strand approach shows that protein interactome data can be generated for insoluble protein complexes.			Lacomble, S (corresponding author), Univ Oxford, Sir William Dunn Sch Pathol, S Parks Rd, Oxford OX1 3RE, England.	keith.gull@path.ox.ac.uk		Portman, Neil/0000-0003-0248-0258	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Ahmed NT, 2008, J CELL BIOL, V183, P313, DOI 10.1083/jcb.200802025; Bastin P, 1999, J CELL SCI, V112, P3769; Bastin P, 1996, MOL BIOCHEM PARASIT, V77, P235, DOI 10.1016/0166-6851(96)02598-4; Bastin P, 1996, PARASITOL TODAY, V12, P302, DOI 10.1016/0169-4758(96)10031-4; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Bastin P, 2000, J CELL SCI, V113, P3321; Beattie P, 1997, PARASITOLOGY, V115, P47, DOI 10.1017/S0031182097001042; Berriman M, 2005, SCIENCE, V309, P416, DOI 10.1126/science.1112642; Blom N, 1999, J MOL BIOL, V294, P1351, DOI 10.1006/jmbi.1999.3310; Bologna G, 2004, PROTEOMICS, V4, P1626, DOI 10.1002/pmic.200300783; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; BRUN R, 1977, Acta Tropica, V34, P21; Gerdes JM, 2009, CELL, V137, P32, DOI 10.1016/j.cell.2009.03.023; Griffiths S, 2007, EUKARYOT CELL, V6, P1248, DOI 10.1128/EC.00110-07; Hamby SE, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-500; Kall L, 2004, J MOL BIOL, V338, P1027, DOI 10.1016/j.jmb.2004.03.016; Kilburn CL, 2007, J CELL BIOL, V178, P905, DOI 10.1083/jcb.200703109; LaCount DJ, 2005, NATURE, V438, P103, DOI 10.1038/nature04104; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lucker BF, 2005, J BIOL CHEM, V280, P27688, DOI 10.1074/jbc.M505062200; Maga JA, 1999, TRENDS CELL BIOL, V9, P409, DOI 10.1016/S0962-8924(99)01635-9; Monnerat Severine, 2009, BMC Res Notes, V2, P46, DOI 10.1186/1756-0500-2-46; Morris JC, 2002, EMBO J, V21, P4429, DOI 10.1093/emboj/cdf474; Motyka SA, 2004, CURR OPIN MICROBIOL, V7, P362, DOI 10.1016/j.mib.2004.06.004; Oberholzer M, 2007, TRENDS PARASITOL, V23, P71, DOI 10.1016/j.pt.2006.12.002; Oberholzer M, 2007, FASEB J, V21, P720, DOI 10.1096/fj.06-6818com; Ogbadoyi EO, 2003, MOL BIOL CELL, V14, P1769, DOI 10.1091/mbc.E02-08-0525; Portman N, 2009, J BIOL CHEM, V284, P5610, DOI 10.1074/jbc.M808859200; Pullen TJ, 2004, MOL BIOL CELL, V15, P3257, DOI 10.1091/mbc.E04-03-0217; Ridgley E, 2000, MOL BIOCHEM PARASIT, V109, P195, DOI 10.1016/S0166-6851(00)00246-2; ROBINSON DR, 1991, NATURE, V352, P731, DOI 10.1038/352731a0; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Rual JF, 2004, GENOME RES, V14, P2128, DOI 10.1101/gr.2973604; Santrich C, 1997, MOL BIOCHEM PARASIT, V90, P95, DOI 10.1016/S0166-6851(97)00149-7; Subramaniam C, 2006, EUKARYOT CELL, V5, P1539, DOI 10.1128/EC.00141-06; Tam LW, 2007, J CELL BIOL, V176, P819, DOI 10.1083/jcb.200610022; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; VICKERMAN K, 1973, J PROTOZOOL, V20, P394, DOI 10.1111/j.1550-7408.1973.tb00909.x; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; Wickstead B, 2002, MOL BIOCHEM PARASIT, V125, P211, DOI 10.1016/S0166-6851(02)00238-4; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X; Yang PF, 2006, J CELL SCI, V119, P1165, DOI 10.1242/jcs.02811; Zhang ZB, 2005, MOL CELL PROTEOMICS, V4, P914, DOI 10.1074/mcp.M400177-MCP200	43	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2009	4	11							e7685	10.1371/journal.pone.0007685	http://dx.doi.org/10.1371/journal.pone.0007685			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RY	19888464	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414500008
J	Hausberger, M; Gautier, E; Biquand, V; Lunel, C; Jego, P				Hausberger, Martine; Gautier, Emmanuel; Biquand, Veronique; Lunel, Christophe; Jego, Patrick			Could Work Be a Source of Behavioural Disorders? A Study in Horses	PLOS ONE			English	Article							STRESS; STEREOTYPIES; AFFECTIVITY; PREVALENCE; MANAGEMENT	Stress at work, as shown by a number of human studies, may lead to a variety of negative and durable effects, such as impaired psychological functioning ( anxiety, depression.). Horses share with humans this characteristic of working on a daily basis and are submitted then to work stressors related to physical constraints and/or more "psychological'' conflicts, such as potential controversial orders from the riders or the requirement to suppress emotions. On another hand, horses may perform abnormal repetitive behaviour ("stereotypies'') in response to adverse life conditions. In the present study, we investigated whether the type of work the horses are used for may have an impact on their tendency to show stereotypic behaviour ( and its type) outside work. Observations in their box of 76 horses all living in the same conditions, belonging to one breed and one sex, revealed that the prevalence and types of stereotypies performed strongly depended upon the type of work they were used for. The stereotypies observed involved mostly mouth movements and head tossing/nodding. Work constraints probably added to unfavourable living conditions, favouring the emergence of chronic abnormal behaviours. This is especially remarkable as the 23 hours spent in the box were influenced by the one hour work performed every day. To our knowledge, this is the first evidence of potential effects of work stressors on the emergence of abnormal behaviours in an animal species. It raises an important line of thought on the chronic impact of the work situation on the daily life of individuals.			Hausberger, M (corresponding author), Univ Rennes 1, CNRS, UMR Ethol Anim & Humaine 6552, Campus Beaulieu, Rennes, France.	martine.hausberger@univ-rennes1.fr						ALTMAN J, 1974, BEHAVIOUR, V19, P227; [Anonymous], 2004, ANIM WELFARE; Benhajali H, 2008, APPL ANIM BEHAV SCI, V112, P196, DOI 10.1016/j.applanim.2007.08.007; BOLGER N, 1989, J PERS SOC PSYCHOL, V57, P808, DOI 10.1037/0022-3514.57.5.808; Broom D. M., 1993, Equine Veterinary Education, V5, P151, DOI 10.1111/j.2042-3292.1993.tb01026.x; Christie JL, 2006, CAN VET J, V47, P136; Cook WR, 2002, J EQUINE VET SCI, V22, P7, DOI 10.1016/S0737-0806(02)70207-4; Cook WR, 2003, PFERDEHEILKUNDE, V19, P75, DOI 10.21836/PEM20030111; Cook WR, 1999, J EQUINE VET SCI, V19, P196, DOI 10.1016/S0737-0806(99)80067-7; Cooper J, 1998, EQUINE VET J S, V27, P5; Cooper JJ, 2000, APPL ANIM BEHAV SCI, V69, P67, DOI 10.1016/S0168-1591(00)00115-5; FRASER AF, 1992, ABNORMAL ANOMALOUS B; Goodwin D, 2002, EQUINE VET J, V34, P686, DOI 10.2746/042516402776250450; Hall C, 2008, J APPL ANIM WELF SCI, V11, P249, DOI 10.1080/10888700802101130; Hausberger M, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P33; Hausberger M, 2004, J COMP PSYCHOL, V118, P434, DOI 10.1037/0735-7036.118.4.434; Hausberger M, 2007, APPL ANIM BEHAV SCI, V107, P299, DOI 10.1016/j.applanim.2006.10.003; Hausberger M, 2008, APPL ANIM BEHAV SCI, V109, P1, DOI 10.1016/j.applanim.2007.04.015; Heleski CR, 2002, APPL ANIM BEHAV SCI, V78, P291, DOI 10.1016/S0168-1591(02)00108-9; HOUTMAN ILD, 1994, SCAND J WORK ENV HEA, V20, P139, DOI 10.5271/sjweh.1419; Hutri M, 2002, J CAREER DEV, V29, P19, DOI 10.1023/A:1016547718122; Iverson RD, 1998, J VOCAT BEHAV, V52, P1, DOI 10.1006/jvbe.1996.1556; MADIGAN JE, 1998, EQUINE VET J S, V27, P28; Mann S, 2004, BRIT J GUID COUNS, V32, P205, DOI 10.1080/0369880410001692247; Mason G, 2007, APPL ANIM BEHAV SCI, V102, P163, DOI 10.1016/j.applanim.2006.05.041; Mason G., 2007, STEREOTYPIC BEHAV CA; MASON GJ, 1991, ANIM BEHAV, V41, P1015, DOI 10.1016/S0003-3472(05)80640-2; McGreevy P, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P196; MCGREEVY PD, 1995, VET REC, V137, P36, DOI 10.1136/vr.137.2.36; Mills DS, 2005, DOMESTIC HORSE: THE ORIGINS, DEVELOPMENT AND MANAGEMENT OF ITS BEHAVIOUR, P212; Mills DS, 2002, IPPOLOGIA, V13, P33; Mills DS, 2002, APPL ANIM BEHAV SCI, V78, P115, DOI 10.1016/S0168-1591(02)00096-5; Newton SA, 2000, EQUINE VET J, V32, P208, DOI 10.2746/042516400776563617; Nicol CJ, 2002, VET REC, V151, P658, DOI 10.1136/vr.151.22.658; O'Brien A, 2008, ANXIETY STRESS COPIN, V21, P55, DOI 10.1080/10615800701529504; Odberg F O, 1999, Equine Vet J Suppl, P26; Odberg F.O., 1978, P 1 WORLD C ETH APPL, V1, P475; ODBERG FO, 1987, EQUINE VET J, V19, P268, DOI 10.1111/j.2042-3306.1987.tb01402.x; SANKEY C, 2008, ANIM COGN IN PRESS; Schaubroeck J, 2000, J ORGAN BEHAV, V21, P163, DOI 10.1002/(SICI)1099-1379(200003)21:2<163::AID-JOB37>3.0.CO;2-L; von Borstel UU, 2009, APPL ANIM BEHAV SCI, V116, P228, DOI 10.1016/j.applanim.2008.10.001; Waters AJ, 2002, EQUINE VET J, V34, P572, DOI 10.2746/042516402776180241	42	41	41	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7625	10.1371/journal.pone.0007625	http://dx.doi.org/10.1371/journal.pone.0007625			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	511UJ	19862328	Green Published, gold, Green Submitted			2022-12-27	WOS:000271194600014
J	Liu, JL; Li, M; Dang, XR; Wang, ZH; Rao, ZR; Wu, SX; Li, YQ; Wang, W				Liu, Jun-Li; Li, Min; Dang, Xiao-Rong; Wang, Zheng-Hong; Rao, Zhi-Ren; Wu, Sheng-Xi; Li, Yun-Qing; Wang, Wen			A NMDA Receptor Antagonist, MK-801 Impairs Consolidating Extinction of Auditory Conditioned Fear Responses in a Pavlovian Model	PLOS ONE			English	Article							IMMEDIATE EXTINCTION; PROTEIN-SYNTHESIS; ACQUISITION; RECONSOLIDATION; EXPRESSION; STIMULUS; RAT; AMYGDALA; MEMORY; INHIBITION	Background: In auditory fear conditioning, repeated presentation of the tone in the absence of shock leads to extinction of the acquired fear responses. The glutamate N-methyl-D-aspartate receptor (NMDAR) is thought to be involved in the extinction of the conditioned fear responses, but its detailed role in initiating and consolidating or maintaining the fear extinction memory is unclear. Here we investigated this issue by using a NMDAR antagonist, MK-801. Methods/Main Findings: The effects of immediate (beginning at 10 min after the conditioning) and delayed (beginning at 24 h after conditioning) extinctions were first compared with the finding that delayed extinction caused a better and long-lasting (still significant on the 20(th) day after extinction) depression on the conditioned fear responses. In a second experiment, MK-801 was intraperitoneally (i.p.) injected at 40 min before, 4 h or 12 h after the delayed extinction, corresponding to critical time points for initiating, consolidating or maintaining the fear extinction memory. i.p. injection of MK-801 at either 40 min before or 4 h after delayed extinction resulted in an impairment of initiating and consolidating fear extinction memory, which caused a long lasting increased freezing score that was still significant on the 7th day after extinction, compared with extinction group. However, MK-801 administered at 12 h after the delayed extinction, when robust consolidation has been occurred and stabilized, did not affect the established extinction memory. Furthermore, the changed freezing behaviors was not due to an alteration in general anxiety levels, since MK-801 treatment had no effect on the percentage of open-arm time or open-arm entries in an Elevated Plus Maze (EPM) task. Conclusions/Significance: Our data suggested that the activation of NMDARs plays important role in initiation and consolidation but not maintenance of fear extinction memory. Together with the fact that NMDA receptor is very important for memory, our data added experimental evidence to the concept that the extinction of conditioned fear responses is a procedure of initiating and consolidating new memory other than simply "erasing'' the fear memory.			Liu, JL (corresponding author), Fourth Mil Med Univ, Dept Teaching & Training, Xian 710032, Peoples R China.	xllm113@hotmail.com; wangwen@fmmu.edu.cn						Alberini CM, 2006, CELL MOL LIFE SCI, V63, P999, DOI 10.1007/s00018-006-6025-7; Amaral Olavo B, 2008, Recent Pat CNS Drug Discov, V3, P166, DOI 10.2174/157488908786242470; Baker JD, 1996, BEHAV NEUROSCI, V110, P618, DOI 10.1037/0735-7044.110.3.618; Cammarota M, 2007, REV BRAS PSIQUIATR, V29, P80, DOI 10.1590/S1516-44462007000100019; CAMPEAU S, 1992, BEHAV NEUROSCI, V106, P569, DOI 10.1037/0735-7044.106.3.569; CRUZ APM, 1993, BRAZ J MED BIOL RES, V26, P615; Davis Michael, 2006, NeuroRx, V3, P82, DOI 10.1016/j.nurx.2005.12.008; Eisenberg M, 2004, EUR J NEUROSCI, V20, P3397, DOI 10.1111/j.1460-9568.2004.03818.x; Filipkowski RK, 2001, NEUROSCIENCE, V106, P679, DOI 10.1016/S0306-4522(01)00310-4; Garakani A, 2006, MT SINAI J MED, V73, P941; Goosens KA, 2004, EUR J NEUROSCI, V20, P537, DOI 10.1111/j.1460-9568.2004.03513.x; Johnson DM, 2000, BRAIN RES, V857, P66, DOI 10.1016/S0006-8993(99)02388-4; Langton JM, 2007, LEARN MEMORY, V14, P665, DOI 10.1101/lm.692407; Larkin AE, 2008, BRAIN RES, V1199, P126, DOI 10.1016/j.brainres.2008.01.019; Lee JLC, 2004, SCIENCE, V304, P839, DOI 10.1126/science.1095760; Lee JLC, 2006, J NEUROSCI, V26, P10051, DOI 10.1523/JNEUROSCI.2466-06.2006; Myers KM, 2006, LEARN MEMORY, V13, P216, DOI 10.1101/lm.119806; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Ng D, 2009, PLOS BIOL, V7, P278, DOI 10.1371/journal.pbio.1000041; Pedreira ME, 2003, NEURON, V38, P863, DOI 10.1016/S0896-6273(03)00352-0; Rodrigues SM, 2001, J NEUROSCI, V21, P6889, DOI 10.1523/JNEUROSCI.21-17-06889.2001; Sacchetti B, 1999, J NEUROSCI, V19, P9570; Schiller D, 2008, LEARN MEMORY, V15, P394, DOI 10.1101/lm.909208; Sullivan GM, 2004, NEUROSCIENCE, V128, P7, DOI 10.1016/j.neuroscience.2004.06.015; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; van der Meulen JAJ, 2003, NEUROREPORT, V14, P2225, DOI 10.1097/00001756-200312020-00018; Wang W, 2008, NEUROSCI LETT, V441, P237, DOI 10.1016/j.neulet.2008.06.031; Woods AM, 2008, LEARN MEMORY, V15, P909, DOI 10.1101/lm.1078508; Zellner MR, 2009, BEHAV BRAIN RES, V197, P442, DOI 10.1016/j.bbr.2008.10.013; Zhang WN, 2004, BEHAV BRAIN RES, V154, P199, DOI 10.1016/j.bbr.2004.02.016	30	36	37	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7548	10.1371/journal.pone.0007548	http://dx.doi.org/10.1371/journal.pone.0007548			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	511ER	19855841	Green Published, Green Submitted, gold			2022-12-27	WOS:000271147200003
J	Alvarez-Rueda, N; Biron, M; Le Pape, P				Alvarez-Rueda, Nidia; Biron, Marlene; Le Pape, Patrice			Infectivity of Leishmania mexicana Is Associated with Differential Expression of Protein Kinase C-Like Triggered during a Cell-Cell Contact	PLOS ONE			English	Article							PROTOZOAN PARASITE LEISHMANIA; EXTRACELLULAR PHOSPHORYLATION; TRYPANOSOMA-BRUCEI; FLAGELLAR-LENGTH; DRUG TARGETS; DONOVANI; SURFACE; IDENTIFICATION; RESISTANCE; VIRULENCE	Mammalian host cell invasion by Leishmania is a complex process in which various parasite and host cell components interact, triggering the activation of signaling cascades in both cells. Little is known regarding PKC biological functions in Leishmania sp. during parasite-macrophage interaction. PKC-like enzyme was first identified in homogenates and membrane fraction of L. mexicana stationary promastigotes by immunoblot. PKC-like enzyme activity was then detected in cell homogenates but also on intact promastigotes showing for the first time the presence of an ecto-PKC dependent on Ca(2+)/phosphatidylserine for activation. This ecto-PKC was activated with phorbol myristate acetate (PMA) and inhibited by RO-32-0432, a selective PKC alpha beta(I)epsilon bisindolylmaleimide inhibitor. Interestingly, the Leishmania PKC-activity was higher in the infective stationary than in non-infective logarithmic stage. Then, promastigotes at different stages of time proliferation curve were used in order to identify the role of PKC-like during macrophage invasion. After attachment to macrophages, PKC-like is over-expressed in promastigotes at the 6(th) culture day but also at the 4(th) day of culture corresponding to the maximal infection capacity. An antibody microarray for MAPK and PKC corroborate the Leishmania PKC-like over-expression during contact with macrophages. Pretreatment with RO-32-0432 inhibitor reduced the number of infected macrophages and the parasite burden. These data suggest for the first time a direct link between PKC expression level and infectivity, and provide evidence that PKC-like plays a critical role in attachment and in the internalization steps involved in the invasion process.			Alvarez-Rueda, N (corresponding author), Univ Nantes, Nantes Atlantique Univ, EA IICiMed 1155, Dept Parasitol & Mycol Med,Fac Pharm, Nantes, France.	patrice.le-pape@univ-nantes.fr	Le Pape, Patrice/AAY-3632-2021; Le Pape, Patrice/W-1472-2019	Le Pape, Patrice/0000-0001-5059-6402; ALVAREZ RUEDA, Nidia/0000-0002-5629-1930				Alexander J, 1999, J CELL SCI, V112, P2993; Alvarez N, 2002, J ENZYM INHIB MED CH, V17, P443, DOI 10.1080/1475636021000005749; Babinska A, 2000, AM J PHYSIOL-HEART C, V278, pH2008, DOI 10.1152/ajpheart.2000.278.6.H2008; BANERJEE C, 1990, J GEN MICROBIOL, V136, P1051, DOI 10.1099/00221287-136-6-1051; BANERJEE C, 1992, MOL BIOCHEM PARASIT, V52, P195, DOI 10.1016/0166-6851(92)90052-L; Barreto-De-Souza V, 2006, J INFECT DIS, V194, P846, DOI 10.1086/506618; Besteiro S, 2006, J BIOL CHEM, V281, P11384, DOI 10.1074/jbc.M512307200; Beverley SM, 1995, ANN TROP MED PARASIT, V89, P11, DOI 10.1080/00034983.1995.11813009; BIRCHALL AM, 1994, J PHARMACOL EXP THER, V268, P922; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; BRITTINGHAM A, 1995, J IMMUNOL, V155, P3102; Croft SL, 2003, TRENDS PARASITOL, V19, P502, DOI 10.1016/j.pt.2003.09.008; Croft SL, 2005, TRENDS PARASITOL, V21, P508, DOI 10.1016/j.pt.2005.08.026; de Almeida-Amaral EE, 2008, EXP PARASITOL, V118, P165, DOI 10.1016/j.exppara.2007.07.001; Desjeux P, 2004, COMP IMMUNOL MICROB, V27, P305, DOI 10.1016/j.cimid.2004.03.004; DOYLE PS, 1991, EXP PARASITOL, V73, P326, DOI 10.1016/0014-4894(91)90104-5; EPAND RM, 1990, TRENDS PHARMACOL SCI, V11, P317, DOI 10.1016/0165-6147(90)90234-Y; Erdmann M, 2006, MOL BIOL CELL, V17, P2035, DOI 10.1091/mbc.E05-10-0976; Gallagher SR., 2007, CURR PROTOC CELL BIO; Gomez ML, 1999, INT J PARASITOL, V29, P981, DOI 10.1016/S0020-7519(99)00041-7; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; HERMOSO T, 1994, ACTA TROP, V56, P1, DOI 10.1016/0001-706X(94)90034-5; Hermoso Tomas, 1993, Biological Research, V26, P267; Herrling PL, 2005, PROG DRUG RES, V62, P1; Hsieh YH, 2007, CANCER RES, V67, P4320, DOI 10.1158/0008-5472.CAN-06-2486; Ivens AC, 2005, SCIENCE, V309, P436, DOI 10.1126/science.1112680; Jaken S, 1996, CURR OPIN CELL BIOL, V8, P168, DOI 10.1016/S0955-0674(96)80062-7; KEITH K, 1990, MOL BIOCHEM PARASIT, V43, P107, DOI 10.1016/0166-6851(90)90135-9; Knockaert M, 2000, CHEM BIOL, V7, P411, DOI 10.1016/S1074-5521(00)00124-1; Korzeniewski Krzysztof, 2004, Int Marit Health, V55, P155; Kuhn D, 2005, MOL MICROBIOL, V56, P1169, DOI 10.1111/j.1365-2958.2005.04614.x; Kultz D, 1998, J MOL EVOL, V46, P571, DOI 10.1007/PL00006338; Lam JSY, 2008, NEUROSCI LETT, V434, P150, DOI 10.1016/j.neulet.2008.01.064; Le Pape P, 2008, J ENZYM INHIB MED CH, V23, P708, DOI [10.1080/14756360802208137, 10.1080/14756360802208137 ]; LESTER DS, 1990, BIOCHIM BIOPHYS ACTA, V1052, P293, DOI 10.1016/0167-4889(90)90224-2; Makioka A, 2000, EXP PARASITOL, V95, P288, DOI 10.1006/expr.2000.4538; McGwire BS, 2002, J BIOL CHEM, V277, P8802, DOI 10.1074/jbc.M109072200; Merritt JE, 1999, CANCER CHEMOTH PHARM, V43, P371, DOI 10.1007/s002800050909; Murray HW, 2005, LANCET, V366, P1561, DOI 10.1016/S0140-6736(05)67629-5; Myler PJ, 2008, ADV EXP MED BIOL, V625, P133, DOI 10.1007/978-0-387-77570-8_11; Naula C, 2005, BBA-PROTEINS PROTEOM, V1754, P151, DOI 10.1016/j.bbapap.2005.08.018; NEWTON AC, 1995, J BIOL CHEM, V270, P28495, DOI 10.1074/jbc.270.48.28495; OUELLETTE M, 1991, RES MICROBIOL, V142, P737, DOI 10.1016/0923-2508(91)90089-S; Parsons M, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-127; Reithinger R, 2003, EMERG INFECT DIS, V9, P727; Robert-Gangneux F, 2000, PARASITE, V7, P95, DOI 10.1051/parasite/2000072095; Roffey J, 2009, CURR OPIN CELL BIOL, V21, P268, DOI 10.1016/j.ceb.2009.01.019; Sacerdoti-Sierra N, 1997, J BIOL CHEM, V272, P30760, DOI 10.1074/jbc.272.49.30760; Saeij JPJ, 2006, SCIENCE, V314, P1780, DOI 10.1126/science.1133690; Seaman J, 1996, INT J EPIDEMIOL, V25, P862, DOI 10.1093/ije/25.4.862; Vannier-Santos MA, 2002, CURR PHARM DESIGN, V8, P297, DOI 10.2174/1381612023396230; VANNIERSANTOS MA, 1995, EUR J CELL BIOL, V67, P112; Vieira LL, 1997, MOL BIOCHEM PARASIT, V90, P449, DOI 10.1016/S0166-6851(97)00180-1; Wiese M, 2003, EUKARYOT CELL, V2, P769, DOI 10.1128/EC.2.4.769-777.2003; Wiese M, 2007, INT J PARASITOL, V37, P1053, DOI 10.1016/j.ijpara.2007.04.008; Yao CQ, 2002, MOL BIOCHEM PARASIT, V121, P119, DOI 10.1016/S0166-6851(02)00030-0	56	19	19	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7581	10.1371/journal.pone.0007581	http://dx.doi.org/10.1371/journal.pone.0007581			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851504	gold, Green Published, Green Submitted			2022-12-27	WOS:000271022300013
J	Pardo, J; Galvez, EM; Koskinen, A; Simon, MM; Lobigs, M; Regner, M; Mullbacher, A				Pardo, Julian; Ma Galvez, Eva; Koskinen, Aulikki; Simon, Markus M.; Lobigs, Mario; Regner, Matthias; Muellbacher, Arno			Caspase-Dependent Inhibition of Mousepox Replication by gzmB	PLOS ONE			English	Article							GRANZYME-B; ECTROMELIA VIRUS; CELL-DEATH; MEDIATED APOPTOSIS; VIRAL PROTEIN; IN-VITRO; T-CELLS; PERFORIN; VIVO; FAS	Background: Ectromelia virus is a natural mouse pathogen, causing mousepox. The cytotoxic T (Tc) cell granule serine-protease, granzyme B, is important for its control, but the underlying mechanism is unknown. Using ex vivo virus immune Tc cells, we have previously shown that granzyme B is able to activate several independent pro-apoptotic pathways, including those mediated by Bid/Bak/Bax and caspases-3/-7, in target cells pulsed with Tc cell determinants. Methods and Findings: Here we analysed the physiological relevance of those pro-apoptotic pathways in ectromelia infection, by incubating ectromelia-immune ex vivo Tc cells from granzyme A deficient (GzmB(+) Tc cells) or granzyme A and granzyme B deficient (GzmAxB(-/-) Tc cell) mice with ectromelia-infected target cells. We found that gzmB-induced apoptosis was totally blocked in ectromelia infected or peptide pulsed cells lacking caspases-3/-7. However ectromelia inhibited only partially apoptosis in cells deficient for Bid/Bak/Bax and not at all when both pathways were operative suggesting that the virus is able to interfere with apoptosis induced by gzmB in case not all pathways are activated. Importantly, inhibition of viral replication in vitro, as seen with wild type cells, was not affected by the lack of Bid/Bak/Bax but was significantly reduced in caspase-3/-7- deficient cells. Both caspase dependent processes were strictly dependent on gzmB, since Tc cells, lacking both gzms, neither induced apoptosis nor reduced viral titers. Significance: Out findings present the first evidence on the biological importance of the independent gzmB-inducible proapoptotic pathways in a physiological relevant virus infection model.	[Pardo, Julian] Fdn Aragon I D ARAID, Gobierno De Aragon, Spain; [Ma Galvez, Eva] CSIC, Inst Carboquim, Zaragoza, Spain; [Koskinen, Aulikki; Regner, Matthias; Muellbacher, Arno] Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Viral Immunol Grp, Canberra, ACT, Australia; [Lobigs, Mario] Australian Natl Univ, John Curtin Sch Med Res, Div Immunol & Genet, Mol Virol Grp, Canberra, ACT, Australia; [Simon, Markus M.] Max Planck Inst Immunobiol, Metschnikoff Lab, Freiburg, Germany	Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Carboquimica (ICB); Australian National University; John Curtin School of Medical Research; Australian National University; John Curtin School of Medical Research; Max Planck Society	Pardo, J (corresponding author), Univ Zaragoza, Fac Ciencias, Dept Bioquim & Biol Mol & Celular, E-50009 Zaragoza, Spain.	pardojim@unizar.es; Matthias.Regner@anu.edu.au; arno.mullbacher@anu.edu.au	Pardo, Julián/K-6764-2014; Galvez, Eva M./K-6751-2014; lobigs, mario/ABC-5711-2020	Pardo, Julián/0000-0003-0154-0730; Galvez, Eva M./0000-0001-6928-5516; 				Adams JM, 2007, ONCOGENE, V26, P1324, DOI 10.1038/sj.onc.1210220; Aoyagi M, 2007, PROTEIN SCI, V16, P118, DOI 10.1110/ps.062454707; Ashton-Rickardt PG, 2005, CRIT REV IMMUNOL, V25, P161, DOI 10.1615/CritRevImmunol.v25.i3.10; Benedict CA, 2002, NAT IMMUNOL, V3, P1013, DOI 10.1038/ni1102-1013; BLANDEN RV, 1974, TRANSPLANT REV, V19, P56; Bossi G, 2005, SEMIN IMMUNOL, V17, P87, DOI 10.1016/j.smim.2004.09.007; Boya P, 2003, BIOCHEM BIOPH RES CO, V304, P575, DOI 10.1016/S0006-291X(03)00630-2; Brick DJ, 2000, J GEN VIROL, V81, P1087, DOI 10.1099/0022-1317-81-4-1087; Callus BA, 2007, CELL DEATH DIFFER, V14, P73, DOI 10.1038/sj.cdd.4402034; Chen NH, 2003, VIROLOGY, V317, P165, DOI 10.1016/S0042-6822(03)00520-8; Chipuk JE, 2006, CELL DEATH DIFFER, V13, P994, DOI 10.1038/sj.cdd.4401908; Dobbelstein M, 1996, J VIROL, V70, P6479, DOI 10.1128/JVI.70.9.6479-6485.1996; FENNER F, 1949, J IMMUNOL, V63, P341; Fischer SF, 2006, CELL DEATH DIFFER, V13, P109, DOI 10.1038/sj.cdd.4401718; Gardai SJ, 2005, CELL, V123, P321, DOI 10.1016/j.cell.2005.08.032; KAGI D, 1994, NATURE, V369, P31, DOI 10.1038/369031a0; KAGI D, 1994, SCIENCE, V265, P528, DOI 10.1126/science.7518614; Krzyowska M, 2002, MICROBES INFECT, V4, P599, DOI 10.1016/S1286-4579(02)01578-2; Lakhani SA, 2006, SCIENCE, V311, P847, DOI 10.1126/science.1115035; Li P, 1997, CELL, V91, P479, DOI 10.1016/S0092-8674(00)80434-1; Lieberman J, 2003, CURR OPIN IMMUNOL, V15, P553, DOI 10.1016/S0952-7915(03)00108-0; Macen JL, 1996, P NATL ACAD SCI USA, V93, P9108, DOI 10.1073/pnas.93.17.9108; Martin P, 2005, BLOOD, V106, P2871, DOI 10.1182/blood-2005-04-1522; Metkar SS, 2008, IMMUNITY, V29, P720, DOI 10.1016/j.immuni.2008.08.014; Mullbacher A, 1999, P NATL ACAD SCI USA, V96, P13950, DOI 10.1073/pnas.96.24.13950; Mullbacher A, 1996, P NATL ACAD SCI USA, V93, P5783, DOI 10.1073/pnas.93.12.5783; Mullbacher A, 1999, J VIROL, V73, P1665; Mullbacher A, 2004, PROG MOL SUBCELL BIO, V36, P39; Mullbacher A, 1999, J IMMUNOL, V162, P7315; Obeid M, 2007, NAT MED, V13, P54, DOI 10.1038/nm1523; Pardo J, 2008, CELL DEATH DIFFER, V15, P567, DOI 10.1038/sj.cdd.4402289; Pardo J, 2007, CELL DEATH DIFFER, V14, P1768, DOI 10.1038/sj.cdd.4402183; Pardo J, 2004, J CELL BIOL, V167, P457, DOI 10.1083/jcb.200406115; Pardo J, 2002, EUR J IMMUNOL, V32, P1980, DOI 10.1002/1521-4141(200207)32:7<1980::AID-IMMU1980>3.0.CO;2-Z; Pardo J, 2002, EUR J IMMUNOL, V32, P2881, DOI 10.1002/1521-4141(2002010)32:10<2881::AID-IMMU2881>3.0.CO;2-K; PEITSCH MC, 1994, METHOD ENZYMOL, V244, P80; Pereira RA, 2000, J VIROL, V74, P1029, DOI 10.1128/JVI.74.2.1029-1032.2000; Pham CTN, 1996, P NATL ACAD SCI USA, V93, P13090, DOI 10.1073/pnas.93.23.13090; PICKUP DJ, 1986, P NATL ACAD SCI USA, V83, P7698, DOI 10.1073/pnas.83.20.7698; POSTIGO A, 2006, CELL DEATH DIFFER; Regner M, 2009, J IMMUNOL, V183, P37, DOI 10.4049/jimmunol.0900466; Revell PA, 2005, J IMMUNOL, V174, P2124, DOI 10.4049/jimmunol.174.4.2124; Riera L, 2000, EUR J IMMUNOL, V30, P1350, DOI 10.1002/(SICI)1521-4141(200005)30:5<1350::AID-IMMU1350>3.0.CO;2-J; ROUVIER E, 1993, J EXP MED, V177, P195, DOI 10.1084/jem.177.1.195; Russell JH, 2002, ANNU REV IMMUNOL, V20, P323, DOI 10.1146/annurev.immunol.20.100201.131730; SIMON MM, 1994, METHOD ENZYMOL, V244, P68; Simon MM, 1997, J EXP MED, V186, P1781, DOI 10.1084/jem.186.10.1781; Smyth MJ, 2000, J EXP MED, V192, P755, DOI 10.1084/jem.192.5.755; TEWARI M, 1995, J BIOL CHEM, V270, P22705, DOI 10.1074/jbc.270.39.22705; Trapani JA, 2003, CURR OPIN IMMUNOL, V15, P533, DOI 10.1016/S0952-7915(03)00107-9; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Turk B, 2007, FEBS LETT, V581, P2761, DOI 10.1016/j.febslet.2007.05.038; Turner SJ, 2000, J GEN VIROL, V81, P2425, DOI 10.1099/0022-1317-81-10-2425; vandenBroek HF, 1995, EUR J IMMUNOL, V25, P3514, DOI 10.1002/eji.1830251246; vandenBroek MF, 1996, J EXP MED, V184, P1781, DOI 10.1084/jem.184.5.1781; Voskoboinik I, 2006, NAT REV IMMUNOL, V6, P940, DOI 10.1038/nri1983; Wallich R, 2001, VIRAL IMMUNOL, V14, P71, DOI 10.1089/08828240151061428; Wang Y, 2004, IMMUNOL CELL BIOL, V82, P170, DOI 10.1046/j.0818-9641.2004.01227.x; Wasilenko ST, 2005, J VIROL, V79, P14031, DOI 10.1128/JVI.79.22.14031-14043.2005; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0	61	13	13	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7512	10.1371/journal.pone.0007512	http://dx.doi.org/10.1371/journal.pone.0007512			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838298	gold, Green Published, Green Submitted			2022-12-27	WOS:000270880900013
J	Sacristan, S; Vigouroux, M; Pedersen, C; Skamnioti, P; Thordal-Christensen, H; Micali, C; Brown, JKM; Ridout, CJ				Sacristan, Soledad; Vigouroux, Marielle; Pedersen, Carsten; Skamnioti, Pari; Thordal-Christensen, Hans; Micali, Cristina; Brown, James K. M.; Ridout, Christopher J.			Coevolution between a Family of Parasite Virulence Effectors and a Class of LINE-1 Retrotransposons	PLOS ONE			English	Article							POWDERY MILDEW RESISTANCE; TRANSPOSABLE ELEMENTS; PHYLOGENETIC ANALYSIS; ADAPTIVE EVOLUTION; BLUMERIA-GRAMINIS; RXLR EFFECTORS; GENE FAMILY; DISEASE; PROTEIN; FUNGI	Parasites are able to evolve rapidly and overcome host defense mechanisms, but the molecular basis of this adaptation is poorly understood. Powdery mildew fungi (Erysiphales, Ascomycota) are obligate biotrophic parasites infecting nearly 10,000 plant genera. They obtain their nutrients from host plants through specialized feeding structures known as haustoria. We previously identified the AVRk1 powdery mildew-specific gene family encoding effectors that contribute to the successful establishment of haustoria. Here, we report the extensive proliferation of the AVRk1 gene family throughout the genome of B. graminis, with sequences diverging in formae speciales adapted to infect different hosts. Also, importantly, we have discovered that the effectors have coevolved with a particular family of LINE-1 retrotransposons, named TE1a. The coevolution of these two entities indicates a mutual benefit to the association, which could ultimately contribute to parasite adaptation and success. We propose that the association would benefit 1) the powdery mildew fungus, by providing a mechanism for amplifying and diversifying effectors and 2) the associated retrotransposons, by providing a basis for their maintenance through selection in the fungal genome.			Sacristan, S (corresponding author), John Innes Ctr, Dept Dis & Stress Biol, Norwich, Norfolk, England.	soledad.sacristan@upm.es	Pedersen, Carsten/F-6797-2014; Thordal-Christensen, Hans/F-6281-2014; Pedersen, Carsten/L-7266-2013; SACRISTAN, SOLEDAD/H-1062-2015	Pedersen, Carsten/0000-0002-9520-2232; Thordal-Christensen, Hans/0000-0001-8813-0157; Pedersen, Carsten/0000-0002-9520-2232; SACRISTAN, SOLEDAD/0000-0002-5753-2644; Ridout, Christopher/0000-0001-9287-938X	BBSRC [BB/E000983/1] Funding Source: UKRI; Biotechnology and Biological Sciences Research Council [BB/E000983/1, BB/C506299/1, BBS/E/J/0000A252] Funding Source: researchfish	BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Alfano JR, 2004, ANNU REV PHYTOPATHOL, V42, P385, DOI 10.1146/annurev.phyto.42.040103.110731; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bairoch A, 2007, NUCLEIC ACIDS RES, V35, pD193, DOI 10.1093/nar/gkl929; Birch PRJ, 2008, CURR OPIN PLANT BIOL, V11, P373, DOI 10.1016/j.pbi.2008.04.005; Brown JKM, 2002, POWDERY MILDEWS: A COMPREHENSIVE TREATISE, P56; Brown JKM, 1995, PLANT PATHOL, V44, P1039, DOI 10.1111/j.1365-3059.1995.tb02663.x; Catanzariti AM, 2007, FEMS MICROBIOL LETT, V269, P181, DOI 10.1111/j.1574-6968.2007.00684.x; Charleston MA, 1998, MATH BIOSCI, V149, P191, DOI 10.1016/S0025-5564(97)10012-8; Charleston MA, 2002, SYST BIOL, V51, P528, DOI 10.1080/10635150290069940; Devos KM, 2002, GENOME RES, V12, P1075, DOI 10.1101/gr.132102; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; FLOR HH, 1971, ANNU REV PHYTOPATHOL, V9, P275, DOI 10.1146/annurev.py.09.090171.001423; Goodier JL, 2008, CELL, V135, P23, DOI 10.1016/j.cell.2008.09.022; Grell MN, 2003, GENE, V311, P181, DOI 10.1016/S0378-1119(03)00610-3; HAFNER MS, 1988, NATURE, V332, P258, DOI 10.1038/332258a0; HIURA U., 1955, Berichte des Ohara Instituts fur Landwirtschaftliche Biologie, Okayama Universitat, V10, P135; Hughes J, 2007, SYST BIOL, V56, P232, DOI 10.1080/10635150701311370; Inuma T, 2007, MOL PHYLOGENET EVOL, V44, P741, DOI 10.1016/j.ympev.2007.01.007; JENSEN J, 1995, HEREDITAS, V122, P197, DOI 10.1111/j.1601-5223.1995.00197.x; Jiang RHY, 2006, GENOME RES, V16, P827, DOI 10.1101/gr.5193806; Jones JDG, 2006, NATURE, V444, P323, DOI 10.1038/nature05286; JORGENSEN JH, 1994, CRIT REV PLANT SCI, V13, P97, DOI 10.1080/713608055; KEARNEY B, 1988, NATURE, V332, P541, DOI 10.1038/332541a0; Khang CH, 2008, MOL PLANT MICROBE IN, V21, P658, DOI 10.1094/MPMI-21-5-0658; Kidwell MG, 2000, TRENDS ECOL EVOL, V15, P95, DOI 10.1016/S0169-5347(99)01817-0; Kulikova T, 2007, NUCLEIC ACIDS RES, V35, pD16, DOI 10.1093/nar/gkl913; Kvitko BH, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000388; LENK A, 2009, ADV BOT RES IN PRESS; Ma WB, 2008, CURR OPIN PLANT BIOL, V11, P412, DOI 10.1016/j.pbi.2008.05.001; Marchal E, 1902, CR HEBD ACAD SCI, V135, P210; Munroe SH, 2004, J CELL BIOCHEM, V93, P664, DOI 10.1002/jcb.20252; OKU T, 1985, Annals of the Phytopathological Society of Japan, V51, P613, DOI 10.3186/jjphytopath.51.613; Page RDM, 1998, TRENDS ECOL EVOL, V13, P356, DOI 10.1016/S0169-5347(98)01438-4; Rice P, 2000, TRENDS GENET, V16, P276, DOI 10.1016/S0168-9525(00)02024-2; Ridout CJ, 2006, PLANT CELL, V18, P2402, DOI 10.1105/tpc.106.043307; Rokas A, 2006, PLOS BIOL, V4, P1899, DOI 10.1371/journal.pbio.0040352; Ronquist F, 1995, CLADISTICS, V11, P73, DOI 10.1111/j.1096-0031.1995.tb00005.x; Sacristan S, 2008, MOL PLANT PATHOL, V9, P369, DOI 10.1111/J.1364-3703.2007.00460.X; Schmidt HA, 2002, BIOINFORMATICS, V18, P502, DOI 10.1093/bioinformatics/18.3.502; Shen QH, 2003, PLANT CELL, V15, P732, DOI 10.1105/tpc.009258; Shen QH, 2007, SCIENCE, V315, P1098, DOI 10.1126/science.1136372; Skamnioti P, 2005, MOL PLANT PATHOL, V6, P551, DOI [10.1111/j.1364-3703.2005.00302.x, 10.1111/J.1364-3703.2005.00302.X]; Skamnioti P, 2008, FUNGAL GENET BIOL, V45, P243, DOI 10.1016/j.fgb.2007.09.011; Slotkin RK, 2007, NAT REV GENET, V8, P272, DOI 10.1038/nrg2072; Smartt JS, 1995, EVOLUTION CROP PLANT, VSecond edn., P133; Soanes DM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002300; Soanes DM, 2006, MOL PLANT PATHOL, V7, P61, DOI 10.1111/J.1364-3703.2005.00317.X; Staden R, 1996, MOL BIOTECHNOL, V5, P233, DOI 10.1007/BF02900361; Stevens C, 1998, MOL MICROBIOL, V29, P165, DOI 10.1046/j.1365-2958.1998.00918.x; Strimmer K, 1997, P NATL ACAD SCI USA, V94, P6815, DOI 10.1073/pnas.94.13.6815; Takamatsu Susumu, 2004, Mycoscience, V45, P340, DOI 10.1007/s10267-004-0187-7; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; TOSA Y, 1995, JPN J GENET, V70, P127, DOI 10.1266/jjg.70.127; Wernersson R, 2003, NUCLEIC ACIDS RES, V31, P3537, DOI 10.1093/nar/gkg609; Win J, 2007, PLANT CELL, V19, P2349, DOI 10.1105/tpc.107.051037; Wong WSW, 2004, GENETICS, V168, P1041, DOI 10.1534/genetics.104.031153; Yahiaoui N, 2006, PLANT J, V47, P85, DOI 10.1111/j.1365-313X.2006.02772.x; Yang ZH, 2000, GENETICS, V155, P431; Yang ZH, 2005, MOL BIOL EVOL, V22, P1107, DOI 10.1093/molbev/msi097; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhou EX, 2007, FUNGAL GENET BIOL, V44, P1024, DOI 10.1016/j.fgb.2007.02.003; Zohary D., 1988, DOMESTICATION PLANTS	63	50	50	4	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7463	10.1371/journal.pone.0007463	http://dx.doi.org/10.1371/journal.pone.0007463			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829700	Green Submitted, Green Published, gold			2022-12-27	WOS:000270847800006
J	Szymanski, J; Jozefczuk, S; Nikoloski, Z; Selbig, J; Nikiforova, V; Catchpole, G; Willmitzer, L				Szymanski, Jedrzej; Jozefczuk, Szymon; Nikoloski, Zoran; Selbig, Joachim; Nikiforova, Victoria; Catchpole, Gareth; Willmitzer, Lothar			Stability of Metabolic Correlations under Changing Environmental Conditions in Escherichia coli - A Systems Approach	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; SMALL-WORLD; TREHALOSE SYNTHESIS; GENE-EXPRESSION; TEMPERATURE; STRESS; NETWORKS; YEAST; STABILIZATION; TRANSCRIPTOME	Background: Biological systems adapt to changing environments by reorganizing their cellular and physiological program with metabolites representing one important response level. Different stresses lead to both conserved and specific responses on the metabolite level which should be reflected in the underlying metabolic network. Methodology/Principal Findings: Starting from experimental data obtained by a GC-MS based high-throughput metabolic profiling technology we here develop an approach that: (1) extracts network representations from metabolic condition-dependent data by using pairwise correlations, (2) determines the sets of stable and condition-dependent correlations based on a combination of statistical significance and homogeneity tests, and (3) can identify metabolites related to the stress response, which goes beyond simple observations about the changes of metabolic concentrations. The approach was tested with Escherichia coli as a model organism observed under four different environmental stress conditions (cold stress, heat stress, oxidative stress, lactose diauxie) and control unperturbed conditions. By constructing the stable network component, which displays a scale free topology and small-world characteristics, we demonstrated that: (1) metabolite hubs in this reconstructed correlation networks are significantly enriched for those contained in biochemical networks such as EcoCyc, (2) particular components of the stable network are enriched for functionally related biochemical pathways, and (3) independently of the response scale, based on their importance in the reorganization of the correlation network a set of metabolites can be identified which represent hypothetical candidates for adjusting to a stress-specific response. Conclusions/Significance: Network-based tools allowed the identification of stress-dependent and general metabolic correlation networks. This correlation-network-based approach does not rely on major changes in concentration to identify metabolites important for stress adaptation, but rather on the changes in network properties with respect to metabolites. This should represent a useful complementary technique in addition to more classical approaches.			Szymanski, J (corresponding author), Max Planck Inst Mol Plant Physiol, Potsdam, Germany.	willmitzer@mpimp-golm.mpg.de	Willmitzer, Lothar/F-7377-2011	Nikoloski, Zoran/0000-0003-2671-6763; Szymanski, Jedrzej/0000-0003-1086-0920				Akaike H, 1983, INT STAT I, V44, P277, DOI DOI 10.1086/PHOS.50.4.187553; Albert R, 2005, J CELL SCI, V118, P4947, DOI 10.1242/jcs.02714; Albert R, 2000, PHYS REV LETT, V85, P5234, DOI 10.1103/PhysRevLett.85.5234; Amaral LAN, 2000, P NATL ACAD SCI USA, V97, P11149, DOI 10.1073/pnas.200327197; Arita M, 2005, J BIOCHEM, V138, P1, DOI 10.1093/jb/mvi094; ATTFIELD PV, 1987, FEBS LETT, V225, P259, DOI 10.1016/0014-5793(87)81170-5; Batagelj V., 1998, CONNECTIONS, V21, P47, DOI DOI 10.1017/CB09780511996368; Becerra M, 2003, COMP FUNCT GENOM, V4, P366, DOI 10.1002/cfg.301; Benaroudj N, 2001, J BIOL CHEM, V276, P24261, DOI 10.1074/jbc.M101487200; Bijlsma R., 1997, ENV STRESS ADAPTATIO; Bolten CJ, 2007, ANAL CHEM, V79, P3843, DOI 10.1021/ac0623888; Brauer MJ, 2006, P NATL ACAD SCI USA, V103, P19302, DOI 10.1073/pnas.0609508103; CARPENTER JF, 1988, CRYOBIOLOGY, V25, P459, DOI 10.1016/0011-2240(88)90054-5; Chang DE, 2002, MOL MICROBIOL, V45, P289, DOI 10.1046/j.1365-2958.2002.03001.x; CSARDI G, IGRAPH LIB, P29; CSONKA LN, 1991, ANNU REV MICROBIOL, V45, P569, DOI 10.1146/annurev.mi.45.100191.003033; Evans RI, 1998, INT J FOOD MICROBIOL, V40, P159, DOI 10.1016/S0168-1605(98)00029-4; FELL D, 1992, BIOCH J         0901, P313; Fell DA, 2000, NAT BIOTECHNOL, V18, P1121, DOI 10.1038/81025; Gadgil M, 2005, BIOTECHNOL PROGR, V21, P689, DOI 10.1021/bp049630l; Hirt H., 2004, PLANT RESPONSES ABIO; HOTTIGER T, 1994, EUR J BIOCHEM, V219, P187, DOI 10.1111/j.1432-1033.1994.tb19929.x; Hounsa CG, 1998, MICROBIOL-UK, V144, P671, DOI 10.1099/00221287-144-3-671; Ihaka R., 1996, J COMPUT GRAPH STAT, V5, P299, DOI [DOI 10.1080/10618600.1996.10474713, 10.2307/1390807]; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Kandror O, 2002, P NATL ACAD SCI USA, V99, P9727, DOI 10.1073/pnas.142314099; Karp PD, 2002, NUCLEIC ACIDS RES, V30, P56, DOI 10.1093/nar/30.1.56; Keseler IM, 2005, NUCLEIC ACIDS RES, V33, pD334, DOI 10.1093/nar/gki108; Koerkamp MG, 2002, MOL BIOL CELL, V13, P2783, DOI 10.1091/mbc.E02-02-0075; Kopka J, 2006, J BIOTECHNOL, V124, P312, DOI 10.1016/j.jbiotec.2005.12.012; Kose F, 2001, BIOINFORMATICS, V17, P1198, DOI 10.1093/bioinformatics/17.12.1198; Kusano M, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-53; Lisec J, 2006, NAT PROTOC, V1, P387, DOI 10.1038/nprot.2006.59; Ma HW, 2003, BIOINFORMATICS, V19, P1423, DOI 10.1093/bioinformatics/btg177; Maharjan RP, 2003, ANAL BIOCHEM, V313, P145; MARCOTTE EM, 2001, NAT BIOTECHNOL, P626; MARR AG, 1962, J BACTERIOL, V84, P1260, DOI 10.1128/JB.84.6.1260-1267.1962; Muller-Linow M, 2007, BMC SYST BIOL, V1, DOI 10.1186/1752-0509-1-44; NEIDHARDT FC, 1974, J BACTERIOL, V119, P736, DOI 10.1128/JB.119.3.736-747.1974; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Nikiforova VJ, 2005, J EXP BOT, V56, P1887, DOI 10.1093/jxb/eri179; Ohashi Y, 2008, MOL BIOSYST, V4, P135, DOI 10.1039/b714176a; Phadtare S, 2004, J BACTERIOL, V186, P7007, DOI 10.1128/JB.186.20.7007-7014.2004; Pomposiello PJ, 2001, J BACTERIOL, V183, P3890, DOI 10.1128/JB.183.13.3890-3902.2001; Roessner U, 2001, PLANT CELL, V13, P11, DOI 10.1105/tpc.13.1.11; ROTTEM S, 1978, EUR J BIOCHEM, V85, P445, DOI 10.1111/j.1432-1033.1978.tb12258.x; RUDOLPH AS, 1985, CRYOBIOLOGY, V22, P367, DOI 10.1016/0011-2240(85)90184-1; Sahara T, 2002, J BIOL CHEM, V277, P50015, DOI 10.1074/jbc.M209258200; Sakamoto T, 1986, AKAIKE INFORM CRITER; Schade B, 2004, MOL BIOL CELL, V15, P5492, DOI 10.1091/mbc.E04-03-0167; Schauer N, 2006, TRENDS PLANT SCI, V11, P508, DOI 10.1016/j.tplants.2006.08.007; Schuster S, 2001, TRENDS BIOTECHNOL, V19, P85, DOI 10.1016/S0167-7799(01)01573-6; Shahjee HM, 2002, J BIOSCIENCES, V27, P515, DOI 10.1007/BF02705049; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Smart AG, 2008, P NATL ACAD SCI USA, V105, P13223, DOI 10.1073/pnas.0803571105; Southam AD, 2008, J PROTEOME RES, V7, P5277, DOI 10.1021/pr800353t; STEFAN H, 2003, YEAST STRESS RESPONS; Steuer R, 2003, BIOINFORMATICS, V19, P1019, DOI 10.1093/bioinformatics/btg120; Steuer R, 2007, BIOINFORMATICS, V23, P1378, DOI 10.1093/bioinformatics/btm065; Storz G, 2000, BACTERIAL STRESS RESPONSES, P47; Strogatz SH, 2001, NATURE, V410, P268, DOI 10.1038/35065725; Szymanski J, 2007, PHYTOCHEMISTRY, V68, P2163, DOI 10.1016/j.phytochem.2007.04.017; Tai SL, 2007, MOL BIOL CELL, V18, P5100, DOI 10.1091/mbc.E07-02-0131; Taymaz-Nikerel H, 2009, ANAL BIOCHEM, V386, P9, DOI 10.1016/j.ab.2008.11.018; Traxler MF, 2006, P NATL ACAD SCI USA, V103, P2374, DOI 10.1073/pnas.0510995103; Virgilio C. de, 1994, European Journal of Biochemistry, V219, P179, DOI 10.1111/j.1432-1033.1994.tb19928.x; Watts DJ, 1998, NATURE, V393, P440, DOI 10.1038/30918; Weckwerth W, 2002, CURR OPIN BIOTECH, V13, P156, DOI 10.1016/S0958-1669(02)00299-9; Winder CL, 2008, ANAL CHEM, V80, P2939, DOI 10.1021/ac7023409; Wittmann C, 2007, J BIOTECHNOL, V132, P375, DOI 10.1016/j.jbiotec.2007.07.495; Zhang YM, 2008, NAT REV MICROBIOL, V6, P222, DOI 10.1038/nrmicro1839	71	28	29	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7441	10.1371/journal.pone.0007441	http://dx.doi.org/10.1371/journal.pone.0007441			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829699	Green Published, Green Submitted, gold			2022-12-27	WOS:000270847800003
J	Pich, OQ; Burgos, R; Querol, E; Pinol, J				Pich, Oscar Q.; Burgos, Raul; Querol, Enrique; Pinol, Jaume			P110 and P140 Cytadherence-Related Proteins Are Negative Effectors of Terminal Organelle Duplication in Mycoplasma genitalium	PLOS ONE			English	Article							MINIMAL GENE COMPLEMENT; GLIDING MOTILITY; ATTACHMENT ORGANELLE; CELL-ADHESION; PNEUMONIAE; ULTRASTRUCTURE; TRANSCRIPTION; REVEALS; MOBILE; P41	Background: The terminal organelle is a complex structure involved in many aspects of the biology of mycoplasmas such as cell adherence, motility or cell division. Mycoplasma genitalium cells display a single terminal organelle and duplicate this structure prior to cytokinesis in a coordinated manner with the cell division process. Despite the significance of the terminal organelle in mycoplasma virulence, little is known about the mechanisms governing its duplication. Methodology/Principal Findings: In this study we describe the isolation of a mutant, named T192, with a transposon insertion close to the 39 end of the mg192 gene encoding for P110 adhesin. This mutant shows a truncated P110, low levels of P140 and P110 adhesins, a large number of non-motile cells and a high frequency of new terminal organelle formation. Further analyses revealed that the high rates of new terminal organelle formation in T192 cells are a direct consequence of the reduced levels of P110 and P140 rather than to the expression of a truncated P110. Consistently, the phenotype of the T192 mutant was successfully complemented by the reintroduction of the mg192 WT allele which restored the levels of P110 and P140 to those of the WT strain. Quantification of DAPI-stained DNA also showed that the increase in the number of terminal organelles in T192 cells is not accompanied by a higher DNA content, indicating that terminal organelle duplication does not trigger DNA replication in mycoplasmas. Conclusions/Significance: Our results demonstrate the existence of a mechanism regulating terminal organelle duplication in M. genitalium and strongly suggest the implication of P110 and P140 adhesins in this mechanism.			Pich, OQ (corresponding author), Univ Autonoma Barcelona, Inst Biotecnol & Biomed, E-08193 Barcelona, Spain.	jaume.pinyol@uab.es	Pich, Oscar Quijada/F-7795-2016; Burgos, Raul/AAL-3612-2021	Pich, Oscar Quijada/0000-0003-3561-630X; Pinol, Jaume/0000-0002-9055-8934; Burgos, Raul/0000-0002-4452-9235				BOATMAN ES, 1979, MYCOPLASMAS, V1, P63; BREDT W, 1977, J BACTERIOL, V130, P937, DOI 10.1128/JB.130.2.937-938.1977; BREDT W, 1968, PATHOL MICROBIOL, V32, P321, DOI 10.1159/000162074; Burgos R, 2008, MOL MICROBIOL, V69, P1029, DOI 10.1111/j.1365-2958.2008.06343.x; Burgos R, 2007, J BACTERIOL, V189, P7014, DOI 10.1128/JB.00975-07; Burgos R, 2006, J BACTERIOL, V188, P8627, DOI 10.1128/JB.00978-06; FRASER CM, 1995, SCIENCE, V270, P397, DOI 10.1126/science.270.5235.397; GOBEL U, 1981, J CELL BIOL, V91, P537, DOI 10.1083/jcb.91.2.537; Hasselbring BA, 2006, J BACTERIOL, V188, P6335, DOI 10.1128/JB.00698-06; Hasselbring BM, 2007, J BACTERIOL, V189, P7442, DOI 10.1128/JB.00867-07; Hasselbring BM, 2007, MOL MICROBIOL, V63, P44, DOI 10.1111/j.1365-2958.2006.05507.x; Hasselbring BM, 2006, P NATL ACAD SCI USA, V103, P16478, DOI 10.1073/pnas.0608051103; Hatchel JM, 2008, MICROBIOL-SGM, V154, P286, DOI 10.1099/mic.0.2007/012765-0; Hatchel JM, 2006, MICROBIOL-SGM, V152, P2181, DOI 10.1099/mic.0.28905-0; Hegermann J, 2002, NATURWISSENSCHAFTEN, V89, P453, DOI 10.1007/s00114-002-0359-2; Herrmann R, 1998, CURR OPIN MICROBIOL, V1, P572, DOI 10.1016/S1369-5274(98)80091-X; Hottes AK, 2005, MOL MICROBIOL, V58, P1340, DOI 10.1111/j.1365-2958.2005.04912.x; HU PC, 1987, INFECT IMMUN, V55, P1126, DOI 10.1128/IAI.55.5.1126-1131.1987; Lluch-Senar M, 2007, MICROBIOL-SGM, V153, P2743, DOI 10.1099/mic.0.2006/007559-0; MENG KE, 1980, J BACTERIOL, V144, P390, DOI 10.1128/JB.144.1.390-399.1980; MERNAUGH GR, 1993, CLIN INFECT DIS, V17, pS69, DOI 10.1093/clinids/17.Supplement_1.S69; Miyata M, 2000, MICROBIOL-UK, V146, P1311, DOI 10.1099/00221287-146-6-1311; Nakane D, 2007, P NATL ACAD SCI USA, V104, P19518, DOI 10.1073/pnas.0704280104; Pich OQ, 2006, MICROBIOL-SGM, V152, P519, DOI 10.1099/mic.0.28287-0; Pich OQ, 2008, MICROBIOL-SGM, V154, P3188, DOI 10.1099/mic.0.2008/020636-0; Pich OQ, 2006, MOL MICROBIOL, V60, P1509, DOI 10.1111/j.1365-2958.2006.05187.x; QUINLAN DC, 1972, J BACTERIOL, V112, P1375, DOI 10.1128/JB.112.3.1375-1379.1972; RADESTOCK U, 1977, J BACTERIOL, V129, P1495, DOI 10.1128/JB.129.3.1495-1501.1977; Regula JT, 2001, MICROBIOL-UK, V147, P1045, DOI 10.1099/00221287-147-4-1045; ROSENGARTEN R, 1987, J BACTERIOL, V169, P1891, DOI 10.1128/jb.169.5.1891-1898.1987; Seto S, 2001, J BACTERIOL, V183, P1621, DOI 10.1128/JB.183.5.1621-1630.2001; TAYLORROBINSON D, 1983, YALE J BIOL MED, V56, P910; TULLY JG, 1979, J INFECT DIS, V139, P478, DOI 10.1093/infdis/139.4.478	33	14	14	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7452	10.1371/journal.pone.0007452	http://dx.doi.org/10.1371/journal.pone.0007452			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19829712	Green Published, gold, Green Submitted			2022-12-27	WOS:000270808700013
J	de Leeuw, M; Reuveni, S; Klafter, J; Granek, R				de Leeuw, Marina; Reuveni, Shlomi; Klafter, Joseph; Granek, Rony			Coexistence of Flexibility and Stability of Proteins: An Equation of State	PLOS ONE			English	Article								We consider a recently suggested "equation of state" for natively folded proteins, and verify its validity for a set of about 5800 proteins. The equation is based on a fractal viewpoint of proteins, on a generalization of the Landau-Peierls instability, and on a marginal stability criterion. The latter allows for coexistence of stability and flexibility of proteins, which is required for their proper function. The equation of state relates the protein fractal dimension d(f), its spectral dimension d(s), and the number of amino acids N. Using structural data from the protein data bank (PDB) and the Gaussian network model (GNM), we compute d(f) and d(s) for the entire set and demonstrate that the equation of state is well obeyed. Addressing the fractal properties and making use of the equation of state may help to engineer biologically inspired catalysts.			de Leeuw, M (corresponding author), Ben Gurion Univ Negev, Dept Biotechnol Engn, IL-84105 Beer Sheva, Israel.	rgranek@bgu.ac.il	GRANEK, RONY/F-1987-2012; Reuveni, Shlomi/M-3296-2016	GRANEK, RONY/0000-0001-6839-5393; Reuveni, Shlomi/0000-0003-2292-8005; de Leeuw, Marina/0000-0003-1858-8685				ALEXANDER S, 1989, PHYS REV B, V40, P7953, DOI 10.1103/PhysRevB.40.7953; Atilgan AR, 2001, BIOPHYS J, V80, P505, DOI 10.1016/S0006-3495(01)76033-X; Bahar I, 1997, J MOL BIOL, V266, P195, DOI 10.1006/jmbi.1996.0758; Bahar I, 1997, FOLD DES, V2, P173, DOI 10.1016/S1359-0278(97)00024-2; BERNSTEIN FC, 1977, J MOL BIOL, V112, P535, DOI 10.1016/S0022-2836(77)80200-3; Burioni R, 2002, EUROPHYS LETT, V58, P806, DOI 10.1209/epl/i2002-00445-5; Burioni R, 2004, PROTEINS, V55, P529, DOI 10.1002/prot.20072; Chennubhotla C, 2005, PHYS BIOL, V2, pS173, DOI 10.1088/1478-3975/2/4/S12; ELBER R, 1986, PHYS REV LETT, V56, P394, DOI 10.1103/PhysRevLett.56.394; Enright MB, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011912; Granek R, 2005, PHYS REV LETT, V95, DOI 10.1103/PhysRevLett.95.098106; Haliloglu T, 1997, PHYS REV LETT, V79, P3090, DOI 10.1103/PhysRevLett.79.3090; Henzler-Wildman KA, 2007, NATURE, V450, P913, DOI 10.1038/nature06407; Kou SC, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.180603; Li MS, 2004, PHYS REV LETT, V93, DOI 10.1103/PhysRevLett.93.268107; Lushnikov SG, 2005, JETP LETT+, V82, P30, DOI 10.1134/1.2045334; Min W, 2005, PHYS REV LETT, V94, DOI 10.1103/PhysRevLett.94.198302; Neusius T, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.188103; Peierls RE., 1934, HELV PHYS ACTA, V7, P81, DOI DOI 10.5169/SEALS-110415; Reuveni S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.208101; Rothlisberger D, 2008, NATURE, V453, P190, DOI 10.1038/nature06879; Senet P, 2008, P NATL ACAD SCI USA, V105, P19708, DOI 10.1073/pnas.0810679105; STAPLETON HJ, 1980, PHYS REV LETT, V45, P1456, DOI 10.1103/PhysRevLett.45.1456; STAUFFER D, 1994, INTRO PERCOLATION TH; Yang LW, 2007, STRUCTURE, V15, P741, DOI 10.1016/j.str.2007.04.014	25	15	15	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7296	10.1371/journal.pone.0007296	http://dx.doi.org/10.1371/journal.pone.0007296			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816577	Green Published, Green Submitted, gold			2022-12-27	WOS:000270594300003
J	Willner, D; Furlan, M; Haynes, M; Schmieder, R; Angly, FE; Silva, J; Tammadoni, S; Nosrat, B; Conrad, D; Rohwer, F				Willner, Dana; Furlan, Mike; Haynes, Matthew; Schmieder, Robert; Angly, Florent E.; Silva, Joas; Tammadoni, Sassan; Nosrat, Bahador; Conrad, Douglas; Rohwer, Forest			Metagenomic Analysis of Respiratory Tract DNA Viral Communities in Cystic Fibrosis and Non-Cystic Fibrosis Individuals	PLOS ONE			English	Article								The human respiratory tract is constantly exposed to a wide variety of viruses, microbes and inorganic particulates from environmental air, water and food. Physical characteristics of inhaled particles and airway mucosal immunity determine which viruses and microbes will persist in the airways. Here we present the first metagenomic study of DNA viral communities in the airways of diseased and non-diseased individuals. We obtained sequences from sputum DNA viral communities in 5 individuals with cystic fibrosis (CF) and 5 individuals without the disease. Overall, diversity of viruses in the airways was low, with an average richness of 175 distinct viral genotypes. The majority of viral diversity was uncharacterized. CF phage communities were highly similar to each other, whereas Non-CF individuals had more distinct phage communities, which may reflect organisms in inhaled air. CF eukaryotic viral communities were dominated by a few viruses, including human herpesviruses and retroviruses. Functional metagenomics showed that all Non-CF viromes were similar, and that CF viromes were enriched in aromatic amino acid metabolism. The CF metagenomes occupied two different metabolic states, probably reflecting different disease states. There was one outlying CF virome which was characterized by an over-representation of Guanosine-5'-triphosphate, 3'-diphosphate pyrophosphatase, an enzyme involved in the bacterial stringent response. Unique environments like the CF airway can drive functional adaptations, leading to shifts in metabolic profiles. These results have important clinical implications for CF, indicating that therapeutic measures may be more effective if used to change the respiratory environment, as opposed to shifting the taxonomic composition of resident microbiota.			Willner, D (corresponding author), San Diego State Univ, Dept Biol, San Diego, CA 92182 USA.	willner9@aol.com	Angly, Florent E/A-7717-2011; Rohwer, Forest/AAC-5315-2019; Silva, joas/AAS-6484-2021; Silva, Joas L/C-1407-2012	Angly, Florent E/0000-0002-8999-0738; Silva, joas/0000-0003-3967-5286; Rohwer, Forest/0000-0003-1548-5429				Allander T, 2005, P NATL ACAD SCI USA, V102, P12891, DOI 10.1073/pnas.0504666102; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Andersson AF, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002836; Angly F, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-41; Angly FE, 2006, PLOS BIOL, V4, P2121, DOI 10.1371/journal.pbio.0040368; [Anonymous], 2008, CYST FIBR FDN PAT RE; Azeredo J, 2008, CURR PHARM BIOTECHNO, V9, P261, DOI 10.2174/138920108785161604; Aziz RK, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-75; Bench SR, 2007, APPL ENVIRON MICROB, V73, P7629, DOI 10.1128/AEM.00938-07; Beringer P M, 2000, Curr Opin Pulm Med, V6, P545, DOI 10.1097/00063198-200011000-00015; Breitbart M, 2005, BIOTECHNIQUES, V39, P729, DOI 10.2144/000112019; Breitbart M, 2003, J BACTERIOL, V185, P6220, DOI 10.1128/JB.185.20.6220-6223.2003; Breitbart M, 2002, P NATL ACAD SCI USA, V99, P14250, DOI 10.1073/pnas.202488399; Corne JM, 2002, LANCET, V359, P831, DOI 10.1016/S0140-6736(02)07953-9; Dean FB, 2002, P NATL ACAD SCI USA, V99, P5261, DOI 10.1073/pnas.082089499; Desnues C, 2008, NATURE, V452, P340, DOI 10.1038/nature06735; Dinsdale EA, 2008, NATURE, V452, P629, DOI 10.1038/nature06810; Everitt B. S., 2006, HDB STAT ANAL USING; Fuhrman JA, 2003, BIOL BULL-US, V204, P192, DOI 10.2307/1543557; Gentles AJ, 2001, GENOME RES, V11, P540, DOI 10.1101/gr.163101; Gill SR, 2006, SCIENCE, V312, P1355, DOI 10.1126/science.1124234; Goerke C, 2006, MOL MICROBIOL, V61, P1673, DOI 10.1111/j.1365-2958.2006.05354.x; Goldman MJ, 1997, HUM GENE THER, V8, P2261, DOI 10.1089/hum.1997.8.18-2261; Green P., PHRAP; Harrison F, 2007, MICROBIOL-SGM, V153, P917, DOI 10.1099/mic.0.2006/004077-0; Heyder Joachim, 2004, Proc Am Thorac Soc, V1, P315, DOI 10.1513/pats.200409-046TA; Jain V, 2006, J MICROBIOL, V44, P1; KLEIN F, 2008, LUNG CANC; Knowles MR, 2002, J CLIN INVEST, V109, P571, DOI 10.1172/JCI200215217; Kulczycki LL, 2003, AM J MED GENET A, V116A, P262, DOI 10.1002/ajmg.a.10886; Liu WT, 1997, APPL ENVIRON MICROB, V63, P4516, DOI 10.1128/AEM.63.11.4516-4522.1997; Livraghi A, 2007, TOXICOL PATHOL, V35, P116, DOI 10.1080/01926230601060025; Lohavanichbutr P, 2009, ARCH OTOLARYNGOL, V135, P180, DOI 10.1001/archoto.2008.540; McManus TE, 2008, RESP MED, V102, P1575, DOI 10.1016/j.rmed.2008.06.006; Meyer F, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-386; MILLER RV, 1984, J CLIN MICROBIOL, V19, P717, DOI 10.1128/JCM.19.5.717-719.1984; Nakamura S, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004219; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Overbeek R, 2005, NUCLEIC ACIDS RES, V33, P5691, DOI 10.1093/nar/gki866; Palmer KL, 2007, J BACTERIOL, V189, P8079, DOI 10.1128/JB.01138-07; Palmer KL, 2005, J BACTERIOL, V187, P5267, DOI 10.1128/JB.187.15.5267-5277.2005; Pinard R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-216; Potrykus K, 2008, ANNU REV MICROBIOL, V62, P35, DOI 10.1146/annurev.micro.62.081307.162903; R Foundation for Statistical Computing, R LANG ENV STAT COMP; Randell SH, 2006, AM J RESP CELL MOL, V35, P20, DOI 10.1165/rcmb.2006-0082SF; Raskin DM, 2007, P NATL ACAD SCI USA, V104, P4636, DOI 10.1073/pnas.0611650104; Rodriguez-Brito B, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-162; Rogers DF, 2004, CURR OPIN PHARMACOL, V4, P241, DOI 10.1016/j.coph.2004.01.011; Rogers GB, 2006, J CLIN MICROBIOL, V44, P2601, DOI 10.1128/JCM.02282-05; Rogers GB, 2004, J CLIN MICROBIOL, V42, P5176, DOI 10.1128/JCM.42.11.5176-5183.2004; Rohwer F, 2002, J BACTERIOL, V184, P4529, DOI 10.1128/JB.184.16.4529-4535.2002; Schoenfeld T, 2008, APPL ENVIRON MICROB, V74, P4164, DOI 10.1128/AEM.02598-07; See H, 2008, PAEDIATR RESPIR REV, V9, P243, DOI 10.1016/j.prrv.2008.04.001; Thurber RV, 2009, NAT PROTOC, V4, P470, DOI 10.1038/nprot.2009.10; Tringe SG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001862; Turnbaugh PJ, 2006, NATURE, V444, P1027, DOI 10.1038/nature05414; Turnbaugh PJ, 2009, NATURE, V457, P480, DOI 10.1038/nature07540; Vadivukarasi T, 2007, J BIOSCIENCES, V32, P17, DOI 10.1007/s12038-007-0003-6; van Ewijk Bart E, 2005, J Cyst Fibros, V4 Suppl 2, P31, DOI 10.1016/j.jcf.2005.05.011; Wartha F, 2007, CURR OPIN MICROBIOL, V10, P52, DOI 10.1016/j.mib.2006.12.005; WILLNER D, 2009, ENV MICROBIOL; WINNIE GB, 1992, PEDIATR INFECT DIS J, V11, P722, DOI 10.1097/00006454-199209000-00010; Xiang XY, 2002, J VIROL METHODS, V101, P127, DOI 10.1016/S0166-0934(01)00431-1; Zawadzka-Glos L, 2003, INT J PEDIATR OTORHI, V67, P1117, DOI 10.1016/S0165-5876(03)00191-5; Zhang T, 2006, PLOS BIOL, V4, P108, DOI 10.1371/journal.pbio.0040003	65	283	291	1	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7370	10.1371/journal.pone.0007370	http://dx.doi.org/10.1371/journal.pone.0007370			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816605	Green Submitted, Green Published, gold			2022-12-27	WOS:000270594300006
J	Huque, T; Cowart, BJ; Dankulich-Nagrudny, L; Pribitkin, EA; Bayley, DL; Spielman, AI; Feldman, RS; Mackler, SA; Brand, JG				Huque, Taufiqul; Cowart, Beverly J.; Dankulich-Nagrudny, Luba; Pribitkin, Edmund A.; Bayley, Douglas L.; Spielman, Andrew I.; Feldman, Roy S.; Mackler, Scott A.; Brand, Joseph G.			Sour Ageusia in Two Individuals Implicates Ion Channels of the ASIC and PKD Families in Human Sour Taste Perception at the Anterior Tongue	PLOS ONE			English	Article							RECEPTOR-CELLS; P-GLYCOPROTEIN; ACID; MECHANISMS; PATHWAYS; CURRENTS; MEMBERS; BITTER; SWEET	Background: The perception of sour taste in humans is incompletely understood at the receptor cell level. We report here on two patients with an acquired sour ageusia. Each patient was unresponsive to sour stimuli, but both showed normal responses to bitter, sweet, and salty stimuli. Methods and Findings: Lingual fungiform papillae, containing taste cells, were obtained by biopsy from the two patients, and from three sour-normal individuals, and analyzed by RT-PCR. The following transcripts were undetectable in the patients, even after 50 cycles of amplification, but readily detectable in the sour-normal subjects: acid sensing ion channels (ASICs) 1a, 1 beta, 2a, 2b, and 3; and polycystic kidney disease (PKD) channels PKD1L3 and PKD2L1. Patients and sour-normals expressed the taste-related phospholipase C-beta 2, the delta-subunit of epithelial sodium channel (ENaC) and the bitter receptor T2R14, as well as beta-actin. Genomic analysis of one patient, using buccal tissue, did not show absence of the genes for ASIC1a and PKD2L1. Immunohistochemistry of fungiform papillae from sour-normal subjects revealed labeling of taste bud cells by antibodies to ASICs 1a and 1 beta, PKD2L1, phospholipase C-beta 2, and delta-ENaC. An antibody to PKD1L3 labeled tissue outside taste bud cells. Conclusions: These data suggest a role for ASICs and PKDs in human sour perception. This is the first report of sour ageusia in humans, and the very existence of such individuals ("natural knockouts'') suggests a cell lineage for sour that is independent of the other taste modalities.			Huque, T (corresponding author), Monell Chem Senses Ctr, 3500 Market St, Philadelphia, PA 19104 USA.	thuque@monell.org	Spielman, Andrew I./ABG-1150-2021	Spielman, Andrew I./0000-0002-7052-3689	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R21DC003969, F33DC000219, P50DC006760] Funding Source: NIH RePORTER; NIDCD NIH HHS [#1F33DC00219, P50 DC006760, DC-03969, F33 DC000219] Funding Source: Medline	NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD)); NIDCD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Bachmanov AA, 1996, ALCOHOL CLIN EXP RES, V20, P201, DOI 10.1111/j.1530-0277.1996.tb01630.x; Bandell M, 2007, CURR OPIN NEUROBIOL, V17, P490, DOI 10.1016/j.conb.2007.07.014; Behrens M, 2004, BIOCHEM BIOPH RES CO, V319, P479, DOI 10.1016/j.bbrc.2004.05.019; Bradley RM, 1971, HDB SENSORY PHYSL, VIV, P1; CAO J, 2002, P ASS CHEMORECEPTION, V24, pA76; CARDELLO AV, 1979, CHEM SENS FLAV, V4, P1, DOI 10.1093/chemse/4.1.1; Chandrashekar J, 2006, NATURE, V444, P288, DOI 10.1038/nature05401; COWART BJ, 1989, ANN NY ACAD SCI, V561, P39, DOI 10.1111/j.1749-6632.1989.tb20968.x; DACONCEICAO N, 2007, J FOOD SCI, V72, pR33; DeFazio RA, 2006, J NEUROSCI, V26, P3971, DOI 10.1523/JNEUROSCI.0515-06.2006; DeSimone JA, 2001, RESP PHYSIOL, V129, P231, DOI 10.1016/S0034-5687(01)00293-6; FARBMAN AI, 1988, BRAIN RES, V457, P281, DOI 10.1016/0006-8993(88)90697-X; GILBERTSON TA, 1992, J GEN PHYSIOL, V100, P803, DOI 10.1085/jgp.100.5.803; Hille B., 1992, ION CHANNELS EXCITAB; Holtzman CW, 2006, PHARMACOTHERAPY, V26, P1601, DOI 10.1592/phco.26.11.1601; Holzer P, 2007, AM J PHYSIOL-GASTR L, V292, pG699, DOI 10.1152/ajpgi.00517.2006; Huang AL, 2006, NATURE, V442, P934, DOI [10.1038/nature05084, 10.1038/nature050084]; HUQUE T, 2002, P ASS CHEMORECEPTION, V24; HUQUE T, 2003, P ASS CHEMORECEPTION, V25; HUQUE T, 2001, CHEM SENSES, V26, P1060; Ishimaru Y, 2006, P NATL ACAD SCI USA, V103, P12569, DOI 10.1073/pnas.0602702103; IWAYAMA T, 1967, EXP CELL RES, V46, P607, DOI 10.1016/0014-4827(67)90388-6; Kress N, 2006, CURR TOP MEMBR, V57, P241, DOI 10.1016/S1063-5823(06)57007-3; Krishtal O, 2003, TRENDS NEUROSCI, V26, P477, DOI 10.1016/S0166-2236(03)00210-8; Lingueglia E, 2007, J BIOL CHEM, V282, P17325, DOI 10.1074/jbc.R700011200; Liu LJ, 2001, BRAIN RES, V923, P58, DOI 10.1016/S0006-8993(01)03190-0; LopezJimenez ND, 2006, J NEUROCHEM, V98, P68, DOI 10.1111/j.1471-4159.2006.03842.x; MAKHLOUF GM, 1972, GASTROENTEROLOGY, V63, P67; Nakazato Y, 2008, INTERNAL MED, V47, P877, DOI 10.2169/internalmedicine.47.0735; NELSON TM, 2008, P INT S OLF TAST, V15; NORRIS MB, 1984, PHYSIOL BEHAV, V32, P237, DOI 10.1016/0031-9384(84)90136-7; Pribitkin E, 2003, ANN OTO RHINOL LARYN, V112, P971, DOI 10.1177/000348940311201110; Putnam RW, 2004, AM J PHYSIOL-CELL PH, V287, pC1493, DOI 10.1152/ajpcell.00282.2004; Richter TA, 2004, J NEUROPHYSIOL, V92, P1928, DOI 10.1152/jn.00273.2004; Richter TA, 2004, J NEUROSCI, V24, P4088, DOI 10.1523/JNEUROSCI.0653-04.2004; SANDICK B, 1981, CHEM SENSES, V6, P197, DOI 10.1093/chemse/6.3.197; Schiffman SS, 2007, P NUTR SOC, V66, P331, DOI 10.1017/S0029665107005599; Schiffman Susan S, 2002, Adv Food Nutr Res, V44, P247, DOI 10.1016/S1043-4526(02)44006-5; SHIN YK, 2008, P INT S OLF TAST, V15; Spielman AI., 1995, EXPT CELL BIOL TASTE, P25; Stahler F, 2008, CHEMOSENS PERCEPT, V1, P78, DOI 10.1007/s12078-008-9006-4; Stone LM, 2002, J NEUROSCI, V22, P4522, DOI 10.1523/JNEUROSCI.22-11-04522.2002; *THOMS REUT, 2007, PHYS DESK REF, V61; Tomchik SM, 2007, J NEUROSCI, V27, P10840, DOI 10.1523/JNEUROSCI.1863-07.2007; Ugawa S, 1998, NATURE, V395, P555, DOI 10.1038/26882; Ugawa S, 2003, J NEUROSCI, V23, P3616; Uhr M, 2007, J PSYCHIAT RES, V41, P179, DOI 10.1016/j.jpsychires.2005.10.005; Waldmann R, 1997, NATURE, V386, P173, DOI 10.1038/386173a0; Waldmann R, 1998, CURR OPIN NEUROBIOL, V8, P418, DOI 10.1016/S0959-4388(98)80070-6; Wang H, 2007, J NEUROSCI, V27, P10703, DOI 10.1523/JNEUROSCI.3102-07.2007; WEIFFENBACH JM, 1982, J GERONTOL, V37, P372, DOI 10.1093/geronj/37.3.372; Yamamura H, 2004, J BIOL CHEM, V279, P12529, DOI 10.1074/jbc.M400274200; Zhang YF, 2003, CELL, V112, P293, DOI 10.1016/S0092-8674(03)00071-0	53	58	62	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7347	10.1371/journal.pone.0007347	http://dx.doi.org/10.1371/journal.pone.0007347			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812697	Green Submitted, Green Published, gold			2022-12-27	WOS:000270594200003
J	Kohler, MJ; Lushington, K; van den Heuvel, CJ; Martin, J; Pamula, Y; Kennedy, D				Kohler, Mark J.; Lushington, Kurt; van den Heuvel, Cameron J.; Martin, James; Pamula, Yvonne; Kennedy, Declan			Adenotonsillectomy and Neurocognitive Deficits in Children with Sleep Disordered Breathing	PLOS ONE			English	Article							COGNITIVE DYSFUNCTION; BEHAVIOR; APNEA; PERFORMANCE; ADENOIDECTOMY; TONSILLECTOMY	Background: Sleep Disordered Breathing (SDB) is a common childhood disorder that encompasses a range of sleep-related upper airway obstruction. Children with SDB demonstrate significant neurocognitive deficits. Adenotonsillectomy is the first line of treatment for SDB and whilst this improves respiratory disturbance, it remains to be established whether neurocognitive gains also result. Methods: A total of 44 healthy snoring children aged 3-12 years awaiting adenotonsillectomy (SDB group), and 48 age and gender matched non-snoring controls from the general community, completed the study. All children underwent polysomnography and neurocognitive assessment at baseline and after a 6-month follow-up (after surgery in the snoring group). Our primary aim was to determine whether neurocognitive deficits in snoring children were significantly improved following adenotonsillectomy. Results: Wide ranging neurocognitive deficits were found at baseline in SDB children compared to controls, most notably a 10 point IQ difference (P<.001) and similar deficits in language and executive function. Whilst adenotonsillectomy improved respiratory parameters and snoring frequency at 6 months post surgery, neurocognitive performance did not improve relative to controls. Conclusion: Adenotonsillectomy successfully treated the respiratory effects of SDB in children. However, neurocognitive deficits did not improve 6-months post-operatively.			Kohler, MJ (corresponding author), Univ Adelaide, Childrens Res Ctr, Adelaide, SA, Australia.	mark.kohler@adelaide.edu.au	van den Heuvel, Cameron J./E-1993-2012; Lushington, Kurt/D-1699-2009; Kohler, Mark J/F-4538-2013	van den Heuvel, Cameron J./0000-0001-7264-4655; Lushington, Kurt/0000-0001-8371-273X; Kohler, Mark J/0000-0001-7265-6242				Ali NJ, 1996, EUR J PEDIATR, V155, P56, DOI 10.1007/BF02115629; Arens R, 2004, SLEEP, V27, P997, DOI 10.1093/sleep/27.5.997; Avior G, 2004, OTOLARYNG HEAD NECK, V131, P367, DOI 10.1016/j.otohns.2004.04.015; Bandla P, 2008, SLEEP, V31, P534, DOI 10.1093/sleep/31.4.534; Beebe DW, 2006, SLEEP, V29, P1115, DOI 10.1093/sleep/29.9.1115; Bellizzi MC, 1999, AM J CLIN NUTR, V70, p173S; Blunden S, 2000, J CLIN EXP NEUROPSYC, V22, P554, DOI 10.1076/1380-3395(200010)22:5;1-9;FT554; Boets B, 2008, BRAIN LANG, V106, P29, DOI 10.1016/j.bandl.2007.12.004; BONNET M, 1993, SLEEP, V16, P748; BONNET MH, 1992, SLEEP, V15, P526; Brietzke SE, 2006, OTOLARYNG HEAD NECK, V134, P979, DOI 10.1016/j.otohns.2006.02.033; Carskadon MA, 2004, ANN NY ACAD SCI, V1021, P276, DOI 10.1196/annals.1308.032; Chervin RD, 2006, PEDIATRICS, V117, pE769, DOI 10.1542/peds.2005-1837; Friedman BC, 2003, SLEEP, V26, P999, DOI 10.1093/sleep/26.8.999; Galland BC, 2006, PEDIATR RES, V59, P711, DOI 10.1203/01.pdr.0000214992.69847.6f; Garetz SL, 2008, OTOLARYNG HEAD NECK, V138, pS19, DOI 10.1016/j.otohns.2007.06.738; Giordani B, 2008, J INT NEUROPSYCH SOC, V14, P571, DOI 10.1017/S1355617708080776; Gozal D, 1998, PEDIATRICS, V102, P616, DOI 10.1542/peds.102.3.616; Gozal D, 2007, NEUROLOGY, V69, P243, DOI 10.1212/01.wnl.0000265818.88703.83; Gozal D, 2007, AM J RESP CRIT CARE, V176, P188, DOI 10.1164/rccm.200610-1519OC; Gozal D, 2009, SLEEP MED, V10, P167, DOI 10.1016/j.sleep.2008.01.001; GUILLEMINAULT C, 1982, EUR J PEDIATR, V139, P165, DOI 10.1007/BF01377349; Hansen DE, 1997, J CLIN CHILD PSYCHOL, V26, P304, DOI 10.1207/s15374424jccp2603_9; Harvey JMM, 1999, J PAEDIATR CHILD H, V35, P136, DOI 10.1046/j.1440-1754.1999.t01-1-00336.x; KAIL R, 1994, DEV PSYCHOL, V30, P949, DOI 10.1037/0012-1649.30.6.949; Korkman M., 2007, NEPSY 2, V2nd; Lamberg L, 2007, JAMA-J AM MED ASSOC, V297, P2681, DOI 10.1001/jama.297.24.2681; Li HY, 2006, LARYNGOSCOPE, V116, P1142, DOI 10.1097/01.mlg.0000217542.84013.b5; Loughlin GM, 1996, AM J RESP CRIT CARE, V153, P866; Lumeng Julie C, 2008, Proc Am Thorac Soc, V5, P242, DOI 10.1513/pats.200708-135MG; Marcus CL, 2004, J APPL PHYSIOL, V97, P98, DOI 10.1152/japplphysiol.00462.2003; Montgomery-Downs HE, 2005, EUR RESPIR J, V25, P336, DOI 10.1183/09031936.05.00082904; O'Brien LM, 2004, PEDIATRICS, V114, P44, DOI 10.1542/peds.114.1.44; Owens Judith, 2000, Sleep Breath, V4, P67, DOI 10.1055/s-2000-19814; Rechtschaffen A, 1968, MANUAL STANDARDIZED; Roid GH., 2003, STANFORD BINET INTEL, V5th; Russo PM, 2007, J SLEEP RES, V16, P163, DOI 10.1111/j.1365-2869.2007.00584.x; Scarborough HS, 1998, SPECIFIC READING DISABILITY, P75; Waber DP, 2007, J INT NEUROPSYCH SOC, V13, P729, DOI 10.1017/S1355617707070841	39	82	84	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7343	10.1371/journal.pone.0007343	http://dx.doi.org/10.1371/journal.pone.0007343			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806214	Green Published, Green Accepted, gold, Green Submitted			2022-12-27	WOS:000270593800026
J	Nordenfelt, P; Bauer, S; Lonnbro, P; Tapper, H				Nordenfelt, Pontus; Bauer, Susanne; Lonnbro, Per; Tapper, Hans			Phagocytosis of Streptococcus pyogenes by All-Trans Retinoic Acid-Differentiated HL-60 Cells: Roles of Azurophilic Granules and NADPH Oxidase	PLOS ONE			English	Article							RESPIRATORY BURST; GENERATING-SYSTEM; HUMAN NEUTROPHILS; LINE HL-60; M-PROTEIN; MONOCYTES; COMPONENT; MEMBRANE; MYELOPEROXIDASE; TRANSLOCATION	Background: New experimental approaches to the study of the neutrophil phagosome and bacterial killing prompted a reassessment of the usefulness of all-trans retinoic acid (ATRA)-differentiated HL-60 cells as a neutrophil model. HL-60 cells are special in that they possess azurophilic granules while lacking the specific granules with their associated oxidase components. The resulting inability to mount an effective intracellular respiratory burst makes these cells more dependent on other mechanisms when killing internalized bacteria. Methodology/Principal Findings: In this work phagocytosis and phagosome-related responses of ATRA-differentiated HL-60 cells were compared to those earlier described in human neutrophils. We show that intracellular survival of wild-type S. pyogenes bacteria in HL-60 cells is accompanied by inhibition of azurophilic granule-phagosome fusion. A mutant S. pyogenes bacterium, deficient in M-protein expression, is, on the other hand, rapidly killed in phagosomes that avidly fuse with azurophilic granules. Conclusions/Significance: The current data extend our previous findings by showing that a system lacking in oxidase involvement also indicates a link between inhibition of azurophilic granule fusion and the intraphagosomal fate of S. pyogenes bacteria. We propose that differentiated HL-60 cells can be a useful tool to study certain aspects of neutrophil phagosome maturation, such as azurophilic granule fusion.			Nordenfelt, P (corresponding author), Lund Univ, Dept Clin Sci, Sect Clin & Expt Infect Med, Lund, Sweden.	hans.tapper@med.lu.se	Nordenfelt, Pontus/H-5310-2019	Nordenfelt, Pontus/0000-0002-9481-9951				ABO A, 1992, J BIOL CHEM, V267, P16767; BAEHNER RL, 1976, BLOOD, V48, P309; Bassoe CF, 2000, METHODS, V21, P203, DOI 10.1006/meth.2000.1001; Bauer S, 2004, J LEUKOCYTE BIOL, V76, P1142, DOI 10.1189/jlb.0404260; BIANCO C, 1975, J EXP MED, V141, P1278, DOI 10.1084/jem.141.6.1278; BORREGAARD N, 1983, J CELL BIOL, V97, P52, DOI 10.1083/jcb.97.1.52; BREITMAN TR, 1980, P NATL ACAD SCI-BIOL, V77, P2936, DOI 10.1073/pnas.77.5.2936; BUNCE CM, 1994, LEUKEMIA, V8, P595; BUNCE CM, 1995, LEUKEMIA, V9, P410; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; COLLINS SJ, 1987, BLOOD, V70, P1233; CRABTREE GR, 1980, J IMMUNOL, V125, P448; CROSS AR, 1986, BIOCHEM J, V237, P111, DOI 10.1042/bj2370111; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; DAHLGREN C, 1989, J LEUKOCYTE BIOL, V46, P15, DOI 10.1002/jlb.46.1.15; EMMENDORFFER A, 1990, J IMMUNOL METHODS, V131, P269, DOI 10.1016/0022-1759(90)90198-5; Faurschou M, 2003, MICROBES INFECT, V5, P1317, DOI 10.1016/j.micinf.2003.09.008; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Fleck RA, 2003, IN VITRO CELL DEV-AN, V39, P235; GALLIN JI, 1984, BLOOD, V63, P977; Hampton MB, 1998, BLOOD, V92, P3007, DOI 10.1182/blood.V92.9.3007.421k47_3007_3017; Kihlberg BM, 1995, MICROB PATHOGENESIS, V19, P299, DOI 10.1016/S0882-4010(96)80003-9; Klebanoff SJ, 2005, J LEUKOCYTE BIOL, V77, P598, DOI 10.1189/jlb.1204697; LACAL P, 1988, J BIOL CHEM, V263, P9946; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lambeth JD, 2000, TRENDS BIOCHEM SCI, V25, P459, DOI 10.1016/S0968-0004(00)01658-3; Lambeth JD, 2002, CURR OPIN HEMATOL, V9, P11, DOI 10.1097/00062752-200201000-00003; LeCabec V, 1997, BLOOD, V89, P2113, DOI 10.1182/blood.V89.6.2113; Liu GY, 2005, J EXP MED, V202, P209, DOI 10.1084/jem.20050846; Lonnbro P, 2008, BMC CELL BIOL, V9, DOI 10.1186/1471-2121-9-35; NAKAMURA T, 1988, EUR J HAEMATOL, V41, P258; Nelson D, 2001, P NATL ACAD SCI USA, V98, P4107, DOI 10.1073/pnas.061038398; Nelson D, 2006, P NATL ACAD SCI USA, V103, P10765, DOI 10.1073/pnas.0604521103; NEWBURGER PE, 1979, J CELL BIOL, V82, P315, DOI 10.1083/jcb.82.2.315; Ozeki M, 2008, J LEUKOCYTE BIOL, V84, P769, DOI 10.1189/jlb.1207817; Pantelic M, 2004, FEMS IMMUNOL MED MIC, V42, P261, DOI 10.1016/j.femsim.2004.05.010; REPINE JE, 1979, AM J CLIN PATHOL, V71, P582; ROBERTS PJ, 1982, J CELL BIOL, V95, P720, DOI 10.1083/jcb.95.3.720; ROTHE G, 1988, NATURWISSENSCHAFTEN, V75, P354, DOI 10.1007/BF00368326; SEGAL AW, 1987, NATURE, V326, P88, DOI 10.1038/326088a0; SEGAL AW, 1981, NATURE, V290, P406, DOI 10.1038/290406a0; SENGELOV H, 1992, J BIOL CHEM, V267, P14912; Sheppard FR, 2005, J LEUKOCYTE BIOL, V78, P1025, DOI 10.1189/jlb.0804442; Staali L, 2006, CELL MICROBIOL, V8, P690, DOI 10.1111/j.1462-5822.2005.00662.x; Staali L, 2003, CELL MICROBIOL, V5, P253, DOI 10.1046/j.1462-5822.2003.00272.x; Trayner ID, 1998, LEUKEMIA RES, V22, P537, DOI 10.1016/S0145-2126(98)00041-1; Vignais PV, 2002, CELL MOL LIFE SCI, V59, P1428, DOI 10.1007/s00018-002-8520-9; Voyich JM, 2004, MICROBES INFECT, V6, P1117, DOI 10.1016/j.micinf.2004.05.022; WIENTJES FB, 1993, BIOCHEM J, V296, P557, DOI 10.1042/bj2960557	49	20	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7363	10.1371/journal.pone.0007363	http://dx.doi.org/10.1371/journal.pone.0007363			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806211	Green Published, Green Submitted, gold			2022-12-27	WOS:000270593800032
J	Li, HS; Pauza, CD				Li, Haishan; Pauza, C. David			Effects of 15-Deoxy-Delta(12,14)-Prostaglandin J2 (15d-PGJ2) and Rosiglitazone on Human V delta 2(+) T Cells	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS; NONPEPTIDIC MYCOBACTERIAL LIGANDS; PPAR-GAMMA; MULTIPLE-SCLEROSIS; AUTOIMMUNE INFLAMMATION; INDEPENDENT MECHANISMS; RHEUMATOID-ARTHRITIS; AIRWAY INFLAMMATION; BEHCETS-DISEASE	Background: Thiazolidinediones (TZD) class of drugs, and 15-deoxy-D12,14-prostaglandin J2 (15d-PGJ2) are immune regulators predicted to modulate human autoimmune disease. Their effects on gamma delta T cells, which are involved in animal model and human and animal autoimmune diseases, are unknown. Methodology/Principal Findings: We characterized the activity of rosiglitazone (from the TZD class of drugs) and 15d-PGJ2 in human V delta 2 T cells. We found that 15d-PGJ2 and rosiglitazone had different effects on V delta 2 T cell functions. Both 15d-PGJ2 and rosiglitazone suppressed V delta 2 T cell proliferation in response to IPP and IL2. However, only 15d-PGJ2 suppressed functional responses including cytokine production, degranulation and cytotoxicity against tumor cells. The mechanism for 15d-PGJ2 effects on V delta 2 T cells acts through inhibiting Erk activation. In contrast, rosiglitazone did not affect Erk activation but the IL2 signaling pathway, which accounts for rosiglitazone suppression of IL2-dependent, V delta 2 T cell proliferation without affecting TCR-dependent functions. Rosiglitazone and 15d-PGJ2 are designed to be peroxisome proliferator-activated receptor gamma (PPAR gamma) ligands and PPAR gamma was expressed in V delta 2 T cell. Surprisingly, when PPAR gamma levels were lowered by specific siRNA, 15d-PGJ2 and rosiglitazone were still active, suggesting their target of action induces cellular proteins other than PPAR gamma. Conclusions/Significance: The current findings expand our understanding of how the immune system is regulated by rosiglitazone and 15d-PGJ2 and will be important to evaluate these compounds as therapeutic agents in human autoimmune disease.			Li, HS (corresponding author), Univ Maryland, Sch Med, Inst Human Virol, Baltimore, MD 21201 USA.	cdpauza@ihv.umaryland.edu			NATIONAL CANCER INSTITUTE [R01CA113261, R01CA142458] Funding Source: NIH RePORTER; NCI NIH HHS [CA142458, R01 CA142458-01, R01 CA113261, CA113261, R01 CA142458] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Alexander AAZ, 2008, CLIN CANCER RES, V14, P4232, DOI 10.1158/1078-0432.CCR-07-4912; Augstein P, 2003, BIOCHEM BIOPH RES CO, V304, P378, DOI 10.1016/S0006-291X(03)00590-4; Bank I, 2003, J LAB CLIN MED, V141, P33, DOI 10.1067/mlc.2003.1; BATTISTINI L, 1995, ANN NEUROL, V37, P198, DOI 10.1002/ana.410370210; Battistini L, 2005, MICROBES INFECT, V7, P510, DOI 10.1016/j.micinf.2004.12.008; Beales PE, 1998, EUR J PHARMACOL, V357, P221, DOI 10.1016/S0014-2999(98)00574-3; Berry A, 2007, EUR J IMMUNOL, V37, P1642, DOI 10.1002/eji.200636625; Bright JJ, 2003, J IMMUNOL, V171, P5743, DOI 10.4049/jimmunol.171.11.5743; Brosnan CF, 1996, BRAIN PATHOL, V6, P243, DOI 10.1111/j.1750-3639.1996.tb00853.x; BUKOWSKI JF, 1995, J IMMUNOL, V154, P998; Cairo C, 2005, CLIN EXP IMMUNOL, V141, P116, DOI 10.1111/j.1365-2249.2005.02813.x; Carding SR, 2002, NAT REV IMMUNOL, V2, P336, DOI 10.1038/nri797; Clark RB, 2000, J IMMUNOL, V164, P1364, DOI 10.4049/jimmunol.164.3.1364; CONSTANT P, 1994, SCIENCE, V264, P267, DOI 10.1126/science.8146660; Correia DV, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005657; Cua DJ, 2003, NATURE, V421, P744, DOI 10.1038/nature01355; Evans PS, 2001, IMMUNOLOGY, V104, P19, DOI 10.1046/j.1365-2567.2001.01282.x; Fenoglio D, 2009, BLOOD, V113, P6611, DOI 10.1182/blood-2009-01-198028; Follows GA, 2006, GENOME RES, V16, P1310, DOI 10.1101/gr.5373606; FORMAN BM, 1995, CELL, V83, P803, DOI 10.1016/0092-8674(95)90193-0; Garcia VE, 1997, J IMMUNOL, V159, P1328; Hammad H, 2004, AM J PATHOL, V164, P263, DOI 10.1016/S0002-9440(10)63116-1; HOHLFELD R, 1991, NEW ENGL J MED, V324, P877, DOI 10.1056/NEJM199103283241303; Holoshitz J, 1999, MICROBES INFECT, V1, P197, DOI 10.1016/S1286-4579(99)80034-3; KLOTZ L, 2009, J EXP MED; LANG F, 1995, J IMMUNOL, V154, P5986; Leesnitzer LM, 2002, BIOCHEMISTRY-US, V41, P6640, DOI 10.1021/bi0159581; LEHMANN JM, 1995, J BIOL CHEM, V270, P12953, DOI 10.1074/jbc.270.22.12953; Li HS, 2008, J IMMUNOL, V181, P7131, DOI 10.4049/jimmunol.181.10.7131; Martin B, 2009, IMMUNITY, V31, P321, DOI 10.1016/j.immuni.2009.06.020; Mueller C, 2003, ARCH BIOCHEM BIOPHYS, V418, P186, DOI 10.1016/j.abb.2003.08.006; Murphy CA, 2003, J EXP MED, V198, P1951, DOI 10.1084/jem.20030896; Natarajan C, 2002, GENES IMMUN, V3, P59, DOI 10.1038/sj.gene.6363832; O'Brien RL, 2009, EUR J IMMUNOL, V39, P662, DOI 10.1002/eji.200839120; Ottones F, 2000, J IMMUNOL, V165, P7133, DOI 10.4049/jimmunol.165.12.7133; Pershadsingh HA, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-3; Phulwani NK, 2006, J NEUROCHEM, V99, P1389, DOI 10.1111/j.1471-4159.2006.04183.x; Poccia F, 1999, J INFECT DIS, V180, P858, DOI 10.1086/314925; Rajan AJ, 1996, J IMMUNOL, V157, P941; Ray DM, 2006, J IMMUNOL, V177, P5068, DOI 10.4049/jimmunol.177.8.5068; Roark CL, 2008, CURR OPIN IMMUNOL, V20, P353, DOI 10.1016/j.coi.2008.03.006; Robak E, 1999, MEDIAT INFLAMM, V8, P305, DOI 10.1080/09629359990315; Saubermann LJ, 2002, INFLAMM BOWEL DIS, V8, P330, DOI 10.1097/00054725-200209000-00004; SELMAJ K, 1991, P NATL ACAD SCI USA, V88, P6452, DOI 10.1073/pnas.88.15.6452; Shichita T, 2009, NAT MED, V15, P946, DOI 10.1038/nm.1999; Shiojiri T, 2002, EUR J PHARMACOL, V448, P231, DOI 10.1016/S0014-2999(02)01946-5; Sutton CE, 2009, IMMUNITY, V31, P331, DOI 10.1016/j.immuni.2009.08.001; Szatmari I, 2007, BLOOD, V110, P3271, DOI 10.1182/blood-2007-06-096222; Szeles L, 2007, BBA-MOL CELL BIOL L, V1771, P1014, DOI 10.1016/j.bbalip.2007.02.005; TANAKA Y, 1995, NATURE, V375, P155, DOI 10.1038/375155a0; Tikhonov I, 2006, INT IMMUNOL, V18, P1243, DOI 10.1093/intimm/dxl055; TONTONOZ P, 1995, CURR OPIN GENET DEV, V5, P571, DOI 10.1016/0959-437X(95)80025-5; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Tzartos JS, 2008, AM J PATHOL, V172, P146, DOI 10.2353/ajpath.2008.070690; Ueki S, 2004, INT ARCH ALLERGY IMM, V134, P30, DOI 10.1159/000077790; Wiendl H, 2002, J IMMUNOL, V169, P515, DOI 10.4049/jimmunol.169.1.515; Woerly G, 2003, J EXP MED, V198, P411, DOI 10.1084/jem.20021384; Wohlfert EA, 2007, J IMMUNOL, V178, P4129, DOI 10.4049/jimmunol.178.7.4129; Yamashita N, 1997, CLIN EXP IMMUNOL, V107, P241, DOI 10.1111/j.1365-2249.1997.274-ce1159.x; Zhang X, 2004, BLOOD, V104, P3276, DOI 10.1182/blood-2004-02-0664	60	6	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2009	4	11							e7726	10.1371/journal.pone.0007726	http://dx.doi.org/10.1371/journal.pone.0007726			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RZ	19888466	Green Submitted, Green Published, gold			2022-12-27	WOS:000271414600008
J	Ma, ZM; Kong, J; Kallen, RG				Ma, Zhongming; Kong, Jun; Kallen, Roland G.			Studies of alpha-Helicity and Intersegmental Interactions in Voltage-Gated Na+ Channels: S2D4	PLOS ONE			English	Article							SHAKER K+ CHANNEL; DEPENDENT CONFORMATIONAL-CHANGES; POTASSIUM CHANNEL; GATING CHARGE; TRANSMEMBRANE SEGMENTS; CRYSTAL-STRUCTURE; S4 SEGMENT; ELECTROSTATIC INTERACTIONS; FUNCTIONAL EXPRESSION; MOLECULAR-BASIS	Much data, including crystallographic, support structural models of sodium and potassium channels consisting of S1-S4 transmembrane segments (the "voltage-sensing domain'') clustered around a central pore-forming region (S5-S6 segments and the intervening loop). Voltage gated sodium channels have four non-identical domains which differentiates them from the homotetrameric potassium channels that form the basis for current structural models. Since potassium and sodium channels also exhibit many different functional characteristics and the fourth domain (D4) of sodium channels differs in function from other domains (D1-D3), we have explored its structure in order to determine whether segments in D4 of sodium channels differ significantly from that determined for potassium channels. We have probed the secondary and tertiary structure and the role of the individual amino acid residues of the S2D4) of Na(v)1.4 by employing cysteine-scanning mutagenesis (with tryptophan and glutamine substituted for native cysteine). A Fourier transform power spectrum of perturbations in free energy of steady-state inactivation gating (using midpoint potentials and slopes of Boltzmann equation fits of channel availability, h(infinity)-V plots) indicates a substantial amount of alpha-helical structure in S2D4 (peak at 106 degrees, alpha-Periodicity Index (alpha-PI) of 3.10), This conclusion is supported by alpha-PI values of 3.28 and 2.84 for the perturbations in rate constants of entry into (beta) and exit from (alpha) fast inactivation at 0 mV for mutant channels relative to WT channels assuming a simple two-state model for transition from the open to inactivated state. The results of cysteine substitution at the two most sensitive sites of the S2D4 alpha-helix (N1382 and E1392C) support the existence of electrostatic network interactions between S2 and other transmembrane segments within Na(v)1.4D4 similar to but not identical to those proposed for K+ channels.			Ma, ZM (corresponding author), Univ Penn, Sch Med, Dept Biochem & Biophys, Philadelphia, PA 19104 USA.	rgk@mail.med.upenn.edu			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR041762] Funding Source: NIH RePORTER; NIAMS NIH HHS [AR 41762] Funding Source: Medline; PHS HHS [P01 08075] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Adamian L, 2001, J MOL BIOL, V311, P891, DOI 10.1006/jmbi.2001.4908; Aggarwal SK, 1996, NEURON, V16, P1169, DOI 10.1016/S0896-6273(00)80143-9; AKABAS MH, 1992, SCIENCE, V258, P307, DOI 10.1126/science.1384130; BARCHI RL, 1991, ADV EXP MED BIOL, V308, P107; BEZANILLA F, 1994, BIOPHYS J, V66, P1011, DOI 10.1016/S0006-3495(94)80882-3; Blanchet J, 2007, BIOPHYS J, V92, P3513, DOI 10.1529/biophysj.106.090464; Boutjdir, 1996, J Cardiovasc Pharmacol Ther, V1, P149; CANNON SC, 1995, J NEUROPHYSIOL, V73, P1892, DOI 10.1152/jn.1995.73.5.1892; Cha A, 1999, NATURE, V402, P809, DOI 10.1038/45552; Cha A, 1999, NEURON, V22, P73, DOI 10.1016/S0896-6273(00)80680-7; Cha A, 1997, NEURON, V19, P1127, DOI 10.1016/S0896-6273(00)80403-1; CHAHINE M, 1994, PFLUG ARCH EUR J PHY, V427, P136, DOI 10.1007/BF00585952; Chen LQ, 1996, J GEN PHYSIOL, V108, P549, DOI 10.1085/jgp.108.6.549; Cordes MHJ, 1999, PROTEIN SCI, V8, P318; CORNETTE JL, 1987, J MOL BIOL, V195, P659, DOI 10.1016/0022-2836(87)90189-6; DeCaen PG, 2008, P NATL ACAD SCI USA, V105, P15142, DOI 10.1073/pnas.0806486105; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; Glauner KS, 1999, NATURE, V402, P813, DOI 10.1038/45561; GRANTHAM R, 1974, SCIENCE, V185, P862, DOI 10.1126/science.185.4154.862; Gregoret LM, 1998, FOLD DES, V3, P119, DOI 10.1016/S1359-0278(98)00017-0; GROS P, 1992, BIOCHEMISTRY-US, V31, P1992, DOI 10.1021/bi00122a014; HAMILL OP, 1981, PFLUG ARCH EUR J PHY, V391, P85, DOI 10.1007/BF00656997; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; HILLOVA J, 1975, INTERVIROLOGY, V5, P367, DOI 10.1159/000149935; Hirschberg B, 1995, J GEN PHYSIOL, V106, P1053, DOI 10.1085/jgp.106.6.1053; Islas LD, 1999, J GEN PHYSIOL, V114, P723, DOI 10.1085/jgp.114.5.723; Jiang YX, 2003, NATURE, V423, P33, DOI 10.1038/nature01580; Jiang YX, 2002, NATURE, V417, P515, DOI 10.1038/417515a; Jin WL, 1999, BIOCHEMISTRY-US, V38, P14294, DOI 10.1021/bi991206j; KALLEN RG, 1971, J AM CHEM SOC, V93, P6227, DOI 10.1021/ja00752a039; Keynes RD, 1999, P ROY SOC B-BIOL SCI, V266, P843, DOI 10.1098/rspb.1999.0714; Kuhn FJP, 1999, J GEN PHYSIOL, V114, P167, DOI 10.1085/jgp.114.2.167; Laine M, 2004, FEBS LETT, V564, P257, DOI 10.1016/S0014-5793(04)00273-X; Laine M, 2003, NEURON, V39, P467, DOI 10.1016/S0896-6273(03)00468-9; Larsson HP, 1996, NEURON, V16, P387, DOI 10.1016/S0896-6273(00)80056-2; Ledwell JL, 1999, J GEN PHYSIOL, V113, P389, DOI 10.1085/jgp.113.3.389; Li-Smerin YY, 2000, J GEN PHYSIOL, V115, P33, DOI 10.1085/jgp.115.1.33; LIWO A, 2008, CURR OPIN STRUCT BIO; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Long SB, 2005, SCIENCE, V309, P903, DOI 10.1126/science.1116270; Long SB, 2007, NATURE, V450, P376, DOI 10.1038/nature06265; Ma ZM, 2006, J GEN PHYSIOL, V127, P309, DOI 10.1085/jgp.200509421; MARGOLSKEE RF, 1993, BIOTECHNIQUES, V15, P906; McPhee JC, 1998, J BIOL CHEM, V273, P1121, DOI 10.1074/jbc.273.2.1121; Monks SA, 1999, J GEN PHYSIOL, V113, P415, DOI 10.1085/jgp.113.3.415; Neale EJ, 2007, J BIOL CHEM, V282, P37597, DOI 10.1074/jbc.M706437200; Nguyen TP, 2001, BIOPHYS J, V80, p232A; Nishida M, 2007, EMBO J, V26, P4005, DOI 10.1038/sj.emboj.7601828; OLEARY ME, 1995, J GEN PHYSIOL, V106, P641, DOI 10.1085/jgp.106.4.641; Ottschytsch N, 2005, J PHYSIOL-LONDON, V568, P737, DOI 10.1113/jphysiol.2005.090142; Ottschytsch N, 2002, P NATL ACAD SCI USA, V99, P7986, DOI 10.1073/pnas.122617999; PAKULA AA, 1989, ANNU REV GENET, V23, P289, DOI 10.1146/annurev.ge.23.120189.001445; Panaghie G, 2007, J GEN PHYSIOL, V129, P121, DOI 10.1085/jgp.200609612; Papazian DM, 1997, NEWS PHYSIOL SCI, V12, P203; PAPAZIAN DM, 1995, NEURON, V14, P1293, DOI 10.1016/0896-6273(95)90276-7; Pavlov E, 2005, BIOPHYS J, V89, P232, DOI 10.1529/biophysj.104.056994; PLANELLSCASES R, 1995, P NATL ACAD SCI USA, V92, P9422, DOI 10.1073/pnas.92.20.9422; Post MA, 1996, FEBS LETT, V399, P177, DOI 10.1016/S0014-5793(96)01316-6; REES DC, 1989, ANNU REV BIOCHEM, V58, P607; REES DC, 1989, SCIENCE, V245, P510, DOI 10.1126/science.2667138; Ren DJ, 2001, SCIENCE, V294, P2372, DOI 10.1126/science.1065635; Roden DM, 2002, ANNU REV PHYSIOL, V64, P431, DOI 10.1146/annurev.physiol.64.083101.145105; Sato Y, 2003, J BIOL CHEM, V278, P13227, DOI 10.1074/jbc.M300431200; SCHOPPA NE, 1992, SCIENCE, V255, P1712, DOI 10.1126/science.1553560; SCHREMPF H, 1995, EMBO J, V14, P5170, DOI 10.1002/j.1460-2075.1995.tb00201.x; Seoh SA, 1996, NEURON, V16, P1159, DOI 10.1016/S0896-6273(00)80142-7; Shafrir Y, 2008, BIOPHYS J, V95, P3663, DOI 10.1529/biophysj.108.135335; Smith-Maxwell CJ, 1998, J GEN PHYSIOL, V111, P399, DOI 10.1085/jgp.111.3.399; Tiwari-Woodruff SK, 2000, J GEN PHYSIOL, V115, P123, DOI 10.1085/jgp.115.2.123; TiwariWoodruff SK, 1997, BIOPHYS J, V72, P1489, DOI 10.1016/S0006-3495(97)78797-6; TRIMMER JS, 1989, NEURON, V3, P33, DOI 10.1016/0896-6273(89)90113-X; Yang NB, 1997, BIOPHYS J, V73, P2260, DOI 10.1016/S0006-3495(97)78258-4; Yang NB, 1996, NEURON, V16, P113, DOI 10.1016/S0896-6273(00)80028-8; Yang YC, 2003, J NEUROSCI, V23, P4922; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P321, DOI 10.1085/jgp.103.2.321; ZAGOTTA WN, 1994, J GEN PHYSIOL, V103, P279, DOI 10.1085/jgp.103.2.279	76	5	5	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2009	4	11							e7674	10.1371/journal.pone.0007674	http://dx.doi.org/10.1371/journal.pone.0007674			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RX	19881885	Green Published, Green Submitted, gold			2022-12-27	WOS:000271414400004
J	Taylor, JM; Street, TL; Hao, LZ; Copley, R; Taylor, MS; Hayden, PJ; Stolper, G; Mott, R; Hein, J; Moffatt, MF; Cookson, WOCM				Taylor, Jennifer M.; Street, Teresa L.; Hao, Lizhong; Copley, Richard; Taylor, Martin S.; Hayden, Patrick J.; Stolper, Gina; Mott, Richard; Hein, Jotun; Moffatt, Miriam F.; Cookson, William O. C. M.			Dynamic and Physical Clustering of Gene Expression during Epidermal Barrier Formation in Differentiating Keratinocytes	PLOS ONE			English	Article							ATOPIC-DERMATITIS; HLA-G; PSORIASIS; GENOME; CORNIFICATION; MICROARRAYS; INFECTION; PROTEINS; ENVELOPE; PROTECTS	The mammalian epidermis is a continually renewing structure that provides the interface between the organism and an innately hostile environment. The keratinocyte is its principal cell. Keratinocyte proteins form a physical epithelial barrier, protect against microbial damage, and prepare immune responses to danger. Epithelial immunity is disordered in many common diseases and disordered epithelial differentiation underlies many cancers. In order to identify the genes that mediate epithelial development we used a tissue model of the skin derived from primary human keratinocytes. We measured global gene expression in triplicate at five times over the ten days that the keratinocytes took to fully differentiate. We identified 1282 gene transcripts that significantly changed during differentiation (false discovery rate < 0.01%). We robustly grouped these transcripts by K-means clustering into modules with distinct temporal expression patterns, shared regulatory motifs, and biological functions. We found a striking cluster of late expressed genes that form the structural and innate immune defences of the epithelial barrier. Gene Ontology analyses showed that undifferentiated keratinocytes were characterised by genes for motility and the adaptive immune response. We systematically identified calcium-binding genes, which may operate with the epidermal calcium gradient to control keratinocyte division during skin repair. The results provide multiple novel insights into keratinocyte biology, in particular providing a comprehensive list of known and previously unrecognised major components of the epidermal barrier. The findings provide a reference for subsequent understanding of how the barrier functions in health and disease.			Taylor, JM (corresponding author), Wellcome Trust Ctr Human Genet, Oxford, England.	wcookson@imperial.ac.uk	Taylor, Martin S/C-3825-2009; Cookson, William/HHC-1790-2022; Taylor, Jennifer M/A-1686-2010	Taylor, Martin S/0000-0001-7656-330X; Taylor, Jennifer M/0000-0003-4231-0181; Hayden, Patrick/0000-0001-8977-1845; Mott, Richard/0000-0002-1022-9330	Medical Research Council [G0801056B] Funding Source: researchfish; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Wellcome Trust(Wellcome TrustEuropean Commission)		AHOS, 2004, J CELL BIOCHEM, V92, P1271; Ashburner M, 2001, GENOME RES, V11, P1425; Carninci P, 2005, SCIENCE, V309, P1559, DOI 10.1126/science.1112014; Christiano AM, 1997, TRENDS GENET, V13, P227, DOI 10.1016/S0168-9525(97)01104-9; CLOHESSY PA, 1995, SCAND J IMMUNOL, V42, P551, DOI 10.1111/j.1365-3083.1995.tb03695.x; Cookson W, 2004, NAT REV IMMUNOL, V4, P978, DOI 10.1038/nri1500; Cookson WOCM, 2001, NAT GENET, V27, P372, DOI 10.1038/86867; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Elias PM, 1998, J INVEST DERMATOL, V110, P399, DOI 10.1046/j.1523-1747.1998.00151.x; Freedberg IM, 2001, J INVEST DERMATOL, V116, P633, DOI 10.1046/j.1523-1747.2001.01327.x; Gautier L, 2004, BIOINFORMATICS, V20, P307, DOI 10.1093/bioinformatics/btg405; Gazit E, 2004, HUM IMMUNOL, V65, P39, DOI 10.1016/j.humimm.2003.09.019; Glaser R, 2005, NAT IMMUNOL, V6, P57, DOI 10.1038/ni1142; Gottsch JD, 1999, INFECT IMMUN, V67, P6631; Hardas BD, 1996, J INVEST DERMATOL, V106, P753, DOI 10.1111/1523-1747.ep12345807; Hennings H, 1980, Curr Probl Dermatol, V10, P3; HENNINGS H, 1983, EXP CELL RES, V143, P127, DOI 10.1016/0014-4827(83)90115-5; Holick MF, 2003, BRIT J DERMATOL, V149, P370, DOI 10.1046/j.1365-2133.2003.05437.x; Horton R, 2004, NAT REV GENET, V5, P889, DOI 10.1038/nrg1489; Huh GS, 2000, SCIENCE, V290, P2155, DOI 10.1126/science.290.5499.2155; Hurst LD, 2004, NAT REV GENET, V5, P299, DOI 10.1038/nrg1319; Khochbin S, 2001, GENE, V271, P1, DOI 10.1016/S0378-1119(01)00495-4; Lefort K, 2004, SEMIN CANCER BIOL, V14, P374, DOI 10.1016/j.semcancer.2004.04.017; Lercher MJ, 2002, NAT GENET, V31, P180, DOI 10.1038/ng887; Liu WM, 2002, BIOINFORMATICS, V18, P1593, DOI 10.1093/bioinformatics/18.12.1593; Lohman FP, 1997, EXP CELL RES, V231, P141, DOI 10.1006/excr.1996.3458; MacQueen J., 1967, P 5 BERKELEY S MATH, VVolume 1, P281, DOI DOI 10.1007/S11665-016-2173-6; Marshall D, 2001, P NATL ACAD SCI USA, V98, P13031, DOI 10.1073/pnas.231489198; Marzluff WF, 2002, GENOMICS, V80, P487, DOI 10.1006/geno.2002.6850; Mauro T, 1998, J INVEST DERMATOL, V111, P1198, DOI 10.1046/j.1523-1747.1998.00421.x; Mischke D, 1996, J INVEST DERMATOL, V106, P989, DOI 10.1111/1523-1747.ep12338501; Nair RP, 2000, AM J HUM GENET, V66, P1833, DOI 10.1086/302932; Nicolae D, 2005, AM J HUM GENET, V76, P349, DOI 10.1086/427763; Palmer CNA, 2006, NAT GENET, V38, P441, DOI 10.1038/ng1767; Pavesi G, 2001, Bioinformatics, V17 Suppl 1, pS207; Price TS, 2005, NUCLEIC ACIDS RES, V33, P3455, DOI 10.1093/nar/gki643; Reverter D, 2004, J MOL BIOL, V338, P257, DOI 10.1016/j.jmb.2004.02.058; Roepcke S, 2005, NUCLEIC ACIDS RES, V33, pW438, DOI 10.1093/nar/gki590; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Rustici G, 2004, NAT GENET, V36, P809, DOI 10.1038/ng1377; Sakata Y, 2004, J BIOL CHEM, V279, P5081, DOI 10.1074/jbc.M311585200; Simpson AJ, 1999, FEBS LETT, V452, P309, DOI 10.1016/S0014-5793(99)00670-5; Simpson AJ, 2001, J IMMUNOL, V167, P1778, DOI 10.4049/jimmunol.167.3.1778; South AP, 1999, J INVEST DERMATOL, V112, P910, DOI 10.1046/j.1523-1747.1999.00613.x; Sproul D, 2005, NAT REV GENET, V6, P775, DOI 10.1038/nrg1688; Tavazoie S, 1999, NAT GENET, V22, P281, DOI 10.1038/10343; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Vasilopoulos Y, 2004, J INVEST DERMATOL, V123, P62, DOI 10.1111/j.0022-202X.2004.22708.x; VEAL CD, 2002, AM J HUM GE IN PRESS, V71; Walley AJ, 2001, NAT GENET, V29, P175, DOI 10.1038/ng728	50	26	26	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2009	4	10							e7651	10.1371/journal.pone.0007651	http://dx.doi.org/10.1371/journal.pone.0007651			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RW	19888454	Green Published, gold			2022-12-27	WOS:000271414300009
J	Courtin, D; Oesterholt, M; Huismans, H; Kusi, K; Milet, J; Badaut, C; Gaye, O; Roeffen, W; Remarque, EJ; Sauerwein, R; Garcia, A; Luty, AJF				Courtin, David; Oesterholt, Mayke; Huismans, Harm; Kusi, Kwadwo; Milet, Jacqueline; Badaut, Cyril; Gaye, Oumar; Roeffen, Will; Remarque, Edmond J.; Sauerwein, Robert; Garcia, Andre; Luty, Adrian J. F.			The Quantity and Quality of African Children's IgG Responses to Merozoite Surface Antigens Reflect Protection against Plasmodium falciparum Malaria	PLOS ONE			English	Article							GLUTAMATE-RICH PROTEIN; BLOOD-STAGE ANTIGENS; SICKLE-CELL TRAIT; APICAL MEMBRANE ANTIGEN-1; GROWTH IN-VITRO; CLINICAL MALARIA; ANTIBODY-RESPONSES; IMMUNOGLOBULIN-G; SERUM ANTIBODIES; PARASITE GROWTH	Background Antibodies, particularly cytophilic IgG subclasses, with specificity for asexual blood stage antigens of Plasmodium falciparum, are thought to play an important role in acquired immunity to malaria. Evaluating such responses in longitudinal sero-epidemiological field studies, allied to increasing knowledge of the immunological mechanisms associated with anti-malarial protection, will help in the development of malaria vaccines. Methods and Findings: We conducted a 1-year follow-up study of 305 Senegalese children and identified those resistant or susceptible to malaria. In retrospective analyses we then compared post-follow-up IgG responses to six asexual-stage candidate malaria vaccine antigens in groups of individuals with clearly defined clinical and parasitological histories of infection with P. falciparum. In age-adjusted analyses, children resistant to malaria as well as to high-density parasitemia, had significantly higher IgG1 responses to GLURP and IgG3 responses to MSP2 than their susceptible counterparts. Among those resistant to malaria, high anti-MSP1 IgG1 levels were associated with protection against high-density parasitemia. To assess functional attributes, we used an in vitro parasite growth inhibition assay with purified IgG. Samples from individuals with high levels of IgG directed to MSP1, MSP2 and AMA1 gave the strongest parasite growth inhibition, but a marked age-related decline was observed in these effects. Conclusion: Our data are consistent with the idea that protection against P. falciparum malaria in children depends on acquisition of a constellation of appropriate, functionally active IgG subclass responses directed to multiple asexual stage antigens. Our results suggest at least two distinct mechanisms via which antibodies may exert protective effects. Although declining with age, the growth inhibitory effects of purified IgG measurable in vitro reflected levels of anti-AMA1, -MSP1 and -MSP2, but not of anti-GLURP IgG. The latter could act on parasite growth via indirect parasiticidal pathways.			Courtin, D (corresponding author), Radboud Univ Nijmegen, Med Ctr, NL-6525 ED Nijmegen, Netherlands.	A.Luty@mmb.umcn.nl	Sauerwein, Robert/C-8519-2013; Garcia, Andre/ABA-1820-2020; Luty, Adrian/CAH-2547-2022; Garcia, Andre/S-2959-2016; Remarque, Ed/AAE-8643-2020; Kusi, Kwadwo Asamoah/J-5941-2019; Roeffen, W.F.G./L-4607-2015; Remarque, Edmond J/B-2217-2010; courtin, david/A-1584-2017	Garcia, Andre/0000-0002-1808-472X; Garcia, Andre/0000-0002-1808-472X; Kusi, Kwadwo Asamoah/0000-0001-5483-9985; courtin, david/0000-0002-5263-4430; MILET, Jacqueline/0000-0003-2710-1517; Badaut, Cyril/0000-0002-0064-6384; Luty, Adrian John Frederick/0000-0001-8830-3425				Aidoo M, 2002, LANCET, V359, P1311, DOI 10.1016/S0140-6736(02)08273-9; ALYAMAN F, 1994, AM J TROP MED HYG, V51, P593, DOI 10.4269/ajtmh.1994.51.593; Aribot G, 1996, AM J TROP MED HYG, V54, P449, DOI 10.4269/ajtmh.1996.54.449; Arnot DE, 2008, CLIN VACCINE IMMUNOL, V15, P1345, DOI 10.1128/CVI.00172-08; Bonnet S, 2006, VACCINE, V24, P5997, DOI 10.1016/j.vaccine.2006.04.069; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; Braga TM, 2002, AM J TROP MED HYG, V66, P461, DOI 10.4269/ajtmh.2002.66.461; Branch OH, 1998, AM J TROP MED HYG, V58, P211, DOI 10.4269/ajtmh.1998.58.211; BROWN GV, 1983, AM J TROP MED HYG, V32, P1221, DOI 10.4269/ajtmh.1983.32.1221; Cabrera G, 2005, J INFECT DIS, V191, P1631, DOI 10.1086/429832; COHEN S, 1961, NATURE, V192, P733, DOI 10.1038/192733a0; Corran PH, 2004, INFECT IMMUN, V72, P6185, DOI 10.1128/IAI.72.10.6185-6189.2004; Dent AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003557; Dodoo D, 2000, J INFECT DIS, V181, P1202, DOI 10.1086/315341; Dodoo D, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-142; Egan AF, 1996, J INFECT DIS, V173, P765, DOI 10.1093/infdis/173.3.765; Garcia A, 2004, MICROBES INFECT, V6, P68, DOI 10.1016/j.micinf.2003.09.021; Gray JC, 2007, CLIN CHEM, V53, P1244, DOI 10.1373/clinchem.2006.081695; Hermsen CC, 2007, VACCINE, V25, P2930, DOI 10.1016/j.vaccine.2006.06.081; Iriemenam NC, 2009, VACCINE, V27, P62, DOI 10.1016/j.vaccine.2008.10.025; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Kennedy MC, 2002, INFECT IMMUN, V70, P6948, DOI 10.1128/IAI.70.12.6948-6960.2002; Kocken CHM, 2002, INFECT IMMUN, V70, P4471, DOI 10.1128/IAI.70.8.4471-4476.2002; Lusingu JPA, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-48; MARSH K, 1989, T ROY SOC TROP MED H, V83, P293, DOI 10.1016/0035-9203(89)90478-1; McCallum FJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003571; Meraldi V, 2004, PARASITE IMMUNOL, V26, P265, DOI 10.1111/j.0141-9838.2004.00705.x; Metzger WG, 2003, PARASITE IMMUNOL, V25, P307, DOI 10.1046/j.1365-3024.2003.00636.x; Migot-Nabias F, 2006, MICROBES INFECT, V8, P2352, DOI 10.1016/j.micinf.2006.03.021; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Ntoumi F, 2002, IMMUNOL LETT, V84, P9, DOI 10.1016/S0165-2478(02)00131-1; Oeuvray C, 2000, INFECT IMMUN, V68, P2617, DOI 10.1128/IAI.68.5.2617-2620.2000; Okech BA, 2004, INFECT IMMUN, V72, P1557, DOI 10.1128/IAI.72.3.1557-1567.2004; Osier FHA, 2008, INFECT IMMUN, V76, P2240, DOI 10.1128/IAI.01585-07; Perraut R, 2005, J INFECT DIS, V191, P264, DOI 10.1086/426398; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; RASHEED FN, 1995, PARASITE IMMUNOL, V17, P1, DOI 10.1111/j.1365-3024.1995.tb00960.x; Robert V, 1998, TROP MED INT HEALTH, V3, P667, DOI 10.1046/j.1365-3156.1998.00288.x; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Sarr JB, 2006, MICROBES INFECT, V8, P1260, DOI 10.1016/j.micinf.2005.12.005; Shi YP, 1999, AM J TROP MED HYG, V60, P135, DOI 10.4269/ajtmh.1999.60.135; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Taylor RR, 1998, AM J TROP MED HYG, V58, P406, DOI 10.4269/ajtmh.1998.58.406; Tebo AE, 2001, EXP PARASITOL, V98, P20, DOI 10.1006/expr.2001.4619; Theisen M, 1998, INFECT IMMUN, V66, P11, DOI 10.1128/IAI.66.1.11-17.1998; THEISEN M, 1995, CLIN DIAGN LAB IMMUN, V2, P30, DOI 10.1128/CDLI.2.1.30-34.1995; Tongren JE, 2006, INFECT IMMUN, V74, P257, DOI 10.1128/IAI.74.1.257-264.2006; VERNES A, 1984, AM J TROP MED HYG, V33, P197, DOI 10.4269/ajtmh.1984.33.197; Williams TN, 2005, PLOS MED, V2, P441, DOI 10.1371/journal.pmed.0020128; Williams TN, 2005, J INFECT DIS, V192, P178, DOI 10.1086/430744	52	79	79	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7590	10.1371/journal.pone.0007590	http://dx.doi.org/10.1371/journal.pone.0007590			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859562	Green Published, Green Submitted, gold			2022-12-27	WOS:000271147400008
J	Smith, TK; Vasileva, N; Gluenz, E; Terry, S; Portman, N; Kramer, S; Carrington, M; Michaeli, S; Gull, K; Rudenko, G				Smith, Terry K.; Vasileva, Nadina; Gluenz, Eva; Terry, Stephen; Portman, Neil; Kramer, Susanne; Carrington, Mark; Michaeli, Shulamit; Gull, Keith; Rudenko, Gloria			Blocking Variant Surface Glycoprotein Synthesis in Trypanosoma brucei Triggers a General Arrest in Translation Initiation	PLOS ONE			English	Article							BLOOD-STREAM-FORM; UNFOLDED-PROTEIN RESPONSE; VSG EXPRESSION SITES; CELL-CYCLE ARREST; AFRICAN TRYPANOSOMES; ANTIGENIC VARIATION; PATHWAY; IDENTIFICATION; MEMBRANE; TRANSCRIPTION	Background: The African trypanosome Trypanosoma brucei is covered with a dense layer of Variant Surface Glycoprotein (VSG), which protects it from lysis by host complement via the alternative pathway in the mammalian bloodstream. Blocking VSG synthesis by the induction of VSG RNAi triggers an unusually precise precytokinesis cell-cycle arrest. Methodology/Principal Findings: Here, we characterise the cells arrested after the induction of VSG RNAi. We were able to rescue the VSG221 RNAi induced cell-cycle arrest through expression of a second different VSG (VSG117 which is not recognised by the VSG221 RNAi) from the VSG221 expression site. Metabolic labeling of the arrested cells showed that blocking VSG synthesis triggered a global translation arrest, with total protein synthesis reduced to less than 1-4% normal levels within 24 hours of induction of VSG RNAi. Analysis by electron microscopy showed that the translation arrest was coupled with rapid disassociation of ribosomes from the endoplasmic reticulum. Polysome analysis showed a drastic decrease in polysomes in the arrested cells. No major changes were found in levels of transcription, total RNA transcript levels or global amino acid concentrations in the arrested cells. Conclusions: The cell-cycle arrest phenotype triggered by the induction of VSG221 RNAi is not caused by siRNA toxicity, as this arrest can be alleviated if a second different VSG is inserted downstream of the active VSG221 expression site promoter. Analysis of polysomes in the stalled cells showed that the translation arrest is mediated at the level of translation initiation rather than elongation. The cell-cycle arrest induced in the presence of a VSG synthesis block is reversible, suggesting that VSG synthesis and/or trafficking to the cell surface could be monitored during the cell-cycle as part of a specific cell-cycle checkpoint.			Smith, TK (corresponding author), Univ St Andrews, Ctr Biomol Sci, St Andrews KY16 9AJ, Fife, Scotland.	gloria.rudenko@medawar.ox.ac.uk	Michaeli, Shulamit/AAC-8255-2022; Carrington, Mark/N-3653-2019; Carrington, Mark/N-4892-2018; Kramer, Susanne/M-5026-2017; Terry, Stephen/AAC-8511-2019	Carrington, Mark/0000-0002-6435-7266; Carrington, Mark/0000-0002-6435-7266; Terry, Stephen/0000-0001-8195-898X; Portman, Neil/0000-0003-0248-0258; Rudenko, Gloria/0000-0003-1884-4933; Gluenz, Eva/0000-0003-4346-8896	Wellcome Trust [095161] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Allen CL, 2003, EMBO J, V22, P4991, DOI 10.1093/emboj/cdg481; Amiguet-Vercher A, 2004, MOL MICROBIOL, V51, P1577, DOI 10.1111/j.1365-2958.2003.03937.x; Ariyanayagam MR, 2005, BIOCHEM J, V391, P425, DOI 10.1042/BJ20050911; Bangs JD, 1997, EMBO J, V16, P4285, DOI 10.1093/emboj/16.14.4285; Barry JD, 2005, BIOCHEM SOC T, V33, P986, DOI 10.1042/BST20050986; Bastin P, 1998, NATURE, V391, P548, DOI 10.1038/35300; Benz C, 2007, MOL BIOCHEM PARASIT, V156, P217, DOI 10.1016/j.molbiopara.2007.08.005; Bernales S, 2006, ANNU REV CELL DEV BI, V22, P487, DOI 10.1146/annurev.cellbio.21.122303.120200; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; BLUM ML, 1993, NATURE, V362, P603, DOI 10.1038/362603a0; Brecht M, 1998, MOL BIOCHEM PARASIT, V97, P189, DOI 10.1016/S0166-6851(98)00151-0; Broadhead R, 2006, NATURE, V440, P224, DOI 10.1038/nature04541; CROSS GAM, 1975, PARASITOLOGY, V71, P393, DOI 10.1017/S003118200004717X; Dhalia R, 2006, NUCLEIC ACIDS RES, V34, P2495, DOI 10.1093/nar/gkl290; Djikeng A, 2003, RNA, V9, P802, DOI 10.1261/rna.5270203; Engstler M, 2004, J CELL SCI, V117, P1105, DOI 10.1242/jcs.00938; Engstler M, 2007, CELL, V131, P505, DOI 10.1016/j.cell.2007.08.046; ERONDU NE, 1992, MOL BIOCHEM PARASIT, V51, P111, DOI 10.1016/0166-6851(92)90206-Y; Figueiredo LM, 2008, PLOS BIOL, V6, P1539, DOI 10.1371/journal.pbio.0060161; FREYMANN D, 1990, J MOL BIOL, V216, P141, DOI 10.1016/S0022-2836(05)80066-X; Garcia-Salcedo JA, 2004, EMBO J, V23, P780, DOI 10.1038/sj.emboj.7600094; Gibellini F, 2009, MOL MICROBIOL, V73, P826, DOI 10.1111/j.1365-2958.2009.06764.x; Halic M, 2005, CURR OPIN STRUC BIOL, V15, P116, DOI 10.1016/j.sbi.2005.01.013; Hamanaka RB, 2005, MOL BIOL CELL, V16, P5493, DOI 10.1091/mbc.E05-03-0268; Horn D, 2005, CHROMOSOME RES, V13, P525, DOI 10.1007/s10577-005-0991-8; Hughes K, 2007, EMBO J, V26, P2400, DOI 10.1038/sj.emboj.7601678; Jetton N, 2009, MOL MICROBIOL, V72, P442, DOI 10.1111/j.1365-2958.2009.06657.x; Koumandou VL, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-298; Kramer S, 2008, J CELL SCI, V121, P3002, DOI 10.1242/jcs.031823; Li ZY, 2008, EUKARYOT CELL, V7, P1941, DOI 10.1128/EC.00249-08; Li ZY, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003814; Lillico S, 2003, MOL BIOL CELL, V14, P1182, DOI 10.1091/mbc.E02-03-0167; Lustig Y, 2007, EMBO REP, V8, P408, DOI 10.1038/sj.embor.7400930; Magez S, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000122; Marcello L, 2007, GENOME RES, V17, P1344, DOI 10.1101/gr.6421207; Martin KL, 2006, MOL MICROBIOL, V61, P89, DOI 10.1111/j.1365-2958.2006.05216.x; Martin KL, 2006, BIOCHEM J, V396, P287, DOI 10.1042/BJ20051825; MASTERSON WJ, 1989, CELL, V56, P793, DOI 10.1016/0092-8674(89)90684-3; Moraes MCS, 2007, EUKARYOT CELL, V6, P1979, DOI 10.1128/EC.00249-07; MunozJordan JL, 1996, SCIENCE, V272, P1795, DOI 10.1126/science.272.5269.1795; Navarro M, 2001, NATURE, V414, P759, DOI 10.1038/414759a; Ngo H, 1998, P NATL ACAD SCI USA, V95, P14687, DOI 10.1073/pnas.95.25.14687; Nolan DP, 2008, MOL BIOCHEM PARASIT, V157, P233, DOI 10.1016/j.molbiopara.2007.10.006; Pays E, 2004, CURR OPIN MICROBIOL, V7, P369, DOI 10.1016/j.mib.2004.05.001; Pombo A, 1999, EMBO J, V18, P2241, DOI 10.1093/emboj/18.8.2241; Potter MD, 2001, TRENDS CELL BIOL, V11, P112, DOI 10.1016/S0962-8924(00)01905-X; Rout MP, 2001, J BIOL CHEM, V276, P38261; Rudenko G, 1998, MOL BIOCHEM PARASIT, V95, P97, DOI 10.1016/S0166-6851(98)00099-1; RUDENKO G, 1989, EMBO J, V8, P4259, DOI 10.1002/j.1460-2075.1989.tb08611.x; Seiser RM, 2000, J BIOL CHEM, V275, P33820, DOI 10.1074/jbc.M004462200; Sheader K, 2005, P NATL ACAD SCI USA, V102, P8716, DOI 10.1073/pnas.0501886102; Sheader K, 2004, J BIOL CHEM, V279, P13363, DOI 10.1074/jbc.M312307200; Sivan G, 2007, MOL CELL BIOL, V27, P6639, DOI 10.1128/MCB.00798-07; Taylor JE, 2006, TRENDS GENET, V22, P614, DOI 10.1016/j.tig.2006.08.003; Tkacz ID, 2007, RNA, V13, P30, DOI 10.1261/rna.174307; Valdes J, 1996, NUCLEIC ACIDS RES, V24, P1809, DOI 10.1093/nar/24.10.1809; Wek RC, 2007, ANTIOXID REDOX SIGN, V9, P2357, DOI 10.1089/ars.2007.1764; Westermeier Reiner, 2008, V424, P73, DOI 10.1007/978-1-60327-064-9_7; Wirtz E, 1999, MOL BIOCHEM PARASIT, V99, P89, DOI 10.1016/S0166-6851(99)00002-X	59	38	39	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7532	10.1371/journal.pone.0007532	http://dx.doi.org/10.1371/journal.pone.0007532			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855834	Green Published, Green Accepted, gold			2022-12-27	WOS:000271147200001
J	Gilliland, WD; Vietti, DL; Schweppe, NM; Guo, FL; Johnson, TJ; Hawley, RS				Gilliland, William D.; Vietti, Dana L.; Schweppe, Nicole M.; Guo, Fengli; Johnson, Teri J.; Hawley, R. Scott			Hypoxia Transiently Sequesters Mps1 and Polo to Collagenase-Sensitive Filaments in Drosophila Prometaphase Oocytes	PLOS ONE			English	Article							EARLY EMBRYOGENESIS; SPINDLE CHECKPOINT; MEIOTIC SPINDLE; CYCLIN-B; PROTEIN; KINASE; MELANOGASTER; OOGENESIS; CHROMOSOMES; SEGREGATION	Background: The protein kinases Mps1 and Polo, which are required for proper cell cycle regulation in meiosis and mitosis, localize to numerous ooplasmic filaments during prometaphase in Drosophila oocytes. These filaments first appear throughout the oocyte at the end of prophase and are disassembled after egg activation. Methodology/Principal Findings: We showed here that Mps1 and Polo proteins undergo dynamic and reversible localization to static ooplasmic filaments as part of an oocyte-specific response to hypoxia. The observation that Mps1- and Polo-associated filaments reappear in the same locations through multiple cycles of oxygen deprivation demonstrates that underlying structural components of the filaments must still be present during normoxic conditions. Using immuno-electron microscopy, we observed triple-helical binding of Mps1 to numerous electron-dense filaments, with the gold label wrapped around the outside of the filaments like a garland. In addition, we showed that in live oocytes the relocalization of Mps1 and Polo to filaments is sensitive to injection of collagenase, suggesting that the structural components of the filaments are composed of collagen-like fibrils. However, the collagen-like genes we have been able to test so far (vkg and CG42453) did not appear to be associated with the filaments, demonstrating that the collagenase-sensitive component of the filaments is one of a number of other Drosophila proteins bearing a collagenase cleavage site. Finally, as hypoxia is known to cause Mps1 protein to accumulate at kinetochores in syncytial embryos, we also show that GFP-Polo accumulates at both kinetochores and centrosomes in hypoxic syncytial embryos. Conclusions/Significance: These findings identify both a novel cellular structure (the ooplasmic filaments) as well as a new localization pattern for Mps1 and Polo and demonstrate that hypoxia affects Polo localization in Drosophila.			Gilliland, WD (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	wgillila@depaul.edu		Hawley, R. Scott/0000-0002-6478-0494				Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Bashkirov PV, 2008, CELL, V135, P1276, DOI 10.1016/j.cell.2008.11.028; BLUMBERG B, 1988, J BIOL CHEM, V263, P18328; Bonde P, 2007, J THORAC CARDIOV SUR, V133, P763, DOI 10.1016/j.jtcvs.2006.07.044; BRAND AH, 1994, GENE DEV, V8, P629, DOI 10.1101/gad.8.5.629; Campellone KG, 2008, CELL, V134, P148, DOI 10.1016/j.cell.2008.05.032; Castillo AR, 2002, J CELL BIOL, V156, P453, DOI 10.1083/jcb.200111025; Duman JG, 2002, J CELL SCI, V115, P1251; Fischer MG, 2004, CURR BIOL, V14, P2019, DOI 10.1016/j.cub.2004.11.008; FOE VE, 1985, J CELL BIOL, V100, P1623, DOI 10.1083/jcb.100.5.1623; Gilliland WD, 2005, CURR BIOL, V15, P672; Gilliland WD, 2007, PLOS GENET, V3, P1178, DOI 10.1371/journal.pgen.0030113; Gilliland WD, 2009, DEV BIOL, V325, P122, DOI 10.1016/j.ydbio.2008.10.003; Heeger S, 2005, GENE DEV, V19, P2041, DOI 10.1101/gad.347805; HINTON HE, 1969, ANNU REV ENTOMOL, V14, P343, DOI 10.1146/annurev.en.14.010169.002015; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; Hughes SE, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000348; Hynes RO, 2000, J CELL BIOL, V150, pF89, DOI 10.1083/jcb.150.2.F89; Jacobs HW, 1998, GENE DEV, V12, P3741, DOI 10.1101/gad.12.23.3741; King R. C., 1970, OVARIAN DEV DROSOPHI; KNIBIEHLER B, 1990, CELL DIFFER DEV, V30, P147, DOI 10.1016/0922-3371(90)90082-8; Kramer J, 2003, NAT CELL BIOL, V5, P261, DOI 10.1038/ncb944; LEPARCO Y, 1986, BIOL CELL, V56, P217; MAHAJANMIKLOS S, 1994, DEV BIOL, V165, P336, DOI 10.1006/dbio.1994.1257; MAHOWALD AP, 1980, GENET BIOL DROSOPHIL, P141; Monen J, 2005, NAT CELL BIOL, V7, P1248, DOI 10.1038/ncb1331; Morin X, 2001, P NATL ACAD SCI USA, V98, P15050, DOI 10.1073/pnas.261408198; Moutinho-Santos T, 1999, BIOL CELL, V91, P585, DOI 10.1016/S0248-4900(00)88523-8; OTOUSA J, 1982, GENETICS, V102, P503; Pandey R, 2007, J CELL SCI, V120, P2807, DOI 10.1242/jcs.007690; PARRY DAD, 1978, PROC R SOC SER B-BIO, V203, P305, DOI 10.1098/rspb.1978.0107; Pucadyil TJ, 2008, CELL, V135, P1263, DOI 10.1016/j.cell.2008.11.020; SPRADLING AC, 1994, DEV DROSOPHILA MELAN, P1; Stucke VM, 2002, EMBO J, V21, P1723, DOI 10.1093/emboj/21.7.1723; Sullivan W., 2000, DROSOPHILA PROTOCOLS; THEURKAUF WE, 1992, J CELL BIOL, V116, P1167, DOI 10.1083/jcb.116.5.1167; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Tran DH, 2003, DEVELOPMENT, V130, P6273, DOI 10.1242/dev.00854; VARDY L, 2009, P NATL ACAD SCI US; Vardy L, 2007, DEV CELL, V12, P157, DOI 10.1016/j.devcel.2006.10.017; Winey M, 2002, ONCOGENE, V21, P6161, DOI 10.1038/sj.onc.1205712; Worthington C., 1993, WORTHINGTON ENZYME M; Xiang Y, 2007, PLOS BIOL, V5, P2831, DOI 10.1371/journal.pbio.0050323; Yang YL, 2008, CANCER RES, V68, P4077, DOI 10.1158/0008-5472.CAN-07-6182	44	5	5	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7544	10.1371/journal.pone.0007544	http://dx.doi.org/10.1371/journal.pone.0007544			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847308	Green Published, gold, Green Submitted			2022-12-27	WOS:000271022000013
J	Selinummi, J; Ruusuvuori, P; Podolsky, I; Ozinsky, A; Gold, E; Yli-Harja, O; Aderem, A; Shmulevich, I				Selinummi, Jyrki; Ruusuvuori, Pekka; Podolsky, Irina; Ozinsky, Adrian; Gold, Elizabeth; Yli-Harja, Olli; Aderem, Alan; Shmulevich, Ilya			Bright Field Microscopy as an Alternative to Whole Cell Fluorescence in Automated Analysis of Macrophage Images	PLOS ONE			English	Article							SEGMENTATION	Background: Fluorescence microscopy is the standard tool for detection and analysis of cellular phenomena. This technique, however, has a number of drawbacks such as the limited number of available fluorescent channels in microscopes, overlapping excitation and emission spectra of the stains, and phototoxicity. Methodology: We here present and validate a method to automatically detect cell population outlines directly from bright field images. By imaging samples with several focus levels forming a bright field z -stack, and by measuring the intensity variations of this stack over the z -dimension, we construct a new two dimensional projection image of increased contrast. With additional information for locations of each cell, such as stained nuclei, this bright field projection image can be used instead of whole cell fluorescence to locate borders of individual cells, separating touching cells, and enabling single cell analysis. Using the popular CellProfiler freeware cell image analysis software mainly targeted for fluorescence microscopy, we validate our method by automatically segmenting low contrast and rather complex shaped murine macrophage cells. Significance: The proposed approach frees up a fluorescence channel, which can be used for subcellular studies. It also facilitates cell shape measurement in experiments where whole cell fluorescent staining is either not available, or is dependent on a particular experimental condition. We show that whole cell area detection results using our projected bright field images match closely to the standard approach where cell areas are localized using fluorescence, and conclude that the high contrast bright field projection image can directly replace one fluorescent channel in whole cell quantification. Matlab code for calculating the projections can be downloaded from the supplementary site: http://sites.google.com/site/brightfieldorstaining			Selinummi, J (corresponding author), Inst Syst Biol, Seattle, WA USA.	ishmulevich@systemsbiology.org	Ruusuvuori, Pekka/AAC-2617-2022; Ruusuvuori, Pekka/C-9229-2016	Ruusuvuori, Pekka/0000-0001-9086-9591; Yli-Harja, Olli/0000-0001-8581-4414	NIGMS NIH HHS [P50 GM076547] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM076547] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Ali R, 2008, I S BIOMED IMAGING, P181, DOI 10.1109/ISBI.2008.4540962; Bolte S, 2006, J MICROSC-OXFORD, V224, P213, DOI 10.1111/j.1365-2818.2006.01706.x; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen TB, 2008, J BIOMED INFORM, V41, P1021, DOI 10.1016/j.jbi.2008.02.007; Curl CL, 2005, CYTOM PART A, V65A, P88, DOI 10.1002/cyto.a.20134; Fawcett T, 2006, PATTERN RECOGN LETT, V27, P861, DOI 10.1016/j.patrec.2005.10.010; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Jones TR, 2005, LECT NOTES COMPUT SC, V3765, P535; Korzynska A, 2007, PATTERN ANAL APPL, V10, P301, DOI 10.1007/s10044-007-0069-7; Kvarnstrom M, 2008, OPT EXPRESS, V16, P12943, DOI 10.1364/OE.16.012943; Long X, 2008, IMAGE VISION COMPUT, V26, P578, DOI 10.1016/j.imavis.2007.07.004; Moffat J, 2006, CELL, V124, P1283, DOI 10.1016/j.cell.2006.01.040; Molder A, 2008, J MICROSC-OXFORD, V232, P240, DOI 10.1111/j.1365-2818.2008.02095.x; Niemistoe A, 2007, P ANN INT IEEE EMBS, P5559, DOI 10.1109/IEMBS.2007.4353606; Pacheco P, 2007, J IMMUNOL, V179, P8500, DOI 10.4049/jimmunol.179.12.8500; Schlumberger MC, 2007, MOL MICROBIOL, V65, P741, DOI 10.1111/j.1365-2958.2007.05823.x; Zimmer C, 2006, IEEE SIGNAL PROC MAG, V23, P54, DOI 10.1109/MSP.2006.1628878	18	71	76	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7497	10.1371/journal.pone.0007497	http://dx.doi.org/10.1371/journal.pone.0007497			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847301	Green Published, Green Submitted, gold			2022-12-27	WOS:000271022000009
J	Mendoza-Vargas, A; Olvera, L; Olvera, M; Grande, R; Vega-Alvarado, L; Taboada, B; Jimenez-Jacinto, V; Salgado, H; Juarez, K; Contreras-Moreira, B; Huerta, AM; Collado-Vides, J; Morett, E				Mendoza-Vargas, Alfredo; Olvera, Leticia; Olvera, Maricela; Grande, Ricardo; Vega-Alvarado, Leticia; Taboada, Blanca; Jimenez-Jacinto, Veronica; Salgado, Heladia; Juarez, Katy; Contreras-Moreira, Bruno; Huerta, Araceli M.; Collado-Vides, Julio; Morett, Enrique			Genome-Wide Identification of Transcription Start Sites, Promoters and Transcription Factor Binding Sites in E. coli	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; PROTEIN H-NS; ESCHERICHIA-COLI; RNA-POLYMERASE; MESSENGER-RNA; GENE-EXPRESSION; DNA-SEQUENCES; SIGMA-FACTOR; GROWTH; K-12	Despite almost 40 years of molecular genetics research in Escherichia coli a major fraction of its Transcription Start Sites (TSSs) are still unknown, limiting therefore our understanding of the regulatory circuits that control gene expression in this model organism. RegulonDB (http://regulondb.ccg.unam.mx/) is aimed at integrating the genetic regulatory network of E. coli K12 as an entirely bioinformatic project up till now. In this work, we extended its aims by generating experimental data at a genome scale on TSSs, promoters and regulatory regions. We implemented a modified 59 RACE protocol and an unbiased High Throughput Pyrosequencing Strategy (HTPS) that allowed us to map more than 1700 TSSs with high precision. From this collection, about 230 corresponded to previously reported TSSs, which helped us to benchmark both our methodologies and the accuracy of the previous mapping experiments. The other ca 1500 TSSs mapped belong to about 1000 different genes, many of them with no assigned function. We identified promoter sequences and type of sigma factors that control the expression of about 80% of these genes. As expected, the housekeeping sigma(70) was the most common type of promoter, followed by sigma(38). The majority of the putative TSSs were located between 20 to 40 nucleotides from the translational start site. Putative regulatory binding sites for transcription factors were detected upstream of many TSSs. For a few transcripts, riboswitches and small RNAs were found. Several genes also had additional TSSs within the coding region. Unexpectedly, the HTPS experiments revealed extensive antisense transcription, probably for regulatory functions. The new information in RegulonDB, now with more than 2400 experimentally determined TSSs, strengthens the accuracy of promoter prediction, operon structure, and regulatory networks and provides valuable new information that will facilitate the understanding from a global perspective the complex and intricate regulatory network that operates in E. coli.			Mendoza-Vargas, A (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular & Biocatalisis, Cuernavaca 62191, Morelos, Mexico.	emorett@ibt.unam.mx	Taboada, Blanca/A-3974-2019; Morett, Enrique/G-3401-2013; Contreras-Moreira, Bruno/G-4334-2011	JUAREZ, KATY/0000-0002-4400-4674; Morett, Enrique/0000-0001-5723-0032; Taboada, Blanca/0000-0003-1896-5962; Collado-Vides, Julio/0000-0001-8780-7664; Jimenez-Jacinto, Veronica/0000-0001-6742-1537; Contreras Moreira, Bruno/0000-0002-5462-907X	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071962] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM071962, GM071962-03] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abreu-Goodger C, 2004, TRENDS GENET, V20, P475, DOI 10.1016/j.tig.2004.08.003; BERK AJ, 1977, CELL, V12, P721, DOI 10.1016/0092-8674(77)90272-0; Bernstein JA, 2002, P NATL ACAD SCI USA, V99, P9697, DOI 10.1073/pnas.112318199; Brenner S, 2000, NAT BIOTECHNOL, V18, P630, DOI 10.1038/76469; BURGESS RR, 1969, NATURE, V221, P43, DOI 10.1038/221043a0; Burr T, 2000, NUCLEIC ACIDS RES, V28, P1864, DOI 10.1093/nar/28.9.1864; BYRNE CR, 1988, J BACTERIOL, V170, P3150, DOI 10.1128/jb.170.7.3150-3157.1988; BYSTROM AS, 1989, J MOL BIOL, V208, P575, DOI 10.1016/0022-2836(89)90149-6; COLE ST, 1982, MOL GEN GENET, V188, P472, DOI 10.1007/BF00330051; DERSCH P, 1993, MOL MICROBIOL, V8, P875, DOI 10.1111/j.1365-2958.1993.tb01634.x; Fickett JW, 1997, GENOME RES, V7, P861, DOI 10.1101/gr.7.9.861; Fong SS, 2004, NAT GENET, V36, P1056, DOI 10.1038/ng1432; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; GALAS DJ, 1985, J MOL BIOL, V186, P117, DOI 10.1016/0022-2836(85)90262-1; Gama-Castro S, 2008, NUCLEIC ACIDS RES, V36, pD120, DOI 10.1093/nar/gkm994; Gross CA, 1998, COLD SPRING HARB SYM, V63, P141, DOI 10.1101/sqb.1998.63.141; Gruber TM, 2003, ANNU REV MICROBIOL, V57, P441, DOI 10.1146/annurev.micro.57.030502.090913; HARLEY CB, 1987, NUCLEIC ACIDS RES, V15, P2343, DOI 10.1093/nar/15.5.2343; HAWLEY DK, 1983, NUCLEIC ACIDS RES, V11, P2237, DOI 10.1093/nar/11.8.2237; Herring CD, 2005, J BACTERIOL, V187, P6166, DOI 10.1128/JB.187.17.6166-6174.2005; Hertz GZ, 1999, BIOINFORMATICS, V15, P563, DOI 10.1093/bioinformatics/15.7.563; Huerta AM, 2003, J MOL BIOL, V333, P261, DOI 10.1016/j.jmb.2003.07.017; Huerta AM, 1998, NUCLEIC ACIDS RES, V26, P55, DOI 10.1093/nar/26.1.55; Huerta AM, 2006, PLOS GENET, V2, P1740, DOI 10.1371/journal.pgen.0020185; Isaacs FJ, 2004, NAT BIOTECHNOL, V22, P841, DOI 10.1038/nbt986; Kanhere A, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-1; Ko JH, 2006, FEBS LETT, V580, P539, DOI 10.1016/j.febslet.2005.12.066; LATEANA A, 1989, FEBS LETT, V244, P34, DOI 10.1016/0014-5793(89)81156-1; LIANG P, 1992, SCIENCE, V257, P967, DOI 10.1126/science.1354393; LISSER S, 1993, NUCLEIC ACIDS RES, V21, P1507, DOI 10.1093/nar/21.7.1507; Liu MY, 1997, J BIOL CHEM, V272, P17502, DOI 10.1074/jbc.272.28.17502; Losick R, 2008, SCIENCE, V320, P65, DOI 10.1126/science.1147888; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; McGrath PT, 2007, NAT BIOTECHNOL, V25, P584, DOI 10.1038/nbt1294; Merino E, 2005, TRENDS GENET, V21, P260, DOI 10.1016/j.tig.2005.03.002; Mitchell JE, 2003, NUCLEIC ACIDS RES, V31, P4689, DOI 10.1093/nar/gkg694; NAKAO T, 1987, MOL GEN GENET, V210, P364, DOI 10.1007/BF00325707; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; Ozoline ON, 1997, NUCLEIC ACIDS RES, V25, P4703, DOI 10.1093/nar/25.23.4703; Pedersen AG, 1999, COMPUT CHEM, V23, P191, DOI 10.1016/S0097-8485(99)00015-7; Richard DJ, 1999, MICROBIOL-SGM, V145, P2903, DOI 10.1099/00221287-145-10-2903; Roth ME, 2004, NAT BIOTECHNOL, V22, P418, DOI 10.1038/nbt948; Saha S, 2002, NAT BIOTECHNOL, V20, P508, DOI 10.1038/nbt0502-508; Salgado H, 2006, NUCLEIC ACIDS RES, V34, pD394, DOI 10.1093/nar/gkj156; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; SEEBURG PH, 1977, EUR J BIOCHEM, V74, P107, DOI 10.1111/j.1432-1033.1977.tb11372.x; Shendure J, 2008, NAT BIOTECHNOL, V26, P1135, DOI 10.1038/nbt1486; Shultzaberger RK, 2007, NUCLEIC ACIDS RES, V35, P771, DOI 10.1093/nar/gkl956; THOMPSON JA, 1979, J VIROL, V31, P437, DOI 10.1128/JVI.31.2.437-446.1979; Tjaden B, 2002, NUCLEIC ACIDS RES, V30, P3732, DOI 10.1093/nar/gkf505; TRAVERS AA, 1969, NATURE, V222, P537, DOI 10.1038/222537a0; Turatsinze JV, 2008, NAT PROTOC, V3, P1578, DOI 10.1038/nprot.2008.97; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484	53	187	190	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7526	10.1371/journal.pone.0007526	http://dx.doi.org/10.1371/journal.pone.0007526			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838305	Green Published, gold, Green Submitted			2022-12-27	WOS:000270880900016
J	Naqvi, HA; Hussain, S; Zaman, M; Islam, M				Naqvi, Haider A.; Hussain, Sajjad; Zaman, Muhammad; Islam, Mohammad			Pathways to Care: Duration of Untreated Psychosis from Karachi, Pakistan	PLOS ONE			English	Article							1ST-EPISODE PSYCHOSIS; EARLY INTERVENTION; MENTAL-DISORDERS; SCHIZOPHRENIA; DELAY; HELP; PREVALENCE	Background: Substantial amount of time is lost before initiation of treatment in Schizophrenia. The delay in treatment is labelled as Duration of Untreated Psychosis (DUP). Most of these estimates come from western countries, where health systems are relatively better developed. There is dearth of information on pathway to care from developing countries. Methods and Results: Patients with ICD-10 based diagnosis of Schizophrenia were enrolled by convenient method of sampling. The pathway to care was explored through a semi-structured questionnaire. Onset, course and symptoms of psychosis were assessed using Interview for the Retrospective Assessment of the Onset of Schizophrenia (IRAOS). Ethical approval of the project was taken from The Aga Khan University, Ethics Review Committee. Of the enrolled 93 subjects, 55 (59%) were males and 38 (41%) were females. In our sample, 1.56 mean (median, 2) attempts were made prior to successful help seeking. The duration of untreated psychosis was 14.8 months (St. Deviation; 29.4). DUP was 16.8 months (St. Deviation; 34.9) for males and 11.8 months (St. Deviation; 18.9) for females. In the pathway to care, psychiatrists featured prominently as initial care providers. In the first attempt at help-seeking, 43% patients were initially taken to psychiatrists. After the initial consultation, 45% were prescribed psychotropic medication while 7% were hospitalized. Only 9% subjects were given the diagnosis of schizophrenia initially. When participants were inquired about the reasons for delay, 29% reported financial difficulties as the barrier to care. Positive symptoms of psychosis were present in 57% subjects while negative symptoms were present in 30% subjects. There was a statistically significant difference (Chi-square; 7.928, df: 1, Sig 0.005) between DUP and the positive and negative symptoms category. Conclusion: In the absence of well developed primary care health system in Pakistan, majority of patients present to psychiatrists as a first contact. DUP, as a measurement of help seeking behaviour, tends to be shorter with positive symptoms of Schizophrenia. Substantial amount of time is lost due to non recognition of disease and subsequently, inadequate treatment. Secondary prevention strategies should focus on families, which play an important role in the treatment-seeking process of psychotic patients.			Naqvi, HA (corresponding author), Aga Khan Univ, Dept Psychiat, Karachi, Pakistan.	haider.naqvi@aku.edu						Addington J, 2002, ACTA PSYCHIAT SCAND, V106, P358, DOI 10.1034/j.1600-0447.2002.02004.x; Appiah-Poku J, 2004, SOC PSYCH PSYCH EPID, V39, P208, DOI 10.1007/s00127-004-0725-9; Archie S, 2007, SCHIZOPHRENIA BULL, V33, P1354, DOI 10.1093/schbul/sbm011; Barnes TRE, 2000, BRIT J PSYCHIAT, V177, P207, DOI 10.1192/bjp.177.3.207; Bhui K, 2002, BRIT J PSYCHIAT, V181, P6, DOI 10.1192/bjp.181.1.6; Bhui K., 2002, ADV PSYCHIAT TREATME, V8, P26, DOI DOI 10.1192/APT.8.1.26; Drake RJ, 2000, BRIT J PSYCHIAT, V177, P511, DOI 10.1192/bjp.177.6.511; Goldberg K, 2006, CAN J PSYCHIAT, V51, P895, DOI 10.1177/070674370605101405; Hafner H, 1998, SOC PSYCH PSYCH EPID, V33, P380, DOI 10.1007/s001270050069; Larsen TK, 1996, SCHIZOPHRENIA BULL, V22, P241, DOI 10.1093/schbul/22.2.241; Lincoln C, 1998, BRIT J PSYCHIAT, V172, P21, DOI 10.1192/S0007125000297614; Malla AK, 2005, CAN J PSYCHIAT, V50, P881, DOI 10.1177/070674370505001402; MALLA AK, 1994, BRIT J PSYCHIAT, V164, P487, DOI 10.1192/bjp.164.4.487; MARINO S, 1995, PSYCHOL MED, V25, P1135, DOI 10.1017/S0033291700033110; McGorry PD, 2001, AM J PSYCHIAT, V158, P1161, DOI 10.1176/appi.ajp.158.7.1161-a; Naqvi Haider, 2005, J Coll Physicians Surg Pak, V15, P345; Naqvi Haider A, 2006, J Coll Physicians Surg Pak, V16, P438; Norman RMG, 2004, PSYCHOL MED, V34, P255, DOI 10.1017/S0033291703001119; Okazaki S, 2000, AM J ORTHOPSYCHIAT, V70, P58, DOI 10.1037/h0087751; Olin SCS, 1996, SCHIZOPHRENIA BULL, V22, P223, DOI 10.1093/schbul/22.2.223; Perkins DO, 2005, AM J PSYCHIAT, V162, P1785, DOI 10.1176/appi.ajp.162.10.1785; Perkins DO, 1999, SCHIZOPHR RES, V36, P52; PESCOSOLIDO BA, 1992, AM J SOCIOL, V97, P1096, DOI 10.1086/229863; Saeed K, 2000, SOC PSYCH PSYCH EPID, V35, P480, DOI 10.1007/s001270050267; ten Have M, 2003, ACTA PSYCHIAT SCAND, V107, P178, DOI 10.1034/j.1600-0447.2003.00074.x; Vaglum P, 1996, SCHIZOPHRENIA BULL, V22, P347, DOI 10.1093/schbul/22.2.347	26	25	26	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7409	10.1371/journal.pone.0007409	http://dx.doi.org/10.1371/journal.pone.0007409			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	505VX	19823577	Green Submitted, Green Published, gold			2022-12-27	WOS:000270728500010
J	Rohrbeck, A; Borlak, J				Rohrbeck, Astrid; Borlak, Juergen			Cancer Genomics Identifies Regulatory Gene Networks Associated with the Transition from Dysplasia to Advanced Lung Adenocarcinomas Induced by c-Raf-1	PLOS ONE			English	Article							BONE-MORPHOGENETIC PROTEIN; ENDOTHELIAL GROWTH-FACTOR; HORMONE-RELATED PEPTIDE; ADHESION MOLECULE L1; CELL-ADHESION; DOWN-REGULATION; BETA-CATENIN; VE-CADHERIN; MOUSE LUNG; L-SELECTIN	Background: Lung cancer is a leading cause of cancer morbidity. To improve an understanding of molecular causes of disease a transgenic mouse model was investigated where targeted expression of the serine threonine kinase c-Raf to respiratory epithelium induced initialy dysplasia and subsequently adenocarcinomas. This enables dissection of genetic events associated with precancerous and cancerous lesions. Methodology/Principal Findings: By laser microdissection cancer cell populations were harvested and subjected to whole genome expression analyses. Overall 473 and 541 genes were significantly regulated, when cancer versus transgenic and non-transgenic cells were compared, giving rise to three distinct and one common regulatory gene network. At advanced stages of tumor growth predominately repression of gene expression was observed, but genes previously shown to be up-regulated in dysplasia were also up-regulated in solid tumors. Regulation of developmental programs as well as epithelial mesenchymal and mesenchymal endothelial transition was a hall mark of adenocarcinomas. Additionaly, genes coding for cell adhesion, i.e. the integrins and the tight and gap junction proteins were repressed, whereas ligands for receptor tyrosine kinase such as epi- and amphiregulin were up-regulated. Notably, Vegfr-2 and its ligand Vegfd, as well as Notch and Wnt signalling cascades were regulated as were glycosylases that influence cellular recognition. Other regulated signalling molecules included guanine exchange factors that play a role in an activation of the MAP kinases while several tumor suppressors i.e. Mcc, Hey1, Fat3, Armcx1 and Reck were significantly repressed. Finally, probable molecular switches forcing dysplastic cells into malignantly transformed cells could be identified. Conclusions/Significance: This study provides insight into molecular pertubations allowing dysplasia to progress further to adenocarcinoma induced by exaggerted c-Raf kinase activity.			Rohrbeck, A (corresponding author), Fraunhofer Inst Toxicol & Expt Med, Dept Mol Med & Med Biotechnol, Hannover, Germany.	borlak@item.fraunhofer.de						Achen MG, 2002, GROWTH FACTORS, V20, P99, DOI 10.1080/08977190290031969; Ackerman KG, 2007, AM J RESP CELL MOL, V36, P391, DOI 10.1165/rcmb.2006-0211RC; Ackerman KG, 2005, PLOS GENET, V1, P58, DOI 10.1371/journal.pgen.0010010; Anborgh PH, 1999, MOL CELL BIOL, V19, P4611; ANGGARD E, 1966, ACTA PHYSIOL SCAND, V66, P509, DOI 10.1111/j.1748-1716.1966.tb03231.x; ANGGARD E, 1964, J BIOL CHEM, V239, P4097; Anglim PP, 2008, MOL CANCER, V7, DOI 10.1186/1476-4598-7-62; Baccarini M, 2005, FEBS LETT, V579, P3271, DOI 10.1016/j.febslet.2005.03.024; Bakre MM, 2002, NAT MED, V8, P995, DOI 10.1038/nm753; Banerjee S, 2008, CANCER RES, V68, P7606, DOI 10.1158/0008-5472.CAN-08-1461; Baron M, 2003, SEMIN CELL DEV BIOL, V14, P113, DOI 10.1016/S1084-9521(02)00179-9; BASTIDE B, 1993, CIRC RES, V73, P1138, DOI 10.1161/01.RES.73.6.1138; Beale G, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-200; Belinsky SA, 1998, P NATL ACAD SCI USA, V95, P11891, DOI 10.1073/pnas.95.20.11891; BERGHOLTE JM, 1987, ARCH BIOCHEM BIOPHYS, V257, P444, DOI 10.1016/0003-9861(87)90589-3; Berthoud VA, 2004, CARDIOVASC RES, V62, P256, DOI 10.1016/j.cardiores.2003.12.021; Bhattacharya R, 2008, CELL MOTIL CYTOSKEL, V65, P708, DOI 10.1002/cm.20292; Birkenfeld J, 2008, TRENDS CELL BIOL, V18, P210, DOI 10.1016/j.tcb.2008.02.006; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; Bretscher A, 1999, CURR OPIN CELL BIOL, V11, P109, DOI 10.1016/S0955-0674(99)80013-1; Brunner TB, 2003, CANCER RES, V63, P5656; Burstein HJ, 2008, CLIN CANCER RES, V14, P7871, DOI 10.1158/1078-0432.CCR-08-0593; BURTON PBJ, 1992, FEBS LETT, V305, P228, DOI 10.1016/0014-5793(92)80674-6; BURTON PBJ, 1990, BIOCHEM BIOPH RES CO, V167, P1134, DOI 10.1016/0006-291X(90)90641-Y; Caloca MJ, 2004, J BIOL CHEM, V279, P20435, DOI 10.1074/jbc.M313013200; Cao GY, 2002, AM J PHYSIOL-CELL PH, V282, pC1181, DOI 10.1152/ajpcell.00524.2001; Cao HN, 2001, J HUM GENET, V46, P730, DOI 10.1007/s100380170008; Cekanova M, 2007, CANCER-AM CANCER SOC, V109, P1164, DOI 10.1002/cncr.22520; CENTRELLA M, 1989, ENDOCRINOLOGY, V125, P199, DOI 10.1210/endo-125-1-199; Chang HY, 2004, PLOS BIOL, V2, P206, DOI 10.1371/journal.pbio.0020007; Chelly N, 1999, AM J RESP CELL MOL, V20, P423, DOI 10.1165/ajrcmb.20.3.3201; CHEN AJ, 1995, J EXP MED, V182, P519, DOI 10.1084/jem.182.2.519; CHOI PM, 1990, MOL CELL BIOL, V10, P4650, DOI 10.1128/MCB.10.9.4650; Clyde-Smith J, 2000, J BIOL CHEM, V275, P32260, DOI 10.1074/jbc.M006087200; CONNOLLY DJ, 1995, DEV GENET, V17, P65, DOI 10.1002/dvg.1020170108; Coyne CB, 2003, AM J PHYSIOL-LUNG C, V285, pL1166, DOI 10.1152/ajplung.00182.2003; Crijns APG, 2007, EUR J CANCER, V43, P2495, DOI 10.1016/j.ejca.2007.08.025; Dai ZY, 2004, ONCOGENE, V23, P3521, DOI 10.1038/sj.onc.1207441; Dang TP, 2000, J NATL CANCER I, V92, P1355, DOI 10.1093/jnci/92.16.1355; Debiec H, 1998, J CELL BIOL, V143, P2067, DOI 10.1083/jcb.143.7.2067; Denissenko MF, 1996, SCIENCE, V274, P430, DOI 10.1126/science.274.5286.430; Di Sciullo G, 1998, J EXP MED, V187, P1953, DOI 10.1084/jem.187.12.1953; Diehl D, 2009, INT J CANCER, V124, P2220, DOI 10.1002/ijc.24193; DIRKS RPH, 1993, EUR J BIOCHEM, V216, P487, DOI 10.1111/j.1432-1033.1993.tb18167.x; Dome B, 2006, CANCER RES, V66, P7341, DOI 10.1158/0008-5472.CAN-05-4654; DOOLITTLE RF, 1983, SCIENCE, V221, P275, DOI 10.1126/science.6304883; Drimal J, 2000, EUR J PHARMACOL, V396, P19, DOI 10.1016/S0014-2999(00)00198-9; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Eberhardt C, 1999, ADV EXP MED BIOL, V469, P351; Eberhart CG, 2001, PEDIATR DEVEL PATHOL, V4, P351, DOI 10.1007/s10024001-0037-y; ENSOR CM, 1995, J LIPID MEDIAT CELL, V12, P313, DOI 10.1016/0929-7855(95)00040-W; ESCH FS, 1987, MOL ENDOCRINOL, V1, P849, DOI 10.1210/mend-1-11-849; Eswarakumar VP, 2005, CYTOKINE GROWTH F R, V16, P139, DOI 10.1016/j.cytogfr.2005.01.001; Ferletta M, 2007, MOL CANCER RES, V5, P891, DOI 10.1158/1541-7786.MCR-07-0113; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Fischer A, 2007, CIRC RES, V100, P856, DOI 10.1161/01.RES.0000260913.95642.3b; Fisher A, 1998, BIOESSAYS, V20, P298, DOI 10.1002/(SICI)1521-1878(199804)20:4&lt;298::AID-BIES6&gt;3.0.CO;2-M; Fogel M, 2003, LANCET, V362, P869, DOI 10.1016/S0140-6736(03)14342-5; FONG KM, 1995, CANCER RES, V55, P220; Frints SGM, 2003, HUM MOL GENET, V12, P1463, DOI 10.1093/hmg/ddg165; Futaki S, 2004, MOL CELL BIOL, V24, P10492, DOI 10.1128/MCB.24.23.10492-10503.2004; Gavard J, 2008, NAT CELL BIOL, V10, P883, DOI 10.1038/ncb0808-883; Geerts D, 2003, CANCER LETT, V197, P87, DOI 10.1016/S0304-3835(03)00087-9; GEORGE JN, 1984, NEW ENGL J MED, V311, P1084, DOI 10.1056/NEJM198410253111705; GEORGE KM, 1994, DEVELOPMENT, V120, P2673; GRAHAM A, 1989, CELL, V57, P367, DOI 10.1016/0092-8674(89)90912-4; Gramantieri L, 2007, LIVER INT, V27, P997, DOI 10.1111/j.1478-3231.2007.01544.x; Grusch M, 2006, J HEPATOL, V45, P673, DOI 10.1016/j.jhep.2006.06.014; Gumbiner BM, 1996, CELL, V84, P345, DOI 10.1016/S0092-8674(00)81279-9; Guo LH, 2008, MOL CANCER RES, V6, P1421, DOI 10.1158/1541-7786.MCR-07-2175; Hamm A, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-25; HANSEN H, 1974, PROSTAGLANDINS, V12, P647; Heldin CH, 1998, BBA-REV CANCER, V1378, pF79, DOI 10.1016/S0304-419X(98)00015-8; Henderson AM, 2001, J BIOL CHEM, V276, P6169, DOI 10.1074/jbc.M008506200; Hershko AY, 2003, GENE, V302, P65, DOI 10.1016/S0378111902010910; Hiesberger T, 2005, J BIOL CHEM, V280, P10578, DOI 10.1074/jbc.M414121200; Hilden JM, 1997, BLOOD, V89, P3801, DOI 10.1182/blood.V89.10.3801.3801_3801_3805; Hishikawa D, 2008, P NATL ACAD SCI USA, V105, P2830, DOI 10.1073/pnas.0712245105; Hofmann K, 2000, TRENDS BIOCHEM SCI, V25, P111, DOI 10.1016/S0968-0004(99)01539-X; Hsu SJ, 2004, GENOME, V47, P931, DOI 10.1139/G04-043; Huang CL, 2005, J CLIN ONCOL, V23, P8765, DOI 10.1200/JCO.2005.02.2871; Huang QH, 2004, P NATL ACAD SCI USA, V101, P3456, DOI 10.1073/pnas.0308562100; Huber O, 1996, CURR OPIN CELL BIOL, V8, P685, DOI 10.1016/S0955-0674(96)80110-4; HUNTER T, 1994, CELL, V79, P573, DOI 10.1016/0092-8674(94)90543-6; Hurbin A, 2002, J BIOL CHEM, V277, P49127, DOI 10.1074/jbc.M207584200; Huuskonen J, 2001, ATHEROSCLEROSIS, V155, P269, DOI 10.1016/S0021-9150(01)00447-6; Iemura S, 1998, P NATL ACAD SCI USA, V95, P9337, DOI 10.1073/pnas.95.16.9337; Isakson BE, 2003, AM J RESP CELL MOL, V29, P552, DOI 10.1165/rcmb.2002-0281OC; IWAMURA M, 1994, UROLOGY, V43, P675, DOI 10.1016/0090-4295(94)90183-X; Izumoto S, 1996, CANCER RES, V56, P1440; Ju Z, 2005, MOL GENET GENOMICS, V274, P141, DOI 10.1007/s00438-005-0014-7; KANG W, 2008, BIOCH BIOPHYS RES CO; Kaplan-Albuquerque N, 2005, J BIOL CHEM, V280, P19966, DOI 10.1074/jbc.M500917200; Katoh M, 2002, INT J MOL MED, V9, P363; Katoh Y, 2006, INT J MOL MED, V17, P1163; Kerkhoff E, 2000, CELL GROWTH DIFFER, V11, P185; KIKUCHI K, 1993, BIOCHEM BIOPH RES CO, V196, P409, DOI 10.1006/bbrc.1993.2264; KINZLER KW, 1991, SCIENCE, V251, P1366, DOI 10.1126/science.1848370; Kitareewan S, 2008, INT J ONCOL, V33, P397, DOI 10.3892/ijo_00000021; KOHNO T, 1995, HUM MOL GENET, V4, P667, DOI 10.1093/hmg/4.4.667; Kraunz KS, 2005, BRIT J CANCER, V93, P949, DOI 10.1038/sj.bjc.6602790; Krupp M, 2006, INT J MOL MED, V17, P129; Laakkonen P, 2007, CANCER RES, V67, P593, DOI 10.1158/0008-5472.CAN-06-3567; Lamberti A, 2007, CELL DEATH DIFFER, V14, P952, DOI 10.1038/sj.cdd.4402102; LASKY LA, 1992, SCIENCE, V258, P964, DOI 10.1126/science.1439808; Li DX, 2000, J CELL BIOL, V148, P791, DOI 10.1083/jcb.148.4.791; Li X, 2008, CANCER SCI, V99, P1326, DOI 10.1111/j.1349-7006.2008.00816.x; Liang S, 2007, J NEUROCHEM, V102, P1466, DOI 10.1111/j.1471-4159.2007.04507.x; Lindvall C, 2003, CANCER RES, V63, P1743; Liu L, 2006, CANCER RES, V66, P11851, DOI 10.1158/0008-5472.CAN-06-1377; Liu Y, 2009, LUNG CANCER, V63, P210, DOI 10.1016/j.lungcan.2008.05.010; Lories RJU, 2005, CYTOKINE GROWTH F R, V16, P287, DOI 10.1016/j.cytogfr.2005.02.009; Ma LL, 2006, J EXP CLIN CANC RES, V25, P585; Manenti G, 2000, ONCOGENE, V19, P5324, DOI 10.1038/sj.onc.1203916; Mansson-Broberg A, 2008, BIOCHEM BIOPH RES CO, V373, P355, DOI 10.1016/j.bbrc.2008.06.036; Marks JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000426; Matakidou A, 2007, BRIT J CANCER, V96, P1904, DOI 10.1038/sj.bjc.6603816; Matsumine A, 1996, J BIOL CHEM, V271, P10341, DOI 10.1074/jbc.271.17.10341; Matsumura T, 1997, J IMMUNOL, V158, P3408; Mbikay M, 1997, BRIT J CANCER, V75, P1509, DOI 10.1038/bjc.1997.258; Micke P, 2004, TUMOR BIOL, V25, P235, DOI 10.1159/000081386; Miyamori H, 2001, J BIOL CHEM, V276, P28204, DOI 10.1074/jbc.M103083200; Moldvay J, 2007, LUNG CANCER, V57, P159, DOI 10.1016/j.lungcan.2007.02.018; Morin PJ, 2005, CANCER RES, V65, P9603, DOI 10.1158/0008-5472.CAN-05-2782; MOSKOW JJ, 1995, MOL CELL BIOL, V15, P5434; Mucenski ML, 2003, J BIOL CHEM, V278, P40231, DOI 10.1074/jbc.M305892200; NAKAMURA T, 1990, SCIENCE, V247, P836, DOI 10.1126/science.2106159; Navarro P, 1998, J CELL BIOL, V140, P1475, DOI 10.1083/jcb.140.6.1475; Nickoloff BJ, 2003, ONCOGENE, V22, P6598, DOI 10.1038/sj.onc.1206758; Nolte C, 1999, CELL TISSUE RES, V298, P261, DOI 10.1007/s004419900063; NOMOTO K, 1995, MOL CARCINOGEN, V12, P146, DOI 10.1002/mc.2940120306; Oram JF, 2003, J BIOL CHEM, V278, P52379, DOI 10.1074/jbc.M310695200; Oreffo VIC, 1998, MOL CARCINOGEN, V21, P37, DOI 10.1002/(SICI)1098-2744(199801)21:1<37::AID-MC6>3.0.CO;2-M; Otsubo T, 2008, BRIT J CANCER, V98, P824, DOI 10.1038/sj.bjc.6604193; Packer AI, 2000, DEV DYNAM, V217, P62, DOI 10.1002/(SICI)1097-0177(200001)217:1<62::AID-DVDY6>3.0.CO;2-U; Perez OD, 2002, IMMUNITY, V16, P51, DOI 10.1016/S1074-7613(02)00266-2; Pirinen RT, 2001, J CLIN PATHOL, V54, P391, DOI 10.1136/jcp.54.5.391; Plastaras JP, 2007, CANCER RES, V67, P9443, DOI 10.1158/0008-5472.CAN-07-1473; Polakis P, 2000, GENE DEV, V14, P1837; Pongracz JE, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-15; Quaggin SE, 1999, DEVELOPMENT, V126, P5771; Rabbani SA, 2000, INT J ONCOL, V16, P197; RACHWAL WJ, 1995, BRIT J CANCER, V72, P56, DOI 10.1038/bjc.1995.277; Rahmani M, 2005, J BIOL CHEM, V280, P35217, DOI 10.1074/jbc.M506551200; Raman V, 2000, NATURE, V405, P974, DOI 10.1038/35016125; Ratain MJ, 2006, J CLIN ONCOL, V24, P2505, DOI 10.1200/JCO.2005.03.6723; Rauch T, 2007, P NATL ACAD SCI USA, V104, P5527, DOI 10.1073/pnas.0701059104; RECK M, 2008, J LUNG CANC; Ren RQ, 2007, BLOOD, V109, P2847, DOI 10.1182/blood-2006-08-039743; Rieger S, 2008, DEV DYNAM, V237, P276, DOI 10.1002/dvdy.21410; Rohrbeck A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005637; Rom WN, 2000, AM J RESP CRIT CARE, V161, P1355, DOI 10.1164/ajrccm.161.4.9908012; Roskoski R, 2005, BIOCHEM BIOPH RES CO, V337, P1, DOI 10.1016/j.bbrc.2005.08.055; Ruiz A, 1999, J BIOL CHEM, V274, P3834, DOI 10.1074/jbc.274.6.3834; Russell ST, 2002, BRIT J CANCER, V87, P580, DOI 10.1038/sj.bjc.6600493; Sales KJ, 2005, CANCER RES, V65, P7707, DOI 10.1158/0008-5472.CAN-05-0101; Schlatter MC, 2008, J NEUROCHEM, V104, P731, DOI 10.1111/j.1471-4159.2007.05013.x; Schmid RS, 2008, CURR OPIN NEUROBIOL, V18, P245, DOI 10.1016/j.conb.2008.07.015; Scurr LL, 2008, CLIN CANCER RES, V14, P6924, DOI 10.1158/1078-0432.CCR-07-5189; SERHAN CN, 1993, BIOCHEMISTRY-US, V32, P6313, DOI 10.1021/bi00076a002; Shanmugam K, 1999, MOL CELL BIOL, V19, P7577; Sharff KA, 2009, J BIOL CHEM, V284, P649, DOI 10.1074/jbc.M806389200; Shen R, 2002, MOL CELL BIOL, V22, P3230, DOI 10.1128/MCB.22.10.3230-3236.2002; Shepard CR, 2007, ONCOGENE, V26, P3020, DOI 10.1038/sj.onc.1210115; SHIMIZU T, 1990, J NEUROCHEM, V55, P1, DOI 10.1111/j.1471-4159.1990.tb08813.x; Simon MP, 1997, NAT GENET, V15, P95, DOI 10.1038/ng0197-95; Simone NL, 1998, TRENDS GENET, V14, P272, DOI 10.1016/S0168-9525(98)01489-9; Smith LT, 2006, P NATL ACAD SCI USA, V103, P982, DOI 10.1073/pnas.0510171102; SMITS A, 1992, AM J PATHOL, V140, P639; Smolen JE, 2000, J BIOL CHEM, V275, P15876, DOI 10.1074/jbc.M906232199; Smythe WR, 1999, LUNG CANCER-J IASLC, V24, P157, DOI 10.1016/S0169-5002(99)00032-X; SOMERSALO K, 1995, J BIOL CHEM, V270, P8629, DOI 10.1074/jbc.270.15.8629; Soriano JV, 2000, INT J CANCER, V86, P652; STAUNTON DE, 1989, NATURE, V339, P61, DOI 10.1038/339061a0; Strathdee G, 2007, CLIN CANCER RES, V13, P5048, DOI 10.1158/1078-0432.CCR-07-0919; Suzuki Y, 2008, J BIOCHEM, V143, P199, DOI 10.1093/jb/mvm215; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Takai E, 1996, CANCER-AM CANCER SOC, V78, P1384, DOI 10.1002/(SICI)1097-0142(19961001)78:7<1384::AID-CNCR3>3.0.CO;2-L; Tanaka H, 2004, CLIN CANCER RES, V10, P4885, DOI 10.1158/1078-0432.CCR-0393-03; Tardif G, 2004, ARTHRITIS RHEUM-US, V50, P2521, DOI 10.1002/art.20441; Taylor KL, 2002, MICROVASC RES, V64, P372, DOI 10.1006/mvre.2002.2443; TEDDER TF, 1995, FASEB J, V9, P866, DOI 10.1096/fasebj.9.10.7542213; Thies A, 2002, EUR J CANCER, V38, P1708, DOI 10.1016/S0959-8049(02)00105-3; THOMAS GMH, 1993, CELL, V74, P919, DOI 10.1016/0092-8674(93)90471-2; Thomas RK, 2006, CLIN CANCER RES, V12, p4384S, DOI 10.1158/1078-0432.CCR-06-0098; Tonary AM, 2000, INT J CANCER, V89, P242, DOI 10.1002/1097-0215(20000520)89:3<242::AID-IJC6>3.0.CO;2-6; Toyoda H, 1997, BIOCHEM J, V326, P69, DOI 10.1042/bj3260069; Tsai FY, 1997, BLOOD, V89, P3636, DOI 10.1182/blood.V89.10.3636.3636_3636_3643; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Udaka N, 2007, CANCER LETT, V246, P224, DOI 10.1016/j.canlet.2006.02.020; Ueda S, 2002, BLOOD, V99, P3342, DOI 10.1182/blood.V99.9.3342; ULICH TR, 1994, J CLIN INVEST, V93, P1298, DOI 10.1172/JCI117086; Ulrich K, 2005, AM J PHYSIOL-LUNG C, V288, pL1179, DOI 10.1152/ajplung.00450.2004; Uyttendaele H, 1996, DEVELOPMENT, V122, P2251; Veninga H, 2008, J IMMUNOL, V181, P6574, DOI 10.4049/jimmunol.181.9.6574; Vidal VPI, 2008, J CUTAN PATHOL, V35, P373, DOI 10.1111/j.1600-0560.2007.00815.x; Volpe MV, 2000, BBA-GEN SUBJECTS, V1475, P337, DOI 10.1016/S0304-4165(00)00087-8; WADDELL TK, 1995, J BIOL CHEM, V270, P15403, DOI 10.1074/jbc.270.25.15403; Walsh CM, 2007, DEVELOPMENT, V134, P3585, DOI 10.1242/dev.009522; Wang FS, 2003, AM J RESP CELL MOL, V29, P62, DOI 10.1165/rcmb.2002-0180OC; Warn-Cramer BJ, 2004, BBA-BIOMEMBRANES, V1662, P81, DOI 10.1016/j.bbamem.2003.10.018; WATERFIELD MD, 1983, NATURE, V304, P35, DOI 10.1038/304035a0; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Wikstrom P, 2002, PROSTATE, V51, P268, DOI 10.1002/pros.10083; Wilhelm SM, 2004, CANCER RES, V64, P7099, DOI 10.1158/0008-5472.CAN-04-1443; Wissmann C, 2003, J PATHOL, V201, P204, DOI 10.1002/path.1449; Wodarz A, 1998, ANNU REV CELL DEV BI, V14, P59, DOI 10.1146/annurev.cellbio.14.1.59; Woenckhaus M, 2006, J PATHOL, V210, P192, DOI 10.1002/path.2039; Wolfbauer G, 1999, BBA-MOL CELL BIOL L, V1439, P65, DOI 10.1016/S1388-1981(99)00077-3; Wright JK, 2008, TUMOR BIOL, V29, P130, DOI 10.1159/000141918; Wu DF, 2007, J BIOL CHEM, V282, P22239, DOI 10.1074/jbc.M700941200; Wu JH, 2008, J BIOL CHEM, V283, P3942, DOI 10.1074/jbc.M707882200; Wu Q, 1999, CELL, V97, P779, DOI 10.1016/S0092-8674(00)80789-8; Wu Q, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-45; Xie Y, 2007, CARCINOGENESIS, V28, P2122, DOI 10.1093/carcin/bgm147; Yamada Y, 2000, P NATL ACAD SCI USA, V97, P320, DOI 10.1073/pnas.97.1.320; Yamayoshi T, 2004, J PATHOL, V204, P110, DOI 10.1002/path.1617; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; You L, 2004, ONCOGENE, V23, P6170, DOI 10.1038/sj.onc.1207844; Younes R N, 2000, Rev Hosp Clin Fac Med Sao Paulo, V55, P181; Yu CR, 2005, ONCOGENE, V24, P6861, DOI 10.1038/sj.onc.1208841; ZAKUT R, 1993, ONCOGENE, V8, P2221; Zhang W, 2008, LEUKEMIA, V22, P808, DOI 10.1038/sj.leu.2405098; Zhang YZ, 2007, DEVELOPMENT, V134, P189, DOI 10.1242/dev.02720; Zhou YH, 1998, EMBO J, V17, P6689, DOI 10.1093/emboj/17.22.6689	226	25	26	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7315	10.1371/journal.pone.0007315	http://dx.doi.org/10.1371/journal.pone.0007315			26	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812696	Green Published, Green Submitted, gold			2022-12-27	WOS:000270594200001
J	Bijen, CBM; Vermeulen, KM; Mourits, MJE; de Bock, GH				Bijen, Claudia B. M.; Vermeulen, Karin M.; Mourits, Marian J. E.; de Bock, Geertruida H.			Costs and Effects of Abdominal versus Laparoscopic Hysterectomy: Systematic Review of Controlled Trials	PLOS ONE			English	Article								Objective: Comparative evaluation of costs and effects of laparoscopic hysterectomy (LH) and abdominal hysterectomy (AH). Data sources: Controlled trials from Cochrane Central register of controlled trials, Medline, Embase and prospective trial registers. Selection of studies: Twelve (randomized) controlled studies including the search terms costs, laparoscopy, laparotomy and hysterectomy were identified. Methods: The type of cost analysis, perspective of cost analyses and separate cost components were assessed. The direct and indirect costs were extracted from the original studies. For the cost estimation, hospital stay and procedure costs were selected as most important cost drivers. As main outcome the major complication rate was taken. Findings: Analysis was performed on 2226 patients, of which 1013 (45.5%) in the LH group and 1213 (54.5%) in the AH group. Five studies scored >= 10 points (out of 19) for methodological quality. The reported total direct costs in the LH group ($63,997) were 6.1% higher than the AH group ($60,114). The reported total indirect costs of the LH group ($1,609) were half of the total indirect in the AH group ($3,139). The estimated mean major complication rate in the LH group (14.3%) was lower than in the AH group (15.9%). The estimated total costs in the LH group were $3,884 versus $3,312 in the AH group. The incremental costs for reducing one patient with major complication(s) in the LH group compared to the AH group was $35,750. Conclusions: The shorter hospital stay in the LH group compensates for the increased procedure costs, with less morbidity. LH points in the direction of cost effectiveness, however further research is warranted with a broader costs perspective including long term effects as societal benefit, quality of life and survival.			Bijen, CBM (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Gynecol Oncol, Groningen, Netherlands.	g.h.de.bock@epi.umcg.nl	de Bock, Geertruida Hendrika/F-6529-2014	de Bock, Geertruida Hendrika/0000-0003-3104-4471				Abdelmonem A, 2006, J REPROD MED, V51, P945; Appleby J, 2007, BRIT MED J, V335, P358, DOI 10.1136/bmj.39308.560069.BE; Bijen CBM, 2009, BMC CANCER, V9, DOI 10.1186/1471-2407-9-23; BORNSTEIN SJ, 1995, J REPROD MED, V40, P435; Chapron C, 2000, EUR J OBSTET GYN R B, V89, P141, DOI 10.1016/S0301-2115(99)00220-1; Doucette RC, 1996, J REPROD MED, V41, P1; Ellstrom M, 1998, OBSTET GYNECOL, V91, P30, DOI 10.1016/S0029-7844(97)00579-6; Eltabbakh GH, 2000, GYNECOL ONCOL, V78, P58, DOI 10.1006/gyno.2000.5828; Eltabbakh GH, 2001, CANCER-AM CANCER SOC, V91, P378, DOI 10.1002/1097-0142(20010115)91:2<378::AID-CNCR1012>3.0.CO;2-F; Falcone T, 1999, AM J OBSTET GYNECOL, V180, P955, DOI 10.1016/S0002-9378(99)70667-8; Franchi M, 2001, OBSTET GYNECOL, V97, P696, DOI 10.1016/S0029-7844(01)01192-9; Garry R, 2004, HEALTH TECHNOL ASSES, V8, P1; Garry R, 2004, BRIT MED J, V328, P129, DOI 10.1136/bmj.37984.623889.F6; Gemignani ML, 1999, GYNECOL ONCOL, V73, P5, DOI 10.1006/gyno.1998.5311; *GOG LAP2, 2009, CDR0000064513 GOGLAP; Harkki-Siren P, 2000, ACTA OBSTET GYN SCAN, V79, P866, DOI 10.1034/j.1600-0412.2000.079010866.x; Holub Z, 2003, EUR J OBSTET GYN R B, V107, P195, DOI 10.1016/S0301-2115(02)00373-1; Holub Z, 1999, EUR J GYNAECOL ONCOL, V20, P268; HOWARD FM, 1993, J GYNECOL SURG, V9, P83, DOI 10.1089/gyn.1993.9.83; Janda M, 2006, CONTEMP CLIN TRIALS, V27, P353, DOI 10.1016/j.cct.2006.03.004; Kung FT, 1996, J FORMOS MED ASSOC, V95, P769; Kunz G, 1996, GEBURTSH FRAUENHEILK, V56, P453, DOI 10.1055/s-2007-1022286; Langebrekke A, 1996, ACTA OBSTET GYN SCAN, V75, P404, DOI 10.3109/00016349609033340; Leng Jin-hua, 2004, Zhonghua Fu Chan Ke Za Zhi, V39, P315; Lowell L, 2000, J REPROD MED, V45, P738; Lumsden MA, 2000, BRIT J OBSTET GYNAEC, V107, P1386, DOI 10.1111/j.1471-0528.2000.tb11653.x; Manolitsas TP, 2002, J AM ASSOC GYN LAP, V9, P54, DOI 10.1016/S1074-3804(05)60105-3; Moher D, 1999, LANCET, V354, P1896, DOI 10.1016/S0140-6736(99)04149-5; *NAT CANC I, 2009, CTEP NCI GUID ADV EV; Obermair A, 2005, INT J GYNECOL CANCER, V15, P319, DOI 10.1111/j.1525-1438.2005.15223.x; Olsson, 1996, J Am Assoc Gynecol Laparosc, V3, pS37, DOI 10.1016/S1074-3804(96)80260-X; OOSTENBRINK JB, 2004, GUIDELINES COST STUD; Perino A, 1999, HUM REPROD, V14, P2996, DOI 10.1093/humrep/14.12.2996; RAJU KS, 1994, BRIT J OBSTET GYNAEC, V101, P1068, DOI 10.1111/j.1471-0528.1994.tb13583.x; RAJU KS, 1994, J AM ASSOC GYN LAP, V1, P111, DOI 10.1016/S1074-3804(05)80772-8; REICH H, 1989, BAILLIERE CLIN OB GY, V3, P655, DOI 10.1016/S0950-3552(89)80015-X; Roumm Adam R, 2005, Surg Innov, V12, P261, DOI 10.1177/155335060501200313; Schneider A, 1997, ARCH GYNECOL OBSTET, V259, P79, DOI 10.1007/BF02505313; SCHULZ KF, 1995, JAMA-J AM MED ASSOC, V273, P408, DOI 10.1001/jama.273.5.408; Sculpher M, 2004, BMJ-BRIT MED J, V328, P134, DOI 10.1136/bmj.37942.601331.EE; SEMM K, 1984, FORTSCHR MED, V102, P534; Seracchioli R, 2002, J AM ASSOC GYN LAP, V9, P333, DOI 10.1016/S1074-3804(05)60413-6; Sibbald B, 1998, BRIT MED J, V316, P201; Subak LL, 2000, CLIN OBSTET GYNECOL, V43, P551, DOI 10.1097/00003081-200009000-00016; Summitt RL, 1998, OBSTET GYNECOL, V92, P321, DOI 10.1016/S0029-7844(98)00229-4; Van den Eeden SK, 1998, AM J OBSTET GYNECOL, V178, P91, DOI 10.1016/S0002-9378(98)70633-7	46	60	62	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7340	10.1371/journal.pone.0007340	http://dx.doi.org/10.1371/journal.pone.0007340			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19806210	Green Submitted, gold, Green Published			2022-12-27	WOS:000270593600013
J	Lerner, HRL; Johnson, JA; Lindsay, AR; Kiff, LF; Mindell, DP				Lerner, Heather R. L.; Johnson, Jeff A.; Lindsay, Alec R.; Kiff, Lloyd F.; Mindell, David P.			It's not too Late for the Harpy Eagle (Harpia harpyja): High Levels Of Genetic Diversity and Differentiation Can Fuel Conservation Programs	PLOS ONE			English	Article							EFFECTIVE POPULATION SIZES; MAXIMUM-LIKELIHOOD-ESTIMATION; DNA CONTROL REGION; STATISTICAL TESTS; PAIRWISE; HISTORY; PHYLOGEOGRAPHY; COALESCENT; VEGETATION; NEUTRALITY	Background: The harpy eagle (Harpia harpyja) is the largest Neotropical bird of prey and is threatened by human persecution and habitat loss and fragmentation. Current conservation strategies include local education, captive rearing and reintroduction, and protection or creation of trans-national habitat blocks and corridors. Baseline genetic data prior to reintroduction of captive-bred stock is essential for guiding such efforts but has not been gathered previously. Methodology/Findings: We assessed levels of genetic diversity, population structure and demographic history for harpy eagles using samples collected throughout a large portion of their geographic distribution in Central America (n = 32) and South America (n = 31). Based on 417 bp of mitochondrial control region sequence data, relatively high levels of haplotype and nucleotide diversity were estimated for both Central and South America, although haplotype diversity was significantly higher for South America. Historical restriction of gene flow across the Andes (i.e. between our Central and South American subgroups) is supported by coalescent analyses, the haplotype network and significant F-ST values, however reciprocally monophyletic lineages do not correspond to geographical locations in maximum likelihood analyses. A sudden population expansion for South America is indicated by a mismatch distribution analysis, and further supported by significant (p<0.05) negative values of Fu and Li's D-F and F, and Fu's F-S. This expansion, estimated at approximately 60 000 years BP (99 000-36 000 years BP 95% CI), encompasses a transition from a warm and dry time period prior to 50 000 years BP to an interval of maximum precipitation (50 000-36 000 years BP). Notably, this time period precedes the climatic and habitat changes associated with the last glacial maximum. In contrast, a multimodal distribution of haplotypes was observed for Central America suggesting either population equilibrium or a recent decline. Significance: High levels of mitochondrial genetic diversity in combination with genetic differentiation among subgroups within regions and between regions highlight the importance of local population conservation in order to preserve maximal levels of genetic diversity in this species. Evidence of historically restricted female-mediated gene flow is an important consideration for captive-breeding programs.			Lerner, HRL (corresponding author), Smithsonian Inst, Genet Lab, Natl Zool Pk, Washington, DC 20560 USA.	lernerh@si.edu						ALVAREZCORDERO E, 1996, BIOL CONSERVATION HA; Bandelt HJ, 1999, MOL BIOL EVOL, V16, P37, DOI 10.1093/oxfordjournals.molbev.a026036; Banhos A, 2008, GENET MOL BIOL, V31, P146, DOI 10.1590/S1415-47572008000100025; Bates JM, 1998, J BIOGEOGR, V25, P783, DOI 10.1046/j.1365-2699.1998.2540783.x; Beerli P, 1999, GENETICS, V152, P763; Beerli P, 2001, P NATL ACAD SCI USA, V98, P4563, DOI 10.1073/pnas.081068098; BOLLMER JL, 2005, MOL PHYLOGENETICS EV; BROWER AVZ, 1994, P NATL ACAD SCI USA, V91, P6491, DOI 10.1073/pnas.91.14.6491; CABEZA M, 2007, J APPL ECOL IN PRESS; Cadahia L, 2007, J ORNITHOL, V148, P99, DOI 10.1007/s10336-006-0107-z; Cassens I, 2003, MOL ECOL, V12, P1781, DOI 10.1046/j.1365-294X.2003.01876.x; Chepstow-Lusty A, 2005, QUATERNARY RES, V63, P90, DOI 10.1016/j.yqres.2004.09.008; Collar N.J., 2001, THREATENED BIRDS ASI; COOPER RA, 1994, ANCIENT DNA RECOVERY, P149; Cortes-Ortiz L, 2003, MOL PHYLOGENET EVOL, V26, P64, DOI 10.1016/S1055-7903(02)00308-1; Crandall KA, 1999, ANIM CONSERV, V2, P317, DOI 10.1111/j.1469-1795.1999.tb00078.x; Culver M, 2000, J HERED, V91, P186, DOI 10.1093/jhered/91.3.186; CURTI M, 2007, RELEASED HARPY EAGLE; Curti M, 2009, J ENVIRON EDUC, V40, P3, DOI 10.3200/JOEE.40.4.3-16; Dick CW, 2003, AM NAT, V162, P691, DOI 10.1086/379795; Dowling DK, 2008, TRENDS ECOL EVOL, V23, P546, DOI 10.1016/j.tree.2008.05.011; Drovetski SV, 2003, J BIOGEOGR, V30, P1173, DOI 10.1046/j.1365-2699.2003.00920.x; EASON P, 1989, CONDOR, V91, P469, DOI 10.2307/1368327; Eizirik E, 2001, MOL ECOL, V10, P65, DOI 10.1046/j.1365-294X.2001.01144.x; Eizirik E, 1998, J MOL EVOL, V47, P613, DOI 10.1007/PL00006418; Elliott A., 1994, HDB BIRDS WORLD; EXCOFFIER L, 1992, GENETICS, V131, P479; Excoffier L, 2005, EVOLUTIONARY BIOINFO, V1; FAO, 2006, 147 FAO; FELSENSTEIN J, 1992, GENET RES, V59, P139, DOI 10.1017/S0016672300030354; Ferguson-Lees J, 2001, RAPTORS WORLD; FOWLER JAMES M., 1964, AUK, V81, P257; Frankham R, 2005, BIOL CONSERV, V126, P131, DOI 10.1016/j.biocon.2005.05.002; Fraser DJ, 2007, MOL ECOL, V16, P3866, DOI 10.1111/j.1365-294X.2007.03453.x; FU YX, 1993, GENETICS, V133, P693; Fu YX, 1997, GENETICS, V147, P915; Gemmell NJ, 2001, TRENDS ECOL EVOL, V16, P115, DOI 10.1016/S0169-5347(00)02087-5; Gilbert MTP, 2005, TRENDS ECOL EVOL, V20, P541, DOI 10.1016/j.tree.2005.07.005; Godoy JA, 2004, MOL ECOL, V13, P371, DOI 10.1046/j.1365-294X.2003.02075.x; *GRIN, 2007, GLOB RAPT INF NETW S; Gutierrez JR, 1997, OECOLOGIA, V109, P398, DOI 10.1007/s004420050099; Hailer F, 2007, J BIOGEOGR, V34, P1193, DOI 10.1111/j.1365-2699.2007.01697.x; Hailer F, 2006, BIOL LETTERS, V2, P316, DOI 10.1098/rsbl.2006.0453; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; HASEGAWA M, 1985, J MOL EVOL, V22, P160, DOI 10.1007/BF02101694; Houghton JT, 2001, CLIMATE CHANGE 2001: THE SCIENTIFIC BASIS, P1; IUCN, 2007, IUCN RED LIST THREAT; Johnson JA, 2007, ANIM CONSERV, V10, P349, DOI 10.1111/j.1469-1795.2007.00118.x; Johnson JA, 2008, BIOL CONSERV, V141, P2403, DOI 10.1016/j.biocon.2008.07.001; Johnson JA, 2007, MOL ECOL, V16, P2203, DOI 10.1111/j.1365-294X.2007.03285.x; Lerner HRL, 2005, MOL PHYLOGENET EVOL, V37, P327, DOI 10.1016/j.ympev.2005.04.010; Letourneau DK, 1998, ECOLOGY, V79, P1678, DOI 10.1890/0012-9658(1998)079[1678:ETILTF]2.0.CO;2; Letourneau DK, 1998, BIOTROPICA, V30, P162, DOI 10.1111/j.1744-7429.1998.tb00051.x; Lopez GO, 2005, J TROP ECOL, V21, P445, DOI 10.1017/S0266467405002415; MADDISON WP, 2005, MESQUITE MODULAR SYS; Martinez-Cruz B, 2004, MOL ECOL, V13, P2243, DOI 10.1111/j.1365-294X.2004.02220.x; Mayle FE, 2004, PHILOS T R SOC B, V359, P499, DOI 10.1098/rstb.2003.1434; Milot E, 2007, P ROY SOC B-BIOL SCI, V274, P779, DOI 10.1098/rspb.2006.0221; MUELA A., 2005, WINGSPAN, V14, P14; Muniz-Lopez R., 2007, NEOTROPICAL RAPTORS, P22; Nielsen R, 2001, GENETICS, V158, P885; OBRIEN SJ, 1994, P NATL ACAD SCI USA, V91, P5748, DOI 10.1073/pnas.91.13.5748; Omland KE, 2006, MOL ECOL, V15, P795, DOI 10.1111/j.1365-294X.2005.02827.x; Piana Renzo P., 2007, Revista Peruana de Biologia, V14, P135; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Ramos-Onsins SE, 2002, MOL BIOL EVOL, V19, P2092, DOI 10.1093/oxfordjournals.molbev.a004034; Reed DH, 2003, CONSERV BIOL, V17, P230, DOI 10.1046/j.1523-1739.2003.01236.x; RETTIG NL, 1978, AUK, V95, P629; ROGERS AR, 1995, EVOLUTION, V49, P608, DOI 10.1111/j.1558-5646.1995.tb02297.x; ROGERS AR, 1992, MOL BIOL EVOL, V9, P552; Roques S, 2005, BIOL CONSERV, V126, P41, DOI 10.1016/j.biocon.2005.04.020; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Schneider S, 1999, GENETICS, V152, P1079; Schulenberg TS., 2009, NEOTROPICAL BIRDS ON; Seltzer GO, 2002, SCIENCE, V296, P1685, DOI 10.1126/science.1070136; Sergio F, 2005, NATURE, V436, P192, DOI 10.1038/436192a; Sergio F, 2006, J APPL ECOL, V43, P1049, DOI 10.1111/j.1365-2664.2006.01218.x; Shephard JM, 2005, CONSERV GENET, V6, P413, DOI 10.1007/s10592-005-4987-x; SLATKIN M, 1991, GENETICS, V129, P555; Sorenson MD, 1996, P NATL ACAD SCI USA, V93, P15239, DOI 10.1073/pnas.93.26.15239; Spielman D, 2004, P NATL ACAD SCI USA, V101, P15261, DOI 10.1073/pnas.0403809101; Strong AM, 2000, OECOLOGIA, V125, P370, DOI 10.1007/s004420000467; TAJIMA F, 1989, GENETICS, V123, P597; TAJIMA F, 1989, GENETICS, V123, P585; Terborgh J, 2006, J ECOL, V94, P253, DOI 10.1111/j.1365-2745.2006.01106.x; Terborgh J, 2001, SCIENCE, V294, P1923, DOI 10.1126/science.1064397; Terborgh J, 1997, ECOLOGY, V78, P1494, DOI 10.1890/0012-9658(1997)078[1494:BCITTL]2.0.CO;2; Trinca Cristiano Trape, 2008, Cotinga, V30, P12; Van Bael SA, 2003, P NATL ACAD SCI USA, V100, P8304, DOI 10.1073/pnas.1431621100; Vargas JD, 2006, ORNITOL NEOTROP, V17, P39; Wakeley J, 2004, EVOLUTION OF POPULATION BIOLOGY, P193, DOI 10.1017/CBO9780511542619.013; Wang JL, 2005, PHILOS T R SOC B, V360, P1395, DOI 10.1098/rstb.2005.1682; Weber DS, 2004, J HERED, V95, P144, DOI 10.1093/jhered/esh018; Wisely SM, 2002, J HERED, V93, P231, DOI 10.1093/jhered/93.4.231	95	28	29	0	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7336	10.1371/journal.pone.0007336	http://dx.doi.org/10.1371/journal.pone.0007336			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802391	Green Published, Green Submitted, gold			2022-12-27	WOS:000270593600011
J	Leal, WS; Ishida, Y; Pelletier, J; Xu, W; Rayo, J; Xu, XZ; Ames, JB				Leal, Walter S.; Ishida, Yuko; Pelletier, Julien; Xu, Wei; Rayo, Josep; Xu, Xianzhong; Ames, James B.			Olfactory Proteins Mediating Chemical Communication in the Navel Orangeworm Moth, Amyelois transitella	PLOS ONE			English	Article							PHEROMONE-BINDING-PROTEIN; MOLECULAR-CLONING; NMR STRUCTURE; OSTRINIA-NUBILALIS; LEPIDOPTERA; RELEASE; PH; ATTRACTANTS; BEHAVIOR; ANTENNAE	Background: The navel orangeworm, Amyelois transitella Walker (Lepidoptera: Pyralidae), is the most serious insect pest of almonds and pistachios in California for which environmentally friendly alternative methods of control - like pheromone-based approaches - are highly desirable. Some constituents of the sex pheromone are unstable and could be replaced with parapheromones, which may be designed on the basis of molecular interaction of pheromones and pheromone-detecting olfactory proteins. Methodology: By analyzing extracts from olfactory and non-olfactory tissues, we identified putative olfactory proteins, obtained their N-terminal amino acid sequences by Edman degradation, and used degenerate primers to clone the corresponding cDNAs by SMART RACE. Additionally, we used degenerate primers based on conserved sequences of known proteins to fish out other candidate olfactory genes. We expressed the gene encoding a newly identified pheromone-binding protein, which was analyzed by circular dichroism, fluorescence, and nuclear magnetic resonance, and used in a binding assay to assess affinity to pheromone components. Conclusion: We have cloned nine cDNAs encoding olfactory proteins from the navel orangeworm, including two pheromone-binding proteins, two general odorant-binding proteins, one chemosensory protein, one glutathione S-transferase, one antennal binding protein X, one sensory neuron membrane protein, and one odorant receptor. Of these, AtraPBP1 is highly enriched in male antennae. Fluorescence, CD and NMR studies suggest a dramatic pH-dependent conformational change, with high affinity to pheromone constituents at neutral pH and no binding at low pH.			Leal, WS (corresponding author), Univ Calif Davis, Dept Entomol, Davis, CA 95616 USA.	wsleal@ucdavis.edu	Leal, Walter/ABC-6940-2021; Xu, Wei/G-4709-2010; Rayo, Josep/C-2394-2015; Xu, Xianzhong/B-6311-2014	Rayo, Josep/0000-0002-8459-8235; Leal Filho, Walter/0000-0002-1241-5225; Leal, Walter/0000-0002-6800-1240; Xu, Wei/0000-0003-4019-5140	NATIONAL EYE INSTITUTE [R01EY012347] Funding Source: NIH RePORTER; Division Of Integrative Organismal Systems [0918177] Funding Source: National Science Foundation	NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); Division Of Integrative Organismal Systems(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		BREER H, 1990, INSECT BIOCHEM, V20, P735, DOI 10.1016/0020-1790(90)90088-C; COFFELT JA, 1979, J CHEM ECOL, V5, P955, DOI 10.1007/BF00990218; Damberger F, 2000, PROTEIN SCI, V9, P1038, DOI 10.1110/ps.9.5.1038; Damberger FF, 2007, J MOL BIOL, V373, P811, DOI 10.1016/j.jmb.2007.07.078; Grosse-Wilde E, 2007, EUR J NEUROSCI, V25, P2364, DOI 10.1111/j.1460-9568.2007.05512.x; HAMMOCK BD, 1982, PESTIC BIOCHEM PHYS, V17, P1158; Horst R, 2001, P NATL ACAD SCI USA, V98, P14374, DOI 10.1073/pnas.251532998; HUSSEINY MOHAMED MAMDOUH, 1964, HILGARDIA, V36, P113; Ishida Y, 2005, P NATL ACAD SCI USA, V102, P14075, DOI 10.1073/pnas.0505340102; Jansen S, 2007, ARCH INSECT BIOCHEM, V66, P135, DOI 10.1002/arch.20205; KAISSLIN.KE, 1970, NATURWISSENSCHAFTEN, V57, P23, DOI 10.1007/BF00593550; Kaissling K-E, 1987, RH WRIGHT LECT INSEC; KEIL TA, 1987, ANN NY ACAD SCI, V510, P403; KEIL TA, 1984, TISSUE CELL, V16, P705, DOI 10.1016/0040-8166(84)90004-1; KRIEGER J, 1991, BIOCHIM BIOPHYS ACTA, V1088, P277, DOI 10.1016/0167-4781(91)90064-S; KRIEGER J, 1993, INSECT BIOCHEM MOLEC, V23, P449, DOI 10.1016/0965-1748(93)90052-T; Krieger J, 1996, INSECT BIOCHEM MOLEC, V26, P297, DOI 10.1016/0965-1748(95)00096-8; KRIEGER J, 1996, INSECT BIOCHEM MOLEC, P26; Krieger Juergen, 1997, Invertebrate Neuroscience, V3, P137, DOI 10.1007/BF02480368; Lautenschlager C, 2005, BIOCHEM BIOPH RES CO, V335, P1044, DOI 10.1016/j.bbrc.2005.07.176; Lautenschlager C, 2007, STRUCTURE, V15, P1148, DOI 10.1016/j.str.2007.07.013; Leal Walter S., 2003, P447, DOI 10.1016/B978-012107151-6/50017-7; Leal WS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003045; Leal WS, 2005, J CHEM ECOL, V31, P2493, DOI 10.1007/s10886-005-7458-4; Leal WS, 2000, BIOCHEM BIOPH RES CO, V268, P521, DOI 10.1006/bbrc.2000.2158; Leal WS, 2005, P NATL ACAD SCI USA, V102, P5386, DOI 10.1073/pnas.0501447102; Leal WS, 2005, NATURWISSENSCHAFTEN, V92, P139, DOI 10.1007/s00114-004-0598-5; Leal WS, 2005, TOP CURR CHEM, V240, P1, DOI 10.1007/b98314; Maleszka R, 1997, GENE, V202, P39, DOI 10.1016/S0378-1119(97)00448-4; Mohanty S, 2004, J MOL BIOL, V338, P1037, DOI 10.1016/j.jmb.2004.03.052; Mohanty S, 2004, J MOL BIOL, V337, P443, DOI 10.1016/j.jmb.2004.01.009; Parra-Pedrazzoli AL, 2006, NEOTROP ENTOMOL, V35, P769, DOI 10.1590/S1519-566X2006000600008; Pophof B, 2000, J COMP PHYSIOL A, V186, P315, DOI 10.1007/s003590050432; RAMING K, 1989, FEBS LETT, V256, P215, DOI 10.1016/0014-5793(89)81751-X; Riba M, 2005, J AGR FOOD CHEM, V53, P1158, DOI 10.1021/jf048994q; Rogers ME, 1999, J EXP BIOL, V202, P1625; Rogers ME, 2001, J NEUROBIOL, V49, P47, DOI 10.1002/neu.1065; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sandler BH, 2000, CHEM BIOL, V7, P143, DOI 10.1016/S1074-5521(00)00078-8; Sole J, 2008, ENTOMOL EXP APPL, V126, P28, DOI 10.1111/j.1570-7458.2007.00630.x; Syed Z, 2006, P NATL ACAD SCI USA, V103, P16538, DOI 10.1073/pnas.0607874103; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; VOGT RG, 1991, J NEUROBIOL, V22, P74, DOI 10.1002/neu.480220108; VOGT RG, 1991, J NEUROSCI, V11, P2972; Willett CS, 2000, J MOL EVOL, V50, P175, DOI 10.1007/s002399910019; Wojtasek H, 1999, J BIOL CHEM, V274, P30950, DOI 10.1074/jbc.274.43.30950; Xu W, 2008, BIOCHEM BIOPH RES CO, V372, P559, DOI 10.1016/j.bbrc.2008.05.087; Xu XZ, 2008, BIOMOL NMR ASSIGN, V2, P105, DOI 10.1007/s12104-008-9096-6	48	40	45	3	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7235	10.1371/journal.pone.0007235	http://dx.doi.org/10.1371/journal.pone.0007235			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789654	gold, Green Published, Green Submitted			2022-12-27	WOS:000270354100007
J	Folkersen, L; Kyriakou, T; Goel, A; Peden, J; Malarstig, A; Paulsson-Berne, G; Hamsten, A; Franco-Cereceda, A; Gabrielsen, A; Eriksson, P; Watkins, H				Folkersen, Lasse; Kyriakou, Theodosios; Goel, Anuj; Peden, John; Malarstig, Anders; Paulsson-Berne, Gabrielle; Hamsten, Anders; Franco-Cereceda, Anders; Gabrielsen, Anders; Eriksson, Per; Watkins, Hugh		Hugh Watkins PROCARDIS Consortia	Relationship between CAD Risk Genotype in the Chromosome 9p21 Locus and Gene Expression. Identification of Eight New ANRIL Splice Variants	PLOS ONE			English	Article							CORONARY-ARTERY-DISEASE; ASSOCIATION	Background: Several genome-wide association studies have recently linked a group of single nucleotide polymorphisms in the 9p21 region with cardiovascular disease. The molecular mechanisms of this link are not fully understood. We investigated five different expression microarray datasets in order to determine if the genotype had effect on expression of any gene transcript in aorta, mammary artery, carotid plaque and lymphoblastoid cells. Methodology/Principal Findings: After multiple testing correction, no genes were found to have relation to the rs2891168 risk genotype, either on a genome-wide scale or on a regional (8 MB) scale. The neighbouring ANRIL gene was found to have eight novel transcript variants not previously known from literature and these varied by tissue type. We therefore performed a detailed probe-level analysis and found small stretches of significant relation to genotype but no consistent associations. In all investigated tissues we found an inverse correlation between ANRIL and the MTAP gene and a positive correlation between ANRIL and CDKN2A and CDKN2B. Conclusions/Significance: Investigation of relation of the risk genotype to gene expression is complicated by the transcript complexity of the locus. With our investigation of a range of relevant tissue we wish to underscore the need for careful attention to the complexity of the alternative splicing issues in the region and its implications to the design of future gene expression studies.			Folkersen, L (corresponding author), Karolinska Inst, Dept Med, Stockholm, Sweden.	lasse.folkersen@ki.se		Kyriakou, Theodosios/0000-0001-7794-8789; Folkersen, Lasse/0000-0003-0708-9530; Goel, Anuj/0000-0003-2307-4021; Watkins, Hugh/0000-0002-5287-9016; Eriksson, Per/0000-0002-5635-2692				Benovoy D, 2008, NUCLEIC ACIDS RES, V36, P4417, DOI 10.1093/nar/gkn409; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Broadbent HM, 2008, HUM MOL GENET, V17, P806, DOI 10.1093/hmg/ddm352; Burton PR, 2007, NATURE, V447, P661, DOI 10.1038/nature05911; DABNEY A, 2009, BIOCONDUCTOR; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; FOLKERSEN L, 2009, BIOINFORMATICS; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gibbs RA, 2003, NATURE, V426, P789, DOI 10.1038/nature02168; Helgadottir A, 2008, NAT GENET, V40, P217, DOI 10.1038/ng.72; Helgadottir A, 2007, SCIENCE, V316, P1491, DOI 10.1126/science.1142842; Jarinova O, 2009, ARTERIOSCLER THROMB; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Liu Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005027; McPherson R, 2007, SCIENCE, V316, P1488, DOI 10.1126/science.1142447; Pasmant E, 2007, CANCER RES, V67, P3963, DOI 10.1158/0008-5472.CAN-06-2004; Samani NJ, 2007, NEW ENGL J MED, V357, P443, DOI 10.1056/NEJMoa072366; Zhang W, 2008, AM J HUM GENET, V82, P631, DOI 10.1016/j.ajhg.2007.12.015	19	124	135	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2009	4	11							e7677	10.1371/journal.pone.0007677	http://dx.doi.org/10.1371/journal.pone.0007677			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RX	19888323	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414400005
J	Hoffmann, M; Bellance, N; Rossignol, R; Koopman, WJH; Willems, PHGM; Mayatepek, E; Bossinger, O; Distelmaier, F				Hoffmann, Michael; Bellance, Nadege; Rossignol, Rodrigue; Koopman, Werner J. H.; Willems, Peter H. G. M.; Mayatepek, Ertan; Bossinger, Olaf; Distelmaier, Felix			C-elegans ATAD-3 Is Essential for Mitochondrial Activity and Development	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; CELL-CYCLE; GENOME; GENES; INTERFERENCE; DEFICIENCY; GENERATION; NUCLEOIDS; LONGEVITY; MEMBRANE	Background: Mammalian ATAD3 is a mitochondrial protein, which is thought to play an important role in nucleoid organization. However, its exact function is still unresolved. Results: Here, we characterize the Caenorhabditis elegans (C. elegans) ATAD3 homologue (ATAD-3) and investigate its importance for mitochondrial function and development. We show that ATAD-3 is highly conserved among different species and RNA mediated interference against atad-3 causes severe defects, characterized by early larval arrest, gonadal dysfunction and embryonic lethality. Investigation of mitochondrial physiology revealed a disturbance in organellar structure while biogenesis and function, as indicated by complex I and citrate synthase activities, appeared to be unaltered according to the developmental stage. Nevertheless, we observed very low complex I and citrate synthase activities in L1 larvae populations in comparison to higher larval and adult stages. Our findings indicate that atad-3(RNAi) animals arrest at developmental stages with low mitochondrial activity. In addition, a reduced intestinal fat storage and low lysosomal content after depletion of ATAD-3 suggests a central role of this protein for metabolic activity. Conclusions: In summary, our data clearly indicate that ATAD-3 is essential for C. elegans development in vivo. Moreover, our results suggest that the protein is important for the upregulation of mitochondrial activity during the transition to higher larval stages.			Hoffmann, M (corresponding author), Univ Dusseldorf, Univ Childrens Hosp, Dept Gen Pediat, Dusseldorf, Germany.	bossinger@mac.com; felix.distelmaier@med.uni-duesseldorf.de	Willems, P.H.G.M./L-4759-2015; Koopman, Werner J.H./AAC-9668-2020; Rossignol, Rodrigue/K-7821-2014; Koopman, Werner J.H./D-3592-2009	Willems, P.H.G.M./0000-0002-0915-1599; Koopman, Werner J.H./0000-0002-5340-6747; Koopman, Werner J.H./0000-0002-5340-6747; bellance, nadege/0000-0002-8868-8596; Hoffmann, Michael/0000-0001-8677-5031				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Ballard JWO, 2001, CURR OPIN GENET DEV, V11, P667, DOI 10.1016/S0959-437X(00)00251-3; Benard G, 2006, AM J PHYSIOL-CELL PH, V291, pC1172, DOI 10.1152/ajpcell.00195.2006; Benard G, 2008, ANTIOXID REDOX SIGN, V10, P1313, DOI 10.1089/ars.2007.2000; Benedetti C, 2006, GENETICS, V174, P229, DOI 10.1534/genetics.106.061580; Bogenhagen DF, 2008, J BIOL CHEM, V283, P3665, DOI 10.1074/jbc.M708444200; Bratic I, 2009, NUCLEIC ACIDS RES, V37, P1817, DOI 10.1093/nar/gkp018; BRENNER S, 1974, GENETICS, V77, P71; Chen XW, 2005, CIRC RES, V97, P1009, DOI 10.1161/01.RES.0000189270.72915.D1; Curran SP, 2004, J BIOL CHEM, V279, P54655, DOI 10.1074/jbc.M409618200; Da Cruz S, 2003, J BIOL CHEM, V278, P41566, DOI 10.1074/jbc.M304940200; Duchen Michael R., 2004, Molecular Aspects of Medicine, V25, P365, DOI 10.1016/j.mam.2004.03.001; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gires O, 2004, CELL MOL LIFE SCI, V61, P1198, DOI 10.1007/s00018-004-4045-8; Grad LI, 2004, HUM MOL GENET, V13, P303, DOI 10.1093/hmg/ddh027; He JY, 2007, J CELL BIOL, V176, P141, DOI 10.1083/jcb.200609158; Holt IJ, 2007, MITOCHONDRION, V7, P311, DOI 10.1016/j.mito.2007.06.004; Hubstenberger A, 2008, EXP CELL RES, V314, P2870, DOI 10.1016/j.yexcr.2008.06.017; Iwasaki K, 1996, J CELL BIOL, V134, P699, DOI 10.1083/jcb.134.3.699; Kamath RS, 2001, GENOME BIOL, V2, DOI 10.1186/gb-2000-2-1-research0002; Kanazawa T, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000022; Kawasaki I, 2007, MECH DEVELOP, V124, P237, DOI 10.1016/j.mod.2006.11.004; Kimble Judith, 2005, WormBook, P1; Koopman WJH, 2008, METHODS, V46, P304, DOI 10.1016/j.ymeth.2008.09.018; Lee SS, 2003, NAT GENET, V33, P40, DOI 10.1038/ng1056; Linder P, 2000, CURR BIOL, V10, pR887, DOI 10.1016/S0960-9822(00)00857-5; Long XM, 2002, CURR BIOL, V12, P1448, DOI 10.1016/S0960-9822(02)01091-6; MARGULIS L, 1975, BIOSYSTEMS, V7, P266, DOI 10.1016/0303-2647(75)90034-9; Martinez-Diez M, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000107; Maurizi Michael R., 2001, EMBO Reports, V2, P980, DOI 10.1093/embo-reports/kve229; McGhee James D, 2007, WormBook, P1; Minai L, 2008, MOL GENET METAB, V94, P120, DOI 10.1016/j.ymgme.2007.12.007; Mootha VK, 2003, CELL, V115, P629, DOI 10.1016/S0092-8674(03)00926-7; Neuspiel M, 2005, J BIOL CHEM, V280, P25060, DOI 10.1074/jbc.M501599200; Piano F, 2002, CURR BIOL, V12, P1959, DOI 10.1016/S0960-9822(02)01301-5; Pilipiuk J, 2009, DEV BIOL, V327, P34, DOI 10.1016/j.ydbio.2008.11.025; PIPERNO G, 1985, J CELL BIOL, V101, P2085, DOI 10.1083/jcb.101.6.2085; POSAKONY JW, 1977, J CELL BIOL, V74, P468, DOI 10.1083/jcb.74.2.468; Sanz MA, 2003, J BIOL CHEM, V278, P32091, DOI 10.1074/jbc.M304877200; Schaffrik M, 2006, CELL MOL LIFE SCI, V63, P2162, DOI 10.1007/s00018-006-6200-x; Segbert C, 2003, MOL BIOL CELL, V14, P4458, DOI 10.1091/mbc.E03-05-0283; STROME S, 1983, CELL, V35, P15, DOI 10.1016/0092-8674(83)90203-9; Strome Susan, 2005, WormBook, P1, DOI 10.1895/wormbook.1.9.1; Suthammarak W, 2009, J BIOL CHEM, V284, P6425, DOI 10.1074/jbc.M805733200; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; Wai T, 2008, NAT GENET, V40, P1484, DOI 10.1038/ng.258; Wang MC, 2008, SCIENCE, V322, P957, DOI 10.1126/science.1162011; Wood W.B., 1988, Cold Spring Harbor Monograph Series, V17, P1; Yoon YS, 2006, J CELL PHYSIOL, V209, P468, DOI 10.1002/jcp.20753	52	47	50	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2009	4	10							e7644	10.1371/journal.pone.0007644	http://dx.doi.org/10.1371/journal.pone.0007644			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RW	19888333	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414300006
J	Pothlichet, J; Burtey, A; Kubarenko, AV; Caignard, G; Solhonne, B; Tangy, F; Ben-Ali, M; Quintana-Murci, L; Heinzmann, A; Chiche, JD; Vidalain, PO; Weber, ANR; Chignard, M; Si-Tahar, M				Pothlichet, Julien; Burtey, Anne; Kubarenko, Andriy V.; Caignard, Gregory; Solhonne, Brigitte; Tangy, Frederic; Ben-Ali, Meriem; Quintana-Murci, Lluis; Heinzmann, Andrea; Chiche, Jean-Daniel; Vidalain, Pierre-Olivier; Weber, Alexander N. R.; Chignard, Michel; Si-Tahar, Mustapha			Study of Human RIG-I Polymorphisms Identifies Two Variants with an Opposite Impact on the Antiviral Immune Response	PLOS ONE			English	Article							INFLUENZA-A-VIRUS; SIGNALING PATHWAYS; RECRUITMENT DOMAIN; EPITHELIAL-CELLS; CARD; RECOGNITION; COMMON; MDA5; LGP2; ELECTROSTATICS	Background RIG-I is a pivotal receptor that detects numerous RNA and DNA viruses. Thus, its defectiveness may strongly impair the host antiviral immunity. Remarkably, very little information is available on RIG-I single-nucleotide polymorphisms (SNPs) presenting a functional impact on the host response. Methodology/Principal Findings: Here, we studied all non-synonymous SNPs of RIG-I using biochemical and structural modeling approaches. We identified two important variants: (i) a frameshift mutation (P(229)fs) that generates a truncated, constitutively active receptor and (ii) a serine to isoleucine mutation (S183I), which drastically inhibits antiviral signaling and exerts a down-regulatory effect, due to unintended stable complexes of RIG-I with itself and with MAVS, a key downstream adapter protein. Conclusions/Significance: Hence, this study characterized P(229)fs and S(183)ISNPs as major functional RIG-I variants and potential genetic determinants of viral susceptibility. This work also demonstrated that serine 183 is a residue that critically regulates RIG-I-induced antiviral signaling.			Pothlichet, J (corresponding author), Inst Pasteur, Unite Def Innee & Inflammat, Paris, France.	sitahar@pasteur.fr	Si-Tahar, Mustapha/W-8034-2019; Vidalain, Pierre-Olivier/F-9778-2019; Chignard, Michel/B-4351-2008; SI-TAHAR, Mustapha/L-4149-2014; Quintana-Murci, Lluis/AAB-7468-2022; Chiche, Jean-Daniel/P-5220-2017	Si-Tahar, Mustapha/0000-0002-5792-7742; Vidalain, Pierre-Olivier/0000-0003-3082-7407; Chignard, Michel/0000-0003-3810-6575; SI-TAHAR, Mustapha/0000-0002-5792-7742; Chiche, Jean-Daniel/0000-0002-6433-6254; Caignard, Gregory/0000-0001-7021-0749; Quintana-Murci, Lluis/0000-0003-2429-6320; Burtey, Anne/0000-0003-4548-8807; Weber, Alexander/0000-0002-8627-7056				Baker NA, 2001, P NATL ACAD SCI USA, V98, P10037, DOI 10.1073/pnas.181342398; Binder M, 2007, HEPATOLOGY, V46, P1365, DOI 10.1002/hep.21829; Caignard G, 2007, VIROLOGY, V368, P351, DOI 10.1016/j.virol.2007.06.037; Cheng GF, 2007, P NATL ACAD SCI USA, V104, P9035, DOI 10.1073/pnas.0703285104; Cheng G, 2006, P NATL ACAD SCI USA, V103, P8499, DOI 10.1073/pnas.0602957103; Chi HB, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-211; Chou JJ, 1998, CELL, V94, P171, DOI 10.1016/S0092-8674(00)81417-8; Day CL, 1999, CELL DEATH DIFFER, V6, P1125, DOI 10.1038/sj.cdd.4400584; Dolinsky TJ, 2004, NUCLEIC ACIDS RES, V32, pW665, DOI 10.1093/nar/gkh381; Dyson HJ, 2006, P NATL ACAD SCI USA, V103, P13057, DOI 10.1073/pnas.0605504103; Gack MU, 2008, P NATL ACAD SCI USA, V105, P16743, DOI 10.1073/pnas.0804947105; Gack MU, 2007, NATURE, V446, P916, DOI 10.1038/nature05732; Gregersen N, 2006, J INHERIT METAB DIS, V29, P456, DOI 10.1007/s10545-006-0301-4; Guillot L, 2004, J BIOL CHEM, V279, P2712, DOI 10.1074/jbc.M305790200; Hausmann S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003965; Hinds DA, 2005, SCIENCE, V307, P1072, DOI 10.1126/science.1105436; Humke EW, 2000, CELL, V103, P99, DOI 10.1016/S0092-8674(00)00108-2; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kubarenko A, 2007, BIOCHEM SOC T, V35, P1515, DOI 10.1042/BST0351515; Lad SP, 2008, MOL IMMUNOL, V45, P2277, DOI 10.1016/j.molimm.2007.11.018; Le Goffic R, 2007, J IMMUNOL, V178, P3368, DOI 10.4049/jimmunol.178.6.3368; Li H, 2005, PROTEINS, V61, P704, DOI 10.1002/prot.20660; Lloyd AR, 2007, IMMUNOL CELL BIOL, V85, P24, DOI 10.1038/sj.icb.7100010; Manon F, 2007, J MOL BIOL, V365, P160, DOI 10.1016/j.jmb.2006.09.067; Misch EA, 2008, CLIN SCI, V114, P347, DOI 10.1042/CS20070214; Moore CB, 2008, IMMUNITY, V28, P735, DOI 10.1016/j.immuni.2008.05.005; Palsson-McDermott EM, 2007, BIOCHEM SOC T, V35, P1437, DOI 10.1042/BST0351437; Park HH, 2007, ANNU REV IMMUNOL, V25, P561, DOI 10.1146/annurev.immunol.25.022106.141656; Pettit FK, 2007, J MOL BIOL, V369, P863, DOI 10.1016/j.jmb.2007.03.036; Picard C, 2007, IMMUNOL RES, V38, P347, DOI 10.1007/s12026-007-0006-2; Pothlichet J, 2008, J IMMUNOL, V180, P2034, DOI 10.4049/jimmunol.180.4.2034; Potter JA, 2008, BMC STRUCT BIOL, V8, DOI 10.1186/1472-6807-8-11; Ramensky V, 2002, NUCLEIC ACIDS RES, V30, P3894, DOI 10.1093/nar/gkf493; Reiche EMV, 2007, CURR MED CHEM, V14, P1325; Rothenfusser S, 2005, J IMMUNOL, V175, P5260, DOI 10.4049/jimmunol.175.8.5260; Saito T, 2007, P NATL ACAD SCI USA, V104, P582, DOI 10.1073/pnas.0606699104; Sanchez R, 2000, METH MOL B, V143, P97; Sanders CR, 2001, BIOCHEMISTRY-US, V40, P9453, DOI 10.1021/bi010894f; Schlee M, 2009, IMMUNOL REV, V227, P66, DOI 10.1111/j.1600-065X.2008.00724.x; Schroder M, 2007, BIOCHEM SOC T, V35, P1512, DOI 10.1042/BST0351512; Shigemoto T, 2009, J BIOL CHEM, V284, P13348, DOI 10.1074/jbc.M809449200; Smyth DJ, 2006, NAT GENET, V38, P617, DOI 10.1038/ng1800; Stumper R, 2005, J VIROL, V79, P2689, DOI 10.1128/JVI.79.5.2689-2699.2005; Takeuchi O, 2008, CURR OPIN IMMUNOL, V20, P17, DOI 10.1016/j.coi.2008.01.002; Tebbutt SJ, 2007, CHEST, V131, P1216, DOI 10.1378/chest.06-2252; Theofilopoulos AN, 2005, ANNU REV IMMUNOL, V23, P307, DOI 10.1146/annurev.immunol.23.021704.115843; Werts C, 2006, CELL DEATH DIFFER, V13, P798, DOI 10.1038/sj.cdd.4401890; Yoneyama M, 2005, J IMMUNOL, V175, P2851, DOI 10.4049/jimmunol.175.5.2851; Yoneyama M, 2004, NAT IMMUNOL, V5, P730, DOI 10.1038/ni1087; Yoneyama M, 2008, IMMUNITY, V29, P178, DOI 10.1016/j.immuni.2008.07.009; Zhou P, 1999, P NATL ACAD SCI USA, V96, P11265, DOI 10.1073/pnas.96.20.11265	51	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7582	10.1371/journal.pone.0007582	http://dx.doi.org/10.1371/journal.pone.0007582			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859543	Green Published, Green Submitted, gold			2022-12-27	WOS:000271147400006
J	Liu, D; Fan, J; Mei, MX; Ingvarsson, S; Chen, HP				Liu, Dong; Fan, Jing; Mei, Manxue; Ingvarsson, Sigurdur; Chen, Huiping			Identification of miRNAs in a Liver of a Human Fetus by a Modified Method	PLOS ONE			English	Article							CELL-DEATH; MICRORNAS; EXPRESSION; SYSTEM; DIFFERENTIATION; DROSOPHILA; ELEGANS; GENES	Background: miRNAs are 17-25 nucleotides long RNA molecules that have been found to regulate gene expression in human cells. There are studies showing that different groups of miRNAs are involved in development of different tissues. In hepatocytes there are reported particular types of miRNAs that regulate gene expression. Methods: We established a human fetal liver cDNA library by a modified cloning protocol. Then plasmid isolation from the colonies was performed. After sequencing and database searching, the miRNAs were recognized. RT-PCR and sequencing were carried out to validate the miRNAs detected. Real-time PCR was used to analyze the expression of each miRNA. Results: One novel miRNA was discovered, together with another 35 previously-known miRNAs in the fetal liver. Some of them existed in variants. The miRNAs identified were validated by RT-PCR and sequencing. Quantitative analysis showed that they have variable expression. Conclusion: Our results indicate that a special group of miRNAs may play an important role in fetal liver development in a synergistic manner.	[Liu, Dong; Fan, Jing; Chen, Huiping] Huazhong Univ Sci & Technol, Dept Med Genet, Tongji Med Coll, Wuhan, Hubei, Peoples R China; [Mei, Manxue] Wuhan Polytech Univ, Hubei Key Lab Anim Nutr & Feed Sci, Dept Feed Sci, Wuhan, Hubei, Peoples R China; [Ingvarsson, Sigurdur] Univ Iceland, Inst Expt Pathol, Reykjavik, Iceland; [Ingvarsson, Sigurdur] Univ Iceland, Fac Med, Reykjavik, Iceland	Huazhong University of Science & Technology; Wuhan Polytechnic University; University of Iceland; University of Iceland	Liu, D (corresponding author), Huazhong Univ Sci & Technol, Dept Med Genet, Tongji Med Coll, Wuhan, Hubei, Peoples R China.	huiping@mail.hust.edu.cn	Ingvarsson, Sigurdur/E-7448-2011	Ingvarsson, Sigurdur/0000-0003-4125-1714				Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aukerman MJ, 2003, PLANT CELL, V15, P2730, DOI 10.1105/tpc.016238; Barad O, 2004, GENOME RES, V14, P2486, DOI 10.1101/gr.2845604; Brennecke J, 2003, CELL, V113, P25, DOI 10.1016/S0092-8674(03)00231-9; Callis TE, 2007, DNA CELL BIOL, V26, P219, DOI 10.1089/dna.2006.0556; Chen XM, 2004, SCIENCE, V303, P2022, DOI 10.1126/science.1088060; Erson AE, 2008, CLIN GENET, V74, P296, DOI 10.1111/j.1399-0004.2008.01076.x; FU H, 2003, FEBS LETT, V579, P3849; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lagos-Quintana M, 2001, SCIENCE, V294, P853, DOI 10.1126/science.1064921; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Legesse-Miller A, 2009, J BIOL CHEM, V284, P6605, DOI 10.1074/jbc.C900002200; Liao YC, 2008, INT J BIOCHEM CELL B, V40, P843, DOI 10.1016/j.biocel.2007.04.008; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Palatnik JF, 2003, NATURE, V425, P257, DOI 10.1038/nature01958; Reinhart BJ, 2000, NATURE, V403, P901, DOI 10.1038/35002607; Saunders MA, 2007, P NATL ACAD SCI USA, V104, P3300, DOI 10.1073/pnas.0611347104; Schickel R, 2008, ONCOGENE, V27, P5959, DOI 10.1038/onc.2008.274; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Xu PZ, 2003, CURR BIOL, V13, P790, DOI 10.1016/S0960-9822(03)00250-1; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zhang B, 2009, CANCER RES, V69, P75, DOI 10.1158/0008-5472.CAN-08-1393	23	14	14	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7594	10.1371/journal.pone.0007594	http://dx.doi.org/10.1371/journal.pone.0007594			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855840	Green Published, Green Submitted, gold			2022-12-27	WOS:000271147200014
J	Sirima, SB; Tiono, AB; Ouedraogo, A; Diarra, A; Ouedraogo, AL; Yaro, JB; Ouedraogo, E; Gansane, A; Bougouma, EC; Konate, AT; Kabore, Y; Traore, A; Roma, C; Soulama, I; Luty, AJF; Cousens, S; Nebie, I				Sirima, Sodiomon B.; Tiono, Alfred B.; Ouedraogo, Alphonse; Diarra, Amidou; Ouedraogo, Andre Lin; Yaro, Jean Baptiste; Ouedraogo, Esperance; Gansane, Adama; Bougouma, Edith C.; Konate, Amadou T.; Kabore, Youssouf; Traore, Abdoulaye; Roma, Chilengi; Soulama, Issiaka; Luty, Adrian J. F.; Cousens, Simon; Nebie, Issa			Safety and Immunogenicity of the Malaria Vaccine Candidate MSP3 Long Synthetic Peptide in 12-24 Months-Old Burkinabe Children	PLOS ONE			English	Article							MEROZOITE SURFACE PROTEIN-3; GLUTAMATE-RICH PROTEIN; PLASMODIUM-FALCIPARUM MALARIA; ASEXUAL BLOOD STAGES; CLINICAL MALARIA; CELLULAR-INHIBITION; PARASITE GROWTH; WEST-AFRICA; ANTIBODIES; PROTECTION	Background: A Phase Ia trial in European volunteers of the candidate vaccine merozoite surface protein 3 (MSP3), a Plasmodium falciparum blood stage membrane, showed that it induces biologically active antibodies able to achieve parasite killing in vitro, while a phase Ib trial in semi-immune adult volunteers in Burkina Faso confirmed that the vaccine was safe. The aim of this study was to assess the safety and immunogenicity of this vaccine candidate in children aged 12 24 months living in malaria endemic area of Burkina Faso. Methods: The study was a double-blind, randomized, controlled, dose escalation phase Ib trial, designed to assess the safety, reactogenicity and immunogenicity of three doses of either 15 or 30 mu g of MSP3-LSP adsorbed on aluminum hydroxide in 45 children 12 to 24 months of age randomized into three equal groups. Each group received 3 vaccine doses (on days 0, 28 and 56) of either 15 mu g of MSP3-LSP, 30 mu g of MSP3-LSP or of the Engerix B hepatitis B vaccine. Children were visited at home daily for the 6 days following each vaccination to solicit symptoms which might be related to vaccination. Serious adverse events occurring during the study period (1 year) were recorded. Antibody responses to MSP3-LSP were measured on days 0, 28, 56 and 84. Results: All 45 enrolled children received three MSP3 vaccine doses. No serious adverse events were reported. Most of the adverse events reported were mild to moderate in severity. The only reported local symptoms with grade 3 severity were swelling and induration, with an apparently dose related response. All grade 3 adverse events resolved without any sequelae. Both MSP3 doses regimens were able to elicit high levels of anti-MSP3 specific IgG1 and IgG3 antibodies in the volunteers with very little or no increase in IgG2, IgG4 and IgM classes: i.e. vaccination induced predominantly the isotypes involved in the monocyte-dependent mechanism of P. falciparum parasite-killing. Conclusion: Our results support the promise of MSP3-LSP as a malaria vaccine candidate, both in terms of tolerability and of immunogenicity. Further assessment of the efficacy of this vaccine is recommended.			Sirima, SB (corresponding author), Ctr Natl Rech & Format Paludisme, Ouagadougou, Burkina Faso.	s.sirima.cnlp@fasonet.bf	SOULAMA, Issiaka/Z-1254-2019; OUEDRAOGO, Alphonse/F-7859-2019; Luty, Adrian/CAH-2547-2022	SOULAMA, Issiaka/0000-0002-0993-0525; Nebie, Issa/0000-0003-3051-3600; Luty, Adrian John Frederick/0000-0001-8830-3425; SIRIMA, Sodiomon Bienvenu/0000-0002-0972-4211; Tiono, B. Alfred/0000-0002-5104-3946; Ouedraogo, Alphonse/0000-0002-3520-6637				Audran R, 2005, INFECT IMMUN, V73, P8017, DOI 10.1128/IAI.73.12.8017-8026.2005; BOUHAROUNTAYOUN H, 1992, MEM I OSWALDO CRUZ, V87, P229, DOI 10.1590/S0074-02761992000700038; BOUHAROUNTAYOUN H, 1990, J EXP MED, V172, P1633, DOI 10.1084/jem.172.6.1633; BOUHAROUNTAYOUN H, 1995, J EXP MED, V182, P409, DOI 10.1084/jem.182.2.409; BOUHAROUNTAYOUN H, 1992, INFECT IMMUN, V60, P1473, DOI 10.1128/IAI.60.4.1473-1481.1992; Dodoo D, 2000, J INFECT DIS, V181, P1202, DOI 10.1086/315341; Druilhe P, 2005, PLOS MED, V2, P1135, DOI 10.1371/journal.pmed.0020344; DRUILHE P, 1994, IMMUNOL LETT, V41, P115, DOI 10.1016/0165-2478(94)90118-X; Druilhe Pierre, 2002, Methods Mol Med, V72, P529, DOI 10.1385/1-59259-271-6:529; Guerin PJ, 2002, LANCET INFECT DIS, V2, P564, DOI 10.1016/S1473-3099(02)00372-9; Jafarshad A, 2007, J IMMUNOL, V178, P3099, DOI 10.4049/jimmunol.178.5.3099; Jordan SJ, 2009, AM J TROP MED HYG, V80, P479, DOI 10.4269/ajtmh.2009.80.479; McColl DJ, 1997, MOL BIOCHEM PARASIT, V90, P21, DOI 10.1016/S0166-6851(97)00130-8; Ndungu FM, 2002, PARASITE IMMUNOL, V24, P77, DOI 10.1046/j.0141-9838.2001.00440.x; Nebie I, 2008, INFECT IMMUN, V76, P759, DOI 10.1128/IAI.01147-07; Oeuvray C, 2000, INFECT IMMUN, V68, P2617, DOI 10.1128/IAI.68.5.2617-2620.2000; OEUVRAY C, 1994, BLOOD, V84, P1594; OEUVRAY C, 1994, MEM I OSWALDO CRUZ, V89, P77, DOI 10.1590/S0074-02761994000600018; SABCHAREON A, 1991, AM J TROP MED HYG, V45, P297, DOI 10.4269/ajtmh.1991.45.297; Sirima SB, 2007, VACCINE, V25, P2723, DOI 10.1016/j.vaccine.2006.05.090; Soe S, 2004, INFECT IMMUN, V72, P247, DOI 10.1128/IAI.72.1.247-252.2004; Tebo AE, 2001, EXP PARASITOL, V98, P20, DOI 10.1006/expr.2001.4619	22	41	43	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7549	10.1371/journal.pone.0007549	http://dx.doi.org/10.1371/journal.pone.0007549			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855847	Green Published, Green Submitted, gold			2022-12-27	WOS:000271147200004
J	Julia, A; Erra, A; Palacio, C; Tomas, C; Sans, X; Barcelo, P; Marsal, S				Julia, Antonio; Erra, Alba; Palacio, Carles; Tomas, Carlos; Sans, Xavier; Barcelo, Pere; Marsal, Sara			An Eight-Gene Blood Expression Profile Predicts the Response to Infliximab in Rheumatoid Arthritis	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; REGULATORY T-CELLS; TNF-ALPHA THERAPY; MONOCLONAL-ANTIBODY; MICROARRAY DATA; DISEASE; CANCER; POPULATION; VALIDATION; SIGNATURE	Background: TNF alpha blockade agents like infliximab are actually the treatment of choice for those rheumatoid arthritis (RA) patients who fail standard therapy. However, a considerable percentage of anti-TNF alpha treated patients do not show a significant clinical response. Given that new therapies for treatment of RA have been recently approved, there is a pressing need to find a system that reliably predicts treatment response. We hypothesized that the analysis of whole blood gene expression profiles of RA patients could be used to build a robust predictor to infliximab therapy. Methods and Findings: We performed microarray gene expression analysis on whole blood RNA samples from RA patients starting infliximab therapy (n = 44). The clinical response to infliximab was determined at week 14 using the EULAR criteria. Blood cell populations were determined using flow cytometry at baseline, week 2 and week 14 of treatment. Using complete cross-validation and repeated random sampling we identified a robust 8-gene predictor model (96.6% Leave One Out prediction accuracy, P = 0.0001). Applying this model to an independent validation set of RA patients, we estimated an 85.7% prediction accuracy (75-100%, 95% CI). In parallel, we also observed a significantly higher number of CD4+CD25+ cells (i.e. regulatory T cells) in the responder group compared to the non responder group at baseline (P = 0.0009). Conclusions: The present 8-gene model obtained from whole blood expression efficiently predicts response to infliximab in RA patients. The application of the present system in the clinical setting could assist the clinician in the selection of the optimal treatment strategy in RA.			Julia, A (corresponding author), Hosp Univ Vall Hebron, Inst Recerca, Grp Recerca Reumatol, Barcelona, Spain.	smarsal@ir.vhebron.net		marsal, sara/0000-0001-5515-3854; Palacio-Garcia, Carles/0000-0002-9085-3327; Julia Cano, Antonio/0000-0001-6064-3620				Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; ARNETT FC, 1989, B RHEUM DIS, V38, P1; Bach JF, 2003, NAT REV IMMUNOL, V3, P189, DOI 10.1038/nri1026; BATLIWALLA FM, 2006, MOL MED; Bolstad B, 2005, BIOINFORMATICS COMPU; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bryl E, 2001, J IMMUNOL, V167, P3231, DOI 10.4049/jimmunol.167.6.3231; Ebert BL, 2008, PLOS MED, V5, P312, DOI 10.1371/journal.pmed.0050035; EFRON B, 1998, INTRO BOOTSTRAP CHAP; ELLIOTT MJ, 1994, LANCET, V344, P1105, DOI 10.1016/S0140-6736(94)90628-9; Fessler MB, 2002, J BIOL CHEM, V277, P31291, DOI 10.1074/jbc.M200755200; Firestein GS, 2003, NATURE, V423, P356, DOI 10.1038/nature01661; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Hyrich KL, 2006, RHEUMATOLOGY, V45, P1558, DOI 10.1093/rheumatology/kel149; Julia A, 2008, ARTHRITIS RHEUM-US, V58, P2275, DOI 10.1002/art.23623; Klareskog L, 2009, LANCET, V373, P659, DOI 10.1016/S0140-6736(09)60008-8; Lande R, 2007, NATURE, V449, P564, DOI 10.1038/nature06116; Lequerre T, 2006, ARTHRITIS RES THER, V8, DOI 10.1186/ar1990; Lodes MJ, 2004, J CLIN INVEST, V113, P1296, DOI 10.1172/JCI200420295; Ma CS, 2007, ANNU REV IMMUNOL, V25, P337, DOI 10.1146/annurev.immunol.25.022106.141651; Marotte H, 2006, ANN RHEUM DIS, V65, P342, DOI 10.1136/ard.2005.037150; Michiels S, 2005, LANCET, V365, P488, DOI 10.1016/S0140-6736(05)17866-0; Mohr S, 2007, TRENDS MOL MED, V13, P422, DOI 10.1016/j.molmed.2007.08.003; Mugnier B, 2003, ARTHRITIS RHEUM, V48, P1849, DOI 10.1002/art.11168; Nadkarni S, 2007, J EXP MED, V204, P33, DOI 10.1084/jem.20061531; Ntzani EE, 2003, LANCET, V362, P1439, DOI 10.1016/S0140-6736(03)14686-7; Olsen NJ, 2004, ANN RHEUM DIS, V63, P1387, DOI 10.1136/ard.2003.017194; PREVOO MLL, 1995, ARTHRITIS RHEUM, V38, P44, DOI 10.1002/art.1780380107; Saag KG, 2008, ARTHRIT RHEUM-ARTHR, V59, P762, DOI 10.1002/art.23721; SALEEM B, 2006, DRUG DISCOV TODAY, V3, P11; Sekiguchi N, 2008, RHEUMATOLOGY, V47, P780, DOI 10.1093/rheumatology/ken083; Smolen JS, 2007, LANCET, V370, P1861, DOI 10.1016/S0140-6736(07)60784-3; Smolkin M, 2003, BMC BIOINFORMATICS, V4, DOI 10.1186/1471-2105-4-36; Strand V, 2007, NAT REV DRUG DISCOV, V6, P75, DOI 10.1038/nrd2196; Tydell CC, 2007, J IMMUNOL, V179, P421, DOI 10.4049/jimmunol.179.1.421; van Gestel AM, 1998, ARTHRITIS RHEUM-US, V41, P1845, DOI 10.1002/1529-0131(199810)41:10<1845::AID-ART17>3.3.CO;2-B; van't Veer LJ, 2002, NATURE, V415, P530, DOI 10.1038/415530a; Vignali DAA, 2008, NAT REV IMMUNOL, V8, P523, DOI 10.1038/nri2343; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499	39	76	84	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7556	10.1371/journal.pone.0007556	http://dx.doi.org/10.1371/journal.pone.0007556			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847310	Green Published, gold, Green Submitted			2022-12-27	WOS:000271022000018
J	Watson, CL; Lockwood, DNJ				Watson, Claire L.; Lockwood, Diana N. J.			Single Nucleotide Polymorphism Analysis of European Archaeological M. leprae DNA	PLOS ONE			English	Article							MYCOBACTERIUM-TUBERCULOSIS; LEPROSY; REMAINS; GENOME	Background: Leprosy was common in Europe eight to twelve centuries ago but molecular confirmation of this has been lacking. We have extracted M. leprae ancient DNA (aDNA) from medieval bones and single nucleotide polymorphism (SNP) typed the DNA, this provides insight into the pattern of leprosy transmission in Europe and may assist in the understanding of M. leprae evolution. Methods and Findings: Skeletons have been exhumed from 3 European countries (the United Kingdom, Denmark and Croatia) and are dated around the medieval period (476 to 1350 A. D.). we tested for the presence of 3 previously identified single nucleotide polymorphisms (SNPs) in 10 aDNA extractions. M. leprae aDNA was extracted from 6 of the 10 bone samples. SNP analysis of these 6 extractions were compared to previously analysed European SNP data using the same PCR assays and were found to be the same. Testing for the presence of SNPs in M. leprae DNA extracted from ancient bone samples is a novel approach to analysing European M. leprae DNA and the findings concur with the previously published data that European M. leprae strains fall in to one group (SNP group 3). Conclusions: These findings support the suggestion that the M. leprae genome is extremely stable and show that archaeological M. leprae DNA can be analysed to gain detailed information about the genotypic make-up of European leprosy, which may assist in the understanding of leprosy transmission worldwide.			Watson, CL (corresponding author), London Sch Hyg & Trop Med, Dept Infect Dis, London WC1, England.	claire.watson@lshtm.ac.uk						ARRIAZA BT, 1995, AM J PHYS ANTHROPOL, V98, P37, DOI 10.1002/ajpa.1330980104; Barnes I, 2006, P ROY SOC B-BIOL SCI, V273, P645, DOI 10.1098/rspb.2005.3339; Boldsen JL, 2006, AM J PHYS ANTHROPOL, V130, P344, DOI 10.1002/ajpa.20363; Bouwman AS, 2005, J ARCHAEOL SCI, V32, P703, DOI 10.1016/j.jas.2004.11.014; BROTHWELL D R, 1958, Med Hist, V2, P287; Cole ST, 2001, NATURE, V409, P1007, DOI 10.1038/35059006; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; Cooper A, 2000, SCIENCE, V289, P1139; Donoghue HD, 1998, LETT APPL MICROBIOL, V27, P265; Donoghue HD, 2005, P ROY SOC B-BIOL SCI, V272, P389, DOI 10.1098/rspb.2004.2966; Donoghue HD, 2004, LANCET INFECT DIS, V4, P584, DOI 10.1016/S1473-3099(04)01133-8; Eiglmeier K, 2001, LEPROSY REV, V72, P387; Gill AL, 2005, QJM-INT J MED, V98, P505, DOI 10.1093/qjmed/hci079; Haas CJ, 2000, AM J CLIN PATHOL, V114, P428, DOI 10.1093/ajcp/114.3.428; Monot M, 2005, SCIENCE, V308, P1040, DOI 10.1126/science/1109759; Nerlich AG, 1997, LANCET, V350, P1404, DOI 10.1016/S0140-6736(05)65185-9; Ortner D. J., 1985, IDENTIFICATION PATHO, V28; RAFI A, 1994, LANCET, V343, P1360, DOI 10.1016/S0140-6736(94)92494-5; REES JW, 1964, BRIT J EXP PATHOL, V45, P207; RICHARDS P, 1960, Centaurus, V7, P101, DOI 10.1111/j.1600-0498.1960.tb00260.x; Rojas-Espinosa O, 2005, CLIN EXP IMMUNOL, V140, P436, DOI 10.1111/j.1365-2249.2005.02776.x; SKINSNES OK, 1976, INT J LEPROSY, V44, P376; Spigelman M, 1993, INT J OSTEOARCHAEOL, V3, P137, DOI DOI 10.1002/0A.1390030211; STORRS EE, 1974, SCIENCE, V183, P851, DOI 10.1126/science.183.4127.851; Taylor GM, 2006, J ARCHAEOL SCI, V33, P1569, DOI 10.1016/j.jas.2006.02.008; Taylor GM, 1999, MICROBIOL-UK, V145, P899, DOI 10.1099/13500872-145-4-899; VOGELSANG T M, 1965, Med Hist, V9, P29; WOODS SA, 1990, MOL MICROBIOL, V4, P1745, DOI 10.1111/j.1365-2958.1990.tb00552.x; Zink AR, 2002, FEMS MICROBIOL LETT, V213, P141, DOI 10.1111/j.1574-6968.2002.tb11298.x	29	24	24	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7547	10.1371/journal.pone.0007547	http://dx.doi.org/10.1371/journal.pone.0007547			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509MN	19847306	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000271022000014
J	Noll, C; Planque, C; Ripoll, C; Guedj, F; Diez, A; Ducros, V; Belin, N; Duchon, A; Paul, JL; Badel, A; de Freminville, B; Grattau, Y; Blehaut, H; Herault, Y; Janel, N; Delabar, JM				Noll, Christophe; Planque, Chris; Ripoll, Clementine; Guedj, Faycal; Diez, Anna; Ducros, Veronique; Belin, Nicole; Duchon, Arnaud; Paul, Jean-Louis; Badel, Anne; de Freminville, Benedicte; Grattau, Yann; Blehaut, Henri; Herault, Yann; Janel, Nathalie; Delabar, Jean-Maurice			DYRK1A, a Novel Determinant of the Methionine-Homocysteine Cycle in Different Mouse Models Overexpressing this Down-Syndrome-Associated Kinase	PLOS ONE			English	Article							S-ADENOSYLHOMOCYSTEINE HYDROLASE; MENTAL-RETARDATION; METABOLISM; LIVER; MICE; PREVALENCE; EXPRESSION; PATHWAYS; DISEASE; CELLS	Background: Hyperhomocysteinemia, characterized by increased plasma homocysteine level, is associated with an increased risk of atherosclerosis. On the contrary, patients with Down syndrome appear to be protected from the development of atherosclerosis. We previously found a deleterious effect of hyperhomocysteinemia on expression of DYRK1A, a Down-syndrome-associated kinase. As increased expression of DYRK1A and low plasma homocysteine level have been associated with Down syndrome, we aimed to analyze the effect of its over-expression on homocysteine metabolism in mice. Methodology/Principal Findings: Effects of DYRK1A over-expression were examined by biochemical analysis of methionine metabolites, real-time quantitative reverse-transcription polymerase chain reaction, and enzyme activities. We found that over-expression of Dyrk1a increased the hepatic NAD(P) H: quinone oxidoreductase and S-adenosylhomocysteine hydrolase activities, concomitant with decreased level of plasma homocysteine in three mice models overexpressing Dyrk1a. Moreover, these effects were abolished by treatment with harmine, the most potent and specific inhibitor of Dyrk1a. The increased NAD(P) H: quinone oxidoreductase and S-adenosylhomocysteine hydrolase activities were also found in lymphoblastoid cell lines from patients with Down syndrome. Conclusions/Significance: Our results might give clues to understand the protective effect of Down syndrome against vascular defect through a decrease of homocysteine level by DYRK1A over-expression. They reveal a link between the Dyrk1a signaling pathway and the homocysteine cycle.			Noll, C (corresponding author), Univ Paris Diderot, CNRS, EAC 4413, Unit Funct & Adapt Biol BFA, Paris, France.	nathalie.janel@univ-paris-diderot.fr	paul, jean-louis/D-8071-2017; duchon, arnaud/D-2764-2013; Herault, Yann/B-5500-2012	duchon, arnaud/0000-0003-3043-702X; Herault, Yann/0000-0001-7049-6900; Diez-Betriu, Anna/0000-0002-4318-2348; Janel, Nathalie/0000-0002-4746-8941				Aleksunes LM, 2006, CELL STRESS CHAPERON, V11, P356, DOI 10.1379/CSC-217.1; Bain J, 2007, BIOCHEM J, V408, P297, DOI 10.1042/BJ20070797; Becker W, 1999, PROG NUCLEIC ACID RE, V62, P1; BENSON AM, 1980, P NATL ACAD SCI-BIOL, V77, P5216, DOI 10.1073/pnas.77.9.5216; Davisson M T, 1993, Prog Clin Biol Res, V384, P117; Davisson Muriel T., 1993, V384, P117; Dowjat WK, 2007, NEUROSCI LETT, V413, P77, DOI 10.1016/j.neulet.2006.11.026; Draheim CC, 2006, MENT RETARD DEV D R, V12, P3, DOI 10.1002/mrdd.20095; Draheim CC, 2002, MENT RETARD, V40, P436, DOI 10.1352/0047-6765(2002)040<0436:POPIAR>2.0.CO;2; Ducros V, 2002, J CHROMATOGR B, V781, P207, DOI 10.1016/S1570-0232(02)00497-X; ERNSTER L, 1967, METHOD ENZYMOL, V10, P309, DOI DOI 10.1016/0076-6879(67)10059-1; Finkelstein JD, 1998, EUR J PEDIATR, V157, pS40, DOI 10.1007/PL00014300; FORTIN LJ, 1995, CLIN BIOCHEM, V28, P155, DOI 10.1016/0009-9120(94)00073-5; Galletti P, 2007, FEBS J, V274, P5263, DOI 10.1111/j.1742-4658.2007.06048.x; Gellekink H, 2005, CLIN CHEM, V51, P1487, DOI 10.1373/clinchem.2004.046995; Hamelet J, 2009, BIOCHEM BIOPH RES CO, V378, P673, DOI 10.1016/j.bbrc.2008.11.126; Han JM, 2007, J PHARMACOL EXP THER, V321, P249, DOI 10.1124/jpet.106.110866; HERSHFIELD MS, 1985, BIOCHEM J, V230, P43, DOI 10.1042/bj2300043; Holtzman DM, 1996, P NATL ACAD SCI USA, V93, P13333, DOI 10.1073/pnas.93.23.13333; Joung EJ, 2007, ANTIOXID REDOX SIGN, V9, P2087, DOI 10.1089/ars.2007.1827; Kloor D, 1998, BIOCHEM PHARMACOL, V56, P1493, DOI 10.1016/S0006-2952(98)00250-0; Kuhn C, 2009, J BIOL CHEM, V284, P17320, DOI 10.1074/jbc.M109.006759; Laguna A, 2008, DEV CELL, V15, P841, DOI 10.1016/j.devcel.2008.10.014; Licastro F, 2006, ARCH GERONTOL GERIAT, V43, P381, DOI 10.1016/j.archger.2006.01.003; MILLER JW, 1994, BIOCHEM J, V298, P415, DOI 10.1042/bj2980415; MURDOCH JC, 1977, BRIT MED J, V2, P226, DOI 10.1136/bmj.2.6081.226; Pogribna M, 2001, AM J HUM GENET, V69, P88, DOI 10.1086/321262; REEVES RH, 1995, NAT GENET, V11, P177, DOI 10.1038/ng1095-177; Seifert A, 2008, FEBS J, V275, P6268, DOI 10.1111/j.1742-4658.2008.06751.x; Selhub J, 1999, ANNU REV NUTR, V19, P217, DOI 10.1146/annurev.nutr.19.1.217; Siarey RJ, 2006, J NEUROCHEM, V98, P1266, DOI 10.1111/j.1471-4159.2006.03971.x; SMITH DJ, 1995, GENOMICS, V27, P425, DOI 10.1006/geno.1995.1073; Smith MD, 1997, J MICROBIOL METH, V28, P21, DOI 10.1016/S0167-7012(96)00958-X; Stead LM, 2000, BIOCHEM J, V350, P685, DOI 10.1042/0264-6021:3500685; Tichopad A, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng122; Villanueva JA, 2004, HEPATOLOGY, V39, P1303, DOI 10.1002/hep.20168; WATANABE M, 1995, P NATL ACAD SCI USA, V92, P1585, DOI 10.1073/pnas.92.5.1585; Welch GN, 1998, NEW ENGL J MED, V338, P1042, DOI 10.1056/NEJM199804093381507; YLAHERTTUALA S, 1989, ATHEROSCLEROSIS, V76, P269, DOI 10.1016/0021-9150(89)90110-X	39	40	42	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7540	10.1371/journal.pone.0007540	http://dx.doi.org/10.1371/journal.pone.0007540			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844572	gold, Green Submitted, Green Published			2022-12-27	WOS:000271013000016
J	Siso-Nadal, F; Fox, JJ; Laporte, SA; Hebert, TE; Swain, PS				Siso-Nadal, Fernando; Fox, Jeffrey J.; Laporte, Stephane A.; Hebert, Terence E.; Swain, Peter S.			Cross-Talk between Signaling Pathways Can Generate Robust Oscillations in Calcium and cAMP	PLOS ONE			English	Article							PROTEIN-KINASE-A; INTRACELLULAR CA2+ OSCILLATIONS; CYCLIC-AMP; PHOSPHOLIPASE-C; INOSITOL 1,4,5-TRISPHOSPHATE; ADENYLYL-CYCLASE; PHOSPHORYLATION; CELLS; BETA; STIMULATION	Background: To control and manipulate cellular signaling, we need to understand cellular strategies for information transfer, integration, and decision-making. A key feature of signal transduction is the generation of only a few intracellular messengers by many extracellular stimuli. Methodology/Principal Findings: Here we model molecular cross-talk between two classic second messengers, cyclic AMP (cAMP) and calcium, and show that the dynamical complexity of the response of both messengers increases substantially through their interaction. In our model of a non-excitable cell, both cAMP and calcium concentrations can oscillate. If mutually inhibitory, cross-talk between the two second messengers can increase the range of agonist concentrations for which oscillations occur. If mutually activating, cross-talk decreases the oscillation range, but can generate 'bursting' oscillations of calcium and may enable better filtering of noise. Conclusion: We postulate that this increased dynamical complexity allows the cell to encode more information, particularly if both second messengers encode signals. In their native environments, it is unlikely that cells are exposed to one stimulus at a time, and cross-talk may help generate sufficiently complex responses to allow the cell to discriminate between different combinations and concentrations of extracellular agonists.			Siso-Nadal, F (corresponding author), Gene Network Sci, Cambridge, MA USA.	peter.swain@ed.ac.uk	Laporte, Stephane/ABC-4228-2021; Fox, Jeff/L-4683-2019; Swain, Peter S/AAW-3265-2020; Laporte, Stephane A/F-3282-2012	Laporte, Stephane/0000-0002-0633-543X; Fox, Jeff/0000-0002-3780-4956; Swain, Peter/0000-0001-7489-8587				Ali H, 1998, J BIOL CHEM, V273, P11012, DOI 10.1074/jbc.273.18.11012; Borghans JAM, 1997, BIOPHYS CHEM, V66, P25, DOI 10.1016/S0301-4622(97)00010-0; Borst A, 1999, NAT NEUROSCI, V2, P947, DOI 10.1038/14731; COOPER DMF, 1995, NATURE, V374, P421, DOI 10.1038/374421a0; Dolmetsch RE, 1998, NATURE, V392, P933, DOI 10.1038/31960; Drin G, 2007, CELL SIGNAL, V19, P1383, DOI 10.1016/j.cellsig.2007.04.006; Dupont G, 2003, LECT NOTES PHYS, V623, P131; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; Flaherty P, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000185; Gorbunova YV, 2002, NATURE, V418, P93, DOI 10.1038/nature00835; GREEN AK, 1994, BIOCHEM J, V302, P949, DOI 10.1042/bj3020949; Guimond J, 2005, CELL SIGNAL, V17, P49, DOI 10.1016/j.cellsig.2004.05.012; Hartwell LH, 1999, NATURE, V402, pC47, DOI 10.1038/35011540; Houart G, 1999, B MATH BIOL, V61, P507, DOI 10.1006/bulm.1999.0095; Houslay MD, 1997, TRENDS BIOCHEM SCI, V22, P217, DOI 10.1016/S0968-0004(97)01050-5; KAWABE J, 1994, J BIOL CHEM, V269, P16554; KEIZER J, 1992, BIOPHYS J, V61, P649, DOI 10.1016/S0006-3495(92)81870-2; KENNEDY CRJ, 1995, BBA-LIPID LIPID MET, V1258, P206, DOI 10.1016/0005-2760(95)00049-I; Kummer U, 2000, BIOPHYS J, V79, P1188, DOI 10.1016/S0006-3495(00)76373-9; Laglia G, 1996, ENDOCRINOLOGY, V137, P3170, DOI 10.1210/en.137.8.3170; Landa LR, 2005, J BIOL CHEM, V280, P31294, DOI 10.1074/jbc.M505657200; Larsen AZ, 2003, LECT NOTES PHYS, V623, P153; Lawler OA, 2001, J BIOL CHEM, V276, P33596, DOI 10.1074/jbc.M104434200; Liu MY, 1996, NATURE, V382, P83, DOI 10.1038/382083a0; Marhl M, 2000, BIOSYSTEMS, V57, P75, DOI 10.1016/S0303-2647(00)00090-3; MEYER T, 1988, P NATL ACAD SCI USA, V85, P5051, DOI 10.1073/pnas.85.14.5051; MEYER T, 1991, ANNU REV BIOPHYS BIO, V20, P153, DOI 10.1146/annurev.bb.20.060191.001101; MEYER T, 1988, SCIENCE, V240, P653, DOI 10.1126/science.2452482; Newton AC, 2001, CHEM REV, V101, P2353, DOI 10.1021/cr0002801; RAPP PE, 1981, J THEOR BIOL, V90, P531, DOI 10.1016/0022-5193(81)90304-0; RAPP PE, 1977, J THEOR BIOL, V66, P497, DOI 10.1016/0022-5193(77)90299-5; Saucerman JJ, 2003, J BIOL CHEM, V278, P47997, DOI 10.1074/jbc.M308362200; Schmidt M, 2001, NAT CELL BIOL, V3, P1020, DOI 10.1038/ncb1101-1020; Schuster S, 2002, EUR J BIOCHEM, V269, P1333, DOI 10.1046/j.0014-2956.2001.02720.x; Shahrezaei V, 2008, CURR OPIN BIOTECH, V19, P369, DOI 10.1016/j.copbio.2008.06.011; Shannon C.E., 1999, MATH THEORY COMMUNIC; SHEN P, 1995, CELL CALCIUM, V17, P225, DOI 10.1016/0143-4160(95)90037-3; Strogatz S.H., 1994, NONLINEAR DYNAMICS C; Tyson JJ, 2001, NAT REV MOL CELL BIO, V2, P908, DOI 10.1038/35103078; VOLPE P, 1990, AM J PHYSIOL, V258, pC1086, DOI 10.1152/ajpcell.1990.258.6.C1086; Werry TD, 2003, BIOCHEM J, V374, P281, DOI 10.1042/BJ20030312; Willoughby D, 2006, J CELL SCI, V119, P828, DOI 10.1242/jcs.02812; WOODS NM, 1986, NATURE, V319, P600, DOI 10.1038/319600a0; Wu BQ, 2006, J CELL BIOL, V173, P327, DOI 10.1083/jcb.200602089; Yu XT, 2004, J NEUROPHYSIOL, V91, P2297, DOI 10.1152/jn.00787.2003; Yue CP, 1998, J BIOL CHEM, V273, P18023, DOI 10.1074/jbc.273.29.18023	46	30	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7189	10.1371/journal.pone.0007189	http://dx.doi.org/10.1371/journal.pone.0007189			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844582	Green Submitted, Green Published, gold			2022-12-27	WOS:000271013000001
J	Davis, R; Rizwani, W; Banerjee, S; Kovacs, M; Haura, E; Coppola, D; Chellappan, S				Davis, Rebecca; Rizwani, Wasia; Banerjee, Sarmistha; Kovacs, Michelle; Haura, Eric; Coppola, Domenico; Chellappan, Srikumar			Nicotine Promotes Tumor Growth and Metastasis in Mouse Models of Lung Cancer	PLOS ONE			English	Article							EPITHELIAL-MESENCHYMAL TRANSITION; RECEPTOR SUBUNIT GENES; ACETYLCHOLINE-RECEPTOR; CIGARETTE-SMOKING; ESTROGEN-RECEPTOR; CELL-PROLIFERATION; SUSCEPTIBILITY LOCUS; COTININE LEVELS; TOBACCO-SMOKE; A/J MICE	Background: Nicotine is the major addictive component of tobacco smoke. Although nicotine is generally thought to have limited ability to initiate cancer, it can induce cell proliferation and angiogenesis in a variety of systems. These properties might enable nicotine to facilitate the growth of tumors already initiated. Here we show that nicotine significantly promotes the progression and metastasis of tumors in mouse models of lung cancer. This effect was observed when nicotine was administered through intraperitoneal injections, or through over-the-counter transdermal patches. Methods and Findings: In the present study, Line1 mouse adenocarcinoma cells were implanted subcutaneously into syngenic BALB/c mice. Nicotine administration either by intraperitoneal (i.p.) injection or transdermal patches caused a remarkable increase in the size of implanted Line1 tumors. Once the tumors were surgically removed, nicotine treated mice had a markedly higher tumor recurrence (59.7%) as compared to the vehicle treated mice (19.5%). Nicotine also increased metastasis of dorsally implanted Line1 tumors to the lungs by 9 folds. These studies on transplanted tumors were extended to a mouse model where the tumors were induced by the tobacco carcinogen, NNK. Lung tumors were initiated in A/J mice by i.p. injection of NNK; administration of 1 mg/kg nicotine three times a week led to an increase in the size and the number of tumors formed in the lungs. In addition, nicotine significantly reduced the expression of epithelial markers, E-Cadherin and beta-Catenin as well as the tight junction protein ZO-1; these tumors also showed an increased expression of the alpha(7) nAChR subunit. We believe that exposure to nicotine either by tobacco smoke or nicotine supplements might facilitate increased tumor growth and metastasis. Conclusions: Our earlier results indicated that nicotine could induce invasion and epithelial-mesenchymal transition (EMT) in cultured lung, breast and pancreatic cancer cells. This study demonstrates for the first time that administration of nicotine either by i.p. injection or through over-the-counter dermal patches can promote tumor growth and metastasis in immunocompetent mice. These results suggest that while nicotine has only limited capacity to initiate tumor formation, it can facilitate the progression and metastasis of tumors pre-initiated by tobacco carcinogens.			Davis, R (corresponding author), Mayo Clin Jacksonville, 4500 San Pablo Rd, Jacksonville, FL 32224 USA.	Srikumar.Chellappan@moffitt.org			NATIONAL CANCER INSTITUTE [R01CA063136, R01CA127725] Funding Source: NIH RePORTER; NCI NIH HHS [CA63136, CA127725, R01 CA063136, R01 CA127725] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahn S, 2003, P NATL ACAD SCI USA, V100, P1740, DOI 10.1073/pnas.262789099; Amos CI, 2008, NAT GENET, V40, P616, DOI 10.1038/ng.109; Berger F, 1998, J NEUROSCI, V18, P6871; BRUNNEMANN KD, 1991, CRIT REV TOXICOL, V21, P235, DOI 10.3109/10408449109017910; Carlisle DL, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-27; CASTONGUAY A, 1983, CANCER RES, V43, P1223; Chanock SJ, 2007, NATURE, V447, P655, DOI 10.1038/447655a; Chen DN, 1997, J BIOL CHEM, V272, P24024, DOI 10.1074/jbc.272.38.24024; Clementi F, 2000, EUR J PHARMACOL, V393, P3, DOI 10.1016/S0014-2999(00)00066-2; Copeland RL, 2007, NEUROTOX RES, V12, P61, DOI 10.1007/BF03033901; Dasgupta P, 2006, P NATL ACAD SCI USA, V103, P6332, DOI 10.1073/pnas.0509313103; Dasgupta P, 2006, CELL CYCLE, V5, P2324, DOI 10.4161/cc.5.20.3366; Dasgupta P, 2009, INT J CANCER, V124, P36, DOI 10.1002/ijc.23894; Dasgupta P, 2006, J CLIN INVEST, V116, P2208, DOI 10.1172/JCI28164; Etard C, 2005, DEV DYNAM, V234, P1016, DOI 10.1002/dvdy.20592; Garces YI, 2004, CHEST, V126, P1733, DOI 10.1378/chest.126.6.1733; Carracedo DG, 2007, ANTICANCER RES, V27, P835; Gautam A, 2003, ONCOGENE, V22, P2135, DOI 10.1038/sj.onc.1206232; GERZANICH V, 1994, MOL PHARMACOL, V45, P212; Gorrod J.W., 1999, ANAL DETERMINATION N; Gottardi CJ, 2001, J CELL BIOL, V153, P1049, DOI 10.1083/jcb.153.5.1049; Grozio A, 2007, ANTI-CANCER AGENT ME, V7, P461; Guo JJ, 2008, CANCER RES, V68, P8473, DOI 10.1158/0008-5472.CAN-08-0131; Hecht SS, 2002, LANCET ONCOL, V3, P461, DOI 10.1016/S1470-2045(02)00815-X; HECHT SS, 1988, CANCER LETT, V42, P141, DOI 10.1016/0304-3835(88)90251-0; Heeschen C, 2001, NAT MED, V7, P833, DOI 10.1038/89961; Hershberger PA, 2005, CANCER RES, V65, P1598, DOI 10.1158/0008-5472.CAN-04-2694; HILL P, 1983, J CHRON DIS, V36, P439, DOI 10.1016/0021-9681(83)90136-4; Huber MA, 2005, CURR OPIN CELL BIOL, V17, P548, DOI 10.1016/j.ceb.2005.08.001; Hung RJ, 2008, NATURE, V452, P633, DOI 10.1038/nature06885; Itier V, 2001, FEBS LETT, V504, P118, DOI 10.1016/S0014-5793(01)02702-8; Jarzynka MJ, 2006, INT J ONCOL, V28, P337; JOHNSTONEARLY A, 1980, JAMA-J AM MED ASSOC, V244, P2175, DOI 10.1001/jama.244.19.2175; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Lam DCL, 2007, CANCER RES, V67, P4638, DOI 10.1158/0008-5472.CAN-06-4628; Lindstrom J, 1997, MOL NEUROBIOL, V15, P193, DOI 10.1007/BF02740634; Lindstrom J, 1996, Ion Channels, V4, P377; MANACKJEE R, 1990, P NATL ACAD SCI USA, V87, P3294; MATHAI M, 1990, AUST NZ J OBSTET GYN, V30, P33, DOI 10.1111/j.1479-828X.1990.tb03192.x; MATSUKURA S, 1984, NEW ENGL J MED, V311, P828, DOI 10.1056/NEJM198409273111305; Mukhin AG, 2008, J NUCL MED, V49, P1628, DOI 10.2967/jnumed.108.050716; Omoto Y, 2001, BIOCHEM BIOPH RES CO, V285, P340, DOI 10.1006/bbrc.2001.5158; Oshikawa J, 2003, AM J PHYSIOL-CELL PH, V285, pC567, DOI 10.1152/ajpcell.00422.2002; Paleari L, 2009, AM J RESP CRIT CARE, V179, P1141, DOI 10.1164/rccm.200806-908OC; Razani-Boroujerdi S, 2007, AM J RESP CELL MOL, V36, P13, DOI 10.1165/rcmb.2005-0330OC; RICHARDSON GE, 1993, ANN INTERN MED, V119, P383, DOI 10.7326/0003-4819-119-5-199309010-00006; Schuller HM, 2009, NAT REV CANCER, V9, P195, DOI 10.1038/nrc2590; Schuller HM, 2003, ANAT REC PART A, V270A, P51, DOI 10.1002/ar.a.10019; SCHULLER HM, 1995, LAB INVEST, V73, P448; Sekido Y, 2003, ANNU REV MED, V54, P73, DOI 10.1146/annurev.med.54.101601.152202; Sharma G, 2002, J NEUROBIOL, V53, P524, DOI 10.1002/neu.10114; Sharma G, 2001, P NATL ACAD SCI USA, V98, P4148, DOI 10.1073/pnas.071540198; Shin VY, 2004, CARCINOGENESIS, V25, P2487, DOI 10.1093/carcin/bgh266; Stabile LP, 2002, CANCER RES, V62, P2141; Stabile LP, 2005, CANCER RES, V65, P1459, DOI 10.1158/0008-5472.CAN-04-1872; THOMPSON SG, 1990, THORAX, V45, P356, DOI 10.1136/thx.45.5.356; Thorgeirsson TE, 2008, NATURE, V452, P638, DOI 10.1038/nature06846; VIJAYARAGHAVAN S, 1995, J NEUROSCI, V15, P3679; WAGENKNECHT LE, 1990, AM J PUBLIC HEALTH, V80, P1053, DOI 10.2105/AJPH.80.9.1053; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang J, 2006, CANCER RES, V66, P4549, DOI 10.1158/0008-5472.CAN-05-3850; YUHAS JM, 1974, CANCER RES, V34, P2005; YUHAS JM, 1975, CANCER RES, V35, P242; YUHAS JM, 1975, CANCER RES, V35, P237; YUHAS JM, 1974, CANCER RES, V34, P722	65	143	150	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7524	10.1371/journal.pone.0007524	http://dx.doi.org/10.1371/journal.pone.0007524			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841737	gold, Green Published, Green Submitted			2022-12-27	WOS:000271012900016
J	Pilka, ES; Niesen, FH; Lee, WH; El-Hawari, Y; Dunford, JE; Kochan, G; Wsol, V; Martin, HJ; Maser, E; Oppermann, U				Pilka, Ewa S.; Niesen, Frank H.; Lee, Wen Hwa; El-Hawari, Yasser; Dunford, James E.; Kochan, Grazyna; Wsol, Vladimir; Martin, Hans-Joerg; Maser, Edmund; Oppermann, Udo			Structural Basis for Substrate Specificity in Human Monomeric Carbonyl Reductases	PLOS ONE			English	Article							SHORT-CHAIN DEHYDROGENASES/REDUCTASES; REDUCTION; DEHYDROGENASE/REDUCTASE; PURIFICATION; ENZYMES; CYTOSOL; LIVER; NNK; SDR	Carbonyl reduction constitutes a phase I reaction for many xenobiotics and is carried out in mammals mainly by members of two protein families, namely aldo-keto reductases and short-chain dehydrogenases/reductases. In addition to their capacity to reduce xenobiotics, several of the enzymes act on endogenous compounds such as steroids or eicosanoids. One of the major carbonyl reducing enzymes found in humans is carbonyl reductase 1 (CBR1) with a very broad substrate spectrum. A paralog, carbonyl reductase 3 (CBR3) has about 70% sequence identity and has not been sufficiently characterized to date. Screening of a focused xenobiotic compound library revealed that CBR3 has narrower substrate specificity and acts on several orthoquinones, as well as isatin or the anticancer drug oracin. To further investigate structure-activity relationships between these enzymes we crystallized CBR3, performed substrate docking, site-directed mutagenesis and compared its kinetic features to CBR1. Despite high sequence similarities, the active sites differ in shape and surface properties. The data reveal that the differences in substrate specificity are largely due to a short segment of a substrate binding loop comprising critical residues Trp229/Pro230, Ala235/Asp236 as well as part of the active site formed by Met141/Gln142 in CBR1 and CBR3, respectively. The data suggest a minor role in xenobiotic metabolism for CBR3.			Pilka, ES (corresponding author), Univ Oxford, Struct Genom Consortium, Headington, England.	udo.oppermann@sgc.ox.ac.uk	Wsol, Vladimir/K-3476-2016; Lee, Wen Hwa/GZA-8183-2022; Maser, Edmund/B-1728-2010; Kochan, Grazyna/A-1094-2009; Lee, Wen Hwa/G-1250-2013	Wsol, Vladimir/0000-0003-3745-7648; Lee, Wen Hwa/0000-0002-4098-5225; Lee, Wen Hwa/0000-0002-4098-5225; Dunford, James/0000-0002-9932-4042; Kochan, Grazyna/0000-0002-0534-9661	CIHR Funding Source: Medline; Wellcome Trust Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)		ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; Atalla A, 1999, TOXICOLOGY, V139, P155, DOI 10.1016/S0300-483X(99)00114-6; Atalla A, 2000, XENOBIOTICA, V30, P755, DOI 10.1080/00498250050119826; Botella JA, 2004, CURR BIOL, V14, P782, DOI 10.1016/j.cub.2004.04.036; Bray JE, 2009, CHEM-BIOL INTERACT, V178, P99, DOI 10.1016/j.cbi.2008.10.058; Carbone DL, 2004, FREE RADICAL BIO MED, V37, P1430, DOI 10.1016/j.freeradbiomed.2004.07.016; Doorn JA, 2004, BIOCHEMISTRY-US, V43, P13106, DOI 10.1021/bi049136q; Doorn JA, 2003, CHEM-BIOL INTERACT, V143, P93, DOI 10.1016/S0009-2797(02)00178-3; Doorn JA, 2002, CHEM RES TOXICOL, V15, P1445, DOI 10.1021/tx025590o; El-Hawari Y, 2009, CHEM-BIOL INTERACT, V178, P234, DOI 10.1016/j.cbi.2008.11.004; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Filling C, 2002, J BIOL CHEM, V277, P25677, DOI 10.1074/jbc.M202160200; Ghosh D, 2001, J BIOL CHEM, V276, P18457, DOI 10.1074/jbc.M100538200; Hoffmann F, 2007, DRUG METAB REV, V39, P87, DOI 10.1080/03602530600969440; Ismail E, 2000, CANCER RES, V60, P1173; Jin Y, 2007, ANNU REV PHARMACOL, V47, P263, DOI 10.1146/annurev.pharmtox.47.120505.105337; Lakhman SS, 2005, DRUG METAB DISPOS, V33, P254, DOI 10.1124/dmd.104.002006; Matsunaga T, 2006, DRUG METAB PHARMACOK, V21, P1, DOI 10.2133/dmpk.21.1; McCoy AJ, 2005, ACTA CRYSTALLOGR D, V61, P458, DOI 10.1107/S0907444905001617; Miura T, 2008, MOL CELL BIOCHEM, V315, P113, DOI 10.1007/s11010-008-9794-5; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Oppermann U, 2003, CHEM-BIOL INTERACT, V143, P247, DOI 10.1016/S0009-2797(02)00164-3; Oppermann U, 2007, ANNU REV PHARMACOL, V47, P293, DOI 10.1146/annurev.pharmtox.47.120505.105316; Persson B, 2009, CHEM-BIOL INTERACT, V178, P94, DOI 10.1016/j.cbi.2008.10.040; Porte S, 2009, CHEM-BIOL INTERACT, V178, P288, DOI 10.1016/j.cbi.2008.10.018; Schlegel BP, 1998, BIOCHEMISTRY-US, V37, P11003, DOI 10.1021/bi980475r; Tanaka M, 2005, PLOS BIOL, V3, P764, DOI 10.1371/journal.pbio.0030128; WERMUTH B, 1986, BIOCHEM PHARMACOL, V35, P1277, DOI 10.1016/0006-2952(86)90271-6; WERMUTH B, 1981, J BIOL CHEM, V256, P1206	29	46	47	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7113	10.1371/journal.pone.0007113	http://dx.doi.org/10.1371/journal.pone.0007113			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841672	Green Published, gold			2022-12-27	WOS:000271012900003
J	Asai, H; Iwamori, S; Kawai, K; Ehira, S; Ishihara, J; Aihara, K; Shoji, S; Iwasaki, H				Asai, Hironori; Iwamori, Shunsuke; Kawai, Kentaro; Ehira, Shigeki; Ishihara, Jun-ichi; Aihara, Kazuyuki; Shoji, Shuichi; Iwasaki, Hideo			Cyanobacterial Cell Lineage Analysis of the Spatiotemporal hetR Expression Profile during Heterocyst Pattern Formation in Anabaena sp PCC 7120	PLOS ONE			English	Article								Diazotrophic heterocyst formation in the filamentous cyanobacterium, Anabaena sp. PCC 7120, is one of the simplest pattern formations known to occur in cell differentiation. Most previous studies on heterocyst patterning were based on statistical analysis using cells collected or observed at different times from a liquid culture, which would mask stochastic fluctuations affecting the process of pattern formation dynamics in a single bacterial filament. In order to analyze the spatiotemporal dynamics of heterocyst formation at the single filament level, here we developed a culture system to monitor simultaneously bacterial development, gene expression, and phycobilisome fluorescence. We also developed micro-liquid chamber arrays to analyze multiple Anabaena filaments at the same time. Cell lineage analyses demonstrated that the initial distributions of hetR::gfp and phycobilisome fluorescence signals at nitrogen step-down were not correlated with the resulting distribution of developed heterocysts. Time-lapse observations also revealed a dynamic hetR expression profile at the single-filament level, including transient upregulation accompanying cell division, which did not always lead to heterocyst development. In addition, some cells differentiated into heterocysts without cell division after nitrogen step-down, suggesting that cell division in the mother cells is not an essential requirement for heterocyst differentiation.			Asai, H (corresponding author), Waseda Univ TWIns, Dept Elect Engn & Biol Sci, Tokyo, Japan.	hideo-iwasaki@waseda.jp	Ehira, Shigeki/D-6081-2013; Kawai, Kentaro/B-6770-2015	Ehira, Shigeki/0000-0002-4121-7367; Kawai, Kentaro/0000-0002-3030-9493; Iwasaki, Hideo/0000-0002-3754-4955				Aldea MR, 2007, J BACTERIOL, V189, P8392, DOI 10.1128/JB.00821-07; Allard JF, 2007, DEV BIOL, V312, P427, DOI 10.1016/j.ydbio.2007.09.045; BLACK TA, 1993, MOL MICROBIOL, V9, P77, DOI 10.1111/j.1365-2958.1993.tb01670.x; Borthakur PB, 2005, MOL MICROBIOL, V57, P111, DOI 10.1111/j.1365-2958.2005.04678.x; BRADLEY S, 1976, J GEN MICROBIOL, V96, P175, DOI 10.1099/00221287-96-1-175; Buikema WJ, 2001, P NATL ACAD SCI USA, V98, P2729, DOI 10.1073/pnas.051624898; BUIKEMA WJ, 1991, GENE DEV, V5, P321, DOI 10.1101/gad.5.2.321; Callahan SM, 2001, MOL MICROBIOL, V40, P941, DOI 10.1046/j.1365-2958.2001.02437.x; Cormack BP, 1996, GENE, V173, P33, DOI 10.1016/0378-1119(95)00685-0; ELHAI J, 1998, METHOD ENZYMOL, V167, P747; Golden JW, 2003, CURR OPIN MICROBIOL, V6, P557, DOI 10.1016/j.mib.2003.10.004; Haselkorn R, 2008, MOL MICROBIOL, V70, P783, DOI 10.1111/j.1365-2958.2008.06475.x; Huang X, 2004, P NATL ACAD SCI USA, V101, P4848, DOI 10.1073/pnas.0400429101; Meeks JC, 2002, MICROBIOL MOL BIOL R, V66, P94, DOI 10.1128/MMBR.66.1.94-121.2002; MITCHISON GJ, 1976, SCIENCE, V191, P866, DOI 10.1126/science.814620; Sakr S, 2006, J BACTERIOL, V188, P1396, DOI 10.1128/JB.188.4.1396-1404.2006; Sakr S, 2006, J BACTERIOL, V188, P5958, DOI 10.1128/JB.00524-06; TURING AM, 1990, B MATH BIOL, V52, P153, DOI 10.1007/BF02459572; WILCOX M, 1973, J CELL SCI, V13, P637; WOLK CP, 1975, DEV BIOL, V46, P370, DOI 10.1016/0012-1606(75)90113-X; Yoon HS, 1998, SCIENCE, V282, P935, DOI 10.1126/science.282.5390.935; Yoon HS, 2001, J BACTERIOL, V183, P2605, DOI 10.1128/JB.183.8.2605-2613.2001; Zhang CC, 2006, MOL MICROBIOL, V59, P367, DOI 10.1111/j.1365-2958.2005.04979.x; Zhou RB, 1998, P NATL ACAD SCI USA, V95, P4959, DOI 10.1073/pnas.95.9.4959	24	21	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7371	10.1371/journal.pone.0007371	http://dx.doi.org/10.1371/journal.pone.0007371			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823574	Green Submitted, Green Published, gold			2022-12-27	WOS:000270728500002
J	Mortensen, OH; Nielsen, AR; Erikstrup, C; Plomgaard, P; Fischer, CP; Krogh-Madsen, R; Lindegaard, B; Petersen, AM; Taudorf, S; Pedersen, BK				Mortensen, Ole Hartvig; Nielsen, Anders Rinnov; Erikstrup, Christian; Plomgaard, Peter; Fischer, Christian Philip; Krogh-Madsen, Rikke; Lindegaard, Birgitte; Petersen, Anne Marie; Taudorf, Sarah; Pedersen, Bente Klarlund			Calprotectin - A Novel Marker of Obesity	PLOS ONE			English	Article								Background: The two inflammatory molecules, S100A8 and S100A9, form a heterodimer, calprotectin. Plasma calprotectin levels are elevated in various inflammatory disorders. We hypothesized that plasma calprotectin levels would be increased in subjects with low-grade systemic inflammation i.e. either obese subjects or subjects with type 2 diabetes. Methodology/Principal Findings: Plasma calprotectin and skeletal muscle S100A8 mRNA levels were measured in a cohort consisting of 199 subjects divided into four groups depending on presence or absence of type 2 diabetes (T2D), and presence or absence of obesity. There was a significant interaction between obesity and T2D (p = 0.012). Plasma calprotectin was increased in obese relative to non-obese controls (p<0.0001), whereas it did not differ between obese and non-obese patients with T2D (p = 0.62). S100A8 mRNA levels in skeletal muscle were not influenced by obesity or T2D. Multivariate regression analysis (adjusting for age, sex, smoking and HOMA2-IR) showed plasma calprotectin to be strongly associated with BMI, even when further adjusted for fitness, CRP, TNF-alpha or neutrophil number. Conclusions/Significance: Plasma calprotectin is a marker of obesity in individuals without type 2 diabetes.			Mortensen, OH (corresponding author), Univ Copenhagen, Fac Hlth Sci, Dept Infect Dis, Ctr Inflammat & Metab, Copenhagen, Denmark.	bkp@rh.dk	Pedersen, Bente Klarlund/AGR-3217-2022; Mortensen, Ole Hartvig/AAA-8835-2019; Lindegaard, Birgitte/AGY-9629-2022	Pedersen, Bente Klarlund/0000-0001-6508-6288; Mortensen, Ole Hartvig/0000-0003-1118-6317; Erikstrup, Christian/0000-0001-6551-6647; Rinnov, Anders Rasmussen/0000-0003-3859-3289; Fischer, Christian/0000-0002-0657-9143; Plomgaard, Peter/0000-0002-2404-2702; Lindegaard, Birgitte/0000-0002-5236-8427; Krogh-Madsen, Rikke/0000-0003-4914-2715				Bouma G, 2004, DIABETES, V53, P1979, DOI 10.2337/diabetes.53.8.1979; Ehlermann P, 2006, CARDIOVASC DIABETOL, V5, DOI 10.1186/1475-2840-5-6; Foell D, 2004, ARTHRITIS RHEUM-US, V50, P3762, DOI 10.1002/art.20631; Krabbe KS, 2007, DIABETOLOGIA, V50, P431, DOI 10.1007/s00125-006-0537-4; Mooren FC, 2006, INT J SPORTS MED, V27, P751, DOI 10.1055/s-2005-872909; Mortensen OH, 2008, J PHYSIOL-LONDON, V586, P3551, DOI 10.1113/jphysiol.2008.153551; Plomgaard P, 2007, DIABETOLOGIA, V50, P2562, DOI 10.1007/s00125-007-0834-6; Rodriguez A, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-379; Striz I, 2004, PHYSIOL RES, V53, P245; Xu K, 2000, J IMMUNOL, V164, P4916, DOI 10.4049/jimmunol.164.9.4916	10	93	94	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7419	10.1371/journal.pone.0007419	http://dx.doi.org/10.1371/journal.pone.0007419			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823685	Green Published, gold, Green Submitted			2022-12-27	WOS:000270728500017
J	Roduit, R; Escher, P; Schorderet, DF				Roduit, Raphael; Escher, Pascal; Schorderet, Daniel F.			Mutations in the DNA-Binding Domain of NR2E3 Affect In Vivo Dimerization and Interaction with CRX	PLOS ONE			English	Article								Background: NR2E3 (PNR) is an orphan nuclear receptor essential for proper photoreceptor determination and differentiation. In humans, mutations in NR2E3 have been associated with the recessively inherited enhanced short wavelength sensitive (S-) cone syndrome (ESCS) and, more recently, with autosomal dominant retinitis pigmentosa (adRP). NR2E3 acts as a suppressor of the cone generation program in late mitotic retinal progenitor cells. In adult rod photoreceptors, NR2E3 represses cone-specific gene expression and acts in concert with the transcription factors CRX and NRL to activate rod-specific genes. NR2E3 and CRX have been shown to physically interact in vitro through their respective DNA-binding domains (DBD). The DBD also contributes to homo-and heterodimerization of nuclear receptors. Methodology/Principal Findings: We analyzed NR2E3 homodimerization and NR2E3/CRX complex formation in an in vivo situation by Bioluminescence Resonance Energy Transfer (BRET(2)). NR2E3 wild-type protein formed homodimers in transiently transfected HEK293T cells. NR2E3 homodimerization was impaired in presence of disease-causing mutations in the DBD, except for the p. R76Q and p. R104W mutant proteins. Strikingly, the adRP-linked p. G56R mutant protein interacted with CRX with a similar efficiency to that of NR2E3 wild-type and p. R311Q proteins. In contrast, all other NR2E3 DBD-mutant proteins did not interact with CRX. The p. G56R mutant protein was also more effective in abolishing the potentiation of rhodospin gene transactivation by the NR2E3 wild-type protein. In addition, the p. G56R mutant enhanced the transrepression of the M-and S-opsin promoter, while all other NR2E3 DBD-mutants did not. Conclusions/Significance: These results suggest different disease mechanisms in adRP- and ESCS-patients carrying NR2E3 mutations. Titration of CRX by the p. G56R mutant protein acting as a repressor in trans may account for the severe clinical phenotype in adRP patients.			Roduit, R (corresponding author), IRO, Inst Res Ophthalmol, Sion, Switzerland.	raphael.roduit@irovision.ch	Roduit, Raphael/AAC-3890-2021	Roduit, Raphael/0000-0001-7440-2799; Schorderet, Daniel/0000-0002-1331-504X				Angers S, 2000, P NATL ACAD SCI USA, V97, P3684, DOI 10.1073/pnas.060590697; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Canals M, 2003, J BIOL CHEM, V278, P46741, DOI 10.1074/jbc.M306451200; Chen JC, 2005, J NEUROSCI, V25, P118, DOI 10.1523/JNEUROSCI.3571-04.2005; Cheng H, 2004, HUM MOL GENET, V13, P1563, DOI 10.1093/hmg/ddh173; Cheng H, 2006, HUM MOL GENET, V15, P2588, DOI 10.1093/hmg/ddl185; Coppieters F, 2007, AM J HUM GENET, V81, P147, DOI 10.1086/518426; Escher P, 2009, HUM MUTAT, V30, P342, DOI 10.1002/humu.20858; Gire AI, 2007, MOL VIS, V13, P1970; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Haider NB, 2000, NAT GENET, V24, P127, DOI 10.1038/72777; Haider NB, 2006, VISUAL NEUROSCI, V23, P917, DOI 10.1017/S095252380623027X; Hamdan Fadi F, 2006, Curr Protoc Neurosci, VChapter 5, DOI 10.1002/0471142301.ns0523s34; Hayashi T, 2005, OPHTHALMOLOGY, V112, P2115, DOI 10.1016/j.ophtha.2005.07.002; Hennig AK, 2008, BRAIN RES, V1192, P114, DOI 10.1016/j.brainres.2007.06.036; JACOBSON SG, 1990, INVEST OPHTH VIS SCI, V31, P827; James JR, 2006, NAT METHODS, V3, P1001, DOI 10.1038/nmeth978; KERSTEN S, 1995, P NATL ACAD SCI USA, V92, P8645, DOI 10.1073/pnas.92.19.8645; Kobayashi M, 1999, P NATL ACAD SCI USA, V96, P4814, DOI 10.1073/pnas.96.9.4814; MANGELSDORF DJ, 1995, CELL, V83, P835, DOI 10.1016/0092-8674(95)90199-X; Milam AH, 2002, P NATL ACAD SCI USA, V99, P473, DOI 10.1073/pnas.022533099; Onishi A, 2009, NEURON, V61, P234, DOI 10.1016/j.neuron.2008.12.006; Owen GI, 2000, CELL MOL LIFE SCI, V57, P809, DOI 10.1007/s000180050043; PANKRATZ MJ, 1992, SCIENCE, V255, P986, DOI 10.1126/science.1546296; Peng GH, 2005, HUM MOL GENET, V14, P747, DOI 10.1093/hmg/ddi070; Pfleger KDG, 2006, NAT METHODS, V3, P165, DOI 10.1038/nmeth841; Rastinejad F, 2000, EMBO J, V19, P1045, DOI 10.1093/emboj/19.5.1045; SCHORDERET DF, 2009, HUM MUTAT; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sharon D, 2003, ARCH OPHTHALMOL-CHIC, V121, P1316, DOI 10.1001/archopht.121.9.1316; Storez H, 2005, J BIOL CHEM, V280, P40210, DOI 10.1074/jbc.M508001200; Terrillon S, 2004, P NATL ACAD SCI USA, V101, P1548, DOI 10.1073/pnas.0305322101; Wright Alan F, 2004, Hum Mutat, V24, P439, DOI 10.1002/humu.9285; YU RT, 1994, NATURE, V370, P375, DOI 10.1038/370375a0; Yu RT, 2000, P NATL ACAD SCI USA, V97, P2621, DOI 10.1073/pnas.050566897; Zhao Q, 1998, MOL CELL, V1, P849, DOI 10.1016/S1097-2765(00)80084-2	36	27	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7379	10.1371/journal.pone.0007379	http://dx.doi.org/10.1371/journal.pone.0007379			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823680	Green Published, gold, Green Submitted			2022-12-27	WOS:000270728500005
J	Duah, NO; Weiss, HA; Jepson, A; Tetteh, KKA; Whittle, HC; Conway, DJ				Duah, Nancy O.; Weiss, Helen A.; Jepson, Annette; Tetteh, Kevin K. A.; Whittle, Hilton C.; Conway, David J.			Heritability of Antibody Isotype and Subclass Responses to Plasmodium falciparum Antigens	PLOS ONE			English	Article								Background: It is important to understand the extent to which genetic factors regulate acquired immunity to common infections. A classical twin study design is useful to estimate the heritable component of variation in measurable immune parameters. Methodology/Principal Findings: This study assessed the relative heritability of different plasma antibody isotypes and subclasses (IgG1, IgG2, IgG3, IgG4, IgM, IgA and IgE) naturally acquired to P. falciparum blood stage antigens AMA1, MSP119, MSP2 (two allelic types) and MSP3 (two allelic types). Separate analyses were performed on plasma from 213 pairs of Gambian adult twins, 199 child twin pairs sampled in a dry season when there was little malaria transmission, and another set of 107 child twin pairs sampled at the end of the annual wet season when malaria was common. There were significantly positive heritability (h(2)) estimates for 48% (20/42) of the specific antibody assays ( for the seven isotypes and subclasses to the six antigens tested) among the adults, 48% (20/42) among the children in the dry season and 31% (13/42) among the children in the wet season. In children, there were significant heritability estimates for IgG4 reactivity against each of the antigens, and this subclass had higher heritability than the other subclasses and isotypes. In adults, 75% (15/20) of the significantly heritable antigen-specific isotype responses were attributable to non-HLA class II genetic variation, whereas none showed a significant HLA contribution. Significance: Genome-wide approaches are now warranted to map the major genetic determinants of variable antibody isotype and subclass responses to malaria, alongside evaluation of their impact on infection and disease. Although plasma levels of IgG4 to malaria antigens are generally low, the exceptionally high heritability of levels of this subclass in children deserves particular investigation.			Duah, NO (corresponding author), London Sch Hyg & Trop Med, Dept Infect & Trop Dis, London WC1, England.	dconway@mrc.gm	weiss, helen/ABC-7823-2021; Tetteh, Kevin/GYQ-9704-2022	weiss, helen/0000-0003-3547-7936; Tetteh, Kevin/0000-0003-2733-0037; Duah-Quashie, Nancy/0000-0001-8819-1793; Conway, David/0000-0002-8711-3037	MRC [G0700837, MC_U190074193] Funding Source: UKRI; Medical Research Council [G0700837, MC_U190074193] Funding Source: Medline; Wellcome Trust [074695/Z/04/Z] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Akpogheneta OJ, 2008, INFECT IMMUN, V76, P1748, DOI 10.1128/IAI.01333-07; BOUHAROUNTAYOUN H, 1992, INFECT IMMUN, V60, P1473, DOI 10.1128/IAI.60.4.1473-1481.1992; BURGHAUS PA, 1994, MOL BIOCHEM PARASIT, V64, P165, DOI 10.1016/0166-6851(94)90144-9; Carpenter D, 2007, HUM IMMUNOL, V68, P165, DOI 10.1016/j.humimm.2006.12.002; Cavanagh DR, 2001, INFECT IMMUN, V69, P1207, DOI 10.1128/IAI.69.2.1207-1211.2001; Dutta S, 2002, INFECT IMMUN, V70, P3101, DOI 10.1128/IAI.70.6.3101-3110.2002; Falconer D. S., 1989, Introduction to quantitative genetics.; FINKELMAN FD, 1990, ANNU REV IMMUNOL, V8, P303, DOI 10.1146/annurev.iy.08.040190.001511; GASCAN H, 1991, J EXP MED, V173, P747, DOI 10.1084/jem.173.3.747; GROUX H, 1990, RES IMMUNOL, V141, P529, DOI 10.1016/0923-2494(90)90021-P; Gyan BA, 2004, CLIN EXP IMMUNOL, V138, P145, DOI 10.1111/j.1365-2249.2004.02590.x; IOW M, 2009, NAT GENET, V41, P657; Israelsson E, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-175; Jepson A, 1997, BRIT MED J, V315, P96, DOI 10.1136/bmj.315.7100.96; Jepson A, 1997, INFECT IMMUN, V65, P872, DOI 10.1128/IAI.65.3.872-876.1997; JEPSON AP, 1995, J INFECT DIS, V172, P316, DOI 10.1093/infdis/172.1.316; Kwiatkowski D, 2008, NATURE, V456, P732, DOI 10.1038/nature07632; Kyvic K., 2000, ADV TWIN SIB PAIR AN, P67; Leoratti FMS, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-186; Luoni G, 2001, GENES IMMUN, V2, P411, DOI 10.1038/sj.gene.6363797; Mackinnon MJ, 2005, PLOS MED, V2, P1253, DOI 10.1371/journal.pmed.0020340; Marchant A, 2006, J INFECT DIS, V193, P1598, DOI 10.1086/503775; Martin N, 1997, NAT GENET, V17, P387, DOI 10.1038/ng1297-387; Min KM, 2003, MOL CELLS, V16, P245; Modiano D, 1996, P NATL ACAD SCI USA, V93, P13206, DOI 10.1073/pnas.93.23.13206; Modiano D, 2001, T ROY SOC TROP MED H, V95, P149, DOI 10.1016/S0035-9203(01)90141-5; Nasr A, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-43; Neale MC, 1997, BEHAV GENET, V27, P113, DOI 10.1023/A:1025681223921; Newport MJ, 2004, GENES IMMUN, V5, P122, DOI 10.1038/sj.gene.6364051; Ntoumi F, 2005, J INFECT DIS, V192, P1975, DOI 10.1086/497611; Plomin R, 1990, BEHAV GENETICS PRIME; Polley SD, 2006, VACCINE, V24, P4233, DOI 10.1016/j.vaccine.2005.06.030; Polley SD, 2004, VACCINE, V23, P718, DOI 10.1016/j.vaccine.2004.05.031; Polley SD, 2007, J INFECT DIS, V195, P279, DOI 10.1086/509806; Posthuma D, 2005, BEHAV GENET, V35, P499, DOI 10.1007/s10519-005-2791-5; PUNNONEN J, 1993, P NATL ACAD SCI USA, V90, P3730, DOI 10.1073/pnas.90.8.3730; Rihet P, 1998, AM J HUM GENET, V63, P498, DOI 10.1086/301967; Rihet P, 1998, GENET EPIDEMIOL, V15, P435, DOI 10.1002/(SICI)1098-2272(1998)15:5<435::AID-GEPI1>3.0.CO;2-#; Roussilhon C, 2007, PLOS MED, V4, P1791, DOI 10.1371/journal.pmed.0040320; Satoguina JS, 2008, EUR J IMMUNOL, V38, P3101, DOI 10.1002/eji.200838193; SJOBERG K, 1992, P NATL ACAD SCI USA, V89, P2101, DOI 10.1073/pnas.89.6.2101; Stanisic DI, 2009, INFECT IMMUN, V77, P1165, DOI 10.1128/IAI.01129-08; Stirnadel HA, 1999, GENET EPIDEMIOL, V17, P16, DOI 10.1002/(SICI)1098-2272(1999)17:1<16::AID-GEPI2>3.0.CO;2-7; Tangye SG, 2002, J IMMUNOL, V169, P4298, DOI 10.4049/jimmunol.169.8.4298; TAYLOR RR, 1995, INFECT IMMUN, V63, P4382, DOI 10.1128/IAI.63.11.4382-4388.1995; Taylor RR, 1996, INT IMMUNOL, V8, P905, DOI 10.1093/intimm/8.6.905; Tebo AE, 2001, EXP PARASITOL, V98, P20, DOI 10.1006/expr.2001.4619; Torcia MG, 2008, P NATL ACAD SCI USA, V105, P646, DOI 10.1073/pnas.0709969105; Troye-Blomberg M, 2002, CHEM IMMUNOL, V80, P243; TROYEBLOMBERG M, 1990, P NATL ACAD SCI USA, V87, P5484, DOI 10.1073/pnas.87.14.5484; TROYEBLOMBERG M, 1991, INT IMMUNOL, V3, P1043, DOI 10.1093/intimm/3.10.1043; VAFA M, 2009, MICROBES INFECT; Verra F, 2004, ACTA TROP, V90, P205, DOI 10.1016/j.actatropica.2003.11.014	53	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7381	10.1371/journal.pone.0007381	http://dx.doi.org/10.1371/journal.pone.0007381			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812685	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000270594200007
J	Gras, L; Jurriaans, S; Bakker, M; van Sighem, A; Bezemer, D; Fraser, C; Lange, J; Prins, JM; Berkhout, B; de Wolf, F				Gras, Luuk; Jurriaans, Suzanne; Bakker, Margreet; van Sighem, Ard; Bezemer, Daniela; Fraser, Christophe; Lange, Joep; Prins, Jan M.; Berkhout, Ben; de Wolf, Frank		ATHENA Natl Observational Cohort S	Viral Load Levels Measured at Set-Point Have Risen Over the Last Decade of the HIV Epidemic in the Netherlands	PLOS ONE			English	Article								Background: HIV-1 RNA plasma concentration at viral set-point is associated not only with disease outcome but also with the transmission dynamics of HIV-1. We investigated whether plasma HIV-1 RNA concentration and CD4 cell count at viral set-point have changed over time in the HIV epidemic in the Netherlands. Methodology/Principal Findings: We selected 906 therapy-naive patients with at least one plasma HIV-1 RNA concentration measured 9 to 27 months after estimated seroconversion. Changes in HIV-1 RNA and CD4 cell count at viral set-point over time were analysed using linear regression models. The ATHENA national observational cohort contributed all patients who seroconverted in or after 1996; the Amsterdam Cohort Studies (ACS) contributed seroconverters before 1996. The mean of the first HIV-1 RNA concentration measured 9-27 months after seroconversion was 4.30 log(10) copies/ml (95% CI 4.17-4.42) for seroconverters from 1984 through 1995 (n = 163); 4.27 (4.16-4.37) for seroconverters 1996-2002 (n = 232), and 4.59 (4.52-4.66) for seroconverters 2003-2007 (n = 511). Compared to patients seroconverting between 2003-2007, the adjusted mean HIV-1 RNA concentration at set-point was 0.28 log(10) copies/ml (95% CI 0.16-0.40; p < 0.0001) and 0.26 (0.11-0.41; p = 0.0006) lower for those seroconverting between 1996-2002 and 1984-1995, respectively. Results were robust regardless of type of HIV-1 RNA assay, HIV-1 subtype, and interval between measurement and seroconversion. CD4 cell count at viral set-point declined over calendar time at approximately 5 cells/mm(3)/year. Conclusion: The HIV-1 RNA plasma concentration at viral set-point has increased over the last decade of the HIV epidemic in the Netherlands. This is accompanied by a decreasing CD4 cell count over the period 1984-2007 and may have implications for both the course of the HIV infection and the epidemic.			Gras, L (corresponding author), Stichting HIV Monitoring, Amsterdam, Netherlands.	l.a.gras@amc.uva.nl	Prins, Jan M./AAF-4945-2020; Fraser, Christophe/A-8109-2008	Fraser, Christophe/0000-0003-2399-9657	MRC [G0600719] Funding Source: UKRI; Medical Research Council [G0600719] Funding Source: Medline; Medical Research Council [G0600719B] Funding Source: researchfish	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Arien KK, 2005, AIDS, V19, P1555, DOI 10.1097/01.aids.0000185989.16477.91; Berger A, 2005, J CLIN VIROL, V33, P43, DOI 10.1016/j.jcv.2004.09.025; BRANGER J, 2008, SEX TRANSM DIS; Bruisten SM, 1997, J VIROL METHODS, V67, P199, DOI 10.1016/S0166-0934(97)00097-9; Crum-Cianflone N, 2009, CLIN INFECT DIS, V48, P1285, DOI 10.1086/597777; deWolf F, 1997, AIDS, V11, P1799, DOI 10.1097/00002030-199715000-00003; Donnelly CA, 2005, HIV MED, V6, P170, DOI 10.1111/j.1468-1293.2005.00285.x; Dorrucci M, 2005, AIDS, V19, P331; Dorrucci M, 2007, J INFECT DIS, V195, P525, DOI 10.1086/510911; Dukers-Muijrers NHTM, 2009, SEX TRANSM INFECT, V85, P226, DOI 10.1136/sti.2008.033191; Elbeik T, 2002, J ACQ IMMUN DEF SYND, V29, P330; Fraser C, 2007, P NATL ACAD SCI USA, V104, P17441, DOI 10.1073/pnas.0708559104; Galai N, 1996, AM J EPIDEMIOL, V143, P278; Gali Y, 2007, VIROLOGY, V364, P140, DOI 10.1016/j.virol.2007.02.021; Galli R, 2005, J CLIN VIROL, V34, P245, DOI 10.1016/j.jcv.2004.12.012; Geskus RB, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-65; Ginocchio CC, 1997, J CLIN MICROBIOL, V35, P2886, DOI 10.1128/JCM.35.11.2886-2893.1997; GRAS L, 2008, MONITORING HUMAN IMM; Griffith BP, 1997, J CLIN MICROBIOL, V35, P3288, DOI 10.1128/JCM.35.12.3288-3291.1997; Heijman RLJ, 2009, SEX TRANSM INFECT, V85, P249, DOI 10.1136/sti.2008.033258; Herbeck JT, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001525; Hollingsworth TD, 2008, J INFECT DIS, V198, P687, DOI 10.1086/590501; Johnson Victoria A, 2008, Top HIV Med, V16, P62; Kanki PJ, 1999, J INFECT DIS, V179, P68, DOI 10.1086/314557; Kawashima Y, 2009, NATURE, V458, P641, DOI 10.1038/nature07746; Keet IPM, 1996, AIDS, V10, P1601, DOI 10.1097/00002030-199611000-00025; Kelley CF, 2007, JAIDS-J ACQ IMM DEF, V45, P445, DOI 10.1097/QAI.0b013e318074ef6e; Kiwanuka N, 2008, J INFECT DIS, V197, P707, DOI 10.1086/527416; KOEDIJK FDH, 2009, 2102610042008 RIVM; Levering WHBM, 2008, CYTOM PART B-CLIN CY, V74B, P79, DOI 10.1002/cyto.b.20370; Mellors JW, 1997, ANN INTERN MED, V126, P946, DOI 10.7326/0003-4819-126-12-199706150-00003; Muller V, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000454; Muller V, 2009, AIDS, V23, P1269, DOI 10.1097/QAD.0b013e32832d4096; Muller V, 2006, AIDS, V20, P889, DOI 10.1097/01.aids.0000218553.51908.6b; Murphy DG, 2000, J CLIN MICROBIOL, V38, P4034, DOI 10.1128/JCM.38.11.4034-4041.2000; Notermans DW, 2000, AIDS RES HUM RETROV, V16, P1507, DOI 10.1089/088922200750006038; Pasquier C, 1999, J VIROL METHODS, V81, P123, DOI 10.1016/S0166-0934(99)00057-9; Quinn TC, 2000, NEW ENGL J MED, V342, P921, DOI 10.1056/NEJM200003303421303; Quinones-Mateu ME, 2000, J VIROL, V74, P9222, DOI 10.1128/JVI.74.19.9222-9233.2000; Stolte IG, 2004, AIDS, V18, P303, DOI 10.1097/00002030-200401230-00021; Stolte IG, 2001, SEX TRANSM INFECT, V77, P184, DOI 10.1136/sti.77.3.184; Swanson P, 2006, J VIROL METHODS, V137, P184, DOI 10.1016/j.jviromet.2006.06.010; Tang JM, 2004, AIDS RES HUM RETROV, V20, P19, DOI 10.1089/088922204322749468; Troude P, 2009, AIDS, V23, P1261, DOI 10.1097/QAD.0b013e32832b51ef; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; VANGRIENSVEN GJP, 1987, AM J EPIDEMIOL, V125, P1048, DOI 10.1093/oxfordjournals.aje.a114620; Vasan A, 2006, CLIN INFECT DIS, V42, P843, DOI 10.1086/499952; Wawer MJ, 2005, J INFECT DIS, V191, P1403, DOI 10.1086/429411	48	36	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7365	10.1371/journal.pone.0007365	http://dx.doi.org/10.1371/journal.pone.0007365			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809510	gold, Green Published, Green Submitted			2022-12-27	WOS:000270594000015
J	Meerow, AW; Noblick, L; Borrone, JW; Couvreur, TLP; Mauro-Herrera, M; Hahn, WJ; Kuhn, DN; Nakamura, K; Oleas, NH; Schnell, RJ				Meerow, Alan W.; Noblick, Larry; Borrone, James W.; Couvreur, Thomas L. P.; Mauro-Herrera, Margarita; Hahn, William J.; Kuhn, David N.; Nakamura, Kyoko; Oleas, Nora H.; Schnell, Raymond J.			Phylogenetic Analysis of Seven WRKY Genes across the Palm Subtribe Attaleinae (Areceaceae) Identifies Syagrus as Sister Group of the Coconut	PLOS ONE			English	Article							TRANSCRIPTION FACTORS; DIVERGENCE TIMES; HISTORICAL BIOGEOGRAPHY; MOLECULAR EVOLUTION; ANDEAN TECTONICS; ABSOLUTE RATES; SPECIES TREES; DNA-BINDING; SEED SIZE; FAMILY	Background: The Cocoseae is one of 13 tribes of Arecaceae subfam. Arecoideae, and contains a number of palms with significant economic importance, including the monotypic and pantropical Cocos nucifera L., the coconut, the origins of which have been one of the "abominable mysteries'' of palm systematics for decades. Previous studies with predominantly plastid genes weakly supported American ancestry for the coconut but ambiguous sister relationships. In this paper, we use multiple single copy nuclear loci to address the phylogeny of the Cocoseae subtribe Attaleinae, and resolve the closest extant relative of the coconut. Methodology/Principal Findings: We present the results of combined analysis of DNA sequences of seven WRKY transcription factor loci across 72 samples of Arecaceae tribe Cocoseae subtribe Attaleinae, representing all genera classified within the subtribe, and three outgroup taxa with maximum parsimony, maximum likelihood, and Bayesian approaches, producing highly congruent and well-resolved trees that robustly identify the genus Syagrus as sister to Cocos and resolve novel and well-supported relationships among the other genera of the Attaleinae. We also address incongruence among the gene trees with gene tree reconciliation analysis, and assign estimated ages to the nodes of our tree. Conclusions/Significance: This study represents the as yet most extensive phylogenetic analyses of Cocoseae subtribe Attaleinae. We present a well-resolved and supported phylogeny of the subtribe that robustly indicates a sister relationship between Cocos and Syagrus. This is not only of biogeographic interest, but will also open fruitful avenues of inquiry regarding evolution of functional genes useful for crop improvement. Establishment of two major clades of American Attaleinae occurred in the Oligocene (ca. 37 MYBP) in Eastern Brazil. The divergence of Cocos from Syagrus is estimated at 35 MYBP. The biogeographic and morphological congruence that we see for clades resolved in the Attaleinae suggests that WRKY loci are informative markers for investigating the phylogenetic relationships of the palm family.			Meerow, AW (corresponding author), ARS, USDA, SHRS Natl Germplasm Repository, Miami, FL USA.	alan.meerow@ars.usda.gov	Couvreur, Thomas LP/D-8172-2011; Meerow, Alan/U-9019-2019; Oleas, Nora/D-3869-2013; Noblick, Larry/S-6599-2019	Couvreur, Thomas LP/0000-0002-8509-6587; Meerow, Alan/0000-0003-1882-8327; Oleas, Nora/0000-0002-1948-4119; 				Akaike H., 1973, P 2 INT S INF THEOR, VI, P610, DOI DOI 10.1007/978-1-4612-1694-0_15; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 2014, TRACER V1 6; [Anonymous], 1987, BIOGEOGRAPHY QUATERN, DOI DOI 10.1890/03-5369; [Anonymous], 2008, ENCY FRUITS NUTS; Antonelli A, 2009, P NATL ACAD SCI USA, V106, P9749, DOI 10.1073/pnas.0811421106; Asmussen CB, 2006, BOT J LINN SOC, V151, P15, DOI 10.1111/j.1095-8339.2006.00521.x; ASMUSSEN CB, 2000, SYSTEMATICS EVOLUTIO, P525; Babu MM, 2006, NUCLEIC ACIDS RES, V34, P6505, DOI 10.1093/nar/gkl888; Baker WJ, 2009, SYST BIOL, V58, P240, DOI 10.1093/sysbio/syp021; BALICK MJ, 1987, AM J BOT, V74, P1013, DOI 10.2307/2443941; Baudouin L, 2009, GENET RESOUR CROP EV, V56, P257, DOI 10.1007/s10722-008-9362-6; BECCARI O, 1963, PRINCIPES, V7, P57; Beck H. T., 1990, USEFUL PALMS WORLD; Bergsten J, 2005, CLADISTICS, V21, P163, DOI 10.1111/j.1096-0031.2005.00059.x; Borrone JW, 2007, MOL PHYLOGENET EVOL, V44, P1141, DOI 10.1016/j.ympev.2007.06.012; Borrone JW, 2004, THEOR APPL GENET, V109, P495, DOI 10.1007/s00122-004-1662-4; BORRONE JW, 2004, THESIS FLORIDA INT U; Bowers JE, 2003, NATURE, V422, P433, DOI 10.1038/nature01521; BREMER K, 1988, EVOLUTION, V42, P795, DOI 10.1111/j.1558-5646.1988.tb02497.x; BROOKS DR, 1990, SYST ZOOL, V39, P14, DOI 10.2307/2992205; Cannon Steven B., 2004, BMC Plant Biology, V4, P10, DOI 10.1186/1471-2229-4-10; Cunningham CW, 1997, MOL BIOL EVOL, V14, P733, DOI 10.1093/oxfordjournals.molbev.a025813; Cunningham CW, 1997, SYST BIOL, V46, P464, DOI 10.2307/2413692; Davis JI, 1998, SYST BIOL, V47, P282, DOI 10.1080/106351598260923; de Candolle A., 1886, ORIGIN CULTIVATED PL, VXLIX, P376; DeSalle R, 1997, SYST BIOL, V46, P751, DOI 10.2307/2413504; Dong JX, 2003, PLANT MOL BIOL, V51, P21, DOI 10.1023/A:1020780022549; Dransfield J., 2008, GENERA PALMARUM THE; Dransfield John, 2005, Kew Bulletin, V60, P559; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Eulgem T, 2000, TRENDS PLANT SCI, V5, P199, DOI 10.1016/S1360-1385(00)01600-9; Farris JS, 1995, SYST BIOL, V44, P570, DOI 10.2307/2413663; FARRIS JS, 1994, CLADISTICS, V10, P315, DOI 10.1111/j.1096-0031.1996.tb00196.x; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; FITCH WM, 1971, SYST ZOOL, V20, P406, DOI 10.2307/2412116; Flynn JJ, 1998, MOL PHYLOGENET EVOL, V9, P414, DOI 10.1006/mpev.1998.0504; Franzosa EA, 2007, TREEROT VERSION 3; Garcia D, 2005, PLANT CELL, V17, P52, DOI 10.1105/tpc.104.027136; Garzione CN, 2008, SCIENCE, V320, P1304, DOI 10.1126/science.1148615; GLASSMAN S, 1972, FIELDIANA BOT, V32, P241; GLASSMAN S., 1987, ILLINOIS BIOL MONOGR, V56, P1; GLASSMAN S.F., 1999, ILLINOIS BIOL MONOGR, V59, P1, DOI DOI 10.5962/BHL.TITLE.49920; Gomez-Navarro C, 2009, AM J BOT, V96, P1300, DOI 10.3732/ajb.0800378; Grover CE, 2004, GENOME RES, V14, P1474, DOI 10.1101/gr.2673204; GRUEZO WS, 1984, BIOTROPICA, V16, P140, DOI 10.2307/2387846; Gunn BF, 2004, ANN MO BOT GARD, V91, P505; Haffer J, 1987, BIOGEOGRAPHY QUATERN, P1; Hahn WJ, 2002, SYST BIOL, V51, P92, DOI 10.1080/106351502753475899; Hahn WJ, 2002, MOL PHYLOGENET EVOL, V23, P189, DOI 10.1016/S1055-7903(02)00022-2; HARRIES HC, 1978, BOT REV, V44, P265, DOI 10.1007/BF02957852; HENDERSON A, 1991, BRITTONIA, V43, P198; HENDERSON A, 1995, FIELD GUIDE PALMS AM; HERNGREEN G F W, 1981, Pollen et Spores, V23, P441; Ho SYW, 2007, J AVIAN BIOL, V38, P409, DOI 10.1111/j.2007.0908-8857.04168.x; Ho SYW, 2005, MOL BIOL EVOL, V22, P1355, DOI 10.1093/molbev/msi125; HOORN C, 1993, PALAEOGEOGR PALAEOCL, V105, P267, DOI 10.1016/0031-0182(93)90087-Y; HOORN C, 1995, GEOLOGY, V23, P237, DOI 10.1130/0091-7613(1995)023<0237:ATAACF>2.3.CO;2; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Hughes CE, 2006, PHILOS T R SOC B, V361, P211, DOI 10.1098/rstb.2005.1735; Hungerbuhler D, 2002, EARTH-SCI REV, V57, P75, DOI 10.1016/S0012-8252(01)00071-X; Jobb G., 2008, TREEFINDER; JOHNSON MAT, 1989, GENOME, V32, P328, DOI 10.1139/g89-449; Katoh K, 2002, NUCLEIC ACIDS RES, V30, P3059, DOI 10.1093/nar/gkf436; Katoh K, 2005, NUCLEIC ACIDS RES, V33, P511, DOI 10.1093/nar/gki198; KUNTZE CEO, 1891, REV GEN PL, V2, P726; Liu L, 2008, BIOINFORMATICS, V24, P2542, DOI 10.1093/bioinformatics/btn484; Liu L, 2007, SYST BIOL, V56, P504, DOI 10.1080/10635150701429982; Lundberg John G., 1998, P13; Luo M, 2005, P NATL ACAD SCI USA, V102, P17531, DOI 10.1073/pnas.0508418102; Maddison WP, 2006, SYST BIOL, V55, P21, DOI 10.1080/10635150500354928; Maddison WP, 1997, SYST BIOL, V46, P523, DOI 10.2307/2413694; Martin AP, 2002, SYST BIOL, V51, P570, DOI 10.1080/10635150290069995; Mauro-Herrera M, 2007, SCI HORTIC-AMSTERDAM, V115, P19, DOI 10.1016/j.scienta.2007.07.005; Mauro-Herrera M, 2006, MOL ECOL NOTES, V6, P904, DOI 10.1111/j.1471-8286.2006.01393.x; Mauro-Herrera M, 2010, GENET RESOUR CROP EV, V57, P203, DOI 10.1007/s10722-009-9463-x; MCDOUGALL I, 1988, EARTH PLANET SC LETT, V89, P207, DOI 10.1016/0012-821X(88)90173-2; Meerow AW, 2006, SYST BOT, V31, P42, DOI 10.1600/036364406775971787; Meerow AW, 2004, SYST BOT, V29, P511, DOI 10.1600/0363644041744400; Meerow AW, 2003, BOT J LINN SOC, V141, P349, DOI 10.1046/j.1095-8339.2003.00142.x; Messenger SL, 1998, SYST BIOL, V47, P90, DOI 10.1080/106351598261058; MOORE H E JR, 1973, Gentes Herbarum, V11, P27; MORAES M, 1990, BRITTONIA, V42, P92; Moraes R. M., 1996, Novon, V6, P85, DOI 10.2307/3392218; Morley R.J., 2000, ORIGIN EVOLUTION TRO; Morley RJ, 2003, PERSPECT PLANT ECOL, V6, P5, DOI 10.1078/1433-8319-00039; Muller Kai, 2005, Appl Bioinformatics, V4, P65; NOBLICK LR, 1994, ACTA HORTIC, V360, P85; Nuttall C.P., 1990, Bulletin of the British Museum (Natural History) Geology, V45, P165; Page RDM, 1997, MOL PHYLOGENET EVOL, V7, P231, DOI 10.1006/mpev.1996.0390; Page RDM, 1998, BIOINFORMATICS, V14, P819, DOI 10.1093/bioinformatics/14.9.819; PAGE RDM, 1994, SYST BIOL, V43, P58, DOI 10.2307/2413581; Pintaud Jean-Christophe, 2008, Rev. peru biol., V15, P55; PLATNICK NI, 1978, SYST ZOOL, V27, P1, DOI 10.2307/2412808; Pond SLK, 2005, BIOINFORMATICS, V21, P676, DOI 10.1093/bioinformatics/bti079; READ R. W., 1966, Principes, V10, P55; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; RODRIGUES JB, 1901, CONTR JARD BOT RIO J, V1, P7; Rokas A, 2003, NATURE, V425, P798, DOI 10.1038/nature02053; Ronquist F, 1997, SYST BIOL, V46, P195, DOI 10.2307/2413643; Ronquist F, 2003, BIOINFORMATICS, V19, P1572, DOI 10.1093/bioinformatics/btg180; RONQUIST F, 1996, DIVA 1 1 1 2 COMPUTE; Ross CA, 2007, J INTEGR PLANT BIOL, V49, P827, DOI 10.1111/j.1744-7909.2007.00504.x; Rossberg M, 2001, PLANT CELL, V13, P979, DOI 10.1105/tpc.13.4.979; Sanderson MJ, 2002, MOL BIOL EVOL, V19, P101, DOI 10.1093/oxfordjournals.molbev.a003974; Sanderson MJ, 1997, MOL BIOL EVOL, V14, P1218, DOI 10.1093/oxfordjournals.molbev.a025731; Sanderson MJ, 2003, BIOINFORMATICS, V19, P301, DOI 10.1093/bioinformatics/19.2.301; Sanmartin I, 2003, J BIOGEOGR, V30, P1883, DOI 10.1046/j.0305-0270.2003.00982.x; Santos C, 2008, PALAEOGEOGR PALAEOCL, V264, P140, DOI 10.1016/j.palaeo.2008.04.010; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Seubert E., 1998, Feddes Repertorium, V109, P89; Seubert E., 1998, Feddes Repertorium, V109, P231; Shono H, 2000, FISHERIES SCI, V66, P608, DOI 10.1046/j.1444-2906.2000.00095.x; Siddall ME, 1997, SYST BIOL, V46, P765, DOI 10.2307/2413505; Simmons MP, 2000, SYST BIOL, V49, P369, DOI 10.1093/sysbio/49.2.369; Steinmann M, 1999, TECTONOPHYSICS, V307, P255, DOI 10.1016/S0040-1951(99)00100-6; Sullivan J, 1996, SYST BIOL, V45, P375, DOI 10.2307/2413571; Swofford DL, 2002, PAUP PHYLOGENETIC AN; Tanabe AS, 2007, MOL ECOL NOTES, V7, P962, DOI 10.1111/j.1471-8286.2007.01807.x; THIEDE J, 1977, AAPG BULL, V61, P929; Thomas BC, 2006, GENOME RES, V16, P934, DOI 10.1101/gr.4708406; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; Thorne JL, 1998, MOL BIOL EVOL, V15, P1647, DOI 10.1093/oxfordjournals.molbev.a025892; Uhl N., 1987, GENERA PALMARUM CLAS; Ulker B, 2004, CURR OPIN PLANT BIOL, V7, P491, DOI 10.1016/j.pbi.2004.07.012; Van Der Hammen T., 1979, TROPICAL BOT, P25; VANDERHAMMEN T, 1973, REV PALAEOBOT PALYNO, V16, P1, DOI 10.1016/0034-6667(73)90031-6; Wendel J.F., 1998, MOL SYSTEMATICS PLAN, P265, DOI 10.1007/978-1-4615-5419-6_10; WENDLAND H, 1878, PALMIERS, P247; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P439; Wesselingh F.P., 2006, Scripta Geologica (Leiden), V133, P1; Wesselingh FP., 2002, CAINOZOIC RES, V1, P35; Wu KL, 2005, DNA RES, V12, P9, DOI 10.1093/dnares/12.1.9; Xie Z, 2005, PLANT PHYSIOL, V137, P176, DOI 10.1104/pp.104.054312; Xiong YQ, 2005, PLANT MOL BIOL, V59, P191, DOI 10.1007/s11103-005-6503-6; Yamasaki K, 2008, PLANT PHYSIOL BIOCH, V46, P394, DOI 10.1016/j.plaphy.2007.12.015; Yoder AD, 2001, SYST BIOL, V50, P408, DOI 10.1080/10635150116801; Zhang YJ, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-1	140	58	68	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7353	10.1371/journal.pone.0007353	http://dx.doi.org/10.1371/journal.pone.0007353			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806212	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593800028
J	Waldemarsson, J; Stalhammar-Carlemalm, M; Sandin, C; Castellino, FJ; Lindahl, G				Waldemarsson, Johan; Stalhammar-Carlemalm, Margaretha; Sandin, Charlotta; Castellino, Francis J.; Lindahl, Gunnar			Functional Dissection of Streptococcus pyogenes M5 Protein: the Hypervariable Region is Essential for Virulence	PLOS ONE			English	Article							CELL-SURFACE PROTEIN; GROUP-A STREPTOCOCCI; BINDING REGIONS; FIBRINOGEN; PHAGOCYTOSIS; COLONIZATION; PLASMINOGEN; EXPRESSION; ADHESION; SEQUENCE	The surface-localized M protein of Streptococcus pyogenes is a major virulence factor that inhibits phagocytosis, as determined ex vivo. Because little is known about the role of M protein in vivo we analyzed the contribution of different M protein regions to virulence, using the fibrinogen (Fg)-binding M5 protein and a mouse model of acute invasive infection. This model was suitable, because M5 is required for mouse virulence and binds mouse and human Fg equally well, as shown here. Mixed infection experiments with wild type bacteria demonstrated that mutants lacking the N-terminal hypervariable region (HVR) or the Fg-binding B-repeat region were strongly attenuated, while a mutant lacking the conserved C-repeats was only slightly attenuated. Because the HVR of M5 is not required for phagocytosis resistance, our data imply that this HVR plays a major but unknown role during acute infection. The B-repeat region is required for phagocytosis resistance and specifically binds Fg, suggesting that it promotes virulence by binding Fg. However, B-repeat mutants were attenuated even in Fg-deficient mice, implying that the B-repeats may have a second function, in addition to Fg-binding. These data demonstrate that two distinct M5 regions, including the HVR, are essential to virulence during the early stages of an infection. In particular, our data provide the first in vivo evidence that the HVR of an M protein plays a major role in virulence, focusing interest on the molecular role of this region.			Waldemarsson, J (corresponding author), Lund Univ, Div Med Microbiol, Dept Lab Med, Lund, Sweden.	gunnar.lindahl@med.lu.se						Abbot EL, 2007, CELL MICROBIOL, V9, P1822, DOI 10.1111/j.1462-5822.2007.00918.x; AKERSTROM B, 1991, MOL IMMUNOL, V28, P349, DOI 10.1016/0161-5890(91)90147-C; AKESSON P, 1994, BIOCHEM J, V300, P877, DOI 10.1042/bj3000877; Andre I, 2006, BIOCHEMISTRY-US, V45, P4559, DOI 10.1021/bi052455c; Ashbaugh CD, 2000, CELL MICROBIOL, V2, P283, DOI 10.1046/j.1462-5822.2000.00050.x; Ashbaugh CD, 1998, J CLIN INVEST, V102, P550, DOI 10.1172/JCI3065; Bessen DE, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-59; Beuzon CR, 2001, MICROBES INFECT, V3, P1345, DOI 10.1016/S1286-4579(01)01496-4; Carapetis JR, 2005, LANCET INFECT DIS, V5, P685, DOI 10.1016/S1473-3099(05)70267-X; Carlsson F, 2005, MOL MICROBIOL, V56, P28, DOI 10.1111/j.1365-2958.2005.04527.x; Carlsson F, 2003, J EXP MED, V198, P1057, DOI 10.1084/jem.20030543; Courtney HS, 2002, ANN MED, V34, P77, DOI 10.1080/07853890252953464; FISCHETTI VA, 1991, SCI AM, V264, P58, DOI 10.1038/scientificamerican0691-58; FISCHETTI VA, 1989, CLIN MICROBIOL REV, V2, P285, DOI 10.1128/CMR.2.3.285-314.1989; Herwald H, 2004, CELL, V116, P367, DOI 10.1016/S0092-8674(04)00057-1; Johnsson E, 1998, J IMMUNOL, V161, P4894; KEHOE MA, 1994, BACTERIAL CELL WALL, P217; Kemper C, 2001, CLIN EXP IMMUNOL, V124, P180, DOI 10.1046/j.1365-2249.2001.01458.x; Kotarsky H, 2001, MOL MICROBIOL, V41, P817, DOI 10.1046/j.1365-2958.2001.02496.x; LANCEFIELD RC, 1957, J EXP MED, V106, P525, DOI 10.1084/jem.106.4.525; McNeil SA, 2005, CLIN INFECT DIS, V41, P1114, DOI 10.1086/444458; MILLER L, 1988, J BIOL CHEM, V263, P5668; Mosesson MW, 2001, ANN NY ACAD SCI, V936, P11; OKADA N, 1995, P NATL ACAD SCI USA, V92, P2489, DOI 10.1073/pnas.92.7.2489; Persson J, 2005, J IMMUNOL METHODS, V297, P83, DOI 10.1016/j.jim.2004.11.024; Persson Jenny, 2006, PLoS Pathogens, V2, DOI 10.1371/journal.ppat.0020047; Ploplis VA, 2000, AM J PATHOL, V157, P703, DOI 10.1016/S0002-9440(10)64582-8; Price JD, 2005, J IMMUNOL, V175, P677, DOI 10.4049/jimmunol.175.2.677; RETNONINGRUM DS, 1994, INFECT IMMUN, V62, P2387, DOI 10.1128/IAI.62.6.2387-2394.1994; Ringdahl U, 2000, MOL MICROBIOL, V37, P1318, DOI 10.1046/j.1365-2958.2000.02062.x; Sandin C, 2006, MOL MICROBIOL, V59, P20, DOI 10.1111/j.1365-2958.2005.04913.x; Shulman ST, 2009, CLIN INFECT DIS, V49, P78, DOI 10.1086/599344; STALHAMMARCARLEMALM M, 1993, J EXP MED, V177, P1593, DOI 10.1084/jem.177.6.1593; STENBERG L, 1994, J BIOL CHEM, V269, P13458; SUH TT, 1995, GENE DEV, V9, P2020, DOI 10.1101/gad.9.16.2020; Sun HM, 2004, SCIENCE, V305, P1283, DOI 10.1126/science.1101245; Sun HM, 2009, BLOOD, V113, P1358, DOI 10.1182/blood-2008-07-170506; Taylor FB, 1999, CLIN INFECT DIS, V29, P167, DOI 10.1086/520147; Thern A, 1998, J IMMUNOL, V160, P860; THERN A, 1995, J IMMUNOL, V154, P375; Todd EW, 1927, BRIT J EXP PATHOL, V8, P289; Todd EW, 1928, J EXP MED, V48, P751, DOI 10.1084/jem.48.6.751; Todd EW, 1927, BRIT J EXP PATHOL, V8, P1; Virgin HW, 2007, NAT IMMUNOL, V8, P1143, DOI 10.1038/ni1529; Waldemarsson J, 2006, J BACTERIOL, V188, P378, DOI 10.1128/JB.188.2.378-388.2006; WANG H, 1995, J INFECT DIS, V171, P85, DOI 10.1093/infdis/171.1.85; WHITNACK E, 1982, J CLIN INVEST, V69, P1042, DOI 10.1172/JCI110508; WISTEDT AC, 1995, MOL MICROBIOL, V18, P569, DOI 10.1111/j.1365-2958.1995.mmi_18030569.x	48	19	19	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2009	4	10							e7279	10.1371/journal.pone.0007279	http://dx.doi.org/10.1371/journal.pone.0007279			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BP	19794915	Green Published, Green Submitted, gold			2022-12-27	WOS:000270354200006
J	Liu, S; Li, Z; Gui, JF				Liu, Sha; Li, Zhi; Gui, Jian-Fang			Fish-Specific Duplicated dmrt2b Contributes to a Divergent Function through Hedgehog Pathway and Maintains Left-Right Asymmetry Establishment Function	PLOS ONE			English	Article							PROTEIN-KINASE-A; ZEBRAFISH EMBRYO; SONIC-HEDGEHOG; NEURAL-TUBE; VERTEBRATE DEVELOPMENT; SIGNAL-TRANSDUCTION; GENE DUPLICATION; EXPRESSION; EMBRYOGENESIS; REVEALS	Gene duplication is thought to provide raw material for functional divergence and innovation. Fish-specific dmrt2b has been identified as a duplicated gene of the dmrt2a/terra in fish genomes, but its function has remained unclear. Here we reveal that Dmrt2b knockdown zebrafish embryos display a downward tail curvature and have U-shaped somites. Then, we demonstrate that Dmrt2b contributes to a divergent function in somitogenesis through Hedgehog pathway, because Dmrt2b knockdown reduces target gene expression of Hedgehog signaling, and also impairs slow muscle development and neural tube patterning through Hedgehog signaling. Moreover, the Dmrt2b morphants display defects in heart and visceral organ asymmetry, and, some lateral-plate mesoderm (LPM) markers expressed in left side are randomized. Together, these data indicate that fish-specific duplicated dmrt2b contributes to a divergent function in somitogenesis through Hedgehog pathway and maintains the common function for left-right asymmetry establishment.			Liu, S (corresponding author), Chinese Acad Sci, Grad Sch, Inst Hydrobiol, State Key Lab Freshwater Ecol & Biotechnol, Wuhan, Peoples R China.	jfgui@ihb.ac.cn		Liu, Sha/0000-0002-7168-330X				Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Altaba AR, 2003, CURR OPIN GENET DEV, V13, P513, DOI 10.1016/j.gde.2003.08.005; Altaba ARI, 1999, TRENDS GENET, V15, P418, DOI 10.1016/S0168-9525(99)01840-5; Barresi MJF, 2000, DEVELOPMENT, V127, P2189; BARTH KA, 1995, DEVELOPMENT, V121, P1755; Bisgrove BW, 1999, DEVELOPMENT, V126, P3253; Conant GC, 2008, NAT REV GENET, V9, P938, DOI 10.1038/nrg2482; Concordet JP, 1996, DEVELOPMENT, V122, P2835; Dong CH, 2004, DEV BIOL, V265, P341, DOI 10.1016/j.ydbio.2003.08.028; Ekker SC, 2000, YEAST, V17, P302, DOI 10.1002/1097-0061(200012)17:4<302::AID-YEA53>3.0.CO;2-#; Ekker SC, 2001, GENESIS, V30, P89, DOI 10.1002/gene.1038; Hammerschmidt M, 1996, GENE DEV, V10, P647, DOI 10.1101/gad.10.6.647; He XL, 2005, GENETICS, V169, P1157, DOI 10.1534/genetics.104.037051; Hong CS, 2007, DEV BIOL, V310, P1, DOI 10.1016/j.ydbio.2007.07.035; Karlstrom RO, 2003, DEVELOPMENT, V130, P1549, DOI 10.1242/dev.00364; Karlstrom RO, 1999, GENE DEV, V13, P388, DOI 10.1101/gad.13.4.388; KIMMEL CB, 1995, DEV DYNAM, V203, P253, DOI 10.1002/aja.1002030302; Koudijs MJ, 2005, PLOS GENET, V1, P223, DOI 10.1371/journal.pgen.0010019; KRAUSS S, 1991, EMBO J, V10, P3609, DOI 10.1002/j.1460-2075.1991.tb04927.x; Link V, 2006, BMC DEV BIOL, V6, DOI 10.1186/1471-213X-6-1; Liu Jing-Xia, 2005, Acta Hydrobiologica Sinica, V29, P359; Liu Jun, 2005, Acta Genetica Sinica, V32, P253; Long S, 2003, DEVELOPMENT, V130, P2303, DOI 10.1242/dev.00436; Mei J, 2008, DEV BIOL, V319, P273, DOI 10.1016/j.ydbio.2008.04.022; Mei J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004979; Meng AM, 1999, DEVELOPMENT, V126, P1259; Nakano Y, 2004, DEV BIOL, V269, P381, DOI 10.1016/j.ydbio.2004.01.022; Nasevicius A, 2000, NAT GENET, V26, P216, DOI 10.1038/79951; Odenthal J, 1998, DEV GENES EVOL, V208, P245, DOI 10.1007/s004270050179; Postlethwait J, 2004, TRENDS GENET, V20, P481, DOI 10.1016/j.tig.2004.08.001; Raymond CS, 1998, NATURE, V391, P691, DOI 10.1038/35618; Robu ME, 2007, PLOS GENET, V3, P787, DOI 10.1371/journal.pgen.0030078; Saude L, 2005, NAT CELL BIOL, V7, P918, DOI 10.1038/ncb1294; Schauerte HE, 1998, DEVELOPMENT, V125, P2983; Schilling TF, 1999, DEV BIOL, V210, P277, DOI 10.1006/dbio.1999.9214; Schlueter PJ, 2006, FASEB J, V20, P1230, DOI 10.1096/fj.05-3882fje; Seo KW, 2006, DEV BIOL, V290, P200, DOI 10.1016/j.ydbio.2005.11.027; Taylor JS, 2003, GENOME RES, V13, P382, DOI 10.1101/gr.640303; Tsukui T, 1999, P NATL ACAD SCI USA, V96, P11376, DOI 10.1073/pnas.96.20.11376; vanEeden FJM, 1996, DEVELOPMENT, V123, P153; Westerfield M., 2000, ZEBRAFISH BOOK GUIDE, V4th Edn; Wilbanks AM, 2004, SCIENCE, V306, P2264, DOI 10.1126/science.1104193; Wolff C, 2004, GENE DEV, V18, P1565, DOI 10.1101/gad.296004; Wolff C, 2003, CURR BIOL, V13, P1169, DOI 10.1016/S0960-9822(03)00461-5; Woods IG, 2005, PLOS BIOL, V3, P476, DOI 10.1371/journal.pbio.0030066; Xia JH, 2008, INT J DEV BIOL, V52, P1089, DOI 10.1387/ijdb.072519jx; Xia W, 2007, MOL CELL ENDOCRINOL, V263, P156, DOI 10.1016/j.mce.2006.09.014; Xie J, 2001, GENE, V271, P109, DOI 10.1016/S0378-1119(01)00491-7; Yelon D, 1999, DEV BIOL, V214, P23, DOI 10.1006/dbio.1999.9406; Yin J, 2007, INT J DEV BIOL, V51, P761, DOI 10.1387/ijdb.072346jy; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8; Zhou L, 2000, J MOL EVOL, V51, P498, DOI 10.1007/s002390010113; Zhou X, 2008, BIOCHIMIE, V90, P878, DOI 10.1016/j.biochi.2008.02.021	53	31	41	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7261	10.1371/journal.pone.0007261	http://dx.doi.org/10.1371/journal.pone.0007261			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789708	gold, Green Published, Green Submitted			2022-12-27	WOS:000270354100018
J	Demers, A; Caron, V; Rodrigue-Way, A; Wahli, W; Ong, H; Tremblay, A				Demers, Annie; Caron, Veronique; Rodrigue-Way, Amelie; Wahli, Walter; Ong, Huy; Tremblay, Andre			A Concerted Kinase Interplay Identifies PPAR gamma as a Molecular Target of Ghrelin Signaling in Macrophages	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; HORMONE-RELEASING PEPTIDE; SMOOTH-MUSCLE-CELLS; PROTEIN-KINASE; ENDOTHELIAL-CELLS; SCAVENGER RECEPTOR; DEFICIENT MICE; MEDIATED PHOSPHORYLATION; ATHEROSCLEROTIC LESIONS; CARDIOVASCULAR HEALTH	The peroxisome proliferator-activator receptor PPAR gamma plays an essential role in vascular biology, modulating macrophage function and atherosclerosis progression. Recently, we have described the beneficial effect of combined activation of the ghrelin/GHS-R1a receptor and the scavenger receptor CD36 to induce macrophage cholesterol release through transcriptional activation of PPAR gamma. Although the interplay between CD36 and PPAR gamma in atherogenesis is well recognized, the contribution of the ghrelin receptor to regulate PPAR gamma remains unknown. Here, we demonstrate that ghrelin triggers PPAR gamma activation through a concerted signaling cascade involving Erk1/2 and Akt kinases, resulting in enhanced expression of downstream effectors LXR alpha and ABC sterol transporters in human macrophages. These effects were associated with enhanced PPAR gamma phosphorylation independently of the inhibitory conserved serine-84. Src tyrosine kinase Fyn was identified as being recruited to GHS-R1a in response to ghrelin, but failure of activated Fyn to enhance PPAR gamma Ser-84 specific phosphorylation relied on the concomitant recruitment of docking protein Dok-1, which prevented optimal activation of the Erk1/2 pathway. Also, substitution of Ser-84 preserved the ghrelin-induced PPAR gamma activity and responsiveness to Src inhibition, supporting a mechanism independent of Ser-84 in PPAR gamma response to ghrelin. Consistent with this, we found that ghrelin promoted the PI3-K/Akt pathway in a G alpha(q)-dependent manner, resulting in Akt recruitment to PPAR gamma, enhanced PPAR gamma phosphorylation and activation independently of Ser-84, and increased expression of LXRa and ABCA1/G1. Collectively, these results illustrate a complex interplay involving Fyn/Dok-1/Erk and G alpha(q)/PI3-K/Akt pathways to transduce in a concerted manner responsiveness of PPAR gamma to ghrelin in macrophages.			Demers, A (corresponding author), Univ Montreal, CHU Ste Justine, Res Ctr, Montreal, PQ, Canada.	andre.tremblay.1@umontreal.ca	Wahli, Walter/I-3194-2019; Wahli, Walter/B-1398-2009	Wahli, Walter/0000-0002-5966-9089	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Adams M, 1997, J BIOL CHEM, V272, P5128, DOI 10.1074/jbc.272.8.5128; Avallone R, 2006, MOL ENDOCRINOL, V20, P3165, DOI 10.1210/me.2006-0146; Baldanzi G, 2002, J CELL BIOL, V159, P1029, DOI 10.1083/jcb.200207165; Barazzoni R, 2005, AM J PHYSIOL-ENDOC M, V288, pE228, DOI 10.1152/ajpendo.00115.2004; Bastie CC, 2007, CELL METAB, V5, P371, DOI 10.1016/j.cmet.2007.04.005; Boulay I, 2005, J IMMUNOL, V175, P4483, DOI 10.4049/jimmunol.175.7.4483; Camina JP, 2007, J CELL PHYSIOL, V213, P187, DOI 10.1002/jcp.21109; Camp HS, 1997, J BIOL CHEM, V272, P10811; Carpino N, 1997, CELL, V88, P197, DOI 10.1016/S0092-8674(00)81840-1; Castrillo A, 2004, ANNU REV CELL DEV BI, V20, P455, DOI 10.1146/annurev.cellbio.20.012103.134432; Chawla A, 2001, MOL CELL, V7, P161, DOI 10.1016/S1097-2765(01)00164-2; Chen C, 1996, J ENDOCRINOL, V148, P381, DOI 10.1677/joe.0.1480381; Chen Z, 2001, ARTERIOSCL THROM VAS, V21, P372, DOI 10.1161/01.ATV.21.3.372; Chorny A, 2008, J IMMUNOL, V180, P8369, DOI 10.4049/jimmunol.180.12.8369; Chung S, 2006, ENDOCRINOLOGY, V147, P5340, DOI 10.1210/en.2006-0536; Collins AR, 2001, ARTERIOSCL THROM VAS, V21, P365, DOI 10.1161/01.ATV.21.3.365; Demers A, 2004, BIOCHEM J, V382, P417, DOI 10.1042/BJ20040036; Demers A, 2008, PPAR RES, V2008, DOI 10.1155/2008/364784; Dixit VD, 2009, BLOOD, V113, P5202, DOI 10.1182/blood-2008-09-181255; Falls HD, 2006, J MOL ENDOCRINOL, V37, P51, DOI 10.1677/jme.1.01943; Feige JN, 2007, J BIOL CHEM, V282, P19152, DOI 10.1074/jbc.M702724200; Feige JN, 2006, PROG LIPID RES, V45, P120, DOI 10.1016/j.plipres.2005.12.002; Feuillet V, 2002, ONCOGENE, V21, P7205, DOI 10.1038/sj.onc.1205929; Filigheddu N, 2007, MOL BIOL CELL, V18, P986, DOI 10.1091/mbc.E06-05-0402; Garcia EA, 2006, CURR OPIN PHARMACOL, V6, P142, DOI 10.1016/j.coph.2005.10.006; Gnanapavan S, 2002, J CLIN ENDOCR METAB, V87, P2988, DOI 10.1210/jc.87.6.2988; Hosooka T, 2008, NAT MED, V14, P188, DOI 10.1038/nm1706; Howard AD, 1996, SCIENCE, V273, P974, DOI 10.1126/science.273.5277.974; Hu ED, 1996, SCIENCE, V274, P2100, DOI 10.1126/science.274.5295.2100; Iantorno M, 2007, AM J PHYSIOL-ENDOC M, V292, pE756, DOI 10.1152/ajpendo.00570.2006; Katugampola SD, 2001, BRIT J PHARMACOL, V134, P143, DOI 10.1038/sj.bjp.0704228; Kojima M, 1999, NATURE, V402, P656, DOI 10.1038/45230; Li AC, 2000, J CLIN INVEST, V106, P523, DOI 10.1172/JCI10370; Li AH, 2007, BIOCHEM BIOPH RES CO, V353, P238, DOI 10.1016/j.bbrc.2006.11.144; Li WG, 2004, CIRCULATION, V109, P2221, DOI 10.1161/01.CIR.0000127956.43874.F2; Lodeiro M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004686; Loppnow H, 2008, INNATE IMMUN-LONDON, V14, P63, DOI 10.1177/1753425908091246; Magun R, 1996, ENDOCRINOLOGY, V137, P3590, DOI 10.1210/en.137.8.3590; Marleau Sylvie, 2005, FASEB J, V19, P1869; McGarrigle D., 2007, SCI STKE, V392, pp, DOI [10.1126/stke.3922007pe35, DOI 10.1126/STKE.3922007PE35]; Muslin AJ, 2008, CLIN SCI, V115, P203, DOI 10.1042/CS20070430; Nanzer AM, 2004, EUR J ENDOCRINOL, V151, P233, DOI 10.1530/eje.0.1510233; Pasceri V, 2000, CIRCULATION, V101, P235, DOI 10.1161/01.CIR.101.3.235; Picard N, 2008, MOL ENDOCRINOL, V22, P317, DOI 10.1210/me.2007-0281; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rangwala SM, 2003, DEV CELL, V5, P657, DOI 10.1016/S1534-5807(03)00274-0; Reddy MA, 2009, ARTERIOSCL THROM VAS, V29, P387, DOI 10.1161/ATVBAHA.108.179150; Ricote M, 2004, ARTERIOSCL THROM VAS, V24, P230, DOI 10.1161/01.ATV.0000103951.67680.B1; Rodrigue-Way A, 2007, ENDOCRINOLOGY, V148, P1009, DOI 10.1210/en.2006-0975; Rossi F, 2008, PEPTIDES, V29, P2046, DOI 10.1016/j.peptides.2008.07.002; Rossi F, 2009, ATHEROSCLEROSIS, V203, P97, DOI 10.1016/j.atherosclerosis.2008.06.015; Rozengurt E, 2007, J CELL PHYSIOL, V213, P589, DOI 10.1002/jcp.21246; Sanchez M, 2007, J BIOL CHEM, V282, P4830, DOI 10.1074/jbc.M607908200; Sauve K, 2009, CANCER RES, V69, P5793, DOI 10.1158/0008-5472.CAN-08-4924; Shao DL, 1998, NATURE, V396, P377, DOI 10.1038/24634; Shimizu Y, 2003, BIOCHEM BIOPH RES CO, V310, P830, DOI 10.1016/j.bbrc.2003.09.085; Shinohara H, 2004, GENES CELLS, V9, P601, DOI 10.1111/j.1356-9597.2004.00748.x; St-Laurent V, 2005, J STEROID BIOCHEM, V94, P23, DOI 10.1016/j.jsbmb.2005.02.001; Sun YT, 2005, BIOCHEMISTRY-US, V44, P14455, DOI 10.1021/bi0509090; Tesauro M, 2005, CIRCULATION, V112, P2986, DOI 10.1161/CIRCULATIONAHA.105.553883; Uto-Kondo H, 2009, J NUTR, V139, P51, DOI 10.3945/jn.108.096131; van der Lely AJ, 2004, ENDOCR REV, V25, P426, DOI 10.1210/er.2002-0029; Wettschureck N, 2005, MOL CELL BIOL, V25, P1942, DOI 10.1128/MCB.25.5.1942-1948.2005; Xu XB, 2008, ENDOCRINOLOGY, V149, P4183, DOI 10.1210/en.2008-0255; YAMANASHI Y, 1997, DOK CELL, V88, P205; Zhang B, 1996, J BIOL CHEM, V271, P31771, DOI 10.1074/jbc.271.50.31771	66	32	33	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2009	4	11							e7728	10.1371/journal.pone.0007728	http://dx.doi.org/10.1371/journal.pone.0007728			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RZ	19888469	gold, Green Published, Green Submitted			2022-12-27	WOS:000271414600009
J	Tariq, M; Memon, M; Jafferani, A; Shoukat, S; Gowani, SA; Nusrat, R; Riaz, M; Patel, J; Jamil, B; Smego, RA				Tariq, Muhammad; Memon, Murtaza; Jafferani, Asif; Shoukat, Sana; Gowani, Saqib Ali; Nusrat, Rabeeya; Riaz, Mehmood; Patel, Junaid; Jamil, Bushra; Smego, Raymond A., Jr.			Massive Fluid Requirements and an Unusual BUN/Creatinine Ratio for Pre-Renal Failure in Patients with Cholera	PLOS ONE			English	Article							VIBRIO-CHOLERAE; DIAGNOSIS; DIARRHEA; THERAPY	Background: Cholera is an important infectious cause of secretory diarrhea. The primary symptom of infection is the sudden onset of watery diarrhea with subsequent volume depletion causing renal insufficiency. The objective of this research is to study the level of dehydration at presentation and subsequent fluid management in patients with cholera. Methods: This study was conducted on 191 patients of Cholera admitted at a tertiary care hospital in Karachi, Pakistan during the period of 5 years. Medical charts were evaluated retrospectively for initial hydration status, baseline lab investigations on admission and discharge and fluid therapy given to all the patients while their stay in the hospital and the data was analyzed on SPSS 15.0. Results: Out of the 191 patients, 83(43%) were males and 108 (57%) were females with mean age of 42.3 years (SD +/- 18.34). The average duration of symptoms was 3.75 days (SD +/- 2.04). Of 191 patients, 175 (92.1%) presented with dehydration, 80 (42.3%) were given Ringer's Lactate (R/L) + Normal Saline (N/S), 45 (24%) patients were given R/L + N/S + Oral Rehydration Therapy (ORS), 27 (14.3%) of the patients were kept on R/L only and remaining were given various combinations of R/L, N/S, ORS and Dextrose Saline (D/S). On admission mean Blood Urea Nitrogen (BUN) was 24.54 (SD +/- 16.6), mean creatinine was 2.47 (SD +/- 2.35) and mean BUN/Creatinine ratio was 11.63 (SD +/- 5.7). Conclusion: Aggressive fluid rehydration remains the cornerstone of management of cholera. Instead of presenting with a classical BUN/Creatinine ratio of. 20: 1, patients with pre-renal failure in cholera may present with a BUN/Creatinine ratio of, <5:1.			Tariq, M (corresponding author), Aga Khan Univ, Dept Med, Karachi, Pakistan.	asifahsan_ali@yahoo.co.uk						Albert J, 1999, HUNTERS TROPICAL MED, V8th, P323; [Anonymous], MAN PAT CHOL; Baumann P., 1984, BERGEYS MANUAL SYSTE, P518; Carvounis CP, 2002, KIDNEY INT, V62, P2223, DOI 10.1046/j.1523-1755.2002.00683.x; CASH RA, 1974, J INFECT DIS, V129, P45, DOI 10.1093/infdis/129.1.45; Faruque SM, 1998, MICROBIOL MOL BIOL R, V62, P1301, DOI 10.1128/MMBR.62.4.1301-1314.1998; GOH KT, 1987, T ROY SOC TROP MED H, V81, P230, DOI 10.1016/0035-9203(87)90223-9; Guerrant RL, 2003, CLIN INFECT DIS, V37, P398, DOI 10.1086/376619; Kosek M, 2003, B WORLD HEALTH ORGAN, V81, P197; Le vine MM, 1981, ACUTE ENTERIC INFECT, P443; LENCER WI, 1992, J CELL BIOL, V117, P1197, DOI 10.1083/jcb.117.6.1197; Morris JG, 2003, CLIN INFECT DIS, V37, P272, DOI 10.1086/375600; RAMAMURTHY T, 1993, J CLIN MICROBIOL, V31, P3068, DOI 10.1128/JCM.31.11.3068-3070.1993; SAFRIN S, 1988, REV INFECT DIS, V10, P1012; STEFFEN R, 1986, REV INFECT DIS, V8, pS122	16	11	11	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7552	10.1371/journal.pone.0007552	http://dx.doi.org/10.1371/journal.pone.0007552			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855842	gold, Green Published			2022-12-27	WOS:000271147200005
J	Doucet, S; Soussignan, R; Sagot, P; Schaal, B				Doucet, Sebastien; Soussignan, Robert; Sagot, Paul; Schaal, Benoist			The Secretion of Areolar (Montgomery's) Glands from Lactating Women Elicits Selective, Unconditional Responses in Neonates	PLOS ONE			English	Article							BREAST-FEEDING BEHAVIOR; AUTONOMIC RESPONSES; MAMMARY PHEROMONE; RISK-FACTORS; HUMAN-MILK; HEART-RATE; ODOR; NEWBORNS; PERCEPTION; FEMALES	Background: The communicative meaning of human areolae for newborn infants was examined here in directly exposing 3-day old neonates to the secretion from the areolar glands of Montgomery donated by non related, non familiar lactating women. Methodology/Principal Findings: The effect of the areolar stimulus on the infants' behavior and autonomic nervous system was compared to that of seven reference stimuli originating either from human or non human mammalian sources, or from an arbitrarily-chosen artificial odorant. The odor of the native areolar secretion intensified more than all other stimuli the infants' inspiratory activity and appetitive oral responses. These responses appeared to develop independently from direct experience with the breast or milk. Conclusion/Significance: Areolar secretions from lactating women are especially salient to human newborns. Volatile compounds carried in these substrates are thus in a position to play a key role in establishing behavioral and physiological processes pertaining to milk transfer and production, and, hence, to survival and to the early engagement of attachment and bonding.			Doucet, S (corresponding author), Univ Bourgogne, Dev Ethol & Cognit Psychol Grp, Ctr Europeen Sci Gout, CNRS,UMR 5170, Dijon, France.	schaal@cesg.cnrs.fr						ALBONE ES, 1984, MAMMALIAN SEMIOCHEMI, P360; Allam MDE, 2006, INFANT BEHAV DEV, V29, P308, DOI 10.1016/j.infbeh.2005.12.008; Bengtsson S, 2001, NEUROREPORT, V12, P2027, DOI 10.1097/00001756-200107030-00048; Bingham PM, 2003, ARCH PEDIAT ADOL MED, V157, P72, DOI 10.1001/archpedi.157.10.1031; Carskadon MA, 2004, SLEEP, V27, P402; CLARKSON MG, 1983, CHILD DEV, V54, P162, DOI 10.1111/j.1467-8624.1983.tb00345.x; COOPER WO, 1995, PEDIATRICS, V96, P957; DECHATEAU P, 1977, DEV MED CHILD NEUROL, V19, P575; Dewey KG, 2003, PEDIATRICS, V112, P607, DOI 10.1542/peds.112.3.607; DOUCET S, AREOLAR GLANDS UNPUB; Doucet S, 2007, DEV PSYCHOBIOL, V49, P129, DOI 10.1002/dev.20210; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; ENGEN T, 1963, J COMP PHYSIOL PSYCH, V56, P73, DOI 10.1037/h0043633; GRAF MV, 1984, J CLIN ENDOCR METAB, V59, P127, DOI 10.1210/jcem-59-1-127; GRAHAM FK, 1966, PSYCHOL BULL, V65, P305, DOI 10.1037/h0023258; INSEL TR, 1990, MAMMALIAN PARENTING, P260, DOI DOI 10.1111/J.1749-6632.1992.TB34350.X; Kevern EB, 1990, MAMMALIAN PARENTING, P281; Kruzel ML, 2001, J MOL NEUROSCI, V17, P379, DOI 10.1385/JMN:17:3:379; Macfarlane A, 1975, Ciba Found Symp, P103; MAKIN JW, 1989, CHILD DEV, V60, P803, DOI 10.2307/1131020; Marlier L, 2005, CHILD DEV, V76, P155, DOI 10.1111/j.1467-8624.2005.00836.x; Michel MP, 2007, ARCH PEDIATRIE, V14, P454, DOI 10.1016/j.arcped.2007.01.005; Mizuno K, 2004, EARLY HUM DEV, V76, P83, DOI 10.1016/j.earlhumdev.2003.10.003; MODNEY BK, 1990, MAMMALIAN PARENTING, P305; Moncomble AS, 2005, ANIM BEHAV, V69, P29, DOI 10.1016/j.anbehav.2004.05.006; MONTGOMERY WF, 1837, EXPOSITION SIGNS SYM, P344; MORRONGIELLO BA, 1984, CHILD DEV, V55, P461; MORRONGIELLO BA, 1982, INFANT BEHAV DEV, V5, P249, DOI 10.1016/S0163-6383(82)80035-0; Muller-Schwarze D., 2006, CHEM ECOLOGY VERTEBR, P563; NASR AN, 1965, J HISTOCHEM CYTOCHEM, V13, P498, DOI 10.1177/13.6.498; POMERLEAUMALCUIT A, 1975, PSYCHOPHYSIOLOGY, V12, P527, DOI 10.1111/j.1469-8986.1975.tb00041.x; PORGES SW, 1992, BIOL PSYCHOL, V34, P93, DOI 10.1016/0301-0511(92)90012-J; PRECHTL HFR, 1974, BRAIN RES, V76, P185, DOI 10.1016/0006-8993(74)90454-5; Raimbault C, 2007, ACTA PAEDIATR, V96, P368, DOI 10.1111/j.1651-2227.2007.00114.x; RIGHARD L, 1990, LANCET, V336, P1105, DOI 10.1016/0140-6736(90)92579-7; Robson KS, 1973, EARLY HUM DEV, P224; ROVEE CK, 1969, J EXP CHILD PSYCHOL, V7, P245, DOI 10.1016/0022-0965(69)90047-2; RUSSELL MJ, 1976, NATURE, V260, P520, DOI 10.1038/260520a0; Savic I, 2005, P NATL ACAD SCI USA, V102, P7356, DOI 10.1073/pnas.0407998102; SCHAAL B, 1988, CHEM SENSES, V13, P145, DOI 10.1093/chemse/13.2.145; Schaal B, 2006, DEV PSYCHOBIOL, V48, P100, DOI 10.1002/dev.20122; Schaal B, 2003, NATURE, V424, P68, DOI 10.1038/nature01739; SCHAAL B, 1980, REPROD NUTR DEV, V20, P843, DOI 10.1051/rnd:19800510; Schaal B, 2000, CHEM SENSES, V25, P729, DOI 10.1093/chemse/25.6.729; Schaal B, 2009, BEHAV BRAIN RES, V200, P346, DOI 10.1016/j.bbr.2009.02.008; Sheu HM, 1999, BRIT J DERMATOL, V140, P385, DOI 10.1046/j.1365-2133.1999.02697.x; SMITH DM, 1982, ARCH PATHOL LAB MED, V106, P60; Soussignan R, 1997, PHYSIOL BEHAV, V62, P745, DOI 10.1016/S0031-9384(97)00187-X; Soussignan R, 1999, DEV PSYCHOBIOL, V35, P3, DOI 10.1002/(SICI)1098-2302(199907)35:1&lt;3::AID-DEV2&gt;3.0.CO;2-F; Stuck BA, 2007, SLEEP, V30, P506, DOI 10.1093/sleep/30.4.506; Sullivan RM, 1998, BIOL NEONATE, V74, P402, DOI 10.1159/000014061; Teschemacher H, 1997, BIOPOLYMERS, V43, P99, DOI [10.1002/(SICI)1097-0282(1997)43:2&lt;99::AID-BIP3&gt;3.0.CO;2-V, 10.1002/(SICI)1097-0282(1997)43:2<99::AID-BIP3>3.3.CO;2-8]; UVNASMOBERG K, 1989, ACTA PHYSIOL SCAND, V136, P41; UvnasMoberg K, 1996, ACTA PAEDIATR, V85, P525, DOI 10.1111/j.1651-2227.1996.tb14078.x; Varendi H, 2001, ACTA PAEDIATR, V90, P372, DOI 10.1080/080352501750126131; Zanardo V, 2001, J PEDIATR GASTR NUTR, V33, P160, DOI 10.1097/00005176-200108000-00012	56	78	81	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7579	10.1371/journal.pone.0007579	http://dx.doi.org/10.1371/journal.pone.0007579			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509MQ	19851461	gold, Green Published, Green Submitted			2022-12-27	WOS:000271022300012
J	Lippert, E; Karrasch, T; Sun, XL; Allard, B; Herfarth, HH; Threadgill, D; Jobin, C				Lippert, Elisabeth; Karrasch, Thomas; Sun, Xiaolun; Allard, Brigitte; Herfarth, Hans H.; Threadgill, Deborah; Jobin, Christian			Gnotobiotic IL-10(-/-); NF-kappa B-EGFP Mice Develop Rapid and Severe Colitis Following Campylobacter jejuni Infection	PLOS ONE			English	Article							INTERLEUKIN-10-DEFICIENT MICE; COMMENSAL BACTERIA; ENTERIC BACTERIA; HOST-RESISTANCE; MODEL REVEALS; COLONIZATION; ACTIVATION; INNATE; NOD2; GASTROENTERITIS	Limited information is available on the molecular mechanisms associated with Campylobacter jejuni (C. jejuni) induced food-borne diarrheal illnesses. In this study, we investigated the function of TLR/NF-kappa B signaling in C. jejuni induced pathogenesis using gnotobiotic IL-10(-/-); NF-kappa B EGFP mice. In vitro analysis showed that C. jejuni induced I kappa B phosphorylation, followed by enhanced NF-kappa B transcriptional activity and increased IL-6, MIP-2 alpha and NOD2 mRNA accumulation in infected-mouse colonic epithelial cells CMT93. Importantly, these events were blocked by molecular delivery of an IkB inhibitor (Ad5I kappa BAA). NF-kappa B signalling was also important for C. jejuni-induced cytokine gene expression in bone marrow-derived dendritic cells. Importantly, C. jejuni associated IL-10(-/-); NF-kappa B EGFP mice developed mild (day 5) and severe (day 14) ulcerating colonic inflammation and bloody diarrhea as assessed by colonoscopy and histological analysis. Macroscopic analysis showed elevated EGFP expression indicating NF-kappa B activation throughout the colon of C. jejuni associated IL-10(-/-); NF-kappa B EGFP mice, while fluorescence microscopy revealed EGFP positive cells to be exclusively located in lamina propria mononuclear cells. Pharmacological NF-kappa B inhibition using Bay 11-7085 did not ameliorate C. jejuni induced colonic inflammation. Our findings indicate that C. jejuni induces rapid and severe intestinal inflammation in a susceptible host that correlates with enhanced NF-kappa B activity from lamina propria immune cells.			Lippert, E (corresponding author), Univ N Carolina, Dept Med, Chapel Hill, NC 27515 USA.	Job@med.unc.edu	Schnoy, Elisabeth/AGS-8375-2022; Herfarth, Hans/K-7547-2019	Sun, Xiaolun/0000-0001-5601-0812	NCRR NIH HHS [P40RR018603, P40 RR018603] Funding Source: Medline; NIDDK NIH HHS [R0I DK 47700, R01 DK 73338, R01 DK073338, P30 DK34987, P30 DK034987, R01 DK047700] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P40RR018603] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK047700, P30DK034987, R01DK073338] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BLACK RE, 1988, J INFECT DIS, V157, P472, DOI 10.1093/infdis/157.3.472; Blaser MJ, 1997, J INFECT DIS, V176, pS103, DOI 10.1086/513780; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; Champion OL, 2008, MICROBES INFECT, V10, P922, DOI 10.1016/j.micinf.2008.05.001; Chang C, 2006, INFECT IMMUN, V74, P5261, DOI 10.1128/IAI.01094-05; Coker AO, 2002, EMERG INFECT DIS, V8, P237, DOI 10.3201/eid0803.010233; Dave SH, 2007, J IMMUNOL, V179, P7852, DOI 10.4049/jimmunol.179.11.7852; Dieleman LA, 2000, INFECT IMMUN, V68, P5107, DOI 10.1128/IAI.68.9.5107-5113.2000; DuPont HL, 2007, CLIN INFECT DIS, V45, P1353, DOI 10.1086/522662; Feng CG, 2003, J IMMUNOL, V171, P4758, DOI 10.4049/jimmunol.171.9.4758; Fox JG, 2004, INFECT IMMUN, V72, P1116, DOI 10.1128/IAI.72.2.1116-1125.2004; FRIEDMAN CR, 2001, EPIDEMIOLOGY CAMPYLO, P121; Galanis E, 2007, CAN MED ASSOC J, V177, P570, DOI 10.1503/cmaj.070660; GIBSON DL, 2007, CELL MICROBIOL; Haller D, 2002, J BIOL CHEM, V277, P38168, DOI 10.1074/jbc.M205737200; Hisamatsu T, 2003, GASTROENTEROLOGY, V124, P993, DOI 10.1053/gast.2003.50153; Hofreuter D, 2008, CELL HOST MICROBE, V4, P425, DOI 10.1016/j.chom.2008.10.002; Karrasch T, 2007, J IMMUNOL, V178, P6522, DOI 10.4049/jimmunol.178.10.6522; Kim SC, 2005, GASTROENTEROLOGY, V128, P891, DOI 10.1053/j.gastro.2005.02.009; Kobayashi KS, 2005, SCIENCE, V307, P731, DOI 10.1126/science.1104911; Lebeis SL, 2007, J IMMUNOL, V179, P566, DOI 10.4049/jimmunol.179.1.566; Mansfield LS, 2007, INFECT IMMUN, V75, P1099, DOI 10.1128/IAI.00833-06; Mansfield LS, 2008, MICROB PATHOGENESIS, V45, P241, DOI 10.1016/j.micpath.2008.05.010; McAuley JL, 2007, J CLIN INVEST, V117, P2313, DOI 10.1172/JCI26705; Muhlbauer M, 2008, IMMUNOLOGY, V124, P256, DOI 10.1111/j.1365-2567.2007.02763.x; Murphy C, 2006, J APPL MICROBIOL, V100, P623, DOI 10.1111/j.1365-2672.2006.02903.x; Opitz B, 2004, J BIOL CHEM, V279, P36426, DOI 10.1074/jbc.M403861200; Rath HC, 1999, INFECT IMMUN, V67, P2969, DOI 10.1128/IAI.67.6.2969-2974.1999; Sellon RK, 1998, INFECT IMMUN, V66, P5224, DOI 10.1128/IAI.66.11.5224-5231.1998; Shreeve JE, 2000, AVIAN DIS, V44, P983, DOI 10.2307/1593076; Snelling WJ, 2005, LETT APPL MICROBIOL, V41, P297, DOI 10.1111/j.1472-765X.2005.01788.x; Strober W, 2006, NAT REV IMMUNOL, V6, P9, DOI 10.1038/nri1747; Uronis JM, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006026; Watson RO, 2007, INFECT IMMUN, V75, P1994, DOI 10.1128/IAI.01216-06; Yang YB, 2007, J BIOL CHEM, V282, P36223, DOI 10.1074/jbc.M703079200; Young KT, 2007, NAT REV MICROBIOL, V5, P665, DOI 10.1038/nrmicro1718	36	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7413	10.1371/journal.pone.0007413	http://dx.doi.org/10.1371/journal.pone.0007413			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841748	gold, Green Published, Green Submitted			2022-12-27	WOS:000271012900008
J	Fischer, MD; Huber, G; Beck, SC; Tanimoto, N; Muehlfriedel, R; Fahl, E; Grimm, C; Wenzel, A; Reme, CE; van de Pavert, SA; Wijnholds, J; Pacal, M; Bremner, R; Seeliger, MW				Fischer, M. Dominik; Huber, Gesine; Beck, Susanne C.; Tanimoto, Naoyuki; Muehlfriedel, Regine; Fahl, Edda; Grimm, Christian; Wenzel, Andreas; Reme, Charlotte E.; van de Pavert, Serge A.; Wijnholds, Jan; Pacal, Marek; Bremner, Rod; Seeliger, Mathias W.			Noninvasive, In Vivo Assessment of Mouse Retinal Structure Using Optical Coherence Tomography	PLOS ONE			English	Article							MICE; NRL; DEFICIENT; ORIGIN; RPE65; GENE	Background: Optical coherence tomography (OCT) is a novel method of retinal in vivo imaging. In this study, we assessed the potential of OCT to yield histology-analogue sections in mouse models of retinal degeneration. Methodology/Principal Findings: We achieved to adapt a commercial 3(rd) generation OCT system to obtain and quantify high-resolution morphological sections of the mouse retina which so far required in vitro histology. OCT and histology were compared in models with developmental defects, light damage, and inherited retinal degenerations. In conditional knockout mice deficient in retinal retinoblastoma protein Rb, the gradient of Cre expression from center to periphery, leading to a gradual reduction of retinal thickness, was clearly visible and well topographically quantifiable. In Nrl knockout mice, the layer involvement in the formation of rosette-like structures was similarly clear as in histology. OCT examination of focal light damage, well demarcated by the autofluorescence pattern, revealed a practically complete loss of photoreceptors with preservation of inner retinal layers, but also more subtle changes like edema formation. In Crb1 knockout mice (a model for Leber's congenital amaurosis), retinal vessels slipping through the outer nuclear layer towards the retinal pigment epithelium (RPE) due to the lack of adhesion in the subapical region of the photoreceptor inner segments could be well identified. Conclusions/Significance: We found that with the OCT we were able to detect and analyze a wide range of mouse retinal pathology, and the results compared well to histological sections. In addition, the technique allows to follow individual animals over time, thereby reducing the numbers of study animals needed, and to assess dynamic processes like edema formation. The results clearly indicate that OCT has the potential to revolutionize the future design of respective short- and long-term studies, as well as the preclinical assessment of therapeutic strategies.			Fischer, MD (corresponding author), Univ Tubingen, Inst Ophthalm Res, Ctr Ophthalmol, Div Ocular Neurodegenerat, Tubingen, Germany.	see@uni-tuebingen.de	Wijnholds, Jan/V-3896-2018; Bremner, Rod/I-6490-2012; van de Pavert, Serge A./A-7307-2008	Wijnholds, Jan/0000-0003-0099-460X; Bremner, Rod/0000-0001-9184-7212; van de Pavert, Serge A./0000-0002-7147-4380; Grimm, Christian/0000-0001-9318-4352				Barthelmes D, 2008, INVEST OPHTH VIS SCI, V49, P3529, DOI 10.1167/iovs.07-1320; Baumer N, 2002, DEVELOPMENT, V129, P4535; Chen D, 2004, CANCER CELL, V5, P539, DOI 10.1016/j.ccr.2004.05.025; Chen D, 2007, PLOS BIOL, V5, P1504, DOI 10.1371/journal.pbio.0050179; Edelhauser HF, 2008, INVEST OPHTH VIS SCI, V49, P4712, DOI 10.1167/iovs.08-1904; Feathers KL, 2008, INVEST OPHTH VIS SCI, V49, P1126, DOI 10.1167/iovs.07-1234; Fujimoto JG, 2003, NAT BIOTECHNOL, V21, P1361, DOI 10.1038/nbt892; Kim JT, 2008, PLANT PATHOLOGY J, V24, P17, DOI 10.5423/PPJ.2008.24.1.017; KIM KH, 2008, J VIS, V24, P1; Mears AJ, 2001, NAT GENET, V29, P447, DOI 10.1038/ng774; Ruggeri M, 2007, INVEST OPHTH VIS SCI, V48, P1808, DOI 10.1167/iovs.06-0815; Samardzija M, 2006, FASEB J, V20, P2411, DOI 10.1096/fj.06-5895fje; Sauer B, 1998, METHODS, V14, P381, DOI 10.1006/meth.1998.0593; Seeliger MW, 2005, VISION RES, V45, P3512, DOI 10.1016/j.visres.2005.08.014; van de Pavert SA, 2004, J CELL SCI, V117, P4169, DOI 10.1242/jcs.01301; van de Pavert SA, 2007, GLIA, V55, P1486, DOI 10.1002/glia.20561; Wang NK, 2009, BRIT J OPHTHALMOL, V93, P1234, DOI 10.1136/bjo.2008.153577; Wenzel A, 2005, PROG RETIN EYE RES, V24, P275, DOI 10.1016/j.preteyeres.2004.08.002; Wenzel A, 2007, INVEST OPHTH VIS SCI, V48, P534, DOI 10.1167/iovs.06-0652; Wolf-Schnurrbusch UEK, 2008, INVEST OPHTH VIS SCI, V49, P3095, DOI 10.1167/iovs.07-1460; Xu J, 2009, INVEST OPHTH VIS SCI, V50, P2989, DOI 10.1167/iovs.08-2542	21	162	170	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7507	10.1371/journal.pone.0007507	http://dx.doi.org/10.1371/journal.pone.0007507			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838301	Green Published, gold, Green Submitted			2022-12-27	WOS:000270880900010
J	Klimczak, RR; Koerber, JT; Dalkara, D; Flannery, JG; Schaffer, DV				Klimczak, Ryan R.; Koerber, James T.; Dalkara, Deniz; Flannery, John G.; Schaffer, David V.			A Novel Adeno-Associated Viral Variant for Efficient and Selective Intravitreal Transduction of Rat Muller Cells	PLOS ONE			English	Article							RETINAL-DETACHMENT; VISUAL FUNCTION; GENE-TRANSFER; VIRUS; VECTOR; THERAPY; ASTROCYTES; TROPISM; BINDING; VISION	Background: The pathologies of numerous retinal degenerative diseases can be attributed to a multitude of genetic factors, and individualized treatment options for afflicted patients are limited and cost-inefficient. In light of the shared neurodegenerative phenotype among these disorders, a safe and broad-based neuroprotective approach would be desirable to overcome these obstacles. As a result, gene delivery of secretable-neuroprotective factors to Muller cells, a type of retinal glia that contacts all classes of retinal neurons, represents an ideal approach to mediate protection of the entire retina through a simple and innocuous intraocular, or intravitreal, injection of an efficient vehicle such as an adeno-associated viral vector (AAV). Although several naturally occurring AAV variants have been isolated with a variety of tropisms, or cellular specificities, these vectors inefficiently infect Muller cells via intravitreal injection. Methodology/Principal Findings: We have previously applied directed evolution to create several novel AAV variants capable of efficient infection of both rat and human astrocytes through iterative selection of a panel of highly diverse AAV libraries. Here, in vivo and in vitro characterization of these isolated variants identifies a previously unreported AAV variant ShH10, closely related to AAV serotype 6 (AAV6), capable of efficient, selective Muller cell infection through intravitreal injection. Importantly, this new variant shows significantly improved transduction relative to AAV2 (>60%) and AAV6. Conclusions/Significance: Our findings demonstrate that AAV is a highly versatile vector capable of powerful shifts in tropism from minor sequence changes. This isolated variant represents a new therapeutic vector to treat retinal degenerative diseases through secretion of neuroprotective factors from Muller cells as well as provides new opportunities to study their biological functions in the retina.			Klimczak, RR (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	flannery@berkeley.edu; schaffer@berkeley.edu	Dalkara, Deniz/D-5057-2017	Dalkara, Deniz/0000-0003-4112-9321; Flannery, John/0000-0002-0720-8897	NEI NIH HHS [PN2 EY018241] Funding Source: Medline; NHLBI NIH HHS [R01HL081527, R01 HL081527] Funding Source: Medline; NATIONAL EYE INSTITUTE [PN2EY018241] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL081527] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		ABBOTT NJ, 2006, BLOOD BRAIN BARRIERS, P189; Aleman TS, 2008, INVEST OPHTH VIS SCI, V49, P1580, DOI 10.1167/iovs.07-1110; Bachoo RM, 2004, P NATL ACAD SCI USA, V101, P8384, DOI 10.1073/pnas.0402140101; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Balazs E.A., 1982, AGING HUMAN VISUAL F, P45; BAME KJ, 1991, J BIOL CHEM, V266, P10287; Bartlett JS, 1998, HUM GENE THER, V9, P1181, DOI 10.1089/hum.1998.9.8-1181; Bartlett JS, 2000, J VIROL, V74, P2777, DOI 10.1128/JVI.74.6.2777-2785.2000; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CHIORINI J, 2009, MOL THER, V17; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Ciulla TA, 2009, CURR OPIN OPHTHALMOL, V20, P158, DOI 10.1097/ICU.0b013e32832d25b3; DALKARA D, 2009, MOL THER        0811; Ding W, 2005, GENE THER, V12, P873, DOI 10.1038/sj.gt.3302527; DORRELL MI, 2009, J CLIN INVEST   0202; Flannery JG, 1997, P NATL ACAD SCI USA, V94, P6916, DOI 10.1073/pnas.94.13.6916; Goncalves MAFV, 2005, VIROL J, V2, DOI 10.1186/1743-422X-2-43; Goodyear MJ, 2009, VISUAL NEUROSCI, V26, P159, DOI 10.1017/S0952523809090038; Halbert CL, 2000, J VIROL, V74, P1524, DOI 10.1128/JVI.74.3.1524-1532.2000; Hauck SM, 2003, GLIA, V44, P251, DOI 10.1002/glia.10292; Hellstrom M, 2009, GENE THER, V16, P521, DOI 10.1038/gt.2008.178; Jacobson SG, 2009, INVEST OPHTH VIS SCI, V50, P2368, DOI 10.1167/iovs.08-2696; Jacobson SG, 2009, INVEST OPHTH VIS SCI, V50, P1886, DOI 10.1167/iovs.08-3122; Koerber JT, 2008, MOL THER, V16, P1703, DOI 10.1038/mt.2008.167; KOERBER JT, 2009, MOL THER        0811; Lagali PS, 2008, NAT NEUROSCI, V11, P667, DOI 10.1038/nn.2117; Li QH, 2008, MOL VIS, V14, P1760; Limb GA, 2002, INVEST OPHTH VIS SCI, V43, P864; Lupien CB, 2007, MOL VIS, V13, P1828; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Maheshri N, 2006, NAT BIOTECHNOL, V24, P198, DOI 10.1038/nbt1182; MERIGAN WH, 2008, ARVO ABSTR E, V4514; Nakazawa T, 2007, INVEST OPHTH VIS SCI, V48, P2760, DOI 10.1167/iovs.06-1398; Nakazawa T, 2006, MOL VIS, V12, P867; Park TK, 2009, GENE THER, V16, P916, DOI 10.1038/gt.2009.61; Petrs-Silva H, 2009, MOL THER, V17, P463, DOI 10.1038/mt.2008.269; Sakurai E, 2001, OPHTHALMIC RES, V33, P31, DOI 10.1159/000055638; Salmina AB, 2009, J ALZHEIMERS DIS, V16, P485, DOI 10.3233/JAD-2009-0988; Thomas CE, 2004, J VIROL, V78, P3110, DOI 10.1128/JVI.78.6.3110-3122.2004; Trivino A, 1996, VISION RES, V36, P2015, DOI 10.1016/0042-6989(95)00317-7; Wolf G, 2004, NUTR REV, V62, P283; Wu Z, 2006, J VIROL, V80, P11393, DOI 10.1128/JVI.01288-06; Wu ZJ, 2006, J VIROL, V80, P9093, DOI 10.1128/JVI.00895-06; Xiao XA, 1996, J VIROL, V70, P8098, DOI 10.1128/JVI.70.11.8098-8108.1996; Xie Q, 2002, P NATL ACAD SCI USA, V99, P10405, DOI 10.1073/pnas.162250899	46	122	145	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7467	10.1371/journal.pone.0007467	http://dx.doi.org/10.1371/journal.pone.0007467			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826483	Green Published, gold, Green Submitted			2022-12-27	WOS:000270808700023
J	Aquino, VH; Amarilla, AA; Alfonso, HL; Batista, WC; Figueiredo, LTM				Aquino, Victor Hugo; Amarilla, Alberto Anastacio; Alfonso, Helda Liz; Batista, Weber Cheli; Moraes Figueiredo, Luiz Tadeu			New Genotype of Dengue Type 3 Virus Circulating in Brazil and Colombia Showed a Close Relationship to Old Asian Viruses	PLOS ONE			English	Article							MOLECULAR EPIDEMIOLOGY; EMERGENCE; EVOLUTION	Dengue type 3 genotype V viruses have been recently detected in Brazil and Colombia. In this study, we described another Brazilian isolate belonging to this genotype. Phylogenetic analysis including dengue type 3 viruses isolated worldwide showed that Brazilian and Colombian viruses were closely related to viruses isolated in Asia more than two decades ago. The characteristic evolutionary pattern of dengue type 3 virus cannot explain the close similarity of new circulating viruses with old viruses. Further studies are needed to confirm the origin of the new dengue type III genotype circulating in Brazil and Colombia.			Aquino, VH (corresponding author), Univ Sao Paulo, Fac Ciencias Farmaceut, Dept Anal Clin, Sao Paulo, Brazil.	vhugo@fcfrp.usp.br	Aquino, Victor Hugo/C-1922-2012; Amarilla, Alberto Anastacio/AFO-4805-2022; Ortiz, Alberto Anastacio Amarilla/C-3112-2012; Figueiredo, Luiz T/E-3702-2012	Aquino, Victor Hugo/0000-0003-1910-0776; Amarilla, Alberto Anastacio/0000-0002-6640-3377; Ortiz, Alberto Anastacio Amarilla/0000-0002-4151-2024; 				[Anonymous], 1995, JAMA, V273, P840; Aquino VH, 2006, AM J TROP MED HYG, V75, P710, DOI 10.4269/ajtmh.2006.75.710; ARAUJO J, 2008, INFECT GENET EVOL; Araujo JMG, 2009, INFECT GENET EVOL, V9, P716, DOI 10.1016/j.meegid.2008.10.005; Diaz FJ, 2006, ARCH MED RES, V37, P760, DOI 10.1016/j.arcmed.2006.02.004; Drummond AJ, 2007, BMC EVOL BIOL, V7, DOI 10.1186/1471-2148-7-214; Drummond AJ, 2006, PLOS BIOL, V4, P699, DOI 10.1371/journal.pbio.0040088; Figueiredo LB, 2008, EMERG INFECT DIS, V14, P314, DOI 10.3201/eid1402.070278; Huelsenbeck JP, 2001, BIOINFORMATICS, V17, P754, DOI 10.1093/bioinformatics/17.8.754; Kochel T, 2008, INFECT GENET EVOL, V8, P682, DOI 10.1016/j.meegid.2008.06.008; LANCIOTTI RS, 1994, J GEN VIROL, V75, P65, DOI 10.1099/0022-1317-75-1-65; Li W.H., 1997, MOL EVOLUTION, P487; Messer WB, 2003, EMERG INFECT DIS, V9, P800; Nogueira MB, 2008, MEM I OSWALDO CRUZ, V103, P483, DOI 10.1590/S0074-02762008000500013; Nogueira RMR, 2005, EMERG INFECT DIS, V11, P1376; Posada D, 2006, NUCLEIC ACIDS RES, V34, pW700, DOI 10.1093/nar/gkl042; RODRIGUEZ F, 1990, J THEOR BIOL, V142, P485, DOI 10.1016/S0022-5193(05)80104-3; SCHREIBER M, 2009, J VIROL; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; Twiddy SS, 2003, MOL BIOL EVOL, V20, P122, DOI 10.1093/molbev/msg010; Usme-Ciro JA, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-101; Wittke V, 2002, VIROLOGY, V301, P148, DOI 10.1006/viro.2002.1549	23	20	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7299	10.1371/journal.pone.0007299	http://dx.doi.org/10.1371/journal.pone.0007299			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823677	Green Published, gold, Green Submitted			2022-12-27	WOS:000270808300002
J	Fessenden, JD				Fessenden, James D.			Forster Resonance Energy Transfer Measurements of Ryanodine Receptor Type 1 Structure Using a Novel Site-Specific Labeling Method.	PLOS ONE			English	Article							GREEN FLUORESCENT PROTEIN; CALCIUM-RELEASE CHANNEL; SKELETAL-MUSCLE; 3-DIMENSIONAL ARCHITECTURE; BINDING-SITES; LIVE CELLS; LOCALIZATION; FRET; CALMODULIN; SEQUENCES	Background: While the static structure of the intracellular Ca(2+) release channel, the ryanodine receptor type 1 (RyR1) has been determined using cryo electron microscopy, relatively little is known concerning changes in RyR1 structure that accompany channel gating. Forster resonance energy transfer (FRET) methods can resolve small changes in protein structure although FRET measurements of RyR1 are hampered by an inability to site-specifically label the protein with fluorescent probes. Methodology/Principal Findings: A novel site-specific labeling method is presented that targets a FRET acceptor, Cy3NTA to 10-residue histidine (His) tags engineered into RyR1. Cy3NTA, comprised of the fluorescent dye Cy3, coupled to two Ni(2+)/nitrilotriacetic acid moieties, was synthesized and functionally tested for binding to His-tagged green fluorescent protein (GFP). GFP fluorescence emission and Cy3NTA absorbance spectra overlapped significantly, indicating that FRET could occur (Forster distance = 6.3 nm). Cy3NTA bound to His(10)-tagged GFP, quenching its fluorescence by 88%. GFP was then fused to the N-terminus of RyR1 and His(10) tags were placed either at the N-terminus of the fused GFP or between GFP and RyR1. Cy3NTA reduced fluorescence of these fusion proteins by 75% and this quenching could be reversed by photobleaching Cy3, thus confirming GFP-RyR1 quenching via FRET. A His10 tag was then placed at amino acid position 1861 and FRET was measured from GFP located at either the N-terminus or at position 618 to Cy3NTA bound to this His tag. While minimal FRET was detected between GFP at position 1 and Cy3NTA at position 1861, 53% energy transfer was detected from GFP at position 618 to Cy3NTA at position 1861, thus indicating that these sites are in close proximity to each other. Conclusions/Significance: These findings illustrate the potential of this site-specific labeling system for use in future FRET-based experiments to elucidate novel aspects of RyR1 structure.			Fessenden, JD (corresponding author), Boston Biomed Res Inst, Watertown, MA USA.	Fessenden@bbri.org			NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R21AR056406, K01AR052120] Funding Source: NIH RePORTER; NIAMS NIH HHS [R21 AR056406, K01 AR052120] Funding Source: Medline; PHS HHS [R21ARO56406, K01ARO52120] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Cornea RL, 2009, P NATL ACAD SCI USA, V106, P6128, DOI 10.1073/pnas.0813010106; Guignet EG, 2004, NAT BIOTECHNOL, V22, P440, DOI 10.1038/nbt954; Guignet EG, 2007, CHEMPHYSCHEM, V8, P1221, DOI 10.1002/cphc.200700065; HOCHULI E, 1987, J CHROMATOGR, V411, P177, DOI 10.1016/S0021-9673(00)93969-4; Kapanidis AN, 2001, J AM CHEM SOC, V123, P12123, DOI 10.1021/ja017074a; Kim MJ, 2008, ANAL BIOCHEM, V379, P124, DOI 10.1016/j.ab.2008.04.032; Krishnan B, 2007, CHEM BIOL DRUG DES, V69, P31, DOI 10.1111/j.1747-0285.2007.00463.x; Liu Z, 2005, J BIOL CHEM, V280, P37941, DOI 10.1074/jbc.M505714200; Liu Z, 2001, P NATL ACAD SCI USA, V98, P6104, DOI 10.1073/pnas.111382798; Lorenzon NM, 2001, ARCH BIOCHEM BIOPHYS, V388, P13, DOI 10.1006/abbi.2000.2263; Orlova EV, 1996, NAT STRUCT BIOL, V3, P547, DOI 10.1038/nsb0696-547; Peneva K, 2008, J AM CHEM SOC, V130, P5398, DOI 10.1021/ja711322g; Piston DW, 2007, TRENDS BIOCHEM SCI, V32, P407, DOI 10.1016/j.tibs.2007.08.003; Reichel A, 2007, ANAL CHEM, V79, P8590, DOI 10.1021/ac0714922; Reiken S, 2003, J CELL BIOL, V160, P919, DOI 10.1083/jcb.200211012; Richmond TA, 2000, BIOCHEM BIOPH RES CO, V268, P462, DOI 10.1006/bbrc.1999.1244; Samso M, 2009, PLOS BIOL, V7, P980, DOI 10.1371/journal.pbio.1000085; Soh N, 2006, MOL BIOSYST, V2, P128, DOI 10.1039/b515777c; SORRENTINO V, 1993, TRENDS PHARMACOL SCI, V14, P98, DOI 10.1016/0165-6147(93)90072-R; STRYER L, 1978, ANNU REV BIOCHEM, V47, P819, DOI 10.1146/annurev.bi.47.070178.004131; TAKESHIMA H, 1989, NATURE, V339, P439, DOI 10.1038/339439a0; Taraska JW, 2009, NAT METHODS, V6, P532, DOI 10.1038/nmeth.1341; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Wagenknecht T, 1997, J BIOL CHEM, V272, P32463, DOI 10.1074/jbc.272.51.32463; WAGENKNECHT T, 1989, NATURE, V338, P167, DOI 10.1038/338167a0; Wang RW, 2007, J BIOL CHEM, V282, P17785, DOI 10.1074/jbc.M700660200; Zhang J, 2003, J BIOL CHEM, V278, P14211, DOI 10.1074/jbc.M213164200	27	18	18	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7338	10.1371/journal.pone.0007338	http://dx.doi.org/10.1371/journal.pone.0007338			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823671	Green Submitted, gold, Green Published			2022-12-27	WOS:000270728500001
J	Armesto, M; Cavanagh, D; Britton, P				Armesto, Maria; Cavanagh, Dave; Britton, Paul			The Replicase Gene of Avian Coronavirus Infectious Bronchitis Virus Is a Determinant of Pathogenicity	PLOS ONE			English	Article							MOUSE HEPATITIS-VIRUS; DEFECTIVE RNAS; SPIKE PROTEIN; SEQUENCE; STRAINS; GENOME; EXPRESSION; IDENTIFICATION; PATHOGENESIS; BEAUDETTE	We have previously demonstrated that the replacement of the S gene from an avirulent strain (Beaudette) of infectious bronchitis virus (IBV) with an S gene from a virulent strain (M41) resulted in a recombinant virus (BeauR-M41(S)) with the in vitro cell tropism of the virulent virus but that was still avirulent. In order to investigate whether any of the other structural or accessory genes played a role in pathogenicity we have now replaced these from the Beaudette strain with those from M41. The recombinant IBV was in effect a chimaeric virus with the replicase gene derived from Beaudette and the rest of the genome from M41. This demonstrated that it is possible to exchange a large region of the IBV genome, approximately 8.4 kb, using our transient dominant selection method. Recovery of a viable recombinant IBV also demonstrated that it is possible to interchange a complete replicase gene as we had in effect replaced the M41 replicase gene with the Beaudette derived gene. Analysis of the chimaeric virus showed that it was avirulent indicating that none of the structural or accessory genes derived from a virulent isolate of IBV were able to restore virulence and that therefore, the loss of virulence associated with the Beaudette strain resides in the replicase gene.			Armesto, M (corresponding author), AFRC, Inst Anim Hlth, Compton Lab, Div Microbiol, Newbury RG16 0NN, Berks, England.	paul.britton@bbsrc.ac.uk			Biotechnology and Biological Sciences Research Council [BBS/E/I/00001145, BBS/E/I/00001256] Funding Source: Medline; BBSRC [BBS/E/I/00001256] Funding Source: UKRI	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); BBSRC(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ammayappan A, 2009, ARCH VIROL, V154, P495, DOI 10.1007/s00705-009-0325-9; [Anonymous], [No title captured]; Armesto Maria, 2008, V454, P255, DOI 10.1007/978-1-59745-181-9_19; Bijlenga G, 2004, AVIAN PATHOL, V33, P550, DOI 10.1080/03079450400013154; Bonfield JK, 1995, NUCLEIC ACIDS RES, V23, P4992, DOI 10.1093/nar/23.24.4992; BOURSNELL MEG, 1987, J GEN VIROL, V68, P57, DOI 10.1099/0022-1317-68-1-57; BOURSNELL MEG, 1985, J GEN VIROL, V66, P573, DOI 10.1099/0022-1317-66-3-573; Britton P, 2005, J VIROL METHODS, V123, P203, DOI 10.1016/j.jviromet.2004.09.017; Britton P, 1996, J GEN VIROL, V77, P963, DOI 10.1099/0022-1317-77-5-963; Britton P, 2008, NIDOVIRUSES, P29; Britton Paul, 2007, P161; Cao J, 2008, VIRUS RES, V136, P43, DOI 10.1016/j.virusres.2008.04.015; Casais R, 2005, J VIROL, V79, P8065, DOI 10.1128/JVI.79.13.8065-8078.2005; Casais R, 2003, J VIROL, V77, P9084, DOI 10.1128/JVI.77.16.9084-9089.2003; Casais R, 2001, J VIROL, V75, P12359, DOI 10.1128/JVI.75.24.12359-12369.2001; CAVANAGH D, 1986, VIRUS RES, V4, P133, DOI 10.1016/0168-1702(86)90037-7; Cavanagh D, 2002, AVIAN PATHOL, V31, P81, DOI 10.1080/03079450120106651; Cavanagh D, 2001, AVIAN PATHOL, V30, P355, DOI 10.1080/03079450120066368; CAVANAGH D, 2008, DIS POULTRY, P117; Cavanagh D., 2003, DIS POULTRY, P101; Cavanagh D, 2007, VET RES, V38, P281, DOI 10.1051/vetres:2006055; COOK JKA, 1976, ARCH VIROL, V50, P109, DOI 10.1007/BF01318005; Curtis KM, 2002, J VIROL, V76, P1422, DOI 10.1128/JVI.76.3.1422-1434.2002; Dalton K, 2001, J VIROL, V75, P125, DOI 10.1128/JVI.75.1.125-133.2001; DARBYSHIRE JH, 1979, ARCH VIROL, V61, P227, DOI 10.1007/BF01318057; Dong BQ, 2007, J VIROL, V81, P6920, DOI 10.1128/JVI.00299-07; Eriksson KK, 2008, J VIROL, V82, P12325, DOI 10.1128/JVI.02082-08; GEILHAUSEN HE, 1973, ARCH GES VIRUSFORSCH, V40, P285, DOI 10.1007/BF01242547; GELB J, 1983, AVIAN DIS, V27, P679, DOI 10.2307/1590310; Gomaa MH, 2008, VIRUS RES, V135, P237, DOI 10.1016/j.virusres.2008.03.020; Gonzaalez JM, 2003, ARCH VIROL, V148, P2207, DOI 10.1007/s00705-003-0162-1; Guy JS, 2000, AVIAN PATHOL, V29, P207, DOI 10.1080/03079450050045459; Haijema BJ, 2004, J VIROL, V78, P3863, DOI 10.1128/JVI.78.8.3863-3871.2004; Hodgson T, 2006, J VIROL, V80, P296, DOI 10.1128/JVI.80.1.296-305.2006; Hodgson T, 2004, J VIROL, V78, P13804, DOI 10.1128/JVI.78.24.13804-13811.2004; HODGSON TS, 2005, THESIS U BRISTOL; Jackwood MW, 2003, AVIAN DIS, V47, P627, DOI 10.1637/6094; Jonassen CM, 2005, J GEN VIROL, V86, P1597, DOI 10.1099/vir.0.80927-0; Liu SW, 2009, VACCINE, V27, P4630, DOI 10.1016/j.vaccine.2009.05.072; Mihindukulasuriya KA, 2008, J VIROL, V82, P5084, DOI 10.1128/JVI.02722-07; Navas-Martin S, 2007, J VIROL, V81, P1022, DOI 10.1128/JVI.01944-06; Ortego J, 2003, VIROLOGY, V308, P13, DOI 10.1016/S0042-6822(02)00096-X; PENZES Z, 1994, VIROLOGY, V203, P286, DOI 10.1006/viro.1994.1486; Penzes Z, 1996, J VIROL, V70, P8660; Sola I, 2003, J VIROL, V77, P4357, DOI 10.1128/JVI.77.7.4357-4369.2003; Sperry SM, 2005, J VIROL, V79, P3391, DOI 10.1128/JVI.79.6.3391-3400.2005; Stirrups K, 2000, J GEN VIROL, V81, P791, DOI 10.1099/0022-1317-81-3-791; Woo PCY, 2009, J VIROL, V83, P908, DOI 10.1128/JVI.01977-08; Yount B, 2005, J VIROL, V79, P14909, DOI 10.1128/JVI.79.23.14909-14922.2005; Ziebuhr J, 2008, NIDOVIRUSES, P65; Zust R, 2007, PLOS PATHOG, V3, P1062, DOI 10.1371/journal.ppat.0030109	51	88	93	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7384	10.1371/journal.pone.0007384	http://dx.doi.org/10.1371/journal.pone.0007384			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816578	Green Submitted, Green Published, gold			2022-12-27	WOS:000270594300008
J	Caspani, O; Zurborg, S; Labuz, D; Heppenstall, PA				Caspani, Ombretta; Zurborg, Sandra; Labuz, Dominika; Heppenstall, Paul A.			The Contribution of TRPM8 and TRPA1 Channels to Cold Allodynia and Neuropathic Pain	PLOS ONE			English	Article								Cold allodynia is a common feature of neuropathic pain however the underlying mechanisms of this enhanced sensitivity to cold are not known. Recently the transient receptor potential (TRP) channels TRPM8 and TRPA1 have been identified and proposed to be molecular sensors for cold. Here we have investigated the expression of TRPM8 and TRPA1 mRNA in the dorsal root ganglia (DRG) and examined the cold sensitivity of peripheral sensory neurons in the chronic construction injury (CCI) model of neuropathic pain in mice. In behavioral experiments, chronic constriction injury (CCI) of the sciatic nerve induced a hypersensitivity to both cold and the TRPM8 agonist menthol that developed 2 days post injury and remained stable for at least 2 weeks. Using quantitative RT-PCR and in situ hybridization we examined the expression of TRPM8 and TRPA1 in DRG. Both channels displayed significantly reduced expression levels after injury with no change in their distribution pattern in identified neuronal subpopulations. Furthermore, in calcium imaging experiments, we detected no alterations in the number of cold or menthol responsive neurons in the DRG, or in the functional properties of cold transduction following injury. Intriguingly however, responses to the TRPA1 agonist mustard oil were strongly reduced. Our results indicate that injured sensory neurons do not develop abnormal cold sensitivity after chronic constriction injury and that alterations in the expression of TRPM8 and TRPA1 are unlikely to contribute directly to the pathogenesis of cold allodynia in this neuropathic pain model.			Caspani, O (corresponding author), Charite, Klin Anaesthesiol & Operat Intens Med, Campus Benjamin Franklin, Berlin, Germany.	paul.heppenstall@embl.it		Caspani, Ombretta/0000-0002-9700-3149				Babes A, 2004, EUR J NEUROSCI, V20, P2276, DOI 10.1111/j.1460-9568.2004.03695.x; Bautista DM, 2007, NATURE, V448, P204, DOI 10.1038/nature05910; Bautista DM, 2006, CELL, V124, P1269, DOI 10.1016/j.cell.2006.02.023; Caspani O, 2009, J GEN PHYSIOL, V133, P245, DOI 10.1085/jgp.200810136; Caterina MJ, 2007, AM J PHYSIOL-REG I, V292, pR64, DOI 10.1152/ajpregu.00446.2006; CLIFF MA, 1994, PHYSIOL BEHAV, V56, P1021, DOI 10.1016/0031-9384(94)90338-7; Colburn RW, 2007, NEURON, V54, P379, DOI 10.1016/j.neuron.2007.04.017; Dhaka A, 2008, J NEUROSCI, V28, P566, DOI 10.1523/JNEUROSCI.3976-07.2008; Dhaka A, 2007, NEURON, V54, P371, DOI 10.1016/j.neuron.2007.02.024; Dhaka A, 2006, ANNU REV NEUROSCI, V29, P135, DOI 10.1146/annurev.neuro.29.051605.112958; Djouhri L, 2004, NEUROREPORT, V15, P457, DOI 10.1097/00001756-200403010-00015; Frederick J, 2007, BIOCHEM BIOPH RES CO, V358, P1058, DOI 10.1016/j.bbrc.2007.05.029; GREEN BG, 1992, SOMATOSENS MOT RES, V9, P235, DOI 10.3109/08990229209144774; Hammond DL, 2004, J COMP NEUROL, V475, P575, DOI 10.1002/cne.20209; Hatem S, 2006, PAIN, V122, P190, DOI 10.1016/j.pain.2006.01.026; Hjerling-Leffler J, 2007, J NEUROSCI, V27, P2435, DOI 10.1523/JNEUROSCI.5614-06.2007; Hogan QH, 2007, CROAT MED J, V48, P9; Jensen TS, 2001, EUR J PHARMACOL, V429, P1, DOI 10.1016/S0014-2999(01)01302-4; Ji G, 2007, NEUROSCIENCE, V150, P182, DOI 10.1016/j.neuroscience.2007.09.002; Karashima Y, 2007, J NEUROSCI, V27, P9874, DOI 10.1523/JNEUROSCI.2221-07.2007; Karashima Y, 2009, P NATL ACAD SCI USA, V106, P1273, DOI 10.1073/pnas.0808487106; Kwan KY, 2009, J GEN PHYSIOL, V133, P251, DOI 10.1085/jgp.200810146; LAWSON SN, 1984, J COMP NEUROL, V228, P263, DOI 10.1002/cne.902280211; Lee BH, 1998, EXP BRAIN RES, V120, P432, DOI 10.1007/s002210050416; LINDBLOM U, 1979, J NEUROL NEUROSUR PS, V42, P422, DOI 10.1136/jnnp.42.5.422; Madrid R, 2009, J NEUROSCI, V29, P3120, DOI 10.1523/JNEUROSCI.4778-08.2009; Mahieu F, 2007, J BIOL CHEM, V282, P3325, DOI 10.1074/jbc.M605213200; Maingret F, 2000, EMBO J, V19, P2483, DOI 10.1093/emboj/19.11.2483; Martinez-Caro L, 2000, NEUROREPORT, V11, P1213, DOI 10.1097/00001756-200004270-00014; McKemy DD, 2005, MOL PAIN, V1, DOI 10.1186/1744-8069-1-16; McKemy DD, 2002, NATURE, V416, P52, DOI 10.1038/nature719; Nagata K, 2005, J NEUROSCI, V25, P4052, DOI 10.1523/JNEUROSCI.0013-05.2005; NAGY JI, 1982, NEUROSCIENCE, V7, P89, DOI 10.1016/0306-4522(82)90155-5; NAHIN RL, 1994, PAIN, V58, P95, DOI 10.1016/0304-3959(94)90189-9; Namer B, 2005, NEUROREPORT, V16, P955, DOI 10.1097/00001756-200506210-00015; Nealen ML, 2003, J NEUROPHYSIOL, V90, P515, DOI 10.1152/jn.00843.2002; Obata K, 2005, J CLIN INVEST, V115, P2393, DOI 10.1172/JCI23437; OCHOA JL, 1994, BRAIN, V117, P185, DOI 10.1093/brain/117.1.185; Peier AM, 2002, CELL, V108, P705, DOI 10.1016/S0092-8674(02)00652-9; Persson AK, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-7; Proudfoot CJ, 2006, CURR BIOL, V16, P1591, DOI 10.1016/j.cub.2006.07.061; Reid G, 2005, PFLUG ARCH EUR J PHY, V451, P250, DOI 10.1007/s00424-005-1437-z; Roza C, 2006, PAIN, V120, P24, DOI 10.1016/j.pain.2005.10.006; Sawada Y, 2007, BRAIN RES, V1160, P39, DOI 10.1016/j.brainres.2007.05.047; Seifert F, 2007, NEUROIMAGE, V35, P1168, DOI 10.1016/j.neuroimage.2007.01.021; Story GM, 2003, CELL, V112, P819, DOI 10.1016/S0092-8674(03)00158-2; Stucky CL, 1999, J NEUROSCI, V19, P6497; Thut PD, 2003, NEUROSCIENCE, V119, P1071, DOI 10.1016/S0306-4522(03)00225-2; WAHREN LK, 1992, PAIN, V48, P237, DOI 10.1016/0304-3959(92)90063-H; Walczak JS, 2006, NEUROSCI LETT, V399, P240, DOI 10.1016/j.neulet.2006.01.058; Wasner G, 2004, BRAIN, V127, P1159, DOI 10.1093/brain/awh134; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Xiao B, 2008, J NEUROSCI, V28, P9640, DOI 10.1523/JNEUROSCI.2772-08.2008; Xing H, 2007, J NEUROSCI, V27, P13680, DOI 10.1523/JNEUROSCI.2203-07.2007; YARNITSKY D, 1990, BRAIN, V113, P893, DOI 10.1093/brain/113.4.893; Yosipovitch G, 1996, ARCH DERMATOL RES, V288, P245, DOI 10.1007/s004030050053; Zimmermann M, 2001, EUR J PHARMACOL, V429, P23, DOI 10.1016/S0014-2999(01)01303-6; Zurborg S, 2007, NAT NEUROSCI, V10, P277, DOI 10.1038/nn1843	58	119	120	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7383	10.1371/journal.pone.0007383	http://dx.doi.org/10.1371/journal.pone.0007383			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812688	Green Submitted, Green Published, gold			2022-12-27	WOS:000270594200009
J	Lai, HJ; Lo, SJ; Kage-Nakadai, E; Mitani, S; Xue, D				Lai, Huey-Jen; Lo, Szecheng J.; Kage-Nakadai, Eriko; Mitani, Shohei; Xue, Ding			The Roles and Acting Mechanism of Caenorhabditis elegans DNase II Genes in Apoptotic DNA Degradation and Development	PLOS ONE			English	Article								DNase II enzymes are acidic endonucleases that have been implicated in mediating apoptotic DNA degradation, a critical cell death execution event. C. elegans genome contains three DNase II homologues, NUC-1, CRN-6, and CRN-7, but their expression patterns, acting sites, and roles in apoptotic DNA degradation and development are unclear. We have conducted a comprehensive analysis of three C. elegans DNase II genes and found that nuc-1 plays a major role, crn-6 plays an auxiliary role, and crn-7 plays a negligible role in resolving 3' OH DNA breaks generated in apoptotic cells. Promoter swapping experiments suggest that crn-6 but not crn-7 can partially substitute for nuc-1 in mediating apoptotic DNA degradation and both fail to replace nuc-1 in degrading bacterial DNA in intestine. Despite of their restricted and largely non-overlapping expression patterns, both CRN-6 and NUC-1 can mediate apoptotic DNA degradation in many cells, suggesting that they are likely secreted nucleases that are retaken up by other cells to exert DNA degradation functions. Removal or disruption of NUC-1 secretion signal eliminates NUC-1's ability to mediate DNA degradation across its expression border. Furthermore, blocking cell corpse engulfment does not affect apoptotic DNA degradation mediated by nuc-1, suggesting that NUC-1 acts in apoptotic cells rather than in phagocytes to resolve 3' OH DNA breaks. Our study illustrates how multiple DNase II nucleases play differential roles in apoptotic DNA degradation and development and reveals an unexpected mode of DNase II action in mediating DNA degradation.			Lai, HJ (corresponding author), Univ Colorado, Dept Mol Cellular & Dev Biol, Boulder, CO 80309 USA.	losj@mail.cgu.edu.tw; ding.xue@colorado.edu		XUE, DING/0000-0002-8429-8136	NIGMS NIH HHS [R01 GM079097, R01 GM059083] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059083, R01GM079097] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALNEMRI ES, 1990, J BIOL CHEM, V265, P17323; ARDIZZI JP, 1987, J CELL BIOL, V105, P2763, DOI 10.1083/jcb.105.6.2763; Baker KP, 1998, GENE, V215, P281, DOI 10.1016/S0378-1119(98)00280-7; BERNARDI G, 1971, HYDROLYSIS, P271; BRENNER S, 1974, GENETICS, V77, P71; Counis MF, 2006, BIOCHIMIE, V88, P1851, DOI 10.1016/j.biochi.2006.07.008; ELLIS HM, 1986, CELL, V44, P817, DOI 10.1016/0092-8674(86)90004-8; ELLIS RE, 1991, GENETICS, V129, P79; Enari M, 1998, NATURE, V391, P43, DOI 10.1038/34112; Evans CJ, 2003, GENE, V322, P1, DOI 10.1016/j.gene.2003.08.022; GAVRIELI Y, 1992, J CELL BIOL, V119, P493, DOI 10.1083/jcb.119.3.493; Gottlieb RA, 1996, P NATL ACAD SCI USA, V93, P654, DOI 10.1073/pnas.93.2.654; HEDGECOCK EM, 1983, SCIENCE, V220, P1277, DOI 10.1126/science.6857247; HODGKIN J, 1979, GENETICS, V91, P67; HODGKIN J, 1983, GENETICS, V103, P43; Kaufmann SH, 2000, METHOD ENZYMOL, V322, P3; Kawane K, 2001, SCIENCE, V292, P1546, DOI 10.1126/science.292.5521.1546; Kawane K, 2003, NAT IMMUNOL, V4, P138, DOI 10.1038/ni881; Krieser RJ, 2001, GENE, V269, P205, DOI 10.1016/S0378-1119(01)00434-6; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu XS, 1997, CELL, V89, P175, DOI 10.1016/S0092-8674(00)80197-X; Lyon CJ, 2000, GENE, V252, P147, DOI 10.1016/S0378-1119(00)00213-4; MacLea KS, 2002, BIOCHEM BIOPH RES CO, V292, P415, DOI 10.1006/bbrc.2002.6687; MADURO M, 1995, GENETICS, V141, P977; McIlroy D, 2000, GENE DEV, V14, P549; MELLO CC, 1991, EMBO J, V10, P3959, DOI 10.1002/j.1460-2075.1991.tb04966.x; Mukae N, 2002, GENE DEV, V16, P2662, DOI 10.1101/gad.1022802; Nishimoto S, 2003, NATURE, V424, P1071, DOI 10.1038/nature01895; Parrish J, 2001, NATURE, V412, P90, DOI 10.1038/35083608; Parrish JZ, 2006, CHROMOSOMA, V115, P89, DOI 10.1007/s00412-005-0038-0; Parrish JZ, 2003, MOL CELL, V11, P987, DOI 10.1016/S1097-2765(03)00095-9; Praitis V, 2001, GENETICS, V157, P1217; Seong CS, 2006, CELL IMMUNOL, V240, P5, DOI 10.1016/j.cellimm.2006.05.007; SEYDOUX G, 1994, DEVELOPMENT, V120, P2823; Shaham S, 1999, GENETICS, V153, P1655; Shiokawa D, 1998, BIOCHEM BIOPH RES CO, V247, P864, DOI 10.1006/bbrc.1998.8839; Shiokawa D, 1999, NUCLEIC ACIDS RES, V27, P4083, DOI 10.1093/nar/27.20.4083; STELLER H, 1995, SCIENCE, V267, P1445, DOI 10.1126/science.7878463; SULSTON JE, 1976, PHILOS T ROY SOC B, V275, P287, DOI 10.1098/rstb.1976.0084; SULSTON JE, 1977, DEV BIOL, V56, P110, DOI 10.1016/0012-1606(77)90158-0; SULSTON JE, 1983, DEV BIOL, V100, P64, DOI 10.1016/0012-1606(83)90201-4; Widlak P, 2009, CELL MOL LIFE SCI, V66, P263, DOI 10.1007/s00018-008-8472-9; Widlak P, 2001, MOL CELL BIOCHEM, V218, P125, DOI 10.1023/A:1007231822086; Wu YC, 2000, GENE DEV, V14, P536; WYLLIE AH, 1980, NATURE, V284, P555, DOI 10.1038/284555a0; YAMANAKA M, 1974, J BIOL CHEM, V249, P3884; Yasuda T, 1998, J BIOL CHEM, V273, P2610, DOI 10.1074/jbc.273.5.2610; Zhang JH, 1998, P NATL ACAD SCI USA, V95, P12480, DOI 10.1073/pnas.95.21.12480	48	11	17	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7348	10.1371/journal.pone.0007348	http://dx.doi.org/10.1371/journal.pone.0007348			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809494	Green Published, Green Submitted, gold			2022-12-27	WOS:000270594000011
J	Terrados, G; Capp, JP; Canitrot, Y; Garcia-Diaz, M; Bebenek, K; Kirchhoff, T; Villanueva, A; Boudsocq, F; Bergoglio, V; Cazaux, C; Kunkel, TA; Hoffmann, JS; Blanco, L				Terrados, Gloria; Capp, Jean-Pascal; Canitrot, Yvan; Garcia-Diaz, Miguel; Bebenek, Katarzyna; Kirchhoff, Tomas; Villanueva, Alberto; Boudsocq, Francois; Bergoglio, Valerie; Cazaux, Christophe; Kunkel, Thomas A.; Hoffmann, Jean-Sebastien; Blanco, Luis			Characterization of a Natural Mutator Variant of Human DNA Polymerase lambda which Promotes Chromosomal Instability by Compromising NHEJ	PLOS ONE			English	Article							BASE EXCISION-REPAIR; END-JOINING PATHWAY; POL LAMBDA; BETA; MUTANT; DAMAGE; OVEREXPRESSION; IDENTIFICATION; SUBSTITUTION; CHECKPOINT	Background: DNA polymerase lambda (Pol lambda) is a DNA repair polymerase, which likely plays a role in base excision repair (BER) and in non-homologous end joining (NHEJ) of DNA double-strand breaks (DSB). Principal Findings: Here, we described a novel natural allelic variant of human Pol lambda (hPol lambda) characterized by a single nucleotide polymorphism (SNP), C/T variation in the first base of codon 438, resulting in the amino acid change Arg to Trp. In vitro enzyme activity assays of the purified W438 Pol lambda variant revealed that it retained both DNA polymerization and deoxyribose phosphate (dRP) lyase activities, but had reduced base substitution fidelity. Ectopic expression of the W438 hPol lambda variant in mammalian cells increases mutation frequency, affects the DSB repair NHEJ pathway, and generates chromosome aberrations. All these phenotypes are dependent upon the catalytic activity of the W438 hPol lambda. Conclusions: The expression of a cancer-related natural variant of one specialized DNA polymerase can be associated to generic instability at the cromosomal level, probably due a defective NHEJ. These results establish that chromosomal aberrations can result from mutations in specialized DNA repair polymerases.			Terrados, G (corresponding author), CSIC UAM, Ctr Biol Mol Severo Ochoa, Madrid, Spain.	jseb@ipbs.fr; lblanco@cbm.uam.es	Bergoglio, Valérie VB/P-1624-2014; Blanco, Luis/I-1848-2015; Kunkel, Thomas A./D-5088-2019; Hoffmann, Jean-Sebastien/O-9183-2014	Bergoglio, Valérie VB/0000-0003-2773-3178; Kunkel, Thomas A./0000-0002-9900-1788; Hoffmann, Jean-Sebastien/0000-0003-2222-354X; Capp, Jean-Pascal/0000-0002-6470-079X; Terrados/0000-0002-0513-3692; Kirchhoff, Tomas/0000-0002-9055-2364	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES065070] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		Albertella MR, 2005, DNA REPAIR, V4, P583, DOI 10.1016/j.dnarep.2005.01.005; Aoufouchi S, 2000, NUCLEIC ACIDS RES, V28, P3684, DOI 10.1093/nar/28.18.3684; Beard WA, 2000, MUTAT RES-DNA REPAIR, V460, P231, DOI 10.1016/S0921-8777(00)00029-X; Bebenek K, 1995, METHOD ENZYMOL, V262, P217; Bergoglio V, 2002, CANCER RES, V62, P3511; Bhattacharyya N, 1997, P NATL ACAD SCI USA, V94, P10324, DOI 10.1073/pnas.94.19.10324; Bork P, 1997, FASEB J, V11, P68, DOI 10.1096/fasebj.11.1.9034168; Braithwaite EK, 2005, J BIOL CHEM, V280, P31641, DOI 10.1074/jbc.C500256200; Braithwaite EK, 2005, J BIOL CHEM, V280, P18469, DOI 10.1074/jbc.M411864200; Callebaut I, 1997, FEBS LETT, V400, P25, DOI 10.1016/S0014-5793(96)01312-9; Canitrot Y, 1998, P NATL ACAD SCI USA, V95, P12586, DOI 10.1073/pnas.95.21.12586; Capp JP, 2006, NUCLEIC ACIDS RES, V34, P2998, DOI 10.1093/nar/gkl380; Dalal S, 2005, BIOCHEMISTRY-US, V44, P15664, DOI 10.1021/bi051179z; DOBASHI Y, 1995, HUM GENET, V95, P389; Fan W, 2004, BIOCHEM BIOPH RES CO, V323, P1328, DOI 10.1016/j.bbrc.2004.09.002; Ferguson DO, 2000, P NATL ACAD SCI USA, V97, P6630, DOI 10.1073/pnas.110152897; Garcia-Diaz M, 2005, NAT STRUCT MOL BIOL, V12, P97, DOI 10.1038/nsmb876; Garcia-Diaz M, 2004, MOL CELL, V13, P561, DOI 10.1016/S1097-2765(04)00061-9; Garcia-Diaz M, 2002, J BIOL CHEM, V277, P13184, DOI 10.1074/jbc.M111601200; Garcia-Diaz M, 2001, J BIOL CHEM, V276, P34659, DOI 10.1074/jbc.M106336200; Garcia-Diaz M, 2000, J MOL BIOL, V301, P851, DOI 10.1006/jmbi.2000.4005; Goldsby RE, 2001, NAT MED, V7, P638, DOI 10.1038/88963; Gorgoulis VG, 2005, NATURE, V434, P907, DOI 10.1038/nature03485; Guirouilh-Barbat J, 2004, MOL CELL, V14, P611, DOI 10.1016/j.molcel.2004.05.008; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Hoeijmakers JHJ, 2001, NATURE, V411, P366, DOI 10.1038/35077232; Hubscher U, 2002, ANNU REV BIOCHEM, V71, P133, DOI 10.1146/annurev.biochem.71.090501.150041; Karanjawala ZE, 1999, CURR BIOL, V9, P1501, DOI 10.1016/S0960-9822(00)80123-2; Kirchhoff T, 1999, NEOPLASMA, V46, P290; Kosa JL, 1999, J BIOL CHEM, V274, P35866, DOI 10.1074/jbc.274.50.35866; Kunkel TA, 2003, CANCER CELL, V3, P105, DOI 10.1016/S1535-6108(03)00027-8; Lang TM, 2004, P NATL ACAD SCI USA, V101, P6074, DOI 10.1073/pnas.0308571101; Lee JW, 2004, J BIOL CHEM, V279, P805, DOI 10.1074/jbc.M307913200; Ma YM, 2004, MOL CELL, V16, P701, DOI 10.1016/j.molcel.2004.11.017; McElhinny SAN, 2005, MOL CELL, V19, P357, DOI 10.1016/j.molcel.2005.06.012; Miyamoto H, 1999, INT J CANCER, V83, P708, DOI 10.1002/(SICI)1097-0215(19991126)83:5<708::AID-IJC24>3.0.CO;2-C; Nagasawa K, 2000, J BIOL CHEM, V275, P31233, DOI 10.1074/jbc.M004263200; Opresko PL, 1998, BIOCHEMISTRY-US, V37, P2111, DOI 10.1021/bi9722711; Osheroff WP, 1999, J BIOL CHEM, V274, P20749, DOI 10.1074/jbc.274.30.20749; Osheroff WP, 1999, J BIOL CHEM, V274, P3642, DOI 10.1074/jbc.274.6.3642; Osheroff WP, 2000, J BIOL CHEM, V275, P28033; Picher AJ, 2007, DNA REPAIR, V6, P1749, DOI 10.1016/j.dnarep.2007.06.007; Ponamarev MV, 2002, J BIOL CHEM, V277, P15225, DOI 10.1074/jbc.C200100200; Shah AM, 2001, BIOCHEMISTRY-US, V40, P11372, DOI 10.1021/bi010755y; Shcherbakova Polina V, 2003, Sci Aging Knowledge Environ, V2003, pRE3, DOI 10.1126/sageke.2003.8.re3; Sobol RW, 2001, PROG NUCLEIC ACID RE, V68, P57; Sweasy JB, 2005, P NATL ACAD SCI USA, V102, P14350, DOI 10.1073/pnas.0505166102; Tomka M, 1998, NEOPLASMA, V45, P345; WANG LM, 1992, CANCER RES, V52, P4824	49	15	16	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7290	10.1371/journal.pone.0007290	http://dx.doi.org/10.1371/journal.pone.0007290			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806195	Green Published, Green Submitted, gold			2022-12-27	WOS:000270593800007
J	Abe, M; Setoguchi, Y; Tanaka, T; Awano, W; Takahashi, K; Ueda, R; Nakamura, A; Goto, S				Abe, Masato; Setoguchi, Yuka; Tanaka, Tsubasa; Awano, Wakae; Takahashi, Kuniaki; Ueda, Ryu; Nakamura, Akira; Goto, Satoshi			Membrane Protein Location-Dependent Regulation by PI3K (III) and Rabenosyn-5 in Drosophila Wing Cells	PLOS ONE			English	Article								The class III phosphatidylinositol-3 kinase (PI3K (III)) regulates intracellular vesicular transport at multiple steps through the production of phosphatidylinositol-3-phosphate (PI(3)P). While the localization of proteins at distinct membrane domains are likely regulated in different ways, the roles of PI3K (III) and its effectors have not been extensively investigated in a polarized cell during tissue development. In this study, we examined in vivo functions of PI3K (III) and its effector candidate Rabenosyn-5 (Rbsn-5) in Drosophila wing primordial cells, which are polarized along the apical-basal axis. Knockdown of the PI3K (III) subunit Vps15 resulted in an accumulation of the apical junctional proteins DE-cadherin and Flamingo and also the basal membrane protein beta-integrin in intracellular vesicles. By contrast, knockdown of PI3K (III) increased lateral membrane-localized Fasciclin III (Fas III). Importantly, loss-of-function mutation of Rbsn-5 recapitulated the aberrant localization phenotypes of beta-integrin and Fas III, but not those of DE-cadherin and Flamingo. These results suggest that PI3K (III) differentially regulates localization of proteins at distinct membrane domains and that Rbsn-5 mediates only a part of the PI3K (III)-dependent processes.			Abe, M (corresponding author), Takeda Pharmaceut Co Ltd, Biol Prod Dept, Yamaguchi, Japan.	sgoto@mitils.jp	Nakamura, Akira/V-6869-2019	Nakamura, Akira/0000-0001-6506-9146				APODACA G, 1994, J CELL BIOL, V125, P67, DOI 10.1083/jcb.125.1.67; BOMSEL M, 1989, J CELL BIOL, V109, P3243, DOI 10.1083/jcb.109.6.3243; BRAND AH, 1993, DEVELOPMENT, V118, P401; Brown PS, 2000, TRAFFIC, V1, P124, DOI 10.1034/j.1600-0854.2000.010205.x; Burda P, 2002, J CELL SCI, V115, P3889, DOI 10.1242/jcs.00090; Christoforidis S, 1999, NAT CELL BIOL, V1, P249, DOI 10.1038/12075; De Renzis S, 2002, NAT CELL BIOL, V4, P124, DOI 10.1038/ncb744; Ellson CD, 2002, J CELL SCI, V115, P1099; Fernandez-Borja M, 1999, CURR BIOL, V9, P55, DOI 10.1016/S0960-9822(99)80048-7; FRISTROM D, 1993, DEVELOPMENT, V117, P509; Futter CE, 2001, J CELL BIOL, V155, P1251, DOI 10.1083/jcb.200108152; Gengyo-Ando K, 2007, EMBO REP, V8, P152, DOI 10.1038/sj.embor.7400882; Gillooly DJ, 2000, EMBO J, V19, P4577, DOI 10.1093/emboj/19.17.4577; HERMAN PK, 1990, MOL CELL BIOL, V10, P6742, DOI 10.1128/MCB.10.12.6742; Hickson GRX, 2003, MOL BIOL CELL, V14, P2908, DOI 10.1091/mbc.E03-03-0160; HILES ID, 1992, CELL, V70, P419, DOI 10.1016/0092-8674(92)90166-A; JONES AT, 1995, BIOCHEM J, V311, P31, DOI 10.1042/bj3110031; Juhasz G, 2008, J CELL BIOL, V181, P655, DOI 10.1083/jcb.200712051; Kihara A, 2001, J CELL BIOL, V152, P519, DOI 10.1083/jcb.152.3.519; Komada M, 1997, J BIOL CHEM, V272, P20538, DOI 10.1074/jbc.272.33.20538; LI GP, 1995, P NATL ACAD SCI USA, V92, P10207, DOI 10.1073/pnas.92.22.10207; Lin Y, 2005, J BIOL CHEM, V280, P12799, DOI 10.1074/jbc.M413968200; Marois E, 2006, DEVELOPMENT, V133, P307, DOI 10.1242/dev.02197; MORRISON HA, 2008, MOL BIOL CELL; Muller HAJ, 2000, DEV DYNAM, V218, P52; Naslavsky N, 2004, MOL BIOL CELL, V15, P2410, DOI 10.1091/mbc.E03-10-0733; Nielsen E, 2000, J CELL BIOL, V151, P601, DOI 10.1083/jcb.151.3.601; PARTON RG, 1989, J CELL BIOL, V109, P3259, DOI 10.1083/jcb.109.6.3259; Petiot A, 2003, J CELL BIOL, V162, P971, DOI 10.1083/jcb.200303018; Petiot A, 2000, J BIOL CHEM, V275, P992, DOI 10.1074/jbc.275.2.992; Pulipparacharuvil S, 2005, J CELL SCI, V118, P3663, DOI 10.1242/jcs.02502; Raiborg C, 2002, NAT CELL BIOL, V4, P394, DOI 10.1038/ncb791; Reaves BJ, 1996, J CELL SCI, V109, P749; Riggs B, 2003, J CELL BIOL, V163, P143, DOI 10.1083/jcb.200305115; Roggo L, 2002, EMBO J, V21, P1673, DOI 10.1093/emboj/21.7.1673; SCHU PV, 1993, SCIENCE, V260, P88, DOI 10.1126/science.8385367; Schwartz SL, 2007, J CELL SCI, V120, P3905, DOI 10.1242/jcs.015909; Shih SC, 2002, NAT CELL BIOL, V4, P389, DOI 10.1038/ncb790; Spiro DJ, 1996, MOL BIOL CELL, V7, P355, DOI 10.1091/mbc.7.3.355; STACK JH, 1993, EMBO J, V12, P2195, DOI 10.1002/j.1460-2075.1993.tb05867.x; Stein MP, 2003, TRAFFIC, V4, P754, DOI 10.1034/j.1600-0854.2003.00133.x; Stenmark H, 2002, FEBS LETT, V513, P77, DOI 10.1016/S0014-5793(01)03308-7; Tanaka T, 2008, DEVELOPMENT, V135, P1107, DOI 10.1242/dev.017293; Teo HL, 2006, CELL, V125, P99, DOI 10.1016/j.cell.2006.01.047; Tepass U, 2001, ANNU REV GENET, V35, P747, DOI 10.1146/annurev.genet.35.102401.091415; Tuma PL, 2001, J CELL BIOL, V154, P1197, DOI 10.1083/jcb.200105138; Usui T, 1999, CELL, V98, P585, DOI 10.1016/S0092-8674(00)80046-X; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087	48	14	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7306	10.1371/journal.pone.0007306	http://dx.doi.org/10.1371/journal.pone.0007306			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19798413	Green Published, Green Submitted, gold			2022-12-27	WOS:000270593300011
J	Bettecken, T; Trifonov, EN				Bettecken, Thomas; Trifonov, Edward N.			Repertoires of the Nucleosome-Positioning Dinucleotides	PLOS ONE			English	Article							CHROMATIN DNA; NUCLEOTIDE-SEQUENCE; IN-VITRO; GENOME; INSIGHTS; ELEGANS; REPEAT; PITCH	It is generally accepted that the organization of eukaryotic DNA into chromatin is strongly governed by a code inherent in the genomic DNA sequence. This code, as well as other codes, is superposed on the triplets coding for amino acids. The history of the chromatin code started three decades ago with the discovery of the periodic appearance of certain dinucleotides, with AA/TT and RR/YY giving the strongest signals, all with a period of 10.4 bases. Every base-pair stack in the DNA duplex has specific deformation properties, thus favoring DNA bending in a specific direction. The appearance of the corresponding dinucleotide at the distance 10.4 xn bases will facilitate DNA bending in that direction, which corresponds to the minimum energy of DNA folding in the nucleosome. We have analyzed the periodic appearances of all 16 dinucleotides in the genomes of thirteen different eukaryotic organisms. Our data show that a large variety of dinucleotides (if not all) are, apparently, contributing to the nucleosome positioning code. The choice of the periodical dinucleotides differs considerably from one organism to another. Among other 10.4 base periodicities, a strong and very regular 10.4 base signal was observed for CG dinucleotides in the genome of the honey bee A. mellifera. Also, the dinucleotide CG appears as the only periodical component in the human genome. This observation seems especially relevant since CpG methylation is well known to modulate chromatin packing and regularity. Thus, the selection of the dinucleotides contributing to the chromatin code is species specific, and may differ from region to region, depending on the sequence context.			Bettecken, T (corresponding author), Max Planck Inst Psychiat, CAGT, Munich, Germany.	bettecken@mpipsykl.mpg.de						BOLSHOY A, 1995, NAT STRUCT BIOL, V2, P446, DOI 10.1038/nsb0695-446; Cohanim AB, 2006, J BIOMOL STRUCT DYN, V23, P559, DOI 10.1080/07391102.2006.10507081; Cohanim AB, 2005, J BIOMOL STRUCT DYN, V22, P687, DOI 10.1080/07391102.2005.10507035; Costantini M, 2008, P NATL ACAD SCI USA, V105, P13971, DOI 10.1073/pnas.0803916105; Davey C, 1997, J MOL BIOL, V267, P276, DOI 10.1006/jmbi.1997.0899; Davey CS, 2004, NUCLEIC ACIDS RES, V32, P4322, DOI 10.1093/nar/gkh749; Gabdank I, 2009, J BIOMOL STRUCT DYN, V26, P403, DOI 10.1080/07391102.2009.10507255; Herzel H, 1998, J BIOMOL STRUCT DYN, V16, P341, DOI 10.1080/07391102.1998.10508251; Kato M, 2003, J MOL BIOL, V332, P111, DOI 10.1016/S0022-2836(03)00838-6; Kogan SB, 2006, J BIOMOL STRUCT DYN, V24, P43, DOI 10.1080/07391102.2006.10507097; Krueger A, 2006, BIOPHYS J, V90, P3091, DOI 10.1529/biophysj.105.078774; Manolio TA, 2008, J CLIN INVEST, V118, P1590, DOI 10.1172/JCI34772; MENGERITSKY G, 1983, NUCLEIC ACIDS RES, V11, P3833, DOI 10.1093/nar/11.11.3833; Pennings Sari, 2005, Briefings in Functional Genomics & Proteomics, V3, P351, DOI 10.1093/bfgp/3.4.351; Salih F, 2008, J BIOMOL STRUCT DYN, V26, P273, DOI 10.1080/07391102.2008.10531241; Salih F, 2008, J BIOMOL STRUCT DYN, V26, P9, DOI 10.1080/07391102.2008.10507219; Segal E, 2006, NATURE, V442, P772, DOI 10.1038/nature04979; Thastrom A, 2004, J MOL BIOL, V338, P695, DOI 10.1016/j.jmb.2004.03.032; TRIFONOV EN, 1980, NUCLEIC ACIDS RES, V8, P4041, DOI 10.1093/nar/8.17.4041; TRIFONOV EN, 1979, BIOCHEMISTRY-US, V18, P454, DOI 10.1021/bi00570a011; TRIFONOV EN, 1980, P NATL ACAD SCI-BIOL, V77, P3816, DOI 10.1073/pnas.77.7.3816; TRIFONOV EN, 1995, JERUS SYM Q, V27, P473; ULANOVSKY LE, 1983, CELL BIOPHYS, V5, P281, DOI 10.1007/BF02788626; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260	24	30	33	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2009	4	11							e7654	10.1371/journal.pone.0007654	http://dx.doi.org/10.1371/journal.pone.0007654			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RX	19888331	Green Submitted, gold, Green Published			2022-12-27	WOS:000271414400002
J	Samuel, LJ; Latinkic, BV				Samuel, Lee J.; Latinkic, Branko V.			Early Activation of FGF and Nodal Pathways Mediates Cardiac Specification Independently of Wnt/beta-Catenin Signaling	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; MESODERM-INDUCING SIGNALS; EMBRYONIC STEM-CELLS; GROWTH-FACTOR-BETA; XENOPUS-EMBRYOS; HEART DEVELOPMENT; TGF-BETA; TERMINAL DIFFERENTIATION; ANTERIOR ENDODERM; ZEBRAFISH HEART	Background: Cardiac induction, the first step in heart development in vertebrate embryos, is thought to be initiated by anterior endoderm during gastrulation, but what the signals are and how they act is unknown. Several signaling pathways, including FGF, Nodal, BMP and Wnt have been implicated in cardiac specification, in both gain- and loss-of-function experiments. However, as these pathways regulate germ layer formation and patterning, their specific roles in cardiac induction have been difficult to define. Methodology/Principal Findings: To investigate the mechanisms of cardiac induction directly we devised an assay based on conjugates of anterior endoderm from early gastrula stage Xenopus embryos as the inducing tissue and pluripotent ectodermal explants as the responding tissue. We show that the anterior endoderm produces a specific signal, as skeletal muscle is not induced. Cardiac inducing signal needs up to two hours of interaction with the responding tissue to produce an effect. While we found that the BMP pathway was not necessary, our results demonstrate that the FGF and Nodal pathways are essential for cardiogenesis. They were required only during the first hour of cardiogenesis, while sustained activation of ERK was required for at least four hours. Our results also show that transient early activation of the Wnt/beta-catenin pathway has no effect on cardiogenesis, while later activation of the pathway antagonizes cardiac differentiation. Conclusions/Significance: We have described an assay for investigating the mechanisms of cardiac induction by anterior endoderm. The assay was used to provide evidence for a direct, early and transient requirement of FGF and Nodal pathways. In addition, we demonstrate that Wnt/beta-catenin pathway plays no direct role in vertebrate cardiac specification, but needs to be suppressed just prior to differentiation.			Samuel, LJ (corresponding author), Cardiff Univ, Sch Biosci, Cardiff, S Glam, Wales.	latinkicb@cf.ac.uk		Latinkic, Branko/0000-0003-4952-123X				Agius E, 2000, DEVELOPMENT, V127, P1173; Alsan BH, 2002, DEVELOPMENT, V129, P1935; AMAYA E, 1991, CELL, V66, P257, DOI 10.1016/0092-8674(91)90616-7; Arai A, 1997, DEV DYNAM, V210, P344, DOI 10.1002/(SICI)1097-0177(199711)210:3<344::AID-AJA13>3.0.CO;2-A; Armes NA, 1997, DEVELOPMENT, V124, P3797; Asashima M, 2009, DEV DYNAM, V238, P1309, DOI 10.1002/dvdy.21979; Bouwmeester T, 1996, NATURE, V382, P595, DOI 10.1038/382595a0; CHAMBERS AE, 1994, GENE DEV, V8, P1324, DOI 10.1101/gad.8.11.1324; CHOMCZYNSKI P, 1987, ANAL BIOCHEM, V162, P156, DOI 10.1016/0003-2697(87)90021-2; CHRISTIAN JL, 1993, GENE DEV, V7, P13, DOI 10.1101/gad.7.1.13; Cordenonsi M, 2007, SCIENCE, V315, P840, DOI 10.1126/science.1135961; CORNELL RA, 1995, DEVELOPMENT, V121, P2429; Domingos PM, 2001, DEV BIOL, V239, P148, DOI 10.1006/dbio.2001.0431; Dorey K, 2006, DEV BIOL, V292, P303, DOI 10.1016/j.ydbio.2006.01.006; DRYSDALE TA, 1994, DEV BIOL, V165, P432, DOI 10.1006/dbio.1994.1265; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Glinka A, 1998, NATURE, V391, P357, DOI 10.1038/34848; GRAFF JM, 1994, CELL, V79, P169, DOI 10.1016/0092-8674(94)90409-X; Gritsman K, 1999, CELL, V97, P121, DOI 10.1016/S0092-8674(00)80720-5; GURDON JB, 1985, CELL, V41, P913, DOI 10.1016/S0092-8674(85)80072-6; HEMMATIBRIVANLOU A, 1992, NATURE, V359, P609, DOI 10.1038/359609a0; Hudson C, 1997, CELL, V91, P397, DOI 10.1016/S0092-8674(00)80423-7; Inman GJ, 2002, MOL PHARMACOL, V62, P65, DOI 10.1124/mol.62.1.65; Jones CM, 1999, CURR BIOL, V9, P946, DOI 10.1016/S0960-9822(99)80421-7; KIMELMAN D, 1987, CELL, V51, P869, DOI 10.1016/0092-8674(87)90110-3; Klein PS, 1996, P NATL ACAD SCI USA, V93, P8455, DOI 10.1073/pnas.93.16.8455; Korol O, 2008, DEV BIOL, V324, P131, DOI 10.1016/j.ydbio.2008.09.012; LABONNE C, 1995, DEVELOPMENT, V121, P1475; LaBonne C, 1997, DEV BIOL, V183, P9, DOI 10.1006/dbio.1996.8497; Ladd AN, 1998, DEV BIOL, V204, P407, DOI 10.1006/dbio.1998.9094; Latinkic BV, 2003, DEVELOPMENT, V130, P3865, DOI 10.1242/dev.00599; LOGAN M, 1993, DEVELOPMENT, V118, P865; Lough J, 2000, DEV DYNAM, V217, P327, DOI 10.1002/(SICI)1097-0177(200004)217:4<327::AID-DVDY1>3.3.CO;2-B; Lough J, 1996, DEV BIOL, V178, P198, DOI 10.1006/dbio.1996.0211; Lowe LA, 2001, DEVELOPMENT, V128, P1831; Marques SR, 2008, DEV BIOL, V321, P397, DOI 10.1016/j.ydbio.2008.06.033; Marvin MJ, 2001, GENE DEV, V15, P316, DOI 10.1101/gad.855501; Meijer L, 2003, CHEM BIOL, V10, P1255, DOI 10.1016/j.chembiol.2003.11.010; Mohammadi M, 1997, SCIENCE, V276, P955, DOI 10.1126/science.276.5314.955; Molenaar M, 1996, CELL, V86, P391, DOI 10.1016/S0092-8674(00)80112-9; Movassagh M, 2008, CARDIOVASC RES, V79, P436, DOI 10.1093/cvr/cvn105; Murphy LO, 2006, TRENDS BIOCHEM SCI, V31, P268, DOI 10.1016/j.tibs.2006.03.009; Naito AT, 2006, P NATL ACAD SCI USA, V103, P19812, DOI 10.1073/pnas.0605768103; NASCONE N, 1995, DEVELOPMENT, V121, P515; Parisi S, 2003, J CELL BIOL, V163, P303, DOI 10.1083/jcb.200303010; Piccolo S, 1999, NATURE, V397, P707, DOI 10.1038/17820; Reifers F, 2000, DEVELOPMENT, V127, P225; Reiter JF, 2001, DEV BIOL, V234, P330, DOI 10.1006/dbio.2001.0259; Saga Y, 2000, TRENDS CARDIOVAS MED, V10, P345, DOI 10.1016/S1050-1738(01)00069-X; Schlange T, 2000, MECH DEVELOP, V91, P259, DOI 10.1016/S0925-4773(99)00311-1; Schneider VA, 2001, GENE DEV, V15, P304, DOI 10.1101/gad.855601; SCHULTEMERKER S, 1995, CURR BIOL, V5, P62, DOI 10.1016/S0960-9822(95)00017-0; Schultheiss TM, 1997, COLD SPRING HARB SYM, V62, P413; Schultheiss TM, 1995, DEVELOPMENT, V121, P4203; Shi YQ, 2000, DEV BIOL, V224, P226, DOI 10.1006/dbio.2000.9802; Sive Hazel L., 2000, EARLY DEV XENOPUS LA; SUDARWAT.S, 1971, ROUX ARCH DEV BIOL, V166, P189, DOI 10.1007/BF00650029; Tojo M, 2005, CANCER SCI, V96, P791, DOI 10.1111/j.1349-7006.2005.00103.x; Ueno S, 2007, P NATL ACAD SCI USA, V104, P9685, DOI 10.1073/pnas.0702859104; Walters MJ, 2001, MECH DEVELOP, V100, P263, DOI 10.1016/S0925-4773(00)00535-9; Yatskievych TA, 1997, DEVELOPMENT, V124, P2561; ZHOU XL, 1993, NATURE, V361, P543, DOI 10.1038/361543a0	62	26	28	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7650	10.1371/journal.pone.0007650	http://dx.doi.org/10.1371/journal.pone.0007650			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862329	Green Published, Green Accepted, Green Submitted, gold			2022-12-27	WOS:000271194600021
J	Fan, LJ; Bao, JD; Wang, Y; Yao, JQ; Gui, YJ; Hu, WM; Zhu, JQ; Zeng, MQ; Li, Y; Xu, YB				Fan, Longjiang; Bao, Jiandong; Wang, Yu; Yao, Jianqiang; Gui, Yijie; Hu, Weiming; Zhu, Jinqing; Zeng, Mengqian; Li, Yu; Xu, Yunbi			Post-Domestication Selection in the Maize Starch Pathway	PLOS ONE			English	Article							POPULATION-GENETICS; POSITIVE SELECTION; MOLECULAR EVIDENCE; EVOLUTION; GENES; POLYMORPHISM; MUTATIONS; DIVERSITY; BOTTLENECK; INSIGHTS	Modern crops have usually experienced domestication selection and subsequent genetic improvement (post-domestication selection). Chinese waxy maize, which originated from non-glutinous domesticated maize (Zea mays ssp. mays), provides a unique model for investigating the post-domestication selection of maize. In this study, the genetic diversity of six key genes in the starch pathway was investigated in a glutinous population that included 55 Chinese waxy accessions, and a selective bottleneck that resulted in apparent reductions in diversity in Chinese waxy maize was observed. Significant positive selection in waxy (wx) but not amylose extender1 (ae1) was detected in the glutinous population, in complete contrast to the findings in non-glutinous maize, which indicated a shift in the selection target from ae1 to wx during the improvement of Chinese waxy maize. Our results suggest that an agronomic trait can be quickly improved into a target trait with changes in the selection target among genes in a crop pathway.			Fan, LJ (corresponding author), Zhejiang Univ, Inst Crop Sci, Dept Agron, Hangzhou 310027, Peoples R China.	fanlj@zju.edu.cn	gui, yijiegui@zju.edu.cn/C-9375-2013; Bao, Jiandong/AAG-7303-2020	gui, yijiegui@zju.edu.cn/0000-0002-9201-5212; Bao, Jiandong/0000-0003-3423-5118; Xu, Yunbi/0000-0003-3361-4650; Wang, Zonghua/0000-0002-0869-9683; Wang, Yu/0000-0002-2819-4551; Fan, Longjiang/0000-0003-4846-0500				Akey JM, 2009, GENOME RES, V19, P711, DOI 10.1101/gr.086652.108; Beaumont MA, 2005, TRENDS ECOL EVOL, V20, P435, DOI 10.1016/j.tree.2005.05.017; Burger JC, 2008, AM J BOT, V95, P113, DOI 10.3732/ajb.95.2.113; COLLINS GN, 1909, USDA BUR PLANT IND B, V161, P1; Dinges JR, 2001, PLANT PHYSIOL, V125, P1406, DOI 10.1104/pp.125.3.1406; Doebley JF, 2006, CELL, V127, P1309, DOI 10.1016/j.cell.2006.12.006; Eyre-Walker A, 1998, P NATL ACAD SCI USA, V95, P4441, DOI 10.1073/pnas.95.8.4441; Fan LJ, 2008, MOL BREEDING, V22, P329, DOI 10.1007/s11032-008-9178-2; Hall TA., 1999, NUCL ACIDS S SERIES, V41, P95; HUDSON RR, 1987, GENETICS, V116, P153; James MG, 2003, CURR OPIN PLANT BIOL, V6, P215, DOI 10.1016/S1369-5266(03)00042-6; Komatsuda T, 2007, P NATL ACAD SCI USA, V104, P1424, DOI 10.1073/pnas.0608580104; Manicacci D, 2007, J EVOLUTION BIOL, V20, P503, DOI 10.1111/j.1420-9101.2006.01264.x; Nei M., 1987, MOL EVOLUTIONARY GEN; OKAGAKI RJ, 1991, GENETICS, V128, P425; Olsen KM, 2002, GENETICS, V162, P941; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Rozen S, 2000, Methods Mol Biol, V132, P365; Sang T, 2009, PLANT PHYSIOL, V149, P63, DOI 10.1104/pp.108.128827; Shin JH, 2006, GENOME, V49, P1287, DOI 10.1139/G06-116; TAJIMA F, 1989, GENETICS, V123, P585; Tenaillon MI, 2004, MOL BIOL EVOL, V21, P1214, DOI 10.1093/molbev/msh102; Tenaillon MI, 2001, P NATL ACAD SCI USA, V98, P9161, DOI 10.1073/pnas.151244298; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tian ML, 2009, GENET RESOUR CROP EV, V56, P247, DOI 10.1007/s10722-008-9360-8; Tian MengLiang, 2008, Acta Agronomica Sinica, V34, P729, DOI 10.3724/SP.J.1006.2008.00729; Tiffin P, 2001, GENETICS, V158, P401; TRACY WF, 2006, CROP SCI, V54, P46; WEIR BS, 1984, EVOLUTION, V38, P1358, DOI 10.1111/j.1558-5646.1984.tb05657.x; Whitt SR, 2002, P NATL ACAD SCI USA, V99, P12959, DOI 10.1073/pnas.202476999; Wright SI, 2005, MOL BIOL EVOL, V22, P506, DOI 10.1093/molbev/msi035; Yamasaki M, 2005, PLANT CELL, V17, P2859, DOI 10.1105/tpc.105.037242; Yu YC, 2008, PLANT CELL, V20, P2946, DOI 10.1105/tpc.108.060426; Zhang LQ, 2002, GENETICS, V162, P851; Zhao Q, 2008, GENETICS, V178, P2133, DOI 10.1534/genetics.107.085506; Zhu QH, 2007, MOL BIOL EVOL, V24, P875, DOI 10.1093/molbev/msm005	36	28	33	1	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7612	10.1371/journal.pone.0007612	http://dx.doi.org/10.1371/journal.pone.0007612			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859548	Green Submitted, Green Published, gold			2022-12-27	WOS:000271147400014
J	Kuchenreuther, JM; Stapleton, JA; Swartz, JR				Kuchenreuther, Jon M.; Stapleton, James A.; Swartz, James R.			Tyrosine, Cysteine, and S-Adenosyl Methionine Stimulate In Vitro [FeFe] Hydrogenase Activation	PLOS ONE			English	Article							IRON-MOLYBDENUM COFACTOR; ESCHERICHIA-COLI; CRYSTAL-STRUCTURE; BIOTIN SYNTHASE; ACTIVE-SITE; THERMOTOGA-MARITIMA; THIAZOLE SYNTHASE; PURIFIED PROTEINS; SULFUR CLUSTER; MATURATION	Background: [FeFe] hydrogenases are metalloenzymes involved in the anaerobic metabolism of H(2). These proteins are distinguished by an active site cofactor known as the H-cluster. This unique [6Fe-6S] complex contains multiple non-protein moieties and requires several maturation enzymes for its assembly. The pathways and biochemical precursors for H-cluster biosynthesis have yet to be elucidated. Principal Findings: We report an in vitro maturation system in which, for the first time, chemical additives enhance [FeFe] hydrogenase activation, thus signifying in situ H-cluster biosynthesis. The maturation system is comprised of purified hydrogenase apoprotein; a dialyzed Escherichia coli cell lysate containing heterologous HydE, HydF, and HydG maturases; and exogenous small molecules. Following anaerobic incubation of the Chlamydomonas reinhardtii HydA1 apohydrogenase with S-adenosyl methionine (SAM), cysteine, tyrosine, iron, sulfide, and the non-purified maturases, hydrogenase activity increased 5-fold relative to incubations without the exogenous substrates. No conditions were identified in which addition of guanosine triphosphate (GTP) improved hydrogenase maturation. Significance: The in vitro system allows for direct investigation of [FeFe] hydrogenase activation. This work also provides a foundation for studying the biosynthetic mechanisms of H-cluster biosynthesis using solely purified enzymes and chemical additives.			Kuchenreuther, JM (corresponding author), Stanford Univ, Dept Chem Engn, Stanford, CA 94305 USA.	jswartz@stanford.edu		Stapleton, James/0000-0003-1133-4180				ADAMS MWW, 1990, BIOCHIM BIOPHYS ACTA, V1020, P115, DOI 10.1016/0005-2728(90)90044-5; Blokesch M, 2004, J MOL BIOL, V344, P155, DOI 10.1016/j.jmb.2004.09.040; Boyer ME, 2008, BIOTECHNOL BIOENG, V99, P59, DOI 10.1002/bit.21511; Brazzolotto X, 2006, J BIOL CHEM, V281, P769, DOI 10.1074/jbc.M510310200; Bui BTS, 2006, BIOCHEMISTRY-US, V45, P3824, DOI 10.1021/bi052388m; Cicchillo RM, 2004, BIOCHEMISTRY-US, V43, P6378, DOI 10.1021/bi049528x; Curatti L, 2006, P NATL ACAD SCI USA, V103, P5297, DOI 10.1073/pnas.0601115103; Curatti L, 2007, P NATL ACAD SCI USA, V104, P17626, DOI 10.1073/pnas.0703050104; Escalettes F, 1999, J AM CHEM SOC, V121, P3571, DOI 10.1021/ja9811748; FISH WW, 1988, METHOD ENZYMOL, V158, P357, DOI 10.1016/0076-6879(88)58067-9; Guianvarc'h D, 1997, BIOCHEM BIOPH RES CO, V236, P402, DOI 10.1006/bbrc.1997.6952; Hernandez HL, 2007, BIOCHEMISTRY-US, V46, P5140, DOI 10.1021/bi7000449; Kim DM, 1996, EUR J BIOCHEM, V239, P881, DOI 10.1111/j.1432-1033.1996.0881u.x; King PW, 2006, J BACTERIOL, V188, P2163, DOI 10.1128/JB.188.6.2163-2172.2006; Kriek M, 2007, J BIOL CHEM, V282, P17413, DOI 10.1074/jbc.M700782200; Layer G, 2004, CURR OPIN CHEM BIOL, V8, P468, DOI 10.1016/j.cbpa.2004.08.001; Leonardi R, 2004, J BIOL CHEM, V279, P17054, DOI 10.1074/jbc.M312714200; McGlynn SE, 2008, FEBS LETT, V582, P2183, DOI 10.1016/j.febslet.2008.04.063; McGlynn SE, 2007, J BIOL INORG CHEM, V12, P443, DOI 10.1007/s00775-007-0224-z; Meyer J, 2007, CELL MOL LIFE SCI, V64, P1063, DOI 10.1007/s00018-007-6477-4; MULDER DW, 2009, BIOCHEMISTRY; Nicolet Y, 2002, J INORG BIOCHEM, V91, P1, DOI 10.1016/S0162-0134(02)00392-6; Nicolet Y, 1999, STRUCTURE, V7, P13, DOI 10.1016/S0969-2126(99)80005-7; Nicolet Y, 2008, J BIOL CHEM, V283, P18861, DOI 10.1074/jbc.M801161200; Paschos A, 2002, J BIOL CHEM, V277, P49945, DOI 10.1074/jbc.M204601200; Peters JW, 1998, SCIENCE, V282, P1853, DOI 10.1126/science.282.5395.1853; Pilak O, 2006, J MOL BIOL, V358, P798, DOI 10.1016/j.jmb.2006.02.035; PILET E, 2009, FEBS LETT; Posewitz MC, 2004, J BIOL CHEM, V279, P25711, DOI 10.1074/jbc.M403206200; Reissmann S, 2003, SCIENCE, V299, P1067, DOI 10.1126/science.1080972; Rubach JK, 2005, FEBS LETT, V579, P5055, DOI 10.1016/j.febslet.2005.07.092; Shima S, 2008, SCIENCE, V321, P572, DOI 10.1126/science.1158978; Sybirna K, 2008, BMC BIOTECHNOL, V8, DOI 10.1186/1472-6750-8-73; VOLBEDA A, 1995, NATURE, V373, P580, DOI 10.1038/373580a0; Wolf I, 1998, ARCH MICROBIOL, V170, P451, DOI 10.1007/s002030050666	35	52	54	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7565	10.1371/journal.pone.0007565	http://dx.doi.org/10.1371/journal.pone.0007565			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855833	Green Published, gold, Green Submitted			2022-12-27	WOS:000271147200008
J	Hancock, R; Hadj-Sahraoui, Y				Hancock, Ronald; Hadj-Sahraoui, Yasmina			Isolation of Cell Nuclei Using Inert Macromolecules to Mimic the Crowded Cytoplasm	PLOS ONE			English	Article							RNA-POLYMERASE-II; CHROMATIN FIBER; OSMOTIC-PRESSURE; PHYSICAL STATE; PROTEIN; TRANSCRIPTION; ORGANIZATION; COMPACTION; DIFFUSION; POTASSIUM	Cell nuclei are commonly isolated and studied in media which include millimolar concentrations of cations, which conserve the nuclear volume by screening the negative charges on chromatin and maintaining its compaction. However, two factors question if these ionic conditions correctly reproduce the environment of nuclei in vivo: the small-scale motion and conformation of chromatin in vivo are not reproduced in isolated nuclei, and experiments and theory suggest that small ions in the cytoplasm are not free in the soluble phase but are predominantly bound to macromolecules. We studied the possible role in maintaining the structure and functions of nuclei in vivo of a further but frequently overlooked property of the cytoplasm, the crowding or osmotic effects caused by diffusible macromolecules whose concentration, measured in several studies, is in the range of 130 mg/ml. Nuclei which conserved their volume in the cell and their ultrastructure seen by electron microscopy were released from K562 cells in media containing the inert polymer 70 kDa Ficoll (50% w/v) or 70 kDa dextran (35% w/v) to replace the diffusible cytoplasmic molecules which were dispersed on cell lysis with digitonin, with 100 mu M K-Hepes buffer as the only source of ions. Immunofluorescence labelling and experiments using cells expressing GFP-fusion proteins showed that internal compartments (nucleoli, PML and coiled bodies, foci of RNA polymerase II) were conserved in these nuclei, and nascent RNA transcripts could be elongated. Our observations are consistent with the hypothesis that crowding by diffusible cytoplasmic macromolecules is a crucial but overlooked factor which supports the nucleus in vivo by equilibrating the opposing osmotic pressure cause by the high concentration of macromolecules in the nucleus, and suggest that crowded media provide more physiological conditions to study nuclear structure and functions. They may also help to resolve the long-standing paradox that the small-scale motion and irregular conformation of chromatin seen in vivo are not reproduced in nuclei isolated in conventional ionic media.			Hancock, R (corresponding author), Univ Laval, Canc Res Ctr, Hop Hotel Dieu, Quebec City, PQ, Canada.	ronald.hancock@crhdq.ulaval.ca	Hancock, Ronald/F-8009-2016					AARONSON RP, 1981, J CELL BIOL, V90, P181, DOI 10.1083/jcb.90.1.181; AARONSON RP, 1974, J CELL BIOL, V62, P746, DOI 10.1083/jcb.62.3.746; ALLFREY VG, 1964, J CELL BIOL, V21, P213, DOI 10.1083/jcb.21.2.213; Andersen JS, 2002, CURR BIOL, V12, P1, DOI 10.1016/S0960-9822(01)00650-9; ANDERSON NG, 1952, J GEN PHYSIOL, V35, P781, DOI 10.1085/jgp.35.5.781; Antonenkov VD, 2004, AM J PHYSIOL-CELL PH, V287, pC1623, DOI 10.1152/ajpcell.00142.2004; ArrioDupont M, 1996, BIOPHYS J, V70, P2327, DOI 10.1016/S0006-3495(96)79798-9; BATTIN WT, 1959, EXP CELL RES, V17, P59, DOI 10.1016/0014-4827(59)90152-1; BEDNAR J, 1995, J CELL BIOL, V131, P1365, DOI 10.1083/jcb.131.6.1365; BIRBECK MSC, 1956, J BIOPHYS BIOCHEM CY, V2, P609, DOI 10.1083/jcb.2.5.609; BOHRER MP, 1979, J GEN PHYSIOL, V74, P583, DOI 10.1085/jgp.74.5.583; Busch H, 1977, Methods Cell Biol, V16, P1; CALLAN HG, 1949, EXP CELL RES S, V1, P48; Carter DRF, 2008, BIOCHEM SOC T, V36, P585, DOI 10.1042/BST0360585; Cassany Aurelia, 2008, V464, P181; Chebotareva NA, 2004, BIOCHEMISTRY-MOSCOW+, V69, P1239, DOI 10.1007/s10541-005-0070-y; CUNEO P, 1992, BIOCHEM J, V281, P507, DOI 10.1042/bj2810507; Cunha S, 2001, J STRUCT BIOL, V136, P53, DOI 10.1006/jsbi.2001.4420; Dahl KN, 2005, BIOPHYS J, V89, P2855, DOI 10.1529/biophysj.105.062554; Davis SK, 2004, BIOPHYS J, V86, P555, DOI 10.1016/S0006-3495(04)74134-X; Dekker J, 2008, J BIOL CHEM, V283, P34532, DOI 10.1074/jbc.M806479200; del Alamo M, 2005, J VIROL, V79, P14271, DOI 10.1128/JVI.79.22.14271-14281.2005; Dellaire G, 2006, J CELL SCI, V119, P1026, DOI 10.1242/jcs.02816; EDELMANN L, 1989, SCANNING MICROSCOPY, V3, P1219; Ellis RJ, 2001, TRENDS BIOCHEM SCI, V26, P597, DOI 10.1016/S0968-0004(01)01938-7; Engelhardt M, 2004, BIOCHEM BIOPH RES CO, V324, P1210, DOI 10.1016/j.bbrc.2004.09.175; Eskiw CH, 2008, J CELL SCI, V121, P1999, DOI 10.1242/jcs.027250; Faro-Trindade I, 2006, MOL BIOL CELL, V17, P2910, DOI 10.1091/mbc.E05-11-1024; FULTON AB, 1982, CELL, V30, P345, DOI 10.1016/0092-8674(82)90231-8; Galan A, 2001, J BIOL CHEM, V276, P957, DOI 10.1074/jbc.M006861200; GAMBLE J, 1983, J PHYSIOL-LONDON, V339, P505, DOI 10.1113/jphysiol.1983.sp014730; Granath KA., 1958, J COLLOID SCI, V13, P308; Gunther T, 2006, MAGNESIUM RES, V19, P225; Guigas G, 2007, BIOPHYS J, V93, P316, DOI 10.1529/biophysj.106.099267; Hancock R, 2004, J STRUCT BIOL, V146, P281, DOI 10.1016/j.jsb.2003.12.008; Hancock R, 2007, SEMIN CELL DEV BIOL, V18, P668, DOI 10.1016/j.semcdb.2007.08.006; Handwerger KE, 2006, TRENDS CELL BIOL, V16, P19, DOI 10.1016/j.tcb.2005.11.005; HARDING CV, 1959, J GEN PHYSIOL, V42, P1155, DOI 10.1085/jgp.42.6.1155; Herzfeld J, 2004, J MOL RECOGNIT, V17, P376, DOI 10.1002/JMR.703; Hicks GR, 1995, ANNU REV CELL DEV BI, V11, P155, DOI 10.1146/annurev.cb.11.110195.001103; HOGEBOOM GH, 1948, J BIOL CHEM, V172, P619; HOU L, 1990, BIOPHYS J, V58, P31, DOI 10.1016/S0006-3495(90)82351-1; Hudder A, 2003, MOL CELL BIOL, V23, P9318, DOI 10.1128/MCB.23.24.9318-9326.2003; JACKSON DA, 1988, J CELL SCI, V90, P365; JACKSON DA, 1993, EMBO J, V12, P1059, DOI 10.1002/j.1460-2075.1993.tb05747.x; KELLERMAYER M, 1986, P NATL ACAD SCI USA, V83, P1011, DOI 10.1073/pnas.83.4.1011; Kornberg A, 2000, J BACTERIOL, V182, P3613, DOI 10.1128/JB.182.13.3613-3618.2000; Lam YW, 2002, MOL BIOL CELL, V13, P2461, DOI 10.1091/mbc.02-03-0034; LATERVEER FD, 1995, EUR J BIOCHEM, V232, P569; Lenart P, 2006, METHODS, V38, P17, DOI 10.1016/j.ymeth.2005.07.010; LING GN, 1990, SCANNING MICROSCOPY, V4, P737; LUBYPHELPS K, 1986, J CELL BIOL, V102, P2015, DOI 10.1083/jcb.102.6.2015; LUE NF, 1987, P NATL ACAD SCI USA, V84, P8839, DOI 10.1073/pnas.84.24.8839; Luthi D, 1999, EXP PHYSIOL, V84, P231, DOI 10.1111/j.1469-445X.1999.01799.x; MACGREGOR HC, 1962, EXP CELL RES, V26, P520, DOI 10.1016/0014-4827(62)90156-8; Maughan DW, 2001, BIOPHYS J, V80, P435, DOI 10.1016/S0006-3495(01)76026-2; MAUGHAN DW, 2005, CONCENTRATIONS GLYCO; MURAMATSU M, 1963, CANCER RES, V25, P693; NAORA H, 1961, J GEN PHYSIOL, V44, P713, DOI 10.1085/jgp.44.4.713; Negendank M, 2005, J CELL PHYSL, V104, P443; OLINS DE, 1972, J CELL BIOL, V53, P715, DOI 10.1083/jcb.53.3.715; Parsegian VA, 1995, METHOD ENZYMOL, V259, P43; Pielak GJ, 2005, P NATL ACAD SCI USA, V102, P5901, DOI 10.1073/pnas.0501812102; Platani M, 2000, J CELL BIOL, V151, P1561, DOI 10.1083/jcb.151.7.1561; RIVAS G, 2004, MOL CELL PROTEOMICS, V4, P1541; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; ROSANIA GR, 1995, EXP CELL RES, V218, P114, DOI 10.1006/excr.1995.1137; Sear RP, 2005, J PHYS-CONDENS MAT, V17, pS3587, DOI 10.1088/0953-8984/17/45/052; Singh-Zocchi M, 1999, P NATL ACAD SCI USA, V96, P6711, DOI 10.1073/pnas.96.12.6711; Spitzer JJ, 2005, TRENDS BIOCHEM SCI, V30, P536, DOI 10.1016/j.tibs.2005.08.002; TAKAHASHI Y, 1974, DEV GROWTH DIFFER, V16, P281; van Holde K, 2007, SEMIN CELL DEV BIOL, V18, P651, DOI 10.1016/j.semcdb.2007.08.005; Vandelaer M, 1996, EXP CELL RES, V228, P125, DOI 10.1006/excr.1996.0307; VILKER VL, 1981, J COLLOID INTERF SCI, V79, P548, DOI 10.1016/0021-9797(81)90106-5; WALMSLEY ME, 1975, J CELL SCI, V17, P113; WANSINK DG, 1993, J CELL BIOL, V122, P283, DOI 10.1083/jcb.122.2.283; Weiss M, 2004, BIOPHYS J, V87, P3518, DOI 10.1529/biophysj.104.044263; WICKER U, 1993, BIOCHIM BIOPHYS ACTA, V1142, P228, DOI 10.1016/0005-2728(93)90151-5; WIJMANS JG, 1985, J MEMBRANE SCI, V22, P117, DOI 10.1016/S0376-7388(00)80534-7; Zhou HX, 2008, ANNU REV BIOPHYS, V37, P375, DOI 10.1146/annurev.biophys.37.032807.125817; ZIMMERMAN SB, 1988, NUCLEIC ACIDS RES, V16, P6309, DOI 10.1093/nar/16.14.6309; Zimmerman SB, 2001, J BACTERIOL, V183, P5041, DOI 10.1128/JB.183.17.5041-5049.2001	82	15	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7560	10.1371/journal.pone.0007560	http://dx.doi.org/10.1371/journal.pone.0007560			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851505	gold, Green Published, Green Submitted			2022-12-27	WOS:000271022300007
J	Shirinifard, A; Gens, JS; Zaitlen, BL; Poplawski, NJ; Swat, M; Glazier, JA				Shirinifard, Abbas; Gens, J. Scott; Zaitlen, Benjamin L.; Poplawski, Nikodem J.; Swat, Maciej; Glazier, James A.			3D Multi-Cell Simulation of Tumor Growth and Angiogenesis	PLOS ONE			English	Article							CELLULAR POTTS-MODEL; BLOOD-FLOW; NONLINEAR SIMULATION; MATHEMATICAL-MODEL; VASCULAR NETWORKS; FACTOR VEGF; INVASION; ADHESION; DISEASE; CELLS	We present a 3D multi-cell simulation of a generic simplification of vascular tumor growth which can be easily extended and adapted to describe more specific vascular tumor types and host tissues. Initially, tumor cells proliferate as they take up the oxygen which the pre-existing vasculature supplies. The tumor grows exponentially. When the oxygen level drops below a threshold, the tumor cells become hypoxic and start secreting pro-angiogenic factors. At this stage, the tumor reaches a maximum diameter characteristic of an avascular tumor spheroid. The endothelial cells in the pre-existing vasculature respond to the pro-angiogenic factors both by chemotaxing towards higher concentrations of pro-angiogenic factors and by forming new blood vessels via angiogenesis. The tumor-induced vasculature increases the growth rate of the resulting vascularized solid tumor compared to an avascular tumor, allowing the tumor to grow beyond the spheroid in these linear-growth phases. First, in the linear-spherical phase of growth, the tumor remains spherical while its volume increases. Second, in the linear-cylindrical phase of growth the tumor elongates into a cylinder. Finally, in the linear-sheet phase of growth, tumor growth accelerates as the tumor changes from cylindrical to paddle-shaped. Substantial periods during which the tumor grows slowly or not at all separate the exponential from the linear-spherical and the linear-spherical from the linear-cylindrical growth phases. In contrast to other simulations in which avascular tumors remain spherical, our simulated avascular tumors form cylinders following the blood vessels, leading to a different distribution of hypoxic cells within the tumor. Our simulations cover time periods which are long enough to produce a range of biologically reasonable complex morphologies, allowing us to study how tumor-induced angiogenesis affects the growth rate, size and morphology of simulated tumors.			Shirinifard, A (corresponding author), Indiana Univ, Biocomplex Inst, Bloomington, IN USA.	ashirini@indiana.edu		Glazier, James Alexander/0000-0003-3634-190X	NIGMS NIH HHS [R01 GM076692, R01 GM077138, 5R01 GM076692-01, 1R01 GM077138-01A1] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077138, R01GM076692] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alarcon T, 2005, MULTISCALE MODEL SIM, V3, P440, DOI 10.1137/040603760; Alarcon T, 2004, PROG BIOPHYS MOL BIO, V85, P451, DOI 10.1016/j.pbiomolbio.2004.02.004; Anderson ARA, 1998, B MATH BIOL, V60, P857, DOI 10.1006/bulm.1998.0042; Anderson ARA, 2005, MATH MED BIOL, V22, P163, DOI 10.1093/imammb/dqi005; Balter A, 2007, SINGLE CELL BASED MO, P151, DOI [DOI 10.1007/978-3-7643-8123-3_7, 10.1007/978-3-7643-8123-3_7]; Bartha K, 2006, J THEOR BIOL, V241, P903, DOI 10.1016/j.jtbi.2006.01.022; Bauer AL, 2007, BIOPHYS J, V92, P3105, DOI 10.1529/biophysj.106.101501; Bauer AL, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000445; Bray D., 1992, CELL MOVEMENTS; Burgess PK, 1997, J NEUROPATH EXP NEUR, V56, P704; Carmeliet P, 2001, NATURE, V412, P868, DOI 10.1038/35091178; Carmeliet P, 2000, NATURE, V407, P249, DOI 10.1038/35025220; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chaplain MAJ, 2006, ANNU REV BIOMED ENG, V8, P233, DOI 10.1146/annurev.bioeng.8.061505.095807; Chen N, 2007, COMPUT PHYS COMMUN, V176, P670, DOI 10.1016/j.cpc.2007.03.007; Cristini V, 2009, J MATH BIOL, V58, P723, DOI 10.1007/s00285-008-0215-x; DEJANA E, 1995, FASEB J, V9, P910, DOI 10.1096/fasebj.9.10.7615160; DEWAAL RMW, 2005, MECH ANGIOGENESIS, P65; Dor Y, 2003, TRENDS CELL BIOL, V13, P131, DOI 10.1016/S0962-8924(03)00022-9; Fischer I, 2005, BRAIN PATHOL, V15, P297; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 1996, CELL, V87, P1153, DOI 10.1016/S0092-8674(00)81810-3; Fotos JS, 2006, CYTOTECHNOLOGY, V51, P7, DOI 10.1007/s10616-006-9006-7; Frieboes HB, 2007, NEUROIMAGE, V37, pS59, DOI 10.1016/j.neuroimage.2007.03.008; Friedl P, 2003, NAT REV CANCER, V3, P362, DOI 10.1038/nrc1075; Gerhardt H., 2008, ORGANOGENESIS, V4, P241, DOI [DOI 10.4161/0RG.4.4.7414, DOI 10.4161/org.4.4.7414]; GLAZIER JA, 1993, PHYS REV E, V47, P2128, DOI 10.1103/PhysRevE.47.2128; Glazier JA, 2007, SINGLE CELL BASED MO, P79, DOI [10.1007/978-3-7643-8123-3_4, DOI 10.1007/978-3-7643-8123-3_4]; Glazier JA, 2008, CURR TOP DEV BIOL, V81, P205, DOI 10.1016/S0070-2153(07)81007-6; GRANER F, 1992, PHYS REV LETT, V69, P2013, DOI 10.1103/PhysRevLett.69.2013; Helmlinger G, 1997, NAT MED, V3, P177, DOI 10.1038/nm0297-177; Jewell UR, 2001, FASEB J, V15, P1312, DOI 10.1096/fj.00-0732fje; Jiang BH, 1996, AM J PHYSIOL-CELL PH, V271, pC1172, DOI 10.1152/ajpcell.1996.271.4.C1172; Jurasz P, 2003, BLOOD, V102, P3217, DOI 10.1182/blood-2003-02-0378; Kusters B, 2003, CANCER RES, V63, P5408; Lampugnani MG, 2003, J CELL BIOL, V161, P793, DOI 10.1083/jcb.200209019; Macklin P, 2009, J MATH BIOL, V58, P765, DOI 10.1007/s00285-008-0216-9; Mantzaris NV, 2004, J MATH BIOL, V49, P111, DOI 10.1007/s00285-003-0262-2; Marti H.H., 2005, MECH ANGIOGENESIS, P163; McDougall SR, 2006, J THEOR BIOL, V241, P564, DOI 10.1016/j.jtbi.2005.12.022; Merks RMH, 2006, NONLINEARITY, V19, pC1, DOI 10.1088/0951-7715/19/1/000; Merks RMH, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000163; Owen MR, 2009, J MATH BIOL, V58, P689, DOI 10.1007/s00285-008-0213-z; PERRYN ED, 2003, DEV BIOL, P545; Phng LK, 2009, DEV CELL, V16, P196, DOI 10.1016/j.devcel.2009.01.015; Plank MJ, 2004, B MATH BIOL, V66, P1785, DOI 10.1016/j.bulm.2004.04.001; Popawski NJ, 2009, B MATH BIOL, V71, P1189, DOI 10.1007/s11538-009-9399-5; POPEL AS, 1989, CRIT REV BIOMED ENG, V17, P257; Poplawski NJ, 2008, MATH BIOSCI ENG, V5, P355; Poplawski NJ, 2007, PHYSICA A, V373, P521, DOI 10.1016/j.physa.2006.05.028; Pries AR, 2005, AM J PHYSIOL-HEART C, V288, pH1010, DOI 10.1152/ajpheart.00752.2004; Pries AR, 1996, CARDIOVASC RES, V32, P654, DOI 10.1016/S0008-6363(96)00065-X; Pries A, 2008, MICROCIRCULATION, V15, P753, DOI 10.1080/10739680802229076; Pries AR, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000394; Ramis-Conde I, 2009, PHYS BIOL, V6, DOI 10.1088/1478-3975/6/1/016008; Robinson CJ, 2001, J CELL SCI, V114, P853; Rubenstein BM, 2008, BIOPHYS J, V95, P5661, DOI 10.1529/biophysj.108.140624; Sander LM, 2002, PHYS REV E, V66, DOI 10.1103/PhysRevE.66.051901; Sanga S, 2007, NEUROIMAGE, V37, pS120, DOI 10.1016/j.neuroimage.2007.05.043; Serini G, 2003, EMBO J, V22, P1771, DOI 10.1093/emboj/cdg176; SHIMA DT, 1995, MOL MED, V1, P182, DOI 10.1007/BF03401566; Stephanou A, 2006, MATH COMPUT MODEL, V44, P96, DOI 10.1016/j.mcm.2004.07.021; Stephanou A, 2005, MATH COMPUT MODEL, V41, P1137, DOI 10.1016/j.mcm.2005.05.008; Swat Maciej H., 2009, V500, P361, DOI 10.1007/978-1-59745-525-1_13; VAUPEL P, 1989, CANCER RES, V49, P6449; Wallez Y, 2008, BBA-BIOMEMBRANES, V1778, P794, DOI 10.1016/j.bbamem.2007.09.003; Welter M, 2008, J THEOR BIOL, V250, P257, DOI 10.1016/j.jtbi.2007.09.031; Wenger RH, 2002, FASEB J, V16, DOI 10.1096/fj.01-0944rev; Xu ZL, 2009, SOFT MATTER, V5, P769, DOI 10.1039/b812429a; Zheng X, 2005, B MATH BIOL, V67, P211, DOI 10.1016/j.bulm.2004.08.001	70	183	185	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7190	10.1371/journal.pone.0007190	http://dx.doi.org/10.1371/journal.pone.0007190			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834621	Green Published, gold, Green Submitted			2022-12-27	WOS:000270880700001
J	Godbold, JA; Rosenberg, R; Solan, M				Godbold, Jasmin A.; Rosenberg, Rutger; Solan, Martin			Species-Specific Traits Rather Than Resource Partitioning Mediate Diversity Effects on Resource Use	PLOS ONE			English	Article							SEA SEASTARS ECHINODERMATA; BRISSOPSIS-LYRIFERA FORBES; SHALLOW REEF LAGOON; FEEDING ECOLOGY; ECHINOIDS ECHINODERMATA; PLANT DIVERSITY; DISCOVERY BAY; BIODIVERSITY; SELECTIVITY; HOLOTHURIANS	Background: The link between biodiversity and ecosystem processes has firmly been established, but the mechanisms underpinning this relationship are poorly documented. Most studies have focused on terrestrial plant systems where resource use can be difficult to quantify as species rely on a limited number of common resources. Investigating resource use at the bulk level may not always be of sufficient resolution to detect subtle differences in resource use, as species-specific nutritional niches at the biochemical level may also moderate diversity effects on resource use. Methodology/Principal Findings: Here we use three co-occurring marine benthic echinoderms (Brissopsis lyrifera, Mesothuria intestinalis, Parastichopus tremulus) that feed on the same phytodetrital food source, to determine whether resource partitioning is the principal mechanism underpinning diversity effects on resource use. Specifically we investigate the use of phytodetrital pigments ( chlorophylls and carotenoids) because many of these are essential for biological functions, including reproduction. Pigments were identified and quantified using reverse-phase high performance liquid Chromatography ( HPLC) and data were analysed using a combination of extended linear regression with generalised least squares (GLS) estimation and standard multivariate techniques. Our analyses reveal no species-specific selectivity for particular algal pigments, confirming that these three species do not partition food resources at the biochemical level. Nevertheless, we demonstrate increased total resource use in diverse treatments as a result of selection effects and the dominance of one species (B. lyrifera). Conclusion: Overall, we found no evidence for resource partitioning at the biochemical level, as pigment composition was similar between individuals, which is likely due to plentiful food availability. Reduced intra-specific competition in the species mixture combined with greater adsorption efficiency and differences in feeding behaviour likely explain the dominant use of resources by B. lyrifera.			Godbold, JA (corresponding author), Univ Aberdeen, Oceanlab, Newburgh, Aberdeen, Scotland.	j.a.godbold@abdn.ac.uk	Godbold, Jasmin/AAB-2522-2022; Solan, Martin/E-9338-2012; Godbold, Jasmin A/F-1577-2012	Godbold, Jasmin/0000-0001-5558-8188; Solan, Martin/0000-0001-9924-5574; Godbold, Jasmin A/0000-0001-5558-8188				Aarssen LW, 1997, OIKOS, V80, P183, DOI 10.2307/3546531; AMON RMW, 1991, PSZNI MAR ECOL, V12, P163; Balvanera P, 2006, ECOL LETT, V9, P1146, DOI 10.1111/j.1461-0248.2006.00963.x; BARLOW RG, 1993, DEEP-SEA RES PT II, V40, P459, DOI 10.1016/0967-0645(93)90027-K; Barlow RG, 1997, MAR ECOL PROG SER, V161, P303, DOI 10.3354/meps161303; Behmer ST, 2008, P NATL ACAD SCI USA, V105, P1977, DOI 10.1073/pnas.0711870105; BILLETT DSM, 1991, OCEANOGR MAR BIOL, V29, P259; Bock MJ, 1999, LIMNOL OCEANOGR, V44, P1132, DOI 10.4319/lo.1999.44.4.1132; Boon AR, 1996, J SEA RES, V35, P279, DOI 10.1016/S1385-1101(96)90755-8; BRAY JR, 1957, ECOL MONOGR, V27, P326, DOI 10.2307/1942268; Bulling M, 2008, OECOLOGIA, V158, P511, DOI 10.1007/s00442-008-1160-5; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; Cardinale BJ, 2006, NATURE, V443, P989, DOI 10.1038/nature05202; Casazza G, 2002, B MAR SCI, V71, P1171; Chesson P, 2000, ANNU REV ECOL SYST, V31, P343, DOI 10.1146/annurev.ecolsys.31.1.343; CLARKE KR, 1994, MAR BIOL, V118, P167, DOI 10.1007/BF00699231; Dauwe B, 1998, MAR ECOL PROG SER, V173, P67, DOI 10.3354/meps173067; Duffy JE, 2003, ECOL LETT, V6, P637; Finke DL, 2008, SCIENCE, V321, P1488, DOI 10.1126/science.1160854; Fox JW, 2005, ECOL LETT, V8, P846, DOI 10.1111/j.1461-0248.2005.00795.x; George SB, 2001, AQUACULTURE, V199, P353, DOI 10.1016/S0044-8486(01)00578-6; Ginger ML, 2000, J MAR BIOL ASSOC UK, V80, P139, DOI 10.1017/S0025315499001654; Godbold JA, 2009, OIKOS, V118, P77, DOI 10.1111/j.1600-0706.2008.17072.x; GOWER JC, 1971, BIOMETRICS, V27, P857, DOI 10.2307/2528823; Griffin JN, 2008, ECOLOGY, V89, P298, DOI 10.1890/07-1220.1; HAMMOND LS, 1982, MAR ECOL PROG SER, V8, P25, DOI 10.3354/meps008025; HAMMOND LS, 1983, MAR ECOL PROG SER, V10, P297, DOI 10.3354/meps010297; HAUKSSON E, 1979, SARSIA, V64, P155, DOI 10.1080/00364827.1979.10411376; Hector Andy, 2009, P94; Hiratsuka Y, 2007, COMP BIOCHEM PHYS A, V148, P223, DOI 10.1016/j.cbpa.2007.04.009; Hollertz K, 1998, HYDROBIOLOGIA, V375-76, P287, DOI 10.1023/A:1017013123372; Hollertz K, 2001, MAR BIOL, V139, P951; Hooper DU, 2004, ECOL LETT, V7, P95, DOI 10.1046/j.1461-0248.2003.00555.x; Howell KL, 2004, MAR ECOL PROG SER, V266, P103, DOI 10.3354/meps266103; Howell KL, 2003, MAR ECOL PROG SER, V255, P193, DOI 10.3354/meps255193; Hudson IR, 2005, J MARINE SYST, V57, P201, DOI 10.1016/j.jmarsys.2005.02.004; Hudson IR, 2003, PROG OCEANOGR, V59, P381, DOI 10.1016/j.pocean.2003.11.002; Huston MA, 1997, OECOLOGIA, V110, P449, DOI 10.1007/s004420050180; Ives AR, 2005, ECOL LETT, V8, P102, DOI 10.1111/j.1461-0248.2004.00698.x; Jeffrey S.W., 1997, UNESCO MONOGRAPHS OC, V10; JEFFREY SW, 1997, UNESCO MONOGRAPHS OC, V10, P447; Jonsson M, 2000, OIKOS, V89, P519, DOI 10.1034/j.1600-0706.2000.890311.x; Kawakami T, 1998, J EXP MAR BIOL ECOL, V226, P165, DOI 10.1016/S0022-0981(97)00236-0; Kirwan L, 2007, J ECOL, V95, P530, DOI 10.1111/j.1365-2745.2007.01225.x; Legendre P., 2012, NUMERICAL ECOLOGY; Levinton J, 2004, J EXP MAR BIOL ECOL, V300, P65, DOI 10.1016/j.jembe.2003.12.008; Loreau M, 2000, OIKOS, V91, P3, DOI 10.1034/j.1600-0706.2000.910101.x; Loreau M, 1998, OIKOS, V82, P600, DOI 10.2307/3546381; Loreau M, 2001, NATURE, V412, P72, DOI 10.1038/35083573; Maechler M, 2008, CLUSTER CLUSTER ANAL; MANTOURA RFC, 1983, ANAL CHIM ACTA, V151, P297, DOI 10.1016/S0003-2670(00)80092-6; McKie BG, 2008, J ANIM ECOL, V77, P495, DOI 10.1111/j.1365-2656.2008.01357.x; Miller RJ, 2000, J MAR RES, V58, P653, DOI 10.1357/002224000321511061; Neto RR, 2006, DEEP-SEA RES PT I, V53, P516, DOI 10.1016/j.dsr.2005.12.001; Norberg J, 2000, OECOLOGIA, V122, P264, DOI 10.1007/PL00008855; Oksanen J., 2008, VEGAN COMMUNITY ECOL; PENRY DL, 1987, AM NAT, V129, P69, DOI 10.1086/284623; PETERSON CH, 1980, ECOLOGY, V61, P129, DOI 10.2307/1937163; Pinheiro J., 2006, NLME R PACKAGE FITTI; Pinheiro J, 2001, MIXED EFFECTS MODELS; Plank LR, 2002, J WORLD AQUACULT SOC, V33, P127, DOI 10.1111/j.1749-7345.2002.tb00487.x; Quinn Q. P., 2002, EXPT DESIGN DATA ANA; *R DEV COR TEAM, 2007, A LANG ENV STAT COMP; Roberts D, 2000, OCEANOGR MAR BIOL, V38, P257; Tilman D, 1997, P NATL ACAD SCI USA, V94, P1857, DOI 10.1073/pnas.94.5.1857; Tiunov AV, 2005, ECOL LETT, V8, P618, DOI 10.1111/j.1461-0248.2005.00757.x; Uthicke S, 1999, B MAR SCI, V64, P129; Uthicke S, 1999, J EXP MAR BIOL ECOL, V236, P69, DOI 10.1016/S0022-0981(98)00190-7; Wigham BD, 2008, DEEP-SEA RES PT II, V55, P2478, DOI 10.1016/j.dsr2.2008.06.007; Wigham BD, 2003, PROG OCEANOGR, V59, P409, DOI 10.1016/j.pocean.2003.11.003; Witte U, 2003, MAR ECOL PROG SER, V251, P27, DOI 10.3354/meps251027; Wojdak JM, 2007, ECOLOGY, V88, P2072, DOI 10.1890/06-0651.1; WRIGHT SW, 1997, MONOGR ON OCEAN METH, V10, P327	73	21	21	2	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7423	10.1371/journal.pone.0007423	http://dx.doi.org/10.1371/journal.pone.0007423			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19829703	Green Submitted, Green Published, gold, Green Accepted			2022-12-27	WOS:000270808700006
J	Chandrasekar, A; Kumar, S; Sreenath, J; Sarkar, BN; Urade, BP; Mallick, S; Bandopadhyay, SS; Barua, P; Barik, SS; Basu, D; Kiran, U; Gangopadhyay, P; Sahani, R; Prasad, BVR; Gangopadhyay, S; Lakshmi, GR; Ravuri, RR; Padmaja, K; Venugopal, PN; Sharma, MB; Rao, VR				Chandrasekar, Adimoolam; Kumar, Satish; Sreenath, Jwalapuram; Sarkar, Bishwa Nath; Urade, Bhaskar Pralhad; Mallick, Sujit; Bandopadhyay, Syam Sundar; Barua, Pinuma; Barik, Subihra Sankar; Basu, Debasish; Kiran, Uttaravalli; Gangopadhyay, Prodyot; Sahani, Ramesh; Prasad, Bhagavatula Venkata Ravi; Gangopadhyay, Shampa; Lakshmi, Gandikota Rama; Ravuri, Rajasekhara Reddy; Padmaja, Koneru; Venugopal, Pulamaghatta N.; Sharma, Madhu Bala; Rao, Vadlamudi Raghavendra			Updating Phylogeny of Mitochondrial DNA Macrohaplogroup M in India: Dispersal of Modern Human in South Asian Corridor	PLOS ONE			English	Article							MTDNA VARIATION; GENOME VARIATION; EVOLUTIONARY HISTORY; GENETIC-EVIDENCE; ETHNIC INDIA; POPULATIONS; LINEAGES; ORIGIN; SETTLEMENT; DIVERSITY	To construct maternal phylogeny and prehistoric dispersals of modern human being in the Indian sub continent, a diverse subset of 641 complete mitochondrial DNA (mtDNA) genomes belonging to macrohaplogroup M was chosen from a total collection of 2,783 control-region sequences, sampled from 26 selected tribal populations of India. On the basis of complete mtDNA sequencing, we identified 12 new haplogroups - M53 to M64; redefined/ascertained and characterized haplogroups M2, M3, M4, M5, M6, M8'C'Z, M9, M10, M11, M12-G, D, M18, M30, M33, M35, M37, M38, M39, M40, M41, M43, M45 and M49, which were previously described by control and/or coding-region polymorphisms. Our results indicate that the mtDNA lineages reported in the present study (except East Asian lineages M8'C'Z, M9, M10, M11, M12-G, D) are restricted to Indian region. The deep rooted lineages of macrohaplogroup 'M' suggest in-situ origin of these haplogroups in India. Most of these deep rooting lineages are represented by multiple ethnic/linguist groups of India. Hierarchical analysis of molecular variation (AMOVA) shows substantial subdivisions among the tribes of India (F-ST = 0.16164). The current Indian mtDNA gene pool was shaped by the initial settlers and was galvanized by minor events of gene flow from the east and west to the restricted zones. Northeast Indian mtDNA pool harbors region specific lineages, other Indian lineages and East Asian lineages. We also suggest the establishment of an East Asian gene in North East India through admixture rather than replacement.			Chandrasekar, A (corresponding author), Anthropol Survey India, So Reg Ctr, Mysore, Karnataka, India.	director_ansi@yahoo.co.in						Achilli A, 2004, AM J HUM GENET, V75, P910, DOI 10.1086/425590; Achilli A, 2005, AM J HUM GENET, V76, P883, DOI 10.1086/430073; ANDERSON S, 1981, NATURE, V290, P457, DOI 10.1038/290457a0; Bamshad M, 2001, GENOME RES, V11, P994, DOI 10.1101/gr.GR-1733RR; Bamshad MJ, 1998, NATURE, V395, P651, DOI 10.1038/27103; Barik SS, 2008, AM J PHYS ANTHROPOL, V136, P19, DOI 10.1002/ajpa.20773; Basu A, 2003, GENOME RES, V13, P2277, DOI 10.1101/gr.1413403; Cavalli-Sforza L. L., 1994, HIST GEOGRAPHY HUMAN; Chandrasekar A, 2007, ANN HUM BIOL, V34, P582, DOI 10.1080/03014460701556262; Chaubey G, 2008, INT J HUM GENET, V8, P41, DOI 10.1080/09723757.2008.11886018; CHEN YS, 1995, AM J HUM GENET, V57, P133; Clark VJ, 2000, HUM BIOL, V72, P273; Cordaux R, 2003, EUR J HUM GENET, V11, P253, DOI 10.1038/sj.ejhg.5200949; Derbeneva OA, 2002, AM J HUM GENET, V71, P415, DOI 10.1086/341720; Derenko M, 2007, AM J HUM GENET, V81, P1025, DOI 10.1086/522933; Derenko MV, 2003, ANN HUM GENET, V67, P391, DOI 10.1046/j.1469-1809.2003.00035.x; Derenko MV, 2000, HUM BIOL, V72, P945; EDWIN D, 2002, CURRENT SCI, V83, P25; Excoffier L, 1999, P NATL ACAD SCI USA, V96, P10597, DOI 10.1073/pnas.96.19.10597; Finnila S, 2001, AM J HUM GENET, V68, P1475, DOI 10.1086/320591; Fornarino S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-154; Forster P, 1996, AM J HUM GENET, V59, P935; Friedlaender J, 2005, MOL BIOL EVOL, V22, P1506, DOI 10.1093/molbev/msi142; Herrnstadt C, 2003, AM J HUM GENET, V72, P1585, DOI 10.1086/375406; Herrnstadt C, 2002, AM J HUM GENET, V70, P1152, DOI 10.1086/339933; Horai S, 1996, AM J HUM GENET, V59, P579; Howell N, 2004, MOL BIOL EVOL, V21, P1843, DOI 10.1093/molbev/msh184; Ingman M, 2003, GENOME RES, V13, P1600, DOI 10.1101/gr.686603; Ingman M, 2000, NATURE, V408, P708, DOI 10.1038/35047064; Kivisild T, 2006, GENETICS, V172, P373, DOI 10.1534/genetics.105.043901; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Kivisild T, 1999, CURR BIOL, V9, P1331, DOI 10.1016/S0960-9822(00)80057-3; Kivisild T, 2002, MOL BIOL EVOL, V19, P1737, DOI 10.1093/oxfordjournals.molbev.a003996; KIVISILD T, 2000, MCDONALD I MONOGRAPH, P267; Kivisild T, 2003, EXAMINING FARMING LA, P215; Kong QP, 2006, HUM MOL GENET, V15, P2076, DOI 10.1093/hmg/ddl130; KONG QP, 2003, AM J HUM GENET, V75, P157; Kosambi DD., 1991, CULTURE CIVILISATION; Kumar S, 2009, BMC EVOL BIOL, V9, DOI 10.1186/1471-2148-9-173; Kumar S, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-230; LEWIN R, 1987, SCIENCE, V237, P1292, DOI 10.1126/science.3114877; Maca-Meyer N, 2003, BMC GENET, V4, DOI 10.1186/1471-2156-4-15; Maca-Meyer N, 2001, BMC GENET, V2, DOI 10.1186/1471-2156-2-13; Macaulay V, 2005, SCIENCE, V308, P1034, DOI 10.1126/science.1109792; Majumder PP, 2001, J BIOSCIENCES, V26, P533, DOI 10.1007/BF02704750; Malyarchuk BA, 2001, ANN HUM GENET, V65, P63, DOI 10.1046/j.1469-1809.2001.6510063.x; Malyarchuk BA, 2008, ANN HUM GENET, V72, P228, DOI 10.1111/j.1469-1809.2007.00410.x; MATISOFF JA, 1991, ANNU REV ANTHROPOL, V20, P469, DOI 10.1146/annurev.an.20.100191.002345; Merriwether DA, 2005, P NATL ACAD SCI USA, V102, P13034, DOI 10.1073/pnas.0506195102; Metspalu M, 2004, BMC GENET, V5, DOI 10.1186/1471-2156-5-26; Mishmar D, 2003, P NATL ACAD SCI USA, V100, P171, DOI 10.1073/pnas.0136972100; Olivieri A, 2006, SCIENCE, V314, P1767, DOI 10.1126/science.1135566; Palanichamy MG, 2006, SCIENCE, V311, DOI 10.1126/science.1120176; Palanichamy MG, 2004, AM J HUM GENET, V75, P966, DOI 10.1086/425871; Passarino G, 1996, AM J HUM GENET, V59, P927; Passarino G, 1998, AM J HUM GENET, V62, P420, DOI 10.1086/301702; Quintana-Murci L, 2004, AM J HUM GENET, V74, P827, DOI 10.1086/383236; Quintana-Murci L, 1999, NAT GENET, V23, P437, DOI 10.1038/70550; Rajkumar R, 2005, BMC EVOL BIOL, V5, DOI 10.1186/1471-2148-5-26; Reddy BM, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001141; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Richards MB, 1998, ANN HUM GENET, V62, P241, DOI 10.1046/j.1469-1809.1998.6230241.x; Rieder MJ, 1998, NUCLEIC ACIDS RES, V26, P967, DOI 10.1093/nar/26.4.967; Roychoudhury S, 2000, CURR SCI INDIA, V79, P1182; Roychoudhury S, 2001, HUM GENET, V109, P339, DOI 10.1007/s004390100577; Saillard J, 2000, AM J HUM GENET, V67, P718, DOI 10.1086/303038; Sambrock J, 1989, MOL CLONING LAB MANU, V1; Schurr TG, 1999, AM J PHYS ANTHROPOL, V108, P1, DOI 10.1002/(SICI)1096-8644(199901)108:1<1::AID-AJPA1>3.0.CO;2-1; SINGH KS, 1997, SCHEDULED TRIBES; STRINGER CB, 1989, NATURE, V338, P756, DOI 10.1038/338756a0; Su B, 2000, HUM GENET, V107, P582, DOI 10.1007/s004390000406; Sun C, 2006, MOL BIOL EVOL, V23, P683, DOI 10.1093/molbev/msj078; Tanaka M, 2004, GENOME RES, V14, P1832, DOI 10.1101/gr.2286304; Thangaraj K, 2008, HUM HERED, V66, P1, DOI 10.1159/000114160; Thangaraj K, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-151; Torroni A, 2001, AM J HUM GENET, V69, P844, DOI 10.1086/323485; TORRONI A, 1993, AM J HUM GENET, V53, P563; Trejaut JA, 2005, PLOS BIOL, V3, P1362, DOI 10.1371/journal.pbio.0030247; van Oven M, 2009, HUM MUTAT, V30, pE386, DOI 10.1002/humu.20921; Yao YG, 2002, AM J HUM GENET, V70, P635, DOI 10.1086/338999	80	95	96	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7447	10.1371/journal.pone.0007447	http://dx.doi.org/10.1371/journal.pone.0007447			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823670	Green Published, gold, Green Submitted			2022-12-27	WOS:000270808300019
J	Meng, PH; Raynaud, C; Tcherkez, G; Blanchet, S; Massoud, K; Domenichini, S; Henry, Y; Soubigou-Taconnat, L; Lelarge-Trouverie, C; Saindrenan, P; Renou, JP; Bergounioux, C				Meng, Ping Hong; Raynaud, Cecile; Tcherkez, Guillaume; Blanchet, Sophie; Massoud, Kamal; Domenichini, Severine; Henry, Yves; Soubigou-Taconnat, Ludivine; Lelarge-Trouverie, Caroline; Saindrenan, Patrick; Renou, Jean Pierre; Bergounioux, Catherine			Crosstalks between Myo-Inositol Metabolism, Programmed Cell Death and Basal Immunity in Arabidopsis	PLOS ONE			English	Article							SYSTEMIC ACQUIRED-RESISTANCE; NUCLEAR ANTIGEN PCNA; SALICYLIC-ACID; HYPERSENSITIVE RESPONSE; SIGNAL-TRANSDUCTION; D-MYO-INOSITOL-3-PHOSPHATE SYNTHASE; GENE-EXPRESSION; GIGANTEA GENE; PLANTS; DEFENSE	Background: Although it is a crucial cellular process required for both normal development and to face stress conditions, the control of programmed cell death in plants is not fully understood. We previously reported the isolation of ATXR5 and ATXR6, two PCNA-binding proteins that could be involved in the regulation of cell cycle or cell death. A yeast two-hybrid screen using ATXR5 as bait captured AtIPS1, an enzyme which catalyses the committed step of myo-inositol (MI) biosynthesis. atips1 mutants form spontaneous lesions on leaves, raising the possibility that MI metabolism may play a role in the control of PCD in plants. In this work, we have characterised atips1 mutants to gain insight regarding the role of MI in PCD regulation. Methodology/Principal Findings: - lesion formation in atips1 mutants depends of light intensity, is due to PCD as evidenced by TUNEL labelling of nuclei, and is regulated by phytohormones such as salicylic acid - MI and galactinol are the only metabolites whose accumulation is significantly reduced in the mutant, and supplementation of the mutant with these compounds is sufficient to prevent PCD - the transcriptome profile of the mutant is extremely similar to that of lesion mimic mutants such as cpr5, or wild-type plants infected with pathogens. Conclusion/Significance: Taken together, our results provide strong evidence for the role of MI or MI derivatives in the regulation of PCD. Interestingly, there are three isoforms of IPS in Arabidopsis, but AtIPS1 is the only one harbouring a nuclear localisation sequence, suggesting that nuclear pools of MI may play a specific role in PCD regulation and opening new research prospects regarding the role of MI in the prevention of tumorigenesis. Nevertheless, the significance of the interaction between AtIPS1 and ATXR5 remains to be established.	[Meng, Ping Hong; Raynaud, Cecile; Blanchet, Sophie; Massoud, Kamal; Domenichini, Severine; Henry, Yves; Saindrenan, Patrick; Bergounioux, Catherine] Univ Paris 11, CNRS, UMR 8618, Inst Biotechnol Plantes, Orsay, France; [Tcherkez, Guillaume; Lelarge-Trouverie, Caroline] Univ Paris 11, Inst Biotechnol Plantes, Plateforme Metab Meabolome IFR87, Orsay, France; [Soubigou-Taconnat, Ludivine; Renou, Jean Pierre] Unite Rech Genom Vegetale, Evry, France	Centre National de la Recherche Scientifique (CNRS); UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay; UDICE-French Research Universities; Universite Paris Saclay	Meng, PH (corresponding author), Guizhou Acad Agr Sci, Inst Hort, Guiyang, Guizhou Prov, Peoples R China.	cecile.raynaud@u-psud.fr	Raynaud, Cécile/H-9711-2012; HENRY, Yves/B-8941-2008; Tcherkez, Guillaume/L-1300-2015	Raynaud, Cécile/0000-0002-5231-8120; DOMENICHINI, Severine/0000-0002-5997-2694				Achard P, 2008, CURR BIOL, V18, P656, DOI 10.1016/j.cub.2008.04.034; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; BAILLIEUL F, 1995, PLANT J, V8, P551, DOI 10.1046/j.1365-313X.1995.8040551.x; BOHNERT HJ, 1995, PLANT CELL, V7, P1099, DOI 10.1105/tpc.7.7.1099; Bomblies K, 2007, PLOS BIOL, V5, P1962, DOI 10.1371/journal.pbio.0050236; Bowling SA, 1997, PLANT CELL, V9, P1573, DOI 10.1105/tpc.9.9.1573; Brodersen P, 2002, GENE DEV, V16, P490, DOI 10.1101/gad.218202; Cao SQ, 2005, PLANT CELL REP, V24, P683, DOI 10.1007/s00299-005-0061-x; Crowe ML, 2003, NUCLEIC ACIDS RES, V31, P156, DOI 10.1093/nar/gkg071; DELANCY TP, 1994, SCIENCE, V18, P1247; Duronio V, 2008, BIOCHEM J, V415, P333, DOI 10.1042/BJ20081056; Fowler S, 1999, EMBO J, V18, P4679, DOI 10.1093/emboj/18.17.4679; FromontRacine M, 1997, NAT GENET, V16, P277, DOI 10.1038/ng0797-277; Gendreau E, 1997, PLANT PHYSIOL, V114, P295, DOI 10.1104/pp.114.1.295; Gepstein S, 2003, PLANT J, V36, P629, DOI 10.1046/j.1365-313X.2003.01908.x; Huq E, 2000, P NATL ACAD SCI USA, V97, P9789, DOI 10.1073/pnas.170283997; Ishikawa A, 2005, BIOSCI BIOTECH BIOCH, V69, P1929, DOI 10.1271/bbb.69.1929; Ishitani M, 1996, PLANT J, V9, P537, DOI 10.1046/j.1365-313X.1996.09040537.x; Jacob Y, 2009, NAT STRUCT MOL BIOL, V16, P763, DOI 10.1038/nsmb.1611; Jasinski S, 2002, J CELL SCI, V115, P973; JOHNSON MD, 1995, PLANT PHYSIOL, V107, P613, DOI 10.1104/pp.107.2.613; Keller R, 1998, PLANT J, V16, P403, DOI 10.1046/j.1365-313x.1998.00309.x; Kim MS, 2008, MOL PLANT MICROBE IN, V21, P1643, DOI 10.1094/MPMI-21-12-1643; Kurepa J, 1998, PLANT J, V14, P759, DOI 10.1046/j.1365-313x.1998.00168.x; Lackey KH, 2003, PLANT PHYSIOL, V132, P2240, DOI 10.1104/pp.103.020610; Lawton K, 1995, MOL PLANT MICROBE IN, V8, P863, DOI 10.1094/MPMI-8-0863; Liang H, 2003, GENE DEV, V17, P2636, DOI 10.1101/gad.1140503; Liu YD, 2007, PLANT J, V51, P941, DOI 10.1111/j.1365-313X.2007.03191.x; Loewus FA, 2000, PLANT SCI, V150, P1, DOI 10.1016/S0168-9452(99)00150-8; LOEWUS FA, 1983, ANNU REV PLANT PHYS, V34, P137, DOI 10.1146/annurev.pp.34.060183.001033; Lorrain S, 2003, TRENDS PLANT SCI, V8, P263, DOI 10.1016/S1360-1385(03)00108-0; Love AJ, 2008, TRENDS PLANT SCI, V13, P589, DOI 10.1016/j.tplants.2008.08.006; Lurin C, 2004, PLANT CELL, V16, P2089, DOI 10.1105/tpc.104.022236; Maga G, 2003, J CELL SCI, V116, P3051, DOI 10.1242/jcs.00653; Mateo A, 2004, PLANT PHYSIOL, V136, P2818, DOI 10.1104/pp.104.043646; Morel JB, 1997, CELL DEATH DIFFER, V4, P671, DOI 10.1038/sj.cdd.4400309; Muhlenbock P, 2008, PLANT CELL, V20, P2339, DOI 10.1105/tpc.108.059618; Murphy AM, 2008, PLANT J, V56, P638, DOI 10.1111/j.1365-313X.2008.03629.x; Murray JA, 2009, PLANT MOL BIOL; Nawrath C, 1999, PLANT CELL, V11, P1393, DOI 10.1105/tpc.11.8.1393; Nishizawa A, 2008, PLANT PHYSIOL, V147, P1251, DOI 10.1104/pp.108.122465; Noctor G, 2007, METABOLOMICS, V3, P161, DOI 10.1007/s11306-007-0057-3; Nunes ACS, 2006, PLANTA, V224, P125, DOI 10.1007/s00425-005-0201-0; Ortega X, 2005, BIOL RES, V38, P89, DOI 10.4067/S0716-97602005000100011; Overmyer K, 2003, TRENDS PLANT SCI, V8, P335, DOI 10.1016/S1360-1385(03)00135-3; Park DH, 1999, SCIENCE, V285, P1579, DOI 10.1126/science.285.5433.1579; Park JH, 2002, PLANT J, V31, P1, DOI 10.1046/j.1365-313X.2002.01328.x; Parker JE, 1996, PLANT CELL, V8, P2033, DOI 10.1105/tpc.8.11.2033; Perennes C, 1999, J CELL SCI, V112, P1181; Petersen M, 2000, CELL, V103, P1111, DOI 10.1016/S0092-8674(00)00213-0; Qiu JL, 2008, PLANT PHYSIOL, V148, P212, DOI 10.1104/pp.108.120006; Queval G, 2007, PLANT J, V52, P640, DOI 10.1111/j.1365-313X.2007.03263.x; Raboy V, 2000, PLANT PHYSIOL, V124, P355, DOI 10.1104/pp.124.1.355; Raboy V, 2003, PHYTOCHEMISTRY, V64, P1033, DOI 10.1016/S0031-9422(03)00446-1; Raynaud C, 2005, P NATL ACAD SCI USA, V102, P8216, DOI 10.1073/pnas.0502564102; Raynaud C, 2006, PLANT J, V47, P395, DOI 10.1111/j.1365-313X.2006.02799.x; Reape TJ, 2008, NEW PHYTOL, V180, P13, DOI 10.1111/j.1469-8137.2008.02549.x; Reape TJ, 2008, J EXP BOT, V59, P435, DOI 10.1093/jxb/erm258; Sambrook J., 1989, MOL CLONING; Schwab R, 2006, PLANT CELL, V18, P1121, DOI 10.1105/tpc.105.039834; Smart CC, 1997, PLANT MOL BIOL, V33, P811, DOI 10.1023/A:1005754425440; SMART CC, 1993, PLANT J, V4, P279, DOI 10.1046/j.1365-313X.1993.04020279.x; SUSEK RE, 1993, CELL, V74, P787, DOI 10.1016/0092-8674(93)90459-4; van Wees SCM, 2003, PLANT J, V33, P733, DOI 10.1046/j.1365-313X.2003.01665.x; Wang WM, 2008, PLANT CELL, V20, P3163, DOI 10.1105/tpc.108.060053; Weckwerth W, 2004, P NATL ACAD SCI USA, V101, P7809, DOI 10.1073/pnas.0303415101; Wildermuth MC, 2001, NATURE, V414, P562, DOI 10.1038/35107108; Williams B, 2008, MOL PLANT PATHOL, V9, P531, DOI [10.1111/j.1364-3703.2008.00473.x, 10.1111/J.1364-3703.2008.00473.X]; Zimmermann P, 2004, PLANT PHYSIOL, V136, P2621, DOI 10.1104/pp.104.046367	69	90	95	4	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7364	10.1371/journal.pone.0007364	http://dx.doi.org/10.1371/journal.pone.0007364			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812700	Green Published, gold, Green Submitted			2022-12-27	WOS:000270594200005
J	Olivier, V; Queen, J; Satchell, KJF				Olivier, Verena; Queen, Jessica; Satchell, Karla J. F.			Successful Small Intestine Colonization of Adult Mice by Vibrio cholerae Requires Ketamine Anesthesia and Accessory Toxins	PLOS ONE			English	Article								Vibrio cholerae colonizes the small intestine of adult C57BL/6 mice. In this study, the physical and genetic parameters that facilitate this colonization were investigated. Successful colonization was found to depend upon anesthesia with ketamine-xylazine and neutralization of stomach acid with sodium bicarbonate, but not streptomycin treatment. A variety of common mouse strains were colonized by O1, O139, and non-O1/non-O139 strains. All combinations of mutants in the genes for hemolysin, the multifunctional, autoprocessing RTX toxin (MARTX), and hemagglutinin/protease were assessed, and it was found that hemolysin and MARTX are each sufficient for colonization after a low dose infection. Overall, this study suggests that, after intragastric inoculation, V. cholerae encounters barriers to infection including an acidic environment and an immediate immune response that is circumvented by sodium bicarbonate and the anti-inflammatory effects of ketamine-xylazine. After initial adherence in the small intestine, the bacteria are subjected to additional clearance mechanisms that are evaded by the independent toxic action of hemolysin or MARTX. Once colonization is established, it is suggested that, in humans, these now persisting bacteria initiate synthesis of the major virulence factors to cause cholera disease. This adult mouse model of intestinal V. cholerae infection, now well-characterized and fully optimized, should serve as a valuable tool for studies of pathogenesis and testing vaccine efficacy.			Olivier, V (corresponding author), Intercell AG, Vienna, Austria.	k-satchell@northwestern.edu	Sears, Cynthia L/AAJ-6704-2020; Satchell, Karla/GSN-3100-2022	Sears, Cynthia L/0000-0003-4059-1661; Queen, Jessica/0000-0002-4924-6621	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI051490, R21AI072461] Funding Source: NIH RePORTER; NIAID NIH HHS [R21 AI072461-01A2, AI051490, R01 AI051490, R21 AI072461, AI072461] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		ALM RA, 1988, MOL MICROBIOL, V2, P481; Bina J, 2003, P NATL ACAD SCI USA, V100, P2801, DOI 10.1073/pnas.2628026100; CASH RA, 1974, J INFECT DIS, V129, P45, DOI 10.1093/infdis/129.1.45; Chiang SL, 1999, INFECT IMMUN, V67, P976, DOI 10.1128/IAI.67.2.976-980.1999; Cordero CL, 2007, J CLIN MICROBIOL, V45, P2289, DOI 10.1128/JCM.00349-07; FREYE E, 1994, ANAESTHESIST, V43, P87, DOI 10.1007/s001010050036; Fullner KJ, 2000, EMBO J, V19, P5315, DOI 10.1093/emboj/19.20.5315; Fullner KJ, 2002, J EXP MED, V195, P1455, DOI 10.1084/jem.20020318; Fullner KJ, 1999, INFECT IMMUN, V67, P1393, DOI 10.1128/IAI.67.3.1393-1404.1999; Ghosh A, 2006, INFECT IMMUN, V74, P2937, DOI 10.1128/IAI.74.5.2937-2946.2006; GOLDBERG I, 1986, J BACTERIOL, V165, P715, DOI 10.1128/jb.165.3.715-722.1986; HANNE LF, 1982, INFECT IMMUN, V36, P209, DOI 10.1128/IAI.36.1.209-214.1982; Helmer KS, 2003, J SURG RES, V112, P70, DOI 10.1016/S0022-4804(03)00138-0; Helmer KS, 2003, SHOCK, V20, P63, DOI 10.1097/01.shk.0000065766.72937.cf; Herbert J, 1998, EXP GERONTOL, V33, P713, DOI 10.1016/S0531-5565(98)00039-4; Hsiao A, 2006, P NATL ACAD SCI USA, V103, P14542, DOI 10.1073/pnas.0604650103; Kirn TJ, 2000, MOL MICROBIOL, V35, P896, DOI 10.1046/j.1365-2958.2000.01764.x; KNOP J, 1975, AUST J EXP BIOL MED, V53, P137, DOI 10.1038/icb.1975.14; Li MR, 2002, INFECT IMMUN, V70, P2441, DOI 10.1128/IAI.70.5.2441-2453.2002; MEKALANOS JJ, 1983, CELL, V35, P253, DOI 10.1016/0092-8674(83)90228-3; NIYOGI SG, 1979, INDIAN J MED RES, V70, P892; NYGREN E, 2009, INFECT IMMUN; Olivier V, 2007, INFECT IMMUN, V75, P5043, DOI 10.1128/IAI.00508-07; Olivier V, 2007, INFECT IMMUN, V75, P5035, DOI 10.1128/IAI.00506-07; Sack DA, 2004, LANCET, V363, P223, DOI 10.1016/S0140-6736(03)15328-7; Suliburk JW, 2005, J SURG RES, V127, P203, DOI 10.1016/j.jss.2005.03.021; Valeva A, 2008, MED MICROBIOL IMMUN, V197, P285, DOI 10.1007/s00430-007-0061-2; WALDOR MK, 1994, INFECT IMMUN, V62, P72, DOI 10.1128/IAI.62.1.72-78.1994	28	64	68	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7352	10.1371/journal.pone.0007352	http://dx.doi.org/10.1371/journal.pone.0007352			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812690	Green Published, Green Submitted, gold			2022-12-27	WOS:000270594200004
J	Prasobh, R; Manoj, N				Prasobh, R.; Manoj, Narayanan			The Repertoire of Heterotrimeric G Proteins and RGS Proteins in Ciona intestinalis	PLOS ONE			English	Article								Background: Heterotrimeric G proteins and regulators of G protein signaling (RGS) proteins are key downstream interacting partners in the G protein coupled receptor (GPCR) signaling pathway. The highly versatile GPCR transmembrane signaling system is a consequence of the coupling of a diverse set of receptors to downstream partners that include multiple subforms of G proteins and regulatory proteins including RGS proteins, among others. While the GPCR repertoire of Ciona intestinalis, representing the basal chordate is known, the repertoire of the heterotrimeric G proteins and RGS proteins is unknown. Methodology/Principal Findings: In the present study, we performed an in-silico genome-wide search of C. intestinalis for its complement of G proteins and RGS proteins. The identification of several one-to-one orthologs of human G proteins at the levels of families, subfamilies and types and of homologs of the human RGS proteins suggests an evolutionarily conserved structure function relationship of the GPCR signaling mechanism in the chordates. Conclusions: The C. intestinalis genome encodes a highly conserved, albeit, limited repertoire of the heterotrimeric G protein complexes with the size of subunit types comparable with that in lower eukaryotes.			Prasobh, R (corresponding author), Indian Inst Technol, Dept Biotechnol, Madras 600036, Tamil Nadu, India.	nmanoj@iitm.ac.in	Manoj, Narayanan/W-2301-2019	Manoj, Narayanan/0000-0002-8144-1566				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Birnbaumer L, 2007, BBA-BIOMEMBRANES, V1768, P772, DOI 10.1016/j.bbamem.2006.12.002; Burchett SA, 2000, J NEUROCHEM, V75, P1335, DOI 10.1046/j.1471-4159.2000.0751335.x; Cabrera-Vera TM, 2003, ENDOCR REV, V24, P765, DOI 10.1210/er.2000-0026; Cheever ML, 2008, NAT STRUCT MOL BIOL, V15, P155, DOI 10.1038/nsmb.1377; Chen SH, 2006, DEV CELL, V11, P436, DOI 10.1016/j.devcel.2006.09.011; Clapham DE, 1997, ANNU REV PHARMACOL, V37, P167, DOI 10.1146/annurev.pharmtox.37.1.167; COLEMAN DE, 1994, SCIENCE, V265, P1405, DOI 10.1126/science.8073283; Corbo JC, 2001, CELL, V106, P535, DOI 10.1016/S0092-8674(01)00481-0; Davis TL, 2005, BIOCHEMISTRY-US, V44, P10593, DOI 10.1021/bi050655i; Dehal P, 2002, SCIENCE, V298, P2157, DOI 10.1126/science.1080049; Delsuc F, 2006, NATURE, V439, P965, DOI 10.1038/nature04336; Eddy SR, 1998, BIOINFORMATICS, V14, P755, DOI 10.1093/bioinformatics/14.9.755; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Fredriksson R, 2003, MOL PHARMACOL, V63, P1256, DOI 10.1124/mol.63.6.1256; Gouet P, 1999, BIOINFORMATICS, V15, P305, DOI 10.1093/bioinformatics/15.4.305; GRAF R, 1992, EUR J BIOCHEM, V210, P609, DOI 10.1111/j.1432-1033.1992.tb17461.x; Grishina G, 2000, MOL PHARMACOL, V57, P1081; Hall T.A., 1999, NUCL ACIDS S SER, V41, P95; HIGGINS JB, 1994, J BIOL CHEM, V269, P9067; Imai KS, 2006, SCIENCE, V312, P1183, DOI 10.1126/science.1123404; Jansen G, 1999, NAT GENET, V21, P414, DOI 10.1038/7753; Johnston CA, 2007, MOL PHARMACOL, V72, P219, DOI 10.1124/mol.107.034348; Jones MB, 2004, MOL INTERV, V4, P200, DOI 10.1124/mi.4.4.4; Kamesh N, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-129; LAMBRIGHT DG, 2004, HDB CELL SIGNALING, P575; Liang JJ, 1998, J NEUROCHEM, V71, P345; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Marin EP, 2002, BIOCHEMISTRY-US, V41, P6988, DOI 10.1021/bi025514k; Marsh SR, 1998, MOL PHARMACOL, V53, P981; Onrust R, 1997, SCIENCE, V275, P381, DOI 10.1126/science.275.5298.381; Preininger A.M., 2004, SCI STKE, V218, pre3; Resh MD, 1996, CELL SIGNAL, V8, P403, DOI 10.1016/S0898-6568(96)00088-5; Satoh N, 2003, TRENDS GENET, V19, P376, DOI 10.1016/S0168-9525(03)00144-6; Snow BE, 1998, P NATL ACAD SCI USA, V95, P13307, DOI 10.1073/pnas.95.22.13307; Sondek J, 2001, BIOCHEM PHARMACOL, V61, P1329, DOI 10.1016/S0006-2952(01)00633-5; SPRANG SR, 1997, ANNU REV BIOCHEM, V639, P678; Theodoropoulou MC, 2008, BIOINFORMATICS, V24, P1471, DOI 10.1093/bioinformatics/btn206; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; WALL MA, 1995, CELL, V83, P1047, DOI 10.1016/0092-8674(95)90220-1; Watson AJ, 1996, J BIOL CHEM, V271, P28154, DOI 10.1074/jbc.271.45.28154; Wettschureck N, 2005, PHYSIOL REV, V85, P1159, DOI 10.1152/physrev.00003.2005; Yost EA, 2007, MOL PHARMACOL, V72, P812, DOI 10.1124/mol.107.038075; CIONA INTESTINALIS V	44	1	1	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7349	10.1371/journal.pone.0007349	http://dx.doi.org/10.1371/journal.pone.0007349			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806206	gold, Green Published, Green Submitted			2022-12-27	WOS:000270593800027
J	Sim, SH; Liu, YC; Wang, DL; Novem, V; Sivalingam, SP; Thong, TW; Ooi, EE; Tan, G				Sim, Siew Hoon; Liu, Yichun; Wang, Dongling; Novem, Vidhya; Sivalingam, Suppiah Paramalingam; Thong, Tuck Weng; Ooi, Eng Eong; Tan, Gladys			Innate Immune Responses of Pulmonary Epithelial Cells to Burkholderia pseudomallei Infection	PLOS ONE			English	Article								Background: Burkholderia pseudomallei, a facultative intracellular pathogen, causes systemic infection in humans with high mortality especially when infection occurs through an infectious aerosol. Previous studies indicated that the epithelial cells in the lung are an active participant in host immunity. In this study, we aimed to investigate the innate immune responses of lung epithelial cells against B. pseudomallei. Methodology and Principal Findings: Using a murine lung epithelial cell line, primary lung epithelial cells and an inhalational murine infection model, we characterized the types of innate immunity proteins and peptides produced upon B. pseudomallei infection. Among a wide panel of immune components studied, increased levels of major pro-inflammatory cytokines IL-6 and TNF alpha, chemokine MCP-1, and up-regulation of secretory leukocyte protease inhibitor (SLPI) and chemokine (C-C motif) ligand 20 (CCL20) were observed. Inhibition assays using specific inhibitors suggested that NF-kappa B and p38 MAPK pathways were responsible for these B. pseudomallei-induced antimicrobial peptides. Conclusions: Our findings indicate that the respiratory epithelial cells, which form the majority of the cells lining the epithelial tract and the lung, have important roles in the innate immune response against B. pseudomallei infection.			Sim, SH (corresponding author), Def Med & Environm Res Inst, DSO Natl Labs, Singapore, Singapore.	tgekyen@dso.org.sg	liu, yi/GXE-9662-2022	Ooi, Eng Eong/0000-0002-0520-1544				Abe T, 1997, AM J RESP CRIT CARE, V156, P1235, DOI 10.1164/ajrccm.156.4.9701075; Akinbi HT, 2000, J IMMUNOL, V165, P5760, DOI 10.4049/jimmunol.165.10.5760; Baier J, 2000, J INVEST MED, V48, P457; Bals R, 2004, EUR RESPIR J, V23, P327, DOI 10.1183/09031936.03.00098803; Barnes JL, 2001, IMMUNOL CELL BIOL, V79, P490, DOI 10.1046/j.1440-1711.2001.01038.x; Basu S, 2004, AM J PHYSIOL-LUNG C, V286, pL887, DOI 10.1152/ajplung.00323.2003; BOONSAWAT W, 1990, Journal of the Medical Association of Thailand, V73, P345; Borgatti M, 2007, BIOCHEM BIOPH RES CO, V357, P977, DOI 10.1016/j.bbrc.2007.04.081; Breitbach K, 2006, INFECT IMMUN, V74, P6300, DOI 10.1128/IAI.00966-06; Cheng AC, 2005, CLIN MICROBIOL REV, V18, P383, DOI 10.1128/CMR.18.2.383-416.2005; Choi SC, 2006, WORLD J GASTROENTERO, V12, P4850; Currie Bart, 1993, Southeast Asian Journal of Tropical Medicine and Public Health, V24, P436; Currie BJ, 2003, EMERG INFECT DIS, V9, P1538, DOI 10.3201/eid0912.020750; DANCE DAB, 1991, CLIN MICROBIOL REV, V4, P52, DOI 10.1128/CMR.4.1.52-60.1991; Dance DAB, 2000, ACTA TROP, V74, P115, DOI 10.1016/S0001-706X(99)00059-5; Droemann D, 2005, RESP RES, V6, DOI 10.1186/1465-9921-6-1; Easton A, 2007, J INFECT DIS, V195, P99, DOI 10.1086/509810; ELSINGHORST EA, 1994, METHOD ENZYMOL, V236, P405; Fahlgren A, 2003, CLIN EXP IMMUNOL, V131, P90, DOI 10.1046/j.1365-2249.2003.02035.x; FRIEDLAND JS, 1992, INFECT IMMUN, V60, P2402, DOI 10.1128/IAI.60.6.2402-2408.1992; Gentry M, 2007, INFECT IMMUN, V75, P3969, DOI 10.1128/IAI.00157-07; Giulietti A, 2001, METHODS, V25, P386, DOI 10.1006/meth.2001.1261; Greene CM, 2005, J IMMUNOL, V174, P1638, DOI 10.4049/jimmunol.174.3.1638; Hauber Hans-Peter, 2005, Can Respir J, V12, P13; Hippenstiel S, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-97; Hoover DM, 2002, J BIOL CHEM, V277, P37647, DOI 10.1074/jbc.M203907200; Islam D, 2001, NAT MED, V7, P180, DOI 10.1038/84627; Jia T, 2008, J IMMUNOL, V180, P6846, DOI 10.4049/jimmunol.180.10.6846; Liu Y, 2006, T ROY SOC TROP MED H, V100, P687, DOI 10.1016/j.trstmh.2005.08.017; Mendez-Samperio P, 2008, PEPTIDES, V29, P1657, DOI 10.1016/j.peptides.2008.05.019; Miyagi K, 1997, INFECT IMMUN, V65, P4108, DOI 10.1128/IAI.65.10.4108-4113.1997; Ngauy V, 2005, J CLIN MICROBIOL, V43, P970, DOI 10.1128/JCM.43.2.970-972.2005; O'Brien AD, 1999, AM J PHYSIOL-LUNG C, V276, pL961, DOI 10.1152/ajplung.1999.276.6.L961; Popov S. F., 1992, Mikrobiologicheskii Zhurnal (Kiev), V54, P3; Potera C, 2005, ENVIRON HEALTH PERSP, V113, pA734, DOI 10.1289/ehp.113-a734; Reviglio VE, 2007, MEDIAT INFLAMM, V2007, DOI 10.1155/2007/93857; Rogan MP, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-29; Schutyser E, 2003, CYTOKINE GROWTH F R, V14, P409, DOI 10.1016/S1359-6101(03)00049-2; Simian M, 2001, DEVELOPMENT, V128, P3117; Simpson AJH, 2000, J INFECT DIS, V181, P621, DOI 10.1086/315271; Sitaraman SV, 2001, J CLIN INVEST, V107, P861, DOI 10.1172/JCI11783; Sperandio B, 2008, J EXP MED, V205, P1121, DOI 10.1084/jem.20071698; Tan GYG, 2008, J MED MICROBIOL, V57, P508, DOI 10.1099/jmm.0.47596-0; Tomimori K, 2007, INFECT IMMUN, V75, P5223, DOI 10.1128/IAI.00731-07; Utaisincharoen P, 2004, CLIN EXP IMMUNOL, V138, P61, DOI 10.1111/j.1365-2249.2004.02601.x; Utaisincharoen P, 2000, CLIN EXP IMMUNOL, V122, P324, DOI 10.1046/j.1365-2249.2000.01386.x; Weldon S, 2007, EXP LUNG RES, V33, P485, DOI 10.1080/01902140701756547; White NJ, 2003, LANCET, V361, P1715, DOI 10.1016/S0140-6736(03)13374-0; Wiersinga WJ, 2006, NAT REV MICROBIOL, V4, P272, DOI 10.1038/nrmicro1385; Wu YY, 2007, INFECT IMMUN, V75, P4357, DOI 10.1128/IAI.01660-06; Yang J, 2002, INFECT IMMUN, V70, P3649, DOI 10.1128/IAI.70.7.3649-3655.2002; Zhang Z, 2005, INFECT IMMUN, V73, P7151, DOI 10.1128/IAI.73.11.7151-7160.2005	52	22	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7308	10.1371/journal.pone.0007308	http://dx.doi.org/10.1371/journal.pone.0007308			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806192	Green Published, Green Submitted, gold			2022-12-27	WOS:000270593800016
J	Audran, R; Lurati-Ruiz, F; Genton, B; Blythman, HE; Ofori-Anyinam, O; Reymond, C; Corradin, G; Spertini, F				Audran, Regine; Lurati-Ruiz, Floriana; Genton, Blaise; Blythman, Hildur E.; Ofori-Anyinam, Opokua; Reymond, Christophe; Corradin, Giampietro; Spertini, Francois			The Synthetic Plasmodium falciparum Circumsporozoite Peptide PfCS102 as a Malaria Vaccine Candidate: A Randomized Controlled Phase I Trial	PLOS ONE			English	Article							CYTOTOXIC T-LYMPHOCYTES; PROTEIN VACCINE; IMMUNE-RESPONSE; CELL EPITOPES; ANTIGEN; CD8(+); RECOGNITION; PROTECTION; REGIONS; CD4(+)	Background: Fully efficient vaccines against malaria pre-erythrocytic stage are still lacking. The objective of this dose/adjuvant-finding study was to evaluate the safety, reactogenicity and immunogenicity of a vaccine candidate based on a peptide spanning the C-terminal region of Plasmodium falciparum circumsporozoite protein (PfCS102) in malaria naive adults. Methodology and Principal Findings: Thirty-six healthy malaria-naive adults were randomly distributed into three dose blocks (10, 30 and 100 mu g) and vaccinated with PfCS102 in combination with either Montanide ISA 720 or GSK proprietary Adjuvant System AS02A at days 0, 60, and 180. Primary end-point (safety and reactogenicity) was based on the frequency of adverse events (AE) and of abnormal biological safety tests; secondary-end point (immunogenicity) on P. falciparum specific cell-mediated immunity and antibody response before and after immunization. The two adjuvant formulations were well tolerated and their safety profile was good. Most AEs were local and, when systemic, involved mainly fatigue and headache. Half the volunteers in AS02A groups experienced severe AEs ( mainly erythema). After the third injection, 34 of 35 volunteers developed anti-PfCS102 and anti-sporozoite antibodies, and 28 of 35 demonstrated T-cell proliferative responses and IFN-gamma production. Five of 22 HLA-A2 and HLA-A3 volunteers displayed PfCS102 specific IFN-gamma secreting CD8(+) T cell responses. Responses were only marginally boosted after the 3(rd) vaccination and remained stable for 6 months. For both adjuvants, the dose of 10 mu g was less immunogenic in comparison to 30 and 100 mu g that induced similar responses. AS02A formulations with 30 mu g or 100 mu g PfCS102 induced about 10-folds higher antibody and IFN-gamma responses than Montanide formulations. Conclusions/Significance: PfCS102 peptide was safe and highly immunogenic, allowing the design of more advanced trials to test its potential for protection. Two or three immunizations with a dose of 30 mu g formulated with AS02A appeared the most appropriate choice for such studies.			Audran, R (corresponding author), CHU Vaudois, Div Immunol & Allergy, CH-1011 Lausanne, Switzerland.	Francois.Spertini@chuv.ch						Audran R, 2005, INFECT IMMUN, V73, P8017, DOI 10.1128/IAI.73.12.8017-8026.2005; Ballou WR, 2007, MICROBES INFECT, V9, P761, DOI 10.1016/j.micinf.2007.02.006; Beeson JG, 2008, TRENDS PARASITOL, V24, P578, DOI 10.1016/j.pt.2008.08.008; BLUMTIROUVANZIAM U, 1995, J IMMUNOL, V154, P3922; BLUMTIROUVANZIAM U, 1994, J IMMUNOL, V153, P4134; Bonelo A, 2000, EUR J IMMUNOL, V30, P3079, DOI 10.1002/1521-4141(200011)30:11&lt;3079::AID-IMMU3079&gt;3.0.CO;2-7; Doolan DL, 1999, J IMMUNOL, V163, P884; DOOLAN DL, 1991, INT IMMUNOL, V3, P511, DOI 10.1093/intimm/3.6.511; Garcon N, 2007, EXPERT REV VACCINES, V6, P723, DOI 10.1586/14760584.6.5.723; Gonzalez JM, 2000, PARASITE IMMUNOL, V22, P501, DOI 10.1046/j.1365-3024.2000.00331.x; Kester KE, 2001, J INFECT DIS, V183, P640, DOI 10.1086/318534; Kester KE, 2007, VACCINE, V25, P5359, DOI 10.1016/j.vaccine.2007.05.005; Kumar KA, 2006, NATURE, V444, P937, DOI 10.1038/nature05361; Lalvani A, 1996, EUR J IMMUNOL, V26, P773, DOI 10.1002/eji.1830260408; Lopez JA, 1997, ANN TROP MED PARASIT, V91, P253, DOI 10.1080/00034989761111; Lopez JA, 2001, EUR J IMMUNOL, V31, P1989, DOI 10.1002/1521-4141(200107)31:7&lt;1989::AID-IMMU1989&gt;3.0.CO;2-M; Lopez JA, 1996, AM J TROP MED HYG, V55, P424, DOI 10.4269/ajtmh.1996.55.424; Luke TC, 2003, J EXP BIOL, V206, P3803, DOI 10.1242/jeb.00644; MALIK A, 1991, P NATL ACAD SCI USA, V88, P3300, DOI 10.1073/pnas.88.8.3300; Marsh K, 2006, PARASITE IMMUNOL, V28, P51, DOI 10.1111/j.1365-3024.2006.00808.x; Meraldi V, 2003, VACCINE, V21, P2485, DOI 10.1016/S0264-410X(03)00093-8; NARDIN EH, 1993, ANNU REV IMMUNOL, V11, P687, DOI 10.1146/annurev.iy.11.040193.003351; POTOCNJAK P, 1980, J EXP MED, V151, P1504, DOI 10.1084/jem.151.6.1504; Reece WHH, 2004, NAT MED, V10, P406, DOI 10.1038/nm1009; RENGGLI J, 1995, IMMUNOL LETT, V46, P199, DOI 10.1016/0165-2478(95)00043-5; Roggero MA, 1995, MOL IMMUNOL, V32, P1301, DOI 10.1016/0161-5890(95)00136-0; Schwenk R, 2003, PARASITE IMMUNOL, V25, P17, DOI 10.1046/j.1365-3024.2003.00495.x; Stoute JA, 1997, NEW ENGL J MED, V336, P86, DOI 10.1056/NEJM199701093360202; Sun PF, 2003, J IMMUNOL, V171, P6961, DOI 10.4049/jimmunol.171.12.6961; WEISS WR, 1990, J EXP MED, V171, P763, DOI 10.1084/jem.171.3.763	30	22	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7304	10.1371/journal.pone.0007304	http://dx.doi.org/10.1371/journal.pone.0007304			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19798415	Green Published, Green Submitted, gold			2022-12-27	WOS:000270593300010
J	Clausell, J; Happel, N; Hale, TK; Doenecke, D; Beato, M				Clausell, Jaime; Happel, Nicole; Hale, Tracy K.; Doenecke, Detlef; Beato, Miguel			Histone H1 Subtypes Differentially Modulate Chromatin Condensation without Preventing ATP-Dependent Remodeling by SWI/SNF or NURF	PLOS ONE			English	Article							NUCLEOSOME REPEAT LENGTH; ATOMIC-FORCE MICROSCOPY; DNA-BINDING SITES; CELL-FREE SYSTEM; LINKER HISTONE; GLOBULAR DOMAIN; DROSOPHILA EMBRYOS; SELF-ASSOCIATION; IN-VITRO; POSITIONED NUCLEOSOMES	Although ubiquitously present in chromatin, the function of the linker histone subtypes is partly unknown and contradictory studies on their properties have been published. To explore whether the various H1 subtypes have a differential role in the organization and dynamics of chromatin we have incorporated all of the somatic human H1 subtypes into minichromosomes and compared their influence on nucleosome spacing, chromatin compaction and ATP-dependent remodeling. H1 subtypes exhibit different affinities for chromatin and different abilities to promote chromatin condensation, as studied with the Atomic Force Microscope. According to this criterion, H1 subtypes can be classified as weak condensers (H1.1 and H1.2), intermediate condensers (H1.3) and strong condensers (H1.0, H1.4, H1.5 and H1x). The variable C-terminal domain is required for nucleosome spacing by H1.4 and is likely responsible for the chromatin condensation properties of the various subtypes, as shown using chimeras between H1.4 and H1.2. In contrast to previous reports with isolated nucleosomes or linear nucleosomal arrays, linker histones at a ratio of one per nucleosome do not preclude remodeling of minichromosomes by yeast SWI/SNF or Drosophila NURF. We hypothesize that the linker histone subtypes are differential organizers of chromatin, rather than general repressors.			Clausell, J (corresponding author), Univ Pompeu Fabra, CRG, Barcelona, Spain.	miguel.beato@crg.es	Beato, Miguel/B-5564-2015	Beato, Miguel/0000-0002-2878-2222				Albig W, 1998, FEBS LETT, V435, P245, DOI 10.1016/S0014-5793(98)01084-9; ALLAN J, 1986, J MOL BIOL, V187, P591, DOI 10.1016/0022-2836(86)90337-2; ALLAN J, 1981, J CELL BIOL, V90, P279, DOI 10.1083/jcb.90.2.279; Ausio Juan, 2006, Briefings in Functional Genomics & Proteomics, V5, P228, DOI 10.1093/bfgp/ell020; Becker PB, 2002, EMBO J, V21, P4749, DOI 10.1093/emboj/cdf486; BECKER PB, 1992, MOL CELL BIOL, V12, P2241, DOI 10.1128/MCB.12.5.2241; BERKOWITZ EM, 1981, BIOCHEMISTRY-US, V20, P7284, DOI 10.1021/bi00528a036; BLANK TA, 1995, J MOL BIOL, V252, P305, DOI 10.1006/jmbi.1995.0498; Bonte E, 1999, METH MOL B, V119, P187; Brown DT, 2006, NAT STRUCT MOL BIOL, V13, P250, DOI 10.1038/nsmb1050; Brown KS, 1997, J INSECT CONSERV, V1, P25, DOI 10.1023/A:1018422807610; Bruno M, 2003, MOL CELL, V12, P1599, DOI 10.1016/S1097-2765(03)00499-4; BUCCI LR, 1982, EXP CELL RES, V140, P111, DOI 10.1016/0014-4827(82)90162-8; BUTLER PJG, 1980, J MOL BIOL, V140, P505, DOI 10.1016/0022-2836(80)90268-5; Cano S, 2006, EUR BIOPHYS J BIOPHY, V35, P495, DOI 10.1007/s00249-006-0057-7; Carruthers LM, 1998, BIOCHEMISTRY-US, V37, P14776, DOI 10.1021/bi981684e; Carter GJ, 1998, BIOCHEMISTRY-US, V37, P12477, DOI 10.1021/bi980716v; Chadee DN, 1997, J BIOL CHEM, V272, P8113, DOI 10.1074/jbc.272.13.8113; CHADEE DN, 1995, J BIOL CHEM, V270, P20098, DOI 10.1074/jbc.270.34.20098; Contreras A, 2003, MOL CELL BIOL, V23, P8626, DOI 10.1128/MCB.23.23.8626-8636.2003; Corona DFV, 2007, PLOS BIOL, V5, P2011, DOI 10.1371/journal.pbio.0050232; Doenecke D, 1997, HISTOCHEM CELL BIOL, V107, P1, DOI 10.1007/s004180050083; DOMINGUEZ V, 1992, DEVELOPMENT, V115, P181; Dorigo B, 2004, SCIENCE, V306, P1571, DOI 10.1126/science.1103124; Drabent B, 1996, HISTOCHEM CELL BIOL, V106, P247; DRABENT B, 1991, GENE, V103, P263, DOI 10.1016/0378-1119(91)90284-I; DRAVES PH, 1992, J MOL BIOL, V225, P1105, DOI 10.1016/0022-2836(92)90108-V; DUBOCHET J, 1986, EMBO J, V5, P519, DOI 10.1002/j.1460-2075.1986.tb04241.x; Duggan MM, 2000, J MOL BIOL, V304, P21, DOI 10.1006/jmbi.2000.4205; ELGIN SCR, 1973, BIOCHEMISTRY-US, V12, P4984, DOI 10.1021/bi00748a026; Fan YH, 2003, MOL CELL BIOL, V23, P4559, DOI 10.1128/MCB.23.13.4559-4572.2003; Fan YH, 2001, MOL CELL BIOL, V21, P7933, DOI 10.1128/MCB.21.23.7933-7943.2001; Franke K, 1998, BBA-GENE STRUCT EXPR, V1398, P232, DOI 10.1016/S0167-4781(98)00062-1; Goytisolo FA, 1996, EMBO J, V15, P3421, DOI 10.1002/j.1460-2075.1996.tb00708.x; Gunjan A, 1999, J BIOL CHEM, V274, P37950, DOI 10.1074/jbc.274.53.37950; HALL JM, 1985, BIOCHEMISTRY-US, V24, P7765, DOI 10.1021/bi00347a040; Hamiche A, 2004, METHOD ENZYMOL, V377, P353; Hamiche A, 1996, J MOL BIOL, V257, P30, DOI 10.1006/jmbi.1996.0144; Happel N, 2005, BIOL CHEM, V386, P541, DOI 10.1515/BC.2005.064; Happel N, 2009, GENE, V431, P1, DOI 10.1016/j.gene.2008.11.003; HIGURASHI M, 1987, J BIOL CHEM, V262, P13075; Hill DA, 2000, BIOCHEMISTRY-US, V39, P11649, DOI 10.1021/bi001330z; Horn PJ, 2002, NAT STRUCT BIOL, V9, P263, DOI 10.1038/nsb776; HUANG HC, 1984, J BIOL CHEM, V259, P4237; Huynh VAT, 2005, J MOL BIOL, V345, P957, DOI 10.1016/j.jmb.2004.10.075; KELLER W, 1977, COLD SPRING HARB SYM, V42, P227, DOI 10.1101/SQB.1978.042.01.025; KHADAKE JR, 1995, BIOCHEMISTRY-US, V34, P15792, DOI 10.1021/bi00048a025; Khochbin S, 2001, GENE, V271, P1, DOI 10.1016/S0378-1119(01)00495-4; Koop R, 2003, EMBO J, V22, P588, DOI 10.1093/emboj/cdg052; Lee K, 2007, MOL BIOL CELL, V18, P4013, DOI 10.1091/mbc.E07-05-0437; LENNOX RW, 1982, J BIOL CHEM, V257, P5183; LENNOX RW, 1983, J BIOL CHEM, V258, P262; LENNOX RW, 1984, DEV BIOL, V103, P80, DOI 10.1016/0012-1606(84)90009-5; Leuba SH, 1998, BIOPHYS J, V74, P2830, DOI 10.1016/S0006-3495(98)77990-1; LIAO LW, 1981, J BIOL CHEM, V256, P124; Loborg H, 2000, CYTOMETRY, V40, P1; Luger K, 1997, NATURE, V389, P251, DOI 10.1038/38444; Lusser A, 2005, NAT STRUCT MOL BIOL, V12, P160, DOI 10.1038/nsmb884; Maier VK, 2008, BIOL CHEM, V389, P345, DOI 10.1515/BC.2008.040; Maier VK, 2008, EMBO J, V27, P817, DOI 10.1038/sj.emboj.7601902; MAMAN JD, 1994, BIOCHEMISTRY-US, V33, P1300, DOI 10.1021/bi00172a003; Maresca TJ, 2005, J CELL BIOL, V169, P859, DOI 10.1083/jcb.200503031; Orrego M, 2007, BMC BIOL, V5, DOI 10.1186/1741-7007-5-22; PANYIM S, 1969, BIOCHEM BIOPH RES CO, V37, P1042, DOI 10.1016/0006-291X(69)90237-X; Parseghian MH, 2000, CHROMOSOME RES, V8, P405, DOI 10.1023/A:1009262819961; Parseghian MH, 2001, BIOCHEM CELL BIOL, V79, P289; PENNINGS S, 1994, P NATL ACAD SCI USA, V91, P10275, DOI 10.1073/pnas.91.22.10275; Ponte I, 1998, MOL BIOL EVOL, V15, P702, DOI 10.1093/oxfordjournals.molbev.a025973; Ramachandran A, 2003, J BIOL CHEM, V278, P48590, DOI 10.1074/jbc.M309033200; Ramakrishnan V, 1997, ANNU REV BIOPH BIOM, V26, P83, DOI 10.1146/annurev.biophys.26.1.83; RASHEED BKA, 1989, J CELL SCI, V94, P61; Robinson PJJ, 2006, P NATL ACAD SCI USA, V103, P6506, DOI 10.1073/pnas.0601212103; Rodriguez-Campos A, 2004, NUCLEIC ACIDS RES, V32, DOI 10.1093/nar/gnh107; RODRIGUEZCAMPOS A, 1989, J MOL BIOL, V209, P135, DOI 10.1016/0022-2836(89)90177-0; Routh A, 2008, P NATL ACAD SCI USA, V105, P8872, DOI 10.1073/pnas.0802336105; Saeki H, 2005, P NATL ACAD SCI USA, V102, P5697, DOI 10.1073/pnas.0409824102; Sancho M, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000227; Sandbrink R, 1994, Neurobiol Dis, V1, P13, DOI 10.1006/nbdi.1994.0003; Schalch T, 2005, NATURE, V436, P138, DOI 10.1038/nature03686; Schwarz PM, 1996, BIOCHEMISTRY-US, V35, P4009, DOI 10.1021/bi9525684; SCHWARZ PM, 1994, J BIOL CHEM, V269, P16284; Smith CL, 2003, NAT STRUCT BIOL, V10, P141, DOI 10.1038/nsb888; Stoldt S, 2007, BIOL CELL, V99, P541, DOI 10.1042/BC20060117; Takata H, 2007, FEBS LETT, V581, P3783, DOI 10.1016/j.febslet.2007.06.076; Talasz H, 1998, J BIOL CHEM, V273, P32236, DOI 10.1074/jbc.273.48.32236; Tanaka M, 2001, DEVELOPMENT, V128, P655; Th'ng JPH, 2005, J BIOL CHEM, V280, P27809, DOI 10.1074/jbc.M501627200; THOMA F, 1979, J CELL BIOL, V83, P403, DOI 10.1083/jcb.83.2.403; THOMA F, 1988, CELL, V55, P945, DOI 10.1016/0092-8674(88)90240-1; THOMAS JO, 1992, NUCLEIC ACIDS RES, V20, P187, DOI 10.1093/nar/20.2.187; URA K, 1995, EMBO J, V14, P3752, DOI 10.1002/j.1460-2075.1995.tb00045.x; VARGAWEISZ PD, 1995, EMBO J, V14, P2209, DOI 10.1002/j.1460-2075.1995.tb07215.x; VARSHAVSKY AJ, 1977, COLD SPRING HARB SYM, V42, P457; Venditti P, 1998, NUCLEIC ACIDS RES, V26, P3657, DOI 10.1093/nar/26.16.3657; Vicent GP, 2004, MOL CELL, V16, P439, DOI 10.1016/j.molcel.2004.10.025; Wang HD, 2002, BIOPHYS J, V83, P3619, DOI 10.1016/S0006-3495(02)75362-9; Wisniewski JR, 2007, MOL CELL PROTEOMICS, V6, P72, DOI 10.1074/mcp.M600255-MCP200; WOODCOCK CL, 1993, P NATL ACAD SCI USA, V90, P9021, DOI 10.1073/pnas.90.19.9021; Woodcock CL, 2006, CHROMOSOME RES, V14, P17, DOI 10.1007/s10577-005-1024-3; WORKMAN JL, 1992, SCIENCE, V258, P1780, DOI 10.1126/science.1465613; Zhou YB, 1998, NATURE, V395, P402, DOI 10.1038/26521; ZLATANOVA J, 1994, FASEB J, V8, P1260, DOI 10.1096/fasebj.8.15.8001738; Zofall M, 2006, NAT STRUCT MOL BIOL, V13, P339, DOI 10.1038/nsmb1071	103	104	108	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2009	4	10							e0007243	10.1371/journal.pone.0007243	http://dx.doi.org/10.1371/journal.pone.0007243			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BP	19794910	Green Submitted, Green Published, gold			2022-12-27	WOS:000270354200003
J	Lefkimmiatis, K; Moyer, MP; Curci, S; Hofer, AM				Lefkimmiatis, Konstantinos; Moyer, Mary Pat; Curci, Silvana; Hofer, Aldebaran M.			"cAMP Sponge": A Buffer for Cyclic Adenosine 3 ', 5 '-Monophosphate	PLOS ONE			English	Article							DEPENDENT PROTEIN-KINASE; CELLS; EPAC; PHOSPHORYLATION; COMMUNICATION; INHIBITION; ACTIVATION; INDICATORS; DYNAMICS; CHANNELS	Background: While intracellular buffers are widely used to study calcium signaling, no such tool exists for the other major second messenger, cyclic AMP (cAMP). Methods/Principal Findings: Here we describe a genetically encoded buffer for cAMP based on the high-affinity cAMP-binding carboxy-terminus of the regulatory subunit RI beta of protein kinase A (PKA). Addition of targeting sequences permitted localization of this fragment to the extra-nuclear compartment, while tagging with mCherry allowed quantification of its expression at the single cell level. This construct (named "cAMP sponge") was shown to selectively bind cAMP in vitro. Its expression significantly suppressed agonist-induced cAMP signals and the downstream activation of PKA within the cytosol as measured by FRET-based sensors in single living cells. Point mutations in the cAMP-binding domains of the construct rendered the chimera unable to bind cAMP in vitro or in situ. Cyclic AMP sponge was fruitfully applied to examine feedback regulation of gap junction-mediated transfer of cAMP in epithelial cell couplets. Conclusions: This newest member of the cAMP toolbox has the potential to reveal unique biological functions of cAMP, including insight into the functional significance of compartmentalized signaling events.			Lefkimmiatis, K (corresponding author), Brigham & Womens Hosp, VA Boston Healthcare Syst, W Roxbury, MA USA.	ahofer@rics.bwh.harvard.edu	Lefkimmiatis, Konstantinos/AAL-1647-2021; Lefkimmiatis, Konstantinos/I-1239-2016	Lefkimmiatis, Konstantinos/0000-0001-7137-7866; Lefkimmiatis, Konstantinos/0000-0001-7137-7866				Acin-Perez R, 2009, CELL METAB, V9, P265, DOI 10.1016/j.cmet.2009.01.012; Allen MD, 2006, BIOCHEM BIOPH RES CO, V348, P716, DOI 10.1016/j.bbrc.2006.07.136; Beavo JA, 2002, NAT REV MOL CELL BIO, V3, P710, DOI 10.1038/nrm911; Cheng XD, 2008, ACTA BIOCH BIOPH SIN, V40, P651, DOI 10.1111/j.1745-7270.2008.00438.x; Dao KK, 2006, J BIOL CHEM, V281, P21500, DOI 10.1074/jbc.M603116200; Enserink JM, 2002, NAT CELL BIOL, V4, P901, DOI 10.1038/ncb874; FISCHER U, 1995, CELL, V82, P475, DOI 10.1016/0092-8674(95)90436-0; Gerbino A, 2005, J CELL BIOL, V171, P303, DOI 10.1083/jcb.200507054; Guo YH, 1999, AM J PHYSIOL-LUNG C, V276, pL1018, DOI 10.1152/ajplung.1999.276.6.L1018; Hernandez VH, 2007, NAT METHODS, V4, P353, DOI 10.1038/NMETH1031; Hofer AM, 1998, J CELL BIOL, V140, P325, DOI 10.1083/jcb.140.2.325; HOFMANN F, 1977, J BIOL CHEM, V252, P1441; Kothmann WW, 2007, VISUAL NEUROSCI, V24, P363, DOI 10.1017/S095252380707037X; Lefkimmiatis K, 2009, NAT CELL BIOL, V11, P433, DOI 10.1038/ncb1850; Moyer MP, 1996, IN VITRO CELL DEV-AN, V32, P315; Neves SR, 2002, BIOESSAYS, V24, P1110, DOI 10.1002/bies.1154; Neves SR, 2002, SCIENCE, V296, P1636, DOI 10.1126/science.1071550; Ponsioen B, 2004, EMBO REP, V5, P1176, DOI 10.1038/sj.embor.7400290; Ponsioen B, 2007, EXP CELL RES, V313, P415, DOI 10.1016/j.yexcr.2006.10.029; POTTER RL, 1978, ARCH BIOCHEM BIOPHYS, V190, P174, DOI 10.1016/0003-9861(78)90265-5; SARASWAT LD, 1988, J BIOL CHEM, V263, P18241; Shaner NC, 2004, NAT BIOTECHNOL, V22, P1567, DOI 10.1038/nbt1037; STAGG RB, 1990, ENDOCR REV, V11, P302, DOI 10.1210/edrv-11-2-302; TAYLOR SS, 1990, ANNU REV BIOCHEM, V59, P971, DOI 10.1146/annurev.bi.59.070190.004543; Terrin A, 2006, J CELL BIOL, V175, P441, DOI 10.1083/jcb.200605050; TSIEN RY, 1981, NATURE, V290, P527, DOI 10.1038/290527a0; TSIEN RY, 1980, BIOCHEMISTRY-US, V19, P2396, DOI 10.1021/bi00552a018; Uchiyama T, 2002, J BIOL CHEM, V277, P8106, DOI 10.1074/jbc.M108337200; Willoughby D, 2008, NAT METHODS, V5, P29, DOI 10.1038/NMETH1135; Zhang J, 2005, NATURE, V437, P569, DOI 10.1038/nature04140; Zippin JH, 2004, J CELL BIOL, V164, P527, DOI 10.1083/jcb.200311119; Zippin JH, 2002, FASEB J, V16, P82, DOI 10.1096/fj.02-0598fje	32	28	29	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2009	4	11							e7649	10.1371/journal.pone.0007649	http://dx.doi.org/10.1371/journal.pone.0007649			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RY	19888343	Green Published, Green Submitted, gold			2022-12-27	WOS:000271414500001
J	Katz, DA; Kiarie, JN; John-Stewart, GC; Richardson, BA; John, FN; Farquhar, C				Katz, David A.; Kiarie, James N.; John-Stewart, Grace C.; Richardson, Barbra A.; John, Francis N.; Farquhar, Carey			Male Perspectives on Incorporating Men into Antenatal HIV Counseling and Testing	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; RESOURCE-POOR SETTINGS; PREGNANT-WOMEN; BURKINA-FASO; RURAL MALAWI; COTE-DIVOIRE; SCALING-UP; ACCEPTABILITY; PREVENTION; NEVIRAPINE	Background: Male partner involvement in antenatal voluntary HIV counseling and testing (VCT) has been shown to increase uptake of interventions to reduce the risk of HIV transmission in resource-limited settings. We aimed to identify methods for increasing male involvement in antenatal VCT and determine male correlates of accepting couple counseling in these settings. Methodology/Principal Findings: We invited women presenting to a Nairobi antenatal clinic to return with their male partners for individual or couples VCT. Male attitudes towards VCT and correlates of accompanying female partners to antenatal clinic and receiving couple counseling were determined. Of 1,993 women who invited their partner, 313 (16%) returned with their partners to ANC. Men attending antenatal clinic were married (>99%), employed (98%), and unlikely to report prior HIV testing (14%). Wanting an HIV test (87%) or health information (11%) were the most commonly cited reasons for attending. Most (95%) men who came to antenatal clinic accepted HIV testing and 39% elected to receive counseling as a couple. Men who received counseling with partners were younger, had fewer children, and were less knowledgeable about prevention of mother-to-child HIV transmission (PMTCT) than those who received counseling individually (p<0.05). Only 27% of men stated they would prefer HIV testing at a site other than the ANC. There was agreement between male and female reports for sociodemographic characteristics; however, men were more likely to report HIV preventive behaviors and health communication within the partnership than their partners (p<0.05). Conclusions/Significance: Offering VCT services to men at antenatal clinic with options for couple and individual counseling is an important opportunity and acceptable strategy for increasing male involvement in PMTCT and promoting male HIV testing.			Katz, DA (corresponding author), Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA.	dkatz7@u.washington.edu	John-Stewart, Grace/U-3351-2019; John-Stewart, Grace/L-3650-2019	kiarie, james/0000-0003-4180-7858	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [K24HD054314] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [K23HD041879] Funding Source: NIH RePORTER; FOGARTY INTERNATIONAL CENTER [D43TW000007] Funding Source: NIH RePORTER; FIC NIH HHS [D43 TW000007] Funding Source: Medline; NICHD NIH HHS [K23 HD041879, K24 HD054314] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); FOGARTY INTERNATIONAL CENTER(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); FIC NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Fogarty International Center (FIC)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		[Anonymous], 2001, THE J, V35, P206, DOI [10.1023/A:1010484013306, DOI 10.1023/A:1010484013306, DOI 10.1023/A:1009584623712]; Baiden F, 2005, AIDS CARE, V17, P648, DOI 10.1080/09540120412331319688; Cartoux M, 1998, AIDS, V12, P2489, DOI 10.1097/00002030-199818000-00019; Cartoux M, 1998, AIDS, V12, P2337, DOI 10.1097/00002030-199817000-00016; deGraft-Johnson J, 2005, AIDS BEHAV, V9, P475, DOI 10.1007/s10461-005-9018-x; Desgrees-du-Lou A, 2002, INT J STD AIDS, V13, P462, DOI 10.1258/09564620260079617; Farquhar C, 2004, JAIDS-J ACQ IMM DEF, V37, P1620, DOI 10.1097/00126334-200412150-00016; Farquhar C, 2001, AIDS, V15, P815, DOI 10.1097/00002030-200104130-00027; Gage AJ, 2005, AIDS CARE, V17, P153, DOI 10.1080/09540120512331325635; Homsy J, 2006, JAIDS-J ACQ IMM DEF, V42, P149, DOI 10.1097/01.qai.0000225032.52766.c2; Johnson SK, 2008, LEADERSHIP QUART, V19, P1, DOI 10.1016/j.leaqua.2007.12.001; Kiarie J, 2000, AIDS, V14, P1468, DOI 10.1097/00002030-200007070-00030; Kiarie JN, 2003, AIDS, V17, P65, DOI 10.1097/00002030-200301030-00009; MACHEKANO R, 2000, AIDS BEHAV, V4, P63; Manzi M, 2005, TROP MED INT HEALTH, V10, P1242, DOI 10.1111/j.1365-3156.2005.01526.x; Meda N, 2002, AIDS, V16, P2323, DOI 10.1097/00002030-200211220-00013; Msuya SE, 2006, JAIDS-J ACQ IMM DEF, V43, P85, DOI 10.1097/01.qai.0000225016.50890.7e; Nebie Y, 2001, J ACQ IMMUN DEF SYND, V28, P367, DOI 10.1097/00126334-200112010-00010; Painter TM, 2005, INT J STD AIDS, V16, P237, DOI 10.1258/0956462053420158; Semrau K, 2005, AIDS, V19, P603, DOI 10.1097/01.aids.0000163937.07026.a0; Stringer EM, 2003, AIDS, V17, P1377, DOI 10.1097/00002030-200306130-00012; Stringer JSA, 2003, JAIDS-J ACQ IMM DEF, V32, P506, DOI 10.1097/00126334-200304150-00007; Temmerman M, 2003, AIDS, V17, P1239, DOI 10.1097/00002030-200305230-00016; Urassa P, 2005, AIDS CARE, V17, P842, DOI 10.1080/09540120500038231	24	90	90	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2009	4	11							e7602	10.1371/journal.pone.0007602	http://dx.doi.org/10.1371/journal.pone.0007602			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	514RX	19881884	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414400001
J	Li, M; Li, S; Yuan, J; Wang, ZB; Sun, SC; Schatten, H; Sun, QY				Li, Mo; Li, Sen; Yuan, Ju; Wang, Zhen-Bo; Sun, Shao-Chen; Schatten, Heide; Sun, Qing-Yuan			Bub3 Is a Spindle Assembly Checkpoint Protein Regulating Chromosome Segregation during Mouse Oocyte Meiosis	PLOS ONE			English	Article							ANAPHASE-PROMOTING COMPLEX; MITOTIC CHECKPOINT; KINETOCHORE LOCALIZATION; CYTOSTATIC FACTOR; MAMMALIAN OOCYTES; CELL-CYCLE; CYTOPLASMIC DYNEIN; METAPHASE ARREST; VERTEBRATE EGGS; XENOPUS-OOCYTES	In mitosis, the spindle assembly checkpoint (SAC) prevents anaphase onset until all chromosomes have been attached to the spindle microtubules and aligned correctly at the equatorial metaphase plate. The major checkpoint proteins in mitosis consist of mitotic arrest-deficient (Mad) 1-3, budding uninhibited by benzimidazole (Bub) 1, Bub3, and monopolar spindle 1(Mps1). During meiosis, for the formation of a haploid gamete, two consecutive rounds of chromosome segregation occur with only one round of DNA replication. To pull homologous chromosomes to opposite spindle poles during meiosis I, both sister kinetochores of a homologue must face toward the same pole which is very different from mitosis and meiosis II. As a core member of checkpoint proteins, the individual role of Bub3 in mammalian oocyte meiosis is unclear. In this study, using overexpression and RNA interference (RNAi) approaches, we analyzed the role of Bub3 in mouse oocyte meiosis. Our data showed that overexpressed Bub3 inhibited meiotic metaphase-anaphase transition by preventing homologous chromosome and sister chromatid segregations in meiosis I and II, respectively. Misaligned chromosomes, abnormal polar body and double polar bodies were observed in Bub3 knock-down oocytes, causing aneuploidy. Furthermore, through cold treatment combined with Bub3 overexpression, we found that overexpressed Bub3 affected the attachments of microtubules and kinetochores during metaphase-anaphase transition. We propose that as a member of SAC, Bub3 is required for regulation of both meiosis I and II, and is potentially involved in kinetochore-microtubule attachment in mammalian oocytes.			Li, M (corresponding author), Chinese Acad Sci, Inst Zool, State Key Lab Reprod Biol, Beijing, Peoples R China.	sunqy@ioz.ac.cn	Holt, Janet E/B-2415-2013					Abrieu A, 2001, CELL, V106, P83, DOI 10.1016/S0092-8674(01)00410-X; Babu JR, 2003, J CELL BIOL, V160, P341, DOI 10.1083/jcb.200211048; Bhatt RR, 1999, SCIENCE, V286, P1362, DOI 10.1126/science.286.5443.1362; Brady DM, 2000, CURR BIOL, V10, P675, DOI 10.1016/S0960-9822(00)00515-7; Brunet S, 2003, REPRODUCTION, V126, P443, DOI 10.1530/rep.0.1260443; Burke DJ, 2008, DEV CELL, V14, P474, DOI 10.1016/j.devcel.2008.03.015; Cahill DP, 1998, NATURE, V392, P300, DOI 10.1038/32688; Campbell L, 2003, J CELL SCI, V116, P617, DOI 10.1242/jcs.00255; Chen RH, 2002, J CELL BIOL, V158, P487, DOI 10.1083/jcb.200204048; Cleveland DW, 2003, CELL, V112, P407, DOI 10.1016/S0092-8674(03)00115-6; Hardwick KC, 2000, J CELL BIOL, V148, P871, DOI 10.1083/jcb.148.5.871; Hassold T, 2001, NAT REV GENET, V2, P280, DOI 10.1038/35066065; Homer HA, 2005, CELL CYCLE, V4, P650, DOI 10.4161/cc.4.5.1677; Homer HA, 2005, GENE DEV, V19, P202, DOI 10.1101/gad.328105; Howell BJ, 2004, CURR BIOL, V14, P953, DOI 10.1016/j.cub.2004.05.053; HOYT MA, 1991, CELL, V66, P507, DOI 10.1016/0092-8674(81)90014-3; HUNT P, 1995, HUM MOL GENET, V4, P2007, DOI 10.1093/hmg/4.11.2007; Hunt PA, 2002, SCIENCE, V296, P2181, DOI 10.1126/science.1071907; Hwang LH, 1998, SCIENCE, V279, P1041, DOI 10.1126/science.279.5353.1041; Irniger S, 2006, CELL CYCLE, V5, P405, DOI 10.4161/cc.5.4.2476; Jin DY, 1998, CELL, V93, P81, DOI 10.1016/S0092-8674(00)81148-4; Johnson VL, 2004, J CELL SCI, V117, P1577, DOI 10.1242/jcs.01006; Kalitsis P, 2000, GENE DEV, V14, P2277, DOI 10.1101/gad.827500; Kallio M, 2000, DEV BIOL, V225, P112, DOI 10.1006/dbio.2000.9818; Kallio MJ, 2002, CURR BIOL, V12, P900, DOI 10.1016/S0960-9822(02)00887-4; Kops GJPL, 2005, NAT REV CANCER, V5, P773, DOI 10.1038/nrc1714; Lemaire-Adkins R, 1997, J CELL BIOL, V139, P1611, DOI 10.1083/jcb.139.7.1611; LI R, 1991, CELL, V66, P519, DOI 10.1016/0092-8674(81)90015-5; Lo KWH, 2007, J BIOL CHEM, V282, P11205, DOI 10.1074/jbc.M611279200; Logarinho E, 2008, MOL BIOL CELL, V19, P1798, DOI 10.1091/mbc.E07-07-0633; Lopes CS, 2005, J CELL SCI, V118, P187, DOI 10.1242/jcs.01602; Malmanche N, 2006, FEBS LETT, V580, P2888, DOI 10.1016/j.febslet.2006.03.081; Masui Y, 2001, DIFFERENTIATION, V69, P1, DOI 10.1046/j.1432-0436.2001.690101.x; MCGUINNESS BE, 2009, CURR BIOL; Meraldi P, 2004, DEV CELL, V7, P45, DOI 10.1016/j.devcel.2004.06.006; Millband DN, 2002, MOL CELL BIOL, V22, P2728, DOI 10.1128/MCB.22.8.2728-2742.2002; Morrow CJ, 2005, J CELL SCI, V118, P3639, DOI 10.1242/jcs.02487; Musacchio A, 2002, NAT REV MOL CELL BIO, V3, P731, DOI 10.1038/nrm929; Musacchio A, 2007, NAT REV MOL CELL BIO, V8, P379, DOI 10.1038/nrm2163; Nasmyth K, 2005, CELL, V120, P739, DOI 10.1016/j.cell.2005.03.006; Niault T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001165; Peter M, 2001, NAT CELL BIOL, V3, P83, DOI 10.1038/35050607; Peters JM, 2006, NAT REV MOL CELL BIO, V7, P644, DOI 10.1038/nrm1988; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Pinsky BA, 2005, TRENDS CELL BIOL, V15, P486, DOI 10.1016/j.tcb.2005.07.005; Reimann JDR, 2002, NATURE, V416, P850, DOI 10.1038/416850a; RIEDER CL, 1981, CHROMOSOMA, V84, P145, DOI 10.1007/BF00293368; Rieder CL, 1998, TRENDS CELL BIOL, V8, P310, DOI 10.1016/S0962-8924(98)01299-9; Sakuno T, 2009, NATURE, V458, P852, DOI 10.1038/nature07876; Sakuno T, 2009, CHROMOSOME RES, V17, P239, DOI 10.1007/s10577-008-9013-y; Schmidt A, 2006, J CELL SCI, V119, P1213, DOI 10.1242/jcs.02919; Sharp-Baker H, 2001, J CELL BIOL, V153, P1239, DOI 10.1083/jcb.153.6.1239; Sotillo R, 2007, CANCER CELL, V11, P9, DOI 10.1016/j.ccr.2006.10.019; Sudakin V, 2001, J CELL BIOL, V154, P925, DOI 10.1083/jcb.200102093; Taieb FE, 2001, CURR BIOL, V11, P508, DOI 10.1016/S0960-9822(01)00145-2; Taylor SS, 2001, J CELL SCI, V114, P4385; Taylor SS, 1998, J CELL BIOL, V142, P1, DOI 10.1083/jcb.142.1.1; Tsurumi C, 2004, J CELL BIOL, V167, P1037, DOI 10.1083/jcb.200405165; Tunquist BJ, 2003, GENE DEV, V17, P683, DOI 10.1101/gad.1071303; Tunquist BJ, 2002, CURR BIOL, V12, P1027, DOI 10.1016/S0960-9822(02)00894-1; Vigneron S, 2004, MOL BIOL CELL, V15, P4584, DOI 10.1091/mbc.E04-01-0051; Vogt E, 2008, MUTAT RES-GEN TOX EN, V651, P14, DOI 10.1016/j.mrgentox.2007.10.015; Wang XS, 2001, J BIOL CHEM, V276, P26559, DOI 10.1074/jbc.M101083200; Wassmann K, 2003, CURR BIOL, V13, P1596, DOI 10.1016/j.cub.2003.08.052; Waters JC, 1998, J CELL BIOL, V141, P1181, DOI 10.1083/jcb.141.5.1181; Weiss E, 1996, J CELL BIOL, V132, P111, DOI 10.1083/jcb.132.1.111; Xiong B, 2008, BIOL REPROD, V79, P718, DOI 10.1095/biolreprod.108.069641; Yin S, 2008, CELL CYCLE, V7, P2997, DOI 10.4161/cc.7.19.6809; Yin S, 2006, CELL CYCLE, V5, P2130, DOI 10.4161/cc.5.18.3170; Yin S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003516; Zhang D, 2004, BIOL REPROD, V71, P740, DOI 10.1095/biolreprod.104.028282; Zhang D, 2007, REPRODUCTION, V133, P685, DOI 10.1530/rep.1.01167	72	88	90	2	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2009	4	11							e7701	10.1371/journal.pone.0007701	http://dx.doi.org/10.1371/journal.pone.0007701			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RX	19888327	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414400011
J	Guo, YB; Zhang, XQ; Huang, J; Zeng, Y; Liu, W; Geng, C; Li, KW; Yang, D; Wu, SF; Wei, HD; Han, ZG; Qian, XH; Jiang, Y; He, FC				Guo, Yuanbiao; Zhang, Xuequn; Huang, Jian; Zeng, Yan; Liu, Wei; Geng, Chao; Li, Ka Wan; Yang, Dong; Wu, Songfeng; Wei, Handong; Han, Zeguang; Qian, Xiaohong; Jiang, Ying; He, Fuchu			Relationships between Hematopoiesis and Hepatogenesis in the Midtrimester Fetal Liver Characterized by Dynamic Transcriptomic and Proteomic Profiles	PLOS ONE			English	Article							STEM-CELL PROPERTIES; BONE-MARROW; SELF-RENEWAL; GENE-EXPRESSION; PROTEIN; MOUSE; SYSTEM; GROWTH; DIFFERENTIATION; IDENTIFICATION	In fetal hematopoietic organs, the switch from hematopoiesis is hypothesized to be a critical time point for organogenesis, but it is not yet evidenced. The transient coexistence of hematopoiesis will be useful to understand the development of fetal liver (FL) around this time and its relationship to hematopoiesis. Here, the temporal and the comparative transcriptomic and proteomic profiles were observed during the critical time points corresponding to the initiation (E11.5), peak (E14.5), recession (E15.5), and disappearance (3 ddp) of mouse FL hematopoiesis. We found that E11.5-E14.5 corresponds to a FL hematopoietic expansion phase with distinct molecular features, including the expression of new transcription factors, many of which are novel KRAB (Kruppel-associated box)-containing zinc finger proteins. This time period is also characterized by extensive depression of some liver functions, especially catabolism/utilization, immune and defense, classical complement cascades, and intrinsic blood coagulation. Instead, the other liver functions increased, such as xenobiotic and sterol metabolism, synthesis of carbohydrate and glycan, the alternate and lectin complement cascades and extrinsic blood coagulation, and etc. Strikingly, all of the liver functions were significantly increased at E14.5-E15.5 and thereafter, and the depression of the key pathways attributes to build the hematopoietic microenvironment. These findings signal hematopoiesis emigration is the key to open the door of liver maturation.			Guo, YB (corresponding author), Beijing Inst Radiat Med, Beijing Proteome Res Ctr, State Key Lab Prote, Beijing, Peoples R China.	jiangy@hupo.org.cn; hefc@nic.bmi.ac.cn		Guo, Yuanbiao/0000-0002-7571-8864; Han, Ze-Guang/0000-0002-1018-1752; li, ka wan/0000-0001-6983-5055				Alpy F, 2005, J CELL SCI, V118, P2791, DOI 10.1242/jcs.02485; Bowie MB, 2007, P NATL ACAD SCI USA, V104, P5878, DOI 10.1073/pnas.0700460104; Byrd N, 2002, DEVELOPMENT, V129, P361; Calvano SE, 2005, NATURE, V437, P1032, DOI 10.1038/nature03985; Chagraoui J, 2003, BLOOD, V101, P2973, DOI 10.1182/blood-2002-05-1341; Dikalov S, 2007, HYPERTENSION, V49, P717, DOI 10.1161/01.HYP.0000258594.87211.6b; Dong Z, 2004, J BIOL CHEM, V279, P9215, DOI 10.1074/jbc.M312225200; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Fan CY, 1998, J BIOL CHEM, V273, P15639, DOI 10.1074/jbc.273.25.15639; Galan-Caridad JM, 2007, CELL, V129, P345, DOI 10.1016/j.cell.2007.03.014; Hayhurst GP, 2001, MOL CELL BIOL, V21, P1393, DOI 10.1128/MCB.21.4.1393-1403.2001; Ho AD, 2007, CURR OPIN HEMATOL, V14, P330, DOI 10.1097/MOH.0b013e3281900f12; IKUTA K, 1992, P NATL ACAD SCI USA, V89, P1502, DOI 10.1073/pnas.89.4.1502; Ivanova NB, 2002, SCIENCE, V298, P601, DOI 10.1126/science.1073823; Kamminga LM, 2006, BLOOD, V107, P2170, DOI 10.1182/blood-2005-09-3585; Katayama Y, 2006, CELL, V124, P407, DOI 10.1016/j.cell.2005.10.041; Kiel MJ, 2008, NAT REV IMMUNOL, V8, P290, DOI 10.1038/nri2279; Kikuchi K, 2006, P NATL ACAD SCI USA, V103, P17852, DOI 10.1073/pnas.0603368103; Kinoshita T, 1999, P NATL ACAD SCI USA, V96, P7265, DOI 10.1073/pnas.96.13.7265; Kinoshita T, 2002, BBA-MOL CELL RES, V1592, P303, DOI 10.1016/S0167-4889(02)00323-3; Kung AL, 2000, NAT MED, V6, P1335, DOI 10.1038/82146; LANSDORP PM, 1993, J EXP MED, V178, P787, DOI 10.1084/jem.178.3.787; Li J, 2006, J BIOL CHEM, V281, P16536, DOI 10.1074/jbc.M601386200; Mikkola HKA, 2006, DEVELOPMENT, V133, P3733, DOI 10.1242/dev.02568; MORRISON SJ, 1995, P NATL ACAD SCI USA, V92, P10302, DOI 10.1073/pnas.92.22.10302; MOTOYAMA N, 1995, SCIENCE, V267, P1506, DOI 10.1126/science.7878471; Nogueira MM, 2000, BIOCHEM BIOPH RES CO, V276, P803, DOI 10.1006/bbrc.2000.3543; Nomura S, 1997, EXP HEMATOL, V25, P565; Ohno N, 2001, STEM CELLS, V19, P71, DOI 10.1634/stemcells.19-1-71; Peault B, 1996, J Hematother, V5, P369, DOI 10.1089/scd.1.1996.5.369; Peng HZ, 2000, J BIOL CHEM, V275, P18000, DOI 10.1074/jbc.M001499200; Rasanen TL, 2002, J BIOL CHEM, V277, P39867, DOI 10.1074/jbc.M205967200; Rebel VI, 2002, P NATL ACAD SCI USA, V99, P14789, DOI 10.1073/pnas.232568499; Rudnick DA, 2001, P NATL ACAD SCI USA, V98, P8885, DOI 10.1073/pnas.151217998; Sandhu JS, 2001, AM J PATHOL, V159, P1323, DOI 10.1016/S0002-9440(10)62519-9; Sato EF, 2004, BIOCHEMISTRY-MOSCOW+, V69, P18, DOI 10.1023/B:BIRY.0000016346.61403.24; Sattler M, 1999, BLOOD, V93, P2928; Sitnicka E, 1996, BLOOD, V88, P82; SKORIN C, 1992, BIOCHEM J, V281, P561, DOI 10.1042/bj2810561; SLAPERCORTENBACH I, 1987, BLOOD, V69, P135; Stopka T, 2003, P NATL ACAD SCI USA, V100, P14097, DOI 10.1073/pnas.2336105100; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Takeuchi M, 2002, BLOOD, V99, P1190, DOI 10.1182/blood.V99.4.1190; Tanimizu N, 2003, J CELL SCI, V116, P1775, DOI 10.1242/jcs.00388; Wolber FM, 2002, EXP HEMATOL, V30, P1010, DOI 10.1016/S0301-472X(02)00881-0; Yang Y, 2005, ONCOGENE, V24, P4778, DOI 10.1038/sj.onc.1208666; Ying WT, 2006, MOL CELL PROTEOMICS, V5, P1703, DOI 10.1074/mcp.M500344-MCP200; Zhang XQ, 2006, PROTEOMICS, V6, P5260, DOI 10.1002/pmic.200600006; Zhao R, 2005, HEPATOLOGY, V41, P956, DOI 10.1002/hep.20691	49	22	23	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7641	10.1371/journal.pone.0007641	http://dx.doi.org/10.1371/journal.pone.0007641			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19865483	Green Published, gold, Green Submitted			2022-12-27	WOS:000271194600019
J	McQuisten, KA; Peek, AS				McQuisten, Kyle A.; Peek, Andrew S.			Comparing Artificial Neural Networks, General Linear Models and Support Vector Machines in Building Predictive Models for Small Interfering RNAs	PLOS ONE			English	Article							RATIONAL SIRNA DESIGN; FUNCTIONAL SIRNAS; MAMMALIAN-CELLS; EFFICIENT; SEQUENCES; SELECTION; ANTISENSE; EFFICACY; FEATURES; OLIGONUCLEOTIDES	Background: Exogenous short interfering RNAs (siRNAs) induce a gene knockdown effect in cells by interacting with naturally occurring RNA processing machinery. However not all siRNAs induce this effect equally. Several heterogeneous kinds of machine learning techniques and feature sets have been applied to modeling siRNAs and their abilities to induce knockdown. There is some growing agreement to which techniques produce maximally predictive models and yet there is little consensus for methods to compare among predictive models. Also, there are few comparative studies that address what the effect of choosing learning technique, feature set or cross validation approach has on finding and discriminating among predictive models. Principal Findings: Three learning techniques were used to develop predictive models for effective siRNA sequences including Artificial Neural Networks (ANNs), General Linear Models (GLMs) and Support Vector Machines (SVMs). Five feature mapping methods were also used to generate models of siRNA activities. The 2 factors of learning technique and feature mapping were evaluated by complete 3x5 factorial ANOVA. Overall, both learning techniques and feature mapping contributed significantly to the observed variance in predictive models, but to differing degrees for precision and accuracy as well as across different kinds and levels of model cross-validation. Conclusions: The methods presented here provide a robust statistical framework to compare among models developed under distinct learning techniques and feature sets for siRNAs. Further comparisons among current or future modeling approaches should apply these or other suitable statistically equivalent methods to critically evaluate the performance of proposed models. ANN and GLM techniques tend to be more sensitive to the inclusion of noisy features, but the SVM technique is more robust under large numbers of features for measures of model precision and accuracy. Features found to result in maximally predictive models are not consistent across learning techniques, suggesting care should be taken in the interpretation of feature relevance. In the models developed here, there are statistically differentiable combinations of learning techniques and feature mapping methods where the SVM technique under a specific combination of features significantly outperforms all the best combinations of features within the ANN and GLM techniques.			McQuisten, KA (corresponding author), Integrated DNA Technol Inc, Dept Bioinformat, Coralville, IA USA.	andrew.peek@roche.com			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R43GM079132] Funding Source: NIH RePORTER; NIGMS NIH HHS [NIH-1R43GM079132-01, R43 GM079132] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Amarzguioui M, 2004, BIOCHEM BIOPH RES CO, V316, P1050, DOI 10.1016/j.bbrc.2004.02.157; Bohula EA, 2003, J BIOL CHEM, V278, P15991, DOI 10.1074/jbc.M300714200; Bradac I, 2007, BIOCHEM BIOPH RES CO, V359, P83, DOI 10.1016/j.bbrc.2007.05.056; Chalk AM, 2004, BIOCHEM BIOPH RES CO, V319, P264, DOI 10.1016/j.bbrc.2004.04.181; de Almeida RS, 2008, ANTIVIR RES, V79, P37, DOI 10.1016/j.antiviral.2008.01.159; Dietterich TG, 1998, NEURAL COMPUT, V10, P1895, DOI 10.1162/089976698300017197; Far RKK, 2003, NUCLEIC ACIDS RES, V31, P4417, DOI 10.1093/nar/gkg649; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Ge GT, 2005, BIOCHEM BIOPH RES CO, V336, P723, DOI 10.1016/j.bbrc.2005.08.147; GONG W, 2006, BMC BIOINFORMATICS, V7, P1; Henschel A, 2004, NUCLEIC ACIDS RES, V32, pW113, DOI 10.1093/nar/gkh408; Holen T, 2006, RNA, V12, P1620, DOI 10.1261/rna.81006; Hsieh AC, 2004, NUCLEIC ACIDS RES, V32, P893, DOI 10.1093/nar/gkh238; Huesken D, 2005, NAT BIOTECHNOL, V23, P995, DOI 10.1038/nbt1118; HUESKEN D, 2005, NAT BIOTECHNOL, V23, P1315; Ichihara M, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm699; Jagla B, 2005, RNA, V11, P864, DOI 10.1261/rna.7275905; Jia PL, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-271; Jiang P, 2007, COMPUT METH PROG BIO, V87, P230, DOI 10.1016/j.cmpb.2007.06.001; Katoh T, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl1120; Khvorova A, 2003, CELL, V115, P209, DOI 10.1016/S0092-8674(03)00801-8; Ladunga I, 2007, NUCLEIC ACIDS RES, V35, P433, DOI 10.1093/nar/gkl1065; LU ZJ, 2007, NUCL ACIDS RES; Matveeva O, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm088; Nadeau C, 2003, MACH LEARN, V52, P239, DOI 10.1023/A:1024068626366; Peek AS, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-182; Poliseno L, 2004, OLIGONUCLEOTIDES, V14, P227, DOI 10.1089/oli.2004.14.227; Reynolds A, 2004, NAT BIOTECHNOL, V22, P326, DOI 10.1038/nbt936; Saetrom P, 2004, BIOINFORMATICS, V20, P3055, DOI 10.1093/bioinformatics/bth364; Saetrom P, 2004, BIOCHEM BIOPH RES CO, V321, P247, DOI 10.1016/j.bbrc.2004.06.116; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Shabalina SA, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-65; Tafer H, 2008, NAT BIOTECHNOL, V26, P578, DOI 10.1038/nbt1404; Takasaki S, 2004, CELL CYCLE, V3, P790; Teramoto R, 2005, FEBS LETT, V579, P2878, DOI 10.1016/j.febslet.2005.04.045; Ui-Tei K, 2004, NUCLEIC ACIDS RES, V32, P936, DOI 10.1093/nar/gkh247; Vert JP., 2006, BMC BIOINFORMATICS, V7, P1; Vickers TA, 2003, J BIOL CHEM, V278, P7108, DOI 10.1074/jbc.M210326200; Walters DK, 2002, ANTISENSE NUCLEIC A, V12, P411, DOI 10.1089/108729002321082483; Xue CH, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-310; Yiu SM, 2005, BIOINFORMATICS, V21, P144, DOI 10.1093/bioinformatics/bth498	41	13	13	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7522	10.1371/journal.pone.0007522	http://dx.doi.org/10.1371/journal.pone.0007522			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847297	Green Submitted, Green Published, gold			2022-12-27	WOS:000271022000011
J	Legoffic, A; Calvo, E; Cano, C; Folch-Puy, E; Barthet, M; Delpero, JR; Ferres-Maso, M; Dagorn, JC; Closa, D; Iovanna, J				Legoffic, Aude; Calvo, Ezequiel; Cano, Carla; Folch-Puy, Emma; Barthet, Marc; Delpero, Jean Robert; Ferres-Maso, Montse; Dagorn, Jean Charles; Closa, Daniel; Iovanna, Juan			The reg4 Gene, Amplified in the Early Stages of Pancreatic Cancer Development, Is a Promising Therapeutic Target	PLOS ONE			English	Article							COMPARATIVE GENOMIC HYBRIDIZATION; GASTRIC-CANCER; IV; IDENTIFICATION; MARKER; FAMILY; OVEREXPRESSION; ADENOCARCINOMA; METASTASIS; EXPRESSION	Background: The aim of our work was to identify the genes specifically altered in pancreatic adenocarcinoma and especially those that are altered early in cancer development. Methodology/Principal Findings: Gene copy number was systematically assessed with an ultra-high resolution CGH oligonucleotide microarray in DNA from samples of pancreatic cancer. Several new cancer-associated variations were observed. In this work we focused on one of them, involving the reg4 gene. Gene copy number gain of the reg4 gene was confirmed by qPCR in 14 cancer samples. It was also found with increased copy number in most PanIN3 samples. The relationship betweena gain in reg4 gene copy number and cancer development was investigated on the human pancreatic cancer cell line Mia-PaCa2 xenografted under the skin of nude mice. When cells were transfected with a vector allowing reg4 expression, they generated tumors almost twice larger in size. In addition, these tumors were more resistant to gemcitabine treatment than control tumors. Interestingly, weekly intraperitoneal administration of a monoclonal antibody to reg4 halved the size of tumors generated by Mia-PaCa2 cells, suggesting that the antibody interfered with a paracrine/autocrine mechanism involving reg4 and stimulating cancer progression. The addition of gemcitabine resulted in further reduction, tumors becoming 5 times smaller than control. Exposure to reg4 antibody resulted in a significant decrease in intra-tumor levels of pAkt, Bcl-xL, Bcl-2, survivin and cyclin D1. Conclusions/Significance: It was concluded that adjuvant therapies targeting reg4 could improve the standard treatment of pancreatic cancer with gemcitabine.	[Legoffic, Aude; Cano, Carla; Barthet, Marc; Dagorn, Jean Charles; Iovanna, Juan] INSERM, U624, Parc Sci & Technol Luminy, F-13258 Marseille, France; [Calvo, Ezequiel] CHUL Res Ctr, Mol Endocrinol & Oncol Res Ctr, Quebec City, PQ, Canada; [Folch-Puy, Emma; Ferres-Maso, Montse; Closa, Daniel] IIBB CSIC IDIBAPS, Expt Pathol Dept, CIBERehd, Barcelona, Spain; [Delpero, Jean Robert] Inst Paoli Calmettes, Dept Chirurg Oncol, Marseille, France	Institut National de la Sante et de la Recherche Medicale (Inserm); UDICE-French Research Universities; Aix-Marseille Universite; Laval University; CIBER - Centro de Investigacion Biomedica en Red; CIBEREHD; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Instituto de Investigaciones Biomedicas de Barcelona (IIBB); University of Barcelona; Hospital Clinic de Barcelona; IDIBAPS; UNICANCER; Institut Paoli-Calmette (IPC)	Legoffic, A (corresponding author), INSERM, U624, Parc Sci & Technol Luminy, F-13258 Marseille, France.	juan.iovanna@inserm.fr	Puy, Emma Folch/AAX-5558-2020; Closa, Daniel/Y-3848-2019; Folch Puy, Emma/Q-3157-2017; Iovanna, Juan/M-9805-2017	Puy, Emma Folch/0000-0002-6277-9027; Folch Puy, Emma/0000-0002-6277-9027; Iovanna, Juan/0000-0003-1822-2237; Closa Autet, Daniel/0000-0003-3797-3095; DELPERO, JEAN ROBERT/0000-0002-0000-1332				Bardeesy N, 2002, NAT REV CANCER, V2, P897, DOI 10.1038/nrc949; Bishnupuri KS, 2006, GASTROENTEROLOGY, V130, P137, DOI 10.1053/j.gastro.2005.10.001; Chappuis PO, 2001, CANCER INVEST, V19, P65, DOI 10.1081/CNV-100000076; EGUCHI H, 2009, PANCREAS        0620; Furukawa T, 2006, CANCER SCI, V97, P1, DOI 10.1111/j.1349-7006.2005.00134.x; Gu ZN, 2005, CLIN CANCER RES, V11, P2237, DOI 10.1158/1078-0432.CCR-04-0356; Harada T, 2007, BRIT J CANCER, V96, P373, DOI 10.1038/sj.bjc.6603563; Harada T, 2002, CANCER RES, V62, P835; Hartupee JC, 2001, BBA-GENE STRUCT EXPR, V1518, P287, DOI 10.1016/S0167-4781(00)00284-0; Hruban RH, 2001, AM J SURG PATHOL, V25, P579, DOI 10.1097/00000478-200105000-00003; Hruban RH, 2000, CLIN CANCER RES, V6, P2969; Iovanna JL, 2005, BBA-GEN SUBJECTS, V1723, P8, DOI 10.1016/j.bbagen.2005.01.002; Jemal A, 2007, CA-CANCER J CLIN, V57, P43, DOI 10.3322/canjclin.57.1.43; Kitoh H, 2005, J GASTROENTEROL, V40, P511, DOI 10.1007/s00535-005-1577-0; Kuniyasu H, 2009, CELL PROLIFERAT, V42, P110, DOI 10.1111/j.1365-2184.2008.00577.x; Mahlamaki EH, 1997, GENE CHROMOSOME CANC, V20, P383, DOI 10.1002/(SICI)1098-2264(199712)20:4<383::AID-GCC10>3.0.CO;2-O; Mitani Y, 2007, ONCOGENE, V26, P4383, DOI 10.1038/sj.onc.1210215; Miyagawa K, 2008, ANTICANCER RES, V28, P1169; Nanakin A, 2007, LAB INVEST, V87, P304, DOI 10.1038/labinvest.3700507; Ohara S, 2008, CANCER SCI, V99, P1570, DOI 10.1111/j.1349-7006.2008.00846.x; Olive KP, 2009, SCIENCE, V324, P1457, DOI 10.1126/science.1171362; Oue N, 2004, CANCER RES, V64, P2397, DOI 10.1158/0008-5472.CAN-03-3514; Saif MW, 2007, WORLD J GASTROENTERO, V13, P4423; Schleger C, 2000, J PATHOL, V191, P27, DOI 10.1002/(SICI)1096-9896(200005)191:1<27::AID-PATH582>3.0.CO;2-J; Singh M, 2007, PANCREATOLOGY, V7, P9, DOI 10.1159/000101873; SolinasToldo S, 1996, CANCER RES, V56, P3803; Takehara A, 2006, CANCER SCI, V97, P1191, DOI 10.1111/j.1349-7006.2006.00297.x; Violette S, 2003, INT J CANCER, V103, P185, DOI 10.1002/ijc.10788; WAN J, 2009, J MED CHEM      0126; Zhang YW, 2003, CANCER LETT, V200, P69, DOI 10.1016/S0304-3835(03)00460-9	30	21	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7495	10.1371/journal.pone.0007495	http://dx.doi.org/10.1371/journal.pone.0007495			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834624	Green Published, Green Submitted, gold			2022-12-27	WOS:000270880700017
J	Beaule, C; Swanstrom, A; Leone, MJ; Herzog, ED				Beaule, Christian; Swanstrom, Adrienne; Leone, Maria Juliana; Herzog, Erik D.			Circadian Modulation of Gene Expression, but not Glutamate Uptake, in Mouse and Rat Cortical Astrocytes	PLOS ONE			English	Article							CLOCK GENE; OSCILLATORS; TRANSPORTERS; RHYTHMS; ANALOGS; PROTEIN; GLIA	Background: Circadian clocks control daily rhythms including sleep-wake, hormone secretion, and metabolism. These clocks are based on intracellular transcription-translation feedback loops that sustain daily oscillations of gene expression in many cell types. Mammalian astrocytes display circadian rhythms in the expression of the clock genes Period1 (Per1) and Period2 (Per2). However, a functional role for circadian oscillations in astrocytes is unknown. Because uptake of extrasynaptic glutamate depends on the presence of Per2 in astrocytes, we asked whether glutamate uptake by glia is circadian. Methodology/Principal Findings: We measured glutamate uptake, transcript and protein levels of the astrocyte-specific glutamate transporter, Glast, and the expression of Per1 and Per2 from cultured cortical astrocytes and from explants of somatosensory cortex. We found that glutamate uptake and Glast mRNA and protein expression were significantly reduced in Clock/Clock, Per2- or NPAS2-deficient glia. Uptake was augmented when the medium was supplemented with dibutyryl-cAMP or B27. Critically, glutamate uptake was not circadian in cortical astrocytes cultured from rats or mice or in cortical slices from mice. Conclusion/Significance: We conclude that glutamate uptake levels are modulated by CLOCK, PER2, NPAS2, and the composition of the culture medium, and that uptake does not show circadian variations.			Beaule, C (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	Herzog@wustl.edu		Herzog, Erik/0000-0001-7209-5174	Howard Hughes Medical Institute Funding Source: Medline; NIMH NIH HHS [MH 63104, R01 MH063104] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH063104] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abe M, 2002, J NEUROSCI, V22, P350, DOI 10.1523/JNEUROSCI.22-01-00350.2002; Antoch MP, 1997, CELL, V89, P655, DOI 10.1016/S0092-8674(00)80246-9; Bae K, 2001, NEURON, V30, P525, DOI 10.1016/S0896-6273(01)00302-6; Barnard AR, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000040; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; BRIDGES RJ, 1991, J MED CHEM, V34, P717, DOI 10.1021/jm00106a037; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; Dash MB, 2009, J NEUROSCI, V29, P580, DOI 10.1523/JNEUROSCI.5486-08.2009; DeBruyne JP, 2007, CURR BIOL, V17, pR538, DOI 10.1016/j.cub.2007.05.067; DEBRUYNE JP, 2007, NAT NEUROSCI; Dudley CA, 2003, SCIENCE, V301, P379, DOI 10.1126/science.1082795; Furuta A, 1997, J NEUROSCI, V17, P8363; Garcia JA, 2000, SCIENCE, V288, P2226, DOI 10.1126/science.288.5474.2226; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Hastings MH, 2004, J BIOL RHYTHM, V19, P400, DOI 10.1177/0748730404268786; Hertz L, 1990, Adv Exp Med Biol, V265, P227; Kalivas PW, 2004, CURR OPIN PHARMACOL, V4, P23, DOI 10.1016/j.coph.2003.11.002; King DP, 1997, GENETICS, V146, P1049; Ko CH, 2006, HUM MOL GENET, V15, pR271, DOI 10.1093/hmg/ddl207; MARPEGAN L, 2009, J BIOL RHYTHMS; Maywood ES, 2006, PROG BRAIN RES, V153, P253, DOI 10.1016/S0079-6123(06)53015-8; MCCLUNG CA, 2005, P NATL ACAD SCI US; NOBLE M, 1991, CULTURING NERVE CELL, P499; O'Neill JS, 2008, SCIENCE, V320, P949, DOI 10.1126/science.1152506; Oishi K, 2006, J THROMB HAEMOST, V4, P1774, DOI 10.1111/j.1538-7836.2006.02032.x; Prolo LM, 2005, J NEUROSCI, V25, P404, DOI 10.1523/JNEUROSCI.4133-04.2005; Regan MR, 2007, J NEUROSCI, V27, P6607, DOI 10.1523/JNEUROSCI.0790-07.2007; Reick M, 2001, SCIENCE, V293, P506, DOI 10.1126/science.1060699; ROYBAL K, 2007, P NATL ACAD SCI US; Schlag BD, 1998, MOL PHARMACOL, V53, P355, DOI 10.1124/mol.53.3.355; Spanagel R, 2005, NAT MED, V11, P35, DOI 10.1038/nm1163; Suh J, 2007, NEURON, V55, P435, DOI 10.1016/j.neuron.2007.06.038; TUREK FW, 2005, SCIENCE; VITATERNA MH, 1994, SCIENCE, V264, P719, DOI 10.1126/science.8171325; Waagepetersen HS, 2001, NEUROCHEM RES, V26, P661, DOI 10.1023/A:1010939304104; Womac AD, 2009, EUR J NEUROSCI, V30, P869, DOI 10.1111/j.1460-9568.2009.06874.x; Won CK, 2000, BRAIN RES, V887, P250, DOI 10.1016/S0006-8993(00)02922-X; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Yoo SH, 2004, P NATL ACAD SCI USA, V12, P1	39	53	53	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7476	10.1371/journal.pone.0007476	http://dx.doi.org/10.1371/journal.pone.0007476			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829696	Green Submitted, gold, Green Published			2022-12-27	WOS:000270847800013
J	Krauss, S; So, J; Hambrock, M; Kohler, A; Kunath, M; Scharff, C; Wessling, M; Grzeschik, KH; Schneider, R; Schweiger, S				Krauss, Sybille; So, Joyce; Hambrock, Melanie; Koehler, Andrea; Kunath, Melanie; Scharff, Constance; Wessling, Martina; Grzeschik, Karl-Heinz; Schneider, Rainer; Schweiger, Susann			Point Mutations in GLI3 Lead to Misregulation of its Subcellular Localization	PLOS ONE			English	Article							GREIG CEPHALOPOLYSYNDACTYLY SYNDROME; HEDGEHOG SIGNAL-TRANSDUCTION; PROTEIN PHOSPHATASE 2A; SYNDROME GENE MID1; OPITZ-SYNDROME; SPINAL-CORD; ACTIVATOR FUNCTION; SYNDROME FAMILIES; UBIQUITIN LIGASE; VERTEBRATE LIMB	Background: Mutations in the transcription factor GLI3, a downstream target of Sonic Hedgehog (SHH) signaling, are responsible for the development of malformation syndromes such as Greig-cephalopolysyndactyly-syndrome (GCPS), or Pallister-Hall-syndrome (PHS). Mutations that lead to loss of function of the protein and to haploinsufficiency cause GCPS, while truncating mutations that result in constitutive repressor function of GLI3 lead to PHS. As an exception, some point mutations in the C-terminal part of GLI3 observed in GCPS patients have so far not been linked to loss of function. We have shown recently that protein phosphatase 2A (PP2A) regulates the nuclear localization and transcriptional activity a of GLI3 function. Principal Findings: We have shown recently that protein phosphatase 2A (PP2A) and the ubiquitin ligase MID1 regulate the nuclear localization and transcriptional activity of GLI3. Here we show mapping of the functional interaction between the MID1-a4-PP2A complex and GLI3 to a region between amino acid 568-1100 of GLI3. Furthermore we demonstrate that GCPS-associated point mutations, that are located in that region, lead to misregulation of the nuclear GLI3-localization and transcriptional activity. GLI3 phosphorylation itself however appears independent of its localization and remains untouched by either of the point mutations and by PP2A-activity, which suggests involvement of an as yet unknown GLI3 interaction partner, the phosphorylation status of which is regulated by PP2A activity, in the control of GLI3 subcellular localization and activity. Conclusions: The present findings provide an explanation for the pathogenesis of GCPS in patients carrying C-terminal point mutations, and close the gap in our understanding of how GLI3-genotypes give rise to particular phenotypes. Furthermore, they provide a molecular explanation for the phenotypic overlap between Opitz syndrome patients with dysregulated PP2A-activity and syndromes caused by GLI3-mutations.			Krauss, S (corresponding author), Charite, Dept Dermatol, Berlin, Germany.	rainer.schneider@uibk.ac.at	Krauss, Sybille/L-5328-2016; Scharff, Constance/HHN-0673-2022	Krauss, Sybille/0000-0002-5653-9289				Aranda-Orgilles B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003507; Bai CB, 2004, DEV CELL, V6, P103, DOI 10.1016/S1534-5807(03)00394-0; Bai CYB, 2001, DEVELOPMENT, V128, P5161; Biesecker LG, 1997, NAT GENET, V17, P259, DOI 10.1038/ng1197-259; Bok J, 2007, DEVELOPMENT, V134, P1713, DOI 10.1242/dev.000760; Brunner HG, 2004, NAT REV GENET, V5, P545, DOI 10.1038/nrg1383; Buchner G, 1999, HUM MOL GENET, V8, P1397, DOI 10.1093/hmg/8.8.1397; Buttitta L, 2003, DEVELOPMENT, V130, P6233, DOI 10.1242/dev.00851; Dai P, 1999, J BIOL CHEM, V274, P8143, DOI 10.1074/jbc.274.12.8143; Elson E, 2002, J MED GENET, V39, P804, DOI 10.1136/jmg.39.11.804; Haycraft CJ, 2005, PLOS GENET, V1, P480, DOI 10.1371/journal.pgen.0010053; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Johnston JJ, 2005, AM J HUM GENET, V76, P609, DOI 10.1086/429346; Kalff-Suske M, 1999, HUM MOL GENET, V8, P1769, DOI 10.1093/hmg/8.9.1769; KAMACHI Y, 1993, MOL CELL BIOL, V13, P5206, DOI 10.1128/MCB.13.9.5206; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Kim JH, 2005, DEV DYNAM, V234, P984, DOI 10.1002/dvdy.20542; KLOSE J, 1995, ELECTROPHORESIS, V16, P1034, DOI 10.1002/elps.11501601175; Krauss S, 2008, CANCER RES, V68, P4658, DOI 10.1158/0008-5472.CAN-07-6174; Lei QB, 2004, DEVELOPMENT, V131, P3593, DOI 10.1242/dev.01230; Litingtung Y, 2002, NATURE, V418, P979, DOI 10.1038/nature01033; Liu AM, 2005, DEVELOPMENT, V132, P3103, DOI 10.1242/dev.01894; Murone M, 1999, EXP CELL RES, V253, P25, DOI 10.1006/excr.1999.4676; Nybakken K, 2002, CURR OPIN GENET DEV, V12, P503, DOI 10.1016/S0959-437X(02)00333-7; Pan Y, 2007, J BIOL CHEM, V282, P10846, DOI 10.1074/jbc.M608599200; Perry J, 1999, GENOMICS, V62, P385, DOI 10.1006/geno.1999.6043; Persson M, 2002, GENE DEV, V16, P2865, DOI 10.1101/gad.243402; Price MA, 2002, CELL, V108, P823, DOI 10.1016/S0092-8674(02)00664-5; Quaderi NA, 1997, NAT GENET, V17, P285, DOI 10.1038/ng1197-285; Sasaki H, 1997, DEVELOPMENT, V124, P1313; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; Tempe D, 2006, MOL CELL BIOL, V26, P4316, DOI 10.1128/MCB.02183-05; Therond PP, 1996, P NATL ACAD SCI USA, V93, P4224, DOI 10.1073/pnas.93.9.4224; Trockenbacher A, 2001, NAT GENET, V29, P287, DOI 10.1038/ng762; Tyurina OV, 2005, DEV BIOL, V277, P537, DOI 10.1016/j.ydbio.2004.10.003; VORTKAMP A, 1991, NATURE, V352, P539, DOI 10.1038/352539a0; Wang BL, 2000, CELL, V100, P423, DOI 10.1016/S0092-8674(00)80678-9; Wang CB, 2007, DEV BIOL, V305, P460, DOI 10.1016/j.ydbio.2007.02.029; Welscher PT, 2002, SCIENCE, V298, P827, DOI 10.1126/science.1075620; Wijgerde M, 2002, GENE DEV, V16, P2849, DOI 10.1101/gad.1025702; Wild A, 1997, HUM MOL GENET, V6, P1979, DOI 10.1093/hmg/6.11.1979; Winter J, 2004, HUM GENET, V114, P541, DOI 10.1007/s00439-004-1114-x; Winter J, 2007, BMC MOL BIOL, V8, DOI 10.1186/1471-2199-8-105; Ying LT, 2000, NAT NEUROSCI, V3, P979, DOI 10.1038/79916; ZHOU H, 2006, MOL CELL BIOL MCB	45	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7471	10.1371/journal.pone.0007471	http://dx.doi.org/10.1371/journal.pone.0007471			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829694	gold, Green Published			2022-12-27	WOS:000270847800010
J	Feldhammer, M; Durand, S; Pshezhetsky, AV				Feldhammer, Matthew; Durand, Stephanie; Pshezhetsky, Alexey V.			Protein Misfolding as an Underlying Molecular Defect in Mucopolysaccharidosis III Type C	PLOS ONE			English	Article							GLUCOSAMINIDE N-ACETYLTRANSFERASE; LYSOSOMAL STORAGE DISORDERS; DISEASE TYPE-C; SANFILIPPO-SYNDROME; ACETYL-COA; TRANSMEMBRANE PROTEIN; SKIN FIBROBLASTS; PURIFICATION; NETHERLANDS; PREVALENCE	Mucopolysaccharidosis type IIIC or Sanfilippo syndrome type C (MPS IIIC, MIM #252930) is an autosomal recessive disorder caused by deficiency of the lysosomal membrane enzyme, heparan sulfate acetyl-CoA: alpha-glucosaminide N-acetyltransferase (HGSNAT, EC 2.3.1.78), which catalyses transmembrane acetylation of the terminal glucosamine residues of heparan sulfate prior to their hydrolysis by alpha-N-acetylglucosaminidase. Lysosomal storage of undegraded heparan sulfate in the cells of affected patients leads to neuronal death causing neurodegeneration and is accompanied by mild visceral and skeletal abnormalities, including coarse facies and joint stiffness. Surprisingly, the majority of MPS IIIC patients carrying missense mutations are as severely affected as those with splicing errors, frame shifts or nonsense mutations resulting in the complete absence of HGSNAT protein. In order to understand the effects of the missense mutations in HGSNAT on its enzymatic activity and biogenesis, we have expressed 21 mutant proteins in cultured human fibroblasts and COS-7 cells and studied their folding, targeting and activity. We found that 17 of the 21 missense mutations in HGSNAT caused misfolding of the enzyme, which is abnormally glycosylated and not targeted to the lysosome, but retained in the endoplasmic reticulum. The other 4 mutants represented rare polymorphisms which had no effect on the activity, processing and targeting of the enzyme. Treatment of patient cells with a competitive HGSNAT inhibitor, glucosamine, partially rescued several of the expressed mutants. Altogether our data provide an explanation for the severity of MPS IIIC and suggest that search for pharmaceutical chaperones can in the future result in therapeutic options for this disease.			Feldhammer, M (corresponding author), Univ Montreal, Dept Med Genet, CHU St Justine, Montreal, PQ, Canada.	alexei.pchejetski@umontreal.ca		A, Pshezhetsky/0000-0002-6612-1062				Ausseil K, 2006, MOL GENET METAB, V87, P22, DOI 10.1016/j.ymgme.2005.09.021; BAME KJ, 1986, SCIENCE, V233, P1087, DOI 10.1126/science.3090688; BARTSOCAS C, 1979, EUR J PEDIATR, V130, P251, DOI 10.1007/BF00441361; Berger-Plantinga EG, 2004, J NEUROL, V251, P479, DOI 10.1007/s00415-004-0368-5; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Desnick RJ, 2004, J INHERIT METAB DIS, V27, P385, DOI 10.1023/B:BOLI.0000031101.12838.c6; Fan JQ, 2003, TRENDS PHARMACOL SCI, V24, P355, DOI 10.1016/S0165-6147(03)00158-5; Fan XL, 2006, AM J HUM GENET, V79, P738, DOI 10.1086/508068; Fedele Anthony Olind, 2007, Hum Mutat, V28, P523, DOI 10.1002/humu.9488; Feldhammer M, 2009, HUM MUTAT, V30, P918, DOI 10.1002/humu.20986; Gregersen N, 2001, J INHERIT METAB DIS, V24, P189, DOI 10.1023/A:1010319001722; HE W, 1994, PRENATAL DIAG, V14, P17, DOI 10.1002/pd.1970140104; Hrebicek M, 2006, AM J HUM GENET, V79, P807, DOI 10.1086/508294; KLEIN U, 1981, CLIN GENET, V20, P55; KLEIN U, 1978, P NATL ACAD SCI USA, V75, P5185, DOI 10.1073/pnas.75.10.5185; MALEY F, 1989, ANAL BIOCHEM, V180, P195, DOI 10.1016/0003-2697(89)90115-2; Meikle PJ, 1999, JAMA-J AM MED ASSOC, V281, P249, DOI 10.1001/jama.281.3.249; Neufeld EF, 2001, MUCOPOLYSACCHARIDOSE, P3421, DOI DOI 10.1036/OMMBID.165; Pinto R, 2004, EUR J HUM GENET, V12, P87, DOI 10.1038/sj.ejhg.5201044; Poorthuis BJHM, 1999, HUM GENET, V105, P151, DOI 10.1007/s004390051078; Puig O, 2001, METHODS, V24, P218, DOI 10.1006/meth.2001.1183; Rigaut G, 1999, NAT BIOTECHNOL, V17, P1030, DOI 10.1038/13732; Ruijter GJG, 2008, MOL GENET METAB, V93, P104, DOI 10.1016/j.ymgme.2007.09.011; Seyrantepe V, 2006, HUM GENET, V120, P293, DOI 10.1007/s00439-006-0211-4; Spyropoulos IC, 2004, BIOINFORMATICS, V20, P3258, DOI 10.1093/bioinformatics/bth358; Valstar MJ, 2008, J INHERIT METAB DIS, V31, P240, DOI 10.1007/s10545-008-0838-5	26	58	59	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7434	10.1371/journal.pone.0007434	http://dx.doi.org/10.1371/journal.pone.0007434			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823584	Green Submitted, Green Published, gold			2022-12-27	WOS:000270808300012
J	Rosenbaum, HC; Pomilla, C; Mendez, M; Leslie, MS; Best, PB; Findlay, KP; Minton, G; Erststs, PJ; Collins, T; Engel, MH; Bonatto, SL; Kotze, DPGH; Meyer, M; Barendse, J; Thornton, M; Razafindrakoto, Y; Ngouessono, S; Vely, M; Kiszka, J				Rosenbaum, Howard C.; Pomilla, Cristina; Mendez, Martin; Leslie, Matthew S.; Best, Peter B.; Findlay, Ken P.; Minton, Gianna; Erststs, Peter J.; Collins, Timothy; Engel, Marcia H.; Bonatto, Sandro L.; Kotze, Deon P. G. H.; Meyer, Mike; Barendse, Jaco; Thornton, Meredith; Razafindrakoto, Yvette; Ngouessono, Solange; Vely, Michel; Kiszka, Jeremy			Population Structure of Humpback Whales from Their Breeding Grounds in the South Atlantic and Indian Oceans	PLOS ONE			English	Article							MITOCHONDRIAL-DNA DIVERSITY; MEGAPTERA-NOVAEANGLIAE; PHYLOGEOGRAPHY	Although humpback whales are among the best-studied of the large whales, population boundaries in the Southern Hemisphere (SH) have remained largely untested. We assess population structure of SH humpback whales using 1,527 samples collected from whales at fourteen sampling sites within the Southwestern and Southeastern Atlantic, the Southwestern Indian Ocean, and Northern Indian Ocean (Breeding Stocks A, B, C and X, respectively). Evaluation of mtDNA population structure and migration rates was carried out under different statistical frameworks. Using all genetic evidence, the results suggest significant degrees of population structure between all ocean basins, with the Southwestern and Northern Indian Ocean most differentiated from each other. Effective migration rates were highest between the Southeastern Atlantic and the Southwestern Indian Ocean, followed by rates within the Southeastern Atlantic, and the lowest between the Southwestern and Northern Indian Ocean. At finer scales, very low gene flow was detected between the two neighbouring sub-regions in the Southeastern Atlantic, compared to high gene flow for whales within the Southwestern Indian Ocean. Our genetic results support the current management designations proposed by the International Whaling Commission of Breeding Stocks A, B, C, and X as four strongly structured populations. The population structure patterns found in this study are likely to have been influenced by a combination of long-term maternally directed fidelity of migratory destinations, along with other ecological and oceanographic features in the region.	[Rosenbaum, Howard C.; Pomilla, Cristina; Mendez, Martin; Leslie, Matthew S.; Erststs, Peter J.; Collins, Timothy] Wildlife Conservat Soc, Cetacean Conservat & Res Program, Bronx, NY USA; [Rosenbaum, Howard C.; Pomilla, Cristina; Mendez, Martin; Leslie, Matthew S.] Amer Museum Nat Hist, Sackler Inst Comparat Genom, New York, NY 10024 USA; [Rosenbaum, Howard C.; Pomilla, Cristina; Mendez, Martin; Leslie, Matthew S.] Amer Museum Nat Hist, Conservat Genet Program, New York, NY 10024 USA; [Rosenbaum, Howard C.; Pomilla, Cristina; Erststs, Peter J.] Amer Museum Nat Hist, Ctr Biodivers & Conservat, New York, NY 10024 USA; [Rosenbaum, Howard C.; Mendez, Martin] Columbia Univ, Dept E3B, New York, NY USA; [Best, Peter B.; Barendse, Jaco; Thornton, Meredith] Univ Pretoria, Mammal Res Inst, Cape Town, South Africa; [Minton, Gianna; Collins, Timothy] Environm Soc Oman, Muscat, Oman; [Engel, Marcia H.] Inst Baleia Jubarte, Caravelas, BA, Brazil; [Findlay, Ken P.] Univ Cape Town, Dept Oceanog, ZA-7700 Rondebosch, South Africa; [Kotze, Deon P. G. H.; Meyer, Mike] Marine & Coastal Management, Cape Town, South Africa; [Engel, Marcia H.; Bonatto, Sandro L.] Pontificia Univ Catolica Rio Grande do Sul, Fac Biociencias, Porto Alegre, RS, Brazil; [Razafindrakoto, Yvette] Madagascar Country Program, Wildlife Conservat Soc, Antananarivo, Madagascar; [Ngouessono, Solange] Minist Tourisme & Parcs Nationaux, Agence Natl Parcs Nationaux, Libreville, Gabon; [Vely, Michel] Assoc Megaptera, Paris, France; [Kiszka, Jeremy] Univ La Rochelle, LIENSS, Inst Littoral & Environm, La Rochelle, France	Wildlife Conservation Society; American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); American Museum of Natural History (AMNH); Columbia University; University of Pretoria; University of Cape Town; Pontificia Universidade Catolica Do Rio Grande Do Sul; La Rochelle Universite	Rosenbaum, HC (corresponding author), Wildlife Conservat Soc, Cetacean Conservat & Res Program, Bronx, NY USA.	hrosenbaum@wcs.org	Kiszka, Jeremy J./AAH-2588-2020; Barendse, Jaco/F-7064-2012; Pomilla, Cristina/AAC-4035-2020; Pomilla, Cristina/GYD-9678-2022; Findlay, Ken P/A-5766-2019; Bonatto, Sandro L/A-1240-2010	Kiszka, Jeremy J./0000-0003-1095-8979; Barendse, Jaco/0000-0003-2859-4501; Pomilla, Cristina/0000-0002-2581-8365; Findlay, Ken P/0000-0001-7154-8805; Bonatto, Sandro L/0000-0002-0064-467X; Collins, Tim/0000-0002-7124-4876	National Research Foundation (South Africa) [2053539]; Lenfest Oceans Program	National Research Foundation (South Africa)(National Research Foundation - South Africa); Lenfest Oceans Program	This material is based upon work supported by the National Research Foundation (South Africa) under Grant number 2053539. We also acknowledge Marine and Coastal Management, South Africa, for the cruises of the research vessel Algoa and collection of samples in South Africa and Mozambique, and special thanks go to Herman Oosthuizen. The Instituto Baleia Jubarte was sponsored by Petrleo Brasileiro S.A (PETROBRAS) and Norsul Cia. De Navegao. Funding to HCR was provided by numerous individuals and foundations, especially the Lenfest Oceans Program. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BAKER CS, 1986, MAR ECOL PROG SER, V31, P105, DOI 10.3354/meps031105; Bourjea J, 2007, MOL ECOL, V16, P175, DOI 10.1111/j.1365-294X.2006.03122.x; Bowen BW, 2007, MOL ECOL, V16, P4886, DOI 10.1111/j.1365-294X.2007.03542.x; Calambokidis J, 1996, MAR MAMMAL SCI, V12, P215, DOI 10.1111/j.1748-7692.1996.tb00572.x; CHITTLEBOROUGH R. G., 1965, AUSTRALIAN J MAR FRESHWATER RES, V16, P33; Clapham PJ, 1999, MAMMAL REV, V29, P35; DAVIES JL, 1963, EVOLUTION, V17, P107, DOI 10.2307/2406339; DeSalle R, 2004, NAT REV GENET, V5, P702, DOI 10.1038/nrg1425; Engel MH, 2008, CONSERV GENET, V9, P1253, DOI 10.1007/s10592-007-9453-5; Findlay KP, 1996, MAR MAMMAL SCI, V12, P354, DOI 10.1111/j.1748-7692.1996.tb00589.x; Jorgensen HBH, 2005, MOL ECOL, V14, P3219, DOI 10.1111/j.1365-294X.2005.02658.x; Kaschner K, 2006, MAR ECOL PROG SER, V316, P285, DOI 10.3354/meps316285; Leduc R.G., 2007, Journal of Cetacean Research and Management, V9, P73; MARKINTUDA NA, 1942, DISCOVERY REP, V22, P197; MINTON G, 2006, IUCN REDLIST, V1, P3; Olavarria C, 2007, MAR ECOL PROG SER, V330, P257, DOI 10.3354/meps330257; Palsboll PJ, 2007, TRENDS ECOL EVOL, V22, P11, DOI 10.1016/j.tree.2006.09.003; PALSBOLL PJ, 1995, MAR ECOL PROG SER, V116, P1, DOI 10.3354/meps116001; Patenaude NJ, 2007, J HERED, V98, P147, DOI 10.1093/jhered/esm005; Redfern JV, 2006, MAR ECOL PROG SER, V310, P271, DOI 10.3354/meps310271; Reeves R.R., 1991, Marine Mammal Technical Report, V3, P259	21	72	83	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7318	10.1371/journal.pone.0007318	http://dx.doi.org/10.1371/journal.pone.0007318			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YN	19812698	Green Published, gold, Green Submitted			2022-12-27	WOS:000207567000001
J	Lambert-Langlais, S; Pointud, JC; Lefrancois-Martinez, AM; Volat, F; Manin, M; Coudore, F; Val, P; Sahut-Barnola, I; Ragazzon, B; Louiset, E; Delarue, C; Lefebvre, H; Urade, Y; Martinez, A				Lambert-Langlais, Sarah; Pointud, Jean-Christophe; Lefrancois-Martinez, Anne-Marie; Volat, Fanny; Manin, Michele; Coudore, Francois; Val, Pierre; Sahut-Barnola, Isabelle; Ragazzon, Bruno; Louiset, Estelle; Delarue, Catherine; Lefebvre, Herve; Urade, Yoshihiro; Martinez, Antoine			Aldo Keto Reductase 1B7 and Prostaglandin F-2 alpha Are Regulators of Adrenal Endocrine Functions	PLOS ONE			English	Article							MOUSE VAS-DEFERENS; SIDE-CHAIN CLEAVAGE; GENE AKR1B7 EXPRESSION; AGOUTI-RELATED PROTEIN; ADRENOCORTICAL-CELLS; LEYDIG-CELLS; DEVELOPMENTAL REGULATION; FACTOR-I; GLAND; SYNTHASE	Prostaglandin F-2 alpha (PGF(2 alpha)), represses ovarian steroidogenesis and initiates parturition in mammals but its impact on adrenal gland is unknown. Prostaglandins biosynthesis depends on the sequential action of upstream cyclooxygenases (COX) and terminal synthases but no PGF(2 alpha) synthases (PGFS) were functionally identified in mammalian cells. In vitro, the most efficient mammalian PGFS belong to aldo-keto reductase 1B (AKR1B) family. The adrenal gland is a major site of AKR1B expression in both human (AKR1B1) and mouse (AKR1B3, AKR1B7). Thus, we examined the PGF(2 alpha) biosynthetic pathway and its functional impact on both cortical and medullary zones. Both compartments produced PGF(2 alpha) but expressed different biosynthetic isozymes. In chromaffin cells, PGF(2 alpha) secretion appeared constitutive and correlated to continuous expression of COX1 and AKR1B3. In steroidogenic cells, PGF(2 alpha) secretion was stimulated by adrenocorticotropic hormone (ACTH) and correlated to ACTH-responsiveness of both COX2 and AKR1B7/B1. The pivotal role of AKR1B7 in ACTH-induced PGF(2 alpha) release and functional coupling with COX2 was demonstrated using over-and down-expression in cell lines. PGF(2 alpha) receptor was only detected in chromaffin cells, making medulla the primary target of PGF(2 alpha) action. By comparing PGF(2 alpha)-responsiveness of isolated cells and whole adrenal cultures, we demonstrated that PGF(2 alpha) repressed glucocorticoid secretion by an indirect mechanism involving a decrease in catecholamine release which in turn decreased adrenal steroidogenesis. PGF(2 alpha) may be regarded as a negative autocrine/paracrine regulator within a novel intra-adrenal feedback loop. The coordinated cell-specific regulation of COX2 and AKR1B7 ensures the generation of this stress-induced corticostatic signal.			Lambert-Langlais, S (corresponding author), Clermont Univ, CNRS, Genet Reprod & Dev UMR6247, Aubiere, France.	antoine.martinez@univ-bpclermont.fr	Ragazzon, Bruno/E-6541-2017; Louiset, Estelle/N-5530-2018	Ragazzon, Bruno/0000-0001-9476-4973; Lefebvre, Herve/0000-0002-6181-9648; Louiset, Estelle/0000-0002-4723-095X; Val, Pierre/0000-0001-7648-5567				Aida K, 2000, BIOCHEM BIOPH RES CO, V277, P281, DOI 10.1006/bbrc.2000.3648; Aigueperse C, 1999, J ENDOCRINOL, V160, P147, DOI 10.1677/joe.0.1600147; Aigueperse C, 2001, MOL ENDOCRINOL, V15, P93, DOI 10.1210/me.15.1.93; Albertin G, 2006, INT J MOL MED, V17, P1111; Baron S, 2003, J MOL ENDOCRINOL, V31, P71, DOI 10.1677/jme.0.0310071; Bielohuby M, 2007, AM J PHYSIOL-ENDOC M, V293, pE139, DOI 10.1152/ajpendo.00705.2006; Bornstein SR, 1997, DIABETES, V46, P1235, DOI 10.2337/diabetes.46.7.1235; Brockstedt E, 2000, ENDOCRINOLOGY, V141, P2574, DOI 10.1210/en.141.7.2574; Cao DL, 1998, J BIOL CHEM, V273, P11429, DOI 10.1074/jbc.273.19.11429; Charbonneau C, 2004, BIOCHEM BIOPH RES CO, V319, P518, DOI 10.1016/j.bbrc.2004.05.022; CLARK BJ, 1994, J BIOL CHEM, V269, P28314; Contesse V, 1999, MOL PHARMACOL, V56, P552, DOI 10.1124/mol.56.3.552; De Santa Barbara P, 1998, MOL CELL BIOL, V18, P6653, DOI 10.1128/MCB.18.11.6653; Doghman M, 2004, ENDOCRINOLOGY, V145, P541, DOI 10.1210/en.2003-0605; DONOHUE PJ, 1994, J BIOL CHEM, V269, P8604; Ehrhart-Bornstein M, 1998, ENDOCR REV, V19, P101, DOI 10.1210/er.19.2.101; Fortier MA, 2008, J PHYSIOL PHARMACOL, V59, P65; Frungieri MB, 2006, ENDOCRINOLOGY, V147, P4476, DOI 10.1210/en.2006-0090; Haidan A, 1998, ENDOCRINOLOGY, V139, P772, DOI 10.1210/en.139.2.772; Ho HTB, 2000, MOL CELL BIOL, V20, P5840, DOI 10.1128/MCB.20.16.5840-5846.2000; Hsu HT, 2006, J CLIN ENDOCR METAB, V91, P2761, DOI 10.1210/jc.2005-2383; Hyndman D, 2003, CHEM-BIOL INTERACT, V143, P621, DOI 10.1016/S0009-2797(02)00193-X; Hyndman DJ, 1998, BBA-GENE STRUCT EXPR, V1399, P198, DOI 10.1016/S0167-4781(98)00109-2; Ichitani Y, 2001, CELL TISSUE RES, V303, P235, DOI 10.1007/s004410000296; JAGT DLV, 1995, BBA-PROTEIN STRUCT M, V1249, P117; Kabututu Z, 2009, J BIOCHEM, V145, P161, DOI 10.1093/jb/mvn152; LAU ET, 1995, BIOCHEM J, V312, P609, DOI 10.1042/bj3120609; Lefrancois-Martinez AM, 1999, J BIOL CHEM, V274, P32875, DOI 10.1074/jbc.274.46.32875; Lefrancois-Martinez AM, 2004, J CLIN ENDOCR METAB, V89, P3010, DOI 10.1210/jc.2003-031830; Madore E, 2003, J BIOL CHEM, V278, P11205, DOI 10.1074/jbc.M208318200; Martinez A, 2001, CHEM-BIOL INTERACT, V130, P903, DOI 10.1016/S0009-2797(00)00244-1; MARTINEZ A, 1990, MOL CELL ENDOCRINOL, V72, P201, DOI 10.1016/0303-7207(90)90144-W; Matsuura K, 1996, ARCH BIOCHEM BIOPHYS, V328, P265, DOI 10.1006/abbi.1996.0172; McCracken JA, 1999, PHYSIOL REV, V79, P263, DOI 10.1152/physrev.1999.79.2.263; Mohn CE, 2005, P NATL ACAD SCI USA, V102, P6213, DOI 10.1073/pnas.0502136102; Morel L, 2001, J ANDROL, V22, P549; Murakami M, 1999, J BIOL CHEM, V274, P3103, DOI 10.1074/jbc.274.5.3103; Murakami M, 2000, J BIOL CHEM, V275, P32783, DOI 10.1074/jbc.M003505200; PAILHOUX EA, 1990, J BIOL CHEM, V265, P19932; Powers JF, 2000, CELL TISSUE RES, V302, P309, DOI 10.1007/s004410000290; Pralong FP, 1998, ENDOCRINOLOGY, V139, P4264, DOI 10.1210/en.139.10.4264; Ragazzon B, 2006, ENDOCRINOLOGY, V147, P1805, DOI 10.1210/en.2005-1279; Ramsay RG, 2003, INT J IMMUNOPATH PH, V16, P59; Scher JU, 2009, J INVEST MED, V57, P703, DOI 10.2310/JIM.0b013e31819aaa76; Sicard F, 2006, J CLIN ENDOCR METAB, V91, P3131, DOI 10.1210/jc.2006-0105; Srivastava SK, 2005, ENDOCR REV, V26, P380, DOI 10.1210/er.2004-0028; Suzuki-Yamamoto T, 2007, HISTOCHEM CELL BIOL, V128, P317, DOI 10.1007/s00418-007-0316-4; TARAGNAT C, 1988, J REPROD FERTIL, V83, P835, DOI 10.1530/jrf.0.0830835; Tirard J, 2007, ENDOCRINOLOGY, V148, P1996, DOI 10.1210/en.2006-1707; Ueno N, 2005, BIOCHEM BIOPH RES CO, V338, P70, DOI 10.1016/j.bbrc.2005.08.152; Ueno N, 2001, J BIOL CHEM, V276, P34918, DOI 10.1074/jbc.M100429200; Val P, 2002, ENDOCRINOLOGY, V143, P3435, DOI 10.1210/en.2002-220293; Volle DH, 2004, MOL ENDOCRINOL, V18, P888, DOI 10.1210/me.2003-0338; WILTBANK MC, 1995, BIOL REPROD, V52, P74, DOI 10.1095/biolreprod52.1.74; Yang JY, 2006, AM J PHYSIOL-RENAL, V291, pF186, DOI 10.1152/ajprenal.00506.2005	55	24	24	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7309	10.1371/journal.pone.0007309	http://dx.doi.org/10.1371/journal.pone.0007309			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809495	Green Submitted, Green Published, gold			2022-12-27	WOS:000270594000003
J	Leypoldt, F; Choe, CU; Gelderblom, M; von Leitner, EC; Atzler, D; Schwedhelm, E; Gerloff, C; Sydow, K; Boger, RH; Magnus, T				Leypoldt, Frank; Choe, Chi-Un; Gelderblom, Mathias; von Leitner, Eike-Christin; Atzler, Dorothee; Schwedhelm, Edzard; Gerloff, Christian; Sydow, Karsten; Boeger, Rainer H.; Magnus, Tim			Dimethylarginine Dimethylaminohydrolase-1 Transgenic Mice Are Not Protected from Ischemic Stroke	PLOS ONE			English	Article								Background: Methylated arginines are endogenous analogues of L-arginine, the substrate for nitric oxide (NO) synthase. Asymmetric dimethylarginine (ADMA) interferes with NO formation, causing endothelial dysfunction. ADMA is a predictor of cardiovascular events and mortality in humans. It is eliminated primarily by enzymatic activity of dimethylarginine dimethylaminohydrolase (DDAH). Methodology/Principal Findings: We investigated whether human DDAH-1 (hDDAH-1) transgenicity protects from ischemic tissue damage in temporary middle cerebral artery occlusion (tMCAO) in mice. Infarct sizes did not significantly differ between hDDAH-1 transgenic (TG) mice and wild-type littermates (WT). As expected, ADMA plasma concentrations were significantly decreased, cerebral hDDAH expression and protein significantly increased in transgenic animals. Interestingly, neither brain tissue DDAH activity nor ADMA concentrations were different between TG and WT mice. In contrast, muscular DDAH activity was generally lower than in brain but significantly increased in TG mice. Conclusion/Significance: Our study demonstrates that hDDAH-1 transgenic mice are not protected from ischemic cerebral tissue damage in tMCAO. This lack of protection is due to high basal cerebral DDAH activity, which is not further increasable by transgenic overexpression of DDAH.			Leypoldt, F (corresponding author), Univ Med Ctr Hamburg Eppendorf, Dept Neurol, Hamburg, Germany.		Leypoldt, Frank/ABC-3186-2021	Atzler, Dorothee/0000-0002-6551-1544; Leypoldt, Frank/0000-0002-8972-515X				Achan V, 2003, ARTERIOSCL THROM VAS, V23, P1455, DOI 10.1161/01.ATV.0000081742.92006.59; Boger RH, 2009, CIRCULATION, V119, P1592, DOI 10.1161/CIRCULATIONAHA.108.838268; Boger RH, 2006, ANN MED, V38, P126, DOI 10.1080/07853890500472151; Dayoub H, 2003, CIRCULATION, V108, P3042, DOI 10.1161/01.CIR.0000101924.04515.2E; Dayoub H, 2008, STROKE, V39, P180, DOI 10.1161/STROKEAHA.107.490631; FARACI FM, 1995, AM J PHYSIOL-HEART C, V269, pH1522, DOI 10.1152/ajpheart.1995.269.5.H1522; Gelderblom M, 2009, STROKE, V40, P1849, DOI 10.1161/STROKEAHA.108.534503; Jacobi J, 2005, CIRCULATION, V111, P1431, DOI 10.1161/01.CIR.0000158487.80483.09; Kielstein JT, 2006, STROKE, V37, P2024, DOI 10.1161/01.STR.0000231640.32543.11; Konishi H, 2007, J AM COLL CARDIOL, V49, P1099, DOI 10.1016/j.jacc.2006.10.068; MAAS R, 2009, STROKE; Maas R, 2007, J CHROMATOGR B, V851, P220, DOI 10.1016/j.jchromb.2007.01.020; Maas R, 2007, CLIN CHEM, V53, P693, DOI 10.1373/clinchem.2006.081893; Stuhlinger MC, 2007, CARDIOVASC RES, V75, P417, DOI 10.1016/j.cardiores.2007.04.030; Wanby P, 2006, ATHEROSCLEROSIS, V185, P271, DOI 10.1016/j.atherosclerosis.2005.06.033	15	14	18	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7337	10.1371/journal.pone.0007337	http://dx.doi.org/10.1371/journal.pone.0007337			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809508	Green Submitted, Green Published, gold			2022-12-27	WOS:000270594000009
J	Kim, PJ; Lee, DY; Jeong, H				Kim, Pan-Jun; Lee, Dong-Yup; Jeong, Hawoong			Centralized Modularity of N-Linked Glycosylation Pathways in Mammalian Cells	PLOS ONE			English	Article							GLYCAN STRUCTURES; SYSTEMS; GLYCOFORMS; GLYCOMICS; MECHANISMS; EXPRESSION; LETHALITY; NETWORK; BIOLOGY; IA	Glycosylation is a highly complex process to produce a diverse repertoire of cellular glycans that are attached to proteins and lipids. Glycans are involved in fundamental biological processes, including protein folding and clearance, cell proliferation and apoptosis, development, immune responses, and pathogenesis. One of the major types of glycans, N-linked glycans, is formed by sequential attachments of monosaccharides to proteins by a limited number of enzymes. Many of these enzymes can accept multiple N-linked glycans as substrates, thereby generating a large number of glycan intermediates and their intermingled pathways. Motivated by the quantitative methods developed in complex network research, we investigated the large-scale organization of such N-linked glycosylation pathways in mammalian cells. The N-linked glycosylation pathways are extremely modular, and are composed of cohesive topological modules that directly branch from a common upstream pathway of glycan synthesis. This unique structural property allows the glycan production between modules to be controlled by the upstream region. Although the enzymes act on multiple glycan substrates, indicating cross-talk between modules, the impact of the cross-talk on the module-specific enhancement of glycan synthesis may be confined within a moderate range by transcription-level control. The findings of the present study provide experimentally-testable predictions for glycosylation processes, and may be applicable to therapeutic glycoprotein engineering.	[Kim, Pan-Jun] Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA; [Lee, Dong-Yup] Natl Univ Singapore, Dept Chem & Biomol Engn, Singapore, Singapore; [Lee, Dong-Yup] ASTAR, Bioproc Technol Inst, Singapore, Singapore; [Jeong, Hawoong] Korea Adv Inst Sci & Technol, Inst BioCentury, Daejeon, South Korea; [Jeong, Hawoong] Korea Adv Inst Sci & Technol, Dept Phys, Daejeon, South Korea	University of Illinois System; University of Illinois Urbana-Champaign; National University of Singapore; Agency for Science Technology & Research (A*STAR); A*STAR - Bioprocessing Technology Institute (BTI); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Kim, PJ (corresponding author), Univ Illinois, Inst Genom Biol, Urbana, IL 61801 USA.	cheld@nus.edu.sg; hjeong@kaist.edu	Jeong, Hawoong/AAR-2524-2021; Jeong, Hawoong/A-2469-2009; Lee, Dong-Yup/D-6650-2011; Jeong, Hawoong/C-1587-2011	Jeong, Hawoong/0000-0002-2491-8620; Jeong, Hawoong/0000-0002-2491-8620; Lee, Dong-Yup/0000-0003-0901-708X; Kim, Pan-Jun/0000-0002-9329-4997				Barabasi AL, 2004, NAT REV GENET, V5, P101, DOI 10.1038/nrg1272; Brooks SA, 2006, EXPERT REV PROTEOMIC, V3, P345, DOI 10.1586/14789450.3.3.345; Butler M, 2005, APPL MICROBIOL BIOT, V68, P283, DOI 10.1007/s00253-005-1980-8; CAMPBELL C, 1984, J BIOL CHEM, V259, P3370; Campbell CT, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-11-236; Chen H, 2005, HANDBOOK OF CARBOHYDRATE ENGINEERING, P1; Comelli EM, 2006, GLYCOBIOLOGY, V16, P117, DOI 10.1093/glycob/cwj048; Davies J, 2001, BIOTECHNOL BIOENG, V74, P288, DOI 10.1002/bit.1119.abs; Dorogovtsev SN, 2003, EVOLUTION NETWORKS B; Feist AM, 2008, NAT BIOTECHNOL, V26, P659, DOI 10.1038/nbt1401; Ghim CM, 2005, J THEOR BIOL, V237, P401, DOI 10.1016/j.jtbi.2005.04.025; Hakomori S, 2002, P NATL ACAD SCI USA, V99, P225, DOI 10.1073/pnas.012540899; Helenius A, 2001, SCIENCE, V291, P2364, DOI 10.1126/science.291.5512.2364; Hossler P, 2006, BIOTECHNOL BIOENG, V95, P946, DOI 10.1002/bit.21062; Hossler P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000713; Ishii A, 2007, GLYCOBIOLOGY, V17, P261, DOI 10.1093/glycob/cwl076; Jefferis R, 2005, BIOTECHNOL PROGR, V21, P11, DOI 10.1021/bp040016j; Jeong H, 2000, NATURE, V407, P651, DOI 10.1038/35036627; Jeong H, 2001, NATURE, V411, P41, DOI 10.1038/35075138; Kim DH, 2004, PHYS REV E, V70, DOI 10.1103/PhysRevE.70.046126; Kim JH, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.058701; KORNFELD R, 1985, ANNU REV BIOCHEM, V54, P631, DOI 10.1146/annurev.biochem.54.1.631; Krambeck FJ, 2005, BIOTECHNOL BIOENG, V92, P711, DOI 10.1002/bit.20645; Lal A, 1998, GLYCOBIOLOGY, V8, P981, DOI 10.1093/glycob/8.10.981; Lee EJ, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.056108; Leicht EA, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.118703; Levy SF, 2008, PLOS BIOL, V6, P2588, DOI 10.1371/journal.pbio.0060264; Murrell MF, 2004, CHEMBIOCHEM, V5, P1334, DOI 10.1002/cbic.200400143; Nairn AV, 2008, J BIOL CHEM, V283, P17298, DOI 10.1074/jbc.M801964200; Newman MEJ, 2006, P NATL ACAD SCI USA, V103, P8577, DOI 10.1073/pnas.0601602103; Newman MEJ., 2006, STRUCTURE DYNAMICS N; Ohtsubo K, 2006, CELL, V126, P855, DOI 10.1016/j.cell.2006.08.019; Pons P, 2005, LECT NOTES COMPUT SC, V3733, P284; Raman R, 2005, NAT METHODS, V2, P817, DOI 10.1038/NMETH807; Rudd PM, 2001, SCIENCE, V291, P2370, DOI 10.1126/science.291.5512.2370; Sburlati AR, 1998, BIOTECHNOL PROGR, V14, P189, DOI 10.1021/bp970118s; SINNOTT ML, 1990, CHEM REV, V90, P1171, DOI 10.1021/cr00105a006; Tempel W, 2004, J BIOL CHEM, V279, P29774, DOI 10.1074/jbc.M403065200; Umana P, 1999, NAT BIOTECHNOL, V17, P176, DOI 10.1038/6179; Varki A., 2008, ESSENTIALS GLYCOBIOL; von der Lieth CW, 2004, BRIEF BIOINFORM, V5, P164, DOI 10.1093/bib/5.2.164; Yu HY, 2008, SCIENCE, V322, P104, DOI 10.1126/science.1158684; Yusufi FNK, 2009, BIOPROC BIOSYST ENG, V32, P97, DOI 10.1007/s00449-008-0226-4	44	26	28	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7317	10.1371/journal.pone.0007317	http://dx.doi.org/10.1371/journal.pone.0007317			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802388	Green Submitted, Green Published, gold			2022-12-27	WOS:000270593600007
J	Robertson, HT; Allison, DB				Robertson, Henry T.; Allison, David B.			Drugs Associated with More Suicidal Ideations Are also Associated with More Suicide Attempts	PLOS ONE			English	Article							CONTROLLED-TRIALS; WEIGHT-LOSS	Context: In randomized controlled trials (RCTs), some drugs, including CB1 antagonists for obesity treatment, have been shown to cause increased suicidal ideation. A key question is whether drugs that increase or are associated with increased suicidal ideations are also associated with suicidal behavior, or whether drug-induced suicidal ideations are unlinked epiphenomena that do not presage the more troubling and potentially irrevocable outcome of suicidal behavior. This is difficult to determine in RCTs because of the rarity of suicidal attempts and completions. Objective: To determine whether drugs associated with more suicidal ideations are also associated with more suicide attempts in large spontaneous adverse event (AE) report databases. Methodology: Generalized linear models with negative binomial distribution were fitted to Food and Drug Administration (FDA) Adverse Event (AE) Reporting System (AERS) data from 2004 to 2008. A total of 1,404,470 AEs from 832 drugs were analyzed as a function of reports of suicidal ideations; other non-suicidal adverse reactions; drug class; proportion of reports from males; and average age of subject for which AE was filed. Drug was treated as the unit of analysis, thus the statistical models effectively had 832 observations. Main Outcome Measures: Reported suicide attempts and completed suicides per drug. Results: 832 drugs, ranging from abacavir to zopiclone, were evaluated. The 832 drugs, as primary suspect drugs in a given adverse event, accounted for over 99.9% of recorded AERS. Suicidal ideations had a significant positive association with suicide attempts (p<.0001) and had an approximately 131-fold stronger magnitude of association than non- suicidal AERs, after adjusting for drug class, gender, and age. Conclusions: In AE reports, drugs that are associated with increased suicidal ideations are also associated with increased suicidal attempts or completions. This association suggests that drug-induced suicidal ideations observed in RCTs plausibly represent harbingers that presage the more serious suicide attempts and completions and should be a cause for concern.			Robertson, HT (corresponding author), Univ Alabama, Dept Biostat, Ryals Sch Publ Hlth, Birmingham, AL 35294 USA.	dallison@uab.edu		Allison, David/0000-0003-3566-9399	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK056336] Funding Source: NIH RePORTER; NIDDK NIH HHS [P30 DK056336, P30DK056336] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		*AERS, LAT Q DAT FIL; Astrup A, 2007, OBESITY, V15, P1717, DOI 10.1038/oby.2007.205; Borges G, 2008, J AFFECT DISORDERS, V105, P25, DOI 10.1016/j.jad.2007.01.036; COOPER D, 2008, MERCKS DISCONTINUATI; Despres JP, 2008, LANCET, V371, P555, DOI 10.1016/S0140-6736(08)60261-5; Gadde KM, 2006, CIRCULATION, V114, P974, DOI 10.1161/CIRCULATIONAHA.105.596130; Gibbons RD, 2008, STAT MED, V27, P1814, DOI 10.1002/sim.3241; GOLDSTEIN DJ, 1993, J CLIN PSYCHIAT, V54, P309; Hilbe JM, 2007, NEGATIVE BINOMIAL RE; Miaou S.-P., 1996, FHWARD96040 OAK RIDG; Neal DJ, 2007, PSYCHOL ADDICT BEHAV, V21, P441, DOI 10.1037/0893-164X.21.4.441; SURRENCE K, 2009, BEHAV RES THER  0612	12	18	18	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7312	10.1371/journal.pone.0007312	http://dx.doi.org/10.1371/journal.pone.0007312			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	504DD	19798416	Green Published, Green Submitted, gold			2022-12-27	WOS:000270593300012
J	Hocknull, SA; Piper, PJ; van den Bergh, GD; Due, RA; Morwood, MJ; Kurniawan, I				Hocknull, Scott A.; Piper, Philip J.; van den Bergh, Gert D.; Due, Rokus Awe; Morwood, Michael J.; Kurniawan, Iwan			Dragon's Paradise Lost: Palaeobiogeography, Evolution and Extinction of the Largest-Ever Terrestrial Lizards (Varanidae)	PLOS ONE			English	Article							SQUAMATA; FLORES	Background: The largest living lizard species, Varanus komodoensis Ouwens 1912, is vulnerable to extinction, being restricted to a few isolated islands in eastern Indonesia, between Java and Australia, where it is the dominant terrestrial carnivore. Understanding how large-bodied varanids responded to past environmental change underpins long-term management of V. komodoensis populations. Methodology/Principal Findings: We reconstruct the palaeobiogeography of Neogene giant varanids and identify a new (unnamed) species from the island of Timor. Our data reject the long-held perception that V. komodoensis became a giant because of insular evolution or as a specialist hunter of pygmy Stegodon. Phyletic giantism, coupled with a westward dispersal from mainland Australia, provides the most parsimonious explanation for the palaeodistribution of V. komodoensis and the newly identified species of giant varanid from Timor. Pliocene giant varanid fossils from Australia are morphologically referable to V. komodoensis suggesting an ultimate origin for V. komodoensis on mainland Australia (>3.8 million years ago). Varanus komodoensis body size has remained stable over the last 900,000 years (ka) on Flores, a time marked by major faunal turnovers, extinction of the island's megafauna, the arrival of early hominids by 880 ka, co-existence with Homo floresiensis, and the arrival of modern humans by 10 ka. Within the last 2000 years their populations have contracted severely. Conclusions/Significance: Giant varanids were once a ubiquitous part of Subcontinental Eurasian and Australasian faunas during the Neogene. Extinction played a pivotal role in the reduction of their ranges and diversity throughout the late Quaternary, leaving only V. komodoensis as an isolated long-term survivor. The events over the last two millennia now threaten its future survival.			Hocknull, SA (corresponding author), Queensland Museum, POB 300, Brisbane, Qld 4101, Australia.	scott.hocknull@qm.qld.gov.au	van den Bergh, Gerrit D/I-7670-2016	van den Bergh, Gerrit Dirk/0000-0003-1507-3336; Hocknull, Scott/0000-0003-4157-8434; Piper, Philip/0000-0001-9494-4341				Ast JC, 2001, CLADISTICS, V17, P211, DOI 10.1111/j.1096-0031.2001.tb00118.x; Auffenberg W., 1981, BEHAV ECOLOGY KOMODO; Burness GP, 2001, P NATL ACAD SCI USA, V98, P14518, DOI 10.1073/pnas.251548698; Christian A, 1996, J HERPETOL, V30, P219, DOI 10.2307/1565513; Conrad JL, 2008, B AM MUS NAT HIST, P1, DOI 10.1206/310.1; Dawson Lyndall, 1999, Records of the Western Australian Museum Supplement, V57, P265; de Smet M.E.M., 1990, Journal of Southeast Asian Earth Sciences, V4, P337, DOI 10.1016/0743-9547(90)90005-X; Dennell R, 2006, PALAEOGEOGR PALAEOCL, V234, P168, DOI 10.1016/j.palaeo.2005.10.008; DIAMOND JM, 1987, NATURE, V326, P832, DOI 10.1038/326832a0; DUNN EMMETT REID, 1927, AMER MUS NOVITATES, V286, P1; Falconer H. P., 1868, PALEONTOLOGICAL MEMO; Fitch AJ, 2006, AUST J ZOOL, V54, P253, DOI 10.1071/ZO05038; Fuller S, 1998, MOL PHYLOGENET EVOL, V9, P294, DOI 10.1006/mpev.1997.0476; Gaulke M., 2004, VARANOID LIZARDS WOR, P244; GOULD GC, 2005, B AM MUS NAT HIST, V285, P219; Hammer Oyvind, 2001, Palaeontologia Electronica, V4, pUnpaginated; Head JJ, 2009, ZOOL J LINN SOC-LOND, V155, P445, DOI 10.1111/j.1096-3642.2008.00448.x; Hocknull SA, 2007, EARTH PLANET SC LETT, V264, P317, DOI 10.1016/j.epsl.2007.10.004; HOOIJER D A, 1972, Zoologische Mededelingen (Leiden), V47, P445; Lydekker R., 1886, Palaeontologia Indica, V(10), P1; Lydekker R., 1888, CATALOGUE FOSSIL R 1; Mackness BS, 2000, AUST J EARTH SCI, V47, P807, DOI 10.1046/j.1440-0952.2000.00812.x; Molnar R.E., 2004, DRAGONS DUST PALAEOB; Morwood MJ, 2004, NATURE, V431, P1087, DOI 10.1038/nature02956; Murphy J. B, 2002, KOMODO DRAGONS BIOL; OWEN R, 1859, PHILOS T ROY SOC LON, V149, P43; Pianka ER, 2004, VARANOID LIZARDS OF THE WORLD, P549; PIANKA ER, 1995, AM NAT, V146, P398, DOI 10.1086/285806; Price GJ, 2009, REC AUST MUS, V61, P39, DOI 10.3853/j.0067-1975.61.2009.1518; Reed Elizabeth, 2005, Memoirs of the Queensland Museum, V51, P203; SETIYABUDI E, 2006, THESIS KAGOSHIMA U J; SUWITODIRDJO K, 1975, GEOLOGIC QUADRANGLE; Van den Bergh GD, 2008, QUATERN INT, V182, P16, DOI 10.1016/j.quaint.2007.02.001; van den Bergh GD, 2001, PALAEOGEOGR PALAEOCL, V171, P385, DOI 10.1016/S0031-0182(01)00255-3	34	40	42	1	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7241	10.1371/journal.pone.0007241	http://dx.doi.org/10.1371/journal.pone.0007241			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789642	Green Published, Green Submitted, gold			2022-12-27	WOS:000270354100009
J	Lukens, JR; Dolina, JS; Kim, TS; Tacke, RS; Hahn, YS				Lukens, John R.; Dolina, Joseph S.; Kim, Taeg S.; Tacke, Robert S.; Hahn, Young S.			Liver Is Able to Activate Naive CD8(+) T Cells with Dysfunctional Anti-Viral Activity in the Murine System	PLOS ONE			English	Article							HEPATITIS-C-VIRUS; IMMUNE-RESPONSES; INFILTRATING LYMPHOCYTES; VIRAL-HEPATITIS; PD-1 EXPRESSION; DOWN-REGULATION; HCV INFECTION; CORE PROTEIN; ADENOVIRUS; TOLERANCE	The liver possesses distinct tolerogenic properties because of continuous exposure to bacterial constituents and nonpathogenic food antigen. The central immune mediators required for the generation of effective immune responses in the liver environment have not been fully elucidated. In this report, we demonstrate that the liver can indeed support effector CD8(+) T cells during adenovirus infection when the T cells are primed in secondary lymphoid tissues. In contrast, when viral antigen is delivered predominantly to the liver via intravenous (IV) adenovirus infection, intrahepatic CD8(+) T cells are significantly impaired in their ability to produce inflammatory cytokines and lyse target cells. Additionally, intrahepatic CD8(+) T cells generated during IV adenovirus infection express elevated levels of PD-1. Notably, lower doses of adenovirus infection do not rescue the impaired effector function of intrahepatic CD8(+) T cell responses. Instead, intrahepatic antigen recognition limits the generation of potent anti-viral responses at both priming and effector stages of the CD8(+) T cell response and accounts for the dysfunctional CD8+ T cell response observed during IV adenovirus infection. These results also implicate that manipulation of antigen delivery will facilitate the design of improved vaccination strategies to persistent viral infection.			Lukens, JR (corresponding author), Univ Virginia, Dept Microbiol, Beirne Carter Ctr Immunol Res, Charlottesville, VA 22908 USA.	ysh5e@virginia.edu		Dolina, Joseph/0000-0002-4602-8194; Lukens, John/0000-0002-6795-0866	NIAID NIH HHS [U19AI083024, U19 AI083024, 5T32AI10749608.] Funding Source: Medline; NIDDK NIH HHS [R01 DK063222, DK063222, P30 DK067629] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI083024] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK067629, R01DK063222] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ajuebor MN, 2006, J IMMUNOL, V177, P2039, DOI 10.4049/jimmunol.177.4.2039; Belz GT, 1998, P NATL ACAD SCI USA, V95, P13812, DOI 10.1073/pnas.95.23.13812; Bertolino P, 2001, J IMMUNOL, V166, P5430, DOI 10.4049/jimmunol.166.9.5430; Bowen DG, 2004, J CLIN INVEST, V114, P701, DOI 10.1172/JCI200421593; Cai ZL, 1997, J EXP MED, V185, P641, DOI 10.1084/jem.185.4.641; CALNE R, 1994, LANCET, V343, P67, DOI 10.1016/S0140-6736(94)90809-5; CALNE RY, 1969, NATURE, V223, P472, DOI 10.1038/223472a0; Chisari FV, 1997, J CLIN INVEST, V99, P1472, DOI 10.1172/JCI119308; Crispe IN, 2003, NAT REV IMMUNOL, V3, P51, DOI 10.1038/nri981; Demotte N, 2008, IMMUNITY, V28, P414, DOI 10.1016/j.immuni.2008.01.011; FLEISCHER B, 1990, IMMUNOLOGY, V69, P14; Gehring AJ, 2007, J VIROL, V81, P2940, DOI 10.1128/JVI.02415-06; Golden-Mason L, 2007, J VIROL, V81, P9249, DOI 10.1128/JVI.00409-07; Grayson JM, 2006, J VIROL, V80, P8627, DOI 10.1128/JVI.00855-06; Holz LE, 2008, GASTROENTEROLOGY, V135, P989, DOI 10.1053/j.gastro.2008.05.078; HUANG L, 1994, INT IMMUNOL, V6, P533, DOI 10.1093/intimm/6.4.533; Isogawa M, 2005, IMMUNITY, V23, P53, DOI 10.1016/j.immuni.2005.05.005; Kalyuzhniy O, 2008, P NATL ACAD SCI USA, V105, P5483, DOI 10.1073/pnas.0711757105; Keating R, 2007, J IMMUNOL, V178, P2737, DOI 10.4049/jimmunol.178.5.2737; Kittlesen DJ, 2000, J CLIN INVEST, V106, P1239, DOI 10.1172/JCI10323; Klein I, 2006, J EXP MED, V203, P437, DOI 10.1084/jem.20051775; Krebs P, 2005, J IMMUNOL, V174, P4559, DOI 10.4049/jimmunol.174.8.4559; Large MK, 1999, J IMMUNOL, V162, P931; Lawrence CW, 2004, J IMMUNOL, V173, P1209, DOI 10.4049/jimmunol.173.2.1209; Lechner F, 2000, J EXP MED, V191, P1499, DOI 10.1084/jem.191.9.1499; Lukens JR, 2008, J IMMUNOL, V180, P4875, DOI 10.4049/jimmunol.180.7.4875; Maier H, 2007, J IMMUNOL, V178, P2714, DOI 10.4049/jimmunol.178.5.2714; Masopust D, 2001, SCIENCE, V291, P2413, DOI 10.1126/science.1058867; Mehal WZ, 1999, J IMMUNOL, V163, P3202; MIZUHARA H, 1994, J EXP MED, V179, P1529, DOI 10.1084/jem.179.5.1529; Nakamoto N, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000313; Ocana-Morgner C, 2003, J EXP MED, V197, P143, DOI 10.1084/jem.20021072; Peters MG, 2002, IMMUNOL CELL BIOL, V80, P113, DOI 10.1046/j.0818-9641.2001.01059.x; Polakos NK, 2007, J IMMUNOL, V179, P201, DOI 10.4049/jimmunol.179.1.201; Radziewicz H, 2008, J VIROL, V82, P9808, DOI 10.1128/JVI.01075-08; RASMUSSEN A, 1995, TRANSPLANTATION, V59, P919, DOI 10.1097/00007890-199503270-00025; SCHOFIELD L, 1987, NATURE, V330, P664, DOI 10.1038/330664a0; Sharpe AH, 2007, NAT IMMUNOL, V8, P239, DOI 10.1038/ni1443; Shayakhmetov DM, 2005, J VIROL, V79, P7478, DOI 10.1128/JVI.79.12.7478-7491.2005; Shayakhmetov DM, 2004, J VIROL, V78, P5368, DOI 10.1128/JVI.78.10.5368-5381.2004; Spangenberg HC, 2005, HEPATOLOGY, V42, P828, DOI 10.1002/hep.20856; Stone D, 2007, J VIROL, V81, P4866, DOI 10.1128/JVI.02819-06; Takaki A, 2000, NAT MED, V6, P578, DOI 10.1038/75063; Urban BC, 2003, J EXP MED, V197, P137, DOI 10.1084/jem.20022003; Urbani S, 2006, J VIROL, V80, P11398, DOI 10.1128/JVI.01177-06; van Faassen H, 2004, J IMMUNOL, V172, P3491, DOI 10.4049/jimmunol.172.6.3491; Wack A, 1997, EUR J IMMUNOL, V27, P577, DOI 10.1002/eji.1830270302; Wherry EJ, 2003, J VIROL, V77, P4911, DOI 10.1128/JVI.77.8.4911-4927.2003; Willberg C, 2003, CELL DEATH DIFFER, V10, pS39, DOI 10.1038/sj.cdd.4401122; Wuensch SA, 2006, J IMMUNOL, V177, P1689, DOI 10.4049/jimmunol.177.3.1689; Xiao ZG, 2007, J EXP MED, V204, P2667, DOI 10.1084/jem.20062376	51	12	12	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2009	4	10							e7619	10.1371/journal.pone.0007619	http://dx.doi.org/10.1371/journal.pone.0007619			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RW	19876399	Green Published, Green Submitted, gold			2022-12-27	WOS:000271414300005
J	Clape, C; Fritz, V; Henriquet, C; Apparailly, F; Fernandez, PL; Iborra, F; Avances, C; Villalba, M; Culine, S; Fajas, L				Clape, Cyrielle; Fritz, Vanessa; Henriquet, Corinne; Apparailly, Florence; Fernandez, Pedro Luis; Iborra, Francois; Avances, Christophe; Villalba, Martin; Culine, Stephane; Fajas, Lluis			miR-143 Interferes with ERK5 Signaling, and Abrogates Prostate Cancer Progression in Mice	PLOS ONE			English	Article							ACTIVATED-RECEPTOR-GAMMA; MICRORNA EXPRESSION; PROMOTES ADIPOGENESIS; RADICAL PROSTATECTOMY; INVASION; PATHWAY; AND-145; GROWTH; TUMORS; RISK	Background: Micro RNAs are small, non-coding, single-stranded RNAs that negatively regulate gene expression at the post-transcriptional level. Since miR-143 was found to be down-regulated in prostate cancer cells, we wanted to analyze its expression in human prostate cancer, and test the ability of miR-43 to arrest prostate cancer cell growth in vitro and in vivo. Results: Expression of miR-143 was analyzed in human prostate cancers by quantitative PCR, and by in situ hybridization. miR-143 was introduced in cancer cells in vivo by electroporation. Bioinformatics analysis and luciferase-based assays were used to determine miR-143 targets. We show in this study that miR-143 levels are inversely correlated with advanced stages of prostate cancer. Rescue of miR-143 expression in cancer cells results in the arrest of cell proliferation and the abrogation of tumor growth in mice. Furthermore, we show that the effects of miR-143 are mediated, at least in part by the inhibition of extracellular signal-regulated kinase-5 (ERK5) activity. We show here that ERK5 is a miR-143 target in prostate cancer. Conclusions: miR-143 is as a new target for prostate cancer treatment.			Clape, C (corresponding author), IRCM, Montpellier, France.	lluis.fajas@inserm.fr	Fernandez, Pedro L/H-2594-2017; APPARAILLY, Florence/AAU-5489-2020; APPARAILLY, Florence/D-8635-2016; villalba, martin/N-7123-2017; villalba, martin/AAG-2604-2020; Coll, Lluis Fajas/C-8567-2014	APPARAILLY, Florence/0000-0003-1762-084X; villalba, martin/0000-0002-4385-4888; villalba, martin/0000-0002-4385-4888; Fajas, Lluis/0000-0002-1283-9503				Abella A, 2005, CELL METAB, V2, P239, DOI 10.1016/j.cmet.2005.09.003; Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Akao Y, 2007, DNA CELL BIOL, V26, P311, DOI 10.1089/dna.2006.0550; Amaral FC, 2009, J CLIN ENDOCR METAB, V94, P320, DOI 10.1210/jc.2008-1451; Ambs S, 2008, CANCER RES, V68, P6162, DOI 10.1158/0008-5472.CAN-08-0144; Annicotte JS, 2006, MOL CELL BIOL, V26, P7561, DOI 10.1128/MCB.00605-06; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Bonci D, 2008, NAT MED, V14, P1271, DOI 10.1038/nm.1880; Calin GA, 2004, P NATL ACAD SCI USA, V101, P2999, DOI 10.1073/pnas.0307323101; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Chen X, 2009, ONCOGENE, V28, P1385, DOI 10.1038/onc.2008.474; English JM, 1998, J BIOL CHEM, V273, P3854, DOI 10.1074/jbc.273.7.3854; Epstein JI, 2006, ADV ANAT PATHOL, V13, P57, DOI 10.1097/01.pap.0000202017.78917.18; Esau C, 2004, J BIOL CHEM, V279, P52361, DOI 10.1074/jbc.C400438200; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Feldman BJ, 2001, NAT REV CANCER, V1, P34, DOI 10.1038/35094009; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Heidenreich A, 2008, EUR UROL, V53, P68, DOI 10.1016/j.eururo.2007.09.002; HUGGINS C, 1967, SCIENCE, V156, P1050, DOI 10.1126/science.156.3778.1050; Joniau S, 2008, BJU INT, V101, P5, DOI 10.1111/j.1464-410X.2007.07488.x; Kato Y, 1997, EMBO J, V16, P7054, DOI 10.1093/emboj/16.23.7054; Kattan MW, 1999, J CLIN ONCOL, V17, P1499, DOI 10.1200/JCO.1999.17.5.1499; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mehta PB, 2003, ONCOGENE, V22, P1381, DOI 10.1038/sj.onc.1206154; Michael MZ, 2003, MOL CANCER RES, V1, P882; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Pearson G, 2001, J BIOL CHEM, V276, P7927, DOI 10.1074/jbc.M009764200; Porkka KP, 2007, CANCER RES, V67, P6130, DOI 10.1158/0008-5472.CAN-07-0533; Sarruf DA, 2005, MOL CELL BIOL, V25, P9985, DOI 10.1128/MCB.25.22.9985-9995.2005; Sweat SD, 2002, J UROLOGY, V168, P525, DOI 10.1016/S0022-5347(05)64672-1; Terasawa K, 2003, GENES CELLS, V8, P263, DOI 10.1046/j.1365-2443.2003.00631.x; Thum T, 2008, NATURE, V456, P980, DOI 10.1038/nature07511; TONG AW, 2008, CANC GENE THER; Volinia S, 2006, P NATL ACAD SCI USA, V103, P2257, DOI 10.1073/pnas.0510565103; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; ZHOU GC, 1995, J BIOL CHEM, V270, P12665, DOI 10.1074/jbc.270.21.12665	38	163	181	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7542	10.1371/journal.pone.0007542	http://dx.doi.org/10.1371/journal.pone.0007542			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855844	Green Published, gold, Green Submitted			2022-12-27	WOS:000271147200002
J	Kuntner, M; Coddington, JA				Kuntner, Matjaz; Coddington, Jonathan A.			Discovery of the Largest Orbweaving Spider Species: The Evolution of Gigantism in Nephila	PLOS ONE			English	Article							SEXUAL SIZE DIMORPHISM; ORB-WEAVING SPIDER; DWARF MALES; BODY-SIZE; ARANEAE; SELECTION; COEVOLUTION; CANNIBALISM; SYSTEMATICS; POPULATION	Background: More than 41,000 spider species are known with about 400-500 added each year, but for some well-known groups, such as the giant golden orbweavers, Nephila, the last valid described species dates from the 19(th) century. Nephila are renowned for being the largest web-spinning spiders, making the largest orb webs, and are model organisms for the study of extreme sexual size dimorphism (SSD) and sexual biology. Here, we report on the discovery of a new, giant Nephila species from Africa and Madagascar, and review size evolution and SSD in Nephilidae. Methodology: We formally describe N. komaci sp. nov., the largest web spinning species known, and place the species in phylogenetic context to reconstruct the evolution of mean size (via squared change parsimony). We then test female and male mean size correlation using phylogenetically independent contrasts, and simulate nephilid body size evolution using Monte Carlo statistics. Conclusions: Nephila females increased in size almost monotonically to establish a mostly African clade of true giants. In contrast, Nephila male size is effectively decoupled and hovers around values roughly one fifth of female size. Although N. komaci females are the largest Nephila yet discovered, the males are also large and thus their SSD is not exceptional.			Kuntner, M (corresponding author), Slovenian Acad Sci & Arts, Ctr Sci Res, Inst Biol, Ljubljana, Slovenia.	kuntner@gmail.com	Kuntner, Matjaz/AAE-2195-2020	Coddington, Jonathan A./0000-0001-6004-7730				Agnarsson I, 2005, SYST ENTOMOL, V30, P575, DOI 10.1111/j.1365-3113.2005.00289.x; CODDINGTON JA, 1997, GIANT FEMALE DWARF M, P687; Elgar MA, 2008, BIOL J LINN SOC, V94, P355, DOI 10.1111/j.1095-8312.2008.00986.x; Fairbairn DJ, 1996, EVOLUTION, V50, P1549, DOI 10.1111/j.1558-5646.1996.tb03927.x; Fairbairn DJ, 1997, ANNU REV ECOL SYST, V28, P659, DOI 10.1146/annurev.ecolsys.28.1.659; Fairbairn DJ, 2007, SEX SIZE GENDER ROLE; FELSENSTEIN J, 1985, AM NAT, V125, P1, DOI 10.1086/284325; Foellmer MW, 2005, J EVOLUTION BIOL, V18, P629, DOI 10.1111/j.1420-9101.2005.00868.x; Fromhage L, 2006, BEHAV ECOL, V17, P353, DOI 10.1093/beheco/arj037; Fromhage L, 2007, ETHOLOGY, V113, P813, DOI 10.1111/j.1439-0310.2007.01383.x; Harvey MS, 2007, INVERTEBR SYST, V21, P407, DOI 10.1071/IS05016; Higgins L, 2002, OIKOS, V99, P377, DOI 10.1034/j.1600-0706.2002.990220.x; Hormiga G, 2000, SYST BIOL, V49, P435, DOI 10.1080/10635159950127330; Kasumovic MM, 2007, BEHAV ECOL, V18, P189, DOI 10.1093/beheco/arl072; Kuntner M, 2006, ZOOL SCR, V35, P19, DOI 10.1111/j.1463-6409.2006.00220.x; Kuntner M, 2005, INVERTEBR SYST, V19, P391, DOI 10.1071/IS05024; Kuntner M, 2009, J ZOOL, V277, P257, DOI 10.1111/j.1469-7998.2008.00533.x; Kuntner M, 2005, THESIS G WASHINGTON, P896; Kuntner M, 2008, J ARACHNOL, V36, P583, DOI 10.1636/T07-54.1; Kuntner M, 2008, CLADISTICS, V24, P147, DOI 10.1111/j.1096-0031.2007.00176.x; Kuntner M, 2007, SYST ENTOMOL, V32, P95, DOI 10.1111/j.1365-3113.2006.00348.x; Kuntner M, 2009, INVERTEBR SYST, V23, P193, DOI 10.1071/IS09002; Kuntner M, 2009, EVOLUTION, V63, P1451, DOI 10.1111/j.1558-5646.2009.00634.x; Maddison WP, 2019, MESQUITE MODULAR SYS; Midford P. E., 2008, PDAP PDTREE PACKAGE; MIYASHITA T, 1992, RES POPUL ECOL, V34, P143, DOI 10.1007/BF02513527; Moya-Larano J, 2009, J EVOLUTION BIOL, V22, P954, DOI 10.1111/j.1420-9101.2009.01707.x; Pekar S, 2006, J NAT HIST, V40, P1343, DOI 10.1080/00222930600901417; Prenter J, 1998, P ROY SOC B-BIOL SCI, V265, P57, DOI 10.1098/rspb.1998.0264; Schneider JM, 2005, EVOL ECOL, V19, P419, DOI 10.1007/s10682-005-8310-6; Schneider JM, 2008, AUST J ZOOL, V56, P233, DOI 10.1071/ZO08041; VOLLRATH F, 1992, NATURE, V360, P156, DOI 10.1038/360156a0; Vollrath F, 1998, TRENDS ECOL EVOL, V13, P159, DOI 10.1016/S0169-5347(97)01283-4; Wilder SM, 2008, AM NAT, V172, P431, DOI 10.1086/589518	34	62	63	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7516	10.1371/journal.pone.0007516	http://dx.doi.org/10.1371/journal.pone.0007516			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844575	gold, Green Submitted, Green Published			2022-12-27	WOS:000271013000005
J	Sapriel, G; Quinet, M; Heijde, M; Jourdren, L; Tanty, V; Luo, GZ; Le Crom, S; Lopez, PJ				Sapriel, Guillaume; Quinet, Michelle; Heijde, Marc; Jourdren, Laurent; Tanty, Veronique; Luo, Guangzuo; Le Crom, Stephane; Lopez, Pascal Jean			Genome-Wide Transcriptome Analyses of Silicon Metabolism in Phaeodactylum tricornutum Reveal the Multilevel Regulation of Silicic Acid Transporters	PLOS ONE			English	Article							DIATOM THALASSIOSIRA-PSEUDONANA; PATTERN-FORMATION; SI REQUIREMENT; MARINE; MODEL; BACILLARIOPHYCEAE; PRECIPITATION; SELECTION; PEPTIDES; KINETICS	Background: Diatoms are largely responsible for production of biogenic silica in the global ocean. However, in surface seawater, Si(OH)(4) can be a major limiting factor for diatom productivity. Analyzing at the global scale the genes networks involved in Si transport and metabolism is critical in order to elucidate Si biomineralization, and to understand diatoms contribution to biogeochemical cycles. Methodology/Principal Findings: Using whole genome expression analyses we evaluated the transcriptional response to Si availability for the model species Phaeodactylum tricornutum. Among the differentially regulated genes we found genes involved in glutamine-nitrogen pathways, encoding putative extracellular matrix components, or involved in iron regulation. Some of these compounds may be good candidates for intracellular intermediates involved in silicic acid storage and/ or intracellular transport, which are very important processes that remain mysterious in diatoms. Expression analyses and localization studies gave the first picture of the spatial distribution of a silicic acid transporter in a diatom model species, and support the existence of transcriptional and post-transcriptional regulations. Conclusions/Significance: Our global analyses revealed that about one fourth of the differentially expressed genes are organized in clusters, underlying a possible evolution of P. tricornutum genome, and perhaps other pennate diatoms, toward a better optimization of its response to variable environmental stimuli. High fitness and adaptation of diatoms to various Si levels in marine environments might arise in part by global regulations from gene ( expression level) to genomic (organization in clusters, dosage compensation by gene duplication), and by post-transcriptional regulation and spatial distribution of SIT proteins.			Sapriel, G (corresponding author), Ecole Normale Super, CNRS, UMR 8186, Biomineralizat & Morphogenesis Grp, Paris, France.	pjlopez@biologie.ens.fr	Heijde, Marc/O-8958-2014; Le Crom, Stéphane/P-4176-2016; Lopez, Pascal Jean/A-7427-2011; Lopez, Pascal Jean/P-5813-2019	Le Crom, Stéphane/0000-0002-0534-7797; Lopez, Pascal Jean/0000-0002-9914-4252; Jourdren, Laurent/0000-0003-4253-1048; Luo, Guangzuo/0000-0002-8518-5766; heijde, marc/0000-0002-8109-8999				ALINE RF, 1984, PLANT PHYSIOL, V76, P674, DOI 10.1104/pp.76.3.674; Allen AE, 2008, P NATL ACAD SCI USA, V105, P10438, DOI 10.1073/pnas.0711370105; Allen JT, 2005, NATURE, V437, P728, DOI 10.1038/nature03948; Alverson AJ, 2007, LIMNOL OCEANOGR, V52, P1420, DOI 10.4319/lo.2007.52.4.1420; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; BOROWITZKA LJ, 1977, ARCH MICROBIOL, V112, P147, DOI 10.1007/BF00429327; BOROWITZKA MA, 1978, J PHYCOL, V14, P10; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; BRZEZINSKI MA, 1990, MAR ECOL PROG SER, V67, P83, DOI 10.3354/meps067083; Conesa A, 2005, BIOINFORMATICS, V21, P3674, DOI 10.1093/bioinformatics/bti610; CORADIN T, 2006, FLORICULTURE ORNAMEN, P101; De Martino A, 2007, J PHYCOL, V43, P992, DOI 10.1111/j.1529-8817.2007.00384.x; Del Amo Y, 1999, J PHYCOL, V35, P1162; Descles J, 2008, NEW PHYTOL, V177, P822, DOI 10.1111/j.1469-8137.2007.02303.x; Falciatore A, 2000, SCIENCE, V288, P2363, DOI 10.1126/science.288.5475.2363; Francius G, 2008, ENVIRON MICROBIOL, V10, P1344, DOI 10.1111/j.1462-2920.2007.01551.x; Frigeri LG, 2006, MOL CELL PROTEOMICS, V5, P182, DOI 10.1074/mcp.M500174-MCP200; FUHRMAN JA, 1978, NATURE, V272, P244, DOI 10.1038/272244a0; Grachev MA, 2008, BIOESSAYS, V30, P328, DOI 10.1002/bies.20731; GUILLARD RR, 1973, J PHYCOL, V9, P233; GUTENBRUNNER SA, 1994, J PHYCOL, V30, P129, DOI 10.1111/j.0022-3646.1994.00129.x; Harada H, 2006, PLANT PHYSIOL, V142, P1318, DOI 10.1104/pp.106.086561; Hildebrand M, 1997, NATURE, V385, P688, DOI 10.1038/385688b0; Iler, 1979, CHEM SILICA SOLUBILI; Kakinuma M, 2008, CELL BIOL TOXICOL, V24, P629, DOI 10.1007/s10565-007-9053-7; KLAVENESS D, 1975, J PHYCOL, V11, P349, DOI 10.1111/j.0022-3646.1975.00349.x; Kojima S, 2007, PLANT J, V52, P30, DOI 10.1111/j.1365-313X.2007.03223.x; Kondrashov FA, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-2-research0008; Kroger N, 2007, CURR OPIN CHEM BIOL, V11, P662, DOI 10.1016/j.cbpa.2007.10.009; Kroger N, 1999, SCIENCE, V286, P1129, DOI 10.1126/science.286.5442.1129; Kroger N, 2001, J BIOL CHEM, V276, P26066, DOI 10.1074/jbc.M102093200; Lemoine S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-467; LEWIN JC, 1958, J GEN MICROBIOL, V18, P418, DOI 10.1099/00221287-18-2-418; Likhoshway Ye V, 2006, Dokl Biol Sci, V408, P256, DOI 10.1134/S001249660603015X; Lopez PJ, 2005, CURR OPIN BIOTECH, V16, P180, DOI 10.1016/j.copbio.2005.02.002; Lu SC, 2000, INT J BIOCHEM CELL B, V32, P391, DOI 10.1016/S1357-2725(99)00139-9; Lutz K, 2005, PHYS CHEM CHEM PHYS, V7, P2812, DOI 10.1039/b505945c; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Martin-Jezequal V, 2003, PROG MOLEC, V33, P99; Martin-Jezequel V, 2000, J PHYCOL, V36, P821, DOI 10.1046/j.1529-8817.2000.00019.x; Mock T, 2008, P NATL ACAD SCI USA, V105, P1579, DOI 10.1073/pnas.0707946105; Montsant A, 2005, J NANOSCI NANOTECHNO, V5, P5, DOI 10.1166/jnn.2005.003; NELSON DM, 1984, J PHYCOL, V20, P141, DOI 10.1111/j.0022-3646.1984.00141.x; PAASCHE E, 1973, MAR BIOL, V19, P117, DOI 10.1007/BF00353582; Petrova DP, 2007, DOKL BIOCHEM BIOPHYS, V417, P295, DOI 10.1134/S1607672907060014; PREISIG HR, 1994, PROTOPLASMA, V181, P29, DOI 10.1007/BF01666387; RIEDEL GF, 1985, J PHYCOL, V21, P168; Siaut M, 2007, GENE, V406, P23, DOI 10.1016/j.gene.2007.05.022; Sumper M, 2004, J MATER CHEM, V14, P2059, DOI 10.1039/b401028k; Sumper M, 2008, CHEMBIOCHEM, V9, P1187, DOI 10.1002/cbic.200700764; Sumper M, 2006, CHEMBIOCHEM, V7, P1419, DOI 10.1002/cbic.200600184; Thamatrakoln K, 2005, J NANOSCI NANOTECHNO, V5, P158, DOI 10.1166/jnn.2005.014; Thamatrakoln K, 2008, PLANT PHYSIOL, V146, P1397, DOI 10.1104/pp.107.107094; Thamatrakoln K, 2007, EUKARYOT CELL, V6, P271, DOI 10.1128/EC.00235-06; Thamatrakoln K, 2006, J PHYCOL, V42, P822, DOI 10.1111/j.1529-8817.2006.00233.x; THOMAS W H, 1975, Deep-Sea Research and Oceanographic Abstracts, V22, P671, DOI 10.1016/0011-7471(75)90005-4; TREGUER P, 1995, SCIENCE, V268, P375, DOI 10.1126/science.268.5209.375; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Uemura T, 2007, J BIOL CHEM, V282, P7733, DOI 10.1074/jbc.M611105200; Vartanian M, 2009, NEW PHYTOL, V182, P429, DOI 10.1111/j.1469-8137.2009.02769.x; Volcani B. E., 1981, SILICON SILICEOUS ST; Wenzl S, 2008, ANGEW CHEM INT EDIT, V47, P1729, DOI 10.1002/anie.200704994; Yang ZH, 2000, TRENDS ECOL EVOL, V15, P496, DOI 10.1016/S0169-5347(00)01994-7; Yool A, 2003, GLOBAL BIOGEOCHEM CY, V17, DOI 10.1029/2002GB002018; Zaslavskaia LA, 2000, J PHYCOL, V36, P379, DOI 10.1046/j.1529-8817.2000.99164.x; Zhang Zhang, 2006, Genomics Proteomics & Bioinformatics, V4, P259, DOI 10.1016/S1672-0229(07)60007-2	66	76	80	3	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7458	10.1371/journal.pone.0007458	http://dx.doi.org/10.1371/journal.pone.0007458			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19829693	Green Published, Green Submitted, gold			2022-12-27	WOS:000270808700017
J	Mathew, SJ; Kerridge, S; Leptin, M				Mathew, Sam J.; Kerridge, Stephen; Leptin, Maria			A Small Genomic Region Containing Several Loci Required for Gastrulation in Drosophila	PLOS ONE			English	Article							CYTOGENETIC ANALYSIS; MELANOGASTER; GENES; MORPHOGENESIS; EXPRESSION; EMBRYO; DUMPY; REARRANGEMENTS; LOCALIZATION; COLLECTION	Genetic screens in Drosophila designed to search for loci involved in gastrulation have identified four regions of the genome that are required zygotically for the formation of the ventral furrow. For three of these, the genes responsible for the mutant phenotypes have been found. We now describe a genetic characterization of the fourth region, which encompasses the cytogenetic interval 24C3-25B, and the mapping of genes involved in gastrulation in this region. We have determined the precise breakpoints of several existing deficiencies and have generated new deficiencies. Our results show that the region contains at least three different loci associated with gastrulation effects. One maternal effect gene involved in ventral furrow formation maps at 24F but could not be identified. For a second maternal effect gene which is required for germ band extension, we identify a candidate gene, CG31660, which encodes a G protein coupled receptor. Finally, one gene acts zygotically in ventral furrow formation and we identify it as Traf4.			Mathew, SJ (corresponding author), Univ Cologne, Inst Genet, Weyertal 121, D-5000 Cologne, Germany.	mleptin@uni-koeln.de		Mathew, Sam/0000-0001-7908-6094				Ashburner M., 1989, DROSOPHILA LAB HDB; Carmon A, 2007, GENETICS, V176, P309, DOI 10.1534/genetics.106.060897; Cha GH, 2003, MOL CELL BIOL, V23, P7982, DOI 10.1128/MCB.23.22.7982-7991.2003; DAWES H, 1998, DROS RES C, V39, pA399; FRASCH M, 1987, GENE DEV, V1, P981, DOI 10.1101/gad.1.9.981; Golic KG, 1996, GENETICS, V144, P1693; Gong WJ, 2004, GENETICS, V168, P1467, DOI 10.1534/genetics.104.030874; GRAU Y, 1984, GENETICS, V108, P347; Grosshans J, 2000, CELL, V101, P523, DOI 10.1016/S0092-8674(00)80862-4; Grosshans J, 2003, DEV CELL, V5, P285, DOI 10.1016/S1534-5807(03)00208-9; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; Kuranaga E, 2002, NAT CELL BIOL, V4, P705, DOI 10.1038/ncb842; LEPTIN M, 2008, RE NAMING GENES TRAF; Mata J, 2000, CELL, V101, P511, DOI 10.1016/S0092-8674(00)80861-2; MERRILL PT, 1988, DEVELOPMENT, V104, P495; Muller HAJ, 1999, DEVELOPMENT, V126, P577; Oh SW, 2003, GENETICS, V163, P195; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Preiss A, 2001, MECH DEVELOP, V100, P109, DOI 10.1016/S0925-4773(00)00506-2; RASMUSSEN I, 1960, ATTACHED 2R 2L0, P53; REUTER G, 1983, CHROMOSOMA, V88, P277, DOI 10.1007/BF00292904; REUTER R, 1990, DEVELOPMENT, V110, P1031; ROTH S, 1989, CELL, V59, P1189, DOI 10.1016/0092-8674(89)90774-5; Ryder E, 2004, GENETICS, V167, P797, DOI 10.1534/genetics.104.026658; Ryder E, 2007, GENETICS, V177, P615, DOI 10.1534/genetics.107.076216; Seher TC, 2000, CURR BIOL, V10, P623, DOI 10.1016/S0960-9822(00)00502-9; Seher TC, 2007, MECH DEVELOP, V124, P167, DOI 10.1016/j.mod.2006.12.004; SZIDONYA J, 1988, GENET RES, V51, P197, DOI 10.1017/S0016672300024290; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Wang HS, 2006, EMBO J, V25, P5783, DOI 10.1038/sj.emboj.7601461; Wieschaus E., 1986, P199; Wilkin MB, 2000, CURR BIOL, V10, P559, DOI 10.1016/S0960-9822(00)00482-6	32	12	12	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7437	10.1371/journal.pone.0007437	http://dx.doi.org/10.1371/journal.pone.0007437			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823683	gold, Green Published, Green Submitted			2022-12-27	WOS:000270808300013
J	Verkoczy, L; Moody, MA; Holl, TM; Bouton-Verville, H; Scearce, RM; Hutchinson, J; Alam, SM; Kelsoe, G; Haynes, BF				Verkoczy, Laurent; Moody, M. Anthony; Holl, T. Matt; Bouton-Verville, Hilary; Scearce, Richard M.; Hutchinson, Jennifer; Alam, S. Munir; Kelsoe, Garnett; Haynes, Barton F.			Functional, Non-Clonal IgM(a)-Restricted B Cell Receptor Interactions with the HIV-1 Envelope gp41 Membrane Proximal External Region	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; SUPERANTIGEN-BINDING-SITE; HUMAN MONOCLONAL-ANTIBODIES; CLASS-SWITCH RECOMBINATION; NEUTRALIZING ANTIBODY; MARGINAL-ZONE; SUBTYPE-B; EPITOPE; 2F5; GP120	The membrane proximal external region (MPER) of HIV-1 gp41 has several features that make it an attractive antibody-based vaccine target, but eliciting an effective gp41 MPER-specific protective antibody response remains elusive. One fundamental issue is whether the failure to make gp41 MPER-specific broadly neutralizing antibodies like 2F5 and 4E10 is due to structural constraints with the gp41 MPER, or alternatively, if gp41 MPER epitope-specific B cells are lost to immunological tolerance. An equally important question is how B cells interact with, and respond to, the gp41 MPER epitope, including whether they engage this epitope in a non-canonical manner i.e., by non-paratopic recognition via B cell receptors (BCR). To begin understanding how B cells engage the gp41 MPER, we characterized B cell-gp41 MPER interactions in BALB/c and C57BL/6 mice. Surprisingly, we found that a significant (similar to 7%) fraction of splenic B cells from BALB/c, but not C57BL/6 mice, bound the gp41 MPER via their BCRs. This strain-specific binding was concentrated in IgM(hi) subsets, including marginal zone and peritoneal B1 B cells, and correlated with enriched fractions (similar to 15%) of gp41 MPER-specific IgM secreted by in vitro-activated splenic B cells. Analysis of Igh(a) (BALB/c) and Igh(b) (C57BL/6) congenic mice demonstrated that gp41 MPER binding was controlled by determinants of the Igh(a) locus. Mapping of MPER gp41 interactions with IgM(a) identified MPER residues distinct from those to which mAb 2F5 binds and demonstrated the requirement of Fc C-H regions. Importantly, gp41 MPER ligation produced detectable BCR-proximal signaling events, suggesting that interactions between gp41 MPER and IgM(a) determinants may elicit partial B cell activation. These data suggest that low avidity, non-paratopic interactions between the gp41 MPER and membrane Ig on naive B cells may interfere with or divert bnAb responses.			Verkoczy, L (corresponding author), Duke Univ, Med Ctr, Human Vaccine Inst, Durham, NC 27706 USA.	laurent.verkoczy@duke.edu	Alam, S. Munir/AAC-6711-2019; Moody, M/AAB-6947-2020	Moody, M/0000-0002-3890-5855				ACHAORBEA H, 1995, ANNU REV IMMUNOL, V13, P459, DOI 10.1146/annurev.iy.13.040195.002331; Alam SM, 2008, J VIROL, V82, P115, DOI 10.1128/JVI.00927-07; Alam SM, 2007, J IMMUNOL, V178, P4424, DOI 10.4049/jimmunol.178.7.4424; Allman D, 2001, J IMMUNOL, V167, P6834, DOI 10.4049/jimmunol.167.12.6834; Altman JD, 1996, SCIENCE, V274, P94, DOI 10.1126/science.274.5284.94; Barbato G, 2003, J MOL BIOL, V330, P1101, DOI 10.1016/S0022-2836(03)00611-9; BERBERIAN L, 1994, J ACQ IMMUN DEF SYND, V7, P641; BIKOFF E, 1986, J IMMUNOL, V137, P28; BIKOFF EK, 1991, EUR J IMMUNOL, V21, P1411, DOI 10.1002/eji.1830210613; BLOMBERG B, 1972, SCIENCE, V177, P178, DOI 10.1126/science.177.4044.178; BUCHACHER A, 1994, AIDS RES HUM RETROV, V10, P359, DOI 10.1089/aid.1994.10.359; Bures R, 2000, AIDS RES HUM RETROV, V16, P2019, DOI 10.1089/088922200750054756; Burton DR, 2004, NAT IMMUNOL, V5, P233, DOI 10.1038/ni0304-233; Cardoso RMF, 2005, IMMUNITY, V22, P163, DOI 10.1016/j.immuni.2004.12.011; Cariappa A, 2001, IMMUNITY, V14, P603, DOI 10.1016/S1074-7613(01)00135-2; Chang Q, 2004, J INFECTION, V49, P274, DOI 10.1016/j.jinf.2004.04.007; Coeffier E, 2000, VACCINE, V19, P684, DOI 10.1016/S0264-410X(00)00267-X; DSouza MP, 1997, J INFECT DIS, V175, P1056, DOI 10.1086/516443; Earl PL, 1997, J VIROL, V71, P2674, DOI 10.1128/JVI.71.4.2674-2684.1997; Eckert DM, 2001, ANNU REV BIOCHEM, V70, P777, DOI 10.1146/annurev.biochem.70.1.777; Eckhart L, 1996, J GEN VIROL, V77, P2001, DOI 10.1099/0022-1317-77-9-2001; FORSGREN A, 1966, J IMMUNOL, V97, P822; Gao F, 2005, J VIROL, V79, P1154, DOI 10.1128/JVI.79.2.1154-1163.2005; Gaynor B, 1997, P NATL ACAD SCI USA, V94, P1955, DOI 10.1073/pnas.94.5.1955; Goodyear CS, 2005, SPRINGER SEMIN IMMUN, V26, P463, DOI 10.1007/s00281-004-0190-2; Gorelik L, 2004, J IMMUNOL, V172, P762, DOI 10.4049/jimmunol.172.2.762; HAYAKAWA K, 1987, P NATL ACAD SCI USA, V84, P1379, DOI 10.1073/pnas.84.5.1379; Haynes BF, 2008, IMMUNITY, V28, P10, DOI 10.1016/j.immuni.2007.12.005; Haynes BF, 2006, EXPERT REV VACCINES, V5, P578; Haynes Barton F., 2005, Human Antibodies, V14, P59; Haynes BF, 2006, VIROLOGY, V345, P44, DOI 10.1016/j.virol.2005.08.042; Haynes BF, 2005, SCIENCE, V308, P1906, DOI 10.1126/science.1111781; He B, 2006, J IMMUNOL, V176, P3931, DOI 10.4049/jimmunol.176.7.3931; Joyce JG, 2002, J BIOL CHEM, V277, P45811, DOI 10.1074/jbc.M205862200; Karray S, 1997, P NATL ACAD SCI USA, V94, P1356, DOI 10.1073/pnas.94.4.1356; Karray S, 1998, J IMMUNOL, V161, P6681; Korber B., 1998, HUMAN RETROVIRUSES A, V3, P102; Kouskoff V, 1998, J EXP MED, V188, P1453, DOI 10.1084/jem.188.8.1453; Kwong PD, 1998, NATURE, V393, P648, DOI 10.1038/31405; Kwong PD, 2002, NATURE, V420, P678, DOI 10.1038/nature01188; Liang XP, 1999, VACCINE, V17, P2862, DOI 10.1016/S0264-410X(99)00125-5; Liao HX, 2006, VIROLOGY, V353, P268, DOI 10.1016/j.virol.2006.04.043; Loder F, 1999, J EXP MED, V190, P75, DOI 10.1084/jem.190.1.75; Martin F, 2000, IMMUNOL REV, V175, P70, DOI 10.1034/j.1600-065X.2000.017515.x; Martin F, 2002, NAT REV IMMUNOL, V2, P323, DOI 10.1038/nri799; Martin F, 2000, IMMUNITY, V12, P39, DOI 10.1016/S1074-7613(00)80157-0; Martin F, 2001, CURR OPIN IMMUNOL, V13, P195, DOI 10.1016/S0952-7915(00)00204-1; Marusic C, 2001, J VIROL, V75, P8434, DOI 10.1128/JVI.75.18.8434-8439.2001; Mascola JR, 1999, J VIROL, V73, P4009, DOI 10.1128/JVI.73.5.4009-4018.1999; Mascola JR, 2000, NAT MED, V6, P207, DOI 10.1038/72318; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; MOODY MA, 2008, NATURE BIOTECH UNPUB; MORAHAN G, 1983, NATURE, V301, P720, DOI 10.1038/301720a0; Muller S, 1997, Int Rev Immunol, V14, P339, DOI 10.3109/08830189709116524; MULLER S, 1993, SCAND J IMMUNOL, V38, P327, DOI 10.1111/j.1365-3083.1993.tb01734.x; MUSTER T, 1993, J VIROL, V67, P6642, DOI 10.1128/JVI.67.11.6642-6647.1993; Nelson JD, 2007, J VIROL, V81, P4033, DOI 10.1128/JVI.02588-06; Neshat MN, 2000, INT IMMUNOL, V12, P305, DOI 10.1093/intimm/12.3.305; Newman J, 2003, J IMMUNOL METHODS, V272, P177, DOI 10.1016/S0022-1759(02)00499-4; Ofek G, 2004, J VIROL, V78, P10724, DOI 10.1128/JVI.78.19.10724-10737.2004; Parker CE, 2001, J VIROL, V75, P10906, DOI 10.1128/JVI.75.22.10906-10911.2001; PENNELL CA, 1989, EUR J IMMUNOL, V19, P2115, DOI 10.1002/eji.1830191122; Rice JS, 2005, P NATL ACAD SCI USA, V102, P1608, DOI 10.1073/pnas.0409217102; Richman DD, 2003, P NATL ACAD SCI USA, V100, P4144, DOI 10.1073/pnas.0630530100; ROBEN PW, 1995, J IMMUNOL, V154, P6437; Sanchez-Martinez S, 2006, AIDS RES HUM RETROV, V22, P998, DOI 10.1089/aid.2006.22.998; Scamurra RW, 2000, J IMMUNOL, V164, P5482, DOI 10.4049/jimmunol.164.10.5482; Silverman GJ, 2006, NAT REV IMMUNOL, V6, P465, DOI 10.1038/nri1853; SILVERMAN GP, 1998, J EXP MED, V192, P87; Stiegler G, 2001, AIDS RES HUM RETROV, V17, P1757, DOI 10.1089/08892220152741450; Sun ZYJ, 2008, IMMUNITY, V28, P52, DOI 10.1016/j.immuni.2007.11.018; Tian Y, 2002, J PEPT RES, V59, P264, DOI 10.1034/j.1399-3011.2002.02988.x; Ueda Y, 2007, J IMMUNOL, V178, P3593, DOI 10.4049/jimmunol.178.6.3593; Wei XP, 2003, NATURE, V422, P307, DOI 10.1038/nature01470; Weissenhorn W, 1997, NATURE, V387, P426, DOI 10.1038/387426a0; WYATT R, 1995, J VIROL, V69, P5723, DOI 10.1128/JVI.69.9.5723-5733.1995; Wyatt R, 1998, NATURE, V393, P705, DOI 10.1038/31514; Zolla-Pazner Susan, 2005, Human Antibodies, V14, P69; Zwick MB, 2005, J VIROL, V79, P1252, DOI 10.1128/JVI.79.2.1252-1261.2005; Zwick MB, 2001, J VIROL, V75, P12198, DOI 10.1128/JVI.75.24.12198-12208.2001; Zwick MB, 2001, J VIROL, V75, P10892, DOI 10.1128/JVI.75.22.10892-10905.2001	81	21	22	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7215	10.1371/journal.pone.0007215	http://dx.doi.org/10.1371/journal.pone.0007215			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806186	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593800002
J	Nymark, M; Valle, KC; Brembu, T; Hancke, K; Winge, P; Andresen, K; Johnsen, G; Bones, AM				Nymark, Marianne; Valle, Kristin C.; Brembu, Tore; Hancke, Kasper; Winge, Per; Andresen, Kjersti; Johnsen, Geir; Bones, Atle M.			An Integrated Analysis of Molecular Acclimation to High Light in the Marine Diatom Phaeodactylum tricornutum	PLOS ONE			English	Article							PHOTOSYSTEM-II; CHLAMYDOMONAS-REINHARDTII; ARABIDOPSIS-THALIANA; ENERGY-DISSIPATION; GENE-EXPRESSION; MESSENGER-RNA; PHOTOSYNTHESIS; CHLOROPHYLL; PHOTOPROTECTION; PHOTOINHIBITION	Photosynthetic diatoms are exposed to rapid and unpredictable changes in irradiance and spectral quality, and must be able to acclimate their light harvesting systems to varying light conditions. Molecular mechanisms behind light acclimation in diatoms are largely unknown. We set out to investigate the mechanisms of high light acclimation in Phaeodactylum tricornutum using an integrated approach involving global transcriptional profiling, metabolite profiling and variable fluorescence technique. Algae cultures were acclimated to low light (LL), after which the cultures were transferred to high light (HL). Molecular, metabolic and physiological responses were studied at time points 0.5 h, 3 h, 6 h, 12 h, 24 h and 48 h after transfer to HL conditions. The integrated results indicate that the acclimation mechanisms in diatoms can be divided into an initial response phase (0-0.5 h), an intermediate acclimation phase (3-12 h) and a late acclimation phase (12-48 h). The initial phase is recognized by strong and rapid regulation of genes encoding proteins involved in photosynthesis, pigment metabolism and reactive oxygen species (ROS) scavenging systems. A significant increase in light protecting metabolites occur together with the induction of transcriptional processes involved in protection of cellular structures at this early phase. During the following phases, the metabolite profiling display a pronounced decrease in light harvesting pigments, whereas the variable fluorescence measurements show that the photosynthetic capacity increases strongly during the late acclimation phase. We show that P. tricornutum is capable of swift and efficient execution of photoprotective mechanisms, followed by changes in the composition of the photosynthetic machinery that enable the diatoms to utilize the excess energy available in HL. Central molecular players in light protection and acclimation to high irradiance have been identified.			Nymark, M (corresponding author), Norwegian Univ Sci & Technol, Dept Biol, N-7034 Trondheim, Norway.	atle.bones@bio.ntnu.no	Nymark, Marianne/H-2535-2016; Bones, Atle M/C-6202-2014; Brembu, Tore/J-7166-2015	Nymark, Marianne/0000-0002-0672-0653; Bones, Atle M/0000-0003-0544-7437; Brembu, Tore/0000-0001-5622-8037				Adir N, 2003, PHOTOSYNTH RES, V76, P343, DOI 10.1023/A:1024969518145; Andersen RA, 1997, J PHYCOL, V33, P1, DOI 10.1111/j.0022-3646.1997.00001.x; Armbrust EV, 2004, SCIENCE, V306, P79, DOI 10.1126/science.1101156; Ballottari M, 2007, J BIOL CHEM, V282, P8947, DOI 10.1074/jbc.M606417200; BARBER J, 1995, AUST J PLANT PHYSIOL, V22, P201, DOI 10.1071/PP9950201; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bowler C, 2008, NATURE, V456, P239, DOI 10.1038/nature07410; BROWN JS, 1988, J PHYCOL, V24, P96; BRUNET C, 2009, PIGMENTS OC IN PRESS; Chen H, 2006, PLANT MOL BIOL, V61, P567, DOI 10.1007/s11103-006-0031-x; Clayton R. K., 1971, METHODS ENZYMOLOGY, V23, P696; Coesel S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002896; Enami I, 2008, PHOTOSYNTH RES, V98, P349, DOI 10.1007/s11120-008-9343-9; Falkowski P.G., 2003, LIGHT HARVESTING ANT, P423, DOI 10.1007/978-94-017-2087-8_15; Field CB, 1998, SCIENCE, V281, P237, DOI 10.1126/science.281.5374.237; GENTY B, 1989, BIOCHIM BIOPHYS ACTA, V990, P87, DOI 10.1016/S0304-4165(89)80016-9; Gilmore AM, 1997, PHYSIOL PLANTARUM, V99, P197, DOI 10.1034/j.1399-3054.1997.990127.x; Guillard R.R.L., 1975, CULTURE MARINE INVER, P29, DOI [10.1007/978-1-4615-8714-9_3, DOI 10.1007/978-1-4615-8714-9_3]; Hancke K, 2008, J PHYCOL, V44, P501, DOI 10.1111/j.1529-8817.2008.00487.x; Hihara Y, 2001, PLANT CELL, V13, P793, DOI 10.1105/tpc.13.4.793; Horton P, 1996, ANNU REV PLANT PHYS, V47, P655, DOI 10.1146/annurev.arplant.47.1.655; HORTON P, 1992, PHOTOSYNTH RES, V34, P375, DOI 10.1007/BF00029812; Jensen PE, 2007, BBA-BIOENERGETICS, V1767, P335, DOI 10.1016/j.bbabio.2007.03.004; Johnsen G, 1997, LIMNOL OCEANOGR, V42, P1166, DOI 10.4319/lo.1997.42.5_part_2.1166; Komenda J, 2008, J BIOL CHEM, V283, P22390, DOI 10.1074/jbc.M801917200; Krieger-Liszkay A, 2008, PHOTOSYNTH RES, V98, P551, DOI 10.1007/s11120-008-9349-3; Kroth PG, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001426; Lamkemeyer P, 2006, PLANT J, V45, P968, DOI 10.1111/j.1365-313X.2006.02665.x; Lavaud J, 2004, J PHYCOL, V40, P130, DOI 10.1046/j.1529-8817.2004.03026.x; Li Y, 2008, J INTEGR PLANT BIOL, V50, P1057, DOI 10.1111/j.1744-7909.2008.00689.x; Lohr M, 1999, P NATL ACAD SCI USA, V96, P8784, DOI 10.1073/pnas.96.15.8784; Lohr M, 2001, PLANTA, V212, P382, DOI 10.1007/s004250000403; LONG SP, 1994, ANNU REV PLANT PHYS, V45, P633, DOI 10.1146/annurev.pp.45.060194.003221; Meyer Y, 2008, BBA-MOL CELL RES, V1783, P589, DOI 10.1016/j.bbamcr.2007.10.017; Mock T, 2004, J PHYCOL, V40, P732, DOI 10.1111/j.1529-8817.2004.03224.x; Muller P, 2001, PLANT PHYSIOL, V125, P1558, DOI 10.1104/pp.125.4.1558; NAKAMURA K, 1976, BIOCHIM BIOPHYS ACTA, V423, P227, DOI 10.1016/0005-2728(76)90181-X; Nelson N, 2006, ANNU REV PLANT BIOL, V57, P521, DOI 10.1146/annurev.arplant.57.032905.105350; Niyogi KK, 1999, ANNU REV PLANT PHYS, V50, P333, DOI 10.1146/annurev.arplant.50.1.333; Oeltjen A, 2002, PLANT BIOLOGY, V4, P250, DOI 10.1055/s-2002-25737; OHAD I, 1990, J BIOL CHEM, V265, P1972; Oudot-Le Secq MP, 2007, MOL GENET GENOMICS, V277, P427, DOI 10.1007/s00438-006-0199-4; OWENS TG, 1986, PLANT PHYSIOL, V80, P739, DOI 10.1104/pp.80.3.739; PERRY MJ, 1981, MAR BIOL, V62, P91, DOI 10.1007/BF00388170; Pfaffl MW, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.9.e36; Plucken H, 2002, FEBS LETT, V532, P85, DOI 10.1016/S0014-5793(02)03634-7; Ramakers C, 2003, NEUROSCI LETT, V339, P62, DOI 10.1016/S0304-3940(02)01423-4; Raven JA, 2003, ADV PHOTO RESPIRAT, V14, P385; Richard C, 2000, PLANT MOL BIOL, V42, P303, DOI 10.1023/A:1006340308077; Rodriguez F, 2006, MAR BIOL, V148, P963, DOI 10.1007/s00227-005-0138-7; Roose JL, 2008, J BIOL CHEM, V283, P4044, DOI 10.1074/jbc.M708960200; Ruban AV, 2004, PHOTOSYNTH RES, V82, P165, DOI 10.1007/s11120-004-1456-1; Sakshaug E, 1997, J PLANKTON RES, V19, P1637, DOI 10.1093/plankt/19.11.1637; Savard F, 1996, PLANT MOL BIOL, V32, P461, DOI 10.1007/BF00019098; Schurmann P, 2008, ANTIOXID REDOX SIGN, V10, P1235, DOI 10.1089/ars.2007.1931; Schuster G, 1999, PLANT PHYSIOL, V120, P937, DOI 10.1104/pp.120.4.937; Shapira M, 1997, PLANT MOL BIOL, V33, P1001, DOI 10.1023/A:1005814800641; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Stolte W, 2000, J PHYCOL, V36, P529, DOI 10.1046/j.1529-8817.2000.99158.x; Tanaka R, 2007, ANNU REV PLANT BIOL, V58, P321, DOI 10.1146/annurev.arplant.57.032905.105448; VANKOOTEN O, 1990, PHOTOSYNTH RES, V25, P147, DOI 10.1007/BF00033156; Wang F, 2008, PLANT CELL ENVIRON, V31, P982, DOI 10.1111/j.1365-3040.2008.01810.x; Wilhelm C, 2006, PROTIST, V157, P91, DOI 10.1016/j.protis.2006.02.003; Yamamoto Y, 2008, PHOTOSYNTH RES, V98, P589, DOI 10.1007/s11120-008-9372-4; ZHIRONG L, 2009, ANNU REV PLANT BIOL, V60, P239; Zhu SH, 2008, ENERGY SUN, P261	66	180	180	4	57	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2009	4	11							e7743	10.1371/journal.pone.0007743	http://dx.doi.org/10.1371/journal.pone.0007743			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RY	19888450	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414500012
J	Trobridge, GD; Wu, RA; Beard, BC; Chiu, SY; Munoz, NM; von Laer, D; Rossi, JJ; Kiem, HP				Trobridge, Grant D.; Wu, Robert A.; Beard, Brian C.; Chiu, Sum Ying; Munoz, Nina M.; von Laer, Dorothee; Rossi, John J.; Kiem, Hans-Peter			Protection of Stem Cell-Derived Lymphocytes in a Primate AIDS Gene Therapy Model after In Vivo Selection	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; CANINE REPOPULATING CELLS; LARGE-ANIMAL MODEL; LENTIVIRAL VECTORS; NONHUMAN-PRIMATES; HIV-1 INFECTION; CD34(+) CELLS; HUMAN GENOME; MOUSE MODEL; TRANSDUCTION	Background: There is currently no effective AIDS vaccine, emphasizing the importance of developing alternative therapies. Recently, a patient was successfully transplanted with allogeneic, naturally resistant CCR5-negative (CCR5D32) cells, setting the stage for transplantation of naturally resistant, or genetically modified stem cells as a viable therapy for AIDS. Hematopoietic stem cell (HSC) gene therapy using vectors that express various anti-HIV transgenes has also been attempted in clinical trials, but inefficient gene transfer in these studies has severely limited the potential of this approach. Here we evaluated HSC gene transfer of an anti-HIV vector in the pigtailed macaque (Macaca nemestrina) model, which closely models human transplantation. Methods and Findings: We used lentiviral vectors that inhibited both HIV-1 and simian immunodeficiency virus (SIV)/HIV-1 (SHIV) chimera virus infection, and also expressed a P140K mutant methylguanine methyltransferase (MGMT) transgene to select gene-modified cells by adding chemotherapy drugs. Following transplantation and MGMT-mediated selection we demonstrated transgene expression in over 7% of stem-cell derived lymphocytes. The high marking levels allowed us to demonstrate protection from SHIV in lymphocytes derived from gene-modified macaque long-term repopulating cells that expressed an HIV-1 fusion inhibitor. We observed a statistically significant 4-fold increase of gene-modified cells after challenge of lymphocytes from one macaque that received stem cells transduced with an anti-HIV vector (p<0.02, Student's t-test), but not in lymphocytes from a macaque that received a control vector. We also established a competitive repopulation assay in a second macaque for preclinical testing of promising anti-HIV vectors. The vectors we used were HIV-based and thus efficiently transduce human cells, and the transgenes we used target HIV-1 genes that are also in SHIV, so our findings can be rapidly translated to the clinic. Conclusions: Here we demonstrate the ability to select protected HSC-derived lymphocytes in vivo in a clinically relevant nonhuman primate model of HIV/SHIV infection. This approach can now be evaluated in human clinical trials in AIDS lymphoma patients. In this patient setting, chemotherapy would not only kill malignant cells, but would also increase the number of MGMTP140K-expressing HIV-resistant cells. This approach should allow for high levels of HIV-protected cells in AIDS patients to evaluate AIDS gene therapy.			Trobridge, GD (corresponding author), Fred Hutchinson Canc Res Ctr, Div Clin Res, 1124 Columbia St, Seattle, WA 98104 USA.	hkiem@fhcrc.org		Wu, R. Alex/0000-0003-4190-4615; von Laer, Dorothee/0000-0001-5825-7237	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL053750] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI063959, R01AI080326, P01AI061839] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [P30DK047754, P30DK056465] Funding Source: NIH RePORTER; NHLBI NIH HHS [HL053750, P01 HL053750] Funding Source: Medline; NIAID NIH HHS [AI063959, R01 AI080326, P01 AI061839, R21 AI063959, AI061839] Funding Source: Medline; NIDDK NIH HHS [P30 DK047754, DK056465, DK047754, P30 DK056465] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Aagaard L, 2008, GENE THER, V15, P1566, DOI 10.1038/gt.2008.163; Amado RG, 2004, HUM GENE THER, V15, P251, DOI 10.1089/104303404322886101; An DS, 2006, MOL THER, V14, P494, DOI 10.1016/j.ymthe.2006.05.015; Bahner I, 2007, MOL THER, V15, P76, DOI 10.1038/sj.mt.6300025; Bauer G, 2000, ANN NY ACAD SCI, V918, P318; Berges BK, 2006, RETROVIROLOGY, V3, DOI 10.1186/1742-4690-3-76; Brandt S, 2007, PLOS PATHOG, V3, P518, DOI 10.1371/journal.ppat.0030054; Brennan G, 2007, J VIROL, V81, P12210, DOI 10.1128/JVI.02499-06; Buchschacher GL, 2001, HUM GENE THER, V12, P1013, DOI 10.1089/104303401750214249; Carr A, 2003, NAT REV DRUG DISCOV, V2, P624, DOI 10.1038/nrd1151; Chackerian B, 1997, J VIROL, V71, P3932, DOI 10.1128/JVI.71.5.3932-3939.1997; COLLMAN R, 1992, J VIROL, V66, P7517, DOI 10.1128/JVI.66.12.7517-7521.1992; CRONE TM, 1994, CANCER RES, V54, P6221; Davis BM, 1999, HUM GENE THER, V10, P2769, DOI 10.1089/10430349950016500; Dropulic B, 2006, HUM GENE THER, V17, P577, DOI 10.1089/hum.2006.17.577; Dull T, 1998, J VIROL, V72, P8463, DOI 10.1128/JVI.72.11.8463-8471.1998; Egelhofer M, 2004, J VIROL, V78, P568, DOI 10.1128/JVI.78.2.568-575.2004; Gerull S, 2007, HUM GENE THER, V18, P451, DOI 10.1089/hum.2006.039; Gorantla S, 2007, J VIROL, V81, P2700, DOI 10.1128/JVI.02010-06; Grimm D, 2006, NATURE, V441, P537, DOI 10.1038/nature04791; Hanawa H, 2004, BLOOD, V103, P4062, DOI 10.1182/blood-2004-01-0045; Hermann FG, 2009, HUM GENE THER, V20, P325, DOI 10.1089/hum.2006.158; Horn PA, 2004, BLOOD, V103, P3710, DOI 10.1182/blood-2003-07-2414; HOWELL DN, 1985, J IMMUNOL, V134, P971; Hutter G, 2009, NEW ENGL J MED, V360, P692, DOI 10.1056/NEJMoa0802905; Joag SV, 2000, MICROBES INFECT, V2, P223, DOI 10.1016/S1286-4579(00)00266-5; Jung CW, 2007, EXP HEMATOL, V35, P1132, DOI 10.1016/j.exphem.2007.04.004; Kiem HP, 2010, GENE THER, V17, P37, DOI 10.1038/gt.2009.118; Kiem HP, 2007, BLOOD, V109, P65, DOI 10.1182/blood-2006-04-016741; KIMPTON J, 1992, J VIROL, V66, P2232, DOI 10.1128/JVI.66.4.2232-2239.1992; Klausner RD, 2003, SCIENCE, V300, P2036, DOI 10.1126/science.1086916; Kreklau EL, 2001, J PHARMACOL EXP THER, V297, P524; Levy JA, 1996, J MED PRIMATOL, V25, P163, DOI 10.1111/j.1600-0684.1996.tb00013.x; Li MJ, 2005, METH MOL B, V309, P261; Li MJ, 2003, MOL THER, V8, P196, DOI 10.1016/S1525-0016(03)00165-5; Mautino MR, 2000, HUM GENE THER, V11, P2025, DOI 10.1089/10430340050143444; Mitsuyasu RT, 2009, NAT MED, V15, P285, DOI 10.1038/nm.1932; Miyoshi H, 1999, SCIENCE, V283, P682, DOI 10.1126/science.283.5402.682; Montini E, 2006, NAT BIOTECHNOL, V24, P687, DOI 10.1038/nbt1216; Naldini L, 1998, CURR OPIN BIOTECH, V9, P457, DOI 10.1016/S0958-1669(98)80029-3; Nathanson N, 1999, AIDS, V13, pS113; Neff T, 2005, BLOOD, V105, P997, DOI 10.1182/blood-2004-08-3169; Neff T, 2003, J CLIN INVEST, V112, P1581, DOI 10.1172/JCI200318782; Ngoi SM, 2004, CURR GENE THER, V4, P15, DOI 10.2174/1566523044578095; Rossi JJ, 2007, NAT BIOTECHNOL, V25, P1444, DOI 10.1038/nbt1367; SALTER RD, 1985, IMMUNOGENETICS, V21, P235, DOI 10.1007/BF00375376; Schroder ARW, 2002, CELL, V110, P521, DOI 10.1016/S0092-8674(02)00864-4; Strayer DS, 2002, MOL THER, V5, P33, DOI 10.1006/mthe.2001.0513; Trobridge G, 2005, HUM GENE THER, V16, P1355, DOI 10.1089/hum.2005.16.1355; Trobridge GD, 2008, BLOOD, V111, P5537, DOI 10.1182/blood-2007-09-115022; Warren J, 2002, J MED PRIMATOL, V31, P237, DOI 10.1034/j.1600-0684.2002.02010.x; Wu XL, 2003, SCIENCE, V300, P1749, DOI 10.1126/science.1083413; Xu-Welliver M, 1998, CANCER RES, V58, P1936; Yeni PG, 2002, JAMA-J AM MED ASSOC, V288, P222, DOI 10.1001/jama.288.2.222; 2008, 07 AIDS EPIDEMIC UPD; 2007, NAT MED, V13, P1389	56	50	55	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2009	4	11							e7693	10.1371/journal.pone.0007693	http://dx.doi.org/10.1371/journal.pone.0007693			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RX	19888329	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414400009
J	Menicucci, D; Piarulli, A; Debarnot, U; d'Ascanio, P; Landi, A; Gemignani, A				Menicucci, Danilo; Piarulli, Andrea; Debarnot, Ursula; d'Ascanio, Paola; Landi, Alberto; Gemignani, Angelo			Functional Structure of Spontaneous Sleep Slow Oscillation Activity in Humans	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; LESS-THAN-1 HZ; CORTICAL SYNCHRONIZATION; SYNAPTIC HOMEOSTASIS; NEOCORTICAL NEURONS; WAVE SLEEP; NREM DELTA; IN-VIVO; ELECTROENCEPHALOGRAM; EEG	Background: During non-rapid eye movement (NREM) sleep synchronous neural oscillations between neural silence (down state) and neural activity (up state) occur. Sleep Slow Oscillations (SSOs) events are their EEG correlates. Each event has an origin site and propagates sweeping the scalp. While recent findings suggest a SSO key role in memory consolidation processes, the structure and the propagation of individual SSO events, as well as their modulation by sleep stages and cortical areas have not been well characterized so far. Methodology/Principal Findings: We detected SSO events in EEG recordings and we defined and measured a set of features corresponding to both wave shapes and event propagations. We found that a typical SSO shape has a transition to down state, which is steeper than the following transition from down to up state. We show that during SWS SSOs are larger and more locally synchronized, but less likely to propagate across the cortex, compared to NREM stage 2. Also, the detection number of SSOs as well as their amplitudes and slopes, are greatest in the frontal regions. Although derived from a small sample, this characterization provides a preliminary reference about SSO activity in healthy subjects for 32-channel sleep recordings. Conclusions/Significance: This work gives a quantitative picture of spontaneous SSO activity during NREM sleep: we unveil how SSO features are modulated by sleep stage, site of origin and detection location of the waves. Our measures on SSOs shape indicate that, as in animal models, onsets of silent states are more synchronized than those of neural firing. The differences between sleep stages could be related to the reduction of arousal system activity and to the breakdown of functional connectivity. The frontal SSO prevalence could be related to a greater homeostatic need of the heteromodal association cortices.			Menicucci, D (corresponding author), CNR, Inst Clin Physiol, Via Savi 8, I-56100 Pisa, Italy.	gemignan@dfb.unipi.it	LANDI, ALBERTO/CAE-9552-2022; Gemignani, Angelo/AAC-3308-2022; Landi, Alberto/A-7466-2016	LANDI, ALBERTO/0000-0002-0105-5121; Landi, Alberto/0000-0002-0105-5121; piarulli, andrea/0000-0003-4516-2671; menicucci, danilo/0000-0002-5521-4108; gemignani, angelo/0000-0001-7249-874X; D'ASCANIO, PAOLA/0000-0002-7272-8370				Achermann P, 1997, NEUROSCIENCE, V81, P213, DOI 10.1016/S0306-4522(97)00186-3; Amzica F, 2002, J PHYSIOL-PARIS, V96, P209, DOI 10.1016/S0928-4257(02)00008-6; Amzica F, 2002, SLEEP MED REV, V6, P139, DOI 10.1053/smrv.2001.0181; Amzica F, 1998, ELECTROEN CLIN NEURO, V107, P69, DOI 10.1016/S0013-4694(98)00051-0; AMZICA F, 1995, J NEUROPHYSIOL, V73, P20, DOI 10.1152/jn.1995.73.1.20; Braun AR, 1997, BRAIN, V120, P1173, DOI 10.1093/brain/120.7.1173; Campbell IG, 1996, J NEUROPHYSIOL, V76, P3714, DOI 10.1152/jn.1996.76.6.3714; Campbell IG, 1996, J PHARMACOL EXP THER, V276, P737; Cash SS, 2009, SCIENCE, V324, P1084, DOI 10.1126/science.1169626; Cisse Y, 2007, NEUROSCIENCE, V147, P272, DOI 10.1016/j.neuroscience.2007.04.025; Cohen L., 1995, TIME FREQUENCY ANAL; Compte A, 2003, J NEUROPHYSIOL, V89, P2707, DOI 10.1152/jn.00845.2002; Contreras D, 1996, J PHYSIOL-LONDON, V494, P251, DOI 10.1113/jphysiol.1996.sp021488; CONTRERAS D, 1995, J NEUROSCI, V15, P604; Czisch M, 2004, EUR J NEUROSCI, V20, P566, DOI 10.1111/j.1460-9568.2004.03518.x; Dang-Vu TT, 2008, P NATL ACAD SCI USA, V105, P15160, DOI 10.1073/pnas.0801819105; De Gennaro L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002483; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Destexhe A, 1999, J NEUROSCI, V19, P4595, DOI 10.1523/jneurosci.19-11-04595.1999; Esser SK, 2007, SLEEP, V30, P1617, DOI 10.1093/sleep/30.12.1617; Huber R, 2004, NATURE, V430, P78, DOI 10.1038/nature02663; Huber R, 2006, NAT NEUROSCI, V9, P1169, DOI 10.1038/nn1758; Marshall L, 2006, NATURE, V444, P610, DOI 10.1038/nature05278; Massimini M, 2005, SCIENCE, V309, P2228, DOI 10.1126/science.1117256; Massimini M, 2004, J NEUROSCI, V24, P6862, DOI 10.1523/JNEUROSCI.1318-04.2004; Massimini M, 2007, P NATL ACAD SCI USA, V104, P8496, DOI 10.1073/pnas.0702495104; Molle M, 2002, J NEUROSCI, V22, P10941; Murphy M, 2009, P NATL ACAD SCI USA, V106, P1608, DOI 10.1073/pnas.0807933106; Rechtschaffen A., 1968, BRAIN INFORM SERVICE; Riedner BA, 2007, SLEEP, V30, P1643, DOI 10.1093/sleep/30.12.1643; Sejnowski TJ, 2000, BRAIN RES, V886, P208, DOI 10.1016/S0006-8993(00)03007-9; Siegel S, 1988, NONPARAMETRIC STAT B, V2; Simon NR, 2000, BRAIN RES, V860, P64, DOI 10.1016/S0006-8993(00)01974-0; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; STERIADE M, 1993, J NEUROSCI, V13, P3266; STERIADE M, 1993, J NEUROSCI, V13, P3252, DOI 10.1523/jneurosci.13-08-03252.1993; Tononi G, 2006, SLEEP MED REV, V10, P49, DOI 10.1016/j.smrv.2005.05.002; Tononi G, 2003, BRAIN RES BULL, V62, P143, DOI 10.1016/j.brainresbull.2003.09.004; Volgushev M, 2006, J NEUROSCI, V26, P5665, DOI 10.1523/JNEUROSCI.0279-06.2006; Vyazovskiy V, 2004, NEUROSCIENCE, V124, P481, DOI 10.1016/j.neuroscience.2003.12.018; Wolansky T, 2006, J NEUROSCI, V26, P6213, DOI 10.1523/JNEUROSCI.5594-05.2006; [No title captured]; [No title captured]	43	45	45	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7601	10.1371/journal.pone.0007601	http://dx.doi.org/10.1371/journal.pone.0007601			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855839	Green Submitted, Green Published, gold			2022-12-27	WOS:000271147200017
J	Iacovelli, S; Iosue, I; Di Cesare, S; Guttinger, M				Iacovelli, Stefano; Iosue, Ilaria; Di Cesare, Silvia; Guttinger, Maria			Lymphoid EVA1 Expression Is Required for DN1-DN3 Thymocytes Transition	PLOS ONE			English	Article							T-CELL-DIFFERENTIATION; THYMIC MICROENVIRONMENTS; DEVELOPMENTAL PATHWAY; ANTIGEN EVA; LINEAGE; MOUSE; SPECIFICATION; COMMITMENT; INDUCTION; SUBSETS	Background: Thymus organogenesis and T lymphocyte development are accomplished together during fetal life. Proper development and maintenance of thymus architecture depend on signals generated by a sustained crosstalk between developing thymocytes and stromal elements. Any maturation impairment occurring in either cellular component leads to an aberrant thymic development. Gene expression occurring during T lymphocyte differentiation must be coordinated in a spatio-temporal fashion; one way in which this is achieved is through the regulation by cell-cell adhesion and interactions. Principal Findings: We examined the role played by Epithelial V-like Antigen 1 (EVA1), an Ig adhesion molecule expressed on thymus epithelial cells (TEC) and immature thymocytes, in T cell development by employing RNA interference in vitro and in vivo models. Fetal liver derived haematopoietic progenitors depleted of Eva1, displayed a delayed DN1-DN3 transition and failed to generate CD4CD8 double positive T cells in OP9-DL1 coculture system. In addition, we could observe a coordinated Eva1 up-regulation in stromal and haematopoietic cells in coculture control experiments, suggesting a possible EVA1 involvement in TEC-haematopoietic cells crosstalk mechanisms. Similarly, Rag2-gamma c double knock out mice, transplanted with Eva1 depleted haematopoietic progenitors displayed a 10-fold reduction in thymus reconstitution and a time delayed thymocytes maturation compared to controls. Conclusions: Our findings show that modulation of Eva1 expression in thymocytes is crucial for lymphocyte physiological developmental progression and stromal differentiation.			Iacovelli, S (corresponding author), San Raffaele Biomed Sci Pk Fdn, Rome, Italy.	maria.guttinger@spr-r.it	DI CESARE, SILVIA/AAB-5754-2020	DI CESARE, SILVIA/0000-0002-9912-7997; iacovelli, stefano/0000-0003-0806-6365				Anderson G, 1996, ANNU REV IMMUNOL, V14, P73, DOI 10.1146/annurev.immunol.14.1.73; Anderson MK, 1999, DEVELOPMENT, V126, P3131; DeMonte L, 2007, BIOCHEM BIOPH RES CO, V356, P334, DOI 10.1016/j.bbrc.2007.02.131; GODFREY DI, 1993, J IMMUNOL, V150, P4244; Goldman JP, 1998, BRIT J HAEMATOL, V103, P335, DOI 10.1046/j.1365-2141.1998.00980.x; GOLDSCHNEIDER I, 1986, J EXP MED, V163, P1, DOI 10.1084/jem.163.1.1; Guttinger M, 1998, J CELL BIOL, V141, P1061, DOI 10.1083/jcb.141.4.1061; HOLLANDER GA, 1995, NATURE, V373, P350, DOI 10.1038/373350a0; Itoi M, 2001, INT IMMUNOL, V13, P1203, DOI 10.1093/intimm/13.9.1203; Klug DB, 1998, P NATL ACAD SCI USA, V95, P11822, DOI 10.1073/pnas.95.20.11822; Klug DB, 2002, J IMMUNOL, V169, P2842, DOI 10.4049/jimmunol.169.6.2842; KYEWSKI BA, 1987, J EXP MED, V166, P520, DOI 10.1084/jem.166.2.520; MILLER JFA, 1967, PHYSIOL REV, V47, P437, DOI 10.1152/physrev.1967.47.3.437; Nehls M, 1996, SCIENCE, V272, P886, DOI 10.1126/science.272.5263.886; NEHLS M, 1994, NATURE, V372, P103, DOI 10.1038/372103a0; Patra AK, 2006, J IMMUNOL, V177, P4567, DOI 10.4049/jimmunol.177.7.4567; Schmitt TM, 2002, IMMUNITY, V17, P749, DOI 10.1016/S1074-7613(02)00474-0; Taghon TN, 2005, GENE DEV, V19, P965, DOI 10.1101/gad.1298305; Teesalu T, 1998, DEV GENET, V23, P317, DOI 10.1002/(SICI)1520-6408(1998)23:4<317::AID-DVG6>3.0.CO;2-O; Tydell CC, 2007, J IMMUNOL, V179, P421, DOI 10.4049/jimmunol.179.1.421; van Ewijk W, 2000, DEVELOPMENT, V127, P1583; van Ewijk W, 1999, SEMIN IMMUNOL, V11, P57, DOI 10.1006/smim.1998.0158; van Ewijk W, 2000, CURR TOP MICROBIOL, V251, P125; VANEWIJK W, 1991, ANNU REV IMMUNOL, V9, P591, DOI 10.1146/annurev.iy.09.040191.003111; VANEWIJK W, 1994, IMMUNOL TODAY, V15, P214, DOI 10.1016/0167-5699(94)90246-1; WALLIS VJ, 1975, TRANSPLANTATION, V19, P2, DOI 10.1097/00007890-197501000-00002	26	5	6	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7586	10.1371/journal.pone.0007586	http://dx.doi.org/10.1371/journal.pone.0007586			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851463	Green Published, Green Submitted, gold			2022-12-27	WOS:000271022300017
J	Patch, K; Stewart, SR; Welch, A; Ward, RE				Patch, Kistie; Stewart, Shannon R.; Welch, Aaron; Ward, Robert E., IV			A Second-Site Noncomplementation Screen for Modifiers of Rho1 Signaling during Imaginal Disc Morphogenesis in Drosophila	PLOS ONE			English	Article							NONMUSCLE MYOSIN FUNCTION; ADHERENS JUNCTIONS; CELL REARRANGEMENT; GENETIC-ANALYSIS; MELANOGASTER; GTPASES; ECDYSONE; GROWTH; ACTIVATION; MECHANISM	Background: Rho1 is a small GTPase of the Ras superfamily that serves as the central component in a highly conserved signaling pathway that regulates tissue morphogenesis during development in all animals. Since there is tremendous diversity in the upstream signals that can activate Rho1 as well as the effector molecules that carry out its functions, it is important to define relevant Rho1-interacting genes for each morphogenetic event regulated by this signaling pathway. Previous work from our lab and others has shown that Rho signaling is necessary for the morphogenesis of leg imaginal discs during metamorphosis in Drosophila, although a comprehensive identification of Rho1-interacting genes has not been attempted for this process. Methodology/Principal Findings: We characterized an amorphic allele of Rho1 that displays a poorly penetrant dominant malformed leg phenotype and is capable of being strongly enhanced by Rho1-interacting heterozygous mutations. We then used this allele in a second-site noncomplementation screen with the Exelixis collection of molecularly defined deficiencies to identify Rho1-interacting genes necessary for leg morphogenesis. In a primary screen of 461 deficiencies collectively uncovering similar to 50% of the Drosophila genome, we identified twelve intervals harboring Rho1-interacting genes. Through secondary screening we identified six Rho1-interacting genes including three that were previously identified (RhoGEF2, broad, and stubbloid), thereby validating the screen. In addition, we identified Cdc42, Rheb and Sc2 as novel Rho1-interacting genes involved in adult leg development. Conclusions/Significance: This screen identified well-known and novel Rho1-interacting genes necessary for leg morphogenesis, thereby increasing our knowledge of this important signaling pathway. We additionally found that Rheb may have a unique function in leg morphogenesis that is independent of its regulation of Tor.			Patch, K (corresponding author), Univ Kansas, Dept Mol Biosci, Lawrence, KS 66045 USA.	robward@ku.edu		Stewart, Shannon/0000-0002-5059-1609; Welch, Aaron Zachary/0000-0002-1502-3630	NCRR NIH HHS [P20 RR015563, P20 RR15563] Funding Source: Medline; NICHD NIH HHS [R01HD047570, R01 HD047570] Funding Source: Medline; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD047570] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR015563] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		ANDRES AJ, 1994, METHOD CELL BIOL, V44, P565, DOI 10.1016/S0091-679X(08)60932-2; Bayer CA, 2003, GENETICS, V165, P1417; BRAND AH, 1993, DEVELOPMENT, V118, P401; Britton JS, 2002, DEV CELL, V2, P239, DOI 10.1016/S1534-5807(02)00117-X; Brouns MR, 2000, DEVELOPMENT, V127, P4891; Causeret F, 2004, DEVELOPMENT, V131, P2841, DOI 10.1242/dev.01162; Chen GC, 2004, CURR BIOL, V14, P309, DOI 10.1016/j.cub.2004.01.056; Cohen Stephen M., 1993, P747; CONDIC ML, 1991, DEVELOPMENT, V111, P23; Crawford JM, 1998, DEV BIOL, V204, P151, DOI 10.1006/dbio.1998.9061; Fox DT, 2005, DEVELOPMENT, V132, P4819, DOI 10.1242/dev.02056; FRISTROM D, 1976, DEV BIOL, V54, P163, DOI 10.1016/0012-1606(76)90296-7; FRISTROM D, 1975, DEV BIOL, V43, P1, DOI 10.1016/0012-1606(75)90127-X; Fristrom D, 1993, DEV DROSOPHILA MELAN, P843; Garvalov BK, 2007, J NEUROSCI, V27, P13117, DOI 10.1523/JNEUROSCI.3322-07.2007; Geneva JL, 2000, DEV BIOL, V221, P181, DOI 10.1006/dbio.2000.9671; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; GOTWALS PJ, 1991, GENETICS, V127, P747; Govek EE, 2005, GENE DEV, V19, P1, DOI 10.1101/gad.1256405; Halsell SR, 1998, GENETICS, V148, P1845; Halsell SR, 2000, GENETICS, V155, P1253; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Homem CCF, 2008, DEVELOPMENT, V135, P1005, DOI 10.1242/dev.016337; Jacinto E, 2004, NAT CELL BIOL, V6, P1122, DOI 10.1038/ncb1183; Jacinto E, 2008, IUBMB LIFE, V60, P483, DOI 10.1002/iub.56; Jaffe AB, 2005, ANNU REV CELL DEV BI, V21, P247, DOI 10.1146/annurev.cellbio.21.020604.150721; Johndrow JE, 2004, BIOCHEM CELL BIOL, V82, P643, DOI 10.1139/O04-118; KARIM FD, 1991, GENE DEV, V5, P1067, DOI 10.1101/gad.5.6.1067; Kolsch V, 2007, SCIENCE, V315, P384, DOI 10.1126/science.1134833; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Le T, 2006, GENETICS, V174, P2255, DOI 10.1534/genetics.106.063461; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Lundquist EA, 2001, DEVELOPMENT, V128, P4475; Magie CR, 2005, DEV BIOL, V278, P144, DOI 10.1016/j.ydbio.2004.10.022; Magie CR, 1999, DEVELOPMENT, V126, P5353; Magie Craig R., 2002, Development (Cambridge), V129, P3771; Matsumura F, 2005, TRENDS CELL BIOL, V15, P371, DOI 10.1016/j.tcb.2005.05.004; Meiri KF, 2005, PHILOS T R SOC B, V360, P1663, DOI 10.1098/rstb.2005.1704; Moon YA, 2003, J BIOL CHEM, V278, P7335, DOI 10.1074/jbc.M211684200; Mulinari S, 2008, MOL BIOL CELL, V19, P1883, DOI 10.1091/mbc.E07-12-1230; Neufeld TP, 2003, MECH DEVELOP, V120, P1283, DOI 10.1016/j.mod.2003.07.003; Ng J, 2002, NATURE, V416, P442, DOI 10.1038/416442a; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Patel PH, 2003, J CELL SCI, V116, P3601, DOI 10.1242/jcs.00661; Prokopenko SN, 1999, GENE DEV, V13, P2301, DOI 10.1101/gad.13.17.2301; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Rossman KL, 2005, TRENDS BIOCHEM SCI, V30, P163, DOI 10.1016/j.tibs.2005.02.002; Stocker H, 2003, NAT CELL BIOL, V5, P559, DOI 10.1038/ncb995; Taylor J, 2008, DEV BIOL, V313, P739, DOI 10.1016/j.ydbio.2007.11.009; Tweedie S, 2009, NUCLEIC ACIDS RES, V37, pD555, DOI 10.1093/nar/gkn788; Ward RE, 2003, GENETICS, V165, P1397; Ward RE, 2003, DEV BIOL, V256, P389, DOI 10.1016/S0012-1606(02)00100-8; Wei L, 2001, DEVELOPMENT, V128, P2953; WOHLWILL AD, 1991, GENETICS, V128, P763; Yang Q, 2006, P NATL ACAD SCI USA, V103, P6811, DOI 10.1073/pnas.0602282103; Zhang HB, 2000, GENE DEV, V14, P2712, DOI 10.1101/gad.835000	56	7	7	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7574	10.1371/journal.pone.0007574	http://dx.doi.org/10.1371/journal.pone.0007574			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19862331	Green Published, gold, Green Submitted			2022-12-27	WOS:000271022300010
J	Beghin, A; Belin, S; Sleiman, RH; Manquat, SB; Goddard, S; Tabone, E; Jordheim, LP; Treilleux, I; Poupon, MF; Diaz, JJ; Dumontet, C				Beghin, Anne; Belin, Stephane; Sleiman, Rouba Hage; Manquat, Stephanie Brunet; Goddard, Sophie; Tabone, Eric; Jordheim, Lars P.; Treilleux, Isabelle; Poupon, Marie-France; Diaz, Jean-Jacques; Dumontet, Charles			ADP Ribosylation Factor Like 2 (Arl2) Regulates Breast Tumor Aggressivity in Immunodeficient Mice	PLOS ONE			English	Article							TUBULIN FOLDING COFACTORS; PROTEIN PHOSPHATASE 2A; MICROTUBULE DYNAMICS; BUDDING YEAST; E-CADHERIN; CELL-LINE; IN-VITRO; PP2A; BINDING; MORPHOGENESIS	We have previously reported that ADP ribosylation factor like 2 (Arl2), a small GTPase, content influences microtubule dynamics and cell cycle distribution in breast tumor cells, as well as the degree and distribution of phosphorylated P53. Here we show, in two different human breast adenocarcinoma models, that Arl2 content has a major impact on breast tumor cell aggressivity both in vitro and in vivo. Cells with reduced content of Arl2 displayed reduced contact inhibition, increased clonogenic or cluster formation as well as a proliferative advantage over control cells in an in vitro competition assay. These cells also caused larger tumors in SCID mice, a phenotype which was mimicked by the in vivo administration of siRNA directed against Arl2. Cells with increased Arl2 content displayed reduced aggressivity, both in vitro and in vivo, with enhanced necrosis and were also found to contain increased PP2A phosphatase activity. A rt-PCR analysis of fresh human tumor breast samples suggested that low Arl2 expression was associated with larger tumor size and greater risk of lymph node involvement at diagnosis. These data underline the role of Arl2, a small GTPase, as an important regulator of breast tumor cell aggressivity, both in vitro and in vivo.			Beghin, A (corresponding author), INSERM, U590, F-69008 Lyon, France.	charles.dumontet@chu-lyon.fr	DIAZ, Jean-Jacques/AAT-3846-2021; Jordheim, Lars Petter/X-7228-2019; DIAZ, Jean-Jacques/H-3018-2014	DIAZ, Jean-Jacques/0000-0002-7914-4319; Jordheim, Lars Petter/0000-0003-3948-7090; DIAZ, Jean-Jacques/0000-0002-7914-4319; Dumontet, Charles/0000-0003-1875-134X; Belin, Stephane/0000-0001-7074-6885				Antoshechkin I, 2002, DEV CELL, V2, P579, DOI 10.1016/S1534-5807(02)00146-6; Beghin A, 2008, CELL CYCLE, V7, P3074, DOI 10.4161/cc.7.19.6777; Behin A, 2007, EXP CELL RES, V313, P473, DOI 10.1016/j.yexcr.2006.10.024; Bhamidipati A, 2000, J CELL BIOL, V149, P1087, DOI 10.1083/jcb.149.5.1087; Bode CJ, 2003, EMBO REP, V4, P94, DOI 10.1038/sj.embor.embor716; Calin GA, 2000, ONCOGENE, V19, P1191, DOI 10.1038/sj.onc.1203389; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; FUJIKI H, 1993, ADV CANCER RES, V61, P143, DOI 10.1016/S0065-230X(08)60958-6; Gehringer MM, 2004, FEBS LETT, V557, P1, DOI 10.1016/S0014-5793(03)01447-9; Hoyt MA, 1997, GENETICS, V146, P849; Janssens V, 2005, CURR OPIN GENET DEV, V15, P34, DOI 10.1016/j.gde.2004.12.004; Jordheim LP, 2004, CLIN CANCER RES, V10, P5614, DOI 10.1158/1078-0432.CCR-04-0506; Kahn RA, 2005, BIOCHEM SOC T, V33, P1269, DOI 10.1042/BST0331269; KAHN RA, 1991, J BIOL CHEM, V266, P2606; Lao DH, 2007, J BIOL CHEM, V282, P9117, DOI 10.1074/jbc.M607563200; Lopez-Fanarraga M, 2001, J STRUCT BIOL, V135, P219, DOI 10.1006/jsbi.2001.4386; MESSNER DJ, 2006, J CELL BIOCH; Minshull J, 1996, CURR BIOL, V6, P1609, DOI 10.1016/S0960-9822(02)70784-7; Neviani P, 2005, CANCER CELL, V8, P355, DOI 10.1016/j.ccr.2005.10.015; Radcliffe PA, 2000, FEBS LETT, V468, P84, DOI 10.1016/S0014-5793(00)01202-3; Shern JF, 2003, J BIOL CHEM, V278, P40829, DOI 10.1074/jbc.M308678200; SHULTZ T, 2007, FASEB J; Stehbens SJ, 2006, J CELL SCI, V119, P1801, DOI 10.1242/jcs.02903; Takahashi K, 2006, J CELL PHYSIOL, V206, P814, DOI 10.1002/jcp.20524; TIAN GL, 1995, J BIOL CHEM, V270, P23910, DOI 10.1074/jbc.270.41.23910; Tian GL, 1997, J CELL BIOL, V138, P821, DOI 10.1083/jcb.138.4.821; Tian GL, 1999, J BIOL CHEM, V274, P24054, DOI 10.1074/jbc.274.34.24054; Van Hoof C, 2003, BBA-MOL CELL RES, V1640, P97, DOI 10.1016/S0167-4889(03)00029-6; Wang SS, 1998, SCIENCE, V282, P284, DOI 10.1126/science.282.5387.284	29	17	18	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7478	10.1371/journal.pone.0007478	http://dx.doi.org/10.1371/journal.pone.0007478			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829707	Green Published, gold			2022-12-27	WOS:000270847800015
J	Schleimann, MH; Moller, JML; Kofod-Olsen, E; Hollsberg, P				Schleimann, Mariane H.; Moller, Janni M. L.; Kofod-Olsen, Emil; Hoellsberg, Per			Direct Repeat 6 from Human Herpesvirus-6B Encodes a Nuclear Protein that Forms a Complex with the Viral DNA Processivity Factor p41	PLOS ONE			English	Article							BLOOD MONONUCLEAR-CELLS; BINDING PROTEIN; CODING CONTENT; INFECTION; ACCUMULATION; EXPRESSION; SEQUENCE; FRAGMENT; AGENT; P53	The SalI-L fragment from human herpesvirus 6A (HHV-6A) encodes a protein DR7 that has been reported to produce fibrosarcomas when injected into nude mice, to transform NIH3T3 cells, and to interact with and inhibit the function of p53. The homologous gene in HHV-6B is dr6. Since p53 is deregulated in both HHV-6A and -6B, we characterized the expression of dr6 mRNA and the localization of the translated protein during HHV-6B infection of HCT116 cells. Expression of mRNA from dr6 was inhibited by cycloheximide and partly by phosphonoacetic acid, a known characteristic of herpesvirus early/late genes. DR6 could be detected as a nuclear protein at 24 hpi and accumulated to high levels at 48 and 72 hpi. DR6 located in dots resembling viral replication compartments. Furthermore, a novel interaction between DR6 and the viral DNA processivity factor, p41, could be detected by confocal microscopy and by co-immunoprecipitation analysis. In contrast, DR6 and p53 were found at distinct subcellular locations. Together, our data imply a novel function of DR6 during HHV-6B replication.			Schleimann, MH (corresponding author), Aarhus Univ, Dept Med Microbiol & Immunol, Aarhus, Denmark.	ph@microbiology.au.dk		Schleimann, Mariane/0000-0001-5147-9523				Aberle SW, 1996, J CLIN MICROBIOL, V34, P3223, DOI 10.1128/JCM.34.12.3223-3225.1996; Ahlqvist J, 2005, J NEUROVIROL, V11, P384, DOI 10.1080/13550280591002379; Braun DK, 1997, CLIN MICROBIOL REV, V10, P521, DOI 10.1128/CMR.10.3.521; Cotter TG, 2009, NAT REV CANCER, V9, P501, DOI 10.1038/nrc2663; De Bolle L, 2005, J MED VIROL, V75, P76, DOI 10.1002/jmv.20240; De Bolle L, 2004, FEBS LETT, V560, P25, DOI 10.1016/S0014-5793(04)00035-3; Dominguez G, 1999, J VIROL, V73, P8040, DOI 10.1128/JVI.73.10.8040-8052.1999; GOMPELS UA, 1995, VIROLOGY, V209, P29, DOI 10.1006/viro.1995.1228; Kashanchi F, 1997, ONCOGENE, V14, P359, DOI 10.1038/sj.onc.1200840; KASHANCHI F, 1994, VIROLOGY, V201, P95, DOI 10.1006/viro.1994.1269; Oster B, 2005, J VIROL, V79, P1961, DOI 10.1128/JVI.79.3.1961-1965.2005; Oster B, 2002, J VIROL, V76, P7578, DOI 10.1128/JVI.76.15.7578-7586.2002; Quadt I, 2006, VIRUS RES, V115, P207, DOI 10.1016/j.virusres.2005.09.010; QUINLAN MP, 1984, CELL, V36, P857, DOI 10.1016/0092-8674(84)90035-7; Takemoto M, 2004, J GEN VIROL, V85, P869, DOI 10.1099/vir.0.19626-0; THOMPSON J, 1994, ONCOGENE, V9, P1167; Turcanova VL, 2009, J CLIN VIROL, V46, P15, DOI 10.1016/j.jcv.2009.05.015; YAMANISHI K, 1988, LANCET, V1, P1065; YOSHIKAWA T, 1989, PEDIATRICS, V84, P675; Zerr DM, 2005, NEW ENGL J MED, V352, P768, DOI 10.1056/NEJMoa042207	20	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7457	10.1371/journal.pone.0007457	http://dx.doi.org/10.1371/journal.pone.0007457			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829698	Green Published, Green Submitted, gold			2022-12-27	WOS:000270847800005
J	Sung, YM; Xu, XH; Sun, JF; Mueller, D; Sentissi, K; Johnson, P; Urbach, E; Seillier-Moiseiwitsch, F; Johnson, MD; Mueller, SC				Sung, You Me; Xu, Xuehua; Sun, Junfeng; Mueller, Duane; Sentissi, Kinza; Johnson, Peter; Urbach, Elana; Seillier-Moiseiwitsch, Francoise; Johnson, Michael D.; Mueller, Susette C.			Tumor Suppressor Function of Syk in Human MCF10A In Vitro and Normal Mouse Mammary Epithelium In Vivo	PLOS ONE			English	Article							BREAST-CANCER CELLS; PROTEIN-TYROSINE KINASE; MESENCHYMAL TRANSITION; INVADOPODIA FORMATION; MATRIX DEGRADATION; CARCINOMA CELLS; KAPPA-B; VIMENTIN; GROWTH; MODEL	The normal function of Syk in epithelium of the developing or adult breast is not known, however, Syk suppresses tumor growth, invasion, and metastasis in breast cancer cells. Here, we demonstrate that in the mouse mammary gland, loss of one Syk allele profoundly increases proliferation and ductal branching and invasion of epithelial cells through the mammary fat pad during puberty. Mammary carcinomas develop by one year. Syk also suppresses proliferation and invasion in vitro. siRNA or shRNA knockdown of Syk in MCF10A breast epithelial cells dramatically increased proliferation, anchorage independent growth, cellular motility, and invasion, with formation of functional, extracellular matrix-degrading invadopodia. Morphological and gene microarray analysis following Syk knockdown revealed a loss of luminal and differentiated epithelial features with epithelial to mesenchymal transition and a gain in invadopodial cell surface markers CD44, CD49F, and MMP14. These results support the role of Syk in limiting proliferation and invasion of epithelial cells during normal morphogenesis, and emphasize the critical role of Syk as a tumor suppressor for breast cancer. The question of breast cancer risk following systemic anti-Syk therapy is raised since only partial loss of Syk was sufficient to induce mammary carcinomas.			Sung, YM (corresponding author), Georgetown Univ, Med Ctr, Dept Oncol, Lombardi Comprehens Canc Ctr, Washington, DC 20007 USA.	muellers@georgetown.edu	xu, xuehua/R-1163-2019	xu, xuehua/0000-0002-3863-9593; Urbach, Elana/0000-0002-3205-2484; johnson, Michael/0000-0001-6260-7586	NCATS NIH HHS [UL1 TR000101] Funding Source: Medline; NCI NIH HHS [P30 CA051008, 9R01 CA 112673, 1P30-CA-51008, R01 CA112673] Funding Source: Medline; NCRR NIH HHS [1 S10 RR019291-01A2, S10 RR019291, 1S10 RR15768-01] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA112673, P30CA051008] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000101] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [S10RR015768, S10RR019291] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abtahian F, 2003, SCIENCE, V299, P247, DOI 10.1126/science.1079477; Akisaka T, 2008, CELL TISSUE RES, V331, P625, DOI 10.1007/s00441-007-0552-x; Artym VV, 2006, CANCER RES, V66, P3034, DOI 10.1158/0008-5472.CAN-05-2177; Artym VV, 2009, METHOD MOL BIOL, V522, P1; Bebu I, 2008, STAT MED, V27, P2684, DOI 10.1002/sim.3080; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bindels S, 2006, ONCOGENE, V25, P4975, DOI 10.1038/sj.onc.1209511; CHENG AM, 1995, NATURE, V378, P303, DOI 10.1038/378303a0; Coopman PJ, 2006, CANCER LETT, V241, P159, DOI 10.1016/j.canlet.2005.11.004; Coopman PJ, 1998, CLIN CANCER RES, V4, P507; Coopman PJP, 2000, NATURE, V406, P742, DOI 10.1038/35021086; Debnath J, 2003, METHODS, V30, P256, DOI 10.1016/S1046-2023(03)00032-X; Fillmore C, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1673; Gad A, 2008, CELL MOTIL CYTOSKEL, V65, P614, DOI 10.1002/cm.20287; Galliher AJ, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1524; Gilles C, 1999, J CELL SCI, V112, P4615; Gilles C, 2001, J CELL SCI, V114, P2967; Heppner GH, 2000, BREAST CANCER RES, V2, P331; Honeth G, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2108; Hu M, 2008, CANCER CELL, V13, P394, DOI 10.1016/j.ccr.2008.03.007; Huber MA, 2004, J CLIN INVEST, V114, P569, DOI 10.1172/JCI200421358; Kokkinos MI, 2007, CELLS TISSUES ORGANS, V185, P191, DOI 10.1159/000101320; Krause S, 2008, TISSUE ENG PT C-METH, V14, P261, DOI 10.1089/ten.tec.2008.0030; Li J, 2005, INT J CANCER, V117, P14, DOI 10.1002/ijc.21074; LIU S, 2008, PIGMENT CELL MELANOM; Mahabeleshwar GH, 2003, J BIOL CHEM, V278, P6209, DOI 10.1074/jbc.M208905200; Mandal S, 2008, EXP CELL RES, V314, P3478, DOI 10.1016/j.yexcr.2008.09.013; Masuda ES, 2008, PULM PHARMACOL THER, V21, P461, DOI 10.1016/j.pupt.2007.06.002; Miller F R, 1996, Cancer Treat Res, V83, P243; Miller FR, 2000, J NATL CANCER I, V92, P1185, DOI 10.1093/jnci/92.14.1185A; Moroni M, 2004, CANCER RES, V64, P7346, DOI 10.1158/0008-5472.CAN-03-3520; Mueller Susette C., 2008, P403, DOI 10.1007/978-0-387-69057-5_21; Muthusamy V, 2006, CANCER RES, V66, P11187, DOI 10.1158/0008-5472.CAN-06-1274; Nakahara H, 1996, J BIOL CHEM, V271, P27221, DOI 10.1074/jbc.271.44.27221; Ruschel A, 2004, CELL SIGNAL, V16, P1249, DOI 10.1016/j.cellsig.2004.03.007; Sabeh F, 2009, J CELL BIOL, V185, P11, DOI 10.1083/jcb.200807195; Saltel F, 2008, EUR J CELL BIOL, V87, P459, DOI 10.1016/j.ejcb.2008.01.001; Sarrio D, 2008, CANCER RES, V68, P989, DOI 10.1158/0008-5472.CAN-07-2017; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; SOULE HD, 1990, CANCER RES, V50, P6075; THOMPSON EW, 1992, J CELL PHYSIOL, V150, P534, DOI 10.1002/jcp.1041500314; TURNER M, 1995, NATURE, V378, P298, DOI 10.1038/378298a0; Turner M, 1997, J EXP MED, V186, P2013, DOI 10.1084/jem.186.12.2013; Vikesaa J, 2006, EMBO J, V25, P1456, DOI 10.1038/sj.emboj.7601039; Zhang X, 2006, J BIOL CHEM, V281, P6471, DOI 10.1074/jbc.M512666200; Zhang XY, 2009, MOL CANCER RES, V7, P634, DOI 10.1158/1541-7786.MCR-08-0371; Zhu YH, 2007, TOXICOL APPL PHARM, V221, P268, DOI 10.1016/j.taap.2007.03.027	47	33	35	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7445	10.1371/journal.pone.0007445	http://dx.doi.org/10.1371/journal.pone.0007445			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829710	Green Published, Green Submitted, gold			2022-12-27	WOS:000270847800004
J	Korur, S; Huber, RM; Sivasankaran, B; Petrich, M; Morin, P; Hemmings, BA; Merlo, A; Lino, MM				Korur, Serdar; Huber, Roland M.; Sivasankaran, Balasubramanian; Petrich, Michael; Morin, Pier, Jr.; Hemmings, Brian A.; Merlo, Adrian; Lino, Maria Maddalena			GSK3 beta Regulates Differentiation and Growth Arrest in Glioblastoma	PLOS ONE			English	Article							GLYCOGEN-SYNTHASE KINASE-3-BETA; CANCER STEM-CELLS; FACTOR-KAPPA-B; SELF-RENEWAL; BMI-1; GENE; SENESCENCE; POLYCOMB; SURVIVAL; TUMORS	Cancers are driven by a population of cells with the stem cell properties of self-renewal and unlimited growth. As a subpopulation within the tumor mass, these cells are believed to constitute a tumor cell reservoir. Pathways controlling the renewal of normal stem cells are deregulated in cancer. The polycomb group gene Bmi1, which is required for neural stem cell self-renewal and also controls anti-oxidant defense in neurons, is upregulated in several cancers, including medulloblastoma. We have found that Bmi1 is consistently and highly expressed in GBM. Downregulation of Bmi1 by shRNAs induced a differentiation phenotype and reduced expression of the stem cell markers Sox2 and Nestin. Interestingly, expression of glycogen synthase kinase 3 beta (GSK3 beta), which was found to be consistently expressed in primary GBM, also declined. This suggests a functional link between Bmi1 and GSK3b. Interference with GSK3b activity by siRNA, the specific inhibitor SB216763, or lithium chloride (LiCl) induced tumor cell differentiation. In addition, tumor cell apoptosis was enhanced, the formation of neurospheres was impaired, and clonogenicity reduced in a dose-dependent manner. GBM cell lines consist mainly of CD133-negative (CD133-) cells. Interestingly, ex vivo cells from primary tumor biopsies allowed the identification of a CD133- subpopulation of cells that express stem cell markers and are depleted by inactivation of GSK3b. Drugs that inhibit GSK3, including the psychiatric drug LiCl, may deplete the GBM stem cell reservoir independently of CD133 status.			Korur, S (corresponding author), Univ Basel Hosp, Mol Neurooncol Lab, CH-4031 Basel, Switzerland.	adrian.merlo@gmx.ch	Sivasankaran, Balasubramanian/D-1527-2015	Sivasankaran, Balasubramanian/0000-0001-6207-5516				Beier D, 2007, CANCER RES, V67, P4010, DOI 10.1158/0008-5472.CAN-06-4180; Ben-Porath I, 2008, NAT GENET, V40, P499, DOI 10.1038/ng.127; Bruggeman SWM, 2007, CANCER CELL, V12, P328, DOI 10.1016/j.ccr.2007.08.032; Byfield MP, 2005, J BIOL CHEM, V280, P33076, DOI 10.1074/jbc.M507201200; Cline GW, 2002, DIABETES, V51, P2903, DOI 10.2337/diabetes.51.10.2903; Cohen P, 2004, NAT REV DRUG DISCOV, V3, P479, DOI 10.1038/nrd1415; Cohen Y, 1998, MED ONCOL, V15, P32, DOI 10.1007/BF02787342; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Doble BW, 2003, J CELL SCI, V116, P1175, DOI 10.1242/jcs.00384; Foltz DR, 2002, CURR BIOL, V12, P1006, DOI 10.1016/S0960-9822(02)00888-6; Fong HL, 2008, STEM CELLS, V26, P1931, DOI 10.1634/stemcells.2007-1002; Galli R, 2004, CANCER RES, V64, P7011, DOI 10.1158/0008-5472.CAN-04-1364; GANGEMI RM, 2008, STEM CELLS; Godlewski J, 2008, CANCER RES, V68, P9125, DOI 10.1158/0008-5472.CAN-08-2629; Gould TD, 2002, NEUROSCIENTIST, V8, P497, DOI 10.1177/107385802237176; HAUPT Y, 1993, ONCOGENE, V8, P3161; HEMMINGS BA, 1981, EUR J BIOCHEM, V119, P443, DOI 10.1111/j.1432-1033.1981.tb05628.x; Hoeflich KP, 2000, NATURE, V406, P86, DOI 10.1038/35017574; Ishii N, 1999, BRAIN PATHOL, V9, P469, DOI 10.1111/j.1750-3639.1999.tb00536.x; Jacobs, 1999, Curr Infect Dis Rep, V1, P13, DOI 10.1007/s11908-999-0004-8; Jacobs JJL, 1999, NATURE, V397, P164, DOI 10.1038/16476; Joo KM, 2008, LAB INVEST, V88, P808, DOI 10.1038/labinvest.2008.57; Kotliarova S, 2008, CANCER RES, V68, P6643, DOI 10.1158/0008-5472.CAN-08-0850; Labuhn M, 2001, ONCOGENE, V20, P1103, DOI 10.1038/sj.onc.1204197; Lee J, 2006, CANCER CELL, V9, P391, DOI 10.1016/j.ccr.2006.03.030; Leung C, 2004, NATURE, V428, P337, DOI 10.1038/nature02385; Liu SL, 2006, CANCER RES, V66, P6063, DOI 10.1158/0008-5472.CAN-06-0054; Merlo A, 2003, NEUROSURG REV, V26, P145, DOI 10.1007/s10143-003-0267-8; Molofsky AV, 2005, GENE DEV, V19, P1432, DOI 10.1101/gad.1299505; Molofsky AV, 2003, NATURE, V425, P962, DOI 10.1038/nature02060; MOLOFSKY AV, 2006, NATURE; NEWTON HB, 1994, AM FAM PHYSICIAN, V49, P787; Newton Herbert B, 2004, Expert Rev Anticancer Ther, V4, P803, DOI 10.1586/14737140.4.5.803; Nowak K, 2006, NUCLEIC ACIDS RES, V34, P1745, DOI 10.1093/nar/gkl119; Nowicki MO, 2008, NEURO-ONCOLOGY, V10, P690, DOI 10.1215/15228517-2008-041; Nusse R, 2008, COLD SH Q B, V73, P59, DOI 10.1101/sqb.2008.73.035; Orlando V, 2003, CELL, V112, P599, DOI 10.1016/S0092-8674(03)00157-0; Ougolkov AV, 2005, CANCER RES, V65, P2076, DOI 10.1158/0008-5472.CAN-04-3642; Park IK, 2003, NATURE, V423, P302, DOI 10.1038/nature01587; Park IK, 2004, J CLIN INVEST, V113, P175, DOI 10.1172/JCI200420800; Pfenninger CV, 2007, CANCER RES, V67, P5727, DOI 10.1158/0008-5472.CAN-07-0183; Piccirillo SGM, 2007, ERNST SCHERING FOUND, V5, P59, DOI 10.1007/2789_2007_044; Ryder J, 2003, BIOCHEM BIOPH RES CO, V312, P922, DOI 10.1016/j.bbrc.2003.11.014; Shakhova O, 2005, J MOL MED, V83, P596, DOI 10.1007/s00109-005-0682-0; Singh SK, 2003, CANCER RES, V63, P5821; Singh SK, 2004, NATURE, V432, P396, DOI 10.1038/nature03128; Tan J, 2005, CANCER RES, V65, P9012, DOI 10.1158/0008-5472.CAN-05-1226; Valk-Lingbeek ME, 2004, CELL, V118, P409, DOI 10.1016/j.cell.2004.08.005; Visvader JE, 2008, NAT REV CANCER, V8, P755, DOI 10.1038/nrc2499; Vonlanthen S, 2001, BRIT J CANCER, V84, P1372, DOI 10.1054/bjoc.2001.1791; Wang Z, 2008, NATURE; Wegner M, 1999, NUCLEIC ACIDS RES, V27, P1409, DOI 10.1093/nar/27.6.1409; Zencak D, 2005, J NEUROSCI, V25, P5774, DOI 10.1523/JNEUROSCI.3452-04.2005	53	115	116	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7443	10.1371/journal.pone.0007443	http://dx.doi.org/10.1371/journal.pone.0007443			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823589	Green Submitted, gold, Green Published			2022-12-27	WOS:000270808300018
J	Shortridge, MD; Powers, R				Shortridge, Matthew D.; Powers, Robert			Structural and Functional Similarity between the Bacterial Type III Secretion System Needle Protein PrgI and the Eukaryotic Apoptosis Bcl-2 Proteins	PLOS ONE			English	Article							LIGAND-BINDING; FAMILY PROTEINS; FAST-NMR; EVOLUTION; BAX; INHIBITOR; IDENTIFICATION; MECHANISMS; CHELERYTHRINE; ANNOTATION	Background: Functional similarity is challenging to identify when global sequence and structure similarity is low. Active-sites or functionally relevant regions are evolutionarily more stable relative to the remainder of a protein structure and provide an alternative means to identify potential functional similarity between proteins. We recently developed the FAST-NMR methodology to discover biochemical functions or functional hypotheses of proteins of unknown function by experimentally identifying ligand binding sites. FAST-NMR utilizes our CPASS software and database to assign a function based on a similarity in the structure and sequence of ligand binding sites between proteins of known and unknown function. Methodology/Principal Findings: The PrgI protein from Salmonella typhimurium forms the needle complex in the type III secretion system (T3SS). A FAST-NMR screen identified a similarity between the ligand binding sites of PrgI and the Bcl-2 apoptosis protein Bcl-xL. These ligand binding sites correlate with known protein-protein binding interfaces required for oligomerization. Both proteins form membrane pores through this oligomerization to release effector proteins to stimulate cell death. Structural analysis indicates an overlap between the PrgI structure and the pore forming motif of Bcl-xL. A sequence alignment indicates conservation between the PrgI and Bcl-xL ligand binding sites and pore formation regions. This active-site similarity was then used to verify that chelerythrine, a known Bcl-xL inhibitor, also binds PrgI. Conclusions/Significance: A structural and functional relationship between the bacterial T3SS and eukaryotic apoptosis was identified using our FAST-NMR ligand affinity screen in combination with a bioinformatic analysis based on our CPASS program. A similarity between PrgI and Bcl-xL is not readily apparent using traditional global sequence and structure analysis, but was only identified because of conservation in ligand binding sites. These results demonstrate the unique opportunity that ligand-binding sites provide for the identification of functional relationships when global sequence and structural information is limited.			Shortridge, MD (corresponding author), Univ Nebraska, Dept Chem, Lincoln, NE 68588 USA.	rpowers3@unl.edu	Powers, Robert/AAK-3431-2020	Powers, Robert/0000-0001-9948-6837	NCRR NIH HHS [RR015468-01, C06 RR015468] Funding Source: Medline; NIAID NIH HHS [R21 AI081154, R21AI081154] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [C06RR015468] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI081154] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Annis MG, 2005, EMBO J, V24, P2096, DOI 10.1038/sj.emboj.7600675; Aouacheria A, 2005, MOL BIOL EVOL, V22, P2395, DOI 10.1093/molbev/msi234; ARMOUGOM F, 2006, EXPRESSO AUTOMATIC I, V34, pW604; Batut J, 2004, NAT REV MICROBIOL, V2, P933, DOI 10.1038/nrmicro1044; Billen LP, 2008, PLOS BIOL, V6, P1268, DOI 10.1371/journal.pbio.0060147; Breckenridge DG, 2004, CURR OPIN CELL BIOL, V16, P647, DOI 10.1016/j.ceb.2004.09.009; Bystroff Christopher, 2008, V413, P173; Campbell SJ, 2003, CURR OPIN STRUC BIOL, V13, P389, DOI 10.1016/S0959-440X(03)00075-7; Cartron PF, 2002, HUM MOL GENET, V11, P675, DOI 10.1093/hmg/11.6.675; Chan SL, 2003, J BIOL CHEM, V278, P20453, DOI 10.1074/jbc.C300138200; Chao DT, 1998, ANNU REV IMMUNOL, V16, P395, DOI 10.1146/annurev.immunol.16.1.395; Chou JJ, 1999, CELL, V96, P615, DOI 10.1016/S0092-8674(00)80572-3; Cornelis GR, 2000, ANNU REV MICROBIOL, V54, P735, DOI 10.1146/annurev.micro.54.1.735; Deane JE, 2006, P NATL ACAD SCI USA, V103, P12529, DOI 10.1073/pnas.0602689103; Desagher S, 1999, J CELL BIOL, V144, P891, DOI 10.1083/jcb.144.5.891; Dietmann S, 2001, NUCLEIC ACIDS RES, V29, P55, DOI 10.1093/nar/29.1.55; Er E, 2007, J BIOL CHEM, V282, P24938, DOI 10.1074/jbc.M703823200; Fletchera JI, 2008, P NATL ACAD SCI USA, V105, P18081, DOI 10.1073/pnas.0808691105; Galan JE, 2001, ANNU REV CELL DEV BI, V17, P53, DOI 10.1146/annurev.cellbio.17.1.53; Gauthier A, 2003, J BIOL CHEM, V278, P25273, DOI 10.1074/jbc.R300012200; Gerlt JA, 2001, ANNU REV BIOCHEM, V70, P209, DOI 10.1146/annurev.biochem.70.1.209; Gophna U, 2003, GENE, V312, P151, DOI 10.1016/S0378-1119(03)00612-7; Goping IS, 1998, J CELL BIOL, V143, P207, DOI 10.1083/jcb.143.1.207; Grassme H, 2001, APOPTOSIS, V6, P441, DOI 10.1023/A:1012485506972; Gray MW, 2001, GENOME BIOL, V2; HENIKOFF S, 1993, PROTEINS, V17, P49, DOI 10.1002/prot.340170108; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Holm L, 2000, BIOINFORMATICS, V16, P566, DOI 10.1093/bioinformatics/16.6.566; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Jiang H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-444; Kang MH, 2009, CLIN CANCER RES, V15, P1126, DOI 10.1158/1078-0432.CCR-08-0144; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kimbrough TG, 2002, MICROBES INFECT, V4, P75, DOI 10.1016/S1286-4579(01)01512-X; Koonin EV, 2002, CELL DEATH DIFFER, V9, P394, DOI 10.1038/sj.cdd.4400991; Kubori T, 2000, P NATL ACAD SCI USA, V97, P10225, DOI 10.1073/pnas.170128997; Kuwana T, 2002, CELL, V111, P331, DOI 10.1016/S0092-8674(02)01036-X; Lalier L, 2007, APOPTOSIS, V12, P887, DOI 10.1007/s10495-007-0749-1; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Liu RY, 2007, P NATL ACAD SCI USA, V104, P7116, DOI 10.1073/pnas.0700266104; Liu TQ, 2007, NUCLEIC ACIDS RES, V35, pD198, DOI 10.1093/nar/gkl999; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Marlovits TC, 2006, NATURE, V441, P637, DOI 10.1038/nature04822; McCann HC, 2008, NEW PHYTOL, V177, P33, DOI 10.1111/j.1469-8137.2007.02293.x; McDonnell JM, 1999, CELL, V96, P625, DOI 10.1016/S0092-8674(00)80573-5; Mercier KA, 2006, J AM CHEM SOC, V128, P15292, DOI 10.1021/ja0651759; Mercier KA, 2006, COMB CHEM HIGH T SCR, V9, P515, DOI 10.2174/138620706777935342; Mercier KA, 2009, COMB CHEM HIGH T SCR, V12, P285, DOI 10.2174/138620709787581738; Mirny LA, 1999, J MOL BIOL, V291, P177, DOI 10.1006/jmbi.1999.2911; Morett E, 1998, FEBS LETT, V433, P108, DOI 10.1016/S0014-5793(98)00888-6; Morris GM, 1998, J COMPUT CHEM, V19, P1639, DOI 10.1002/(SICI)1096-987X(19981115)19:14<1639::AID-JCC10>3.0.CO;2-B; Muchmore SW, 1996, NATURE, V381, P335, DOI 10.1038/381335a0; Mulkidjanian AY, 2007, NAT REV MICROBIOL, V5, P892, DOI 10.1038/nrmicro1767; Muller Simone, 2001, Expert Opin Ther Targets, V5, P327, DOI 10.1517/14728222.5.3.327; NICHOLLS A, 1991, J COMPUT CHEM, V12, P435, DOI 10.1002/jcc.540120405; Notredame C, 2003, BIOINFORMATICS AND GENOMES: CURRENT PERSPECTIVES, P27; Oltersdorf T, 2005, NATURE, V435, P677, DOI 10.1038/nature03579; Pallen MJ, 2006, PROTEIN SCI, V15, P935, DOI 10.1110/ps.051958806; Park K, 2008, PROTEINS, V71, P960, DOI 10.1002/prot.21780; Pettersen EF, 2004, J COMPUT CHEM, V25, P1605, DOI 10.1002/jcc.20084; Poirot O, 2003, NUCLEIC ACIDS RES, V31, P3503, DOI 10.1093/nar/gkg522; Powers R, 2007, COMB CHEM HIGH T SCR, V10, P676, DOI 10.2174/138620707782507331; Powers R, 2008, DRUG DISCOV TODAY, V13, P172, DOI 10.1016/j.drudis.2007.11.001; Powers R, 2006, PROTEINS, V65, P124, DOI 10.1002/prot.21092; Rosinski JA, 1999, J MOL EVOL, V49, P301, DOI 10.1007/PL00006552; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Shapiro R, 2006, Q REV BIOL, V81, P105, DOI 10.1086/506024; Shortridge MD, 2008, J COMB CHEM, V10, P948, DOI 10.1021/cc800122m; Stark J, 2008, J AM CHEM SOC, V130, P535, DOI 10.1021/ja0737974; Suzuki M, 2000, CELL, V103, P645, DOI 10.1016/S0092-8674(00)00167-7; Torruellas J, 2005, MOL MICROBIOL, V57, P1719, DOI 10.1111/j.1365-2958.2005.04790.x; Vander Heiden MG, 1999, NAT CELL BIOL, V1, pE209, DOI 10.1038/70237; Wang Y, 2007, J MOL BIOL, V371, P1304, DOI 10.1016/j.jmb.2007.06.034; Wendt MD, 2008, EXPERT OPIN DRUG DIS, V3, P1123, DOI 10.1517/17460441.3.9.1123; Xie L, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000387; Yan L, 2003, FEBS LETT, V555, P545, DOI 10.1016/s0014-5793(03)01346-2; Yan N, 2005, ANNU REV CELL DEV BI, V21, P35, DOI 10.1146/annurev.cellbio.21.012704.131040; Zhang YH, 2006, J MOL BIOL, V364, P536, DOI 10.1016/j.jmb.2006.09.023	78	12	12	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7442	10.1371/journal.pone.0007442	http://dx.doi.org/10.1371/journal.pone.0007442			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823588	Green Published, gold			2022-12-27	WOS:000270808300017
J	Vasilescu, C; Rossi, S; Shimizu, M; Tudor, S; Veronese, A; Ferracin, M; Nicoloso, MS; Barbarotto, E; Popa, M; Stanciulea, O; Fernandez, MH; Tulbure, D; Bueso-Ramos, CE; Negrini, M; Calin, GA				Vasilescu, Catalin; Rossi, Simona; Shimizu, Masayoshi; Tudor, Stefan; Veronese, Angelo; Ferracin, Manuela; Nicoloso, Milena S.; Barbarotto, Elisa; Popa, Monica; Stanciulea, Oana; Fernandez, Michael H.; Tulbure, Dan; Bueso-Ramos, Carlos E.; Negrini, Massimo; Calin, George A.			MicroRNA Fingerprints Identify miR-150 as a Plasma Prognostic Marker in Patients with Sepsis	PLOS ONE			English	Article							EXPRESSION; MACROPHAGES; INFLAMMATION; APOPTOSIS; DEPLETION; PATHWAY; CELLS; IL-18; ICU	Background: The physiopathology of sepsis continues to be poorly understood, and despite recent advances in its management, sepsis is still a life-threatening condition with a poor outcome. If new diagnostic markers related to sepsis pathogenesis will be identified, new specific therapies might be developed and mortality reduced. Small regulatory non-coding RNAs, microRNAs (miRNAs), were recently linked to various diseases; the aim of our prospective study was to identify miRNAs that can differentiate patients with early-stage sepsis from healthy controls and to determine if miRNA levels correlate with the severity assessed by the Sequential Organ Failure Assessment (SOFA) score. Methodology/Principal Findings: By using genome-wide miRNA profiling by microarray in peripheral blood leukocytes, we found that miR-150, miR-182, miR-342-5p, and miR-486 expression profiles differentiated sepsis patients from healthy controls. We also proved by quantitative reverse transcription-polymerase chain reaction that miR-150 levels were significantly reduced in plasma samples of sepsis patients and correlated with the level of disease severity measured by the SOFA score, but were independent of the white blood counts (WBC). We found that plasma levels of tumor necrosis factor alpha, interleukin-10, and interleukin-18, all genes with sequence complementarity to miR-150, were negatively correlated with the plasma levels of this miRNA. Furthermore, we identified that the plasma levels ratio for miR-150/interleukin-18 can be used for assessing the severity of the sepsis. Conclusions/Significance: We propose that miR-150 levels in both leukocytes and plasma correlate with the aggressiveness of sepsis and can be used as a marker of early sepsis. Furthermore, we envision miR-150 restoration as a future therapeutic option in sepsis patients.			Vasilescu, C (corresponding author), Fundeni Clin Hosp, Dept Surg, Bucharest, Romania.	gcalin@mdanderson.org	Vasilescu, Catalin/B-8859-2011; Negrini, Massimo/J-2377-2016; Nicoloso, Milena S/K-6411-2012; Tudor, Stefan/C-2162-2011; Tudor, Ștefan/GWD-6211-2022; Ferracin, Manuela/K-2097-2016; stanciulea, oana/C-5062-2011; Veronese, Angelo/I-4292-2019; Calin, George/E-9390-2011	Negrini, Massimo/0000-0002-0007-1920; Nicoloso, Milena S/0000-0003-4231-9303; Tudor, Stefan/0000-0003-2933-2060; Ferracin, Manuela/0000-0002-1595-6887; Calin, George/0000-0001-6704-5615; Veronese, Angelo/0000-0002-1451-1392				Abe R, 2008, J SURG RES, V147, P1, DOI 10.1016/j.jss.2007.07.009; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Anglicheau D, 2009, P NATL ACAD SCI USA, V106, P5330, DOI 10.1073/pnas.0813121106; Baltimore D, 2008, NAT IMMUNOL, V9, P839, DOI 10.1038/ni.f.209; BARKHAUSEN T, 2009, INJURY; BONE RC, 1992, CHEST, V101, P1644, DOI 10.1378/chest.101.6.1644; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Cortez MA, 2009, EXPERT OPIN BIOL TH, V9, P703, DOI [10.1517/14712590902932889, 10.1517/14712590902932889 ]; DAS S, 2008, METAB SYNDR RELAT DI; Dombrovskiy VY, 2007, CRIT CARE MED, V35, P1244, DOI 10.1097/01.CCM.0000261890.41311.E9; Zaki ME, 2007, IMMUNOL INVEST, V36, P403, DOI 10.1080/08820130701244275; Fredriksson K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003686; George SJ, 2008, ARTERIOSCL THROM VAS, V28, P400, DOI 10.1161/ATVBAHA.107.160952; Grobmyer SR, 2000, J CLIN IMMUNOL, V20, P212, DOI 10.1023/A:1006641630904; Hotchkiss RS, 2006, NAT REV IMMUNOL, V6, P813, DOI 10.1038/nri1943; Hotchkiss RS, 2001, J IMMUNOL, V166, P6952, DOI 10.4049/jimmunol.166.11.6952; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Hotchkiss RS, 2002, J IMMUNOL, V168, P2493, DOI 10.4049/jimmunol.168.5.2493; Hutchins RR, 2004, WORLD J SURG, V28, P137, DOI 10.1007/s00268-003-7067-8; Koff JL, 2008, AM J PHYSIOL-LUNG C, V294, pL1068, DOI 10.1152/ajplung.00025.2008; Libert C, 2003, NATURE, V421, P328, DOI 10.1038/421328a; Lichtenstern C, 2007, DIGEST SURG, V24, P1, DOI 10.1159/000099009; Minne L, 2008, CRIT CARE, V12, DOI 10.1186/cc7160; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Nicoloso MS, 2009, NAT REV CANCER, V9, P293, DOI 10.1038/nrc2619; Oberholzer A, 2001, SHOCK, V16, P411, DOI 10.1097/00024382-200116060-00001; Pereira C, 2008, ARTERIOSCL THROM VAS, V28, P504, DOI 10.1161/ATVBAHA.107.157438; Perkins DO, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-2-r27; Schmidt WM, 2009, BIOCHEM BIOPH RES CO, V380, P437, DOI 10.1016/j.bbrc.2008.12.190; Tili Esmerina, 2008, Int J Med Sci, V5, P73; Tili E, 2007, J IMMUNOL, V179, P5082, DOI 10.4049/jimmunol.179.8.5082; Wang Q, 2008, FASEB J, V22, P4126, DOI 10.1096/fj.08-112326; Weichhart T, 2008, IMMUNITY, V29, P565, DOI 10.1016/j.immuni.2008.08.012; Wu F, 2008, GASTROENTEROLOGY, V135, P1624, DOI 10.1053/j.gastro.2008.07.068; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021	35	248	286	2	36	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7405	10.1371/journal.pone.0007405	http://dx.doi.org/10.1371/journal.pone.0007405			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823581	Green Published, gold, Green Submitted			2022-12-27	WOS:000270728500006
J	Khiabanian, H; Trifonov, V; Rabadan, R				Khiabanian, Hossein; Trifonov, Vladimir; Rabadan, Raul			Reassortment Patterns in Swine Influenza Viruses	PLOS ONE			English	Article							A VIRUSES; GENETIC-CHARACTERIZATION; H1N2; PIGS; IDENTIFICATION; DIVERSITY; EVOLUTION; DATABASE; HUMANS; CANADA	Three human influenza pandemics occurred in the twentieth century, in 1918, 1957, and 1968. Influenza pandemic strains are the results of emerging viruses from non-human reservoirs to which humans have little or no immunity. At least two of these pandemic strains, in 1957 and in 1968, were the results of reassortments between human and avian viruses. Also, many cases of swine influenza viruses have reportedly infected humans, in particular, the recent H1N1 influenza virus of swine origin, isolated in Mexico and the United States. Pigs are documented to allow productive replication of human, avian, and swine influenza viruses. Thus it has been conjectured that pigs are the "mixing vessel'' that create the avian-human reassortant strains, causing the human pandemics. Hence, studying the process and patterns of viral reassortment, especially in pigs, is a key to better understanding of human influenza pandemics. In the last few years, databases containing sequences of influenza A viruses, including swine viruses, collected since 1918 from diverse geographical locations, have been developed and made publicly available. In this paper, we study an ensemble of swine influenza viruses to analyze the reassortment phenomena through several statistical techniques. The reassortment patterns in swine viruses prove to be similar to the previous results found in human viruses, both in vitro and in vivo, that the surface glycoprotein coding segments reassort most often. Moreover, we find that one of the polymerase segments (PB1), reassorted in the strains responsible for the last two human pandemics, also reassorts frequently.			Khiabanian, H (corresponding author), Columbia Univ, Coll Phys & Surg, Dept Biomed Informat, New York, NY 10027 USA.	hossein@c2b2.columbia.edu	Khiabanian, Hossein/N-7207-2019; Rabadan, Raul/AAZ-7367-2020	Khiabanian, Hossein/0000-0003-1446-4394; Rabadan, Raul/0000-0001-7946-9255				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Bao YM, 2008, J VIROL, V82, P596, DOI 10.1128/JVI.02005-07; Boni MF, 2008, J VIROL, V82, P4807, DOI 10.1128/JVI.02683-07; Brown IH, 2000, VET MICROBIOL, V74, P29, DOI 10.1016/S0378-1135(00)00164-4; CASTRUCCI MR, 1993, VIROLOGY, V193, P503, DOI 10.1006/viro.1993.1155; Chutinimitkul S, 2008, ARCH VIROL, V153, P1049, DOI 10.1007/s00705-008-0097-7; Downie JC, 2004, INT CONGR SER, V1263, P714, DOI 10.1016/j.ics.2004.02.140; Ginsberg M., 2009, Morbidity and Mortality Weekly Report, V58, P400; Napolitano L. M., 2009, Morbidity and Mortality Weekly Report, V58, P749; Karasin AI, 2000, J VIROL, V74, P9322, DOI 10.1128/JVI.74.19.9322-9327.2000; Karasin AI, 2000, VIRUS RES, V68, P71, DOI 10.1016/S0168-1702(00)00154-4; Karasin AI, 2006, J CLIN MICROBIOL, V44, P1123, DOI 10.1128/JCM.44.3.1123-1126.2006; Karasin AI, 2002, J CLIN MICROBIOL, V40, P1073, DOI 10.1128/JCM.40.3.1073-1079.2002; Komar N, 2008, EMERG INFECT DIS, V14, P1176, DOI 10.3201/eid1407.080161; Krasnitz M, 2008, J VIROL, V82, P8947, DOI 10.1128/JVI.00101-08; Lekcharoensuk P, 2006, EMERG INFECT DIS, V12, P787; Lindstrom SE, 2004, VIROLOGY, V328, P101, DOI 10.1016/j.virol.2004.06.009; LUBECK MD, 1979, VIROLOGY, V95, P269, DOI 10.1016/0042-6822(79)90430-6; LUDWIG S, 1995, VIROLOGY, V212, P555, DOI 10.1006/viro.1995.1513; Ma W, 2007, P NATL ACAD SCI USA, V104, P20949, DOI 10.1073/pnas.0710286104; Marozin S, 2002, J GEN VIROL, V83, P735, DOI 10.1099/0022-1317-83-4-735; Marsh GA, 2008, J VIROL, V82, P2295, DOI 10.1128/JVI.02267-07; Myers KP, 2007, CLIN INFECT DIS, V44, P1084, DOI 10.1086/512813; NAKAJIMA K, 1978, NATURE, V274, P334, DOI 10.1038/274334a0; Olsen CW, 2006, EMERG INFECT DIS, V12, P1132, DOI 10.3201/eid1207.060268; Qi X, 2006, ARCH VIROL, V151, P2289, DOI 10.1007/s00705-006-0796-x; Rabadan R, 2008, INFLUENZA OTHER RESP, V2, P9, DOI 10.1111/j.1750-2659.2007.00030.x; Rabadan R, 2006, J VIROL, V80, P11887, DOI 10.1128/JVI.01414-06; RAO CR, 1982, THEOR POPUL BIOL, V21, P24, DOI 10.1016/0040-5809(82)90004-1; Saito T, 2008, J VET MED SCI, V70, P423, DOI 10.1292/jvms.70.423; SCHOLTISSEK C, 1978, VIROLOGY, V89, P613, DOI 10.1016/0042-6822(78)90203-9; SCHOLTISSEK C, 1990, Medical Principles and Practice, V2, P65; SCHOLTISSEK C, 1978, VIROLOGY, V87, P13, DOI 10.1016/0042-6822(78)90153-8; Shinde V, 2009, NEW ENGL J MED, V360, P2616, DOI 10.1056/NEJMoa0903812; Taubenberger JK, 2005, NATURE, V437, P889, DOI 10.1038/nature04230; Trifonov V, 2009, EURO SURVEILL, V14; Vincent AL, 2008, ADV VIRUS RES, V72, P127, DOI 10.1016/S0065-3527(08)00403-X; Webby RJ, 2000, J VIROL, V74, P8243, DOI 10.1128/JVI.74.18.8243-8251.2000; YOO GJ, 2008, VIRUS RES, V138, P43; Zell R, 2008, J GEN VIROL, V89, P271, DOI 10.1099/vir.0.83338-0; Zhou NN, 1999, J VIROL, V73, P8851, DOI 10.1128/JVI.73.10.8851-8856.1999	41	39	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7366	10.1371/journal.pone.0007366	http://dx.doi.org/10.1371/journal.pone.0007366			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809504	Green Published, Green Submitted, gold			2022-12-27	WOS:000270594000016
J	Patani, R; Compston, A; Puddifoot, CA; Wyllie, DJA; Hardingham, GE; Allen, ND; Chandran, S				Patani, Rickie; Compston, Alastair; Puddifoot, Clare A.; Wyllie, David J. A.; Hardingham, Giles E.; Allen, Nicholas D.; Chandran, Siddharthan			Activin/Nodal Inhibition Alone Accelerates Highly Efficient Neural Conversion from Human Embryonic Stem Cells and Imposes a Caudal Positional Identity	PLOS ONE			English	Article								Background: Neural conversion from human embryonic stem cells (hESCs) has been demonstrated in a variety of systems including chemically defined suspension culture, not requiring extrinsic signals, as well as in an adherent culture method that involves dual SMAD inhibition using Noggin and SB431542 (an inhibitor of activin/nodal signaling). Previous studies have also determined a role for activin/nodal signaling in development of the neural plate and anterior fate specification. We therefore sought to investigate the independent influence of SB431542 both on neural commitment of hESCs and positional identity of derived neural progenitors in chemically defined substrate-free conditions. Methodology/Principal Findings: We show that in non-adherent culture conditions, treatment with SB431542 alone for 8 days is sufficient for highly efficient and accelerated neural conversion from hESCs with negligible mesendodermal, epidermal or trophectodermal contamination. In addition the resulting neural progenitor population has a predominantly caudal identity compared to the more anterior positional fate of non-SB431542 treated cultures. Finally we demonstrate that resulting neurons are electro-physiologically competent. Conclusions: This study provides a platform for the efficient generation of caudal neural progenitors under defined conditions for experimental study.			Patani, R (corresponding author), Univ Cambridge, Anne McLaren Lab Regenerat Med, Cambridge, England.	sc222@cam.ac.uk	Wyllie, David J A/AAK-4678-2021; allen, nick d/A-4336-2010; Patani, R/J-3107-2018	Wyllie, David J A/0000-0002-4957-6049; Patani, R/0000-0002-3825-7675; Hardingham, Giles/0000-0002-7629-5314; Allen, Nicholas/0000-0003-4009-186X	Medical Research Council [G0700711B] Funding Source: researchfish; National Institute for Health Research [NF-SI-0508-10335] Funding Source: researchfish; MRC [G0701499] Funding Source: UKRI; Medical Research Council [G0701499] Funding Source: Medline; Wellcome Trust Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR)); MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Baxter AW, 2006, J NEUROSCI, V26, P5456, DOI 10.1523/JNEUROSCI.4101-05.2006; Bouhon IA, 2005, BRAIN RES BULL, V68, P62, DOI 10.1016/j.brainresbull.2005.08.022; Camus A, 2006, DEV BIOL, V295, P743, DOI 10.1016/j.ydbio.2006.03.047; CHAMBERS SM, 2009, NAT BIOTECHNOL; Di Giorgio FP, 2008, CELL STEM CELL, V3, P637, DOI 10.1016/j.stem.2008.09.017; Erceg S, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002122; Gajovic S, 1997, DIFFERENTIATION, V62, P187; Hardingham GE, 1997, NATURE, V385, P260, DOI 10.1038/385260a0; Harrington AE, 2006, EMBO J, V25, P1035, DOI 10.1038/sj.emboj.7601000; Ikeda H, 2005, P NATL ACAD SCI USA, V102, P11331, DOI 10.1073/pnas.0500010102; Itsykson P, 2005, MOL CELL NEUROSCI, V30, P24, DOI 10.1016/j.mcn.2005.05.004; Joannides AJ, 2007, STEM CELLS, V25, P731, DOI 10.1634/stemcells.2006-0562; MATSUO I, 1995, GENE DEV, V9, P2646, DOI 10.1101/gad.9.21.2646; MINTA A, 1989, J BIOL CHEM, V264, P8171; Pebay A, 2005, STEM CELLS, V23, P1541, DOI 10.1634/stemcells.2004-0338; Smith JR, 2008, DEV BIOL, V313, P107, DOI 10.1016/j.ydbio.2007.10.003; Soriano FX, 2008, J NEUROSCI, V28, P10696, DOI 10.1523/JNEUROSCI.1207-08.2008; Stern CD, 2001, NAT REV NEUROSCI, V2, P92, DOI 10.1038/35053563; Thomas P, 1996, CURR BIOL, V6, P1487, DOI 10.1016/S0960-9822(96)00753-1; Vallier L, 2004, DEV BIOL, V275, P403, DOI 10.1016/j.ydbio.2004.08.031; Vallier L, 2005, J CELL SCI, V118, P4495, DOI 10.1242/jcs.02553; Vallier Ludovic, 2008, Curr Protoc Stem Cell Biol, VChapter 1, DOI 10.1002/9780470151808.sc01d04s4; Varlet I, 1997, DEVELOPMENT, V124, P1033; Watanabe K, 2005, NAT NEUROSCI, V8, P288, DOI 10.1038/nn1402; Ying QL, 2003, METHOD ENZYMOL, V365, P327; Zhang SC, 2001, NAT BIOTECHNOL, V19, P1129, DOI 10.1038/nbt1201-1129	26	67	69	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7327	10.1371/journal.pone.0007327	http://dx.doi.org/10.1371/journal.pone.0007327			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806200	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000270593800021
J	Rodrigues-Ferreira, S; Di Tommaso, A; Dimitrov, A; Cazaubon, S; Gruel, N; Colasson, H; Nicolas, A; Chaverot, N; Molinie, V; Reyal, F; Sigal-Zafrani, B; Terris, B; Delattre, O; Radvanyi, F; Perez, F; Vincent-Salomon, A; Nahmias, C				Rodrigues-Ferreira, Sylvie; Di Tommaso, Anne; Dimitrov, Ariane; Cazaubon, Sylvie; Gruel, Nadege; Colasson, Helene; Nicolas, Andre; Chaverot, Nathalie; Molinie, Vincent; Reyal, Fabien; Sigal-Zafrani, Brigitte; Terris, Benoit; Delattre, Olivier; Radvanyi, Francois; Perez, Franck; Vincent-Salomon, Anne; Nahmias, Clara			8p22 MTUS1 Gene Product ATIP3 Is a Novel Anti-Mitotic Protein Underexpressed in Invasive Breast Carcinoma of Poor Prognosis	PLOS ONE			English	Article							TUMOR-SUPPRESSOR RASSF1A; CANCER CELL-LINES; AT2 RECEPTOR; EXPRESSION; CORRELATE; PATTERNS; KINASES; TARGETS; BASAL; DNA	Background: Breast cancer is a heterogeneous disease that is not totally eradicated by current therapies. The classification of breast tumors into distinct molecular subtypes by gene profiling and immunodetection of surrogate markers has proven useful for tumor prognosis and prediction of effective targeted treatments. The challenge now is to identify molecular biomarkers that may be of functional relevance for personalized therapy of breast tumors with poor outcome that do not respond to available treatments. The Mitochondrial Tumor Suppressor (MTUS1) gene is an interesting candidate whose expression is reduced in colon, pancreas, ovary and oral cancers. The present study investigates the expression and functional effects of MTUS1 gene products in breast cancer. Methods and Findings: By means of gene array analysis, real-time RT-PCR and immunohistochemistry, we show here that MTUS1/ATIP3 is significantly down-regulated in a series of 151 infiltrating breast cancer carcinomas as compared to normal breast tissue. Low levels of ATIP3 correlate with high grade of the tumor and the occurrence of distant metastasis. ATIP3 levels are also significantly reduced in triple negative (ER-PR-HER2-) breast carcinomas, a subgroup of highly proliferative tumors with poor outcome and no available targeted therapy. Functional studies indicate that silencing ATIP3 expression by siRNA increases breast cancer cell proliferation. Conversely, restoring endogenous levels of ATIP3 expression leads to reduced cancer cell proliferation, clonogenicity, anchorage-independent growth, and reduces the incidence and size of xenografts grown in vivo. We provide evidence that ATIP3 associates with the microtubule cytoskeleton and localizes at the centrosomes, mitotic spindle and intercellular bridge during cell division. Accordingly, live cell imaging indicates that ATIP3 expression alters the progression of cell division by promoting prolonged metaphase, thereby leading to a reduced number of cells ungergoing active mitosis. Conclusions: Our results identify for the first time ATIP3 as a novel microtubule-associated protein whose expression is significantly reduced in highly proliferative breast carcinomas of poor clinical outcome. ATIP3 re-expression limits tumor cell proliferation in vitro and in vivo, suggesting that this protein may represent a novel useful biomarker and an interesting candidate for future targeted therapies of aggressive breast cancer.			Rodrigues-Ferreira, S (corresponding author), Univ Paris 05, INSERM, CNRS, Inst Cochin,U567,UMR8104, Paris, France.	clara.nahmias@inserm.fr	Terris, Benoit/P-1497-2017; Perez, Franck/A-1558-2014	Perez, Franck/0000-0002-9129-9401; Radvanyi, Francois/0000-0002-5696-6424; Nahmias, Clara/0000-0001-6863-370X; delattre, olivier/0000-0002-8730-2276				Adelaide J, 2007, CANCER RES, V67, P11565, DOI 10.1158/0008-5472.CAN-07-2536; Aoki K, 2007, J CELL SCI, V120, P3327, DOI 10.1242/jcs.03485; Bergamaschi A, 2006, GENE CHROMOSOME CANC, V45, P1033, DOI 10.1002/gcc.20366; Chin K, 2006, CANCER CELL, V10, P529, DOI 10.1016/j.ccr.2006.10.009; Chin L, 2008, NATURE, V452, P553, DOI 10.1038/nature06914; COOMBS LM, 1990, ANAL BIOCHEM, V188, P338, DOI 10.1016/0003-2697(90)90617-I; Di Benedetto M, 2006, GENE, V380, P127, DOI 10.1016/j.gene.2006.05.021; Di Benedetto M, 2006, MOL CELL ENDOCRINOL, V252, P207, DOI 10.1016/j.mce.2006.03.014; Dimitrov A, 2009, HUM MOL GENET, V18, P440, DOI 10.1093/hmg/ddn371; Dowsett M, 2008, CLIN CANCER RES, V14, P8019, DOI 10.1158/1078-0432.CCR-08-0974; Frank B, 2007, CARCINOGENESIS, V28, P1442, DOI 10.1093/carcin/bgm033; Hinds DA, 2006, NAT GENET, V38, P82, DOI 10.1038/ng1695; Hirano A, 2001, CLIN CANCER RES, V7, P876; Hu XL, 2009, MOL CANCER RES, V7, P511, DOI 10.1158/1541-7786.MCR-08-0107; Huszar D, 2009, CANCER METAST REV, V28, P197, DOI 10.1007/s10555-009-9185-8; Ishii H, 2001, P NATL ACAD SCI USA, V98, P10374, DOI 10.1073/pnas.181222898; Kenny PA, 2007, MOL ONCOL, V1, P84, DOI 10.1016/j.molonc.2007.02.004; Lee S, 2006, ONCOL REP, V16, P747; Neve RM, 2006, CANCER CELL, V10, P515, DOI 10.1016/j.ccr.2006.10.008; Nizak C, 2003, TRAFFIC, V4, P739, DOI 10.1034/j.1600-0854.2003.00132.x; Nouet S, 2004, J BIOL CHEM, V279, P28989, DOI 10.1074/jbc.M403880200; Parker JS, 2009, J CLIN ONCOL, V27, P1160, DOI 10.1200/JCO.2008.18.1370; Perou CM, 2000, NATURE, V406, P747, DOI 10.1038/35021093; Pils D, 2005, CANCER-AM CANCER SOC, V104, P2417, DOI 10.1002/cncr.21538; Pirollo KF, 2008, CLIN CANCER RES, V14, P2190, DOI 10.1158/1078-0432.CCR-07-1951; Rakha EA, 2008, J CLIN ONCOL, V26, P2568, DOI 10.1200/JCO.2007.13.1748; Rakha EA, 2008, J CLIN ONCOL, V26, P3153, DOI 10.1200/JCO.2007.15.5986; Reyal F, 2005, CANCER RES, V65, P1376, DOI 10.1158/0008-5472.CAN-04-2706; Rong R, 2004, ONCOGENE, V23, P8216, DOI 10.1038/sj.onc.1207901; Seibold S, 2003, FASEB J, V17, P1180, DOI 10.1096/fj.02-0934fje; Song MS, 2004, NAT CELL BIOL, V6, P129, DOI 10.1038/ncb1091; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2009, NEW ENGL J MED, V360, P790, DOI 10.1056/NEJMra0801289; Vincent-Salomon A, 2008, CLIN CANCER RES, V14, P1956, DOI 10.1158/1078-0432.CCR-07-1465; Warner SL, 2006, SEMIN ONCOL, V33, P436, DOI 10.1053/j.seminoncol.2006.04.007; Wolff AC, 2007, J CLIN ONCOL, V25, P4021, DOI 10.1200/JCO.2007.11.4363; Wruck CJ, 2005, ARTERIOSCL THROM VAS, V25, P57, DOI 10.1161/01.ATV.0000150662.51436.14; Ye H, 2007, CANCER GENET CYTOGEN, V176, P100, DOI 10.1016/j.cancergencyto.2007.04.003	38	63	66	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2009	4	10							e7239	10.1371/journal.pone.0007239	http://dx.doi.org/10.1371/journal.pone.0007239			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BP	19794912	Green Submitted, Green Published, gold			2022-12-27	WOS:000270354200002
J	Puill-Stephan, E; Willis, BL; van Herwerden, L; van Oppen, MJH				Puill-Stephan, Eneour; Willis, Bette L.; van Herwerden, Lynne; van Oppen, Madeleine J. H.			Chimerism in Wild Adult Populations of the Broadcast Spawning Coral Acropora millepora on the Great Barrier Reef	PLOS ONE			English	Article							GERM-CELL PARASITISM; NATURAL CHIMERISM; MICROSATELLITE LOCI; SOMATIC MUTATIONS; SELF-RECOGNITION; BUILDING CORAL; ALLORECOGNITION SYSTEM; BOTRYLLUS-SCHLOSSERI; CONTACT REACTIONS; GENETIC-STRUCTURE	Background: Chimeras are organisms containing tissues or cells of two or more genetically distinct individuals, and are known to exist in at least nine phyla of protists, plants, and animals. Although widespread and common in marine invertebrates, the extent of chimerism in wild populations of reef corals is unknown. Methodology/Principal Findings: The extent of chimerism was explored within two populations of a common coral, Acropora millepora, on the Great Barrier Reef, Australia, by using up to 12 polymorphic DNA microsatellite loci. At least 2% and 5% of Magnetic Island and Pelorus Island populations of A. millepora, respectively, were found to be chimeras (3% overall), based on conservative estimates. A slightly less conservative estimate indicated that 5% of colonies in each population were chimeras. These values are likely to be vast underestimates of the true extent of chimerism, as our sampling protocol was restricted to a maximum of eight branches per colony, while most colonies consist of hundreds of branches. Genotypes within chimeric corals showed high relatedness, indicating that genetic similarity is a prerequisite for long-term acceptance of non-self genotypes within coral colonies. Conclusions/Significance: While some brooding corals have been shown to form genetic chimeras in their early life history stages under experimental conditions, this study provides the first genetic evidence of the occurrence of coral chimeras in the wild and of chimerism in a broadcast spawning species. We hypothesize that chimerism is more widespread in corals than previously thought, and suggest that this has important implications for their resilience, potentially enhancing their capacity to compete for space and respond to stressors such as pathogen infection.			Puill-Stephan, E (corresponding author), James Cook Univ, AIMS JCU, Townsville, Qld 4811, Australia.	m.vanoppen@aims.gov.au	van Oppen, Madeleine JH/C-3261-2008; van Herwerden, Lynne/I-1087-2012	van Herwerden, Lynne/0000-0001-6717-8995; PUILL-STEPHAN, Eneour/0000-0003-0618-8051; van Oppen, Madeleine/0000-0003-4607-0744				Amar KO, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-126; BABCOCK RC, 1986, MAR BIOL, V90, P379, DOI 10.1007/BF00428562; Barki Y, 2002, MAR ECOL PROG SER, V231, P91, DOI 10.3354/meps231091; Ben-Shlomo R, 2001, MAR ECOL PROG SER, V209, P109, DOI 10.3354/meps209109; Ben-Shlomo R, 2008, GENETICA, V132, P51, DOI 10.1007/s10709-007-9148-3; BUSS LW, 1990, TRENDS ECOL EVOL, V5, P352, DOI 10.1016/0169-5347(90)90093-S; Chadwick-Furman NE, 2003, BIOL BULL-US, V205, P133, DOI 10.2307/1543234; CHADWICKFURMAN N, 1994, CORAL REEFS, V13, P57, DOI 10.1007/BF00426436; Ellegren H, 2000, TRENDS GENET, V16, P551, DOI 10.1016/S0168-9525(00)02139-9; Estoup A, 2002, MOL ECOL, V11, P1591, DOI 10.1046/j.1365-294X.2002.01576.x; FRANK U, 1994, MAR BIOL, V118, P723, DOI 10.1007/BF00347521; Frank U, 2001, J EXP ZOOL, V291, P25, DOI 10.1002/jez.3; Frank U, 1997, P ROY SOC B-BIOL SCI, V264, P99, DOI 10.1098/rspb.1997.0015; GROSBERG RK, 1988, Q REV BIOL, V63, P377, DOI 10.1086/416026; GROSBERG RK, 1986, NATURE, V322, P456, DOI 10.1038/322456a0; Hall VR, 1996, ECOLOGY, V77, P950, DOI 10.2307/2265514; HEYWARD AJ, 1985, MAR BIOL, V85, P117, DOI 10.1007/BF00397429; HIDAKA M, 1985, CORAL REEFS, V4, P111, DOI 10.1007/BF00300869; Hidaka M, 1997, CORAL REEFS, V16, P13, DOI 10.1007/s003380050054; HIDAKA M, 1985, BIOL BULL, V168, P350, DOI 10.2307/1541517; Hughes RN, 2004, EVOL DEV, V6, P431, DOI 10.1111/j.1525-142X.2004.04051.x; Hughes RN, 1989, FUNCTIONAL BIOL CLON; JACKSON JBC, 1986, B MAR SCI, V39, P588; LEWIS JB, 1974, 2ND P INT S COR REEF, P201; NEIGEL JE, 1983, EVOLUTION, V37, P437, DOI 10.1111/j.1558-5646.1983.tb05561.x; Nozawa Y, 2005, MAR ECOL PROG SER, V286, P115, DOI 10.3354/meps286115; O'Connell LM, 2004, J HERED, V95, P172, DOI 10.1093/jhered/esh024; OLIVER JK, 1987, MAR BIOL, V94, P521, DOI 10.1007/BF00431398; Orive ME, 2001, THEOR POPUL BIOL, V59, P235, DOI 10.1006/tpbi.2001.1515; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Pineda-Krch M, 2004, J EVOLUTION BIOL, V17, P1192, DOI 10.1111/j.1420-9101.2004.00815.x; Pineda-Krch M, 2004, J EVOLUTION BIOL, V17, P1167, DOI 10.1111/j.1420-9101.2004.00808.x; QUELLER DC, 1989, EVOLUTION, V43, P258, DOI 10.2307/2409206; Raymundo LJ, 2004, ECOL APPL, V14, P281, DOI 10.1890/02-5373; Rinkevich B, 2004, HYDROBIOLOGIA, V530, P443, DOI 10.1007/s10750-004-2686-0; Rinkevich B, 2005, J EXP MAR BIOL ECOL, V322, P93, DOI 10.1016/j.jembe.2005.02.020; Rinkevich B, 2004, J EVOLUTION BIOL, V17, P1178, DOI 10.1111/j.1420-9101.2004.00809.x; Rinkevich B, 2004, J EXP BIOL, V207, P3531, DOI 10.1242/jeb.01184; RINKEVICH B, 1985, OECOLOGIA, V66, P100, DOI 10.1007/BF00378559; Rinkevich B, 2002, BIOESSAYS, V24, P730, DOI 10.1002/bies.10123; Rinkevich B, 2001, HUM IMMUNOL, V62, P651, DOI 10.1016/S0198-8859(01)00249-X; Rinkevich B, 1999, SCAND J IMMUNOL, V50, P456; RINKEVICH B, 1992, OIKOS, V63, P119, DOI 10.2307/3545520; RINKEVICH B, 1987, SYMBIOSIS, V4, P117; Rinkevich B, 1998, HUM REPROD, V13, P455, DOI 10.1093/humrep/13.2.455; SAMMARCO PW, 1982, J EXP MAR BIOL ECOL, V61, P31, DOI 10.1016/0022-0981(82)90020-X; Santelices B, 2004, J EVOLUTION BIOL, V17, P1187, DOI 10.1111/j.1420-9101.2004.00813.x; Santelices B, 1999, J PHYCOL, V35, P1127, DOI 10.1046/j.1529-8817.1999.3561127.x; Santelices B, 1999, TRENDS ECOL EVOL, V14, P152, DOI 10.1016/S0169-5347(98)01519-5; SMITH SR, 1997, 8 INT COR REEF S, P1197; Sommerfeldt AD, 1999, MOL ECOL, V8, P885; Sommerfeldt AD, 2003, BIOL J LINN SOC, V79, P183, DOI 10.1046/j.1095-8312.2003.00179.x; STODDART JA, 1985, EVOLUTION, V39, P461, DOI 10.1111/j.1558-5646.1985.tb05682.x; Stoner DS, 1996, P NATL ACAD SCI USA, V93, P15254, DOI 10.1073/pnas.93.26.15254; Strassmann JE, 2004, J EVOLUTION BIOL, V17, P1189, DOI 10.1111/j.1420-9101.2004.00814.x; Van Oppen MJH, 2007, MOL ECOL NOTES, V7, P436, DOI 10.1111/j.1471-8286.2006.01610.x; Wang S, 2009, J HERED, V100, P329, DOI 10.1093/jhered/esn100; WHITHAM TG, 1981, OECOLOGIA, V49, P287, DOI 10.1007/BF00347587; Willis BL, 1985, OECOLOGIA, V65, P516, DOI 10.1007/BF00379666; Wilson ACC, 2004, BEHAV ECOL SOCIOBIOL, V57, P40, DOI 10.1007/s00265-004-0831-4; Wilson K, 2002, AQUACULTURE, V204, P297, DOI 10.1016/S0044-8486(01)00842-0; Zilberberg C, 2001, MAR ECOL PROG SER, V221, P125, DOI 10.3354/meps221125	63	60	60	0	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2009	4	11							e7751	10.1371/journal.pone.0007751	http://dx.doi.org/10.1371/journal.pone.0007751			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RZ	19888471	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000271414600013
J	Geuking, P; Narasimamurthy, R; Lemaitre, B; Basler, K; Leulier, F				Geuking, Peter; Narasimamurthy, Rajesh; Lemaitre, Bruno; Basler, Konrad; Leulier, Francois			A Non-Redundant Role for Drosophila Mkk4 and Hemipterous/Mkk7 in TAK1-Mediated Activation of JNK	PLOS ONE			English	Article							SIGNAL-TRANSDUCTION PATHWAY; INNATE IMMUNE-RESPONSES; PROTEIN-KINASE; PEPTIDOGLYCAN RECOGNITION; GENE-EXPRESSION; KAPPA-B; BACTERIA; EIGER; TOLL	Background: The JNK pathway is a mitogen-activated protein (MAP) kinase pathway involved in the regulation of numerous physiological processes during development and in response to environmental stress. JNK activity is controlled by two MAPK kinases (MAPKK), Mkk4 and Mkk7. Mkk7 plays a prominent role upon Tumor Necrosis Factor (TNF) stimulation. Eiger, the unique TNF-superfamily ligand in Drosophila, potently activates JNK signaling through the activation of the MAPKKK Tak1. Methodology/Principal Findings: In a dominant suppressor screen for new components of the Eiger/JNK-pathway in Drosophila, we have identified an allelic series of the Mkk4 gene. Our genetic and biochemical results demonstrate that Mkk4 is dispensable for normal development and host resistance to systemic bacterial infection but plays a non-redundant role as a MAPKK acting in parallel to Hemipterous/Mkk7 in dTAK1-mediated JNK activation upon Eiger and Imd pathway activation. Conclusions/Significance: In contrast to mammals, it seems that in Drosophila both MAPKKs, Hep/Mkk7 and Mkk4, are required to induce JNK upon TNF or pro-inflammatory stimulation.			Geuking, P (corresponding author), Univ Zurich, Inst Mol Biol, Zurich, Switzerland.	konrad.basler@molbio.uzh.ch; francois.leulier@ibdml.univ-mrs.fr	Lemaitre, Bruno/T-8146-2019	Lemaitre, Bruno/0000-0001-7970-1667; Basler, Konrad/0000-0003-3534-1529				Adachi-Yamada T, 1999, NATURE, V400, P166, DOI 10.1038/22112; BASLER K, 1994, NATURE, V368, P208, DOI 10.1038/368208a0; Boutros M, 2002, DEV CELL, V3, P711, DOI 10.1016/S1534-5807(02)00325-8; Brancho D, 2003, GENE DEV, V17, P1969, DOI 10.1101/gad.1107303; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen W, 2002, J BIOL CHEM, V277, P49105, DOI 10.1074/jbc.M204934200; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Fleming Y, 2000, BIOCHEM J, V352, P145, DOI 10.1042/0264-6021:3520145; Geuking P, 2005, GENETICS, V171, P1683, DOI 10.1534/genetics.105.045534; GLISE B, 1995, CELL, V83, P451, DOI 10.1016/0092-8674(95)90123-X; Han SJ, 1998, J BIOL CHEM, V273, P369, DOI 10.1074/jbc.273.1.369; Han ZQS, 1998, MOL CELL BIOL, V18, P3527, DOI 10.1128/MCB.18.6.3527; Igaki T, 2002, EMBO J, V21, P3009, DOI 10.1093/emboj/cdf306; Leulier F, 2003, NAT IMMUNOL, V4, P478, DOI 10.1038/ni922; Michel T, 2001, NATURE, V414, P756, DOI 10.1038/414756a; Parks AL, 2004, NAT GENET, V36, P288, DOI 10.1038/ng1312; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Schneider DS, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030041; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Sluss HK, 1996, GENE DEV, V10, P2745, DOI 10.1101/gad.10.21.2745; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wang HS, 2006, EMBO J, V25, P5783, DOI 10.1038/sj.emboj.7601461; Wang X, 2007, BBA-MOL CELL RES, V1773, P1349, DOI 10.1016/j.bbamcr.2006.10.016; Weston CR, 2007, CURR OPIN CELL BIOL, V19, P142, DOI 10.1016/j.ceb.2007.02.001; Zhuang ZH, 2006, CELL SIGNAL, V18, P441, DOI 10.1016/j.cellsig.2005.05.013	25	49	51	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2009	4	11							e7709	10.1371/journal.pone.0007709	http://dx.doi.org/10.1371/journal.pone.0007709			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RY	19888449	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414500010
J	Katsel, P; Tan, WL; Haroutunian, V				Katsel, Pavel; Tan, Weilun; Haroutunian, Vahram			Gain in Brain Immunity in the Oldest-Old Differentiates Cognitively Normal from Demented Individuals	PLOS ONE			English	Article							MILD ALZHEIMER-DISEASE; GENE-EXPRESSION; SENILE DEMENTIA; NEUROFIBRILLARY TANGLES; MICROGLIAL ACTIVATION; STEREOLOGIC ANALYSIS; CLINICAL DEMENTIA; NEURITIC PLAQUES; ELDERLY SUBJECTS; GLIAL-CELLS	Background: Recent findings suggest that Alzheimer's disease (AD) neuropathological features (neuritic plaques and NFTs) are not strongly associated with dementia in extreme old (over 90 years of age) and compel a search for neurobiological indices of dementia in this rapidly growing segment of the elderly population. We sought to characterize transcriptional and protein profiles of dementia in the oldest-old. Methods and Findings: Gene and protein expression changes relative to non-demented age-matched controls were assessed by two microarray platforms, qPCR and Western blot in different regions of the brains of oldest-old and younger old persons who died at mild or severe stages of dementia. Our results indicate that: i) consistent with recent neuropathological findings, gene expression changes associated with cognitive impairment in oldest-old persons are distinct from those in cognitively impaired youngest-old persons; ii) transcripts affected in young-old subjects with dementia participate in biological pathways related to synaptic function and neurotransmission while transcripts affected in oldest-old subjects with dementia are associated with immune/inflammatory function; iii) upregulation of immune response genes in cognitively intact oldest-old subjects and their subsequent downregulation in dementia suggests a potential protective role of the brain immune-associated system against dementia in the oldest-old; iv) consistent with gene expression profiles, protein expression of several selected genes associated with the inflammatory/immune system in inferior temporal cortex is significantly increased in cognitively intact oldest-old persons relative to cognitively intact young-old persons, but impaired in cognitively compromised oldest-old persons relative to cognitively intact oldest-old controls. Conclusions: These results suggest that disruption of the robust immune homeostasis that is characteristic of oldest-old individuals who avoided dementia may be directly associated with dementia in the oldest-old and contrast with the synaptic and neurotransmitter system failures that typify dementia in younger old persons.			Katsel, P (corresponding author), Mt Sinai Sch Med, Dept Psychiat, New York, NY 10029 USA.	pavel.katsel@mssm.edu			NIA NIH HHS [P01 AG02219, P01 AG002219] Funding Source: Medline; NATIONAL INSTITUTE ON AGING [P01AG002219] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Akiyama H, 2000, NEUROBIOL AGING, V21, P383, DOI 10.1016/S0197-4580(00)00124-X; ALMEDA S, 1983, J BIOL CHEM, V258, P785; Avignone E, 2008, J NEUROSCI, V28, P9133, DOI 10.1523/JNEUROSCI.1820-08.2008; Becker-Herman S, 2005, MOL BIOL CELL, V16, P5061, DOI 10.1091/mbc.E05-04-0327; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BERCHTOLD NC, 2008, P NATL ACAD SCI US; Blalock EM, 2004, P NATL ACAD SCI USA, V101, P2173, DOI 10.1073/pnas.0308512100; Blasko I, 2004, AGING CELL, V3, P169, DOI 10.1111/j.1474-9728.2004.00101.x; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Bouras C, 2006, J NEUROPATH EXP NEUR, V65, P235, DOI 10.1097/01.jnen.0000203077.53080.2c; Budhraja V, 2003, BMC BIOL, V1, DOI 10.1186/1741-7007-1-1; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Cheepsunthorn P, 1998, J COMP NEUROL, V400, P73; CRYSTAL HA, 1982, J NEUROCHEM, V38, P1781, DOI 10.1111/j.1471-4159.1982.tb06665.x; DAVIS AE, 1986, P NATL ACAD SCI USA, V83, P3161, DOI 10.1073/pnas.83.10.3161; Davis KL, 1999, JAMA-J AM MED ASSOC, V281, P1401, DOI 10.1001/jama.281.15.1401; Dracheva S, 2005, J NEUROSCI RES, V79, P868, DOI 10.1002/jnr.20423; EBLY EM, 1994, NEUROLOGY, V44, P1593, DOI 10.1212/WNL.44.9.1593; Erraji-Benchekroun L, 2005, BIOL PSYCHIAT, V57, P549, DOI 10.1016/j.biopsych.2004.10.034; FALKAI P, 1988, BIOL PSYCHIAT, V24, P515, DOI 10.1016/0006-3223(88)90162-X; Farfara D, 2008, J CELL MOL MED, V12, P762, DOI 10.1111/j.1582-4934.2008.00314.x; Giannakopoulos P, 2003, NEUROLOGY, V60, P1495, DOI 10.1212/01.WNL.0000063311.58879.01; Giannakopoulos P, 1996, J NEUROPATH EXP NEUR, V55, P1210, DOI 10.1097/00005072-199612000-00004; Ginsberg Stephen D, 2006, NeuroRx, V3, P302, DOI 10.1016/j.nurx.2006.05.007; Hall CB, 2005, NEUROLOGY, V65, P882, DOI 10.1212/01.wnl.0000176053.98907.3f; Hardy J, 2006, NEURON, V52, P3, DOI 10.1016/j.neuron.2006.09.016; Haroutunian V, 1998, ARCH NEUROL-CHICAGO, V55, P1185, DOI 10.1001/archneur.55.9.1185; Haroutunian V, 1999, ARCH NEUROL-CHICAGO, V56, P713, DOI 10.1001/archneur.56.6.713; Haroutunian V, 2009, NEUROBIOL AGING, V30, P561, DOI 10.1016/j.neurobiolaging.2007.07.021; Haroutunian V, 2008, ARCH NEUROL-CHICAGO, V65, P1211, DOI 10.1001/archneur.65.9.1211; Haroutunian V, 2006, AM J PSYCHIAT, V163, P1834, DOI 10.1176/appi.ajp.163.10.1834; Harrison JK, 1998, P NATL ACAD SCI USA, V95, P10896, DOI 10.1073/pnas.95.18.10896; Hatori K, 2002, J NEUROSCI RES, V69, P418, DOI 10.1002/jnr.10304; HAUW JJ, 1986, REV NEUROL, V142, P107; Head E, 2009, NEUROBIOL AGING, V30, P1125, DOI 10.1016/j.neurobiolaging.2007.10.001; Hickey WF, 2001, GLIA, V36, P118, DOI 10.1002/glia.1101; Ho L, 2001, NEUROSCI LETT, V298, P191, DOI 10.1016/S0304-3940(00)01753-5; Imhof A, 2007, J NEUROL SCI, V257, P72, DOI 10.1016/j.jns.2007.01.025; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Itoh Y, 1998, J NEUROL SCI, V157, P73, DOI 10.1016/S0022-510X(98)00050-1; Katsel P, 2005, SCHIZOPHR RES, V79, P157, DOI 10.1016/j.schres.2005.06.007; Katsel P, 2005, SCHIZOPHR RES, V77, P241, DOI 10.1016/j.schres.2005.03.020; Katsel P, 2007, NEUROCHEM RES, V32, P845, DOI 10.1007/s11064-007-9297-x; Loring JF, 2001, DNA CELL BIOL, V20, P683, DOI 10.1089/10445490152717541; Lu T, 2004, NATURE, V429, P883, DOI 10.1038/nature02661; Luterman JD, 2000, ARCH NEUROL-CHICAGO, V57, P1153, DOI 10.1001/archneur.57.8.1153; Mariani TJ, 2002, FASEB J, V16, P321, DOI 10.1096/fj.02-0351fje; MATTIACE LA, 1990, AM J PATHOL, V136, P1101; MCGEER PL, 1994, ALZ DIS ASSOC DIS, V8, P149, DOI 10.1097/00002093-199408030-00001; Miech RA, 2002, NEUROLOGY, V58, P209, DOI 10.1212/WNL.58.2.209; Mizuno T, 2003, BRAIN RES, V979, P65, DOI 10.1016/S0006-8993(03)02867-1; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Morris JC, 2001, J MOL NEUROSCI, V17, P101, DOI 10.1385/JMN:17:2:101; Nataf S, 2005, AM J PATHOL, V166, P275, DOI 10.1016/S0002-9440(10)62251-1; Nelson PT, 2007, J NEUROPATH EXP NEUR, V66, P1136, DOI 10.1097/nen.0b013e31815c5efb; Paloneva J, 2000, NAT GENET, V25, P357, DOI 10.1038/77153; Parachikova A, 2007, NEUROBIOL AGING, V28, P1821, DOI 10.1016/j.neurobiolaging.2006.08.014; Perls T, 2004, TRENDS NEUROSCI, V27, P633, DOI 10.1016/j.tins.2004.07.012; PERLS TT, 1993, J AM GERIATR SOC, V41, P1193, DOI 10.1111/j.1532-5415.1993.tb07302.x; Prohovnik I, 2006, NEUROLOGY, V66, P49, DOI 10.1212/01.wnl.0000191298.68045.50; RITCHIE K, 1995, LANCET, V346, P931, DOI 10.1016/S0140-6736(95)91556-7; Roberson ED, 2006, SCIENCE, V314, P781, DOI 10.1126/science.1132813; Rogers J, 2000, ANN NY ACAD SCI, V924, P132; Savva GM, 2009, NEW ENGL J MED, V360, P2302, DOI 10.1056/NEJMoa0806142; SCHOENBERG BS, 1987, ANN NEUROL, V22, P724, DOI 10.1002/ana.410220608; Shen Y, 2003, PROG NEUROBIOL, V70, P463, DOI 10.1016/j.pneurobio.2003.08.001; Silver MH, 2002, PSYCHOSOM MED, V64, P493, DOI 10.1097/00006842-200205000-00014; Snowdon DA, 1997, JAMA-J AM MED ASSOC, V277, P813, DOI 10.1001/jama.277.10.813; Streit Wolfgang J., 2005, Current Alzheimer Research, V2, P187, DOI 10.2174/1567205053585765; STYREN SD, 1990, EXP NEUROL, V110, P93, DOI 10.1016/0014-4886(90)90054-V; Takahashi K, 2005, J EXP MED, V201, P647, DOI 10.1084/jem.20041611; Terry RD, 2006, J GERIATR PSYCH NEUR, V19, P125, DOI 10.1177/0891988706291079; Thal DR, 2003, J NEUROPATH EXP NEUR, V62, P1287, DOI 10.1093/jnen/62.12.1287; Thomassen R, 1998, NEUROLOGY, V50, P283, DOI 10.1212/WNL.50.1.283; TOMLINSON BE, 1970, J NEUROL SCI, V11, P205, DOI 10.1016/0022-510X(70)90063-8; *USCB, 2004, 53 USCB CTR DIS CONT; *USCB, 2002, POP PROJ MIDDL SER; von Gunten A, 2005, EXP NEUROL, V193, P198, DOI 10.1016/j.expneurol.2004.12.005; Walter S, 2007, CELL PHYSIOL BIOCHEM, V20, P947, DOI 10.1159/000110455; WERNICKE TF, 1994, NEUROLOGY, V44, P250, DOI 10.1212/WNL.44.2.250; Xiang Z, 2006, DIS MARKERS, V22, P95, DOI 10.1155/2006/276239; Yao PJ, 2003, NEUROBIOL DIS, V12, P97, DOI 10.1016/S0969-9961(02)00009-8; Zujovic V, 2000, GLIA, V29, P305, DOI 10.1002/(SICI)1098-1136(20000215)29:4<305::AID-GLIA2>3.0.CO;2-V	84	46	47	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7642	10.1371/journal.pone.0007642	http://dx.doi.org/10.1371/journal.pone.0007642			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19865478	Green Published, gold, Green Submitted			2022-12-27	WOS:000271232000012
J	Hart, T; Zhao, A; Garg, A; Bolusani, S; Marcotte, EM				Hart, Traver; Zhao, Alice; Garg, Ankit; Bolusani, Swetha; Marcotte, Edward M.			Human Cell Chips: Adapting DNA Microarray Spotting Technology to Cell-Based Imaging Assays	PLOS ONE			English	Article							HIGH-THROUGHPUT MICROSCOPY; PROTEIN INTERACTIONS; GENE-EXPRESSION; DRUG DISCOVERY; FLOW-CYTOMETRY; PHOSPHORYLATION; PROTEOMICS; SCALE	Here we describe human spotted cell chips, a technology for determining cellular state across arrays of cells subjected to chemical or genetic perturbation. Cells are grown and treated under standard tissue culture conditions before being fixed and printed onto replicate glass slides, effectively decoupling the experimental conditions from the assay technique. Each slide is then probed using immunofluorescence or other optical reporter and assayed by automated microscopy. We show potential applications of the cell chip by assaying HeLa and A549 samples for changes in target protein abundance (of the dsRNA-activated protein kinase PKR), subcellular localization (nuclear translocation of NF kappa B) and activation state (phosphorylation of STAT1 and of the p38 and JNK stress kinases) in response to treatment by several chemical effectors (anisomycin, TNF alpha, and interferon), and we demonstrate scalability by printing a chip with similar to 4,700 discrete samples of HeLa cells. Coupling this technology to high-throughput methods for culturing and treating cell lines could enable researchers to examine the impact of exogenous effectors on the same population of experimentally treated cells across multiple reporter targets potentially representing a variety of molecular systems, thus producing a highly multiplexed dataset with minimized experimental variance and at reduced reagent cost compared to alternative techniques. The ability to prepare and store chips also allows researchers to follow up on observations gleaned from initial screens with maximal repeatability.			Hart, T (corresponding author), Univ Texas Austin, Ctr Syst & Synthet Biol, Austin, TX 78712 USA.	marcotte@icmb.utexas.edu	Zhao, Alice/J-8115-2016	Zhao, Alice/0000-0001-5845-8071; Hart, Traver/0000-0002-1880-3341; Marcotte, Edward/0000-0001-8808-180X				Abraham VC, 2004, TRENDS BIOTECHNOL, V22, P15, DOI 10.1016/j.tibtech.2003.10.012; Albeck JG, 2006, NAT REV MOL CELL BIO, V7, P803, DOI 10.1038/nrm2042; Bailey SN, 2006, NAT METHODS, V3, P117, DOI 10.1038/NMETH848; Camp RL, 2008, J CLIN ONCOL, V26, P5630, DOI 10.1200/JCO.2008.17.3567; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Castel D, 2006, DRUG DISCOV TODAY, V11, P616, DOI 10.1016/j.drudis.2006.05.015; DeRisi JL, 1997, SCIENCE, V278, P680, DOI 10.1126/science.278.5338.680; Fiebitz A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-68; Garcia-Sastre A, 2006, SCIENCE, V312, P879, DOI 10.1126/science.1125676; Glory E, 2007, DEV CELL, V12, P7, DOI 10.1016/j.devcel.2006.12.007; Krutzik PO, 2008, NAT CHEM BIOL, V4, P132, DOI 10.1038/nchembio.2007.59; Krutzik PO, 2004, CLIN IMMUNOL, V110, P206, DOI 10.1016/j.clim.2003.11.009; MacKeigan JP, 2005, NAT CELL BIOL, V7, P591, DOI 10.1038/ncb1258; Michnick SW, 2004, DRUG DISCOV TODAY, V9, P262, DOI 10.1016/S1359-6446(03)03022-8; Narayanaswamy R, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-1-r6; Nelson DE, 2004, SCIENCE, V306, P704, DOI 10.1126/science.1099962; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Reuther-Madrid JY, 2002, MOL CELL BIOL, V22, P8175, DOI 10.1128/MCB.22.23.8175-8183.2002; Sevecka M, 2006, NAT METHODS, V3, P825, DOI 10.1038/nmeth931; Soen Y, 2006, MOL SYST BIOL, V2, DOI 10.1038/msb4100076; Starkuviene V, 2007, BRIT J PHARMACOL, V152, P62, DOI 10.1038/sj.bjp.0707346; Wheeler DB, 2005, NAT GENET, V37, pS25, DOI 10.1038/ng1560; Wu RZ, 2002, TRENDS CELL BIOL, V12, P485, DOI 10.1016/S0962-8924(02)02354-1; Zhao J, 2008, PLOS BIOL, V6, P1306, DOI 10.1371/journal.pbio.0060150; Zhou F, 2007, J PROTEOME RES, V6, P133, DOI 10.1021/pr0602904; Ziauddin J, 2001, NATURE, V411, P107, DOI 10.1038/35075114	27	21	22	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7088	10.1371/journal.pone.0007088	http://dx.doi.org/10.1371/journal.pone.0007088			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862318	Green Published, Green Submitted, gold			2022-12-27	WOS:000271194600001
J	Rangel, A; Madronal, N; Masso, AGI; Gavin, R; Llorens, F; Sumoy, L; Torres, JM; Delgado-Garcia, JM; Del Rio, JA				Rangel, Alejandra; Madronal, Noelia; Gruart i Masso, Agnes; Gavin, Rosalina; Llorens, Franc; Sumoy, Lauro; Maria Torres, Juan; Maria Delgado-Garcia, Jose; Antonio Del Rio, Jose			Regulation of GABA(A) and Glutamate Receptor Expression, Synaptic Facilitation and Long-Term Potentiation in the Hippocampus of Prion Mutant Mice	PLOS ONE			English	Article							CA3-CA1 SYNAPSE; RAT HIPPOCAMPUS; DEFICIENT MICE; KNOCKOUT MICE; KAINIC ACID; NULL MICE; PROTEIN; SEIZURES; BEHAVIOR; LTP	Background: Prionopathies are characterized by spongiform brain degeneration, myoclonia, dementia, and periodic electroencephalographic (EEG) disturbances. The hallmark of prioniopathies is the presence of an abnormal conformational isoform (PrPsc) of the natural cellular prion protein (PrPc) encoded by the Prnp gene. Although several roles have been attributed to PrPc, its putative functions in neuronal excitability are unknown. Although early studies of the behavior of Prnp knockout mice described minor changes, later studies report altered behavior. To date, most functional PrPc studies on synaptic plasticity have been performed in vitro. To our knowledge, only one electrophysiological study has been performed in vivo in anesthetized mice, by Curtis and coworkers. They reported no significant differences in paired-pulse facilitation or LTP in the CA1 region after Schaffer collateral/commissural pathway stimulation. Methodology/Principal Findings: Here we explore the role of PrPc expression in neurotransmission and neural excitability using wild-type, Prnp -/- and PrPc-overexpressing mice (Tg20 strain). By correlating histopathology with electrophysiology in living behaving mice, we demonstrate that both Prnp -/- mice but, more relevantly Tg20 mice show increased susceptibility to KA, leading to significant cell death in the hippocampus. This finding correlates with enhanced synaptic facilitation in paired-pulse experiments and hippocampal LTP in living behaving mutant mice. Gene expression profiling using Illumina (TM) microarrays and Ingenuity pathways analysis showed that 129 genes involved in canonical pathways such as Ubiquitination or Neurotransmission were co-regulated in Prnp -/- and Tg20 mice. Lastly, RT-qPCR of neurotransmission-related genes indicated that subunits of GABA(A) and AMPA-kainate receptors are co-regulated in both Prnp -/- and Tg20 mice. Conclusions/Significance: Present results demonstrate that PrPc is necessary for the proper homeostatic functioning of hippocampal circuits, because of its relationships with GABA(A) and AMPA-Kainate neurotransmission. New PrPc functions have recently been described, which point to PrPc as a target for putative therapies in Alzheimer's disease. However, our results indicate that a "gain of function'' strategy in Alzheimer's disease, or a "loss of function'' in prionopathies, may impair PrPc function, with devastating effects. In conclusion, we believe that present data should be taken into account in the development of future therapies.			Rangel, A (corresponding author), Univ Barcelona, Inst Bioengn Catalonia, Barcelona, Spain.	jmdelgar@upo.es; jadelrio@ibec.pcb.ub.es	Gavín, Rosalina/D-4341-2014; Del Rio Fernandez, Jose A/AAD-1121-2020; Sumoy, Lauro/AGZ-3186-2022; del rio, jose antonio/L-9232-2014; Sumoy, Lauro/K-1680-2013; Torres, Juan Maria/L-8768-2013; Delgado-Garcia, Jose M./V-1567-2019	Gavín, Rosalina/0000-0003-1982-2162; Sumoy, Lauro/0000-0003-0005-4618; del rio, jose antonio/0000-0002-5214-4909; Sumoy, Lauro/0000-0003-0005-4618; Torres, Juan Maria/0000-0003-0443-9232; Rangel, Alejandra/0000-0001-6536-6263; , Franc/0000-0002-9756-7497				Aguzzi A, 2008, ANNU REV NEUROSCI, V31, P439, DOI 10.1146/annurev.neuro.31.060407.125620; BORCHELT DR, 1990, J CELL BIOL, V110, P743, DOI 10.1083/jcb.110.3.743; BUELER H, 1992, NATURE, V356, P577, DOI 10.1038/356577a0; Carleton A, 2001, PFLUG ARCH EUR J PHY, V442, P223, DOI 10.1007/s004240100523; Chiarini LB, 2002, EMBO J, V21, P3317, DOI 10.1093/emboj/cdf324; Chiesa R, 2008, J NEUROSCI, V28, P13258, DOI 10.1523/JNEUROSCI.3109-08.2008; Coitinho AS, 2006, EUR J NEUROSCI, V24, P3255, DOI 10.1111/j.1460-9568.2006.05156.x; Coitinho AS, 2003, NEUROREPORT, V14, P1375, DOI 10.1097/01.wnr.0000078541.07662.90; Colling SB, 1996, NEUROSCI LETT, V209, P49, DOI 10.1016/0304-3940(96)12596-9; COLLINGE J, 1994, NATURE, V370, P295, DOI 10.1038/370295a0; Coltinho AS, 2007, NEUROBIOL DIS, V26, P282, DOI 10.1016/j.nbd.2007.01.005; Criado JR, 2005, NEUROBIOL DIS, V19, P255, DOI 10.1016/j.nbd.2005.01.001; Curtis J, 2003, NEUROBIOL DIS, V13, P55, DOI 10.1016/S0969-9961(03)00017-2; Du P, 2008, BIOINFORMATICS, V24, P1547, DOI 10.1093/bioinformatics/btn224; Ferreiro E, 2006, NEUROBIOL DIS, V23, P669, DOI 10.1016/j.nbd.2006.05.011; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Fukushima F, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003993; Gardoni F, 2009, J NEUROSCI, V29, P669, DOI 10.1523/JNEUROSCI.3921-08.2009; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Gruart A, 2006, J NEUROSCI, V26, P1077, DOI 10.1523/JNEUROSCI.2834-05.2006; Gureviciene I, 2004, NEUROBIOL DIS, V15, P188, DOI 10.1016/j.nbd.2003.11.011; Herms JW, 1995, EUR J NEUROSCI, V7, P2508, DOI 10.1111/j.1460-9568.1995.tb01049.x; Huang SH, 2007, P NATL ACAD SCI USA, V104, P6800, DOI 10.1073/pnas.0608885104; Iihara K, 2001, J NEUROSCI, V21, P2224, DOI 10.1523/JNEUROSCI.21-07-02224.2001; Janssen WGM, 2005, EXP NEUROL, V191, pS28, DOI 10.1016/j.expneurol.2004.08.020; Khosravani H, 2008, J CELL BIOL, V181, P551, DOI 10.1083/jcb.200711002; Khosravani Houman, 2008, J Gen Physiol, V131, pi5, DOI 10.1085/JGP1316OIA5; Lauren J, 2009, NATURE, V457, P1128, DOI 10.1038/nature07761; Lauri SE, 2007, NEUROPHARMACOLOGY, V52, P1, DOI 10.1016/j.neuropharm.2006.06.017; Le Pichon CE, 2009, NAT NEUROSCI, V12, P60, DOI 10.1038/nn.2238; Lee JY, 2000, J NEUROSCI, V20; Linden R, 2008, PHYSIOL REV, V88, P673, DOI 10.1152/physrev.00007.2007; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lledo PM, 1996, P NATL ACAD SCI USA, V93, P2403, DOI 10.1073/pnas.93.6.2403; Macdonald RL, 2004, BIOCHEM PHARMACOL, V68, P1497, DOI 10.1016/j.bcp.2004.07.029; Madronal N, 2007, J NEUROSCI, V27, P12139, DOI 10.1523/JNEUROSCI.3397-07.2007; Madronal N, 2009, FRONT BEHAV NEUROSCI, V3, DOI 10.3389/neuro.08.007.2009; Maglio LE, 2006, BRAIN RES, V1097, P11, DOI 10.1016/j.brainres.2006.04.056; Maglio LE, 2004, MOL BRAIN RES, V131, P58, DOI 10.1016/j.molbrainres.2004.08.004; Mallucci GR, 2002, EMBO J, V21, P202, DOI 10.1093/emboj/21.3.202; McKhann GM, 2003, NEUROSCIENCE, V122, P551, DOI 10.1016/S0306-4522(03)00562-1; McLennan NF, 2004, AM J PATHOL, V165, P227, DOI 10.1016/S0002-9440(10)63291-9; McLin JP, 2006, EUR J NEUROSCI, V24, P2191, DOI 10.1111/j.1460-9568.2006.05111.x; Mouillet-Richard S, 2000, SCIENCE, V289, P1925, DOI 10.1126/science.289.5486.1925; Nicolas O, 2007, FASEB J, V21, P3107, DOI 10.1096/fj.06-7827com; PAN KM, 1993, P NATL ACAD SCI USA, V90, P10962, DOI 10.1073/pnas.90.23.10962; Paxinos G., 2001, MOUSE BRAIN STEREOTA; Peng YG, 1997, FUND APPL TOXICOL, V40, P63, DOI 10.1006/faat.1997.2360; Powell AD, 2008, J NEUROSCI, V28, P3877, DOI 10.1523/JNEUROSCI.0675-08.2008; PRUSINER SB, 1994, ANNU REV NEUROSCI, V17, P311, DOI 10.1146/annurev.ne.17.030194.001523; PRUSINER SB, 1986, BIOESSAYS, V5, P281, DOI 10.1002/bies.950050612; Rangel A, 2007, J NEUROSCI RES, V85, P2741, DOI 10.1002/jnr.21215; Roucou X, 2004, J NEUROSCI RES, V75, P153, DOI 10.1002/jnr.10864; Sakudo A, 2006, MINI-REV MED CHEM, V6, P589, DOI 10.2174/138955706776876159; Schneider B, 2003, P NATL ACAD SCI USA, V100, P13326, DOI 10.1073/pnas.2235648100; Schwartzkroin P A, 1986, Adv Neurol, V44, P991; Sokolov MV, 1998, NEUROSCIENCE, V85, P1, DOI 10.1016/S0306-4522(97)00592-7; Sorensen G, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-114; Steele AD, 2006, P NATL ACAD SCI USA, V103, P3416, DOI 10.1073/pnas.0511290103; Telfeian AE, 2000, NEUROBIOL DIS, V7, P362, DOI 10.1006/nbdi.2000.0294; Thompson CL, 2002, MOL BRAIN RES, V102, P55, DOI 10.1016/S0169-328X(02)00183-3; Tobler I, 1996, NATURE, V380, P639, DOI 10.1038/380639a0; Turrigiano GG, 2004, NAT REV NEUROSCI, V5, P97, DOI 10.1038/nrn1327; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Volianskis A, 2003, J PHYSIOL-LONDON, V550, P459, DOI 10.1113/jphysiol.2003.044214; Walz R, 1999, EPILEPSIA, V40, P1679, DOI 10.1111/j.1528-1157.1999.tb01583.x; WESTAWAY D, 1994, DEGENERATION SKELETA, P117; Whatley SA, 1995, NEUROREPORT, V6, P2333, DOI 10.1097/00001756-199511270-00015; Yang EJ, 2006, J NEUROPHYSIOL, V96, P1683, DOI 10.1152/jn.01332.2005; Zucker RS, 2002, ANNU REV PHYSIOL, V64, P355, DOI 10.1146/annurev.physiol.64.092501.114547	70	50	50	0	25	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7592	10.1371/journal.pone.0007592	http://dx.doi.org/10.1371/journal.pone.0007592			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855845	Green Submitted, Green Published, gold			2022-12-27	WOS:000271147200013
J	Schroeder, K; Jularic, M; Horsburgh, SM; Hirschhausen, N; Neumann, C; Bertling, A; Schulte, A; Foster, S; Kehrel, BE; Peters, G; Heilmann, C				Schroeder, Katrin; Jularic, Mario; Horsburgh, Samantha M.; Hirschhausen, Nina; Neumann, Claudia; Bertling, Anne; Schulte, Anja; Foster, Simon; Kehrel, Beate E.; Peters, Georg; Heilmann, Christine			Molecular Characterization of a Novel Staphylococcus Aureus Surface Protein (SasC) Involved in Cell Aggregation and Biofilm Accumulation	PLOS ONE			English	Article							FIBRONECTIN-BINDING PROTEIN; POLYSACCHARIDE INTERCELLULAR ADHESIN; PROTOPLAST TRANSFORMATION; METHICILLIN RESISTANCE; JOINT INFECTIONS; GENOME SEQUENCE; ICA LOCUS; IN-VITRO; EPIDERMIDIS; GENE	Background: Staphylococci belong to the most important pathogens causing implant-associated infections. Colonization of the implanted medical devices by the formation of a three-dimensional structure made of bacteria and host material called biofilm is considered the most critical factor in these infections. To form a biofilm, bacteria first attach to the surface of the medical device, and then proliferate and accumulate into multilayered cell clusters. Biofilm accumulation may be mediated by polysaccharide and protein factors. Methology/Principal Findings: The information on Staphylococcus aureus protein factors involved in biofilm accumulation is limited, therefore, we searched the S. aureus Col genome for LPXTG-motif containing potential surface proteins and chose the so far uncharacterized S. aureus surface protein C (SasC) for further investigation. The deduced SasC sequence consists of 2186 amino acids with a molecular mass of 238 kDa and has features typical of Gram-positive surface proteins, such as an N-terminal signal peptide, a C-terminal LPXTG cell wall anchorage motif, and a repeat region consisting of 17 repeats similar to the domain of unknown function 1542 (DUF1542). We heterologously expressed sasC in Staphylococcus carnosus, which led to the formation of huge cell aggregates indicative of intercellular adhesion and biofilm accumulation. To localize the domain conferring cell aggregation, we expressed two subclones of sasC encoding either the N-terminal domain including a motif that is found in various architectures (FIVAR) or 8 of the DUF1542 repeats. SasC or its N-terminal domain, but not the DUF1542 repeat region conferred production of huge cell aggregates, higher attachment to polystyrene, and enhanced biofilm formation to S. carnosus and S. aureus. SasC does not mediate binding to fibrinogen, thrombospondin-1, von Willebrand factor, or platelets as determined by flow cytometry. Conclusions/Significance: Thus, SasC represents a novel S. aureus protein factor involved in cell aggregation and biofilm formation, which may play an important role in colonization during infection with this important pathogen.			Schroeder, K (corresponding author), Univ Hosp Munster, Inst Med Microbiol, Munster, Germany.	heilmac@uni-muenster.de						Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Baba T, 2002, LANCET, V359, P1819, DOI 10.1016/S0140-6736(02)08713-5; Baba T, 2008, J BACTERIOL, V190, P300, DOI 10.1128/JB.01000-07; Bae T, 2003, J BACTERIOL, V185, P2910, DOI 10.1128/JB.185.9.2910-2919.2003; Bateman BT, 2001, INFECT IMMUN, V69, P7851, DOI 10.1128/IAI.69.12.7851-7857.2001; Beenken KE, 2003, INFECT IMMUN, V71, P4206, DOI 10.1128/IAI.71.7.4206-4211.2003; Biswas R, 2006, FEMS MICROBIOL LETT, V259, P260, DOI 10.1111/j.1574-6968.2006.00281.x; Clarke SR, 2006, J INFECT DIS, V193, P1098, DOI 10.1086/501471; Clarke SR, 2002, INFECT IMMUN, V70, P6680, DOI 10.1128/IAI.70.12.6680-6687.2002; Conrady DG, 2008, P NATL ACAD SCI USA, V105, P19456, DOI 10.1073/pnas.0807717105; Corrigan RM, 2007, MICROBIOL-SGM, V153, P2435, DOI 10.1099/mic.0.2007/006676-0; Cramton SE, 1999, INFECT IMMUN, V67, P5427, DOI 10.1128/IAI.67.10.5427-5433.1999; Cucarella C, 2001, J BACTERIOL, V183, P2888, DOI 10.1128/JB.183.9.2888-2896.2001; Diep BA, 2006, LANCET, V367, P731, DOI 10.1016/S0140-6736(06)68231-7; Dormann D, 2000, BLOOD, V96, P2469, DOI 10.1182/blood.V96.7.2469.h8002469_2469_2478; Finn RD, 2006, NUCLEIC ACIDS RES, V34, pD247, DOI 10.1093/nar/gkj149; FLOCK JI, 1987, EMBO J, V6, P2351, DOI 10.1002/j.1460-2075.1987.tb02511.x; Fournier B, 2000, J BACTERIOL, V182, P3955, DOI 10.1128/JB.182.14.3955-3964.2000; Fujigaki Y, 1998, J PATHOL, V184, P436; Gill SR, 2005, J BACTERIOL, V187, P2426, DOI 10.1128/JB.187.7.2426-2438.2005; Gillaspy A.F., 2006, GRAM POSITIVE PATHOG, P381; GOTZ F, 1987, FEMS MICROBIOL LETT, V40, P285, DOI 10.1016/0378-1097(87)90391-0; GOTZ F, 1983, MOL GEN GENET, V189, P340, DOI 10.1007/BF00337828; Gross M, 2001, INFECT IMMUN, V69, P3423, DOI 10.1128/IAI.69.5.3423-3426.2001; Hartleib J, 2000, BLOOD, V96, P2149; Heilmann C, 2002, J INFECT DIS, V186, P32, DOI 10.1086/341081; Heilmann C, 1996, INFECT IMMUN, V64, P277, DOI 10.1128/IAI.64.1.277-282.1996; Heilmann C, 1996, MOL MICROBIOL, V20, P1083, DOI 10.1111/j.1365-2958.1996.tb02548.x; Heilmann C, 1997, MOL MICROBIOL, V24, P1013, DOI 10.1046/j.1365-2958.1997.4101774.x; HERRMANN M, 1993, J INFECT DIS, V167, P312, DOI 10.1093/infdis/167.2.312; Holden MTG, 2004, P NATL ACAD SCI USA, V101, P9786, DOI 10.1073/pnas.0402521101; Horsburgh MJ, 2002, J BACTERIOL, V184, P5457, DOI 10.1128/JB.184.19.5457-5467.2002; HORSBURGH SM, 2002, THESIS U SHEFFIELD S; Hussain M, 1997, INFECT IMMUN, V65, P519, DOI 10.1128/IAI.65.2.519-524.1997; Jefferson KK, 2004, J BACTERIOL, V186, P2449, DOI 10.1128/JB.186.8.2449-2456.2004; JONSSON K, 1991, EUR J BIOCHEM, V202, P1041, DOI 10.1111/j.1432-1033.1991.tb16468.x; KEHREL B, 1991, BIOCHEM BIOPH RES CO, V179, P985, DOI 10.1016/0006-291X(91)91915-Y; Kogan G, 2006, FEMS MICROBIOL LETT, V255, P11, DOI 10.1111/j.1574-6968.2005.00043.x; Komatsuzawa H, 2000, J ANTIMICROB CHEMOTH, V45, P421, DOI 10.1093/jac/45.4.421; Kuroda M, 2001, LANCET, V357, P1225, DOI 10.1016/S0140-6736(00)04403-2; Lahav J, 2002, BLOOD, V100, P2472, DOI 10.1182/blood-2001-12-0339; Lentino JR, 2003, CLIN INFECT DIS, V36, P1157, DOI 10.1086/374554; Lim Y, 2004, J BACTERIOL, V186, P722, DOI 10.1128/JB.186.3.722-729.2004; LOFDAHL S, 1983, P NATL ACAD SCI-BIOL, V80, P697, DOI 10.1073/pnas.80.3.697; Mack D, 1996, J BACTERIOL, V178, P175, DOI 10.1128/jb.178.1.175-183.1996; MACK D, 1992, INFECT IMMUN, V60, P2048, DOI 10.1128/IAI.60.5.2048-2057.1992; MCDEVITT D, 1994, MOL MICROBIOL, V11, P237, DOI 10.1111/j.1365-2958.1994.tb00304.x; Niemann S, 2004, CIRCULATION, V110, P193, DOI 10.1161/01.CIR.0000134486.93030.E7; O'Neill E, 2008, J BACTERIOL, V190, P3835, DOI 10.1128/JB.00167-08; PASCUAL A, 1986, EUR J CLIN MICROBIOL, V5, P518, DOI 10.1007/BF02017694; PATTI JM, 1994, ANNU REV MICROBIOL, V48, P585, DOI 10.1146/annurev.mi.48.100194.003101; PATTI JM, 1992, J BIOL CHEM, V267, P4766; PEARSON WR, 1988, P NATL ACAD SCI USA, V85, P2444, DOI 10.1073/pnas.85.8.2444; Pratten J, 2001, MICROBES INFECT, V3, P633, DOI 10.1016/S1286-4579(01)01418-6; Rice KC, 2007, P NATL ACAD SCI USA, V104, P8113, DOI 10.1073/pnas.0610226104; Rohde H, 2005, MOL MICROBIOL, V55, P1883, DOI 10.1111/j.1365-2958.2005.04515.x; Rohde H, 2007, BIOMATERIALS, V28, P1711, DOI 10.1016/j.biomaterials.2006.11.046; Sambrook J., 2002, MOL CLONING LAB MANU; Savolainen K, 2001, INFECT IMMUN, V69, P3013, DOI 10.1128/IAI.69.5.3013-3020.2001; Tsang LH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003361; Tung HS, 2000, BIOCHEM J, V345, P611, DOI 10.1042/0264-6021:3450611; UHLEN M, 1984, J BIOL CHEM, V259, P1695; Vuong C, 2000, J INFECT DIS, V182, P1688, DOI 10.1086/317606; WIELAND KP, 1995, GENE, V158, P91, DOI 10.1016/0378-1119(95)00137-U; Williams RJ, 2002, INFECT IMMUN, V70, P6805, DOI 10.1128/IAI.70.12.6805-6810.2002; Wu SW, 1999, MICROB DRUG RESIST, V5, P9, DOI 10.1089/mdr.1999.5.9; Yarwood JM, 2004, J BACTERIOL, V186, P1838, DOI 10.1128/JB.186.6.1838-1850.2004; Ziebuhr W, 2001, Contrib Microbiol, V8, P102	68	92	97	3	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7567	10.1371/journal.pone.0007567	http://dx.doi.org/10.1371/journal.pone.0007567			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851500	gold, Green Submitted, Green Published			2022-12-27	WOS:000271022300009
J	Ballesteros, S; Vergu, E; Cazelles, B				Ballesteros, Sebastien; Vergu, Elisabeta; Cazelles, Bernard			Influenza A Gradual and Epochal Evolution: Insights from Simple Models	PLOS ONE			English	Article							CRITICAL COMMUNITY SIZE; POSITIVE SELECTION; DYNAMICS; H3N2; PERSISTENCE; MEASLES; HEMAGGLUTININ; TRANSMISSION; REINFECTION; SEASONALITY	The recurrence of influenza A epidemics has originally been explained by a "continuous antigenic drift" scenario. Recently, it has been shown that if genetic drift is gradual, the evolution of influenza A main antigen, the haemagglutinin, is punctuated. As a consequence, it has been suggested that influenza A dynamics at the population level should be approximated by a serial SIR model. Here, simple models are used to test whether a serial SIR model requires gradual antigenic drift within groups of strains with the same antigenic properties (antigenic clusters). We compare the effect of status based and history based frameworks and the influence of reduced susceptibility and infectivity assumptions on the transient dynamics of antigenic clusters. Our results reveal that the replacement of a resident antigenic cluster by a mutant cluster, as observed in data, is reproduced only by the status based model integrating the reduced infectivity assumption. This combination of assumptions is useful to overcome the otherwise extremely high model dimensionality of models incorporating many strains, but relies on a biological hypothesis not obviously satisfied. Our findings finally suggest the dynamical importance of gradual antigenic drift even in the presence of punctuated immune escape. A more regular renewal of susceptible pool than the one implemented in a serial SIR model should be part of a minimal theory for influenza at the population level.			Ballesteros, S (corresponding author), Ecole Normale Super, CNRS, UPMC ENS AgroParisTech, Unit Ecoevolutionary Math,UMR 7625, Paris, France.	sebastien.ballesteros@biologie.ens.fr	Cazelles, Bernard/B-1572-2013	Cazelles, Bernard/0000-0002-7972-361X				Alonso WJ, 2007, AM J EPIDEMIOL, V165, P1434, DOI 10.1093/aje/kwm012; Andreasen V, 1997, J MATH BIOL, V35, P825, DOI 10.1007/s002850050079; Andreasen V, 2006, THEOR POPUL BIOL, V70, P164, DOI 10.1016/j.tpb.2006.04.004; BARTLETT MS, 1960, J R STAT SOC SER A-G, V123, P37, DOI 10.2307/2343186; BARTLETT MS, 1957, J R STAT SOC SER A-G, V120, P48, DOI 10.2307/2342553; BARTLETT MS, 1964, ROY STAT SOC C-APP, V13, P2; Bjornstad ON, 2002, ECOL MONOGR, V72, P169, DOI 10.1890/0012-9615(2002)072[0169:DOMEES]2.0.CO;2; Blackburne BP, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000058; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Cobey S, 2008, TRENDS ECOL EVOL, V23, P572, DOI 10.1016/j.tree.2008.06.008; COG JR, 2008, VACCINE S3, V26, pC15; Conlan AJK, 2007, P ROY SOC B-BIOL SCI, V274, P1133, DOI 10.1098/rspb.2006.0030; Dawes JHP, 2002, J MATH BIOL, V45, P471, DOI 10.1007/s00285-002-0163-9; DESTGROTH SF, 1966, J EXP MED, V124, P331, DOI 10.1084/jem.124.3.331; DIECKMANN U, 2002, PURSUIT VIRULENCE MA; Diekmann O., 2000, MATH EPIDEMIOLOGY IN; Du X, 2008, GENOME RES, V18, P178, DOI 10.1101/gr.6969007; Earn DJD, 2000, SCIENCE, V287, P667, DOI 10.1126/science.287.5453.667; Ferguson NM, 2005, NATURE, V437, P209, DOI 10.1038/nature04017; Ferguson NM, 2003, NATURE, V422, P428, DOI 10.1038/nature01509; Finkenstadt BF, 2005, STAT MED, V24, P3447, DOI 10.1002/sim.2196; FRANCIS T, 1953, ANN INTERN MED, V39, P203, DOI 10.7326/0003-4819-39-2-203; Francis T, 1960, P AM PHILOS SOC, V104, P572, DOI DOI 10.1371/JOURNAL.PPAT.1005806; Frank S. A., 2002, IMMUNOLOGY EVOLUTION, P33; Galassi M., 2003, GNU SCI LIB REFERENC; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; Girvan M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.031915; Gog JR, 2002, P NATL ACAD SCI USA, V99, P17209, DOI 10.1073/pnas.252512799; Gog JR, 2002, J MATH BIOL, V44, P169, DOI 10.1007/s002850100120; Gokaydin D, 2007, J R SOC INTERFACE, V4, P137, DOI 10.1098/rsif.2006.0159; Gomes MGM, 2005, J THEOR BIOL, V236, P111, DOI 10.1016/j.jtbi.2005.03.001; Gomes MGM, 2004, J THEOR BIOL, V228, P539, DOI 10.1016/j.jtbi.2004.02.015; Grenfell BT, 2004, SCIENCE, V303, P327, DOI 10.1126/science.1090727; Gupta S, 1998, SCIENCE, V280, P912, DOI 10.1126/science.280.5365.912; Holmes EC, 2005, PLOS BIOL, V3, P1579, DOI 10.1371/journal.pbio.0030300; JANEWAY C, 1999, CURRENT BIOL; Kamo M, 2002, PHYSICA D, V165, P228, DOI 10.1016/S0167-2789(02)00389-5; Keeling M, 2000, P ROY SOC B-BIOL SCI, V267, P385, DOI 10.1098/rspb.2000.1013; Keeling MJ, 1997, SCIENCE, V275, P65, DOI 10.1126/science.275.5296.65; Keeling MJ, 2002, P ROY SOC B-BIOL SCI, V269, P335, DOI 10.1098/rspb.2001.1898; Koelle K, 2006, SCIENCE, V314, P1898, DOI 10.1126/science.1132745; Kryazhimskiy S, 2007, PLOS COMPUT BIOL, V3, P1513, DOI 10.1371/journal.pcbi.0030159; Lavenu A, 2004, VIRUS RES, V103, P101, DOI 10.1016/j.virusres.2004.02.021; Lloyd-Smith JO, 2005, TRENDS ECOL EVOL, V20, P511, DOI 10.1016/j.tree.2005.07.004; Mathews JD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001220; MINAYEV P, 2009, J R SOC INTERFACE; Minayev P, 2009, J R SOC INTERFACE, V6, P509, DOI 10.1098/rsif.2008.0333; Nasell I, 2005, THEOR POPUL BIOL, V67, P203, DOI 10.1016/j.tpb.2005.01.002; Nelson MI, 2007, PLOS PATHOG, V3, P1220, DOI 10.1371/journal.ppat.0030131; Nelson MI, 2006, PLOS PATHOG, V2, P1144, DOI 10.1371/journal.ppat.0020125; Nelson MI, 2007, NAT REV GENET, V8, P196, DOI 10.1038/nrg2053; Olinky R, 2008, J MATH BIOL, V56, P827, DOI 10.1007/s00285-007-0140-4; PEASE CM, 1987, THEOR POPUL BIOL, V31, P422, DOI 10.1016/0040-5809(87)90014-1; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Recker M, 2007, P NATL ACAD SCI USA, V104, P7711, DOI 10.1073/pnas.0702154104; Russell CA, 2008, SCIENCE, V320, P340, DOI 10.1126/science.1154137; Shih ACC, 2007, P NATL ACAD SCI USA, V104, P6283, DOI 10.1073/pnas.0701396104; Smith DJ, 2004, SCIENCE, V305, P371, DOI 10.1126/science.1097211; Suzuki Y, 2008, GENE, V427, P111, DOI 10.1016/j.gene.2008.09.012; Tria F, 2005, J STAT MECH-THEORY E, DOI 10.1088/1742-5468/2005/07/P07008; Viboud C, 2006, PLOS MED, V3, P468, DOI 10.1371/journal.pmed.0030089; Wagner R, 2002, REV MED VIROL, V12, P159, DOI 10.1002/rmv.352; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; *WHO, 2003, 211 WHO; Wolf YI, 2006, BIOL DIRECT, V1, DOI 10.1186/1745-6150-1-34	65	19	19	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7426	10.1371/journal.pone.0007426	http://dx.doi.org/10.1371/journal.pone.0007426			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841740	Green Published, gold, Green Submitted			2022-12-27	WOS:000271012900009
J	Kashav, T; Nitharwal, R; Abdulrehman, SA; Gabdoulkhakov, A; Saenger, W; Dhar, SK; Gourinath, S				Kashav, Tara; Nitharwal, Ramgopal; Abdulrehman, S. Arif; Gabdoulkhakov, Azat; Saenger, Wolfram; Dhar, Suman Kumar; Gourinath, Samudrala			Three-Dimensional Structure of N-Terminal Domain of DnaB Helicase and Helicase-Primase Interactions in Helicobacter pylori	PLOS ONE			English	Article							ESCHERICHIA-COLI DNAB; SINGLE-STRANDED-DNA; FUNCTIONAL-CHARACTERIZATION; REPLICATIVE HELICASE; MAXIMUM-LIKELIHOOD; DIFFRACTION DATA; PROTEIN; MECHANISM; BINDING; SEQUENCE	Replication initiation is a crucial step in genome duplication and homohexameric DnaB helicase plays a central role in the replication initiation process by unwinding the duplex DNA and interacting with several other proteins during the process of replication. N-terminal domain of DnaB is critical for helicase activity and for DnaG primase interactions. We present here the crystal structure of the N-terminal domain (NTD) of H. pylori DnaB (HpDnaB) helicase at 2.2 angstrom resolution and compare the structural differences among helicases and correlate with the functional differences. The structural details of NTD suggest that the linker region between NTD and C-terminal helicase domain plays a vital role in accurate assembly of NTD dimers. The sequence analysis of the linker regions from several helicases reveals that they should form four helix bundles. We also report the characterization of H. pylori DnaG primase and study the helicase-primase interactions, where HpDnaG primase stimulates DNA unwinding activity of HpDnaB suggesting presence of helicase-primase cohort at the replication fork. The protein-protein interaction study of C-terminal domain of primase and different deletion constructs of helicase suggests that linker is essential for proper conformation of NTD to interact strongly with HpDnaG. The surface charge distribution on the primase binding surface of NTDs of various helicases suggests that DnaB-DnaG interaction and stability of the complex is most probably charge dependent. Structure of the linker and helicase-primase interactions indicate that HpDnaB differs greatly from E. coli DnaB despite both belong to gram negative bacteria.			Kashav, T (corresponding author), Jawaharlal Nehru Univ, Sch Life Sci, New Delhi 110067, India.	sgourinath@mail.jnu.ac.in	Gabdulkhakov, Azat/H-4343-2013	Gabdulkhakov, Azat/0000-0003-1016-5936				Bailey S, 2007, SCIENCE, V318, P459, DOI 10.1126/science.1147353; Bailey S, 2007, NUCLEIC ACIDS RES, V35, P4728, DOI 10.1093/nar/gkm507; Barcena M, 1998, J MOL BIOL, V283, P809, DOI 10.1006/jmbi.1998.2128; Bird LE, 2000, BIOCHEMISTRY-US, V39, P171, DOI 10.1021/bi9918801; Biswas EE, 1999, BIOCHEMISTRY-US, V38, P10919, DOI 10.1021/bi990048t; BISWAS SB, 1994, BIOCHEMISTRY-US, V33, P11307, DOI 10.1021/bi00203a028; Biswas T, 2008, FEBS J, V275, P3064, DOI 10.1111/j.1742-4658.2008.06460.x; Brunger AT, 1998, ACTA CRYSTALLOGR D, V54, P905, DOI 10.1107/S0907444998003254; Cadman CJ, 2004, NUCLEIC ACIDS RES, V32, P6378, DOI 10.1093/nar/gkh980; DeLano WL, 2002, PYMOL USERS MANUAL; Donate LE, 2000, J MOL BIOL, V303, P383, DOI 10.1006/jmbi.2000.4132; EGELMAN EH, 1995, P NATL ACAD SCI USA, V92, P3869, DOI 10.1073/pnas.92.9.3869; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; FREY J, 1984, J MOL BIOL, V179, P171, DOI 10.1016/0022-2836(84)90464-9; Hall MC, 1999, MOL MICROBIOL, V34, P867, DOI 10.1046/j.1365-2958.1999.01659.x; KABSCH W, 1993, J APPL CRYSTALLOGR, V26, P795, DOI 10.1107/S0021889893005588; Kim SS, 1996, CELL, V84, P643, DOI 10.1016/S0092-8674(00)81039-9; Kleywegt GJ, 1996, STRUCTURE, V4, P897, DOI 10.1016/S0969-2126(96)00097-4; LANKA E, 1983, NUCLEIC ACIDS RES, V11, P987, DOI 10.1093/nar/11.4.987; LEBOWITZ JH, 1986, J BIOL CHEM, V261, P4738; Lu YB, 1996, P NATL ACAD SCI USA, V93, P12902, DOI 10.1073/pnas.93.23.12902; Manna AC, 1996, CELL, V87, P881, DOI 10.1016/S0092-8674(00)81995-9; Mitkova AV, 2003, J BIOL CHEM, V278, P52253, DOI 10.1074/jbc.M308956200; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nitharwal RG, 2007, NUCLEIC ACIDS RES, V35, P2861, DOI 10.1093/nar/gkm167; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Rain JC, 2001, NATURE, V409, P211, DOI 10.1038/35051615; Read RJ, 2001, ACTA CRYSTALLOGR D, V57, P1373, DOI 10.1107/S0907444901012471; Romano M, 2006, NAT CLIN PRACT GASTR, V3, P622, DOI 10.1038/ncpgasthep0634; Scherzinger E, 1997, J BIOL CHEM, V272, P30228, DOI 10.1074/jbc.272.48.30228; Sharma A, 2009, FEBS J, V276, P519, DOI 10.1111/j.1742-4658.2008.06799.x; Soni RK, 2005, BIOCHEM J, V389, P541, DOI 10.1042/BJ20050062; Soni RK, 2003, NUCLEIC ACIDS RES, V31, P6828, DOI 10.1093/nar/gkg895; Su XC, 2006, FEBS J, V273, P4997, DOI 10.1111/j.1742-4658.2006.05495.x; Thirlway J, 2004, NUCLEIC ACIDS RES, V32, P2977, DOI 10.1093/nar/gkh628; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Tomb JF, 1997, NATURE, V388, P539, DOI 10.1038/41483; Wang G, 2008, NAT STRUCT MOL BIOL, V15, P94, DOI 10.1038/nsmb1356; WICKNER S, 1975, P NATL ACAD SCI USA, V72, P921, DOI 10.1073/pnas.72.3.921	39	27	27	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7515	10.1371/journal.pone.0007515	http://dx.doi.org/10.1371/journal.pone.0007515			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841750	Green Published, Green Submitted, gold			2022-12-27	WOS:000271012900013
J	Shen, T; Kuang, YH; Ashby, CR; Lei, Y; Chen, A; Zhou, Y; Chen, X; Tiwari, AK; Hopper-Borge, E; Ouyang, JY; Chen, ZS				Shen, Tong; Kuang, Ye-Hong; Ashby, Charles R., Jr.; Lei, Yu; Chen, Angel; Zhou, Ying; Chen, Xiang; Tiwari, Amit K.; Hopper-Borge, Elizabeth; Ouyang, Jiangyong; Chen, Zhe-Sheng			Imatinib and Nilotinib Reverse Multidrug Resistance in Cancer Cells by Inhibiting the Efflux Activity of the MRP7 (ABCC10)	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; SUBFAMILY-B MEMBER-1; DRUG-RESISTANCE; PROTEIN-7 ABCC10; KINASE INHIBITOR; BINDING; TRANSPORTERS; MUTATIONS; DOCETAXEL; LINES	Background: One of the major mechanisms that could produce resistance to antineoplastic drugs in cancer cells is the ATP binding cassette (ABC) transporters. The ABC transporters can significantly decrease the intracellular concentration of antineoplastic drugs by increasing their efflux, thereby lowering the cytotoxic activity of antineoplastic drugs. One of these transporters, the multiple resistant protein 7 (MRP7, ABCC10), has recently been shown to produce resistance to antineoplastic drugs by increasing the efflux of paclitaxel. In this study, we examined the effects of BCR-Abl tyrosine kinase inhibitors imatinib, nilotinib and dasatinib on the activity and expression of MRP7 in HEK293 cells transfected with MRP7, designated HEK-MRP7-2. Methodology and/or Principal Findings: We report for the first time that imatinib and nilotinib reversed MRP7-mediated multidrug resistance. Our MTT assay results indicated that MRP7 expression in HEK-MRP7-2 cells was not significantly altered by incubation with 5 mu M of imatinib or nilotinib for up to 72 hours. In addition, imatinib and nilotinib (1-5 mu M) produced a significant concentration-dependent reversal of MRP7-mediated multidrug resistance by enhancing the sensitivity of HEK-MRP7-2 cells to paclitaxel and vincristine. Imatinib and nilotinib, at 5 mu M, significantly increased the accumulation of [(3)H]-paclitaxel in HEK-MRP7-2 cells. The incubation of the HEK-MRP7-2 cells with imatinib or nilotinib (5 mu M) also significantly inhibited the efflux of paclitaxel. Conclusions: Imatinib and nilotinib reverse MRP7-mediated paclitaxel resistance, most likely due to their inhibition of the efflux of paclitaxel via MRP7. These findings suggest that imatinib or nilotinib, in combination with other antineoplastic drugs, may be useful in the treatment of certain resistant cancers.			Shen, T (corresponding author), St Johns Univ, Coll Pharm & Allied Hlth Profess, Dept Pharmaceut Sci, Queens, NY USA.	Chenz@stjohns.edu	Shen, Tong/C-8853-2012; Tiwari, Amit/A-3667-2012	Tiwari, Amit/0000-0002-7427-7155; Tiwari, Amit/0000-0002-0275-0724; Chen, Zhe-Sheng/0000-0002-8289-097X				AKIYAMA SI, 1985, SOMAT CELL MOLEC GEN, V11, P117, DOI 10.1007/BF01534700; Borges-Walmsley MI, 2003, BIOCHEM J, V376, P313, DOI 10.1042/BJ20020957; Bradbury PA, 2004, ANTI-CANCER DRUG, V15, P421, DOI 10.1097/01.cad.0000127665.74096.93; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Couture L, 2006, PHARMACOL REV, V58, P244, DOI 10.1124/pr.58.2.7; Dai CL, 2008, CANCER RES, V68, P7905, DOI 10.1158/0008-5472.CAN-08-0499; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Deeley RG, 2006, PHYSIOL REV, V86, P849, DOI 10.1152/physrev.00035.2005; Gora-Tybor J, 2008, CURR MED CHEM, V15, P3036, DOI 10.2174/092986708786848578; Hirota S, 1998, SCIENCE, V279, P577, DOI 10.1126/science.279.5350.577; Hiwase DK, 2008, CLIN CANCER RES, V14, P3881, DOI 10.1158/1078-0432.CCR-07-5095; Hopper-Borge E, 2004, CANCER RES, V64, P4927, DOI 10.1158/0008-5472.CAN-03-3111; Hopper-Borge E, 2009, CANCER RES, V69, P178, DOI 10.1158/0008-5472.CAN-08-1420; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jordanides NE, 2006, BLOOD, V108, P1370, DOI 10.1182/blood-2006-02-003145; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Mendelsohn J, 2003, J CLIN ONCOL, V21, P2787, DOI 10.1200/JCO.2003.01.504; Naramoto H, 2007, INT J ONCOL, V30, P393; Schittenhelm MM, 2006, CANCER RES, V66, P473, DOI 10.1158/0008-5472.CAN-05-2050; Shah NP, 2002, CANCER CELL, V2, P117, DOI 10.1016/S1535-6108(02)00096-X; Shi Z, 2007, CANCER RES, V67, P11012, DOI 10.1158/0008-5472.CAN-07-2686; Sumizawa T, 1997, MOL PHARMACOL, V51, P399; TANAKA C, CLIN PHARM IN PRESS; Tiwari AK, 2009, BIOCHEM PHARMACOL, V78, P153, DOI 10.1016/j.bcp.2009.04.002; Wu Chung-Pu, 2008, Curr Mol Pharmacol, V1, P93; Zhou Y, 2009, BIOCHEM PHARMACOL, V77, P993, DOI 10.1016/j.bcp.2008.12.005	26	60	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7520	10.1371/journal.pone.0007520	http://dx.doi.org/10.1371/journal.pone.0007520			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841739	Green Published, Green Submitted, gold			2022-12-27	WOS:000271012900015
J	Takeda, Y; Mishima, Y; Fujiwara, T; Sakamoto, H; Inoue, K				Takeda, Yasuaki; Mishima, Yuichiro; Fujiwara, Toshinobu; Sakamoto, Hiroshi; Inoue, Kunio			DAZL Relieves miRNA-Mediated Repression of Germline mRNAs by Controlling Poly(A) Tail Length in Zebrafish	PLOS ONE			English	Article							BINDING PROTEINS; IN-VIVO; TRANSLATION; CELLS; MICRORNAS; COMPONENT; XENOPUS; PLASM; GENE; DIFFERENTIATION	Background: During zebrafish embryogenesis, microRNA (miRNA) miR-430 contributes to restrict Nanos1 and TDRD7 to primordial germ cells (PGCs) by inducing mRNA deadenylation, mRNA degradation, and translational repression of nanos1 and tdrd7 mRNAs in somatic cells. The nanos1 and tdrd7 3'UTRs include cis-acting elements that allow activity in PGCs even in the presence of miRNA-mediated repression. Methodology/Principal Findings: Using a GFP reporter mRNA that was fused with tdrd7 3'UTR, we show that a germline-specific RNA-binding protein DAZ-like (DAZL) can relieve the miR-430-mediated repression of tdrd7 mRNA by inducing poly(A) tail elongation (polyadenylation) in zebrafish. We also show that DAZL enhances protein synthesis via the 3'UTR of dazl mRNA, another germline mRNA targeted by miR-430. Conclusions/Significance: Our present study indicated that DAZL acts as an "anti-miRNA factor'' during vertebrate germ cell development. Our data also suggested that miRNA-mediated regulation can be modulated on specific target mRNAs through the poly(A) tail control.			Takeda, Y (corresponding author), Kobe Univ, Grad Sch Sci, Dept Biol, Kobe, Hyogo 657, Japan.	kunio@kobe-u.ac.jp	Mishima, Yuichiro/I-3881-2019	Mishima, Yuichiro/0000-0002-1075-9454				Bhattacharyya SN, 2006, CELL, V125, P1111, DOI 10.1016/j.cell.2006.04.031; Collier B, 2005, EMBO J, V24, P2656, DOI 10.1038/sj.emboj.7600738; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; de Moor CH, 2005, SEMIN CELL DEV BIOL, V16, P49, DOI 10.1016/j.semcdb.2004.11.007; Flynt AS, 2008, NAT REV GENET, V9, P831, DOI 10.1038/nrg2455; Fox M, 2005, GENOMICS, V85, P92, DOI 10.1016/j.ygeno.2004.10.003; Giraldez AJ, 2006, SCIENCE, V312, P75, DOI 10.1126/science.1122689; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Hashimoto Y, 2004, DEV BIOL, V268, P152, DOI 10.1016/j.ydbio.2003.12.013; Houston DW, 2000, DEVELOPMENT, V127, P447; INOUE K, 1989, GENE DEV, V3, P1472, DOI 10.1101/gad.3.9.1472; Kedde M, 2008, CELL CYCLE, V7, P899, DOI 10.4161/cc.7.7.5644; Kedde M, 2007, CELL, V131, P1273, DOI 10.1016/j.cell.2007.11.034; Knaut H, 2000, J CELL BIOL, V149, P875, DOI 10.1083/jcb.149.4.875; Knaut H, 2002, CURR BIOL, V12, P454, DOI 10.1016/S0960-9822(02)00723-6; Koprunner M, 2001, GENE DEV, V15, P2877; Maegawa S, 2002, GENES CELLS, V7, P971, DOI 10.1046/j.1365-2443.2002.00576.x; Mishima Y, 2006, CURR BIOL, V16, P2135, DOI 10.1016/j.cub.2006.08.086; Piskounova E, 2008, J BIOL CHEM, V283, P21310, DOI 10.1074/jbc.C800108200; Reynolds N, 2005, HUM MOL GENET, V14, P3899, DOI 10.1093/hmg/ddi414; Reynolds N, 2007, RNA, V13, P974, DOI 10.1261/rna.465507; RUPP RAW, 1994, GENE DEV, V8, P1311, DOI 10.1101/gad.8.11.1311; Schwamborn JC, 2009, CELL, V136, P913, DOI 10.1016/j.cell.2008.12.024; Vasudevan S, 2006, GENE DEV, V20, P138, DOI 10.1101/gad.1398906; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; Weidinger G, 2003, CURR BIOL, V13, P1429, DOI 10.1016/S0960-9822(03)00537-2; Wilkie GS, 2003, TRENDS BIOCHEM SCI, V28, P182, DOI 10.1016/S0968-0004(03)00051-3; Wolke U, 2002, CURR BIOL, V12, P289, DOI 10.1016/S0960-9822(02)00679-6; Xu EY, 2001, P NATL ACAD SCI USA, V98, P7414, DOI 10.1073/pnas.131090498; Zeng M, 2008, BMB REP, V41, P300, DOI 10.5483/BMBRep.2008.41.4.300	31	68	72	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7513	10.1371/journal.pone.0007513	http://dx.doi.org/10.1371/journal.pone.0007513			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838299	Green Published, Green Submitted, gold			2022-12-27	WOS:000270880900014
J	Fouchet, D; Leblanc, G; Sauvage, F; Guiserix, M; Poulet, H; Pontier, D				Fouchet, David; Leblanc, Guillaume; Sauvage, Frank; Guiserix, Micheline; Poulet, Herve; Pontier, Dominique			Using Dynamic Stochastic Modelling to Estimate Population Risk Factors in Infectious Disease: The Example of FIV in 15 Cat Populations	PLOS ONE			English	Article							FELINE IMMUNODEFICIENCY VIRUS; DOMESTIC CATS; TRANSMISSION; SELECTION; EPIDEMICS; INFLUENZA; INFERENCE; OUTBREAK	Background: In natural cat populations, Feline Immunodeficiency Virus (FIV) is transmitted through bites between individuals. Factors such as the density of cats within the population or the sex-ratio can have potentially strong effects on the frequency of fight between individuals and hence appear as important population risk factors for FIV. Methodology/Principal Findings: To study such population risk factors, we present data on FIV prevalence in 15 cat populations in northeastern France. We investigate five key social factors of cat populations; the density of cats, the sex-ratio, the number of males and the mean age of males and females within the population. We overcome the problem of dependence in the infective status data using sexually-structured dynamic stochastic models. Only the age of males and females had an effect (p = 0.043 and p = 0.02, respectively) on the male-to-female transmission rate. Due to multiple tests, it is even likely that these effects are, in reality, not significant. Finally we show that, in our study area, the data can be explained by a very simple model that does not invoke any risk factor. Conclusion: Our conclusion is that, in host-parasite systems in general, fluctuations due to stochasticity in the transmission process are naturally very large and may alone explain a larger part of the variability in observed disease prevalence between populations than previously expected. Finally, we determined confidence intervals for the simple model parameters that can be used to further aid in management of the disease.			Fouchet, D (corresponding author), Univ Lyon, Lyon, France.	fouchet@biomserv.univ-lyon1.fr		Pontier, Dominique/0000-0003-4700-3543				Bahi-Jaber N, 2008, J R SOC INTERFACE, V5, P1031, DOI 10.1098/rsif.2007.1326; BEGON M, 1999, P ROY SOC LOND B BIO, V266, P1339; BENDINELLI M, 1995, CLIN MICROBIOL REV, V8, P87, DOI 10.1128/CMR.8.1.87; CALLANAN JJ, 1991, VET REC, V128, P332, DOI 10.1136/vr.128.14.332; Cauchemez S, 2004, STAT MED, V23, P3469, DOI 10.1002/sim.1912; Clancy D, 2007, SCAND J STAT, V34, P259, DOI 10.1111/j.1467-9469.2006.00522.x; Cooper B, 2004, BIOSTATISTICS, V5, P223, DOI 10.1093/biostatistics/5.2.223; Cooper BS, 2008, AM J EPIDEMIOL, V168, P548, DOI 10.1093/aje/kwn176; COURCHAMP F, 1994, CR ACAD SCI III-VIE, V317, P1123; Courchamp F, 2000, WILDLIFE RES, V27, P603, DOI 10.1071/WR99049; Courchamp F, 1998, EPIDEMIOL INFECT, V121, P227, DOI 10.1017/S0950268898008875; De Jong M., 1995, EPIDEMIC MODELS THEI, P84; Eisenberg JNS, 2003, EPIDEMIOLOGY, V14, P442, DOI 10.1097/01.ede.0000071411.19255.4c; ENGELMAN C, 1972, P ACM ANN C ACM NEW, V2; Ferguson NM, 2003, NATURE, V425, P681, DOI 10.1038/nature02007; Fraser C, 2004, P NATL ACAD SCI USA, V101, P6146, DOI 10.1073/pnas.0307506101; Gibson GJ, 2004, P NATL ACAD SCI USA, V101, P12120, DOI 10.1073/pnas.0400829101; JACQUEZ JA, 1993, MATH BIOSCI, V117, P77, DOI 10.1016/0025-5564(93)90018-6; Kanzaki LIB, 2004, FRONT BIOSCI-LANDMRK, V9, P370, DOI 10.2741/1235; Krebs JR, 2002, NATURE, V415, P115, DOI 10.1038/415115a; Lipsitch M, 2003, SCIENCE, V300, P1966, DOI 10.1126/science.1086616; LUTZ H, 1988, J VET MED B, V35, P773, DOI 10.1111/j.1439-0450.1988.tb00559.x; MATTEUCCI D, 1993, J CLIN MICROBIOL, V31, P494, DOI 10.1128/JCM.31.3.494-501.1993; Natoli E, 2005, NEUROSCI BIOBEHAV R, V29, P151, DOI 10.1016/j.neubiorev.2004.06.011; Neal PJ, 2004, BIOSTATISTICS, V5, P249, DOI 10.1093/biostatistics/5.2.249; O'Neill PD, 2000, J ROY STAT SOC C-APP, V49, P517, DOI 10.1111/1467-9876.00210; O'Neill PD, 2005, STAT MED, V24, P2011, DOI 10.1002/sim.2090; Ostrowski S, 2003, J WILDLIFE DIS, V39, P696, DOI 10.7589/0090-3558-39.3.696; Ovaskainen O, 2001, J APPL PROBAB, V38, P898, DOI 10.1017/S0021900200019112; PASCAL M, 1978, TERRE VIE-REV ECOL A, V32, P529; PEDERSEN NC, 1989, VET IMMUNOL IMMUNOP, V21, P111, DOI 10.1016/0165-2427(89)90134-7; Pontier D, 1998, P ROY SOC B-BIOL SCI, V265, P167, DOI 10.1098/rspb.1998.0278; SPARGER EE, 1993, VET CLIN N AM-SMALL, V23, P173, DOI 10.1016/S0195-5616(93)50011-6; Stone P, 2008, J MATH BIOL, V56, P743, DOI 10.1007/s00285-007-0136-0; Troyer JL, 2005, J VIROL, V79, P8282, DOI 10.1128/JVI.79.13.8282-8294.2005; UELAND K, 1992, VET IMMUNOL IMMUNOP, V33, P301, DOI 10.1016/0165-2427(92)90002-8; XEMAR V, 1997, THESIS ECOLE NATL VE, P184; YAMAMOTO JK, 1989, J AM VET MED ASSOC, V194, P213; Yang Y, 2007, EMERG INFECT DIS, V13, P1348, DOI 10.3201/eid1309.070111	39	6	6	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7377	10.1371/journal.pone.0007377	http://dx.doi.org/10.1371/journal.pone.0007377			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19888418	Green Submitted, Green Published, gold			2022-12-27	WOS:000270880700003
J	Li, YP; Reznichenko, M; Tribe, RM; Hess, PE; Taggart, M; Kim, H; DeGnore, JP; Gangopadhyay, S; Morgan, KG				Li, Yunping; Reznichenko, Maya; Tribe, Rachel M.; Hess, Philip E.; Taggart, Michael; Kim, HakRim; DeGnore, Jon P.; Gangopadhyay, Samudra; Morgan, Kathleen G.			Stretch Activates Human Myometrium via ERK, Caldesmon and Focal Adhesion Signaling	PLOS ONE			English	Article							SMOOTH-MUSCLE; CELL-MIGRATION; RAT MYOMETRIUM; ALPHA-ACTININ; PHOSPHORYLATION; PROTEIN; KINASE; LABOR; CONTRACTILITY; EXPRESSION	An incomplete understanding of the molecular mechanisms responsible for myometrial activation from the quiescent pregnant state to the active contractile state during labor has hindered the development of effective therapies for preterm labor. Myometrial stretch has been implicated clinically in the initiation of labor and the etiology of preterm labor, but the molecular mechanisms involved in the human have not been determined. We investigated the mechanisms by which gestation-dependent stretch contributes to myometrial activation, by using human uterine samples from gynecologic hysterectomies and Cesarean sections. Here we demonstrate that the Ca requirement for activation of the contractile filaments in human myometrium increases with caldesmon protein content during gestation and that an increase in caldesmon phosphorylation can reverse this inhibitory effect during labor. By using phosphotyrosine screening and mass spectrometry of stretched human myometrial samples, we identify 3 stretch-activated focal adhesion proteins, FAK, p130Cas, and alpha actinin. FAK-Y397, which signals integrin engagement, is constitutively phosphorylated in term human myometrium whereas FAK-Y925, which signals downstream ERK activation, is phosphorylated during stretch. We have recently identified smooth muscle Archvillin (SmAV) as an ERK regulator. A newly produced SmAV-specific antibody demonstrates gestation-specific increases in SmAV protein levels and stretch-specific increases in SmAV association with focal adhesion proteins. Thus, whereas increases in caldesmon levels suppress human myometrium contractility during pregnancy, stretch-dependent focal adhesion signaling, facilitated by the ERK activator SmAV, can contribute to myometrial activation. These results suggest that focal adhesion proteins may present new targets for drug discovery programs aimed at regulation of uterine contractility.			Li, YP (corresponding author), Harvard Univ, Beth Israel Deaconess Med Ctr, Sch Med, Dept Anesthesia Crit Care & Pain Med, Boston, MA 02215 USA.	yli1@bidmc.harvard.edu	Taggart, Michael/A-1288-2012; Hess, Philip/A-8577-2013	Hess, Philip/0000-0002-1206-0102; Tribe, Rachel/0000-0003-3675-9978; Taggart, Michael/0000-0002-9981-2783; Morgan, Kathleen/0000-0003-3300-3630	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD043054] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL086655, R01HL080003] Funding Source: NIH RePORTER; NHLBI NIH HHS [P01 HL086655, HL86655, R01 HL080003, HL80003] Funding Source: Medline; NICHD NIH HHS [R01 HD043054, HD043054] Funding Source: Medline; Wellcome Trust Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); Wellcome Trust(Wellcome TrustEuropean Commission)		AFTING EG, 1979, BIOCHEM J, V177, P99, DOI 10.1042/bj1770099; Bershadsky A, 2006, CURR OPIN CELL BIOL, V18, P472, DOI 10.1016/j.ceb.2006.08.012; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Calderwood DA, 2001, NAT CELL BIOL, V3, P1060, DOI 10.1038/ncb1201-1060; Craig DH, 2007, AM J PHYSIOL-CELL PH, V293, pC1862, DOI 10.1152/ajpcell.00118.2007; Cunningham FG, 2005, WILLIAMS OBSTET; D'Angelo G, 1999, J BIOL CHEM, V274, P30115, DOI 10.1074/jbc.274.42.30115; Gangopadhyay SS, 2009, J BIOL CHEM, V284, P17607, DOI 10.1074/jbc.M109.002386; Gangopadhyay SS, 2004, J CELL SCI, V117, P5043, DOI 10.1242/jcs.01378; Gerthoffer WT, 2001, J APPL PHYSIOL, V91, P963, DOI 10.1152/jappl.2001.91.2.963; Goel HL, 2002, CELL BIOL INT, V26, P557, DOI 10.1006/cbir.2002.0878; Huang RJ, 2003, BIOCHEMISTRY-US, V42, P2513, DOI 10.1021/bi0268605; HURD WW, 2008, AM J OBSTET GYNECOL, V198; Kwong L, 2003, MOL CELL BIOL, V23, P933, DOI 10.1128/MCB.23.3.933-949.2003; LAPORTE R, 1998, AM J OBSTET GYNECOL, V180, pS133; Li YP, 2004, AM J PHYSIOL-REG I, V287, pR328, DOI 10.1152/ajpregu.00042.2004; Li YP, 2003, AM J PHYSIOL-REG I, V284, pR192, DOI 10.1152/ajpregu.00290.2002; Li YP, 2007, J CELL BIOCHEM, V100, P129, DOI 10.1002/jcb.21033; Longhurst CM, 1998, CELL MOL LIFE SCI, V54, P514, DOI 10.1007/s000180050180; Macphee DJ, 2000, ENDOCRINOLOGY, V141, P274, DOI 10.1210/en.141.1.274; Morgan KG, 2001, J APPL PHYSIOL, V91, P953, DOI 10.1152/jappl.2001.91.2.953; Oldenhof AD, 2002, AM J PHYSIOL-CELL PH, V283, pC1530, DOI 10.1152/ajpcell.00607.2001; Riley M, 2005, J CELL MOL MED, V9, P122, DOI 10.1111/j.1582-4934.2005.tb00342.x; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Sharma CP, 2004, CELL BIOL INT, V28, P935, DOI 10.1016/j.cellbi.2004.09.006; Shynlova O, 2007, REPRODUCTION, V134, P503, DOI 10.1530/REP-07-0004; Sooranna SR, 2005, J CLIN ENDOCR METAB, V90, P3517, DOI 10.1210/jc.2004-1390; Taggart MJ, 2007, SEMIN CELL DEV BIOL, V18, P296, DOI 10.1016/j.semcdb.2007.05.006; Takizawa N, 2006, J CELL BIOL, V174, P447, DOI 10.1083/jcb.200512051; Triplett JW, 2006, AM J PHYSIOL-CELL PH, V291, pC909, DOI 10.1152/ajpcell.00113.2006; WORD RA, 1993, J CLIN INVEST, V92, P29, DOI 10.1172/JCI116564; Wu X, 2008, J CELL MOL MED, V12, P1360, DOI 10.1111/j.1582-4934.2008.00306.x; YATES JR, 1995, ANAL CHEM, V67, P1426, DOI 10.1021/ac00104a020; Zhang ZY, 2006, J BIOL CHEM, V281, P1746, DOI 10.1074/jbc.M509590200	34	38	39	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7489	10.1371/journal.pone.0007489	http://dx.doi.org/10.1371/journal.pone.0007489			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834610	Green Published, Green Submitted, gold			2022-12-27	WOS:000270880700013
J	Williams, DJ; Puhl, HL; Ikeda, SR				Williams, Damian J.; Puhl, Henry L., III; Ikeda, Stephen R.			Rapid Modification of Proteins Using a Rapamycin-Inducible Tobacco Etch Virus Protease System	PLOS ONE			English	Article							TEV PROTEASE; SUBSTRATE-SPECIFICITY; FLUORESCENT PROTEIN; FRET EFFICIENCY; COMPLEMENTATION; SOLUBILITY; VARIANT; FAMILY; GENE; SITE	Background: The ability to disrupt the function of a specific protein on a rapid time scale provides a powerful tool for biomedical research. Specific proteases provide a potential method to selectively cleave a chosen protein, but rapid control of protease activity is difficult. Methodology/Principal Findings: A heterologous expression system for rapid target-directed proteolysis in mammalian cells was developed. The system consists of an inducible NIa protease from the tobacco etch virus (TEVp) and a chosen protein into which a TEVp substrate recognition sequence (TRS) has been inserted. Inducible activity was conferred to the TEVp using rapamycin-controlled TEVp fragment complementation. TEVp activity was assayed using a FRET-based reporter construct. TEVp expression was well tolerated by mammalian cells and complete cleavage of the substrate was possible. Cleavage at 37 degrees C proceeded exponentially with a time constant of approximately 150 minutes. Attempts to improve cleavage efficiency were hampered by substantial background activity, which was attributed to inherent affinity between the TEVp fragments. A second TEVp assay, based on changes in inactivation of a modified K(V)3.4 channel, showed that functional properties of a channel can be using altered using an inducible TEVp system. Similar levels of background activity and variability were observed in both electrophysiological and FRET assays. Conclusions/Significance: The results suggested that an optimum level of TEVp expression leading to sufficient inducible activity (with minimal background activity) exists but the variability in expression levels between cells makes the present system rather impractical for single cell experiments. The system is likely to be more suitable for experiments in which the cell-to-cell variability is less of an issue; for example, in experiments involving large populations of cells.			Williams, DJ (corresponding author), NIAAA, Lab Mol Physiol, NIH, Bethesda, MD USA.	sikeda@mail.nih.gov		Williams, Damian/0000-0001-5891-6300; Ikeda, Stephen/0000-0002-4088-9508; Puhl, Henry/0000-0003-3095-7201	Intramural NIH HHS Funding Source: Medline; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM [ZIAAA000430] Funding Source: NIH RePORTER	Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA))		Cabrita LD, 2007, PROTEIN SCI, V16, P2360, DOI 10.1110/ps.072822507; CARRINGTON JC, 1987, J VIROL, V61, P2540, DOI 10.1128/JVI.61.8.2540-2548.1987; Chen H, 2006, BIOPHYS J, V91, pL39, DOI 10.1529/biophysj.106.088773; Chen HM, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2799171; Cumming G, 2007, J CELL BIOL, V177, P7, DOI 10.1083/jcb.200611141; DOUGHERTY WG, 1989, VIROLOGY, V171, P356, DOI 10.1016/0042-6822(89)90603-X; Erickson MG, 2001, NEURON, V31, P973, DOI 10.1016/S0896-6273(01)00438-X; Fivaz M, 2003, NEURON, V40, P319, DOI 10.1016/S0896-6273(03)00634-2; Gordon GW, 1998, BIOPHYS J, V74, P2702, DOI 10.1016/S0006-3495(98)77976-7; HOSHI T, 1990, SCIENCE, V250, P533, DOI 10.1126/science.2122519; HUMMLER E, 1994, P NATL ACAD SCI USA, V91, P5647, DOI 10.1073/pnas.91.12.5647; JOHNSSON N, 1994, P NATL ACAD SCI USA, V91, P10340, DOI 10.1073/pnas.91.22.10340; Kapust RB, 2001, PROTEIN ENG, V14, P993, DOI 10.1093/protein/14.12.993; Kapust RB, 2002, BIOCHEM BIOPH RES CO, V294, P949, DOI 10.1016/S0006-291X(02)00574-0; Karimova G, 1998, P NATL ACAD SCI USA, V95, P5752, DOI 10.1073/pnas.95.10.5752; Koushik SV, 2006, BIOPHYS J, V91, pL99, DOI 10.1529/biophysj.106.096206; Krumins AM, 2006, J BIOL CHEM, V281, P10250, DOI 10.1074/jbc.M511551200; Lucast LJ, 2001, BIOTECHNIQUES, V30, P544, DOI 10.2144/01303st06; MACKINNON R, 1993, SCIENCE, V262, P757, DOI 10.1126/science.7694359; Michnick SW, 2007, NAT REV DRUG DISCOV, V6, P569, DOI 10.1038/nrd2311; Michnick SW, 2000, METHOD ENZYMOL, V328, P208, DOI 10.1016/S0076-6879(00)28399-7; Mondigler M, 1996, J BACTERIOL, V178, P2986, DOI 10.1128/jb.178.10.2986-2988.1996; Nagai T, 2002, NAT BIOTECHNOL, V20, P87, DOI 10.1038/nbt0102-87; Nunn CM, 2005, J MOL BIOL, V350, P145, DOI 10.1016/j.jmb.2005.04.013; PARKS TD, 1994, ANAL BIOCHEM, V216, P413, DOI 10.1006/abio.1994.1060; Paschon DE, 2005, J MOL BIOL, V353, P26, DOI 10.1016/j.jmb.2005.08.026; Pauli A, 2008, DEV CELL, V14, P239, DOI 10.1016/j.devcel.2007.12.009; Paulmurugan R, 2005, CANCER RES, V65, P7413, DOI 10.1158/0008-5472.CAN-05-0588; Paulmurugan R, 2003, ANAL CHEM, V75, P1584, DOI 10.1021/ac020731c; Paulmurugan R, 2002, P NATL ACAD SCI USA, V99, P15608, DOI 10.1073/pnas.242594299; Pelletier JN, 1998, P NATL ACAD SCI USA, V95, P12141, DOI 10.1073/pnas.95.21.12141; Phan J, 2002, J BIOL CHEM, V277, P50564, DOI 10.1074/jbc.M207224200; RICHARDS FM, 1958, P NATL ACAD SCI USA, V44, P162, DOI 10.1073/pnas.44.2.162; Rizzo MA, 2004, NAT BIOTECHNOL, V22, P445, DOI 10.1038/nbt945; Rollins CT, 2000, P NATL ACAD SCI USA, V97, P7096, DOI 10.1073/pnas.100101997; ROUTTENBERG A, 1995, NATURE, V374, P314, DOI 10.1038/374314b0; Segel I.H., 1976, BIOCH CALCULATIONS S; Thomas M, 2005, P NATL ACAD SCI USA, V102, P5679, DOI 10.1073/pnas.0502067102; Tozser J, 2005, FEBS J, V272, P514, DOI 10.1111/j.1742-4658.2004.04493.x; van den Berg S, 2006, J BIOTECHNOL, V121, P291, DOI 10.1016/j.jbiotec.2005.08.006; Wehr MC, 2006, NAT METHODS, V3, P985, DOI 10.1038/nmeth967; WEINTRAUB H, 1993, CELL, V75, P1241, DOI 10.1016/0092-8674(93)90610-3; Yang XW, 2005, BMC MOL BIOL, V6, DOI 10.1186/1471-2199-6-13; Zal T, 2004, BIOPHYS J, V86, P3923, DOI 10.1529/biophysj.103.022087; Zhu GY, 1998, J NEUROSCI METH, V81, P73, DOI 10.1016/S0165-0270(98)00019-3	45	28	28	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7474	10.1371/journal.pone.0007474	http://dx.doi.org/10.1371/journal.pone.0007474			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19830250	Green Published, gold, Green Submitted			2022-12-27	WOS:000270847800012
J	Schouest, KR; Kurasawa, Y; Furuta, T; Hisamoto, N; Matsumoto, K; Schumacher, JM				Schouest, Katherine R.; Kurasawa, Yasuhiro; Furuta, Tokiko; Hisamoto, Naoki; Matsumoto, Kunihiro; Schumacher, Jill M.			The Germinal Center Kinase GCK-1 Is a Negative Regulator of MAP Kinase Activation and Apoptosis in the C-elegans Germline	PLOS ONE			English	Article							OOCYTE MEIOTIC MATURATION; STE20 GROUP KINASES; CAENORHABDITIS-ELEGANS; PROTEIN-KINASE; HERMAPHRODITE GERMLINE; STE20-RELATED KINASE; SEX DETERMINATION; CELL-GROWTH; LET-60 RAS; PATHWAY	The germinal center kinases (GCK) constitute a large, highly conserved family of proteins that has been implicated in a wide variety of cellular processes including cell growth and proliferation, polarity, migration, and stress responses. Although diverse, these functions have been attributed to an evolutionarily conserved role for GCKs in the activation of ERK, JNK, and p38 MAP kinase pathways. In addition, multiple GCKs from different species promote apoptotic cell death. In contrast to these paradigms, we found that a C. elegans GCK, GCK-1, functions to inhibit MAP kinase activation and apoptosis in the C. elegans germline. In the absence of GCK-1, a specific MAP kinase isoform is ectopically activated and oocytes undergo abnormal development. Moreover, GCK-1-deficient animals display a significant increase in germ cell death. Our results suggest that individual germinal center kinases act in mechanistically distinct ways and that these functions are likely to depend on organ- and developmental-specific contexts.			Schouest, KR (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Genet, Houston, TX 77030 USA.	jschumac@mdanderson.org	Schumacher, Jill/B-2932-2012					Bishop JD, 2005, MOL BIOL CELL, V16, P742, DOI 10.1091/mbc.E04-08-0682; Bradham C, 2006, CELL CYCLE, V5, P824, DOI 10.4161/cc.5.8.2685; BRENNER S, 1974, GENETICS, V77, P71; Burrows AE, 2006, DEVELOPMENT, V133, P697, DOI 10.1242/dev.02241; Ceol CJ, 2006, GENETICS, V173, P709, DOI 10.1534/genetics.106.056465; Chen Z, 2001, J BIOL CHEM, V276, P16070, DOI 10.1074/jbc.M100681200; CHURCH DL, 1995, DEVELOPMENT, V121, P2525; Clifford R, 2000, DEVELOPMENT, V127, P5265; Corl AB, 2009, CELL, V137, P949, DOI 10.1016/j.cell.2009.03.020; Corrigan C, 2005, DEVELOPMENT, V132, P5225, DOI 10.1242/dev.02083; CRITTENDEN SL, 1994, DEVELOPMENT, V120, P2901; Dan I, 2002, J BIOL CHEM, V277, P5929, DOI 10.1074/jbc.M110882200; Dan I, 2001, TRENDS CELL BIOL, V11, P220, DOI 10.1016/S0962-8924(01)01980-8; de Bono M, 2002, NATURE, V419, P899, DOI 10.1038/nature01169; Eisenmann DM, 1997, GENETICS, V146, P553; Fan HY, 2004, BIOL REPROD, V70, P535, DOI 10.1095/biolreprod.103.022830; Fantz DA, 2001, J BIOL CHEM, V276, P27256, DOI 10.1074/jbc.M102512200; Ferrell JE, 1999, BIOESSAYS, V21, P833, DOI 10.1002/(SICI)1521-1878(199910)21:10<833::AID-BIES5>3.0.CO;2-P; Gartner A, 2000, MOL CELL, V5, P435, DOI 10.1016/S1097-2765(00)80438-4; Gengyo-Ando K, 2000, BIOCHEM BIOPH RES CO, V269, P64, DOI 10.1006/bbrc.2000.2260; GOLDSTEIN P, 1986, MUTAT RES, V174, P99, DOI 10.1016/0165-7992(86)90098-9; Graves JD, 1998, EMBO J, V17, P2224, DOI 10.1093/emboj/17.8.2224; Gumienny TL, 1999, DEVELOPMENT, V126, P1011; HACCARD O, 1995, DEV BIOL, V168, P677, DOI 10.1006/dbio.1995.1112; Hansen D, 2004, DEV BIOL, V268, P342, DOI 10.1016/j.ydbio.2003.12.023; Hao W, 2006, J BIOL CHEM, V281, P3075, DOI 10.1074/jbc.M511744200; Hay BA, 2003, DEV CELL, V5, P361, DOI 10.1016/S1534-5807(03)00270-3; Hipfner DR, 2003, PLOS BIOL, V1, P244, DOI 10.1371/journal.pbio.0000035; Hirai S, 1997, J BIOL CHEM, V272, P15167, DOI 10.1074/jbc.272.24.15167; HIRSH D, 1976, DEV BIOL, V49, P200, DOI 10.1016/0012-1606(76)90267-0; Hsu J., 1996, MULTIPLE COMP THEORY; Hsu JY, 2000, CELL, V102, P279, DOI 10.1016/S0092-8674(00)00034-9; Hughes SC, 2006, J CELL BIOL, V175, P305, DOI 10.1083/jcb.200608009; Hutchison M, 1998, J BIOL CHEM, V273, P28625, DOI 10.1074/jbc.273.44.28625; Kelly WG, 2002, DEVELOPMENT, V129, P479; Kosinski M, 2005, DEVELOPMENT, V132, P3357, DOI 10.1242/dev.01916; Krens SFG, 2006, FEBS LETT, V580, P4984, DOI 10.1016/j.febslet.2006.08.025; Lackner MR, 1998, GENETICS, V150, P103; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lee MH, 2006, EMBO J, V25, P88, DOI 10.1038/sj.emboj.7600901; Lee MH, 2007, GENETICS, V177, P2039, DOI 10.1534/genetics.107.081356; Lehtinen MK, 2006, CELL, V125, P987, DOI 10.1016/j.cell.2006.03.046; Lieb JD, 1998, CELL, V92, P265, DOI 10.1016/S0092-8674(00)80920-4; Lin JL, 2001, ONCOGENE, V20, P6559, DOI 10.1038/sj.onc.1204818; Ling P, 2008, CELL SIGNAL, V20, P1237, DOI 10.1016/j.cellsig.2007.12.019; MacQueen AJ, 2001, GENE DEV, V15, P1674, DOI 10.1101/gad.902601; Maller JL, 2001, BIOL CELL, V93, P27, DOI 10.1016/S0248-4900(01)01127-3; McCarter J, 1997, DEV BIOL, V181, P121, DOI 10.1006/dbio.1996.8429; McCarter J, 1999, DEV BIOL, V205, P111, DOI 10.1006/dbio.1998.9109; Meinecke B, 2003, ZYGOTE, V11, P7, DOI 10.1017/S0967199403001023; Miller MA, 2001, SCIENCE, V291, P2144, DOI 10.1126/science.1057586; Miller MA, 2003, GENE DEV, V17, P187, DOI 10.1101/gad.1028303; MINSHULL J, 1994, CELL, V79, P475, DOI 10.1016/0092-8674(94)90256-9; Nicke B, 2005, MOL CELL, V20, P673, DOI 10.1016/j.molcel.2005.10.038; O'Neill E, 2005, CELL CYCLE, V4, P365, DOI 10.4161/cc.4.3.1531; Ohmachi M, 2002, CURR BIOL, V12, P427, DOI 10.1016/S0960-9822(02)00690-5; Pombo CM, 2007, FRONT BIOSCI-LANDMRK, V12, P850, DOI 10.2741/2107; POMBO CM, 1995, NATURE, V377, P750, DOI 10.1038/377750a0; Radu M, 2009, CURR BIOL, V19, pR421, DOI 10.1016/j.cub.2009.04.022; Rogers E, 2002, J CELL BIOL, V157, P219, DOI 10.1083/jcb.200110045; Sabourin LA, 1999, ONCOGENE, V18, P7566, DOI 10.1038/sj.onc.1203119; SCHEDL T, 1988, GENETICS, V119, P43; Siegfried KR, 2004, GENETICS, V166, P171, DOI 10.1534/genetics.166.1.171; Sijen T, 2001, CELL, V107, P465, DOI 10.1016/S0092-8674(01)00576-1; Tassi E, 1999, J BIOL CHEM, V274, P33287, DOI 10.1074/jbc.274.47.33287; Timmons L, 1998, NATURE, V395, P854, DOI 10.1038/27579; van Drogen F, 2000, CURR BIOL, V10, P630, DOI 10.1016/S0960-9822(00)00511-X; VERLHAC MH, 1994, DEVELOPMENT, V120, P1017; Wallenfang MR, 2000, NATURE, V408, P89, DOI 10.1038/35040562; WU CL, 1995, J BIOL CHEM, V270, P15984, DOI 10.1074/jbc.270.27.15984	70	9	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7450	10.1371/journal.pone.0007450	http://dx.doi.org/10.1371/journal.pone.0007450			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826475	Green Published, Green Submitted, gold			2022-12-27	WOS:000270808700011
J	Flint-Garcia, SA; Buckler, ES; Tiffin, P; Ersoz, E; Springer, NM				Flint-Garcia, Sherry A.; Buckler, Edward S.; Tiffin, Peter; Ersoz, Elhan; Springer, Nathan M.			Heterosis Is Prevalent for Multiple Traits in Diverse Maize Germplasm	PLOS ONE			English	Article							GENE-EXPRESSION; INBRED LINES; HYBRID; ARABIDOPSIS; YIELD; LOCI	Background: Heterosis describes the superior phenotypes observed in hybrids relative to their inbred parents. Maize is a model system for studying heterosis due to the high levels of yield heterosis and commercial use of hybrids. Methods: The inbred lines from an association mapping panel were crossed to a common inbred line, B73, to generate nearly 300 hybrid genotypes. Heterosis was evaluated for seventeen phenotypic traits in multiple environments. The majority of hybrids exhibit better-parent heterosis in most of the hybrids measured. Correlations between the levels of heterosis for different traits were generally weak, suggesting that the genetic basis of heterosis is trait-dependent. Conclusions: The ability to predict heterosis levels using inbred phenotype or genetic distance between the parents varied for the different traits. For some traits it is possible to explain a significant proportion of the heterosis variation using linear modeling while other traits are more difficult to predict.			Flint-Garcia, SA (corresponding author), Univ Missouri, USDA, ARS, Plant Genet Res Unit, Columbia, MO 65211 USA.	sherry.flint-garcia@ars.usda.gov; springer@umn.edu	Buckler, Edward/L-7651-2019; Buckler, Edward/GPS-4932-2022; Springer, Nathan/F-2680-2013	Buckler, Edward/0000-0002-3100-371X; Springer, Nathan/0000-0002-7301-4759; Flint-Garcia, Sherry/0000-0003-4156-5318; Tiffin, Peter/0000-0003-1975-610X				Auger DL, 2005, GENETICS, V169, P389, DOI 10.1534/genetics.104.032987; Barth S, 2003, HEREDITY, V91, P36, DOI 10.1038/sj.hdy.6800276; Birchler JA, 2003, PLANT CELL, V15, P2236, DOI 10.1105/tpc.151030; Duvick DN, 2001, NAT REV GENET, V2, P69, DOI 10.1038/35047587; EAST EM, 1908, REP CONN AGR EXP STN, V1907, P419; Falconer D. S., 1996, INTRO QUANTITATIVE G; Flint-Garcia SA, 2005, PLANT J, V44, P1054, DOI 10.1111/j.1365-313X.2005.02591.x; Garcia AAF, 2008, GENETICS, V180, P1707, DOI 10.1534/genetics.107.082867; Frascaroli E, 2007, GENETICS, V176, P625, DOI 10.1534/genetics.106.064493; HAMBLIN MT, 2008, PLOSONE; Hoecker N, 2006, THEOR APPL GENET, V112, P421, DOI 10.1007/s00122-005-0139-4; Holland JB, 2002, PL BRED RE, V22, P9; Kearsey MJ, 2003, HEREDITY, V91, P456, DOI 10.1038/sj.hdy.6800306; Li LZ, 2008, GENETICS, V180, P1725, DOI 10.1534/genetics.108.091942; Lippman ZB, 2007, TRENDS GENET, V23, P60, DOI 10.1016/j.tig.2006.12.006; Liu KJ, 2003, GENETICS, V165, P2117; Melchinger AE, 1999, GENETICS AND EXPLOITATION OF HETEROSIS IN CROPS, P99; Melchinger AE, 1998, CSSA SPEC PUBL, P29; Meyer RC, 2004, PLANT PHYSIOL, V134, P1813, DOI 10.1104/pp.103.033001; MOLL RH, 1965, GENETICS, V52, P139; Riddle NC, 2008, THEOR APPL GENET, V116, P563, DOI 10.1007/s00122-007-0691-1; Semel Y, 2006, P NATL ACAD SCI USA, V103, P12981, DOI 10.1073/pnas.0604635103; SHULL G.H., 1908, J HERED, V4, P296; SORENSEN DA, 1984, J ANIM SCI, V59, P1213, DOI 10.2527/jas1984.5951213x; Springer NM, 2007, GENOME RES, V17, P264, DOI 10.1101/gr.5347007; STUBER CW, 1992, GENETICS, V132, P823; Stupar RM, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-33; Tollenaar M, 2004, CROP SCI, V44, P2086, DOI 10.2135/cropsci2004.2086; Tracy WF, 2006, PLANT BREEDING: ARNEL R HALLAUER INTERNATIONAL SYMPOSIUM, P219; Troyer AF, 2006, CROP SCI, V46, P528, DOI 10.2135/cropsci2005.0065; WILLIAMS W, 1959, NATURE, V184, P527, DOI 10.1038/184527a0	31	120	123	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7433	10.1371/journal.pone.0007433	http://dx.doi.org/10.1371/journal.pone.0007433			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823591	Green Published, gold, Green Submitted			2022-12-27	WOS:000270808300011
J	Im, HI; Nakajima, A; Gong, B; Xiong, XL; Mamiya, T; Gershon, ES; Zhuo, M; Tang, YP				Im, Heh-In; Nakajima, Akira; Gong, Bo; Xiong, Xiaoli; Mamiya, Takayoshi; Gershon, Elliot S.; Zhuo, Min; Tang, Ya-Ping			Post-Training Dephosphorylation of eEF-2 Promotes Protein Synthesis for Memory Consolidation	PLOS ONE			English	Article							LONG-TERM-POTENTIATION; SYNAPTIC PLASTICITY; TRANSLATIONAL CONTROL; MOLECULAR-MECHANISMS; RECEPTOR ACTIVATION; ALZHEIMERS-DISEASE; FEAR MEMORY; KINASE-III; HIPPOCAMPUS; ELONGATION	Memory consolidation, which converts acquired information into long-term storage, is new protein synthesis-dependent. As protein synthesis is a dynamic process that is under the control of multiple translational mechanisms, however, it is still elusive how these mechanisms are recruited in response to learning for memory consolidation. Here we found that eukaryotic elongation factor-2 (eEF-2) was dramatically dephosphorylated within 0.5-2 hr in the hippocampus and amygdala of mice following training in a fear-conditioning test, whereas genome-wide microarrays did not reveal any significant change in the expression level of the mRNAs for translational machineries or their related molecules. Moreover, blockade of NMDA receptors with MK-801 immediately following the training significantly impeded both the post-training eEF-2 dephosphorylation and memory retention. Notably, with an elegant sophisticated transgenic strategy, we demonstrated that hippocampus-specific overexpression of eEF-2 kinase, a kinase that specifically phosphorylates and hence inactivates eEF-2, significantly inhibited protein synthesis in the hippocampus, and this effects was more robust during an "ongoing'' protein synthesis process. As a result, late phase long-term potentiation (L-LTP) in the hippocampus and long-term hippocampus-dependent memory in the mice were significantly impaired, whereas short-term memory and long-term hippocampus-independent memory remained intact. These results reveal a novel translational underpinning for protein synthesis pertinent to memory consolidation in the mammalian brain.			Im, HI (corresponding author), Scripps Florida, Dept Mol Therapeut, Jupiter, FL USA.	ytang1@lsuhsc.edu	Gong, Bo/E-6820-2011; Zhuo, Min/A-2072-2008; Tang, Ya-Ping/A-1035-2011; Nakajima, Akira/I-7077-2014	Gong, Bo/0000-0001-6028-1818; Zhuo, Min/0000-0001-9062-3241; Tang, Ya-Ping/0000-0002-0445-4072	NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH066243] Funding Source: NIH RePORTER; NIMH NIH HHS [MH066243, R01 MH066243] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		Abel T, 2001, CURR OPIN NEUROBIOL, V11, P180, DOI 10.1016/S0959-4388(00)00194-X; Allison DB, 2006, NAT REV GENET, V7, P55, DOI 10.1038/nrg1749; Banko JL, 2005, J NEUROSCI, V25, P9581, DOI 10.1523/JNEUROSCI.2423-05.2005; Baubet V, 1996, NEUROSCI LETT, V219, P187, DOI 10.1016/S0304-3940(96)13209-2; Bekinschtein P, 2007, NEUROBIOL LEARN MEM, V87, P303, DOI 10.1016/j.nlm.2006.08.007; Blundell J, 2008, NEUROBIOL LEARN MEM, V90, P28, DOI 10.1016/j.nlm.2007.12.004; BOURTCHULADZE R, 1994, CELL, V79, P59, DOI 10.1016/0092-8674(94)90400-6; Browne GJ, 2002, EUR J BIOCHEM, V269, P5360, DOI 10.1046/j.1432-1033.2002.03290.x; Carroll M, 2004, J NEUROCHEM, V90, P1464, DOI 10.1111/j.1471-4159.2004.02634.x; Chen Q, 2006, P NATL ACAD SCI USA, V103, P3881, DOI 10.1073/pnas.0505407103; Chen Q, 2008, J NEUROSCI RES, V86, P1615, DOI 10.1002/jnr.21601; Cheng MF, 2008, HORM BEHAV, V53, P1, DOI 10.1016/j.yhbeh.2007.08.007; Chotiner JK, 2003, NEUROSCIENCE, V116, P743, DOI 10.1016/S0306-4522(02)00797-2; Costa-Mattioli M, 2005, NATURE, V436, P1166, DOI 10.1038/nature03897; Costa-Mattioli M, 2007, CELL, V129, P195, DOI 10.1016/j.cell.2007.01.050; Crawley JN, 2008, NEURON, V57, P809, DOI 10.1016/j.neuron.2008.03.001; D'Agata V, 2002, REV NEUROSCIENCE, V13, P209; DAVIES JM, 1992, PSYCHOANALYTIC DIALO, V2, P5, DOI DOI 10.1080/10481889209538920; DAVIS HP, 1984, PSYCHOL BULL, V96, P518, DOI 10.1037/0033-2909.96.3.518; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; Diggle TA, 1998, BIOCHEM J, V336, P525, DOI 10.1042/bj3360525; Dorovkov MV, 2002, BIOCHEMISTRY-US, V41, P13444, DOI 10.1021/bi026494p; Flint J, 1999, BRAIN, V122, P2015, DOI 10.1093/brain/122.11.2015; Flint J, 2008, NATURE, V456, P724, DOI 10.1038/nature07630; Fonseca R, 2006, NAT NEUROSCI, V9, P478, DOI 10.1038/nn1667; FREY U, 1993, SCIENCE, V260, P1661, DOI 10.1126/science.8389057; Friedman D, 2007, CLIN EEG NEUROSCI, V38, P2, DOI 10.1177/155005940703800105; Germano C, 2005, NEUROPSYCHOL REV, V15, P1, DOI 10.1007/s11065-005-3583-7; Gingras AC, 1999, ANNU REV BIOCHEM, V68, P913, DOI 10.1146/annurev.biochem.68.1.913; GOLD PE, 2007, NEUROBIOL LEARN MEM; Helmstetter FJ, 2008, NEUROBIOL LEARN MEM, V89, P324, DOI 10.1016/j.nlm.2007.09.002; Hoeffer CA, 2008, NEURON, V60, P832, DOI 10.1016/j.neuron.2008.09.037; Holahan MR, 2007, HIPPOCAMPUS, V17, P93, DOI 10.1002/hipo.20245; Kelleher RJ, 2004, CELL, V116, P467, DOI 10.1016/S0092-8674(04)00115-1; Kelly A, 2000, HIPPOCAMPUS, V10, P431, DOI 10.1002/1098-1063(2000)10:4<431::AID-HIPO9>3.0.CO;2-Z; Lazarov O, 2005, CELL, V120, P701, DOI 10.1016/j.cell.2005.01.015; LeDoux JE, 2000, ANNU REV NEUROSCI, V23, P155, DOI 10.1146/annurev.neuro.23.1.155; Lombroso P, 2009, J AM ACAD CHILD PSY, V48, P5, DOI 10.1097/CHI.0b013e318190c4b3; Luft AR, 2004, J NEUROSCI, V24, P6515, DOI 10.1523/JNEUROSCI.1034-04.2004; Mayes AR, 2001, PHILOS T ROY SOC B, V356, P1395, DOI 10.1098/rstb.2001.0941; McDonald RJ, 2005, EUR J NEUROSCI, V22, P1201, DOI 10.1111/j.1460-9568.2005.04272.x; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Millecamps S, 2004, METHOD CELL BIOL, V78, P555; MITSUI K, 1993, J BIOL CHEM, V268, P13422; MIYASHITA T, 2007, NEUROBIOL LEARN MEM; NAIRN AC, 1985, P NATL ACAD SCI USA, V82, P7939, DOI 10.1073/pnas.82.23.7939; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Quevedo J, 2004, BEHAV BRAIN RES, V154, P339, DOI 10.1016/j.bbr.2004.03.001; Raught B, 2001, P NATL ACAD SCI USA, V98, P7037, DOI 10.1073/pnas.121145898; Reijmers LG, 2007, SCIENCE, V317, P1230, DOI 10.1126/science.1143839; Richardson JTE, 2007, CORTEX, V43, P635, DOI 10.1016/S0010-9452(08)70493-3; Richter JD, 2005, NATURE, V433, P477, DOI 10.1038/nature03205; RYAZANOV AG, 1988, NATURE, V334, P170, DOI 10.1038/334170a0; RYAZANOV AG, 1993, TRANSLATIONAL REGULA, P295; Santini E, 2001, J NEUROSCI, V21, P9009, DOI 10.1523/JNEUROSCI.21-22-09009.2001; Schafe GE, 2000, J NEUROSCI, V20, part. no., DOI 10.1523/JNEUROSCI.20-18-j0003.2000; Schaim SS, 2003, CURR BIOL, V13, P797, DOI 10.1016/S0960-9822(03)00329-4; Scheetz AJ, 2000, NAT NEUROSCI, V3, P211, DOI 10.1038/72915; Scheetz AJ, 1997, P NATL ACAD SCI USA, V94, P14770, DOI 10.1073/pnas.94.26.14770; Shimizu E, 2000, SCIENCE, V290, P1170, DOI 10.1126/science.290.5494.1170; Steward O, 1997, NEURON, V18, P9, DOI 10.1016/S0896-6273(01)80041-6; Sutton MA, 2007, NEURON, V55, P648, DOI 10.1016/j.neuron.2007.07.030; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Vecsey CG, 2007, J NEUROSCI, V27, P6128, DOI 10.1523/JNEUROSCI.0296-07.2007; Vendrell M, 1998, MOL BRAIN RES, V63, P25, DOI 10.1016/S0169-328X(98)00248-4; Wanisch K, 2005, BEHAV BRAIN RES, V157, P63, DOI 10.1016/j.bbr.2004.06.009; Winder DG, 1998, CELL, V92, P25, DOI 10.1016/S0092-8674(00)80896-X; Zhao MG, 2005, NEURON, V47, P859, DOI 10.1016/j.neuron.2005.08.014	68	29	30	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7424	10.1371/journal.pone.0007424	http://dx.doi.org/10.1371/journal.pone.0007424			17	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	506WQ	19823585	Green Published, Green Submitted, gold			2022-12-27	WOS:000270808300007
J	Erickson, GM; Rauhut, OWM; Zhou, ZH; Turner, AH; Inouye, BD; Hu, DY; Norell, MA				Erickson, Gregory M.; Rauhut, Oliver W. M.; Zhou, Zhonghe; Turner, Alan H.; Inouye, Brian D.; Hu, Dongyu; Norell, Mark A.			Was Dinosaurian Physiology Inherited by Birds? Reconciling Slow Growth in Archaeopteryx	PLOS ONE			English	Article							PERIOSTEAL BONE; EVOLUTION; PATTERNS; FLIGHT; SIZE; ORIGIN; RATES	Background: Archaeopteryx is the oldest and most primitive known bird (Avialae). It is believed that the growth and energetic physiology of basalmost birds such as Archaeopteryx were inherited in their entirety from non-avialan dinosaurs. This hypothesis predicts that the long bones in these birds formed using rapidly growing, well-vascularized woven tissue typical of non-avialan dinosaurs. Methodology/Principal Findings: We report that Archaeopteryx long bones are composed of nearly avascular parallel-fibered bone. This is among the slowest growing osseous tissues and is common in ectothermic reptiles. These findings dispute the hypothesis that non-avialan dinosaur growth and physiology were inherited in totality by the first birds. Examining these findings in a phylogenetic context required intensive sampling of outgroup dinosaurs and basalmost birds. Our results demonstrate the presence of a scale-dependent maniraptoran histological continuum that Archaeopteryx and other basalmost birds follow. Growth analysis for Archaeopteryx suggests that these animals showed exponential growth rates like non-avialan dinosaurs, three times slower than living precocial birds, but still within the lowermost range for all endothermic vertebrates. Conclusions/Significance: The unexpected histology of Archaeopteryx and other basalmost birds is actually consistent with retention of the phylogenetically earlier paravian dinosaur condition when size is considered. The first birds were simply feathered dinosaurs with respect to growth and energetic physiology. The evolution of the novel pattern in modern forms occurred later in the group's history.			Erickson, GM (corresponding author), Florida State Univ, Dept Biol Sci, B-157, Tallahassee, FL 32306 USA.	gerickson@bio.fsu.edu	Rauhut, Oliver/AAG-1029-2020	Rauhut, Oliver/0000-0003-3958-603X				ALEXANDER RM, 1983, J ZOOL, V200, P215; Bakker R. T., 1986, DINOSAUR HERESIES NE, P481; BLUEWEISS L, 1978, OECOLOGIA, V37, P257, DOI 10.1007/BF00344996; Boarman William I., 1999, Birds of North America, V476, P1; Calder WA., 1984, SIZE FUNCTION LIFE H; Cambra-Moo O, 2006, CR PALEVOL, V5, P685, DOI 10.1016/j.crpv.2005.12.018; CASE TJ, 1978, Q REV BIOL, V53, P243, DOI 10.1086/410622; Castanet J, 2000, CR ACAD SCI III-VIE, V323, P543, DOI 10.1016/S0764-4469(00)00181-5; Castanet J, 1996, CR ACAD SCI III-VIE, V319, P301; Chatterjee S, 2003, NATURWISSENSCHAFTEN, V90, P27, DOI 10.1007/s00114-002-0385-0; Chiappe L. M., 2002, MESOZOIC BIRDS HEADS; Chiappe L.M., 2007, GLORIFIED DINOSAURS; CHIAPPE LM, 1995, NATURE, V378, P349, DOI 10.1038/378349a0; Chiappe Luis M, 2008, Biol Lett, V4, P719, DOI 10.1098/rsbl.2008.0409; Chinsamy A, 2001, NATURE, V412, P402, DOI 10.1038/35086650; Chinsamy A., 2005, MICROSTRUCTURE DINOS; Chinsamy A, 2004, DINOSAURIA, 2ND EDITION, P643; Chinsamy Anusuya, 2002, P421; Clarke JA, 2006, J ANAT, V208, P287, DOI 10.1111/j.1469-7580.2006.00534.x; De Ricqles AJ, 2003, J VERTEBR PALEONTOL, V23, P373, DOI 10.1671/0272-4634(2003)023[0373:OOCSTA]2.0.CO;2; Enlow D. E., 1958, Texas Journal of Science, V10, P187; Enlow D. H., 1956, Texas Journal of Science, V8, P405; Enlow D. H., 1969, pUnpaginated; Enlow D. H., 1957, Texas Journal of Science, V9, P186; Erickson GM, 2004, NATURE, V430, P772, DOI 10.1038/nature02699; Erickson GM, 2005, TRENDS ECOL EVOL, V20, P677, DOI 10.1016/j.tree.2005.08.012; Erickson GM, 2000, ZOOL J LINN SOC-LOND, V130, P551, DOI 10.1006/zjls.2000.0243; Erickson GM, 2001, NATURE, V412, P429, DOI 10.1038/35086558; Erickson GM, 2009, ANAT REC, V292, P1514, DOI 10.1002/ar.20992; Foote J. S., 1916, Washington DC Smithsonian Institution Cont Knowl, V35; Francillon-Vieillot H., 1990, P471; Gauthier J, 2001, NEW PERSPECTIVES ON THE ORIGIN AND EARLY EVOLUTION OF BIRDS, P7; GILL FB, 2007, ORNITHOLOGY; Goloboff P.A., 2003, TREE ANAL USING NEW; HOUCK MA, 1990, SCIENCE, V247, P195, DOI 10.1126/science.247.4939.195; Klevezal G., 1996, RECORDING STRUCTURES; Lunn DJ, 2000, STAT COMPUT, V10, P325, DOI 10.1023/A:1008929526011; Makovicky PJ, 2005, NATURE, V437, P1007, DOI 10.1038/nature03996; McLennan JA, 2004, NEW ZEAL J ECOL, V28, P241; McNab BK, 1996, AUK, V113, P687, DOI 10.2307/4088996; Padian K, 2004, J VERTEBR PALEONTOL, V24, P555, DOI 10.1671/0272-4634(2004)024[0555:GISDAP]2.0.CO;2; Padian K, 1998, BIOL REV, V73, P1, DOI 10.1111/j.1469-185X.1997.tb00024.x; Padian K, 2001, NATURE, V412, P405, DOI 10.1038/35086500; Padian K, 2004, DINOSAURIA, 2ND EDITION, P660; RICKLEFS RE, 1973, IBIS, V115, P177, DOI 10.1111/j.1474-919X.1973.tb02636.x; RUBEN J, 1991, EVOLUTION, V45, P1, DOI 10.1111/j.1558-5646.1991.tb05261.x; Sander P.M., 2003, PALAEONTOL Z, V77, P161, DOI DOI 10.1007/BF03004566; Senter P, 2003, J VERTEBR PALEONTOL, V23, P961, DOI 10.1671/22; Senter P, 2006, ACTA PALAEONTOL POL, V51, P305; Turner AH, 2007, SCIENCE, V317, P1378, DOI 10.1126/science.1144066; Wellnhofer P., 2008, ARCHAEOPTERYX; WELLS JW, 1963, NATURE, V197, P948, DOI 10.1038/197948a0; YALDEN DW, 1971, BIOL REV, V113, P349; Zhang Fucheng, 1998, Vertebrata Palasiatica, V36, P126; Zhou ZH, 2003, CAN J EARTH SCI, V40, P731, DOI 10.1139/E03-011; Zhou ZH, 2002, NATURE, V418, P405, DOI 10.1038/nature00930	56	124	129	0	69	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7390	10.1371/journal.pone.0007390	http://dx.doi.org/10.1371/journal.pone.0007390			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816582	Green Published, gold, Green Submitted			2022-12-27	WOS:000270594300010
J	Yang, OO				Yang, Otto O.			Candidate Vaccine Sequences to Represent Intra- and Inter-Clade HIV-1 Variation	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; T-CELL RESPONSES; CRYSTAL-STRUCTURE; INFECTION; LYMPHOCYTES; DEPLETION; ESCAPE; CLEARANCE; SELECTION; EFFICACY	A likely key factor in the failure of a HIV-1 vaccine based on cytotoxic T lymphocytes (CTL) is the natural immunodominance of epitopes that fall in variable regions of the proteome, which both increases the chance of epitope sequence mismatch with the incoming challenge strain and replicates the pathogenesis of early CTL failure due to epitope escape mutation during natural infection. To identify potential vaccine sequences to focus the CTL response on highly conserved epitopes, the whole proteomes of HIV-1 clades A1, B, C, and D were assessed for Shannon entropy at each amino acid position. Highly conserved regions in Gag (cGag-1, Gag 148-214, and cGag-2, Gag 253-331), Env (cEnv, Env 521-606), and Nef (cNef, Nef 106-148) were identified across clades. Inter- and intra-clade variability of amino acids within the regions tended to overlap, suggesting that polyvalent representation of consensus sequences for the four clades would allow broad HIV-1 strain representation. These four conserved regions were rich in both known and predicted CTL epitopes presented by a breadth of HLA types, and screening of 54 persons with chronic HIV-1 infection revealed that these regions are commonly immunogenic in the context of natural infection. These data suggest that vaccine delivery of a 16-valent mixture of these regions could focus the CTL response against conserved epitopes that are broadly representative of circulating HIV-1 strains.			Yang, OO (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, Dept Med, Div Infect Dis, Los Angeles, CA 90095 USA.	oyang@mednet.ucla.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI043203, R01AI051970] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI051970, AI043203, R01 AI043203, AI051970] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bennett MS, 2008, J INFECT DIS, V197, P390, DOI 10.1086/525281; Bennett MS, 2007, J VIROL, V81, P4973, DOI 10.1128/JVI.02362-06; Borrow P, 1997, NAT MED, V3, P205, DOI 10.1038/nm0297-205; Buchbinder SP, 2008, LANCET, V372, P1881, DOI 10.1016/S0140-6736(08)61591-3; FRAHM N, 2008, HIV MOL IMMUNOLOGY 2, P3; Goulder PJR, 2001, J EXP MED, V193, P181, DOI 10.1084/jem.193.2.181; Hartikka J, 2008, VACCINE; HECKERMAN D, 2009, VACCINE INDUCED TARG; Ibarrondo FJ, 2005, J VIROL, V79, P4289, DOI 10.1128/JVI.79.7.4289-4297.2005; JACKS T, 1988, NATURE, V331, P280, DOI 10.1038/331280a0; Jin X, 1999, J EXP MED, V189, P991, DOI 10.1084/jem.189.6.991; Jones N, 2003, J IMMUNOL METHODS, V274, P139, DOI 10.1016/S0022-1759(02)00510-0; Jones NA, 2004, J EXP MED, V200, P1243, DOI 10.1084/jem.20040511; Karlsson AC, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000225; Kedl RM, 2000, J EXP MED, V192, P1105, DOI 10.1084/jem.192.8.1105; Kiepiela P, 2007, NAT MED, V13, P46, DOI 10.1038/nm1520; Korber B, 2001, BRIT MED BULL, V58, P19, DOI 10.1093/bmb/58.1.19; Lee CH, 1996, CELL, V85, P931, DOI 10.1016/S0092-8674(00)81276-3; Letourneau S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000984; Lichterfeld M, 2004, AIDS, V18, P1383, DOI 10.1097/01.aids.0000131329.51633.a3; Lichterfeld M, 2007, J VIROL, V81, P4199, DOI 10.1128/JVI.01388-06; Matano T, 1998, J VIROL, V72, P164, DOI 10.1128/JVI.72.1.164-169.1998; Mattapallil JJ, 2005, NATURE, V434, P1093, DOI 10.1038/nature03501; Matthews PC, 2009, J VIROL, V83, P4605, DOI 10.1128/JVI.02017-08; McElrath MJ, 2008, LANCET, V372, P1894, DOI 10.1016/S0140-6736(08)61592-5; Mehandru S, 2004, J EXP MED, V200, P761, DOI 10.1084/jem.20041196; Momany C, 1996, NAT STRUCT BIOL, V3, P763, DOI 10.1038/nsb0996-763; Montero M, 2008, MICROBIOL MOL BIOL R, V72, P54, DOI 10.1128/MMBR.00020-07; Novitsky V, 2003, J VIROL, V77, P882, DOI 10.1128/JVI.77.2.882-890.2003; Palmowski MJ, 2002, J IMMUNOL, V168, P4391, DOI 10.4049/jimmunol.168.9.4391; Price DA, 1997, P NATL ACAD SCI USA, V94, P1890, DOI 10.1073/pnas.94.5.1890; Reisinger KS, 2007, PEDIATR INFECT DIS J, V26, P201, DOI 10.1097/01.inf.0000253970.29190.5a; RIVIERE Y, 1995, AIDS RES HUM RETROV, V11, P903, DOI 10.1089/aid.1995.11.903; Rodriguez F, 2002, J VIROL, V76, P4251, DOI 10.1128/JVI.76.9.4251-4259.2002; Rolland M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001424; Rolland M, 2007, PLOS PATHOG, V3, P1551, DOI 10.1371/journal.ppat.0030157; Schmitz JE, 1999, SCIENCE, V283, P857, DOI 10.1126/science.283.5403.857; SHAPIRO ED, 1991, NEW ENGL J MED, V325, P1453, DOI 10.1056/NEJM199111213252101; Veazey RS, 2000, J VIROL, V74, P57, DOI 10.1128/JVI.74.1.57-64.2000; Yang OO, 1996, J VIROL, V70, P5799, DOI 10.1128/JVI.70.9.5799-5806.1996; Yang OO, 1997, J VIROL, V71, P3120, DOI 10.1128/JVI.71.4.3120-3128.1997; Yang OO, 2008, AIDS, V22, P325, DOI 10.1097/QAD.0b013e3282f29491	42	33	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7388	10.1371/journal.pone.0007388	http://dx.doi.org/10.1371/journal.pone.0007388			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812689	Green Submitted, Green Published, gold			2022-12-27	WOS:000270594200012
J	Ahmed, SU; Milner, J				Ahmed, Shafiq Uddin; Milner, Jo			Basal Cancer Cell Survival Involves JNK2 Suppression of a Novel JNK1/c-Jun/Bcl-3 Apoptotic Network	PLOS ONE			English	Article								Background: The regulation of apoptosis under basal (non-stress) conditions is crucial for normal mammalian development and also for normal cellular turnover in different tissues throughout life. Deficient regulation of basal apoptosis, or its perturbation, can result in impaired development and/or disease states including cancer. In contrast to stress-induced apoptosis the regulation of apoptosis under basal conditions is poorly understood. To address this issue we have compared basal-and stress-induced apoptosis in human epithelial cells of normal and cancerous origins. For this purpose we focussed our study on the opposing pro-apoptotic JNK/anti-apoptotic NF kappa B pathways. Methodology/Principal Findings: Combinatorial RNAi plus gene knockout were employed to access and map basal regulatory pathways of apoptosis. Follow-on, in-depth analyses included exogenous expression of phosphorylation mutants and chromatin immunoprecipitation. We demonstrate that basal apoptosis is constitutively suppressed by JNK2 in a range of human cancer cell lines. This effect was not observed in non-cancer cells. Silencing JNK2 by RNAi resulted in JNK1-dependent apoptosis of cancer cells via up-regulation of the AP-1 factor c-Jun. Unexpectedly we discovered that JNK1 and c-Jun promote basal apoptosis in the absence of "activating phosphorylations'' typically induced by stress. Hypophosphorylated c-Jun accumulated to high levels following JNK2 silencing, auto-regulated its own expression and suppressed expression of Bcl-3, an unusual I kappa B protein and regulator of NF kappa B. Basal apoptosis was mediated by components of the TNF alpha response pathway but was mechanistically distinct from TNF alpha-induced apoptosis. Conclusions/Significance: Our results demonstrate that mechanistically distinct pathways operate to regulate apoptosis in mammalian cells under basal (physiological) versus stress-induced conditions. We also describe a novel apoptotic network which governs the basal survival of cancer cells. Such information is crucial for understanding normal cellular turnover during mammalian development and subsequently throughout life. This information also opens new avenues for therapeutic intervention in human proliferative disease states including cancer.			Ahmed, SU (corresponding author), Univ York, Dept Biol, YCR Res Unit P53, York YO10 5DD, N Yorkshire, England.	ajm24@york.ac.uk		Ahmed, Shafiq U/0000-0001-8701-6889				Allison SJ, 2007, CELL CYCLE, V6, P2669, DOI 10.4161/cc.6.21.4866; Anzi S, 2008, CELL SIGNAL, V20, P862, DOI 10.1016/j.cellsig.2007.12.020; Bordone L, 2005, NAT REV MOL CELL BIO, V6, P298, DOI 10.1038/nrm1616; Brooks CL, 2009, NAT REV CANCER, V9, P123, DOI 10.1038/nrc2562; Bunz F, 1998, SCIENCE, V282, P1497, DOI 10.1126/science.282.5393.1497; Chang LF, 2001, NATURE, V410, P37, DOI 10.1038/35065000; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dunn KC, 1996, EXP EYE RES, V62, P155, DOI 10.1006/exer.1996.0020; Fantin VR, 2006, CANCER CELL, V9, P425, DOI 10.1016/j.ccr.2006.04.023; Ford J, 2005, CANCER RES, V65, P10457, DOI 10.1158/0008-5472.CAN-05-1923; Ford J, 2008, CELL CYCLE, V7, P3091, DOI 10.4161/cc.7.19.6799; FRANZOSO G, 1992, NATURE, V359, P339, DOI 10.1038/359339a0; Fuchs SY, 1998, GENE DEV, V12, P2658, DOI 10.1101/gad.12.17.2658; Gallagher E, 2006, P NATL ACAD SCI USA, V103, P1717, DOI 10.1073/pnas.0510664103; Ghosh S, 1998, ANNU REV IMMUNOL, V16, P225, DOI 10.1146/annurev.immunol.16.1.225; Grummt I, 2008, CELL, V133, P577, DOI 10.1016/j.cell.2008.04.026; Hess J, 2004, J CELL SCI, V117, P5965, DOI 10.1242/jcs.01589; HIBI M, 1993, GENE DEV, V7, P2135, DOI 10.1101/gad.7.11.2135; Jaeschke A, 2006, MOL CELL, V23, P899, DOI 10.1016/j.molcel.2006.07.028; Lei K, 2002, MOL CELL BIOL, V22, P4929, DOI 10.1128/MCB.22.13.4929-4942.2002; Liu ZG, 1996, CELL, V87, P565, DOI 10.1016/S0092-8674(00)81375-6; Michel F, 2001, EMBO J, V20, P6180, DOI 10.1093/emboj/20.22.6180; Mocellin S, 2008, FRONT BIOSCI-LANDMRK, V13, P2774, DOI 10.2741/2884; Morton S, 2003, EMBO J, V22, P3876, DOI 10.1093/emboj/cdg388; OHNO H, 1990, CELL, V60, P991, DOI 10.1016/0092-8674(90)90347-H; Philp NJ, 2003, INVEST OPHTH VIS SCI, V44, P1716, DOI 10.1167/iovs.02-0287; Pratt MAC, 2003, MOL CELL BIOL, V23, P6887, DOI 10.1128/MCB.23.19.6887-6900.2003; PULVERER BJ, 1991, NATURE, V353, P670, DOI 10.1038/353670a0; Rebollo A, 2000, MOL CELL BIOL, V20, P3407, DOI 10.1128/MCB.20.10.3407-3416.2000; Reed J. C., 2004, SCI STKE, V2004, pre9, DOI DOI 10.1126/STKE.2392004RE9; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; SMEAL T, 1992, MOL CELL BIOL, V12, P3507, DOI 10.1128/MCB.12.8.3507; Tong C, 2007, AM J PATHOL, V171, P297, DOI 10.2353/ajpath.2007.061036; Tournier C, 1997, P NATL ACAD SCI USA, V94, P7337, DOI 10.1073/pnas.94.14.7337; Wei WY, 2005, CANCER CELL, V8, P25, DOI 10.1016/j.ccr.2005.06.005; Weiss C, 2003, EMBO J, V22, P3686, DOI 10.1093/emboj/cdg364; Westerheide SD, 2001, MOL CELL BIOL, V21, P8428, DOI 10.1128/MCB.21.24.8428-8436.2001; Wilson TR, 2007, CANCER RES, V67, P5754, DOI 10.1158/0008-5472.CAN-06-3585; WULCZYN FG, 1992, NATURE, V358, P597, DOI 10.1038/358597a0; Yamamoto K, 1999, MOL CELL BIOL, V19, P8469; Zong WX, 2001, GENE DEV, V15, P1481, DOI 10.1101/gad.897601	41	30	38	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7305	10.1371/journal.pone.0007305	http://dx.doi.org/10.1371/journal.pone.0007305			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806201	Green Submitted, gold, Green Published			2022-12-27	WOS:000270593800014
J	Owusu-Agyei, S; Ansong, D; Asante, K; Owusu, SK; Owusu, R; Brobby, NAW; Dosoo, D; Akoto, AO; Osei-Kwakye, K; Adjei, EA; Boahen, KO; Sylverken, J; Adjei, G; Sambian, D; Apanga, S; Kayan, K; Vekemans, J; Ofori-Anyinam, O; Leach, A; Lievens, M; Demoitie, MA; Dubois, MC; Cohen, J; Ballou, WR; Savarese, B; Chandramohan, D; Gyapong, JO; Milligan, P; Antwi, S; Agbenyega, T; Greenwood, B; Evans, J				Owusu-Agyei, Seth; Ansong, Daniel; Asante, Kwaku; Owusu, Sandra Kwarteng; Owusu, Ruth; Brobby, Naana Ayiwa Wireko; Dosoo, David; Akoto, Alex Osei; Osei-Kwakye, Kingsley; Adjei, Emmanuel Asafo; Boahen, Kwadwo Owusu; Sylverken, Justice; Adjei, George; Sambian, David; Apanga, Stephen; Kayan, Kingsley; Vekemans, Johan; Ofori-Anyinam, Opokua; Leach, Amanda; Lievens, Marc; Demoitie, Marie-Ange; Dubois, Marie-Claude; Cohen, Joe; Ballou, W. Ripley; Savarese, Barbara; Chandramohan, Daniel; Gyapong, John Owusu; Milligan, Paul; Antwi, Sampson; Agbenyega, Tsiri; Greenwood, Brian; Evans, Jennifer			Randomized Controlled Trial of RTS,S/AS02(D) and RTS,S/AS01(E) Malaria Candidate Vaccines Given According to Different Schedules in Ghanaian Children	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; IMMUNOGENICITY TRIAL; MOZAMBICAN CHILDREN; SAFETY; EFFICACY; FORMULATIONS; DISEASE; REGION; ADULTS	Backgroud: The target delivery channel of RTS,S candidate malaria vaccines in malaria-endemic countries in Africa is the World Health Organisation Expanded Program on Immunization. As an Adjuvant System, age de-escalation and schedule selection step, this study assessed 3 schedules of RTS,S/AS01(E) and RTS,S/AS02(D) in infants and young children 5-17 months of age in Ghana. Methodology: A Phase II, partially-blind randomized controlled study (blind to vaccine, not to schedule), of 19 months duration was conducted in two (2) centres in Ghana between August 2006 and May 2008. Subjects were allocated randomly (1:1:1:1:1:1) to one of six study groups at each study site, each defining which vaccine should be given and by which schedule (0,1-, 0,1,2- or 0,1,7-months). For the 0,1,2-month schedule participants received RTS,S/AS01(E) or rabies vaccine at one center and RTS,S/AS01(E) or RTS,S/AS02(D) at the other. For the other schedules at both study sites, they received RTS,S/AS01(E) or RTS,S/AS02(D). The primary outcome measure was the occurrence of serious adverse events until 10 months post dose 1. Results: The number of serious adverse events reported across groups was balanced. One child had a simple febrile convulsion, which evolved favourably without sequelae, considered to be related to RTS, S/AS01E vaccination. Low grade reactions occurred slightly more frequently in recipients of RTS,S/AS than rabies vaccines; grade 3 reactions were infrequent. Less local reactogenicity occurred with RTS,S/AS01(E) than RTS,S/AS02(D). Both candidate vaccines were highly immunogenic for anti-circumsporozoite and anti-Hepatitis B Virus surface antigen antibodies. Recipients of RTS,S/AS01(E) compared to RTS,S/AS02(D) had higher peak anti-circumsporozoite antibody responses for all 3 schedules. Three dose schedules were more immunogenic than 2 dose schedules. Area under the curve analyses for anti-circumsporozoite antibodies were comparable between the 0,1,2- and 0,1,7-month RTS,S/AS01(E) schedules. Conclusions: Both candidate malaria vaccines were well tolerated. Anti-circumsporozoite responses were greater with RTS,S/AS01(E) than RTS,S/AS02(D) and when 3 rather than 2 doses were given. This study supports the selection of RTS, S/AS01E and a 3 dose schedule for further development in children and infants.			Owusu-Agyei, S (corresponding author), Kintampo Hlth Res Ctr, Hlth Res Unit, Kintampo, Ghana.	Seth.owusu-agyei@ghana-khrc.org	Milligan, Paul/D-8985-2017; Leach, Amanda/AAS-1120-2020	Milligan, Paul/0000-0003-3430-3395; Leach, Amanda/0000-0002-7114-9967; ANSONG, Daniel/0000-0003-1328-9117; Owusu-Agyei, Seth/0000-0002-0807-1781; Gyapong, John/0000-0002-8415-1468	Wellcome Trust Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Abdulla S, 2008, NEW ENGL J MED, V359, P2533, DOI 10.1056/NEJMoa0807773; Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Archampong EQ, 2000, HEPATO-GASTROENTEROL, V47, P185; Bejon P, 2008, NEW ENGL J MED, V359, P2521, DOI 10.1056/NEJMoa0807381; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bojang KA, 2005, VACCINE, V23, P4148, DOI 10.1016/j.vaccine.2005.03.019; Bonhoeffer J, 2004, VACCINE, V22, P557, DOI 10.1016/j.vaccine.2003.09.008; Breman JG, 2001, AM J TROP MED HYG, V64, pIV, DOI 10.4269/ajtmh.2001.64.iv; Doherty JF, 1999, AM J TROP MED HYG, V61, P865, DOI 10.4269/ajtmh.1999.61.865; HADLER SC, 1989, VACCINE, V7, P106, DOI 10.1016/0264-410X(89)90046-7; JILG W, 1989, INFECTION, V17, P70, DOI 10.1007/BF01646879; KESTER KE, 2005, ASTMH PHIL US 11 15; Kester KE, 2007, VACCINE, V25, P5359, DOI 10.1016/j.vaccine.2007.05.005; LELL B, 2007, ASTMH PHIL US NOV 5; Macete E, 2007, TROP MED INT HEALTH, V12, P37, DOI 10.1111/j.1365-3156.2006.01754.x; Macete EV, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-11; POLHEMUS ME, 2006, ASTMH ATL GA US 13 1; Sacarlal J, 2008, VACCINE, V26, P174, DOI 10.1016/j.vaccine.2007.11.003; Sachs JD, 2002, SCIENCE, V298, P122, DOI 10.1126/science.1077900; Stewart VA, 2006, VACCINE, V24, P6483, DOI 10.1016/j.vaccine.2006.06.033; Stoute JA, 2006, AM J TROP MED HYG, V75, P166, DOI 10.4269/ajtmh.2006.75.166; *WHO IVR, 2005, STAT ART VACC RES DE	23	52	56	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7302	10.1371/journal.pone.0007302	http://dx.doi.org/10.1371/journal.pone.0007302			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19806184	gold, Green Submitted, Green Published, Green Accepted			2022-12-27	WOS:000270593300009
J	Sirovich, L; Stoeckle, MY; Zhang, Y				Sirovich, Lawrence; Stoeckle, Mark Y.; Zhang, Yu			A Scalable Method for Analysis and Display of DNA Sequences	PLOS ONE			English	Article							ORGANIZATION; DELIMITATION; BARCODE	Background: Comparative DNA sequence analysis provides insight into evolution and helps construct a natural classification reflecting the Tree of Life. The growing numbers of organisms represented in DNA databases challenge tree-building techniques and the vertical hierarchical classification may obscure relationships among some groups. Approaches that can incorporate sequence data from large numbers of taxa and enable visualization of affinities across groups are desirable. Methodology/Principal Findings: Toward this end, we developed a procedure for extracting diagnostic patterns in the form of indicator vectors from DNA sequences of taxonomic groups. In the present instance the indicator vectors were derived from mitochondrial cytochrome c oxidase I (COI) sequences of those groups and further analyzed on this basis. In the first example, indicator vectors for birds, fish, and butterflies were constructed from a training set of COI sequences, then correlations with test sequences not used to construct the indicator vector were determined. In all cases, correlation with the indicator vector correctly assigned test sequences to their proper group. In the second example, this approach was explored at the species level within the bird grouping; this also gave correct assignment, suggesting the possibility of automated procedures for classification at various taxonomic levels. A false-color matrix of vector correlations displayed affinities among species consistent with higher-order taxonomy. Conclusions/Significance: The indicator vectors preserved DNA character information and provided quantitative measures of correlations among taxonomic groups. This method is scalable to the largest datasets envisioned in this field, provides a visually-intuitive display that captures relational affinities derived from sequence data across a diversity of life forms, and is potentially a useful complement to current tree-building techniques for studying evolutionary processes based on DNA sequence data.			Sirovich, L (corresponding author), Mt Sinai Sch Med, Lab Appl Math, New York, NY USA.	lawrence.sirovich@mssm.edu	Stoeckle, Mark/D-3729-2011	Stoeckle, Mark/0000-0002-8280-4795	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [P50GM071558] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; *AM ORN UN, AM ORN UN CHECK LIST; Ausubel JH, 2009, P NATL ACAD SCI USA, V106, P12569, DOI 10.1073/pnas.0906757106; DAVIS JI, 1992, SYST BIOL, V41, P421, DOI 10.2307/2992584; DESALLE R, 2000, TECHNIQUES MOL SYSTE; Goloboff PA, 2009, CLADISTICS, V25, P211, DOI 10.1111/j.1096-0031.2009.00255.x; Hajibabaei M, 2006, P NATL ACAD SCI USA, V103, P968, DOI 10.1073/pnas.0510466103; HAMMING RW, 1950, BELL SYST TECH J, V29, P147, DOI 10.1002/j.1538-7305.1950.tb00463.x; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; HENNIG W, 1999, PHYLOGENETIC SYSTEMA; Hillis DM, 2004, ASSEMBLING THE TREE OF LIFE, P545; HILLIS DM, 2005, SYST BIOL; Hubert N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002490; Kent WJ, 2002, GENOME RES, V12, P656, DOI [10.1101/gr.229202, 10.1101/gr.229202. Article published online before March 2002]; Kerr Kevin C R, 2007, Mol Ecol Notes, V7, P535; Munch K, 2008, SYST BIOL, V57, P750, DOI 10.1080/10635150802422316; Nei M, 2000, MOL EVOLUTION PHYLOG; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Ratnasingham S, 2007, MOL ECOL NOTES, V7, P355, DOI 10.1111/j.1471-8286.2007.01678.x; Sanderson MJ, 2006, BIOINFORMATICS, V22, P1004, DOI 10.1093/bioinformatics/btl044; Sarkar IN, 2008, MOL ECOL RESOUR, V8, P1256, DOI 10.1111/j.1755-0998.2008.02235.x; Sirovich L, 2004, P NATL ACAD SCI USA, V101, P16941, DOI 10.1073/pnas.0407450101; Sirovich L, 1996, PHYSICA D, V96, P355, DOI 10.1016/0167-2789(96)00033-4; Tamura K, 2004, P NATL ACAD SCI USA, V101, P11030, DOI 10.1073/pnas.0404206101; WILSON EO, 1985, BIOSCIENCE, V35, P700, DOI 10.2307/1310051; WOESE CR, 1977, P NATL ACAD SCI USA, V74, P5088, DOI 10.1073/pnas.74.11.5088	26	22	25	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7051	10.1371/journal.pone.0007051	http://dx.doi.org/10.1371/journal.pone.0007051			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19798412	Green Published, gold			2022-12-27	WOS:000270593300002
J	Tassi, E; Braga, M; Longhi, R; Gavazzi, F; Parmiani, G; Di Carlo, V; Protti, MP				Tassi, Elena; Braga, Marco; Longhi, Renato; Gavazzi, Francesca; Parmiani, Giorgio; Di Carlo, Valerio; Protti, Maria Pia			Non-Redundant Role for IL-12 and IL-27 in Modulating Th2 Polarization of Carcinoembryonic Antigen Specific CD4 T Cells from Pancreatic Cancer Patients	PLOS ONE			English	Article								Background: Pancreatic cancer is a very aggressive disease with dismal prognosis; peculiar is the tumor microenvironment characterized by an extensive fibrotic stroma, which favors rapid tumor progression. We previously reported that pancreatic cancer patients have a selective Th2 skew in the anti-carcinoembryonic antigen (CEA) CD4(+) T cell immunity, which correlates with the presence of a predominant GATA-3(+) tumor lymphoid infiltrate. This has negative effects in both effective anti-tumor immunity and further favoring fibrinogenesis. Aim of this study was to evaluate whether the Th2 polarization of CEA-specific CD4(+) T cells from pancreatic cancer patients is stable or can be reverted by immunomodulating cytokines. Methodology/Principal Findings: We first evaluated the influence of IL-12 and IL-27, as single agents and in association, on the polarization of CEA-specific Th2 CD4+ T cell clones from a pancreatic cancer patient. We found that only the combination of IL-12 and IL-27 modified the polarization of Th2 effectors by both reduction of IL-5, GM-CSF and IL-13 and induction of IFN-gamma production, which lasted after cytokine removal. Second, we evaluated the effect of the combined treatment on polyclonal CEA-specific CD4(+) T cells in short-time re-stimulation assays. In agreement with the data obtained with the clones, we found that the combined treatment functionally modulated the Th2 polarization of CEA-specific CD4(+) T cells and enhanced pre-existing Th1 type immunity. Conclusions/Significance: Collectively, our results demonstrate that tumor antigen specific Th2 CD4(+) T cells in pancreatic cancer are endowed with functional plasticity. Hence, loco-regional cytokines delivery or targeted therapy based on antibodies or molecules directed to the tumor stroma might improve anti-tumor immunity and ameliorate fibrosis, without systemic toxicity.			Tassi, E (corresponding author), Ist Sci San Raffaele, Tumor Immunol Unit, I-20132 Milan, Italy.	m.protti@hsr.it	Tassi, Enrico/K-3958-2015; Tassi, Elena/C-1982-2017; Protti, Maria Pia/J-7899-2016	Tassi, Elena/0000-0002-2921-8666; Protti, Maria Pia/0000-0001-9079-2336; Gavazzi, Francesca/0000-0003-3207-0292				Annunziato F, 2001, J ALLERGY CLIN IMMUN, V108, P815; Bellone M, 2008, TRENDS IMMUNOL, V29, P235, DOI 10.1016/j.it.2008.02.003; Bonecchi R, 1998, J EXP MED, V187, P129, DOI 10.1084/jem.187.1.129; BRUNDA MJ, 1993, J EXP MED, V178, P1223, DOI 10.1084/jem.178.4.1223; Campi G, 2003, CANCER RES, V63, P8481; Chiyo M, 2005, INT J CANCER, V115, P437, DOI 10.1002/ijc.20848; Colombo MP, 2002, CYTOKINE GROWTH F R, V13, P155, DOI 10.1016/S1359-6101(01)00032-6; Constant SL, 1997, ANNU REV IMMUNOL, V15, P297, DOI 10.1146/annurev.immunol.15.1.297; Cosmi L, 2000, EUR J IMMUNOL, V30, P2972, DOI 10.1002/1521-4141(200010)30:10<2972::AID-IMMU2972>3.0.CO;2-#; Crosti M, 2006, J IMMUNOL, V176, P5093, DOI 10.4049/jimmunol.176.8.5093; Curnis F, 2004, CANCER RES, V64, P565, DOI 10.1158/0008-5472.CAN-03-1753; Del Vecchio M, 2007, CLIN CANCER RES, V13, P4677, DOI 10.1158/1078-0432.CCR-07-0776; Esposito I, 2006, J PATHOL, V208, P673, DOI 10.1002/path.1935; Filipazzi P, 2007, J CLIN ONCOL, V25, P2546, DOI 10.1200/JCO.2006.08.5829; Galon J, 2006, SCIENCE, V313, P1960, DOI 10.1126/science.1129139; Heinzerling L, 2005, HUM GENE THER, V16, P35, DOI 10.1089/hum.2005.16.35; Hisada M, 2004, CANCER RES, V64, P1152, DOI 10.1158/0008-5472.CAN-03-2084; Kleeff J, 2007, INT J CANCER, V121, P699, DOI 10.1002/ijc.22871; Roa RIL, 2008, INT IMMUNOPHARMACOL, V8, P1715, DOI 10.1016/j.intimp.2008.07.010; Marturano J, 2008, CANCER RES, V68, P1555, DOI 10.1158/0008-5472.CAN-07-5233; Mazzolini G, 2005, J CLIN ONCOL, V23, P999, DOI 10.1200/JCO.2005.00.463; Neri D, 2005, NAT REV CANCER, V5, P436, DOI 10.1038/nrc1627; Oniki S, 2006, CANCER RES, V66, P6395, DOI 10.1158/0008-5472.CAN-05-4087; Pflanz S, 2002, IMMUNITY, V16, P779, DOI 10.1016/S1074-7613(02)00324-2; Serafini P, 2004, CANCER RES, V64, P6337, DOI 10.1158/0008-5472.CAN-04-0757; Seresini S, 2007, J IMMUNOL, V179, P7176, DOI 10.4049/jimmunol.179.10.7176; Shimizu M, 2006, J IMMUNOL, V176, P7317, DOI 10.4049/jimmunol.176.12.7317; Smits HH, 2001, EUR J IMMUNOL, V31, P1055, DOI 10.1002/1521-4141(200104)31:4<1055::AID-IMMU1055>3.0.CO;2-7; Tassi E, 2008, J IMMUNOL, V181, P6595, DOI 10.4049/jimmunol.181.9.6595; Tatsumi T, 2003, CANCER RES, V63, P4481; Tatsumi T, 2002, J EXP MED, V196, P619, DOI 10.1084/jem.20012142; Trinchieri G, 2003, NAT REV IMMUNOL, V3, P133, DOI 10.1038/nri1001; Trinchieri G, 2003, IMMUNITY, V19, P641, DOI 10.1016/S1074-7613(03)00296-6; Triozzi PL, 2005, HUM GENE THER, V16, P91, DOI 10.1089/hum.2005.16.91; Vagliani M, 1996, CANCER RES, V56, P467; Varga EM, 2000, J IMMUNOL, V165, P2877, DOI 10.4049/jimmunol.165.5.2877; WARSHAW AL, 1992, NEW ENGL J MED, V326, P455, DOI 10.1056/NEJM199202133260706; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Yoshimoto T, 2007, J IMMUNOL, V179, P4415, DOI 10.4049/jimmunol.179.7.4415	39	24	25	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7234	10.1371/journal.pone.0007234	http://dx.doi.org/10.1371/journal.pone.0007234			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19798410	Green Published, Green Submitted, gold			2022-12-27	WOS:000270593300003
J	Pascoal, S; Creer, S; Taylor, MI; Queiroga, H; Carvalho, G; Mendo, S				Pascoal, Sonia; Creer, Simon; Taylor, Martin I.; Queiroga, Henrique; Carvalho, Gary; Mendo, Sonia			Development and Application of Microsatellites in Carcinus maenas: Genetic Differentiation between Northern and Central Portuguese Populations	PLOS ONE			English	Article							EUROPEAN GREEN CRAB; PROPAGULE DISPERSAL; INVASIVE CRAB; SHORE CRAB; DYNAMICS; BEHAVIOR; LARVAL; SIZE; PREDATION; PATTERNS	Carcinus maenas, the common shore crab of European coastal waters, has recently gained notoriety due to its globally invasive nature associated with drastic ecological and economic effects. The native ubiquity and worldwide importance of C. maenas has resulted in it becoming one of the best-studied estuarine crustacean species globally. Accordingly, there is significant interest in investigating the population genetic structure of this broadly distributed crab along European and invaded coastlines. Here, we developed polymerase chain reaction (PCR) primers for one dinucleotide and two trinucleotide microsatellite loci, resulting from an enrichment process based on Portuguese populations. Combining these three new markers with six existing markers, we examined levels of genetic diversity and population structure of C. maenas in two coastal regions from Northern and Central Portugal. Genotypes showed that locus polymorphism ranged from 10 to 42 alleles (N = 135) and observed heterozygosity per locus ranged from 0.745 to 0.987 with expected heterozygosity ranging from 0.711 to 0.960; values typical of marine decapods. The markers revealed weak, but significant structuring among populations (global F-ST = 0.004) across a 450 km (over-water distance) spatial scale. Combinations of these and existing markers will be useful for studying population genetic parameters at a range of spatial scales of C. maenas throughout its expanding species range.			Pascoal, S (corresponding author), Univ Aveiro, CESAM, Campus Univ Santiago, P-3800 Aveiro, Portugal.	spascoal@ua.pt	Queiroga, Henrique/C-5134-2008; Mendo, Sónia A/E-1095-2011; Taylor, Martin I/B-4298-2013	Queiroga, Henrique/0000-0002-2338-0013; Mendo, Sónia A/0000-0001-5057-5660; 				BROEKHUYSEN GJ, 1936, ARCH NEERL ZOOL, V2, P255; Caley MJ, 1996, ANNU REV ECOL SYST, V27, P477, DOI 10.1146/annurev.ecolsys.27.1.477; Chambers GK, 2000, COMP BIOCHEM PHYS B, V126, P455, DOI 10.1016/S0305-0491(00)00233-9; Clark PF, 2001, J CRUSTACEAN BIOL, V21, P288, DOI 10.1651/0278-0372(2001)021[0288:AMAORV]2.0.CO;2; Darling JA, 2008, MOL ECOL, V17, P4992, DOI 10.1111/j.1365-294X.2008.03978.x; DAWIRS RR, 1985, MAR ECOL PROG SER, V24, P297, DOI 10.3354/meps024297; Diekmann OE, 2005, MAR ECOL PROG SER, V290, P89, DOI 10.3354/meps290089; Diz AP, 2008, MAR BIOL, V154, P277, DOI 10.1007/s00227-008-0921-3; Ford BA, 1998, AM J BOT, V85, P546, DOI 10.2307/2446439; Geller JB, 1997, MOL ECOL, V6, P901, DOI 10.1046/j.1365-294X.1997.00256.x; Goudet J., 2002, FSTAT PROGRAM ESTIMA; Grosholz ED, 2000, ECOLOGY, V81, P1206, DOI 10.2307/177202; GROSHOLZ ED, 1995, MAR BIOL, V122, P239; Hidalgo FJ, 2005, BIOL INVASIONS, V7, P547, DOI 10.1007/s10530-004-5452-3; Kinlan BP, 2005, DIVERS DISTRIB, V11, P139, DOI 10.1111/j.1366-9516.2005.00158.x; Levin LA, 2006, INTEGR COMP BIOL, V46, P282, DOI 10.1093/icb/icj024; Lima FP, 2006, J BIOGEOGR, V33, P812, DOI 10.1111/j.1365-2699.2006.01457.x; Lowe S., 2000, ENCY BIOL INVASIONS; Mascaro M, 2000, J SHELLFISH RES, V19, P283; MOHAMEDEEN H, 1989, J EXP MAR BIOL ECOL, V134, P1, DOI 10.1016/0022-0981(90)90053-F; Park SDE, 2001, THESIS U DUBLIN; Peakall R, 2006, MOL ECOL NOTES, V6, P288, DOI 10.1111/j.1471-8286.2005.01155.x; Peliz A, 2005, DEEP-SEA RES PT I, V52, P621, DOI 10.1016/j.dsr.2004.11.005; Peliz A, 2007, J MARINE SYST, V68, P215, DOI 10.1016/j.jmarsys.2006.11.007; Queiroga H, 2005, ADV MAR BIOL, V47, P107; Queiroga H, 1997, MAR ECOL PROG SER, V149, P121, DOI 10.3354/meps149121; Raymond M, 2004, GENEPOP POPULATION G; Roman J, 2004, MOL ECOL, V13, P2891, DOI 10.1111/j.1365-294X.2004.02255.x; ROUGHGARDEN J, 1985, ECOLOGY, V66, P54, DOI 10.2307/1941306; ROUSSET F, 1995, GENETICS, V140, P1413; Rozen S, 2000, Methods Mol Biol, V132, P365; Shanks AL, 2003, ECOL APPL, V13, pS159; Sotelo G, 2008, MAR ECOL PROG SER, V362, P211, DOI 10.3354/meps07433; Sotelo G, 2009, MAR BIOL, V156, P1039, DOI 10.1007/s00227-009-1148-7; SPAARGAREN DH, 1989, J EXP MAR BIOL ECOL, V129, P251, DOI 10.1016/0022-0981(89)90107-X; Tepolt CK, 2006, MOL ECOL NOTES, V6, P343, DOI 10.1111/j.1471-8286.2006.01226.x; THOMAS NJ, 1981, MAR BEHAV PHYSIOL, V7, P277, DOI 10.1080/10236248109386988; Thresher R, 2003, MAR BIOL, V142, P867, DOI 10.1007/s00227-003-1011-1; Udekem d'Acoz C d', 1999, INVENTAIRE DISTRIBUT; Van Oosterhout C, 2004, MOL ECOL NOTES, V4, P535, DOI 10.1111/j.1471-8286.2004.00684.x; Walton WC, 2002, J EXP MAR BIOL ECOL, V272, P171, DOI 10.1016/S0022-0981(02)00127-2; Zane L, 2002, MOL ECOL, V11, P1, DOI 10.1046/j.0962-1083.2001.01418.x	42	19	19	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7268	10.1371/journal.pone.0007268	http://dx.doi.org/10.1371/journal.pone.0007268			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789651	Green Published, Green Submitted, gold			2022-12-27	WOS:000270354100021
J	Mucke, N; Klenin, K; Kirmse, R; Bussiek, M; Herrmann, H; Hafner, M; Langowski, J				Muecke, Norbert; Klenin, Konstantin; Kirmse, Robert; Bussiek, Malte; Herrmann, Harald; Hafner, Mathias; Langowski, Joerg			Filamentous Biopolymers on Surfaces: Atomic Force Microscopy Images Compared with Brownian Dynamics Simulation of Filament Deposition	PLOS ONE			English	Article							INTERMEDIATE-FILAMENTS; DNA; VIMENTIN; FLEXIBILITY; PROTEINS; POLYMERS; LENGTH; UNITS; HEAD; MICA	Nanomechanical properties of filamentous biopolymers, such as the persistence length, may be determined from two-dimensional images of molecules immobilized on surfaces. For a single filament in solution, two principal adsorption scenarios are possible. Both scenarios depend primarly on the interaction strength between the filament and the support: i) For interactions in the range of the thermal energy, the filament can freely equilibrate on the surface during adsorption; ii) For interactions much stronger than the thermal energy, the filament will be captured by the surface without having equilibrated. Such a 'trapping' mechanism leads to more condensed filament images and hence to a smaller value for the apparent persistence length. To understand the capture mechanism in more detail we have performed Brownian dynamics simulations of relatively short filaments by taking the two extreme scenarios into account. We then compared these 'ideal' adsorption scenarios with observed images of immobilized vimentin intermediate filaments on different surfaces. We found a good agreement between the contours of the deposited vimentin filaments on mica ('ideal' trapping) and on glass ('ideal' equilibrated) with our simulations. Based on these data, we have developed a strategy to reliably extract the persistence length of short worm-like chain fragments or network forming filaments with unknown polymer-surface interactions.			Mucke, N (corresponding author), German Canc Res Ctr, Div Biophys Macromol, D-6900 Heidelberg, Germany.	jl@dkfz.de	Langowski, Jörg/A-1843-2011	Langowski, Jörg/0000-0001-8600-0666; Mucke, Norbert/0000-0002-0683-4386				Bussiek M, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng137; ERMAK DL, 1978, J CHEM PHYS, V69, P1352, DOI 10.1063/1.436761; FRONTALI C, 1979, BIOPOLYMERS, V18, P1353, DOI 10.1002/bip.1979.360180604; Garcia HG, 2007, BIOPOLYMERS, V85, P115, DOI 10.1002/bip.20627; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 2003, INT REV CYTOL, V223, P83; HERRMANN H, 1992, J MOL BIOL, V223, P637, DOI 10.1016/0022-2836(92)90980-X; INIESTA A, 1990, J CHEM PHYS, V92, P2015, DOI 10.1063/1.458034; Klenin K, 1998, BIOPHYS J, V74, P780, DOI 10.1016/S0006-3495(98)74003-2; KRATKY O, 1949, RECL TRAV CHIM PAY B, V68, P1106; Landau LD, 1986, THEORY ELASTICITY, DOI 10.1016/C2009-0-25521-8; Langowski J., 2004, CHROMATIN STRUCTURE, P397; Merlitz H, 1998, BIOPHYS J, V74, P773, DOI 10.1016/S0006-3495(98)74002-0; Mucke N, 2005, J STRUCT BIOL, V150, P268, DOI 10.1016/j.jsb.2005.02.012; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; Mucke N, 2004, J MOL BIOL, V335, P1241, DOI 10.1016/j.jmb.2003.11.038; Rivetti C, 1996, J MOL BIOL, V264, P919, DOI 10.1006/jmbi.1996.0687; ROTNE J, 1969, J CHEM PHYS, V50, P4831, DOI 10.1063/1.1670977; Schulz A, 1998, J MOL BIOL, V283, P821, DOI 10.1006/jmbi.1998.2131; SUSHKO ML, 2006, SIMPLE MODEL DNA ADS, P22; Wickert U, 2005, EUR J CELL BIOL, V84, P379, DOI 10.1016/j.ejcb.2005.01.004; Wiggins PA, 2006, NAT NANOTECHNOL, V1, P137, DOI 10.1038/nnano.2006.63; YAMAKAWA H, 1972, J CHEM PHYS, V57, P2843, DOI 10.1063/1.1678675	25	21	21	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2009	4	11							e7756	10.1371/journal.pone.0007756	http://dx.doi.org/10.1371/journal.pone.0007756			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RZ	19888472	Green Submitted, gold, Green Published			2022-12-27	WOS:000271414600014
J	Yung, GLP; Fidler, M; Albani, E; Spermon, N; Teklenburg, G; Newbury, R; Schechter, N; van den Broek, T; Prakken, B; Billetta, R; Dohil, R; Albani, S				Yung, Gisella L. Puga; Fidler, Meredith; Albani, Erika; Spermon, Naomi; Teklenburg, Gijs; Newbury, Robert; Schechter, Nicole; van den Broek, Theo; Prakken, Berent; Billetta, Rosario; Dohil, Ranjan; Albani, Salvatore			Heat Shock Protein-Derived T-Cell Epitopes Contribute to Autoimmune Inflammation in Pediatric Crohn's Disease	PLOS ONE			English	Article							MOLECULAR MIMICRY; IMMUNE-RESPONSES; ADJUVANT ARTHRITIS; BOWEL-DISEASE; HEAT-SHOCK-PROTEIN-60; PATHOGENESIS; EXPRESSION; IMMUNOTHERAPY; MYCOBACTERIUM; INHIBITION	Pediatric Crohn's disease is a chronic auto inflammatory bowel disorder affecting children under the age of 17 years. A putative etiopathogenesis of Crohn's disease (CD) is associated with disregulation of immune response to antigens commonly present in the gut microenvironment. Heat shock proteins (HSP) have been identified as ubiquitous antigens with the ability to modulate inflammatory responses associated with several autoimmune diseases. The present study tested the contribution of immune responses to HSP in the amplification of autoimmune inflammation in chronically inflamed mucosa of pediatric CD patients. Colonic biopsies obtained from normal and CD mucosa were stimulated with pairs of Pan HLA-DR binder HSP60-derived peptides (human/bacterial homologues). The modulation of RNA and protein levels of induced proinflammatory cytokines were measured. We identified two epitopes capable of sustaining proinflammatory responses, specifically TNF < and IFN (c) induction, in the inflamed intestinal mucosa in CD patients. The responses correlated positively with clinical and histological measurements of disease activity, thus suggesting a contribution of immune responses to HSP in pediatric CD site-specific mucosal inflammation.			Yung, GLP (corresponding author), Univ Hosp Geneva, Dept Internal Med, Serv Immunol & Allergy, Geneva, Switzerland.	salbani@arthritis.arizona.edu	, van den Broek T/I-9651-2019	, van den Broek T/0000-0002-2781-5731; , Gisella/0000-0002-2283-7798				Agnello D, 2002, INT IMMUNOPHARMACOL, V2, P463, DOI 10.1016/S1567-5769(01)00188-6; Albani S, 2006, ARTHRITIS RHEUM, V54, P19, DOI 10.1002/art.21520; Albani S, 1996, IMMUNOL TODAY, V17, P466, DOI 10.1016/0167-5699(96)20029-G; ALBANI S, 1995, NAT MED, V1, P448, DOI 10.1038/nm0595-448; Bason C, 2003, LANCET, V362, P1971, DOI 10.1016/S0140-6736(03)15016-7; Bouma G, 2003, NAT REV IMMUNOL, V3, P521, DOI 10.1038/nri1132; Brimnes J, 2001, EUR J IMMUNOL, V31, P23, DOI 10.1002/1521-4141(200101)31:1<23::AID-IMMU23>3.0.CO;2-2; Chauhan SK, 2004, CLIN EXP IMMUNOL, V138, P547, DOI 10.1111/j.1365-2249.2004.02644.x; Cohen IR, 2000, SEMIN IMMUNOL, V12, P215, DOI 10.1006/smim.2000.0234; COHEN IR, 2000, SEMIN IMMUNOL, V12, P257, DOI DOI 10.1006/SMIM.2000.0234; de Kleer IM, 2003, ARTHRITIS RHEUM, V48, P2001, DOI 10.1002/art.11174; FELDMAN M, 2002, SLEISENGER FORDTRANS, V41; Fiocchi C, 1998, GASTROENTEROLOGY, V115, P182, DOI 10.1016/S0016-5085(98)70381-6; Homan M, 2005, NAT CLIN PRACT GASTR, V2, P572, DOI 10.1038/ncpgasthep0338; Hu S, 2007, GASTROENTEROLOGY, V133, P1893, DOI 10.1053/j.gastro.2007.09.026; HYAMS JS, 1991, J PEDIATR GASTR NUTR, V12, P439, DOI 10.1097/00005176-199105000-00005; Kamphuis S, 2005, LANCET, V366, P50, DOI 10.1016/S0140-6736(05)66827-4; Kamradt T, 2001, NEW ENGL J MED, V344, P655, DOI 10.1056/NEJM200103013440907; KOFFEMAN EC, 2009, ARTHRITIS R IN PRESS; Linskens RK, 2001, SCAND J GASTROENTERO, V36, P29, DOI 10.1080/003655201753265082; Ludwig D, 1999, DIGEST DIS SCI, V44, P1440, DOI 10.1023/A:1026616221950; MacDonald TT, 2005, JPEN-PARENTER ENTER, V29, pS118, DOI 10.1177/01486071050290S4S118; Massa M, 2007, ARTHRITIS RHEUM, V56, P1648, DOI 10.1002/art.22567; McKaig BC, 2002, AM J PHYSIOL-CELL PH, V282, pC172, DOI 10.1152/ajpcell.00048.2001; Oldstone MBA, 1998, FASEB J, V12, P1255, DOI 10.1096/fasebj.12.13.1255; Olsen T, 2009, SCAND J GASTROENTERO, V44, P727, DOI 10.1080/00365520902803507; PEETERMANS WE, 1995, GASTROENTEROLOGY, V108, P75, DOI 10.1016/0016-5085(95)90010-1; Prakken BJ, 2001, CURR DIRECT AUTOIMMU, V3, P51; Prakken BJ, 2004, P NATL ACAD SCI USA, V101, P4228, DOI 10.1073/pnas.0400061101; Prohaszka Z, 2004, MOL IMMUNOL, V41, P29, DOI 10.1016/j.molimm.2004.02.001; Raz I, 2001, LANCET, V358, P1749, DOI 10.1016/S0140-6736(01)06801-5; Sartor RB, 1997, AM J GASTROENTEROL, V92, pS5; Southwood S, 1998, J IMMUNOL, V160, P3363; Spahn TW, 1997, DIGESTION, V58, P469, DOI 10.1159/000201485; Strober W, 2002, ANNU REV IMMUNOL, V20, P495, DOI 10.1146/annurev.immunol.20.100301.064816; SZEWCZUK MR, 1992, CLIN INVEST MED, V15, P494; van Eden W, 2005, NAT REV IMMUNOL, V5, P318, DOI 10.1038/nri1593; Viscido A, 2005, NUCL MED COMMUN, V26, P649, DOI 10.1097/01.mnm.0000169205.21377.6a; WALKER WA, 2000, PEDIAT GASTROINTESTI; Wendling U, 2000, J IMMUNOL, V164, P2711, DOI 10.4049/jimmunol.164.5.2711; Whittall T, 2006, CLIN EXP IMMUNOL, V143, P550, DOI 10.1111/j.1365-2249.2006.03010.x; WIETEN L, 2009, CELL STRESS CHAPERON; Yung GLP, 2003, INFLAMM RES, V52, P443, DOI 10.1007/s00011-003-1204-6	43	19	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2009	4	11							e7714	10.1371/journal.pone.0007714	http://dx.doi.org/10.1371/journal.pone.0007714			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RX	19888320	gold, Green Submitted, Green Published			2022-12-27	WOS:000271414400014
J	Mavigner, M; Delobel, P; Cazabat, M; Dubois, M; L'Faqihi-Olive, FE; Raymond, S; Pasquier, C; Marchou, B; Massip, P; Izopet, J				Mavigner, Maud; Delobel, Pierre; Cazabat, Michelle; Dubois, Martine; L'Faqihi-Olive, Fatima-Ezzahra; Raymond, Stephanie; Pasquier, Christophe; Marchou, Bruno; Massip, Patrice; Izopet, Jacques			HIV-1 Residual Viremia Correlates with Persistent T-Cell Activation in Poor Immunological Responders to Combination Antiretroviral Therapy	PLOS ONE			English	Article							HUMAN-IMMUNODEFICIENCY-VIRUS; HUMAN PERIPHERAL-BLOOD; IN-VIVO; VIRAL LOAD; REPLICATION-COMPETENT; INFECTED PATIENTS; LATENT RESERVOIR; PROGENITOR CELLS; DRUG-RESISTANCE; PLASMA VIREMIA	Background: The clinical significance and cellular sources of residual human immunodeficiency virus type 1 (HIV-1) production despite suppressive combination antiretroviral therapy (cART) remain unclear and the effect of low-level viremia on T-cell homeostasis is still debated. Methodology/Principal Findings: We characterized the recently produced residual viruses in the plasma and short-lived blood monocytes of 23 patients with various immunological responses to sustained suppressive cART. We quantified the residual HIV-1 in the plasma below 50 copies/ml, and in the CD14(high) CD16(-) and CD16(+) monocyte subsets sorted by flow cytometry, and predicted coreceptor usage by genotyping V3 env sequences. We detected residual viremia in the plasma of 8 of 10 patients with poor CD4(+) T-cell reconstitution in response to cART and in only 5 of 13 patients with good CD4(+) T-cell reconstitution. CXCR4-using viruses were frequent among the recently produced viruses in the plasma and in the main CD14(high) CD16(-) monocyte subset. Finally, the residual viremia was correlated with persistent CD4(+) and CD8(+) T-cell activation in patients with poor immune reconstitution. Conclusions: Low-level viremia could result from the release of archived viruses from cellular reservoirs and/or from ongoing virus replication in some patients. The compartmentalization of the viruses between the plasma and the blood monocytes suggests at least two origins of residual virus production during effective cART. CXCR4-using viruses might be produced preferentially in patients on cART. Our results also suggest that low-level HIV-1 production in some patients may contribute to persistent immune dysfunction despite cART.			Mavigner, M (corresponding author), Fac Med Toulouse, INSERM, U563, U317, F-31073 Toulouse, France.	izopet.j@chu-toulouse.fr	Delobel, Pierre/Q-6028-2019; Raymond, Stephanie/L-8401-2019; IZOPET, Jacques/L-5756-2014; Raymond, Stephanie/K-4507-2014; Delobel, Pierre/K-3166-2014	Delobel, Pierre/0000-0002-2874-3581; Raymond, Stephanie/0000-0002-3780-5844; Delobel, Pierre/0000-0002-2874-3581; PASQUIER, Christophe/0000-0001-9223-0150				Alexaki A, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000215; Bailey JR, 2006, J VIROL, V80, P6441, DOI 10.1128/JVI.00591-06; Benito JM, 2004, AIDS RES HUM RETROV, V20, P227, DOI 10.1089/088922204773004950; Blaak H, 2000, P NATL ACAD SCI USA, V97, P1269, DOI 10.1073/pnas.97.3.1269; Bleul CC, 1997, P NATL ACAD SCI USA, V94, P1925, DOI 10.1073/pnas.94.5.1925; Brenchley JM, 2004, J VIROL, V78, P1160, DOI 10.1128/JVI.78.3.1160-1168.2004; Brooks DG, 2001, NAT MED, V7, P459, DOI 10.1038/86531; BUZON M, 2009, TRANSIENT INCREASE E; Chun TW, 2000, NAT MED, V6, P757, DOI 10.1038/77481; Chun TW, 1997, P NATL ACAD SCI USA, V94, P13193, DOI 10.1073/pnas.94.24.13193; Chun TW, 1998, P NATL ACAD SCI USA, V95, P8869, DOI 10.1073/pnas.95.15.8869; Crowe S, 2003, J LEUKOCYTE BIOL, V74, P635, DOI 10.1189/jlb.0503204; DAVIS BR, 1991, J VIROL, V65, P1985, DOI 10.1128/JVI.65.4.1985-1990.1991; Delobel P, 2005, JAIDS-J ACQ IMM DEF, V38, P382, DOI 10.1097/01.qai.0000152835.17747.47; Delobel P, 2007, J CLIN MICROBIOL, V45, P1572, DOI 10.1128/JCM.02090-06; Delobel P, 2006, J VIROL, V80, P10229, DOI 10.1128/JVI.00965-06; Diaz M, 2003, AIDS, V17, P1145, DOI 10.1097/00002030-200305230-00005; Dinoso JB, 2009, P NATL ACAD SCI USA, V106, P9403, DOI 10.1073/pnas.0903107106; Dion ML, 2004, IMMUNITY, V21, P757, DOI 10.1016/j.immuni.2004.10.013; Dornadula G, 1999, JAMA-J AM MED ASSOC, V282, P1627, DOI 10.1001/jama.282.17.1627; Douek DC, 2003, ANNU REV IMMUNOL, V21, P265, DOI 10.1146/annurev.immunol.21.120601.141053; Ellery PJ, 2007, J IMMUNOL, V178, P6581, DOI 10.4049/jimmunol.178.10.6581; EVERING T, 2009, SINGLE GENOME ANAL H; Finzi D, 1999, NAT MED, V5, P512, DOI 10.1038/8394; Finzi D, 1997, SCIENCE, V278, P1295, DOI 10.1126/science.278.5341.1295; Fulcher JA, 2004, J VIROL, V78, P7883, DOI 10.1128/JVI.78.15.7883-7893.2004; Furtado MR, 1999, NEW ENGL J MED, V340, P1614, DOI 10.1056/NEJM199905273402102; GANDHI R, 2009, RALTEGRAVIR INTENSIF; GARTNER S, 1986, SCIENCE, V233, P215, DOI 10.1126/science.3014648; Grage-Griebenow E, 2001, J LEUKOCYTE BIOL, V69, P11; Gunthard HF, 1999, VIROLOGY, V259, P154, DOI 10.1006/viro.1999.9774; Havlir DV, 2003, J VIROL, V77, P11212, DOI 10.1128/JVI.77.20.11212-11219.2003; Hermankova M, 2001, JAMA-J AM MED ASSOC, V286, P196, DOI 10.1001/jama.286.2.196; HO DD, 1995, NATURE, V373, P123, DOI 10.1038/373123a0; Johnston ER, 2003, J VIROL, V77, P7682, DOI 10.1128/JVI.77.13.7682-7688.2003; JONES J, 2009, DECREASE RESIDUAL VI; Kieffer TL, 2004, J INFECT DIS, V189, P1452, DOI 10.1086/382488; Kolluri SK, 1999, GENE DEV, V13, P1742, DOI 10.1101/gad.13.13.1742; Llewellyn N, 2006, J LEUKOCYTE BIOL, V80, P1118, DOI 10.1189/jlb.0306144; Maldarelli F, 2007, PLOS PATHOG, V3, P484, DOI 10.1371/journal.ppat.0030046; Martinez MA, 1999, VIROLOGY, V256, P180, DOI 10.1006/viro.1999.9601; Melby T, 2006, J INFECT DIS, V194, P238, DOI 10.1086/504693; MEURET G, 1974, BLOOD, V44, P801, DOI 10.1182/blood.V44.6.801.801; Natarajan V, 1999, LANCET, V353, P119, DOI 10.1016/S0140-6736(05)76156-0; NEAL TF, 1995, BLOOD, V86, P1749, DOI 10.1182/blood.V86.5.1749.bloodjournal8651749; Nettles RE, 2005, JAMA-J AM MED ASSOC, V293, P817, DOI 10.1001/jama.293.7.817; Nokta MA, 2002, AIDS, V16, P2119, DOI 10.1097/00002030-200211080-00003; Orenstein JM, 1997, SCIENCE, V276, P1857, DOI 10.1126/science.276.5320.1857; Ostrowski MA, 1999, J VIROL, V73, P6430, DOI 10.1128/JVI.73.8.6430-6435.1999; Ostrowski SR, 2008, SCAND J IMMUNOL, V68, P652, DOI 10.1111/j.1365-3083.2008.02184.x; Owen A, 2004, J VIROL, V78, P12022, DOI 10.1128/JVI.78.21.12022-12029.2004; Palmer S, 2003, J CLIN MICROBIOL, V41, P4531, DOI 10.1128/JCM.41.10.4531-4536.2003; Palmer S, 2008, P NATL ACAD SCI USA, V105, P3879, DOI 10.1073/pnas.0800050105; Palmisano L, 2005, AIDS, V19, P1843, DOI 10.1097/01.aids.0000188426.87538.ed; Parera M, 2004, J INFECT DIS, V189, P1444, DOI 10.1086/382485; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Ramratnam B, 2000, NAT MED, V6, P82, DOI 10.1038/71577; Raymond S, 2008, AIDS, V22, pF11, DOI 10.1097/QAD.0b013e32830ebcd4; Sahu GK, 2009, J MED VIROL, V81, P9, DOI 10.1002/jmv.21366; Schmitt N, 2003, J VIROL, V77, P5784, DOI 10.1128/JVI.77.10.5784-5793.2003; Sharkey M, 2005, J VIROL, V79, P5203, DOI 10.1128/JVI.79.8.5203-5210.2005; Sharkey ME, 2000, NAT MED, V6, P76, DOI 10.1038/71569; Siliciano JD, 2003, NAT MED, V9, P727, DOI 10.1038/nm880; Sonza S, 2001, AIDS, V15, P17, DOI 10.1097/00002030-200101050-00005; Steel A, 2007, ANTIVIR THER, V12, P971; Taylor JR, 2001, J VIROL, V75, P8752, DOI 10.1128/JVI.75.18.8752-8760.2001; Tilling R, 2002, AIDS, V16, P589, DOI 10.1097/00002030-200203080-00010; Tobin NH, 2005, J VIROL, V79, P9625, DOI 10.1128/JVI.79.15.9625-9634.2005; VONLAER D, 1990, BLOOD, V76, P1281; Weber C, 2000, J LEUKOCYTE BIOL, V67, P699, DOI 10.1002/jlb.67.5.699; WEI XP, 1995, NATURE, V373, P117, DOI 10.1038/373117a0; WHITELAW DM, 1972, CELL TISSUE KINET, V5, P311, DOI 10.1111/j.1365-2184.1972.tb00369.x; Wilkin TJ, 2007, CLIN INFECT DIS, V44, P591, DOI 10.1086/511035; Wong JK, 1997, SCIENCE, V278, P1291, DOI 10.1126/science.278.5341.1291; Xu YN, 2008, J INFECT DIS, V197, P309, DOI 10.1086/524847; Zhang LQ, 2000, J CLIN INVEST, V106, P839, DOI 10.1172/JCI10565; Zhang LQ, 1999, NEW ENGL J MED, V340, P1605, DOI 10.1056/NEJM199905273402101; Zhu TF, 2002, J VIROL, V76, P707, DOI 10.1128/JVI.76.2.707-716.2002; ZieglerHeitbrock HWL, 1996, IMMUNOL TODAY, V17, P424, DOI 10.1016/0167-5699(96)10029-3	79	108	109	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2009	4	10							e7658	10.1371/journal.pone.0007658	http://dx.doi.org/10.1371/journal.pone.0007658			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RW	19876401	Green Published, Green Submitted, gold			2022-12-27	WOS:000271414300012
J	Riva, A; Pesole, G				Riva, Alberto; Pesole, Graziano			A Unique, Consistent Identifier for Alternatively Spliced Transcript Variants	PLOS ONE			English	Article							DATABASE; RESOURCE; PYRUVATE	Background: As research into alternative splicing reveals the fundamental importance of this phenomenon in the genome expression of higher organisms, there is an increasing need for a standardized, consistent and unique identifier for alternatively spliced isoforms. Such an identifier would be useful to eliminate ambiguities in references to gene isoforms, and would allow for the reliable comparison of isoforms from different sources ( e. g., known genes vs. computational predictions). Commonly used identifiers for gene transcripts prove to be unsuitable for this purpose. Methodology: We propose an algorithm to compute an isoform signature based on the arrangement of exons and introns in a primary transcript. The isoform signature uniquely identifies a transcript structure, and can therefore be used as a key in databases of alternatively spliced isoforms, or to compare alternative splicing predictions produced by different methods. In this paper we present the algorithm to generate isoform signatures, we provide some examples of its application, and we describe a web-based resource to generate isoform signatures and use them in database searches. Conclusions: Isoform signatures are simple, so that they can be easily generated and included in publications and databases, but flexible enough to unambiguously represent all possible isoform structures, including information about coding sequence position and variable transcription start and end sites. We believe that the adoption of isoform signatures can help establish a consistent, unambiguous nomenclature for alternative splicing isoforms. The system described in this paper is freely available at http://genome.ufl.edu/genesig/, and supplementary materials can be found at http://genome.ufl.edu/genesig-files/.			Riva, A (corresponding author), Univ Florida, Dept Mol Genet & Microbiol, Gainesville, FL 32610 USA.	ariva@ufl.edu	Pesole, Graziano/K-5283-2019; Pesole, Graziano/E-9051-2014; Pesole, Graziano/C-1408-2009	Pesole, Graziano/0000-0003-3663-0859; Pesole, Graziano/0000-0003-3663-0859; Riva, Alberto/0000-0001-9150-8333	Telethon [GGP06158] Funding Source: Medline	Telethon(Fondazione Telethon)		Bonizzoni P, 2009, J COMPUT BIOL, V16, P43, DOI 10.1089/cmb.2008.0028; Castrignano T, 2008, BIOINFORMATICS, V24, P1300, DOI 10.1093/bioinformatics/btn113; Christofk HR, 2008, NATURE, V452, P230, DOI 10.1038/nature06734; *FIPS, 1801 FIPS; Kim N, 2007, NUCLEIC ACIDS RES, V35, pD93, DOI 10.1093/nar/gkl884; Kreahling J, 2004, TRENDS GENET, V20, P1, DOI 10.1016/j.tig.2003.11.001; Lee BTK, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-189; Lee Y, 2007, NUCLEIC ACIDS RES, V35, pD99, DOI 10.1093/nar/gkl992; Matlin AJ, 2005, NAT REV MOL CELL BIO, V6, P386, DOI 10.1038/nrm1645; Nagasaki H, 2006, BIOINFORMATICS, V22, P1211, DOI 10.1093/bioinformatics/btl067; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; Sammeth M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000147; Stamm S, 2006, NUCLEIC ACIDS RES, V34, pD46, DOI 10.1093/nar/gkj031; Thangaraju M, 2009, BIOCHEM J, V417, P379, DOI 10.1042/BJ20081132; Thierry-Mieg D, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-s1-s12; Venables JP, 2004, CANCER RES, V64, P7647, DOI 10.1158/0008-5472.CAN-04-1910; Wang ET, 2008, NATURE, V456, P470, DOI 10.1038/nature07509; Wang GS, 2007, NAT REV GENET, V8, P749, DOI 10.1038/nrg2164; Wilming LG, 2008, NUCLEIC ACIDS RES, V36, pD753, DOI 10.1093/nar/gkm987; Wu TD, 2005, BIOINFORMATICS, V21, P1859, DOI 10.1093/bioinformatics/bti310	20	8	8	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7631	10.1371/journal.pone.0007631	http://dx.doi.org/10.1371/journal.pone.0007631			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19865484	Green Published, gold, Green Submitted			2022-12-27	WOS:000271194600015
J	Simonetta, SH; Migliori, ML; Romanowski, A; Golombek, DA				Simonetta, Sergio H.; Laura Migliori, Maria; Romanowski, Andres; Golombek, Diego A.			Timing of Locomotor Activity Circadian Rhythms in Caenorhabditis elegans	PLOS ONE			English	Article							C-ELEGANS; CLOCK; TEMPERATURE; DROSOPHILA; GENETICS; GENES; LIGHT; ROBUSTNESS; EXPRESSION; HOMOLOGS	Circadian rhythms are driven by endogenous biological clocks and are synchronized to environmental cues. The chronobiological study of Caenorhabditis elegans, an extensively used animal model for developmental and genetic research, might provide fundamental information about the basis of circadian rhythmicity in eukaryotes, due to its ease of use and manipulations, as well as availability of genetic data and mutant strains. The aim of this study is to fully characterize the circadian rhythm of locomotor activity in C. elegans, as well as a means for genetic screening in this nematode and the identification of circadian mutants. We have developed an infrared method to measure locomotor activity in C. elegans and found that, under constant conditions, although inter-individual variability is present, circadian periodicity shows a population distribution of periods centered at 23.9 +/- 0.4 h and is temperature-compensated. Locomotor activity is entrainable by light-dark cycles and by low-amplitude temperature cycles, peaking around the night-day transition and day, respectively. In addition, lin-42(mg152) or lin-42(n1089) mutants (bearing a mutation in the lin-42 gene, homolog to the per gene) exhibit a significantly longer circadian period of 25.2 +/- 0.4 h or 25.6 +/- 0.5 h, respectively. Our results represent a complete description of the locomotor activity rhythm in C. elegans, with a methodology that allowed us to uncover three of the key features of circadian systems: entrainment, free-running and temperature compensation. In addition, abnormal circadian periods in clock mutants suggest a common molecular machinery responsible for circadian rhythmicity. Our analysis of circadian rhythmicity in C. elegans opens the possibility for further screening for circadian mutations in this species.			Simonetta, SH (corresponding author), Univ Nacl Quilmes, Dept Ciencia & Tecnol, Buenos Aires, DF, Argentina.	dgolombek@unq.edu.ar	Romanowski, Andres/P-2153-2017	Romanowski, Andres/0000-0003-0737-2408; Golombek, Diego/0000-0002-6291-5586				Allada R, 2001, ANNU REV NEUROSCI, V24, P1091, DOI 10.1146/annurev.neuro.24.1.1091; Avivi A, 2002, P NATL ACAD SCI USA, V99, P11718, DOI 10.1073/pnas.182423299; Banerjee D, 2005, DEV CELL, V8, P287, DOI 10.1016/j.devcel.2004.12.006; Boothroyd CE, 2007, PLOS GENET, V3, DOI 10.1371/journal.pgen.0030054; Branicky R, 2000, BIOESSAYS, V22, P48, DOI 10.1002/(SICI)1521-1878(200001)22:1&lt;48::AID-BIES9&gt;3.0.CO;2-F; BRENNER S, 1974, GENETICS, V77, P71; Buckingham Steven D., 2008, Invertebrate Neuroscience, V8, P121, DOI 10.1007/s10158-008-0077-3; BURR AH, 1985, PHOTOCHEM PHOTOBIOL, V41, P577, DOI 10.1111/j.1751-1097.1985.tb03529.x; Butcher RA, 2007, NAT CHEM BIOL, V3, P420, DOI 10.1038/nchembio.2007.3; Chan RC, 2003, NATURE, V423, P1002, DOI 10.1038/nature01697; Dunlap JC, 1999, GENES CELLS, V4, P1, DOI 10.1046/j.1365-2443.1999.00239.x; Edwards SL, 2008, PLOS BIOL, V6, P1715, DOI 10.1371/journal.pbio.0060198; Fukuto HS, 2004, NEURON, V42, P581, DOI 10.1016/S0896-6273(04)00252-1; Gallego M, 2007, NAT REV MOL CELL BIO, V8, P139, DOI 10.1038/nrm2106; Glaser FT, 2007, COLD SH Q B, V72, P233, DOI 10.1101/sqb.2007.72.046; Gonze D, 2006, CHAOS, V16, DOI 10.1063/1.2211767; Gonze D, 2002, P NATL ACAD SCI USA, V99, P673, DOI 10.1073/pnas.022628299; Hasegawa K, 2005, CHRONOBIOL INT, V22, P1, DOI 10.1081/CBI-200038149; HUANG SX, 2004, COMPUTER INTEGRATED, V1, P1; Iwasaki K, 1997, TRENDS GENET, V13, P111, DOI 10.1016/S0168-9525(97)01059-7; IWASAKI K, 1995, P NATL ACAD SCI USA, V92, P10317, DOI 10.1073/pnas.92.22.10317; Janssen T, 2008, J BIOL CHEM, V283, P15241, DOI 10.1074/jbc.M709060200; Jeon M, 1999, SCIENCE, V286, P1141, DOI 10.1126/science.286.5442.1141; Kippert F, 2002, CURR BIOL, V12, pR47, DOI 10.1016/S0960-9822(01)00670-4; KONOPKA RJ, 1971, P NATL ACAD SCI USA, V68, P2112, DOI 10.1073/pnas.68.9.2112; LAMPRECHT G, 1986, NSS B, V47, P147; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-5; Levine JD, 2002, BMC NEUROSCI, V3, DOI 10.1186/1471-2202-3-1; PITTENDRIGH CS, 1981, HDB BEHAVIORAL NEURO, V4, P95; Qin HT, 2006, DEV BIOL, V298, P606, DOI 10.1016/j.ydbio.2006.07.017; Ramot D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002208; Rosato E, 2006, NAT PROTOC, V1, P559, DOI 10.1038/nprot.2006.79; Rosbash M, 2009, PLOS BIOL, V7, P421, DOI 10.1371/journal.pbio.1000062; Saigusa T, 2002, CURR BIOL, V12, pR46, DOI 10.1016/S0960-9822(01)00669-8; Simonetta SH, 2008, J COMP PHYSIOL A, V194, P821, DOI 10.1007/s00359-008-0353-z; Simonetta SH, 2007, J NEUROSCI METH, V161, P273, DOI 10.1016/j.jneumeth.2006.11.015; Szewczyk NJ, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-19; Take-uchi M, 2005, MOL BIOL CELL, V16, P1355, DOI 10.1091/mbc.E04-04-0273; Tanaka D, 2007, NEUROPHARMACOLOGY, V53, P157, DOI 10.1016/j.neuropharm.2007.04.017; Tennessen JM, 2006, DEV BIOL, V289, P30, DOI 10.1016/j.ydbio.2005.09.044; Ward A, 2008, NAT NEUROSCI, V11, P916, DOI 10.1038/nn.2155; WRIGHT STW, 1997, SCI ENG GUIDE DIGITA; Yu WJ, 2006, J CELL SCI, V119, P4793, DOI 10.1242/jcs.03174; ZIMMERMAN WF, 1968, J INSECT PHYSIOL, V14, P669, DOI 10.1016/0022-1910(68)90226-6	44	32	36	2	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7571	10.1371/journal.pone.0007571	http://dx.doi.org/10.1371/journal.pone.0007571			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859568	Green Published, gold, Green Submitted			2022-12-27	WOS:000271147400004
J	Wang, L; Wang, YC; Hu, XB; Zhang, BF; Dou, GR; He, F; Gao, F; Feng, F; Liang, YM; Dou, KF; Han, H				Wang, Lin; Wang, Yao-Chun; Hu, Xing-Bin; Zhang, Bing-Fang; Dou, Guo-Rui; He, Fei; Gao, Fang; Feng, Fan; Liang, Ying-Min; Dou, Ke-Feng; Han, Hua			Notch-RBP-J Signaling Regulates the Mobilization and Function of Endothelial Progenitor Cells by Dynamic Modulation of CXCR4 Expression in Mice	PLOS ONE			English	Article							BONE-MARROW-CELLS; LIVER-REGENERATION; NEOVASCULARIZATION CAPACITY; TRANSPLANTATION; ANGIOGENESIS; RECRUITMENT; FIBROSIS; DISEASE; TRAFFICKING; CONTRIBUTE	Bone marrow (BM)-derived endothelial progenitor cells (EPC) have therapeutic potentials in promoting tissue regeneration, but how these cells are modulated in vivo has been elusive. Here, we report that RBP-J, the critical transcription factor mediating Notch signaling, modulates EPC through CXCR4. In a mouse partial hepatectomy (PHx) model, RBP-J deficient EPC showed attenuated capacities of homing and facilitating liver regeneration. In resting mice, the conditional deletion of RBP-J led to a decrease of BM EPC, with a concomitant increase of EPC in the peripheral blood. This was accompanied by a down-regulation of CXCR4 on EPC in BM, although CXCR4 expression on EPC in the circulation was up-regulated in the absence of RBP-J. PHx in RBP-J deficient mice induced stronger EPC mobilization. In vitro, RBP-J deficient EPC showed lowered capacities of adhering, migrating, and forming vessel-like structures in three-dimensional cultures. Over-expression of CXCR4 could at least rescue the defects in vessel formation by the RBP-J deficient EPC. These data suggested that the RBP-J-mediated Notch signaling regulated EPC mobilization and function, at least partially through dynamic modulation of CXCR4 expression. Our findings not only provide new insights into the regulation of EPC, but also have implications for clinical therapies using EPC in diseases.			Wang, L (corresponding author), Fourth Mil Med Univ, Xi Jing Hosp, State Key Lab Canc Biol, Dept Med Genet & Dev Biol, Xian 710032, Peoples R China.	doukef@fmmu.edu.cn; huahan@fmmu.edu.cn	Hu, XB/U-8501-2019	Gao, Fang/0000-0003-1099-8620				Aoki M, 2004, STEM CELLS, V22, P994, DOI 10.1634/stemcells.22-6-994; Artavanis-Tsakonas S, 1999, SCIENCE, V284, P770, DOI 10.1126/science.284.5415.770; Asahara T, 2004, AM J PHYSIOL-CELL PH, V287, pC572, DOI 10.1152/ajpcell.00330.2003; Beaudry P, 2007, J PEDIATR SURG, V42, P1190, DOI 10.1016/j.jpedsurg.2007.02.034; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Chavakis E, 2005, J EXP MED, V201, P63, DOI 10.1084/jem.20041402; Dalakas E, 2005, FASEB J, V19, P1225, DOI 10.1096/fj.04-2604rev; Dou GR, 2008, FASEB J, V22, P1606, DOI 10.1096/fj.07-9998com; Fausto N, 2006, HEPATOLOGY, V43, pS45, DOI 10.1002/hep.20969; Fujii H, 2002, J HEPATOL, V36, P653, DOI 10.1016/S0168-8278(02)00043-0; Gridley T, 2007, DEVELOPMENT, V134, P2709, DOI 10.1242/dev.004184; Grunewald M, 2006, CELL, V124, P175, DOI 10.1016/j.cell.2005.10.036; Han H, 2002, INT IMMUNOL, V14, P637, DOI 10.1093/intimm/dxf030; Higashiyama R, 2007, HEPATOLOGY, V45, P213, DOI 10.1002/hep.21477; Houlihan DD, 2008, GASTROENTEROLOGY, V135, P438, DOI 10.1053/j.gastro.2008.05.040; Kalka C, 2000, P NATL ACAD SCI USA, V97, P3422, DOI 10.1073/pnas.070046397; Kawamoto A, 2001, CIRCULATION, V103, P634; Kwon SM, 2008, CIRCULATION, V118, P157, DOI 10.1161/CIRCULATIONAHA.107.754978; LeCouter J, 2003, SCIENCE, V299, P890, DOI 10.1126/science.1079562; Matsumoto K, 2001, SCIENCE, V294, P559, DOI 10.1126/science.1063889; Nakamura T, 2007, GASTROENTEROLOGY, V133, P91, DOI 10.1053/j.gastro.2007.03.110; Oh IY, 2007, BLOOD, V110, P3891, DOI 10.1182/blood-2006-10-048991; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Petit I, 2007, TRENDS IMMUNOL, V28, P299, DOI 10.1016/j.it.2007.05.007; Sakaida I, 2004, HEPATOLOGY, V40, P1304, DOI 10.1002/hep.20452; Sharpe EE, 2006, AM J PATHOL, V168, P1710, DOI 10.2353/ajpath.2006.050556; Taniguchi E, 2006, GASTROENTEROLOGY, V130, P521, DOI 10.1053/j.gastro.2005.10.050; Ueno T, 2006, MED MOL MORPHOL, V39, P16, DOI 10.1007/s00795-006-0311-1; Urbich C, 2004, CIRC RES, V95, P343, DOI 10.1161/01.RES.0000137877.89448.78; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; Wang L, 2009, HEPATOLOGY, V49, P268, DOI 10.1002/hep.22579; Yamaguchi J, 2003, CIRCULATION, V107, P1322, DOI 10.1161/01.CIR.0000055313.77510.22	32	30	33	0	48	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7572	10.1371/journal.pone.0007572	http://dx.doi.org/10.1371/journal.pone.0007572			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859544	Green Published, gold, Green Submitted			2022-12-27	WOS:000271147400005
J	Cai, F; Menon, BB; Cannon, GC; Curry, KJ; Shively, JM; Heinhorst, S				Cai, Fei; Menon, Balaraj B.; Cannon, Gordon C.; Curry, Kenneth J.; Shively, Jessup M.; Heinhorst, Sabine			The Pentameric Vertex Proteins Are Necessary for the Icosahedral Carboxysome Shell to Function as a CO2 Leakage Barrier	PLOS ONE			English	Article							CARBONIC-ANHYDRASE; HALOTHIOBACILLUS-NEAPOLITANUS; THIOBACILLUS-NEAPOLITANUS; POLYHEDRAL BODIES; ORGANELLES; FORM; MICROCOMPARTMENT; ULTRASTRUCTURE; SALMONELLA; GENERATE	Background: Carboxysomes are polyhedral protein microcompartments found in many autotrophic bacteria; they encapsulate the CO2 fixing enzyme, ribulose-1,5-bisphosphate carboxylase/oxygenase (RubisCO) within a thin protein shell and provide an environment that enhances the catalytic capabilities of the enzyme. Two types of shell protein constituents are common to carboxysomes and related microcompartments of heterotrophic bacteria, and the genes for these proteins are found in a large variety of bacteria. Methodology/Principal Findings: We have created a Halothiobacillus neapolitanus knockout mutant that does not produce the two paralogous CsoS4 proteins thought to occupy the vertices of the icosahedral carboxysomes and related microcompartments. Biochemical and ultrastructural analyses indicated that the mutant predominantly forms carboxysomes of normal appearance, in addition to some elongated microcompartments. Despite their normal shape, purified mutant carboxysomes are functionally impaired, although the activities of the encapsulated enzymes are not negatively affected. Conclusions/Significance: In the absence of the CsoS4 proteins the carboxysome shell loses its limited permeability to CO2 and is no longer able to provide the catalytic advantage RubisCO derives from microcompartmentalization. This study presents direct evidence that the diffusion barrier property of the carboxysome shell contributes significantly to the biological function of the carboxysome.			Cai, F (corresponding author), Univ So Mississippi, Dept Chem & Biochem, Hattiesburg, MS 39406 USA.	sabine.heinhorst@usm.edu			Div Of Molecular and Cellular Bioscience [0818680] Funding Source: National Science Foundation	Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO))		Baker SH, 1998, J BACTERIOL, V180, P4133, DOI 10.1128/JB.180.16.4133-4139.1998; Bobik TA, 2006, APPL MICROBIOL BIOT, V70, P517, DOI 10.1007/s00253-005-0295-0; Cai F, 2008, ARCH MICROBIOL, V189, P141, DOI 10.1007/s00203-007-0305-y; CANNON GC, 1983, ARCH MICROBIOL, V134, P52, DOI 10.1007/BF00429407; Cannon GC, 2003, CURR MICROBIOL, V46, P115, DOI 10.1007/s00284-002-3825-3; Crowley CS, 2008, STRUCTURE, V16, P1324, DOI 10.1016/j.str.2008.05.013; Dou ZC, 2008, J BIOL CHEM, V283, P10377, DOI 10.1074/jbc.M709285200; ENGLISH RS, 1995, APPL ENVIRON MICROB, V61, P3256, DOI 10.1128/AEM.61.9.3256-3260.1995; GANTT E, 1969, J BACTERIOL, V97, P1486, DOI 10.1128/JB.97.3.1486-1493.1969; Havemann GD, 2002, J BACTERIOL, V184, P1253, DOI 10.1128/JB.184.5.1253-1261.2002; Heinhorst S., 2006, COMPLEX INTRACELLULA, P141; Heinhorst S, 2006, J BACTERIOL, V188, P8087, DOI 10.1128/JB.00990-06; Johnson JE, 1997, J MOL BIOL, V269, P665, DOI 10.1006/jmbi.1997.1068; Kerfeld CA, 2005, SCIENCE, V309, P936, DOI 10.1126/science.1113397; KHALIFAH RG, 1971, J BIOL CHEM, V246, P2561; KLEIN MG, 2009, J MOL BIOL IN PRESS; Menon BB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003570; Parsons JB, 2008, J BIOL CHEM, V283, P14366, DOI 10.1074/jbc.M709214200; PRICE GD, 1989, PLANT PHYSIOL, V91, P514, DOI 10.1104/pp.91.2.514; PRICE GD, 1991, CAN J BOT, V69, P963, DOI 10.1139/b91-124; PRICE GD, 1993, J BACTERIOL, V175, P2871, DOI 10.1128/JB.175.10.2871-2879.1993; Sagermann M, 2009, P NATL ACAD SCI USA, V106, P8883, DOI 10.1073/pnas.0902324106; Sato T, 1968, J Electron Microsc (Tokyo), V17, P158; Sawaya MR, 2006, J BIOL CHEM, V281, P7546, DOI 10.1074/jbc.M510464200; Shively JM, 1998, CAN J BOT, V76, P906, DOI 10.1139/b98-088; SHIVELY JM, 1973, J BACTERIOL, V116, P1405, DOI 10.1128/JB.116.3.1405-1411.1973; SHIVELY JM, 1970, J BACTERIOL, V101, P618, DOI 10.1128/JB.101.2.618-627.1970; So AKC, 2004, J BACTERIOL, V186, P623, DOI 10.1128/JB.186.3.623-630.2004; Tanaka S, 2008, SCIENCE, V319, P1083, DOI 10.1126/science.1151458; Tanaka S, 2009, PROTEIN SCI, V18, P108, DOI 10.1002/pro.14; Tsai Y, 2007, PLOS BIOL, V5, P1345, DOI 10.1371/journal.pbio.0050144; Yeates TO, 2008, NAT REV MICROBIOL, V6, P681, DOI 10.1038/nrmicro1913; Yu DG, 2000, P NATL ACAD SCI USA, V97, P5978, DOI 10.1073/pnas.100127597	33	79	85	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7521	10.1371/journal.pone.0007521	http://dx.doi.org/10.1371/journal.pone.0007521			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844578	Green Published, Green Submitted, gold			2022-12-27	WOS:000271013000008
J	Jacquot, G; Le Rouzic, E; Maidou-Peindara, P; Maizy, M; Lefrere, JJ; Daneluzzi, V; Monteiro, CMR; Hong, DP; Planelles, V; Morand-Joubert, L; Benichou, S				Jacquot, Guillaume; Le Rouzic, Erwann; Maidou-Peindara, Priscilla; Maizy, Marion; Lefrere, Jean-Jacques; Daneluzzi, Vincent; Monteiro-Filho, Carlos M. R.; Hong, Duanping; Planelles, Vicente; Morand-Joubert, Laurence; Benichou, Serge			Characterization of the Molecular Determinants of Primary HIV-1 Vpr Proteins: Impact of the Q65R and R77Q Substitutions on Vpr Functions	PLOS ONE			English	Article							IMMUNODEFICIENCY-VIRUS TYPE-1; CELL-CYCLE ARREST; NUCLEAR-PORE COMPLEX; DISEASE PROGRESSION; G(2) ARREST; MACROPHAGE INFECTION; VIRION INCORPORATION; MUTATIONAL ANALYSIS; UBIQUITIN LIGASE; IN-VIVO	Although HIV-1 Vpr displays several functions in vitro, limited information exists concerning their relevance during infection. Here, we characterized Vpr variants isolated from a rapid and a long-term non-progressor (LTNP). Interestingly, vpr alleles isolated from longitudinal samples of the LTNP revealed a dominant sequence that subsequently led to diversity similar to that observed in the progressor patient. Most of primary Vpr proteins accumulated at the nuclear envelope and interacted with host-cell partners of Vpr. They displayed cytostatic and proapoptotic activities, although a LTNP allele, harboring the Q65R substitution, failed to bind the DCAF1 subunit of the Cul4a/DDB1 E3 ligase and was inactive. This Q65R substitution correlated with impairment of Vpr docking at the nuclear envelope, raising the possibility of a functional link between this property and the Vpr cytostatic activity. In contradiction with published results, the R77Q substitution, found in LTNP alleles, did not influence Vpr proapoptotic activity.			Jacquot, G (corresponding author), Univ Paris 05, CNRS, UMR 8104, Inst Cochin, Paris, France.	laurence.morand-joubert@sat.aphp.fr; serge.benichou@inserm.fr		Benichou, Serge/0000-0003-3602-3530	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R56AI049057, R01AI049057] Funding Source: NIH RePORTER; NIAID NIH HHS [AI49057, R01 AI049057, R56 AI049057] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agostini I, 2002, AIDS RES HUM RETROV, V18, P283, DOI 10.1089/088922202753472856; Andersen JL, 2005, CURR HIV RES, V3, P43, DOI 10.2174/1570162052772988; Andersen JL, 2006, PLOS PATHOG, V2, P1106, DOI 10.1371/journal.ppat.0020127; Bell CM, 2007, AIDS RES HUM RETROV, V23, P322, DOI 10.1089/aid.2006.0181; Belzile JP, 2007, PLOS PATHOG, V3, P882, DOI 10.1371/journal.ppat.0030085; Chen MZ, 1999, J VIROL, V73, P3236, DOI 10.1128/JVI.73.4.3236-3245.1999; CHEN R, 2004, J BIOL CHEM; CHIU YL, 2007, ANN REV IMMUNOL; de Noronha CMC, 2001, SCIENCE, V294, P1105, DOI 10.1126/science.1063957; DeHart JL, 2007, VIROL J, V4, DOI 10.1186/1743-422X-4-57; DIMARZIO P, 1995, J VIROL, V69, P7909, DOI 10.1128/JVI.69.12.7909-7916.1995; Fischer A, 2004, AIDS, V18, P1346, DOI 10.1097/00002030-200406180-00018; Fouchier RAM, 1998, J VIROL, V72, P6004, DOI 10.1128/JVI.72.7.6004-6013.1998; GIBBS JS, 1995, J VIROL, V69, P2378, DOI 10.1128/JVI.69.4.2378-2383.1995; Goh WC, 1998, NAT MED, V4, P65, DOI 10.1038/nm0198-065; Hrecka K, 2007, P NATL ACAD SCI USA, V104, P11778, DOI 10.1073/pnas.0702102104; Jacquot G, 2007, RETROVIROLOGY, V4, DOI 10.1186/1742-4690-4-84; Lai MY, 2006, CELL CYCLE, V5, P2275, DOI 10.4161/cc.5.19.3317; Lamine A, 2007, AIDS, V21, P1043, DOI 10.1097/QAD.0b013e3280d5a7ac; LANG SM, 1993, J VIROL, V67, P902, DOI 10.1128/JVI.67.2.902-912.1993; Le Rouzic E, 2005, RETROVIROLOGY, V2, DOI 10.1186/1742-4690-2-11; Le Rouzic E, 2002, J BIOL CHEM, V277, P45091, DOI 10.1074/jbc.M207439200; Le Rouzic E, 2007, CELL CYCLE, V6, P182, DOI 10.4161/cc.6.2.3732; Lefrere JJ, 2004, TRANSFUSION, V44, P623, DOI 10.1111/j.1537-2995.2004.00354.x; Lefrere JJ, 1997, BLOOD, V90, P1133, DOI 10.1182/blood.V90.3.1133.1133_1133_1140; Lum JJ, 2003, J CLIN INVEST, V111, P1547, DOI 10.1172/JCI200316233; Mahalingam S, 1997, J VIROL, V71, P6339, DOI 10.1128/JVI.71.9.6339-6347.1997; Mansky LM, 2000, J VIROL, V74, P7039, DOI 10.1128/JVI.74.15.7039-7047.2000; MEIER UC, 1995, SCIENCE, V270, P1360, DOI 10.1126/science.270.5240.1360; Mologni D, 2006, AIDS, V20, P567, DOI 10.1097/01.aids.0000210611.60459.0e; Morellet N, 2003, J MOL BIOL, V327, P215, DOI 10.1016/S0022-2836(03)00060-3; Nishizawa M, 2000, VIROLOGY, V276, P16, DOI 10.1006/viro.2000.0534; NITAHARA K, 2007, J VIROL; Pantaleo G, 1996, ANNU REV MICROBIOL, V50, P825, DOI 10.1146/annurev.micro.50.1.825; PHILLIPS RE, 1991, NATURE, V354, P453, DOI 10.1038/354453a0; Popov S, 1998, J BIOL CHEM, V273, P13347, DOI 10.1074/jbc.273.21.13347; Py B, 2004, J IMMUNOL, V172, P4008, DOI 10.4049/jimmunol.172.7.4008; Rajan D, 2006, AIDS, V20, P831, DOI 10.1097/01.aids.0000218546.31716.7f; Schrofelbauer B, 2007, P NATL ACAD SCI USA, V104, P4130, DOI 10.1073/pnas.0610167104; Selig L, 1999, J VIROL, V73, P592, DOI 10.1128/JVI.73.1.592-600.1999; Selig L, 1997, J VIROL, V71, P4842, DOI 10.1128/JVI.71.6.4842-4846.1997; TAN L, 2007, J VIROL; Troyer RM, 2005, J VIROL, V79, P9006, DOI 10.1128/JVI.79.14.9006-9018.2005; Vodicka MA, 1998, GENE DEV, V12, P175, DOI 10.1101/gad.12.2.175; Waldhuber MG, 2003, VIROLOGY, V313, P91, DOI 10.1016/S0042-6822(03)00258-7; WEN X, 2007, J BIOL CHEM; YAO XJ, 1995, J VIROL, V69, P7032, DOI 10.1128/JVI.69.11.7032-7044.1995; Zhou Y, 2000, J VIROL, V74, P6520, DOI 10.1128/JVI.74.14.6520-6527.2000	48	21	22	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7514	10.1371/journal.pone.0007514	http://dx.doi.org/10.1371/journal.pone.0007514			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838296	Green Published, gold, Green Submitted			2022-12-27	WOS:000270880900015
J	Li, H; MacLean, G; Cameron, D; Clagett-Dame, M; Petkovich, M				Li, Hui; MacLean, Glenn; Cameron, Don; Clagett-Dame, Margaret; Petkovich, Martin			Cyp26b1 Expression in Murine Sertoli Cells Is Required to Maintain Male Germ Cells in an Undifferentiated State during Embryogenesis	PLOS ONE			English	Article							RETINOIC ACID; MITOTIC ARREST; MOUSE; HINDBRAIN; FETAL; RAT; ENZYME; TESTIS	In mammals, germ cells within the developing gonad follow a sexually dimorphic pathway. Germ cells in the murine ovary enter meiotic prophase during embryogenesis, whereas germ cells in the embryonic testis arrest in G0 of mitotic cell cycle and do not enter meiosis until after birth. In mice, retinoic acid (RA) signaling has been implicated in controlling entry into meiosis in germ cells, as meiosis in male embryonic germ cells is blocked by the activity of a RA-catabolizing enzyme, CYP26B1. However, the mechanisms regulating mitotic arrest in male germ cells are not well understood. Cyp26b1 expression in the testes begins in somatic cells at embryonic day (E) 11.5, prior to mitotic arrest, and persists throughout fetal development. Here, we show that Sertoli cell-specific loss of CYP26B1 activity between E15.5 and E16.5, several days after germ cell sex determination, causes male germ cells to exit from G0, re-enter the mitotic cell cycle and initiate meiotic prophase. These results suggest that male germ cells retain the developmental potential to differentiate in meiosis until at least at E15.5. CYP26B1 in Sertoli cells acts as a masculinizing factor to arrest male germ cells in the G0 phase of the cell cycle and prevents them from entering meiosis, and thus is essential for the maintenance of the undifferentiated state of male germ cells during embryonic development.			Li, H (corresponding author), Univ Wisconsin, Dept Biochem, 420 Henry Mall, Madison, WI 53705 USA.	petkovic@queensu.ca			Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Abu-Abed S, 2001, GENE DEV, V15, P226, DOI 10.1101/gad.855001; Baltus AE, 2006, NAT GENET, V38, P1430, DOI 10.1038/ng1919; BELLVE AR, 1977, J CELL BIOL, V74, P68, DOI 10.1083/jcb.74.1.68; Bowles J, 2006, SCIENCE, V312, P596, DOI 10.1126/science.1125691; KOSHIMIZU U, 1995, DEV BIOL, V168, P683, DOI 10.1006/dbio.1995.1113; Koubova J, 2006, P NATL ACAD SCI USA, V103, P2474, DOI 10.1073/pnas.0510813103; LAMMERS JHM, 1994, MOL CELL BIOL, V14, P1137, DOI 10.1128/MCB.14.2.1137; Lecureuil C, 2002, GENESIS, V33, P114, DOI 10.1002/gene.10100; Livera G, 2000, BIOL REPROD, V62, P1303, DOI 10.1095/biolreprod62.5.1303; MacLean G, 2007, ENDOCRINOLOGY, V148, P4560, DOI 10.1210/en.2007-0492; Maclean G, 2009, DEV DYNAM, V238, P732, DOI 10.1002/dvdy.21878; McLaren A, 2003, DEV BIOL, V262, P1, DOI 10.1016/S0012-1606(03)00214-8; McLaren A, 1997, DEV BIOL, V187, P107, DOI 10.1006/dbio.1997.8584; Nagano R, 2000, ANAT REC, V258, P210; Niederreither K, 1999, NAT GENET, V21, P444, DOI 10.1038/7788; Niederreither K, 2008, NAT REV GENET, V9, P541, DOI 10.1038/nrg2340; O'Shaughnessy PJ, 2007, ENDOCRINOLOGY, V148, P2914, DOI 10.1210/en.2006-1412; Pennimpede T, 2006, AD DEV BIOL, V16, P65, DOI 10.1016/S1574-3349(06)16003-2; Sakai Y, 2001, GENE DEV, V15, P213, DOI 10.1101/gad.851501; Trautmann E, 2008, CELL CYCLE, V7, P656, DOI 10.4161/cc.7.5.5482; Western PS, 2008, STEM CELLS, V26, P339, DOI 10.1634/stemcells.2007-0622; White JC, 2000, DEV BIOL, V220, P263, DOI 10.1006/dbio.2000.9635; Wu JW, 2008, ASIAN J ANDROL, V10, P569, DOI 10.1111/j.1745-7262.2008.00408.x; Yashiro K, 2004, DEV CELL, V6, P411, DOI 10.1016/S1534-5807(04)00062-0	24	61	62	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7501	10.1371/journal.pone.0007501	http://dx.doi.org/10.1371/journal.pone.0007501			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838304	Green Submitted, gold, Green Published			2022-12-27	WOS:000270880900007
J	Hussain, R; Talat, N; Shahid, F; Dawood, G				Hussain, Rabia; Talat, Najeeha; Shahid, Firdaus; Dawood, Ghaffar			Biomarker Changes Associated with Tuberculin Skin Test (TST) Conversion: A Two-Year Longitudinal Follow-Up Study in Exposed Household Contacts	PLOS ONE			English	Article							TUMOR-NECROSIS-FACTOR; ALPHA TNF-ALPHA; MYCOBACTERIUM-TUBERCULOSIS; BLOOD-TEST; RESPONSES; IL-10; INTERLEUKIN-6; PREVALENCE; INFECTION; RECOMBINANT	Background: A high prevalence (50-80%) of Tuberculin Skin Test Positivity (TST+ >= 10 mm indurations) has been reported in TB endemic countries. This pool forms a huge reservoir for new incident TB cases. However, immune biomarkers associated with TST conversion are largely unknown. The objective of this study was to identify immune biomarkers associated with TST conversion after acute Mycobacterium tuberculosis (MTB) exposure. Methodology/Principal Findings: A 24 month longitudinal study was carried out in a recently MTB exposed cohort of household contacts (HC = 93; 75% TST+). Control group consisted of unexposed community controls (EC = 59; 46% TST+). Cytokine secretion was assessed in whole blood cultures in response to either mycobacterial culture filtrate (CF) antigens or mitogens (PHA or LPS) using Elisa methodology. Compared to the EC group, the HC group at recruitment (Kruskal-Wallis Test) showed significantly suppressed IFN gamma ( p = 0.0001), raised IL-10 ( p = 0.0005) and raised TNF alpha ( p = 0.001) in response to CF irrespective of their TST status. Seventeen TST-HC, showed TST conversion when retested at 6 months. Post TST conversion (paired t tests) significant increases were observed for CF induced IFN gamma (p = 0.038), IL-10 (p = 0.001) and IL-6 ( p = 0.006). Cytokine responses were also compared in the exposed HC group with either recent infection [(TST converters ( N = 17)] or previous infection [TST+ HC ( N = 54)] at 0, 6, 12 and 24 months using ANOVA on repeated measures. Significant differences between the exposed HC groups were noted only at 6 months. CF induced IFN gamma was higher in previously infected HC group ( p = 0.038) while IL-10 was higher in recently infected HC group ( p = 0.041). Mitogen induced cytokine secretion showed similar differences for different group. Conclusions/Significance: Our results suggest that TST conversion is associated with early increases in IFN gamma and IL-10 responses and precedes latency by several months post exposure.			Hussain, R (corresponding author), Aga Khan Univ, Dept Pathol & Microbiol, Karachi, Pakistan.	rabia.hussain@aku.edu	Hussain, Rabia/E-9982-2015					Abebe F, 2006, CLIN EXP IMMUNOL, V143, P180, DOI 10.1111/j.1365-2249.2005.02976.x; Akhtar S, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-70; Black GF, 2003, CLIN DIAGN LAB IMMUN, V10, P602, DOI 10.1128/CDLI.10.4.602-611.2003; Black GF, 2001, INT J TUBERC LUNG D, V5, P664; Britton WJ, 2005, TUBERCULOSIS, V85, P137, DOI 10.1016/j.tube.2004.06.003; CROFTON J, 1990, CROFTON DOUGLAS RESP, P395; Demissie A, 2006, INFECT IMMUN, V74, P2817, DOI 10.1128/IAI.74.5.2817-2822.2006; Diel R, 2006, RESP RES, V7, DOI 10.1186/1465-9921-7-77; Dye C, 1999, JAMA-J AM MED ASSOC, V282, P677, DOI 10.1001/jama.282.7.677; Elliott AM, 2004, T ROY SOC TROP MED H, V98, P660, DOI 10.1016/j.trstmh.2004.01.007; Ewer K, 2006, AM J RESP CRIT CARE, V174, P831, DOI 10.1164/rccm.200511-1783OC; FIORENTINO DF, 1991, J IMMUNOL, V147, P3815; Gaikwad AN, 2008, CLIN EXP IMMUNOL, V151, P414, DOI 10.1111/j.1365-2249.2007.03585.x; Higgins DM, 2009, TUBERCULOSIS, V89, P149, DOI 10.1016/j.tube.2009.01.001; Hill PC, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001379; Hill PC, 2007, PLOS MED, V4, P1061, DOI 10.1371/journal.pmed.0040192; Hussain H, 2003, INT J EPIDEMIOL, V32, P794, DOI 10.1093/ije/dyg247; Hussain R, 2002, J IMMUNOL METHODS, V264, P95, DOI 10.1016/S0022-1759(02)00092-3; Hussain R, 2001, CLIN EXP IMMUNOL, V123, P210, DOI 10.1046/j.1365-2249.2001.01439.x; Hussain R, 2007, CLIN VACCINE IMMUNOL, V14, P1578, DOI 10.1128/CVI.00289-07; Ito T, 2007, EUR J IMMUNOL, V37, P2847, DOI 10.1002/eji.200737603; Katakura T, 2004, J IMMUNOL, V172, P1407, DOI 10.4049/jimmunol.172.3.1407; Keane J, 2005, RHEUMATOLOGY, V44, P714, DOI 10.1093/rheumatology/keh567; KINDLER V, 1989, CELL, V56, P731, DOI 10.1016/0092-8674(89)90676-4; Leal IS, 1999, INFECT IMMUN, V67, P5747, DOI 10.1128/IAI.67.11.5747-5754.1999; LUE C, 1991, CELL IMMUNOL, V132, P423, DOI 10.1016/0008-8749(91)90039-E; Menzies D, 1999, AM J RESP CRIT CARE, V159, P15, DOI 10.1164/ajrccm.159.1.9801120; O'Garra A, 2004, J CLIN INVEST, V114, P1372, DOI 10.1172/JCI200423215; Rathi SK, 2002, INT J TUBERC LUNG D, V6, P851; Saunders BM, 2000, INFECT IMMUN, V68, P3322, DOI 10.1128/IAI.68.6.3322-3326.2000; SORENSEN AL, 1995, INFECT IMMUN, V63, P1710; Stenger S, 2002, CURR OPIN IMMUNOL, V14, P452, DOI 10.1016/S0952-7915(02)00355-2; Streeton JA, 1998, INT J TUBERC LUNG D, V2, P443; Talat N, 2009, SCAND J IMMUNOL, V69, P537, DOI 10.1111/j.1365-3083.2009.02250.x; Thakurdas SM, 2004, CLIN EXP IMMUNOL, V136, P320, DOI 10.1111/j.1365-2249.2004.02459.x; WALLIS RS, 1993, INFECT IMMUN, V61, P627, DOI 10.1128/IAI.61.2.627-632.1993; WALLIS RS, 1990, P NATL ACAD SCI USA, V87, P3348, DOI 10.1073/pnas.87.9.3348; Whalen CC, 2006, AM J TROP MED HYG, V75, P55, DOI 10.4269/ajtmh.2006.75.55; *WHO, 2009, REV NAT IMM COV 1980; *WHO, 2007, WHO GLOB TUB CONTR S; *WHO, 2008, WHO REP 2008 COUNTR, P133; Young DB, 2009, TRENDS MICROBIOL, V17, P183, DOI 10.1016/j.tim.2009.02.005; 2009, WHO STAT 2009	43	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7444	10.1371/journal.pone.0007444	http://dx.doi.org/10.1371/journal.pone.0007444			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826490	Green Published, Green Submitted, gold			2022-12-27	WOS:000270808700008
J	Yamamoto, S; Humle, T; Tanaka, M				Yamamoto, Shinya; Humle, Tatyana; Tanaka, Masayuki			Chimpanzees Help Each Other upon Request	PLOS ONE			English	Article							TOOL-USE; NAIVE CHIMPANZEES; CAPUCHIN MONKEYS; FOOD; ALTRUISM; CONSPECIFICS; COOPERATION; RECIPROCITY; EVOLUTION; MOTHERS	Background: The evolution of altruism has been explained mainly from ultimate perspectives. However, it remains to be investigated from a proximate point of view how and in which situations such social propensity is achieved. We investigated chimpanzees' targeted helping in a tool transfer paradigm, and discuss the similarities and differences in altruism between humans and chimpanzees. Previously it has been suggested that chimpanzees help human experimenters by retrieving an object which the experimenter is trying to reach. In the present study, we investigated the importance of communicative interactions between chimpanzees themselves and the influence of conspecific partner's request on chimpanzees' targeted helping. Methodology/Principal Findings: We presented two tool-use situations ( a stick-use situation and a straw-use situation) in two adjacent booths, and supplied non-corresponding tools to paired chimpanzees in the two booths. For example, a chimpanzee in the stick-use situation was supplied with a straw, and the partner in the straw-use situation possessed a stick. Spontaneous tool transfer was observed between paired chimpanzees. The tool transfer events occurred predominantly following recipients' request. Even without any hope of reciprocation from the partner, the chimpanzees continued to help the partner as long as the partner required help. Conclusions/Significance: These results provide further evidence for altruistic helping in chimpanzees in the absence of direct personal gain or even immediate reciprocation. Our findings additionally highlight the importance of request as a proximate mechanism motivating prosocial behavior in chimpanzees whether between kin or non-kin individuals and the possible confounding effect of dominance on the symmetry of such interactions. Finally, in contrast to humans, our study suggests that chimpanzees rarely perform acts of voluntary altruism. Voluntary altruism in chimpanzees is not necessarily prompted by simple observation of another's struggle to attain a goal and therefore an accurate understanding of others' desires in the absence of communicative signals.			Yamamoto, S (corresponding author), Kyoto Univ, Primate Res Inst, Aichi, Japan.	yamamoto@darwin.c.u-tokyo.ac.jp						Boesch C, 2000, CHIMPANZEES TAI FORE; Brosnan SF, 2009, J COMP PSYCHOL, V123, P181, DOI 10.1037/a0015092; Burkart JM, 2007, P NATL ACAD SCI USA, V104, P19762, DOI 10.1073/pnas.0710310104; Call J, 2008, TRENDS COGN SCI, V12, P187, DOI 10.1016/j.tics.2008.02.010; Celli ML, 2004, INT J PRIMATOL, V25, P1267, DOI 10.1023/B:IJOP.0000043962.60837.16; Cronin KA, 2009, J COMP PSYCHOL, V123, P231, DOI 10.1037/a0015094; De Waal F., 1996, GOOD NATURED; de Waal FBM, 2000, NATURE, V404, P563, DOI 10.1038/35007138; de Waal FBM, 2008, P NATL ACAD SCI USA, V105, P13685, DOI 10.1073/pnas.0807060105; de Waal FBM, 2008, ANNU REV PSYCHOL, V59, P279, DOI 10.1146/annurev.psych.59.103006.093625; DEWAAL FBM, 1989, J HUM EVOL, V18, P433, DOI 10.1016/0047-2484(89)90074-2; Dufour V, 2009, BIOL LETTERS, V5, P172, DOI 10.1098/rsbl.2008.0644; Dugatkin L.A., 1997, COOPERATION ANIMALS; Goodall J., 1986, CHIMPANZEES GOMBE PA; HAMILTON WD, 1964, J THEOR BIOL, V7, P1, DOI 10.1016/0022-5193(64)90039-6; Hattori Y, 2005, J COMP PSYCHOL, V119, P335, DOI 10.1037/0735-7036.119.3.335; Hauser MD, 2003, P ROY SOC B-BIOL SCI, V270, P2363, DOI 10.1098/rspb.2003.2509; Hayashi M, 2005, PRIMATES, V46, P91, DOI 10.1007/s10329-004-0110-z; Hikami K., 1991, Primate Research, V7, P12; Hirata S, 2000, J COMP PSYCHOL, V114, P291, DOI 10.1037/0735-7036.114.3.291; Hirata S, 2003, ANIM COGN, V6, P235, DOI 10.1007/s10071-003-0187-6; Hirata S, 2007, PRIMATES, V48, P13, DOI 10.1007/s10329-006-0022-1; Hockings KJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000886; Jensen K, 2006, P ROY SOC B-BIOL SCI, V273, P1013, DOI 10.1098/rspb.2005.3417; Lakshminarayanan VR, 2008, CURR BIOL, V18, pR999, DOI 10.1016/j.cub.2008.08.057; Matsuzawa T, 2003, ANIM COGN, V6, P199, DOI 10.1007/s10071-003-0199-2; Matsuzawa T, 2001, PRIMATE ORIGINS OF HUMAN COGNITION AND BEHAVIOR, P557; Matsuzawa T., 2006, COGNITIVE DEV CHIMPA; Melis AP, 2008, ANIM BEHAV, V76, P951, DOI 10.1016/j.anbehav.2008.05.014; Melis AP, 2006, ANIM BEHAV, V72, P275, DOI 10.1016/j.anbehav.2005.09.018; Mitani JC, 2001, ANIM BEHAV, V61, P915, DOI 10.1006/anbe.2000.1681; OCHIAI T, 1998, P 3 INT C ENV ENR OR, P355; SAVAGERUMBAUGH ES, 1978, BEHAV BRAIN SCI, V1, P539, DOI 10.1017/S0140525X00076536; Silk JB, 2005, NATURE, V437, P1357, DOI 10.1038/nature04243; Stevens JR, 2004, P ROY SOC B-BIOL SCI, V271, P451, DOI 10.1098/rspb.2003.2625; Tanaka M, 2009, ANIM COGN, V12, pS19, DOI 10.1007/s10071-009-0270-8; TELEKI G, 1973, PREDATORY BEHAV WILD; Tomonaga M, 2004, JPN PSYCHOL RES, V46, P227, DOI 10.1111/j.1468-5584.2004.00254.x; TRIVERS RL, 1971, Q REV BIOL, V46, P35, DOI 10.1086/406755; Ueno A, 2004, PRIMATES, V45, P231, DOI 10.1007/s10329-004-0085-9; Van Schaik CP, 2006, COOPERATION IN PRIMATES AND HUMANS: MECHANISMS AND EVOLUTIONS, P3; Vonk J, 2008, ANIM BEHAV, V75, P1757, DOI 10.1016/j.anbehav.2007.09.036; Warneken F, 2006, SCIENCE, V311, P1301, DOI 10.1126/science.1121448; Warneken F, 2007, PLOS BIOL, V5, P1414, DOI 10.1371/journal.pbio.0050184; Yamamoto S, 2009, ANIM COGN, V12, pS27, DOI 10.1007/s10071-009-0276-2; Yamamoto S, 2009, J COMP PSYCHOL, V123, P242, DOI 10.1037/a0015838; Yamamoto S, 2009, INTERACT STUD, V10, P150, DOI 10.1075/is.10.2.04yam; [No title captured]	48	116	119	3	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7416	10.1371/journal.pone.0007416	http://dx.doi.org/10.1371/journal.pone.0007416			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	506WT	19826478	Green Published, gold, Green Accepted, Green Submitted			2022-12-27	WOS:000270808700005
J	Akcay, E; Roughgarden, J				Akcay, Erol; Roughgarden, Joan			The Perfect Family: Decision Making in Biparental Care	PLOS ONE			English	Article							PARENTAL CARE; SEXUAL SELECTION; OFFSPRING CARE; NEGOTIATION; TITS; MANIPULATION; CONFLICT; BEHAVIOR; FEMALES; PARUS	Background: Previous theoretical work on parental decisions in biparental care has emphasized the role of the conflict between evolutionary interests of parents in these decisions. A prominent prediction from this work is that parents should compensate for decreases in each other's effort, but only partially so. However, experimental tests that manipulate parents and measure their responses fail to confirm this prediction. At the same time, the process of parental decision making has remained unexplored theoretically. We develop a model to address the discrepancy between experiments and the theoretical prediction, and explore how assuming different decision making processes changes the prediction from the theory. Model Description: We assume that parents make decisions in behavioral time. They have a fixed time budget, and allocate it between two parental tasks: provisioning the offspring and defending the nest. The proximate determinant of the allocation decisions are parents' behavioral objectives. We assume both parents aim to maximize the offspring production from the nest. Experimental manipulations change the shape of the nest production function. We consider two different scenarios for how parents make decisions: one where parents communicate with each other and act together (the perfect family), and one where they do not communicate, and act independently (the almost perfect family). Conclusions/Significance: The perfect family model is able to generate all the types of responses seen in experimental studies. The kind of response predicted depends on the nest production function, i.e. how parents' allocations affect offspring production, and the type of experimental manipulation. In particular, we find that complementarity of parents' allocations promotes matching responses. In contrast, the relative responses do not depend on the type of manipulation in the almost perfect family model. These results highlight the importance of the interaction between nest production function and how parents make decisions, factors that have largely been overlooked in previous models.			Akcay, E (corresponding author), Stanford Univ, Dept Biol, Stanford, CA 94305 USA.	erol@nimbios.org	Akcay, Erol/G-3167-2011	Akcay, Erol/0000-0001-8149-7124				AKCAY E, EVOLUTION O IN PRESS; Andre JB, 2007, J THEOR BIOL, V247, P11, DOI 10.1016/j.jtbi.2007.02.007; Arnqvist Goran, 2005, pUnpaginated; CHASE ID, 1980, AM NAT, V115, P827, DOI 10.1086/283603; Clutton-Brock T.H., 1991, EVOLUTION PARENTAL C; CLUTTONBROCK TH, 1991, NATURE, V351, P58; Dekel E, 2007, REV ECON STUD, V74, P685; Dobler R, 2009, ANIM BEHAV, V77, P1427, DOI 10.1016/j.anbehav.2009.02.013; Hinde CA, 2006, BEHAV ECOL, V17, P6, DOI 10.1093/beheco/ari092; Houston A.I., 1985, P471; Houston AI, 2005, TRENDS ECOL EVOL, V20, P33, DOI 10.1016/j.tree.2004.10.008; Houston AI, 2002, PHILOS T ROY SOC B, V357, P351, DOI 10.1098/rstb.2001.0925; Johnstone RA, 2006, BEHAV ECOL, V17, P818, DOI 10.1093/beheco/arl009; Lessells CM, 2002, PHILOS T R SOC B, V357, P381, DOI 10.1098/rstb.2001.0928; MARKMAN S, 1995, ANIM BEHAV, V50, P655, DOI 10.1016/0003-3472(95)80127-8; Martin T.E., 1992, Current Ornithology, V9, P163; Maynard-Smith J, 1977, ANIM BEHAV, V25, P1, DOI [10.1016/0003-3472(77)90062-8, DOI 10.1016/0003-3472(77)90062-8, DOI 10.1016/0003-3472(77)90062-8)]; McFarland DJ., 1981, QUANTITATIVE ETHOLOG; McNamara JM, 1999, NATURE, V401, P368, DOI 10.1038/43869; Roughgarden J, 2006, SCIENCE, V311, P965, DOI 10.1126/science.1110105; Sanz JJ, 2000, J ANIM ECOL, V69, P74, DOI 10.1046/j.1365-2656.2000.00373.x; Schwagmeyer PL, 2002, BEHAV ECOL, V13, P713, DOI 10.1093/beheco/13.5.713; SLAGSVOLD T, 1994, NATURE, V370, P136, DOI 10.1038/370136a0; SLAGSVOLD T, 1990, ECOLOGY, V71, P1258, DOI 10.2307/1938263; Trivers R. L., 1972, SEXUAL SELECTION DES, P136, DOI DOI 10.1002/AJPA.1330400226; WINKLER DW, 1987, AM NAT, V130, P526, DOI 10.1086/284729; WRIGHT J, 1989, BEHAV ECOL SOCIOBIOL, V25, P171, DOI 10.1007/BF00302916	27	9	9	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7345	10.1371/journal.pone.0007345	http://dx.doi.org/10.1371/journal.pone.0007345			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823687	gold, Green Published, Green Submitted			2022-12-27	WOS:000270808300005
J	Sasvari, Z; Bach, S; Blondel, M; Nagy, PD				Sasvari, Zsuzsanna; Bach, Stephane; Blondel, Marc; Nagy, Peter D.			Inhibition of RNA Recruitment and Replication of an RNA Virus by Acridine Derivatives with Known Anti-Prion Activities	PLOS ONE			English	Article							BUSHY-STUNT-VIRUS; CUCUMBER-NECROSIS-VIRUS; HEPATITIS-C VIRUS; PROTEIN-FOLDING ACTIVITY; TOMBUSVIRUS REPLICATION; IN-VITRO; GENOME REPLICATION; HOST FACTORS; MODEL HOST; VIRAL-RNA	Background: Small molecule inhibitors of RNA virus replication are potent antiviral drugs and useful to dissect selected steps in the replication process. To identify antiviral compounds against Tomato bushy stunt virus (TBSV), a model positive stranded RNA virus, we tested acridine derivatives, such as chlorpromazine (CPZ) and quinacrine (QC), which are active against prion-based diseases. Methodology/Principal Findings: Here, we report that CPZ and QC compounds inhibited TBSV RNA accumulation in plants and in protoplasts. In vitro assays revealed that the inhibitory effects of these compounds were manifested at different steps of TBSV replication. QC was shown to have an effect on multiple steps, including: (i) inhibition of the selective binding of the p33 replication protein to the viral RNA template, which is required for recruitment of viral RNA for replication; (ii) reduction of minus-strand synthesis by the tombusvirus replicase; and (iii) inhibition of translation of the uncapped TBSV genomic RNA. In contrast, CPZ was shown to inhibit the in vitro assembly of the TBSV replicase, likely due to binding of CPZ to intracellular membranes, which are important for RNA virus replication. Conclusion/Significance: Since we found that CPZ was also an effective inhibitor of other plant viruses, including Tobacco mosaic virus and Turnip crinkle virus, it seems likely that CPZ has a broad range of antiviral activity. Thus, these inhibitors constitute effective tools to study similarities in replication strategies of various RNA viruses.			Sasvari, Z (corresponding author), Univ Kentucky, Dept Plant Pathol, Lexington, KY 40546 USA.	pdnagy2@uky.edu	Blondel, Marc/AAJ-9049-2020; BACH, Stéphane/ABD-5865-2020	Blondel, Marc/0000-0003-4897-2995; 				Acosta EG, 2008, J GEN VIROL, V89, P474, DOI 10.1099/vir.0.83357-0; Ahlquist P, 2003, J VIROL, V77, P8181, DOI 10.1128/JVI.77.15.8181-8186.2003; Bach S, 2003, NAT BIOTECHNOL, V21, P1075, DOI 10.1038/nbt855; Beaulieu PL, 2007, CURR OPIN INVEST DR, V8, P614; Bosch B, 2008, ANTIVIR RES, V80, P185, DOI 10.1016/j.antiviral.2008.06.004; Caramelli M, 2006, CNS DRUGS, V20, P15, DOI 10.2165/00023210-200620010-00002; Carlson CB, 2003, CHEM BIOL, V10, P663, DOI 10.1016/S1074-5521(03)00147-9; Comer JE, 2006, J TOXICOL ENV HEAL A, V69, P1083, DOI 10.1080/15287390500360281; Doh-Ura K, 2000, J VIROL, V74, P4894, DOI 10.1128/JVI.74.10.4894-4897.2000; Dolphin GT, 2008, CHEMBIOCHEM, V9, P952, DOI 10.1002/cbic.200700602; Fasano C, 2008, J NEUROCHEM, V105, P239, DOI 10.1111/j.1471-4159.2007.05140.x; Giri P, 2008, ARCH BIOCHEM BIOPHYS, V474, P183, DOI 10.1016/j.abb.2008.03.013; Graci JD, 2008, ANTIMICROB AGENTS CH, V52, P971, DOI 10.1128/AAC.01056-07; Graci JD, 2006, REV MED VIROL, V16, P37, DOI 10.1002/rmv.483; Inoue Y, 2007, J VIROL, V81, P8722, DOI 10.1128/JVI.00253-07; Jiang Y, 2006, J VIROL, V80, P7394, DOI 10.1128/JVI.02686-05; Jin H, 2008, HEPATOL RES, V38, P909, DOI 10.1111/j.1872-034X.2008.00352.x; Kalia S, 2007, DERMATOL THER, V20, P160, DOI 10.1111/j.1529-8019.2007.00131.x; KARAMANAKOS PN, 2008, ARCH TOXICOL; Koch U, 2007, CURR TOP MED CHEM, V7, P1302; Kopek BG, 2007, PLOS BIOL, V5, P2022, DOI 10.1371/journal.pbio.0050220; Korth C, 2001, P NATL ACAD SCI USA, V98, P9836, DOI 10.1073/pnas.161274798; Leyssen P, 2008, ANTIVIR RES, V78, P9, DOI 10.1016/j.antiviral.2008.01.004; Li ZH, 2008, J VIROL, V82, P6911, DOI 10.1128/JVI.00702-08; Li ZH, 2009, VIROLOGY, V385, P245, DOI 10.1016/j.virol.2008.11.041; Liang GW, 2008, FUND CLIN PHARMACOL, V22, P429, DOI 10.1111/j.1472-8206.2008.00613.x; McCartney AW, 2005, PLANT CELL, V17, P3513, DOI 10.1105/tpc.105.036350; Melikyan GB, 1997, J CELL BIOL, V136, P995, DOI 10.1083/jcb.136.5.995; Monkewich S, 2005, J VIROL, V79, P4848, DOI 10.1128/JVI.79.8.4848-4858.2005; Nagy PD, 2000, VIROLOGY, V276, P279, DOI 10.1006/viro.2000.0577; Nagy PD, 2006, VIROLOGY, V344, P211, DOI 10.1016/j.virol.2005.09.017; Nagy PD, 2008, ANNU REV PHYTOPATHOL, V46, P217, DOI 10.1146/annurev.phyto.121407.093958; Nagy Peter D., 2008, V451, P55, DOI 10.1007/978-1-59745-102-4_4; NUGENT KM, 1984, ARCH VIROL, V81, P163, DOI 10.1007/BF01309305; Nussio MR, 2009, LANGMUIR, V25, P1086, DOI 10.1021/la803288s; Oster SK, 1998, J VIROL, V72, P5845, DOI 10.1128/JVI.72.7.5845-5851.1998; Panavas T, 2005, VIROLOGY, V338, P81, DOI 10.1016/j.virol.2005.04.025; Panavas T, 2005, P NATL ACAD SCI USA, V102, P7326, DOI 10.1073/pnas.0502604102; Panavas T, 2003, VIROLOGY, V314, P315, DOI 10.1016/S0042-6822(03)00436-7; Panavas T, 2002, VIROLOGY, V296, P263, DOI 10.1006/viro.2002.1423; Panavas T, 2002, VIROLOGY, V296, P275, DOI 10.1006/viro.2002.1422; Panaviene Z, 2005, J VIROL, V79, P10608, DOI 10.1128/JVI.79.16.10608-10618.2005; Panaviene Z, 2004, J VIROL, V78, P8254, DOI 10.1128/JVI.78.15.8254-8263.2004; Panaviene Z, 2003, VIROLOGY, V308, P191, DOI 10.1016/S0042-6822(02)00132-0; Pogany J, 2005, J VIROL, V79, P4859, DOI 10.1128/JVI.79.8.4859-4869.2005; Pogany J, 2008, P NATL ACAD SCI USA, V105, P19956, DOI 10.1073/pnas.0810851105; Pogany J, 2008, J VIROL, V82, P5967, DOI 10.1128/JVI.02737-07; Pu YH, 2008, J VIROL, V82, P8112, DOI 10.1128/JVI.00837-08; Rajendran KS, 2006, VIROLOGY, V345, P270, DOI 10.1016/j.virol.2005.09.038; Rajendran KS, 2003, J VIROL, V77, P9244, DOI 10.1128/JVI.77.17.9244-9258.2003; SCHLESINGER MJ, 1989, VIROLOGY, V168, P187, DOI 10.1016/0042-6822(89)90421-2; Sebastian L, 2009, INT J ANTIMICROB AG, V33, P168, DOI 10.1016/j.ijantimicag.2008.07.013; Sebestik J, 2007, CURR PROTEIN PEPT SC, V8, P471, DOI 10.2174/138920307782411400; Serva S, 2006, J VIROL, V80, P2162, DOI 10.1128/JVI.80.5.2162-2169.2006; Simon M, 2009, J GEN VIROL, V90, P210, DOI 10.1099/vir.0.006387-0; Sinha R, 2007, BBA-GEN SUBJECTS, V1770, P1636, DOI 10.1016/j.bbagen.2007.08.018; Spilman P, 2008, P NATL ACAD SCI USA, V105, P10595, DOI 10.1073/pnas.0803671105; Sun XJ, 2005, VIROLOGY, V338, P53, DOI 10.1016/j.virol.2005.05.006; Thi HTN, 2008, BIOORGAN MED CHEM, V16, P6737, DOI 10.1016/j.bmc.2008.05.060; Thompson A, 2009, J HEPATOL, V50, P184, DOI 10.1016/j.jhep.2008.10.011; Toniutto P, 2008, IDRUGS, V11, P738; Tribouillard-Tanvier D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002174; Vendeville A, 2004, MOL BIOL CELL, V15, P2347, DOI 10.1091/mbc.E03-12-0921; Vogtherr M, 2003, J MED CHEM, V46, P3563, DOI 10.1021/jm034093h; Voisset Cecile, 2008, Biotechnology Journal, V3, P1033, DOI 10.1002/biot.200800134; Wang RYL, 2008, CELL HOST MICROBE, V3, P178, DOI 10.1016/j.chom.2008.02.005; Wang RYL, 2009, J VIROL, V83, P3276, DOI 10.1128/JVI.02313-08; WHITE KA, 1994, J VIROL, V68, P14, DOI 10.1128/JVI.68.1.14-24.1994; White KA, 2004, PROG NUCLEIC ACID RE, V78, P187, DOI 10.1016/S0079-6603(04)78005-8; Yan ZH, 2004, BIOORG MED CHEM LETT, V14, P5889, DOI 10.1016/j.bmcl.2004.09.021	70	14	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7376	10.1371/journal.pone.0007376	http://dx.doi.org/10.1371/journal.pone.0007376			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823675	Green Submitted, Green Published, gold			2022-12-27	WOS:000270808300006
J	Pasupuleti, M; Roupe, M; Rydengard, V; Surewicz, K; Surewicz, WK; Chalupka, A; Malmsten, M; Sorensen, OE; Schmidtchen, A				Pasupuleti, Mukesh; Roupe, Markus; Rydengard, Victoria; Surewicz, Krystyna; Surewicz, Witold K.; Chalupka, Anna; Malmsten, Martin; Sorensen, Ole E.; Schmidtchen, Artur			Antimicrobial Activity of Human Prion Protein Is Mediated by Its N-Terminal Region	PLOS ONE			English	Article								Background: Cellular prion-related protein (PrP(c)) is a cell-surface protein that is ubiquitously expressed in the human body. The multifunctionality of PrP(c), and presence of an exposed cationic and heparin-binding N-terminus, a feature characterizing many antimicrobial peptides, made us hypotesize that PrP(c) could exert antimicrobial activity. Methodology and Principal Findings: Intact recombinant PrP exerted antibacterial and antifungal effects at normal and low pH. Studies employing recombinant PrP and N-and C-terminally truncated variants, as well as overlapping peptide 20mers, demonstrated that the antimicrobial activity is mediated by the unstructured N-terminal part of the protein. Synthetic peptides of the N-terminus of PrP killed the Gram-negative bacteria Escherichia coli and Pseudomonas aeruginosa, and the Gram-positive Bacillus subtilis and Staphylococcus aureus, as well as the fungus Candida parapsilosis. Fluorescence studies of peptide-treated bacteria, paired with analysis of peptide effects on liposomes, showed that the peptides exerted membrane-breaking effects similar to those seen after treatment with the "classical'' human antimicrobial peptide LL-37. In contrast to LL-37, however, no marked helix induction was detected for the PrP-derived peptides in presence of negatively charged (bacteria-mimicking) liposomes. PrP furthermore showed an inducible expression during wounding of human skin ex vivo and in vivo, as well as stimulation of keratinocytes with TGF-alpha in vitro. Conclusions: The demonstration of an antimicrobial activity of PrP, localisation of its activity to the N-terminal and heparin-binding region, combined with results showing an increased expression of PrP during wounding, indicate that PrPs could have a previously undisclosed role in host defense.			Pasupuleti, M (corresponding author), Lund Univ, Dept Clin Sci, Div Dermatol & Venereol, Lund, Sweden.	mukesh.pasupuleti@med.lu.se; artur.schmidtchen@med.lu.se	Pasupuleti, Mukesh/H-7605-2013; Pasupuleti, Mukesh/AAF-4066-2020; Roupé, Karl/K-6502-2014; Pasupuleti, Mukesh/AAD-9977-2020; Schmidtchen, Artur/F-9507-2015	Pasupuleti, Mukesh/0000-0001-6337-6257; Roupé, Karl/0000-0001-5472-8134; Sorensen, Ole E./0000-0001-8681-6921				Andersson E, 2004, EUR J BIOCHEM, V271, P1219, DOI 10.1111/j.1432-1033.2004.04035.x; Beisswenger C, 2005, CURR PROTEIN PEPT SC, V6, P255, DOI 10.2174/1389203054065428; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; Brown DR, 1998, BIOCHEM J, V334, P423, DOI 10.1042/bj3340423; Bulet P, 2004, IMMUNOL REV, V198, P169, DOI 10.1111/j.0105-2896.2004.0124.x; Chen FY, 2003, BIOPHYS J, V84, P3751, DOI 10.1016/S0006-3495(03)75103-0; Cobb NJ, 2008, J BIOL CHEM, V283, P34704, DOI 10.1074/jbc.M806701200; Durr UHN, 2006, BBA-BIOMEMBRANES, V1758, P1408, DOI 10.1016/j.bbamem.2006.03.030; Elsbach P, 2003, J CLIN INVEST, V111, P1643, DOI 10.1172/JCI200318761; Frick IM, 2006, EMBO J, V25, P5569, DOI 10.1038/sj.emboj.7601422; Ganz T, 2001, Semin Respir Infect, V16, P4; GREENFIE.N, 1969, BIOCHEMISTRY-US, V8, P4108, DOI 10.1021/bi00838a031; Harris B, 2003, CLIO MED, V71, P85; Huang HW, 2006, BBA-BIOMEMBRANES, V1758, P1292, DOI 10.1016/j.bbamem.2006.02.001; Jiang ZQ, 2008, CHEM BIOL DRUG DES, V72, P483, DOI 10.1111/j.1747-0285.2008.00728.x; Kacprzyk L, 2007, BBA-BIOMEMBRANES, V1768, P2667, DOI 10.1016/j.bbamem.2007.06.020; Konturek PC, 2005, WORLD J GASTROENTERO, V11, P7651, DOI 10.3748/wjg.v11.i48.7651; LEHRER RI, 1991, J IMMUNOL METHODS, V137, P167, DOI 10.1016/0022-1759(91)90021-7; Lohner K, 2005, COMB CHEM HIGH T SCR, V8, P241, DOI 10.2174/1386207053764576; Magzoub M, 2005, BBA-BIOMEMBRANES, V1716, P126, DOI 10.1016/j.bbamem.2005.09.009; Malmsten M, 2007, GROWTH FACTORS, V25, P60, DOI 10.1080/08977190701344120; McBride SM, 2005, MED HYPOTHESES, V65, P570, DOI 10.1016/j.mehy.2005.02.038; McMahon HEM, 2001, J BIOL CHEM, V276, P2286, DOI 10.1074/jbc.M007243200; Morillas M, 1999, J BIOL CHEM, V274, P36859, DOI 10.1074/jbc.274.52.36859; Nilsson M, 2008, MOL MICROBIOL, V67, P482, DOI 10.1111/j.1365-2958.2007.05974.x; Nordahl EA, 2004, P NATL ACAD SCI USA, V101, P16879, DOI 10.1073/pnas.0406678101; Nordahl EA, 2005, J BIOL CHEM, V280, P34832, DOI 10.1074/jbc.M507249200; OPPENHEIM FG, 1988, J BIOL CHEM, V263, P7472; Pammer J, 1998, AM J PATHOL, V153, P1353, DOI 10.1016/S0002-9440(10)65720-3; Pan T, 2002, BIOCHEM J, V368, P81, DOI 10.1042/BJ20020773; Parkinson H, 2009, NUCLEIC ACIDS RES, V37, pD868, DOI 10.1093/nar/gkn889; Pasupuleti M, 2008, BIOCHEMISTRY-US, V47, P9057, DOI 10.1021/bi800991e; Pasupuleti M, 2007, J BIOL CHEM, V282, P2520, DOI 10.1074/jbc.M607848200; Pauly PC, 1998, J BIOL CHEM, V273, P33107, DOI 10.1074/jbc.273.50.33107; PEREIRA HA, 1995, J LEUKOCYTE BIOL, V57, P805, DOI 10.1002/jlb.57.6.805; Powers JPS, 2003, PEPTIDES, V24, P1681, DOI 10.1016/j.peptides.2003.08.023; Ramamoorthy A, 2006, BIOPHYS J, V91, P206, DOI 10.1529/biophysj.105.073890; Ringstad L, 2008, LANGMUIR, V24, P208, DOI 10.1021/la702538k; Ringstad L, 2007, BBA-BIOMEMBRANES, V1768, P715, DOI 10.1016/j.bbamem.2006.11.016; Ringstad L, 2006, LANGMUIR, V22, P5042, DOI 10.1021/la060317y; Ringstad L, 2007, BIOPHYS J, V92, P87, DOI 10.1529/biophysj.106.088161; ROUPE KM, 2009, J INVEST DERMATOL; Rydengard V, 2006, FEBS J, V273, P2399, DOI 10.1111/j.1742-4658.2006.05246.x; Rydengard V, 2007, FEBS J, V274, P377, DOI 10.1111/j.1742-4658.2006.05586.x; Rydengard V, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000116; Schittek B, 2001, NAT IMMUNOL, V2, P1133, DOI 10.1038/ni732; Sjogren H, 2005, BIOPHYS CHEM, V116, P11, DOI 10.1016/j.bpc.2005.01.007; Stewart RS, 2001, MOL BIOL CELL, V12, P881, DOI 10.1091/mbc.12.4.881; Stromstedt AA, 2007, J COLLOID INTERF SCI, V311, P59, DOI 10.1016/j.jcis.2007.02.070; Tossi A, 2002, CURR PHARM DESIGN, V8, P743, DOI 10.2174/1381612023395475; Wang YQ, 1998, J BIOL CHEM, V273, P33115, DOI 10.1074/jbc.273.50.33115; Yang D, 2003, J LEUKOCYTE BIOL, V74, P448, DOI 10.1189/jlb.0103024; Yang D, 2004, ANNU REV IMMUNOL, V22, P181, DOI 10.1146/annurev.immunol.22.012703.104603; Yount NY, 2006, BIOPOLYMERS, V84, P435, DOI 10.1002/bip.20543; Zasloff M, 2002, NATURE, V415, P389, DOI 10.1038/415389a; Zelezetsky I, 2006, BBA-BIOMEMBRANES, V1758, P1436, DOI 10.1016/j.bbamem.2006.03.021; Zhang CC, 2006, P NATL ACAD SCI USA, V103, P2184, DOI 10.1073/pnas.0510577103; Zomosa-Signoret V, 2008, VET RES, V39, DOI 10.1051/vetres:2007048	58	58	59	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7358	10.1371/journal.pone.0007358	http://dx.doi.org/10.1371/journal.pone.0007358			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809501	Green Published, gold, Green Submitted			2022-12-27	WOS:000270594000013
J	Arsac, JN; Betemps, D; Morignat, E; Feraudet, C; Bencsik, A; Aubert, D; Grassi, J; Baron, T				Arsac, Jean-Noeel; Betemps, Dominique; Morignat, Eric; Feraudet, Cecile; Bencsik, Anna; Aubert, Denise; Grassi, Jacques; Baron, Thierry			Transmissibility of Atypical Scrapie in Ovine Transgenic Mice: Major Effects of Host Prion Protein Expression and Donor Prion Genotype	PLOS ONE			English	Article								Atypical scrapie or Nor98 has been identified as a transmissible spongiform encephalopathy (TSE) that is clearly distinguishable from classical scrapie and BSE, notably regarding the biochemical features of the protease-resistant prion protein PrP(res) and the genetic factors involved in susceptibility to the disease. In this study we transmitted the disease from a series of 12 French atypical scrapie isolates in a transgenic mouse model (TgOvPrP4) overexpressing in the brain similar to 0.25, 1.5 or 6x the levels of the PrP(ARQ) ovine prion protein under the control of the neuron-specific enolase promoter. We used an approach based on serum PrP(c) measurements that appeared to reflect the different PrP(c) expression levels in the central nervous system. We found that transmission of atypical scrapie, much more than in classical scrapie or BSE, was strongly influenced by the PrP(c) expression levels of TgOvPrP4 inoculated mice. Whereas TgOvPrP4 mice overexpressing similar to 6x the normal PrP(c) level died after a survival periods of 400 days, those with similar to 1.5x the normal PrP(c) level died at around 700 days. The transmission of atypical scrapie in TgOvPrP4 mouse line was also strongly influenced by the prnp genotypes of the animal source of atypical scrapie. Isolates carrying the AF(141)RQ or AHQ alleles, associated with increased disease susceptibility in the natural host, showed a higher transmissibility in TgOvPrP4 mice. The biochemical analysis of PrP(res) in TgOvPrP4 mouse brains showed a fully conserved pattern, compared to that in the natural host, with three distinct PrP(res) products. Our results throw light on the transmission features of atypical scrapie and suggest that the risk of transmission is intrinsically lower than that of classical scrapie or BSE, especially in relation to the expression level of the prion protein.			Arsac, JN (corresponding author), Agence Francaise Secur Sanit Aliments, Lyon, France.	t.baron@afssa.fr	BENCSIK, Anna A/HGC-4260-2022	BENCSIK, Anna A/0000-0002-8671-6290; Aubert, Denise/0000-0002-1442-3384				Arsac JN, 2007, EMERG INFECT DIS, V13, P58, DOI 10.3201/eid1301.060393; Banks WA, 2009, EXP NEUROL, V218, P162, DOI 10.1016/j.expneurol.2009.04.025; Baron T, 2004, J VIROL, V78, P6243, DOI 10.1128/JVI.78.12.6243-6251.2004; Baron TGM, 2000, NEUROSCI LETT, V284, P175, DOI 10.1016/S0304-3940(00)01047-8; Baron TGM, 1999, FEMS IMMUNOL MED MIC, V25, P379, DOI 10.1111/j.1574-695X.1999.tb01363.x; Baron T, 2007, J VIROL, V81, P7230, DOI 10.1128/JVI.02475-06; Baron T, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000137; Barron RM, 2003, J GEN VIROL, V84, P3165, DOI 10.1099/vir.0.19147-0; Baylis M, 2004, CURR MOL MED, V4, P385, DOI 10.2174/1566524043360672; Bencsik AA, 2008, HISTOCHEM CELL BIOL, V129, P643, DOI 10.1007/s00418-008-0382-2; Benestad SL, 2003, VET REC, V153, P202, DOI 10.1136/vr.153.7.202; Bossers A, 1996, J GEN VIROL, V77, P2669, DOI 10.1099/0022-1317-77-10-2669; Bruce ME, 2007, VET REC, V160, P665, DOI 10.1136/vr.160.19.665; Bruce ME, 2002, J GEN VIROL, V83, P695, DOI 10.1099/0022-1317-83-3-695; Buschmann A, 2004, J VIROL METHODS, V117, P27, DOI 10.1016/j.jviromet.2003.11.017; Castilla J, 2005, CELL, V121, P195, DOI 10.1016/j.cell.2005.02.011; CHANDLER RL, 1961, LANCET, V1, P1378; Chiesa R, 2003, J VIROL, V77, P7611, DOI 10.1128/JVI.77.13.7611-7622.2003; Chiesa R, 1998, NEURON, V21, P1339, DOI 10.1016/S0896-6273(00)80653-4; Cordier C, 2006, J GEN VIROL, V87, P3763, DOI 10.1099/vir.0.82062-0; Crozet C, 2001, EMBO REP, V2, P952, DOI 10.1093/embo-reports/kve204; Crozet C, 2001, J VIROL, V75, P5328, DOI 10.1128/JVI.75.11.5328-5334.2001; Crozet C, 2007, J INFECT DIS, V195, P997, DOI 10.1086/512085; DAVIS BP, 1988, GENE DEV, V2, P13, DOI 10.1101/gad.2.1.13; Dawson M, 1998, VET REC, V142, P623; Demart S, 1999, BIOCHEM BIOPH RES CO, V265, P652, DOI 10.1006/bbrc.1999.1730; *EFSA, 2005, EFSA J, V276, P1; El-Agnaf OMA, 2003, FASEB J, V17, P1945, DOI 10.1096/fj.03-0098fje; *EUR COMM, 2006, REP MON TEST RUM PRE; Fediaevsky A, 2008, BMC VET RES, V4, DOI 10.1186/1746-6148-4-19; Feraudet C, 2005, J BIOL CHEM, V280, P11247, DOI 10.1074/jbc.M407006200; Festenstein R, 1996, SCIENCE, V271, P1123, DOI 10.1126/science.271.5252.1123; Fitzmaurice TJ, 2008, BIOCHEM J, V409, P367, DOI 10.1042/BJ20071122; FOSTER JD, 1988, VET REC, V123, P5, DOI 10.1136/vr.123.1.5; FRASER H, 1968, J COMP PATHOL, V78, P301, DOI 10.1016/0021-9975(68)90006-6; Ghetti B, 1996, BRAIN PATHOL, V6, P127, DOI 10.1111/j.1750-3639.1996.tb00796.x; Giraldo P, 2003, TRANSGENIC RES, V12, P751, DOI 10.1023/B:TRAG.0000005089.30408.25; GOLDMANN W, 1994, J GEN VIROL, V75, P989, DOI 10.1099/0022-1317-75-5-989; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; Grassi J, 2000, ARCH VIROL, P197; Hegde RS, 1999, NATURE, V402, P822, DOI 10.1038/45574; Hetz C, 2007, J BIOL CHEM, V282, P12725, DOI 10.1074/jbc.M611909200; Hopp P, 2006, J GEN VIROL, V87, P3729, DOI 10.1099/vir.0.81951-0; HSIAO KK, 1994, P NATL ACAD SCI USA, V91, P9126, DOI 10.1073/pnas.91.19.9126; HUNTER N, 1994, ARCH VIROL, V137, P171, DOI 10.1007/BF01311184; Hunter N, 1997, VET REC, V140, P59, DOI 10.1136/vr.140.3.59; Krasemann S, 1999, J BIOTECHNOL, V73, P119, DOI 10.1016/S0168-1656(99)00115-7; Le Dur A, 2005, P NATL ACAD SCI USA, V102, P16031, DOI 10.1073/pnas.0502296102; Legname G, 2004, SCIENCE, V305, P673, DOI 10.1126/science.1100195; Lezmi S, 2004, J VIROL, V78, P3654, DOI 10.1128/JVI.78.7.3654-3662.2004; Luhken G, 2007, VET RES, V38, P65, DOI 10.1051/vetres:2006046; Luhken G, 2004, ARCH VIROL, V149, P1571, DOI 10.1007/s00705-004-0303-1; Ma JY, 2002, SCIENCE, V298, P1785, DOI 10.1126/science.1073619; Ma JY, 2001, P NATL ACAD SCI USA, V98, P14955, DOI 10.1073/pnas.011578098; Madec JY, 2004, J GEN VIROL, V85, P3483, DOI 10.1099/vir.0.80220-0; Moreno CR, 2007, ARCH VIROL, V152, P1229, DOI 10.1007/s00705-007-0956-7; Moudjou M, 2001, J GEN VIROL, V82, P2017, DOI 10.1099/0022-1317-82-8-2017; Moum T, 2005, J GEN VIROL, V86, P231, DOI 10.1099/vir.0.80437-0; Nazor KE, 2005, EMBO J, V24, P2472, DOI 10.1038/sj.emboj.7600717; Nentwig A, 2007, PLOS PATHOG, V3, P743, DOI 10.1371/journal.ppat.0030082; Orge L, 2004, J GEN VIROL, V85, P3487, DOI 10.1099/vir.0.80246-0; ORourke KI, 1997, J GEN VIROL, V78, P975, DOI 10.1099/0022-1317-78-4-975; PRUSINER SB, 1982, SCIENCE, V216, P136, DOI 10.1126/science.6801762; Saunders GC, 2006, J GEN VIROL, V87, P3141, DOI 10.1099/vir.0.81779-0; Simmons HA, 2009, BMC VET RES, V5, DOI 10.1186/1746-6148-5-8; Simmons Marion M, 2007, BMC Vet Res, V3, P20, DOI 10.1186/1746-6148-3-20; Stewart RS, 2005, J NEUROSCI, V25, P3469, DOI 10.1523/JNEUROSCI.0105-05.2005; TAGLIAVINI F, 1991, EMBO J, V10, P513, DOI 10.1002/j.1460-2075.1991.tb07977.x; Tagliavini F, 2001, J BIOL CHEM, V276, P6009, DOI 10.1074/jbc.M007062200; TATEISHI J, 1995, BRAIN PATHOL, V5, P53, DOI 10.1111/j.1750-3639.1995.tb00577.x; Thackray AM, 2008, J VIROL, V82, P11197, DOI 10.1128/JVI.01454-08; Vilotte JL, 2001, J VIROL, V75, P5977, DOI 10.1128/JVI.75.13.5977-5984.2001	72	28	28	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7300	10.1371/journal.pone.0007300	http://dx.doi.org/10.1371/journal.pone.0007300			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806224	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593800012
J	Downing, BPB; Rutenberg, AD; Touhami, A; Jericho, M				Downing, Benjamin P. B.; Rutenberg, Andrew D.; Touhami, Ahmed; Jericho, Manfred			Subcellular Min Oscillations as a Single-Cell Reporter of the Action of Polycations, Protamine, and Gentamicin on Escherichia coli	PLOS ONE			English	Article								Background: In Escherichia coli, MinD-GFP fusion proteins show rapid pole to pole oscillations. The objective was to investigate the effects of extracellular cations on the subcellular oscillation of cytoplasmic MinD within Escherichia coli. Methodology/Principal Findings: We exposed bacteria to the extracellular cations Ca(++), Mg(++), the cationic antimicrobial peptide (CAP) protamine, and the cationic aminoglycoside gentamicin. We found rapid and substantial increases in the average MinD oscillation periods in the presence of any of these polyvalent cations. For Ca(++) and Mg(++) the increases in period were transient, even with a constant extracellular concentration, while increases in period for protamine or gentamicin were apparently irreversible. We also found striking interdependence in the action of the small cations with protamine or gentamicin, distorted oscillations under the action of intermediate levels of gentamicin and Ca(++), and reversible freezing of the Min oscillation at high cationic concentrations. Conclusions/Significance: Intracellular Min oscillations provide a fast single-cell reporter of bacterial response to extracellular polycations, which can be explained by the penetration of polycations into cells.			Downing, BPB (corresponding author), Simon Fraser Univ, Dept Phys, Burnaby, BC V5A 1S6, Canada.	Jericho@fizz.phys.dal.ca		Rutenberg, Andrew/0000-0002-4264-6809				Aires JR, 2005, J BACTERIOL, V187, P1923, DOI 10.1128/JB.187.6.1923-1929.2005; ALATOSSAVA T, 1985, J BACTERIOL, V162, P413, DOI 10.1128/JB.162.1.413-419.1985; Aldridge C, 2005, J BIOL CHEM, V280, P31673, DOI 10.1074/jbc.M505126200; Aspedon A, 1996, MICROBIOL-SGM, V142, P3389, DOI 10.1099/13500872-142-12-3389; Brogden KA, 2005, NAT REV MICROBIOL, V3, P238, DOI 10.1038/nrmicro1098; BRYAN LE, 1975, J ANTIBIOT, V28, P696, DOI 10.7164/antibiotics.28.696; De Kerchove AJ, 2008, LANGMUIR, V24, P3392, DOI 10.1021/la7036229; DEBOER PAJ, 1991, EMBO J, V10, P4371, DOI 10.1002/j.1460-2075.1991.tb05015.x; Dominguez DC, 2004, MOL MICROBIOL, V54, P291, DOI 10.1111/j.1365-2958.2004.04276.x; Farruggia G, 2006, J AM CHEM SOC, V128, P344, DOI 10.1021/ja056523u; Fu XL, 2001, P NATL ACAD SCI USA, V98, P980, DOI 10.1073/pnas.031549298; Hale CA, 2001, EMBO J, V20, P1563, DOI 10.1093/emboj/20.7.1563; HANCOCK REW, 1981, J ANTIMICROB CHEMOTH, V8, P249, DOI 10.1093/jac/8.4.249; Hayashi I, 2001, EMBO J, V20, P1819, DOI 10.1093/emboj/20.8.1819; Hu ZL, 2002, P NATL ACAD SCI USA, V99, P6761, DOI 10.1073/pnas.102059099; Hu ZL, 1999, MOL MICROBIOL, V34, P82, DOI 10.1046/j.1365-2958.1999.01575.x; Jenssen H, 2006, CLIN MICROBIOL REV, V19, P491, DOI 10.1128/CMR.00056-05; Johansen C, 1996, APPL ENVIRON MICROB, V62, P1058, DOI 10.1128/AEM.62.3.1058-1064.1996; Jones HE, 2002, CELL CALCIUM, V32, P183, DOI 10.1016/S0143416002001537; Jones HE, 1999, CELL CALCIUM, V25, P265, DOI 10.1054/ceca.1999.0028; JOSEPOVITZ C, 1982, J PHARMACOL EXP THER, V223, P314; KADURUGAMUWA JL, 1993, J BACTERIOL, V175, P5798, DOI 10.1128/JB.175.18.5798-5805.1993; LEPEZUNIGA JL, 1987, J IMMUNOL METHODS, V103, P145, DOI 10.1016/0022-1759(87)90253-5; LEVITON IM, 1995, ANTIMICROB AGENTS CH, V39, P467, DOI 10.1128/AAC.39.2.467; Lin J, 2002, ANTIMICROB AGENTS CH, V46, P2124, DOI 10.1128/AAC.46.7.2124-2131.2002; LOH B, 1984, ANTIMICROB AGENTS CH, V26, P546, DOI 10.1128/AAC.26.4.546; LORIAN V, 1982, J CLIN MICROBIOL, V16, P70, DOI 10.1128/JCM.16.1.70-76.1982; Lutkenhaus J, 2007, ANNU REV BIOCHEM, V76, P539, DOI 10.1146/annurev.biochem.75.103004.142652; Maguire ME, 2006, FRONT BIOSCI-LANDMRK, V11, P3149, DOI 10.2741/2039; Naseem R, 2008, BBA-BIOMEMBRANES, V1778, P1415, DOI 10.1016/j.bbamem.2008.02.006; Naseem R, 2007, BIOCHEM BIOPH RES CO, V360, P33, DOI 10.1016/j.bbrc.2007.05.223; Norris V, 1996, J BACTERIOL, V178, P3677, DOI 10.1128/jb.178.13.3677-3682.1996; OLIVEIRA RG, 2008, CR CHIM, V12, P209; Pink DA, 2003, LANGMUIR, V19, P8852, DOI 10.1021/la030193e; Potter R, 2005, INT J FOOD MICROBIOL, V103, P23, DOI 10.1016/j.ijfoodmicro.2004.12.019; RAMOS S, 1976, P NATL ACAD SCI USA, V73, P1892, DOI 10.1073/pnas.73.6.1892; Raskin DM, 1999, J BACTERIOL, V181, P6419, DOI 10.1128/JB.181.20.6419-6424.1999; Raskin DM, 1999, P NATL ACAD SCI USA, V96, P4971, DOI 10.1073/pnas.96.9.4971; Ripoll C, 2004, BIOESSAYS, V26, P549, DOI 10.1002/bies.20019; Shih YL, 2002, EMBO J, V21, P3347, DOI 10.1093/emboj/cdf323; Smith RL, 1998, MOL MICROBIOL, V28, P217, DOI 10.1046/j.1365-2958.1998.00810.x; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; Szeto TH, 2002, P NATL ACAD SCI USA, V99, P15693, DOI 10.1073/pnas.232590599; Touhami A, 2006, J BACTERIOL, V188, P7661, DOI 10.1128/JB.00911-06; WATKINS NJ, 1995, BIOCHEM J, V306, P865, DOI 10.1042/bj3060865; Yu XC, 1997, EMBO J, V16, P5455, DOI 10.1093/emboj/16.17.5455; Zhang LJ, 2001, J BIOL CHEM, V276, P35714, DOI 10.1074/jbc.M104925200	47	5	5	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7285	10.1371/journal.pone.0007285	http://dx.doi.org/10.1371/journal.pone.0007285			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789705	Green Published, gold			2022-12-27	WOS:000270354100030
J	Ferhat, M; Atlan, D; Vianney, A; Lazzaroni, JC; Doublet, P; Gilbert, C				Ferhat, Mourad; Atlan, Daniele; Vianney, Anne; Lazzaroni, Jean-Claude; Doublet, Patricia; Gilbert, Christophe			The TolC Protein of Legionella pneumophila Plays a Major Role in Multi-Drug Resistance and the Early Steps of Host Invasion	PLOS ONE			English	Article							ENTERICA SEROVAR TYPHIMURIUM; PERIPLASMIC SUPEROXIDE-DISMUTASE; ESCHERICHIA-COLI; ACRAB-TOLC; EFFLUX; ACTIVATION; SECRETION; MECHANISM; MEMBRANE; MUTANTS	Pneumonia associated with Iegionnaires's disease is initiated in humans after inhalation of contaminated aerosols. In the environment, Legionella pneumophila is thought to survive and multiply as an intracellular parasite within free-living amoeba. In the genome of L. pneumophila Lens, we identified a unique gene, tolC, encoding a protein that is highly homologous to the outer membrane protein TolC of Escherichia coli. Deletion of tolC by allelic exchange in L. pneumophila caused increased sensitivity to various drugs. The complementation of the tolC mutation in trans restored drug resistance, indicating that TolC is involved in multi-drug efflux machinery. In addition, deletion of tolC caused a significant attenuation of virulence towards both amoebae and macrophages. Thus, the TolC protein appears to play a crucial role in virulence which could be mediated by its involvement in efflux pump mechanisms. These findings will be helpful in unraveling the pathogenic mechanisms of L. pneumophila as well as in developing new therapeutic agents affecting the efflux of toxic compounds.			Ferhat, M (corresponding author), Univ Lyon, Lyon, France.	gilbert@biomserv.univ-lyon1.fr	Vianney, Anne/L-9544-2014; Doublet, Patricia/L-9480-2014; Gilbert, Christophe/M-6005-2014	Doublet, Patricia/0000-0001-5848-4317; Gilbert, Christophe/0000-0003-3021-7350				Bandyopadhyay P, 2003, INFECT IMMUN, V71, P4526, DOI 10.1128/IAI.71.8.4526-4535.2003; Baucheron S, 2004, ANTIMICROB AGENTS CH, V48, P3729, DOI 10.1128/AAC.48.10.3729-3735.2004; BERGER KH, 1994, MOL MICROBIOL, V14, P809, DOI 10.1111/j.1365-2958.1994.tb01317.x; Bokma E, 2007, AMINO ACIDS, V33, pVIII; Buckley AM, 2006, CELL MICROBIOL, V8, P847, DOI 10.1111/j.1462-5822.2005.00671.x; Bunikis I, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000009; Cazalet C, 2004, NAT GENET, V36, P1165, DOI 10.1038/ng1447; Chen DQ, 2006, PLASMID, V56, P167, DOI 10.1016/j.plasmid.2006.05.008; Cosme AM, 2008, MOL PLANT MICROBE IN, V21, P947, DOI 10.1094/MPMI-21-7-0947; DeLeo FR, 1999, J IMMUNOL, V163, P6732; Frohner IE, 2009, MOL MICROBIOL, V71, P240, DOI 10.1111/j.1365-2958.2008.06528.x; Gil H, 2006, P NATL ACAD SCI USA, V103, P12897, DOI 10.1073/pnas.0602582103; Giraud E, 2000, ANTIMICROB AGENTS CH, V44, P1223, DOI 10.1128/AAC.44.5.1223-1228.2000; Golubeva YA, 2006, J BACTERIOL, V188, P7853, DOI 10.1128/JB.00706-06; Isberg RR, 2009, NAT REV MICROBIOL, V7, P12, DOI 10.1038/nrmicro1967; Karatzas KAG, 2008, APPL ENVIRON MICROB, V74, P1508, DOI 10.1128/AEM.01931-07; Keith KE, 2007, INFECT IMMUN, V75, P2451, DOI 10.1128/IAI.01556-06; Lau SY, 2005, J BACTERIOL, V187, P7815, DOI 10.1128/JB.187.22.7815-7825.2005; Li XZ, 2004, DRUGS, V64, P159, DOI 10.2165/00003495-200464020-00004; Lobedanz S, 2007, P NATL ACAD SCI USA, V104, P4612, DOI 10.1073/pnas.0610160104; Mahamoud A, 2007, J ANTIMICROB CHEMOTH, V59, P1223, DOI 10.1093/jac/dkl493; Marchler-Bauer A, 2007, NUCLEIC ACIDS RES, V35, pD237, DOI 10.1093/nar/gkl951; Martin RG, 2008, J MOL BIOL, V380, P278, DOI 10.1016/j.jmb.2008.05.015; Molmeret M, 2004, MICROBES INFECT, V6, P129, DOI 10.1016/j.micinf.2003.11.004; Molmeret M, 2007, INFECT IMMUN, V75, P3290, DOI 10.1128/IAI.00292-07; Nishino K, 2003, ANTIMICROB AGENTS CH, V47, P3030, DOI 10.1128/AAC.47.9.3030-3033.2003; Poole K, 2004, CLIN MICROBIOL INFEC, V10, P12, DOI 10.1111/j.1469-0691.2004.00763.x; Poole Keith, 2003, Curr Opin Investig Drugs, V4, P128; POPE CD, 1994, FEMS MICROBIOL LETT, V124, P107, DOI 10.1111/j.1574-6968.1994.tb07269.x; Posadas DM, 2007, INFECT IMMUN, V75, P379, DOI 10.1128/IAI.01349-06; Seeger MA, 2008, CURR DRUG TARGETS, V9, P729, DOI 10.2174/138945008785747789; Shin S, 2008, CELL MICROBIOL, V10, P1209, DOI 10.1111/j.1462-5822.2008.01145.x; STONE BJ, 1995, MOL MICROBIOL, V17, P701, DOI 10.1111/j.1365-2958.1995.mmi_17040701.x; Sulavik MC, 2001, ANTIMICROB AGENTS CH, V45, P1126, DOI 10.1128/AAC.45.4.1126-1136.2001; SWANSON MS, 1995, INFECT IMMUN, V63, P3609, DOI 10.1128/IAI.63.9.3609-3620.1995; Tilney LG, 2001, J CELL SCI, V114, P4637; Virlogeux-Payant I, 2008, INT J MED MICROBIOL, V298, P561, DOI 10.1016/j.ijmm.2007.12.006; Viveiros M, 2008, INT J ANTIMICROB AG, V31, P458, DOI 10.1016/j.ijantimicag.2007.12.015; Yamanaka H, 2008, J BACTERIOL, V190, P7693, DOI 10.1128/JB.00853-08; Zhang A, 2008, MOL MICROBIOL, V69, P1450, DOI 10.1111/j.1365-2958.2008.06371.x	40	39	39	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2009	4	11							e7732	10.1371/journal.pone.0007732	http://dx.doi.org/10.1371/journal.pone.0007732			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RZ	19888467	Green Submitted, Green Published, gold			2022-12-27	WOS:000271414600010
J	Martin, L; Che, A; Endy, D				Martin, Lance; Che, Austin; Endy, Drew			Gemini, a Bifunctional Enzymatic and Fluorescent Reporter of Gene Expression	PLOS ONE			English	Article							ALPHA-COMPLEMENTATION; BETA-GALACTOSIDASE; BIOLOGY; CONSTRUCTION; PROTEIN; REFINEMENT; PROGRAM; DEVICES; PARTS; CELLS	Background: The development of collections of quantitatively characterized standard biological parts should facilitate the engineering of increasingly complex and novel biological systems. The existing enzymatic and fluorescent reporters that are used to characterize biological part functions exhibit strengths and limitations. Combining both enzymatic and fluorescence activities within a single reporter protein would provide a useful tool for biological part characterization. Methodology/Principal Findings: Here, we describe the construction and quantitative characterization of Gemini, a fusion between the beta-galactosidase (beta-gal) alpha-fragment and the N-terminus of full-length green fluorescent protein (GFP). We show that Gemini exhibits functional beta-gal activity, which we assay with plates and fluorometry, and functional GFP activity, which we assay with fluorometry and microscopy. We show that the protein fusion increases the sensitivity of beta-gal activity and decreases the sensitivity of GFP. Conclusions/Significance: Gemini is therefore a bifunctional reporter with a wider dynamic range than the beta-gal alpha-fragment or GFP alone. Gemini enables the characterization of gene expression, screening assays via enzymatic activity, and quantitative single-cell microscopy or FACS via fluorescence activity. The analytical flexibility afforded by Gemini will likely increase the efficiency of research, particularly for screening and characterization of libraries of standard biological parts.			Martin, L (corresponding author), Stanford Univ, Dept Bioengn, Stanford, CA 94305 USA.	endy@stanford.edu		Endy, Drew/0000-0001-6952-8098				Anderson JC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100173; Baker D, 2006, SCI AM, V294, P44, DOI 10.1038/scientificamerican0606-44; Bennett MR, 2009, NAT REV GENET, V10, P628, DOI 10.1038/nrg2625; Canton B, 2008, NAT BIOTECHNOL, V26, P787, DOI 10.1038/nbt1413; Corish P, 1999, PROTEIN ENG, V12, P1035, DOI 10.1093/protein/12.12.1035; David HE, 2003, ENVIRON TOXICOL CHEM, V22, P111, DOI [10.1897/1551-5028(2003)022&lt;0111:CAEOAT&gt;2.0.CO;2, 10.1002/etc.5620220114]; Ellis T, 2009, NAT BIOTECHNOL, V27, P465, DOI 10.1038/nbt.1536; Hwang CN, 2006, BIOTECHNOL LETT, V28, P287, DOI 10.1007/s10529-005-5715-9; Juers DH, 2000, PROTEIN SCI, V9, P1685, DOI 10.1110/ps.9.9.1685; Kelly Jason R, 2009, J Biol Eng, V3, P4, DOI 10.1186/1754-1611-3-4; Marguet P, 2007, J R SOC INTERFACE, V4, P607, DOI 10.1098/rsif.2006.0206; Purnick PEM, 2009, NAT REV MOL CELL BIO, V10, P410, DOI 10.1038/nrm2698; SHETTY R, 2009, 29 BBF RFC; Tabor JJ, 2009, CELL, V137, P1272, DOI 10.1016/j.cell.2009.04.048; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Voigt CA, 2006, CURR OPIN BIOTECH, V17, P548, DOI 10.1016/j.copbio.2006.09.001; Walhout AJM, 2001, METHODS, V24, P297, DOI 10.1006/meth.2001.1190; ZAMENHOF PJ, 1972, J BACTERIOL, V110, P171, DOI 10.1128/JB.110.1.171-178.1972; Zhang J, 2002, NAT REV MOL CELL BIO, V3, P906, DOI 10.1038/nrm976	19	26	26	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2009	4	11							e7569	10.1371/journal.pone.0007569	http://dx.doi.org/10.1371/journal.pone.0007569			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RZ	19888458	Green Published, Green Submitted, gold			2022-12-27	WOS:000271414600002
J	Perez, N; Trevino, J; Liu, ZY; Ho, SCM; Babitzke, P; Sumby, P				Perez, Nataly; Trevino, Jeanette; Liu, Zhuyun; Ho, Siu Chun Michael; Babitzke, Paul; Sumby, Paul			A Genome-Wide Analysis of Small Regulatory RNAs in the Human Pathogen Group A Streptococcus	PLOS ONE			English	Article							SMALL NONCODING RNAS; RECOGNITION PARTICLE PATHWAY; VIRULENCE FACTOR REGULATION; RESPONSE REGULATOR; GENETIC-LOCUS; PYOGENES; IDENTIFICATION; EXPRESSION; PREDICTION; SYSTEM	The coordinated regulation of gene expression is essential for pathogens to infect and cause disease. A recently appreciated mechanism of regulation is that afforded by small regulatory RNA (sRNA) molecules. Here, we set out to assess the prevalence of sRNAs in the human bacterial pathogen group A Streptococcus (GAS). Genome-wide identification of candidate GAS sRNAs was performed through a tiling Affymetrix microarray approach and identified 40 candidate sRNAs within the M1T1 GAS strain MGAS2221. Together with a previous bioinformatic approach this brings the number of novel candidate sRNAs in GAS to 75, a number that approximates the number of GAS transcription factors. Transcripts were confirmed by Northern blot analysis for 16 of 32 candidate sRNAs tested, and the abundance of several of these sRNAs were shown to be temporally regulated. Six sRNAs were selected for further study and the promoter, transcriptional start site, and Rho-independent terminator identified for each. Significant variation was observed between the six sRNAs with respect to their stability during growth, and with respect to their inter- and/or intra-serotype-specific levels of abundance. To start to assess the contribution of sRNAs to gene regulation in M1T1 GAS we deleted the previously described sRNA PEL from four clinical isolates. Data from genome-wide expression microarray, quantitative RT-PCR, and Western blot analyses are consistent with PEL having no regulatory function in M1T1 GAS. The finding that candidate sRNA molecules are prevalent throughout the GAS genome provides significant impetus to the study of this fundamental gene-regulatory mechanism in an important human pathogen.			Perez, N (corresponding author), Methodist Hosp, Res Inst, Ctr Mol & Translat Human Infect Dis Res, 6535 Fannin, Houston, TX 77030 USA.	psumby@tmhs.org	Babitzke, Paul/AAL-3048-2020	Babitzke, Paul/0000-0003-2481-1062; Sumby, Paul/0000-0002-0093-4159	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI078159] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM059969] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aziz RK, 2008, EMERG INFECT DIS, V14, P1511, DOI 10.3201/eid1410.071660; Barnett TC, 2007, J BACTERIOL, V189, P1866, DOI 10.1128/JB.01658-06; Beres SB, 2006, P NATL ACAD SCI USA, V103, P7059, DOI 10.1073/pnas.0510279103; Bernish B, 1999, J BIOL CHEM, V274, P4786, DOI 10.1074/jbc.274.8.4786; Betschel SD, 1998, INFECT IMMUN, V66, P1671, DOI 10.1128/IAI.66.4.1671-1679.1998; Biswas I, 2001, INFECT IMMUN, V69, P7029, DOI 10.1128/IAI.69.11.7029-7038.2001; Blount KF, 2006, NAT BIOTECHNOL, V24, P1558, DOI 10.1038/nbt1268; Cunningham MW, 2000, CLIN MICROBIOL REV, V13, P470, DOI 10.1128/CMR.13.3.470-511.2000; Eberhard T H, 2001, BMC Microbiol, V1, P33, DOI 10.1186/1471-2180-1-33; Federle MJ, 1999, J BACTERIOL, V181, P3649, DOI 10.1128/JB.181.12.3649-3657.1999; Gottesman S, 2005, TRENDS GENET, V21, P399, DOI 10.1016/j.tig.2005.05.008; Graham MR, 2005, AM J PATHOL, V166, P455, DOI 10.1016/S0002-9440(10)62268-7; Graham MR, 2002, P NATL ACAD SCI USA, V99, P13855, DOI 10.1073/pnas.202353699; Hasona A, 2005, P NATL ACAD SCI USA, V102, P17466, DOI 10.1073/pnas.0508778102; Herskovits AA, 2000, MOL MICROBIOL, V38, P927, DOI 10.1046/j.1365-2958.2000.02198.x; Huntzinger E, 2005, EMBO J, V24, P824, DOI 10.1038/sj.emboj.7600572; Keiler KC, 2007, CURR OPIN MICROBIOL, V10, P169, DOI 10.1016/j.mib.2007.03.014; Kreikemeyer B, 2003, TRENDS MICROBIOL, V11, P224, DOI 10.1016/S0966-842X(03)00098-2; Kreikemeyer B, 2001, MOL MICROBIOL, V39, P392, DOI 10.1046/j.1365-2958.2001.02226.x; Kuwayama H, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.2.e2; Landt SG, 2008, MOL MICROBIOL, V68, P600, DOI 10.1111/j.1365-2958.2008.06172.x; Levin JC, 1998, MOL MICROBIOL, V30, P209, DOI 10.1046/j.1365-2958.1998.01057.x; Li ZQ, 1999, J BACTERIOL, V181, P6019, DOI 10.1128/JB.181.19.6019-6027.1999; Livny J, 2007, CURR OPIN MICROBIOL, V10, P96, DOI 10.1016/j.mib.2007.03.005; Livny J, 2006, NUCLEIC ACIDS RES, V34, P3484, DOI 10.1093/nar/gkl453; Mangold M, 2004, MOL MICROBIOL, V53, P1515, DOI 10.1111/j.1365-2958.2004.04222.x; McIver KS, 2009, CONTRIB MICROBIOL, V16, P103, DOI 10.1159/000219375; Morita T, 2005, GENE DEV, V19, P2176, DOI 10.1101/gad.1330405; Nizet V, 2000, INFECT IMMUN, V68, P4245, DOI 10.1128/IAI.68.7.4245-4254.2000; Ostberg Y, 2004, J BACTERIOL, V186, P8472, DOI 10.1128/JB.186.24.8472-8477.2004; Pichon C, 2005, P NATL ACAD SCI USA, V102, P14249, DOI 10.1073/pnas.0503838102; Reichenbach B, 2008, NUCLEIC ACIDS RES, V36, P2570, DOI 10.1093/nar/gkn091; Roberts SA, 2007, MOL MICROBIOL, V66, P1506, DOI 10.1111/j.1365-2958.2007.06015.x; Roberts SA, 2007, J BACTERIOL, V189, P1459, DOI 10.1128/JB.01026-06; Romby P, 2006, CURR OPIN MICROBIOL, V9, P229, DOI 10.1016/j.mib.2006.02.005; Rosch JW, 2008, INFECT IMMUN, V76, P2612, DOI 10.1128/IAI.00239-07; Shelburne SA, 2008, P NATL ACAD SCI USA, V105, P1698, DOI 10.1073/pnas.0711767105; Shelburne SA, 2007, INFECT IMMUN, V75, P2981, DOI 10.1128/IAI.00081-07; Sorek R, 2008, NAT REV MICROBIOL, V6, P181, DOI 10.1038/nrmicro1793; Sumby P, 2005, J INFECT DIS, V192, P771, DOI 10.1086/432514; Sumby P, 2003, J BACTERIOL, V185, P6841, DOI 10.1128/JB.185.23.6841-6851.2003; Sumby P, 2006, PLOS PATHOG, V2, P41, DOI 10.1371/journal.ppat.0020005; Tjaden B, 2008, J MATH BIOL, V56, P183, DOI 10.1007/s00285-007-0079-5; Tjaden B, 2006, NUCLEIC ACIDS RES, V34, P2791, DOI 10.1093/nar/gkl356; Toledo-Arana A, 2007, CURR OPIN MICROBIOL, V10, P182, DOI 10.1016/j.mib.2007.03.004; Toledo-Arana A, 2009, NATURE, V459, P950, DOI 10.1038/nature08080; Traber KE, 2008, MICROBIOL-SGM, V154, P2265, DOI 10.1099/mic.0.2007/011874-0; Vitreschak AG, 2004, TRENDS GENET, V20, P44, DOI 10.1016/j.tig.2003.11.008; Vogel J, 2005, BIOL CHEM, V386, P1219, DOI 10.1515/BC.2005.140; Wassarman KM, 2007, CURR OPIN MICROBIOL, V10, P164, DOI 10.1016/j.mib.2007.03.008	50	72	75	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2009	4	11							e7668	10.1371/journal.pone.0007668	http://dx.doi.org/10.1371/journal.pone.0007668			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RX	19888332	Green Submitted, Green Published, gold			2022-12-27	WOS:000271414400003
J	Djagaeva, I; Doronkin, S				Djagaeva, Inna; Doronkin, Sergey			COP9 Limits Dendritic Branching via Cullin3-Dependent Degradation of the Actin-Crosslinking BTB-Domain Protein Kelch	PLOS ONE			English	Article							SMITH-MAGENIS-SYNDROME; LINKED MENTAL-RETARDATION; UBIQUITIN LIGASES; NEURONAL MORPHOGENESIS; DROSOPHILA OOGENESIS; SENSORY NEURONS; SIGNALOSOME; GENE; MAINTENANCE; PLASTICITY	Components of the COP9 signalosome (CSN), a key member of the conserved 26S proteasome degradation pathway, have been detected to be altered in patients of several debilitating syndromes. These findings suggest that CSN acts in neural circuits, but the exact function of CSN in brain remains unidentified. Previously, using Drosophila peripheral nervous system (PNS) as a model system, we determined that CSN is a critical regulator of dendritic morphogenesis. We found that defects in CSN led to the strikingly contrast phenotype of either reducing or stimulating dendritic branching. In particular, we have reported that CSN stimulates dendritic branching via Cullin1-mediated proteolysis. Here we describe that CSN inhibits dendritic arborization in PNS neurons acting via control of Cullin3 function: loss of Cullin3 causes excessive dendritic branching. We also identified a downstream target for Cullin3-dependent degradation in neurons - the actin-crosslinking BTB-domain protein Kelch. Inappropriate accumulation of Kelch, either due to the impaired Cullin3-dependent turnover, or ectopic expression of Kelch, leads to uncontrolled dendritic branching. These findings indicate that the CSN pathway modulates neuronal network in a multilayer manner, providing the foundation for new insight into the CSN role in human mental retardation disorders and neurodegenerative disease.			Djagaeva, I (corresponding author), Univ Tennessee, Ctr Hlth Sci, Dept Anat & Neurobiol, Memphis, TN 38163 USA.	sdoronki@utmem.edu						Bagni C, 2005, NAT REV NEUROSCI, V6, P376, DOI 10.1038/nrn1667; Bomont P, 2000, NAT GENET, V26, P370, DOI 10.1038/81701; BRAND AH, 1993, DEVELOPMENT, V118, P401; Chen Y, 2002, J BIOL CHEM, V277, P30495, DOI 10.1074/jbc.M202076200; Cingolani LA, 2008, NAT REV NEUROSCI, V9, P344, DOI 10.1038/nrn2373; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Dailey ME, 1996, J NEUROSCI, V16, P2983; Day M, 2006, NAT NEUROSCI, V9, P251, DOI 10.1038/nn1632; Deshaies RJ, 2009, ANNU REV BIOCHEM, V78, P399, DOI 10.1146/annurev.biochem.78.101807.093809; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; Djagaeva I, 2005, DEV BIOL, V284, P143, DOI 10.1016/j.ydbio.2005.05.012; DJAGAEVA I, 2009, PLOS ONE IN PRESS; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Elsea SH, 1999, AM J MED GENET, V87, P342, DOI 10.1002/(SICI)1096-8628(19991203)87:4<342::AID-AJMG12>3.3.CO;2-1; Furukawa M, 2003, NAT CELL BIOL, V5, P1001, DOI 10.1038/ncb1056; Geyer R, 2003, MOL CELL, V12, P783, DOI 10.1016/S1097-2765(03)00341-1; Grueber WB, 2003, CURR BIOL, V13, P618, DOI 10.1016/S0960-9822(03)00207-0; Grueber WB, 2002, DEVELOPMENT, V129, P2867; He Y, 2006, J NEUROSCI, V26, P9975, DOI 10.1523/JNEUROSCI.2595-06.2006; Hegde AN, 2004, PROG NEUROBIOL, V73, P311, DOI 10.1016/j.pneurobio.2004.05.005; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Kuazi AD, 2003, J PATHOL, V199, P259, DOI 10.1002/path.1283; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lewis DA, 2003, ANN NY ACAD SCI, V1003, P102, DOI 10.1196/annals.1300.007; Luo LQ, 2002, ANNU REV CELL DEV BI, V18, P601, DOI 10.1146/annurev.cellbio.18.031802.150501; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Matus A, 2005, CURR OPIN NEUROBIOL, V15, P67, DOI 10.1016/j.conb.2005.01.015; Mori F, 2005, NEUROPATH APPL NEURO, V31, P53, DOI 10.1111/j.1365-2990.2004.00603.x; Oono K, 2004, NEUROCHEM INT, V45, P765, DOI 10.1016/j.neuint.2004.01.003; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Persico AM, 2006, TRENDS NEUROSCI, V29, P349, DOI 10.1016/j.tins.2006.05.010; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Peyrl A, 2002, ELECTROPHORESIS, V23, P152, DOI 10.1002/1522-2683(200201)23:1<152::AID-ELPS152>3.0.CO;2-T; Pickett J, 2005, J NEUROPATH EXP NEUR, V64, P925, DOI 10.1097/01.jnen.0000186921.42592.6c; Pintard L, 2003, NATURE, V425, P311, DOI 10.1038/nature01959; Potocki L, 1999, GENOMICS, V57, P180, DOI 10.1006/geno.1998.5748; Potocki L, 2000, J MED GENET, V37, P428, DOI 10.1136/jmg.37.6.428; Robinson DN, 1997, DEVELOPMENT, V124, P1405; Robinson DN, 1997, J CELL BIOL, V138, P799, DOI 10.1083/jcb.138.4.799; Robinson R, 2004, HIGH EDUC, V47, P1, DOI 10.1023/B:HIGH.0000009803.70418.9c; Sarlette A, 2008, J NEUROPATH EXP NEUR, V67, P1055, DOI 10.1097/NEN.0b013e31818b4906; SCHUPBACH T, 1991, GENETICS, V129, P1119; Schwechheimer C, 2004, BBA-MOL CELL RES, V1695, P45, DOI 10.1016/j.bbamcr.2004.09.023; Spires TL, 2004, EUR J NEUROSCI, V19, P2799, DOI 10.1111/j.0953-816X.2004.03374.x; Sweeney NT, 2002, DEV BIOL, V247, P76, DOI 10.1006/dbio.2002.0702; Tada T, 2006, CURR OPIN NEUROBIOL, V16, P95, DOI 10.1016/j.conb.2005.12.001; Tai HC, 2008, NAT REV NEUROSCI, V9, P826, DOI 10.1038/nrn2499; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Urbanska M, 2008, ACTA NEUROBIOL EXP, V68, P264; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Xu L, 2003, NATURE, V425, P316, DOI 10.1038/nature01985; Yan J, 2003, MOL CELL BIOL, V23, P6798, DOI 10.1128/MCB.23.19.6798-6808.2003; Yi JJ, 2007, PHARMACOL REV, V59, P14, DOI 10.1124/pr.59.1.4; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7; Zhou ZL, 2006, NEURON, V52, P255, DOI 10.1016/j.neuron.2006.09.037; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489	63	20	20	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7598	10.1371/journal.pone.0007598	http://dx.doi.org/10.1371/journal.pone.0007598			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859546	Green Published, gold, Green Submitted			2022-12-27	WOS:000271147400009
J	Pepper, ASR; Beerman, RW; Bhogal, B; Jongens, TA				Pepper, Anita S. -R.; Beerman, Rebecca W.; Bhogal, Balpreet; Jongens, Thomas A.			Argonaute2 Suppresses Drosophila Fragile X Expression Preventing Neurogenesis and Oogenesis Defects	PLOS ONE			English	Article							MENTAL-RETARDATION PROTEIN; MESSENGER-RNA; TREMOR/ATAXIA SYNDROME; INTERFERING RNAS; SOMATIC-CELLS; P-BODIES; GENE; PATHWAY; BEHAVIOR; BRAIN	Fragile X Syndrome is caused by the silencing of the Fragile X Mental Retardation gene (FMR1). Regulating dosage of FMR1 levels is critical for proper development and function of the nervous system and germ line, but the pathways responsible for maintaining normal expression levels are less clearly defined. Loss of Drosophila Fragile X protein (dFMR1) causes several behavioral and developmental defects in the fly, many of which are analogous to those seen in Fragile X patients. Overexpression of dFMR1 also causes specific neuronal and behavioral abnormalities. We have found that Argonaute2 (Ago2), the core component of the small interfering RNA (siRNA) pathway, regulates dfmr1 expression. Previously, the relationship between dFMR1 and Ago2 was defined by their physical interaction and co-regulation of downstream targets. We have found that Ago2 and dFMR1 are also connected through a regulatory relationship. Ago2 mediated repression of dFMR1 prevents axon growth and branching defects of the Drosophila neuromuscular junction (NMJ). Consequently, the neurogenesis defects in larvae mutant for both dfmr1 and Ago2 mirror those in dfmr1 null mutants. The Ago2 null phenotype at the NMJ is rescued in animals carrying an Ago2 genomic rescue construct. However, animals carrying a mutant Ago2 allele that produces Ago2 with significantly reduced endoribonuclease catalytic activity are normal with respect to the NMJ phenotypes examined. dFMR1 regulation by Ago2 is also observed in the germ line causing a multiple oocyte in a single egg chamber mutant phenotype. We have identified Ago2 as a regulator of dfmr1 expression and have clarified an important developmental role for Ago2 in the nervous system and germ line that requires dfmr1 function.			Pepper, ASR (corresponding author), Univ Penn, Sch Med, Dept Genet, Philadelphia, PA 19104 USA.	jongens@mail.med.upenn.edu	Pepper, Anita/GWC-7680-2022	Beerman, Rebecca/0000-0002-2057-4170; Bhogal, Balpreet/0000-0002-3997-7316	NATIONAL INSTITUTE OF MENTAL HEALTH [R21MH086705] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS046573] Funding Source: NIH RePORTER; NIMH NIH HHS [MH086705, R21 MH086705] Funding Source: Medline; NINDS NIH HHS [NS046573, R01 NS046573] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ASHLEY CT, 1993, NAT GENET, V4, P244, DOI 10.1038/ng0793-244; Ashraf SI, 2006, CELL, V124, P191, DOI 10.1016/j.cell.2005.12.017; Barbee SA, 2006, NEURON, V52, P997, DOI 10.1016/j.neuron.2006.10.028; Berry-Kravis E, 2003, ANN NEUROL, V53, P616, DOI 10.1002/ana.10522; Beumer KJ, 1999, DEVELOPMENT, V126, P5833; Bolduc FV, 2008, NAT NEUROSCI, V11, P1143, DOI 10.1038/nn.2175; Caudy AA, 2002, GENE DEV, V16, P2491, DOI 10.1101/gad.1025202; Comery TA, 1997, P NATL ACAD SCI USA, V94, P5401, DOI 10.1073/pnas.94.10.5401; Costa A, 2005, DEV CELL, V8, P331, DOI 10.1016/j.devcel.2005.01.011; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; Dockendorff TC, 2002, NEURON, V34, P973, DOI 10.1016/S0896-6273(02)00724-9; Eulalio A, 2007, MOL CELL BIOL, V27, P3970, DOI 10.1128/MCB.00128-07; Eulalio A, 2007, NAT REV MOL CELL BIO, V8, P9, DOI 10.1038/nrm2080; Feng Y, 1997, J NEUROSCI, V17, P1539; Gabus C, 2004, NUCLEIC ACIDS RES, V32, P2129, DOI 10.1093/nar/gkh535; Garber K, 2006, CURR OPIN GENET DEV, V16, P270, DOI 10.1016/j.gde.2006.04.010; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Hagerman PJ, 2004, MENT RETARD DEV D R, V10, P25, DOI 10.1002/mrdd.20005; Hagerman RJ, 2001, MOL GENET METAB, V74, P89, DOI 10.1006/mgme.2001.3225; HINTON VJ, 1991, AM J MED GENET, V41, P289, DOI 10.1002/ajmg.1320410306; Hou LF, 2006, NEURON, V51, P441, DOI 10.1016/j.neuron.2006.07.005; Irwin SA, 2000, CEREB CORTEX, V10, P1038, DOI 10.1093/cercor/10.10.1038; Irwin SA, 2001, AM J MED GENET, V98, P161, DOI 10.1002/1096-8628(20010115)98:2<161::AID-AJMG1025>3.0.CO;2-B; Ishizuka A, 2002, GENE DEV, V16, P2497, DOI 10.1101/gad.1022002; Jacquemont S, 2004, AM J MENT RETARD, V109, P154, DOI 10.1352/0895-8017(2004)109<154:AIIWTF>2.0.CO;2; Jacquemont S, 2003, AM J HUM GENET, V72, P869, DOI 10.1086/374321; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kim K, 2007, RNA, V13, P22, DOI 10.1261/rna.283207; Lee A, 2003, DEVELOPMENT, V130, P5543, DOI 10.1242/dev.00792; Leehey MA, 2003, ARCH NEUROL-CHICAGO, V60, P117, DOI 10.1001/archneur.60.1.117; Ling SC, 2004, P NATL ACAD SCI USA, V101, P17428, DOI 10.1073/pnas.0408114101; Meyer WJ, 2006, PLOS GENET, V2, P1224, DOI 10.1371/journal.pgen.0020134; Monzo K, 2006, P NATL ACAD SCI USA, V103, P18160, DOI 10.1073/pnas.0606508103; Morales J, 2002, NEURON, V34, P961, DOI 10.1016/S0896-6273(02)00731-6; Murashov AK, 2007, FASEB J, V21, P656, DOI 10.1096/fj.06-6155com; OBERLE I, 1991, SCIENCE, V252, P1097, DOI 10.1126/science.252.5009.1097; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Okamura K, 2008, NAT REV MOL CELL BIO, V9, P673, DOI 10.1038/nrm2479; Okamura K, 2008, NATURE, V453, P803, DOI 10.1038/nature07015; Page SL, 2001, GENE DEV, V15, P3130, DOI 10.1101/gad.935001; Pan L, 2008, MOL CELL NEUROSCI, V37, P747, DOI 10.1016/j.mcn.2008.01.003; Pan LY, 2004, CURR BIOL, V14, P1863, DOI 10.1016/j.cub.2004.09.085; Papaceit M, 2004, GENETICS, V167, P289, DOI 10.1534/genetics.167.1.289; Peier AM, 2000, HUM MOL GENET, V9, P1145, DOI 10.1093/hmg/9.8.1145; PIERETTI M, 1991, CELL, V66, P817, DOI 10.1016/0092-8674(91)90125-I; Rehwinkel J, 2006, MOL CELL BIOL, V26, P2965, DOI 10.1128/MCB.26.8.2965-2975.2006; Rohrbough J, 2000, J NEUROSCI, V20, P6868, DOI 10.1523/JNEUROSCI.20-18-06868.2000; Schaeffer C, 2001, EMBO J, V20, P4803, DOI 10.1093/emboj/20.17.4803; Schenck A, 2002, NEUROBIOL DIS, V11, P53, DOI 10.1006/nbdi.2002.0510; Schneider MD, 2006, J CELL BIOL, V174, P349, DOI 10.1083/jcb.200512103; SIOMI H, 1993, CELL, V74, P291, DOI 10.1016/0092-8674(93)90420-U; Siomi MC, 2005, RNA, V11, P1004, DOI 10.1261/rna.2280105; Sofola O, 2008, J NEUROSCI, V28, P10200, DOI 10.1523/JNEUROSCI.2786-08.2008; Sonenberg N, 2007, MOL CELL, V28, P721, DOI 10.1016/j.molcel.2007.11.018; Wan LL, 2000, MOL CELL BIOL, V20, P8536, DOI 10.1128/MCB.20.22.8536-8547.2000; WARREN ST, 1994, JAMA-J AM MED ASSOC, V271, P536, DOI 10.1001/jama.271.7.536; Xu KY, 2004, CURR BIOL, V14, P1025, DOI 10.1016/j.cub.2004.05.055; Zarnescu DC, 2005, GENES BRAIN BEHAV, V4, P385, DOI 10.1111/j.1601-183X.2005.00136.x; Zhang YQ, 2001, CELL, V107, P591, DOI 10.1016/S0092-8674(01)00589-X; ZINSMAIER KE, 1990, J NEUROGENET, V7, P15, DOI 10.3109/01677069009084150	61	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7618	10.1371/journal.pone.0007618	http://dx.doi.org/10.1371/journal.pone.0007618			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19888420	gold, Green Published, Green Submitted			2022-12-27	WOS:000271147400016
J	Fang, ZA; Wang, GH; Chen, AL; Li, YF; Liu, JP; Li, YY; Bolotin-Fukuhara, M; Bao, WG				Fang, Zi-An; Wang, Guang-Hui; Chen, Ai-Lian; Li, You-Fang; Liu, Jian-Ping; Li, Yu-Yang; Bolotin-Fukuhara, Monique; Bao, Wei-Guo			Gene Responses to Oxygen Availability in Kluyveromyces lactis: an Insight on the Evolution of the Oxygen-Responding System in Yeast	PLOS ONE			English	Article							CYTOCHROME-C-OXIDASE; DNA-BINDING PROTEIN; SACCHAROMYCES-CEREVISIAE; HYPOXIC GENES; CANDIDA-ALBICANS; COPROPORPHYRINOGEN OXIDASE; TRANSCRIPTIONAL CONTROL; DIFFERENTIAL REGULATION; ANAEROBIC CONDITIONS; NEGATIVE REGULATION	The whole-genome duplication (WGD) may provide a basis for the emergence of the very characteristic life style of Saccharomyces cerevisiae-its fermentation-oriented physiology and its capacity of growing in anaerobiosis. Indeed, we found an over-representation of oxygen-responding genes in the ohnologs of S. cerevisiae. Many of these duplicated genes are present as aerobic/hypoxic(anaerobic) pairs and form a specialized system responding to changing oxygen availability. HYP2/ANB1 and COX5A/COX5B are such gene pairs, and their unique orthologs in the 'non-WGD' Kluyveromyces lactis genome behaved like the aerobic versions of S. cerevisiae. ROX1 encodes a major oxygen-responding regulator in S. cerevisiae. The synteny, structural features and molecular function of putative KlROX1 were shown to be different from that of ROX1. The transition from the K. lactis-type ROX1 to the S. cerevisiae-type ROX1 could link up with the development of anaerobes in the yeast evolution. Bioinformatics and stochastic analyses of the Rox1p-binding site (YYYATTGTTCTC) in the upstream sequences of the S. cerevisiae Rox1p-mediated genes and of the K. lactis orthologs also indicated that K. lactis lacks the specific gene system responding to oxygen limiting environment, which is present in the 'post-WGD' genome of S. cerevisiae. These data suggested that the oxygen-responding system was born for the specialized physiology of S. cerevisiae.			Fang, ZA (corresponding author), Univ Paris 11, CNRS, UMR 8621, Inst Genet & Microbiol, Orsay, France.	weiguo.bao@igmors.u-psud.fr		Bolotin-Fukuhara, Monique/0000-0002-5285-5006				AMILLET JM, 1995, CURR GENET, V28, P503, DOI 10.1007/BF00518161; BALASUBRAMANIAN B, 1993, MOL CELL BIOL, V13, P6071, DOI 10.1128/MCB.13.10.6071; Bao WG, 2008, EUKARYOT CELL, V7, P1895, DOI 10.1128/EC.00018-08; Billard P, 1996, J BACTERIOL, V178, P5860, DOI 10.1128/jb.178.20.5860-5866.1996; Bolotin-Fukuhara M, 2000, FEBS LETT, V487, P66, DOI 10.1016/S0014-5793(00)02282-1; BOLOTINFUKUHARA M, 2006, COMP GENOMICS USING, P165; Burke PV, 1997, J BIOL CHEM, V272, P14705, DOI 10.1074/jbc.272.23.14705; Byrne KP, 2005, GENOME RES, V15, P1456, DOI 10.1101/gr.3672305; Chen H, 2008, MOL BIOL EVOL, V25, P2513, DOI 10.1093/molbev/msn212; CHEN XJ, 1993, GENETICS, V133, P517; Conant GC, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100170; COOPER CE, 1991, BIOCHEM CELL BIOL, V69, P586, DOI 10.1139/o91-089; DECKERT J, 1995, MOL CELL BIOL, V15, P6109; Deckert J, 1998, GENETICS, V150, P1429; Dietrich FS, 2004, SCIENCE, V304, P304, DOI 10.1126/science.1095781; DOOIJES D, 1993, J BIOL CHEM, V268, P24813; Fairhead C, 1996, YEAST, V12, P1439; Feller W., 1970, INTRO PROBABILITY TH, V3; Fontanesi F, 2006, FEMS YEAST RES, V6, P414, DOI 10.1111/j.1567-1364.2005.00011.x; Freire-Picos MA, 2001, YEAST, V18, P1347, DOI 10.1002/yea.787; FREIREPICOS MA, 1995, FEBS LETT, V360, P39, DOI 10.1016/0014-5793(95)00016-3; Fukuhara H, 2003, FEMS YEAST RES, V3, P327, DOI 10.1016/S1567-1356(03)00112-0; Gojkovic Z, 2004, MOL GENET GENOMICS, V271, P387, DOI 10.1007/s00438-004-0995-7; Gonzalez-Dominguez M, 2000, CURR GENET, V38, P171, DOI 10.1007/s002940000146; Hall C, 2005, EUKARYOT CELL, V4, P1102, DOI 10.1128/EC.4.6.1102-1115.2005; Herrmann JM, 2005, GENE, V354, P43, DOI 10.1016/j.gene.2005.03.017; HODGE MR, 1990, MOL CELL BIOL, V10, P5510, DOI 10.1128/MCB.10.10.5510; HODGE MR, 1989, MOL CELL BIOL, V9, P1958, DOI 10.1128/MCB.9.5.1958; Hon T, 2003, J BIOL CHEM, V278, P50771, DOI 10.1074/jbc.M303677200; Kadosh D, 2005, MOL BIOL CELL, V16, P2903, DOI 10.1091/mbc.E05-01-0073; Kadosh D, 2001, MOL CELL BIOL, V21, P2496, DOI 10.1128/MCB.21.7.2496-2505.2001; Kastaniotis AJ, 2000, MOL CELL BIOL, V20, P7088, DOI 10.1128/MCB.20.19.7088-7098.2000; Kastaniotis AJ, 2000, ADV EXP MED BIOL, V475, P185; Kellis M, 2004, NATURE, V428, P617, DOI 10.1038/nature02424; KELLY M, 1988, EMBO J, V7, P1537, DOI 10.1002/j.1460-2075.1988.tb02973.x; Keogh RS, 1998, YEAST, V14, P443, DOI 10.1002/(SICI)1097-0061(19980330)14:5<443::AID-YEA243>3.0.CO;2-L; Khalaf RA, 2001, GENETICS, V157, P1503; Klinkenberg LG, 2005, EUKARYOT CELL, V4, P649, DOI 10.1128/EC.4.4.649-660.2005; KOLAROV J, 1990, J BIOL CHEM, V265, P12711; Kwast KE, 2002, J BACTERIOL, V184, P250, DOI 10.1128/JB.184.1.250-265.2002; Kwast KE, 1998, J EXP BIOL, V201, P1177; Li YF, 2007, FEMS YEAST RES, V7, P657, DOI 10.1111/j.1567-1364.2007.00231.x; LOWRY CV, 1986, MOL CELL BIOL, V6, P4145, DOI 10.1128/MCB.6.12.4145; Mennella TA, 2003, EUKARYOT CELL, V2, P1288, DOI 10.1128/EC.2.6.1288-1303.2003; Merico A, 2007, FEBS J, V274, P976, DOI 10.1111/j.1742-4658.2007.05645.x; Moller K, 2001, J BACTERIOL, V183, P2485, DOI 10.1128/JB.183.8.2485-2489.2001; NAGY M, 1992, P NATL ACAD SCI USA, V89, P8966, DOI 10.1073/pnas.89.19.8966; NIINO YS, 1995, J BIOL CHEM, V270, P1983, DOI 10.1074/jbc.270.5.1983; Panozzo C, 2002, FEBS LETT, V517, P97, DOI 10.1016/S0014-5793(02)02585-1; Piskur J, 2004, MOL MICROBIOL, V53, P381, DOI 10.1111/j.1365-2958.2004.04182.x; Piskur J, 2001, TRENDS GENET, V17, P302, DOI 10.1016/S0168-9525(01)02308-3; Rodriguez-Navarro S, 2002, YEAST, V19, P1261, DOI 10.1002/yea.916; SCANNELL DR, 2007, YEAST; SCHMITT ME, 1990, NUCLEIC ACIDS RES, V18, P3091, DOI 10.1093/nar/18.10.3091; SCHNIER J, 1991, MOL CELL BIOL, V11, P3105, DOI 10.1128/MCB.11.6.3105; SCHWELBERGER HG, 1993, J BIOL CHEM, V268, P14018; Seoane S, 2005, J BIOTECHNOL, V118, P149, DOI 10.1016/j.jbiotec.2005.03.003; Sertil O, 2003, NUCLEIC ACIDS RES, V31, P5831, DOI 10.1093/nar/gkg792; Snoek ISI, 2007, YEAST, V24, P1, DOI 10.1002/yea.1430; ter Linde JJM, 1999, J BACTERIOL, V181, P7409, DOI 10.1128/JB.181.24.7409-7413.1999; Ter Linde JJM, 2002, YEAST, V19, P825, DOI 10.1002/yea.879; THORSNESS M, 1989, MOL CELL BIOL, V9, P5702, DOI 10.1128/MCB.9.12.5702; TRUEBLOOD CE, 1988, GENETICS, V120, P671; TRUEBLOOD CE, 1988, MOL CELL BIOL, V8, P4537, DOI 10.1128/MCB.8.10.4537; van Beest M, 2000, J BIOL CHEM, V275, P27266; VERDIERE J, 1991, MOL GEN GENET, V228, P300; Wolfe KH, 1997, NATURE, V387, P708, DOI 10.1038/42711; Wong S, 2005, NAT GENET, V37, P777, DOI 10.1038/ng1584; Wong S, 2002, P NATL ACAD SCI USA, V99, P9272, DOI 10.1073/pnas.142101099; ZAGOREC M, 1988, J BIOL CHEM, V263, P9718; Zhang L, 1999, CELL MOL LIFE SCI, V56, P415, DOI 10.1007/s000180050442; ZITOMER RS, 1992, MICROBIOL REV, V56, P1	72	10	10	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7561	10.1371/journal.pone.0007561	http://dx.doi.org/10.1371/journal.pone.0007561			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855843	gold, Green Submitted, Green Published			2022-12-27	WOS:000271147200006
J	Lucchetta, EM; Carthew, RW; Ismagilov, RF				Lucchetta, Elena M.; Carthew, Richard W.; Ismagilov, Rustem F.			The Endo-siRNA Pathway Is Essential for Robust Development of the Drosophila Embryo	PLOS ONE			English	Article							REPLICATION CHECKPOINT CONTROL; CELL-CYCLE; REGULATORY RNAS; DISTINCT ROLES; MESSENGER-RNAS; HUNCHBACK; SEGMENTATION; EXPRESSION; MICRORNAS; PATTERN	Background: Robustness to natural temperature fluctuations is critical to proper development in embryos and to cellular functions in adult organisms. However, mechanisms and pathways which govern temperature compensation remain largely unknown beyond circadian rhythms. Pathways which ensure robustness against temperature fluctuations may appear to be nonessential under favorable, uniform environmental conditions used in conventional laboratory experiments where there is little variation for which to compensate. The endo-siRNA pathway, which produces small double-stranded RNAs in Drosophila, appears to be nonessential for robust development of the embryo under ambient uniform temperature and to be necessary only for viral defense. Embryos lacking a functional endo-siRNA pathway develop into phenotypically normal adults. However, we hypothesized that small RNAs may regulate the embryo's response to temperature, as a ribonucleoprotein complex has been previously shown to mediate mammalian cell response to heat shock. Principal Findings: Here, we show that the genes DICER-2 and ARGONAUTE2, which code for integral protein components of the endo-siRNA pathway, are essential for robust development and temperature compensation in the Drosophila embryo when exposed to temperature perturbations. The regulatory functions of DICER-2 and ARGONAUTE2 were uncovered by using microfluidics to expose developing Drosophila embryos to a temperature step, in which each half of the embryo develops at a different temperature through developmental cycle 14. Under this temperature perturbation, dicer-2 or argonaute2 embryos displayed abnormal segmentation. The abnormalities in segmentation are presumably due to the inability of the embryo to compensate for temperature-induced differences in rate of development and to coordinate developmental timing in the anterior and posterior halves. A deregulation of the length of nuclear division cycles 10-14 is also observed in dicer-2 embryos at high temperatures. Conclusions: Results presented herein uncover a novel function of the endo-siRNA pathway in temperature compensation and cell cycle regulation, and we hypothesize that the endo-siRNA pathway may regulate the degradation of maternal cell cycle regulators. Endo-siRNAs may have a more general role buffering against environmental perturbations in other organisms.			Lucchetta, EM (corresponding author), Univ Chicago, Dept Chem, 5735 S Ellis Ave, Chicago, IL 60637 USA.	elucchetta@gmail.com			NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM077581, R01GM077331, R01GM068743] Funding Source: NIH RePORTER; NIGMS NIH HHS [5R01GM068743-05, R01 GM077331, 1R01GM077331, R01 GM077331-04, R01 GM068743, R01 GM077581] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bushati N, 2008, CURR BIOL, V18, P501, DOI 10.1016/j.cub.2008.02.081; CASANOVA J, 1990, DEVELOPMENT, V110, P621; Chou TB, 1996, GENETICS, V144, P1673; Czech B, 2008, NATURE, V453, P798, DOI 10.1038/nature07007; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Deshpande G, 2005, GENE DEV, V19, P1680, DOI 10.1101/gad.1316805; DRIEVER W, 1989, NATURE, V337, P138, DOI 10.1038/337138a0; Duchaine TF, 2006, CELL, V124, P343, DOI [10.1016/j.cell.2005.11.036, 10.1016/j.cel.2005.11.036]; Edgar BA, 1996, GENE DEV, V10, P1966, DOI 10.1101/gad.10.15.1966; EDGAR BA, 1994, GENE DEV, V8, P440, DOI 10.1101/gad.8.4.440; Eldar A, 2004, CURR OPIN GENET DEV, V14, P435, DOI 10.1016/j.gde.2004.06.009; Fang G, 2005, MOL BIOL EVOL, V22, P2147, DOI 10.1093/molbev/msi211; FRASCH M, 1987, EMBO J, V6, P749, DOI 10.1002/j.1460-2075.1987.tb04817.x; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Ghildiyal M, 2008, SCIENCE, V320, P1077, DOI 10.1126/science.1157396; Habayeb MS, 2006, J GEN VIROL, V87, P3045, DOI 10.1099/vir.0.81997-0; Hartwell L, 2004, SCIENCE, V303, P774, DOI 10.1126/science.1094731; Hobert O, 2006, COLD SPRING HARB SYM, V71, P181, DOI 10.1101/sqb.2006.71.006; Hong CI, 2007, P NATL ACAD SCI USA, V104, P1195, DOI 10.1073/pnas.0601378104; Hornstein E, 2006, NAT GENET, V38, pS20, DOI 10.1038/ng1803; Houchmandzadeh B, 2002, NATURE, V415, P798, DOI 10.1038/415798a; Ji JY, 2004, DEVELOPMENT, V131, P401, DOI 10.1242/dev.00944; Kawamura Y, 2008, NATURE, V453, P793, DOI 10.1038/nature06938; Kennerdell JR, 2002, GENE DEV, V16, P1884, DOI 10.1101/gad.990802; Lee RC, 2006, RNA, V12, P589, DOI 10.1261/rna.2231506; Lee YS, 2004, CELL, V117, P69, DOI 10.1016/S0092-8674(04)00261-2; LEHMANN R, 1987, DEV BIOL, V119, P402, DOI 10.1016/0012-1606(87)90045-5; Levine E, 2007, PLOS COMPUT BIOL, V3, P2356, DOI 10.1371/journal.pcbi.0030233; Li Y, 2006, GENE DEV, V20, P2793, DOI 10.1101/gad.1466306; Lucchetta EM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003651; Lucchetta EM, 2005, NATURE, V434, P1134, DOI 10.1038/nature03509; Lucchetta EM, 2006, LAB CHIP, V6, P185, DOI 10.1039/b516119c; MARGOLIS JS, 1987, J CELL BIOCHEM, P22; Namba R, 1997, DEVELOPMENT, V124, P1393; Okamura K, 2004, GENE DEV, V18, P1655, DOI 10.1101/gad.1210204; Patel NH, 2001, DEVELOPMENT, V128, P3459; Rao CV, 2002, NATURE, V420, P231, DOI 10.1038/nature01258; SHERMOEN AW, 1991, CELL, V67, P303, DOI 10.1016/0092-8674(91)90182-X; Sibon OCM, 1999, CURR BIOL, V9, P302, DOI 10.1016/S0960-9822(99)80138-9; Sibon OCM, 1997, NATURE, V388, P93, DOI 10.1038/40439; Sieber P, 2007, DEVELOPMENT, V134, P1051, DOI 10.1242/dev.02817; SON EB, 1896, CELL DEV INHERITANCE; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Stelling J, 2004, CELL, V118, P675, DOI 10.1016/j.cell.2004.09.008; SULLIVAN W, 2000, PREPARATION LARVAL A; Takada S, 2007, DEVELOPMENT, V134, P1737, DOI 10.1242/dev.02831; TAUTZ D, 1988, NATURE, V332, P281, DOI 10.1038/332281a0; Theodosiou NA, 1998, METHODS, V14, P355, DOI 10.1006/meth.1998.0591; Tong AHY, 2001, SCIENCE, V294, P2364, DOI 10.1126/science.1065810; Tsang J, 2007, MOL CELL, V26, P753, DOI 10.1016/j.molcel.2007.05.018; Tyler DM, 2008, GENE DEV, V22, P26, DOI 10.1101/gad.1615208; Tyson JJ, 1999, BIOPHYS J, V77, P2411, DOI 10.1016/S0006-3495(99)77078-5; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; WIESCHAUS E, 1984, ROUX ARCH DEV BIOL, V193, P296, DOI 10.1007/BF00848158	55	27	29	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7576	10.1371/journal.pone.0007576	http://dx.doi.org/10.1371/journal.pone.0007576			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851503	gold, Green Published, Green Accepted, Green Submitted			2022-12-27	WOS:000271022300011
J	Lee, JH; Schell, MJ; Roetzheim, R				Lee, Ji-Hyun; Schell, Michael J.; Roetzheim, Richard			Analysis of Group Randomized Trials with Multiple Binary Endpoints and Small Number of Groups	PLOS ONE			English	Article							COMMUNITY-HEALTH CENTERS; LINEAR MIXED MODELS; CANCER; DESIGN; ESTIMATORS; LIKELIHOOD; INFERENCE; ATTENDEES	The group randomized trial (GRT) is a common study design to assess the effect of an intervention program aimed at health promotion or disease prevention. In GRTs, groups rather than individuals are randomized into intervention or control arms. Then, responses are measured on individuals within those groups. A number of analytical problems beset GRT designs. The major problem emerges from the likely positive intraclass correlation among observations of individuals within a group. This paper provides an overview of the analytical method for GRT data and applies this method to a randomized cancer prevention trial, where multiple binary primary endpoints were obtained. We develop an index of extra variability to investigate group-specific effects on response. The purpose of the index is to understand the influence of individual groups on evaluating the intervention effect, especially, when a GRT study involves a small number of groups. The multiple endpoints from the GRT design are analyzed using a generalized linear mixed model and the stepdown Bonferroni method of Holm.			Lee, JH (corresponding author), Univ S Florida, Coll Med, H Lee Moffitt Canc Ctr & Res Inst, Tampa, FL 33612 USA.	ji-hyun.lee@moffitt.org	Roetzheim, Richard/J-4696-2012		NATIONAL CANCER INSTITUTE [R01CA077282, P30CA076292] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA77282, P30 CA076292, 2P30CA76292-08] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bellamy SL, 2000, STAT METHODS MED RES, V9, P135, DOI 10.1191/096228000672549488; BRESLOW NE, 1993, J AM STAT ASSOC, V88, P9, DOI 10.1080/01621459.1993.10594284; Brown BW, 1997, STAT MED, V16, P2511, DOI 10.1002/(SICI)1097-0258(19971130)16:22<2511::AID-SIM693>3.0.CO;2-4; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Fay MP, 2001, BIOMETRICS, V57, P1198, DOI 10.1111/j.0006-341X.2001.01198.x; Feng ZD, 2001, ANNU REV PUBL HEALTH, V22, P167, DOI 10.1146/annurev.publhealth.22.1.167; HOLM S, 1979, SCAND J STAT, V6, P65; Kenward MG, 1997, BIOMETRICS, V53, P983, DOI 10.2307/2533558; Klar N, 2000, DESIGN ANAL CLUSTER, DOI [10.17843/rpmesp.2016.333.2293, DOI 10.17843/RPMESP.2016.333.2293]; LIANG KY, 1986, BIOMETRIKA, V73, P13, DOI 10.1093/biomet/73.1.13; Lu B, 2007, BIOMETRICS, V63, P935, DOI 10.1111/j.1541-0420.2007.00764.x; Murray DM, 2008, JNCI-J NATL CANCER I, V100, P483, DOI 10.1093/jnci/djn066; Murray DM, 2004, AM J PUBLIC HEALTH, V94, P423, DOI 10.2105/AJPH.94.3.423; Murray DM, 1998, DESIGN ANAL GROUP RA; Roetzheim RG, 2005, ANN FAM MED, V3, P109, DOI 10.1370/afm.240; Roetzheim RG, 2004, ANN FAM MED, V2, P294, DOI 10.1370/afm.101; SIMPSON JM, 1995, AM J PUBLIC HEALTH, V85, P1378, DOI 10.2105/AJPH.85.10.1378; Smith PJ, 1997, J CLIN EPIDEMIOL, V50, P137, DOI 10.1016/S0895-4356(96)00338-1; Varnell SP, 2004, AM J PUBLIC HEALTH, V94, P393, DOI 10.2105/AJPH.94.3.393; WOLFINGER R, 1993, J STAT COMPUT SIM, V48, P233, DOI 10.1080/00949659308811554	20	17	17	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7265	10.1371/journal.pone.0007265	http://dx.doi.org/10.1371/journal.pone.0007265			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509JU	19844579	gold, Green Published, Green Submitted			2022-12-27	WOS:000271013000003
J	Plummer, TW; Ditchfield, PW; Bishop, LC; Kingston, JD; Ferraro, JV; Braun, DR; Hertel, F; Potts, R				Plummer, Thomas W.; Ditchfield, Peter W.; Bishop, Laura C.; Kingston, John D.; Ferraro, Joseph V.; Braun, David R.; Hertel, Fritz; Potts, Richard			Oldest Evidence of Toolmaking Hominins in a Grassland-Dominated Ecosystem	PLOS ONE			English	Article							DIETARY ADAPTATIONS; OLDUVAI GORGE; KOOBI-FORA; EARLY HOMO; EVOLUTION; KENYA; PALEOENVIRONMENTS; HABITAT; BASIN; PALEOECOLOGY	Background: Major biological and cultural innovations in late Pliocene hominin evolution are frequently linked to the spread or fluctuating presence of C-4 grass in African ecosystems. Whereas the deep sea record of global climatic change provides indirect evidence for an increase in C-4 vegetation with a shift towards a cooler, drier and more variable global climatic regime beginning approximately 3 million years ago (Ma), evidence for grassland-dominated ecosystems in continental Africa and hominin activities within such ecosystems have been lacking. Methodology/Principal Findings: We report stable isotopic analyses of pedogenic carbonates and ungulate enamel, as well as faunal data from similar to 2.0 Ma archeological occurrences at Kanjera South, Kenya. These document repeated hominin activities within a grassland-dominated ecosystem. Conclusions/Significance: These data demonstrate what hitherto had been speculated based on indirect evidence: that grassland-dominated ecosystems did in fact exist during the Plio-Pleistocene, and that early Homo was active in open settings. Comparison with other Oldowan occurrences indicates that by 2.0 Ma hominins, almost certainly of the genus Homo, used a broad spectrum of habitats in East Africa, from open grassland to riparian forest. This strongly contrasts with the habitat usage of Australopithecus, and may signal an important shift in hominin landscape usage.			Plummer, TW (corresponding author), Queens Coll, Dept Anthropol, Flushing, NY USA.	thomas.plummer@qc.cuny.edu		Bishop, Laura C/0000-0002-4216-8667				Anton Susan C., 2008, P443, DOI 10.1007/978-0-387-76585-3_20; Bamford MK, 2008, PALAEOGEOGR PALAEOCL, V257, P280, DOI 10.1016/j.palaeo.2007.09.003; BEHRENSMEYER AK, 1995, J HUM EVOL, V29, P247, DOI 10.1006/jhev.1995.1059; Bernor RL, 1999, HUMAN EVOLUT SER, P189; Bishop LC, 1999, HUMAN EVOLUT SER, P216; Bobe R, 2004, PALAEOGEOGR PALAEOCL, V207, P399, DOI 10.1016/j.palaeo.2003.09.033; Bramble DM, 2004, NATURE, V432, P345, DOI 10.1038/nature03052; BRAUN DR, 2006, PALEOANTHROPOL A, V14; Cerling TE, 2003, J MAMMAL, V84, P456, DOI 10.1644/1545-1542(2003)084&lt;0456:DOEABB&gt;2.0.CO;2; Cerling TE, 1997, NATURE, V389, P153, DOI 10.1038/38229; CERLING TE, 1986, QUATERNARY RES, V25, P63, DOI 10.1016/0033-5894(86)90044-X; Cerling TE, 1999, OECOLOGIA, V120, P364, DOI 10.1007/s004420050869; CERLING TE, 1988, PALAEOGEOGR PALAEOCL, V63, P335, DOI 10.1016/0031-0182(88)90104-6; Cerling Thure E., 2003, P605; d'Errico F, 2009, J ARCHAEOL SCI, V36, P1764, DOI 10.1016/j.jas.2009.04.005; DeMenocal PB, 2004, EARTH PLANET SC LETT, V220, P3, DOI 10.1016/S0012-821X(04)00003-2; ESTES RD, 1991, BEHAV GUIDE AFRICAN; Feakins SJ, 2005, GEOLOGY, V33, P977, DOI 10.1130/G21814.1; Ferraro JV, 2007, THESIS U CALIFORNIA; Harris JM, 2002, J ZOOL, V256, P45, DOI 10.1017/S0952836902000067; HOWELL FC, 1987, J HUM EVOL, V16, P665; Kappelman J, 1997, J HUM EVOL, V32, P229, DOI 10.1006/jhev.1996.0105; Kimbel William H., 2009, P31, DOI 10.1007/978-1-4020-9980-9_4; Kingdon J, 2011, KINGDON FIELD GUIDE, V4th; KINGSTON JD, 1994, SCIENCE, V264, P955, DOI 10.1126/science.264.5161.955; Kingston JD, 2007, YEARB PHYS ANTHROPOL, V50, P20, DOI 10.1002/ajpa.20733; Kingston JD, 2007, PALAEOGEOGR PALAEOCL, V243, P272, DOI 10.1016/j.palaeo.2006.08.002; Kingston John D., 1999, P69; LEETHORP JA, 1994, J HUM EVOL, V27, P361, DOI 10.1006/jhev.1994.1050; Levin NE, 2006, P NATL ACAD SCI USA, V103, P11201, DOI 10.1073/pnas.0604719103; Lieberman DE, 1996, J HUM EVOL, V30, P97, DOI 10.1006/jhev.1996.0008; Lopez-Saez JA, 2009, GEOBIOS-LYON, V42, P503, DOI 10.1016/j.geobios.2008.12.002; Plummer T, 1999, J HUM EVOL, V36, P151, DOI 10.1006/jhev.1998.0256; Plummer T, 2004, YEARB PHYS ANTHROPOL, V47, P118, DOI 10.1002/ajpa.20157; PLUMMER TW, 1994, J HUM EVOL, V27, P47, DOI 10.1006/jhev.1994.1035; Potts R, 2007, VERTEBR PALEOBIOL PA, P25, DOI 10.1007/978-1-4020-3098-7_2; Potts R, 1998, YEARB PHYS ANTHROPOL, V41, P93; Potts R., 1988, EARLY HOMINID ACTIVI; Prat S, 2005, J HUM EVOL, V49, P230, DOI 10.1016/j.jhevol.2005.03.009; Quade J, 2004, GEOL SOC AM BULL, V116, P1529, DOI 10.1130/B25358.1; Quinn RL, 2007, J HUM EVOL, V53, P560, DOI 10.1016/j.jhevol.2007.01.013; Reed KE, 1997, J HUM EVOL, V32, P289, DOI 10.1006/jhev.1996.0106; Rightmire G. Philip, 2009, P39, DOI 10.1007/978-1-4020-9980-9_5; Roche Helene, 2009, P135, DOI 10.1007/978-1-4020-9980-9_12; SHIPMAN P, 1998, EVOLUTIONARY HIST RO, P343; Sikes NE, 2007, J HUM EVOL, V53, P574, DOI 10.1016/j.jhevol.2006.12.008; Sikes NE, 1999, J HUM EVOL, V37, P721, DOI 10.1006/jhev.1999.0343; SIKES NE, 1994, J HUM EVOL, V27, P25, DOI 10.1006/jhev.1994.1034; Spencer LM, 1997, J HUM EVOL, V32, P201, DOI 10.1006/jhev.1996.0102; Sponheimer M, 2003, S AFR J SCI, V99, P273; SUSMAN RL, 1991, J ANTHROPOL RES, V47, P129, DOI 10.1086/jar.47.2.3630322; TURNER A, 1993, J HUM EVOL, V24, P301, DOI 10.1006/jhev.1993.1023; van der Merwe NJ, 2003, J HUM EVOL, V44, P581, DOI 10.1016/S0047-2484(03)00050-2; Vrba E.S., 1980, P247; Vrba ES, 1995, PALEOCLIMATE AND EVOLUTION, WITH EMPHASIS ON HUMAN ORIGINS, P24; Walker A., 1993, NARIOKOTOME HOMO ERE; WHEELER PE, 1991, J HUM EVOL, V21, P107, DOI 10.1016/0047-2484(91)90002-D; WoldeGabriel G, 2001, NATURE, V412, P175, DOI 10.1038/35084058; Wood B., 1991, HOMINID CRANIAL REMA, V4; Wynn JG, 2004, AM J PHYS ANTHROPOL, V123, P106, DOI 10.1002/ajpa.10317; Wynn JG, 2000, J HUM EVOL, V39, P411, DOI 10.1006/jhev.2000.0431	61	79	79	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7199	10.1371/journal.pone.0007199	http://dx.doi.org/10.1371/journal.pone.0007199			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509JU	19844568	Green Published, Green Accepted, gold			2022-12-27	WOS:000271013000002
J	Wang, KK; Fang, H; Xiao, DK; Zhu, XH; He, MM; Pan, XL; Shi, JT; Zhang, H; Jia, XH; Du, YZ; Zhang, J				Wang, Kankan; Fang, Hai; Xiao, Dakai; Zhu, Xuehua; He, Miaomiao; Pan, Xiaoling; Shi, Jiantao; Zhang, Hui; Jia, Xiaohong; Du, Yanzhi; Zhang, Ji			Converting Redox Signaling to Apoptotic Activities by Stress-Responsive Regulators HSF1 and NRF2 in Fenretinide Treated Cancer Cells	PLOS ONE			English	Article							ACUTE PROMYELOCYTIC LEUKEMIA; ENDOPLASMIC-RETICULUM STRESS; HEAT-SHOCK FACTOR-1; ARSENIC TRIOXIDE; HYDROGEN-PEROXIDE; MYELOID-LEUKEMIA; CARCINOMA-CELLS; GROWTH-FACTOR; DEATH; EXPRESSION	Background: Pharmacological intervention of redox balance in cancer cells often results in oxidative stress-mediated apoptosis, attracting much attention for the development of a new generation of targeted therapy in cancer. However, little is known about mechanisms underlying the conversion from oxidative signaling to downstream activities leading cells to death. Methodology/Principal Findings: We here report a systematic detection of transcriptome changes in response to oxidative signals generated in leukemia cells upon fenretinide treatment, implicating the occurrence of numerous stress-responsive events during the fenretinide induced apoptosis, such as redox response, endoplasmic reticulum stress/unfolded protein response, translational repression and proteasome activation. Moreover, the configuration of these relevant events is primarily orchestrated by stress responsive transcription factors, as typically highlighted by NF-E2-related factor-2 (NRF2) and heat shock factor 1 (HSF1). Several lines of evidence suggest that the coordinated regulation of these transcription factors and thus their downstream genes are involved in converting oxidative signaling into downstream stress-responsive events regulating pro-apoptotic and apoptotic activities at the temporal and spatial levels, typifying oxidative stress-mediated programmed death rather than survival in cancer cells. Conclusions/Significance: This study provides a roadmap for understanding oxidative stress-mediated apoptosis in cancer cells, which may be further developed into more sophisticated therapeutic protocols, as implicated by synergistic induction of cell apoptosis using proteasome inhibitors with fenretinide.			Wang, KK (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ruijin Hosp, State Key Lab Med Genom, Shanghai 200030, Peoples R China.	jizhang@sibs.ac.cn	Fang, Hai/H-7879-2012					Ahn SG, 2003, GENE DEV, V17, P516, DOI 10.1101/gad.1044503; Alcivar A, 2003, ONCOGENE, V22, P291, DOI 10.1038/sj.onc.1206099; ASSOIAN RK, 1987, P NATL ACAD SCI USA, V84, P6020, DOI 10.1073/pnas.84.17.6020; BI YF, 2009, ENDOCR RELAT CANC; Chou WC, 2004, P NATL ACAD SCI USA, V101, P4578, DOI 10.1073/pnas.0306687101; COLLINS SJ, 1977, NATURE, V270, P347, DOI 10.1038/270347a0; D'Autreaux B, 2007, NAT REV MOL CELL BIO, V8, P813, DOI 10.1038/nrm2256; Du YZ, 2006, BLOOD, V107, P1582, DOI 10.1182/blood-2005-06-2318; Fang H, 2008, CURR DRUG METAB, V9, P1038, DOI 10.2174/138920008786927802; Goranov BB, 2006, CELL DEATH DIFFER, V13, P676, DOI 10.1038/sj.cdd.4401824; Guzman ML, 2005, BLOOD, V105, P4163, DOI 10.1182/blood-2004-10-4135; Guzman ML, 2002, P NATL ACAD SCI USA, V99, P16220, DOI 10.1073/pnas.252462599; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Haynes CM, 2004, MOL CELL, V15, P767, DOI 10.1016/j.molcel.2004.08.025; Hitomi J, 2004, J CELL BIOL, V165, P347, DOI 10.1083/jcb.200310015; Huang P, 2000, NATURE, V407, P390, DOI 10.1038/35030140; Jing YK, 1999, BLOOD, V94, P2102, DOI 10.1182/blood.V94.6.2102; Kadara H, 2007, CANCER BIOL THER, V6, P705, DOI 10.4161/cbt.6.5.3963; Kel AE, 2003, NUCLEIC ACIDS RES, V31, P3576, DOI 10.1093/nar/gkg585; Kitareewan S, 1999, ONCOGENE, V18, P5747, DOI 10.1038/sj.onc.1202981; Kwak MK, 2002, MOL CELL BIOL, V22, P2883, DOI 10.1128/MCB.22.9.2883-2892.2002; LANOTTE M, 1991, BLOOD, V77, P1080; Lovat PE, 2004, JNCI-J NATL CANCER I, V96, P1288, DOI 10.1093/jnci/djh254; Lovat PE, 2002, CANCER RES, V62, P5158; MARAIS R, 1993, CELL, V73, P381, DOI 10.1016/0092-8674(93)90237-K; Meusser B, 2005, NAT CELL BIOL, V7, P766, DOI 10.1038/ncb0805-766; Murray JI, 2004, MOL BIOL CELL, V15, P2361, DOI 10.1091/mbc.E03-11-0799; Niu C, 1999, BLOOD, V94, P3315, DOI 10.1182/blood.V94.10.3315.422k16_3315_3324; Oridate N, 1997, J NATL CANCER I, V89, P1191, DOI 10.1093/jnci/89.16.1191; Romano MF, 2003, CELL DEATH DIFFER, V10, P383, DOI 10.1038/sj.cdd.4401167; Schumacker PT, 2006, CANCER CELL, V10, P175, DOI 10.1016/j.ccr.2006.08.015; Shen JS, 2002, DEV CELL, V3, P99, DOI 10.1016/S1534-5807(02)00203-4; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sun SY, 1999, CANCER RES, V59, P2493; SZATROWSKI TP, 1991, CANCER RES, V51, P794; Tailleux L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001403; Trachootham D, 2006, CANCER CELL, V10, P241, DOI 10.1016/j.ccr.2006.08.009; Trinklein ND, 2004, CELL STRESS CHAPERON, V9, P21, DOI 10.1379/1466-1268(2004)009<0021:TRABOH>2.0.CO;2; Tu BP, 2000, SCIENCE, V290, P1571, DOI 10.1126/science.290.5496.1571; Veronesi U, 2006, ANN ONCOL, V17, P1065, DOI 10.1093/annonc/mdl047; Wang H, 2008, MOL CANCER THER, V7, P2967, DOI 10.1158/1535-7163.MCT-08-0549; Wu JM, 2001, APOPTOSIS, V6, P377, DOI 10.1023/A:1011342220621; Xiao L, 2003, FEBS LETT, V538, P117, DOI 10.1016/S0014-5793(03)00156-X; Zhang YS, 2004, MOL CANCER THER, V3, P885; Zheng PZ, 2005, P NATL ACAD SCI USA, V102, P7653, DOI 10.1073/pnas.0502825102	45	32	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7538	10.1371/journal.pone.0007538	http://dx.doi.org/10.1371/journal.pone.0007538			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844581	Green Published, gold, Green Submitted			2022-12-27	WOS:000271013000014
J	Wunderlich, K; Mayer, D; Ranadheera, C; Holler, AS; Manz, B; Martin, A; Chase, G; Tegge, W; Frank, R; Kessler, U; Schwemmle, M				Wunderlich, Kerstin; Mayer, Daniel; Ranadheera, Charlene; Holler, Anne-Sophie; Maenz, Benjamin; Martin, Arnold; Chase, Geoffrey; Tegge, Werner; Frank, Ronald; Kessler, Ulrich; Schwemmle, Martin			Identification of a PA-Binding Peptide with Inhibitory Activity against Influenza A and B Virus Replication	PLOS ONE			English	Article							SMALL-MOLECULE ANTAGONISTS; RNA-POLYMERASE; ANTIVIRAL ACTIVITY; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; SUBUNIT; PROTEIN; ENDONUCLEASE; OSELTAMIVIR; COMPLEX	There is an urgent need for new drugs against influenza type A and B viruses due to incomplete protection by vaccines and the emergence of resistance to current antivirals. The influenza virus polymerase complex, consisting of the PB1, PB2 and PA subunits, represents a promising target for the development of new drugs. We have previously demonstrated the feasibility of targeting the protein-protein interaction domain between the PB1 and PA subunits of the polymerase complex of influenza A virus using a small peptide derived from the PA-binding domain of PB1. However, this influenza A virus-derived peptide did not affect influenza B virus polymerase activity. Here we report that the PA-binding domain of the polymerase subunit PB1 of influenza A and B viruses is highly conserved and that mutual amino acid exchange shows that they cannot be functionally exchanged with each other. Based on phylogenetic analysis and a novel biochemical ELISA-based screening approach, we were able to identify an influenza A-derived peptide with a single influenza B-specific amino acid substitution which efficiently binds to PA of both virus types. This dual-binding peptide blocked the viral polymerase activity and growth of both virus types. Our findings provide proof of principle that protein-protein interaction inhibitors can be generated against influenza A and B viruses. Furthermore, this dual-binding peptide, combined with our novel screening method, is a promising platform to identify new antiviral lead compounds.			Wunderlich, K (corresponding author), Univ Freiburg, Dept Virol, Freiburg, Germany.	martin.schwemmle@uniklinik-freiburg.de	Mayer, Daniel/ABB-5655-2020					Ambroise Y, 2002, CHEM BIOL, V9, P1219, DOI 10.1016/S1074-5521(02)00246-6; BAINE WB, 1980, AM J MED, V68, P181, DOI 10.1016/0002-9343(80)90352-6; Berg T, 2002, P NATL ACAD SCI USA, V99, P3830, DOI 10.1073/pnas.062036999; Berg T, 2008, CURR OPIN DRUG DISC, V11, P666; Brownlee GG, 2002, J VIROL, V76, P7103, DOI 10.1128/JVI.76.14.7103-7113.2002; Chen RB, 2008, J MOL EVOL, V66, P655, DOI 10.1007/s00239-008-9119-z; Chokephaibulkit K, 2005, PEDIATR INFECT DIS J, V24, P162, DOI 10.1097/01.inf.0000151037.25237.1e; CLARK PS, 1970, J AMER MED ASSOC, V214, P507, DOI 10.1001/jama.214.3.507; Crescenzo-Chaigne B, 1999, VIROLOGY, V265, P342, DOI 10.1006/viro.1999.0059; DAVIES WL, 1964, SCIENCE, V144, P862, DOI 10.1126/science.144.3620.862; De Clercq E, 2006, NAT REV DRUG DISCOV, V5, P1015, DOI 10.1038/nrd2175; Dharan NJ, 2009, JAMA-J AM MED ASSOC, V301, P1034, DOI 10.1001/jama.2009.294; Dias A, 2009, NATURE, V458, P914, DOI 10.1038/nature07745; Dostmann WRG, 2000, P NATL ACAD SCI USA, V97, P14772, DOI 10.1073/pnas.97.26.14772; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Fechter P, 2003, J BIOL CHEM, V278, P20381, DOI 10.1074/jbc.M300130200; Fodor E, 2002, J VIROL, V76, P8989, DOI 10.1128/JVI.76.18.8989-9001.2002; Ghanem A, 2007, J VIROL, V81, P7801, DOI 10.1128/JVI.00724-07; Gubareva LV, 1998, J INFECT DIS, V178, P1257, DOI 10.1086/314440; Guilligay D, 2008, NAT STRUCT MOL BIOL, V15, P500, DOI 10.1038/nsmb.1421; Hatakeyama S, 2007, JAMA-J AM MED ASSOC, V297, P1435, DOI 10.1001/jama.297.13.1435; He XJ, 2008, NATURE, V454, P1123, DOI 10.1038/nature07120; Iwatsuki-Horimoto K, 2008, VIRUS RES, V135, P161, DOI 10.1016/j.virusres.2008.03.010; Jambrina E, 1997, VIROLOGY, V235, P209, DOI 10.1006/viro.1997.8682; KIM HW, 1979, AM J EPIDEMIOL, V109, P464, DOI 10.1093/oxfordjournals.aje.a112704; Kosugi S, 2008, CHEM BIOL, V15, P940, DOI 10.1016/j.chembiol.2008.07.019; Li ML, 2001, EMBO J, V20, P2078, DOI 10.1093/emboj/20.8.2078; Moscona A, 2005, NEW ENGL J MED, V353, P1363, DOI 10.1056/NEJMra050740; Moscona A, 2009, NEW ENGL J MED, V360, P953, DOI 10.1056/NEJMp0900648; Munch J, 2007, CELL, V129, P263, DOI 10.1016/j.cell.2007.02.042; Neumann G, 2009, NATURE, V459, P931, DOI 10.1038/nature08157; Ninio S, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000278; NOLAN TF, 1980, J INFECT DIS, V142, P360, DOI 10.1093/infdis/142.3.360; NORTON GP, 1987, VIROLOGY, V156, P204, DOI 10.1016/0042-6822(87)90399-0; Obayashi E, 2008, NATURE, V454, P1127, DOI [10.1038/nature07225, 10.5940/jcrsj.50.329]; Parrish CR, 2005, ANNU REV MICROBIOL, V59, P553, DOI 10.1146/annurev.micro.59.030804.121059; Perales B, 1997, J VIROL, V71, P1381, DOI 10.1128/JVI.71.2.1381-1385.1997; PEREZ DR, 1995, J VIROL, V69, P6932; Perez DR, 2001, J VIROL, V75, P8127, DOI 10.1128/JVI.75.17.8127-8136.2001; Pilger BD, 2004, CHEM BIOL, V11, P647, DOI 10.1016/j.chembiol.2004.01.018; Pleschka S, 1996, J VIROL, V70, P4188, DOI 10.1128/JVI.70.6.4188-4192.1996; Schmidtke M, 2001, J VIROL METHODS, V95, P133, DOI 10.1016/S0166-0934(01)00305-6; Schneider U, 2003, J VIROL, V77, P11781, DOI 10.1128/JVI.77.21.11781-11789.2003; SCHWEMMLE M, 1995, VIROLOGY, V206, P545, DOI 10.1016/S0042-6822(95)80071-9; Sugaya N, 2007, CLIN INFECT DIS, V44, P197, DOI 10.1086/509925; Sugiyama K, 2009, EMBO J, V28, P1803, DOI 10.1038/emboj.2009.138; Torreira E, 2007, NUCLEIC ACIDS RES, V35, P3774, DOI 10.1093/nar/gkm336; TUMPEY TM, 2009, ANN REV MICROBIOL; Vassilev LT, 2004, SCIENCE, V303, P844, DOI 10.1126/science.1092472; Wells JA, 2007, NATURE, V450, P1001, DOI 10.1038/nature06526; White PW, 2003, J BIOL CHEM, V278, P26765, DOI 10.1074/jbc.M303608200; WRIGHT PF, 1980, J INFECT DIS, V141, P430, DOI 10.1093/infdis/141.4.430; Yuan PW, 2009, NATURE, V458, P909, DOI 10.1038/nature07720	53	71	80	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7517	10.1371/journal.pone.0007517	http://dx.doi.org/10.1371/journal.pone.0007517			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841738	Green Published, gold, Green Submitted			2022-12-27	WOS:000271012900014
J	Olvera, L; Mendoza-Vargas, A; Flores, N; Olvera, M; Sigala, JC; Gosset, G; Morett, E; Bolivar, F				Olvera, Leticia; Mendoza-Vargas, Alfredo; Flores, Noemi; Olvera, Maricela; Sigala, Juan Carlos; Gosset, Guillermo; Morett, Enrique; Bolivar, Francisco			Transcription Analysis of Central Metabolism Genes in Escherichia coli. Possible Roles of sigma(38) in Their Expression, as a Response to Carbon Limitation	PLOS ONE			English	Article							ENCODES ACETYL-COENZYME; PYRUVATE OXIDASE; STRESS-RESPONSE; PHOSPHOTRANSFERASE SYSTEM; SIGMA(S)-DEPENDENT GENES; NUCLEOTIDE-SEQUENCE; EXPONENTIAL-GROWTH; STATIONARY-PHASE; STRAINS LACKING; ISOMERASE GENE	The phosphoenolpyruvate: carbohydrate transferase system (PTS) transports glucose in Escherichia coli. Previous work demonstrated that strains lacking PTS, such as PB11, grow slow on glucose. PB11 has a reduced expression of glycolytic, and upregulates poxB and acs genes as compared to the parental strain JM101, when growing on glucose. The products of the latter genes are involved in the production of AcetylCoA. Inactivation of rpoS that codes for the RNA polymerase sigma(38) subunit, reduces further (50%) growth of PB11, indicating that sigma(38) plays a central role in the expression of central metabolism genes in slowly growing cells. In fact, transcription levels of glycolytic genes is reduced in strain PB11rpoS(-) as compared to PB11. In this report we studied the role of sigma(70) and sigma(38) in the expression of the complete glycolytic pathway and poxB and acs genes in certain PTS- strains and their rpoS 2 derivatives. We determined the transcription start sites (TSSs) and the corresponding promoters, in strains JM101, PB11, its derivative PB12 that recovered its growth capacity, and in their rpoS(-) derivatives, by 5'RACE and pyrosequencing. In all these genes the presence of sequences resembling sigma 38 recognition sites allowed the proposition that they could be transcribed by both sigma factors, from overlapping putative promoters that initiate transcription at the same site. Fourteen new TSSs were identified in seventeen genes. Besides, more than 30 putative promoters were proposed and we confirmed ten previously reported. In vitro transcription experiments support the functionality of putative dual promoters. Alternatives that could also explain lower transcription levels of the rpoS(-) derivatives are discussed. We propose that the presence if real, of both sigma(70) and sigma(38) dependent promoters in all glycolytic genes and operons could allow a differential transcription of these central metabolism genes by both sigma subunits as an adaptation response to carbon limitation.			Olvera, L (corresponding author), Univ Nacl Autonoma Mexico, Inst Biotecnol, Dept Ingn Celular Biocatalisis, Cuernavaca 62191, Morelos, Mexico.	emorett@ibt.unam.mx; bolivar@ibt.unam.mx	Gosset, Guillermo/K-9356-2017; Morett, Enrique/G-3401-2013	Gosset, Guillermo/0000-0003-3127-0911; Sigala Alanis, Juan Carlos/0000-0002-1665-5680; Morett, Enrique/0000-0001-5723-0032	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM071962] Funding Source: NIH RePORTER; NIGMS NIH HHS [GM071962-03, R01 GM071962] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Abdel-Hamid AM, 2001, MICROBIOL-SGM, V147, P1483, DOI 10.1099/00221287-147-6-1483; Artsimovitch I, 2004, CELL, V117, P299, DOI 10.1016/S0092-8674(04)00401-5; Baez-Viveros JL, 2004, BIOTECHNOL BIOENG, V87, P516, DOI 10.1002/bit.20159; BAKER MM, 2001, J MOL BIOL, V305, P689; Bardey V, 2005, MOL MICROBIOL, V57, P1265, DOI 10.1111/j.1365-2958.2005.04762.x; Beatty CM, 2003, J BACTERIOL, V185, P5148, DOI 10.1128/JB.185.17.5148-5157.2003; Becker G, 2001, MOL MICROBIOL, V39, P1153, DOI 10.1046/j.1365-2958.2001.02313.x; Bledig SA, 1996, J BACTERIOL, V178, P280, DOI 10.1128/jb.178.1.280-283.1996; BOLIVAR F, 1977, GENE, V2, P95, DOI 10.1016/0378-1119(77)90000-2; Bordes P, 2000, MOL MICROBIOL, V35, P845, DOI 10.1046/j.1365-2958.2000.01758.x; Browning DF, 2004, NAT REV MICROBIOL, V2, P57, DOI 10.1038/nrmicro787; CHANG YY, 1994, MOL MICROBIOL, V11, P1019, DOI 10.1111/j.1365-2958.1994.tb00380.x; CHARPENTIER B, 1994, J BACTERIOL, V176, P830, DOI 10.1128/jb.176.3.830-839.1994; Charpentier B, 1998, J BACTERIOL, V180, P6476, DOI 10.1128/JB.180.24.6476-6483.1998; Ciria R, 2004, BIOINFORMATICS, V20, P2307, DOI 10.1093/bioinformatics/bth216; Cunningham L, 1998, FEMS MICROBIOL LETT, V169, P403, DOI 10.1111/j.1574-6968.1998.tb13347.x; CURTIS SJ, 1975, J BACTERIOL, V122, P1189, DOI 10.1128/JB.122.3.1189-1199.1975; DEATH A, 1994, J BACTERIOL, V176, P5101, DOI 10.1128/jb.176.16.5101-5107.1994; Dong T, 2008, MOL GENET GENOMICS, V279, P267, DOI 10.1007/s00438-007-0311-4; Ferenci T, 2003, TRENDS MICROBIOL, V11, P457, DOI 10.1016/j.tim.2003.08.003; Ferenci T, 2001, ENVIRON MICROBIOL, V3, P605, DOI 10.1046/j.1462-2920.2001.00238.x; Flores N, 2004, J MOL MICROB BIOTECH, V8, P209, DOI 10.1159/000086702; Flores N, 2005, METAB ENG, V7, P70, DOI 10.1016/j.ymben.2004.10.002; Flores N, 1996, NAT BIOTECHNOL, V14, P620, DOI 10.1038/nbt0596-620; Flores N, 2008, J MOL MICROB BIOTECH, V14, P176, DOI 10.1159/000109945; Flores S, 2005, J MOL MICROB BIOTECH, V10, P51, DOI 10.1159/000090348; Flores S, 2002, METAB ENG, V4, P124, DOI 10.1006/mben.2001.0209; FRANKEL D, 1996, ESCHERICHIA COLI SAL, V1, P217; FROHMAN MA, 1988, P NATL ACAD SCI USA, V85, P8998, DOI 10.1073/pnas.85.23.8998; FROMAN BE, 1989, MOL GEN GENET, V217, P126, DOI 10.1007/BF00330951; Gaal T, 2001, MOL MICROBIOL, V42, P939, DOI 10.1046/j.1365-2958.2001.02703.x; Gimenez R, 2003, J BACTERIOL, V185, P6448, DOI 10.1128/JB.185.21.6448-6455.2003; Grainger DC, 2008, MOL MICROBIOL, V68, P1366, DOI 10.1111/j.1365-2958.2008.06253.x; HELLINGA HW, 1985, EUR J BIOCHEM, V149, P363, DOI 10.1111/j.1432-1033.1985.tb08934.x; Hengge-Aronis R, 2002, MICROBIOL MOL BIOL R, V66, P373, DOI 10.1128/MMBR.66.3.373-395.2002; HENGGEARONIS R, 1996, ESCHERICHIA COLI SAL, V1, P1497; Hua Q, 2004, APPL ENVIRON MICROB, V70, P2354, DOI 10.1128/AEM.70.4.2354-2366.2004; IUCHI S, 1988, P NATL ACAD SCI USA, V85, P1888, DOI 10.1073/pnas.85.6.1888; Jishage M, 2002, GENE DEV, V16, P1260, DOI 10.1101/gad.227902; KOLB A, 1995, NUCLEIC ACIDS RES, V23, P819, DOI 10.1093/nar/23.5.819; KUMARI S, 1995, J BACTERIOL, V177, P2878, DOI 10.1128/jb.177.10.2878-2886.1995; Kumari S, 2000, J BACTERIOL, V182, P551, DOI 10.1128/JB.182.2.551-554.2000; Lacour S, 2004, J BACTERIOL, V186, P7186, DOI 10.1128/JB.186.21.7186-7195.2004; LENGELER JW, 1999, BIOL PROKARYOTS, P505; Liu XQ, 2004, J BIOL CHEM, V279, P12588, DOI 10.1074/jbc.M313454200; Maeda H, 2000, NUCLEIC ACIDS RES, V28, P3497, DOI 10.1093/nar/28.18.3497; MARTINEZ K, 2008, MICROB CELL FACT, V7, pR1; MCFALL E, 1996, ESCHERICHIA COLI SAL, V1, P358; Meyer D, 1997, J BACTERIOL, V179, P1298, DOI 10.1128/jb.179.4.1298-1306.1997; Moreau PL, 2004, J BACTERIOL, V186, P7364, DOI 10.1128/JB.186.21.7364-7368.2004; Morett E, 2003, NAT BIOTECHNOL, V21, P790, DOI 10.1038/nbt834; Nonaka G, 2006, GENE DEV, V20, P1776, DOI 10.1101/gad.1428206; Nystrom T, 2004, MOL MICROBIOL, V54, P855, DOI 10.1111/j.1365-2958.2004.04342.x; Perrenoud A, 2005, J BACTERIOL, V187, P3171, DOI 10.1128/JB.187.9.3171-3179.2005; PICHERSKY E, 1984, MOL GEN GENET, V195, P314, DOI 10.1007/BF00332765; PONCE E, 1995, J BACTERIOL, V177, P5719, DOI 10.1128/jb.177.19.5719-5722.1995; Postma P.W., 1996, ESCHERICHIA COLI SAL, P1149; QUAIL MA, 1994, MOL MICROBIOL, V12, P95, DOI 10.1111/j.1365-2958.1994.tb00998.x; Rahman M, 2006, BIOTECHNOL BIOENG, V94, P585, DOI 10.1002/bit.20858; Rhodius VA, 2006, PLOS BIOL, V4, P43, DOI 10.1371/journal.pbio.0040002; Saier MH, 1996, J BACTERIOL, V178, P3411, DOI 10.1128/jb.178.12.3411-3417.1996; Saier MH, 2000, J BACTERIOL, V182, P5029, DOI 10.1128/JB.182.18.5029-5035.2000; Sanchez-SanMartin C, 2001, J BACTERIOL, V183, P2823, DOI 10.1128/JB.183.9.2823-2833.2001; SCHAEFER BC, 1995, ANAL BIOCHEM, V227, P255, DOI 10.1006/abio.1995.1279; Shimada T, 2005, GENES CELLS, V10, P907, DOI 10.1111/j.1365-2443.2005.00888.x; SIGALA JC, 2008, J MOL MICRO IN PRESS; SPENCER ME, 1985, MOL GEN GENET, V200, P145, DOI 10.1007/BF00383328; Thouvenot B, 2004, BIOCHEM J, V383, P371, DOI 10.1042/BJ20040792; Typas A, 2007, MOL MICROBIOL, V63, P1296, DOI 10.1111/j.1365-2958.2007.05601.x; Ueguchi C, 2001, J BACTERIOL, V183, P520, DOI 10.1128/JB.183.2.520-527.2001; Vassinova N, 2000, MICROBIOL-SGM, V146, P3171, DOI 10.1099/00221287-146-12-3171; Wade JT, 2006, NAT STRUCT MOL BIOL, V13, P806, DOI 10.1038/nsmb1130; Weber H, 2005, J BACTERIOL, V187, P1591, DOI 10.1128/JB.187.5.1591-1603.2005; Wise A, 1996, J BACTERIOL, V178, P2785, DOI 10.1128/jb.178.10.2785-2793.1996; Wolfe AJ, 2005, MICROBIOL MOL BIOL R, V69, P12, DOI 10.1128/MMBR.69.1.12-50.2005	75	18	18	1	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7466	10.1371/journal.pone.0007466	http://dx.doi.org/10.1371/journal.pone.0007466			23	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838295	Green Published, Green Submitted, gold			2022-12-27	WOS:000270880900003
J	Wang, DH; Cui, ZZ; Zeng, QW; Kuang, H; Wang, LP; Tsien, JZ; Cao, XH				Wang, Deheng; Cui, Zhenzhong; Zeng, Qingwen; Kuang, Hui; Wang, L. Phillip; Tsien, Joe Z.; Cao, Xiaohua			Genetic Enhancement of Memory and Long-Term Potentiation but Not CA1 Long-Term Depression in NR2B Transgenic Rats	PLOS ONE			English	Article							DEPENDENT SYNAPTIC PLASTICITY; HETEROMERIC NMDA RECEPTORS; WORKING-MEMORY; SPATIAL MEMORY; HIPPOCAMPAL; BRAIN; MAGNESIUM; EXPRESSION; SUBTYPES; STARTLE	One major theory in learning and memory posits that the NR2B gene is a universal genetic factor that acts as rate-limiting molecule in controlling the optimal NMDA receptor's coincidence-detection property and subsequent learning and memory function across multiple animal species. If so, can memory function be enhanced via transgenic overexpression of NR2B in another species other than the previously reported mouse species? To examine these crucial issues, we generated transgenic rats in which NR2B is overexpressed in the cortex and hippocampus and investigated the role of NR2B gene in NMDA receptor-mediated synaptic plasticity and memory functions by combining electrophysiological technique with behavioral measurements. We found that overexpression of the NR2B subunit had no effect on CA1-LTD, but rather resulted in enhanced CA1-LTP and improved memory performances in novel object recognition test, spatial water maze, and delayed-to-nonmatch working memory test. Our slices recordings using NR2A- and NR2B-selective antagonists further demonstrate that the larger LTP in transgenic hippocampal slices was due to contribution from the increased NR2B-containing NMDARs. Therefore, our genetic experiments suggest that NR2B at CA1 synapses is not designated as a rate-limiting factor for the induction of long-term synaptic depression, but rather plays a crucial role in initiating the synaptic potentiation. Moreover, our studies provide strong evidence that the NR2B subunit represents a universal rate-limiting molecule for gating NMDA receptor's optimal coincidence-detection property and for enhancing memory function in adulthood across multiple mammalian species.			Wang, DH (corresponding author), E China Normal Univ, Shanghai Inst Brain Funct Genom, Key Labs MOE & STCSM, Shanghai 200062, Peoples R China.	jtsien@mcg.edu; xhcao@brain.ecnu.edu.cn	Kuang, Hui/I-1006-2013	Kuang, Hui/0000-0002-7806-2864; Wang, Deheng/0000-0001-7979-9756	PHS HHS [060236, 024022, 034663] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Bear Mark F., 1994, Current Opinion in Neurobiology, V4, P389, DOI 10.1016/0959-4388(94)90101-5; Berberich S, 2005, J NEUROSCI, V25, P6907, DOI 10.1523/JNEUROSCI.1905-05.2005; Berberich S, 2007, NEUROPHARMACOLOGY, V52, P77, DOI 10.1016/j.neuropharm.2006.07.016; Billard JM, 2006, MAGNESIUM RES, V19, P199; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Burke SN, 2006, NAT REV NEUROSCI, V7, P30, DOI 10.1038/nrn1809; Cao XH, 2007, EUR J NEUROSCI, V25, P1815, DOI 10.1111/j.1460-9568.2007.05431.x; CARMIGNOTO G, 1992, SCIENCE, V258, P1007, DOI 10.1126/science.1279803; DAVIS M, 1986, BEHAV NEUROSCI, V100, P814, DOI 10.1037/0735-7044.100.6.814; Fadok JP, 2009, J NEUROSCI, V29, P11089, DOI 10.1523/JNEUROSCI.1616-09.2009; FALLS WA, 1992, J NEUROSCI, V12, P854; GALLAGHER M, 2000, AMYGDALA; Ghia N, 2000, AM J OBSTET GYNECOL, V183, P940, DOI 10.1067/mob.2000.109045; HESTRIN S, 1992, NATURE, V357, P686, DOI 10.1038/357686a0; Hoane MR, 2007, MAGNESIUM RES, V20, P229; Hoane MR, 2005, RESTOR NEUROL NEUROS, V23, P67; Ingram DK, 1996, ANN NY ACAD SCI, V786, P348, DOI 10.1111/j.1749-6632.1996.tb39076.x; Li F, 2009, NEW ENGL J MED, V361, P302, DOI 10.1056/NEJMcibr0902052; LINDEN DJ, 1995, ANNU REV NEUROSCI, V18, P319, DOI 10.1146/annurev.ne.18.030195.001535; Lisman JE, 2005, NEURON, V46, P703, DOI 10.1016/j.neuron.2005.05.002; Liu LD, 2004, SCIENCE, V304, P1021, DOI 10.1126/science.1096615; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Malenka RC, 1999, SCIENCE, V285, P1870, DOI 10.1126/science.285.5435.1870; MONYER H, 1994, NEURON, V12, P529, DOI 10.1016/0896-6273(94)90210-0; MONYER H, 1992, SCIENCE, V256, P1217, DOI 10.1126/science.256.5060.1217; Morishita W, 2007, NEUROPHARMACOLOGY, V52, P71, DOI 10.1016/j.neuropharm.2006.07.005; NAKANISHI S, 1992, SCIENCE, V258, P597, DOI 10.1126/science.1329206; Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x; Nomura Masahiko, 2004, Clin Calcium, V14, P71; O'Reilly RC, 2001, PSYCHOL REV, V108, P311, DOI 10.1037//0033-295X.108.2.311; Reisel D, 2002, NAT NEUROSCI, V5, P868, DOI 10.1038/nn910; Sanes JR, 1999, NAT NEUROSCI, V2, P597, DOI 10.1038/10154; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; SHENG M, 1994, NATURE, V368, P144, DOI 10.1038/368144a0; Slutsky I, 2004, NEURON, V44, P835, DOI 10.1016/j.neuron.2004.11.013; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; Thompson RE, 2005, ANNU REV PSYCHOL, V56, P1, DOI 10.1146/annurev.psych.56.091103.070239; THOMPSON RF, 1994, ANNU REV NEUROSCI, V17, P519, DOI 10.1146/annurev.neuro.17.1.519; Tsien JZ, 2000, CURR OPIN NEUROBIOL, V10, P266, DOI 10.1016/S0959-4388(00)00070-2; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Walker DL, 2008, LEARN MEMORY, V15, P67, DOI 10.1101/lm.798908; WHITWELL RJ, 1904, VIERTELJAHRSCHRIFT S, V2, P1	42	98	101	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7486	10.1371/journal.pone.0007486	http://dx.doi.org/10.1371/journal.pone.0007486			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838302	Green Submitted, gold, Green Published			2022-12-27	WOS:000270880900004
J	Spivak, AC; Canuel, EA; Duffy, JE; Richardson, JP				Spivak, Amanda C.; Canuel, Elizabeth A.; Duffy, J. Emmett; Richardson, J. Paul			Nutrient Enrichment and Food Web Composition Affect Ecosystem Metabolism in an Experimental Seagrass Habitat	PLOS ONE			English	Article							SEDIMENT ORGANIC-MATTER; TROPHIC INTERACTIONS; TOP-DOWN; RESOURCE AVAILABILITY; SPECIES-DIVERSITY; GRAZER DIVERSITY; PLANT DIVERSITY; CARBON; PRODUCTIVITY; BIODIVERSITY	Background: Food web composition and resource levels can influence ecosystem properties such as productivity and elemental cycles. In particular, herbivores occupy a central place in food webs as the species richness and composition of this trophic level may simultaneously influence the transmission of resource and predator effects to higher and lower trophic levels, respectively. Yet, these interactions are poorly understood. Methodology/Principal Findings: Using an experimental seagrass mesocosm system, we factorially manipulated water column nutrient concentrations, food chain length, and diversity of crustacean grazers to address two questions: (1) Does food web composition modulate the effects of nutrient enrichment on plant and grazer biomasses and stoichiometry? (2) Do ecosystem fluxes of dissolved oxygen and nutrients more closely reflect above-ground biomass and community structure or sediment processes? Nutrient enrichment and grazer presence generally had strong effects on biomass accumulation, stoichiometry, and ecosystem fluxes, whereas predator effects were weaker or absent. Nutrient enrichment had little effect on producer biomass or net ecosystem production but strongly increased seagrass nutrient content, ecosystem flux rates, and grazer secondary production, suggesting that enhanced production was efficiently transferred from producers to herbivores. Gross ecosystem production (oxygen evolution) correlated positively with above-ground plant biomass, whereas inorganic nutrient fluxes were unrelated to plant or grazer biomasses, suggesting dominance by sediment microbial processes. Finally, grazer richness significantly stabilized ecosystem processes, as predators decreased ecosystem production and respiration only in the zero- and one-species grazer treatments. Conclusions/Significance: Overall, our results indicate that consumer presence and species composition strongly influence ecosystem responses to nutrient enrichment, and that increasing herbivore diversity can stabilize ecosystem flux rates in the face of perturbations.			Spivak, AC (corresponding author), Miami Univ, Dept Zool, Oxford, OH 45056 USA.	Amanda.spivak@muohio.edu	Duffy, J. Emmett/ABF-9200-2020	Duffy, J. Emmett/0000-0001-8595-6391; Spivak, Amanda/0000-0001-6743-0783				Alcoverro T, 2001, MAR ECOL PROG SER, V211, P105, DOI 10.3354/meps211105; Anderson TR, 2005, AM NAT, V165, P1, DOI 10.1086/426598; Arnold TM, 2002, J CHEM ECOL, V28, P1919, DOI 10.1023/A:1020737609151; Bakker ES, 2006, ECOL LETT, V9, P780, DOI 10.1111/j.1461-0248.2006.00925.x; Bardgett RD, 1998, SOIL BIOL BIOCHEM, V30, P1867, DOI 10.1016/S0038-0717(98)00069-8; BEARE MH, 1992, ECOL MONOGR, V62, P569, DOI 10.2307/2937317; Bogren, 2002, DETERMINATION ORTHOP; Borer ET, 2006, ECOLOGY, V87, P2813, DOI 10.1890/0012-9658(2006)87[2813:AICREO]2.0.CO;2; Borer ET, 2005, ECOLOGY, V86, P528, DOI 10.1890/03-0816; Boschker HTS, 1999, LIMNOL OCEANOGR, V44, P309, DOI 10.4319/lo.1999.44.2.0309; Boyer KE, 2009, OIKOS, V118, P1062, DOI 10.1111/j.1600-0706.2009.17252.x; Bruno JF, 2008, ECOLOGY, V89, P2518, DOI 10.1890/07-1345.1; Burkepile DE, 2006, ECOLOGY, V87, P3128, DOI 10.1890/0012-9658(2006)87[3128:HVNCOM]2.0.CO;2; Canuel EA, 2007, LIMNOL OCEANOGR, V52, P590, DOI 10.4319/lo.2007.52.2.0590; Cardinale BJ, 2000, OIKOS, V91, P175, DOI 10.1034/j.1600-0706.2000.910117.x; Cardinale BJ, 2007, P NATL ACAD SCI USA, V104, P18123, DOI 10.1073/pnas.0709069104; CARPENTER SR, 1985, BIOSCIENCE, V35, P634, DOI 10.2307/1309989; Chase JM, 2003, OIKOS, V101, P187, DOI 10.1034/j.1600-0706.2003.12062.x; Cloern JE, 2001, MAR ECOL PROG SER, V210, P223, DOI 10.3354/meps210223; Dahllof I, 2005, MAR CHEM, V94, P17, DOI 10.1016/j.marchem.2004.07.008; Douglass JG, 2007, MAR ECOL PROG SER, V348, P71, DOI 10.3354/meps07091; Downing AL, 2005, ECOLOGY, V86, P701, DOI 10.1890/03-0239; Duffy JE, 2007, ECOL LETT, V10, P522, DOI 10.1111/j.1461-0248.2007.01037.x; Duffy JE, 2005, ECOL LETT, V8, P301, DOI 10.1111/j.1461-0248.2005.00725.x; Duffy JE, 2003, ECOL LETT, V6, P637; Duffy JE, 2001, MAR ECOL PROG SER, V223, P201, DOI 10.3354/meps223201; Duffy JE, 2001, ECOLOGY, V82, P2417; Duffy JE, 2000, ECOL MONOGR, V70, P237, DOI 10.1890/0012-9615(2000)070[0237:SIOGAO]2.0.CO;2; DUFFY JE, 2009, FRONTIERS ECOLOGY EN; Dzialowski AR, 2008, FRESHWATER BIOL, V53, P148, DOI 10.1111/j.1365-2427.2007.01883.x; EDGAR GJ, 1990, J EXP MAR BIOL ECOL, V137, P195, DOI 10.1016/0022-0981(90)90185-F; ELSER JJ, 1995, AQUAT MICROB ECOL, V9, P105, DOI 10.3354/ame009105; Elser JJ, 1996, BIOSCIENCE, V46, P674, DOI 10.2307/1312897; Elser JJ, 1999, ECOLOGY, V80, P735, DOI 10.2307/177013; Elser JJ, 2000, ECOL LETT, V3, P540, DOI 10.1046/j.1461-0248.2000.00185.x; Elser JJ, 1998, ECOSYSTEMS, V1, P120, DOI 10.1007/s100219900009; Forrester GE, 1999, LIMNOL OCEANOGR, V44, P1187, DOI 10.4319/lo.1999.44.5.1187; Fridley JD, 2002, OECOLOGIA, V132, P271, DOI 10.1007/s00442-002-0965-x; Frost PC, 2002, J N AM BENTHOL SOC, V21, P515, DOI 10.2307/1468427; Godbold JA, 2009, OIKOS, V118, P77, DOI 10.1111/j.1600-0706.2008.17072.x; Haddad NM, 2001, AM NAT, V158, P17, DOI 10.1086/320866; Halpern BS, 2006, SCIENCE, V312, P1230, DOI 10.1126/science.1128613; Hansen JW, 2000, AQUAT BOT, V66, P281, DOI 10.1016/S0304-3770(99)00078-9; HAY ME, 1994, ECOLOGY, V75, P1714, DOI 10.2307/1939631; Heck KL, 2000, LIMNOL OCEANOGR, V45, P1041, DOI 10.4319/lo.2000.45.5.1041; HEDGES JI, 1984, LIMNOL OCEANOGR, V29, P657, DOI 10.4319/lo.1984.29.3.0657; Hessen DO, 2004, ECOLOGY, V85, P1179, DOI 10.1890/02-0251; Hillebrand H, 2004, ECOL LETT, V7, P192, DOI 10.1111/j.1461-0248.2004.00570.x; Hopkinson Charles S. Jr, 2005, P122, DOI 10.1093/acprof:oso/9780198527084.003.0008; Hughes AR, 2004, MAR ECOL PROG SER, V282, P87, DOI 10.3354/meps282087; Jonsson M, 2002, P ROY SOC B-BIOL SCI, V269, P1047, DOI 10.1098/rspb.2002.1979; Koch EM, 2001, ESTUARIES, V24, P1, DOI 10.2307/1352808; LIAO N, 2002, DETERMINATION AMMONI; MacKay NA, 1998, LIMNOL OCEANOGR, V43, P339, DOI 10.4319/lo.1998.43.2.0339; McGlathery KJ, 2007, MAR ECOL PROG SER, V348, P1, DOI 10.3354/meps07132; MCGLATHERY KJ, 1995, MAR ECOL PROG SER, V122, P239, DOI 10.3354/meps122239; Middelburg Jack J., 2005, P206; Moksnes PO, 2008, OIKOS, V117, P763, DOI 10.1111/j.0030-1299.2008.16521.x; Moran MD, 2003, OIKOS, V100, P403, DOI 10.1034/j.1600-0706.2003.12010.x; Nakagawa S, 2004, BEHAV ECOL, V15, P1044, DOI 10.1093/beheco/arh107; Neubauer SC, 2000, MAR ECOL PROG SER, V199, P13, DOI 10.3354/meps199013; Nixon SW, 2002, ESTUARIES, V25, P782, DOI 10.1007/BF02804905; Nixon SW, 1980, MARINE BENTHIC DYNAM, P219; Olejnik S, 2003, PSYCHOL METHODS, V8, P434, DOI 10.1037/1082-989X.8.4.434; Orth RJ, 2006, BIOSCIENCE, V56, P987, DOI 10.1641/0006-3568(2006)56[987:AGCFSE]2.0.CO;2; Shurin JB, 2002, ECOL LETT, V5, P785, DOI 10.1046/j.1461-0248.2002.00381.x; Skelly DK, 2002, ECOLOGY, V83, P2097, DOI 10.1890/0012-9658(2002)083[2097:EVAEOI]2.0.CO;2; Smith P., 2001, DETERMINATION NITRAT; Spivak AC, 2007, LIMNOL OCEANOGR, V52, P2595, DOI 10.4319/lo.2007.52.6.2595; Spivak AC, 2009, MAR ECOL PROG SER, V376, P55, DOI 10.3354/meps07813; Stachowicz JJ, 2008, P NATL ACAD SCI USA, V105, P18842, DOI 10.1073/pnas.0806425105; Sterner R.W, 2002, ECOLOGICAL STOICHIOM, DOI DOI 10.1086/382444; Taylor RB, 1998, LIMNOL OCEANOGR, V43, P600, DOI 10.4319/lo.1998.43.4.0600; Thebault E, 2003, P NATL ACAD SCI USA, V100, P14949, DOI 10.1073/pnas.2434847100; Valentine JF, 2006, SEAGRASSES: BIOLOGY, ECOLOGY AND CONSERVATION, P463; Valiela I, 1995, MARINE ECOLOGICAL PR; Vanni MJ, 2002, ANNU REV ECOL SYST, V33, P341, DOI 10.1146/annurev.ecolsys.33.010802.150519; Vanni MJ, 1997, ECOLOGY, V78, P21; Vanni MJ, 1997, ECOLOGY, V78, P1; Vrede T, 2004, ECOLOGY, V85, P1217, DOI 10.1890/02-0249; Zhang QG, 2006, OIKOS, V114, P385, DOI 10.1111/j.2006.0030-1299.14723.x	81	29	30	0	47	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7473	10.1371/journal.pone.0007473	http://dx.doi.org/10.1371/journal.pone.0007473			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829713	Green Published, gold, Green Submitted			2022-12-27	WOS:000270847800011
J	Garlapati, S; Wang, CC				Garlapati, Srinivas; Wang, Ching C.			Giardiavirus Internal Ribosome Entry Site Has an Apparently Unique Mechanism of Initiating Translation	PLOS ONE			English	Article							TRACT-BINDING-PROTEIN; ENCEPHALOMYOCARDITIS VIRUS-RNA; CAP-INDEPENDENT TRANSLATION; CRICKET PARALYSIS VIRUS; 5 NONCODING REGION; HEPATITIS-C; MESSENGER-RNA; MEDIATED TRANSLATION; LA AUTOANTIGEN; POLIOVIRUS RNA	Giardiavirus (GLV) utilizes an internal ribosome entry site (IRES) for translation initiation in the early branching eukaryote Giardia lamblia. Unlike most of the viral IRESs among higher eukaryotes, which localize primarily within the 5'-untranslated region (UTR), the GLV IRES comprises 253 nts of 5'UTR and the initial 264 nts in the open-reading-frame (ORF). To test if GLV IRES also functions in higher eukaryotic systems, we examined it in rabbit reticulocyte lysate (RRL) and found that it functions much less efficiently than the IRES from the Encephalomyocarditis virus ( EMCV) or Cricket paralysis virus ( CrPV). In contrast, both EMCV-IRES and CrPV-IRESs were inactive in transfected Giardia cells. Structure-function analysis indicated that only the stem-loop U5 from the 5'UTR and the stem-loop 1 plus the downstream box (Dbox) from the ORF of GLV IRES are required for limited IRES function in RRL. Edeine, a translation initiation inhibitor, did not significantly affect the function of GLV IRES in either RRL or Giardia, indicating that a pre-initiation complex is not required for GLV IRES-mediated translation initiation. However, the small ribosomal subunit purified from Giardia did not bind to GLV IRES, indicating that additional protein factors may be necessary. A member of the helicase family IBP1 and two known viral IRES binding proteins La autoantigen and SRp20 have been identified in Giardia that bind to GLV IRES in vitro. These three proteins could be involved in facilitating small ribosome recruitment for initiating translation.			Garlapati, S (corresponding author), Univ Calif San Francisco, Dept Pharmaceut Chem, San Francisco, CA 94143 USA.	ccwang@cgl.ucsf.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI030475] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-30475, R01 AI030475] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ali N, 1997, P NATL ACAD SCI USA, V94, P2249, DOI 10.1073/pnas.94.6.2249; Bachler M, 1999, RNA, V5, P1509, DOI 10.1017/S1355838299991574; Baird SD, 2006, RNA, V12, P1755, DOI 10.1261/rna.157806; Bedard KM, 2007, EMBO J, V26, P459, DOI 10.1038/sj.emboj.7601494; Belsham GJ, 2000, TRENDS MICROBIOL, V8, P330, DOI 10.1016/S0966-842X(00)01788-1; Bergamini G, 2000, RNA, V6, P1781, DOI 10.1017/S1355838200001679; Blyn LB, 1996, P NATL ACAD SCI USA, V93, P11115, DOI 10.1073/pnas.93.20.11115; BOROVJAGIN A, 1994, FEBS LETT, V351, P299, DOI 10.1016/0014-5793(94)00848-5; BOUSQUET A, 2009, RNA, V15, P750; CHAMPNEY WS, 1992, INT J BIOCHEM, V24, P1125, DOI 10.1016/0020-711X(92)90383-C; CONSTANTINO D, 2005, RNA, V11, P332; Cornelis S, 2000, MOL CELL, V5, P597, DOI 10.1016/S1097-2765(00)80239-7; Costa-Mattioli M, 2004, MOL CELL BIOL, V24, P6861, DOI 10.1128/mcb.24.15.6861-6870.2004; Craig AWB, 1997, MOL CELL BIOL, V17, P163, DOI 10.1128/MCB.17.1.163; Dinos G, 2004, MOL CELL, V13, P113, DOI 10.1016/S1097-2765(04)00002-4; Gamarnik AV, 1997, RNA, V3, P882; Garlapati S, 2005, EUKARYOT CELL, V4, P742, DOI 10.1128/EC.4.4.742-754.2005; Garlapati S, 2004, J BIOL CHEM, V279, P3389, DOI 10.1074/jbc.M307565200; Garlapati S, 2002, RNA, V8, P601, DOI 10.1017/S135583820202071X; Garlapati S, 2001, J MOL BIOL, V308, P623, DOI 10.1006/jmbi.2001.4568; Graff J, 1998, J VIROL, V72, P9668, DOI 10.1128/JVI.72.12.9668-9675.1998; HELLEN CUT, 1993, P NATL ACAD SCI USA, V90, P7642, DOI 10.1073/pnas.90.16.7642; Hellen CUT, 2001, GENE DEV, V15, P1593, DOI 10.1101/gad.891101; Herbreteau CH, 2005, NAT STRUCT MOL BIOL, V12, P1001, DOI 10.1038/nsmb1011; Izumi RE, 2004, J VIROL, V78, P3763, DOI 10.1128/JVI.78.7.3763-3776.2004; Jan E, 2003, P NATL ACAD SCI USA, V100, P15410, DOI 10.1073/pnas.2535183100; Jan E, 2002, J MOL BIOL, V324, P889, DOI 10.1016/S0022-2836(02)01099-9; Jan E, 2006, VIRUS RES, V119, P16, DOI 10.1016/j.virusres.2005.10.011; Ji H, 2004, P NATL ACAD SCI USA, V101, P16990, DOI 10.1073/pnas.0407402101; Kaminski A, 1995, RNA, V1, P924; Kieft JS, 1999, J MOL BIOL, V292, P513, DOI 10.1006/jmbi.1999.3095; Kieft JS, 2001, RNA, V7, P194, DOI 10.1017/S1355838201001790; Kim YK, 1999, J GEN VIROL, V80, P3159, DOI 10.1099/0022-1317-80-12-3159; Kolupaeva VG, 1996, RNA, V2, P1199; Kolupaeva VG, 2003, MOL CELL BIOL, V23, P687, DOI 10.1128/MCB.23.2.687-698.2003; Komar AA, 2005, J BIOL CHEM, V280, P23425, DOI 10.1074/jbc.R400041200; KOZAK M, 1978, J BIOL CHEM, V253, P6568; Lancaster AM, 2006, RNA, V12, P894, DOI 10.1261/rna.2342306; Li L, 2004, J BIOL CHEM, V279, P14656, DOI 10.1074/jbc.M309879200; Li L, 2001, J VIROL, V75, P10612, DOI 10.1128/JVI.75.22.10612-10622.2001; Locker N, 2006, RNA, V12, P683, DOI 10.1261/rna.2227906; Locker N, 2007, METHOD ENZYMOL, V429, P83, DOI 10.1016/S0076-6879(07)29005-6; Lytle JR, 2001, J VIROL, V75, P7629, DOI 10.1128/JVI.75.16.7629-7636.2001; Martinez-Salas E, 2001, J GEN VIROL, V82, P973, DOI 10.1099/0022-1317-82-5-973; Martinez-Salas E, 2008, J GEN VIROL, V89, P611, DOI 10.1099/vir.0.83426-0; MEEROVITCH K, 1989, GENE DEV, V3, P1026, DOI 10.1101/gad.3.7.1026; Merrick WC., 1996, TRANSLATION CONTROL, P31; ODOM OW, 1978, J BIOL CHEM, V253, P1807; Pestova TV, 1998, GENE DEV, V12, P67, DOI 10.1101/gad.12.1.67; Pestova TV, 1996, MOL CELL BIOL, V16, P6870; Pestova TV, 1996, MOL CELL BIOL, V16, P6859, DOI 10.1128/mcb.16.12.6859; Pfingsten JS, 2006, SCIENCE, V314, P1450, DOI 10.1126/science.1133281; Pyronnet S, 2000, MOL CELL, V5, P607, DOI 10.1016/S1097-2765(00)80240-3; Ray PS, 2002, NUCLEIC ACIDS RES, V30, P4500, DOI 10.1093/nar/gkf583; Sanford JR, 2004, GENE DEV, V18, P755, DOI 10.1101/gad.286404; Sasaki J, 1999, J VIROL, V73, P1219, DOI 10.1128/JVI.73.2.1219-1226.1999; Semler BL, 2008, TRENDS MICROBIOL, V16, P1, DOI 10.1016/j.tim.2007.11.001; Shirakura T, 2001, MOL BIOCHEM PARASIT, V112, P153, DOI 10.1016/S0166-6851(00)00356-X; Siridechadilok B, 2005, SCIENCE, V310, P1513, DOI 10.1126/science.1118977; Spahn CMT, 2004, CELL, V118, P465, DOI 10.1016/j.cell.2004.08.001; Spahn CMT, 2001, SCIENCE, V291, P1959, DOI 10.1126/science.1058409; Stoneley M, 2004, ONCOGENE, V23, P3200, DOI 10.1038/sj.onc.1207551; Thompson SR, 2001, P NATL ACAD SCI USA, V98, P12972, DOI 10.1073/pnas.241286698; WANG AL, 1991, PARASITOL TODAY, V7, P76, DOI 10.1016/0169-4758(91)90198-W; WANG AL, 1986, MOL BIOCHEM PARASIT, V21, P269, DOI 10.1016/0166-6851(86)90132-5; WANG AL, 1993, P NATL ACAD SCI USA, V90, P8595, DOI 10.1073/pnas.90.18.8595; Wilson JE, 2000, CELL, V102, P511, DOI 10.1016/S0092-8674(00)00055-6; Wilson JE, 2000, MOL CELL BIOL, V20, P4990, DOI 10.1128/MCB.20.14.4990-4999.2000; Yu DC, 1998, MOL BIOCHEM PARASIT, V96, P151, DOI 10.1016/S0166-6851(98)00126-1; Yu DC, 1996, RNA, V2, P824; YU DC, 1995, MOL CELL BIOL, V15, P4867	71	5	5	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7435	10.1371/journal.pone.0007435	http://dx.doi.org/10.1371/journal.pone.0007435			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826476	Green Published, Green Submitted, gold			2022-12-27	WOS:000270808700007
J	Margolin, AA; Ong, SE; Schenone, M; Gould, R; Schreiber, SL; Carr, SA; Golub, TR				Margolin, Adam A.; Ong, Shao-En; Schenone, Monica; Gould, Robert; Schreiber, Stuart L.; Carr, Steven A.; Golub, Todd R.			Empirical Bayes Analysis of Quantitative Proteomics Experiments	PLOS ONE			English	Article							FALSE DISCOVERY RATES; CELL-CULTURE SILAC; MULTIPLEXED PROTEIN QUANTITATION; MASS-SPECTROMETRY; AMINO-ACIDS; GEL-ELECTROPHORESIS; SIGNALING NETWORKS; EXPRESSION; REVEALS; PHOSPHOPROTEOMICS	Background: Advances in mass spectrometry-based proteomics have enabled the incorporation of proteomic data into systems approaches to biology. However, development of analytical methods has lagged behind. Here we describe an empirical Bayes framework for quantitative proteomics data analysis. The method provides a statistical description of each experiment, including the number of proteins that differ in abundance between 2 samples, the experiment's statistical power to detect them, and the false-positive probability of each protein. Methodology/Principal Findings: We analyzed 2 types of mass spectrometric experiments. First, we showed that the method identified the protein targets of small-molecules in affinity purification experiments with high precision. Second, we re-analyzed a mass spectrometric data set designed to identify proteins regulated by microRNAs. Our results were supported by sequence analysis of the 3' UTR regions of predicted target genes, and we found that the previously reported conclusion that a large fraction of the proteome is regulated by microRNAs was not supported by our statistical analysis of the data. Conclusions/Significance: Our results highlight the importance of rigorous statistical analysis of proteomic data, and the method described here provides a statistical framework to robustly and reliably interpret such data.			Margolin, AA (corresponding author), Broad Inst, Harvard & MIT Canc Program, Cambridge, MA USA.	margolin@broad.mit.edu	Carr, Steven A./AAH-8366-2019		NATIONAL CANCER INSTITUTE [RL1CA133834] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR024924] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [RL1GM084437] Funding Source: NIH RePORTER; NCI NIH HHS [RL1 CA133834, RL1 CA 133834] Funding Source: Medline; NCRR NIH HHS [UL1 RR024924, UL1 RR 024924] Funding Source: Medline; NIGMS NIH HHS [RL1 GM084437, RL1 GM 084437] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bantscheff M, 2007, ANAL BIOANAL CHEM, V389, P1017, DOI 10.1007/s00216-007-1486-6; Bantscheff M, 2007, NAT BIOTECHNOL, V25, P1035, DOI 10.1038/nbt1328; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Blagoev B, 2004, NAT BIOTECHNOL, V22, P1139, DOI 10.1038/nbt1005; Blagoev B, 2003, NAT BIOTECHNOL, V21, P315, DOI 10.1038/nbt790; Chang JS, 2004, J PROTEOME RES, V3, P1210, DOI 10.1021/pr049886m; Chen XQ, 2008, MOL CELL PROTEOMICS, V7, P2323, DOI 10.1074/mcp.M700575-MCP200; Cox J, 2008, NAT BIOTECHNOL, V26, P1367, DOI 10.1038/nbt.1511; Daub H, 2008, MOL CELL, V31, P438, DOI 10.1016/j.molcel.2008.07.007; de Godoy LMF, 2008, NATURE, V455, P1251, DOI 10.1038/nature07341; Efron B, 2001, J AM STAT ASSOC, V96, P1151, DOI 10.1198/016214501753382129; Efron B, 2002, GENET EPIDEMIOL, V23, P70, DOI 10.1002/gepi.1124; Efron B, 2005, LOCAL FALSE DISCOVER; Efron B, 2008, STAT SCI, V23, P1, DOI 10.1214/07-STS236; Efron B, 2007, ANN STAT, V35, P1351, DOI 10.1214/009053606000001460; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; Everley PA, 2004, MOL CELL PROTEOMICS, V3, P729, DOI 10.1074/mcp.M400021-MCP200; Gruhler A, 2005, MOL CELL PROTEOMICS, V4, P310, DOI 10.1074/mcp.M400219-MCP200; Guha U, 2008, P NATL ACAD SCI USA, V105, P14112, DOI 10.1073/pnas.0806158105; Gygi SP, 1999, NAT BIOTECHNOL, V17, P994, DOI 10.1038/13690; Hendrickson EL, 2006, ANALYST, V131, P1335, DOI 10.1039/b610957h; Karaman MW, 2008, NAT BIOTECHNOL, V26, P127, DOI 10.1038/nbt1358; Keenan T, 1998, BIOORGAN MED CHEM, V6, P1309, DOI 10.1016/S0968-0896(98)00125-4; Kim B, 2007, P NATL ACAD SCI USA, V104, P16068, DOI 10.1073/pnas.0704573104; Kreil DP, 2004, BIOINFORMATICS, V20, P2026, DOI 10.1093/bioinformatics/bth193; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Liao JG, 2004, BIOINFORMATICS, V20, P2694, DOI 10.1093/bioinformatics/bth310; Lin WT, 2006, J PROTEOME RES, V5, P2328, DOI 10.1021/pr060132c; Lutz T, 2006, FEBS LETT, V580, P5851, DOI 10.1016/j.febslet.2006.09.049; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Marelli M, 2004, J CELL BIOL, V167, P1099, DOI 10.1083/jcb.200404119; Margolin AA, 2009, P NATL ACAD SCI USA, V106, P244, DOI 10.1073/pnas.0806445106; Mertins P, 2008, MOL CELL PROTEOMICS, V7, P1763, DOI 10.1074/mcp.M800196-MCP200; Olsen JV, 2006, CELL, V127, P635, DOI 10.1016/j.cell.2006.09.026; Ong SE, 2002, MOL CELL PROTEOMICS, V1, P376, DOI 10.1074/mcp.M200025-MCP200; Ong SE, 2003, J PROTEOME RES, V2, P173, DOI 10.1021/pr0255708; Ong SE, 2005, NAT CHEM BIOL, V1, P252, DOI 10.1038/nchembio736; Ong SE, 2006, NAT PROTOC, V1, P2650, DOI 10.1038/nprot.2006.427; Ong SE, 2009, P NATL ACAD SCI USA, V106, P4617, DOI 10.1073/pnas.0900191106; Ono M, 2006, MOL CELL PROTEOMICS, V5, P1338, DOI 10.1074/mcp.T500039-MCP200; Pan CP, 2009, MOL CELL PROTEOMICS, V8, P443, DOI 10.1074/mcp.M800258-MCP200; Pan Wei, 2003, Functional & Integrative Genomics, V3, P117; PICKANDS J, 1975, ANN STAT, V3, P119; Rappsilber J, 2007, NAT PROTOC, V2, P1896, DOI 10.1038/nprot.2007.261; Rinner O, 2007, NAT BIOTECHNOL, V25, P345, DOI 10.1038/nbt1289; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; Saito A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-15; Schulze WX, 2004, J BIOL CHEM, V279, P10756, DOI 10.1074/jbc.M309909200; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Storey JD, 2003, ANN STAT, V31, P2013, DOI 10.1214/aos/1074290335; Storey JD, 2002, J ROY STAT SOC B, V64, P479, DOI 10.1111/1467-9868.00346; Xia QW, 2007, INT J MASS SPECTROM, V259, P105, DOI 10.1016/j.ijms.2006.08.004; Xiao CC, 2007, CELL, V131, P146, DOI 10.1016/j.cell.2007.07.021; Zhang B, 2006, J PROTEOME RES, V5, P2909, DOI 10.1021/pr0600273	56	42	43	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7454	10.1371/journal.pone.0007454	http://dx.doi.org/10.1371/journal.pone.0007454			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19829701	Green Published, Green Submitted, gold			2022-12-27	WOS:000270808700014
J	Wong, A				Wong, Albert			Modified Epidermal Growth Factor Receptor (EGFR)-Bearing Liposomes (MRBLs) Are Sensitive to EGF in Solution	PLOS ONE			English	Article							HUMAN PANCREATIC-CARCINOMA; DRUG-DELIVERY; RECONSTITUTION; CHEMOTHERAPY; RADIOTHERAPY; INHIBITORS; H-1-NMR	Cancers often overexpress EGF and other growth factors to promote cell replication and migration. Previous work has not produced targeted drug carriers sensitive to abnormal amounts of growth factors. This work demonstrates that liposomes bearing EGF receptors covalently crosslinked to p-toluic acid or methyl-PEO4-NHS ester (or, in short, MRBLs) exhibit an increased rate of release of encapsulated drug compounds when EGF is present in solution. Furthermore, the modified EGF receptors retain the abilities to form dimers in the presence of EGF and bind specifically to EGF. These results demonstrate that MRBLs are sensitive to EGF in solution and indicate that MRBL-reconstituted modified EGF receptors, in the presence of EGF in solution, form dimers which increase MRBL permeability to encapsulated compounds.			Wong, A (corresponding author), Yale Univ, Program Biol & Biomed Sci, New Haven, CT 06520 USA.	albert.wong@yale.edu						Agero ALC, 2006, J AM ACAD DERMATOL, V55, P657, DOI 10.1016/j.jaad.2005.10.010; ARNUM PV, 2006, PHARM TECH EPT; DeAngelis LM, 2002, J CLIN ONCOL, V20, P4643, DOI 10.1200/JCO.2002.11.013; DeSilva NS, 2003, AM J RESP CELL MOL, V29, P757, DOI 10.1165/rcmb.2003-0186OC; Dromi S, 2007, CLIN CANCER RES, V13, P2722, DOI 10.1158/1078-0432.CCR-06-2443; FEIGENSON GW, 1974, NUCL MAGNETIC RELAXA; Forastiere AA, 2003, NEW ENGL J MED, V349, P2091, DOI 10.1056/NEJMoa031317; Galimont-Collen AFS, 2007, EUR J CANCER, V43, P845, DOI 10.1016/j.ejca.2006.11.016; Gansauge F, 1998, LANGENBECK ARCH SURG, V383, P152, DOI 10.1007/PL00008076; Ge GX, 2001, BIOCHEM BIOPH RES CO, V282, P511, DOI 10.1006/bbrc.2001.4600; Gerasimov OV, 1999, ADV DRUG DELIVER REV, V38, P317, DOI 10.1016/S0169-409X(99)00035-6; GRABAREK Z, 1990, ANAL BIOCHEM, V185, P131, DOI 10.1016/0003-2697(90)90267-D; JURETSCHKE HP, 1984, EUR J BIOCHEM, V143, P651, DOI 10.1111/j.1432-1033.1984.tb08418.x; Kumar V., 2004, ROBBINS COTRAN PATHO; LAX I, 1991, J BIOL CHEM, V266, P13828; Lemmon MA, 1997, EMBO J, V16, P281, DOI 10.1093/emboj/16.2.281; Maurer N, 1998, BBA-BIOMEMBRANES, V1374, P9, DOI 10.1016/S0005-2736(98)00125-4; MIMMS LT, 1981, BIOCHEMISTRY-US, V20, P833, DOI 10.1021/bi00507a028; Mouritsen OG, 2005, FRONT COLLECT, P1, DOI 10.1007/b138577; PANAYOTOU GN, 1985, FEBS LETT, V183, P321, DOI 10.1016/0014-5793(85)80802-4; PATEL TB, 2006, EPIDERMAL GROWTH FAC; Poch B, 2001, PANCREAS, V23, P280, DOI 10.1097/00006676-200110000-00009; Robert C, 2006, TARGET ONCOL, V1, P100, DOI 10.1007/s11523-006-0013-6; Schlessinger J, 2002, CELL, V110, P669, DOI 10.1016/S0092-8674(02)00966-2; SCHNEIDER WJ, 1983, J CELL BIOCHEM, V23, P95, DOI 10.1002/jcb.240230110; Tuthill TJ, 2006, J VIROL, V80, P172, DOI 10.1128/JVI.80.1.172-180.2006	26	5	5	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7391	10.1371/journal.pone.0007391	http://dx.doi.org/10.1371/journal.pone.0007391			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816581	gold, Green Published, Green Submitted			2022-12-27	WOS:000270594300011
J	Cain, JE; Islam, E; Haxho, F; Chen, L; Bridgewater, D; Nieuwenhuis, E; Hui, CC; Rosenblum, ND				Cain, Jason E.; Islam, Epshita; Haxho, Fiona; Chen, Lin; Bridgewater, Darren; Nieuwenhuis, Erica; Hui, Chi-Chung; Rosenblum, Norman D.			GLI3 Repressor Controls Nephron Number via Regulation of Wnt11 and Ret in Ureteric Tip Cells	PLOS ONE			English	Article								Truncating GLI3 mutations in Pallister-Hall Syndrome with renal malformation suggests a requirement for Hedgehog signaling during renal development. HH-dependent signaling increases levels of GLI transcriptional activators and decreases processing of GLI3 to a shorter transcriptional repressor. Previously, we showed that Shh-deficiency interrupts early inductive events during renal development in a manner dependent on GLI3 repressor. Here we identify a novel function for GLI3 repressor in controlling nephron number. During renal morphogenesis, HH signaling activity, assayed by expression of Ptc1-lacZ, is localized to ureteric cells of the medulla, but is undetectable in the cortex. Targeted inactivation of Smo, the HH effector, in the ureteric cell lineage causes no detectable abnormality in renal morphogenesis. The functional significance of absent HH signaling activity in cortical ureteric cells was determined by targeted deletion of Ptc1, the SMO inhibitor, in the ureteric cell lineage. Ptc1(-/-UB) mice demonstrate ectopic Ptc1-lacZ expression in ureteric branch tips and renal hypoplasia characterized by reduced kidney size and a paucity of mature and intermediate nephrogenic structures. Ureteric tip cells are remarkable for abnormal morphology and impaired expression of Ret and Wnt11, markers of tip cell differentiation. A finding of renal hypoplasia in Gli3(-/-) mice suggests a pathogenic role for reduced GLI3 repressor in the Ptc1(-/-UB) mice. Indeed, constitutive expression of GLI3 repressor via the Gli3(D699) allele in Ptc1(-/-UB) mice restores the normal pattern of HH signaling, and expression of Ret and Wnt11 and rescued the renal phenotype. Thus, GLI3 repressor controls nephron number by regulating ureteric tip cell expression of Wnt11 and Ret.			Cain, JE (corresponding author), Hosp Sick Children, Program Dev & Stem Cell Biol, Toronto Med Discovery Towers, Toronto, ON M5G 1X8, Canada.	norman.rosenblum@sickkids.ca	islam, Ejazul/G-2130-2015; Rosenblum, Norman D/H-4737-2015	Rosenblum, Norman D/0000-0003-1767-6464				Bai CB, 2002, DEVELOPMENT, V129, P4753; Bertram JF, 1995, INT REV CYTOL, V161, P111; Bose J, 2002, HUM MOL GENET, V11, P1129, DOI 10.1093/hmg/11.9.1129; Boyle S, 2008, DEV BIOL, V313, P234, DOI 10.1016/j.ydbio.2007.10.014; BRENNER BM, 1988, AM J HYPERTENS, V1, P335, DOI 10.1093/ajh/1.4.335; BRENNER BM, 1994, AM J KIDNEY DIS, V23, P171, DOI 10.1016/S0272-6386(12)80967-X; Bridgewater D, 2008, DEV BIOL, V317, P83, DOI 10.1016/j.ydbio.2008.02.010; Buttitta L, 2003, DEVELOPMENT, V130, P6233, DOI 10.1242/dev.00851; Cain JE, 2005, KIDNEY INT, V67, P420, DOI 10.1111/j.1523-1755.2005.67098.x; Cano-Gauci DF, 1999, J CELL BIOL, V146, P255; Carroll TJ, 2005, DEV CELL, V9, P283, DOI 10.1016/j.devcel.2005.05.016; Dennler S, 2007, CANCER RES, V67, P6981, DOI 10.1158/0008-5472.CAN-07-0491; di Magliano MP, 2006, GENE DEV, V20, P3161, DOI 10.1101/gad.1470806; Ding Q, 1998, DEVELOPMENT, V125, P2533; Dziarmaga A, 2003, J AM SOC NEPHROL, V14, P2767, DOI 10.1097/01.ASN.0000094082.11026.EE; Ellis T, 2003, GENESIS, V36, P158, DOI 10.1002/gene.10208; Fisher CE, 2001, DEVELOPMENT, V128, P4329; Goodrich LV, 1996, GENE DEV, V10, P301, DOI 10.1101/gad.10.3.301; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; GORLIN RJ, 1987, MEDICINE, V66, P98, DOI 10.1097/00005792-198703000-00002; HALL JG, 1980, AM J MED GENET, V7, P47, DOI 10.1002/ajmg.1320070110; Hoy WE, 2006, KIDNEY INT, V70, P104, DOI 10.1038/sj.ki.5000397; Hu MC, 2006, DEVELOPMENT, V133, P569, DOI 10.1242/dev.02220; Hughson M, 2006, KIDNEY INT, V69, P671, DOI 10.1038/sj.ki.5000041; HUI CC, 1993, NAT GENET, V3, P241, DOI 10.1038/ng0393-241; Jain S, 2006, GENE DEV, V20, P321, DOI 10.1101/gad.1387206; Ji ZY, 2007, J BIOL CHEM, V282, P14048, DOI 10.1074/jbc.M611089200; JOHNSON DR, 1967, J EMBRYOL EXP MORPH, V17, P543; Kang S, 1997, NAT GENET, V15, P266, DOI 10.1038/ng0397-266; Keller G, 2003, NEW ENGL J MED, V348, P101, DOI 10.1056/NEJMoa020549; Kobayashi A, 2008, CELL STEM CELL, V3, P169, DOI 10.1016/j.stem.2008.05.020; Long FX, 2001, DEVELOPMENT, V128, P5099; Majumdar A, 2003, DEVELOPMENT, V130, P3175, DOI 10.1242/dev.00520; Marigo V, 1996, DEVELOPMENT, V122, P1225; Michael L, 2007, J ANAT, V210, P89, DOI 10.1111/j.1469-7580.2006.00670.x; Mo R, 1997, DEVELOPMENT, V124, P113; Motoyama J, 2003, DEV BIOL, V259, P150, DOI 10.1016/S0012-1606(03)00159-3; Mugford JW, 2009, DEV BIOL, V333, P312, DOI 10.1016/j.ydbio.2009.06.043; Mugford JW, 2008, DEV BIOL, V324, P88, DOI 10.1016/j.ydbio.2008.09.010; Park HL, 2000, DEVELOPMENT, V127, P1593; Pepicelli CV, 1997, DEV BIOL, V192, P193, DOI 10.1006/dbio.1997.8745; Sanchez MP, 1996, NATURE, V382, P70, DOI 10.1038/382070a0; SCHUCHARDT A, 1994, NATURE, V367, P380, DOI 10.1038/367380a0; Schuchardt A, 1996, DEVELOPMENT, V122, P1919; Self M, 2006, EMBO J, V25, P5214, DOI 10.1038/sj.emboj.7601381; Shakya R, 2005, DEV CELL, V8, P65, DOI 10.1016/j.devcel.2004.11.008; Srinivas S, 1999, DEV GENET, V24, P241; STARK K, 1994, NATURE, V372, P679, DOI 10.1038/372679a0; Weber S, 2008, J AM SOC NEPHROL, V19, P891, DOI 10.1681/ASN.2006111282; Yu J, 2002, DEVELOPMENT, V129, P5301; Yu J, 2009, DEVELOPMENT, V136, P161, DOI 10.1242/dev.022087; Zhang XM, 2001, CELL, V105, P781, DOI 10.1016/S0092-8674(01)00385-3; Zhang Z, 2008, J AM SOC NEPHROL, V19, P2027, DOI 10.1681/ASN.2007101098; Zhao HT, 2004, DEV BIOL, V276, P403, DOI 10.1016/j.ydbio.2004.09.002	54	51	51	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7313	10.1371/journal.pone.0007313	http://dx.doi.org/10.1371/journal.pone.0007313			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809516	Green Submitted, Green Published, gold			2022-12-27	WOS:000270594000004
J	Olsen, L; Klausen, M; Helboe, L; Nielsen, FC; Werge, T				Olsen, Line; Klausen, Mikkel; Helboe, Lone; Nielsen, Finn Cilius; Werge, Thomas			MicroRNAs Show Mutually Exclusive Expression Patterns in the Brain of Adult Male Rats	PLOS ONE			English	Article							ESTROGEN-RECEPTOR-ALPHA; GENE-EXPRESSION; NEURONAL DIFFERENTIATION; MAMMALIAN MICRORNAS; MICROARRAY ANALYSIS; IMPACT; MIRNA; NORMALIZATION; PATHWAY; CELLS	Background: The brain is a major site of microRNA (miRNA) gene expression, but the spatial expression patterns of miRNAs within the brain have not yet been fully covered. Methodology/Principal Findings: We have characterized the regional expression profiles of miRNAs in five distinct regions of the adult rat brain: amygdala, cerebellum, hippocampus, hypothalamus and substantia nigra. Microarray profiling uncovered 48 miRNAs displaying more than three-fold enrichment between two or more brain regions. Notably, we found reciprocal expression profiles for a subset of the miRNAs predominantly found (>ten times) in either the cerebellum (miR-206 and miR-497) or the forebrain regions (miR-132, miR-212, miR-221 and miR-222). Conclusions/Significance: The results indicate that some miRNAs could be important for area-specific functions in the brain. Our data, combined with previous studies in mice, provides additional guidance for future investigations of miRNA functions in the brain.			Olsen, L (corresponding author), Psychiat Ctr Sct Hans, Inst Biol Psychiat, Roskilde, Denmark.	thomas.werge@shh.regionh.dk	Klausen, Mikkel/C-6254-2008; Werge, Thomas/G-7263-2012; Nielsen, Finn Cilius/AAA-4926-2020	Klausen, Mikkel/0000-0002-5741-0794; Nielsen, Finn Cilius/0000-0002-9829-1031				ADAMS BD, 2007, MOL ENDOCRINOL; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Bak M, 2008, RNA, V14, P432, DOI 10.1261/rna.783108; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bondy CA, 2004, EUR J PHARMACOL, V490, P25, DOI 10.1016/j.ejphar.2004.02.042; Cheng HYM, 2007, NEURON, V54, P813, DOI 10.1016/j.neuron.2007.05.017; Cooke J, 2004, BIOL REV, V79, P377, DOI 10.1017/S1464793103006298; Corballis MC, 2003, BEHAV BRAIN SCI, V26, P199, DOI 10.1017/S0140525X03000062; D'Ercole AJ, 2008, ENDOCRINOLOGY, V149, P5958, DOI 10.1210/en.2008-0920; Dostie J, 2003, RNA, V9, P180, DOI 10.1261/rna.2141503; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Futschik Matthias E., 2005, Journal of Bioinformatics and Computational Biology, V3, P965, DOI 10.1142/S0219720005001375; Halpern ME, 2005, J NEUROSCI, V25, P10351, DOI 10.1523/JNEUROSCI.3439-05.2005; Hansen T, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000873; Hohjoh H, 2007, GENE, V391, P39, DOI 10.1016/j.gene.2006.11.018; Hua YJ, 2008, GENOMICS, V92, P122, DOI 10.1016/j.ygeno.2008.04.002; Kapsimali M, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r173; Kefas B, 2008, CANCER RES, V68, P3566, DOI 10.1158/0008-5472.CAN-07-6639; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; Kim J, 2004, P NATL ACAD SCI USA, V101, P360, DOI 10.1073/pnas.2333854100; Kim J, 2007, SCIENCE, V317, P1220, DOI 10.1126/science.1140481; Kocerha J, 2009, P NATL ACAD SCI USA, V106, P3507, DOI 10.1073/pnas.0805854106; Kondo N, 2008, CANCER RES, V68, P5004, DOI 10.1158/0008-5472.CAN-08-0180; Krichevsky AM, 2003, RNA, V9, P1274, DOI 10.1261/rna.5980303; Krichevsky AM, 2006, STEM CELLS, V24, P857, DOI 10.1634/stemcells.2005-0441; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Lugli G, 2005, J NEUROCHEM, V94, P896, DOI 10.1111/j.1471-4159.2005.03224.x; Makeyev EV, 2007, MOL CELL, V27, P435, DOI 10.1016/j.molcel.2007.07.015; Martinez V, 2004, BEHAV NEUROSCI, V118, P984, DOI 10.1037/0735-7044.118.5.984; MCCARTHY JJ, 2008, BIOCH BIOPHYS ACTA; Mehler MF, 2006, J PHYSIOL-LONDON, V575, P333, DOI 10.1113/jphysiol.2006.113191; Mendez P, 2006, FRONT NEUROENDOCRIN, V27, P391, DOI 10.1016/j.yfrne.2006.09.001; Miska EA, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-9-r68; Moskal JR, 2006, HIPPOCAMPUS, V16, P629, DOI 10.1002/hipo.20198; Nelson PT, 2006, RNA, V12, P187, DOI 10.1261/rna.2258506; Paxinos G, 1998, RAT BRAIN; Ritchie ME, 2007, BIOINFORMATICS, V23, P2700, DOI 10.1093/bioinformatics/btm412; Schaefer A, 2007, J EXP MED, V204, P1553, DOI 10.1084/jem.20070823; Schratt GM, 2006, NATURE, V439, P283, DOI 10.1038/nature04367; Sempere LF, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-3-r13; Shan ZX, 2009, BIOCHEM BIOPH RES CO, V381, P597, DOI 10.1016/j.bbrc.2009.02.097; Sillitoe RV, 2005, PROG BRAIN RES, V148, P283, DOI 10.1016/S0079-6123(04)48022-4; Smyth GK, 2003, METHODS, V31, P265, DOI 10.1016/S1046-2023(03)00155-5; SMYTH GK, 2004, STAT APPL GENET MOL, V3; Stark A, 2005, CELL, V123, P1133, DOI 10.1016/j.cell.2005.11.023; Sun T, 2005, SCIENCE, V308, P1794, DOI 10.1126/science.1110324; Tang YM, 2008, ALCOHOL CLIN EXP RES, V32, P355, DOI 10.1111/j.1530-0277.2007.00584.x; Thuringer D, 2004, ANN NY ACAD SCI, V1030, P14, DOI 10.1196/annals.1329.003; Tonelli DD, 2008, DEVELOPMENT, V135, P3911, DOI 10.1242/dev.025080; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; VELLECA MA, 1994, MOL CELL BIOL, V14, P7095, DOI 10.1128/MCB.14.11.7095; Visvanathan J, 2007, GENE DEV, V21, P744, DOI 10.1101/gad.1519107; Vo N, 2005, P NATL ACAD SCI USA, V102, P16426, DOI 10.1073/pnas.0508448102; Wayman GA, 2008, P NATL ACAD SCI USA, V105, P9093, DOI 10.1073/pnas.0803072105; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Zhao JJ, 2008, J BIOL CHEM, V283, P31079, DOI 10.1074/jbc.M806041200	60	90	106	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7225	10.1371/journal.pone.0007225	http://dx.doi.org/10.1371/journal.pone.0007225			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806225	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593800003
J	Qin, Z; Kreplak, L; Buehler, MJ				Qin, Zhao; Kreplak, Laurent; Buehler, Markus J.			Hierarchical Structure Controls Nanomechanical Properties of Vimentin Intermediate Filaments	PLOS ONE			English	Article								Intermediate filaments (IFs), in addition to microtubules and microfilaments, are one of the three major components of the cytoskeleton in eukaryotic cells, playing a vital role in mechanotransduction and in providing mechanical stability to cells. Despite the importance of IF mechanics for cell biology and cell mechanics, the structural basis for their mechanical properties remains unknown. Specifically, our understanding of fundamental filament properties, such as the basis for their great extensibility, stiffening properties, and their exceptional mechanical resilience remains limited. This has prevented us from answering fundamental structure-function relationship questions related to the biomechanical role of intermediate filaments, which is crucial to link structure and function in the protein material's biological context. Here we utilize an atomistic-level model of the human vimentin dimer and tetramer to study their response to mechanical tensile stress, and describe a detailed analysis of the mechanical properties and associated deformation mechanisms. We observe a transition from alpha-helices to beta-sheets with subsequent interdimer sliding under mechanical deformation, which has been inferred previously from experimental results. By upscaling our results we report, for the first time, a quantitative comparison to experimental results of IF nanomechanics, showing good agreement. Through the identification of links between structures and deformation mechanisms at distinct hierarchical levels, we show that the multi-scale structure of IFs is crucial for their characteristic mechanical properties, in particular their ability to undergo severe deformation of approximate to 300% strain without breaking, facilitated by a cascaded activation of a distinct deformation mechanisms operating at different levels. This process enables IFs to combine disparate properties such as mechanosensitivity, strength and deformability. Our results enable a new paradigm in studying biological and mechanical properties of IFs from an atomistic perspective, and lay the foundation to understanding how properties of individual protein molecules can have profound effects at larger length-scales.			Qin, Z (corresponding author), MIT, Lab Atomist & Mol Mech, Dept Civil & Environm Engn, 77 Massachusetts Ave, Cambridge, MA 02139 USA.	mbuehler@MIT.EDU	Qin, Zhao/B-4667-2010; Buehler, Markus/C-4580-2008	Qin, Zhao/0000-0001-5696-8553; kreplak, laurent/0000-0001-9370-9809; Buehler, Markus/0000-0002-4173-9659				Ackbarow T, 2009, EXP MECH, V49, P79, DOI 10.1007/s11340-007-9100-6; Ackbarow T, 2007, P NATL ACAD SCI USA, V104, P16410, DOI 10.1073/pnas.0705759104; Ackbarow T, 2007, J MATER SCI, V42, P8771, DOI 10.1007/s10853-007-1719-2; Ackbarow T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006015; Brenner M, 2001, NAT GENET, V27, P117, DOI 10.1038/83679; Brown JH, 1996, PROTEINS, V26, P134; Dahl KN, 2004, J CELL SCI, V117, P4779, DOI 10.1242/jcs.01357; Frishman D, 1995, PROTEINS, V23, P566, DOI 10.1002/prot.340230412; Fudge D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002327; Fudge DS, 2003, BIOPHYS J, V85, P2015, DOI 10.1016/S0006-3495(03)74629-3; GITTES F, 1993, J CELL BIOL, V120, P923, DOI 10.1083/jcb.120.4.923; Goldie KN, 2007, J STRUCT BIOL, V158, P378, DOI 10.1016/j.jsb.2006.12.007; Guzman C, 2006, J MOL BIOL, V360, P623, DOI 10.1016/j.jmb.2006.05.030; Hearle JWS, 2000, INT J BIOL MACROMOL, V27, P123, DOI 10.1016/S0141-8130(00)00116-1; Herrmann H, 2004, ANNU REV BIOCHEM, V73, P749, DOI 10.1146/annurev.biochem.73.011303.073823; Herrmann H, 1996, J MOL BIOL, V264, P933, DOI 10.1006/jmbi.1996.0688; Herrmann H, 1999, J MOL BIOL, V286, P1403, DOI 10.1006/jmbi.1999.2528; Herrmann H, 2007, NAT REV MOL CELL BIO, V8, P562, DOI 10.1038/nrm2197; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Hutchison CJ, 2002, NAT REV MOL CELL BIO, V3, P848, DOI 10.1038/nrm950; Keten S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.198301; Keten S, 2008, NANO LETT, V8, P743, DOI 10.1021/nl0731670; Kreplak L, 2004, EXP CELL RES, V301, P77, DOI 10.1016/j.yexcr.2004.08.021; Kreplak L, 2004, BIOPHYS J, V87, P640, DOI 10.1529/biophysj.103.036749; Kreplak L, 2002, BIOPHYS J, V82, P2265, DOI 10.1016/S0006-3495(02)75572-0; Kreplak L, 2009, J MOL BIOL, V385, P1043, DOI 10.1016/j.jmb.2008.10.095; Kreplak L, 2001, BIOPOLYMERS, V58, P526, DOI 10.1002/1097-0282(20010415)58:5<526::AID-BIP1028>3.0.CO;2-L; Kreplak L, 2008, BIOPHYS J, V94, P2790, DOI 10.1529/biophysj.107.119826; Lazaridis T, 1997, SCIENCE, V278, P1928, DOI 10.1126/science.278.5345.1928; Lazaridis T, 1999, PROTEINS, V35, P133, DOI 10.1002/(SICI)1097-0134(19990501)35:2<133::AID-PROT1>3.0.CO;2-N; Leduc P, 2007, CELL BIOCHEM BIOPHYS, V48, P16, DOI 10.1007/s12013-007-0012-y; Lewis MK, 2003, J STRUCT BIOL, V143, P56, DOI 10.1016/S1047-8477(03)00121-7; Luca S, 2007, BIOCHEMISTRY-US, V46, P13505, DOI 10.1021/bi701427q; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Monticelli L, 2008, J CHEM THEORY COMPUT, V4, P819, DOI 10.1021/ct700324x; Mucke N, 2004, J MOL BIOL, V340, P97, DOI 10.1016/j.jmb.2004.04.039; Nelson MT, 1996, INT J SUPERCOMPUT AP, V10, P251, DOI 10.1177/109434209601000401; Omary MB, 2004, NEW ENGL J MED, V351, P2087, DOI 10.1056/NEJMra040319; Paci E, 2000, P NATL ACAD SCI USA, V97, P6521, DOI 10.1073/pnas.100124597; Parry DAD, 1999, Q REV BIOPHYS, V32, P99, DOI 10.1017/S0033583500003516; Parry DAD, 2007, EXP CELL RES, V313, P2204, DOI 10.1016/j.yexcr.2007.04.009; Qin Z, 2009, INT J APPL MECH, V1, P85, DOI 10.1142/S1758825109000058; Rafik E, 2004, BIOPHYS J, V86, P3893, DOI 10.1529/biophysj.103.034694; Schwaiger I, 2002, NAT MATER, V1, P232, DOI 10.1038/nmat776; Smith TA, 2002, J STRUCT BIOL, V137, P128, DOI 10.1006/jsbi.2002.4438; Sokolova AV, 2006, P NATL ACAD SCI USA, V103, P16206, DOI 10.1073/pnas.0603629103; Sotomayor M, 2007, SCIENCE, V316, P1144, DOI 10.1126/science.1137591; Strelkov SV, 2002, EMBO J, V21, P1255, DOI 10.1093/emboj/21.6.1255; Strelkov SV, 2001, J MOL BIOL, V306, P773, DOI 10.1006/jmbi.2001.4442; Stultz CM, 2006, PROTEIN SCI, V15, P2166, DOI 10.1110/ps.062124606; Sulkowska JI, 2007, J PHYS-CONDENS MAT, V19, DOI 10.1088/0953-8984/19/28/283201; Wang N, 2002, J MUSCLE RES CELL M, V23, P535, DOI 10.1023/A:1023470709071; WANG N, 1993, SCIENCE, V260, P1124, DOI 10.1126/science.7684161; West DK, 2006, BIOPHYS J, V90, P287, DOI 10.1529/biophysj.105.071035; Wilson KL, 2001, CELL, V104, P647, DOI 10.1016/S0092-8674(02)01452-6	55	136	139	1	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7294	10.1371/journal.pone.0007294	http://dx.doi.org/10.1371/journal.pone.0007294			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806221	Green Published, Green Submitted, gold			2022-12-27	WOS:000270593800009
J	Sardiu, ME; Gilmore, JM; Carrozza, MJ; Li, B; Workman, JL; Florens, L; Washburn, MP				Sardiu, Mihaela E.; Gilmore, Joshua M.; Carrozza, Michael J.; Li, Bing; Workman, Jerry L.; Florens, Laurence; Washburn, Michael P.			Determining Protein Complex Connectivity Using a Probabilistic Deletion Network Derived from Quantitative Proteomics	PLOS ONE			English	Article							COREPRESSOR COMPLEX; SIGNAL-TRANSDUCTION; IDENTIFICATION; SIN3; COMPONENT; METHYLATION; REPRESSION; REVEALS; DOMAIN	Protein complexes are key molecular machines executing a variety of essential cellular processes. Despite the availability of genome-wide protein-protein interaction studies, determining the connectivity between proteins within a complex remains a major challenge. Here we demonstrate a method that is able to predict the relationship of proteins within a stable protein complex. We employed a combination of computational approaches and a systematic collection of quantitative proteomics data from wild-type and deletion strain purifications to build a quantitative deletion-interaction network map and subsequently convert the resulting data into an interdependency-interaction model of a complex. We applied this approach to a data set generated from components of the Saccharomyces cerevisiae Rpd3 histone deacetylase complexes, which consists of two distinct small and large complexes that are held together by a module consisting of Rpd3, Sin3 and Ume1. The resulting representation reveals new protein-protein interactions and new submodule relationships, providing novel information for mapping the functional organization of a complex.			Sardiu, ME (corresponding author), Stowers Inst Med Res, Kansas City, MO USA.	mpw@stowers-institute.org		Florens, Laurence/0000-0002-9310-6650; Washburn, Michael/0000-0001-7568-2585	NIGMS NIH HHS [R37 GM047867] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R37GM047867] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alland L, 2002, MOL CELL BIOL, V22, P2743, DOI 10.1128/MCB.22.8.2743-2750.2002; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Carrozza MJ, 2005, BBA-GENE STRUCT EXPR, V1731, P77, DOI 10.1016/j.bbaexp.2005.09.005; Carrozza MJ, 2005, CELL, V123, P581, DOI 10.1016/j.cell.2005.10.023; Collins SR, 2007, MOL CELL PROTEOMICS, V6, P439, DOI 10.1074/mcp.M600381-MCP200; David G, 2003, GENE DEV, V17, P2396, DOI 10.1101/gad.1109403; Doyle JP, 2008, CELL, V135, P749, DOI 10.1016/j.cell.2008.10.029; Florens L, 2006, METHODS, V40, P303, DOI 10.1016/j.ymeth.2006.07.028; Florens Laurence, 2006, V328, P159; Gavin AC, 2006, NATURE, V440, P631, DOI 10.1038/nature04532; Guenther MG, 2002, GENE DEV, V16, P3130, DOI 10.1101/gad.1037502; Han JDJ, 2004, NATURE, V430, P88, DOI 10.1038/nature02555; Keogh MC, 2005, CELL, V123, P593, DOI 10.1016/j.cell.2005.10.025; Laherty CD, 1998, MOL CELL, V2, P33, DOI 10.1016/S1097-2765(00)80111-2; Le Guezennec X, 2006, NUCLEIC ACIDS RES, V34, P3929, DOI 10.1093/nar/gkl537; Liu WL, 2008, MOL CELL, V29, P81, DOI 10.1016/j.molcel.2007.11.003; Lottersberger F, 2007, MOL CELL BIOL, V27, P3266, DOI 10.1128/MCB.01767-06; Meunier B, 2007, J PROTEOME RES, V6, P358, DOI 10.1021/pr060343h; Mitchell L, 2008, MOL CELL BIOL, V28, P2244, DOI 10.1128/MCB.01653-07; Nikolaev AY, 2004, BIOCHEM BIOPH RES CO, V323, P1216, DOI 10.1016/j.bbrc.2004.08.227; Pang CNI, 2008, PROTEOMICS, V8, P425, DOI 10.1002/pmic.200700801; Paoletti AC, 2006, P NATL ACAD SCI USA, V103, P18928, DOI 10.1073/pnas.0606379103; Reva B, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r232; Sahu SC, 2008, J MOL BIOL, V375, P1444, DOI 10.1016/j.jmb.2007.11.079; Sardiu ME, 2008, P NATL ACAD SCI USA, V105, P1454, DOI 10.1073/pnas.0706983105; Shahbazian MD, 2007, ANNU REV BIOCHEM, V76, P75, DOI 10.1146/annurev.biochem.76.052705.162114; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Steeg PS, 2003, NAT REV CANCER, V3, P55, DOI 10.1038/nrc967; van de Peppel J, 2005, MOL CELL, V19, P511, DOI 10.1016/j.molcel.2005.06.033; van Ingen H, 2006, J MOL BIOL, V358, P485, DOI 10.1016/j.jmb.2006.01.100; Viiri KM, 2006, NUCLEIC ACIDS RES, V34, P3288, DOI 10.1093/nar/gkl401; WANG HM, 1990, MOL CELL BIOL, V10, P5927, DOI 10.1128/MCB.10.11.5927; Yildirim MA, 2007, NAT BIOTECHNOL, V25, P1119, DOI 10.1038/nbt1338	33	28	28	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7310	10.1371/journal.pone.0007310	http://dx.doi.org/10.1371/journal.pone.0007310			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806189	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593800017
J	Smith, LP; Nierstenhoefer, M; Yoo, SW; Penzias, AS; Tobiasch, E; Usheva, A				Smith, Laura P.; Nierstenhoefer, Maik; Yoo, Sang Wook; Penzias, Alan S.; Tobiasch, Edda; Usheva, Anny			The Bile Acid Synthesis Pathway Is Present and Functional in the Human Ovary	PLOS ONE			English	Article							LIVER RECEPTOR HOMOLOG-1; NUCLEAR RECEPTOR; CHOLESTEROL; ACTIVATION; EXPRESSION; LRH-1; CELLS; RAT; LXR	Background: Bile acids, end products of the pathway for cholesterol elimination, are required for dietary lipid and fat-soluble vitamin absorption and maintain the balance between cholesterol synthesis in the liver and cholesterol excretion. They are composed of a steroid structure and are primarily made in the liver by the oxidation of cholesterol. Cholesterol is also highly abundant in the human ovarian follicle, where it is used in the formation of the sex steroids. Methodology/Principal Findings: Here we describe for the first time evidence that all aspects of the bile acid synthesis pathway are present in the human ovarian follicle, including the enzymes in both the classical and alternative pathways, the nuclear receptors known to regulate the pathway, and the end product bile acids. Furthermore, we provide functional evidence that bile acids are produced by the human follicular granulosa cells in response to cholesterol presence in the culture media. Conclusions/Significance: These findings establish a novel pathway present in the human ovarian follicle that has the capacity to compete directly with sex steroid synthesis.			Smith, LP (corresponding author), Beth Israel Deaconess Med Ctr, Dept Obstet & Gynecol, Div Reprod Endocrinol & Infertil, Boston, MA 02215 USA.	ausheva@bidmc.harvard.edu		Penzias, Alan/0000-0002-7160-494X				Chiang John Y. L., 1998, Frontiers in Bioscience, V3, pD176; Chiang JYL, 2000, J BIOL CHEM, V275, P10918, DOI 10.1074/jbc.275.15.10918; Duggavathi R, 2008, GENE DEV, V22, P1871, DOI 10.1101/gad.472008; Ferdinandusse S, 2006, BBA-MOL CELL RES, V1763, P1427, DOI 10.1016/j.bbamcr.2006.09.001; Fiorucci S, 2005, J PHARMACOL EXP THER, V313, P604, DOI 10.1124/jpet.104.079665; FRANCHIMONT P, 1989, FERTIL STERIL, V52, P1006; Goodwin B, 2000, MOL CELL, V6, P517, DOI 10.1016/S1097-2765(00)00051-4; Goodwin B, 2003, MOL ENDOCRINOL, V17, P386, DOI 10.1210/me.2002-0246; Hall E, 2001, AM J PHYSIOL-GASTR L, V281, pG293, DOI 10.1152/ajpgi.2001.281.1.G293; Hasler Julia A., 1999, Molecular Aspects of Medicine, V20, P1, DOI 10.1016/S0098-2997(99)00005-9; Hinshelwood MM, 2005, DEV DYNAM, V234, P159, DOI 10.1002/dvdy.20490; Ishida H, 1999, J BIOCHEM-TOKYO, V126, P19, DOI 10.1093/oxfordjournals.jbchem.a022422; Janowski BA, 1996, NATURE, V383, P728, DOI 10.1038/383728a0; JAVITT NB, 1994, FASEB J, V8, P1308, DOI 10.1096/fasebj.8.15.8001744; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Lu TT, 2000, MOL CELL, V6, P507, DOI 10.1016/S1097-2765(00)00050-2; Makishima M, 1999, SCIENCE, V284, P1362, DOI 10.1126/science.284.5418.1362; MCNATTY KP, 1979, J CLIN ENDOCR METAB, V49, P687, DOI 10.1210/jcem-49-5-687; Mendelson CR, 2007, J STEROID BIOCHEM, V106, P62, DOI 10.1016/j.jsbmb.2007.05.001; NG TB, 1993, INT J FERTIL, V38, P316; Nguyen LB, 1999, METABOLISM, V48, P1542, DOI 10.1016/S0026-0495(99)90243-3; Norlin M, 2007, CURR MOL MED, V7, P199, DOI 10.2174/156652407780059168; Parks DJ, 1999, SCIENCE, V284, P1365, DOI 10.1126/science.284.5418.1365; Raufman JP, 2003, DIGEST DIS SCI, V48, P1431, DOI 10.1023/A:1024733500950; Saxena D, 2007, ENDOCRINOLOGY, V148, P726, DOI 10.1210/en.2006-0108; SUCHANEK E, 1988, J CLIN CHEM CLIN BIO, V26, P543; Torchia EC, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-11; Wu ZL, 1999, J LIPID RES, V40, P2195; Zimon A, 2006, NUCLEIC ACIDS RES, V34, P3279, DOI 10.1093/nar/gkl387	29	33	34	1	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7333	10.1371/journal.pone.0007333	http://dx.doi.org/10.1371/journal.pone.0007333			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806215	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593800024
J	Wilson, JA; Marsicano, CA; Smith, RMH				Wilson, Jeffrey A.; Marsicano, Claudia A.; Smith, Roger M. H.			Dynamic Locomotor Capabilities Revealed by Early Dinosaur Trackmakers from Southern Africa	PLOS ONE			English	Article							EARLY EVOLUTION; THEROPOD DINOSAUR; TETRAPOD FAUNA; UPPER ELLIOT	Background: A new investigation of the sedimentology and ichnology of the Early Jurassic Moyeni tracksite in Lesotho, southern Africa has yielded new insights into the behavior and locomotor dynamics of early dinosaurs. Methodology/Principal Findings: The tracksite is an ancient point bar preserving a heterogeneous substrate of varied consistency and inclination that includes a ripple-marked riverbed, a bar slope, and a stable algal-matted bar top surface. Several basal ornithischian dinosaurs and a single theropod dinosaur crossed its surface within days or perhaps weeks of one another, but responded to substrate heterogeneity differently. Whereas the theropod trackmaker accommodated sloping and slippery surfaces by gripping the substrate with its pedal claws, the basal ornithischian trackmakers adjusted to the terrain by changing between quadrupedal and bipedal stance, wide and narrow gauge limb support (abduction range = 31 degrees), and plantigrade and digitigrade foot posture. Conclusions/Significance: The locomotor adjustments coincide with changes in substrate consistency along the trackway and appear to reflect 'real time' responses to a complex terrain. It is proposed that these responses foreshadow important locomotor transformations characterizing the later evolution of the two main dinosaur lineages. Ornithischians, which shifted from bipedal to quadrupedal posture at least three times in their evolutionary history, are shown to have been capable of adopting both postures early in their evolutionary history. The substrate-gripping behavior demonstrated by the early theropod, in turn, is consistent with the hypothesized function of pedal claws in bird ancestors.			Wilson, JA (corresponding author), Univ Michigan, Museum Paleontol, Ann Arbor, MI 48109 USA.	wilsonja@umich.edu	Wilson, Jeffrey/C-2737-2008; Smith, Roger/AAF-7947-2019					[Anonymous], [No title captured]; BOCK WALTER J., 1959, AMER MUS NOVITATES, V1931, P1; Butler RJ, 2008, J SYST PALAEONTOL, V6, P1, DOI 10.1017/S1477201907002271; Butler RJ, 2007, P ROY SOC B-BIOL SCI, V274, P2041, DOI 10.1098/rspb.2007.0367; Butler RJ, 2005, ZOOL J LINN SOC-LOND, V145, P175, DOI 10.1111/j.1096-3642.2005.00182.x; Carrano MT, 2001, PALEOBIOLOGY, V27, P564, DOI 10.1666/0094-8373(2001)027<0564:TDATTT>2.0.CO;2; Carrano MT, 2000, PALEOBIOLOGY, V26, P489, DOI 10.1666/0094-8373(2000)026<0489:HATEOD>2.0.CO;2; CASAMIQUELA RM, 1967, AMEGHINIANA, V4, P47; COLBERT EH, 1981, MUSEUM NO ARIZONA B, V53, P1; Day JJ, 2002, NATURE, V415, P494, DOI 10.1038/415494a; Dial KP, 2006, BIOSCIENCE, V56, P437, DOI 10.1641/0006-3568(2006)056[0437:WUIHAW]2.0.CO;2; Dial KP, 2003, SCIENCE, V299, P402, DOI 10.1126/science.1078237; ELLENBERGER F, 1967, INT S GONDW GEOL UNE, P333; ELLENBERGER F, 1963, C R SOMM SEANCE SOC, P315; ELLENBERGER P, 1974, PALEOVERTEBRATA MEMO, V1, P1; Ezquerra R, 2007, GEOLOGY, V35, P507, DOI 10.1130/G23452A.1; Farlow JO, 2000, AM ZOOL, V40, P640, DOI 10.1668/0003-1569(2000)040[0640:TL]2.0.CO;2; Gatesy SM, 1999, NATURE, V399, P141, DOI 10.1038/20167; GIERLINSKI G, 1991, PALAEOGEOGR PALAEOCL, V85, P137, DOI 10.1016/0031-0182(91)90030-U; Gradstein F.M., 2004, GEOLOGIC TIME SCALE; HAUBOLD H, 1986, BEGINNING AGE DINOSA, P189; Henderson Donald M., 2003, Ichnos, V10, P99, DOI 10.1080/10420940390257914; Knoll F, 2005, B SOC GEOL FR, V176, P81, DOI 10.2113/176.1.81; Knoll F, 2004, B SOC GEOL FR, V175, P73, DOI 10.2113/175.1.73; Lockley Martin, 2003, Ichnos, V10, P169, DOI 10.1080/10420940390256249; LULL RS, 1953, B CONNECTICUT STATE, V81, P1; LULL RS, 1915, B CONNECTICUT STATE, V24, P1; Milner ARC, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004591; MILNER ARC, 2006, MUS NAT HIST SCI B, V37, P315; Norman DB, 2004, DINOSAURIA, 2ND EDITION, P325; OLSEN P E, 1984, Palaeontologia Africana, V25, P87; Olsen P.E., 1986, P61; Olsen PE, 2002, SCIENCE, V296, P1305, DOI 10.1126/science.1065522; Olsen PE, 2003, GREAT RIFT VALLEYS OF PANGEA IN EASTERN NORTH AMERICA, VOL 2, P314; Owen R., 1861, MONOGRAPHS PALAEONTO, V13, P1; RAINFORTH E.C., 2002, GEOLOGICAL SOC AM AB, V34, P61; ROGERS RR, 1993, SCIENCE, V260, P794, DOI 10.1126/science.260.5109.794; Santa Luca A.P., 1980, Annals of the South African Museum, V79, P159; Sereno P.C., 1991, Journal of Vertebrate Paleontology, V11, P168; Sereno PC, 1999, SCIENCE, V284, P2137, DOI 10.1126/science.284.5423.2137; SERENO PC, 1993, NATURE, V361, P64, DOI 10.1038/361064a0; SMITH RMH, PALAIOS IN PRESS, V24; THULBORN R A, 1972, Palaeontology (Oxford), V15, P29; Thulborn RA., 1990, DINOSAUR TRACKS; Yates Adam M., 2005, Palaeontologia Africana, V41, P105	45	39	40	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7331	10.1371/journal.pone.0007331	http://dx.doi.org/10.1371/journal.pone.0007331			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806213	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593800023
J	Rose, AMC; Gerstl, S; Mahamane, AEH; Sidikou, F; Djibo, S; Bonte, L; Caugant, DA; Guerin, PJ; Chanteau, S				Rose, Angela M. C.; Gerstl, Sibylle; Mahamane, Ali E. -H.; Sidikou, Fati; Djibo, Saacou; Bonte, Laurence; Caugant, Dominique A.; Guerin, Philippe J.; Chanteau, Suzanne			Field Evaluation of Two Rapid Diagnostic Tests for Neisseria meningitidis Serogroup A during the 2006 Outbreak in Niger	PLOS ONE			English	Article							POLYMERASE-CHAIN-REACTION; MENINGOCOCCAL MENINGITIS; BACTERIAL-MENINGITIS; IDENTIFICATION; SURVEILLANCE; ASSAY; BELT	The Pastorex (R) (BioRad) rapid agglutination test is one of the main rapid diagnostic tests (RDTs) for meningococcal disease currently in use in the "meningitis belt''. Earlier evaluations, performed after heating and centrifugation of cerebrospinal fluid (CSF) samples, under good laboratory conditions, showed high sensitivity and specificity. However, during an epidemic, the test may be used without prior sample preparation. Recently a new, easy-to-use dipstick RDT for meningococcal disease detection on CSF was developed by the Centre de Recherche Medicale et Sanitaire in Niger and the Pasteur Institute in France. We estimate diagnostic accuracy in the field during the 2006 outbreak of Neisseria meningitidis serogroup A in Maradi, Niger, for the dipstick RDT and Pastorex (R) on unprepared CSF, (a) by comparing each test's sensitivity and specificity with previously reported values; and (b) by comparing results for each test on paired samples, using McNemar's test. We also (c) estimate diagnostic accuracy of the dipstick RDT on diluted whole blood. We tested unprepared CSF and diluted whole blood from 126 patients with suspected meningococcal disease presenting at four health posts. (a) Pastorex (R) sensitivity (69%; 95%CI 57-79) was significantly lower than found previously for prepared CSF samples [87% (81-91); or 88% (85-91)], as was specificity [81% (95%CI 68-91) vs 93% (90-95); or 93% (87-96)]. Sensitivity of the dipstick RDT [89% (95%CI 80-95)] was similar to previously reported values for ideal laboratory conditions [89% (84-93) and 94% (90-96)]. Specificity, at 62% (95%CI 48-75), was significantly lower than found previously [94% (92-96) and 97% (94-99)]. (b) McNemar's test for the dipstick RDT vs Pastorex (R) was statistically significant (p<0.001). (c) The dipstick RDT did not perform satisfactorily on diluted whole blood (sensitivity 73%; specificity 57%). Sensitivity and specificity of Pastorex (R) without prior CSF preparation were poorer than previously reported results from prepared samples; therefore we caution against using this test during an epidemic if sample preparation is not possible. For the dipstick RDT, sensitivity was similar to, while specificity was not as high as previously reported during a more stable context. Further studies are needed to evaluate its field performance, especially for different populations and other serogroups.			Rose, AMC (corresponding author), Epictr, Paris, France.	angela.rose@cavehill.uwi.edu	, dcaugant/AAH-6843-2019; Rose, Angela MC/O-1645-2019; Rose, Angela/I-5584-2014; Guerin, Philippe/AAH-8873-2021	, dcaugant/0000-0003-2765-9844; Rose, Angela MC/0000-0002-2493-8082; Rose, Angela/0000-0002-2493-8082; Guerin, Philippe/0000-0002-6008-2963				Boisier P, 2007, CLIN INFECT DIS, V44, P657, DOI 10.1086/511646; Borel T, 2006, T ROY SOC TROP MED H, V100, P964, DOI 10.1016/j.trstmh.2006.03.002; Caugant DA, 1996, SCAND J INFECT DIS, V28, P149, DOI 10.3109/00365549609049066; Chanteau S, 2006, T ROY SOC TROP MED H, V100, P677, DOI 10.1016/j.trstmh.2005.09.006; Chanteau S, 2006, PLOS MED, V3, P1579, DOI 10.1371/journal.pmed.0030337; Chanteau S, 2007, VACCINE, V25, pA30, DOI 10.1016/j.vaccine.2007.04.037; Djibo S, 2006, T ROY SOC TROP MED H, V100, P573, DOI 10.1016/j.trstmh.2005.10.002; FERMON F, 2004, MANAGEMENT EPIDEMIC; Nathan N, 2007, EMERG INFECT DIS, V13, P920, DOI 10.3201/eid1306.060940; Newcombe RG, 1998, STAT MED, V17, P873, DOI 10.1002/(SICI)1097-0258(19980430)17:8<873::AID-SIM779>3.0.CO;2-I; Sidikou F, 2003, EMERG INFECT DIS, V9, P1486, DOI 10.3201/eid0911.030462; Taha MK, 2000, J CLIN MICROBIOL, V38, P855, DOI 10.1128/JCM.38.2.855-857.2000	12	12	12	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7326	10.1371/journal.pone.0007326	http://dx.doi.org/10.1371/journal.pone.0007326			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802392	gold, Green Submitted, Green Published			2022-12-27	WOS:000270593600008
J	Tsui, M; Xie, T; Orth, JD; Carpenter, AE; Rudnicki, S; Kim, S; Shamu, CE; Mitchison, TJ				Tsui, Melody; Xie, Tiao; Orth, James D.; Carpenter, Anne E.; Rudnicki, Stewart; Kim, Suejong; Shamu, Caroline E.; Mitchison, Timothy J.			An Intermittent Live Cell Imaging Screen for siRNA Enhancers and Suppressors of a Kinesin-5 Inhibitor	PLOS ONE			English	Article								Kinesin-5 (also known as Eg5, KSP and Kif11) is required for assembly of a bipolar mitotic spindle. Small molecule inhibitors of Kinesin-5, developed as potential anti-cancer drugs, arrest cell in mitosis and promote apoptosis of cancer cells. We performed a genome-wide siRNA screen for enhancers and suppressors of a Kinesin-5 inhibitor in human cells to elucidate cellular responses, and thus identify factors that might predict drug sensitivity in cancers. Because the drug's actions play out over several days, we developed an intermittent imaging screen. Live HeLa cells expressing GFP-tagged histone H2B were imaged at 0, 24 and 48 hours after drug addition, and images were analyzed using open-source software that incorporates machine learning. This screen effectively identified siRNAs that caused increased mitotic arrest at low drug concentrations (enhancers), and vice versa (suppressors), and we report siRNAs that caused both effects. We then classified the effect of siRNAs for 15 genes where 3 or 4 out of 4 siRNA oligos tested were suppressors as assessed by time lapse imaging, and by testing for suppression of mitotic arrest in taxol and nocodazole. This identified 4 phenotypic classes of drug suppressors, which included known and novel genes. Our methodology should be applicable to other screens, and the suppressor and enhancer genes we identified may open new lines of research into mitosis and checkpoint biology.			Tsui, M (corresponding author), Harvard Univ, Sch Med, Dept Syst Biol, Boston, MA 02115 USA.	timothy_mitchison@hms.harvard.edu	Carpenter, Anne/C-4982-2008; Orth, James/Q-4905-2019	Carpenter, Anne/0000-0003-1555-8261; ORTH, JAMES/0000-0002-8559-6186	NATIONAL CANCER INSTITUTE [P01CA078048] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM089652] Funding Source: NIH RePORTER; NCI NIH HHS [CA078048, P01 CA078048] Funding Source: Medline; NIGMS NIH HHS [R01 GM089652] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bartz SR, 2006, MOL CELL BIOL, V26, P9377, DOI 10.1128/MCB.01229-06; Bergnes G, 2005, CURR TOP MED CHEM, V5, P127, DOI 10.2174/1568026053507697; Birmingham A, 2006, NAT METHODS, V3, P199, DOI 10.1038/NMETH854; Blangy A, 1995, CELL, V83, P1159, DOI 10.1016/0092-8674(95)90142-6; Carpenter AE, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-10-r100; Chen JG, 2002, CANCER RES, V62, P1935; ENOS AP, 1990, CELL, V60, P1019, DOI 10.1016/0092-8674(90)90350-N; Gascoigne KE, 2008, CANCER CELL, V14, P111, DOI 10.1016/j.ccr.2008.07.002; HERMAN B, 2002, CURR PROTOC CELL BIO, pCH4; Jackson AL, 2006, RNA, V12, P1179, DOI 10.1261/rna.25706; Jackson JR, 2007, NAT REV CANCER, V7, P107, DOI 10.1038/nrc2049; Jones TR, 2009, P NATL ACAD SCI USA, V106, P1826, DOI 10.1073/pnas.0808843106; Jones TR, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-482; Kanda T, 1998, CURR BIOL, V8, P377, DOI 10.1016/S0960-9822(98)70156-3; Liscum L, 2004, BBA-MOL CELL BIOL L, V1685, P22, DOI 10.1016/j.bbalip.2004.08.008; Malpica N, 1997, CYTOMETRY, V28, P289, DOI 10.1002/(SICI)1097-0320(19970801)28:4<289::AID-CYTO3>3.0.CO;2-7; Mayer TU, 1999, SCIENCE, V286, P971, DOI 10.1126/science.286.5441.971; Mountain V, 1999, J CELL BIOL, V147, P351, DOI 10.1083/jcb.147.2.351; Neumann B, 2006, NAT METHODS, V3, P385, DOI 10.1038/NMETH876; Orth JD, 2008, MOL CANCER THER, V7, P3480, DOI 10.1158/1535-7163.MCT-08-0684; RIDLER TW, 1978, IEEE T SYST MAN CYB, V8, P630, DOI 10.1109/tsmc.1978.4310039; Rines DR, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r44; SAWIN KE, 1992, J CELL SCI, V101, P303; Shi J, 2008, CANCER RES, V68, P3269, DOI 10.1158/0008-5472.CAN-07-6699; Shibue T, 2006, INT J CANCER, V119, P2036, DOI 10.1002/ijc.21751; Swanton C, 2007, CANCER CELL, V11, P498, DOI 10.1016/j.ccr.2007.04.011; Tao WK, 2005, CANCER CELL, V8, P49, DOI 10.1016/j.ccr.2005.06.003; Whitehurst AW, 2007, NATURE, V446, P815, DOI 10.1038/nature05697	28	19	20	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7339	10.1371/journal.pone.0007339	http://dx.doi.org/10.1371/journal.pone.0007339			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802393	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593600012
J	Nan, J; Brostromer, E; Liu, XY; Kristensen, O; Su, XD				Nan, Jie; Brostromer, Erik; Liu, Xiang-Yu; Kristensen, Ole; Su, Xiao-Dong			Bioinformatics and Structural Characterization of a Hypothetical Protein from Streptococcus mutans: Implication of Antibiotic Resistance	PLOS ONE			English	Article								As an oral bacterial pathogen, Streptococcus mutans has been known as the aetiologic agent of human dental caries. Among a total of 1960 identified proteins within the genome of this organism, there are about 500 without any known functions. One of these proteins, SMU. 440, has very few homologs in the current protein databases and it does not fall into any protein functional families. Phylogenetic studies showed that SMU. 440 is related to a particular ecological niche and conserved specifically in some oral pathogens, due to lateral gene transfer. The co-occurrence of a MarR protein within the same operon among these oral pathogens suggests that SMU. 440 may be associated with antibiotic resistance. The structure determination of SMU. 440 revealed that it shares the same fold and a similar pocket as polyketide cyclases, which indicated that it is very likely to bind some polyketide-like molecules. From the interlinking structural and bioinformatics studies, we have concluded that SMU. 440 could be involved in polyketide-like antibiotic resistance, providing a better understanding of this hypothetical protein. Besides, the combination of multiple methods in this study can be used as a general approach for functional studies of a protein with unknown function.			Nan, J (corresponding author), Peking Univ, Natl Lab Prot Engn & Plant Genet Engn, Coll Life Sci, Beijing 100871, Peoples R China.	xdsu@pku.edu.cn	Nan, Jie/I-5327-2013	Nan, Jie/0000-0003-1054-5082				Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Afonine P., 2005, CCP4 NEWSLETTER; Ajdic D, 2007, J BACTERIOL, V189, P5049, DOI 10.1128/JB.00338-07; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; [Anonymous], 1994, ACTA CRYSTALLOGR D, V50, P760; Beiko Robert G., 2008, V452, P457, DOI 10.1007/978-1-60327-159-2_21; Carlsson J, 1997, Adv Dent Res, V11, P75; Chevalier M, 2008, BIOL PLANTARUM, V52, P718, DOI 10.1007/s10535-008-0138-9; Cowtan K., 1994, CRYSTALLOGRAPHY, V31, P34; DeLano W.L., 2002, PYMOL MOL GRAPHICS S; Deng DM, 2009, J BACTERIOL, V191, P394, DOI 10.1128/JB.00838-08; Dundas J, 2006, NUCLEIC ACIDS RES, V34, pW116, DOI 10.1093/nar/gkl282; Edgar RC, 2004, NUCLEIC ACIDS RES, V32, P1792, DOI 10.1093/nar/gkh340; Finn RD, 2008, NUCLEIC ACIDS RES, V36, pD281, DOI 10.1093/nar/gkm960; Holm L, 2008, BIOINFORMATICS, V24, P2780, DOI 10.1093/bioinformatics/btn507; HOLM L, 1995, TRENDS BIOCHEM SCI, V20, P478, DOI 10.1016/S0968-0004(00)89105-7; HOSHINO E, 1985, J DENT RES, V64, P1195, DOI 10.1177/00220345850640100301; Jaroszewski L, 2005, NUCLEIC ACIDS RES, V33, pW284, DOI 10.1093/nar/gki418; JONES TA, 1991, ACTA CRYSTALLOGR A, V47, P110, DOI 10.1107/S0108767390010224; Kado CI, 2009, MOL PLANT PATHOL, V10, P143, DOI 10.1111/j.1364-3703.2008.00518.x; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Lawrence JG, 1997, TRENDS MICROBIOL, V5, P355, DOI 10.1016/S0966-842X(97)01110-4; Lawrence JG, 1999, CURR OPIN MICROBIOL, V2, P519, DOI 10.1016/S1369-5274(99)00010-7; LOESCHE WJ, 1986, MICROBIOL REV, V50, P353, DOI 10.1128/MMBR.50.4.353-380.1986; MATTHEWS BW, 1968, J MOL BIOL, V33, P491, DOI 10.1016/0022-2836(68)90205-2; Mogensen JE, 2002, J BIOL CHEM, V277, P23684, DOI 10.1074/jbc.M202065200; Niu GQ, 2008, J BACTERIOL, V190, P7268, DOI 10.1128/JB.00967-08; NYVAD B, 1990, CARIES RES, V24, P267, DOI 10.1159/000261281; Ochman H, 2000, NATURE, V405, P299, DOI 10.1038/35012500; Ochman H, 2005, P NATL ACAD SCI USA, V102, P6595, DOI 10.1073/pnas.0502035102; Otwinowski Z, 1997, METHOD ENZYMOL, V276, P307, DOI 10.1016/S0076-6879(97)76066-X; Page RDM, 1996, COMPUT APPL BIOSCI, V12, P357; Paster BJ, 2001, J BACTERIOL, V183, P3770, DOI 10.1128/JB.183.12.3770-3783.2001; Peterson JD, 2001, NUCLEIC ACIDS RES, V29, P123, DOI 10.1093/nar/29.1.123; Ragan MA, 2006, TRENDS MICROBIOL, V14, P4, DOI 10.1016/j.tim.2005.11.004; Su XD, 2006, ACTA CRYSTALLOGR D, V62, P843, DOI 10.1107/S0907444906024395; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; Vonrhein Clemens, 2007, Methods Mol Biol, V364, P215, DOI 10.1385/1-59745-266-1:215; Waterhouse A.M., 2009, BIOINFORMATICS; Wen J, 1997, MOL PHYLOGENET EVOL, V8, P317, DOI 10.1006/mpev.1997.0447; Wilkinson SP, 2006, CURR ISSUES MOL BIOL, V8, P51; Wilson D, 2009, NUCLEIC ACIDS RES, V37, pD380, DOI 10.1093/nar/gkn762; Zawada RJX, 1999, CHEM BIOL, V6, P607	43	11	12	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7245	10.1371/journal.pone.0007245	http://dx.doi.org/10.1371/journal.pone.0007245			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19798411	gold, Green Published, Green Submitted			2022-12-27	WOS:000270593300006
J	Islam, Z; van Belkum, A; Wagenaar, JA; Cody, AJ; de Boer, AG; Tabor, H; Jacobs, BC; Talukder, KA; Endtz, HP				Islam, Zhahirul; van Belkum, Alex; Wagenaar, Jaap A.; Cody, Alison J.; de Boer, Albert G.; Tabor, Helen; Jacobs, Bart C.; Talukder, Kaisar A.; Endtz, Hubert P.			Comparative Genotyping of Campylobacter jejuni Strains from Patients with Guillain-Barre Syndrome in Bangladesh	PLOS ONE			English	Article								Background: Campylobacter jejuni is a common cause of acute gastroenteritis and is associated with post-infectious neuropathies such as the Guillain-Barre syndrome (GBS) and the Miller Fisher syndrome (MFS). We here present comparative genotyping of 49 C. jejuni strains from Bangladesh that were recovered from patients with enteritis or GBS. All strains were serotyped and analyzed by lipo-oligosaccharide (LOS) genotyping, amplified fragment length polymorphism (AFLP) analysis, multilocus sequence typing (MLST), and pulsed-field gel electrophoresis (PFGE). Methodology/Principal Findings: C. jejuni HS:23 was a predominant serotype among GBS patients (50%), and no specific serotype was significantly associated with GBS compared to enteritis. PCR screening showed that 38/49 (78%) of strains could be assigned to LOS classes A, B, C, or E. The class A locus (4/7 vs 3/39; p<0.01) was significantly associated in the GBS-related strains as compared to enteritis strains. All GBS/oculomotor related strains contained the class B locus; which was also detected in 46% of control strains. Overlapping clonal groups were defined by MLST, AFLP and PFGE for strains from patients with gastroenteritis and GBS. MLST defined 22 sequence types (STs) and 7 clonal complexes including 7 STs not previously identified (ST-3742, ST-3741, ST-3743, ST-3748, ST-3968, ST-3969 and ST-3970). C. jejuni HS: 23 strains from patients with GBS or enteritis were clonal and all strains belonged to ST-403 complex. Concordance between LOS class B and ST-403 complex was revealed. AFLP defined 25 different types at 90% similarity. The predominant AFLP type AF-20 coincided with the C. jejuni HS: 23 and ST-403 complex. Conclusion/Significance: LOS genotyping, MLST, AFLP and PFGE helped to identify the HS: 23 strains from GBS or enteritis patients as clonal. Overall, genotypes exclusive for enteritis or for GBS-related strains were not obtained although LOS class A was significantly associated with GBS strains. Particularly, the presence of a clonal and putative neuropathogenic C. jejuni HS: 23 serotype may contribute to the high prevalence of C. jejuni related GBS in Bangladesh.			Islam, Z (corresponding author), Int Ctr Diarrhoeal Dis Res, GPO Box 128, Dhaka 1000, Bangladesh.	zislam@icddrb.org	Jacobs, Bart/ABE-2210-2021	Cody, Alison/0000-0002-2868-6580; Islam, Dr. Zhahirul/0000-0003-0935-8079				Allos BM, 2001, CLIN INFECT DIS, V32, P1201, DOI 10.1086/319760; Ang CW, 2002, INFECT IMMUN, V70, P1202, DOI 10.1128/IAI.70.3.1202-1208.2002; ASBURY AK, 1990, ANN NEUROL, V27, pS21, DOI 10.1002/ana.410270707; Butzler JP, 2004, CLIN MICROBIOL INFEC, V10, P868, DOI 10.1111/j.1469-0691.2004.00983.x; Clark CG, 2005, J CLIN MICROBIOL, V43, P2080, DOI 10.1128/JCM.43.5.2080-2091.2005; Dingle KE, 2001, J CLIN MICROBIOL, V39, P14, DOI 10.1128/JCM.39.1.14-23.2001; Dingle KE, 2002, EMERG INFECT DIS, V8, P949; Duim B, 2000, APPL ENVIRON MICROB, V66, P3917, DOI 10.1128/AEM.66.9.3917-3923.2000; Endtz HP, 2000, J CLIN MICROBIOL, V38, P2297; Engberg J, 2001, J INFECT DIS, V184, P215, DOI 10.1086/322010; Fujimoto S, 1997, J INFECT DIS, V176, P1105, DOI 10.1086/516522; Godschalk PCR, 2004, J CLIN INVEST, V114, P1659, DOI 10.1172/JCI200415707; Godschalk PCR, 2007, J CLIN MICROBIOL, V45, P2316, DOI 10.1128/JCM.00203-07; Godschalk PCR, 2007, INFECT IMMUN, V75, P1245, DOI 10.1128/IAI.00872-06; Habib I, 2009, APPL ENVIRON MICROB, V75, P4277, DOI 10.1128/AEM.02269-08; Hanninen ML, 2001, APPL ENVIRON MICROB, V67, P1581, DOI 10.1128/AEM.67.4.1581-1586.2001; Hughes RAC, 2005, LANCET, V366, P1653, DOI 10.1016/S0140-6736(05)67665-9; Humphrey T, 2007, INT J FOOD MICROBIOL, V117, P237, DOI 10.1016/j.ijfoodmicro.2007.01.006; Islam Z, 2009, EMERG INFECT DIS, V15, P1316, DOI 10.3201/eid1508.090120; Jolley KA, 2001, BIOINFORMATICS, V17, P1230, DOI 10.1093/bioinformatics/17.12.1230; Karlyshev AV, 2000, MOL MICROBIOL, V35, P529, DOI 10.1046/j.1365-2958.2000.01717.x; Koga M, 2006, J INFECT DIS, V193, P547, DOI 10.1086/499969; Magira EE, 2003, J IMMUNOL, V170, P3074, DOI 10.4049/jimmunol.170.6.3074; Miller WG, 2005, J CLIN MICROBIOL, V43, P2315, DOI 10.1128/JCM.43.5.2315-2329.2005; Nachamkin I, 2002, INFECT IMMUN, V70, P5299, DOI 10.1128/IAI.70.9.5299-5303.2002; Nachamkin I, 1998, CLIN MICROBIOL REV, V11, P555, DOI 10.1128/CMR.11.3.555; Owen RJ, 1997, EUR J EPIDEMIOL, V13, P837, DOI 10.1023/A:1007497005152; Parker CT, 2008, J BACTERIOL, V190, P5681, DOI 10.1128/JB.00254-08; Parker CT, 2005, J CLIN MICROBIOL, V43, P2771, DOI 10.1128/JCM.43.6.2771-2781.2005; PENNER JL, 1983, EUR J CLIN MICROBIOL, V2, P378, DOI 10.1007/BF02019474; Quinones B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002015; Sopwith W, 2006, EMERG INFECT DIS, V12, P1500, DOI 10.3201/eid1210.060048; Taboada EN, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-359; van Belkum A, 2001, NAT MED, V7, P752, DOI 10.1038/89831; vanBelkum A, 1997, J CLIN MICROBIOL, V35, P978, DOI 10.1128/JCM.35.4.978-981.1997; Wassenaar TM, 2000, APPL ENVIRON MICROB, V66, P1, DOI 10.1128/AEM.66.1.1-9.2000; Willison HJ, 2002, BRAIN, V125, P2591, DOI 10.1093/brain/awf272; Yuki N, 2007, J PERIPHER NERV SYST, V12, P238, DOI 10.1111/j.1529-8027.2007.00153.x; Yuki N, 2007, MUSCLE NERVE, V35, P691, DOI 10.1002/mus.20762; 2007, EFSA J, V130, P118	40	32	32	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7257	10.1371/journal.pone.0007257	http://dx.doi.org/10.1371/journal.pone.0007257			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789649	Green Published, Green Submitted, gold			2022-12-27	WOS:000270354100016
J	Sarrazin, N; Di Blasi, F; Roullot-Lacarriere, V; Rouge-Pont, F; Le Roux, A; Costet, P; Revest, JM; Piazza, PV				Sarrazin, Nadege; Di Blasi, Francesco; Roullot-Lacarriere, Valerie; Rouge-Pont, Francoise; Le Roux, Anne; Costet, Pierre; Revest, Jean-Michel; Piazza, Pier Vincenzo			Transcriptional Effects of Glucocorticoid Receptors in the Dentate Gyrus Increase Anxiety-Related Behaviors	PLOS ONE			English	Article							ELEVATED PLUS-MAZE; LONG-TERM DEPRESSION; SPATIAL MEMORY; SYNAPTIC PLASTICITY; GLUTAMATE UPTAKE; STRESS HORMONES; GENE-EXPRESSION; ANIMAL-MODELS; DNA-BINDING; HIPPOCAMPUS	The Glucocorticoid Receptor (GR) is a transcription factor ubiquitously expressed in the brain. Activation of brain GRs by high levels of glucocorticoid (GC) hormones modifies a large variety of physiological and pathological-related behaviors. Unfortunately the specific cellular targets of GR-mediated behavioral effects of GC are still largely unknown. To address this issue, we generated a mutated form of the GR called Delta GR. Delta GR is a constitutively transcriptionally active form of the GR that is localized in the nuclei and activates transcription without binding to glucocorticoids. Using the tetracycline-regulated system (Tet-OFF), we developed an inducible transgenic approach that allows the expression of the Delta GR in specific brain areas. We focused our study on a mouse line that expressed Delta GR almost selectively in the glutamatergic neurons of the dentate gyrus (DG) of the hippocampus. This restricted expression of the Delta GR increased anxiety-related behaviors without affecting other behaviors that could indirectly influence performance in anxiety-related tests. This behavioral phenotype was also associated with an up-regulation of the MAPK signaling pathway and Egr-1 protein in the DG. These findings identify glutamatergic neurons in the DG as one of the cellular substrate of stress-related pathologies.			Sarrazin, N (corresponding author), INSERM, Pathophysiol Addict Grp, Neuroctr Magendie, U862, Bordeaux, France.	jean-michel.revest@inserm.fr; pier-vincenzo.piazza@inserm.fr		Di Blasi, Francesco/0000-0001-8085-7538				Amir S, 2002, PROG BRAIN RES, V138, P191, DOI 10.1016/S0079-6123(02)38079-8; Baldwin David S, 2002, Psychopharmacol Bull, V36 Suppl 2, P158; Bannerman DM, 2004, NEUROSCI BIOBEHAV R, V28, P273, DOI 10.1016/j.neubiorev.2004.03.004; BARON U, 1995, NUCLEIC ACIDS RES, V23, P3605, DOI 10.1093/nar/23.17.3605; Boyle MP, 2006, J NEUROSCI, V26, P1971, DOI 10.1523/JNEUROSCI.2173-05.2006; Braw Y, 2006, PSYCHONEUROENDOCRINO, V31, P1105, DOI 10.1016/j.psyneuen.2006.07.003; Castagne V, 2009, EUR J PHARMACOL, V616, P128, DOI 10.1016/j.ejphar.2009.06.018; Chen JS, 1998, MOL PHARMACOL, V54, P495, DOI 10.1124/mol.54.3.495; Dalm S, 2005, NEUROENDOCRINOLOGY, V81, P372, DOI 10.1159/000089555; DANIELSEN M, 1986, EMBO J, V5, P2513, DOI 10.1002/j.1460-2075.1986.tb04529.x; de Kloet ER, 1999, TRENDS NEUROSCI, V22, P422, DOI 10.1016/S0166-2236(99)01438-1; De Kloet ER, 1998, ENDOCR REV, V19, P269, DOI 10.1210/er.19.3.269; DEROCHE V, 1993, BRAIN RES, V611, P352, DOI 10.1016/0006-8993(93)90526-S; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Duclos M, 2009, PSYCHONEUROENDOCRINO, V34, P436, DOI 10.1016/j.psyneuen.2008.10.008; Dulawa SC, 1999, J NEUROSCI, V19, P9550; Eichenbaum H, 2000, NAT REV NEUROSCI, V1, P41, DOI 10.1038/35036213; Einat H, 2003, J NEUROSCI, V23, P7311; File SE, 2001, BEHAV BRAIN RES, V125, P151, DOI 10.1016/S0166-4328(01)00292-3; Fontella FU, 2004, NEUROCHEM RES, V29, P1703, DOI 10.1023/B:NERE.0000035805.46592.6c; FUNDER JW, 1992, J STEROID BIOCHEM, V43, P389, DOI 10.1016/0960-0760(92)90074-S; GANSS R, 1994, EMBO J, V13, P3083, DOI 10.1002/j.1460-2075.1994.tb06607.x; GILAD GM, 1990, BRAIN RES, V525, P335, DOI 10.1016/0006-8993(90)90886-G; Giraldo P, 2001, TRANSGENIC RES, V10, P83, DOI 10.1023/A:1008918913249; Hafezi-Moghadam A, 2002, NAT MED, V8, P473, DOI 10.1038/nm0502-473; Holsboer F, 2000, NEUROPSYCHOPHARMACOL, V23, P477, DOI 10.1016/S0893-133X(00)00159-7; Jovanovic JN, 2000, NAT NEUROSCI, V3, P323, DOI 10.1038/73888; KARPEN GH, 1994, CURR OPIN GENET DEV, V4, P281, DOI 10.1016/S0959-437X(05)80055-3; Kelz MB, 1999, NATURE, V401, P272, DOI 10.1038/45790; KIM JJ, 1992, SCIENCE, V256, P675, DOI 10.1126/science.1585183; Kitchener P, 2004, EUR J NEUROSCI, V19, P1837, DOI 10.1111/j.1460-9568.2004.03267.x; Kolber BJ, 2008, P NATL ACAD SCI USA, V105, P12004, DOI 10.1073/pnas.0803216105; Kolber BJ, 2009, BRAIN RES, V1293, P85, DOI 10.1016/j.brainres.2009.03.061; Krestel HE, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.7.e39; la Fleur SE, 2006, PHYSIOL BEHAV, V89, P110, DOI 10.1016/j.physbeh.2006.01.028; Lamprea MR, 2000, BEHAV BRAIN RES, V117, P97, DOI 10.1016/S0166-4328(00)00294-1; LOWY MT, 1993, J NEUROCHEM, V61, P1957, DOI 10.1111/j.1471-4159.1993.tb09839.x; LOWY MT, 1995, J NEUROCHEM, V65, P268; Maren S, 1996, NEURON, V16, P237, DOI 10.1016/S0896-6273(00)80041-0; Martin David I. K., 1996, Bioessays, V18, P919, DOI 10.1002/bies.950181111; Martin SJ, 2007, CELL MOL LIFE SCI, V64, P401, DOI 10.1007/s00018-007-6336-3; McEwen BS, 2000, BIOL PSYCHIAT, V48, P721, DOI 10.1016/S0006-3223(00)00964-1; McGaugh JL, 2002, CURR OPIN NEUROBIOL, V12, P205, DOI 10.1016/S0959-4388(02)00306-9; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; MOGHADDAM B, 1993, J NEUROCHEM, V60, P1650, DOI 10.1111/j.1471-4159.1993.tb13387.x; Moreira CM, 2007, BRAIN RES BULL, V71, P466, DOI 10.1016/j.brainresbull.2006.10.004; Moser MB, 1998, HIPPOCAMPUS, V8, P608, DOI 10.1002/(SICI)1098-1063(1998)8:6<608::AID-HIPO3>3.0.CO;2-7; Oitzl MS, 1997, EUR J NEUROSCI, V9, P2284, DOI 10.1111/j.1460-9568.1997.tb01646.x; Oitzl MS, 2001, P NATL ACAD SCI USA, V98, P12790, DOI 10.1073/pnas.231313998; PELLOW S, 1985, J NEUROSCI METH, V14, P149, DOI 10.1016/0165-0270(85)90031-7; PHILLIPS RG, 1992, BEHAV NEUROSCI, V106, P274, DOI 10.1037/0735-7044.106.2.274; Piazza PV, 1997, BRAIN RES REV, V25, P359, DOI 10.1016/S0165-0173(97)00025-8; Ponchel F, 2003, BMC BIOTECHNOL, V3, DOI 10.1186/1472-6750-3-18; PORSOLT RD, 1977, ARCH INT PHARMACOD T, V229, P327; Porsolt RD, 2000, REV NEUROSCIENCE, V11, P53; Reichardt HM, 2000, MOL CELL BIOL, V20, P9009, DOI 10.1128/MCB.20.23.9009-9017.2000; Revest JM, 2009, MOL PSYCHIATR, V14, P959, DOI 10.1038/mp.2009.15; Revest JM, 2005, NAT NEUROSCI, V8, P664, DOI 10.1038/nn1441; Sandi C, 1998, NEURAL PLAST, V6, P41, DOI 10.1155/NP.1998.41; Sapolsky RM, 2003, NEUROCHEM RES, V28, P1735, DOI 10.1023/A:1026021307833; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Sheldon LA, 1999, MOL CELL BIOL, V19, P8146; Spiga F, 2007, J NEUROENDOCRINOL, V19, P891, DOI 10.1111/j.1365-2826.2007.01605.x; Tronche F, 1999, NAT GENET, V23, P99, DOI 10.1038/12703; Tronche F, 1998, CURR OPIN GENET DEV, V8, P532, DOI 10.1016/S0959-437X(98)80007-5; Tsetsenis T, 2007, NAT NEUROSCI, V10, P896, DOI 10.1038/nn1919; Walf AA, 2007, NAT PROTOC, V2, P322, DOI 10.1038/nprot.2007.44; Wei Q, 2004, P NATL ACAD SCI USA, V101, P11851, DOI 10.1073/pnas.0402208101; WILSON C, 1990, ANNU REV CELL BIOL, V6, P679, DOI 10.1146/annurev.cellbio.6.1.679; Wong TP, 2007, P NATL ACAD SCI USA, V104, P11471, DOI 10.1073/pnas.0702308104; Xu L, 1998, P NATL ACAD SCI USA, V95, P3204, DOI 10.1073/pnas.95.6.3204; Yang CH, 2005, J NEUROSCI, V25, P4288, DOI 10.1523/JNEUROSCI.0406-05.2005; Yang CH, 2004, J NEUROSCI, V24, P11029, DOI 10.1523/JNEUROSCI.3968-04.2004; Yun JJ, 2006, NUCLEIC ACIDS RES, V34, P6718, DOI 10.1093/nar/gkl1020	74	21	21	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2009	4	11							e7704	10.1371/journal.pone.0007704	http://dx.doi.org/10.1371/journal.pone.0007704			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RX	19888328	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414400012
J	Hayashi, H; Cuddy, M; Shu, VCW; Yip, KW; Madiraju, C; Diaz, P; Matsuyama, T; Kaibara, M; Taniyama, K; Vasile, S; Sergienko, E; Reed, JC				Hayashi, Hideki; Cuddy, Michael; Shu, Vincent Chih-Wen; Yip, Kenneth W.; Madiraju, Charitha; Diaz, Paul; Matsuyama, Toshifumi; Kaibara, Muneshige; Taniyama, Kohtaro; Vasile, Stefan; Sergienko, Eduard; Reed, John C.			Versatile Assays for High Throughput Screening for Activators or Inhibitors of Intracellular Proteases and Their Cellular Regulators	PLOS ONE			English	Article							SACCHAROMYCES-CEREVISIAE; DEATH DOMAIN; YEAST; APOPTOSIS; CASPASES; RECEPTOR; AUTOPHAGY; PROTEINS; FAMILY; CED-3	Background: Intracellular proteases constitute a class of promising drug discovery targets. Methods for high throughput screening against these targets are generally limited to in vitro biochemical assays that can suffer many technical limitations, as well as failing to capture the biological context of proteases within the cellular pathways that lead to their activation. Methods & Findings: We describe here a versatile system for reconstituting protease activation networks in yeast and assaying the activity of these pathways using a cleavable transcription factor substrate in conjunction with reporter gene read-outs. The utility of these versatile assay components and their application for screening strategies was validated for all ten human Caspases, a family of intracellular proteases involved in cell death and inflammation, including implementation of assays for high throughput screening (HTS) of chemical libraries and functional screening of cDNA libraries. The versatility of the technology was also demonstrated for human autophagins, cysteine proteases involved in autophagy. Conclusions: Altogether, the yeast-based systems described here for monitoring activity of ectopically expressed mammalian proteases provide a fascile platform for functional genomics and chemical library screening.			Hayashi, H (corresponding author), Burnham Inst Med Res, La Jolla, CA 92037 USA.	Reedoffice@burnham.org		Hayashi, Hideki/0000-0003-4585-6542; Shu, Chih-Wen/0000-0002-7774-0002	NIAID NIH HHS [U01 AI078048, U01-AI078048, R01 AI082629, R01-AI082629] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI082629, U01AI078048] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Bakshi P, 2005, J BIOMOL SCREEN, V10, P1, DOI 10.1177/1087057104270068; Bao Q, 2007, MOL CELL, V25, P181, DOI 10.1016/j.molcel.2006.12.013; Brachmann CB, 1998, YEAST, V14, P115; Chang CI, 2009, MOL THER, V17, P725, DOI 10.1038/mt.2008.298; CHINNAIYAN AM, 1995, CELL, V81, P505, DOI 10.1016/0092-8674(95)90071-3; CHRISTIANSON TW, 1992, GENE, V110, P119, DOI 10.1016/0378-1119(92)90454-W; Cirman T, 2004, J BIOL CHEM, V279, P3578, DOI 10.1074/jbc.M308347200; Edbauer D, 2003, NAT CELL BIOL, V5, P486, DOI 10.1038/ncb960; ESTOJAK J, 1995, MOL CELL BIOL, V15, P5820; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Hawkins CJ, 1999, P NATL ACAD SCI USA, V96, P2885, DOI 10.1073/pnas.96.6.2885; Hawkins CJ, 2001, APOPTOSIS, V6, P331, DOI 10.1023/A:1011329917895; Ho PK, 2005, FEBS J, V272, P1401, DOI 10.1111/j.1742-4658.2005.04573.x; Irmler M, 1997, NATURE, V388, P190, DOI 10.1038/40657; ITOH N, 1991, CELL, V66, P233, DOI 10.1016/0092-8674(91)90614-5; Jabbour AM, 2004, CELL DEATH DIFFER, V11, P1309, DOI 10.1038/sj.cdd.4401501; Jabbour AM, 2006, J CELL SCI, V119, P2572, DOI 10.1242/jcs.02985; Jiang XJ, 2004, ANNU REV BIOCHEM, V73, P87, DOI 10.1146/annurev.biochem.73.011303.073706; Kabeya Y, 2005, MOL BIOL CELL, V16, P2544, DOI 10.1091/mbc.E04-08-0669; Kang JJ, 1999, J BIOL CHEM, V274, P3189, DOI 10.1074/jbc.274.5.3189; Kim SY, 2004, MOL BIOTECHNOL, V27, P1, DOI 10.1385/MB:27:1:01; Kirisako T, 2000, J CELL BIOL, V151, P263, DOI 10.1083/jcb.151.2.263; Li J, 2008, ONCOGENE, V27, P6194, DOI 10.1038/onc.2008.297; Marino G, 2003, J BIOL CHEM, V278, P3671, DOI 10.1074/jbc.M208247200; Martinon F, 2007, CELL DEATH DIFFER, V14, P10, DOI 10.1038/sj.cdd.4402038; Marx J, 2006, SCIENCE, V312, P1160, DOI 10.1126/science.312.5777.1160; Mizushima N, 2008, NATURE, V451, P1069, DOI 10.1038/nature06639; MUMBERG D, 1995, GENE, V156, P119, DOI 10.1016/0378-1119(95)00037-7; Pan GH, 1997, SCIENCE, V277, P815, DOI 10.1126/science.277.5327.815; Pan GH, 1997, SCIENCE, V276, P111, DOI 10.1126/science.276.5309.111; Puryer MA, 2006, APOPTOSIS, V11, P509, DOI 10.1007/s10495-006-5114-2; Ryser S, 1999, CURR GENET, V36, P21, DOI 10.1007/s002940050468; Sheridan JP, 1997, SCIENCE, V277, P818, DOI 10.1126/science.277.5327.818; SIKORSKI RS, 1989, GENETICS, V122, P19; Silke J, 2001, EMBO J, V20, P3114, DOI 10.1093/emboj/20.12.3114; Slee EA, 1999, J CELL BIOL, V144, P281, DOI 10.1083/jcb.144.2.281; Stagljar I, 1998, P NATL ACAD SCI USA, V95, P5187, DOI 10.1073/pnas.95.9.5187; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Timmer JC, 2007, CELL DEATH DIFFER, V14, P66, DOI 10.1038/sj.cdd.4402059; Walczak H, 1997, EMBO J, V16, P5386, DOI 10.1093/emboj/16.17.5386; Westein SJ, 2008, BBA-MOL CELL RES, V1783, P448, DOI 10.1016/j.bbamcr.2007.10.003; Wright ME, 1999, FEBS LETT, V446, P9, DOI 10.1016/S0014-5793(99)00159-3; Wright ME, 2000, FEBS LETT, V481, P13, DOI 10.1016/S0014-5793(00)01962-1; Xiao F, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkm486; Zhang H, 2001, METHOD CELL BIOL, V66, P453	45	14	15	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2009	4	10							e7655	10.1371/journal.pone.0007655	http://dx.doi.org/10.1371/journal.pone.0007655			18	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RW	19876397	Green Submitted, gold, Green Published			2022-12-27	WOS:000271414300011
J	Wang, QY; Yang, MJ; Xiao, JF; Wu, HZ; Wang, X; Lv, YZ; Xu, LL; Zheng, HJ; Wang, SY; Zhao, GP; Liu, Q; Zhang, YX				Wang, Qiyao; Yang, Minjun; Xiao, Jingfan; Wu, Haizhen; Wang, Xin; Lv, Yuanzhi; Xu, Lili; Zheng, Huajun; Wang, Shengyue; Zhao, Guoping; Liu, Qin; Zhang, Yuanxing			Genome Sequence of the Versatile Fish Pathogen Edwardsiella tarda Provides Insights into its Adaptation to Broad Host Ranges and Intracellular Niches	PLOS ONE			English	Article							III SECRETION; PROTEIN SECRETION; VIRULENCE FACTORS; GENE-EXPRESSION; IDENTIFICATION; BIOSYNTHESIS; PREDICTION; SYSTEM; 2-COMPONENT; SIDEROPHORE	Background: Edwardsiella tarda is the etiologic agent of edwardsiellosis, a devastating fish disease prevailing in worldwide aquaculture industries. Here we describe the complete genome of E. tarda, EIB202, a highly virulent and multi-drug resistant isolate in China. Methodology/Principal Findings: E. tarda EIB202 possesses a single chromosome of 3,760,463 base pairs containing 3,486 predicted protein coding sequences, 8 ribosomal rRNA operons, and 95 tRNA genes, and a 43,703 bp conjugative plasmid harboring multi-drug resistant determinants and encoding type IV A secretion system components. We identified a full spectrum of genetic properties related to its genome plasticity such as repeated sequences, insertion sequences, phage-like proteins, integrases, recombinases and genomic islands. In addition, analysis also indicated that a substantial proportion of the E. tarda genome might be devoted to the growth and survival under diverse conditions including intracellular niches, with a large number of aerobic or anaerobic respiration-associated proteins, signal transduction proteins as well as proteins involved in various stress adaptations. A pool of genes for secretion systems, pili formation, nonfimbrial adhesions, invasions and hemagglutinins, chondroitinases, hemolysins, iron scavenging systems as well as the incomplete flagellar biogenesis might feature its surface structures and pathogenesis in a fish body. Conclusion/Significance: Genomic analysis of the bacterium offered insights into the phylogeny, metabolism, drug-resistance, stress adaptation, and virulence characteristics of this versatile pathogen, which constitutes an important first step in understanding the pathogenesis of E. tarda to facilitate construction of a practical effective vaccine used for combating fish edwardsiellosis.			Wang, QY (corresponding author), E China Univ Sci & Technol, State Key Lab Bioreactor Engn, Shanghai 200237, Peoples R China.	qinliu@ecust.edu.cn; yxzhang@ecust.edu.cn	Yang, Minjun/AGJ-3201-2022; xu, li/GNH-3667-2022	Zhao, Guo-Ping/0000-0002-7621-6620; Yang, Minjun/0000-0002-3324-1498				Abbott SL, 2006, PROKARYOTES: A HANDBOOK ON THE BIOLOGY OF BACTERIA, VOL 6, THIRD EDITION, P72, DOI 10.1007/0-387-30746-x_4; AHMAD S, 1990, J BACTERIOL, V172, P1051, DOI 10.1128/jb.172.2.1051-1061.1990; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Backert S, 2006, CURR OPIN MICROBIOL, V9, P207, DOI 10.1016/j.mib.2006.02.008; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; BlancPotard AB, 1997, EMBO J, V16, P5376, DOI 10.1093/emboj/16.17.5376; BOCKEMUHL J, 1971, PATHOL MICROBIOL, V37, P393, DOI 10.1159/000162341; Chain PSG, 2006, J BACTERIOL, V188, P4453, DOI 10.1128/JB.00124-06; Chilcott GS, 2000, MICROBIOL MOL BIOL R, V64, P694, DOI 10.1128/MMBR.64.4.694-708.2000; Chiu CH, 2005, NUCLEIC ACIDS RES, V33, P1690, DOI 10.1093/nar/gki297; Christen B, 2006, J BIOL CHEM, V281, P32015, DOI 10.1074/jbc.M603589200; Delcher AL, 1999, NUCLEIC ACIDS RES, V27, P4636, DOI 10.1093/nar/27.23.4636; Du M, 2007, APPL ENVIRON MICROB, V73, P1349, DOI 10.1128/AEM.02243-06; Emanuelsson O, 2007, NAT PROTOC, V2, P953, DOI 10.1038/nprot.2007.131; GARDNER PP, 2009, NUCLEIC ACIDS RES, V136, pD101; Gardy JL, 2005, BIOINFORMATICS, V21, P617, DOI 10.1093/bioinformatics/bti057; Gerlach RG, 2007, INT J MED MICROBIOL, V297, P401, DOI 10.1016/j.ijmm.2007.03.017; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hoch JA, 2000, CURR OPIN MICROBIOL, V3, P165, DOI 10.1016/S1369-5274(00)00070-9; JANDA JM, 1991, J CLIN MICROBIOL, V29, P1997, DOI 10.1128/JCM.29.9.1997-2001.1991; JARBOE H H, 1984, Journal of Wildlife Diseases, V20, P352; Kanehisa M, 2000, NUCLEIC ACIDS RES, V28, P27, DOI 10.1093/nar/28.1.27; LAINE MJ, 1994, PLASMID, V32, P270, DOI 10.1006/plas.1994.1066; Ling SHM, 2000, MICROBIOL-SGM, V146, P7, DOI 10.1099/00221287-146-1-7; Low DA, 2001, INFECT IMMUN, V69, P7197, DOI 10.1128/IAI.69.12.7197-7204.2001; Lowe TM, 1997, NUCLEIC ACIDS RES, V25, P955, DOI 10.1093/nar/25.5.955; Lukashin AV, 1998, NUCLEIC ACIDS RES, V26, P1107, DOI 10.1093/nar/26.4.1107; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Miao EA, 2006, NAT IMMUNOL, V7, P569, DOI 10.1038/ni1344; Mohanty BR, 2007, J BIOSCIENCES, V32, P1331, DOI 10.1007/s12038-007-0143-8; MOORE RN, 2001, INFECT IMMUN, V69, P5689; Morohoshi T, 2004, J BIOSCI BIOENG, V98, P274, DOI 10.1016/S1389-1723(04)00281-6; Nawrocki EP, 2009, BIOINFORMATICS, V25, P1335, DOI 10.1093/bioinformatics/btp157; Newman RM, 2006, INFECT IMMUN, V74, P594, DOI 10.1128/IAI.74.1.594-601.2006; Ochsner UA, 2002, P NATL ACAD SCI USA, V99, P8312, DOI 10.1073/pnas.082238299; Okuda J, 2006, MICROB PATHOGENESIS, V41, P226, DOI 10.1016/j.micpath.2006.08.002; Padros F, 2006, J FISH DIS, V29, P87, DOI 10.1111/j.1365-2761.2006.00685.x; Partridge SR, 2003, J BACTERIOL, V185, P6371, DOI 10.1128/JB.185.21.6371-6384.2003; Phillips AD, 1998, FEMS MICROBIOL LETT, V161, P317, DOI 10.1016/S0378-1097(98)00089-5; Rao PSS, 2004, MOL MICROBIOL, V53, P573, DOI 10.1111/j.1365-2958.2004.04123.x; Rao PSS, 2003, MICROBIOL-SGM, V149, P2635, DOI 10.1099/mic.0.26478-0; Rose RW, 2002, MOL MICROBIOL, V45, P943, DOI 10.1046/j.1365-2958.2002.03090.x; Sahoo P K, 2000, ASIAN FISH SCI, V13, P357; SAKAI T, 2004, INFECT IMMUN, V72, P1364; Sakai T, 2009, MICROBIOL IMMUNOL, V53, P131, DOI 10.1111/j.1348-0421.2009.00108.x; Schnappinger D, 2003, J EXP MED, V198, P693, DOI 10.1084/jem.20030846; Schneiker S, 2007, NAT BIOTECHNOL, V25, P1281, DOI 10.1038/nbt1354; Siddique A, 2002, J BACTERIOL, V184, P1788, DOI 10.1128/JB.184.6.1788-1793.2002; Smith KD, 2003, NAT IMMUNOL, V4, P1247, DOI 10.1038/ni1011; Sommerset I, 2005, EXPERT REV VACCINES, V4, P89, DOI 10.1586/14760584.4.1.89; Sperandio V, 2002, MOL MICROBIOL, V43, P809, DOI 10.1046/j.1365-2958.2002.02803.x; Sun K, 2009, AQUACULTURE, V289, P134, DOI 10.1016/j.aquaculture.2008.12.021; Tan YP, 2005, MICROBIOL-SGM, V151, P2301, DOI 10.1099/mic.0.28005-0; Tanabe T, 2003, J BACTERIOL, V185, P6938, DOI 10.1128/JB.185.23.6938-6949.2003; Tatusov RL, 1997, SCIENCE, V278, P631, DOI 10.1126/science.278.5338.631; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Tettelin H, 1999, GENOMICS, V62, P500, DOI 10.1006/geno.1999.6048; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673; Thune RL, 2007, APPL ENVIRON MICROB, V73, P7934, DOI 10.1128/AEM.01115-07; Tu Q, 2003, FEMS MICROBIOL LETT, V221, P269, DOI 10.1016/S0378-1097(03)00204-0; Waack S, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-142; Wang QY, 2007, ARCH MICROBIOL, V188, P433, DOI 10.1007/s00203-007-0261-6; Wang Y, 2009, J ORTHOP RES, V27, P477, DOI 10.1002/jor.20782; Waters CM, 2005, ANNU REV CELL DEV BI, V21, P319, DOI 10.1146/annurev.cellbio.21.012704.131001; Williams ML, 2008, J APPL MICROBIOL, V104, P1790, DOI 10.1111/j.1365-2672.2007.03704.x; WONG JD, 1989, J CLIN MICROBIOL, V27, P1797, DOI 10.1128/JCM.27.8.1797-1801.1989; Wortham BW, 2007, ADV EXP MED BIOL, V603, P106; Wu M, 2005, PLOS GENET, V1, P563, DOI 10.1371/journal.pgen.0010065; Wuyts J, 2004, NUCLEIC ACIDS RES, V32, pD101, DOI 10.1093/nar/gkh065; Xiao JF, 2009, APPL MICROBIOL BIOT, V83, P151, DOI 10.1007/s00253-009-1924-9; Xiao JF, 2008, AQUAC RES, V40, P13, DOI 10.1111/j.1365-2109.2008.02101.x; Zhang M, 2008, MICROBIOL-SGM, V154, P2060, DOI 10.1099/mic.0.2008/017343-0; ZHANG Y, 2007, SYST APPL MICROBIOL, V93, P23	73	187	211	0	45	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7646	10.1371/journal.pone.0007646	http://dx.doi.org/10.1371/journal.pone.0007646			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19865481	gold, Green Published, Green Submitted			2022-12-27	WOS:000271232000013
J	Tzur, G; Israel, A; Levy, A; Benjamin, H; Meiri, E; Shufaro, Y; Meir, K; Khvalevsky, E; Spector, Y; Rojansky, N; Bentwich, Z; Reubinoff, BE; Galun, E				Tzur, Galit; Israel, Ariel; Levy, Asaf; Benjamin, Hila; Meiri, Eti; Shufaro, Yoel; Meir, Karen; Khvalevsky, Elina; Spector, Yael; Rojansky, Nathan; Bentwich, Zvi; Reubinoff, Benjamin E.; Galun, Eithan			Comprehensive Gene and microRNA Expression Profiling Reveals a Role for microRNAs in Human Liver Development	PLOS ONE			English	Article							HUMAN FETAL LIVER; ANIMAL DEVELOPMENT; MESSENGER-RNAS; IDENTIFICATION; MURINE; MOUSE; DETERMINANTS; MICROARRAYS; SOFTWARE; LIBRARY	Background and Aims: microRNAs (miRNAs) are small noncoding RNAs that regulate cognate mRNAs post-transcriptionally. miRNAs have been implicated in regulating gene expression in embryonic developmental processes, including proliferation and differentiation. The liver is a multifunctional organ, which undergoes rapid changes during the developmental period and relies on tightly-regulated gene expression. Little is known regarding the complex expression patterns of both mRNAs and miRNAs during the early stages of human liver development, and the role of miRNAs in the regulation of this process has not been studied. The aim of this work was to study the impact of miRNAs on gene expression during early human liver development. Methods: Global gene and miRNA expression were profiled in adult and in 9-12w human embryonic livers, using high-density microarrays and quantitative RT-PCR. Results: Embryonic liver samples exhibited a gene expression profile that differentiated upon progression in the developmental process, and revealed multiple regulated genes. miRNA expression profiling revealed four major expression patterns that correlated with the known function of regulated miRNAs. Comparison of the expression of the most regulated miRNAs to that of their putative targets using a novel algorithm revealed a significant anti-correlation for several miRNAs, and identified the most active miRNAs in embryonic and in adult liver. Furthermore, our algorithm facilitated the identification of TGFb-R1 as a novel target gene of let-7. Conclusions: Our results uncover multiple regulated miRNAs and genes throughout human liver development, and our algorithm assists in identification of novel miRNA targets with potential roles in liver development.			Tzur, G (corresponding author), Hadassah Hebrew Univ Hosp, Goldyne Savad Inst Gene Therapy, Jerusalem, Israel.	eithang@hadassah.org.il	Galun, Eithan/AAD-9117-2022; Israel, Ariel/AFL-8794-2022; Levy, Asaf/ABA-2623-2020; Shufaro, Yoel/N-6227-2019	Galun, Eithan/0000-0002-6243-6702; Reubinoff, Benjamin/0000-0003-0353-1299; Shufaro, Yoel/0000-0003-2759-5588				Alvarez-Garcia I, 2005, DEVELOPMENT, V132, P4653, DOI 10.1242/dev.02073; Anderson C, 2006, NUCLEIC ACIDS RES, V34, P5863, DOI 10.1093/nar/gkl743; Arora A, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-5-r82; Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Boyerinas B, 2008, CANCER RES, V68, P2587, DOI 10.1158/0008-5472.CAN-08-0264; Chang Jinhong, 2004, RNA Biol, V1, P106, DOI 10.4161/rna.1.2.1066; Cheng C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001989; de Hoon MJL, 2004, BIOINFORMATICS, V20, P1453, DOI 10.1093/bioinformatics/bth078; DIETSCHY JM, 1993, J LIPID RES, V34, P1637; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Einstein M, 2001, MOL CELL BIOL, V21, P5122, DOI 10.1128/MCB.21.15.5122-5131.2001; Farh KKH, 2005, SCIENCE, V310, P1817, DOI 10.1126/science.1121158; Fu HJ, 2005, FEBS LETT, V579, P3849, DOI 10.1016/j.febslet.2005.05.064; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grasl-Kraupp B, 1998, HEPATOLOGY, V28, P717, DOI 10.1002/hep.510280318; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2004, NAT REV GENET, V5, P522, DOI 10.1038/nrg1379; Isfort RJ, 1997, J CELL SCI, V110, P3117; Israel A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006045; Jochheim A, 2003, DIFFERENTIATION, V71, P62, DOI 10.1046/j.1432-0436.2003.700606.x; Jochheim-Richter A, 2006, DIFFERENTIATION, V74, P167, DOI 10.1111/j.1432-0436.2006.00066.x; Karolchik D, 2003, NUCLEIC ACIDS RES, V31, P51, DOI 10.1093/nar/gkg129; Krek A, 2005, NAT GENET, V37, P495, DOI 10.1038/ng1536; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Lee YS, 2007, GENE DEV, V21, P1025, DOI 10.1101/gad.1540407; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lim LP, 2005, NATURE, V433, P769, DOI 10.1038/nature03315; Malhotra K, 1999, NUCLEIC ACIDS RES, V27, P839, DOI 10.1093/nar/27.3.839; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; Nielsen CB, 2007, RNA, V13, P1894, DOI 10.1261/rna.768207; Nierhoff D, 2007, HEPATOLOGY, V46, P535, DOI 10.1002/hep.21721; Reed Steven I., 2006, V42, P147, DOI 10.1007/b136681; Rosenfeld N, 2008, NAT BIOTECHNOL, V26, P462, DOI 10.1038/nbt1392; Saldanha AJ, 2004, BIOINFORMATICS, V20, P3246, DOI 10.1093/bioinformatics/bth349; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Stefani G, 2008, NAT REV MOL CELL BIO, V9, P219, DOI 10.1038/nrm2347; Tavian M, 1999, DEVELOPMENT, V126, P793; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Tong AW, 2008, CANCER GENE THER, V15, P341, DOI 10.1038/cgt.2008.8; TONG AW, 2008, CANC GENE THER; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wu ZJ, 2004, J AM STAT ASSOC, V99, P909, DOI 10.1198/016214504000000683; Zhan M, 2007, EXP HEMATOL, V35, P1015, DOI 10.1016/j.exphem.2007.03.014	44	91	96	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7511	10.1371/journal.pone.0007511	http://dx.doi.org/10.1371/journal.pone.0007511			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841744	Green Submitted, gold, Green Published			2022-12-27	WOS:000271012900012
J	Ujvari, B; Madsen, T				Ujvari, Beata; Madsen, Thomas			Short Telomeres in Hatchling Snakes: Erythrocyte Telomere Dynamics and Longevity in Tropical Pythons	PLOS ONE			English	Article							FREE-RANGING PYTHONS; LONG-LIVED BIRDS; LENGTH; HYPOTHESIS; MORTALITY; EVOLUTION; MAMMALS; BLOOD; AGE	Background: Telomere length (TL) has been found to be associated with life span in birds and humans. However, other studies have demonstrated that TL does not affect survival among old humans. Furthermore, replicative senescence has been shown to be induced by changes in the protected status of the telomeres rather than the loss of TL. In the present study we explore whether age- and sex-specific telomere dynamics affect life span in a long-lived snake, the water python (Liasis fuscus). Methodology/Principal Findings: Erythrocyte TL was measured using the Telo TAGGG TL Assay Kit (Roche). In contrast to other vertebrates, TL of hatchling pythons was significantly shorter than that of older snakes. However, during their first year of life hatchling TL increased substantially. While TL of older snakes decreased with age, we did not observe any correlation between TL and age in cross-sectional sampling. In older snakes, female TL was longer than that of males. When using recapture as a proxy for survival, our results do not support that longer telomeres resulted in an increased water python survival/longevity. Conclusions/Significance: In fish high telomerase activity has been observed in somatic cells exhibiting high proliferation rates. Hatchling pythons show similar high somatic cell proliferation rates. Thus, the increase in TL of this group may have been caused by increased telomerase activity. In older humans female TL is longer than that of males. This has been suggested to be caused by high estrogen levels that stimulate increased telomerase activity. Thus, high estrogen levels may also have caused the longer telomeres in female pythons. The lack of correlation between TL and age among old snakes and the fact that longer telomeres did not appear to affect python survival do not support that erythrocyte telomere dynamics has a major impact on water python longevity.			Ujvari, B (corresponding author), Univ Wollongong, Sch Biol Sci, Wollongong, NSW, Australia.	madsen@uow.edu.au	Ujvari, Beata/K-8722-2012; Ujvari, Beata/L-7541-2019	Ujvari, Beata/0000-0003-2391-2988; Ujvari, Beata/0000-0003-2391-2988; Madsen, Thomas/0000-0002-0998-8372				Benetos A, 2001, HYPERTENSION, V37, P381, DOI 10.1161/01.HYP.37.2.381; BLACKBURN EH, 1991, NATURE, V350, P569, DOI 10.1038/350569a0; Bronikowski AM, 2008, AGE, V30, P169, DOI 10.1007/s11357-008-9060-5; Cawthon RM, 2003, LANCET, V361, P393, DOI 10.1016/S0140-6736(03)12384-7; Cogger H, 2000, REPTILES AMPHIBIANS; Finch CE, 1997, SCIENCE, V278, P407, DOI 10.1126/science.278.5337.407; Greider CW, 1996, ANNU REV BIOCHEM, V65, P337, DOI 10.1146/annurev.bi.65.070196.002005; Hall ME, 2004, P ROY SOC B-BIOL SCI, V271, P1571, DOI 10.1098/rspb.2004.2768; HARLEY CB, 1990, NATURE, V345, P458, DOI 10.1038/345458a0; HARLEY CB, 1992, EXP GERONTOL, V27, P375, DOI 10.1016/0531-5565(92)90068-B; Haussmann MF, 2008, MOL BIOL EVOL, V25, P220, DOI 10.1093/molbev/msm244; Haussmann MF, 2005, BIOL LETTERS, V1, P212, DOI 10.1098/rsbl.2005.0301; Haussmann MF, 2003, P ROY SOC B-BIOL SCI, V270, P1387, DOI 10.1098/rspb.2003.2385; Jemielity S, 2007, AGING CELL, V6, P225, DOI 10.1111/j.1474-9726.2007.00279.x; Karlseder J, 2002, SCIENCE, V295, P2446, DOI 10.1126/science.1069523; KIRKWOOD TBL, 1977, NATURE, V270, P301, DOI 10.1038/270301a0; Klapper W, 1998, FEBS LETT, V434, P409, DOI 10.1016/S0014-5793(98)01020-5; Kyo S, 1999, CANCER RES, V59, P5917; Madsen T, 2000, AUSTRAL ECOL, V25, P670, DOI 10.1046/j.1442-9993.2000.01067.x; Madsen T, 2000, J ANIM ECOL, V69, P952, DOI 10.1046/j.1365-2656.2000.00477.x; Martin-Ruiz CM, 2005, AGING CELL, V4, P287, DOI 10.1111/j.1474-9726.2005.00171.x; Matsubara K, 2006, P NATL ACAD SCI USA, V103, P18190, DOI 10.1073/pnas.0605274103; MEYNE J, 1989, P NATL ACAD SCI USA, V86, P7049, DOI 10.1073/pnas.86.18.7049; Michikawa Y, 1999, SCIENCE, V286, P774, DOI 10.1126/science.286.5440.774; Miller RA, 1996, SCIENCE, V273, P70, DOI 10.1126/science.273.5271.70; Nawrot TS, 2004, LANCET, V363, P507, DOI 10.1016/S0140-6736(04)15535-9; Okuda K, 2002, PEDIATR RES, V52, P377, DOI 10.1203/01.PDR.0000022341.72856.72; Pauliny A, 2006, MOL ECOL, V15, P1681, DOI 10.1111/j.1365-294X.2006.02862.x; Sambrook J., 2002, MOL CLONING LAB MANU	29	49	50	2	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7493	10.1371/journal.pone.0007493	http://dx.doi.org/10.1371/journal.pone.0007493			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834611	Green Published, gold, Green Submitted			2022-12-27	WOS:000270880700016
J	Wray, JA; Sugden, MC; Zeldin, DC; Greenwood, GK; Samsuddin, S; Miller-Degraff, L; Bradbury, JA; Holness, MJ; Warner, TD; Bishop-Bailey, D				Wray, Jessica A.; Sugden, Mary C.; Zeldin, Darryl C.; Greenwood, Gemma K.; Samsuddin, Salma; Miller-Degraff, Laura; Bradbury, J. Alyce; Holness, Mark J.; Warner, Timothy D.; Bishop-Bailey, David			The Epoxygenases CYP2J2 Activates the Nuclear Receptor PPAR alpha In Vitro and In Vivo	PLOS ONE			English	Article								Background: Peroxisome proliferator-activated receptors (PPARs) are a family of three (PPAR alpha, -beta/delta, and -gamma) nuclear receptors. In particular, PPAR alpha is involved in regulation of fatty acid metabolism, cell growth and inflammation. PPAR alpha mediates the cardiac fasting response, increasing fatty acid metabolism, decreasing glucose utilisation, and is the target for the fibrate lipid-lowering class of drugs. However, little is known regarding the endogenous generation of PPAR ligands. CYP2J2 is a lipid metabolising cytochrome P450, which produces anti-inflammatory mediators, and is considered the major epoxygenase in the human heart. Methodology/Principal Findings: Expression of CYP2J2 in vitro results in an activation of PPAR responses with a particular preference for PPAR alpha. The CYP2J2 products 8,9-and 11-12-EET also activate PPAR alpha. In vitro, PPAR alpha activation by its selective ligand induces the PPAR alpha target gene pyruvate dehydrogenase kinase (PDK) 4 in cardiac tissue. In vivo, in cardiac-specific CYP2J2 transgenic mice, fasting selectively augments the expression of PDK4. Conclusions/Significance: Our results establish that CYP2J2 produces PPAR alpha ligands in vitro and in vivo, and suggests that lipid metabolising CYPs are prime candidates for the integration of global lipid changes to transcriptional signalling events.				d.bishop-bailey@qmul.ac.uk	Zeldin, Darryl C/Y-7091-2018; Warner, Timothy D/A-1980-2009	Zeldin, Darryl C/0000-0002-2087-7307; Warner, Timothy D/0000-0003-3988-4408; Bishop-Bailey, David/0000-0003-2455-596X	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [ZIAES025034] Funding Source: NIH RePORTER; British Heart Foundation [FS/04/075, BS/02/002, FS/04/047, PG/08/070/25464] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; Wellcome Trust Funding Source: Medline	NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); British Heart Foundation(British Heart Foundation); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Wellcome Trust(Wellcome TrustEuropean Commission)		Athirakul K, 2008, FASEB J, V22, P4096, DOI 10.1096/fj.08-114413; Barger PM, 2000, TRENDS CARDIOVAS MED, V10, P238, DOI 10.1016/S1050-1738(00)00077-3; Bishop-Bailey D, 2003, PROSTAG OTH LIPID M, V71, P1, DOI 10.1016/S0090-6980(03)00003-0; Bishop-Bailey D, 1999, J BIOL CHEM, V274, P17042, DOI 10.1074/jbc.274.24.17042; Cowart LA, 2002, J BIOL CHEM, V277, P35105, DOI 10.1074/jbc.M201575200; Delerive P, 2000, FEBS LETT, V471, P34, DOI 10.1016/S0014-5793(00)01364-8; Djouadi F, 1998, J CLIN INVEST, V102, P1083, DOI 10.1172/JCI3949; Fang X, 2006, AM J PHYSIOL-HEART C, V290, pH55, DOI 10.1152/ajpheart.00427.2005; He TC, 1999, CELL, V99, P335, DOI 10.1016/S0092-8674(00)81664-5; Huang JT, 1999, NATURE, V400, P378, DOI 10.1038/22572; Lee CR, 2007, PHARMACOGENET GENOM, V17, P349, DOI 10.1097/FPC.0b013e32809913ea; Liu Y, 2005, P NATL ACAD SCI USA, V102, P16747, DOI 10.1073/pnas.0508081102; Liu Y, 2004, CIRCULATION, V110, P1128, DOI 10.1161/01.CIR.0000139850.08365.EC; Marx N, 2004, CIRC RES, V94, P1168, DOI 10.1161/01.RES.0000127122.22685.0A; Nelson DR, 2004, PHARMACOGENETICS, V14, P1, DOI 10.1097/00008571-200401000-00001; Node K, 1999, SCIENCE, V285, P1276, DOI 10.1126/science.285.5431.1276; PRICE S, EUR J PHARM, V449, P279; Roberts RA, 1998, CARCINOGENESIS, V19, P43, DOI 10.1093/carcin/19.1.43; Seubert J, 2004, CIRC RES, V95, P506, DOI 10.1161/01.RES.0000139436.89654.c8; Spiecker M, 2005, ARCH BIOCHEM BIOPHYS, V433, P413, DOI 10.1016/j.abb.2004.10.009; Spiecker M, 2006, TRENDS CARDIOVAS MED, V16, P204, DOI 10.1016/j.tcm.2006.04.001; Sugden MC, 2003, AM J PHYSIOL-ENDOC M, V284, pE855, DOI 10.1152/ajpendo.00526.2002; Sugden MC, 2001, ARCH BIOCHEM BIOPHYS, V395, P246, DOI 10.1006/abbi.2001.2586; Swales KE, 2006, CANCER RES, V66, P10120, DOI 10.1158/0008-5472.CAN-06-2399; Wu PF, 2001, BIOCHEM BIOPH RES CO, V287, P391, DOI 10.1006/bbrc.2001.5608; Wu S, 1996, J BIOL CHEM, V271, P3460; Zeldin DC, 2001, J BIOL CHEM, V276, P36059, DOI 10.1074/jbc.R100030200; Ziouzenkova O, 2003, P NATL ACAD SCI USA, V100, P2730, DOI 10.1073/pnas.0538015100	28	49	50	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7421	10.1371/journal.pone.0007421	http://dx.doi.org/10.1371/journal.pone.0007421			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823578	Green Published, gold, Green Submitted			2022-12-27	WOS:000270728500019
J	Rice, SH; Papadopoulos, A				Rice, Sean H.; Papadopoulos, Anthony			Evolution with Stochastic Fitness and Stochastic Migration	PLOS ONE			English	Article							NATURAL-SELECTION; PRICE EQUATION; POPULATION-SIZE; DISPERSAL; DENSITY; MODELS; POLYMORPHISMS; COEVOLUTION; ADAPTATION; SPECIATION	Background: Migration between local populations plays an important role in evolution - influencing local adaptation, speciation, extinction, and the maintenance of genetic variation. Like other evolutionary mechanisms, migration is a stochastic process, involving both random and deterministic elements. Many models of evolution have incorporated migration, but these have all been based on simplifying assumptions, such as low migration rate, weak selection, or large population size. We thus have no truly general and exact mathematical description of evolution that incorporates migration. Methodology/Principal Findings: We derive an exact equation for directional evolution, essentially a stochastic Price equation with migration, that encompasses all processes, both deterministic and stochastic, contributing to directional change in an open population. Using this result, we show that increasing the variance in migration rates reduces the impact of migration relative to selection. This means that models that treat migration as a single parameter tend to be biassed overestimating the relative impact of immigration. We further show that selection and migration interact in complex ways, one result being that a strategy for which fitness is negatively correlated with migration rates ( high fitness when migration is low) will tend to increase in frequency, even if it has lower mean fitness than do other strategies. Finally, we derive an equation for the effective migration rate, which allows some of the complex stochastic processes that we identify to be incorporated into models with a single migration parameter. Conclusions/Significance: As has previously been shown with selection, the role of migration in evolution is determined by the entire distributions of immigration and emigration rates, not just by the mean values. The interactions of stochastic migration with stochastic selection produce evolutionary processes that are invisible to deterministic evolutionary theory.			Rice, SH (corresponding author), Texas Tech Univ, Dept Biol Sci, Lubbock, TX 79409 USA.	sean.h.rice@ttu.edu						Alleaume-Benharira M, 2006, J EVOLUTION BIOL, V19, P203, DOI 10.1111/j.1420-9101.2005.00976.x; Altwegg R, 2003, J ANIM ECOL, V72, P391, DOI 10.1046/j.1365-2656.2003.00706.x; Catchpole EA, 2004, J AGR BIOL ENVIR ST, V9, P1, DOI 10.1198/1085711043172; Charnov EL, 2006, AM NAT, V167, P578, DOI 10.1086/501141; Doebeli M, 2003, NATURE, V421, P259, DOI 10.1038/nature01274; FELSENSTEIN J, 1981, EVOLUTION, V35, P124, DOI 10.1111/j.1558-5646.1981.tb04864.x; Frank, 1998, FDN SOCIAL EVOLUTION; FRANK SA, 1986, J THEOR BIOL, V122, P303, DOI 10.1016/S0022-5193(86)80122-9; Gaggiotti OE, 1996, AM NAT, V147, P919, DOI 10.1086/285886; Gaggiotti OE, 1996, THEOR POPUL BIOL, V50, P178, DOI 10.1006/tpbi.1996.0028; Gandon S, 2002, J EVOLUTION BIOL, V15, P451, DOI 10.1046/j.1420-9101.2002.00402.x; Gardner A, 2006, J EVOLUTION BIOL, V19, P1707, DOI 10.1111/j.1420-9101.2006.01104.x; Gavrilets S, 2004, FITNESS LANDSCAPES O; GILLESPIE JH, 1973, GENET RES, V21, P115, DOI 10.1017/S001667230001329X; GILLESPIE JH, 1977, AM NAT, V111, P1010, DOI 10.1086/283230; Grafen A, 2000, P ROY SOC B-BIOL SCI, V267, P1223, DOI 10.1098/rspb.2000.1131; Haldane J. B. S., 1963, Journal of Genetics, V58, P237, DOI 10.1007/BF02986143; Haldane JB., 1990, CAUSES EVOLUTION; HAMILTON WD, 1977, NATURE, V269, P578, DOI 10.1038/269578a0; HARTL DL, 1973, THEOR POPUL BIOL, V4, P163, DOI 10.1016/0040-5809(73)90026-9; Heywood JS, 2005, EVOLUTION, V59, P2287, DOI 10.1111/j.0014-3820.2005.tb00939.x; Hochberg ME, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-238; JOHNSON ML, 1990, ANNU REV ECOL SYST, V21, P449, DOI 10.1146/annurev.ecolsys.21.1.449; Kasuya E, 2000, ANIM BEHAV, V59, P629, DOI 10.1006/anbe.1999.1334; Kawecki TJ, 1997, EVOLUTION, V51, P1751, DOI 10.1111/j.1558-5646.1997.tb05099.x; Kawecki TJ, 2002, AM NAT, V160, P333, DOI 10.1086/341519; Kerr B, 2009, EVOLUTION, V63, P531, DOI 10.1111/j.1558-5646.2008.00570.x; Kirkpatrick M, 1997, AM NAT, V150, P1, DOI 10.1086/286054; Lande R, 2007, EVOLUTION, V61, P1835, DOI 10.1111/j.1558-5646.2007.00170.x; Le Galliard JF, 2003, P ROY SOC B-BIOL SCI, V270, P1163, DOI 10.1098/rspb.2003.2360; Lena JP, 1998, BEHAV ECOL, V9, P500, DOI 10.1093/beheco/9.5.500; Lundy IJ, 1998, GENET RES, V71, P237, DOI 10.1017/S0016672398003139; MARUYAMA T, 1970, Theoretical Population Biology, V1, P273, DOI 10.1016/0040-5809(70)90047-X; Matthysen E, 2005, ECOGRAPHY, V28, P403, DOI 10.1111/j.0906-7590.2005.04073.x; Nager RG, 1996, OECOLOGIA, V107, P204, DOI 10.1007/BF00327904; NAGYLAKI T, 1979, GENETICS, V91, P163; Peck SL, 2000, EVOLUTION, V54, P324, DOI 10.1111/j.0014-3820.2000.tb00035.x; PRICE GR, 1970, NATURE, V227, P520, DOI 10.1038/227520a0; Proulx SR, 2004, J EVOLUTION BIOL, V17, P924, DOI 10.1111/j.1420-9101.2004.00723.x; Rehmeier RL, 2004, J MAMMAL, V85, P562, DOI 10.1644/1545-1542(2004)085<0562:LMOTDM>2.0.CO;2; Rice S. H., 2004, EVOLUTIONARY THEORY; Rice SH, 2008, BMC EVOL BIOL, V8, DOI 10.1186/1471-2148-8-262; Servedio MR, 2000, EVOLUTION, V54, P21, DOI 10.1111/j.0014-3820.2000.tb00003.x; Servedio MR, 1997, EVOLUTION, V51, P1764, DOI 10.1111/j.1558-5646.1997.tb05100.x; TAYLOR PD, 1988, J THEOR BIOL, V130, P363, DOI 10.1016/S0022-5193(88)80035-3; TILMAN D, 1994, NATURE, V371, P65, DOI 10.1038/371065a0; Travis JMJ, 2009, J THEOR BIOL, V259, P151, DOI 10.1016/j.jtbi.2009.03.008; VANBALEN JH, 1989, ORNIS SCAND, V20, P99, DOI 10.2307/3676875; WAHLSTROM LK, 1995, J ZOOL, V235, P455, DOI 10.1111/j.1469-7998.1995.tb01762.x; Wauters LA, 2004, J ANIM ECOL, V73, P11, DOI 10.1111/j.1365-2656.2004.00792.x; WHITLOCK MC, 1992, EVOLUTION, V46, P608, DOI [10.2307/2409631, 10.1111/j.1558-5646.1992.tb02069.x]; Wright S, 1931, GENETICS, V16, P0097	52	38	38	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7130	10.1371/journal.pone.0007130	http://dx.doi.org/10.1371/journal.pone.0007130			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816580	Green Published, gold, Green Submitted			2022-12-27	WOS:000270594300001
J	Sims, DW; Queiroz, N; Humphries, NE; Lima, FP; Hays, GC				Sims, David W.; Queiroz, Nuno; Humphries, Nicolas E.; Lima, Fernando P.; Hays, Graeme C.			Long-Term GPS Tracking of Ocean Sunfish Mola mola Offers a New Direction in Fish Monitoring	PLOS ONE			English	Article								Satellite tracking of large pelagic fish provides insights on free-ranging behaviour, distributions and population structuring. Up to now, such fish have been tracked remotely using two principal methods: direct positioning of transmitters by Argos polar-orbiting satellites, and satellite relay of tag-derived light-level data for post hoc track reconstruction. Error fields associated with positions determined by these methods range from hundreds of metres to hundreds of kilometres. However, low spatial accuracy of tracks masks important details, such as foraging patterns. Here we use a fast-acquisition global positioning system (Fastloc GPS) tag with remote data retrieval to track long-term movements, in near real time and position accuracy of <70 m, of the world's largest bony fish, the ocean sunfish Mola mola. Search-like movements occurred over at least three distinct spatial scales. At fine scales, sunfish spent longer in highly localised areas with faster, straighter excursions between them. These 'stopovers' during long-distance movement appear consistent with finding and exploiting food patches. This demonstrates the feasibility of GPS tagging to provide tracks of unparalleled accuracy for monitoring movements of large pelagic fish, and with nearly four times as many locations obtained by the GPS tag than by a conventional Argos transmitter. The results signal the potential of GPS-tagged pelagic fish that surface regularly to be detectors of resource 'hotspots' in the blue ocean and provides a new capability for understanding large pelagic fish behaviour and habitat use that is relevant to ocean management and species conservation.			Sims, DW (corresponding author), Marine Biol Assoc United Kingdom Lab, Plymouth PL1 2PB, Devon, England.	dws@mba.ac.uk	Lima, Fernando P./C-1398-2008; Humphries, Nick/AAE-7170-2019; Queiroz, Nuno/G-3850-2010	Lima, Fernando P./0000-0001-9575-9834; Humphries, Nick/0000-0003-3741-1594; Queiroz, Nuno/0000-0002-3860-7356; Hays, Graeme/0000-0002-3314-8189; Sims, David/0000-0002-0916-7363				Block BA, 2005, NATURE, V434, P1121, DOI 10.1038/nature03463; Block BA, 2001, SCIENCE, V293, P1310, DOI 10.1126/science.1061197; Bonfil R, 2005, SCIENCE, V310, P100, DOI 10.1126/science.1114898; Bradshaw CJA, 2007, ECOL APPL, V17, P628, DOI 10.1890/06-0964; Cartamil DP, 2004, MAR ECOL PROG SER, V266, P245, DOI 10.3354/meps266245; DAWSON C. E., 1965, PROC LOUISIANA ACAD SCI, V28, P86; Gudger EW, 1928, SCI MON, V26, P257; Guilford T, 2009, P ROY SOC B-BIOL SCI, V276, P1215, DOI 10.1098/rspb.2008.1577; Hays GC, 2006, ECOLOGY, V87, P2647, DOI 10.1890/0012-9658(2006)87[2647:FFMOLT]2.0.CO;2; Hazel J, 2009, J EXP MAR BIOL ECOL, V374, P58, DOI 10.1016/j.jembe.2009.04.009; Houghton JDR, 2006, ECOLOGY, V87, P1967, DOI 10.1890/0012-9658(2006)87[1967:JAALTF]2.0.CO;2; Metcalfe JD, 2006, J FISH BIOL, V69, P48, DOI 10.1111/j.1095-8649.2006.01275.x; MYERS GS, 1930, COPEIA, V1, P11; PRIEDE IG, 1984, FISH RES, V2, P201, DOI 10.1016/0165-7836(84)90003-1; Riding TAC, 2009, MAR ECOL PROG SER, V377, P255, DOI 10.3354/meps07809; Ropert-Coudert Y, 2005, FRONT ECOL ENVIRON, V3, P437, DOI 10.2307/3868660; Rutz C, 2009, BIOL LETTERS, V5, P289, DOI 10.1098/rsbl.2009.0089; Schofield G, 2007, J EXP MAR BIOL ECOL, V347, P58, DOI 10.1016/j.jembe.2007.03.009; Sims DW, 2006, P ROY SOC B-BIOL SCI, V273, P1195, DOI 10.1098/rspb.2005.3444; Sims DW, 2009, J EXP MAR BIOL ECOL, V370, P127, DOI 10.1016/j.jembe.2008.12.011; Sims DW, 1998, NATURE, V393, P460, DOI 10.1038/30959; Sims DW, 2003, MAR ECOL PROG SER, V248, P187, DOI 10.3354/meps248187; Sims DW, 2002, J MAR BIOL ASSOC UK, V82, P927, DOI 10.1017/S0025315402006409; SIMS DW, 2009, BIOL SHARKS IN PRESS; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Watanabe Y, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003446; Weimerskirch H, 2002, SCIENCE, V295, P1259, DOI 10.1126/science.1068034	27	54	57	0	49	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7351	10.1371/journal.pone.0007351	http://dx.doi.org/10.1371/journal.pone.0007351			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816576	Green Published, gold			2022-12-27	WOS:000270594300004
J	Lee, CH; Subramanian, S; Beck, AH; Espinosa, I; Senz, J; Zhu, SX; Huntsman, D; van de Rijn, M; Gilks, CB				Lee, Cheng-Han; Subramanian, Subbaya; Beck, Andrew H.; Espinosa, Inigo; Senz, Janine; Zhu, Shirley X.; Huntsman, David; van de Rijn, Matt; Gilks, C. Blake			MicroRNA Profiling of BRCA1/2 Mutation-Carrying and Non-Mutation-Carrying High-Grade Serous Carcinomas of Ovary	PLOS ONE			English	Article							FALLOPIAN-TUBE; EXPRESSION PROFILES; GENE-EXPRESSION; NEW-MODEL; CANCER; P53; CELL; IDENTIFICATION; TUMORIGENESIS; ACCUMULATION	Background: MicroRNAs (miRNA) are 20,25 nucleotide non-coding RNAs that inhibit the translation of targeted mRNA, and they have been implicated in the development of human malignancies. High grade serous ovarian carcinomas, the most common and lethal subtype of ovarian cancer, can occur sporadically or in the setting of BRCA1/2 syndromes. Little is known regarding the miRNA expression profiles of high grade serous carcinoma in relation to BRCA1/2 status, and compared to normal tubal epithelium, the putative tissue of origin for high grade serous carcinomas. Methodology/Principal Findings: Global miRNA expression profiling was performed on a series of 33 high grade serous carcinomas, characterized with respect to BRCA1/2 status ( mutation, epigenetic silencing with loss of expression or normal), and with clinical follow-up, together with 2 low grade serous carcinomas, 2 serous borderline tumors, and 3 normal fallopian tube samples, using miRNA microarrays ( 328 human miRNA). Unsupervised hierarchical clustering based on miRNA expression profiles showed no clear separation between the groups of carcinomas with different BRCA1/2 status. There were relatively few miRNAs that were differentially expressed between the genotypic subgroups. Comparison of 33 high grade serous carcinomas to 3 normal fallopian tube samples identified several dysregulated miRNAs (false discovery rate <5%), including miR-422b and miR-34c. Quantitative RT-PCR analysis performed on selected miRNAs confirmed the pattern of differential expression shown by microarray analysis. Prognostically, lower level miR-422b and miR-34c in high grade serous carcinomas were both associated with decreased disease-specific survival by Kaplan-Meier analysis (p<0.05). Conclusions/Significance: High grade serous ovarian carcinomas with and without BRCA1/2 abnormalities demonstrate very similar miRNA expression profiles. High grade serous carcinomas as a group exhibit significant miRNA dysregulation in comparison to tubal epithelium and the levels of miR-34c and miR-422b appear to be prognostically important.			Lee, CH (corresponding author), Univ British Columbia, Vancouver Gen Hosp, Dept Pathol & Lab Med, Vancouver, BC V5Z 1M9, Canada.	chenghan@interchange.ubc.ca	Huntsman, David/ABE-6082-2020	Subramanian, Subbaya/0000-0002-2544-480X; van de Rijn, Matt/0000-0002-1909-9739				Akao Y, 2007, CANCER SCI, V98, P1914, DOI 10.1111/j.1349-7006.2007.00618.x; Akao Y, 2006, ONCOL REP, V16, P845; Asangani I. A., 2007, ONCOGENE; Bandres E, 2006, MOL CANCER, V5, DOI 10.1186/1476-4598-5-29; Calin GA, 2005, NEW ENGL J MED, V353, P1793, DOI 10.1056/NEJMoa050995; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Cho WCS, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-1; Chuaqui RF, 2002, NAT GENET, V32, P509, DOI 10.1038/ng1034; Corney DC, 2008, HISTOL HISTOPATHOL, V23, P1161, DOI 10.14670/HH-23.1161; Corney DC, 2007, CANCER RES, V67, P8433, DOI 10.1158/0008-5472.CAN-07-1585; Crum CP, 2007, CLIN MED RES, V5, P35, DOI 10.3121/cmr.2007.702; Crum CP, 2007, CURR OPIN OBSTET GYN, V19, P3, DOI 10.1097/GCO.0b013e328011a21f; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Dubeau L, 2008, LANCET ONCOL, V9, P1191, DOI 10.1016/S1470-2045(08)70308-5; Eisen MB, 1998, P NATL ACAD SCI USA, V95, P14863, DOI 10.1073/pnas.95.25.14863; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Esteller M, 2000, JNCI-J NATL CANCER I, V92, P564, DOI 10.1093/jnci/92.7.564; Etienne W, 2004, BIOTECHNIQUES, V36, P618, DOI 10.2144/04364ST02; Folkins AK, 2009, GYNECOL ONCOL, V113, P391, DOI 10.1016/j.ygyno.2009.01.013; Gilks CB, 2005, GYNECOL ONCOL, V96, P684, DOI 10.1016/j.ygyno.2004.11.039; Gregory RI, 2005, CANCER RES, V65, P3509, DOI 10.1158/0008-5472.CAN-05-0298; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; He L, 2007, NAT REV CANCER, V7, P819, DOI 10.1038/nrc2232; He L, 2007, NATURE, V447, P1130, DOI 10.1038/nature05939; Hermeking H, 2007, CANCER CELL, V12, P414, DOI 10.1016/j.ccr.2007.10.028; Hirst JE, 2009, INT J GYNECOL CANCER, V19, P826, DOI 10.1111/IGC.0b013e3181a1b5dc; Iorio MV, 2007, CANCER RES, V67, P8699, DOI 10.1158/0008-5472.CAN-07-1936; Iorio MV, 2005, CANCER RES, V65, P7065, DOI 10.1158/0008-5472.CAN-05-1783; Kindelberger DW, 2007, AM J SURG PATHOL, V31, P161, DOI 10.1097/01.pas.0000213335.40358.47; Koebel Martin, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S146239940800077X; KUPRYJANCZYK J, 1993, P NATL ACAD SCI USA, V90, P4961, DOI 10.1073/pnas.90.11.4961; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Levanon K, 2008, J CLIN ONCOL, V26, P5284, DOI 10.1200/JCO.2008.18.1107; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Mayr C, 2007, SCIENCE, V315, P1576, DOI 10.1126/science.1137999; Meng FY, 2007, GASTROENTEROLOGY, V133, P647, DOI 10.1053/j.gastro.2007.05.022; Michael MZ, 2003, MOL CANCER RES, V1, P882; MILNER BJ, 1993, CANCER RES, V53, P2128; Morey JS, 2006, BIOL PROCED ONLINE, V8, P175, DOI 10.1251/bpo126; Nam EJ, 2008, CLIN CANCER RES, V14, P2690, DOI 10.1158/1078-0432.CCR-07-1731; O'Neill CJ, 2005, AM J SURG PATHOL, V29, P1034; OZEN M, 2007, ONCOGENE; Pal T, 2005, CANCER-AM CANCER SOC, V104, P2807, DOI 10.1002/cncr.21536; Press JZ, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-17; Salvador S, 2008, GYNECOL ONCOL, V110, P408, DOI 10.1016/j.ygyno.2008.05.010; Sampson VB, 2007, CANCER RES, V67, P9762, DOI 10.1158/0008-5472.CAN-07-2462; Shen J, 2008, CARCINOGENESIS, V29, P1963, DOI 10.1093/carcin/bgn172; Sherlock G, 2001, NUCLEIC ACIDS RES, V29, P152, DOI 10.1093/nar/29.1.152; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Singer G, 2005, AM J SURG PATHOL, V29, P218, DOI 10.1097/01.pas.0000146025.91953.8d; SUBRAMANIAN S, 2007, ONCOGENE; Thrall M, 2006, INT J GYNECOL CANCER, V16, P166, DOI 10.1111/j.1525-1438.2006.00504.x; Tong GX, 2007, MODERN PATHOL, V20, P856, DOI 10.1038/modpathol.3800827; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Valencia-Sanchez MA, 2006, GENE DEV, V20, P515, DOI 10.1101/gad.1399806; Wyman SK, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005311; Yang H, 2008, CANCER RES, V68, P425, DOI 10.1158/0008-5472.CAN-07-2488; Zhang L, 2008, P NATL ACAD SCI USA, V105, P7004, DOI 10.1073/pnas.0801615105; Zhang WY, 2007, AM J PATHOL, V171, P728, DOI 10.2353/ajpath.2007.070070; Zorn KK, 2003, CLIN CANCER RES, V9, P4811	61	75	79	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7314	10.1371/journal.pone.0007314	http://dx.doi.org/10.1371/journal.pone.0007314			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19798417	gold, Green Submitted, Green Published			2022-12-27	WOS:000270593300013
J	van Donkelaar, P; Lin, Y; Hewlett, D				van Donkelaar, Paul; Lin, Yu; Hewlett, David			The Human Frontal Oculomotor Cortical Areas Contribute Asymmetrically to Motor Planning in a Gap Saccade Task	PLOS ONE			English	Article							TRANSCRANIAL MAGNETIC STIMULATION; EYE FIELD; BRAIN-STEM; MOVEMENTS; LATENCY; CORTEX; TMS; FEF	Background: Saccadic eye movements are used to rapidly align the fovea with the image of objects of interest in peripheral vision. We have recently shown that in children there is a high preponderance of quick latency but poorly planned saccades that consistently fall short of the target goal. The characteristics of these multiple saccades are consistent with a lack of proper inhibitory control of cortical oculomotor areas on the brainstem saccade generation circuitry. Methodology/Principal Findings: In the present paper, we directly tested this assumption by using single pulse transcranial magnetic stimulation (TMS) to transiently disrupt neuronal activity in the frontal eye fields (FEF) and supplementary eye fields (SEF) in adults performing a gap saccade task. The results showed that the incidence of multiple saccades was increased for ispiversive but not contraversive directions for the right and left FEF, the left SEF, but not for the right SEF. Moreover, this disruption was most substantial during the similar to 50 ms period around the appearance of the peripheral target. A control condition in which the dorsal motor cortex was stimulated demonstrated that this was not due to any non-specific effects of the TMS influencing the spatial distribution of attention. Conclusions/Significance: Taken together, the results are consistent with a direction-dependent role of the FEF and left SEF in delaying the release of saccadic eye movements until they have been fully planned.			van Donkelaar, P (corresponding author), Univ Oregon, Dept Human Physiol, Eugene, OR 97403 USA.	paulvd@uoregon.edu						Bisley James W, 2003, Adv Neurol, V93, P141; BRAUN D, 1992, BRAIN, V115, P1359, DOI 10.1093/brain/115.5.1359; Campana G, 2007, NEUROPSYCHOLOGIA, V45, P2340, DOI 10.1016/j.neuropsychologia.2007.02.009; Carpenter RHS, 2004, CURR BIOL, V14, P1576, DOI 10.1016/j.cub.2004.08.058; Drew AS, 2007, CEREB CORTEX, V17, P2618, DOI 10.1093/cercor/bhl169; Enderle JD, 2002, PROG BRAIN RES, V140, P21; Everling S, 2000, J NEUROSCI, V20, P387, DOI 10.1523/JNEUROSCI.20-01-00387.2000; Gagnon D, 2006, J NEUROSCI, V26, P458, DOI 10.1523/JNEUROSCI.2789-05.2006; Girard B, 2005, PROG NEUROBIOL, V77, P215, DOI 10.1016/j.pneurobio.2005.11.001; Isa T, 2004, PROG BRAIN RES, V143, P299, DOI 10.1016/S0079-6123(03)43029-X; Izawa Y, 2004, J NEUROPHYSIOL, V92, P2248, DOI 10.1152/jn.01021.2003; Juan CH, 2008, CEREB CORTEX, V18, P2410, DOI 10.1093/cercor/bhn001; Munoz DP, 2004, NAT REV NEUROSCI, V5, P218, DOI 10.1038/nrn1345; MURI RM, 1991, EXP BRAIN RES, V86, P219; Neggers SFW, 2005, EUR J NEUROSCI, V21, P2853, DOI 10.1111/j.1460-9568.2005.04129.x; Nyffeler T, 2008, J COGNITIVE NEUROSCI, V20, P1583, DOI 10.1162/jocn.2008.20073; Nyffeler T, 2006, NEUROSCI LETT, V409, P57, DOI 10.1016/j.neulet.2006.09.011; O'Shea J, 2004, J COGNITIVE NEUROSCI, V16, P1060, DOI 10.1162/0898929041502634; Pierrot-Deseilligny C, 2004, CURR OPIN NEUROL, V17, P17, DOI 10.1097/00019052-200402000-00005; Prime SL, 2010, CEREB CORTEX, V20, P759, DOI 10.1093/cercor/bhp148; Reddi BAJ, 2000, NAT NEUROSCI, V3, P827, DOI 10.1038/77739; Ro T, 1999, NEUROPSYCHOLOGIA, V37, P225; SALAPATEK P, 1980, CHILD DEV, V51, P1090, DOI 10.1111/j.1467-8624.1980.tb02657.x; Schall JD, 2004, ANNU REV PSYCHOL, V55, P23, DOI 10.1146/annurev.psych.55.090902.141907; Schlag J, 1998, J NEUROPHYSIOL, V79, P64, DOI 10.1152/jn.1998.79.1.64; Scudder CA, 2002, EXP BRAIN RES, V142, P439, DOI 10.1007/s00221-001-0912-9; Taylor PCJ, 2007, CEREB CORTEX, V17, P391, DOI 10.1093/cercor/bhj156; van Donkelaar P, 2007, J NEUROPHYSIOL, V97, P3148, DOI 10.1152/jn.01339.2006	29	8	8	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7278	10.1371/journal.pone.0007278	http://dx.doi.org/10.1371/journal.pone.0007278			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	501BO	19789706	Green Published, gold, Green Submitted			2022-12-27	WOS:000270354100026
J	Brito, MO; Caso, LM; Balbuena, H; Bailey, RC				Brito, Maximo O.; Caso, Lilliam M.; Balbuena, Hannabell; Bailey, Robert C.			Acceptability of Male Circumcision for the Prevention of HIV/AIDS in the Dominican Republic	PLOS ONE			English	Article							HIV PREVENTION; MEN; WILLINGNESS; INFECTION; UGANDA; TRIAL; RISK; SEX	Background: Male circumcision (MC) is an effective strategy to prevent HIV infection in heterosexual men. To our knowledge, there are no studies of the acceptability of this procedure in the Dominican Republic (DR). The main objective of this study was to assess the acceptability of MC to prevent HIV transmission among men ages 18 to 50 years in the Altagracia Province in the Dominican Republic. Because differences in culture and beliefs between Haitians and Dominicans could potentially influence their acceptability of MC, we conducted a comparative analysis based on national origin. Methods: A survey was administered to a convenience sample of 368 men. The questionnaire was divided in 3 sections: 1) Background demographics (including national origin), 2) Male circumcision and 3) Sexual health. Stratified and logistic multivariate regression analyses were performed to identify factors associated with the acceptability of MC. Results: The sample consisted of 238 (65%) Dominicans and 130 (35%) Haitian immigrants. Almost all participants were uncircumcised (95%) and about half (52%) were single. The overall acceptability of MC was 29%. The number of men willing to be circumcised increased to 67% after an information session explaining the benefits of the procedure. 74% of men reported that they would be willing to circumcise their sons after hearing that information. In multivariate analysis, Haitian nationality (OR = 1.86, 95% CI 1.01-3.41), knowing that circumcision improves hygiene (OR = 2.78, 95% CI 1.29-6.0) and not believing that circumcision decreases sexual pleasure (OR = 2.18, 95% CI 1.20-3.94) were associated with a higher acceptability of the procedure. Although age was not significantly associated with the willingness to be circumcised in the multivariate analysis, stratified analysis based on national origin suggested that younger Dominicans (<30 years of age) are more likely to accept the procedure when compared to their older counterparts (OR = 2.17, 95% CI 1.14-4.12). Conclusions: An important number of sexually active men in the DR may be willing to be circumcised if educational resources detailing the benefits of the procedure are made available. These educational activities would constitute a great opportunity to teach about sexual health and reinforce safe sex practices.			Brito, MO (corresponding author), Univ Illinois, Infect Dis Sect, Chicago, IL 60607 USA.	mbrito@uic.edu	Brito, Maximo O./AAI-4905-2021	Brito, Maximo O./0000-0003-4463-514X	NIAID NIH HHS [2U01AI050440-06, U01 AI050440] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI050440] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Auvert B, 2005, PLOS MED, V2, P1112, DOI 10.1371/journal.pmed.0020298; Bailey RC, 1999, J ACQ IMMUN DEF SYND, V22, P294; Bailey RC, 2007, LANCET, V369, P643, DOI 10.1016/S0140-6736(07)60312-2; Begley EB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002731; BRITO M, 2008, AIDS 2008 17 INT AID; *CESDEM, 2007, ENC DEM SAL; *CESDEM, 2007, ENC SOC SOBR VIH SID; Drain PK, 2006, BMC INFECT DIS, V6, DOI 10.1186/1471-2334-6-172; Gray RH, 2007, LANCET, V369, P657, DOI 10.1016/S0140-6736(07)60313-4; GUANIRA J, 2007, 4 IAS C HIV PATH TRE; Halperin D., 2006, AIDS 2006 16 INT AID; Halperin DT, 2009, JAIDS-J ACQ IMM DEF, V51, pS52, DOI 10.1097/QAI.0b013e3181a267e4; *JOINT UN PROGR HI, 2008, REP GLOB AIDS EP; Kebaabetswe P, 2003, SEX TRANSM INFECT, V79, P214, DOI 10.1136/sti.79.3.214; KRUPP K, 2008, IND AIDS 2008 17 INT; Rain-Taljaard RC, 2003, AIDS CARE, V15, P315, DOI 10.1080/0954012031000105379; Ruan YH, 2009, AIDS PATIENT CARE ST, V23, P315, DOI 10.1089/apc.2008.0199; TIEU H, 2008, AIDS 2008 17 INT AID; VIOLANTE T, 2004, 15 INT AIDS C; Westercamp N, 2007, AIDS BEHAV, V11, P341, DOI 10.1007/s10461-006-9169-4	20	35	38	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2009	4	11							e7687	10.1371/journal.pone.0007687	http://dx.doi.org/10.1371/journal.pone.0007687			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RX	19888322	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414400006
J	Chenu, O; Vuillerme, N; Demongeot, J; Payan, Y				Chenu, Olivier; Vuillerme, Nicolas; Demongeot, Jacques; Payan, Yohan			A Wireless Lingual Feedback Device to Reduce Overpressures in Seated Posture: A Feasibility Study	PLOS ONE			English	Article							PLACED TACTILE BIOFEEDBACK; ELECTROTACTILE STIMULUS ARRAY; JOINT POSITION SENSE; TONGUE; THRESHOLD; SYSTEM; ANKLE	Background: Pressure sores are localized injuries to the skin and underlying tissues and are mainly resulting from overpressure. Paraplegic peoples are particularly subjects to pressure sores because of long-time seated postures and sensory deprivation at the lower limbs. Methodology/Principal Findings: Here we report outcomes of a feasibility trial involving a biofeedback system aimed at reducing buttock overpressure whilst an individual is seated. The system consists of (1) pressure sensors, (2) a laptop coupling sensors and actuator (3) a wireless Tongue Display Unit (TDU) consisting of a circuit embedded in a dental retainer with electrodes put in contact with the tongue. The principle consists in (1) detecting overpressures in people who are seated over long periods of time, (2) estimating a postural change that could reduce these overpressures and (3) communicating this change through directional information transmitted by the TDU. Twenty-four healthy subjects voluntarily participated in this study. Twelve healthy subjects initially formed the experimental group (EG) and were seated on a chair with the wireless TDU inside their mouth. They were asked to follow TDU orders that were randomly spread throughout the session. They were evaluated during two experimental sessions during which 20 electro-stimulations were sent. Twelve other subjects, added retrospectively, formed the control group (CG). These subjects participated in one session of the same experiment without any biofeedback. Three dependent variables were computed: (1) the ability of subjects to reach target posture (EG versus CG), (2) high pressure reductions after a biofeedback (EG versus CG) and (3) the level of these reductions relative to their initial values (EG only). Results show (1) that EG reached target postures in 90.2% of the trials, against 5,3% in the CG, (2) a significant reduction in overpressures in the EG compared to the CG and (3), for the EG, that the higher the initial pressures were, the more they were decreased. Conclusions/Significance: The findings suggest that, in this trial, subjects were able to use a tongue tactile feedback system to reduce buttock overpressure while seated. Further evaluation of this system on paraplegic subjects remains to be done.			Chenu, O (corresponding author), TIMC IMAG, CNRS, UJF, UMR 5525, La Tronche, France.	olivier.chenu@imag.fr	Demongeot, Jacques/GQI-1558-2022; PAYAN, Yohan/E-3993-2013; Payan, Yohan/N-3980-2019; Demongeot, Jacques/AAZ-2539-2020; Nicolas, Vuillerme/C-6692-2009; VUILLERME, Nicolas/U-5767-2019	PAYAN, Yohan/0000-0002-6012-4123; Payan, Yohan/0000-0002-6012-4123; Demongeot, Jacques/0000-0002-8335-9240; Nicolas, Vuillerme/0000-0002-5202-4173; VUILLERME, Nicolas/0000-0003-3773-393X				BACH P, 1969, NATURE, V221, P963, DOI 10.1038/221963a0; Bach-y-Rita P, 1998, J REHABIL RES DEV, V35, P427; Bach-y-Rita P., 1972, BRAIN MECH SENSORY S; Cardenas DD, 2004, ARCH PHYS MED REHAB, V85, P1757, DOI 10.1016/j.apmr.2004.03.016; COLIN B, 2008, Patent No. 2008139099; CULLUM N, 2004, COCHRANE DATABASE SY; KACZMAREK KA, 1991, THESIS U WISCONSIN M; Linder-Ganz E, 2006, J BIOMECH, V39, P2725, DOI 10.1016/j.jbiomech.2005.08.010; Moreau-Gaudry A, 2006, STUD HEALTH TECHNOL, V124, P926; Reddy M, 2006, JAMA-J AM MED ASSOC, V296, P974, DOI 10.1001/jama.296.8.974; Robineau F, 2007, IEEE T BIO-MED ENG, V54, P711, DOI 10.1109/TBME.2006.889180; Sampaio E, 2001, BRAIN RES, V908, P204, DOI 10.1016/S0006-8993(01)02667-1; Trulsson M, 1997, J NEUROPHYSIOL, V77, P737, DOI 10.1152/jn.1997.77.2.737; Vuillerme N, 2008, NEUROSCI LETT, V431, P206, DOI 10.1016/j.neulet.2007.11.049; Vuillerme N, 2007, EXP BRAIN RES, V183, P235, DOI 10.1007/s00221-007-1039-4; Vuillerme N, 2007, EXP BRAIN RES, V181, P547, DOI 10.1007/s00221-007-0953-9; Vuillerme N, 2007, EXP BRAIN RES, V179, P409, DOI 10.1007/s00221-006-0800-4; Vuillerme N, 2006, NEUROSCI LETT, V405, P19, DOI 10.1016/j.neulet.2006.06.035	18	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2009	4	10							e7550	10.1371/journal.pone.0007550	http://dx.doi.org/10.1371/journal.pone.0007550			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RW	19888336	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414300002
J	Deak, E; Wilson, SD; White, E; Carr, JH; Balajee, SA				Deak, Eszter; Wilson, Selwyn D.; White, Elizabeth; Carr, Janice H.; Balajee, S. Arunmozhi			Aspergillus terreus Accessory Conidia Are Unique in Surface Architecture, Cell Wall Composition and Germination Kinetics	PLOS ONE			English	Article							AMPHOTERICIN-B; CANDIDA-ALBICANS; PULMONARY ASPERGILLOSIS; ERGOSTEROL CONTENT; MURINE MODEL; FUMIGATUS; SUSCEPTIBILITY; INFECTIONS; BIOSYNTHESIS; QUANTITATION	Infection with Aspergillus terreus is more likely to result in invasive, disseminated disease when compared to other Aspergillus species; importantly this species appears to be less susceptible to the antifungal drug amphotericin B. Unique to this species is the ability to produce specialized structures denoted as accessory conidia (AC) directly on hyphae both in vitro and in vivo. With the hypothesis that production of AC by A. terreus may enhance virulence of this organism, we analyzed the phenotype, structure and metabolic potential of these conidia. Comparison of A. terreus phialidic conidia (conidia that arise from conidiophores, PC) and AC architecture by electron microscopy revealed distinct morphological differences between the two conidial forms; AC have a smoother, thicker outer cell surface with no apparent pigment-like layer. Further, AC germinated rapidly, had enhanced adherence to microspheres, and were metabolically more active compared to PC. Additionally, AC contained less cell membrane ergosterol, which correlated with decreased susceptibility to AMB as determined using a flow cytometry based analysis. Furthermore, AC exhibited surface patches of beta 1-3 glucan, suggestive of attachment scarring. Collectively, the findings of this study suggest a possible role for AC in A. terreus pathogenesis.			Deak, E (corresponding author), Ctr Dis Control & Prevent, Mycot Dis Branch, Atlanta, GA 30333 USA.	fir3@cdc.gov						AINSWORTH G. C., 1955, Veterinary Record, V67, P88; Arthington-Skaggs BA, 1999, J CLIN MICROBIOL, V37, P3332, DOI 10.1128/JCM.37.10.3332-3337.1999; Arthington-Skaggs BA, 2000, ANTIMICROB AGENTS CH, V44, P2081, DOI 10.1128/AAC.44.8.2081-2085.2000; Balajee SA, 2002, J CLIN MICROBIOL, V40, P2741, DOI 10.1128/JCM.40.8.2741-2745.2002; Bernard M, 2001, MED MYCOL, V39, P9, DOI 10.1080/mmy.39.1.9.17; CLSI/Clinical a.L.S. Institute, 2002, M38A CLSI; Dannaoui E, 2000, J MED MICROBIOL, V49, P601, DOI 10.1099/0022-1317-49-7-601; Gantner BN, 2005, EMBO J, V24, P1277, DOI 10.1038/sj.emboj.7600594; Girardin H, 1999, LETT APPL MICROBIOL, V29, P364, DOI 10.1046/j.1472-765X.1999.00643.x; Hohl TM, 2005, PLOS PATHOG, V1, P232, DOI 10.1371/journal.ppat.0010030; Iwen PC, 1998, CLIN INFECT DIS, V26, P1092, DOI 10.1086/520297; Langfelder K, 1998, MED MICROBIOL IMMUN, V187, P79, DOI 10.1007/s004300050077; Lass-Florl C, 2005, ANTIMICROB AGENTS CH, V49, P2539, DOI 10.1128/AAC.49.6.2539-2540.2005; Latge J P, 1993, Arch Med Res, V24, P269; Luther K, 2007, CELL MICROBIOL, V9, P368, DOI 10.1111/j.1462-5822.2006.00796.x; Magill SS, 2008, EXPERT OPIN PHARMACO, V9, P193, DOI 10.1517/14656566.9.2.193 ; Malani AN, 2007, DRUGS, V67, P1803, DOI 10.2165/00003495-200767130-00001; Moss BJ, 2008, BIOTECHNOL PROGR, V24, P780, DOI 10.1021/bp070334t; Raper BK., 1965, GENUS ASPERGILLUS; SANDE WV, 2009, MED MYCOL, P1; Steinbach WJ, 2004, CLIN INFECT DIS, V39, P192, DOI 10.1086/421950; Sterling TR, 1998, DRUG RESIST UPDATE, V1, P161, DOI 10.1016/S1368-7646(98)80034-4; THAU N, 1994, INFECT IMMUN, V62, P4380, DOI 10.1128/IAI.62.10.4380-4388.1994; Walsh TJ, 2004, CLIN MICROBIOL INFEC, V10, P48, DOI 10.1111/j.1470-9465.2004.00839.x; Walsh TJ, 2003, J INFECT DIS, V188, P305, DOI 10.1086/377210; Wheeler RT, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000227	26	34	34	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2009	4	10							e7673	10.1371/journal.pone.0007673	http://dx.doi.org/10.1371/journal.pone.0007673			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RW	19888344	Green Published, gold			2022-12-27	WOS:000271414300017
J	Mehra, R; Londono, D; Sondey, M; Lawson, C; Cadavid, D				Mehra, Rohit; Londono, Diana; Sondey, Marie; Lawson, Catherine; Cadavid, Diego			Structure-Function Investigation of Vsp Serotypes of the Spirochete Borrelia hermsii	PLOS ONE			English	Article							SURFACE PROTEIN-C; RELAPSING FEVER BORRELIOSIS; LYME-DISEASE SPIROCHETE; ANTIGENIC VARIATION; CRYSTAL-STRUCTURE; PERSISTENT INFECTION; NEUROTROPIC STRAIN; MOUSE MODEL; TURICATAE; BURGDORFERI	Background: Relapsing fever (RF) spirochetes are notable for multiphasic antigenic variation of polymorphic outer membrane lipoproteins, a phenomenon responsible for immune evasion. An additional role in tissue localization is suggested by the finding that isogenic serotypes 1 (Bt1) and 2 (Bt2) of the RF spirochete Borrelia turicatae, which differ only in the Vsp they express, exhibit marked differences in clinical disease severity and tissue localization during infection. Methodology/Principal Findings: Here we used known vsp DNA sequences encoding for B. turicatae and Borrelia hermsii Vsp proteins with variable regions and then studied whether there are differences in disease expression and tissue localization of their corresponding serotypes during mouse infection. For sequence and structural comparisons we focused exclusively on amino acid residues predicted to project away from the spirochetes surface, referred to as the Vsp dome. Disease severity and tissue localization were studied during persistent infection with individual or mixed serotypes in SCID mice. The results showed that all Vsp domes clustered into 3 main trunks, with the domes for B. turicatae Vsp1 (BtVsp1) and BtVsp2 clustering into separate ones. B. hermsii serotypes whose Vsp domes clustered with the BtVsp1 dome were less virulent but localized to the brain more. The BtVsp2 dome was the oddball among all and Bt2 was the only serotype that caused severe arthritis. Conclusion/Significance: These findings indicate that there is significant variability in Vsp dome structure, disease severity, and tissue localization among serotypes of B. hermsii.			Mehra, R (corresponding author), UMDNJ New Jersey Med Sch, Dept Neurol, Newark, NJ USA.	dcadavid@partners.org		Lawson, Catherine/0000-0002-3261-7035	NINDS NIH HHS [R21 NS057545, R21 NS057545-01A2, 1R21NS053997-01, R21 NS057545-02, R21 NS053997, 7R21NS057545-02, R21 NS057545-03] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS053997, R21NS057545] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Alugupalli KR, 2003, J IMMUNOL, V170, P3819, DOI 10.4049/jimmunol.170.7.3819; BARBOUR AG, 1991, MOL MICROBIOL, V5, P489, DOI 10.1111/j.1365-2958.1991.tb02132.x; BARBOUR AG, 1986, MICROBIOL REV, V50, P381, DOI 10.1128/MMBR.50.4.381-400.1986; Barbour AG, 2000, INFECT IMMUN, V68, P7114, DOI 10.1128/IAI.68.12.7114-7121.2000; Barbour AG, 2001, INFECT IMMUN, V69, P1009, DOI 10.1128/IAI.69.2.1009-1015.2001; Barbour AG, 2006, P NATL ACAD SCI USA, V103, P18290, DOI 10.1073/pnas.0605302103; Bunikis J, 2004, EMERG INFECT DIS, V10, P1661, DOI 10.3201/eid1009.040236; Byram R, 2004, J BACTERIOL, V186, P3561, DOI 10.1128/JB.186.11.3561-3569.2004; Cadavid D, 1998, CLIN INFECT DIS, V26, P151, DOI 10.1086/516276; CADAVID D, 1994, J EXP MED, V179, P631, DOI 10.1084/jem.179.2.631; Cadavid D, 1997, INFECT IMMUN, V65, P3352, DOI 10.1128/IAI.65.8.3352-3360.1997; Cadavid D, 2001, INFECT IMMUN, V69, P3389, DOI 10.1128/IAI.69.5.3389-3397.2001; CADAVID D, 1993, J INFECT DIS, V168, P143, DOI 10.1093/infdis/168.1.143; Cadavid D, 2007, J INFECT DIS, V195, P1686, DOI 10.1086/516783; CARTER CJ, 1994, INFECT IMMUN, V62, P2792, DOI 10.1128/IAI.62.7.2792-2799.1994; Connolly SE, 2001, J IMMUNOL, V167, P3029, DOI 10.4049/jimmunol.167.6.3029; Dai QY, 2006, MOL MICROBIOL, V60, P1329, DOI 10.1111/j.1365-2958.2006.05177.x; Deitsch KW, 1997, MICROBIOL MOL BIOL R, V61, P281, DOI 10.1128/.61.3.281-293.1997; DIANA MAL, 2008, INFECT IMMUN, V77, P5508; Eicken C, 2001, J BIOL CHEM, V276, P10010, DOI 10.1074/jbc.M010062200; ENGH RA, 1991, ACTA CRYSTALLOGR A, V47, P392, DOI 10.1107/S0108767391001071; Fiser A, 2003, METHOD ENZYMOL, V374, P461, DOI 10.1016/S0076-6879(03)74020-8; FRENCH CJ, 1978, BIOCHIM BIOPHYS ACTA, V537, P386, DOI 10.1016/0005-2795(78)90523-8; Gelderblom H, 2007, J NEUROPATH EXP NEUR, V66, P208, DOI 10.1097/01.jnen.0000248556.30209.6d; Gelderblom H, 2007, AM J PATHOL, V170, P251, DOI 10.2353/ajpath.2007.060407; Grimm D, 2004, P NATL ACAD SCI USA, V101, P3142, DOI 10.1073/pnas.0306845101; Hinnebusch BJ, 1998, INFECT IMMUN, V66, P432, DOI 10.1128/IAI.66.2.432-440.1998; Kumaran D, 2001, EMBO J, V20, P971, DOI 10.1093/emboj/20.5.971; Lawson CL, 2006, J BACTERIOL, V188, P4522, DOI 10.1128/JB.00028-06; Li H, 1997, P NATL ACAD SCI USA, V94, P3584, DOI 10.1073/pnas.94.8.3584; Lin T, 2003, FEMS MICROBIOL LETT, V228, P249, DOI 10.1016/S0378-1097(03)00763-8; Londono D, 2005, INFECT IMMUN, V73, P7669, DOI 10.1128/IAI.73.11.7669-7676.2005; LONDONO D, 2008, J NEUROPATHOL EXP NE, V67; Londono D, 2008, J IMMUNOL, V181, P2076, DOI 10.4049/jimmunol.181.3.2076; Magoun L, 2000, MOL MICROBIOL, V36, P886, DOI 10.1046/j.1365-2958.2000.01906.x; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Pennington PM, 1997, INFECT IMMUN, V65, P285, DOI 10.1128/IAI.65.1.285-292.1997; Pennington PM, 1999, INFECT IMMUN, V67, P4637, DOI 10.1128/IAI.67.9.4637-4645.1999; Porcella SF, 2005, INFECT IMMUN, V73, P6647, DOI 10.1128/IAI.73.10.6647-6658.2005; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Sethi N, 2006, INFECT IMMUN, V74, P6408, DOI 10.1128/IAI.00538-06; STOENNER HG, 1982, J EXP MED, V156, P1297, DOI 10.1084/jem.156.5.1297; Tilly K, 2007, INFECT IMMUN, V75, P1517, DOI 10.1128/IAI.01725-06; Tilly K, 2006, INFECT IMMUN, V74, P3554, DOI 10.1128/IAI.01950-05; Zucker WR, 2001, J BIOL CHEM, V276, P457, DOI 10.1074/jbc.M008449200; Zuckert WR, 2004, INFECT IMMUN, V72, P1463, DOI 10.1128/IAI.72.3.1463-1469.2004	46	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2009	4	10							e7597	10.1371/journal.pone.0007597	http://dx.doi.org/10.1371/journal.pone.0007597			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RW	19888463	Green Submitted, Green Published, gold			2022-12-27	WOS:000271414300004
J	Szanton, SL; Johnson, B; Thorpe, RJ; Whitfield, K				Szanton, Sarah L.; Johnson, Brandon; Thorpe, Roland J., Jr.; Whitfield, Keith			Education in Time: Cohort Differences in Educational Attainment in African-American Twins	PLOS ONE			English	Article							SOCIOECONOMIC POSITION; LIFE EXPECTANCY; HEALTH; MORTALITY; PAIRS; RACE	Objectives: Educational opportunities for African-Americans expanded throughout the 20(th) century. Twin pairs are an informative population in which to examine changes in educational attainment because each twin has the same parents and childhood socioeconomic status. We hypothesized that correlation in educational attainment of older twin pairs would be higher compared to younger twin pairs reflecting changes in educational access over time and potentially reflecting a "ceiling effect'' associated with Jim Crow laws and discrimination. Methodology and Principal Findings: We used data from 211 same-sex twin pairs (98 identical, 113 fraternal) in the Carolina African-American Twin Study of Aging who were identified through birth records. Participants completed an in-person interview. The twins were predominantly female (61%), with a mean age of 50 years (SD = 0.5). We found that older age groups had a stronger intra-twin correlation of attained educational level. Further analysis across strata revealed a trend across zygosity, with identical twins demonstrating more similar educational attainment levels than did their fraternal twin counterparts, suggesting a genetic influence. Discussion: These findings suggest that as educational opportunities broadened in the 20th century, African-Americans gained access to educational opportunities that better matched their individual abilities.			Szanton, SL (corresponding author), Johns Hopkins Univ, Johns Hopkins Sch Nursing, Baltimore, MD 21218 USA.	sszanton@son.jhmi.edu			NCRR NIH HHS [1KL2RR025006-01, KL2 RR025006] Funding Source: Medline; NIA NIH HHS [1R01-AG13662-01A2] Funding Source: Medline; NINR NIH HHS [P30 NR008995] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025006] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCH [P30NR008995] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R01AG013662] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NINR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE OF NURSING RESEARCH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Chafe WH, 2001, REMEMBERING J CROW A; Feinglass J, 2007, J GERONTOL B-PSYCHOL, V62, pS209, DOI 10.1093/geronb/62.4.S209; GURALNIK JM, 1993, NEW ENGL J MED, V329, P110, DOI 10.1056/NEJM199307083290208; Hummer R. A., 2004, CRIT PERSPECT, P69; Krieger N, 2005, PLOS MED, V2, P645, DOI 10.1371/journal.pmed.0020162; LINK BG, 1995, J HEALTH SOC BEHAV, V35, P80, DOI 10.2307/2626958; Manly JJ, 2006, MED CARE, V44, pS10, DOI 10.1097/01.mlr.0000245427.22788.be; Manton KG, 1997, J AGING HEALTH, V9, P419, DOI 10.1177/089826439700900401; Osler M, 2007, INT J EPIDEMIOL, V36, P77, DOI 10.1093/ije/dyl266; Plomin R, 1990, BEHAV GENETICS PRIME; Steenland K, 2004, AM J EPIDEMIOL, V159, P1047, DOI 10.1093/aje/kwh129; THOM T, 2004, MORBIDITY MORTALITY; Whitfield KE, 2003, EXP AGING RES, V29, P407, DOI 10.1080/03610730303699; Whitfield KE, 2000, J AGING HEALTH, V12, P69, DOI 10.1177/089826430001200104; Whitfield Keith E., 1997, Ethnicity and Disease, V7, P127; Wiggins SebrinaA, 2003, J BLACK PSYCHOL, V29, P275, DOI DOI 10.1177/0095798403254209; WONG E, 2008, AM Q, V60, P455	17	6	6	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2009	4	10							e7664	10.1371/journal.pone.0007664	http://dx.doi.org/10.1371/journal.pone.0007664			3	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RW	19888338	gold, Green Submitted, Green Published			2022-12-27	WOS:000271414300014
J	Pan, D; Zhang, LQ				Pan, Deng; Zhang, Liqing			An Atlas of the Speed of Copy Number Changes in Animal Gene Families and Its Implications	PLOS ONE			English	Article							DROSOPHILA-MELANOGASTER; COMPARATIVE GENOMICS; SEQUENCE DIVERGENCE; DNA LOSS; EVOLUTION; DUPLICATION; EUKARYOTES; EXPANSION; REVEALS; MAMMALS	The notion that gene duplications generating new genes and functions is commonly accepted in evolutionary biology. However, this assumption is more speculative from theory rather than well proven in genome-wide studies. Here, we generated an atlas of the rate of copy number changes (CNCs) in all the gene families of ten animal genomes. We grouped the gene families with similar CNC dynamics into rate pattern groups (RPGs) and annotated their function using a novel bottom-up approach. By comparing CNC rate patterns, we showed that most of the species-specific CNC rates groups are formed by gene duplication rather than gene loss, and most of the changes in rates of CNCs may be the result of adaptive evolution. We also found that the functions of many RPGs match their biological significance well. Our work confirmed the role of gene duplication in generating novel phenotypes, and the results can serve as a guide for researchers to connect the phenotypic features to certain gene duplications.			Pan, D (corresponding author), Virginia Tech, Dept Comp Sci, Blacksburg, VA 24061 USA.	lqzhang@vt.edu	Pan, Deng/F-1794-2011					Aravind L, 2000, P NATL ACAD SCI USA, V97, P11319, DOI 10.1073/pnas.200346997; Bai YS, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-1-r11; Birney E, 2006, NUCLEIC ACIDS RES, V34, pD556, DOI 10.1093/nar/gkj133; Blomme T, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-5-r43; Danchin EGJ, 2006, BMC EVOL BIOL, V6, DOI 10.1186/1471-2148-6-5; Demuth JP, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000085; Felsenstein J., 2005, PHYLIP PHYLOGENY INF, DOI DOI 10.1111/J.1096-0031.1989.TB00562.X; Frohlich H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-166; Furano AV, 2004, TRENDS GENET, V20, P9, DOI 10.1016/j.tig.2003.11.006; Graves JAM, 2002, TRENDS GENET, V18, P517, DOI 10.1016/S0168-9525(02)02772-5; Hahn MW, 2005, GENOME RES, V15, P1153, DOI 10.1101/gr.3567505; Harrison PM, 2003, NUCLEIC ACIDS RES, V31, P1033, DOI 10.1093/nar/gkg169; Hedges SB, 2002, NAT REV GENET, V3, P838, DOI 10.1038/nrg929; Jiang J., 1998, P INT C RES COMP LIN; Karuppasamy M, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-3-r52; Killian JK, 2001, MAMM GENOME, V12, P513, DOI 10.1007/s003350020026; Kortschak RD, 2003, CURR BIOL, V13, P2190, DOI 10.1016/j.cub.2003.11.030; Krylov DM, 2003, GENOME RES, V13, P2229, DOI 10.1101/gr.1589103; Lespinet O, 2002, GENOME RES, V12, P1048, DOI 10.1101/gr.174302; Lopez-Bigas N, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r33; Lynch M, 2000, SCIENCE, V290, P1151, DOI 10.1126/science.290.5494.1151; Pan D, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-8-r158; Pavlidis P, 2003, BIOINFORMATICS, V19, P295, DOI 10.1093/bioinformatics/19.2.295; Petrov DA, 1998, MOL BIOL EVOL, V15, P293, DOI 10.1093/oxfordjournals.molbev.a025926; Petrov DA, 2002, GENETICA, V115, P81, DOI 10.1023/A:1016076215168; R Development Core Team, 2006, R LANG ENV STAT COMP; Raible F, 2004, CURR BIOL, V14, pR106, DOI 10.1016/j.cub.2004.01.015; Roest Crollius H, 2005, GENOME RES, V15, P1675, DOI 10.1101/gr.3735805; SAITOU N, 1987, MOL BIOL EVOL, V4, P406, DOI 10.1093/oxfordjournals.molbev.a040454; Sargeant TJ, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-2-r12; Vogel C, 2006, PLOS COMPUT BIOL, V2, P370, DOI 10.1371/journal.pcbi.0020048; Wakefield MJ, 2003, EMBO REP, V4, P143, DOI 10.1038/sj.embor.embor739; Wapinski I, 2007, NATURE, V449, P54, DOI 10.1038/nature06107; Zhang JZ, 2003, TRENDS ECOL EVOL, V18, P292, DOI 10.1016/S0169-5347(03)00033-8	34	1	1	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7342	10.1371/journal.pone.0007342	http://dx.doi.org/10.1371/journal.pone.0007342			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851465	gold, Green Published, Green Submitted			2022-12-27	WOS:000271022300001
J	Zanic, M; Stear, JH; Hyman, AA; Howard, J				Zanic, Marija; Stear, Jeffrey H.; Hyman, Anthony A.; Howard, Jonathon			EB1 Recognizes the Nucleotide State of Tubulin in the Microtubule Lattice	PLOS ONE			English	Article							PLUS-END TRACKING; DYNAMICS; PROTEIN; COMPLEX; GTP; FORMS; MCAK	Plus-end-tracking proteins (+TIPs) are localized at the fast-growing, or plus end, of microtubules, and link microtubule ends to cellular structures. One of the best studied +TIPs is EB1, which forms comet-like structures at the tips of growing microtubules. The molecular mechanisms by which EB1 recognizes and tracks growing microtubule ends are largely unknown. However, one clue is that EB1 can bind directly to a microtubule end in the absence of other proteins. Here we use an in vitro assay for dynamic microtubule growth with two-color total-internal-reflection-fluorescence imaging to investigate binding of mammalian EB1 to both stabilized and dynamic microtubules. We find that under conditions of microtubule growth, EB1 not only tip tracks, as previously shown, but also preferentially recognizes the GMPCPP microtubule lattice as opposed to the GDP lattice. The interaction of EB1 with the GMPCPP microtubule lattice depends on the E-hook of tubulin, as well as the amount of salt in solution. The ability to distinguish different nucleotide states of tubulin in microtubule lattice may contribute to the end-tracking mechanism of EB1.			Zanic, M (corresponding author), Max Planck Inst Mol Cell Biol & Genet, Dresden, Germany.	howard@mpi-cbg.de	Hyman, Anthony A/B-3917-2017; Howard, Jonathon/J-7492-2016; Hyman, Tony/F-1923-2011; Howard, Jonathon/D-4229-2011	Hyman, Anthony A/0000-0003-3664-154X; Howard, Jonathon/0000-0003-0086-1196; Howard, Jonathon/0000-0003-0086-1196; Zanic, Marija/0000-0002-5127-5819; Stear, Jeffrey/0000-0002-2255-8297				Akhmanova A, 2008, NAT REV MOL CELL BIO, V9, P309, DOI 10.1038/nrm2369; Ashford AJ, 1998, CELL BIOLOGY - A LABORATORY HANDBOOK, 2ND EDITION, VOL 2, P205; Bieling P, 2007, NATURE, V450, P1100, DOI 10.1038/nature06386; Bieling P, 2008, J CELL BIOL, V183, P1223, DOI 10.1083/jcb.200809190; Brouhard GJ, 2008, CELL, V132, P79, DOI 10.1016/j.cell.2007.11.043; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; Cooper JR, 2009, CURR OPIN CELL BIOL, V21, P68, DOI 10.1016/j.ceb.2009.01.005; des Georges A, 2008, NAT STRUCT MOL BIOL, V15, P1102, DOI 10.1038/nsmb.1482; Desai A, 1997, ANNU REV CELL DEV BI, V13, P83, DOI 10.1146/annurev.cellbio.13.1.83; Dimitrov A, 2008, SCIENCE, V322, P1353, DOI 10.1126/science.1165401; Dixit R, 2009, P NATL ACAD SCI USA, V106, P492, DOI 10.1073/pnas.0807614106; Helenius J, 2006, NATURE, V441, P115, DOI 10.1038/nature04736; Howard J, 2003, NATURE, V422, P753, DOI 10.1038/nature01600; Hunter AW, 2003, MOL CELL, V11, P445, DOI 10.1016/S1097-2765(03)00049-2; HYMAN A, 1991, METHOD ENZYMOL, V196, P478; HYMAN AA, 1992, MOL BIOL CELL, V3, P1155, DOI 10.1091/mbc.3.10.1155; Lansbergen G, 2006, TRAFFIC, V7, P499, DOI 10.1111/j.1600-0854.2006.00400.x; Morrison EE, 1998, ONCOGENE, V17, P3471, DOI 10.1038/sj.onc.1202247; Sandall S, 2006, CELL, V127, P1179, DOI 10.1016/j.cell.2006.09.049; Severin FF, 1997, NATURE, V388, P888, DOI 10.1038/42270; Westermann S, 2005, MOL CELL, V17, P277, DOI 10.1016/j.molcel.2004.12.019	21	115	115	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7585	10.1371/journal.pone.0007585	http://dx.doi.org/10.1371/journal.pone.0007585			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851462	Green Published, gold, Green Submitted			2022-12-27	WOS:000271022300016
J	Johansen, KK; Wang, L; Aasly, JO; White, LR; Matson, WR; Henchcliffe, C; Beal, MF; Bogdanov, M				Johansen, Krisztina K.; Wang, Lei; Aasly, Jan O.; White, Linda R.; Matson, Wayne R.; Henchcliffe, Claire; Beal, M. Flint; Bogdanov, Mikhail			Metabolomic Profiling in LRRK2-Related Parkinson's Disease	PLOS ONE			English	Article								Background: Mutations in LRRK2 gene represent the most common known genetic cause of Parkinson's disease (PD). Methodology/Principal Findings: We used metabolomic profiling to identify biomarkers that are associated with idiopathic and LRRK2 PD. We compared plasma metabolomic profiles of patients with PD due to the G2019S LRRK2 mutation, to asymptomatic family members of these patients either with or without G2019S LRRK2 mutations, and to patients with idiopathic PD, as well as non-related control subjects. We found that metabolomic profiles of both idiopathic PD and LRRK2 PD subjects were clearly separated from controls. LRRK2 PD patients had metabolomic profiles distinguishable from those with idiopathic PD, and the profiles could predict whether the PD was secondary to LRRK2 mutations or idiopathic. Metabolomic profiles of LRRK2 PD patients were well separated from their family members, but there was a slight overlap between family members with and without LRRK2 mutations. Both LRRK2 and idiopathic PD patients showed significantly reduced uric acid levels. We also found a significant decrease in levels of hypoxanthine and in the ratios of major metabolites of the purine pathway in plasma of PD patients. Conclusions/Significance: These findings show that LRRK2 patients with the G2019S mutation have unique metabolomic profiles that distinguish them from patients with idiopathic PD. Furthermore, asymptomatic LRRK2 carriers can be separated from gene negative family members, which raises the possibility that metabolomic profiles could be useful in predicting which LRRK2 carriers will eventually develop PD. The results also suggest that there are aberrations in the purine pathway in PD which may occur upstream from uric acid.			Johansen, KK (corresponding author), Norwegian Univ Sci & Technol, Dept Neurosci, N-7034 Trondheim, Norway.	mbb2002@med.cornell.edu			NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R21NS060262] Funding Source: NIH RePORTER; NINDS NIH HHS [1R21NS060262, R21 NS060262] Funding Source: Medline	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		Aasly JO, 2005, ANN NEUROL, V57, P762, DOI 10.1002/ana.20456; Annanmaki T, 2007, MOVEMENT DISORD, V22, P1133, DOI 10.1002/mds.21502; ASCHERIO A, 2009, ARCH NEUROL; Bogdanov M, 2008, BRAIN, V131, P389, DOI 10.1093/brain/awm304; Bras JM, 2005, MOVEMENT DISORD, V20, P1653, DOI 10.1002/mds.20682; Brindle JT, 2002, NAT MED, V8, P1439, DOI 10.1038/nm802; Brucke T, 2000, J NEUROL, V247, P2; de Lau LML, 2005, ANN NEUROL, V58, P797, DOI 10.1002/ana.20663; Di Leo A, 2007, ANN ONCOL, V18, P8, DOI 10.1093/annonc/mdm533; El-Agnaf OMA, 2006, FASEB J, V20, P419, DOI 10.1096/fj.03-1449com; Eriksson L., 2001, MULTI MEGAVARIATE DA; Gamache PH, 2004, J AM SOC MASS SPECTR, V15, P1717, DOI 10.1016/j.jasms.2004.08.016; Gao X, 2008, AM J EPIDEMIOL, V167, P831, DOI 10.1093/aje/kwm385; Gelb DJ, 1999, ARCH NEUROL-CHICAGO, V56, P33, DOI 10.1001/archneur.56.1.33; Goldwurm S, 2006, PARKINSONISM RELAT D, V12, P410, DOI 10.1016/j.parkreldis.2006.04.001; Goodacre R, 2004, TRENDS BIOTECHNOL, V22, P245, DOI 10.1016/j.tibtech.2004.03.007; Griffin JL, 2006, PHARMACOGENOMICS, V7, P1095, DOI 10.2217/14622416.7.7.1095; Hardy J, 2006, ANN NEUROL, V60, P389, DOI 10.1002/ana.21022; Healy DG, 2008, LANCET NEUROL, V7, P583, DOI 10.1016/S1474-4422(08)70117-0; Holmes E, 2006, PLOS MED, V3, P1420, DOI 10.1371/journal.pmed.0030327; Khan NL, 2005, BRAIN, V128, P2786, DOI 10.1093/brain/awh667; Kim YJ, 2002, MOVEMENT DISORD, V17, P303, DOI 10.1002/mds.10042; Klein C, 2007, NEUROLOGY, V69, P2093, DOI 10.1212/01.wnl.0000271880.27321.a7; Kristal BS, 1998, ANAL BIOCHEM, V263, P18, DOI 10.1006/abio.1998.2831; Kristal BS, 1999, ARCH BIOCHEM BIOPHYS, V370, P22, DOI 10.1006/abbi.1999.1387; Lesage S, 2005, ANN NEUROL, V58, P784, DOI 10.1002/ana.20636; LEWITT PA, 1992, NEUROLOGY, V42, P2111, DOI 10.1212/WNL.42.11.2111; Ozelius LJ, 2006, NEW ENGL J MED, V354, P424, DOI 10.1056/NEJMc055509; Rozen S, 2005, METABOLOMICS, V1, P101, DOI 10.1007/s11306-005-4810-1; Rubingh CM, 2006, METABOLOMICS, V2, P53, DOI 10.1007/s11306-006-0022-6; Scherzer CR, 2007, P NATL ACAD SCI USA, V104, P955, DOI 10.1073/pnas.0610204104; Schiesling C, 2008, NEUROPATH APPL NEURO, V34, P255, DOI 10.1111/j.1365-2990.2008.00952.x; Schwarzschild MA, 2008, ARCH NEUROL-CHICAGO, V65, P716, DOI 10.1001/archneur.2008.65.6.nct70003; Shi HL, 2002, ANAL BIOCHEM, V302, P239, DOI 10.1006/abio.2001.5568; Thomas B, 2007, HUM MOL GENET, V16, pR183, DOI 10.1093/hmg/ddm159; Tokuda T, 2006, BIOCHEM BIOPH RES CO, V349, P162, DOI 10.1016/j.bbrc.2006.08.024; Underwood BR, 2006, BRAIN, V129, P877, DOI 10.1093/brain/awl027; Vigneau-Callahan KE, 2001, J NUTR, V131, p924S, DOI 10.1093/jn/131.3.924S; Westerhuis JA, 2008, METABOLOMICS, V4, P81, DOI 10.1007/s11306-007-0099-6	40	119	125	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7551	10.1371/journal.pone.0007551	http://dx.doi.org/10.1371/journal.pone.0007551			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847307	Green Published, Green Submitted, gold			2022-12-27	WOS:000271022000015
J	Raush, E; Totrov, M; Marsden, BD; Abagyan, R				Raush, Eugene; Totrov, Max; Marsden, Brian D.; Abagyan, Ruben			A New Method for Publishing Three-Dimensional Content	PLOS ONE			English	Article											Raush, E (corresponding author), Molsoft LLC, San Diego, CA USA.	rabagyan@ucsd.edu		totrov, maxim/0000-0001-8594-274X	CIHR Funding Source: Medline; Wellcome Trust Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)		Abagyan R, 2006, TRENDS BIOCHEM SCI, V31, P76, DOI 10.1016/j.tibs.2005.12.006; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Hodis E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r121; Kleywegt GJ, 2004, ACTA CRYSTALLOGR D, V60, P2240, DOI 10.1107/S0907444904013253; Tyzack JK, 2008, TRENDS BIOCHEM SCI, V33, P405, DOI 10.1016/j.tibs.2008.07.001; 2006, NAT STRUCT MOL BIOL, V13, P93	6	33	33	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7394	10.1371/journal.pone.0007394	http://dx.doi.org/10.1371/journal.pone.0007394			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841676	Green Published, gold, Green Submitted			2022-12-27	WOS:000271012900007
J	Becquet, R; Bland, R; Leroy, V; Rollins, NC; Ekouevi, DK; Coutsoudis, A; Dabis, F; Coovadia, HM; Salamon, R; Newell, ML				Becquet, Renaud; Bland, Ruth; Leroy, Valeriane; Rollins, Nigel C.; Ekouevi, Didier K.; Coutsoudis, Anna; Dabis, Francois; Coovadia, Hoosen M.; Salamon, Roger; Newell, Marie-Louise			Duration, Pattern of Breastfeeding and Postnatal Transmission of HIV: Pooled Analysis of Individual Data from West and South African Cohorts	PLOS ONE			English	Article							TO-CHILD TRANSMISSION; HUMAN-IMMUNODEFICIENCY-VIRUS; SINGLE-DOSE NEVIRAPINE; COTE-DIVOIRE; UNINFECTED WOMEN; INFECTED MOTHERS; RANDOMIZED-TRIAL; POTENTIAL METHOD; DITRAME PLUS; ZIDOVUDINE	Background: Both breastfeeding pattern and duration are associated with postnatal HIV acquisition; their relative contribution has not been reliably quantified. Methodology and Principal Findings: Pooled data from 2 cohorts: in urban West Africa where breastfeeding cessation at 4 months was recommended but exclusive breastfeeding was rare (Ditrame Plus, DP); in rural South Africa where high rates of exclusive breastfeeding were achieved, but with longer duration (Vertical Transmission Study, VTS). 18-months HIV postnatal transmission (PT) was estimated by Kaplan-Meier in infants who were HIV negative, and assumed uninfected, at age >1 month. Censoring with (to assess impact of mode of breastfeeding) and without (to assess effect of breastfeeding duration) breastfeeding cessation considered as a competing event. Of 1195 breastfed infants, not HIV-infected perinatally, 38% DP and 83% VTS children were still breastfed at age 6 months. By age 3 months, 66% of VTS children were exclusively breastfed since birth and 55% of DP infants predominantly breastfed (breastmilk+water-based drinks). 18-month PT risk (95% CI) in VTS was double that in DP: 9% (7-11) and 5% (3-8), respectively (p = 0.03). However, once duration of breastfeeding was allowed for in a competing risk analysis assuming that all children would have been breastfed for 18-month, the estimated PT risk was 16% (8-28) in DP and 14% (10-18) in VTS (p = 0.32). 18-months PT risk was 3.9% (2.3-6.5) among infants breastfed for less than 6 months, and 8.7% (6.8-11.0) among children breastfed for more than 6 months; crude hazard ratio (HR): 2.1 (1.2-3.7), p = 0.02; adjusted HR 1.8 (0.9-3.4), p = 0.06. In individual analyses of PT rates for specific breastfeeding durations, risks among children exclusively breastfed were very similar to those in children predominantly breastfed for the same period. Children exposed to solid foods during the first 2 months of life were 2.9 (1.1-8.0) times more likely to be infected postnatally than children never exposed to solids this early (adjusted competing risk analysis, p = 0.04). Conclusions: Breastfeeding duration is a major determinant of postnatal HIV transmission. The PT risk did not differ between exclusively and predominantly breastfed children; the negative effect of mixed breastfeeding with solids on PT were confirmed.			Becquet, R (corresponding author), Univ KwaZulu Natal, Africa Ctr Hlth & Populat Studies, Somkhele, South Africa.	Renaud.Becquet@isped.u-bordeaux2.fr	EKOUEVI, Didier K/E-7960-2014; DABIS, FRANCOIS/S-9298-2019; Leroy, Valeriane/F-8129-2013; Becquet, Renaud/F-4837-2013; Newell, Marie-Louise/AAE-8222-2019; Leroy, Valeriane/GQB-1102-2022; Leroy, Valeriane/AAO-5175-2020	DABIS, FRANCOIS/0000-0002-1614-8857; Leroy, Valeriane/0000-0003-3542-8616; Becquet, Renaud/0000-0003-3277-0985; Newell, Marie-Louise/0000-0002-1074-7699; Leroy, Valeriane/0000-0003-3542-8616; Leroy, Valeriane/0000-0003-3542-8616; Bland, Ruth/0000-0003-1675-9268	Wellcome Trust [063009/Z/00/2, 050524] Funding Source: Medline	Wellcome Trust(Wellcome TrustEuropean Commission)		Alioum A, 2003, AM J EPIDEMIOL, V158, P596, DOI 10.1093/aje/kwg188; Alioum A, 2001, STAT MED, V20, P3539, DOI 10.1002/sim.1076; Bahl R, 2005, B WORLD HEALTH ORGAN, V83, P418; Becquet R, 2006, PEDIATRICS, V117, pE701, DOI 10.1542/peds.2005-1911; Becquet R, 2005, JAIDS-J ACQ IMM DEF, V40, P600, DOI 10.1097/01.qai.0000171726.17436.82; BECQUET R, 2007, FUTURE HIV THERAPY, V1, P17; Becquet R, 2007, CURR OPIN HIV AIDS, V2, P361, DOI 10.1097/COH.0b013e3282cecef4; Becquet R, 2007, PLOS MED, V4, P139, DOI 10.1371/journal.pmed.0040017; Bedri A, 2008, LANCET, V372, P300, DOI 10.1016/S0140-6736(08)61114-9; Bland RM, 2007, CLIN INFECT DIS, V45, P1502, DOI 10.1086/523320; Bland RM, 2007, B WORLD HEALTH ORGAN, V85, P289, DOI 10.2471/BLT.06.032441; Bland RM, 2003, ARCH DIS CHILD, V88, P778, DOI 10.1136/adc.88.9.778; Bland RM, 2002, ACTA PAEDIATR, V91, P704, DOI 10.1080/080352502760069151; Bland RM, 2008, AIDS, V22, P883, DOI 10.1097/QAD.0b013e3282f768de; Blettner M, 1999, INT J EPIDEMIOL, V28, P1, DOI 10.1093/ije/28.1.1; Bryce J, 2005, LANCET, V365, P1147, DOI 10.1016/S0140-6736(05)71877-8; CAMES C, 2006, 16 INT AIDS C TOR CA; Cassol S, 1997, J CLIN MICROBIOL, V35, P2795, DOI 10.1128/JCM.35.11.2795-2801.1997; Colvin M, 2007, B WORLD HEALTH ORGAN, V85, P466, DOI 10.2471/BLT.06.033639; COOVADIA H, 2007, LANCET, V369, P1607; Coutinho SB, 2005, LANCET, V366, P1094, DOI 10.1016/S0140-6736(05)67421-1; Coutsoudis A, 1999, LANCET, V354, P471, DOI 10.1016/S0140-6736(99)01101-0; Coutsoudis A, 2004, J INFECT DIS, V189, P2154, DOI 10.1086/420834; Coutsoudis A, 2001, AIDS, V15, P379, DOI 10.1097/00002030-200102160-00011; Cox D. R., 1984, ANAL SURVIVAL DATA; CREEK T, 2007, 14 C RETR OPP INF LO; Dabis F, 2005, AIDS, V19, P309; Edmond KM, 2006, PEDIATRICS, V117, pE380, DOI 10.1542/peds.2005-1496; Gaillard P, 2001, STAT MED, V20, P3525, DOI 10.1002/sim.1092; Guay LA, 1999, LANCET, V354, P795, DOI 10.1016/S0140-6736(99)80008-7; Iliff PJ, 2005, AIDS, V19, P699, DOI 10.1097/01.aids.0000166093.16446.c9; Israel-Ballard K, 2007, JAIDS-J ACQ IMM DEF, V45, P318; Jeffery BS, 2000, J TROP PEDIATRICS, V46, P219, DOI 10.1093/tropej/46.4.219; JOHNSON W, 2006, CHALLENGE PROVIDING; Joly P, 1999, COMPUT METH PROG BIO, V60, P225, DOI 10.1016/S0169-2607(99)00018-8; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; KUHN L, 2008, N ENGL J MED; Kumwenda NI, 2008, NEW ENGL J MED, V359, P119, DOI 10.1056/NEJMoa0801941; Leroy V, 2005, AIDS, V19, P1865, DOI 10.1097/01.aids.0000188423.02786.55; Leroy V, 2003, AIDS, V17, P1493, DOI 10.1097/00002030-200307040-00010; Leroy V, 2007, JAIDS-J ACQ IMM DEF, V44, P77, DOI 10.1097/01.qai.0000243115.37035.97; Luzuriaga K, 2006, LANCET, V368, P511, DOI 10.1016/S0140-6736(06)69159-9; Magoni M, 2005, AIDS, V19, P433, DOI 10.1097/01.aids.0000161773.29029.c0; Mofenson LM, 2000, LANCET, V355, P2237, DOI 10.1016/S0140-6736(00)02415-6; Nduati R, 2000, JAMA-J AM MED ASSOC, V283, P1167, DOI 10.1001/jama.283.9.1167; Oddy Wendy H, 2002, Breastfeed Rev, V10, P5; Poggensee G, 2004, TROP MED INT HEALTH, V9, P477, DOI 10.1111/j.1365-3156.2004.01214.x; POPKIN BM, 1990, PEDIATRICS, V86, P874; Rollins NC, 2007, JAIDS-J ACQ IMM DEF, V44, P321, DOI 10.1097/QAI.0b013e31802ea4b0; Rouet F, 2005, J CLIN MICROBIOL, V43, P2709, DOI 10.1128/JCM.43.6.2709-2717.2005; Rouet F, 2001, AIDS, V15, P1849, DOI 10.1097/00002030-200109280-00015; Taha TE, 2007, J INFECT DIS, V196, P10, DOI 10.1086/518511; Thior I, 2006, JAMA-J AM MED ASSOC, V296, P794, DOI 10.1001/jama.296.7.794; THOMAS T, 2007, 14 C RETR OPP INF LO; THOMAS T, 2008, 15 C RETR OPP INF BO; TONWE G, 2007, PLOS MED, V4, pE257; [WHO UNICEF UNAIDS], 2000, HIV INF FEED COUNS T; WHO, 2001, BREASTF REPL FEED PR; *WHO, 2007, CONS STAT WHO HIV IN; *WHO, 2004, HIV TRANSM BREASTF R; WHO & UNICEF (World Health Organization & UNICEF), 1993, BREASTF COUNS TRAIN; World Health Organization, 2004, GUID PRINC FEED NONB; World Health Organization, 1991, IND ASS BREAST FEED	63	49	50	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7397	10.1371/journal.pone.0007397	http://dx.doi.org/10.1371/journal.pone.0007397			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834601	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000270880700004
J	Ndjomou, J; Park, IW; Liu, Y; Mayo, LD; He, JJ				Ndjomou, Jean; Park, In-woo; Liu, Ying; Mayo, Lindsey D.; He, Johnny J.			Up-Regulation of Hepatitis C Virus Replication and Production by Inhibition of MEK/ERK Signaling	PLOS ONE			English	Article							SUBGENOMIC RNA REPLICATION; PROTEIN-KINASES; PATHWAY; ERK; CASCADE; GENOME; CELLS; PHOSPHORYLATION; ACTIVATION; INDUCTION	Background: Viruses interact with and exploit the host cellular machinery for their multiplication and propagation. The MEK/ERK signaling pathway positively regulates replication of many RNA viruses. However, whether and how this signaling pathway affects hepatitis C virus (HCV) replication and production is not well understood. Methods and Results: In this study, we took advantage of two well-characterized MEK/ERK inhibitors and MEK/ERK dominant negative mutants and investigated the roles of the MEK/ERK signaling pathway in HCV gene expression and replication. We showed that inhibition of MEK/ERK signaling enhanced HCV gene expression, plus-and minus-strand RNA synthesis, and virus production. In addition, we showed that this enhancement was independent of interferon-alpha (IFN-alpha) antiviral activity and did not require prior activation of the MEK/ERK signaling pathway. Furthermore, we showed that only MEK and ERK-2 but not ERK-1 was involved in HCV replication, likely through regulation of HCV RNA translation. Conclusions: Taken together, these results demonstrate a negative regulatory role of the MEK/ERK signaling pathway in HCV replication and suggest a potential risk in targeting this signaling pathway to treat and prevent neoplastic transformation of HCV-infected liver cells.			Ndjomou, J (corresponding author), Indiana Univ, Sch Med, Dept Microbiol & Immunol, Indianapolis, IN 46202 USA.	jjhe@iupui.edu						Battcock SA, 2006, J VIROL, V80, P4422, DOI 10.1128/JVI.80.9.4422-4430.2006; Cai YY, 2007, J VIROL, V81, P446, DOI 10.1128/JVI.01705-06; DUDLEY DT, 1995, P NATL ACAD SCI USA, V92, P7686, DOI 10.1073/pnas.92.17.7686; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Frese M, 2001, J GEN VIROL, V82, P723, DOI 10.1099/0022-1317-82-4-723; Goodbourn S, 2000, J GEN VIROL, V81, P2341, DOI 10.1099/0022-1317-81-10-2341; Huang Y, 2006, HEPATOLOGY, V43, P81, DOI 10.1002/hep.21011; Ichikawa T, 2002, BIOCHEM BIOPH RES CO, V294, P414, DOI 10.1016/S0006-291X(02)00502-8; Jackson MW, 2006, J BIOL CHEM, V281, P16814, DOI 10.1074/jbc.M511617200; Johnson GL, 2002, SCIENCE, V298, P1911, DOI 10.1126/science.1072682; Katze MG, 2000, VIROLOGY, V278, P501, DOI 10.1006/viro.2000.0662; Kim SJ, 2004, J BIOL CHEM, V279, P50031, DOI 10.1074/jbc.M408617200; Lauer GM, 2001, NEW ENGL J MED, V345, P41, DOI 10.1056/NEJM200107053450107; Lindenbach BD, 2007, FIELDS VIROLOGY, P1101; Luo HL, 2002, J VIROL, V76, P3365, DOI 10.1128/JVI.76.7.3365-3373.2002; Murata T, 2005, VIROLOGY, V340, P105, DOI 10.1016/j.virol.2005.06.015; Ndjomou J, 2007, BIOCHEM BIOPH RES CO, V359, P57, DOI 10.1016/j.bbrc.2007.05.073; Neddermann P, 2004, J VIROL, V78, P13306, DOI 10.1128/JVI.78.23.13306-13314.2004; Planz O, 2001, J VIROL, V75, P4871, DOI 10.1128/JVI.75.10.4871-4877.2001; Pleschka S, 2001, NAT CELL BIOL, V3, P301, DOI 10.1038/35060098; Reed KE, 2000, CURR TOP MICROBIOL, V242, P55; Reed KE, 1998, J VIROL, V72, P6199, DOI 10.1128/JVI.72.7.6199-6206.1998; Roux PP, 2004, MICROBIOL MOL BIOL R, V68, P320, DOI 10.1128/MMBR.68.2.320-344.2004; Seeff LB, 1997, HEPATOLOGY, V26, pS21, DOI 10.1002/hep.510260704; Smith KD, 2006, J VIROL, V80, P1110, DOI 10.1128/JVI.80.3.1110-1120.2006; Takeuchi T, 1999, GASTROENTEROLOGY, V116, P636, DOI 10.1016/S0016-5085(99)70185-X; Wakita T, 2005, NAT MED, V11, P791, DOI 10.1038/nm1268; Wang F, 2004, NAT IMMUNOL, V5, P1266, DOI 10.1038/ni1132; Yang XY, 1999, J VIROL, V73, P3460, DOI 10.1128/JVI.73.4.3460-3466.1999; Zheng YY, 2003, J VIROL, V77, P7707, DOI 10.1128/JVI.77.14.7707-7712.2003; Zhu HZ, 2003, J VIROL, V77, P5493, DOI 10.1128/JVI.77.9.5493-5498.2003	31	16	17	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7498	10.1371/journal.pone.0007498	http://dx.doi.org/10.1371/journal.pone.0007498			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834602	gold, Green Published, Green Submitted			2022-12-27	WOS:000270880700019
J	Oyagi, A; Oida, Y; Kakefuda, K; Shimazawa, M; Shioda, N; Moriguchi, S; Kitaichi, K; Nanba, D; Yamaguchi, K; Furuta, Y; Fukunaga, K; Higashiyama, S; Hara, H				Oyagi, Atsushi; Oida, Yasuhisa; Kakefuda, Kenichi; Shimazawa, Masamitsu; Shioda, Norifumi; Moriguchi, Shigeki; Kitaichi, Kiyoyuki; Nanba, Daisuke; Yamaguchi, Kazumasa; Furuta, Yasuhide; Fukunaga, Kohji; Higashiyama, Shigeki; Hara, Hideaki			Generation and Characterization of Conditional Heparin-Binding EGF-Like Growth Factor Knockout Mice	PLOS ONE			English	Article							CENTRAL-NERVOUS-SYSTEM; FACTOR HB-EGF; RAT-BRAIN; SCHIZOPHRENIC-PATIENTS; PREPULSE INHIBITION; ABNORMAL EXPRESSION; DENDRITIC SPINES; TRANSGENIC MICE; CELL-MIGRATION; IN-VIVO	Recently, neurotrophic factors and cytokines have been shown to be associated in psychiatric disorders, such as schizophrenia, bipolar disorder, and depression. Heparin-binding epidermal growth factor-like growth factor (HB-EGF) is a member of the EGF family, serves as a neurotrophic molecular and plays a significant role in the brain. We generated mice in which HB-EGF activity is disrupted specifically in the ventral forebrain. These knockout mice showed (a) behavioral abnormalities similar to those described in psychiatric disorders, which were ameliorated by typical or atypical antipsychotics, (b) altered dopamine and serotonin levels in the brain, (c) decreases in spine density in neurons of the prefrontal cortex, (d) reductions in the protein levels of the NR1 subunit of the N-methyl-D-aspartate (NMDA) receptor and post-synaptic protein-95 (PSD-95), (e) decreases in the EGF receptor, and in the calcium/calmodulin-dependent protein kinase II (CaMK II) signal cascade. These results suggest the alterations affecting HB-EGF signaling could comprise a contributing factor in psychiatric disorder.			Oyagi, A (corresponding author), Gifu Pharmaceut Univ, Dept Biofunct Evaluat, Gifu, Japan.	hidehara@gifu-pu.ac.jp	Fukunaga, Kohji/AAI-8811-2021	Fukunaga, Kohji/0000-0001-8526-2824				ADAMSON ED, 1984, DEV BIOL, V103, P62, DOI 10.1016/0012-1606(84)90007-1; BARNARD JA, 1995, GASTROENTEROLOGY, V108, P564, DOI 10.1016/0016-5085(95)90087-X; CARLSSON A, 1963, ACTA PHARMACOL TOX, V20, P140; Cicchetti D, 1999, DEV PSYCHOPATHOL, V11, P375, DOI 10.1017/S0954579499002114; Ehrlich I, 2007, P NATL ACAD SCI USA, V104, P4176, DOI 10.1073/pnas.0609307104; Elenius K, 1997, EMBO J, V16, P1268, DOI 10.1093/emboj/16.6.1268; Farkas LM, 2002, J NEURAL TRANSM, V109, P267, DOI 10.1007/s007020200022; FERRARI G, 1991, J NEUROSCI RES, V30, P493, DOI 10.1002/jnr.490300306; FILE SE, 1978, BRIT J PHARMACOL, V62, pP425; Furuta Y, 2000, GENESIS, V26, P130, DOI 10.1002/(SICI)1526-968X(200002)26:2<130::AID-GENE9>3.0.CO;2-I; Futamura T, 2002, MOL PSYCHIATR, V7, P673, DOI 10.1038/sj.mp.4001081; Futamura T, 2003, MOL PSYCHIATR, V8, P19, DOI 10.1038/sj.mp.4001138; Gainetdinov RR, 2001, P NATL ACAD SCI USA, V98, P11047, DOI 10.1073/pnas.191353298; Glantz LA, 2000, ARCH GEN PSYCHIAT, V57, P65, DOI 10.1001/archpsyc.57.1.65; GOMEZPINILLA F, 1988, BRAIN RES, V438, P385, DOI 10.1016/0006-8993(88)91369-8; HARRIS KM, 1994, ANNU REV NEUROSCI, V17, P341, DOI 10.1146/annurev.ne.17.030194.002013; Harvey PD, 2004, J CLIN PSYCHIAT, V65, P361; Hashimoto H, 2001, P NATL ACAD SCI USA, V98, P13355, DOI 10.1073/pnas.231094498; Hayase Y, 1998, BRAIN RES, V784, P163, DOI 10.1016/S0006-8993(97)01325-5; Hayashi ML, 2004, NEURON, V42, P773, DOI 10.1016/j.neuron.2004.05.003; HIGASHIYAMA S, 1991, SCIENCE, V251, P936, DOI 10.1126/science.1840698; ISHIYAMA J, 1991, NEUROSCI RES, V12, P403, DOI 10.1016/0168-0102(91)90071-6; Iwamoto R, 2003, P NATL ACAD SCI USA, V100, P3221, DOI 10.1073/pnas.0537588100; Jin KL, 2002, J NEUROSCI, V22, P5365; Kiuchi S, 2006, CYTOGENET GENOME RES, V115, P51, DOI 10.1159/000094801; Kornblum HI, 1999, EUR J NEUROSCI, V11, P3236, DOI 10.1046/j.1460-9568.1999.00744.x; Linn GS, 2003, PSYCHOPHARMACOLOGY, V169, P234, DOI 10.1007/s00213-003-1533-8; Mine N, 2005, DEVELOPMENT, V132, P4317, DOI 10.1242/dev.02030; Mishima K, 1996, NEUROSCI LETT, V213, P153; Miyamoto Y, 2004, EUR J NEUROSCI, V19, P151, DOI 10.1111/j.1460-9568.2004.03086.x; Moore H, 1999, BIOL PSYCHIAT, V46, P40, DOI 10.1016/S0006-3223(99)00078-5; MORRISON RS, 1987, SCIENCE, V238, P72, DOI 10.1126/science.3498986; Mouri A, 2007, MOL PHARMACOL, V71, P1598, DOI 10.1124/mol.106.032961; Nabeshima T, 2006, ANN NY ACAD SCI, V1086, P160, DOI 10.1196/annals.1377.003; Nakagawa T, 1998, DEV BRAIN RES, V108, P263, DOI 10.1016/S0165-3806(98)00057-1; NASRALLAH HA, 1991, BIOL PSYCHIAT, V29, P1, DOI 10.1016/0006-3223(91)90205-Z; Nishi E, 2001, EMBO J, V20, P3342, DOI 10.1093/emboj/20.13.3342; NODA Y, 1995, EUR J PHARMACOL, V286, P291, DOI 10.1016/0014-2999(95)00464-X; Oliver G, 1995, DEVELOPMENT, V121, P4045; PEREIRA A, 2009, J MOL NEUROSCI; PETERS A, 1970, AM J ANAT, V127, P321, DOI 10.1002/aja.1001270402; Portera-Cailliau C, 2003, J NEUROSCI, V23, P7129, DOI 10.1523/JNEUROSCI.23-18-07129.2003; Raab G, 1997, BBA-REV CANCER, V1333, pF179, DOI 10.1016/S0304-419X(97)00024-3; Rapoport JL, 2005, MOL PSYCHIATR, V10, P434, DOI 10.1038/sj.mp.4001642; Sakaue M, 2003, PSYCHOPHARMACOLOGY, V170, P73, DOI 10.1007/s00213-003-1515-x; Sams-Dodd F, 1998, NEUROPSYCHOPHARMACOL, V18, P293; SARTER M, 1988, PSYCHOPHARMACOLOGY, V94, P491, DOI 10.1007/BF00212843; Satoh Y, 2007, J NEUROSCI, V27, P10765, DOI 10.1523/JNEUROSCI.0117-07.2007; Takahashi M, 2000, MOL PSYCHIATR, V5, P293, DOI 10.1038/sj.mp.4000718; Tang YP, 1999, NATURE, V401, P63, DOI 10.1038/43432; TOWBIN H, 1979, P NATL ACAD SCI USA, V76, P4350, DOI 10.1073/pnas.76.9.4350; Ultanir SK, 2007, P NATL ACAD SCI USA, V104, P19553, DOI 10.1073/pnas.0704031104; WATANABE T, 1994, J BIOL CHEM, V269, P9966; Winograd-Gurvich C, 2006, BRAIN RES BULL, V70, P312, DOI 10.1016/j.brainresbull.2006.06.007; YAN T, 2009, J PSYCHOPHARMACOL; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071	56	30	30	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7461	10.1371/journal.pone.0007461	http://dx.doi.org/10.1371/journal.pone.0007461			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19829704	Green Submitted, Green Published, gold			2022-12-27	WOS:000270808700020
J	Soh, J; Okumura, N; Lockwood, WW; Yamamoto, H; Shigematsu, H; Zhang, W; Chari, R; Shames, DS; Tang, XM; MacAulay, C; Varella-Garcia, M; Vooder, T; Wistuba, II; Lam, S; Brekken, R; Toyooka, S; Minna, JD; Lam, WL; Gazdar, AF				Soh, Junichi; Okumura, Naoki; Lockwood, William W.; Yamamoto, Hiromasa; Shigematsu, Hisayuki; Zhang, Wei; Chari, Raj; Shames, David S.; Tang, Ximing; MacAulay, Calum; Varella-Garcia, Marileila; Vooder, Tonu; Wistuba, Ignacio I.; Lam, Stephen; Brekken, Rolf; Toyooka, Shinichi; Minna, John D.; Lam, Wan L.; Gazdar, Adi F.			Oncogene Mutations, Copy Number Gains and Mutant Allele Specific Imbalance (MASI) Frequently Occur Together in Tumor Cells	PLOS ONE			English	Article							ACQUIRED UNIPARENTAL DISOMY; BRONCHIAL EPITHELIAL-CELLS; FACTOR RECEPTOR GENE; LUNG-CANCER PATIENTS; COLORECTAL-CANCER; SIGNALING PATHWAY; EGFR; GEFITINIB; LINES; EXPRESSION	Background: Activating mutations in one allele of an oncogene (heterozygous mutations) are widely believed to be sufficient for tumorigenesis. However, mutant allele specific imbalance (MASI) has been observed in tumors and cell lines harboring mutations of oncogenes. Methodology/Principal Findings: We determined 1) mutational status, 2) copy number gains (CNGs) and 3) relative ratio between mutant and wild type alleles of KRAS, BRAF, PIK3CA and EGFR genes by direct sequencing and quantitative PCR assay in over 400 human tumors, cell lines, and xenografts of lung, colorectal, and pancreatic cancers. Examination of a public database indicated that homozygous mutations of five oncogenes were frequent (20%) in 833 cell lines of 12 tumor types. Our data indicated two major forms of MASI: 1) MASI with CNG, either complete or partial; and 2) MASI without CNG (uniparental disomy; UPD), due to complete loss of wild type allele. MASI was a frequent event in mutant EGFR (75%) and was due mainly to CNGs, while MASI, also frequent in mutant KRAS (58%), was mainly due to UPD. Mutant: wild type allelic ratios at the genomic level were precisely maintained after transcription. KRAS mutations or CNGs were significantly associated with increased ras GTPase activity, as measured by ELISA, and the two molecular changes were synergistic. Of 237 lung adenocarcinoma tumors, the small number with both KRAS mutation and CNG were associated with shortened survival. Conclusions: MASI is frequently present in mutant EGFR and KRAS tumor cells, and is associated with increased mutant allele transcription and gene activity. The frequent finding of mutations, CNGs and MASI occurring together in tumor cells indicates that these three genetic alterations, acting together, may have a greater role in the development or maintenance of the malignant phenotype than any individual alteration.			Soh, J (corresponding author), Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dallas, TX 75390 USA.	Adi.Gazdar@UTSouthwestern.edu	Lockwood, William W/A-2879-2009; MacAulay, Calum/K-1795-2016; Chari, Raj/G-3285-2019; SOH, Junichi/B-2388-2011; Soh, Junichi/AAV-1053-2020; Soh, Junichi/AAT-7095-2021; Chari, Rajagopal/B-6980-2008	Soh, Junichi/0000-0001-8532-7915; Soh, Junichi/0000-0001-8532-7915; MacAulay, Calum/0000-0003-4440-2792	NATIONAL CANCER INSTITUTE [P50CA070907, U01CA084971] Funding Source: NIH RePORTER; NCI NIH HHS [U01 CA084971, P50CA70907, P50 CA070907, U01CA084971] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Albertson DG, 2003, NAT GENET, V34, P369, DOI 10.1038/ng1215; Andersen CL, 2007, CARCINOGENESIS, V28, P38, DOI 10.1093/carcin/bgl086; Asano H, 2006, CLIN CANCER RES, V12, P43, DOI 10.1158/1078-0432.CCR-05-0934; Bell DW, 2005, NAT GENET, V37, P1315, DOI 10.1038/ng1671; Bengtsson H, 2008, BIOINFORMATICS, V24, P759, DOI 10.1093/bioinformatics/btn016; BOS JL, 1989, CANCER RES, V49, P4682; Brugge J, 2007, CANCER CELL, V12, P104, DOI 10.1016/j.ccr.2007.07.014; Cappuzzo F, 2005, JNCI-J NATL CANCER I, V97, P643, DOI 10.1093/jnci/dji112; Chari R, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-324; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Cutz JC, 2006, CLIN CANCER RES, V12, P4043, DOI 10.1158/1078-0432.CCR-06-0252; Davies H, 2002, NATURE, V417, P949, DOI 10.1038/nature00766; Endoh H, 2006, J THORAC ONCOL, V1, P629; ENGEL E, 1980, AM J MED GENET, V6, P137, DOI 10.1002/ajmg.1320060207; Fitzgibbon J, 2005, CANCER RES, V65, P9152, DOI 10.1158/0008-5472.CAN-05-2017; Gandhi J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004576; GAZDAR AF, 2008, CANCER PREV RES, V1, P5; Gupta M, 2008, GENE CHROMOSOME CANC, V47, P729, DOI 10.1002/gcc.20573; HERRMANN BG, 1987, METHOD ENZYMOL, V152, P180; Hirsch FR, 2007, ANN ONCOL, V18, P752, DOI 10.1093/annonc/mdm003; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; LaFramboise T, 2005, PLOS COMPUT BIOL, V1, P507, DOI 10.1371/journal.pcbi.0010065; Lander ES, 2001, NATURE, V409, P860, DOI 10.1038/35057062; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; Melcher R, 2007, CYTOGENET GENOME RES, V118, P214, DOI 10.1159/000108303; MITSUDOMI T, 1991, ONCOGENE, V6, P1353; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2005, PLOS MED, V2, P225, DOI 10.1371/journal.pmed.0020073; Pratilas CA, 2008, CANCER RES, V68, P9375, DOI 10.1158/0008-5472.CAN-08-2223; Ramirez RD, 2004, CANCER RES, V64, P9027, DOI 10.1158/0008-5472.CAN-04-3703; Sato M, 2006, CANCER RES, V66, P2116, DOI 10.1158/0008-5472.CAN-05-2521; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; Shigematsu H, 2005, JNCI-J NATL CANCER I, V97, P339, DOI 10.1093/jnci/dji055; Singh A, 2009, CANCER CELL, V15, P489, DOI 10.1016/j.ccr.2009.03.022; Soh J, 2008, J THORAC ONCOL, V3, P340, DOI 10.1097/JTO.0b013e318168d20a; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tuna M, 2009, TRENDS MOL MED, V15, P120, DOI 10.1016/j.molmed.2009.01.005; Uchiyama M, 2003, INT J CANCER, V107, P962, DOI 10.1002/ijc.11493; Vogelstein B, 2004, NAT MED, V10, P789, DOI 10.1038/nm1087; Walsh CS, 2008, CLIN CANCER RES, V14, P7645, DOI 10.1158/1078-0432.CCR-08-1291; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yamamoto G, 2007, AM J HUM GENET, V81, P114, DOI 10.1086/518809; Yamamoto H, 2008, CANCER RES, V68, P6913, DOI 10.1158/0008-5472.CAN-07-5084; Yuen ST, 2002, CANCER RES, V62, P6451; Zhang ZQ, 2001, NAT GENET, V29, P25, DOI 10.1038/ng721	45	172	179	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7464	10.1371/journal.pone.0007464	http://dx.doi.org/10.1371/journal.pone.0007464			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826477	Green Submitted, Green Published, gold			2022-12-27	WOS:000270808700022
J	Wang, YQ; Abu Irqeba, A; Ayalew, M; Suntay, K				Wang, Yuqi; Abu Irqeba, Ameair; Ayalew, Mihretu; Suntay, Kristina			Sumoylation of Transcription Factor Tec1 Regulates Signaling of Mitogen-Activated Protein Kinase Pathways in Yeast	PLOS ONE			English	Article							FUSION-DIRECTED SUMOYLATION; INVASIVE GROWTH; MAPK; SPECIFICITY; PHEROMONE; TRANSDUCTION; PHOSPHORYLATION; KSS1; DEGRADATION; STRESS	Tec1 is a transcription factor in the yeast mitogen-activated protein kinase ( MAPK) pathway that controls invasive growth. Previously we reported that a fraction of Tec1 protein is sumoylated on residue lysine 54 in normally growing cells. Here we describe regulation and functional consequences of Tec1 sumoylation. We found that activation of Kss1, the MAPK that directly activates Tec1, results in a decrease in Tec1 sumoylation and a concurrent increase of Tec1 transcriptional activity. Consistent with a role of sumoylation in inhibiting Tec1 activity, specifically increasing sumoylation of Tec1 by fusing it to the sumoylating enzyme Ubc9 leads to a dramatic decrease of Tec1 transcriptional activity. Invasive growth is also compromised in Tec1-Ubc9. In contrast, fusing sumoylation-site mutant Tec1, i.e., Tec1 K54R, to Ubc9 did not significantly alter transcriptional activation and had a less effect on invasive growth. Taken together, these findings provide evidence for regulated sumoylation as a mechanism to modulate the activity of Tec1 and validate Ubc9 fusion-directed sumoylation as a useful approach for studying protein sumoylation.			Wang, YQ (corresponding author), St Louis Univ, Dept Biol, St Louis, MO 63103 USA.	ywang8@slu.edu		Abu Irqeba, Ameair/0000-0002-6664-8892				BALLARD MJ, 1991, EMBO J, V10, P3753, DOI 10.1002/j.1460-2075.1991.tb04944.x; Bao MZ, 2004, CELL, V119, P991, DOI 10.1016/j.cell.2004.11.052; Baur M, 1997, MOL CELL BIOL, V17, P4330, DOI 10.1128/MCB.17.8.4330; Breitkreutz A, 2002, TRENDS CELL BIOL, V12, P254, DOI 10.1016/S0962-8924(02)02284-5; Bruckner S, 2004, CURR GENET, V46, P331, DOI 10.1007/s00294-004-0545-1; Chen RE, 2007, BBA-MOL CELL RES, V1773, P1311, DOI 10.1016/j.bbamcr.2007.05.003; Chou S, 2004, CELL, V119, P981, DOI 10.1016/j.cell.2004.11.053; Cook JG, 1996, GENE DEV, V10, P2831, DOI 10.1101/gad.10.22.2831; DAVENPORT KR, 1995, J BIOL CHEM, V270, P30157; Dhanasekaran DN, 2007, ONCOGENE, V26, P3097, DOI 10.1038/sj.onc.1210395; Dohlman HG, 2001, ANNU REV BIOCHEM, V70, P703, DOI 10.1146/annurev.biochem.70.1.703; ERREDE B, 1989, GENE DEV, V3, P1349, DOI 10.1101/gad.3.9.1349; Esch RK, 2006, EUKARYOT CELL, V5, P2147, DOI 10.1128/EC.00270-06; Gao M, 2004, SCIENCE, V306, P271, DOI 10.1126/science.1099414; Hao N, 2008, MOL CELL, V30, P649, DOI 10.1016/j.molcel.2008.04.016; Hao N, 2008, J BIOL CHEM, V283, P33798, DOI 10.1074/jbc.C800179200; Jakobs A, 2007, NAT METHODS, V4, P245, DOI 10.1038/NMETH1006; Johnson ES, 2004, ANNU REV BIOCHEM, V73, P355, DOI 10.1146/annurev.biochem.73.011303.074118; Kruse JP, 2008, CELL, V133, DOI 10.1016/j.cell.2008.05.020; Levin DE, 2005, MICROBIOL MOL BIOL R, V69, P262, DOI 10.1128/MMBR.69.2.262-291.2005; Li SJ, 2000, MOL CELL BIOL, V20, P2367, DOI 10.1128/MCB.20.7.2367-2377.2000; Li SJ, 1999, NATURE, V398, P246, DOI 10.1038/18457; Madhani HD, 1997, SCIENCE, V275, P1314, DOI 10.1126/science.275.5304.1314; Niedenthal R, 2007, BIOCHEM SOC T, V35, P1430, DOI 10.1042/BST0351430; O'Rourke SM, 1998, GENE DEV, V12, P2874, DOI 10.1101/gad.12.18.2874; Pearson G, 2001, ENDOCR REV, V22, P153, DOI 10.1210/er.22.2.153; Pokholok DK, 2006, SCIENCE, V313, P533, DOI 10.1126/science.1127677; Proft M, 2006, MOL CELL, V23, P241, DOI 10.1016/j.molcel.2006.05.031; Sabbagh W, 2001, MOL CELL, V8, P683, DOI 10.1016/S1097-2765(01)00322-7; Shock TR, 2009, EUKARYOT CELL, V8, P606, DOI 10.1128/EC.00005-09; Tedford K, 1997, CURR BIOL, V7, P228, DOI 10.1016/S0960-9822(06)00118-7; Truckses DM, 2004, SCIENCE, V306, P1509, DOI 10.1126/science.1104677; Wang YQ, 2006, J BIOL CHEM, V281, P1964, DOI 10.1074/jbc.M508985200; Wang YQ, 2004, SCIENCE, V306, P1508, DOI 10.1126/science.1104568; Wang YQ, 2008, J BIOL CHEM, V283, P1954, DOI 10.1074/jbc.M705682200; Westfall PJ, 2004, SCIENCE, V306, P1511, DOI 10.1126/science.1104879; Zeitlinger J, 2003, CELL, V113, P395, DOI 10.1016/S0092-8674(03)00301-5	37	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7456	10.1371/journal.pone.0007456	http://dx.doi.org/10.1371/journal.pone.0007456			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826484	Green Published, Green Submitted, gold			2022-12-27	WOS:000270808700016
J	Jung, K; Lee, JE; Kim, HZ; Kim, HM; Park, BS; Hwang, SI; Lee, JO; Kim, SC; Koh, GY				Jung, Keehoon; Lee, Jung-Eun; Kim, Hak-Zoo; Kim, Ho Min; Park, Beom Seok; Hwang, Seong-Ik; Lee, Jie-Oh; Kim, Sun Chang; Koh, Gou Young			Toll-Like Receptor 4 Decoy, TOY, Attenuates Gram-Negative Bacterial Sepsis	PLOS ONE			English	Article								Lipopolysaccharide (LPS), the Gram-negative bacterial outer membrane glycolipid, induces sepsis through its interaction with myeloid differentiation protein-2 (MD-2) and Toll-like receptor 4 (TLR4). To block interaction between LPS/MD-2 complex and TLR4, we designed and generated soluble fusion proteins capable of binding MD-2, dubbed TLR4 decoy receptor (TOY) using 'the Hybrid leucine-rich repeats (LRR) technique'. TOY contains the MD-2 binding ectodomain of TLR4, the LRR motif of hagfish variable lymphocyte receptor (VLR), and the Fc domain of IgG1 to make it soluble, productive, and functional. TOY exhibited strong binding to MD-2, but not to the extracellular matrix (ECM), resulting in a favorable pharmacokinetic profile in vivo. TOY significantly extended the lifespan, when administered in either preventive or therapeutic manners, in both the LPS- and cecal ligation/puncture-induced sepsis models in mice. TOY markedly attenuated LPS-triggered NF-kappa B activation, secretion of proinflammatory cytokines, and thrombus formation in multiple organs. Taken together, the targeting strategy for sequestration of LPS/MD-2 complex using the decoy receptor TOY is effective in treating LPS-and bacteria-induced sepsis; furthermore, the strategy used in TOY development can be applied to the generation of other novel decoy receptor proteins.	[Jung, Keehoon; Lee, Jung-Eun; Kim, Hak-Zoo; Hwang, Seong-Ik; Koh, Gou Young] Korea Adv Inst Sci & Technol, Natl Res Lab Vasc Biol, Taejon 305701, South Korea; [Jung, Keehoon; Lee, Jung-Eun; Kim, Hak-Zoo; Hwang, Seong-Ik; Kim, Sun Chang; Koh, Gou Young] Korea Adv Inst Sci & Technol, Dept Biol Sci, Taejon 305701, South Korea; [Kim, Ho Min; Park, Beom Seok; Lee, Jie-Oh] Korea Adv Inst Sci & Technol, Dept Chem, Taejon 305701, South Korea; [Lee, Jie-Oh; Kim, Sun Chang; Koh, Gou Young] Korea Adv Inst Sci & Technol, Inst BioCentury, Taejon 305701, South Korea; [Koh, Gou Young] Korea Adv Inst Sci & Technol, Grad Sch Nanosci & Technol WCU, Taejon 305701, South Korea	Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST); Korea Advanced Institute of Science & Technology (KAIST)	Jung, K (corresponding author), Korea Adv Inst Sci & Technol, Natl Res Lab Vasc Biol, Taejon 305701, South Korea.	gykoh@kaist.ac.kr	Lee, Jie-Oh/C-1581-2011; Kim, Sun/GSN-4867-2022; Koh, Gou Young/C-1615-2011; Kim, Sun Chang/C-2026-2011; Lee, Jie-Oh/AAG-4302-2020; Kim, Ho Min/G-2712-2011	Jung, Keehoon/0000-0002-2199-5292; Lee, Jie-Oh/0000-0001-6519-6049				Barton GM, 2003, SCIENCE, V300, P1524, DOI 10.1126/science.1085536; Bella J, 2008, CELL MOL LIFE SCI, V65, P2307, DOI 10.1007/s00018-008-8019-0; Beutler B, 2003, NAT REV IMMUNOL, V3, P169, DOI 10.1038/nri1004; Beutler B, 2004, NATURE, V430, P257, DOI 10.1038/nature02761; Carlsen H, 2002, J IMMUNOL, V168, P1441, DOI 10.4049/jimmunol.168.3.1441; Cohen J, 2002, NATURE, V420, P885, DOI 10.1038/nature01326; Daubeuf B, 2007, J IMMUNOL, V179, P6107, DOI 10.4049/jimmunol.179.9.6107; Fort MM, 2005, J IMMUNOL, V174, P6416, DOI 10.4049/jimmunol.174.10.6416; Hwang SJ, 2005, PROTEIN EXPRES PURIF, V39, P175, DOI 10.1016/j.pep.2004.09.005; Hyakushima N, 2004, J IMMUNOL, V173, P6949, DOI 10.4049/jimmunol.173.11.6949; Kang S, 2009, BLOOD, V113, P2605, DOI 10.1182/blood-2008-07-166934; Kawai T, 2007, SEMIN IMMUNOL, V19, P24, DOI 10.1016/j.smim.2006.12.004; Kim HM, 2007, J BIOL CHEM, V282, P6726, DOI 10.1074/jbc.M608471200; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; Miyake K, 2003, INT IMMUNOPHARMACOL, V3, P119, DOI 10.1016/S1567-5769(02)00258-8; Nagai Y, 2002, NAT IMMUNOL, V3, P667, DOI 10.1038/ni809; Ohto U, 2007, SCIENCE, V316, P1632, DOI 10.1126/science.1139111; Pugin J, 2004, BLOOD, V104, P4071, DOI 10.1182/blood-2003-04-1290; Riedemann NC, 2003, J CLIN INVEST, V112, P460, DOI 10.1172/JCI200319523; Roger T, 2009, P NATL ACAD SCI USA, V106, P2348, DOI 10.1073/pnas.0808146106; Rossignol Daniel P, 2005, Curr Opin Investig Drugs, V6, P496; Shimazu R, 1999, J EXP MED, V189, P1777, DOI 10.1084/jem.189.11.1777; Tasaka S, 2003, AM J RESP CELL MOL, V29, P252, DOI 10.1165/rcmb.2002-0132OC; TOBIAS PS, 1986, J EXP MED, V164, P777, DOI 10.1084/jem.164.3.777; Viriyakosol S, 2001, J BIOL CHEM, V276, P38044; Visintin A, 2005, J IMMUNOL, V175, P6465, DOI 10.4049/jimmunol.175.10.6465; Visintin A, 2006, IMMUNOBIOLOGY, V211, P437, DOI 10.1016/j.imbio.2006.05.010; Wright K, 1990, Science, V249, P22, DOI 10.1126/science.2367850; Wu X, 2005, INFLAMM RES, V54, P451, DOI 10.1007/s00011-005-1378-1	31	21	26	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7403	10.1371/journal.pone.0007403	http://dx.doi.org/10.1371/journal.pone.0007403			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816595	gold, Green Published, Green Submitted			2022-12-27	WOS:000270594300017
J	Roy, S; Lavine, J; Chiaromonte, F; Terwee, J; VandeWoude, S; Bjornstad, O; Poss, M				Roy, Sunando; Lavine, Jennie; Chiaromonte, Francesca; Terwee, Julie; VandeWoude, Sue; Bjornstad, Ottar; Poss, Mary			Multivariate Statistical Analyses Demonstrate Unique Host Immune Responses to Single and Dual Lentiviral Infection	PLOS ONE			English	Article							FELINE IMMUNODEFICIENCY VIRUS; PROTECTION; EVOLUTION; CATS; RESISTANCE; WILD	Background: Feline immunodeficiency virus (FIV) and human immunodeficiency virus (HIV) are recently identified lentiviruses that cause progressive immune decline and ultimately death in infected cats and humans. It is of great interest to understand how to prevent immune system collapse caused by these lentiviruses. We recently described that disease caused by a virulent FIV strain in cats can be attenuated if animals are first infected with a feline immunodeficiency virus derived from a wild cougar. The detailed temporal tracking of cat immunological parameters in response to two viral infections resulted in high-dimensional datasets containing variables that exhibit strong co-variation. Initial analyses of these complex data using univariate statistical techniques did not account for interactions among immunological response variables and therefore potentially obscured significant effects between infection state and immunological parameters. Methodology and Principal Findings: Here, we apply a suite of multivariate statistical tools, including Principal Component Analysis, MANOVA and Linear Discriminant Analysis, to temporal immunological data resulting from FIV superinfection in domestic cats. We investigated the co-variation among immunological responses, the differences in immune parameters among four groups of five cats each (uninfected, single and dual infected animals), and the "immune profiles'' that discriminate among them over the first four weeks following superinfection. Dual infected cats mount an immune response by 24 days post superinfection that is characterized by elevated levels of CD8 and CD25 cells and increased expression of IL4 and IFN gamma, and FAS. This profile discriminates dual infected cats from cats infected with FIV alone, which show high IL-10 and lower numbers of CD8 and CD25 cells. Conclusions: Multivariate statistical analyses demonstrate both the dynamic nature of the immune response to FIV single and dual infection and the development of a unique immunological profile in dual infected cats, which are protected from immune decline.			Roy, S (corresponding author), Penn State Univ, Dept Biol, University Pk, PA 16802 USA.	mposs@bx.psu.edu	Bjornstad, Ottar N/I-4518-2012	VandeWoude, Sue/0000-0001-9227-1622	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL092791] Funding Source: NIH RePORTER; NHLBI NIH HHS [R01 HL092791, R01HL092791] Funding Source: Medline	NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Biek R, 2006, CAN J ZOOL, V84, P365, DOI 10.1139/z06-006; Biek R, 2003, J VIROL, V77, P9578, DOI 10.1128/JVI.77.17.9578-9589.2003; Biek R, 2006, J WILDLIFE DIS, V42, P606, DOI 10.7589/0090-3558-42.3.606; Burkhard MJ, 2003, CURR HIV RES, V1, P15, DOI 10.2174/1570162033352101; Collette A, 2004, J IMMUNOL, V173, P4568, DOI 10.4049/jimmunol.173.7.4568; Dabo-Niang S., 2008, FUNCTIONAL OPERATORI; de Monte M, 2002, J VIROL METHODS, V103, P157, DOI 10.1016/S0166-0934(02)00024-1; de Rozieres S, 2004, J VIROL, V78, P8971, DOI 10.1128/JVI.78.17.8971-8982.2004; DRAY S., 2003, T GIS, V7, P411, DOI DOI 10.1111/1467-9671.00153; Everitt B.S., 2005, R S PLUS COMPANION M; Fisher RA, 1936, ANN EUGENIC, V7, P179, DOI 10.1111/j.1469-1809.1936.tb02137.x; Friedrich TC, 2008, CURR OPIN HIV AIDS, V3, P393, DOI 10.1097/COH.0b013e3282faa461; Genser B, 2007, BMC IMMUNOL, V8, DOI 10.1186/1471-2172-8-27; Gnanadesikan R, 1997, METHODS STAT DATA AN; Gollob KJ, 2008, INT IMMUNOPHARMACOL, V8, P1338, DOI 10.1016/j.intimp.2008.03.016; Keil D, 1999, TOXICOL SCI, V51, P245, DOI 10.1093/toxsci/51.2.245; Koff WC, 2006, NAT IMMUNOL, V7, P19, DOI 10.1038/ni1296; Krzanowski W. J., 1988, PRINCIPLES MULTIVARI; Lifson JD, 2001, J VIROL, V75, P10187, DOI 10.1128/JVI.75.21.10187-10199.2001; Lionel A, 2005, IMMUNOL LETT, V97, P55, DOI 10.1016/j.imlet.2004.09.014; McLachlan G. J., 1992, DISCRIMINANT ANAL ST, DOI DOI 10.1002/0471725293; OLSON CL, 1974, J AM STAT ASSOC, V69, P894, DOI 10.2307/2286159; OLSON CL, 1976, PSYCHOL BULL, V83, P579, DOI 10.1037/0033-2909.83.4.579; Poss M, 2006, J VIROL, V80, P2728, DOI 10.1128/JVI.80.6.2728-2737.2006; Ramsay J., 2005, FUNCTIONAL DATA ANAL, DOI 10.1007/b98888; SAMARADASA W, 2004, GEN INFERENCE REPEAT; Seber G.A.F., 2004, MULTIVARIATE OBSERVA; TerWee JA, 2005, J VIROL, V79, P2797, DOI 10.1128/JVI.79.5.2797-2806.2005; TerWee JA, 2008, VIROLOGY, V377, P63, DOI 10.1016/j.virol.2008.03.037; TRAVERS K, 1995, SCIENCE, V268, P1612, DOI 10.1126/science.7539936; VandeWoude S, 2002, J ACQ IMMUN DEF SYND, V29, P1; VandeWoude S, 2006, CLIN MICROBIOL REV, V19, P728, DOI 10.1128/CMR.00009-06	32	10	10	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7359	10.1371/journal.pone.0007359	http://dx.doi.org/10.1371/journal.pone.0007359			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806226	Green Published, Green Submitted, gold			2022-12-27	WOS:000270593800031
J	Lebarbenchon, C; Albespy, F; Brochet, AL; Grandhomme, V; Renaud, F; Fritz, H; Green, AJ; Thomas, F; van der Werf, S; Aubry, P; Guillemain, M; Gauthier-Clerc, M				Lebarbenchon, Camille; Albespy, Frederic; Brochet, Anne-Laure; Grandhomme, Viviane; Renaud, Francois; Fritz, Herve; Green, Andy J.; Thomas, Frederic; van der Werf, Sylvie; Aubry, Philippe; Guillemain, Matthieu; Gauthier-Clerc, Michel			Spread of Avian Influenza Viruses by Common Teal (Anas crecca) in Europe	PLOS ONE			English	Article							WATER-BORNE TRANSMISSION; WILD BIRDS; A VIRUS; MIGRATORY WATERFOWL; H5N1; CAMARGUE; PERSISTENCE; DUCKS; SURVEILLANCE; INFECTIVITY	Since the recent spread of highly pathogenic (HP) H5N1 subtypes, avian influenza virus (AIV) dispersal has become an increasing focus of research. As for any other bird-borne pathogen, dispersal of these viruses is related to local and migratory movements of their hosts. In this study, we investigated potential AIV spread by Common Teal (Anas crecca) from the Camargue area, in the South of France, across Europe. Based on bird-ring recoveries, local duck population sizes and prevalence of infection with these viruses, we built an individual-based spatially explicit model describing bird movements, both locally (between wintering areas) and at the flyway scale. We investigated the effects of viral excretion duration and inactivation rate in water by simulating AIV spread with varying values for these two parameters. The results indicate that an efficient AIV dispersal in space is possible only for excretion durations longer than 7 days. Virus inactivation rate in the environment appears as a key parameter in the model because it allows local persistence of AIV over several months, the interval between two migratory periods. Virus persistence in water thus represents an important component of contamination risk as ducks migrate along their flyway. Based on the present modelling exercise, we also argue that HP H5N1 AIV is unlikely to be efficiently spread by Common Teal dispersal only.	[Lebarbenchon, Camille; Albespy, Frederic; Brochet, Anne-Laure; Gauthier-Clerc, Michel] Ctr Rech Tour Valat, Arles, France; [Lebarbenchon, Camille; Grandhomme, Viviane; Renaud, Francois; Thomas, Frederic] IRD, UMR CNRS IRD 2724, GEMI, Montpellier, France; [Lebarbenchon, Camille; Grandhomme, Viviane; van der Werf, Sylvie] Univ Paris Diderot, Unite Genet Mol Virus ARN, CNRS, URA3015,EA302,Inst Pasteur, Paris, France; [Albespy, Frederic; Brochet, Anne-Laure; Guillemain, Matthieu] CNERA Avifaune Migratrice Tour Du Valat, ONCFS, Arles, France; [Albespy, Frederic; Aubry, Philippe] Direct Etud & Rech, ONCFS, Le Perray En Yvelines, France; [Fritz, Herve] Univ Claude Bernard Lyon 1, Univ Lyon, CNRS, UMR 5558 Biometrie & Biol Evolut, Villeurbanne, France; [Green, Andy J.] CSIC, Dept Wetland Ecol, Estn Biol Donana, Seville, Spain; [Thomas, Frederic] Univ Montreal, Dept Sci Biol, Inst Rech Biol Vegetale, Montreal, PQ, Canada	Institut de Recherche pour le Developpement (IRD); Centre National de la Recherche Scientifique (CNRS); Le Reseau International des Instituts Pasteur (RIIP); Institut Pasteur Paris; UDICE-French Research Universities; Universite Paris Cite; Centre National de la Recherche Scientifique (CNRS); CNRS - Institute of Ecology & Environment (INEE); UDICE-French Research Universities; Universite Claude Bernard Lyon 1; Consejo Superior de Investigaciones Cientificas (CSIC); CSIC - Estacion Biologica de Donana (EBD); Universite de Montreal	Lebarbenchon, C (corresponding author), Ctr Rech Tour Valat, Arles, France.	cleb@uga.edu	Fritz, Herve/D-1729-2014; Lebarbenchon, Camille/H-7245-2013; Green, Andy J/A-5189-2008; Lebarbenchon, Camille/GLQ-7287-2022	Fritz, Herve/0000-0002-7106-3661; Lebarbenchon, Camille/0000-0002-0922-7573; Green, Andy J/0000-0002-1268-4951; Lebarbenchon, Camille/0000-0002-0922-7573; Aubry, Philippe/0000-0002-0964-1942; THOMAS, Frederic/0000-0003-2238-1978; van der WERF, Sylvie/0000-0002-1148-4456				Breban R, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000346; BROCHET A, POTENTIAL DIST UNPUB; Brown JD, 2007, AVIAN DIS, V51, P285, DOI 10.1637/7636-042806R.1; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Brown JD, 2009, VET MICROBIOL, V136, P20, DOI 10.1016/j.vetmic.2008.10.027; Chen H, 2006, P NATL ACAD SCI USA, V103, P2845, DOI 10.1073/pnas.0511120103; Chen R, 2009, VIROLOGY, V383, P156, DOI 10.1016/j.virol.2008.10.015; Clausen P, 2002, ACTA OECOL, V23, P191, DOI 10.1016/S1146-609X(02)01150-5; Cramp S., 1977, HDB BIRDS EUROPE MID; Delany S, 2006, WATERBIRD POPULATION; Donnelly A, 2009, INT J BIOMETEOROL, V53, P211, DOI 10.1007/s00484-009-0206-7; Duncan P, 1999, J APPL ECOL, V36, P11, DOI 10.1046/j.1365-2664.1999.00363.x; *EUR ENV AG OP GUI, 2006, GUID GEOGR DAT MAPS; Feare CJ, 2006, VIROL J, V3, DOI 10.1186/1743-422X-3-96; Fouchier RAM, 2000, J CLIN MICROBIOL, V38, P4096, DOI 10.1128/JCM.38.11.4096-4101.2000; Fransson T, 2001, SWEDISH BIRD RINGING, V1; Gaidet N, 2008, EMERG INFECT DIS, V14, P1164, DOI 10.3201/eid1407.071477; Gaidet N, 2007, J WILDLIFE DIS, V43, pS22; Gaidet N, 2007, EMERG INFECT DIS, V13, P626, DOI 10.3201/eid1304.061011; Gaidet N, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000127; Gauthier-Clerc M, 2007, IBIS, V149, P202, DOI 10.1111/j.1474-919X.2007.00699.x; Gauthier-Clerc M, 2001, ARDEA, V89, P221; Gilbert M, 2006, EMERG INFECT DIS, V12, P1650, DOI 10.3201/eid1211.060223; Globig A, 2009, TRANSBOUND EMERG DIS, V56, P57, DOI 10.1111/j.1865-1682.2008.01061.x; Guillemain M, 2005, IBIS, V147, P688, DOI 10.1111/j.1474-919X.2005.00446.x; Guillemain M, 2005, WILDLIFE BIOL, V11, P81, DOI 10.2981/0909-6396(2005)11[81:LCTABS]2.0.CO;2; GUILLEMAIN M, COMP MIGRAT IN PRESS; Guillemain M, 2007, WILDLIFE BIOL, V13, P102, DOI 10.2981/0909-6396(2007)13[102:WTOLDD]2.0.CO;2; Guillemain M, 2006, WILDLIFE BIOL, V12, P163, DOI 10.2981/0909-6396(2006)12[163:SMDOTA]2.0.CO;2; HINSHAW VS, 1979, INTERVIROLOGY, V11, P66, DOI 10.1159/000149014; Jourdain E, 2007, EMERG INFECT DIS, V13, P365, DOI 10.3201/eid1303.060301; Kayser Y, 2008, REV ECOL-TERRE VIE, V63, P299; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Khalenkov A, 2008, J VIROL METHODS, V149, P180, DOI 10.1016/j.jviromet.2008.01.001; Kilpatrick AM, 2006, P NATL ACAD SCI USA, V103, P19368, DOI 10.1073/pnas.0609227103; Latorre-Margalef N, 2009, P ROY SOC B-BIOL SCI, V276, P1029, DOI 10.1098/rspb.2008.1501; Le Gall-Recule G, 2008, AVIAN PATHOL, V37, P15, DOI 10.1080/03079450701774835; LEBARBENCHON C, AVIAN DIS IN PRESS; Lebarbenchon C, 2007, INFECT GENET EVOL, V7, P604, DOI 10.1016/j.meegid.2007.05.009; LEBRETON JD, 1973, CR ACAD SCI D NAT, V277, P2417; Leung YHC, 2007, EMERG INFECT DIS, V13, P1380, DOI 10.3201/eid1309.070517; Lu HG, 2004, AVIAN DIS, V48, P263, DOI 10.1637/7064; MARKWELL DD, 1982, APPL ENVIRON MICROB, V43, P110, DOI 10.1128/AEM.43.1.110-115.1982; Matthiopoulos J, 2003, ECOL MODEL, V159, P239, DOI 10.1016/S0304-3800(02)00293-4; Melville DS, 2006, LETT APPL MICROBIOL, V42, P435, DOI 10.1111/j.1472-765X.2006.01892.x; Munster VJ, 2007, PLOS PATHOG, V3, P630, DOI 10.1371/journal.ppat.0030061; Nagy A, 2009, VET MICROBIOL, V133, P257, DOI 10.1016/j.vetmic.2008.07.013; Newton I, 2008, MIGRATION ECOLOGY OF BIRDS, P1; OGILVIE M, 1983, THESIS U BRISTOL UK; OIE, 2009, UPD HIGHL PATH AV IN; Olsen B, 2006, SCIENCE, V312, P384, DOI 10.1126/science.1122438; Pradel R, 1997, J WILDLIFE MANAGE, V61, P816, DOI 10.2307/3802189; Rambaut A, 2008, NATURE, V453, P615, DOI 10.1038/nature06945; Ridgill, 1990, COLD WEATHER MOVEMEN; Roche B, 2009, INFECT GENET EVOL, V9, P800, DOI 10.1016/j.meegid.2009.04.009; Rohani P, 2009, P NATL ACAD SCI USA, V106, P10365, DOI 10.1073/pnas.0809026106; Rubolini D, 2007, CLIM RES, V35, P135, DOI 10.3354/cr00720; Scott D.A., 1996, ATLAS ANATIDAE POPUL; Smith GJD, 2009, EMERG INFECT DIS, V15, P402, DOI 10.3201/eid1503.081190; STALLKNECHT DE, 1990, AVIAN DIS, V34, P406, DOI 10.2307/1591428; STALLKNECHT DE, 1990, AVIAN DIS, V34, P412, DOI 10.2307/1591429; Tamisier A., 1999, CAMARGUE CANARDS FOU; Teifke JP, 2007, VET PATHOL, V44, P137, DOI 10.1354/vp.44-2-137; Tottrup AP, 2008, BIOL LETTERS, V4, P685, DOI 10.1098/rsbl.2008.0290; Van der Goot JA, 2003, EPIDEMIOL INFECT, V131, P1003, DOI 10.1017/S0950268803001067; van Gils JA, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000184; Wallensten A, 2007, EMERG INFECT DIS, V13, P404, DOI 10.3201/eid1303.061130; Weber TP, 2007, EMERG INFECT DIS, V13, P1139, DOI 10.3201/eid1308.070319; Weber TP, 2008, J INFECTION, V57, P361, DOI 10.1016/j.jinf.2008.08.013; Weber TP, 2008, VIROL J, V5, DOI 10.1186/1743-422X-5-57; WEBSTER RG, 1978, VIROLOGY, V84, P268, DOI 10.1016/0042-6822(78)90247-7; WEBSTER RG, 1992, MICROBIOL REV, V56, P152, DOI 10.1128/MMBR.56.1.152-179.1992; WOLFF WJ, 1966, ARDEA, V54, P230	73	41	42	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7289	10.1371/journal.pone.0007289	http://dx.doi.org/10.1371/journal.pone.0007289			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802387	gold, Green Published, Green Submitted			2022-12-27	WOS:000270593600005
J	van de Sluis, B; Groot, AJ; Vermeulen, J; van der Wall, E; van Diest, PJ; Wijmenga, C; Klomp, LW; Vooijs, M				van de Sluis, Bart; Groot, Arjan J.; Vermeulen, Jeroen; van der Wall, Elsken; van Diest, Paul J.; Wijmenga, Cisca; Klomp, Leo W.; Vooijs, Marc			COMMD1 Promotes pVHL and O-2-Independent Proteolysis of HIF-1 alpha via HSP90/70	PLOS ONE			English	Article							HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; HIF-ALPHA; UBIQUITIN LIGASE; COPPER TOXICOSIS; FACTOR-I; DEGRADATION; PROTEIN; BINDING; INHIBITORS; MURR1	Background: The Copper Metabolism MURR1 Domain containing 1 protein COMMD1 has been associated with copper homeostasis, NF-kappa B signaling, and sodium transport. Recently, we identified COMMD1 as a novel protein in HIF-1 signaling. Mouse embryos deficient for Commd1 have increased expression of hypoxia/HIF-regulated genes i.e. VEGF, PGK and Bnip3. Hypoxia-inducible factors (HIFs) are master regulators of oxygen homeostasis, which control angiogenesis, erythropoiesis, glycolysis and cell survival/proliferation under normal and pathologic conditions. Although HIF activity is mainly controlled by ubiquitination and protein degradation by the von Hippel Lindau (pVHL) tumor suppressor gene other mechanisms have recently been identified that regulate HIF signaling independently of pVHL. Principal Findings: Here we characterized the mechanism by which COMMD1 regulates HIF-1 alpha protein degradation. We show that COMMD1 competes with the chaperone heat shock protein HSP90b for binding to the NH2-terminal DNA-binding and heterodimerization domain of HIF-1 alpha to regulate HIF-1 alpha stability together with HSP70. Inhibition of HSP90 activity with 17-Allylamino-17-demethoxygeldanamycin (17-AAG) increased COMMD1-mediated HIF-1 alpha degradation independent of ubiquitin and pVHL. Conclusion/Significance: These data reveal a novel role for COMMD1 in conjunction with HSP90 beta/HSP70 in the ubiquitin and O-2-independent regulation of HIF-1 alpha.			van de Sluis, B (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Pathol & Lab Med, NL-9713 AV Groningen, Netherlands.	m.vooijs@umcutrecht.nl	Vooijs, Marc/K-3522-2019; Wijmenga, Cisca/D-2173-2009; Wijmenga, Cisca/AAE-7719-2019	Wijmenga, Cisca/0000-0002-5635-1614; van de Sluis, Bart (A.J.A.)/0000-0003-3039-4365				Bos R, 2003, CANCER, V97, P1573, DOI 10.1002/cncr.11246; Bruick RK, 2001, SCIENCE, V294, P1337, DOI 10.1126/science.1066373; Burstein E, 2005, J BIOL CHEM, V280, P22222, DOI 10.1074/jbc.M501928200; Cho S, 2001, FEBS LETT, V498, P62, DOI 10.1016/S0014-5793(01)02499-1; de Bie P, 2007, GASTROENTEROLOGY, V133, P1316, DOI 10.1053/j.gastro.2007.07.020; Fath DM, 2006, J BIOL CHEM, V281, P13612, DOI 10.1074/jbc.M600456200; Isaacs JS, 2002, J BIOL CHEM, V277, P29936, DOI 10.1074/jbc.M204733200; Ivan M, 2001, SCIENCE, V292, P464, DOI 10.1126/science.1059817; Jaakkola P, 2001, SCIENCE, V292, P468, DOI 10.1126/science.1059796; Klomp AEM, 2003, J HEPATOL, V39, P703, DOI 10.1016/S0168-8278(03)00380-5; Kong XG, 2006, MOL CELL BIOL, V26, P2019, DOI 10.1128/MCB.26.6.2019-2028.2006; Kong XG, 2007, J BIOL CHEM, V282, P15498, DOI 10.1074/jbc.M700704200; KULKA RG, 1988, J BIOL CHEM, V263, P15726; Liu YV, 2007, CELL CYCLE, V6, P656, DOI 10.4161/cc.6.6.3981; Liu YV, 2007, MOL CELL, V25, P207, DOI 10.1016/j.molcel.2007.01.001; Mabjeesh NJ, 2002, CANCER RES, V62, P2478; Maine GN, 2007, CELL MOL LIFE SCI, V64, P1997, DOI 10.1007/s00018-007-7078-y; Maine GN, 2007, EMBO J, V26, P436, DOI 10.1038/sj.emboj.7601489; Maine GN, 2009, BIOCHEM J, V417, P601, DOI 10.1042/BJ20080854; Mao XC, 2009, GENE DEV, V23, P849, DOI 10.1101/gad.1748409; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Minet E, 1999, FEBS LETT, V460, P251, DOI 10.1016/S0014-5793(99)01359-9; MULLER PA, 2009, NUCL CYTOSOLIC TRANS; Picard D, 2002, CELL MOL LIFE SCI, V59, P1640, DOI 10.1007/PL00012491; Pouyssegur J, 2006, NATURE, V441, P437, DOI 10.1038/nature04871; PUGH CW, 1991, P NATL ACAD SCI USA, V88, P10553, DOI 10.1073/pnas.88.23.10553; SEMENIUK C, 2007, WETLANDS ECOL CONSER, V1, P1; Semenza GL, 2007, DRUG DISCOV TODAY, V12, P853, DOI 10.1016/j.drudis.2007.08.006; Tao TY, 2003, J BIOL CHEM, V278, P41593, DOI 10.1074/jbc.C300391200; van de Sluis B, 2002, HUM MOL GENET, V11, P165, DOI 10.1093/hmg/11.2.165; van de Sluis B, 2007, CELL CYCLE, V6, P2091, DOI 10.4161/cc.6.17.4646; van de Sluis B, 2007, MOL CELL BIOL, V27, P4142, DOI 10.1128/MCB.01932-06; WANG GL, 1993, J BIOL CHEM, V268, P21513; WANG GL, 1995, P NATL ACAD SCI USA, V92, P5510, DOI 10.1073/pnas.92.12.5510; Zhou J, 2004, J BIOL CHEM, V279, P13506, DOI 10.1074/jbc.M310164200	35	40	41	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7332	10.1371/journal.pone.0007332	http://dx.doi.org/10.1371/journal.pone.0007332			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802386	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593600010
J	Fayad, W; Fryknas, M; Brnjic, S; Olofsson, MH; Larsson, R; Linder, S				Fayad, Walid; Fryknas, Marten; Brnjic, Slavica; Olofsson, Maria Haegg; Larsson, Rolf; Linder, Stig			Identification of a Novel Topoisomerase Inhibitor Effective in Cells Overexpressing Drug Efflux Transporters	PLOS ONE			English	Article								Background: Natural product structures have high chemical diversity and are attractive as lead structures for discovery of new drugs. One of the disease areas where natural products are most frequently used as therapeutics is oncology. Method and Findings: A library of natural products (NCI Natural Product set) was screened for compounds that induce apoptosis of HCT116 colon carcinoma cells using an assay that measures an endogenous caspase-cleavage product. One of the apoptosis-inducing compounds identified in the screen was thaspine ( taspine), an alkaloid from the South American tree Croton lechleri. The cortex of this tree is used for medicinal purposes by tribes in the Amazonas basin. Thaspine was found to induce conformational activation of the pro-apoptotic proteins Bak and Bax, mitochondrial cytochrome c release and mitochondrial membrane permeabilization in HCT116 cells. Analysis of the gene expression signature of thaspine-treated cells suggested that thaspine is a topoisomerase inhibitor. Inhibition of both topoisomerase I and II was observed using in vitro assays, and thaspine was found to have a reduced cytotoxic effect on a cell line with a mutated topoisomerase II enzyme. Interestingly, in contrast to the topoisomerase II inhibitors doxorubicin, etoposide and mitoxantrone, thaspine was cytotoxic to cell lines overexpressing the PgP or MRP drug efflux transporters. We finally show that thaspine induces wide-spread apoptosis in colon carcinoma multicellular spheroids and that apoptosis is induced in two xenograft mouse models in vivo. Conclusions: The alkaloid thaspine from the cortex of Croton lechleri is a dual topoisomerase inhibitor effective in cells overexpressing drug efflux transporters and induces wide-spread apoptosis in multicellular spheroids.			Fayad, W (corresponding author), Karolinska Hosp & Inst, Dept Pathol & Oncol, Stockholm, Sweden.	Stig.Linder@ki.se	Fayad, Walid M. O. H./O-7269-2018	Fayad, Walid M. O. H./0000-0002-7975-0343				Arcamone FM, 1998, BIOCHIMIE, V80, P201, DOI 10.1016/S0300-9084(98)80003-5; Baldo P, 2008, CURR CANCER DRUG TAR, V8, P647, DOI 10.2174/156800908786733513; BODLEY A, 1989, CANCER RES, V49, P5969; BROCKMAN RW, 1976, CANCER TREAT REP, V60, P1317; BUGG BY, 1991, P NATL ACAD SCI USA, V88, P7654, DOI 10.1073/pnas.88.17.7654; CHANCE B, 1963, J BIOL CHEM, V238, P418; Cummings J, 2008, BRIT J PHARMACOL, V153, P646, DOI 10.1038/sj.bjp.0707441; da Rocha Adriana B., 2001, Current Opinion in Pharmacology, V1, P364; DANKS MK, 1988, BIOCHEMISTRY-US, V27, P8861, DOI 10.1021/bi00424a026; Denny WA, 2003, CURR TOP MED CHEM, V3, P339, DOI 10.2174/1568026033452555; Dittrich C, 2003, INVEST NEW DRUG, V21, P347, DOI 10.1023/A:1025476813365; DURAND RE, 1981, CANCER RES, V41, P3495; ERLICHMAN C, 1984, CANCER RES, V44, P5369; Gavathiotis E, 2008, NATURE, V455, P1076, DOI 10.1038/nature07396; Griffiths GJ, 1999, J CELL BIOL, V144, P903, DOI 10.1083/jcb.144.5.903; GUPTA RS, 1983, CANCER RES, V43, P505; Hagg M, 2002, INVEST NEW DRUG, V20, P253, DOI 10.1023/A:1016249728664; Herrmann R, 2008, J BIOMOL SCREEN, V13, P1, DOI 10.1177/1087057107310442; ITOKAWA H, 1991, CHEM PHARM BULL, V39, P1041, DOI 10.1248/cpb.39.1041; Jonsson E, 1997, BRIT J CANCER, V76, P211, DOI 10.1038/bjc.1997.364; Kaufmann SH, 2000, EXP CELL RES, V256, P42, DOI 10.1006/excr.2000.4838; KOBAYASHI H, 1993, P NATL ACAD SCI USA, V90, P3294, DOI 10.1073/pnas.90.8.3294; Koehn FE, 2005, NAT REV DRUG DISCOV, V4, P206, DOI 10.1038/nrd1657; Kola I, 2004, NAT REV DRUG DISCOV, V3, P711, DOI 10.1038/nrd1470; Kramer G, 2004, CANCER RES, V64, P1751, DOI 10.1158/0008-5472.CAN-03-2455; Labi V, 2006, CELL DEATH DIFFER, V13, P1325, DOI 10.1038/sj.cdd.4401940; Lamb J, 2006, SCIENCE, V313, P1929, DOI 10.1126/science.1132939; Lemasters JJ, 1998, BBA-BIOENERGETICS, V1366, P177, DOI 10.1016/S0005-2728(98)00112-1; LEVINSON C, 1967, NATURE, V216, P74, DOI 10.1038/216074a0; Lindhagen E, 2008, NAT PROTOC, V3, P1364, DOI 10.1038/nprot.2008.114; Ling V, 1997, CANCER CHEMOTH PHARM, V40, pS3, DOI 10.1007/s002800051053; Lloyd DG, 2006, DRUG DISCOV TODAY, V11, P149, DOI 10.1016/S1359-6446(05)03688-3; Mandic A, 2001, MOL CELL BIOL, V21, P3684, DOI 10.1128/MCB.21.11.3684-3691.2001; Nakashima T, 2000, CANCER RES, V60, P1229; Nitiss JL, 2009, NAT REV CANCER, V9, P338, DOI 10.1038/nrc2607; Nygren P, 2003, J INTERN MED, V253, P46, DOI 10.1046/j.1365-2796.2003.01098.x; OLOFSSON MH, CANC BIOMAR IN PRESS; PERDUE G P, 1979, Journal of Pharmaceutical Sciences, V68, P124, DOI 10.1002/jps.2600680145; PIETERS L, 1993, J NAT PROD, V56, P899, DOI 10.1021/np50096a013; Pommier Y, 2006, NAT REV CANCER, V6, P789, DOI 10.1038/nrc1977; Radhakrishnan SK, 2006, CANCER RES, V66, P9731, DOI 10.1158/0008-5472.CAN-06-1576; Seibert SF, 2006, ORG BIOMOL CHEM, V4, P2233, DOI 10.1039/b601386d; Srivastava V, 2005, BIOORGAN MED CHEM, V13, P5892, DOI 10.1016/j.bmc.2005.05.066; SUTHERLAND R M, 1976, Current Topics in Radiation Research Quarterly, V11, P87; SUTHERLAND RM, 1988, SCIENCE, V240, P177, DOI 10.1126/science.2451290; TAKAHASHI M, 1987, BIOCHIM BIOPHYS ACTA, V926, P215, DOI 10.1016/0304-4165(87)90206-6; Teicher BA, 2008, BIOCHEM PHARMACOL, V75, P1262, DOI 10.1016/j.bcp.2007.10.016; Uehara Y, 2003, CURR CANCER DRUG TAR, V3, P325, DOI 10.2174/1568009033481796; Vandenberghe I, 2008, BIOCHEM PHARMACOL, V76, P453, DOI 10.1016/j.bcp.2008.05.031; Wei MC, 2001, SCIENCE, V292, P727, DOI 10.1126/science.1059108; Wickstrom M, 2007, BIOCHEM PHARMACOL, V73, P25, DOI 10.1016/j.bcp.2006.08.016; YAGI M, 1981, BIOCHEM BIOPH RES CO, V98, P642, DOI 10.1016/0006-291X(81)91162-1; YAMASHITA Y, 1990, CANCER RES, V50, P5841; YORK J, 1981, BIOCHEM PHARMACOL, V30, P3239, DOI 10.1016/0006-2952(81)90524-4; ZHANG Y, 2008, CANC LETT; Zhang Yan-Min, 2007, Zhongguo Zhong Yao Za Zhi, V32, P953; Zhang Yan-min, 2007, Zhong Yao Cai, V30, P429	57	40	40	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7238	10.1371/journal.pone.0007238	http://dx.doi.org/10.1371/journal.pone.0007238			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19798419	Green Published, Green Submitted, gold			2022-12-27	WOS:000270593300004
J	Chang, AYW; Chan, JYH; Chuang, YC; Chan, SHH				Chang, Alice Y. W.; Chan, Julie Y. H.; Chuang, Yao-Chung; Chan, Samuel H. H.			Brain Stem Death as the Vital Determinant for Resumption of Spontaneous Circulation after Cardiac Arrest in Rats	PLOS ONE			English	Article							ROSTRAL VENTROLATERAL MEDULLA; SYSTEMIC ARTERIAL-PRESSURE; CONFERS CARDIOVASCULAR PROTECTION; ACUTE MEVINPHOS INTOXICATION; TIME SPECTRAL-ANALYSIS; SIGNALS; HEAT-SHOCK-PROTEIN-70; APOPTOSIS; ONLINE	Background: Spontaneous circulation returns to less than half of adult cardiac arrest victims who received in-hospital resuscitation. One clue for this disheartening outcome arises from the prognosis that asystole invariably takes place, after a time lag, on diagnosis of brain stem death. The designation of brain stem death as the point of no return further suggests that permanent impairment of the brain stem cardiovascular regulatory machinery precedes death. It follows that a crucial determinant for successful revival of an arrested heart is that spontaneous circulation must resume before brain stem death commences. Here, we evaluated the hypothesis that maintained functional integrity of the rostral ventrolateral medulla (RVLM), a neural substrate that is intimately related to brain stem death and central circulatory regulation, holds the key to the vital time-window between cardiac arrest and resumption of spontaneous circulation. Methodology/Principal Findings: An animal model of brain stem death employing the pesticide mevinphos as the experimental insult in Sprague-Dawley rats was used. Intravenous administration of lethal doses of mevinphos elicited an abrupt cardiac arrest, accompanied by elevated systemic arterial pressure and anoxia, augmented neuronal excitability and enhanced microvascular perfusion in RVLM. This period represents the vital time-window between cardiac arrest and resumption of spontaneous circulation in our experimental model. Animals with restored spontaneous circulation exhibited maintained neuronal functionality in RVLM beyond this critical time-window, alongside resumption of baseline tissue oxygen and enhancement of local blood flow. Intriguingly, animals that subsequently died manifested sustained anoxia, diminished local blood flow, depressed mitochondrial electron transport activities and reduced ATP production, leading to necrotic cell death in RVLM. That amelioration of mitochondrial dysfunction and bioenergetic failure in RVLM by coenzyme Q10, the mobile electron carrier in mitochondrial respiratory chain, or oxygenation restored spontaneous circulation further established a causal relationship between functionality of RVLM and resumed spontaneous circulation after cardiac arrest. Conclusions/Significance: We conclude that whereas necrotic cell death because of bioenergetic failure triggered by anoxia in RVLM, which precipitates brain stem death, negates resuscitation of an arrested heart, maintained functional integrity of this neural substrate holds the key to resumption of spontaneous circulation after cardiac arrest in rats.			Chang, AYW (corresponding author), Chang Gung Mem Hosp, Kaohsiung Med Ctr, Ctr Translat Res Biomed Sci, Kaohsiung, Kaohsiung Cty, Taiwan.	achang@adm.cgmh.org.tw; shhchan@adm.cgmh.org.tw	Chan, Julie/X-5253-2019					[Anonymous], 1976, BMJ-BRIT MED J, V2, P1187; Chan JYH, 2007, J PHYSIOL-LONDON, V581, P1293, DOI 10.1113/jphysiol.2007.130872; Chan JYH, 2007, J BIOL CHEM, V282, P4585, DOI 10.1074/jbc.M603394200; Chan JYH, 2005, PROG NEUROBIOL, V77, P396, DOI 10.1016/j.pneurobio.2005.11.004; DEREUCK J, 1979, CLIN NEUROL NEUROSUR, V81, P247, DOI 10.1016/0303-8467(79)90029-5; Eguchi Y, 1997, CANCER RES, V57, P1835; ERNSTER L, 1995, BBA-MOL BASIS DIS, V1271, P195, DOI 10.1016/0925-4439(95)00028-3; FREI B, 1990, P NATL ACAD SCI USA, V87, P4879, DOI 10.1073/pnas.87.12.4879; HATEFI Y, 1985, ANNU REV BIOCHEM, V54, P1015, DOI 10.1146/annurev.biochem.54.1.1015; HUNG TP, 1995, J NEUROL NEUROSUR PS, V58, P75, DOI 10.1136/jnnp.58.1.75; Kroemer G, 1999, BIOCHEM SOC SYMP, V66, P1; Kuo TBJ, 1997, AM J PHYSIOL-HEART C, V272, pH485, DOI 10.1152/ajpheart.1997.272.1.H485; KUO TBJ, 1993, AM J PHYSIOL, V264, pH2208, DOI 10.1152/ajpheart.1993.264.6.H2208; Kuo TBJ, 1997, AM J PHYSIOL-HEART C, V273, pH1291, DOI 10.1152/ajpheart.1997.273.3.H1291; Leist M, 1997, J EXP MED, V185, P1481, DOI 10.1084/jem.185.8.1481; Li PL, 2001, CIRCULATION, V103, P2114; LYNN J, 1981, JAMA-J AM MED ASSOC, V246, P2184; Matthews RT, 1998, P NATL ACAD SCI USA, V95, P8892, DOI 10.1073/pnas.95.15.8892; MOHANDAS A, 1971, J NEUROSURG, V35, P211, DOI 10.3171/jns.1971.35.2.0211; PALLIS C, 1983, A B C BRAIN STEM DEA; Peberdy MA, 2003, RESUSCITATION, V58, P297, DOI 10.1016/S0300-9572(03)00215-6; Sheh YL, 2007, FREE RADICAL BIO MED, V42, P1610, DOI 10.1016/j.freeradbiomed.2007.02.019; SPYER KM, 1994, J PHYSIOL-LONDON, V474, P1; Yang CH, 1995, J PHARMACOL EXP THER, V275, P1568; YANG MW, 1995, AM J PHYSIOL-HEART C, V268, pH2329, DOI 10.1152/ajpheart.1995.268.6.H2329; Yen DHT, 2005, SHOCK, V23, P353, DOI 10.1097/01.shk.0000156673.44063.e8; Yen DHT, 2001, SHOCK, V15, P35, DOI 10.1097/00024382-200115010-00006; Yen DHT, 2000, CRIT CARE MED, V28, P2805, DOI 10.1097/00003246-200008000-00021; Yien HW, 1997, CRIT CARE MED, V25, P258, DOI 10.1097/00003246-199702000-00011	29	15	15	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2009	4	11							e7744	10.1371/journal.pone.0007744	http://dx.doi.org/10.1371/journal.pone.0007744			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RZ	19888468	gold, Green Published			2022-12-27	WOS:000271414600011
J	Hayano-Kanashiro, C; Calderon-Vazquez, C; Ibarra-Laclette, E; Herrera-Estrella, L; Simpson, J				Hayano-Kanashiro, Corina; Calderon-Vazquez, Carlos; Ibarra-Laclette, Enrique; Herrera-Estrella, Luis; Simpson, June			Analysis of Gene Expression and Physiological Responses in Three Mexican Maize Landraces under Drought Stress and Recovery Irrigation	PLOS ONE			English	Article							HIGH-SALINITY STRESSES; ABSCISIC-ACID; PLANT-RESPONSES; CDNA MICROARRAY; ABIOTIC STRESS; CARBOHYDRATE-METABOLISM; REGULATORY NETWORKS; SIGNAL-TRANSDUCTION; MESSENGER-RNA; ABI3 GENE	Background: Drought is one of the major constraints for plant productivity worldwide. Different mechanisms of drought-tolerance have been reported for several plant species including maize. However, the differences in global gene expression between drought-tolerant and susceptible genotypes and their relationship to physiological adaptations to drought are largely unknown. The study of the differences in global gene expression between tolerant and susceptible genotypes could provide important information to design more efficient breeding programs to produce maize varieties better adapted to water limiting conditions. Methodology/Principal Findings: Changes in physiological responses and gene expression patterns were studied under drought stress and recovery in three Mexican maize landraces which included two drought tolerant (Cajete criollo and Michoacan 21) and one susceptible (85-2) genotypes. Photosynthesis, stomatal conductance, soil and leaf water potentials were monitored throughout the experiment and microarray analysis was carried out on transcripts obtained at 10 and 17 days following application of stress and after recovery irrigation. The two tolerant genotypes show more drastic changes in global gene expression which correlate with different physiological mechanisms of adaptation to drought. Differences in the kinetics and number of up-and down-regulated genes were observed between the tolerant and susceptible maize genotypes, as well as differences between the two tolerant genotypes. Interestingly, the most dramatic differences between the tolerant and susceptible genotypes were observed during recovery irrigation, suggesting that the tolerant genotypes activate mechanisms that allow more efficient recovery after a severe drought. Conclusions/Significance: A correlation between levels of photosynthesis and transcription under stress was observed and differences in the number, type and expression levels of transcription factor families were also identified under drought and recovery between the three maize landraces. Gene expression analysis suggests that the drought tolerant landraces have a greater capacity to rapidly modulate more genes under drought and recovery in comparison to the susceptible landrace. Modulation of a greater number of differentially expressed genes of different TF gene families is an important characteristic of the tolerant genotypes. Finally, important differences were also noted between the tolerant landraces that underlie different mechanisms of achieving tolerance.			Hayano-Kanashiro, C (corresponding author), Ctr Invest & Estudios Avanzados, Dept Ingn Genet Plantas, Guanajuato, Mexico.	jsimpson@ira.cinvestav.mx	Herrera-Estrella, Luis/ABC-7431-2020; Simpson, June/I-1057-2012; Herrera-Estrella, Luis/AAL-2472-2020; Calderon-Vazquez, Carlos/R-3601-2018; Estrella, Luis R Herrera/G-7351-2011	Simpson, June/0000-0002-1891-4914; Herrera-Estrella, Luis/0000-0001-7936-3856; Calderon-Vazquez, Carlos/0000-0002-6674-2504; Estrella, Luis R Herrera/0000-0001-7936-3856; Hayano-Kanashiro, Corina/0000-0001-7846-6124				Bartels D, 2005, CRIT REV PLANT SCI, V24, P23, DOI 10.1080/07352680590910410; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bhatnagar-Mathur P, 2008, PLANT CELL REP, V27, P411, DOI 10.1007/s00299-007-0474-9; Brady SM, 2003, PLANT J, V34, P67, DOI 10.1046/j.1365-313X.2003.01707.x; Bray EA, 1997, TRENDS PLANT SCI, V2, P48, DOI 10.1016/S1360-1385(97)82562-9; Bruce WB, 2002, J EXP BOT, V53, P13, DOI 10.1093/jexbot/53.366.13; Brugiere N, 2003, PLANT PHYSIOL, V132, P1228, DOI 10.1104/pp.102.017707; Calderon-Vazquez C, 2008, J EXP BOT, V59, P2479, DOI 10.1093/jxb/ern115; Chaves MM, 2003, FUNCT PLANT BIOL, V30, P239, DOI 10.1071/FP02076; Degenkolbe T, 2009, PLANT MOL BIOL, V69, P133, DOI 10.1007/s11103-008-9412-7; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Fischer KS., 1983, BREEDING SELECTION D; Foyer CH, 1998, PLANT PHYSIOL, V117, P283, DOI 10.1104/pp.117.1.283; Garcion C, 2006, TRENDS PLANT SCI, V11, P320, DOI 10.1016/j.tplants.2006.05.009; Gibson G., 2004, GENETIC ANAL COMPLEX, P251; Vendruscolo ECG, 2007, J PLANT PHYSIOL, V164, P1367, DOI 10.1016/j.jplph.2007.05.001; Gutierrez RA, 2007, J EXP BOT, V58, P2359, DOI 10.1093/jxb/erm079; Hegeman CE, 2001, PLANT PHYSIOL, V125, P1941, DOI 10.1104/pp.125.4.1941; Ingram J, 1996, ANNU REV PLANT PHYS, V47, P377, DOI 10.1146/annurev.arplant.47.1.377; International Maize and Wheat Improvement Center (CIMMYT), 2001, CIMMYT 1999 2000 WOR; Jia JP, 2006, PLANT J, V48, P710, DOI 10.1111/j.1365-313X.2006.02905.x; Kawaguchi R, 2004, PLANT J, V38, P823, DOI 10.1111/j.1365-313X.2004.02090.x; Kishor PBK, 2005, CURR SCI INDIA, V88, P424; Koch KE, 1996, ANNU REV PLANT PHYS, V47, P509, DOI 10.1146/annurev.arplant.47.1.509; Li WX, 2008, PLANT CELL, V20, P2238, DOI 10.1105/tpc.108.059444; Mahajan S, 2005, ARCH BIOCHEM BIOPHYS, V444, P139, DOI 10.1016/j.abb.2005.10.018; Massonneau A, 2004, J EXP BOT, V55, P2549, DOI 10.1093/jxb/erh274; Mohammadi M, 2007, PLANT CELL ENVIRON, V30, P630, DOI 10.1111/j.1365-3040.2007.01645.x; Morcuende R, 2007, PLANT CELL ENVIRON, V30, P85, DOI 10.1111/j.1365-3040.2006.01608.x; MUNOZ OA, 1983, AGROCIENCIA, V51, P115; Nelson DE, 2007, P NATL ACAD SCI USA, V104, P16450, DOI 10.1073/pnas.0707193104; Oono Y, 2003, PLANT J, V34, P868, DOI 10.1046/j.1365-313X.2003.01774.x; Ozturk ZN, 2002, PLANT MOL BIOL, V48, P551, DOI 10.1023/A:1014875215580; Park JE, 2007, J BIOL CHEM, V282, P10036, DOI 10.1074/jbc.M610524200; Parry MAJ, 2005, ANN APPL BIOL, V147, P211, DOI 10.1111/j.1744-7348.2005.00032.x; Pelleschi S, 1997, PLANT CELL ENVIRON, V20, P493, DOI 10.1046/j.1365-3040.1997.d01-89.x; PEREZ JG, 1979, COMPORTAMIENTO MAICE; PHILLIPS RD, 1976, NEW PHYTOL, V77, P599, DOI 10.1111/j.1469-8137.1976.tb04652.x; Pingali P.L., 2001, M WORLD MAIZ NEEDS T; Poroyko V, 2007, J EXP BOT, V58, P279, DOI 10.1093/jxb/erl119; Rabbani MA, 2003, PLANT PHYSIOL, V133, P1755, DOI 10.1104/pp.103.025742; Reynolds M, 2007, J EXP BOT, V58, P177, DOI 10.1093/jxb/erl250; Ribaut JM, 2007, J EXP BOT, V58, P351, DOI 10.1093/jxb/erl214; Schafleitner R, 2007, PLANT PHYSIOL BIOCH, V45, P673, DOI 10.1016/j.plaphy.2007.06.003; Seki M, 2002, PLANT J, V31, P279, DOI 10.1046/j.1365-313X.2002.01359.x; Seki M, 2007, CURR OPIN PLANT BIOL, V10, P296, DOI 10.1016/j.pbi.2007.04.014; Shen QX, 2001, PLANT MOL BIOL, V45, P327, DOI 10.1023/A:1006460231978; Shinozaki K, 1997, PLANT PHYSIOL, V115, P327, DOI 10.1104/pp.115.2.327; Shinozaki K, 2007, J EXP BOT, V58, P221, DOI 10.1093/jxb/erl164; Smyth G., 2003, LIMMA LINEAR MODELS; Spollen WG, 2008, BMC PLANT BIOL, V8, DOI 10.1186/1471-2229-8-32; Sun WN, 2002, BBA-GENE STRUCT EXPR, V1577, P1, DOI 10.1016/S0167-4781(02)00417-7; Talame V, 2007, J EXP BOT, V58, P229, DOI 10.1093/jxb/erl163; Tamminen I, 2001, PLANT J, V25, P1, DOI 10.1046/j.1365-313x.2001.00927.x; Thimm O, 2004, PLANT J, V37, P914, DOI 10.1111/j.1365-313X.2004.02016.x; Tuberosa R, 2007, CROP SCI, V47, pS120, DOI 10.2135/cropsci2007.04.0001IPBS; Umezawa T, 2006, CURR OPIN BIOTECH, V17, P113, DOI 10.1016/j.copbio.2006.02.002; Vinocur B, 2005, CURR OPIN BIOTECH, V16, P123, DOI 10.1016/j.copbio.2005.02.001; Wang WX, 2003, PLANTA, V218, P1, DOI 10.1007/s00425-003-1105-5; Wasilewska A, 2008, MOL PLANT, V1, P198, DOI 10.1093/mp/ssm022; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Xiao WY, 2000, PLANT MOL BIOL, V44, P451, DOI 10.1023/A:1026501430422; Xiong LM, 2002, PLANT CELL, V14, pS165, DOI 10.1105/tpc.000596; Xue GP, 2008, PLANT MOL BIOL, V67, P197, DOI 10.1007/s11103-008-9311-y; Yamaguchi-Shinozaki K, 2006, ANNU REV PLANT BIOL, V57, P781, DOI 10.1146/annurev.arplant.57.032905.105444; Yang YH, 2002, NUCLEIC ACIDS RES, V30, DOI 10.1093/nar/30.4.e15; Yu LX, 2003, PLANT PHYSIOL, V131, P568, DOI 10.1104/pp.014365; Zheng J, 2004, PLANT MOL BIOL, V55, P807, DOI 10.1007/s11103-005-1969-9	68	149	177	3	42	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2009	4	10							e7531	10.1371/journal.pone.0007531	http://dx.doi.org/10.1371/journal.pone.0007531			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RW	19888455	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414300001
J	Heim, KC; Gamsby, JJ; Hever, MP; Freemantle, SJ; Loros, JJ; Dunlap, JC; Spinella, MJ				Heim, Kelly C.; Gamsby, Joshua J.; Hever, Mary P.; Freemantle, Sarah J.; Loros, Jennifer J.; Dunlap, Jay C.; Spinella, Michael J.			Retinoic Acid Mediates Long-Paced Oscillations in Retinoid Receptor Activity: Evidence for a Potential Role for RIP140	PLOS ONE			English	Article							TRANSCRIPTIONAL COREPRESSOR RIP140; INTERACTING PROTEIN-140; NUCLEAR RECEPTOR; ANDROGEN RECEPTOR; OXIDATIVE-METABOLISM; NEGATIVE-FEEDBACK; ESTROGEN; BINDING; GENE; EXPRESSION	Background: Mechanisms that underlie oscillatory transcriptional activity of nuclear receptors (NRs) are incompletely understood. Evidence exists for rapid, cyclic recruitment of coregulatory complexes upon activation of nuclear receptors. RIP140 is a NR coregulator that represses the transactivation of agonist-bound nuclear receptors. Previously, we showed that RIP140 is inducible by all-trans retinoic acid ( RA) and mediates limiting, negative-feedback regulation of retinoid signaling. Methodology and Findings: Here we report that in the continued presence of RA, long-paced oscillations of retinoic acid receptor (RAR) activity occur with a period ranging from 24 to 35 hours. Endogenous expression of RIP140 and other RA-target genes also oscillate in the presence of RA. Cyclic retinoid receptor transactivation is ablated by constitutive overexpression of RIP140. Further, depletion of RIP140 disrupts cyclic expression of the RA target gene HOXA5. Evidence is provided that RIP140 may limit RAR signaling in a selective, non-redundant manner in contrast to the classic NR coregulators NCoR1 and SRC1 that are not RA-inducible, do not cycle, and may be partially redundant in limiting RAR activity. Finally, evidence is provided that RIP140 can repress and be induced by other nuclear receptors in a manner that suggests potential participation in other NR oscillations. Conclusions and Significance: We provide evidence for novel, long-paced oscillatory retinoid receptor activity and hypothesize that this may be paced in part, by RIP140. Oscillatory NR activity may be involved in mediating hormone actions of physiological and pathological importance.			Heim, KC (corresponding author), Dept Pharmacol & Toxicol, Hanover, NH 03755 USA.	Michael.Spinella@Dartmouth.EDU	Dunlap, Jay/L-6232-2013; Spinella, Michael/B-7210-2014; Loros, Jennifer/B-6293-2014; Gamsby, Joshua J/H-9606-2014	Dunlap, Jay/0000-0003-1577-0457; 	NCI NIH HHS [R01 CA104312, R21 CA124817, T32-CA-009658, R21-CA124817, T32 CA009658, R01-CA104312] Funding Source: Medline; NIGMS NIH HHS [R37 GM034985, R01 GM034985, GM083336, GM034985, R01 GM083336, R01 GM034985-25] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R21CA124817, R01CA104312, T32CA009658] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM083336, R01GM034985, R37GM034985] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Aoyagi S, 2008, MOL CELL ENDOCRINOL, V280, P1, DOI 10.1016/j.mce.2007.08.016; Augereau P, 2006, MOL PHARMACOL, V69, P1338, DOI 10.1124/mol.105.017376; Augereau P, 2006, J STEROID BIOCHEM, V102, P51, DOI 10.1016/j.jsbmb.2006.09.005; Buletic Z, 2006, CRIT REV EUKAR GENE, V16, P193, DOI 10.1615/CritRevEukarGeneExpr.v16.i3.10; Carascossa S, 2006, MOL ENDOCRINOL, V20, P1506, DOI 10.1210/me.2005-0286; Carroll JS, 2006, NAT GENET, V38, P1289, DOI 10.1038/ng1901; Chen YX, 2004, MOL CELL ENDOCRINOL, V226, P43, DOI 10.1016/j.mce.2004.07.001; Debevec D, 2007, MOL ENDOCRINOL, V21, P1581, DOI 10.1210/me.2007-0103; DETHE H, 1990, NATURE, V343, P177, DOI 10.1038/343177a0; Frasor J, 2003, ENDOCRINOLOGY, V144, P4562, DOI 10.1210/en.2003-0567; Freemantle SJ, 2003, ONCOGENE, V22, P7305, DOI 10.1038/sj.onc.1206936; Gamsby JJ, 2009, J BIOL RHYTHM, V24, P193, DOI 10.1177/0748730409334748; Gurevich I, 2007, TOXICOL APPL PHARM, V223, P288, DOI 10.1016/j.taap.2007.05.019; Heim KC, 2007, MOL CANCER, V6, DOI 10.1186/1476-4598-6-57; Herzog B, 2007, MOL ENDOCRINOL, V21, P2687, DOI 10.1210/me.2007-0213; Hu XL, 2004, J BIOL CHEM, V279, P319, DOI 10.1074/jbc.M307621200; Kang ZG, 2002, J BIOL CHEM, V277, P48366, DOI 10.1074/jbc.M209074200; Kerley JS, 2001, BIOCHEM BIOPH RES CO, V285, P969, DOI 10.1006/bbrc.2001.5274; Kim S, 2005, J BONE MINER RES, V20, P305, DOI 10.1359/JBMR.041112; Lahav G, 2008, ADV EXP MED BIOL, V641, P28; Lee CH, 1999, J BIOL CHEM, V274, P31320, DOI 10.1074/jbc.274.44.31320; Leonardsson G, 2004, P NATL ACAD SCI USA, V101, P8437, DOI 10.1073/pnas.0401013101; LEROY P, 1991, P NATL ACAD SCI USA, V88, P10138, DOI 10.1073/pnas.88.22.10138; Lin R, 2002, MOL ENDOCRINOL, V16, P1243, DOI 10.1210/me.16.6.1243; Liu X, 2009, CLIN CANCER RES, V15, P1177, DOI 10.1158/1078-0432.CCR-08-1355; Loots G, 2007, BIOINFORMATICS, V23, P122, DOI 10.1093/bioinformatics/btl546; Mark Manuel, 2009, Nucl Recept Signal, V7, pe002, DOI 10.1621/nrs.07002; Metivier R, 2003, CELL, V115, P751, DOI 10.1016/S0092-8674(03)00934-6; Metivier R, 2008, NATURE, V452, P45, DOI 10.1038/nature06544; Nagaich AK, 2004, MOL CELL, V14, P163, DOI 10.1016/S1097-2765(04)00178-9; Nichol D, 2006, J BIOL CHEM, V281, P32140, DOI 10.1074/jbc.M604803200; Niles RM, 2004, MUTAT RES-FUND MOL M, V555, P81, DOI 10.1016/j.mrfmmm.2004.05.020; Perissi V, 2005, NAT REV MOL CELL BIO, V6, P542, DOI 10.1038/nrm1680; Powelka AM, 2006, J CLIN INVEST, V116, P125, DOI 10.1172/JCI26040; Reid G, 2003, MOL CELL, V11, P695, DOI 10.1016/S1097-2765(03)00090-X; Seth A, 2007, CELL METAB, V6, P236, DOI 10.1016/j.cmet.2007.08.004; Shang YF, 2000, CELL, V103, P843, DOI 10.1016/S0092-8674(00)00188-4; Sonoda J, 2008, FEBS LETT, V582, P2, DOI 10.1016/j.febslet.2007.11.016; Subramaniam N, 1999, J BIOL CHEM, V274, P18121, DOI 10.1074/jbc.274.25.18121; Teboul M, 2008, MOL ENDOCRINOL, V22, P2573, DOI 10.1210/me.2007-0521; Tigges M, 2009, NATURE, V457, P309, DOI 10.1038/nature07616; Treuter E, 1998, MOL ENDOCRINOL, V12, P864, DOI 10.1210/me.12.6.864; Tsai TYC, 2008, SCIENCE, V321, P126, DOI 10.1126/science.1156951; Vo N, 2001, MOL CELL BIOL, V21, P6181, DOI 10.1128/MCB.21.18.6181-6188.2001; Wang QB, 2005, MOL CELL, V19, P631, DOI 10.1016/j.molcel.2005.07.018; Wei LN, 2000, J BIOL CHEM, V275, P40782, DOI 10.1074/jbc.M004821200; White KA, 2003, J BIOL CHEM, V278, P43889, DOI 10.1074/jbc.C300374200; White R, 2008, FEBS LETT, V582, P39, DOI 10.1016/j.febslet.2007.11.017; Wu RC, 2007, CELL, V129, P1125, DOI 10.1016/j.cell.2007.04.039	50	8	8	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7639	10.1371/journal.pone.0007639	http://dx.doi.org/10.1371/journal.pone.0007639			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862326	Green Submitted, Green Published, gold			2022-12-27	WOS:000271194600017
J	Linker, RA; Brechlin, P; Jesse, S; Steinacker, P; Lee, DH; Asif, AR; Jahn, O; Tumani, H; Gold, R; Otto, M				Linker, Ralf A.; Brechlin, Peter; Jesse, Sarah; Steinacker, Petra; Lee, D. H.; Asif, Abdul R.; Jahn, Olaf; Tumani, Hayrettin; Gold, Ralf; Otto, Markus			Proteome Profiling in Murine Models of Multiple Sclerosis: Identification of Stage Specific Markers and Culprits for Tissue Damage	PLOS ONE			English	Article							EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; CLINICALLY ISOLATED SYNDROMES; FIBRILLARY ACIDIC PROTEIN; INTRATHECAL IGM-SYNTHESIS; ANTIMYELIN ANTIBODIES; NERVOUS-SYSTEM; RISK; CNS; GENE; MICE	The identification of new biomarkers is of high interest for the prediction of the disease course and also for the identification of pathomechanisms in multiple sclerosis ( MS). To specify markers of the chronic disease phase, we performed proteome profiling during the later phase of myelin oligodendrocyte glycoprotein induced experimental autoimmune encephalomyelitis (MOG-EAE, day 35 after immunization) as a model disease mimicking many aspects of secondary progressive MS. In comparison to healthy controls, high resolution 2 dimensional gel electrophoresis revealed a number of regulated proteins, among them glial fibrilary acidic protein (GFAP). Phase specific up-regulation of GFAP in chronic EAE was confirmed by western blotting and immunohistochemistry. Protein levels of GFAP were also increased in the cerebrospinal fluid of MS patients with specificity for the secondary progressive disease phase. In a next step, proteome profiling of an EAE model with enhanced degenerative mechanisms revealed regulation of alpha-internexin, syntaxin binding protein 1, annexin V and glutamate decarboxylase in the ciliary neurotrophic factor ( CNTF) knockout mouse. The identification of these proteins implicate an increased apoptosis and enhanced axonal disintegration and correlate well the described pattern of tissue injury in CNTF-/- mice which involve oligodendrocyte (OL) apoptosis and axonal injury. In summary, our findings underscore the value of proteome analyses as screening method for stage specific biomarkers and for the identification of new culprits for tissue damage in chronic autoimmune demyelination.			Linker, RA (corresponding author), Ruhr Univ Bochum, St Josef Hosp, Dept Neurol, D-4630 Bochum, Germany.	markus.otto@uni-ulm.de	Linker, Ralf/AAD-8884-2020; Asif, Abdul Rahman/G-7924-2011; Otto, Markus/F-4304-2015; Jahn, Olaf/AAD-8212-2020; Asif, Abdul R./A-9432-2016	Otto, Markus/0000-0003-4273-4267; Jahn, Olaf/0000-0002-3397-8924; Asif, Abdul R./0000-0002-8581-3187				Alt C, 2005, BRAIN PATHOL, V15, P1; Asif AR, 2006, J PROTEOME RES, V5, P954, DOI 10.1021/pr0504586; Balboni I, 2006, ANNU REV IMMUNOL, V24, P391, DOI 10.1146/annurev.immunol.24.021605.090709; Bielekova B, 2004, BRAIN, V127, P1463, DOI 10.1093/brain/awh176; Brechlin P, 2008, PROTEOMICS, V8, P4357, DOI 10.1002/pmic.200800375; Brex PA, 2002, NEW ENGL J MED, V346, P158, DOI 10.1056/NEJMoa011341; Brex PA, 2001, J NEUROL NEUROSUR PS, V70, P390, DOI 10.1136/jnnp.70.3.390; Comabella M, 2007, J NEUROIMMUNOL, V187, P1, DOI 10.1016/j.jneuroim.2007.02.009; Duzhak T, 2003, CELL MOL BIOL, V49, P723; Fossey SC, 2007, J MOL DIAGN, V9, P197, DOI 10.2353/jmoldx.2007.060147; Giovannoni G, 2006, DIS MARKERS, V22, P187, DOI 10.1155/2006/509476; Gold R, 2006, BRAIN, V129, P1953, DOI 10.1093/brain/awl075; Hafler DA, 2007, NEW ENGL J MED, V357, P851, DOI 10.1056/NEJMoa073493; Herrero-Herranz E, 2008, NEUROBIOL DIS, V30, P162, DOI 10.1016/j.nbd.2008.01.001; Ibrahim SM, 2005, CURR OPIN NEUROL, V18, P231, DOI 10.1097/01.wco.0000169738.06664.3b; Ibrahim SM, 2001, BRAIN, V124, P1927, DOI 10.1093/brain/124.10.1927; Jahn O, 2006, ANAL BIOANAL CHEM, V386, P92, DOI 10.1007/s00216-006-0592-1; KOTHAVALE A, 1995, GLIA, V14, P216, DOI 10.1002/glia.440140307; Kroner A, 2005, ANN NEUROL, V58, P50, DOI 10.1002/ana.20514; Kuhle J, 2007, J NEUROL, V254, P160, DOI 10.1007/s00415-006-0299-4; Lassmann H, 2003, BRAIN, V126, P1347, DOI 10.1093/brain/awg127; Liedtke W, 1996, NEURON, V17, P607, DOI 10.1016/S0896-6273(00)80194-4; Liedtke W, 1998, AM J PATHOL, V152, P251; Linker RA, 2002, NAT MED, V8, P620, DOI 10.1038/nm0602-620; Liu T, 2007, J PROTEOME RES, V6, P2565, DOI 10.1021/pr070012k; Lutterotti A, 2007, CURR MED CHEM, V14, P1956; MASU Y, 1993, NATURE, V365, P27, DOI 10.1038/365027a0; Mathey EK, 2007, J EXP MED, V204, P2363, DOI 10.1084/jem.20071053; Mergia E, 2003, CELL SIGNAL, V15, P189, DOI 10.1016/S0898-6568(02)00078-5; Norgren N, 2004, NEUROLOGY, V63, P1586, DOI 10.1212/01.WNL.0000142988.49341.D1; Petzold A, 2004, J IMMUNOL METHODS, V287, P169, DOI 10.1016/j.jim.2004.01.015; Petzold A, 2003, J NEUROIMMUNOL, V138, P45, DOI 10.1016/S0165-5728(03)00092-4; Petzold A, 2002, BRAIN, V125, P1462, DOI 10.1093/brain/awf165; Rauer S, 2006, J NEUROL NEUROSUR PS, V77, P739, DOI 10.1136/jnnp.2005.077784; Rejdak K, 2004, NEUROLOGY, V63, P1439; Robinson WH, 2003, NAT BIOTECHNOL, V21, P1033, DOI 10.1038/nbt859; Schneider R, 2007, EUR J NEUROL, V14, P907, DOI 10.1111/j.1468-1331.2007.01871.x; Schott P, 2008, BASIC RES CARDIOL, V103, P232, DOI 10.1007/s00395-008-0696-1; Steinacker P, 2005, MOL CELL BIOL, V25, P1339, DOI 10.1128/MCB.25.4.1339-1346.2005; Sturzebecher S, 2003, BRAIN, V126, P1419, DOI 10.1093/brain/awg147; Tastet C, 2003, ELECTROPHORESIS, V24, P1787, DOI 10.1002/elps.200305400; Tintore M, 2006, NEUROLOGY, V67, P968, DOI 10.1212/01.wnl.0000237354.10144.ec; Villar LM, 2005, J CLIN INVEST, V115, P187, DOI 10.1172/JCI200522833; Villar LM, 2003, ANN NEUROL, V53, P222, DOI 10.1002/ana.10441; Werner HB, 2007, J NEUROSCI, V27, P7717, DOI 10.1523/JNEUROSCI.1254-07.2007; Werner P, 2000, ADV RES NEURODEGENER, V8, P375; Werner P, 2001, ANN NEUROL, V50, P169, DOI 10.1002/ana.1077	47	42	42	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7624	10.1371/journal.pone.0007624	http://dx.doi.org/10.1371/journal.pone.0007624			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19865482	Green Published, gold			2022-12-27	WOS:000271194600013
J	Roeth, JF; Sawyer, JK; Wilner, DA; Peifer, M				Roeth, Jeremiah F.; Sawyer, Jessica K.; Wilner, Daniel A.; Peifer, Mark			Rab11 Helps Maintain Apical Crumbs and Adherens Junctions in the Drosophila Embryonic Ectoderm	PLOS ONE			English	Article							MESSENGER-RNA LOCALIZATION; E-CADHERIN TRAFFICKING; CELL-CELL ADHESION; P120 CATENIN; EPITHELIAL MORPHOGENESIS; POLARITY; MEMBRANE; ENDOCYTOSIS; HOMOLOG; COMPLEX	Background: Tissue morphogenesis and organogenesis require that cells retain stable cell-cell adhesion while changing shape and moving. One mechanism to accommodate this plasticity in cell adhesion involves regulated trafficking of junctional proteins. Methodology/ Principal Findings: Here we explored trafficking of junctional proteins in two well-characterized model epithelia, the Drosophila embryonic ectoderm and amnioserosa. We find that DE-cadherin, the transmembrane protein of adherens junctions, is actively trafficked through putative vesicles, and appears to travel through both Rab5-positive and Rab11-positive structures. We manipulated the functions of Rab11 and Rab5 to examine the effects on junctional stability and morphogenesis. Reducing Rab11 function, either using a dominant negative construct or loss of function alleles, disrupts integrity of the ectoderm and leads to loss of adherens junctions. Strikingly, the apical junctional regulator Crumbs is lost before AJs are destabilized, while the basolateral protein Dlg remains cortical. Altering Rab5 function had less dramatic effects, not disrupting adherens junction integrity but affecting dorsal closure. Conclusions/Significance: We contrast our results with what others saw when disrupting other trafficking regulators, and when disrupting Rab function in other tissues; together these data suggest distinct mechanisms regulate junctional stability and plasticity in different tissues.			Roeth, JF (corresponding author), Univ N Carolina, Dept Biol, Chapel Hill, NC 27515 USA.	peifer@unc.edu	Tsai, Yu-Chen/B-5852-2008	Sawyer, Jessica/0000-0001-9026-0559; Peifer, Mark/0000-0003-1412-3987; Wilner, David/0000-0003-1526-7587	NIGMS NIH HHS [R01 GM047857, R01GM47857] Funding Source: Medline; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM047857] Funding Source: NIH RePORTER	NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Beronja S, 2005, J CELL BIOL, V169, P635, DOI 10.1083/jcb.200410081; Bilder D, 2000, SCIENCE, V289, P113, DOI 10.1126/science.289.5476.113; Blankenship JT, 2007, J CELL SCI, V120, P3099, DOI 10.1242/jcs.004770; Bloor JW, 2002, DEVELOPMENT, V129, P3173; Bogard N, 2007, DEVELOPMENT, V134, P3413, DOI 10.1242/dev.008466; Bryant DM, 2004, TRENDS CELL BIOL, V14, P427, DOI 10.1016/j.tcb.2004.07.007; Cao J, 2008, J CELL BIOL, V182, P301, DOI 10.1083/jcb.200712036; Chen N, 2003, NEUROSCIENCE, V120, P163, DOI 10.1016/S0306-4522(03)00259-8; Chen YT, 1999, J CELL BIOL, V144, P687, DOI 10.1083/jcb.144.4.687; Chiasson CM, 2009, MOL BIOL CELL, V20, P1970, DOI 10.1091/mbc.E08-07-0735; Classen AK, 2005, DEV CELL, V9, P805, DOI 10.1016/j.devcel.2005.10.016; Cox RT, 1996, J CELL BIOL, V134, P133, DOI 10.1083/jcb.134.1.133; Davis MA, 2003, J CELL BIOL, V163, P525, DOI 10.1083/jcb.200307111; Delva E, 2009, TRAFFIC, V10, P259, DOI 10.1111/j.1600-0854.2008.00862.x; Desclozeaux M, 2008, AM J PHYSIOL-CELL PH, V295, pC545, DOI 10.1152/ajpcell.00097.2008; Dollar G, 2002, DEVELOPMENT, V129, P517; Drees F, 2005, CELL, V123, P903, DOI 10.1016/j.cell.2005.09.021; Entchev EV, 2000, CELL, V103, P981, DOI 10.1016/S0092-8674(00)00200-2; Fox DT, 2007, DEVELOPMENT, V134, P567, DOI 10.1242/dev.02748; Fujita Y, 2002, NAT CELL BIOL, V4, P222, DOI 10.1038/ncb758; Fujita Yasuyuki, 2005, Novartis Found Symp, V269, P144; Fujita Y, 2006, METHOD ENZYMOL, V407, P359, DOI 10.1016/S0076-6879(05)07030-8; Georgiou M, 2008, CURR BIOL, V18, P1631, DOI 10.1016/j.cub.2008.09.029; Grevengoed EE, 2001, J CELL BIOL, V155, P1185, DOI 10.1083/jcb.200105102; Halbleib JM, 2006, GENE DEV, V20, P3199, DOI 10.1101/gad.1486806; Harris KP, 2008, J CELL BIOL, V183, P1129, DOI 10.1083/jcb.200807020; Harris TJC, 2005, J CELL BIOL, V170, P813, DOI 10.1083/jcb.200505127; Harris TJC, 2004, J CELL BIOL, V167, P135, DOI 10.1083/jcb.200406024; Hogan C, 2004, MOL CELL BIOL, V24, P6690, DOI 10.1128/mcb.24.15.6690-6700.2004; Homem CCF, 2008, DEVELOPMENT, V135, P1005, DOI 10.1242/dev.016337; Ireton RC, 2002, J CELL BIOL, V159, P465, DOI 10.1083/jcb.200205115; Jankovics F, 2001, GENETICS, V158, P1177; Jeanes A, 2008, ONCOGENE, V27, P6920, DOI 10.1038/onc.2008.343; Kerman BE, 2008, DEV BIOL, V320, P278, DOI 10.1016/j.ydbio.2008.05.541; Knox AL, 2002, SCIENCE, V295, P1285, DOI 10.1126/science.1067549; Langevin J, 2005, DEV CELL, V9, P365, DOI 10.1016/j.devcel.2005.07.013; Leibfried A, 2008, CURR BIOL, V18, P1639, DOI 10.1016/j.cub.2008.09.063; Li BX, 2007, J CELL BIOL, V177, P659, DOI 10.1083/jcb.200610157; Lien WH, 2006, CURR OPIN CELL BIOL, V18, P499, DOI 10.1016/j.ceb.2006.07.001; Lock JG, 2005, MOL BIOL CELL, V16, P1744, DOI 10.1091/mbc.E04-10-0867; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Magie CR, 1999, DEVELOPMENT, V126, P5353; Myster SH, 2003, J CELL BIOL, V160, P433, DOI 10.1083/jcb.200211083; Nelson WJ, 2008, BIOCHEM SOC T, V36, P149, DOI 10.1042/BST0360149; Pacquelet A, 2003, J CELL BIOL, V160, P313, DOI 10.1083/jcb.200207160; Pelissier A, 2003, CURR BIOL, V13, P1848, DOI 10.1016/j.cub.2003.10.023; Pellikka M, 2002, NATURE, V416, P143, DOI 10.1038/nature721; Pettitt J, 2003, J CELL BIOL, V162, P15, DOI 10.1083/jcb.200212136; Prekeris Rytis, 2003, ScientificWorldJournal, V3, P870; Riggs B, 2003, J CELL BIOL, V163, P143, DOI 10.1083/jcb.200305115; Sasikumar S, 2009, GENESIS, V47, P32, DOI 10.1002/dvg.20441; Satoh AK, 2005, DEVELOPMENT, V132, P1487, DOI 10.1242/dev.01704; Seto ES, 2006, J CELL BIOL, V173, P95, DOI 10.1083/jcb.200510123; Shaye DD, 2008, NAT CELL BIOL, V10, P964, DOI 10.1038/ncb1756; Shimizu H, 2003, J CELL SCI, V116, P3583, DOI 10.1242/jcs.00676; Suzuki SC, 2008, DEV GROWTH DIFFER, V50, pS119, DOI 10.1111/j.1440-169X.2008.01002.x; TEPASS U, 1990, CELL, V61, P787, DOI 10.1016/0092-8674(90)90189-L; Tepass U, 1996, DEV BIOL, V177, P217, DOI 10.1006/dbio.1996.0157; Tepass U, 1996, GENE DEV, V10, P672, DOI 10.1101/gad.10.6.672; Tiwari AK, 2009, EUR J CELL BIOL, V88, P445, DOI 10.1016/j.ejcb.2009.02.188; Uemura T, 1996, GENE DEV, V10, P659, DOI 10.1101/gad.10.6.659; Ulrich F, 2005, DEV CELL, V9, P555, DOI 10.1016/j.devcel.2005.08.011; Warner SJ, 2009, J CELL BIOL, V187, P119, DOI [10.1083/jcb.200906047, 10.1083/jcb.200901029]; Wieschaus E., 1986, P199; Wucherpfennig T, 2003, J CELL BIOL, V161, P609, DOI 10.1083/jcb.200211087; Xiao KY, 2003, J CELL BIOL, V163, P535, DOI 10.1083/jcb.200306001; Yamada S, 2005, CELL, V123, P889, DOI 10.1016/j.cell.2005.09.020; Yap AS, 2007, CURR OPIN CELL BIOL, V19, P508, DOI 10.1016/j.ceb.2007.09.008	68	75	76	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7634	10.1371/journal.pone.0007634	http://dx.doi.org/10.1371/journal.pone.0007634			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862327	gold, Green Published, Green Submitted			2022-12-27	WOS:000271194600016
J	Riddell, C; Adams, S; Schmid-Hempel, P; Mallon, EB				Riddell, Carolyn; Adams, Sally; Schmid-Hempel, Paul; Mallon, Eamonn B.			Differential Expression of Immune Defences Is Associated with Specific Host-Parasite Interactions in Insects	PLOS ONE			English	Article							ANTIMICROBIAL PEPTIDE GENES; FIBRINOGEN-RELATED PROTEINS; DROSOPHILA-MELANOGASTER; EVOLUTIONARY ECOLOGY; APIS-MELLIFERA; INFECTION; CRITHIDIA; BACTERIAL; PATHWAY; SYSTEMS	Recent ecological studies in invertebrates show that the outcome of an infection is dependent on the specific pairing of host and parasite. Such specificity contrasts the long-held view that invertebrate innate immunity depends on a broad-spectrum recognition system. An important question is whether this specificity is due to the immune response rather than some other interplay between host and parasite genotypes. By measuring the expression of putative bumblebee homologues of antimicrobial peptides in response to infection by their gut trypanosome Crithidia bombi, we demonstrate that expression differences are associated with the specific interactions.			Riddell, C (corresponding author), Univ Leicester, Dept Biol, Leicester, Leics, England.	paul.schmid-hempel@env.ethz.ch	Mallon, Eamonn/H-1834-2011	Mallon, Eamonn/0000-0002-4198-4611; Adams, Sally/0000-0002-3353-7459; Riddell, Carolyn/0000-0003-0089-9135	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Boulanger N, 2004, INFECT IMMUN, V72, P7140, DOI 10.1128/IAI.72.12.7140-7146.2004; Boulanger N, 2002, INSECT BIOCHEM MOLEC, V32, P369, DOI 10.1016/S0965-1748(02)00029-2; Boulanger N, 2001, INSECT BIOCHEM MOLEC, V31, P129, DOI 10.1016/S0965-1748(00)00096-5; Boulanger N, 2006, TRENDS PARASITOL, V22, P262, DOI 10.1016/j.pt.2006.04.003; Du Pasquier L, 2005, SCIENCE, V309, P1826, DOI 10.1126/science.1118828; Evans JD, 2005, EVOLUTION, V59, P2270, DOI 10.1111/j.0014-3820.2005.tb00935.x; Gillespie JP, 1997, ANNU REV ENTOMOL, V42, P611, DOI 10.1146/annurev.ento.42.1.611; Hauton C, 2007, BIOESSAYS, V29, P1138, DOI 10.1002/bies.20650; Liehl P, 2006, PLOS PATHOG, V2, P551, DOI 10.1371/journal.ppat.0020056; Rutschmann S, 2002, J IMMUNOL, V168, P1542, DOI 10.4049/jimmunol.168.4.1542; Ryu JH, 2006, EMBO J, V25, P3693, DOI 10.1038/sj.emboj.7601233; Schluns H, 2007, INSECT MOL BIOL, V16, P753, DOI 10.1111/j.1365-2583.2007.00768.x; Schmid-Hempel P, 2003, TRENDS ECOL EVOL, V18, P27, DOI 10.1016/S0169-5347(02)00013-7; Schmid-Hempel P, 1999, EVOLUTION, V53, P426, DOI 10.1111/j.1558-5646.1999.tb03778.x; Schmid-Hempel P, 2004, PARASITOLOGY, V129, P147, DOI 10.1017/S0031182004005542; Schmid-Hempel P, 2005, BIOESSAYS, V27, P1026, DOI 10.1002/bies.20282; Siva-Jothy MT, 2005, ADV INSECT PHYSIOL, V32, P1, DOI 10.1016/S0065-2806(05)32001-7; Tzou P, 2000, IMMUNITY, V13, P737, DOI 10.1016/S1074-7613(00)00072-8; Wang XG, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-114; Watson FL, 2005, SCIENCE, V309, P1874, DOI 10.1126/science.1116887; Zhang SM, 2004, GENE, V341, P255, DOI 10.1016/j.gene.2004.07.003	21	47	47	0	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7621	10.1371/journal.pone.0007621	http://dx.doi.org/10.1371/journal.pone.0007621			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859547	Green Published, gold			2022-12-27	WOS:000271147400017
J	Wu, HQ; Ye, CT; Ramirez, D; Manjunath, N				Wu, Haoquan; Ye, Chunting; Ramirez, Danielle; Manjunath, N.			Alternative Processing of Primary microRNA Transcripts by Drosha Generates 5 ' End Variation of Mature microRNA	PLOS ONE			English	Article							C-ELEGANS; RNA-INTERFERENCE; POSTTRANSCRIPTIONAL REGULATION; MICROPROCESSOR COMPLEX; DICER; EXPRESSION; MATURATION; ENZYME; DROSOPHILA; CLEAVAGE	Background: It is generally believed that the miRNA processing machinery ensures the generation of a mature miRNA with a fixed sequence, particularly at its 59 end. However, we and others have recently noted that the ends of a given mature miRNA are not absolutely fixed, but subject to variation. Neither the significance nor the mechanism behind the generation of such miRNA polymorphism is understood. miR-142 is an abundantly expressed miRNA in hematopoietic cells and exhibits a high frequency of 59 end polymorphism. Methodology/Principal Findings: Here we show that a shift in the Drosha processing of pri-miRNA generates multiple forms of miR-142s in vivo with differing 59 ends that might target different genes. Sequence analysis of several pre-miRNA ends cloned from T cells reveals that unlike many other pri-miRNAs that are processed into a single pre-miRNA, pri-miR-142 is processed into 3 distinct pre-miR-142s. Dicer processing studies suggest that each of the 3 pre-miR-142s is processed into a distinct double-stranded miRNA, giving rise to 4 mature miRNA variants that might regulate different target gene pools. Conclusions/Significance: Thus, alternative Drosha processing might be a novel mechanism for diversification of the miRNA target gene pool.			Wu, HQ (corresponding author), Texas Tech Univ, Hlth Sci Ctr, Ctr Excellence Infect Dis Res, Dept Biomed Sci,Paul L Foster Sch Med, El Paso, TX USA.	haoquan.wu@ttuhsc.edu; manjunath.swamy@ttuhsc.edu		Wu, Haoquan/0000-0001-9386-3187	PHS HHS [U01A1075419] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Aravin A, 2005, FEBS LETT, V579, P5830, DOI 10.1016/j.febslet.2005.08.009; Bartel DP, 2004, CELL, V116, P281, DOI 10.1016/S0092-8674(04)00045-5; Basyuk E, 2003, NUCLEIC ACIDS RES, V31, P6593, DOI 10.1093/nar/gkg855; Bernstein E, 2003, NAT GENET, V35, P215, DOI 10.1038/ng1253; Chen CZ, 2004, SCIENCE, V303, P83, DOI 10.1126/science.1091903; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Chivukula RR, 2008, TRENDS BIOCHEM SCI, V33, P474, DOI 10.1016/j.tibs.2008.06.008; Cullen BR, 2009, NATURE, V457, P421, DOI 10.1038/nature07757; Davis BN, 2008, NATURE, V454, P56, DOI 10.1038/nature07086; Denli AM, 2004, NATURE, V432, P231, DOI 10.1038/nature03049; Doench JG, 2004, GENE DEV, V18, P504, DOI 10.1101/gad.1184404; Forstemann K, 2005, PLOS BIOL, V3, P1187, DOI 10.1371/journal.pbio.0030236; Fukuda T, 2007, NAT CELL BIOL, V9, P604, DOI 10.1038/ncb1577; Garzon R, 2009, ANNU REV MED, V60, P167, DOI 10.1146/annurev.med.59.053006.104707; Gregory RI, 2005, CELL, V123, P631, DOI 10.1016/j.cell.2005.10.022; Gregory RI, 2004, NATURE, V432, P235, DOI 10.1038/nature03120; Grishok A, 2001, CELL, V106, P23, DOI 10.1016/S0092-8674(01)00431-7; Guil S, 2007, NAT STRUCT MOL BIOL, V14, P591, DOI 10.1038/nsmb1250; Haase AD, 2005, EMBO REP, V6, P961, DOI 10.1038/sj.embor.7400509; Han JJ, 2006, CELL, V125, P887, DOI 10.1016/j.cell.2006.03.043; Hutvagner G, 2001, SCIENCE, V293, P834, DOI 10.1126/science.1062961; Jiang F, 2005, GENE DEV, V19, P1674, DOI 10.1101/gad.1334005; Kawahara Y, 2007, EMBO REP, V8, P763, DOI 10.1038/sj.embor.7401011; Ketting RF, 2001, GENE DEV, V15, P2654, DOI 10.1101/gad.927801; Lagos-Quintana M, 2002, CURR BIOL, V12, P735, DOI 10.1016/S0960-9822(02)00809-6; Lai EC, 2002, NAT GENET, V30, P363, DOI 10.1038/ng865; Landgraf P, 2007, CELL, V129, P1401, DOI 10.1016/j.cell.2007.04.040; Landthaler M, 2004, CURR BIOL, V14, P2162, DOI 10.1016/j.cub.2004.11.001; LEE RC, 1993, CELL, V75, P843, DOI 10.1016/0092-8674(93)90529-Y; Lee Y, 2003, NATURE, V425, P415, DOI 10.1038/nature01957; Lee Y, 2006, EMBO J, V25, P522, DOI 10.1038/sj.emboj.7600942; Lee Y, 2002, EMBO J, V21, P4663, DOI 10.1093/emboj/cdf476; Lewis BP, 2003, CELL, V115, P787, DOI 10.1016/S0092-8674(03)01018-3; MacRae IJ, 2006, SCIENCE, V311, P195, DOI 10.1126/science.1121638; Matranga C, 2005, CELL, V123, P607, DOI 10.1016/j.cell.2005.08.044; Neilson JR, 2007, GENE DEV, V21, P578, DOI 10.1101/gad.1522907; Okamura K, 2007, CELL, V130, P89, DOI 10.1016/j.cell.2007.06.028; Ramkissoon SH, 2006, LEUKEMIA RES, V30, P643, DOI 10.1016/j.leukres.2005.09.001; Rand TA, 2005, CELL, V123, P621, DOI 10.1016/j.cell.2005.10.020; Ruby JG, 2007, NATURE, V448, P83, DOI 10.1038/nature05983; Ruby JG, 2006, CELL, V127, P1193, DOI 10.1016/j.cell.2006.10.040; Saito K, 2005, PLOS BIOL, V3, P1202, DOI 10.1371/journal.pbio.0030235; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Seitz H, 2008, CURR BIOL, V18, P147, DOI 10.1016/j.cub.2007.12.049; Suzuki HI, 2009, NATURE, V460, P529, DOI 10.1038/nature08199; Viswanathan SR, 2008, SCIENCE, V320, P97, DOI 10.1126/science.1154040; WIGHTMAN B, 1993, CELL, V75, P855, DOI 10.1016/0092-8674(93)90530-4; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yang WD, 2006, NAT STRUCT MOL BIOL, V13, P13, DOI 10.1038/nsmb1041; Ye XC, 2007, J BIOL CHEM, V282, P28373, DOI 10.1074/jbc.M705208200; Zeng Y, 2005, EMBO J, V24, P138, DOI 10.1038/sj.emboj.7600491; Zhang HD, 2002, EMBO J, V21, P5875, DOI 10.1093/emboj/cdf582	53	103	105	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7566	10.1371/journal.pone.0007566	http://dx.doi.org/10.1371/journal.pone.0007566			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859542	Green Submitted, Green Published, gold			2022-12-27	WOS:000271147400002
J	Salehzada, T; Cambier, L; Thi, NV; Manchon, L; Regnier, L; Bisbal, C				Salehzada, Tamim; Cambier, Linda; Thi, Nga Vu; Manchon, Laurent; Regnier, Laetitia; Bisbal, Catherine			Endoribonuclease L (RNase L) Regulates the Myogenic and Adipogenic Potential of Myogenic Cells	PLOS ONE			English	Article							EMBRYONIC STEM-CELLS; SKELETAL-MUSCLE REGENERATION; BINDING PROTEIN; SATELLITE CELLS; TRANSCRIPTIONAL REPRESSOR; MUSCULAR-DYSTROPHY; INTERFERON SYSTEM; C2C12 MYOBLASTS; GENE-EXPRESSION; SELF-RENEWAL	Skeletal muscle maintenance and repair involve several finely coordinated steps in which pluripotent stem cells are activated, proliferate, exit the cell cycle and differentiate. This process is accompanied by activation of hundreds of muscle-specific genes and repression of genes associated with cell proliferation or pluripotency. Mechanisms controlling myogenesis are precisely coordinated and regulated in time to allow the sequence of activation/inactivation of genes expression. Muscular differentiation is the result of the interplay between several processes such as transcriptional induction, transcriptional repression and mRNA stability. mRNA stability is now recognized as an essential mechanism of control of gene expression. For instance, we previously showed that the endoribonuclease L (RNase L) and its inhibitor (RLI) regulates MyoD mRNA stability and consequently muscle differentiation. We now performed global gene expression analysis by SAGE to identify genes that were down-regulated upon activation of RNase L in C2C12 myogenic cells, a model of satellite cells. We found that RNase L regulates mRNA stability of factors implicated in the control of pluripotency and cell differentiation. Moreover, inappropriate RNase L expression in C2C12 cells led to inhibition of myogenesis and differentiation into adipocytes even when cells were grown in conditions permissive for muscle differentiation. Conversely, over-expression of RLI allowed muscle differentiation of myogenic C2C12 cells even in non permissive conditions. These findings reveal the central role of RNase L and RLI in controlling gene expression and cell fate during myogenesis. Our data should provide valuable insights into the mechanisms that control muscle stem cell differentiation and into the mechanism of metaplasia observed in aging or muscular dystrophy where adipose infiltration of muscle occurs.			Salehzada, T (corresponding author), Univ Montpellier 1, CHU Arnaud de Villeneuve, EA4202, INSERM ESPRI Muscle & Pathol 25, Montpellier, France.	Catherine.bisbal@inserm.fr	Bisbal, Catherine/I-6984-2016; Linda, Cambier/AAL-9928-2020	Bisbal, Catherine/0000-0003-1086-020X; Linda, Cambier/0000-0001-9482-1413; MANCHON, Laurent/0000-0001-9242-4385				Alahari SK, 2000, J CELL BIOL, V151, P1141, DOI 10.1083/jcb.151.6.1141; Alisi A, 2008, CELL SIGNAL, V20, P534, DOI 10.1016/j.cellsig.2007.11.006; Arnold HH, 1996, INT J DEV BIOL, V40, P345; Asakura A, 2001, DIFFERENTIATION, V68, P245, DOI 10.1046/j.1432-0436.2001.680412.x; Assou S, 2007, STEM CELLS, V25, P961, DOI 10.1634/stemcells.2006-0352; BIRNBAUM M, 1990, DIFFERENTIATION, V45, P138, DOI 10.1111/j.1432-0436.1990.tb00467.x; BIRNBAUM M, 1993, VIROLOGY, V194, P865, DOI 10.1006/viro.1993.1332; BISBAL C, 1995, J BIOL CHEM, V270, P13308, DOI 10.1074/jbc.270.22.13308; BISBAL C, 1987, BIOCHEMISTRY-US, V26, P5172, DOI 10.1021/bi00390a041; Bisbal C, 2000, MOL CELL BIOL, V20, P4959, DOI 10.1128/MCB.20.14.4959-4969.2000; Bisbal C, 2007, BIOCHIMIE, V89, P789, DOI 10.1016/j.biochi.2007.02.006; CAPUT D, 1986, P NATL ACAD SCI USA, V83, P1670, DOI 10.1073/pnas.83.6.1670; Castelli JC, 1998, CELL DEATH DIFFER, V5, P313, DOI 10.1038/sj.cdd.4400352; Cheng M, 2008, AM J PHYSIOL-CELL PH, V294, pC1183, DOI 10.1152/ajpcell.00568.2007; Collins CA, 2005, CELL, V122, P289, DOI 10.1016/j.cell.2005.05.010; COOK JS, 1988, P NATL ACAD SCI USA, V85, P2949, DOI 10.1073/pnas.85.9.2949; De Rossi M, 2000, INT IMMUNOL, V12, P1329, DOI 10.1093/intimm/12.9.1329; Dulor JP, 1998, FEBS LETT, V439, P89, DOI 10.1016/S0014-5793(98)01216-2; FLOYDSMITH G, 1981, SCIENCE, V212, P1030, DOI 10.1126/science.6165080; Formigli L, 2005, J CELL SCI, V118, P1161, DOI 10.1242/jcs.01695; Gabory A, 2006, CYTOGENET GENOME RES, V113, P188, DOI 10.1159/000090831; GARD DL, 1980, CELL, V19, P263, DOI 10.1016/0092-8674(80)90408-0; GREEN H, 1974, CELL, V1, P113, DOI 10.1016/0092-8674(74)90126-3; Guttman M, 2009, NATURE, V458, P223, DOI 10.1038/nature07672; Hao SL, 2009, NAT IMMUNOL, V10, P281, DOI 10.1038/ni.1699; HE GP, 1995, NATURE, V378, P92, DOI 10.1038/378092a0; Hoffman LM, 2006, J CELL BIOL, V172, P771, DOI 10.1083/jcb.200512115; Holst D, 2003, EXP CELL RES, V288, P168, DOI 10.1016/S0014-4827(03)00179-4; Hovanessian AG, 2007, BIOCHIMIE, V89, P779, DOI 10.1016/j.biochi.2007.02.003; HU ED, 1995, P NATL ACAD SCI USA, V92, P9856, DOI 10.1073/pnas.92.21.9856; Huang HY, 2005, BIOCHEM BIOPH RES CO, V338, P1185, DOI 10.1016/j.bbrc.2005.10.057; KACHINSKY AM, 1994, DEV BIOL, V165, P216, DOI 10.1006/dbio.1994.1248; Kahn BB, 2000, J CLIN INVEST, V106, P473, DOI 10.1172/JCI10842; Khabar KSA, 2007, BIOCHIMIE, V89, P761, DOI 10.1016/j.biochi.2007.02.008; KIESS M, 1995, ONCOGENE, V10, P61; Kim SW, 2001, J BIOL CHEM, V276, P10199, DOI 10.1074/jbc.M010640200; Kinoshita M, 2006, CURR OPIN CELL BIOL, V18, P54, DOI 10.1016/j.ceb.2005.12.005; Kobayashi O, 1996, NEUROLOGY, V46, P815, DOI 10.1212/WNL.46.3.815; Kronfeld-Kinar Y, 1999, CELL GROWTH DIFFER, V10, P201; Kuang S, 2008, TRENDS MOL MED, V14, P82, DOI 10.1016/j.molmed.2007.12.004; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lane MD, 1999, BIOCHEM BIOPH RES CO, V266, P677, DOI 10.1006/bbrc.1999.1885; Le Roy F, 2007, CELL DEATH DIFFER, V14, P1406, DOI 10.1038/sj.cdd.4402130; Le Roy F, 2005, NAT STRUCT MOL BIOL, V12, P505, DOI 10.1038/nsmb944; Malathi K, 2005, P NATL ACAD SCI USA, V102, P14533, DOI 10.1073/pnas.0507551102; Malathi K, 2004, CANCER RES, V64, P9144, DOI 10.1158/0008-5472.CAN-04-2226; Marden FA, 2005, SKELETAL RADIOL, V34, P140, DOI 10.1007/s00256-004-0825-3; McKinsey TA, 2002, CURR OPIN CELL BIOL, V14, P763, DOI 10.1016/S0955-0674(02)00389-7; McKinsey TA, 2001, CURR OPIN GENET DEV, V11, P497, DOI 10.1016/S0959-437X(00)00224-0; Melchior K, 2008, BIOL CHEM, V389, P897, DOI 10.1515/BC.2008.108; Milligan L, 2000, ONCOGENE, V19, P5810, DOI 10.1038/sj.onc.1203965; Montarras D, 2005, SCIENCE, V309, P2064, DOI 10.1126/science.1114758; Olsen DB, 2003, J NEUROL, V250, P1328, DOI 10.1007/s00415-003-0206-1; Pajcini KV, 2008, J CELL BIOL, V180, P1005, DOI 10.1083/jcb.200707191; Pandey Mitali, 2004, RNA Biol, V1, P21; Pereira RC, 2007, BONE, V40, P619, DOI 10.1016/j.bone.2006.09.028; Piquemal D, 2002, GENOMICS, V80, P361, DOI 10.1006/geno.2002.6836; Remels AH, 2007, CLIN CHEST MED, V28, P537, DOI 10.1016/j.ccm.2007.06.003; SALZBERG S, 1995, EXP CELL RES, V220, P509; Salzberg S, 2000, EXP CELL RES, V254, P45, DOI 10.1006/excr.1999.4721; SALZBERG S, 1995, EXP CELL RES, V219, P223, DOI 10.1006/excr.1995.1222; Sbrana F, 2008, AM J PHYSIOL-CELL PH, V295, pC160, DOI 10.1152/ajpcell.00014.2008; Sen A, 2001, J CELL BIOCHEM, V81, P312, DOI 10.1002/1097-4644(20010501)81:2<312::AID-JCB1046>3.0.CO;2-Q; Shefer G, 2006, DEV BIOL, V294, P50, DOI 10.1016/j.ydbio.2006.02.022; Sirajuddin M, 2007, NATURE, V449, P311, DOI 10.1038/nature06052; Sun LG, 2007, J CELL BIOL, V179, P129, DOI 10.1083/jcb.200703184; Tang QQ, 2000, P NATL ACAD SCI USA, V97, P12446, DOI 10.1073/pnas.220425597; Taylor-Jones JM, 2002, MECH AGEING DEV, V123, P649, DOI 10.1016/S0047-6374(01)00411-0; Te Velthuis Aartjan J W, 2007, PLoS One, V2, pe189, DOI 10.1371/journal.pone.0000189; TEBOUL L, 1995, J BIOL CHEM, V270, P28183, DOI 10.1074/jbc.270.47.28183; TONTONOZ P, 1994, CELL, V79, P1147, DOI 10.1016/0092-8674(94)90006-X; Ura H, 2008, J BIOL CHEM, V283, P9713, DOI 10.1074/jbc.M707275200; Vallenius T, 2004, EXP CELL RES, V293, P117, DOI 10.1016/j.yexcr.2003.09.004; VELCULESCU VE, 1995, SCIENCE, V270, P484, DOI 10.1126/science.270.5235.484; Wagatsuma A, 2006, EXP PHYSIOL, V91, P747, DOI 10.1113/expphysiol.2006.033662; Wang H, 2002, J INTERF CYTOK RES, V22, P729, DOI 10.1089/10799900260100231; Wang KP, 2008, J BIOL CHEM, V283, P34029, DOI 10.1074/jbc.M803012200; WHITAKER JR, 1980, ANAL BIOCHEM, V109, P156, DOI 10.1016/0003-2697(80)90024-X; WRESCHNER DH, 1982, EUR J BIOCHEM, V124, P261; WRESCHNER DH, 1981, NUCLEIC ACIDS RES, V9, P1571, DOI 10.1093/nar/9.7.1571; YAFFE D, 1977, DIFFERENTIATION, V7, P159, DOI 10.1111/j.1432-0436.1977.tb01507.x; Zammit PS, 2006, J HISTOCHEM CYTOCHEM, V54, P1177, DOI 10.1369/jhc.6R6995.2006; ZUBIAGA AM, 1995, MOL CELL BIOL, V15, P2219	83	22	22	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7563	10.1371/journal.pone.0007563	http://dx.doi.org/10.1371/journal.pone.0007563			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851509	Green Published, gold, Green Submitted			2022-12-27	WOS:000271022300008
J	Kahai, S; Lee, SC; Lee, DY; Yang, J; Li, MH; Wang, CH; Jiang, ZD; Zhang, Y; Peng, C; Yang, BB				Kahai, Shireen; Lee, Shao-Chen; Lee, Daniel Y.; Yang, Jennifer; Li, Minhui; Wang, Chia-Hui; Jiang, Zide; Zhang, Yaou; Peng, Chun; Yang, Burton B.			MicroRNA miR-378 Regulates Nephronectin Expression Modulating Osteoblast Differentiation by Targeting GalNT-7	PLOS ONE			English	Article							STEM-CELL DIVISION; PRODUCT SECRETION; G3 DOMAIN; GLYCOSAMINOGLYCAN MODIFICATION; EMBRYONIC-DEVELOPMENT; INSULIN-SECRETION; GENE-REGULATION; BREAST-CANCER; GROWTH; MIRNA	MicroRNAs (miRNAs) are small fragments of single-stranded RNA containing 18-24 nucleotides, and are generated from endogenous transcripts. MicroRNAs function in post-transcriptional gene silencing by targeting the 3'-untranslated region (UTR) of mRNAs, resulting in translational repression. We have developed a system to study the role of miRNAs in cell differentiation. We have found that one of the miRNAs tested in our system (miR-378, also called miR-378*) plays a role in modulating nephronectin-mediated differentiation in the osteoblastic cell line, MC3T3-E1. Nephronectin is an extracellular matrix protein, and we have demonstrated that its over-expression enhanced osteoblast differentiation and bone nodule formation. Furthermore, we found that the nephronectin 3'-untranslated region (3'UTR) contains a binding site for miR-378. Stable transfection of MC3T3-E1 cells with miR-378 inhibited cell differentiation. MC3T3-E1 cells stably transfected with nephronectin exhibited higher rates of differentiation and nodule formation as compared with cells transfected with nephronectin containing the 3'UTR in the early stages of development, suggesting that endogenous miR-378 is present and active. However, in the later stages of MC3T3-E1 development, the differentiation rates were opposite, with higher rates of differentiation and nodule formation in the cells over-expressing the 3'UTR of nephronectin. This appeared to be the consequence of competition between nephronectin and UDP-N-acetyl-alpha-D-galactosamine: polypeptide N-acetylgalac-tosaminyltransferase 7 (GalNAc-T7 or GalNT7) for miR-378 binding, resulting in increased GalNT7 activity, which in turn lead to increased nephronectin glycosylation and product secretion, thereby resulting in a higher rate of osteoblast differentiation.			Kahai, S (corresponding author), Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Toronto, ON M4N 3M5, Canada.	byang@sri.utoronto.ca			Canadian Institutes of Health Research [MOP89931] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Aguda BD, 2008, P NATL ACAD SCI USA, V105, P19678, DOI 10.1073/pnas.0811166106; BINETTE F, 1994, J BIOL CHEM, V269, P19116; Brandenberger R, 2001, J CELL BIOL, V154, P447, DOI 10.1083/jcb.200103069; Calin GA, 2006, NAT REV CANCER, V6, P857, DOI 10.1038/nrc1997; Chapman EJ, 2004, GENE DEV, V18, P1179, DOI 10.1101/gad.1201204; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen LW, 2002, J BIOL CHEM, V277, P2657, DOI 10.1074/jbc.M101153200; Chen YX, 2007, CANCER RES, V67, P976, DOI 10.1158/0008-5472.CAN-06-3667; Chendrimada TP, 2005, NATURE, V436, P740, DOI 10.1038/nature03868; Croce CM, 2005, CELL, V122, P6, DOI 10.1016/j.cell.2005.06.036; Dahiya N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002436; Dickins RA, 2005, NAT GENET, V37, P1289, DOI 10.1038/ng1651; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Foekens JA, 2008, P NATL ACAD SCI USA, V105, P13021, DOI 10.1073/pnas.0803304105; Fontana L, 2007, NAT CELL BIOL, V9, P775, DOI 10.1038/ncb1613; Fontana L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002236; Harris TA, 2008, P NATL ACAD SCI USA, V105, P1516, DOI 10.1073/pnas.0707493105; Hatfield SD, 2005, NATURE, V435, P974, DOI 10.1038/nature03816; Hayashi K, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001738; Hua Z, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000116; Huang QH, 2008, NAT CELL BIOL, V10, P202, DOI 10.1038/ncb1681; Huang TH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003225; Hutvagner G, 2002, SCIENCE, V297, P2056, DOI 10.1126/science.1073827; Johnston RJ, 2003, NATURE, V426, P845, DOI 10.1038/nature02255; Jopling CL, 2005, SCIENCE, V309, P1577, DOI 10.1126/science.1113329; Kawasaki H, 2003, NATURE, V426, P100, DOI 10.1038/nature02141; Kiani C, 2001, BIOCHEM J, V354, P199, DOI 10.1042/0264-6021:3540199; Laneve P, 2007, P NATL ACAD SCI USA, V104, P7957, DOI 10.1073/pnas.0700071104; Lecellier CH, 2005, SCIENCE, V308, P557, DOI 10.1126/science.1108784; Lee DY, 2007, P NATL ACAD SCI USA, V104, P20350, DOI 10.1073/pnas.0706901104; Lee DY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004527; Li X, 2005, CELL, V123, P1267, DOI 10.1016/j.cell.2005.10.040; LI Z, 2008, P NATL ACAD SCI US; Lim LP, 2003, SCIENCE, V299, P1540, DOI 10.1126/science.1080372; Lu J, 2005, NATURE, V435, P834, DOI 10.1038/nature03702; Lund E, 2004, SCIENCE, V303, P95, DOI 10.1126/science.1090599; Mello CC, 2004, NAT MED, V10, P1297, DOI 10.1038/nm1204-1297; Mercatelli N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004029; Morton SU, 2008, P NATL ACAD SCI USA, V105, P17830, DOI 10.1073/pnas.0804673105; Murphy E, 2008, P NATL ACAD SCI USA, V105, P5453, DOI 10.1073/pnas.0711910105; Poliseno L, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002542; Poy MN, 2004, NATURE, V432, P226, DOI 10.1038/nature03076; Rubartelli A, 1997, EUR J IMMUNOL, V27, P1893, DOI 10.1002/eji.1830270812; Ruvkun G, 2006, SCIENCE, V311, P36; Rybak A, 2008, NAT CELL BIOL, V10, P987, DOI 10.1038/ncb1759; Salter KH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001908; Shan SW, 2009, NAT CELL BIOL, V11, P1031, DOI 10.1038/ncb1917; Sokol NS, 2005, GENE DEV, V19, P2343, DOI 10.1101/gad.1356105; Thompson BJ, 2006, CELL, V126, P767, DOI 10.1016/j.cell.2006.07.013; Thomson JM, 2006, GENE DEV, V20, P2202, DOI 10.1101/gad.1444406; Tzur G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003726; Voorhoeve PM, 2006, CELL, V124, P1169, DOI 10.1016/j.cell.2006.02.037; Wang CH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002420; Wang XH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002557; Wienholds E, 2005, SCIENCE, V309, P310, DOI 10.1126/science.1114519; Woltering JM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001396; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Yanaihara N, 2006, CANCER CELL, V9, P189, DOI 10.1016/j.ccr.2006.01.025; Yang BL, 2000, J BIOL CHEM, V275, P21255, DOI 10.1074/jbc.M001443200; Ye WB, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001719; Yu XM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002997; Zhang Y, 1998, J BIOL CHEM, V273, P33054, DOI 10.1074/jbc.273.49.33054; Zhao Y, 2005, NATURE, V436, P214, DOI 10.1038/nature03817	63	139	145	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7535	10.1371/journal.pone.0007535	http://dx.doi.org/10.1371/journal.pone.0007535			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844573	gold, Green Published, Green Submitted			2022-12-27	WOS:000271013000013
J	Bilodeau, M; MacRae, T; Gaboury, L; Laverdure, JP; Hardy, MP; Mayotte, N; Paradis, V; Harton, S; Perreault, C; Sauvageau, G				Bilodeau, Melanie; MacRae, Tara; Gaboury, Louis; Laverdure, Jean-Philippe; Hardy, Marie-Pierre; Mayotte, Nadine; Paradis, Veronique; Harton, Sebastien; Perreault, Claude; Sauvageau, Guy			Analysis of Blood Stem Cell Activity and Cystatin Gene Expression in a Mouse Model Presenting a Chromosomal Deletion Encompassing Csta and Stfa2l1	PLOS ONE			English	Article							STEFIN-A; PROGNOSTIC-SIGNIFICANCE; CYSTEINE CATHEPSINS; GASTRIC-CARCINOMA; TISSUE-LEVELS; CANCER; MICE; METASTASIS; PROTEIN; OVEREXPRESSION	The cystatin protein superfamily is characterized by the presence of conserved sequences that display cysteine protease inhibitory activity (e.g., towards cathepsins). Type 1 and 2 cystatins are encoded by 25 genes of which 23 are grouped in 2 clusters localized on mouse chromosomes 16 and 2. The expression and essential roles of most of these genes in mouse development and hematopoiesis remain poorly characterized. In this study, we describe a set of quantitative real-time PCR assays and a global expression profile of cystatin genes in normal mouse tissues. Benefiting from our collection of DelES embryonic stem cell clones harboring large chromosomal deletions (to be reported elsewhere), we selected a clone in which a 95-kb region of chromosome 16 is missing (Del(16qB3 Delta/+)). In this particular clone, 2 cystatin genes, namely Csta and Stfa2l1 are absent along with 2 other genes (Fam162a, Ccdc58) and associated intergenic regions. From this line, we established a new homozygous mutant mouse model (Del(16qB3 Delta/16qB3 Delta)) to assess the in vivo biological functions of the 2 deleted cystatins. Stfa2l1 gene expression is high in wild-type fetal liver, bone marrow, and spleen, while Csta is ubiquitously expressed. Homozygous Del(16qB3 Delta/16qB3 Delta) animals are phenotypically normal, fertile, and not overtly susceptible to spontaneous or irradiation-induced tumor formation. The hematopoietic stem and progenitor cell activity in these mutant mice are also normal. Interestingly, quantitative real-time PCR expression profiling reveals a marked increase in the expression levels of Stfa2l1/Csta phylogenetically-related genes (Stfa1, Stfa2, and Stfa3) in Del(16qB3 Delta/16qB3 Delta) hematopoietic tissues, suggesting that these candidate genes might be contributing to compensatory mechanisms. Overall, this study presents an optimized approach to globally monitor cystatin gene expression as well as a new mouse model deficient in Stfa2l1/Csta genes, expanding the available tools to dissect cystatin roles under normal and pathological conditions.			Bilodeau, M (corresponding author), Univ Montreal, Inst Res Immunol & Canc, Montreal, PQ, Canada.	guy.sauvageau@umontreal.ca	Perreault, Claude/A-7220-2008	Perreault, Claude/0000-0001-9453-7383; Bilodeau, Melanie/0000-0001-7648-1021; Sauvageau, Guy/0000-0002-4333-7266	Canadian Institutes of Health Research [82814] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Abascal F, 2005, BIOINFORMATICS, V21, P2104, DOI 10.1093/bioinformatics/bti263; Bijl J, 2008, ONCOGENE, V27, P6356, DOI 10.1038/onc.2008.233; Bilodeau M, 2007, NAT METHODS, V4, P263, DOI 10.1038/NMETH1011; Cho YE, 2009, HUM PATHOL, V40, P975, DOI 10.1016/j.humpath.2008.12.007; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Jackson RJ, 2003, CANCER RES, V63, P3021; Kiel MJ, 2005, CELL, V121, P1109, DOI 10.1016/j.cell.2005.05.026; Kroon E, 1998, EMBO J, V17, P3714, DOI 10.1093/emboj/17.13.3714; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Lee MJ, 2004, MOL CELL BIOL, V24, P3918, DOI 10.1128/MCB.24.9.3918-3927.2004; Li WD, 2005, CLIN CANCER RES, V11, P8753, DOI 10.1158/1078-0432.CCR-05-0597; Luo AP, 2004, ONCOGENE, V23, P1291, DOI 10.1038/sj.onc.1207218; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; MLINARICRASCAN I, 1994, AM J PATHOL, V145, P902; NAGY A, 1993, P NATL ACAD SCI USA, V90, P8424, DOI 10.1073/pnas.90.18.8424; Parker BS, 2008, J PATHOL, V214, P337, DOI 10.1002/path.2265; Primoz S, 2008, HISTOPATHOLOGY, V53, P612, DOI 10.1111/j.1365-2559.2008.03142.x; Roesch-Ely M, 2007, ONCOGENE, V26, P54, DOI 10.1038/sj.onc.1209770; Roper RJ, 2003, J IMMUNOL, V170, P5886, DOI 10.4049/jimmunol.170.12.5886; Russo A, 2000, CLIN CANCER RES, V6, P178; Sauvageau G, 1997, IMMUNITY, V6, P13, DOI 10.1016/S1074-7613(00)80238-1; Sauvageau M, 2008, BLOOD, V111, P790, DOI 10.1182/blood-2007-07-098236; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Turk V, 2008, FRONT BIOSCI-LANDMRK, V13, P5406, DOI 10.2741/3089; Werle B, 2006, ONCOL REP, V16, P647; Zavasnik-Bergant T, 2006, TISSUE ANTIGENS, V67, P349, DOI 10.1111/j.1399-0039.2006.00585.x; Zavasnik-Bergant T, 2008, FRONT BIOSCI-LANDMRK, V13, P4625, DOI 10.2741/3028	28	13	15	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7500	10.1371/journal.pone.0007500	http://dx.doi.org/10.1371/journal.pone.0007500			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838297	Green Submitted, Green Published, gold			2022-12-27	WOS:000270880900006
J	Hans, CP; Feng, YM; Naura, AS; Zerfaoui, M; Rezk, BM; Xia, HJ; Kaye, AD; Matrougui, K; Lazartigues, E; Boulares, AH				Hans, Chetan P.; Feng, Yumei; Naura, Amarjit S.; Zerfaoui, Mourad; Rezk, Bashir M.; Xia, Huijing; Kaye, Alan D.; Matrougui, Khalid; Lazartigues, Eric; Boulares, A. Hamid			Protective Effects of PARP-1 Knockout on Dyslipidemia-Induced Autonomic and Vascular Dysfunction in ApoE(-/-) Mice: Effects on eNOS and Oxidative Stress	PLOS ONE			English	Article							E-DEFICIENT MICE; DECREASED BAROREFLEX SENSITIVITY; POLY(ADP-RIBOSE) POLYMERASE; NITRIC-OXIDE; ENDOTHELIAL DYSFUNCTION; PHARMACOLOGICAL INHIBITION; HEART-RATE; OVEREXPRESSION; HYPERTENSION; REFLEX	The aims of this study were to investigate the role of poly(ADP-ribose) polymerase (PARP)-1 in dyslipidemia-associated vascular dysfunction as well as autonomic nervous system dysregulation. Apolipoprotein (ApoE)(-/-) mice fed a high-fat diet were used as a model of atherosclerosis. Vascular and autonomic functions were measured in conscious mice using telemetry. The study revealed that PARP-1 plays an important role in dyslipidemia-associated vascular and autonomic dysfunction. Inhibition of this enzyme by gene knockout partially restored baroreflex sensitivity in ApoE(-/-) mice without affecting baseline heart-rate and arterial pressure, and also improved heart-rate responses following selective blockade of the autonomic nervous system. The protective effect of PARP-1 gene deletion against dyslipidemia-induced endothelial dysfunction was associated with preservation of eNOS activity. Dyslipidemia induced PARP-1 activation was accompanied by oxidative tissue damage, as evidenced by increased expression of iNOS and subsequent protein nitration. PARP-1 gene deletion reversed these effects, suggesting that PARP-1 may contribute to vascular and autonomic pathologies by promoting oxidative tissue injury. Further, inhibition of this oxidative damage may account for protective effects of PARP-1 gene deletion on vascular and autonomic functions. This study demonstrates that PARP-1 participates in dyslipidemia-mediated dysregulation of the autonomic nervous system and that PARP-1 gene deletion normalizes autonomic and vascular dysfunctions. Maintenance of eNOS activity may be associated with the protective effect of PARP-1 gene deletion against dyslipidemia-induced endothelial dysfunction.			Hans, CP (corresponding author), Louisiana State Univ, Hlth Sci Ctr, Dept Pharmacol & Expt Therapeut, New Orleans, LA USA.	hboulr@lsuhsc.edu	Hans, Chetan/C-5490-2012	Lazartigues, Eric/0000-0001-7290-0786	NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR018766] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [R01HL072889] Funding Source: NIH RePORTER; NCRR NIH HHS [1P20RR18766, P20 RR018766] Funding Source: Medline; NHLBI NIH HHS [R01 HL072889, HL072889] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Aktan F, 2004, LIFE SCI, V75, P639, DOI 10.1016/j.lfs.2003.10.042; Anderson TJ, 2003, HEART FAIL REV, V8, P71, DOI 10.1023/A:1022199021949; Benko R, 2004, LIFE SCI, V75, P1255, DOI 10.1016/j.lfs.2004.04.007; Bishop V S, 1994, New Horiz, V2, P415; Braam B, 2007, CURR PHARM DESIGN, V13, P1727, DOI 10.2174/138161207780831275; CAMPOS C, 2008, EXP TOXICOL PATHOL; Crauwels HM, 2003, CARDIOVASC RES, V59, P189, DOI 10.1016/S0008-6363(03)00353-5; Feng YM, 2008, CIRC RES, V102, P729, DOI 10.1161/CIRCRESAHA.107.169110; Gava AL, 2008, CAN J PHYSIOL PHARM, V86, P458, DOI [10.1139/Y08-044, 10.1139/y08-044]; Gero D, 2008, CURR OPIN ANESTHESIO, V21, P111, DOI 10.1097/ACO.0b013e3282f63c15; Godecke A, 2002, CARDIOVASC RES, V53, P253, DOI 10.1016/S0008-6363(01)00432-1; Grassi G, 2005, DIABETOLOGIA, V48, P1359, DOI 10.1007/s00125-005-1798-z; Guyenet PG, 2006, NAT REV NEUROSCI, V7, P335, DOI 10.1038/nrn1902; Hans CP, 2008, CARDIOVASC RES, V78, P429, DOI 10.1093/cvr/cvn018; HANS CP, 2009, J PHARM EXPT THERAPE; Jessani S, 2007, AM J HYPERTENS, V20, P676, DOI 10.1016/j.amjhyper.2007.02.003; Kawashima S, 2004, J PHARMACOL SCI, V96, P411, DOI 10.1254/jphs.FMJ04006X6; Kovacs K, 2006, BIOCHEM PHARMACOL, V71, P441, DOI 10.1016/j.bcp.2005.05.036; Kukreja RC, 2007, J MOL CELL CARDIOL, V42, P280, DOI 10.1016/j.yjmcc.2006.10.011; La Rovere MT, 2008, ANN NONINVAS ELECTRO, V13, P191, DOI 10.1111/j.1542-474X.2008.00219.x; Lai CJ, 2006, J APPL PHYSIOL, V100, P1974, DOI 10.1152/japplphysiol.01051.2005; Lazartigues E, 2004, FASEB J, V18, pA299; Liao SJ, 2007, CLIN EXP PHARMACOL P, V34, P1260, DOI 10.1111/j.1440-1681.2007.04719.x; Libby P, 2006, AM J CARDIOL, V98, p3Q, DOI 10.1016/j.amjcard.2006.09.020; Manea A., 2007, Archives of Physiology and Biochemistry, V113, P163, DOI 10.1080/13813450701531235; Mustapha O, 2006, J IMMUNOL, V177, P6489, DOI 10.4049/jimmunol.177.9.6489; Nasr N, 2005, STROKE, V36, P1891, DOI 10.1161/01.STR.0000177890.30065.cb; Naura AS, 2009, EUR RESPIR J, V33, P252, DOI 10.1183/09031936.00089008; NAURA AS, 2008, EUR RESP J; O'Connell BJ, 2001, CIRCULATION, V104, P1978, DOI 10.1161/hc3901.096667; Oumouna-Benachour K, 2007, CIRCULATION, V115, P2442, DOI 10.1161/CIRCULATIONAHA.106.668756; Pacher P, 2004, J PHARMACOL EXP THER, V311, P485, DOI 10.1124/jpet.104.069658; Pacher P, 2007, CARDIOVASC DRUG REV, V25, P235, DOI 10.1111/j.1527-3466.2007.00018.x; Pacher P, 2007, PHYSIOL REV, V87, P315, DOI 10.1152/physrev.00029.2006; PARATI G, 1988, HYPERTENSION, V12, P214, DOI 10.1161/01.HYP.12.2.214; Rose RA, 2007, CIRC RES, V101, P1274, DOI 10.1161/CIRCRESAHA.107.158428; Russell JC, 2006, CARDIOVASC PATHOL, V15, P318, DOI 10.1016/j.carpath.2006.09.001; Soriano FG, 2001, CIRC RES, V89, P684, DOI 10.1161/hh2001.097797; Stauss HM, 2006, AM J PHYSIOL-HEART C, V291, pH482, DOI 10.1152/ajpheart.00228.2006; Szabo C, 2002, CIRCULATION, V106, P2680, DOI 10.1161/01.CIR.0000038365.78031.9C; Takasaki Yuji, 2005, Journal of Physiological Anthropology and Applied Human Science, V24, P511, DOI 10.2114/jpa.24.511; Tank J, 2004, HYPERTENSION, V43, P1042, DOI 10.1161/01.HYP.0000125884.49812.72; von Lukowicz T, 2008, CARDIOVASC RES, V78, P158, DOI 10.1093/cvr/cvm110; Wang YX, 2005, NEUROBIOL AGING, V26, P309, DOI 10.1016/j.neurobiolaging.2004.06.018; Xia HJ, 2009, HYPERTENSION, V53, P210, DOI 10.1161/HYPERTENSIONAHA.108.123844; Zheng W, 2004, AM J PHYSIOL-HEART C, V286, pH1994, DOI 10.1152/ajpheart.00991.2003	46	32	36	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7430	10.1371/journal.pone.0007430	http://dx.doi.org/10.1371/journal.pone.0007430			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823587	Green Submitted, gold, Green Published			2022-12-27	WOS:000270808300009
J	Ngo, DT; Erhart, A; Speybroeck, N; Nguyen, XX; Nguyen, NT; Pham, VK; Le, XH; Le, KT; Coosemans, M; D'Alessandro, U				Ngo Duc Thang; Erhart, Annette; Speybroeck, Niko; Nguyen Xuan Xa; Nguyen Ngoc Thanh; Pham Van Ky; Le Xuan Hung; Le Khanh Thuan; Coosemans, Marc; D'Alessandro, Umberto			Long-Lasting Insecticidal Hammocks for Controlling Forest Malaria: A Community-Based Trial in a Rural Area of Central Vietnam	PLOS ONE			English	Article							CHALLENGE	Background: In Vietnam, malaria remains a problem in some remote areas located along its international borders and in the central highlands, partly due to the bionomics of the local vector, mainly found in forested areas and less vulnerable to standard control measures. Long Lasting Insecticidal Hammocks (LLIH), a tailored and user-friendly tool for forest workers, may further contribute in reducing the malaria burden. Their effectiveness was tested in a large community-based intervention trial carried out in Ninh Thuan province in Central Vietnam. Methods and Findings: Thirty villages (population 18,646) were assembled in 20 clusters (1,000 individuals per cluster) that were randomly allocated to either the intervention or control group (no LLIH) after stratification according to the pre-intervention P. falciparum antibody prevalence (<30%; >= 30%). LLIH were distributed to the intervention group in December 2004. For the following 2 years, the incidence of clinical malaria and the prevalence of infection were determined by passive case detection at community level and by bi-annual malariometric surveys. A 2-fold larger effect on malaria incidence in the intervention as compared to the control group was observed. Similarly, malaria prevalence decreased more substantially in the intervention (1.6-fold greater reduction) than in the control group. Both for incidence and prevalence, a stronger and earlier effect of the intervention was observed in the high endemicity stratum. The number of malaria cases and infections averted by the intervention overall was estimated at 10.5 per 1,000 persons and 5.6/100 individuals, respectively, for the last half of 2006. In the high endemicity stratum, the impact was much higher, i.e. 29/1000 malaria cases and 15.7 infections/100 individuals averted. Conclusions: LLIH reduced malaria incidence and prevalence in this remote and forested area of Central Vietnam. As the targets of the newly-launched Global Malaria Action Plan include the 75% reduction of the global malaria cases by 2015 and eventually the elimination/eradication of malaria in the long term, LLIH may represent an additional tool for reaching such objectives, particularly in high endemicity areas where standard control tools have a modest impact, such as in remote and forested areas of Southeast Asia and possibly South America.			Ngo, DT (corresponding author), Natl Inst Malariol Parasitol & Entomol, Hanoi, Vietnam.	thangnimpevn@yahoo.com		Speybroeck, Niko/0000-0003-3322-3502				[Anonymous], 2001, 5 WHOPES WORK GROUP; Erhart A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-58; Erhart A, 2004, AM J TROP MED HYG, V70, P110, DOI 10.4269/ajtmh.2004.70.110; Hayes RJ, 1999, INT J EPIDEMIOL, V28, P319, DOI 10.1093/ije/28.2.319; Hougard JM, 2007, J MED ENTOMOL, V44, P651, DOI 10.1603/0022-2585(2007)44[651:PFTOAL]2.0.CO;2; Macintyre K, 2003, INT J EPIDEMIOL, V32, P157, DOI 10.1093/ije/dyg019; Ngo DT, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-3; *NIMPE, 2006, ANN REP NAT MAL CONT; *NIMPE, 2007, ANN REP NAT MAL CONT; *NIMPE, 2002, ANN REP NAT MAL CONT; NIMPE, 2004, ANN REP NAT MAL CONT; *NIMPE, 2008, ANN REP NAT MAL CONT; Obsomer V, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-26; Roll Back Malaria Partnership, 2008, GLOB MAL ACT PLAN MA; Thang ND, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-28; Trung HD, 2005, TROP MED INT HEALTH, V10, P251, DOI 10.1111/j.1365-3156.2004.01378.x; Trung HD, 2004, TROP MED INT HEALTH, V9, P230, DOI 10.1046/j.1365-3156.2003.01179.x	17	56	56	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7369	10.1371/journal.pone.0007369	http://dx.doi.org/10.1371/journal.pone.0007369			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809502	Green Published, gold			2022-12-27	WOS:000270594000019
J	Fletcher, N; Storey, EJ; Johnson, M; Reish, DJ; Hardege, JD				Fletcher, Nichola; Storey, Ellen J.; Johnson, Magnus; Reish, Donald J.; Hardege, Joergt D.			Experience Matters: Females Use Smell to Select Experienced Males for Paternal Care	PLOS ONE			English	Article							MATE CHOICE; SEXUAL SELECTION; PARENTAL CARE; REPRODUCTIVE ISOLATION; RAPID SPECIATION; FOUNDER EVENT; EVOLUTION; DOMINANT; BEHAVIOR; SUCCESS	Mate choice and mating preferences often rely on the information content of signals exchanged between potential partners. In species where a female's reproduction is the terminal event in life it is to be expected that females choose high quality males and assess males using some honest indicator of male quality. The Nereidid polychaete, Neanthes acuminata, exhibits monogamous pairing and the release of eggs by females terminates her life and larval success relies entirely on a male's ability to provide paternal care. As such females should have developed reliable, condition-dependent criteria to choose mates to guarantee survival and care for offspring. We show that females actively chose males experienced in fatherhood over others. In the absence of experienced males dominance, as evident from male-male fights, is utilized for mate selection. The preference for experienced males is not affected by previous social interactions between the individuals. We show that the choice of the partner is based on chemical signals demonstrating a 'scent of experience' to females providing evidence for the role of chemical signals in sexual selection for paternal care adding to our understanding of the mechanisms regulating condition-dependent mate choice.			Fletcher, N (corresponding author), Univ Hull, Dept Biol Sci, Kingston Upon Hull HU6 7RX, N Humberside, England.	j.d.hardege@hull.ac.uk		Johnson, Magnus/0000-0002-8163-4026				ANDERSSON M, 1982, BIOL J LINN SOC, V17, P375, DOI 10.1111/j.1095-8312.1982.tb02028.x; Bailey NW, 2008, BEHAV ECOL, V19, P960, DOI 10.1093/beheco/arn054; Brooks R, 2001, TRENDS ECOL EVOL, V16, P308, DOI 10.1016/S0169-5347(01)02147-4; COLLINS SA, 1995, ANIM BEHAV, V49, P479, DOI 10.1006/anbe.1995.0062; Cooke SJ, 2003, J THERM BIOL, V28, P445, DOI 10.1016/S0306-4565(03)00038-X; Cotton S, 2006, CURR BIOL, V16, pR755, DOI 10.1016/j.cub.2006.08.022; Darwin Charles, 1871, DESCENT MAN SEXUAL S; DRICKAMER LC, 1992, ANIM BEHAV, V43, P868, DOI 10.1016/S0003-3472(05)80212-X; Forsgren E, 1997, P ROY SOC B-BIOL SCI, V264, P1283, DOI 10.1098/rspb.1997.0177; Guevara-Fiore P, 2009, ANIM BEHAV, V77, P425, DOI 10.1016/j.anbehav.2008.10.018; Hale RE, 2008, ANIM BEHAV, V75, P1283, DOI 10.1016/j.anbehav.2007.09.034; Hardege JD, 2004, PEPTIDES, V25, P1517, DOI 10.1016/j.peptides.2003.11.029; Howard RW, 2003, J CHEM ECOL, V29, P961, DOI 10.1023/A:1022992002239; Jennions MD, 1997, BIOL REV, V72, P283, DOI 10.1017/S0006323196005014; Johansson BG, 2007, BIOL REV, V82, P265, DOI 10.1111/j.1469-185X.2007.00009.x; Johnstone RA, 1996, EVOLUTION, V50, P1382, DOI [10.2307/2410876, 10.1111/j.1558-5646.1996.tb03912.x]; KIRKPATRICK M, 1982, EVOLUTION, V36, P1, DOI 10.1111/j.1558-5646.1982.tb05003.x; Kodric-Brown A, 2001, AM NAT, V157, P316, DOI 10.1086/319191; Kokko H, 2008, CURR BIOL, V18, pR121, DOI 10.1016/j.cub.2007.11.063; Kvarnemo C, 1995, ANIM BEHAV, V50, P1455, DOI 10.1016/0003-3472(95)80002-6; Martin J, 2000, P ROY SOC B-BIOL SCI, V267, P1265, DOI 10.1098/rspb.2000.1137; Martin OY, 2003, NATURE, V423, P979, DOI 10.1038/nature01752; Moore AJ, 1999, P ROY SOC B-BIOL SCI, V266, P711, DOI 10.1098/rspb.1999.0694; Pampoulie C, 2004, BEHAV ECOL, V15, P199, DOI 10.1093/beheco/arg107; POOLE JH, 1989, ANIM BEHAV, V37, P842, DOI 10.1016/0003-3472(89)90068-7; Proulx SR, 2001, EVOLUTION, V55, P2401; Qvarnstrom A, 1998, TRENDS ECOL EVOL, V13, P498, DOI 10.1016/S0169-5347(98)01513-4; Ram JL, 2008, J EXP BIOL, V211, P757, DOI 10.1242/jeb.012773; Reburn CJ, 1999, HORM BEHAV, V35, P163, DOI 10.1006/hbeh.1998.1509; REISH D J, 1968, Bulletin Southern California Academy of Sciences, V67, P21; REISH DJ, 1985, TETHYS, V11, P335; REISH DONALD J., 1957, PACIFIC SCI, V11, P216; RIDLEY M, 1978, ANIM BEHAV, V26, P904, DOI 10.1016/0003-3472(78)90156-2; RodriguezTrelles F, 1996, EVOLUTION, V50, P457, DOI 10.1111/j.1558-5646.1996.tb04509.x; Schradin C, 1999, NEWS PHYSIOL SCI, V14, P223, DOI 10.1152/physiologyonline.1999.14.6.223; Shackleton MA, 2005, BEHAV ECOL SOCIOBIOL, V58, P1, DOI 10.1007/s00265-004-0907-1; Starczak VR, 1984, THESIS U CONNECTICUT; Sutton R, 2005, J CHEM ECOL, V31, P1865, DOI 10.1007/s10886-005-5931-8; Tallamy DW, 2001, ANNU REV ENTOMOL, V46, P139, DOI 10.1146/annurev.ento.46.1.139; Van Alphen JJM, 2001, J EVOLUTION BIOL, V14, P874, DOI 10.1046/j.1420-9101.2001.00343.x; WEINBERG JR, 1992, EVOLUTION, V46, P1214, DOI 10.1111/j.1558-5646.1992.tb00629.x; WEINBERG JR, 1990, MAR BIOL, V107, P205, DOI 10.1007/BF01319819; Wong BBM, 2004, ANIM BEHAV, V67, P583, DOI 10.1016/j.anbehav.2003.08.015; Wong BBM, 2005, BIOL REV, V80, P559, DOI 10.1017/S1464793105006809; ZEH DW, 1985, AM ZOOL, V25, P785	45	9	9	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2009	4	11							e7672	10.1371/journal.pone.0007672	http://dx.doi.org/10.1371/journal.pone.0007672			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RZ	19888341	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414600005
J	Horner, JR; Goodwin, MB				Horner, John R.; Goodwin, Mark B.			Extreme Cranial Ontogeny in the Upper Cretaceous Dinosaur Pachycephalosaurus	PLOS ONE			English	Article							RELATIVE GROWTH; ORNITHISCHIA; HISTOLOGY; SYNONOMY	Background: Extended neoteny and late stage allometric growth increase morphological disparity between growth stages in at least some dinosaurs. Coupled with relatively low dinosaur density in the Upper Cretaceous of North America, ontogenetic transformational representatives are often difficult to distinguish. For example, many hadrosaurids previously reported to represent relatively small lambeosaurine species were demonstrated to be juveniles of the larger taxa. Marginocephalians (pachycephalosaurids + ceratopsids) undergo comparable and extreme cranial morphological change during ontogeny. Methodology/Principal Findings: Cranial histology, morphology and computer tomography reveal patterns of internal skull development that show the purported diagnostic characters for the pachycephalosaurids Dracorex hogwartsia and Stygimoloch spinifer are ontogenetically derived features. Coronal histological sections of the frontoparietal dome of an adult Pachycephalosaurus wyomingensis reveal a dense structure composed of metaplastic bone with a variety of extremely fibrous and acellular tissue. Coronal histological sections and computer tomography of a skull and frontoparietal dome of Stygimoloch spinifer reveal an open intrafrontal suture indicative of a subadult stage of development. These dinosaurs employed metaplasia to rapidly grow and change the size and shape of their horns, cranial ornaments and frontoparietal domes, resulting in extreme cranial alterations during late stages of growth. We propose that Dracorex hogwartsia, Stygimoloch spinifer and Pachycephalosaurus wyomingensis are the same taxon and represent an ontogenetic series united by shared morphology and increasing skull length. Conclusions/Significance: Dracorex hogwartsia (juvenile) and Stygimoloch spinifer (subadult) are reinterpreted as younger growth stages of Pachycephalosaurus wyomingensis (adult). This synonymy reduces the number of pachycephalosaurid taxa from the Upper Cretaceous of North America and demonstrates the importance of cranial ontogeny in evaluating dinosaur diversity and taxonomy. These growth stages reflect a continuum rather than specific developmental steps defined by "known'' terminal morphologies.			Horner, JR (corresponding author), Montana State Univ, Museum Rockies, Bozeman, MT 59717 USA.	jhorner@montana.edu		Goodwin, Mark/0000-0001-7127-439X				BAKKER RT, 2006, LATE CRETACEOUS VERT, V35, P331; Brown B., 1940, Annals of the New York Academy of Sciences, V40, P133; DODSON P, 1975, SYST ZOOL, V24, P37, DOI 10.2307/2412696; DODSON P, 1976, J PALEONTOL, V50, P929; Francillon-Vieillot H., 1990, P471; GALIANO H, 2001, DINO PRESS, V4, P2; GALTON PM, 1983, CAN J EARTH SCI, V20, P462, DOI 10.1139/e83-043; GIFFIN EB, 1989, J PALEONTOL, V63, P525, DOI 10.1017/S0022336000019739; Goodwin M, 2004, J VERTEBR PALEONTOL, V24, p65A; Goodwin MB, 2004, PALEOBIOLOGY, V30, P253, DOI 10.1666/0094-8373(2004)030<0253:CHOPOM>2.0.CO;2; Goodwin MB, 1998, J VERTEBR PALEONTOL, V18, P363, DOI 10.1080/02724634.1998.10011064; HAINES RW, 1968, J ANAT, V103, P527; Horner J, 2007, J VERTEBR PALEONTOL, V27, p92A; Horner JR, 2008, J VERTEBR PALEONTOL, V28, P134, DOI 10.1671/0272-4634(2008)28[134:OOCEIT]2.0.CO;2; Horner JR, 2006, P ROY SOC B-BIOL SCI, V273, P2757, DOI 10.1098/rspb.2006.3643; HUXLEY JS, 1932, PROBLEMS RELATIVE GR, P312; LEVRATCALVIAC V, 1986, AM J ANAT, V176, P437, DOI 10.1002/aja.1001760406; Main RP, 2005, PALEOBIOLOGY, V31, P291, DOI 10.1666/0094-8373(2005)031[0291:TEAFOT]2.0.CO;2; MOSS ML, 1969, ACTA ANAT, V73, P510; Opperman LA, 2000, DEV DYNAM, V219, P472, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1073>3.0.CO;2-F; Parsons T.S., 1969, BIOL REPTILIA, VI, P81, DOI DOI 10.1093/ICB/ICP063; Reid R.E.H., 1996, Brigham Young University Geology Studies, V41, P25; ROZHDESTVENSKY AK, 1965, PALEONTOL ZH, V13, P95; Sampson SD, 1997, ZOOL J LINN SOC-LOND, V121, P293, DOI 10.1111/j.1096-3642.1997.tb00340.x; Sereno Paul C., 2000, P480; Sullivan RM, 2003, J VERTEBR PALEONTOL, V23, P181, DOI 10.1671/0272-4634(2003)23[181:ROTDSL]2.0.CO;2; SULLIVAN RM, 2006, LATE CRETACEOUS VERT, V35, P347; Sullivan R, 2007, J VERTEBR PALEONTOL, V27, p154A; Vickaryous MK, 2008, J MORPHOL, V269, P398, DOI 10.1002/jmor.10575; Williamson T.E., 2005, NEW MEXICO GEOLOGY, V27, P45; Williamson TE, 2002, J VERTEBR PALEONTOL, V22, P779, DOI 10.1671/0272-4634(2002)022[0779:ANGODP]2.0.CO;2; Zylberberg L., 1992, BONE BONE METAB MINE, V4, P171	32	104	107	1	35	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7626	10.1371/journal.pone.0007626	http://dx.doi.org/10.1371/journal.pone.0007626			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859556	gold, Green Published, Green Submitted			2022-12-27	WOS:000271147400018
J	Perrot, O; Laroche, D; Pozzo, T; Marie, C				Perrot, Olivier; Laroche, Davy; Pozzo, Thierry; Marie, Christine			Quantitative Assessment of Stereotyped and Challenged Locomotion after Lesion of the Striatum: A 3D Kinematic Study in Rats	PLOS ONE			English	Article							NIGRA PARS RETICULATA; BASAL GANGLIA; TREADMILL LOCOMOTION; MOTOR CORTEX; HINDLIMB KINEMATICS; PARKINSONS-DISEASE; QUINOLINIC ACID; GAIT ASYMMETRY; BRAIN-LESION; STROKE	Background: Although the striatum is in position to regulate motor function, the role of the structure in locomotor behaviour is poorly understood. Therefore, a detailed analysis of locomotion-and obstacle avoidance-related parameters was performed after unilateral lesion of the striatum in rats. Methods and Results: Using the three dimensional motion capture technology, kinematics of walking and clearing obstacles, head and body orientation were analyzed before and up to 60 days after the lesion. Recordings were performed in treadmill running rats with or without obstacles attached to the treadmill belt. The lesion, which was induced by the direct injection of the mitochondrial toxin malonate into the left caudoputamen resulted in the complete destruction of the dorsal striatum. During the first three days following the lesion, rats were unable to run on the treadmill. Thereafter, rats showed normal looking locomotion, yet the contralesional limbs exhibited changes in length and timing parameters, and were overflexed. Moreover, the head of lesioned rats was orientated towards the side of the lesion, and their postural vertical shifted towards the contralesional side. During obstructed running, the contralesional limbs when they were leading the crossing manoeuvre stepped on the obstacle rather than to overcome obstacle without touching it, yet more frequently with the forelimb than the hindlimb. Unsuccessful crossings appeared to be due to a paw placement farther away from the front of the obstacles, and not to an inappropriate limb elevation. Importantly, deficit in locomotor behaviour did not regress over the time. Conclusion: Our results argue that the striatum of one hemisphere controls kinematics of contralateral limbs during stereotyped locomotion and plays a prominent role in the selection of the right motor program so that these limbs successfully cross over obstacle.			Perrot, O (corresponding author), Univ Bourgogne, INSERM, Motr Plast U887, Dijon, France.	chmarie@u-bourgogne.fr	Laroche, Davy/K-4298-2015	Laroche, Davy/0000-0003-1599-4258; Pozzo, Thierry/0000-0002-0585-7965; marie, christine/0000-0003-3724-0713				ALEXANDER GE, 1990, PROG BRAIN RES, V85, P119; Alexander LD, 2009, STROKE, V40, P537, DOI 10.1161/STROKEAHA.108.527374; Armstrong DM, 1996, CAN J PHYSIOL PHARM, V74, P443, DOI 10.1139/cjpp-74-4-443; BENECKE R, 1987, BRAIN, V110, P361, DOI 10.1093/brain/110.2.361; Berger MF, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-23; Bezard E, 2003, TRENDS NEUROSCI, V26, P215, DOI 10.1016/S0166-2236(03)00038-9; BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; BROWN LL, 1992, P NATL ACAD SCI USA, V89, P7403, DOI 10.1073/pnas.89.16.7403; Brown LL, 1997, CURR OPIN NEUROBIOL, V7, P157, DOI 10.1016/S0959-4388(97)80003-7; CLARKE KA, 1986, PHYSIOL BEHAV, V38, P345, DOI 10.1016/0031-9384(86)90105-8; Courtine G, 2008, NAT MED, V14, P69, DOI 10.1038/nm1682; Couto PA, 2008, J NEUROSCI METH, V173, P193, DOI 10.1016/j.jneumeth.2008.06.006; Da Cunha C, 2008, BEHAV BRAIN RES, V189, P364, DOI 10.1016/j.bbr.2008.01.012; Dawes H, 2008, EXP BRAIN RES, V186, P325, DOI 10.1007/s00221-007-1237-0; DELONG MR, 1990, TRENDS NEUROSCI, V13, P281, DOI 10.1016/0166-2236(90)90110-V; Demougeot C, 2001, J NEUROCHEM, V77, P408, DOI 10.1046/j.1471-4159.2001.00285.x; Deniau JM, 1996, NEUROSCIENCE, V73, P761, DOI 10.1016/0306-4522(96)00088-7; DENOTTER AR, 2005, EXP BRAIN RES, V92, P161; Dietz V, 2008, BRAIN, V131, P3421, DOI 10.1093/brain/awn263; Drew T, 1996, CAN J PHYSIOL PHARM, V74, P426, DOI 10.1139/cjpp-74-4-426; Drew T, 2002, BRAIN RES REV, V40, P178, DOI 10.1016/S0165-0173(02)00200-X; Drew T, 2008, BRAIN RES REV, V57, P199, DOI 10.1016/j.brainresrev.2007.07.017; Duhamel A, 2004, GAIT POSTURE, V20, P204, DOI 10.1016/j.gaitpost.2003.09.010; Filipe VM, 2006, J NEUROSCI METH, V153, P55, DOI 10.1016/j.jneumeth.2005.10.006; GARCIA RE, 1986, BRAIN RES, V396, P47; Garnier C, 2008, BEHAV BRAIN RES, V186, P57, DOI 10.1016/j.bbr.2007.07.023; GREENE JG, 1993, J NEUROCHEM, V61, P1151, DOI 10.1111/j.1471-4159.1993.tb03634.x; Greene JG, 1996, J NEUROCHEM, V66, P637; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Hebb MO, 1999, NEUROSCIENCE, V90, P413, DOI 10.1016/S0306-4522(98)00433-3; Henderson JM, 2005, BEHAV BRAIN RES, V160, P267, DOI 10.1016/j.bbr.2004.12.008; Hikosaka O, 2007, PROG BRAIN RES, V160, P209, DOI 10.1016/S0079-6123(06)60012-5; Karl JM, 2008, BRAIN RES BULL, V77, P42, DOI 10.1016/j.brainresbull.2008.04.012; Lafosse C, 2004, NEUROREPORT, V15, P887, DOI 10.1097/00001756-200404090-00031; Lajoie K, 2007, J NEUROPHYSIOL, V97, P2339, DOI 10.1152/jn.01196.2006; MARSHALL JF, 1980, J COMP PHYSIOL PSYCH, V94, P833, DOI 10.1037/h0077825; Metz GAS, 1998, BEHAV BRAIN RES, V96, P37, DOI 10.1016/S0166-4328(97)00195-2; Middleton FA, 2000, BRAIN RES REV, V31, P236, DOI 10.1016/S0165-0173(99)00040-5; MIKLYAEVA EI, 1995, BRAIN RES, V681, P23, DOI 10.1016/0006-8993(95)00277-W; Millerot-Serrurot E, 2007, NEUROCHEM INT, V50, P328, DOI 10.1016/j.neuint.2006.08.016; MIYASHITA N, 1995, NEUROREPORT, V6, P1257, DOI 10.1097/00001756-199506090-00007; Muir GD, 1999, BEHAV BRAIN RES, V103, P45, DOI 10.1016/S0166-4328(99)00018-2; Patterson KK, 2008, ARCH PHYS MED REHAB, V89, P304, DOI 10.1016/j.apmr.2007.08.142; Perennou DA, 2008, BRAIN, V131, P2401, DOI 10.1093/brain/awn170; Rossignol S, 2006, PHYSIOL REV, V86, P89, DOI 10.1152/physrev.00028.2005; Said CM, 1999, ARCH PHYS MED REHAB, V80, P1054, DOI 10.1016/S0003-9993(99)90060-6; SCHALLERT T, 1983, PHARMACOL BIOCHEM BE, V18, P753, DOI 10.1016/0091-3057(83)90019-9; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; SEITZ RJ, 1992, EUR J NEUROSCI, V4, P154, DOI 10.1111/j.1460-9568.1992.tb00862.x; Shi LH, 2004, EXP BRAIN RES, V157, P303, DOI 10.1007/s00221-004-1844-y; Sparrow WA, 1996, HUM MOVEMENT SCI, V15, P605, DOI 10.1016/0167-9457(96)00022-X; Takakusaki K, 2003, NEUROSCIENCE, V119, P293, DOI 10.1016/S0306-4522(03)00095-2; Takakusaki K, 2008, BRAIN RES REV, V57, P192, DOI 10.1016/j.brainresrev.2007.06.024; Takakusaki Kaoru, 2009, Rinsho Shinkeigaku, V49, P325; Thota AK, 2005, J NEUROTRAUM, V22, P442, DOI 10.1089/neu.2005.22.442; Wagner J, 2008, EXP BRAIN RES, V191, P247, DOI 10.1007/s00221-008-1520-8; Wang YG, 2008, J CEREBR BLOOD F MET, V28, P1936, DOI 10.1038/jcbfm.2008.82	57	12	12	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7616	10.1371/journal.pone.0007616	http://dx.doi.org/10.1371/journal.pone.0007616			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859550	Green Submitted, gold, Green Published			2022-12-27	WOS:000271147400015
J	Marshall, JL; Huestis, DL; Hiromasa, Y; Wheeler, S; Oppert, C; Marshall, SA; Tomich, JM; Oppert, B				Marshall, Jeremy L.; Huestis, Diana L.; Hiromasa, Yasuaki; Wheeler, Shanda; Oppert, Cris; Marshall, Susan A.; Tomich, John M.; Oppert, Brenda			Identification, RNAi Knockdown, and Functional Analysis of an Ejaculate Protein that Mediates a Postmating, Prezygotic Phenotype in a Cricket	PLOS ONE			English	Article							SEMINAL FLUID PROTEIN; DOUBLE-STRANDED-RNA; DROSOPHILA-MELANOGASTER; POSITIVE SELECTION; ALLONEMOBIUS-FASCIATUS; REPRODUCTIVE ISOLATION; MOLECULAR EVOLUTION; SEXUAL-DIMORPHISM; GENE; HYBRIDIZATION	Postmating, prezygotic phenotypes, especially those that underlie reproductive isolation between closely related species, have been a central focus of evolutionary biologists over the past two decades. Such phenotypes are thought to evolve rapidly and be nearly ubiquitous among sexually reproducing eukaryotes where females mate with multiple partners. Because these phenotypes represent interplay between the male ejaculate and female reproductive tract, they are fertile ground for reproductive senescence-as ejaculate composition and female physiology typically change over an individual's life span. Although these phenotypes and their resulting dynamics are important, we have little understanding of the proteins that mediate these phenotypes, particularly for species groups where postmating, prezygotic traits are the primary mechanism of reproductive isolation. Here, we utilize proteomics, RNAi, mating experiments, and the Allonemobius socius complex of crickets, whose members are primarily isolated from one another by postmating, prezygotic phenotypes (including the ability of a male to induce a female to lay eggs), to demonstrate that one of the most abundant ejaculate proteins (a male accessory gland-biased protein similar to a trypsin-like serine protease) decreases in abundance over a male's reproductive lifetime and mediates the induction of egg-laying in females. These findings represent one of the first studies to identify a protein that plays a role in mediating both a postmating, prezygotic isolation pathway and reproductive senescence.			Marshall, JL (corresponding author), Kansas State Univ, Dept Entomol, Manhattan, KS 66506 USA.	cricket@ksu.edu	Marshall, Jeremy/D-1436-2013	Huestis, Diana/0000-0001-6649-4785; TOMICH, JOHN/0000-0001-7848-8307				Andres JA, 2006, MOL BIOL EVOL, V23, P1574, DOI 10.1093/molbev/msl020; Arakane Y, 2005, INSECT MOL BIOL, V14, P453, DOI 10.1111/j.1365-2583.2005.00576.x; Arnqvist Goran, 2005, pUnpaginated; Baines JF, 2008, MOL BIOL EVOL, V25, P1639, DOI 10.1093/molbev/msn111; Chapman T, 2003, P NATL ACAD SCI USA, V100, P9923, DOI 10.1073/pnas.1631635100; Chapman T, 2001, HEREDITY, V87, P511, DOI 10.1046/j.1365-2540.2001.00961.x; Civetta A, 2003, MOL BIOL EVOL, V20, P21, DOI 10.1093/molbev/msg002; Clark NL, 2006, REPRODUCTION, V131, P11, DOI 10.1530/rep.1.00357; Doherty JA, 1996, ANIM BEHAV, V51, P981, DOI 10.1006/anbe.1996.0101; Dong Y, 2005, BMC BIOTECHNOL, V5, DOI 10.1186/1472-6750-5-25; Dzitoyeva S, 2003, BMC GENOMICS, V4, DOI 10.1186/1471-2164-4-33; Fire A, 1998, NATURE, V391, P806, DOI 10.1038/35888; Gillott C, 2003, ANNU REV ENTOMOL, V48, P163, DOI 10.1146/annurev.ento.48.091801.112657; GREGORY PG, 1993, ANN ENTOMOL SOC AM, V86, P694, DOI 10.1093/aesa/86.6.694; GREGORY PG, 1994, EVOLUTION, V48, P705, DOI [10.2307/2410480, 10.1111/j.1558-5646.1994.tb01355.x]; Gregory PG, 1998, ENTOMOL EXP APPL, V87, P263, DOI 10.1023/A:1003280322549; Henkel R, 2005, FERTIL STERIL, V84, P1430, DOI 10.1016/j.fertnstert.2005.05.020; HOWARD DJ, 1991, EVOLUTION, V45, P1120, DOI 10.1111/j.1558-5646.1991.tb04379.x; Howard DJ, 1998, EVOLUTION, V52, P511, DOI 10.1111/j.1558-5646.1998.tb01650.x; HOWARD DJ, 1986, ANN ENTOMOL SOC AM, V79, P472, DOI 10.1093/aesa/79.3.472; HOWARD DJ, 1986, EVOLUTION, V40, P34, DOI 10.1111/j.1558-5646.1986.tb05715.x; Howard DJ, 1998, ENDLESS FORMS, P279; Lehmann GUC, 2009, BIOL J LINN SOC, V96, P354, DOI 10.1111/j.1095-8312.2008.01129.x; Lung O, 2002, GENETICS, V160, P211; Lycett GJ, 2006, INSECT MOL BIOL, V15, P321, DOI 10.1111/j.1365-2583.2006.00647.x; Maestro JL, 2006, ARCH INSECT BIOCHEM, V62, P73, DOI 10.1002/arch.20123; Marshall JL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000720; Marshall JL, 2004, EVOLUTION, V58, P2409, DOI 10.1111/j.0014-3820.2004.tb00871.x; MAYS D L, 1971, Florida Entomologist, V54, P113, DOI 10.2307/3493557; Meyering-Vos M, 2006, INSECT BIOCHEM MOLEC, V36, P492, DOI 10.1016/j.ibmb.2006.03.008; Moller AP, 2009, J EVOLUTION BIOL, V22, P334, DOI 10.1111/j.1420-9101.2008.01650.x; Mutti NS, 2006, J INSECT SCI, V6, DOI 10.1673/031.006.3801; Nelson CM, 2007, PLOS BIOL, V5, P673, DOI 10.1371/journal.pbio.0050062; Neubaum DM, 1999, GENETICS, V153, P845; Palumbi SR, 1999, P NATL ACAD SCI USA, V96, P12632, DOI 10.1073/pnas.96.22.12632; Pizzari T, 2008, TRENDS ECOL EVOL, V23, P131, DOI 10.1016/j.tree.2007.12.003; Qazi MCB, 2003, J EXP BIOL, V206, P3521, DOI 10.1242/jeb.00585; Rinn JL, 2005, TRENDS GENET, V21, P298, DOI 10.1016/j.tig.2005.03.005; Ross J, 2003, GENE, V304, P117, DOI 10.1016/S0378-1119(02)01187-3; Si Sheng-li, 2000, Acta Entomologica Sinica, V43, P120; Simmons L. W., 2001, MG BEH ECOL; Simmons LW, 2007, BIOL LETTERS, V3, P520, DOI 10.1098/rsbl.2007.0328; SWANSON WJ, 1995, P NATL ACAD SCI USA, V92, P4957, DOI 10.1073/pnas.92.11.4957; Swanson WJ, 2002, ANNU REV ECOL SYST, V33, P161, DOI 10.1146/annurev.ecolsys.33.010802.150439; Torgerson DG, 2002, MOL BIOL EVOL, V19, P1973, DOI 10.1093/oxfordjournals.molbev.a004021; Tram U, 1999, GENETICS, V153, P837; Turner LM, 2006, MOL BIOL EVOL, V23, P1656, DOI 10.1093/molbev/msl035; Vacquier VD, 1998, SCIENCE, V281, P1995, DOI 10.1126/science.281.5385.1995; Wolf KN, 2000, BIOL REPROD, V63, P179, DOI 10.1095/biolreprod63.1.179; Wolfner MF, 1997, INSECT BIOCHEM MOLEC, V27, P179, DOI 10.1016/S0965-1748(96)00084-7; Wong A, 2008, MOL BIOL EVOL, V25, P497, DOI 10.1093/molbev/msm270; Zajitschek F, 2009, AM NAT, V173, P792, DOI 10.1086/598486; Zhang Z, 2004, MOL BIOL EVOL, V21, P2130, DOI 10.1093/molbev/msh223; Zhou XG, 2006, P NATL ACAD SCI USA, V103, P4499, DOI 10.1073/pnas.0508866103	54	44	46	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7537	10.1371/journal.pone.0007537	http://dx.doi.org/10.1371/journal.pone.0007537			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851502	gold, Green Submitted, Green Published			2022-12-27	WOS:000271022300005
J	Pozharskaya, V; Torres-Gonzalez, E; Rojas, M; Gal, A; Amin, M; Dollard, S; Roman, J; Stecenko, AA; Mora, AL				Pozharskaya, Veronika; Torres-Gonzalez, Edilson; Rojas, Mauricio; Gal, Anthony; Amin, Minal; Dollard, Sheila; Roman, Jesse; Stecenko, Arlene A.; Mora, Ana L.			Twist: A Regulator of Epithelial-Mesenchymal Transition in Lung Fibrosis	PLOS ONE			English	Article							IDIOPATHIC PULMONARY-FIBROSIS; BARR-VIRUS DNA; GENE-EXPRESSION; UP-REGULATION; N-CADHERIN; TGF-BETA; IN-VIVO; CELLS; DISEASE; CANCER	Background: Several studies have implicated viral infection as an important factor in the pathogenesis of IPF and related fibrotic lung disorders. Viruses are thought to cause epithelial cell injury and promote epithelial-mesenchymal transition (EMT), a process whereby differentiated epithelial cells undergo transition to a mesenchymal phenotype, and considered a source of fibroblasts in the setting of lung injury. We have demonstrated an association between the epithelial injury caused by chronic herpes virus infection with the murine gamma-herpes virus, MHV68, and lung fibrosis. We hypothesize that EMT in this model of virus-induced pulmonary fibrosis is driven by the expression of the transcription factor Twist. Methods/Findings: In vitro MHV68 infection of murine lung epithelial cells induced expression of Twist, and mesenchymal markers. Stable overexpression of Twist promoted EMT in MLE15 lung epithelial cells. Transient knockdown expression of Twist resulted in preservation of epithelial phenotype after in vitro MHV68 infection. In concordance, high expression of Twist was found in lung epithelial cells of MHV68 infected mice, but not in mock infected mice. Alveolar epithelial cells from lung tissue of idiopathic pulmonary fibrosis (IPF) patients were strongly positive for Twist. These cells demonstrated features of EMT with low expression of E-cadherin and upregulation of the mesenchymal marker N-cadherin. Finally, IPF tissue with high Twist protein levels was also positive for the herpesvirus, EBV. Conclusions/Significance: We conclude that Twist contributes to EMT in the model of virus-induced pulmonary fibrosis. We speculate that in some IPF cases, gamma-herpes virus infection with EBV might be a source of injury precipitating EMT through the expression of Twist.			Pozharskaya, V (corresponding author), Emory Univ, Dept Pediat, Div Pulm Allergy Immunol Cyst Fibrosis & Sleep, Atlanta, GA 30322 USA.	amora@emory.edu			NCATS NIH HHS [UL1 TR000454] Funding Source: Medline; NHLBI NIH HHS [R21 HL080284, K01 HL073154, R21 HL 080284-01] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES [UL1TR000454] Funding Source: NIH RePORTER; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [K01HL073154, R21HL080284] Funding Source: NIH RePORTER	NCATS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI))		Ahn JW, 2002, J VIROL, V76, P6244, DOI 10.1128/JVI.76.12.6244-6256.2002; Alexander NR, 2006, CANCER RES, V66, P3365, DOI 10.1158/0008-5472.CAN-05-3401; CHEN ZF, 1995, GENE DEV, V9, P686, DOI 10.1101/gad.9.6.686; Dong YF, 2007, MOL ENDOCRINOL, V21, P2805, DOI 10.1210/me.2007-0199; EGAN JJ, 1995, THORAX, V50, P1234, DOI 10.1136/thx.50.12.1234; Geiger T, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001574; Horikawa T, 2007, CANCER RES, V67, P1970, DOI 10.1158/0008-5472.CAN-06-3933; Howe LR, 2003, CANCER RES, V63, P1906; Iwano M, 2002, J CLIN INVEST, V110, P341, DOI 10.1172/JCI200215518; Kelly BG, 2002, AM J RESP CRIT CARE, V166, P510, DOI 10.1164/rccm.2103058; Kida Y, 2007, J HISTOCHEM CYTOCHEM, V55, P661, DOI 10.1369/jhc.6A7157.2007; Kim KK, 2006, P NATL ACAD SCI USA, V103, P13180, DOI 10.1073/pnas.0605669103; Kim KK, 2009, J CLIN INVEST, V119, P213, DOI 10.1172/JCI36940; Konigshoff M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002142; Lawson WE, 2008, AM J PHYSIOL-LUNG C, V294, pL1119, DOI 10.1152/ajplung.00382.2007; Li Tian-yu, 2007, Zhonghua Wai Ke Za Zhi, V45, P1491; Lo HW, 2007, CANCER RES, V67, P9066, DOI 10.1158/0008-5472.CAN-07-0575; Lok S S, 2000, Monaldi Arch Chest Dis, V55, P146; Maestro R, 1999, GENE DEV, V13, P2207, DOI 10.1101/gad.13.17.2207; MALIZIA AP, 2008, AM J PHYSL LUNG CELL; Meneghin A, 2007, J CLIN INVEST, V117, P530, DOI 10.1172/JCI30595; Mironchik Y, 2005, CANCER RES, V65, P10801, DOI 10.1158/0008-5472.CAN-05-0712; Mora AL, 2005, AM J PHYSIOL-LUNG C, V289, pL711, DOI 10.1152/ajplung.00007.2005; Mora AL, 2007, AM J RESP CRIT CARE, V175, P1139, DOI 10.1164/rccm.200610-1426OC; Niesner U, 2008, J EXP MED, V205, P1889, DOI 10.1084/jem.20072468; Ryan JL, 2004, J MOL DIAGN, V6, P378, DOI 10.1016/S1525-1578(10)60535-1; Sosic D, 2003, CELL, V112, P169, DOI 10.1016/S0092-8674(03)00002-3; Stewart JP, 1999, AM J RESP CRIT CARE, V159, P1336, DOI 10.1164/ajrccm.159.4.9807077; Strieter RM, 2007, J CLIN INVEST, V117, P549, DOI 10.1172/JCI30562; Studer Sean M, 2007, Proc Am Thorac Soc, V4, P85, DOI 10.1513/pats.200607-139JG; Tabata T, 2008, AM J PATHOL, V172, P1127, DOI 10.2353/ajpath.2008.070448; Tang YW, 2003, J CLIN MICROBIOL, V41, P2633, DOI 10.1128/JCM.41.6.2633-2640.2003; THISSE B, 1987, NUCLEIC ACIDS RES, V15, P3439, DOI 10.1093/nar/15.8.3439; Tsukamoto K, 2000, THORAX, V55, P958, DOI 10.1136/thorax.55.11.958; Willis BC, 2005, AM J PATHOL, V166, P1321, DOI 10.1016/S0002-9440(10)62351-6; Willis BC, 2007, AM J PHYSIOL-LUNG C, V293, pL525, DOI 10.1152/ajplung.00163.2007; Yang J, 2004, CELL, V117, P927, DOI 10.1016/j.cell.2004.06.006; Yang MH, 2008, CELL CYCLE, V7, P2090, DOI 10.4161/cc.7.14.6324; Yang MH, 2008, NAT CELL BIOL, V10, P295, DOI 10.1038/ncb1691; Yang Z, 2007, BIOCHEM BIOPH RES CO, V358, P925, DOI 10.1016/j.bbrc.2007.05.023; Zavadil J, 2005, ONCOGENE, V24, P5764, DOI 10.1038/sj.onc.1208927	41	100	107	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7559	10.1371/journal.pone.0007559	http://dx.doi.org/10.1371/journal.pone.0007559			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851501	Green Published, Green Submitted, gold			2022-12-27	WOS:000271022300006
J	Mazzoni, P; Wexler, NS				Mazzoni, Pietro; Wexler, Nancy S.			Parallel Explicit and Implicit Control of Reaching	PLOS ONE			English	Article							CEREBRAL GLUCOSE-METABOLISM; LINKING BASAL GANGLIA; AGE-OF-ONSET; HUNTINGTONS-DISEASE; NEUROPSYCHOLOGICAL MANIFESTATIONS; PARKINSONS-DISEASE; RECEPTOR-BINDING; MEMORY-SYSTEMS; MOTOR; CARRIERS	Background: Human movement can be guided automatically (implicit control) or attentively (explicit control). Explicit control may be engaged when learning a new movement, while implicit control enables simultaneous execution of multiple actions. Explicit and implicit control can often be assigned arbitrarily: we can simultaneously drive a car and tune the radio, seamlessly allocating implicit or explicit control to either action. This flexibility suggests that sensorimotor signals, including those that encode spatially overlapping perception and behavior, can be accurately segregated to explicit and implicit control processes. Methodology/Principal Findings: We tested human subjects' ability to segregate sensorimotor signals to parallel control processes by requiring dual (explicit and implicit) control of the same reaching movement and testing for interference between these processes. Healthy control subjects were able to engage dual explicit and implicit motor control without degradation of performance compared to explicit or implicit control alone. We then asked whether segregation of explicit and implicit motor control can be selectively disrupted by studying dual-control performance in subjects with no clinically manifest neurologic deficits in the presymptomatic stage of Huntington's disease (HD). These subjects performed successfully under either explicit or implicit control alone, but were impaired in the dual-control condition. Conclusion/Significance: The human nervous system can exert dual control on a single action, and is therefore able to accurately segregate sensorimotor signals to explicit and implicit control. The impairment observed in the presymptomatic stage of HD points to a possible crucial contribution of the striatum to the segregation of sensorimotor signals to multiple control processes.			Mazzoni, P (corresponding author), Columbia Univ, Dept Neurol, Motor Performance Lab, New York, NY 10027 USA.	pm125@columbia.edu		Lauwereyns, Jan/0000-0003-0551-2550; Mazzoni, Pietro/0000-0002-7367-8811	NINDS NIH HHS [R01 NS049206] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS049206] Funding Source: NIH RePORTER	NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Antonini A, 1996, BRAIN, V119, P2085, DOI 10.1093/brain/119.6.2085; Aylward EH, 1996, ARCH NEUROL-CHICAGO, V53, P1293, DOI 10.1001/archneur.1996.00550120105023; Baars BJ, 2003, TRENDS COGN SCI, V7, P166, DOI 10.1016/S1364-6613(03)00056-1; Baddeley A, 2000, TRENDS COGN SCI, V4, P417, DOI 10.1016/S1364-6613(00)01538-2; Badgaiyan RD, 2000, HUM BRAIN MAPP, V9, P38, DOI 10.1002/(SICI)1097-0193(2000)9:1<38::AID-HBM4>3.0.CO;2-T; Bock O, 2005, EXP BRAIN RES, V160, P259, DOI 10.1007/s00221-004-2133-5; Bonfiglioli C, 1998, NEUROPSYCHOLOGIA, V36, P1203, DOI 10.1016/S0028-3932(97)00171-1; Brandt J, 2002, J INT NEUROPSYCH SOC, V8, P918, DOI 10.1017/S1355617702870060; Brown RG, 2001, BRAIN, V124, P2188, DOI 10.1093/brain/124.11.2188; Craufurd D., 2002, HUNTINGTONS DIS, P62; de Boo GM, 1999, J CLIN EXP NEUROPSYC, V21, P831; Delval A, 2008, MOVEMENT DISORD, V23, P1446, DOI 10.1002/mds.22125; DESPOSITO M, 1995, NATURE, V378, P279, DOI 10.1038/378279a0; Eversheim U, 2001, LEARN MEMORY, V8, P183, DOI 10.1101/lm.39301; Foerde K, 2006, P NATL ACAD SCI USA, V103, P11778, DOI 10.1073/pnas.0602659103; Gabrieli JDE, 1997, NEUROPSYCHOLOGY, V11, P272, DOI 10.1037/0894-4105.11.2.272; Ghilardi MF, 2000, BRAIN RES, V871, P127, DOI 10.1016/S0006-8993(00)02365-9; GRAFTON ST, 1992, ARCH NEUROL-CHICAGO, V49, P1161, DOI 10.1001/archneur.1992.00530350075022; Graybiel A M, 1991, Curr Opin Neurobiol, V1, P644, DOI 10.1016/S0959-4388(05)80043-1; Heyder K, 2004, ACTA PSYCHOL, V115, P271, DOI 10.1016/j.actpsy.2003.12.010; HOUK JC, 1995, CEREB CORTEX, V5, P95, DOI 10.1093/cercor/5.2.95; Huang VS, 2007, J NEUROPHYSIOL, V97, P3976, DOI 10.1152/jn.01281.2006; Inoue K, 2000, NEUROIMAGE, V11, P505, DOI 10.1006/nimg.2000.0554; Kirkwood SC, 2000, J NEUROL NEUROSUR PS, V69, P773, DOI 10.1136/jnnp.69.6.773; Krakauer JW, 2000, J NEUROSCI, V20, P8916, DOI 10.1523/jneurosci.20-23-08916.2000; Krakauer JW, 2004, J NEUROPHYSIOL, V91, P924, DOI 10.1152/jn.00675.2003; Langbehn DR, 2004, CLIN GENET, V65, P267, DOI 10.1111/j.1399-0004.2004.00241.x; Lawrence AD, 1998, BRAIN, V121, P1329, DOI 10.1093/brain/121.7.1329; Lawrence AD, 1998, BRAIN, V121, P1343, DOI 10.1093/brain/121.7.1343; Luft AR, 2005, MOL NEUROBIOL, V32, P205, DOI 10.1385/MN:32:3:205; MAZZIOTTA JC, 1987, NEW ENGL J MED, V316, P357, DOI 10.1056/NEJM198702123160701; Mazzoni P, 2006, J NEUROSCI, V26, P3642, DOI 10.1523/JNEUROSCI.5317-05.2006; Mazzoni P, 2007, J NEUROSCI, V27, P7105, DOI 10.1523/JNEUROSCI.0264-07.2007; Mink JW, 1996, PROG NEUROBIOL, V50, P381, DOI 10.1016/S0301-0082(96)00042-1; Mullen R, 2007, BRIT J PSYCHOL, V98, P141, DOI 10.1348/000712606X114336; O'Shea S, 2002, PHYS THER, V82, P888, DOI 10.1093/ptj/82.9.888; Plotnik M, 2009, J NEUROL NEUROSUR PS, V80, P347, DOI 10.1136/jnnp.2008.157362; Poldrack RA, 2005, J NEUROSCI, V25, P5356, DOI 10.1523/JNEUROSCI.3880-04.2005; Postle BR, 1999, COGNITIVE BRAIN RES, V8, P107, DOI 10.1016/S0926-6410(99)00010-5; Reber A.S., 1993, IMPLICIT LEARNING TA; Rosas HD, 2003, NEUROLOGY, V60, P1615, DOI 10.1212/01.WNL.0000065888.88988.6E; ROSENBERG NK, 1995, J MED GENET, V32, P600, DOI 10.1136/jmg.32.8.600; ROTHLIND JC, 1993, ARCH NEUROL-CHICAGO, V50, P799, DOI 10.1001/archneur.1993.00540080010005; Rubinsztein DC, 1997, P NATL ACAD SCI USA, V94, P3872, DOI 10.1073/pnas.94.8.3872; SEGER CA, 1994, PSYCHOL BULL, V115, P163, DOI 10.1037/0033-2909.115.2.163; SHOULSON I, 1975, ANNU REV MED, V26, P419, DOI 10.1146/annurev.me.26.020175.002223; Smith EE, 1996, CEREB CORTEX, V6, P11, DOI 10.1093/cercor/6.1.11; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Smith MA, 2005, J NEUROPHYSIOL, V93, P2809, DOI 10.1152/jn.00943.2004; Smith MA, 2000, NATURE, V403, P544, DOI 10.1038/35000576; SPRENGELMEYER R, 1995, BRAIN, V118, P145, DOI 10.1093/brain/118.1.145; Squire LR, 1996, P NATL ACAD SCI USA, V93, P13515, DOI 10.1073/pnas.93.24.13515; STRAUSS ME, 1990, ARCH NEUROL-CHICAGO, V47, P905, DOI 10.1001/archneur.1990.00530080093016; Szmalec A, 2007, Q J EXP PSYCHOL, V60, P1116, DOI 10.1080/17470210600896484; VONSATTEL JP, 1985, J NEUROPATH EXP NEUR, V44, P559, DOI 10.1097/00005072-198511000-00003; Weeks RA, 1996, ANN NEUROL, V40, P49, DOI 10.1002/ana.410400110; Willingham DB, 1998, PSYCHOL REV, V105, P558, DOI 10.1037/0033-295X.105.3.558; Wu T, 2005, BRAIN, V128, P2250, DOI 10.1093/brain/awh569; Wu T, 2004, J NEUROPHYSIOL, V91, P1690, DOI 10.1152/jn.01052.2003; YOUNG AB, 1986, NEUROLOGY, V36, P244, DOI 10.1212/WNL.36.2.244	61	19	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7557	10.1371/journal.pone.0007557	http://dx.doi.org/10.1371/journal.pone.0007557			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509MN	19847295	Green Submitted, Green Published, gold			2022-12-27	WOS:000271022000019
J	Traglia, M; Sala, C; Masciullo, C; Cverhova, V; Lori, F; Pistis, G; Bione, S; Gasparini, P; Ulivi, S; Ciullo, M; Nutile, T; Bosi, E; Sirtori, M; Mignogna, G; Rubinacci, A; Buetti, I; Camaschella, C; Petretto, E; Toniolo, D				Traglia, Michela; Sala, Cinzia; Masciullo, Corrado; Cverhova, Valeria; Lori, Francesca; Pistis, Giorgio; Bione, Silvia; Gasparini, Paolo; Ulivi, Sheila; Ciullo, Marina; Nutile, Teresa; Bosi, Emanuele; Sirtori, Marcella; Mignogna, Giovanna; Rubinacci, Alessandro; Buetti, Iwan; Camaschella, Clara; Petretto, Enrico; Toniolo, Daniela			Heritability and Demographic Analyses in the Large Isolated Population of Val Borbera Suggest Advantages in Mapping Complex Traits Genes	PLOS ONE			English	Article							GENETICALLY ISOLATED POPULATION; ERASMUS RUCPHEN FAMILY; FOUNDER POPULATION; METABOLIC SYNDROME; SUSCEPTIBILITY LOCUS; QUANTITATIVE TRAITS; INSULIN-RESISTANCE; IRON OVERLOAD; VARIANTS; SARDINIA	Background: Isolated populations are a useful resource for mapping complex traits due to shared stable environment, reduced genetic complexity and extended Linkage Disequilibrium (LD) compared to the general population. Here we describe a large genetic isolate from the North West Apennines, the mountain range that runs through Italy from the North West Alps to the South. Methodology/Principal Findings: The study involved 1,803 people living in 7 villages of the upper Borbera Valley. For this large population cohort, data from genealogy reconstruction, medical questionnaires, blood, anthropometric and bone status QUS parameters were evaluated. Demographic and epidemiological analyses indicated a substantial genetic component contributing to each trait variation as well as overlapping genetic determinants and family clustering for some traits. Conclusions/Significance: The data provide evidence for significant heritability of medical relevant traits that will be important in mapping quantitative traits. We suggest that this population isolate is suitable to identify rare variants associated with complex phenotypes that may be difficult to study in larger but more heterogeneous populations.			Traglia, M (corresponding author), Ist Sci San Raffaele, Div Genet & Cell Biol, I-20132 Milan, Italy.	daniela.toniolo@hsr.it	Camaschella, Clara/A-3289-2015; Toniolo, Daniela/AAE-2969-2019; Traglia, Michela/AAX-5816-2020; Sala, Cinzia Felicita/AAN-1900-2020; Gasparini, Paolo/B-6173-2014; Ciullo, Marina/AAE-3041-2020; Ulivi, Sheila/H-3700-2013; Rubinacci, Alessandro/AAF-6627-2020; Rubinacci, Alessandro/ABG-5732-2020	Toniolo, Daniela/0000-0001-9545-6032; Ciullo, Marina/0000-0002-9621-9984; Ulivi, Sheila/0000-0003-3606-835X; Rubinacci, Alessandro/0000-0003-1736-0531; Bione, Silvia/0000-0002-3924-4606; Gasparini, Paolo/0000-0002-0859-0856; Venkatasubramanian, Siddharth/0000-0002-5860-0768; NUTILE, TERESA/0000-0001-7062-8352; s, hema/0000-0002-3440-9475	MRC [MC_U120097112] Funding Source: UKRI; Medical Research Council [MC_U120097112] Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC))		Abney M, 2001, AM J HUM GENET, V68, P1302, DOI 10.1086/320112; Almasy L, 1998, AM J HUM GENET, V62, P1198, DOI 10.1086/301844; Angius A, 2001, HUM GENET, V109, P198, DOI 10.1007/s004390100557; Arcos-Burgos M, 2002, CLIN GENET, V61, P233, DOI 10.1034/j.1399-0004.2002.610401.x; Aulchenko YS, 2009, NAT GENET, V41, P47, DOI 10.1038/ng.269; Bodmer W, 2008, NAT GENET, V40, P695, DOI 10.1038/ng.f.136; Bourgain C, 2003, AM J HUM GENET, V73, P612, DOI 10.1086/378208; Brudevold R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003547; Cappello N, 1996, ANN HUM GENET, V60, P125, DOI 10.1111/j.1469-1809.1996.tb01183.x; Chen WM, 2007, AM J HUM GENET, V81, P913, DOI 10.1086/521580; Ciullo M, 2006, HUM MOL GENET, V15, P1735, DOI 10.1093/hmg/ddl097; Colonna V, 2007, HUM HERED, V64, P123, DOI 10.1159/000101964; Falchi M, 2008, BIOINFORMATICS, V24, P724, DOI 10.1093/bioinformatics/btm617; Frazer KA, 2009, NAT REV GENET, V10, P241, DOI 10.1038/nrg2554; Grundy SM, 2004, ENDOCRIN METAB CLIN, V33, pIX, DOI 10.1016/S0889-8529(04)00035-0; Henneman P, 2008, J MED GENET, V45, P572, DOI 10.1136/jmg.2008.058388; Jakkula E, 2008, AM J HUM GENET, V83, P787, DOI 10.1016/j.ajhg.2008.11.005; Kallio SP, 2009, HUM MOL GENET, V18, P1670, DOI 10.1093/hmg/ddp073; Kinjo M, 2007, J CLIN ENDOCR METAB, V92, P4161, DOI 10.1210/jc.2007-0757; Marroni F, 2008, HUM HERED, V65, P175, DOI 10.1159/000109734; Mendler MH, 1999, GASTROENTEROLOGY, V117, P1155, DOI 10.1016/S0016-5085(99)70401-4; Njajou OT, 2006, HUM HERED, V61, P222, DOI 10.1159/000094777; Pilia G, 2006, PLOS GENET, V2, P1207, DOI 10.1371/journal.pgen.0020132; Sabatti C, 2009, NAT GENET, V41, P35, DOI 10.1038/ng.271; Tepper BJ, 2008, OBESITY, V16, P2289, DOI 10.1038/oby.2008.357; TRECARTIN RF, 1981, J CLIN INVEST, V68, P1012, DOI 10.1172/JCI110323; Varilo T, 2004, CURR OPIN GENET DEV, V14, P316, DOI 10.1016/j.gde.2004.04.008; Wright AF, 1999, NAT GENET, V23, P397, DOI 10.1038/70501; YAMAGUCHI T, 2009, ASS COMPONENTS METAB	29	34	34	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7554	10.1371/journal.pone.0007554	http://dx.doi.org/10.1371/journal.pone.0007554			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847309	Green Published, gold, Green Submitted			2022-12-27	WOS:000271022000016
J	Tong, YF; Tempel, W; Nedyalkova, L; MacKenzie, F; Park, HW				Tong, Yufeng; Tempel, Wolfram; Nedyalkova, Lyudmila; MacKenzie, Farrell; Park, Hee-Won			Crystal Structure of the N-Acetylmannosamine Kinase Domain of GNE	PLOS ONE			English	Article							ACETYLGLUCOSAMINE 2-EPIMERASE/N-ACETYLMANNOSAMINE KINASE; INCLUSION-BODY MYOPATHY; ESCHERICHIA-COLI; SUGAR KINASES; SIALIC ACIDS; SIALYLATION; PROTEINS; ENZYME; 2-EPIMERASE; METABOLISM	Background: UDP-GlcNAc 2-epimerase/ ManNAc 6-kinase, GNE, is a bi-functional enzyme that plays a key role in sialic acid biosynthesis. Mutations of the GNE protein cause sialurea or autosomal recessive inclusion body myopathy/Nonaka myopathy. GNE is the only human protein that contains a kinase domain belonging to the ROK (repressor, ORF, kinase) family. Principal Findings: We solved the structure of the GNE kinase domain in the ligand-free state. The protein exists predominantly as a dimer in solution, with small populations of monomer and higher-order oligomer in equilibrium with the dimer. Crystal packing analysis reveals the existence of a crystallographic hexamer, and that the kinase domain dimerizes through the C-lobe subdomain. Mapping of disease-related missense mutations onto the kinase domain structure revealed that the mutation sites could be classified into four different groups based on the location -dimer interface, interlobar helices, protein surface, or within other secondary structural elements. Conclusions: The crystal structure of the kinase domain of GNE provides a structural basis for understanding disease-causing mutations and a model of hexameric wild type full length enzyme.			Tong, YF (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	heewon.park@utoronto.ca	Tong, Yufeng/D-2785-2011	Tong, Yufeng/0000-0001-7740-1812	CIHR Funding Source: Medline; Wellcome Trust Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)		Adams PD, 2002, ACTA CRYSTALLOGR D, V58, P1948, DOI 10.1107/S0907444902016657; Adderson EE, 2000, MOL GENET METAB, V71, P451, DOI 10.1006/mgme.2000.3025; Ahmad S, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-51; Angata T, 2002, CHEM REV, V102, P439, DOI 10.1021/cr000407m; Blume A, 2004, BIOCHEM J, V384, P599, DOI 10.1042/BJ20040917; BORK P, 1992, P NATL ACAD SCI USA, V89, P7290, DOI 10.1073/pnas.89.16.7290; Davis IW, 2004, NUCLEIC ACIDS RES, V32, pW615, DOI 10.1093/nar/gkh398; Effertz K, 1999, J BIOL CHEM, V274, P28771, DOI 10.1074/jbc.274.40.28771; Eisenberg I, 2001, NAT GENET, V29, P83, DOI 10.1038/ng718; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Ghaderi D, 2007, J MOL BIOL, V369, P746, DOI 10.1016/j.jmb.2007.03.037; Holmes Ken C., 1993, Trends in Cell Biology, V3, P53, DOI 10.1016/0962-8924(93)90161-S; Huizing M, 2009, BBA-MOL BASIS DIS, V1792, P881, DOI 10.1016/j.bbadis.2009.07.001; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; Keppler OT, 1999, SCIENCE, V284, P1372, DOI 10.1126/science.284.5418.1372; Krissinel E, 2007, J MOL BIOL, V372, P774, DOI 10.1016/j.jmb.2007.05.022; Larion M, 2007, BIOCHEMISTRY-US, V46, P13564, DOI 10.1021/bi700924d; Lunin VV, 2004, J BACTERIOL, V186, P6915, DOI 10.1128/JB.186.20.6915-6927.2004; Miyagi T, 2003, GLYCOCONJUGATE J, V20, P189, DOI 10.1023/B:GLYC.0000024250.48506.bf; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; Nam TW, 2008, P NATL ACAD SCI USA, V105, P3751, DOI 10.1073/pnas.0709295105; Paltrinieri S, 2008, J FELINE MED SURG, V10, P514, DOI 10.1016/j.jfms.2008.04.004; Penner J, 2006, BIOCHEMISTRY-US, V45, P2968, DOI 10.1021/bi0522504; Reinke SO, 2009, GLYCOCONJUGATE J, V26, P415, DOI 10.1007/s10719-008-9189-6; Schiefner A, 2005, J BIOL CHEM, V280, P29073, DOI 10.1074/jbc.M504215200; Schwarzkopf M, 2002, P NATL ACAD SCI USA, V99, P5267, DOI 10.1073/pnas.072066199; Seppala R, 1999, AM J HUM GENET, V64, P1563, DOI 10.1086/302411; Terwilliger TC, 2003, METHOD ENZYMOL, V374, P22, DOI 10.1016/S0076-6879(03)74002-6; TITGEMEYER F, 1994, MICROBIOL-UK, V140, P2349, DOI 10.1099/13500872-140-9-2349; Traving C, 1998, CELL MOL LIFE SCI, V54, P1330, DOI 10.1007/s000180050258; Ye YZ, 2004, NUCLEIC ACIDS RES, V32, pW582, DOI 10.1093/nar/gkh430	31	22	23	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7165	10.1371/journal.pone.0007165	http://dx.doi.org/10.1371/journal.pone.0007165			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841673	Green Submitted, gold, Green Published			2022-12-27	WOS:000271012900004
J	Rignell-Hydbom, A; Lidfeldt, J; Kiviranta, H; Rantakokko, P; Samsioe, G; Agardh, CD; Rylander, L				Rignell-Hydbom, Anna; Lidfeldt, Jonas; Kiviranta, Hannu; Rantakokko, Panu; Samsioe, Goran; Agardh, Carl-David; Rylander, Lars			Exposure to p,p '-DDE: A Risk Factor for Type 2 Diabetes	PLOS ONE			English	Article							PERSISTENT ORGANIC POLLUTANTS; POLYCHLORINATED-BIPHENYLS; SERUM CONCENTRATIONS; NATIONAL-HEALTH; ASSOCIATION; MELLITUS; DIOXINS; CONSUMPTION; CHEMICALS; OBESITY	Background: Persistent organic pollutants (POPs), such as PCBs, DDT and dioxins have in several cross-sectional studies shown strong associations with type 2 diabetes mellitus. Reversed causality can however not be excluded. The aim of this case-control study was to evaluate whether POPs concentration is a risk factor for type 2 diabetes. Methodology/Principal Findings: A case-control study was performed within a well-defined cohort of women, age 50-59 years, from the Southern part of Sweden. Biomarkers for POP exposure, 2,2',4,4',5,5'-hexachlorobiphenyl (CB-153) and 1,1-dichloro-2,2-bis (p-chlorophenyl)-ethylene (p,p'-DDE) were analyzed in stored serum samples, which were collected at the baseline examination when the cohort was established. For 107 out of the 371 cases, serum samples were stored at least three years before their type 2 diabetes was diagnosed. In this data set, CB-153 and p, p'-DDE were not associated with an increased risk to develop type 2 diabetes. However, when only the cases (n = 39) that were diagnosed more than six years after the baseline examination and their controls were studied, the women in the highest exposed quartile showed an increased risk to develop type 2 diabetes (OR of 1.6 [95% 0.61, 4.0] for CB-153 and 5.5 [95% CI 1.2, 25] for p,p '-DDE). Conclusions/Significance: The results from the present case-control study, including a follow-up design, confirms that p, p'-DDE exposure can be a risk factor for type 2 diabetes.			Rignell-Hydbom, A (corresponding author), Lund Univ, Univ Hosp, Dept Lab Med, Div Occupat & Environm Med, Lund, Sweden.	anna.rignell-hydbom@med.lu.se		Rylander, Lars/0000-0001-8288-8207; Kiviranta, Hannu/0000-0002-7168-1611				Alonso-Magdalena P, 2005, ENVIRON HEALTH PERSP, V113, P969, DOI 10.1289/ehp.8002; Bernard A, 2002, INT J TOXICOL, V21, P333, DOI 10.1080/10915810290096540; Chen JW, 2008, ENVIRON RES, V107, P245, DOI 10.1016/j.envres.2008.01.004; Codru N, 2007, ENVIRON HEALTH PERSP, V115, P1442, DOI 10.1289/ehp.10315; ENAN E, 1994, J BIOCHEM TOXICOL, V9, P97, DOI 10.1002/jbt.2570090207; Everett CJ, 2007, ENVIRON RES, V103, P413, DOI 10.1016/j.envres.2006.11.002; Fierens S, 2003, BIOMARKERS, V8, P529, DOI 10.1080/1354750032000158420; Gavin JR, 1997, DIABETES CARE, V20, P1183; Glynn AW, 2000, SCI TOTAL ENVIRON, V263, P197, DOI 10.1016/S0048-9697(00)00703-8; Grandjean P, 2008, ENVIRON SCI TECHNOL, V42, P6991, DOI 10.1021/es800778q; Grimvall E, 1997, ARCH ENVIRON CON TOX, V32, P329, DOI 10.1007/s002449900193; Jones OAH, 2008, LANCET, V371, P287, DOI 10.1016/S0140-6736(08)60147-6; King H, 1998, DIABETES CARE, V21, P1414, DOI 10.2337/diacare.21.9.1414; Lee DH, 2007, DIABETES CARE, V30, P1596, DOI 10.2337/dc07-0072; Lee DH, 2007, DIABETES CARE, V30, P622, DOI 10.2337/dc06-2190; Lee DH, 2006, DIABETES CARE, V29, P1638, DOI 10.2337/dc06-0543; Lidfeldt J, 2001, EUR J EPIDEMIOL, V17, P943, DOI 10.1023/A:1016291426124; LIU H, 1992, MOL CELL ENDOCRINOL, V87, P19, DOI 10.1016/0303-7207(92)90229-Y; Longnecker MP, 2000, EPIDEMIOLOGY, V11, P44, DOI 10.1097/00001648-200001000-00010; Mensah GA, 2004, CARDIOL CLIN, V22, P485, DOI 10.1016/j.ccl.2004.06.005; Oken E, 2003, OBES RES, V11, P496, DOI 10.1038/oby.2003.69; OLSEN H, 1994, ENVIRON HEALTH PERSP, V102, P454, DOI 10.2307/3432040; Rantakokko P, 2009, J CHROMATOGR A, V1216, P897, DOI 10.1016/j.chroma.2008.12.013; Rasier G, 2006, MOL CELL ENDOCRINOL, V254, P187, DOI 10.1016/j.mce.2006.04.002; Rignell-Hydbom A, 2007, HUM EXP TOXICOL, V26, P447, DOI 10.1177/0960327107076886; Rylander Lars, 2005, Environ Health, V4, P28, DOI 10.1186/1476-069X-4-28; Sjodin A, 2000, ENVIRON HEALTH PERSP, V108, P1035, DOI 10.2307/3434955; Skakkebaek NE, 2001, HUM REPROD, V16, P972, DOI 10.1093/humrep/16.5.972; Sweeney MH, 1997, TERATOGEN CARCIN MUT, V17, P241, DOI 10.1002/(SICI)1520-6866(1997)17:4/5<241::AID-TCM6>3.0.CO;2-I; Turyk M, 2009, CHEMOSPHERE, V75, P674, DOI 10.1016/j.chemosphere.2008.12.035; Uemura H, 2008, ENVIRON RES, V108, P63, DOI 10.1016/j.envres.2008.06.002; Vasiliu O, 2006, EPIDEMIOLOGY, V17, P352, DOI 10.1097/01.ede.0000220553.84350.c5; VIRTANEN HE, 2002, TOXICOL APPL PHARM, V2, P501; Wada K, 2007, J PHARMACOL SCI, V105, P133, DOI 10.1254/jphs.FM0070034; Wang SL, 2008, DIABETES CARE, V31, P1574, DOI 10.2337/dc07-2449	35	103	111	2	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7503	10.1371/journal.pone.0007503	http://dx.doi.org/10.1371/journal.pone.0007503			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838294	Green Published, gold, Green Submitted			2022-12-27	WOS:000270880900008
J	Seney, ML; Kelly, DA; Goldman, BD; Sumbera, R; Forger, NG				Seney, Marianne L.; Kelly, Diane A.; Goldman, Bruce D.; Sumbera, Radim; Forger, Nancy G.			Social Structure Predicts Genital Morphology in African Mole-Rats	PLOS ONE			English	Article							STRIATED PENILE MUSCLES; LEVATOR ANI; SEXUAL-DIFFERENTIATION; HETEROCEPHALUS-GLABER; COLONY FORMATION; EUSOCIALITY; CRYPTOMYS; FAMILY; COPULATION; MECHANISMS	Background: African mole-rats (Bathyergidae, Rodentia) exhibit a wide range of social structures, from solitary to eusocial. We previously found a lack of sex differences in the external genitalia and morphology of the perineal muscles associated with the phallus in the eusocial naked mole-rat. This was quite surprising, as the external genitalia and perineal muscles are sexually dimorphic in all other mammals examined. We hypothesized that the lack of sex differences in naked mole-rats might be related to their unusual social structure. Methodology/Principal Findings: We compared the genitalia and perineal muscles in three African mole-rat species: the naked mole-rat, the solitary silvery mole-rat, and the Damaraland mole-rat, a species considered to be eusocial, but with less reproductive skew than naked mole-rats. Our findings support a relationship between social structure, mating system, and sexual differentiation. Naked mole-rats lack sex differences in genitalia and perineal morphology, silvery mole-rats exhibit sex differences, and Damaraland mole-rats are intermediate. Conclusions/Significance: The lack of sex differences in naked mole-rats is not an attribute of all African mole-rats, but appears to have evolved in relation to their unusual social structure and reproductive biology.			Seney, ML (corresponding author), Univ Massachusetts, Ctr Neuroendocrine Studies, Amherst, MA 01003 USA.	marianne.seney@gmail.com	Šumbera, Radim/D-9072-2016; Seney, Marianne L/AAT-3810-2020	Šumbera, Radim/0000-0001-8658-9378; Seney, Marianne L/0000-0002-6401-9494	NATIONAL INSTITUTE OF MENTAL HEALTH [K02MH072825] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [F31NS058258] Funding Source: NIH RePORTER; NIMH NIH HHS [K02 MH072825] Funding Source: Medline; NINDS NIH HHS [F31 NS058258] Funding Source: Medline	NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS))		[Anonymous], [No title captured]; Bennett N.C., 2000, AFRICAN MOLE RATS EC; BOONSTRA R, 1993, J MAMMAL, V74, P224, DOI 10.2307/1381924; Braude S, 2000, BEHAV ECOL, V11, P7, DOI 10.1093/beheco/11.1.7; Brett R.A., 1991, P97; Burda H, 2000, BEHAV ECOL SOCIOBIOL, V47, P293, DOI 10.1007/s002650050669; CIHAK R, 1970, J ANAT, V106, P93; Ciszek D, 2000, BEHAV ECOL, V11, P1, DOI 10.1093/beheco/11.1.1; DARWIN CR, 1871, PRINCIPLES SEXUAL SE, P253; Drea CM, 2008, J MORPHOL, V269, P451, DOI 10.1002/jmor.10594; Faulkes CG, 2004, MOL ECOL, V13, P613, DOI 10.1046/j.1365-294X.2004.02099.x; FAULKES CG, 1994, J REPROD FERTIL, V100, P411; FAULKES CG, 1990, J REPROD FERTIL, V88, P559; Faulkes CG, 2001, TRENDS ECOL EVOL, V16, P184, DOI 10.1016/S0169-5347(01)02116-4; Glickman SE, 2006, TRENDS ENDOCRIN MET, V17, P349, DOI 10.1016/j.tem.2006.09.005; GRAY H, 1918, ANATOMY HUMAN BODY, P424; HART BL, 1972, ANAT REC, V173, P1, DOI 10.1002/ar.1091730101; HART BL, 1983, PHYSIOL BEHAV, V31, P807, DOI 10.1016/0031-9384(83)90277-9; HAYES KJ, 1965, ACTA ENDOCRINOL-COP, V48, P337, DOI 10.1530/acta.0.0480337; HILL WCO, 1957, P ZOOL SOC LOND, V128, P456; HOLMES GM, 1994, PHYSIOL BEHAV, V55, P255, DOI 10.1016/0031-9384(94)90131-7; Holmes MM, 2007, P NATL ACAD SCI USA, V104, P10548, DOI 10.1073/pnas.0610344104; Ingram CM, 2004, MOL PHYLOGENET EVOL, V31, P997, DOI 10.1016/j.ympev.2003.11.004; Jacobs DS, 1998, S AFR J ZOOL, V33, P189; Jarvis J.U.M., 1991, P66; JARVIS JUM, 1993, BEHAV ECOL SOCIOBIOL, V33, P253, DOI 10.1007/BF02027122; JARVIS JUM, 1981, SCIENCE, V212, P571, DOI 10.1126/science.7209555; JARVIS JUM, 1994, TRENDS ECOL EVOL, V9, P47, DOI 10.1016/0169-5347(94)90267-4; KARACAN I, 1983, SCIENCE, V220, P1080, DOI 10.1126/science.6844930; Kock D, 2006, ZOOTAXA, P51, DOI 10.11646/zootaxa.1142.1.4; Lacey E.A., 1991, P275; MARGULIS SW, 1995, HORM BEHAV, V29, P227, DOI 10.1006/hbeh.1995.1017; MATTHEWS L. HARRISON, 1939, PHIL TRANS ROY SOC LONDON SER B BIOL SCI, V230, P1; MCKENNA KE, 1986, J COMP NEUROL, V248, P532, DOI 10.1002/cne.902480406; Nickel R, 1973, VISCERA DOMESTIC ANI; Parag A, 2006, J ZOOL, V270, P323, DOI 10.1111/j.1469-7998.2006.00141.x; PATZENHAUEROVA H, BEHAV ECOL SOC UNPUB; Peroulakis ME, 2002, J NEUROBIOL, V51, P33, DOI 10.1002/neu.10039; Poortmans A, 1998, ANAT REC, V251, P20, DOI 10.1002/(SICI)1097-0185(199805)251:1<20::AID-AR5>3.0.CO;2-I; REEVE HK, 1990, P NATL ACAD SCI USA, V87, P2496, DOI 10.1073/pnas.87.7.2496; SACHS BD, 1982, J REPROD FERTIL, V66, P433, DOI 10.1530/jrf.0.0660433; SCHMIDT MH, 1993, SLEEP, V16, P171, DOI 10.1093/sleep/16.2.171; Seney M, 2006, J NEUROBIOL, V66, P1354, DOI 10.1002/neu.20314; SHAPIRO LE, 1991, BRAIN RES, V541, P232, DOI 10.1016/0006-8993(91)91023-T; Short R.V., 1979, Advances in the Study of Behavior, V9, P131, DOI 10.1016/S0065-3454(08)60035-2; Sumbera R, 2003, J MAMMAL, V84, P278, DOI 10.1644/1545-1542(2003)084<0278:RBOASS>2.0.CO;2; Sumbera R, 2007, SUBTERRANEAN RODENTS: NEWS FROM UNDERGROUND, P221, DOI 10.1007/978-3-540-69276-8_16; Tullberg T., 1899, NOVA ACTA REG SOC, V3, P1; WILSON JD, 1980, BIOL REPROD, V22, P9, DOI 10.1095/biolreprod22.1.9	49	27	27	5	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7477	10.1371/journal.pone.0007477	http://dx.doi.org/10.1371/journal.pone.0007477			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829697	Green Submitted, Green Published, gold			2022-12-27	WOS:000270847800014
J	Heaslip, AT; Ems-McClung, SC; Hu, K				Heaslip, Aoife T.; Ems-McClung, Stephanie C.; Hu, Ke			TgICMAP1 Is a Novel Microtubule Binding Protein in Toxoplasma gondii	PLOS ONE			English	Article							CHROMOSOME CONDENSATION; TUBULIN TYROSINATION; NUCLEAR DIVISION; SMC PROTEINS; COILED COILS; TRANSPORT; INVASION; KINESIN; CYTOSKELETON; ORGANELLES	The microtubule cytoskeleton provides essential structural support for all eukaryotic cells and can be assembled into various higher order structures that perform drastically different functions. Understanding how microtubule-containing assemblies are built in a spatially and temporally controlled manner is therefore fundamental to understanding cell physiology. Toxoplasma gondii, a protozoan parasite, contains at least five distinct tubulin-containing structures, the spindle pole, centrioles, cortical microtubules, the conoid, and the intra-conoid microtubules. How these five structurally and functionally distinct sets of tubulin containing structures are constructed and maintained in the same cell is an intriguing problem. Previously, we performed a proteomic analysis of the T. gondii apical complex, a cytoskeletal complex located at the apical end of the parasite that is composed of the conoid, three ring-like structures, and the two short intra-conoid microtubules. Here we report the characterization of one of the proteins identified in that analysis, TgICMAP1. We show that TgICMAP1 is a novel microtubule binding protein that can directly bind to microtubules in vitro and stabilizes microtubules when ectopically expressed in mammalian cells. Interestingly, in T. gondii, TgICMAP1 preferentially binds to the intra-conoid microtubules, providing us the first molecular tool to investigate the intra-conoid microtubule assembly process during daughter construction.			Heaslip, AT (corresponding author), Indiana Univ, Dept Biol, Bloomington, IN 47405 USA.	kehu@indiana.edu		Heaslip, Aoife/0000-0002-7838-3617				Alexander DL, 2005, PLOS PATHOG, V1, P137, DOI 10.1371/journal.ppat.0010017; Carruthers VB, 1997, EUR J CELL BIOL, V73, P114; Cassimeris L, 2001, INT REV CYTOL, V210, P163; Cerede O, 2005, J EXP MED, V201, P453, DOI 10.1084/jem.20041672; Desai A, 2001, METH MOL B, V164, P109; Ems-McClung SC, 2004, MOL BIOL CELL, V15, P46, DOI 10.1091/mbc.E03-07-0454; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hammond JW, 2008, CURR OPIN CELL BIOL, V20, P71, DOI 10.1016/j.ceb.2007.11.010; Hertzer KM, 2006, MOL BIOL CELL, V17, P700, DOI 10.1091/mbc.E05-08-0821; Hirano T, 2006, NAT REV MOL CELL BIO, V7, P311, DOI 10.1038/nrm1909; HIRANO T, 1994, CELL, V79, P449, DOI 10.1016/0092-8674(94)90254-2; Hirokawa N, 1998, SCIENCE, V279, P519, DOI 10.1126/science.279.5350.519; Holland GN, 1999, AM J OPHTHALMOL, V128, P502, DOI 10.1016/S0002-9394(99)00263-9; Hu K, 2002, MOL BIOL CELL, V13, P593, DOI 10.1091/mbc.01-06-0309; Hu K, 2002, J CELL BIOL, V156, P1039, DOI 10.1083/jcb.200112086; Hu K, 2006, PLOS PATHOG, V2, P121, DOI 10.1371/journal.ppat.0020013; Hu K, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.0040010; Huynh MH, 2003, EMBO J, V22, P2082, DOI 10.1093/emboj/cdg217; Huynh MH, 2006, PLOS PATHOG, V2, P753, DOI 10.1371/journal.ppat.0020084; Kessler H, 2008, J CELL SCI, V121, P947, DOI 10.1242/jcs.022350; Konishi Y, 2009, NAT NEUROSCI, V12, P559, DOI 10.1038/nn.2314; LEVINE ND, 1988, J PROTOZOOL, V35, P518, DOI 10.1111/j.1550-7408.1988.tb04141.x; Liao GJ, 1998, J BIOL CHEM, V273, P9797, DOI 10.1074/jbc.273.16.9797; Losada A, 2005, GENE DEV, V19, P1269, DOI 10.1101/gad.1320505; LUFT BJ, 1993, NEW ENGL J MED, V329, P995, DOI 10.1056/NEJM199309303291403; LUPAS A, 1991, SCIENCE, V252, P1162, DOI 10.1126/science.252.5009.1162; Mann T, 2002, J BIOL CHEM, V277, P41240, DOI 10.1074/jbc.M205056200; Mann T, 2001, MOL BIOCHEM PARASIT, V115, P257, DOI 10.1016/S0166-6851(01)00289-4; MASSON D, 1993, J CELL BIOL, V123, P357, DOI 10.1083/jcb.123.2.357; Matsuyama A, 2002, EMBO J, V21, P6820, DOI 10.1093/emboj/cdf682; Mazumdar J, 2006, P NATL ACAD SCI USA, V103, P13192, DOI 10.1073/pnas.0603391103; Melby TE, 1998, J CELL BIOL, V142, P1595, DOI 10.1083/jcb.142.6.1595; MITAL J, 2006, INVESTIGATING ROLE A, V1; Montoya JG, 1996, CLIN INFECT DIS, V23, P277, DOI 10.1093/clinids/23.2.277; Montoya JG, 2004, LANCET, V363, P1965, DOI 10.1016/S0140-6736(04)16412-X; Morrissette NS, 2002, MICROBIOL MOL BIOL R, V66, P21, DOI 10.1128/MMBR.66.1.21-38.2002; Morrissette NS, 2002, J CELL SCI, V115, P1017; Morrissette NS, 1997, J CELL SCI, V110, P35; NAGEL SD, 1988, MOL BIOCHEM PARASIT, V29, P261, DOI 10.1016/0166-6851(88)90081-3; NICHOLS BA, 1987, J PROTOZOOL, V34, P217, DOI 10.1111/j.1550-7408.1987.tb03162.x; PARK RS, 1984, J MORPHOL, V179, P13, DOI 10.1002/jmor.1051790103; Peris L, 2006, J CELL BIOL, V174, P839, DOI 10.1083/jcb.200512058; Reed NA, 2006, CURR BIOL, V16, P2166, DOI 10.1016/j.cub.2006.09.014; ROOS DS, 1994, METHOD CELL BIOL, V45, P27; SAKA Y, 1994, EMBO J, V13, P4938, DOI 10.1002/j.1460-2075.1994.tb06821.x; SASSE R, 1988, J CELL SCI, V90, P577; Shaw MK, 2000, J CELL SCI, V113, P1241; STRUNNIKOV AV, 1993, J CELL BIOL, V123, P1635, DOI 10.1083/jcb.123.6.1635; Tuma MC, 1998, J CELL BIOL, V143, P1547, DOI 10.1083/jcb.143.6.1547; Umeshima H, 2007, P NATL ACAD SCI USA, V104, P16182, DOI 10.1073/pnas.0708047104; Vale RD, 2003, CELL, V112, P467, DOI 10.1016/S0092-8674(03)00111-9; Westermann S, 2003, NAT REV MOL CELL BIO, V4, P938, DOI 10.1038/nrm1260; Zhao C, 2001, CELL, V105, P587, DOI 10.1016/S0092-8674(01)00363-4; [No title captured]	54	23	23	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7406	10.1371/journal.pone.0007406	http://dx.doi.org/10.1371/journal.pone.0007406			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823689	gold, Green Published, Green Submitted			2022-12-27	WOS:000270728500007
J	Lange, J; De Lussanet, M; Kuhlmann, S; Zimmermann, A; Lappe, M; Zwitserlood, P; Dobel, C				Lange, Joachim; De Lussanet, Marc; Kuhlmann, Simone; Zimmermann, Anja; Lappe, Markus; Zwitserlood, Pienie; Dobel, Christian			Impairments of Biological Motion Perception in Congenital Prosopagnosia	PLOS ONE			English	Article							FUSIFORM FACE AREA; DEVELOPMENTAL PROSOPAGNOSIA; SEPARATE FACE; IMPAIRED FACE; RECOGNITION; BODY; INVERSION; REPRESENTATION; SPECIFICITY; SELECTIVITY	Prosopagnosia is a deficit in recognizing people from their faces. Acquired prosopagnosia results after brain damage, developmental or congenital prosopagnosia (CP) is not caused by brain lesion, but has presumably been present from early childhood onwards. Since other sensory, perceptual, and cognitive abilities are largely spared, CP is considered to be a stimulus-specific deficit, limited to face processing. Given that recent behavioral and imaging studies indicate a close relationship of face and biological-motion perception in healthy adults, we hypothesized that biological motion processing should be impaired in CP. Five individuals with CP and ten matched healthy controls were tested with diverse biological-motion stimuli and tasks. Four of the CP individuals showed severe deficits in biological-motion processing, while one performed within the lower range of the controls. A discriminant analysis classified all participants correctly with a very high probability for each participant. These findings demonstrate that in CP, impaired perception of faces can be accompanied by impaired biological-motion perception. We discuss implications for dedicated and shared mechanisms involved in the perception of faces and biological motion.			Lange, J (corresponding author), Univ Dusseldorf, Inst Clin Neurosci & Med Psychol, Dusseldorf, Germany.	joachim.lange@med.uni-duesseldorf.de; cdobel@uni-muenster.de	de Lussanet, Marc H.E./H-2437-2013	de Lussanet, Marc H.E./0000-0003-3754-6675				Allison T, 2000, TRENDS COGN SCI, V4, P267, DOI 10.1016/S1364-6613(00)01501-1; Barton JJS, 2004, BRAIN, V127, P1706, DOI 10.1093/brain/awh194; Barton JJS, 2002, NEUROLOGY, V58, P71, DOI 10.1212/WNL.58.1.71; Behrmann M, 2005, J COGNITIVE NEUROSCI, V17, P1130, DOI 10.1162/0898929054475154; Behrmann M, 2005, TRENDS COGN SCI, V9, P180, DOI 10.1016/j.tics.2005.02.011; Beintema JA, 2006, PERCEPT PSYCHOPHYS, V68, P613, DOI 10.3758/BF03208763; Beintema JA, 2002, P NATL ACAD SCI USA, V99, P5661, DOI 10.1073/pnas.082483699; BERTENTHAL BI, 1987, J EXP PSYCHOL HUMAN, V13, P577, DOI 10.1037/0096-1523.13.4.577; BIEDERMAN I, 1987, PSYCHOL REV, V94, P115, DOI 10.1037/0033-295X.94.2.115; Blake R, 2003, PSYCHOL SCI, V14, P151, DOI 10.1111/1467-9280.01434; Blake R, 2007, ANNU REV PSYCHOL, V58, P47, DOI 10.1146/annurev.psych.57.102904.190152; BODAMER J, 1947, Arch Psychiatr Nervenkr Z Gesamte Neurol Psychiatr, V118, P6, DOI 10.1007/BF00352849; Bukach CM, 2006, TRENDS COGN SCI, V10, P159, DOI 10.1016/j.tics.2006.02.004; CUTTING JE, 1978, BEHAV RES METH INSTR, V10, P91, DOI 10.3758/BF03205105; DAMASIO AR, 1982, NEUROLOGY, V32, P331, DOI 10.1212/WNL.32.4.331; de Gelder B, 2000, NEUROREPORT, V11, P3145, DOI 10.1097/00001756-200009280-00021; Dobel C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002326; Dobel C, 2007, CORTEX, V43, P718, DOI 10.1016/S0010-9452(08)70501-X; Downing PE, 2006, CEREB CORTEX, V16, P1453, DOI 10.1093/cercor/bhj086; Downing PE, 2001, SCIENCE, V293, P2470, DOI 10.1126/science.1063414; Duchaine BC, 2006, CURR OPIN NEUROBIOL, V16, P166, DOI 10.1016/j.conb.2006.03.003; Duchaine BC, 2000, NEUROREPORT, V11, P79, DOI 10.1097/00001756-200001170-00016; Duchaine BC, 2006, COGN NEUROPSYCHOL, V23, P714, DOI 10.1080/02643290500441296; FARAH MJ, 1990, J CLIN EXP NEUROPSYC, V12, P32; FAST K, 2008, FAMOUS FACES TEST FF; Gauthier I, 2000, NAT NEUROSCI, V3, P191, DOI 10.1038/72140; Grelotti DJ, 2002, DEV PSYCHOBIOL, V40, P213, DOI 10.1002/dev.10028; Grill-Spector K, 2004, NAT NEUROSCI, V7, P555, DOI 10.1038/nn1224; Hadjikhani N, 2003, CURR BIOL, V13, P2201, DOI 10.1016/j.cub.2003.11.049; Haxby JV, 2001, SCIENCE, V293, P2425, DOI 10.1126/science.1063736; Hefter RL, 2005, NEUROLOGY, V65, P1620, DOI 10.1212/01.wnl.0000184498.16959.c0; Jellema T, 2003, J COGNITIVE NEUROSCI, V15, P961, DOI 10.1162/089892903770007353; JOHANSSON G, 1973, PERCEPT PSYCHOPHYS, V14, P201, DOI 10.3758/BF03212378; Jones RD, 2001, J CLIN EXP NEUROPSYC, V23, P265, DOI 10.1076/jcen.23.3.265.1183; Kanwisher N, 2000, NAT NEUROSCI, V3, P759, DOI 10.1038/77664; Kanwisher N, 2006, PHILOS T R SOC B, V361, P2109, DOI 10.1098/rstb.2006.1934; Keysers C, 2004, TRENDS COGN SCI, V8, P501, DOI 10.1016/j.tics.2004.09.005; Kress T, 2003, NEUROSCI LETT, V352, P133, DOI 10.1016/j.neulet.2003.08.047; Lange J, 2006, J NEUROSCI, V26, P2894, DOI 10.1523/JNEUROSCI.4915-05.2006; Lange Joachim, 2008, Adv Cogn Psychol, V3, P419, DOI 10.2478/v10053-008-0006-3; LOBMAIER J, 2008, CONFIGURAL FEA UNPUB; Marotta JJ, 2002, COGN NEUROPSYCHOL, V19, P31, DOI 10.1080/02643290143000079; MARR D, 1982, PROC R SOC SER B-BIO, V214, P501, DOI 10.1098/rspb.1982.0024; MATHER G, 1992, P ROY SOC B-BIOL SCI, V249, P149, DOI 10.1098/rspb.1992.0097; Maurer D, 2002, TRENDS COGN SCI, V6, P255, DOI 10.1016/S1364-6613(02)01903-4; Moscovitch M, 1997, J COGNITIVE NEUROSCI, V9, P555, DOI 10.1162/jocn.1997.9.5.555; Nunn JA, 2001, NEUROCASE, V7, P15, DOI 10.1093/neucas/7.1.15; Pavlova M, 2000, PERCEPT PSYCHOPHYS, V62, P889, DOI 10.3758/BF03212075; Peelen MV, 2005, J NEUROPHYSIOL, V93, P603, DOI 10.1152/jn.00513.2004; Pitcher D, 2009, CURR BIOL, V19, P319, DOI 10.1016/j.cub.2009.01.007; Reed CL, 2003, PSYCHOL SCI, V14, P302, DOI 10.1111/1467-9280.14431; Righart R, 2007, P NATL ACAD SCI USA, V104, P17234, DOI 10.1073/pnas.0707753104; Schwarzlose RF, 2005, J NEUROSCI, V25, P11055, DOI 10.1523/JNEUROSCI.2621-05.2005; Spiridon M, 2006, HUM BRAIN MAPP, V27, P77, DOI 10.1002/hbm.20169; Steeves JKE, 2006, NEUROPSYCHOLOGIA, V44, P594, DOI 10.1016/j.neuropsychologia.2005.06.013; TANAKA JW, 1993, Q J EXP PSYCHOL-A, V46, P225, DOI 10.1080/14640749308401045; Tarr MJ, 2003, TRENDS COGN SCI, V7, P23, DOI 10.1016/S1364-6613(02)00010-4; Thomas C, 2009, NAT NEUROSCI, V12, P29, DOI 10.1038/nn.2224; Thomas SM, 2004, J EXP PSYCHOL HUMAN, V30, P873, DOI 10.1037/0096-1523.30.5.873; Thompson JC, 2008, TRENDS COGN SCI, V12, P283, DOI 10.1016/j.tics.2008.05.002; Thompson JC, 2005, J NEUROSCI, V25, P9059, DOI 10.1523/JNEUROSCI.2129-05.2005; Tong F, 2000, COGNITIVE NEUROPSYCH, V17, P257, DOI 10.1080/026432900380607; Troje NF, 2006, CURR BIOL, V16, P821, DOI 10.1016/j.cub.2006.03.022; Van den Stock J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003195; Warrington E, 1992, TESTBATTERIE VISUELL; WHITELEY AM, 1977, J NEUROL NEUROSUR PS, V40, P395, DOI 10.1136/jnnp.40.4.395; YIN RK, 1969, J EXP PSYCHOL, V81, P141, DOI 10.1037/h0027474; Yovel G, 2006, J COGNITIVE NEUROSCI, V18, P580, DOI 10.1162/jocn.2006.18.4.580; Yovel G, 2004, NEURON, V44, P889, DOI 10.1016/S0896-6273(04)00728-7	69	28	29	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7414	10.1371/journal.pone.0007414	http://dx.doi.org/10.1371/journal.pone.0007414			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	505VX	19823580	Green Published, gold, Green Submitted			2022-12-27	WOS:000270728500013
J	van der Loo, E; Gais, S; Congedo, M; Vanneste, S; Plazier, M; Menovsky, T; Van de Heyning, P; De Ridder, D				van der Loo, Elsa; Gais, Steffen; Congedo, Marco; Vanneste, Sven; Plazier, Mark; Menovsky, Tomas; Van de Heyning, Paul; De Ridder, Dirk			Tinnitus Intensity Dependent Gamma Oscillations of the Contralateral Auditory Cortex	PLOS ONE			English	Article								Background: Non-pulsatile tinnitus is considered a subjective auditory phantom phenomenon present in 10 to 15% of the population. Tinnitus as a phantom phenomenon is related to hyperactivity and reorganization of the auditory cortex. Magnetoencephalography studies demonstrate a correlation between gamma band activity in the contralateral auditory cortex and the presence of tinnitus. The present study aims to investigate the relation between objective gamma-band activity in the contralateral auditory cortex and subjective tinnitus loudness scores. Methods and Findings: In unilateral tinnitus patients (N = 15; 10 right, 5 left) source analysis of resting state electroencephalographic gamma band oscillations shows a strong positive correlation with Visual Analogue Scale loudness scores in the contralateral auditory cortex (max r = 0.73, p<0.05). Conclusion: Auditory phantom percepts thus show similar sound level dependent activation of the contralateral auditory cortex as observed in normal audition. In view of recent consciousness models and tinnitus network models these results suggest tinnitus loudness is coded by gamma band activity in the contralateral auditory cortex but might not, by itself, be responsible for tinnitus perception.			van der Loo, E (corresponding author), Univ Antwerp Hosp, Brain Res Ctr Antwerp Innovat & Interdisciplinary, Antwerp, Belgium.	elsa.vanderloo@ua.ac.be	Heyning, Paul H Vande/I-8278-2017	Heyning, Paul H Vande/0000-0002-8424-3717; Vanneste, Sven/0000-0003-1513-5752				Andersson G, 2000, ACTA OTO-LARYNGOL, V120, P967, DOI 10.1080/00016480050218717; Arnold W, 1996, ORL J OTO-RHINO-LARY, V58, P195, DOI 10.1159/000276835; Ashton H, 2007, NEUROSCI LETT, V426, P23, DOI 10.1016/j.neulet.2007.08.034; AXELSSON A, 1989, British Journal of Audiology, V23, P53, DOI 10.3109/03005368909077819; Boly M, 2005, NEUROPSYCHOL REHABIL, V15, P283, DOI 10.1080/09602010443000371; Boly M, 2004, ARCH NEUROL-CHICAGO, V61, P233, DOI 10.1001/archneur.61.2.233; Christmann C, 2007, NEUROIMAGE, V34, P1428, DOI 10.1016/j.neuroimage.2006.11.006; CONGEDO MFL, 2004, PERMUTATION MULTIPLE, P22; Crone NE, 2001, CLIN NEUROPHYSIOL, V112, P565, DOI 10.1016/S1388-2457(00)00545-9; de Lafuente V, 2005, NAT NEUROSCI, V8, P1698, DOI 10.1038/nn1587; Dehaene S, 2006, TRENDS COGN SCI, V10, P204, DOI 10.1016/j.tics.2006.03.007; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Eggermont JJ, 2004, TRENDS NEUROSCI, V27, P676, DOI 10.1016/j.tins.2004.08.010; Eggermont JJ, 2003, AURIS NASUS LARYNX, V30, pS7; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Gross J, 2007, PLOS BIOL, V5, P1168, DOI 10.1371/journal.pbio.0050133; Heller AJ, 2003, OTOLARYNG CLIN N AM, V36, P239, DOI 10.1016/S0030-6665(02)00160-3; JASTREBOFF PJ, 1990, NEUROSCI RES, V8, P221, DOI 10.1016/0168-0102(90)90031-9; JOLIOT M, 1994, P NATL ACAD SCI USA, V91, P11748, DOI 10.1073/pnas.91.24.11748; Kovacs S, 2006, INVEST RADIOL, V41, P87, DOI 10.1097/01.rli.0000189637.42344.09; Laureys S, 2000, BRAIN, V123, P1589, DOI 10.1093/brain/123.8.1589; Llinas R, 2005, TRENDS NEUROSCI, V28, P325, DOI 10.1016/j.tins.2005.04.006; Llinas R, 1998, PHILOS T ROY SOC B, V353, P1841, DOI 10.1098/rstb.1998.0336; Llinas RR, 1999, P NATL ACAD SCI USA, V96, P15222, DOI 10.1073/pnas.96.26.15222; Lockwood AH, 1999, SCAND AUDIOL, V28, P47; Lockwood AH, 1998, NEUROLOGY, V50, P114, DOI 10.1212/WNL.50.1.114; Melcher JR, 2000, J NEUROPHYSIOL, V83, P1058, DOI 10.1152/jn.2000.83.2.1058; Moller AR, 2003, OTOLARYNG CLIN N AM, V36, P249, DOI 10.1016/S0030-6665(02)00170-6; Moller AR, 2003, OTOLARYNGOL CLIN N A, V36, pv, DOI DOI 10.1016/S0030-6665(02)00170-6; Muhlnickel W, 1998, P NATL ACAD SCI USA, V95, P10340, DOI 10.1073/pnas.95.17.10340; Mulert C, 2005, NEUROIMAGE, V28, P49, DOI 10.1016/j.neuroimage.2005.05.041; Nir RR, 2008, J PAIN, V9, P1058, DOI 10.1016/j.jpain.2008.06.008; Pascual-Marqui RD, 1999, PSYCHIAT RES-NEUROIM, V90, P169, DOI 10.1016/S0925-4927(99)00013-X; PASCUALMARQUI RD, 1994, INT J PSYCHOPHYSIOL, V18, P49, DOI 10.1016/0167-8760(84)90014-X; RIBARY U, 1991, P NATL ACAD SCI USA, V88, P11037, DOI 10.1073/pnas.88.24.11037; Schlee W, 2009, BMC NEUROSCI, V10, DOI 10.1186/1471-2202-10-11; Smits M, 2007, NEURORADIOLOGY, V49, P669, DOI 10.1007/s00234-007-0231-3; Steriade M, 2006, NEUROSCIENCE, V137, P1087, DOI 10.1016/j.neuroscience.2005.10.029; Talairach J., 1988, COPLANAR STEREOTAXIC; TIITINEN H, 1993, NATURE, V364, P59, DOI 10.1038/364059a0; Weisz N, 2005, PLOS MED, V2, P546, DOI 10.1371/journal.pmed.0020153; Weisz N, 2007, J NEUROSCI, V27, P1479, DOI 10.1523/JNEUROSCI.3711-06.2007	42	188	189	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7396	10.1371/journal.pone.0007396	http://dx.doi.org/10.1371/journal.pone.0007396			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816597	Green Published, gold, Green Submitted			2022-12-27	WOS:000270594300013
J	Spalding, MD; Prigge, ST				Spalding, Maroya D.; Prigge, Sean T.			The Amidase Domain of Lipoamidase Specifically Inactivates Lipoylated Proteins In Vivo	PLOS ONE			English	Article								Background: In the 1950s, Reed and coworkers discovered an enzyme activity in Streptococcus faecalis ( Enterococcus faecalis) extracts that inactivated the Escherichia. coli and E. faecalis pyruvate dehydrogenase complexes through cleavage of the lipoamide bond. The enzyme that caused this lipoamidase activity remained unidentified until Jiang and Cronan discovered the gene encoding lipoamidase (Lpa) through the screening of an expression library. Subsequent cloning and characterization of the recombinant enzyme revealed that lipoamidase is an 80 kDa protein composed of an amidase domain containing a classic Ser-Ser-Lys catalytic triad and a carboxy-terminal domain of unknown function. Here, we show that the amidase domain can be used as an in vivo probe which specifically inactivates lipoylated enzymes. Methodology/Principal Findings: We evaluated whether Lpa could function as an inducible probe of alpha-ketoacid dehydrogenase inactivation using E. coli as a model system. Lpa expression resulted in cleavage of lipoic acid from the three lipoylated proteins expressed in E. coli, but did not result in cleavage of biotin from the sole biotinylated protein, the biotin carboxyl carrier protein. When expressed in lipoylation deficient E. coli, Lpa is not toxic, indicating that Lpa does not interfere with any other critical metabolic pathways. When truncated to the amidase domain, Lpa retained lipoamidase activity without acquiring biotinidase activity, indicating that the carboxy-terminal domain is not essential for substrate recognition or function. Substitution of any of the three catalytic triad amino acids with alanine produced inactive Lpa proteins. Conclusions/Significance: The enzyme lipoamidase is active against a broad range of lipoylated proteins in vivo, but does not affect the growth of lipoylation deficient E. coli. Lpa can be truncated to 60% of its original size with only a partial loss of activity, resulting in a smaller probe that can be used to study the effects of alpha-ketoacid dehydrogenase inactivation in vivo.			Spalding, MD (corresponding author), Johns Hopkins Bloomberg Sch Publ Hlth, Dept Biochem & Mol Biol, Baltimore, MD 21218 USA.	sprigge@jhsph.edu	Prigge, Sean/GVS-9197-2022	Prigge, Sean/0000-0001-9684-1733	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI065853] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI065853-04, R01 AI065853] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Allary M, 2007, MOL MICROBIOL, V63, P1331, DOI 10.1111/j.1365-2958.2007.05592.x; BERMAN JN, 1981, BIOCHEM J, V199, P513, DOI 10.1042/bj1990513; Cassey B, 1998, FEMS MICROBIOL LETT, V159, P325; Davis R., 1980, ADV BACTERIAL GENETI; Douce R, 2001, TRENDS PLANT SCI, V6, P167, DOI 10.1016/S1360-1385(01)01892-1; Fujiwara K, 1996, J BIOL CHEM, V271, P12932, DOI 10.1074/jbc.271.22.12932; FUJIWARA K, 1986, J BIOL CHEM, V261, P8836; Gong XM, 2000, J BIOL CHEM, V275, P13645, DOI 10.1074/jbc.275.18.13645; HACKERT ML, 1983, P NATL ACAD SCI-BIOL, V80, P2907, DOI 10.1073/pnas.80.10.2907; HERBERT AA, 1975, ARCH MICROBIOL, V106, P259, DOI 10.1007/BF00446532; Jiang YF, 2005, J BIOL CHEM, V280, P2244, DOI 10.1074/jbc.M408612200; KOIKE M, 1960, J BIOL CHEM, V235, P1924; Lack G, 2006, J BIOL CHEM, V281, P9538, DOI 10.1074/jbc.M509119200; LI SJ, 1993, J BACTERIOL, V175, P332, DOI 10.1128/JB.175.2.332-340.1993; LIU SJ, 1995, J BIOL CHEM, V270, P793, DOI 10.1074/jbc.270.2.793; MORRIS TW, 1994, J BIOL CHEM, V269, P16091; Muench SP, 2003, ACTA CRYSTALLOGR D, V59, P1246, DOI 10.1107/S0907444903008813; NAWA H, 1960, J AM CHEM SOC, V82, P896, DOI 10.1021/ja01489a033; Neuburger M, 2000, EUR J BIOCHEM, V267, P2882, DOI 10.1046/j.1432-1327.2000.01301.x; OKANE DJ, 1948, J BACTERIOL, V56, P499, DOI 10.1128/JB.56.4.499-506.1948; Perham RN, 2000, ANNU REV BIOCHEM, V69, P961, DOI 10.1146/annurev.biochem.69.1.961; Polyak SW, 2001, J BIOL CHEM, V276, P3037, DOI 10.1074/jbc.M003968200; Prigge ST, 2003, BIOCHEMISTRY-US, V42, P1160, DOI 10.1021/bi026847k; RADKE GA, 1993, BIOCHEM BIOPH RES CO, V190, P982, DOI 10.1006/bbrc.1993.1146; Reche P, 1998, BIOCHEM J, V329, P589, DOI 10.1042/bj3290589; REED KE, 1993, J BACTERIOL, V175, P1325, DOI 10.1128/JB.175.5.1325-1336.1993; REED LJ, 1958, J BIOL CHEM, V232, P143; REED LJ, 1990, J BIOL CHEM, V265, P8971; Reed LJ, 2001, J BIOL CHEM, V276, P38329, DOI 10.1074/jbc.R100026200; Roberts EL, 1999, BIOCHEMISTRY-US, V38, P5045, DOI 10.1021/bi982466o; STEPP LR, 1981, BIOCHEMISTRY-US, V20, P4555, DOI 10.1021/bi00519a007; SUZUKI K, 1963, J BIOL CHEM, V238, P4021; THOMPSON JD, 1994, NUCLEIC ACIDS RES, V22, P4673, DOI 10.1093/nar/22.22.4673	33	11	11	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7392	10.1371/journal.pone.0007392	http://dx.doi.org/10.1371/journal.pone.0007392			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812687	Green Submitted, Green Published, gold			2022-12-27	WOS:000270594200013
J	Lehours, P; Zheng, ZL; Skoglund, A; Megraud, F; Engstrand, L				Lehours, Philippe; Zheng, Zongli; Skoglund, Anna; Megraud, Francis; Engstrand, Lars			Is There a Link between the Lipopolysaccharide of Helicobacter pylori Gastric MALT Lymphoma Associated Strains and Lymphoma Pathogenesis?	PLOS ONE			English	Article								The aim of this study was to investigate the Lewis antigen expression in Helicobacter pylori gastric MALT lymphoma associated strains in comparison to chronic gastritis only strains. Forty MALT strains (19 cagPAI (-) and 21 cagPAI (+)) and 39 cagPAI frequency-matched gastritis strains (17 cagPAI (-) and 22 cagPAI (+)) were included in this study. The lipopolyssacharide for each strain was extracted using a hot phenol method and the expression of Le(x) and Le(y) were investigated using Western Blot. The data were analyzed according to the strains' cagPAI status and vacA genotype. Le(x) was identified in 21 (52.5%) MALT strains and 29 (74.3%) gastritis strains. Le(y) was identified in 30 (75%) MALT strains and 31 (79.5%) gastritis strains. There was an association between cagPAI positivity and Le(x) expression among MALT strains (p<0.0001), but not in gastritis strains (p = 0.64). Among cagPAI (-) strains, isolates expressing solely Le(y) were associated with MALT with an odds ratio of 64.2 (95% CI 4.9-841.0) when compared to strains expressing both Le(x) and Le(y). vacA genotypes did not modify the association between Lewis antigen expression and disease status. In conclusion, cagPAI (-) MALT strains have a particular Lewis antigen profile which could represent an adaptive mechanism to the host response or participate in MALT lymphomagenesis.			Lehours, P (corresponding author), INSERM, U853, Bordeaux, France.	philippe.lehours@labhel.u-bordeaux2.fr	zheng, zongli/B-2917-2011; zheng, zongli/C-7309-2008; Lehours, Philippe/I-2780-2014	zheng, zongli/0000-0003-4849-4903; 				[Anonymous], 1994, IARC Monogr Eval Carcinog Risks Hum, V61, P1; Aro P, 2004, SCAND J GASTROENTERO, V39, P1280, DOI 10.1080/00365520410008141; ATHERTON JC, 1995, J BIOL CHEM, V270, P17771, DOI 10.1074/jbc.270.30.17771; Bergman MP, 2004, J EXP MED, V200, P979, DOI 10.1084/jem.20041061; Broutet N, 2002, J INFECT DIS, V185, P503, DOI 10.1086/339016; D'Elios MM, 1999, GASTROENTEROLOGY, V117, P1105, DOI 10.1016/S0016-5085(99)70395-1; DElios MM, 1997, J IMMUNOL, V158, P962; Ferreira-Chagas B, 2007, HELICOBACTER, V12, P616, DOI 10.1111/j.1523-5378.2007.00546.x; Ferreri AJM, 2009, J INTERN MED, V265, P421, DOI 10.1111/j.1365-2796.2009.02083.x; Fukui T, 2004, LAB INVEST, V84, P485, DOI 10.1038/labinvest.3700056; Gerhard M, 1999, P NATL ACAD SCI USA, V96, P12778, DOI 10.1073/pnas.96.22.12778; Gonzalez-Valencia G, 2008, J CLIN MICROBIOL, V46, P2783, DOI 10.1128/JCM.02370-07; Greiner A, 1997, AM J PATHOL, V150, P1583; Heneghan MA, 2000, INFECT IMMUN, V68, P937, DOI 10.1128/IAI.68.2.937-941.2000; HUSSELL T, 1993, LANCET, V342, P571, DOI 10.1016/0140-6736(93)91408-E; Hynes SO, 2000, FEMS MICROBIOL LETT, V190, P67, DOI 10.1016/S0378-1097(00)00323-2; KOBAYASHI K, 1993, AM J GASTROENTEROL, V88, P919; Koehler CI, 2003, J CLIN PATHOL-MOL PA, V56, P36, DOI 10.1136/mp.56.1.36; Lehours P, 2005, Rocz Akad Med Bialymst, V50, P54; Lehours P, 2004, GUT, V53, P931, DOI 10.1136/gut.2003.028811; Lehours P, 2004, INFECT IMMUN, V72, P880, DOI 10.1128/IAI.72.2.880-888.2004; Marshall DG, 1999, FEMS IMMUNOL MED MIC, V24, P79, DOI 10.1111/j.1574-695X.1999.tb01268.x; Monteiro MA, 1998, J BIOL CHEM, V273, P11533, DOI 10.1074/jbc.273.19.11533; Moran AP, 2008, CARBOHYD RES, V343, P1952, DOI 10.1016/j.carres.2007.12.012; Moran AP, 1999, J PHYSIOL PHARMACOL, V50, P787; Mueller A, 2003, P NATL ACAD SCI USA, V100, P1292, DOI 10.1073/pnas.242741699; Nilsson C, 2006, P NATL ACAD SCI USA, V103, P2863, DOI 10.1073/pnas.0511119103; Nilsson C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003811; O'Rourke JL, 2008, J GASTROEN HEPATOL, V23, pS151, DOI 10.1111/j.1440-1746.2008.05553.x; Rescigno M, 2008, CURR OPIN IMMUNOL, V20, P669, DOI 10.1016/j.coi.2008.09.007; Skoglund A, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005885; Suarez F, 2006, BLOOD, V107, P3034, DOI 10.1182/blood-2005-09-3679; Vandenbroucke-Grauls CMJE, 1998, ITAL J GASTROENTEROL, V30, pS259; Wang G, 1999, MOL MICROBIOL, V31, P1265, DOI 10.1046/j.1365-2958.1999.01268.x; Wang G, 2000, MOL MICROBIOL, V36, P1187, DOI 10.1046/j.1365-2958.2000.01934.x; Wirth HP, 1996, INFECT IMMUN, V64, P4598, DOI 10.1128/IAI.64.11.4598-4605.1996	36	14	14	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7297	10.1371/journal.pone.0007297	http://dx.doi.org/10.1371/journal.pone.0007297			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806222	Green Submitted, gold, Green Published			2022-12-27	WOS:000270593800010
J	Sullivan, JC; Wolenski, FS; Reitzel, AM; French, CE; Traylor-Knowles, N; Gilmore, TD; Finnerty, JR				Sullivan, James C.; Wolenski, Francis S.; Reitzel, Adam M.; French, Courtney E.; Traylor-Knowles, Nikki; Gilmore, Thomas D.; Finnerty, John R.			Two Alleles of NF-kappa B in the Sea Anemone Nematostella vectensis Are Widely Dispersed in Nature and Encode Proteins with Distinct Activities	PLOS ONE			English	Article								Background: NF-kappa B is an evolutionarily conserved transcription factor that controls the expression of genes involved in many key organismal processes, including innate immunity, development, and stress responses. NF-kappa B proteins contain a highly conserved DNA-binding/dimerization domain called the Rel homology domain. Methods/Principal Findings: We characterized two NF-kappa B alleles in the sea anemone Nematostella vectensis that differ at nineteen single-nucleotide polymorphisms (SNPs). Ten of these SNPs result in amino acid substitutions, including six within the Rel homology domain. Both alleles are found in natural populations of Nematostella. The relative abundance of the two NF-kappa B alleles differs between populations, and departures from Hardy-Weinberg equilibrium within populations indicate that the locus may be under selection. The proteins encoded by the two Nv-NF-kappa B alleles have different molecular properties, in part due to a Cys/Ser polymorphism at residue 67, which resides within the DNA recognition loop. In nearly all previously characterized NF-kappa B proteins, the analogous residue is fixed for Cys, and conversion of human RHD proteins from Cys to Ser at this site has been shown to increase DNA-binding ability and increase resistance to inhibition by thiol-reactive compounds. However, the naturally-occurring Nematostella variant with Cys at position 67 binds DNA with a higher affinity than the Ser variant. On the other hand, the Ser variant activates transcription in reporter gene assays more effectively, and it is more resistant to inhibition by a thiol-reactive compound. Reciprocal Cys <-> Ser mutations at residue 67 of the native Nv-NF-kappa B proteins affect DNA binding as in human NF-kappa B proteins, e. g., a Cys-> Ser mutation increases DNA binding of the native Cys variant. Conclusions/Significance: These results are the first demonstration of a naturally occurring and functionally significant polymorphism in NF-kappa B in any species. The functional differences between these alleles and their uneven distribution in the wild suggest that different genotypes could be favored in different environments, perhaps environments that vary in their levels of peroxides or thiol-reactive compounds.			Sullivan, JC (corresponding author), Vertex Pharmaceut, Cambridge, MA USA.	jrf3@bu.edu	Finnerty, John R/B-6564-2011; Reitzel, Adam M/A-9129-2017; Traylor-Knowles, Nikki G/D-4354-2012	Reitzel, Adam M/0000-0001-5734-7118; 	NATIONAL CANCER INSTITUTE [R01CA047763, R29CA047763] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES [P42ES007381] Funding Source: NIH RePORTER; Div Of Molecular and Cellular Bioscience [0924749] Funding Source: National Science Foundation; NCI NIH HHS [CA047763, R01 CA047763] Funding Source: Medline; NIEHS NIH HHS [P42 ES007381, 5 P42 ES07381] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS)); Div Of Molecular and Cellular Bioscience(National Science Foundation (NSF)NSF - Directorate for Biological Sciences (BIO)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIEHS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS))		AbeleOeschger D, 1997, COMP BIOCHEM PHYS C, V117, P123, DOI 10.1016/S0742-8413(97)00059-5; ABELEOESCHGER D, 1995, DTSCH XOOL GES, V88, P93; Brennan P, 1996, BIOCHEM J, V320, P975, DOI 10.1042/bj3200975; Cernuda-Morollon E, 2001, J BIOL CHEM, V276, P35530, DOI 10.1074/jbc.M104518200; Collins GA, 2006, CURR OPIN GENET DEV, V16, P197, DOI 10.1016/j.gde.2006.02.009; Darling JA, 2004, MOL ECOL, V13, P2969, DOI 10.1111/j.1365-294X.2004.02313.x; Dryden CL, 2007, MAR CHEM, V103, P276, DOI 10.1016/j.marchem.2006.09.003; Dushay MS, 1996, P NATL ACAD SCI USA, V93, P10343, DOI 10.1073/pnas.93.19.10343; *EMBL, EBI AL SEQ US CLUSTA; Flohe L, 1997, FREE RADICAL BIO MED, V22, P1115, DOI 10.1016/S0891-5849(96)00501-1; Garcia-Pineres AJ, 2001, J BIOL CHEM, V276, P39713, DOI 10.1074/jbc.M101985200; Gauthier M, 2008, DEV GENES EVOL, V218, P23, DOI 10.1007/s00427-007-0197-5; *GEOSP, 2006, FINCHTV 1 4 0; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Glineur C, 2000, BIOCHEM J, V352, P583, DOI 10.1042/0264-6021:3520583; Graef IA, 2001, P NATL ACAD SCI USA, V98, P5740, DOI 10.1073/pnas.101602398; HAND C, 1992, BIOL BULL, V182, P169, DOI 10.2307/1542110; Hayden MS, 2008, CELL, V132, P344, DOI 10.1016/j.cell.2008.01.020; Hayden MS, 2004, GENE DEV, V18, P2195, DOI 10.1101/gad.1228704; Hoffmann A, 2006, ONCOGENE, V25, P6706, DOI 10.1038/sj.onc.1209933; Huguet C, 1997, ONCOGENE, V15, P2965, DOI 10.1038/sj.onc.1201471; Kabe Y, 2005, ANTIOXID REDOX SIGN, V7, P395, DOI 10.1089/ars.2005.7.395; Kashuk CS, 2005, P NATL ACAD SCI USA, V102, P8949, DOI 10.1073/pnas.0503259102; KUMAR S, 1992, MOL CELL BIOL, V12, P3094, DOI 10.1128/MCB.12.7.3094; Leeman JR, 2008, ONCOGENE, V27, P6770, DOI 10.1038/onc.2008.284; Liang MC, 2006, BIOCHEM PHARMACOL, V71, P634, DOI 10.1016/j.bcp.2005.11.013; Liang MC, 2006, CANCER LETT, V241, P69, DOI 10.1016/j.canlet.2005.10.004; MATTHEWS JR, 1993, NUCLEIC ACIDS RES, V21, P1727, DOI 10.1093/nar/21.8.1727; Matthews JR, 1996, NUCLEIC ACIDS RES, V24, P2236, DOI 10.1093/nar/24.12.2236; MATTHEWS JR, 1992, NUCLEIC ACIDS RES, V20, P3821, DOI 10.1093/nar/20.15.3821; MEYER E, 2009, ACROPORA MILLEPORA P; NEI M, 1977, ANN HUM GENET, V41, P225, DOI 10.1111/j.1469-1809.1977.tb01918.x; NEI M, 1973, P NATL ACAD SCI USA, V70, P3321, DOI 10.1073/pnas.70.12.3321; Pearson CVM, 2002, MOL ECOL, V11, P2285, DOI 10.1046/j.1365-294X.2002.01621.x; Putnam NH, 2007, SCIENCE, V317, P86, DOI 10.1126/science.1139158; Reitzel AM, 2008, BIOL INVASIONS, V10, P1197, DOI 10.1007/s10530-007-9196-8; Stephens M, 2003, AM J HUM GENET, V73, P1162, DOI 10.1086/379378; Straus DS, 2000, P NATL ACAD SCI USA, V97, P4844, DOI 10.1073/pnas.97.9.4844; Sullivan JC, 2007, DEV GENES EVOL, V217, P63, DOI 10.1007/s00427-006-0111-6	39	41	42	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7311	10.1371/journal.pone.0007311	http://dx.doi.org/10.1371/journal.pone.0007311			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806194	Green Submitted, Green Published, gold			2022-12-27	WOS:000270593800018
J	Ducret, A; Maisonneuve, E; Notareschi, P; Grossi, A; Mignot, T; Dukan, S				Ducret, Adrien; Maisonneuve, Etienne; Notareschi, Philippe; Grossi, Alain; Mignot, Tam; Dukan, Sam			A Microscope Automated Fluidic System to Study Bacterial Processes in Real Time	PLOS ONE			English	Article							ESCHERICHIA-COLI; MYXOCOCCUS-XANTHUS; GLIDING MOTILITY; OXIDATIVE DAMAGE; GENE-EXPRESSION; STRESS DEFENSE; FLOW-CYTOMETRY; CELL; PROTEIN; INDUCTION	Most time lapse microscopy experiments studying bacterial processes ie growth, progression through the cell cycle and motility have been performed on thin nutrient agar pads. An important limitation of this approach is that dynamic perturbations of the experimental conditions cannot be easily performed. In eukaryotic cell biology, fluidic approaches have been largely used to study the impact of rapid environmental perturbations on live cells and in real time. However, all these approaches are not easily applicable to bacterial cells because the substrata are in all cases specific and also because microfluidics nanotechnology requires a complex lithography for the study of micrometer sized bacterial cells. In fact, in many cases agar is the experimental solid substratum on which bacteria can move or even grow. For these reasons, we designed a novel hybrid micro fluidic device that combines a thin agar pad and a custom flow chamber. By studying several examples, we show that this system allows real time analysis of a broad array of biological processes such as growth, development and motility. Thus, the flow chamber system will be an essential tool to study any process that take place on an agar surface at the single cell level.			Ducret, A (corresponding author), Aix Marseille Univ, Chim Bacterienne Lab, UPR 9043, Inst Microbiol Mediterrane,CNRS,IFR 88, 31 Chemin Joseph Aiguier, Marseille, France.	tmignot@ifr88.cnrs-mrs.fr; sdukan@ifr88.cnrs-mrs.fr		maisonneuve, Etienne/0000-0003-3451-1223; Mignot, Tam/0000-0003-4338-9063				Allegra S, 2008, APPL ENVIRON MICROB, V74, P7813, DOI 10.1128/AEM.01364-08; Balaban NQ, 2004, SCIENCE, V305, P1622, DOI 10.1126/science.1099390; Bodvarsson B, 2008, IMAGE VISION COMPUT, V26, P1073, DOI 10.1016/j.imavis.2007.11.008; Brehm-Stecher BF, 2004, MICROBIOL MOL BIOL R, V68, P538, DOI 10.1128/MMBR.68.3.538-559.2004; Bustamante VH, 2004, MOL MICROBIOL, V53, P1501, DOI 10.1111/j.1365-2958.2004.04221.x; CAMPOS JM, 1978, J MOL BIOL, V119, P167, DOI 10.1016/0022-2836(78)90431-X; Charvin G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001468; Chronis N, 2007, NAT METHODS, V4, P727, DOI 10.1038/NMETH1075; Chung BG, 2005, LAB CHIP, V5, P401, DOI 10.1039/b417651k; Chung BG, 2007, BMC BIOTECHNOL, V7, DOI 10.1186/1472-6750-7-60; Cookson S, 2005, MOL SYST BIOL, V1, DOI 10.1038/msb4100032; Cuny C, 2005, J BACTERIOL, V187, P2244, DOI 10.1128/JB.187.7.2244-2248.2005; Desnues B, 2003, EMBO REP, V4, P400, DOI 10.1038/sj.embor.embor799; Dubnau D, 2006, MOL MICROBIOL, V61, P564, DOI 10.1111/j.1365-2958.2006.05249.x; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Dukan S, 1998, GENE DEV, V12, P3431, DOI 10.1101/gad.12.21.3431; Elowitz MB, 2002, SCIENCE, V297, P1183, DOI 10.1126/science.1070919; Gefen O, 2008, P NATL ACAD SCI USA, V105, P6145, DOI 10.1073/pnas.0711712105; Gordon A, 2007, NAT METHODS, V4, P175, DOI 10.1038/nmeth1008; Huang SS, 2007, J BACTERIOL, V189, P4681, DOI 10.1128/JB.00282-07; Jaffe JD, 2004, J BACTERIOL, V186, P4254, DOI 10.1128/JB.186.13.4254-4261.2004; JEON H, 2009, BIOMED MICRODEVICES; Jeon NL, 2002, NAT BIOTECHNOL, V20, P826, DOI 10.1038/nbt712; Lee HJ, 2003, APPL MICROBIOL BIOT, V60, P577, DOI 10.1007/s00253-002-1168-4; Lin F, 2006, LAB CHIP, V6, P1462, DOI 10.1039/b607071j; Lindner AB, 2008, P NATL ACAD SCI USA, V105, P3076, DOI 10.1073/pnas.0708931105; Maisonneuve E, 2008, J BACTERIOL, V190, P6609, DOI 10.1128/JB.00588-08; Massey RC, 2001, CURR BIOL, V11, P1810, DOI 10.1016/S0960-9822(01)00507-3; MCBRIDE MJ, 1992, J BACTERIOL, V174, P4246, DOI 10.1128/JB.174.13.4246-4257.1992; Nystrom T, 2003, CELL MOL LIFE SCI, V60, P1333, DOI 10.1007/s00018-003-2310-X; ORR WC, 1994, SCIENCE, V263, P1128, DOI 10.1126/science.8108730; Roostalu J, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-68; Rosenfeld N, 2005, SCIENCE, V307, P1962, DOI 10.1126/science.1106914; Saadi W, 2007, BIOMED MICRODEVICES, V9, P627, DOI 10.1007/s10544-007-9051-9; SETHI IK, 1987, T PATTERN ANAL MACHI, V9; Shapiro Howard M., 2008, V142, P175, DOI 10.1007/978-1-59745-246-5_14; Sliusarenko O, 2007, J BACTERIOL, V189, P611, DOI 10.1128/JB.01206-06; Smits WK, 2006, NAT REV MICROBIOL, V4, P259, DOI 10.1038/nrmicro1381; SPORMANN AM, 1995, J BACTERIOL, V177, P5846, DOI 10.1128/jb.177.20.5846-5852.1995; Stewart EJ, 2005, PLOS BIOL, V3, P295, DOI 10.1371/journal.pbio.0030045; Veening JW, 2008, P NATL ACAD SCI USA, V105, P4393, DOI 10.1073/pnas.0700463105; VEENMAN CJ, 1998, FAST ROBUST POINT TR; Vincent L, 1993, IEEE T IMAGE PROCESS, V2, P176, DOI 10.1109/83.217222; Wu SS, 1997, MOL MICROBIOL, V23, P109, DOI 10.1046/j.1365-2958.1997.1791550.x; Xu J, 2008, LETT APPL MICROBIOL, V47, P174, DOI 10.1111/j.1472-765X.2008.02407.x; Yan LJ, 1997, P NATL ACAD SCI USA, V94, P11168, DOI 10.1073/pnas.94.21.11168	46	42	44	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7282	10.1371/journal.pone.0007282	http://dx.doi.org/10.1371/journal.pone.0007282			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789641	Green Submitted, Green Published, gold			2022-12-27	WOS:000270354100028
J	Kotoula, V; Charalambous, E; Biesmans, B; Malousi, A; Vrettou, E; Fountzilas, G; Karkavelas, G				Kotoula, Vassiliki; Charalambous, Elpida; Biesmans, Bart; Malousi, Andigoni; Vrettou, Eleni; Fountzilas, George; Karkavelas, George			Targeted KRAS Mutation Assessment on Patient Tumor Histologic Material in Real Time Diagnostics	PLOS ONE			English	Article							METASTATIC COLORECTAL-CANCER; PARAFFIN-EMBEDDED TISSUES; K-RAS MUTATIONS; BREAST-CANCER; DNA PROBES; EGFR; CETUXIMAB; PCR; ASSAYS; CARCINOMA	Background: Testing for tumor specific mutations on routine formalin-fixed paraffin-embedded (FFPE) tissues may predict response to treatment in Medical Oncology and has already entered diagnostics, with KRAS mutation assessment as a paradigm. The highly sensitive real time PCR (Q-PCR) methods developed for this purpose are usually standardized under optimal template conditions. In routine diagnostics, however, suboptimal templates pose the challenge. Herein, we addressed the applicability of sequencing and two Q-PCR methods on prospectively assessed diagnostic cases for KRAS mutations. Methodology/Principal Findings: Tumor FFPE-DNA from 135 diagnostic and 75 low-quality control samples was obtained upon macrodissection, tested for fragmentation and assessed for KRAS mutations with dideoxy-sequencing and with two QPCR methods (Taqman-minor-groove-binder [TMGB] probes and DxS-KRAS-IVD). Samples with relatively well preserved DNA could be accurately analyzed with sequencing, while Q-PCR methods yielded informative results even in cases with very fragmented DNA (p<0.0001) with 100% sensitivity and specificity vs each other. However, Q-PCR efficiency (Ct values) also depended on DNA-fragmentation (p<0.0001). Q-PCR methods were sensitive to detect <= 1% mutant cells, provided that samples yielded cycle thresholds (Ct) <29, but this condition was met in only 38.5% of diagnostic samples. In comparison, FFPE samples (>99%) could accurately be analyzed at a sensitivity level of 10% (external validation of TMGB results). DNA quality and tumor cell content were the main reasons for discrepant sequencing/Q-PCR results (1.5%). Conclusions/Significance: Diagnostic targeted mutation assessment on FFPE-DNA is very efficient with Q-PCR methods in comparison to dideoxy-sequencing. However, DNA fragmentation/amplification capacity and tumor DNA content must be considered for the interpretation of Q-PCR results in order to provide accurate information for clinical decision making.			Kotoula, V (corresponding author), Aristotle Univ Thessaloniki, Dept Pathol, Papageorgiou Hosp, Sch Med, GR-54006 Thessaloniki, Greece.	vkotoula@auth.gr	Malousi, Andigoni D/A-9460-2012; Malousi, Andigoni/K-3754-2019; Fountzilas, George/ABF-2139-2020	Malousi, Andigoni D/0000-0002-1968-7020; 				Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Andreassen CN, 2004, RADIOTHER ONCOL, V72, P351, DOI 10.1016/j.radonc.2004.07.006; Andreyev HJN, 1997, GUT, V41, P323, DOI 10.1136/gut.41.3.323; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; Ang PW, 2008, CLIN CHEM LAB MED, V46, P1117, DOI 10.1515/CCLM.2008.217; Bach PB, 2009, NEW ENGL J MED, V360, P626, DOI 10.1056/NEJMhpr0807774; Beeghly-Fadiel A, 2008, CANCER RES, V68, P6453, DOI 10.1158/0008-5472.CAN-08-0636; Benlloch S, 2006, J MOL DIAGN, V8, P540, DOI 10.2353/jmoldx.2006.060070; Brink M, 2003, CARCINOGENESIS, V24, P703, DOI 10.1093/carcin/bgg009; BURMER GC, 1991, ENVIRON HEALTH PERSP, V93, P27, DOI 10.2307/3431164; Ciardiello F, 2008, NEW ENGL J MED, V358, P1160, DOI 10.1056/NEJMra0707704; Cronin M, 2004, AM J PATHOL, V164, P35, DOI 10.1016/S0002-9440(10)63093-3; Cross J, 2008, PHARMACOGENOMICS, V9, P463, DOI 10.2217/14622416.9.4.463; Cukier HN, 2009, ANAL BIOCHEM, V386, P288, DOI 10.1016/j.ab.2008.11.040; De La Vega FA, 2005, MUTAT RES-FUND MOL M, V573, P111, DOI 10.1016/j.mrfmmm.2005.01.008; De Roock W, 2008, ANN ONCOL, V19, P508, DOI 10.1093/annonc/mdm496; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; Do H, 2008, BMC CANCER, V8, DOI 10.1186/1471-2407-8-142; *EMEA, 2007, EMEA4051132007; *EMEA, 2008, EMEACHMP2804022008; FEARON ER, 1990, CELL, V61, P759, DOI 10.1016/0092-8674(90)90186-I; Frayling IM, 2002, J CLIN PATHOL-MOL PA, V55, P73, DOI 10.1136/mp.55.2.73; Gibson NJ, 2006, CLIN CHIM ACTA, V363, P32, DOI 10.1016/j.cccn.2005.06.022; Hewitt SM, 2008, ARCH PATHOL LAB MED, V132, P1929, DOI 10.1043/1543-2165-132.12.1929; Itabashi T, 2004, INT J ONCOL, V24, P687; JIMENO A, 2009, J CLIN ONCOL; Johnson NA, 2006, LAB INVEST, V86, P968, DOI 10.1038/labinvest.3700441; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Kim S, 2007, ANNU REV BIOMED ENG, V9, P289, DOI 10.1146/annurev.bioeng.9.060906.152037; Kosel S, 2001, NEUROGENETICS, V3, P163; Kutyavin IV, 2000, NUCLEIC ACIDS RES, V28, P655, DOI 10.1093/nar/28.2.655; Legrand B, 2002, FORENSIC SCI INT, V125, P205, DOI 10.1016/S0379-0738(01)00641-7; Letertre C, 2003, MOL CELL PROBE, V17, P307, DOI 10.1016/j.mcp.2003.08.004; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Lievre A, 2008, J CLIN ONCOL, V26, P374, DOI 10.1200/JCO.2007.12.5906; Lim EH, 2007, J THORAC ONCOL, V2, P387, DOI 10.1097/01.JTO.0000268671.49378.c2; Marchetti A, 2006, NEW ENGL J MED, V354, P526; Messersmith WA, 2008, NEW ENGL J MED, V359, P1834, DOI 10.1056/NEJMe0806778; Morita A, 2007, MOL CELL PROBE, V21, P171, DOI 10.1016/j.mcp.2006.10.005; Morlan J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004584; Nielsen K, 2008, FORENSIC SCI INT-GEN, V2, P226, DOI 10.1016/j.fsigen.2008.02.008; Ogino S, 2005, J MOL DIAGN, V7, P413, DOI 10.1016/S1525-1578(10)60571-5; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Packham D, 2009, DIAGN MOL PATHOL, V18, P62, DOI 10.1097/PDM.0b013e318182af52; Paik S, 2005, NAT CLIN PRACT ONCOL, V2, P246, DOI 10.1038/ncponc0171; PRETLOW TP, 1993, J NATL CANCER I, V85, P2004, DOI 10.1093/jnci/85.24.2004; Quach Nancy, 2004, BMC Clin Pathol, V4, P1, DOI 10.1186/1472-6890-4-1; Rauser S, 2007, CLIN CANCER RES, V13, P5115, DOI 10.1158/1078-0432.CCR-07-0465; Ruiz MIG, 2007, CELL ONCOL, V29, P257; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Stewart DJ, 2009, J CLIN ONCOL, V27, P328, DOI 10.1200/JCO.2008.18.9621; Tol J, 2009, NEW ENGL J MED, V360, P563, DOI 10.1056/NEJMoa0808268; van Dongen JJM, 2003, LEUKEMIA, V17, P2257, DOI 10.1038/sj.leu.2403202; van Krieken JHJM, 2008, VIRCHOWS ARCH, V453, P417, DOI 10.1007/s00428-008-0665-y; von Ahlfen S, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001261; Wang FF, 2007, J MOL DIAGN, V9, P441, DOI 10.2353/jmoldx.2007.070004; Zhu CQ, 2008, J CLIN ONCOL, V26, P4268, DOI 10.1200/JCO.2007.14.8924	57	74	76	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2009	4	11							e7746	10.1371/journal.pone.0007746	http://dx.doi.org/10.1371/journal.pone.0007746			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RZ	19888477	Green Published, Green Submitted, gold			2022-12-27	WOS:000271414600012
J	Levinson, NM; Visperas, PR; Kuriyan, J				Levinson, Nicholas M.; Visperas, Patrick R.; Kuriyan, John			The Tyrosine Kinase Csk Dimerizes through Its SH3 Domain	PLOS ONE			English	Article							TERMINAL SRC KINASE; C-SRC; CRYSTAL-STRUCTURE; STRUCTURAL BASIS; PHOSPHATASE PEP; P50(CSK); ACTIVATION; SEQUENCE; BINDING; HCK	The Src family kinases possess two sites of tyrosine phosphorylation that are critical to the regulation of kinase activity. Autophosphorylation on an activation loop tyrosine residue (Tyr 416 in commonly used chicken c-Src numbering) increases catalytic activity, while phosphorylation of a C-terminal tyrosine (Tyr 527 in c-Src) inhibits activity. The latter modification is achieved by the tyrosine kinase Csk (C-terminal Src Kinase), but the complete inactivation of the Src family kinases also requires the dephosphorylation of the activation loop tyrosine. The SH3 domain of Csk recruits the tyrosine phosphatase PEP, allowing for the coordinated inhibition of Src family kinase activity. We have discovered that Csk forms homodimers through interactions mediated by the SH3 domain in a manner that buries the recognition surface for SH3 ligands. The formation of this dimer would therefore block the recruitment of tyrosine phosphatases and may have important implications for the regulation of Src kinase activity.			Levinson, NM (corresponding author), Univ Calif Berkeley, Dept Mol & Cell Biol, 229 Stanley Hall, Berkeley, CA 94720 USA.	kuriyan@berkeley.edu		Levinson, Nicholas/0000-0003-4338-8087	Howard Hughes Medical Institute Funding Source: Medline	Howard Hughes Medical Institute(Howard Hughes Medical Institute)		BORCHERT TV, 1994, FEBS LETT, V341, P79, DOI 10.1016/0014-5793(94)80244-0; Brown MT, 1996, BBA-REV CANCER, V1287, P121, DOI 10.1016/0304-419X(96)00003-0; Cloutier JF, 1996, EMBO J, V15, P4909, DOI 10.1002/j.1460-2075.1996.tb00871.x; Cloutier JF, 1999, J EXP MED, V189, P111, DOI 10.1084/jem.189.1.111; CLOUTIER JF, 1995, MOL CELL BIOL, V15, P5937; Davidson D, 1997, J BIOL CHEM, V272, P23455, DOI 10.1074/jbc.272.37.23455; FENG SB, 1994, SCIENCE, V266, P1241, DOI 10.1126/science.7526465; Ghose R, 2001, NAT STRUCT BIOL, V8, P998, DOI 10.1038/nsb1101-998; Gregorieff A, 1998, J BIOL CHEM, V273, P13217, DOI 10.1074/jbc.273.21.13217; Kawabuchi M, 2000, NATURE, V404, P999, DOI 10.1038/35010121; Kholodenko BN, 2000, TRENDS CELL BIOL, V10, P173, DOI 10.1016/S0962-8924(00)01741-4; Kuriyan J, 1997, ANNU REV BIOPH BIOM, V26, P259, DOI 10.1146/annurev.biophys.26.1.259; Kuriyan J, 2007, NATURE, V450, P983, DOI 10.1038/nature06524; Levinson NM, 2008, CELL, V134, P124, DOI 10.1016/j.cell.2008.05.051; LIM WA, 1994, NATURE, V372, P375, DOI 10.1038/372375a0; Moarefi I, 1997, NATURE, V385, P650, DOI 10.1038/385650a0; Ogawa A, 2002, J BIOL CHEM, V277, P14351, DOI 10.1074/jbc.C200086200; OKADA M, 1991, J BIOL CHEM, V266, P24249; SABE H, 1994, P NATL ACAD SCI USA, V91, P3984, DOI 10.1073/pnas.91.9.3984; Schindler T, 1999, MOL CELL, V3, P639, DOI 10.1016/S1097-2765(00)80357-3; Sicheri F, 1997, NATURE, V385, P602, DOI 10.1038/385602a0; Takeuchi S, 2000, J BIOL CHEM, V275, P29183, DOI 10.1074/jbc.C000326200; TAKEYA T, 1983, CELL, V32, P881, DOI 10.1016/0092-8674(83)90073-9; Xu WQ, 1997, NATURE, V385, P595, DOI 10.1038/385595a0; Xu WQ, 1999, MOL CELL, V3, P629, DOI 10.1016/S1097-2765(00)80356-1; Yamaguchi H, 1996, NATURE, V384, P484, DOI 10.1038/384484a0	26	19	21	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2009	4	11							e7683	10.1371/journal.pone.0007683	http://dx.doi.org/10.1371/journal.pone.0007683			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RZ	19888460	Green Submitted, Green Published, gold			2022-12-27	WOS:000271414600006
J	Zhang, SM; Gerhard, GS				Zhang, Shiming; Gerhard, Glenn S.			Heme Mediates Cytotoxicity from Artemisinin and Serves as a General Anti-Proliferation Target	PLOS ONE			English	Article							ANTIMALARIAL-DRUG ARTEMISININ; PHOTODYNAMIC THERAPY; TOPOISOMERASE-I; CANCER-CELLS; MALARIAL PARASITE; LEISHMANIA-DONOVANI; INFECTED MICE; BREAST-CANCER; HOST-CELLS; CORALYNE	Heme (Fe2+ protoporphyrin IX) is an essential molecule that has been implicated the potent antimalarial action of artemisinin and its derivatives, although the source and nature of the heme remain controversial. Artemisinins also exhibit selective cytotoxicity against cancer cells in vitro and in vivo. We demonstrate that intracellular heme is the physiologically relevant mediator of the cytotoxic effects of artemisinins. Increasing intracellular heme synthesis through the addition of aminolevulinic acid, protoporphyrin IX, or transferrin-bound iron increased the cytotoxicity of dihydroartemisinin, while decreasing heme synthesis through the addition of succinyl acetone decreased its cytotoxic activity. A simple and robust high throughput assay was developed to screen chemical compounds that were capable of interacting with heme. A natural products library was screened which identified the compound coralyne, in addition to artemisinin, as a heme interacting compound with heme synthesis dependent cytotoxic activity. These results indicate that cellular heme may serve a general target for the development of both anti-parasitic and anti-cancer therapeutics.			Zhang, SM (corresponding author), Weis Ctr Res, Geisinger Clin, Danville, PA 17822 USA.	gsgerhard@geisinger.edu	Hua, QX/HGE-3640-2022					Avery MA, 2003, J MED CHEM, V46, P4244, DOI 10.1021/jm030181q; Berger TG, 2005, ONCOL REP, V14, P1599; Bhadra K, 2008, DNA CELL BIOL, V27, P675, DOI 10.1089/dna.2008.0779; Bilia AR, 2002, LIFE SCI, V70, P769, DOI 10.1016/S0024-3205(01)01447-3; Bonday ZQ, 1997, J BIOL CHEM, V272, P21839, DOI 10.1074/jbc.272.35.21839; Bonday ZQ, 2000, NAT MED, V6, P898, DOI 10.1038/78659; Cortazar TM, 2007, EXP PARASITOL, V116, P475, DOI 10.1016/j.exppara.2007.02.018; Creek DJ, 2008, ANTIMICROB AGENTS CH, V52, P1291, DOI 10.1128/AAC.01033-07; Dell'Eva R, 2004, BIOCHEM PHARMACOL, V68, P2359, DOI 10.1016/j.bcp.2004.08.021; DEMATTEIS F, 1983, FEBS LETT, V159, P127, DOI 10.1016/0014-5793(83)80430-X; Di Iorio E. E., 1981, METHOD ENZYMOL, P57; Efferth T, 2006, CURR DRUG TARGETS, V7, P407, DOI 10.2174/138945006776359412; Efferth T, 2004, FREE RADICAL BIO MED, V37, P998, DOI 10.1016/j.freeradbiomed.2004.06.023; Efferth T, 2003, MOL PHARMACOL, V64, P382, DOI 10.1124/mol.64.2.382; Efferth T, 2001, INT J ONCOL, V18, P767; Efferth T, 2007, PLANTA MED, V73, P299, DOI 10.1055/s-2007-967138; Egan TJ, 2004, J INORG BIOCHEM, V98, P144, DOI 10.1016/j.jinorgbio.2003.09.007; Fukuda H, 2005, INT J BIOCHEM CELL B, V37, P272, DOI 10.1016/j.biocel.2004.04.018; GARDNER LC, 1988, J BIOL CHEM, V263, P6676; Gatto B, 1996, CANCER RES, V56, P2795; Haddad RE, 2003, J AM CHEM SOC, V125, P1253, DOI 10.1021/ja0280933; Huang XJ, 2007, J PHARM PHARMACOL, V59, P849, DOI 10.1211/jpp.59.6.0011; Huynh C, 2008, CELL MICROBIOL, V10, P293, DOI 10.1111/j.1462-5822.2007.01095.x; Huynh C, 2006, J EXP MED, V203, P2363, DOI 10.1084/jem.20060559; ISLAM MM, 2009, J PHYS CHEM B; Jean-Moreno V, 2006, EXP PARASITOL, V112, P21, DOI 10.1016/j.exppara.2005.08.014; Jefford CW, 2001, CURR MED CHEM, V8, P1803, DOI 10.2174/0929867013371608; Jones M, 2009, BIOORG MED CHEM LETT, V19, P2033, DOI 10.1016/j.bmcl.2009.02.028; Kinnamon KE, 1998, AM J TROP MED HYG, V58, P804, DOI 10.4269/ajtmh.1998.58.804; Kwok JC, 2002, CRIT REV ONCOL HEMAT, V42, P65, DOI 10.1016/S1040-8428(01)00213-X; Lai H, 2006, CANCER LETT, V231, P43, DOI 10.1016/j.canlet.2005.01.019; LAI H, 1995, CANCER LETT, V91, P41, DOI 10.1016/0304-3835(94)03716-V; Liu ZM, 2004, ONCOGENE, V23, P503, DOI 10.1038/sj.onc.1207173; Loor G, 2008, CELL DEATH DIFFER, V15, P686, DOI 10.1038/cdd.2008.13; Makhey D, 1996, BIOORGAN MED CHEM, V4, P781, DOI 10.1016/0968-0896(96)00054-5; Malo N, 2006, NAT BIOTECHNOL, V24, P167, DOI 10.1038/nbt1186; Mercer AE, 2009, CURR OPIN DRUG DISC, V12, P125; Meshnick SR, 1996, MICROBIOL REV, V60, P301, DOI 10.1128/MMBR.60.2.301-315.1996; MESHNICK SR, 1991, MOL BIOCHEM PARASIT, V49, P181, DOI 10.1016/0166-6851(91)90062-B; Moore CM, 2009, NAT CLIN PRACT UROL, V6, P18, DOI 10.1038/ncpuro1274; Mu DG, 2008, CANCER CHEMOTH PHARM, V61, P639, DOI 10.1007/s00280-007-0517-5; Pandey AV, 1999, J BIOL CHEM, V274, P19383, DOI 10.1074/jbc.274.27.19383; Parapini S, 2004, FEBS LETT, V575, P91, DOI 10.1016/j.febslet.2004.08.039; PASTERNACK RF, 1985, BIOCHEMISTRY-US, V24, P5443, DOI 10.1021/bi00341a024; Peng Q, 1997, CANCER-AM CANCER SOC, V79, P2282; Posner GH, 2004, J MED CHEM, V47, P1299, DOI 10.1021/jm0303711; Reungpatthanaphong P, 2002, BIOL PHARM BULL, V25, P1555, DOI 10.1248/bpb.25.1555; Robert A, 2005, P NATL ACAD SCI USA, V102, P13676, DOI 10.1073/pnas.0500972102; Sah JF, 2002, J BIOL CHEM, V277, P14902, DOI 10.1074/jbc.M200107200; Sekhon BK, 2008, ASSAY DRUG DEV TECHN, V6, P711, DOI 10.1089/adt.2008.148; Selmeczi K, 2004, FEBS LETT, V556, P245, DOI 10.1016/S0014-5793(03)01448-0; Sen R, 2007, J MED MICROBIOL, V56, P1213, DOI 10.1099/jmm.0.47364-0; Sinclair PR, 2001, HEPATOLOGY, V33, P406, DOI 10.1053/jhep.2001.21409; SINCLAIR PR, 1990, ARCH BIOCHEM BIOPHYS, V282, P386, DOI 10.1016/0003-9861(90)90133-J; Singh NP, 2006, INTEGR CANCER THER, V5, P391, DOI 10.1177/1534735406295311; Singh NP, 2004, ANTICANCER RES, V24, P2277; Singh NP, 2001, LIFE SCI, V70, P49, DOI 10.1016/S0024-3205(01)01372-8; SUNDAR SN, 2008, CARCINOGENESIS; Tekwani BL, 2005, COMB CHEM HIGH T SCR, V8, P63, DOI 10.2174/1386207053328101; Tracz MJ, 2007, J AM SOC NEPHROL, V18, P414, DOI 10.1681/ASN.2006080894; Vogt A, 2005, J BIOL CHEM, V280, P19078, DOI 10.1074/jbc.M501467200; Wang J, 2008, PHARMACOLOGY, V82, P148, DOI 10.1159/000148261; Wang LK, 1996, CHEM RES TOXICOL, V9, P75, DOI 10.1021/tx950080y; Willoughby JA, 2009, J BIOL CHEM, V284, P2203, DOI 10.1074/jbc.M804491200; WILSON WD, 1976, J MED CHEM, V19, P1261, DOI 10.1021/jm00232a020; YANG DM, 1993, PARASITOLOGY, V106, P7, DOI 10.1017/S0031182000074758; ZEECHENG KY, 1974, J MED CHEM, V17, P347, DOI 10.1021/jm00249a020; Zhang JH, 1999, J BIOMOL SCREEN, V4, P67, DOI 10.1177/108705719900400206; Zhang SM, 2008, BIOORGAN MED CHEM, V16, P7853, DOI 10.1016/j.bmc.2008.02.034	69	66	75	1	33	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7472	10.1371/journal.pone.0007472	http://dx.doi.org/10.1371/journal.pone.0007472			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862332	Green Published, Green Submitted, gold			2022-12-27	WOS:000271194600003
J	Cardinali, B; Castellani, L; Fasanaro, P; Basso, A; Alema, S; Martelli, F; Falcone, G				Cardinali, Beatrice; Castellani, Loriana; Fasanaro, Pasquale; Basso, Annalisa; Alema, Stefano; Martelli, Fabio; Falcone, Germana			Microrna-221 and Microrna-222 Modulate Differentiation and Maturation of Skeletal Muscle Cells	PLOS ONE			English	Article							GENE-EXPRESSION; TYROSINE KINASE; MYOGENESIS; MIR-222; MYOD; PROLIFERATION; TRANSCRIPTION; DOWNSTREAM; RAS; P27	Background: MicroRNAs (miRNAs) are a class of small non-coding RNAs that have recently emerged as important regulators of gene expression. They negatively regulate gene expression post-transcriptionally by translational repression and target mRNA degradation. miRNAs have been shown to play crucial roles in muscle development and in regulation of muscle cell proliferation and differentiation. Methodology/Principal Findings: By comparing miRNA expression profiling of proliferating myoblasts versus differentiated myotubes, a number of modulated miRNAs, not previously implicated in regulation of myogenic differentiation, were identified. Among these, miR-221 and miR-222 were strongly down-regulated upon differentiation of both primary and established myogenic cells. Conversely, miR-221 and miR-222 expression was restored in post-mitotic, terminally differentiated myotubes subjected to Src tyrosine kinase activation. By the use of specific inhibitors we provide evidence that expression of miR-221 and miR-222 is under the control of the Ras-MAPK pathway. Both in myoblasts and in myotubes, levels of the cell cycle inhibitor p27 inversely correlated with miR-221 and miR-222 expression, and indeed we show that p27 mRNA is a direct target of these miRNAs in myogenic cells. Ectopic expression of miR-221 and miR-222 in myoblasts undergoing differentiation induced a delay in withdrawal from the cell cycle and in myogenin expression, followed by inhibition of sarcomeric protein accumulation. When miR-221 and miR-222 were expressed in myotubes undergoing maturation, a profound alteration of myofibrillar organization was observed. Conclusions/Significance: miR-221 and miR-222 have been found to be modulated during myogenesis and to play a role both in the progression from myoblasts to myocytes and in the achievement of the fully differentiated phenotype. Identification of miRNAs modulating muscle gene expression is crucial for the understanding of the circuits controlling skeletal muscle differentiation and maintenance.			Cardinali, B (corresponding author), CNR, Ist Biol Cellulare, I-00016 Monterotondo, Italy.	gfalcone@ibc.cnr.it	Falcone, Germana/A-3735-2016; Cardinali, Beatrice/M-8862-2015; Martelli, Fabio/AAL-3788-2020	Cardinali, Beatrice/0000-0002-3333-3384; Martelli, Fabio/0000-0002-8624-7738; Castellani, Loriana/0000-0002-8519-3504; Alema, Stefano/0000-0002-9869-6354; Falcone, Germana/0000-0002-3508-7623				Baek D, 2008, NATURE, V455, P64, DOI 10.1038/nature07242; Baskerville S, 2005, RNA, V11, P241, DOI 10.1261/rna.7240905; Berkes CA, 2005, SEMIN CELL DEV BIOL, V16, P585, DOI 10.1016/j.semcdb.2005.07.006; Besson A, 2008, DEV CELL, V14, P159, DOI 10.1016/j.devcel.2008.01.013; BLAU HM, 1985, SCIENCE, V230, P758, DOI 10.1126/science.2414846; Caporossi D, 2003, FREE RADICAL BIO MED, V35, P1355, DOI 10.1016/j.freeradbiomed.2003.08.008; Care A, 2007, NAT MED, V13, P613, DOI 10.1038/nm1582; Castellani L, 1996, J CELL SCI, V109, P1335; Chen CZ, 2005, SEMIN IMMUNOL, V17, P155, DOI 10.1016/j.smim.2005.01.001; Chen JF, 2006, NAT GENET, V38, P228, DOI 10.1038/ng1725; Chu I, 2007, CELL, V128, P281, DOI 10.1016/j.cell.2006.11.049; Ciafre SA, 2005, BIOCHEM BIOPH RES CO, V334, P1351, DOI 10.1016/j.bbrc.2005.07.030; Ciuffini L, 2008, ONCOGENE, V27, P528, DOI 10.1038/sj.onc.1210665; Davis BN, 2009, J BIOL CHEM, V284, P3728, DOI 10.1074/jbc.M808788200; Doench JG, 2003, GENE DEV, V17, P438, DOI 10.1101/gad.1064703; Eisenberg I, 2007, P NATL ACAD SCI USA, V104, P17016, DOI 10.1073/pnas.0708115104; FALCONE G, 1991, MOL CELL BIOL, V11, P3331, DOI 10.1128/MCB.11.6.3331; Falcone G, 2003, ONCOGENE, V22, P8302, DOI 10.1038/sj.onc.1206915; Fasanaro P, 2008, J BIOL CHEM, V283, P15878, DOI 10.1074/jbc.M800731200; Fazi F, 2005, CELL, V123, P819, DOI 10.1016/j.cell.2005.09.023; FORNARI F, 2008, ONCOGENE; Galardi S, 2007, J BIOL CHEM, V282, P23716, DOI 10.1074/jbc.M701805200; He HL, 2005, P NATL ACAD SCI USA, V102, P19075, DOI 10.1073/pnas.0509603102; Johnson D, 1998, ONCOGENE, V16, P2017, DOI 10.1038/sj.onc.1201727; Kim HK, 2006, J CELL BIOL, V174, P677, DOI 10.1083/jcb.200603008; LASSAR AB, 1989, CELL, V58, P659, DOI 10.1016/0092-8674(89)90101-3; le Sage C, 2007, EMBO J, V26, P3699, DOI 10.1038/sj.emboj.7601790; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Makeyev EV, 2008, SCIENCE, V319, P1789, DOI 10.1126/science.1152326; McCarthy JJ, 2007, J APPL PHYSIOL, V102, P306, DOI 10.1152/japplphysiol.00932.2006; Medina R, 2008, CANCER RES, V68, P2773, DOI 10.1158/0008-5472.CAN-07-6754; Messina G, 2005, MOL BIOL CELL, V16, P1469, DOI 10.1091/mbc.e04-07-0612; Pajalunga D, 2007, CELL CYCLE, V6, P1415; Pallante P, 2006, ENDOCR-RELAT CANCER, V13, P497, DOI 10.1677/erc.1.01209; Perry RLS, 2001, MOL CELL, V8, P291, DOI 10.1016/S1097-2765(01)00302-1; Puri PL, 2000, J CELL PHYSIOL, V185, P155, DOI 10.1002/1097-4652(200011)185:2<155::AID-JCP1>3.0.CO;2-Z; Rao PK, 2006, P NATL ACAD SCI USA, V103, P8721, DOI 10.1073/pnas.0602831103; Russo S, 1997, ONCOGENE, V14, P63, DOI 10.1038/sj.onc.1200805; Sartorelli V, 2005, CURR OPIN GENET DEV, V15, P528, DOI 10.1016/j.gde.2005.04.015; Schwarz DS, 2003, CELL, V115, P199, DOI 10.1016/S0092-8674(03)00759-1; Selbach M, 2008, NATURE, V455, P58, DOI 10.1038/nature07228; Sweetman D, 2008, DEV BIOL, V321, P491, DOI 10.1016/j.ydbio.2008.06.019; Tiainen M, 1996, CELL GROWTH DIFFER, V7, P1039; Vaccarello G, 2006, J MOL BIOL, V356, P578, DOI 10.1016/j.jmb.2005.12.024; van Rooij E, 2008, TRENDS GENET, V24, P159, DOI 10.1016/j.tig.2008.01.007; Visone R, 2007, ENDOCR-RELAT CANCER, V14, P791, DOI 10.1677/ERC-07-0129; Wang H, 2008, CANCER CELL, V14, P369, DOI 10.1016/j.ccr.2008.10.006	48	167	182	0	21	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7607	10.1371/journal.pone.0007607	http://dx.doi.org/10.1371/journal.pone.0007607			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859555	Green Published, Green Submitted, gold			2022-12-27	WOS:000271147400011
J	Nakagawa, H; Suzuki, H; Machida, S; Suzuki, J; Ohashi, K; Jin, M; Miyamoto, S; Terasaki, AG				Nakagawa, Hiroyuki; Suzuki, Hiroshi; Machida, Satoshi; Suzuki, Junko; Ohashi, Kazuyo; Jin, Mingyue; Miyamoto, Shigeaki; Terasaki, Asako G.			Contribution of the LIM Domain and Nebulin-Repeats to the Interaction of Lasp-2 with Actin Filaments and Focal Adhesions	PLOS ONE			English	Article							BINDING PROTEIN; CELL-MIGRATION; SH3 DOMAINS; LAMELLIPODIA; FILOPODIA; ORGANIZATION; EXPRESSION; MOTILITY; GENE; IDENTIFICATION	Lasp-2 binds to actin filaments and concentrates in the actin bundles of filopodia and lamellipodia in neural cells and focal adhesions in fibroblastic cells. Lasp-2 has three structural regions: a LIM domain, a nebulin-repeat region, and an SH3 domain; however, the region(s) responsible for its interactions with actin filaments and focal adhesions are still unclear. In this study, we revealed that the N-terminal fragment from the LIM domain to the first nebulin-repeat module (LIM-n1) retained actin-binding activity and showed a similar subcellular localization to full-length lasp-2 in neural cells. The LIM domain fragment did not interact with actin filaments or localize to actin filament bundles. In contrast, LIM-n1 showed a clear subcellular localization to filopodial actin bundles. Although truncation of the LIM domain caused the loss of F-actin binding activity and the accumulation of filopodial actin bundles, these truncated fragments localized to focal adhesions. These results suggest that lasp-2 interactions with actin filaments are mediated through the cooperation of the LIM domain and the first nebulin-repeat module in vitro and in vivo. Actin filament binding activity may be a major contributor to the subcellular localization of lasp-2 to filopodia but is not crucial for lasp-2 recruitment to focal adhesions.			Nakagawa, H (corresponding author), Fukuoka Univ, Fac Sci, Div Biol, Fukuoka 81401, Japan.	hnakagawa@fukuoka-u.ac.jp						Block J, 2008, J MICROSC-OXFORD, V231, P506, DOI 10.1111/j.1365-2818.2008.02063.x; Chew CS, 2008, AM J PHYSIOL-GASTR L, V295, pG37, DOI 10.1152/ajpgi.90247.2008; Chew CS, 2002, J CELL SCI, V115, P4787, DOI 10.1242/jcs.00174; Chew CS, 1998, AM J PHYSIOL-CELL PH, V275, pC56, DOI 10.1152/ajpcell.1998.275.1.C56; Deng XA, 2008, CELL MOTIL CYTOSKEL, V65, P827, DOI 10.1002/cm.20304; Grubinger M, 2004, FEBS LETT, V557, P88, DOI 10.1016/S0014-5793(03)01451-0; JIN JP, 1991, J BIOL CHEM, V266, P21215; Kadrmas JL, 2004, NAT REV MOL CELL BIO, V5, P920, DOI 10.1038/nrm1499; Katoh M, 2003, INT J MOL MED, V12, P405; Khurana B, 2002, EMBO J, V21, P5331, DOI 10.1093/emboj/cdf550; Li B, 2004, J BIOL CHEM, V279, P20401, DOI 10.1074/jbc.M310304200; Lin YH, 2004, J CELL BIOL, V165, P421, DOI 10.1083/jcb.200311045; Lukoyanova N, 2002, CURR BIOL, V12, P383, DOI 10.1016/S0960-9822(02)00678-4; Mattila PK, 2008, NAT REV MOL CELL BIO, V9, P446, DOI 10.1038/nrm2406; Mayer BJ, 2001, J CELL SCI, V114, P1253; Nakagawa H, 2006, FEBS LETT, V580, P3223, DOI 10.1016/j.febslet.2006.04.082; Nakagawa H, 2003, J CELL SCI, V116, P2577, DOI 10.1242/jcs.00462; Nakagawa H, 2001, J CELL SCI, V114, P1555; Nozumi M, 2003, J CELL SCI, V116, P239, DOI 10.1242/jcs.00233; Panaviene Z, 2007, CELL TISSUE RES, V327, P353, DOI 10.1007/s00441-006-0305-2; Pellegrin S, 2007, J CELL SCI, V120, P3491, DOI 10.1242/jcs.018473; Pollard TD, 2003, CELL, V112, P453, DOI 10.1016/S0092-8674(03)00120-X; Schreiber VR, 1998, MOL MED, V4, P675, DOI 10.1007/BF03401929; Small JV, 2002, TRENDS CELL BIOL, V12, P112, DOI 10.1016/S0962-8924(01)02237-1; SPUDICH JA, 1971, J BIOL CHEM, V246, P4866; Strasser A, 2006, EJC SUPPL, V4, P3, DOI 10.1016/S1359-6349(06)70010-6; Suyama R, 2009, DEVELOPMENT, V136, P95, DOI 10.1242/dev.027698; Svitkina TM, 1999, J CELL BIOL, V145, P1009, DOI 10.1083/jcb.145.5.1009; Terasaki AG, 2004, BIOCHEM BIOPH RES CO, V313, P48, DOI 10.1016/j.bbrc.2003.11.085; Terasaki AG, 2006, CYTOGENET GENOME RES, V112, P141, DOI 10.1159/000087526; Terasaki AG, 2008, BBA-GENE REGUL MECH, V1779, P51, DOI 10.1016/j.bbagrm.2007.08.001; TOMASETTO C, 1995, GENOMICS, V28, P367, DOI 10.1006/geno.1995.1163; Tran TC, 2005, BMC CELL BIOL, V6, DOI 10.1186/1471-2121-6-45; Vignjevic D, 2006, J CELL BIOL, V174, P863, DOI 10.1083/jcb.200603013; Wang K, 1996, J BIOL CHEM, V271, P4304; Yang C, 2007, PLOS BIOL, V5, P2624, DOI 10.1371/journal.pbio.0050317; Zieseniss A, 2008, CELL MOTIL CYTOSKEL, V65, P59, DOI 10.1002/cm.20244	37	9	9	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7530	10.1371/journal.pone.0007530	http://dx.doi.org/10.1371/journal.pone.0007530			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851499	Green Submitted, Green Published, gold			2022-12-27	WOS:000271022300003
J	Brooks, KK; Liang, B; Watts, JL				Brooks, Kyleann K.; Liang, Bin; Watts, Jennifer L.			The Influence of Bacterial Diet on Fat Storage in C. elegans	PLOS ONE			English	Article							CAENORHABDITIS-ELEGANS; ESCHERICHIA-COLI; REGULATES FAT; LIFE-SPAN; INSULIN; ACID; GENE; BIOSYNTHESIS; PATHWAY; MODEL	Background: The nematode Caenorhabditis elegans has emerged as an important model for studies of the regulation of fat storage. C. elegans feed on bacteria, and various strains of E. coli are commonly used in research settings. However, it is not known whether particular bacterial diets affect fat storage and metabolism. Methodology/Principal Findings: Fat staining of fixed nematodes, as well as biochemical analysis of lipid classes, revealed considerable differences in fat stores in C. elegans growing on four different E. coli strains. Fatty acid composition and carbohydrate levels differ in the E. coli strains examined in these studies, however these nutrient differences did not appear to have a causative effect on fat storage levels in worms. Analysis of C. elegans strains carrying mutations disrupting neuroendocrine and other fat-regulatory pathways demonstrated that the intensity of Nile Red staining of live worms does not correlate well with biochemical methods of fat quantification. Several neuroendocrine pathway mutants and eating defective mutants show higher or lower fat storage levels than wild type, however, these mutants still show differences in fat stores when grown on different bacterial strains. Of all the mutants tested, only pept-1 mutants, which lack a functional intestinal peptide transporter, fail to show differential fat stores. Furthermore, fatty acid analysis of triacylglycerol stores reveals an inverse correlation between total fat stores and the levels of 15-methylpalmitic acid, derived from leucine catabolism. Conclusions: These studies demonstrate that nutritional cues perceived in the intestine regulate fat storage levels independently of neuroendocrine cues. The involvement of peptide transport and the accumulation of a fatty acid product derived from an amino acid suggest that specific peptides or amino acids may provide nutritional signals regulating fat metabolism and fat storage levels.			Brooks, KK (corresponding author), Washington State Univ, Sch Mol Biosci, Pullman, WA 99164 USA.	jwatts@wsu.edu	Watts, Jennifer/AAC-7425-2020	Watts, Jennifer/0000-0003-4349-0639	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK074114] Funding Source: NIH RePORTER; NIDDK NIH HHS [R01DK74114, R01 DK074114] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Ashrafi K, 2003, NATURE, V421, P268, DOI 10.1038/nature01279; Avery L, 2003, J EXP BIOL, V206, P2441, DOI 10.1242/jeb.00433; BOYER HW, 1969, J MOL BIOL, V41, P459, DOI 10.1016/0022-2836(69)90288-5; Braeckman BP, 2002, MECH AGEING DEV, V123, P105, DOI 10.1016/S0047-6374(01)00331-1; BRENNER S, 1974, GENETICS, V77, P71; Brock TJ, 2007, GENETICS, V176, P865, DOI 10.1534/genetics.107.071860; Carroll K, 2004, NAT REV MOL CELL BIO, V5, P55, DOI 10.1038/nrm1278; Dasgupta S, 1998, MOL MICROBIOL, V28, P629, DOI 10.1046/j.1365-2958.1998.00828.x; Davis MW, 1995, J NEUROSCI, V15, P8408; Greer ER, 2008, CELL METAB, V8, P118, DOI 10.1016/j.cmet.2008.06.005; Grogan DW, 1997, MICROBIOL MOL BIOL R, V61, P429, DOI 10.1128/.61.4.429-441.1997; Hobert O, 1997, NEURON, V19, P345, DOI 10.1016/S0896-6273(00)80944-7; Jones KT, 2009, DIS MODEL MECH, V2, P224, DOI 10.1242/dmm.001933; Kamath RS, 2003, NATURE, V421, P231, DOI 10.1038/nature01278; Kang CH, 2009, GENE DEV, V23, P12, DOI 10.1101/gad.1723409; KENYON C, 1993, NATURE, V366, P461, DOI 10.1038/366461a0; Kimura KD, 1997, SCIENCE, V277, P942, DOI 10.1126/science.277.5328.942; Kleemann GA, 2009, MOL CELL ENDOCRINOL, V299, P51, DOI 10.1016/j.mce.2008.10.048; Kniazeva M, 2004, PLOS BIOL, V2, P1446, DOI 10.1371/journal.pbio.0020257; Kniazeva M, 2008, GENE DEV, V22, P2102, DOI 10.1101/gad.1692008; Lakowski B, 1998, P NATL ACAD SCI USA, V95, P13091, DOI 10.1073/pnas.95.22.13091; Mak HY, 2006, NAT GENET, V38, P363, DOI 10.1038/ng1739; Meissner B, 2004, J BIOL CHEM, V279, P36739, DOI 10.1074/jbc.M403415200; MORRIS DL, 1948, SCIENCE, V107, P254, DOI 10.1126/science.107.2775.254; Mukhopadhyay A, 2005, CELL METAB, V2, P35, DOI 10.1016/j.cmet.2005.06.004; Mukhopadhyay A, 2007, EMBO REP, V8, P931, DOI 10.1038/sj.embor.7401055; Mullaney BC, 2009, BBA-MOL CELL BIOL L, V1791, P474, DOI 10.1016/j.bbalip.2008.12.013; NEIDHARDT FC, 1996, ESCHERICHIA COLI SAL, P13; Nicholas HR, 2004, MOL IMMUNOL, V41, P479, DOI 10.1016/j.molimm.2004.03.037; OKU H, 1988, J BIOL CHEM, V263, P18386; Panowski SH, 2009, TRENDS ENDOCRIN MET, V20, P259, DOI 10.1016/j.tem.2009.03.006; Perez CL, 2008, CELL METAB, V8, P266, DOI 10.1016/j.cmet.2008.08.007; Raizen DM, 2006, GENETICS, V173, P177, DOI 10.1534/genetics.106.057380; Savage-Dunn C., 2005, TGF BETA SIGNALING, P1, DOI [10.1895/wormbook.1.22.1, DOI 10.1895/WORMB00K.1.22.1]; Schroeder LK, 2007, MOL BIOL CELL, V18, P995, DOI 10.1091/mbc.E06-08-0685; Shtonda BB, 2006, J EXP BIOL, V209, P89, DOI 10.1242/jeb.01955; Soukas AA, 2009, GENE DEV, V23, P496, DOI 10.1101/gad.1775409; Spanier B, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006279; Tan MW, 1999, P NATL ACAD SCI USA, V96, P715, DOI 10.1073/pnas.96.2.715; Timmons L, 2001, GENE, V263, P103, DOI 10.1016/S0378-1119(00)00579-5; VANHANDEL E, 1985, J AM MOSQUITO CONTR, V1, P299; Watts JL, 2006, DEV BIOL, V292, P381, DOI 10.1016/j.ydbio.2006.01.013; Watts JL, 2002, P NATL ACAD SCI USA, V99, P5854, DOI 10.1073/pnas.092064799; WATTS JL, 2009, TRENDS ENDOCRINOL ME; Whitfield C, 2006, ANNU REV BIOCHEM, V75, P39, DOI 10.1146/annurev.biochem.75.103004.142545; You YJ, 2008, CELL METAB, V7, P249, DOI 10.1016/j.cmet.2008.01.005; Zhang Y, 2005, NATURE, V438, P179, DOI 10.1038/nature04216	47	197	213	2	66	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7545	10.1371/journal.pone.0007545	http://dx.doi.org/10.1371/journal.pone.0007545			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844570	Green Published, gold, Green Submitted			2022-12-27	WOS:000271013000018
J	Funada, J; Betts, TR; Hodson, L; Humphreys, SM; Timperley, J; Frayn, KN; Karpe, F				Funada, Junichi; Betts, Tim R.; Hodson, Leanne; Humphreys, Sandy M.; Timperley, Jon; Frayn, Keith N.; Karpe, Fredrik			Substrate Utilization by the Failing Human Heart by Direct Quantification Using Arterio-Venous Blood Sampling	PLOS ONE			English	Article							MYOCARDIAL FATTY-ACID; GENE-EXPRESSION; ADIPOSE-TISSUE; GLUCOSE-UPTAKE; METABOLISM; FAILURE	Metabolic substrate utilization of the human failing heart is an area of controversy. The purpose of this study is to directly quantify myocardial substrate utilization in moderately severe heart failure, type 2 diabetes and healthy controls using simultaneous coronary sinus and arterial blood sampling. Patients with heart failure (n = 9, mean NYHA 2.7 +/- 0.5), with type 2 diabetes (n = 5) and with normal heart function (n = 10) were studied after an overnight fast in connection with electrophysiological investigations/treatments. A systemic infusion of [(2)H(2)] palmitate allowed for the calculation of absolute palmitate extraction across the heart. Blood samples were analysed for non-esterified fatty acids, triacylglycerol, glycerol, glucose, pyruvate, lactate, 3-hydroxybutyrate, and blood gases after simultaneous sampling of arterial and coronary sinus blood. Arterio-coronary sinus metabolite concentration differences and fractional extractions for all substrates were similar between the groups. The absolute NEFA uptakes assessed by [(2)H(2)] palmitate extraction were also similar between the groups. Using direct measurements of metabolic substrate uptake by arterio-venous difference technique, the compensated human failing heart does not appear to have reduced myocardial fatty acid uptake.			Funada, J (corresponding author), Churchill Hosp, Oxford Ctr Diabet Endocrinol & Metab, Oxford OX3 7LJ, England.	Fredrik.Karpe@ocdem.ox.ac.uk		Karpe, Fredrik/0000-0002-2751-1770; Hodson, Leanne/0000-0002-2648-6526; Betts, Timothy/0000-0001-9063-9905	Wellcome Trust [nr 082345] Funding Source: Medline; Medical Research Council [G0600717B] Funding Source: researchfish	Wellcome Trust(Wellcome TrustEuropean Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission)		Abozguia K, 2006, NAT CLIN PRACT CARD, V3, P490, DOI 10.1038/ncpcardio0583; Bickerton AST, 2007, DIABETES, V56, P168, DOI 10.2337/db06-0822; BLAIN JM, 1956, AM J MED, V20, P820, DOI 10.1016/0002-9343(56)90203-0; Davila-Roman VG, 2002, J AM COLL CARDIOL, V40, P271, DOI 10.1016/S0735-1097(02)01967-8; FERRANNINI E, 1993, AM J PHYSIOL, V264, pE308, DOI 10.1152/ajpendo.1993.264.2.E308; HARIHARAN R, 1995, CIRCULATION, V91, P2435, DOI 10.1161/01.CIR.91.9.2435; Iacobellis G, 2005, NAT CLIN PRACT CARD, V2, P536, DOI 10.1038/ncpcardio0319; Korvald C, 2000, AM J PHYSIOL-HEART C, V278, pH1345, DOI 10.1152/ajpheart.2000.278.4.H1345; LASSERS BW, 1972, EUR J CLIN INVEST, V2, P348, DOI 10.1111/j.1365-2362.1972.tb00661.x; Razeghi P, 2001, CIRCULATION, V104, P2923, DOI 10.1161/hc4901.100526; Stanley WC, 2005, PHYSIOL REV, V85, P1093, DOI 10.1152/physrev.00006.2004; Taegtmeyer H, 2004, ANN NY ACAD SCI, V1015, P202, DOI 10.1196/annals.1302.017; Taylor M, 2001, J NUCL MED, V42, P55; Wallhaus TR, 2001, CIRCULATION, V103, P2441	14	36	36	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7533	10.1371/journal.pone.0007533	http://dx.doi.org/10.1371/journal.pone.0007533			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844574	Green Published, Green Submitted, gold			2022-12-27	WOS:000271013000011
J	Ansseau, E; Laoudj-Chenivesse, D; Marcowycz, A; Tassin, A; Vanderplanck, C; Sauvage, S; Barro, M; Mahieu, I; Leroy, A; Leclercq, I; Mainfroid, V; Figlewicz, D; Mouly, V; Butler-Browne, G; Belayew, A; Coppee, F				Ansseau, Eugenie; Laoudj-Chenivesse, Dalila; Marcowycz, Aline; Tassin, Alexandra; Vanderplanck, Celine; Sauvage, Sebastien; Barro, Marietta; Mahieu, Isabelle; Leroy, Axelle; Leclercq, India; Mainfroid, Veronique; Figlewicz, Denise; Mouly, Vincent; Butler-Browne, Gillian; Belayew, Alexandra; Coppee, Frederique			DUX4c Is Up-Regulated in FSHD. It Induces the MYF5 Protein and Human Myoblast Proliferation	PLOS ONE			English	Article							FACIOSCAPULOHUMERAL MUSCULAR-DYSTROPHY; 4Q35 LOCUS; GENE-EXPRESSION; CANDIDATE GENE; D4Z4; REGION; MUSCLE; REPEAT; DNA; EVOLUTION	Facioscapulohumeral muscular dystrophy (FSHD) is a dominant disease linked to contractions of the D4Z4 repeat array in 4q35. We have previously identified a double homeobox gene (DUX4) within each D4Z4 unit that encodes a transcription factor expressed in FSHD but not control myoblasts. DUX4 and its target genes contribute to the global dysregulation of gene expression observed in FSHD. We have now characterized the homologous DUX4c gene mapped 42 kb centromeric of the D4Z4 repeat array. It encodes a 47-kDa protein with a double homeodomain identical to DUX4 but divergent in the carboxyl-terminal region. DUX4c was detected in primary myoblast extracts by Western blot with a specific antiserum, and was induced upon differentiation. The protein was increased about 2-fold in FSHD versus control myotubes but reached 2-10-fold induction in FSHD muscle biopsies. We have shown by Western blot and by a DNA-binding assay that DUX4c overexpression induced the MYF5 myogenic regulator and its DNA-binding activity. DUX4c might stabilize the MYF5 protein as we detected their interaction by co-immunoprecipitation. In keeping with the known role of Myf5 in myoblast accumulation during mouse muscle regeneration DUX4c over-expression activated proliferation of human primary myoblasts and inhibited their differentiation. Altogether, these results suggested that DUX4c could be involved in muscle regeneration and that changes in its expression could contribute to the FSHD pathology.			Ansseau, E (corresponding author), Univ Mons, Mol Biol Lab, B-7000 Mons, Belgium.	frederique.coppee@umons.ac.be	Mouly, Gillian/G-6595-2017; BELAYEW, Alexandra/D-5205-2013	BELAYEW, Alexandra/0000-0001-5115-2424; Mouly, Vincent/0000-0003-3809-4033; butler-browne, gillian/0000-0002-3431-242X				Alexiadis V, 2007, BBA-GENE STRUCT EXPR, V1769, P29, DOI 10.1016/j.bbaexp.2006.11.006; Beckers MC, 2001, GENE, V264, P51, DOI 10.1016/S0378-1119(00)00602-8; Booth HAF, 2007, GENE, V387, P7, DOI 10.1016/j.gene.2006.07.034; BOSNAKOVSKI D, 2008, EXP NEUROL; Bosnakovski D, 2008, EMBO J, V27, P2766, DOI 10.1038/emboj.2008.201; Bouju S, 1999, NEUROMUSCULAR DISORD, V9, P3, DOI 10.1016/S0960-8966(98)00087-X; Buckingham M, 2007, CR BIOL, V330, P530, DOI 10.1016/j.crvi.2007.03.015; Butz M, 2003, J NEUROL, V250, P932, DOI 10.1007/s00415-003-1116-y; Castillo-Davis CI, 2005, TRENDS GENET, V21, P533, DOI 10.1016/j.tig.2005.08.001; Celegato B, 2006, PROTEOMICS, V6, P5303, DOI 10.1002/pmic.200600056; Chtarto A, 2007, EXP NEUROL, V204, P387, DOI 10.1016/j.expneurol.2006.11.014; Clapp J, 2007, AM J HUM GENET, V81, P264, DOI 10.1086/519311; Coppee F, 2004, FSHD - FACIOSCAPULOHUMERAL MUSCULAR DYSTROPHY: CLINICAL MEDICINE AND MOLECULAR CELL BIOLOGY, P117; Ding H, 1998, HUM MOL GENET, V7, P1681, DOI 10.1093/hmg/7.11.1681; DIXIT M, 2007, FASEB J, V21; Dixit M, 2007, P NATL ACAD SCI USA, V104, P18157, DOI 10.1073/pnas.0708659104; Dmitriev P, 2009, NEUROMUSCULAR DISORD, V19, P17, DOI 10.1016/j.nmd.2008.09.004; Doucet Christine, 2005, BMC Biochem, V6, P27, DOI 10.1186/1471-2091-6-27; Gabellini D, 2006, NATURE, V439, P973, DOI 10.1038/nature04422; Gabellini D, 2002, CELL, V110, P339, DOI 10.1016/S0092-8674(02)00826-7; Gabriels J, 1999, GENE, V236, P25, DOI 10.1016/S0378-1119(99)00267-X; Gayraud-Morel B, 2007, DEV BIOL, V312, P13, DOI 10.1016/j.ydbio.2007.08.059; Hanel ML, 2009, DEV DYNAM, V238, P1502, DOI 10.1002/dvdy.21830; Haslett JN, 2002, P NATL ACAD SCI USA, V99, P15000, DOI 10.1073/pnas.192571199; HEWITT JE, 1994, HUM MOL GENET, V3, P1287, DOI 10.1093/hmg/3.8.1287; Holterman CE, 2005, SEMIN CELL DEV BIOL, V16, P575, DOI 10.1016/j.semcdb.2005.07.004; Jiang GC, 2003, HUM MOL GENET, V12, P2909, DOI 10.1093/hmg/ddg323; KAWAMURA S, 2006, HUM MOL GENET; Kirsch S, 2005, GENOME RES, V15, P195, DOI 10.1101/gr.3302705; Kitzmann M, 1998, J CELL BIOL, V142, P1447, DOI 10.1083/jcb.142.6.1447; Kowaljow V, 2007, NEUROMUSCULAR DISORD, V17, P611, DOI 10.1016/j.nmd.2007.04.002; Laoudj-Chenivesse D, 2005, J MOL MED, V83, P216, DOI 10.1007/s00109-004-0583-7; Lemmers RJLF, 2007, AM J HUM GENET, V81, P884, DOI 10.1086/521986; Lemmers RJFL, 2004, AM J HUM GENET, V75, P1124, DOI 10.1086/426035; Lemmers RJLF, 2003, NEUROLOGY, V61, P178, DOI 10.1212/01.WNL.0000078889.51444.81; Lemmers RJLF, 1998, HUM MOL GENET, V7, P1207, DOI 10.1093/hmg/7.8.1207; LUNT PW, 1995, HUM MOL GENET, V4, P1243; LUNT PW, 1995, HUM MOL GENET, V4, P951, DOI 10.1093/hmg/4.5.951; LYLE R, 1995, GENOMICS, V28, P389, DOI 10.1006/geno.1995.1166; Nicolas N, 1998, CR ACAD SCI III-VIE, V321, P355, DOI 10.1016/S0764-4469(98)80298-9; Pandya S, 2008, PHYS THER, V88, P105, DOI 10.2522/ptj.20070104; Petrov A, 2006, P NATL ACAD SCI USA, V103, P6982, DOI 10.1073/pnas.0511235103; Petrov A, 2008, GENOME RES, V18, P39, DOI 10.1101/gr.6620908; Pirozhkova I, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003389; Ricci E, 1999, ANN NEUROL, V45, P751, DOI 10.1002/1531-8249(199906)45:6<751::AID-ANA9>3.0.CO;2-M; Rijkers T, 2004, J MED GENET, V41, P826, DOI 10.1136/jmg.2004.019364; Schmidt J, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005288; Tawil R, 1996, ANN NEUROL, V39, P744, DOI 10.1002/ana.410390610; Ustanina S, 2007, STEM CELLS, V25, P2006, DOI 10.1634/stemcells.2006-0736; van der Maarel SM, 2007, BBA-MOL BASIS DIS, V1772, P186, DOI 10.1016/j.bbadis.2006.05.009; van der Maarel SM, 2005, AM J HUM GENET, V76, P375, DOI 10.1086/428361; van Geel M, 2002, GENOMICS, V79, P210, DOI 10.1006/geno.2002.6690; van Geel M, 2000, CYTOGENET CELL GENET, V88, P316, DOI 10.1159/000015518; van Overveld PGM, 2005, ANN NEUROL, V58, P569, DOI 10.1002/ana.20625; vanDeutekom JCT, 1996, HUM MOL GENET, V5, P581, DOI 10.1093/hmg/5.5.581; WIJMENGA C, 1992, NAT GENET, V2, P26, DOI 10.1038/ng0992-26; Winokur ST, 2003, HUM MOL GENET, V12, P2895, DOI 10.1093/hmg/ddg327; WRIGHT TJ, 1993, HUM MOL GENET, V2, P1673, DOI 10.1093/hmg/2.10.1673; Wuebbles RD, 2009, DIS MODEL MECH, V2, P267, DOI 10.1242/dmm.002261; Yamane A, 2004, EUR J ORAL SCI, V112, P177, DOI 10.1111/j.0909-8836.2004.00106.x; Zhu CH, 2007, AGING CELL, V6, P515, DOI 10.1111/j.1474-9726.2007.00306.x	61	46	52	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7482	10.1371/journal.pone.0007482	http://dx.doi.org/10.1371/journal.pone.0007482			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829708	gold, Green Submitted, Green Published			2022-12-27	WOS:000270847800016
J	Casey, T; Patel, O; Dykema, K; Dover, H; Furge, K; Plaut, K				Casey, Theresa; Patel, Osman; Dykema, Karl; Dover, Heather; Furge, Kyle; Plaut, Karen			Molecular Signatures Reveal Circadian Clocks May Orchestrate the Homeorhetic Response to Lactation	PLOS ONE			English	Article							SHORT-DAY PHOTOPERIOD; GENE-EXPRESSION; ADIPOSE-TISSUE; MAMMARY-GLAND; DIURNAL-VARIATIONS; MILK-PRODUCTION; PREPARTUM PHOTOPERIOD; SHORT COMMUNICATION; LIPID-METABOLISM; GROWTH-HORMONE	Genes associated with lactation evolved more slowly than other genes in the mammalian genome. Higher conservation of milk and mammary genes suggest that species variation in milk composition is due in part to the environment and that we must look deeper into the genome for regulation of lactation. At the onset of lactation, metabolic changes are coordinated among multiple tissues through the endocrine system to accommodate the increased demand for nutrients and energy while allowing the animal to remain in homeostasis. This process is known as homeorhesis. Homeorhetic adaptation to lactation has been extensively described; however how these adaptations are orchestrated among multiple tissues remains elusive. To develop a clearer picture of how gene expression is coordinated across multiple tissues during the pregnancy to lactation transition, total RNA was isolated from mammary, liver and adipose tissues collected from rat dams (n = 5) on day 20 of pregnancy and day 1 of lactation, and gene expression was measured using Affymetrix GeneChips. Two types of gene expression analysis were performed. Genes that were differentially expressed between days within a tissue were identified with linear regression, and univariate regression was used to identify genes commonly up-regulated and down-regulated across all tissues. Gene set enrichment analysis showed genes commonly up regulated among the three tissues enriched gene ontologies primary metabolic processes, macromolecular complex assembly and negative regulation of apoptosis ontologies. Genes enriched in transcription regulator activity showed the common up regulation of 2 core molecular clock genes, ARNTL and CLOCK. Commonly down regulated genes enriched Rhythmic process and included: NR1D1, DBP, BHLHB2, OPN4, and HTR7, which regulate intracellular circadian rhythms. Changes in mammary, liver and adipose transcriptomes at the onset of lactation illustrate the complexity of homeorhetic adaptations and suggest that these changes are coordinated through molecular clocks.			Casey, T (corresponding author), Michigan State Univ, Dept Anim Sci, E Lansing, MI 48824 USA.	ande1218@msu.edu	Casey, Theresa Marie/F-1171-2015	Casey, Theresa Marie/0000-0002-8835-3550	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD050201] Funding Source: NIH RePORTER; NICHD NIH HHS [HD50201, R01 HD050201] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Aharoni Y, 2000, J DAIRY SCI, V83, P2779, DOI 10.3168/jds.S0022-0302(00)75174-5; Akhtar RA, 2002, CURR BIOL, V12, P540, DOI 10.1016/S0960-9822(02)00759-5; AMARA U, 2009, CURRENT TOPICS COMPL, V2, P68; Anderson SM, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1653; Ando H, 2005, ENDOCRINOLOGY, V146, P5631, DOI 10.1210/en.2005-0771; Andrade BR, 2008, J DAIRY SCI, V91, P2299, DOI 10.3168/jds.2007-0687; Auchtung TL, 2005, J DAIRY SCI, V88, P121, DOI 10.3168/jds.S0022-0302(05)72669-2; Augustine RA, 2008, J PHYSIOL-LONDON, V586, P387, DOI 10.1113/jphysiol.2007.146316; Auldist MJ, 2007, J DAIRY RES, V74, P52, DOI 10.1017/S0022029906002160; Balsalobre A, 1998, CELL, V93, P929, DOI 10.1016/S0092-8674(00)81199-X; Barber MC, 1997, BBA-LIPID LIPID MET, V1347, P101, DOI 10.1016/S0005-2760(97)00079-9; Barkova EN, 2005, B EXP BIOL MED+, V140, P394, DOI 10.1007/s10517-005-0500-2; Barres R, 2006, MOL ENDOCRINOL, V20, P2864, DOI 10.1210/me.2005-0455; BAUMAN DE, 1973, J DAIRY SCI, V56, P1520, DOI 10.3168/jds.S0022-0302(73)85401-3; BAUMAN DE, 1982, FED PROC, V41, P2538; BAUMAN DE, 1980, J DAIRY SCI, V63, P1514, DOI 10.3168/jds.S0022-0302(80)83111-0; BAUMAN DE, 1983, CONTROL NUTR PARTITI, P437; Bell AW, 1997, J MAMMARY GLAND BIOL, V2, P265, DOI 10.1023/A:1026336505343; Bernabucci U, 2006, J DAIRY SCI, V89, P4678, DOI 10.3168/jds.S0022-0302(06)72518-8; Billups SC, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-96; Bolstad BM, 2003, BIOINFORMATICS, V19, P185, DOI 10.1093/bioinformatics/19.2.185; Brewer M, 2005, J BIOL RHYTHM, V20, P195, DOI 10.1177/0748730405275952; Brown SA, 1999, CURR OPIN GENET DEV, V9, P588, DOI 10.1016/S0959-437X(99)00009-X; Bustin SA, 2009, CLIN CHEM, V55, P611, DOI 10.1373/clinchem.2008.112797; CHAVES JM, 1978, BIOCHEM BIOPH RES CO, V85, P1299, DOI 10.1016/0006-291X(78)91144-0; Connor EE, 2007, J DAIRY SCI, V90, pE55, DOI 10.3168/jds.2006-466; Dahl GE, 2008, J ANIM SCI, V86, P10, DOI 10.2527/jas.2007-0311; Dahl GE, 2003, J ANIM SCI, V81, P11; Dahl GE, 2004, VET CLIN N AM-FOOD A, V20, P675, DOI 10.1016/j.cvfa.2004.06.004; Dahl GE, 2002, REPRODUCTION, P191; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Damiola F, 2000, GENE DEV, V14, P2950, DOI 10.1101/gad.183500; Darlington TK, 1998, SCIENCE, V280, P1599, DOI 10.1126/science.280.5369.1599; Dennis PB, 2001, SCIENCE, V294, P1102, DOI 10.1126/science.1063518; Dinulescu DM, 2000, J BIOL CHEM, V275, P6695, DOI 10.1074/jbc.275.10.6695; Dolatshad H, 2006, HUM REPROD, V21, P68, DOI 10.1093/humrep/dei313; Duke-Cohan JS, 2004, J ENVIRON PATHOL TOX, V23, P1, DOI 10.1615/JEnvPathToxOncol.v23.i1.10; Elsik CG, 2009, SCIENCE, V324, P522, DOI 10.1126/science.1169588; FAILOR KL, 2007, MOL ENDOCRINOLOGY; FORMAN BM, 1994, MOL ENDOCRINOL, V8, P1253, DOI 10.1210/me.8.9.1253; Freeman ME, 2000, PHYSIOL REV, V80, P1523, DOI 10.1152/physrev.2000.80.4.1523; Froy O, 2007, FRONT NEUROENDOCRIN, V28, P61, DOI 10.1016/j.yfrne.2007.03.001; Fruhbeck G, 2001, AM J PHYSIOL-ENDOC M, V280, pE827, DOI 10.1152/ajpendo.2001.280.6.E827; FUKUDA H, 1985, BIOCHIM BIOPHYS ACTA, V835, P163, DOI 10.1016/0005-2760(85)90269-3; Furge KA, 2007, CANCER RES, V67, P3171, DOI 10.1158/0008-5472.CAN-06-4571; Gekakis N, 1998, SCIENCE, V280, P1564, DOI 10.1126/science.280.5369.1564; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grundschober C, 2001, J BIOL CHEM, V276, P46751, DOI 10.1074/jbc.M107499200; Guan Y, 2004, MOL ENDOCRINOL, V18, P214, DOI 10.1210/me.2003-0014; Guillaumond F, 2005, J BIOL RHYTHM, V20, P391, DOI 10.1177/0748730405277232; Gunn TM, 2000, TRENDS CARDIOVAS MED, V10, P76, DOI 10.1016/S1050-1738(00)00052-9; Hastings M, 2007, J ENDOCRINOL, V195, P187, DOI 10.1677/JOE-07-0378; Herrera E, 2002, ENDOCRINE, V19, P43, DOI 10.1385/ENDO:19:1:43; HERRERA E, 1994, BRAZ J MED BIOL RES, V27, P2499; Herrera E, 2000, EUR J CLIN NUTR, V54, pS47, DOI 10.1038/sj.ejcn.1600984; HERRERA E, 1991, DIABETES, V40, P83, DOI 10.2337/diab.40.2.S83; Higami Y, 2006, J NUTR, V136, P343, DOI 10.1093/jn/136.2.343; Higami Y, 2003, FASEB J, V17, P415, DOI 10.1096/fj.03-0678fje; HOLNESS MJ, 1993, BIOCHEM J, V292, P431, DOI 10.1042/bj2920431; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Hoshino K, 2006, ENDOCRINOLOGY, V147, P1916, DOI 10.1210/en.2005-1343; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jequier E, 2002, ANN NY ACAD SCI, V967, P379, DOI 10.1111/j.1749-6632.2002.tb04293.x; Johnson MS, 2001, J EXP BIOL, V204, P1925; Jost M, 2000, EUR J DERMATOL, V10, P505; KAELIN CB, INT J OBES, V32, pS19; Kelly PA, 2002, MOL CELL ENDOCRINOL, V197, P127, DOI 10.1016/S0303-7207(02)00286-1; Kim SJ, 2000, CYTOKINE GROWTH F R, V11, P159, DOI 10.1016/S1359-6101(99)00039-8; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Konturek SJ, 2004, J PHYSIOL PHARMACOL, V55, P137; Kume K, 1999, CELL, V98, P193, DOI 10.1016/S0092-8674(00)81014-4; Lemay DG, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r43; Lintault LM, 2007, J APPL PHYSIOL, V102, P2186, DOI 10.1152/japplphysiol.01015.2006; LINTAULT LM, 2007, J APPL PHYSIOL; LIU LB, 2003, INSULIN RECRUITS GLU, P30157; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lizunov VA, 2005, J CELL BIOL, V169, P481, DOI 10.1083/jcb.200412069; Maningat PD, 2009, PHYSIOL GENOMICS, V37, P12, DOI 10.1152/physiolgenomics.90341.2008; MARTINHIDALGO A, 1994, AM J PHYSIOL, V266, pE930, DOI 10.1152/ajpendo.1994.266.6.E930; MCNAMARA JP, 1978, J DAIRY SCI, V61, P156; Metz RP, 2006, DEV DYNAM, V235, P263, DOI 10.1002/dvdy.20605; MICHELE MB, 2008, FEBS J, V275, P2356; Mikolayunas CM, 2008, J DAIRY SCI, V91, P85, DOI 10.3168/jds.2007-0586; Morin LP, 1999, ANN MED, V31, P12, DOI 10.3109/07853899909019259; MUNDAY MR, 1983, BIOCHEM J, V214, P183, DOI 10.1042/bj2140183; Neville MC, 2002, J MAMMARY GLAND BIOL, V7, P49, DOI 10.1023/A:1015770423167; Neville MC, 2001, PEDIATR CLIN N AM, V48, P35, DOI 10.1016/S0031-3955(05)70284-4; Nielsen NI, 2003, J VET MED A, V50, P88, DOI 10.1046/j.1439-0442.2003.00496.x; Noshiro M, 2007, J BIOL RHYTHM, V22, P299, DOI 10.1177/0748730407302461; Oates JE, 2007, GEN COMP ENDOCR, V150, P445, DOI 10.1016/j.ygcen.2006.11.004; Oftedal OT, 2000, P NUTR SOC, V59, P99, DOI 10.1017/S0029665100000124; Oosterom J, 2001, J BIOL CHEM, V276, P931, DOI 10.1074/jbc.M007261200; ORMANDY CJ, 2003, INVESTIGATION TRANSC, P297; Panda S, 2002, CELL, V109, P307, DOI 10.1016/S0092-8674(02)00722-5; Patel OV, 2008, EUR J APPL PHYSIOL, V104, P847, DOI 10.1007/s00421-008-0840-5; Plaut K, 1999, P SOC EXP BIOL MED, V222, P85, DOI 10.1111/j.1525-1373.1999.09999.x; Plaut K, 2003, J APPL PHYSIOL, V95, P2350, DOI 10.1152/japplphysiol.00287.2003; PLAUT KI, 1989, J ANIM SCI, V67, P1509; PONCECASTANEDA MV, 1991, J DAIRY SCI, V74, P4013, DOI 10.3168/jds.S0022-0302(91)78596-2; POND CM, 1977, EVOLUTION, V31, P177, DOI [10.2307/2407556, 10.1111/j.1558-5646.1977.tb00995.x]; Preitner N, 2002, CELL, V110, P251, DOI 10.1016/S0092-8674(02)00825-5; Rea MA, 1998, CHRONOBIOL INT, V15, P395, DOI 10.3109/07420529808998699; Reppert SM, 2001, ANNU REV PHYSIOL, V63, P647, DOI 10.1146/annurev.physiol.63.1.647; Rius AG, 2006, J DAIRY SCI, V89, P2080, DOI 10.3168/jds.S0022-0302(06)72277-9; RONCA AE, 2003, COMMENTS THEORETICAL, V8, P627; Schibler U, 2003, J BIOL RHYTHM, V18, P250, DOI 10.1177/0748730403018003007; SEO S, 2009, HUM MOL GENET; Sheward WJ, 2007, J NEUROSCI, V27, P4351, DOI 10.1523/JNEUROSCI.4843-06.2007; SMYTH GK, 2004, R PROJECT STAT COMPU; Speakman JR, 2000, ADV ECOL RES, V30, P177; Speakman JR, 1996, PHYSIOL ZOOL, V69, P746, DOI 10.1086/physzool.69.4.30164228; Storch KF, 2002, NATURE, V417, P78, DOI 10.1038/nature744; TUCKER HA, 1987, J DAIRY SCI, V70, P1958, DOI 10.3168/jds.S0022-0302(87)80238-2; Turek FW, 2005, SCIENCE, V308, P1043, DOI 10.1126/science.1108750; Unger RH, 2003, ANNU REV PHYSIOL, V65, P333, DOI 10.1146/annurev.physiol.65.092101.142622; Virshup DM, 2007, COLD SPRING HARB SYM, V72, P413, DOI 10.1101/sqb.2007.72.048; Wall EH, 2005, J DAIRY SCI, V88, P3145, DOI 10.3168/jds.S0022-0302(05)72997-0; Weber ET, 1998, J BIOL RHYTHM, V13, P209, DOI 10.1177/074873098129000057; Wheatley KE, 2008, OECOLOGIA, V155, P11, DOI 10.1007/s00442-007-0888-7; WILLIAMSON DH, 1984, FED PROC, V43, P2443; WILLIAMSON DH, 1986, REPROD NUTR DEV, V26, P597, DOI 10.1051/rnd:19860409; Wren AM, 2007, GASTROENTEROLOGY, V132, P2116, DOI 10.1053/j.gastro.2007.03.048; Yagita K, 2000, GENE DEV, V14, P1353; Yamazaki S, 2000, SCIENCE, V288, P682, DOI 10.1126/science.288.5466.682; Zakrzewska E I, 2004, J Gravit Physiol, V11, pP157	125	29	31	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7395	10.1371/journal.pone.0007395	http://dx.doi.org/10.1371/journal.pone.0007395			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816599	Green Published, Green Submitted, gold			2022-12-27	WOS:000270594300012
J	Palmer, CV; Modi, CK; Mydlarz, LD				Palmer, Caroline V.; Modi, Chintan K.; Mydlarz, Laura D.			Coral Fluorescent Proteins as Antioxidants	PLOS ONE			English	Article							OXIDATIVE STRESS; ULTRAVIOLET-RADIATION; SCLERACTINIAN CORAL; REACTIVE OXYGEN; GREEN; MARINE; DIVERSITY; EVOLUTION; PIGMENTS; DISEASE	Background: A wide array of fluorescent proteins (FP) is present in anthozoans, although their biochemical characteristics and function in host tissue remain to be determined. Upregulation of FP's frequently occurs in injured or compromised coral tissue, suggesting a potential role of coral FPs in host stress responses. Methodology/Principal Findings: The presence of FPs was determined and quantified for a subsample of seven healthy Caribbean coral species using spectral emission analysis of tissue extracts. FP concentration was correlated with the in vivo antioxidant potential of the tissue extracts by quantifying the hydrogen peroxide (H2O2) scavenging rates. FPs of the seven species varied in both type and abundance and demonstrated a positive correlation between H2O2 scavenging rate and FP concentration. To validate this data, the H2O2 scavenging rates of four pure scleractinian FPs, cyan (CFP), green (GFP), red (RFP) and chromoprotein (CP), and their mutant counterparts (without chromophores), were investigated. In vitro, each FP scavenged H2O2 with the most efficient being CP followed by equivalent activity of CFP and RFP. Scavenging was significantly higher in all mutant counterparts. Conclusions/Significance: Both naturally occurring and pure coral FPs have significant H2O2 scavenging activity. The higher scavenging rate of RFP and the CP in vitro is consistent with observed increases of these specific FPs in areas of compromised coral tissue. However, the greater scavenging ability of the mutant counterparts suggests additional roles of scleractinian FPs, potentially pertaining to their color. This study documents H2O2 scavenging of scleractinian FPs, a novel biochemical characteristic, both in vivo across multiple species and in vitro with purified proteins. These data support a role for FPs in coral stress and immune responses and highlights the multi-functionality of these conspicuous proteins.			Palmer, CV (corresponding author), Univ Newcastle, Sch Biol, Newcastle Upon Tyne, Tyne & Wear, England.	Caroline.palmer@jcu.edu.au	Palmer, Caroline/B-6498-2011; Mydlarz, Laura/B-8132-2011; Modi, Chintan/N-7177-2013	Palmer, Caroline/0000-0002-5903-995X; Modi, Chintan/0000-0002-9913-3887				Alieva NO, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002680; ARONSON R, 2008, IUCN 2008 2008 IUCN; Bandaranayake WM, 2006, NAT PROD REP, V23, P223, DOI 10.1039/b307612c; Bay LK, 2009, MOL ECOL, V18, P3062, DOI 10.1111/j.1365-294X.2009.04257.x; BENDICH A, 1989, J NUTR, V119, P112, DOI 10.1093/jn/119.1.112; Bou-Abdallah F, 2006, BBA-GEN SUBJECTS, V1760, P1690, DOI 10.1016/j.bbagen.2006.08.014; CATALASTUCKI R, 1959, NATURE, V183, P949, DOI 10.1038/183949a0; Cornet S, 2007, BIOLOGY LETT, V3, P284, DOI 10.1098/rsbl.2007.0003; COX G, 2006, MULTIMODAL MICROSCOP; Cox G, 2007, MICROSC RES TECHNIQ, V70, P243, DOI 10.1002/jemt.20410; Croquer A, 2009, DIS AQUAT ORGAN, V83, P209, DOI 10.3354/dao02012; Cvejic J, 2007, MAR BIOL, V152, P855, DOI 10.1007/s00227-007-0738-5; Dove S, 2006, LIMNOL OCEANOGR, V51, P1149, DOI 10.4319/lo.2006.51.2.1149; Dove SG, 2001, CORAL REEFS, V19, P197, DOI 10.1007/PL00006956; Dove SG, 2008, PLANT CELL ENVIRON, V31, P1523, DOI 10.1111/j.1365-3040.2008.01852.x; Downs CA, 2002, FREE RADICAL BIO MED, V33, P533, DOI 10.1016/S0891-5849(02)00907-3; Dunlap W, 2003, MAR BIOTECHNOL, V5, P294, DOI 10.1007/s10126-002-0074-1; DYKENS JA, 1984, MAR BIOL LETT, V5, P291; Edmunds PJ, 2007, ECOL MONOGR, V77, P3, DOI 10.1890/05-1081; Fang FC, 2004, NAT REV MICROBIOL, V2, P820, DOI 10.1038/nrmicro1004; Gardner TA, 2003, SCIENCE, V301, P958, DOI 10.1126/science.1086050; GLEASON DF, 1993, LIMNOL OCEANOGR, V38, P1452, DOI 10.4319/lo.1993.38.7.1452; Gordon MH, 1996, NAT PROD REP, V13, P265, DOI 10.1039/np9961300265; Green DH, 2008, MAR ECOL PROG SER, V359, P1, DOI 10.3354/meps07454; Griffin SP, 2006, COMP BIOCHEM PHYS A, V144, P155, DOI 10.1016/j.cbpa.2006.02.017; GRUBER DF, 2008, BIOL B, V215; Halliwell B, 1996, ANNU REV NUTR, V16, P33, DOI 10.1146/annurev.nu.16.070196.000341; Harvell C. D., 2007, OCEANOGRAPHY, V20, P58; Harvell CD, 1999, SCIENCE, V285, P1505, DOI 10.1126/science.285.5433.1505; Hawkridge JM, 2000, MAR BIOL, V137, P1, DOI 10.1007/s002270000324; HUGHES TP, 1994, SCIENCE, V265, P1547, DOI 10.1126/science.265.5178.1547; Hughes TP, 2000, ECOLOGY, V81, P2250, DOI 10.1890/0012-9658(2000)081[2250:RFLHAL]2.0.CO;2; Kao HT, 2007, MAR BIOTECHNOL, V9, P733, DOI 10.1007/s10126-007-9025-1; Kawaguti S., 1944, Palao Tropical Biological Station Studies Tokyo, V2, P617; Kawaguti S., 1969, Micronesica, V5, P313; Kelmanson IV, 2003, MOL BIOL EVOL, V20, P1125, DOI 10.1093/molbev/msg130; Labas YA, 2002, P NATL ACAD SCI USA, V99, P4256, DOI 10.1073/pnas.062552299; Lesser MP, 2006, ANNU REV PHYSIOL, V68, P253, DOI 10.1146/annurev.physiol.68.040104.110001; Lesser MP, 1997, CORAL REEFS, V16, P187, DOI 10.1007/s003380050073; Lesser MP, 1996, LIMNOL OCEANOGR, V41, P271, DOI 10.4319/lo.1996.41.2.0271; Leutenegger A, 2007, J EXP MAR BIOL ECOL, V353, P221, DOI 10.1016/j.jembe.2007.09.013; Leverette CL, 2008, SPECTROCHIM ACTA A, V69, P1058, DOI 10.1016/j.saa.2007.07.018; Levy O, 2003, J EXP BIOL, V206, P4041, DOI 10.1242/jeb.00622; Martindale JL, 2002, J CELL PHYSIOL, V192, P1, DOI 10.1002/jcp.10119; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; Matz MV, 2006, PHOTOCHEM PHOTOBIOL, V82, P345, DOI 10.1562/2005-08-18-RA-653; Matz MV, 2002, BIOESSAYS, V24, P953, DOI 10.1002/bies.10154; Mazel CH, 2003, LIMNOL OCEANOGR, V48, P402, DOI 10.4319/lo.2003.48.1_part_2.0402; MAZEL CH, 1995, MAR ECOL PROG SER, V120, P185, DOI 10.3354/meps120185; Meredith P, 2006, SOFT MATTER, V2, P37, DOI 10.1039/b511922g; Merle PL, 2007, FREE RADICAL BIO MED, V42, P236, DOI 10.1016/j.freeradbiomed.2006.10.038; Meszaros A, 1999, J INVERTEBR PATHOL, V73, P321, DOI 10.1006/jipa.1999.4851; Mydlarz LD, 2006, ANNU REV ECOL EVOL S, V37, P251, DOI 10.1146/annurev.ecolsys.37.091305.110103; Mydlarz LD, 2007, COMP BIOCHEM PHYS A, V146, P54, DOI 10.1016/j.cbpa.2006.09.005; Mydlarz LD, 2006, MAR FRESHW BEHAV PHY, V39, P143, DOI 10.1080/10236240600708512; Mydlarz LD, 2004, PHYTOCHEMISTRY, V65, P3231, DOI 10.1016/j.phytochem.2004.09.014; Nappi AJ, 2005, INSECT BIOCHEM MOLEC, V35, P443, DOI 10.1016/j.ibmb.2005.01.014; Palmer CV, 2008, P ROY SOC B-BIOL SCI, V275, P2687, DOI 10.1098/rspb.2008.0335; Palmer CV, 2009, BIOL BULL-US, V216, P68, DOI 10.1086/BBLv216n1p68; Protas ME, 2008, ANNU REV CELL DEV BI, V24, P425, DOI 10.1146/annurev.cellbio.24.110707.175302; Richier S, 2006, FEBS J, V273, P4186, DOI 10.1111/j.1742-4658.2006.05414.x; Roulin A, 2004, BIOL REV, V79, P815, DOI 10.1017/S1464793104006487; Salih A, 2004, P SOC PHOTO-OPT INS, V5329, P61, DOI 10.1117/12.548926; Salih A, 2000, NATURE, V408, P850, DOI 10.1038/35048564; Salih A, 1998, P AUSTR COR REEF SOC, P217; SALIH A, 2006, PROGR BIOMEDICAL OPT, V7, P60980; Smith DJ, 2005, GLOBAL CHANGE BIOL, V11, P1, DOI 10.1111/j.1529-8817.2003.00895.x; Smith-Keune C, 2008, MAR BIOTECHNOL, V10, P166, DOI 10.1007/s10126-007-9049-6; Soderhall K, 1998, CURR OPIN IMMUNOL, V10, P23, DOI 10.1016/S0952-7915(98)80026-5; SUGUMARAN M, 1993, REGULATION INSECT HE, P317; Sutherland KP, 2004, MAR ECOL PROG SER, V266, P273, DOI 10.3354/meps266273; Tchernov D, 2004, P NATL ACAD SCI USA, V101, P13531, DOI 10.1073/pnas.0402907101; THOMSON CM, 2002, BIOLUMINESENCE CHEMI; Tsien RY, 1998, ANNU REV BIOCHEM, V67, P509, DOI 10.1146/annurev.biochem.67.1.509; Veron J.E.N., 2000, CORALS WORLD, V1-3; Vershinin A, 1999, BIOFACTORS, V10, P99, DOI 10.1002/biof.5520100203; Ward JR, 2006, DIS AQUAT ORGAN, V69, P23, DOI 10.3354/dao069023; Ward WW, 1998, GREEN FLUORESCENT PROTEIN: PROPERTIES, APPLICATIONS, AND PROTOCOLS, P45; WARD WW, 2002, BIOLUMINESCENCE CHEM, P123; Weis VM, 2008, J EXP BIOL, V211, P3059, DOI 10.1242/jeb.009597; Wiedenmann J, 2004, MAR BIOTECHNOL, V6, P270, DOI 10.1007/s10126-004-3006-4; Wiedenmann J, 2002, P NATL ACAD SCI USA, V99, P13358, DOI 10.1073/pnas.212371999; Willis BL, 2004, CORAL HEALTH AND DISEASE, P69	83	110	111	1	28	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7298	10.1371/journal.pone.0007298	http://dx.doi.org/10.1371/journal.pone.0007298			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806218	Green Published, gold, Green Accepted			2022-12-27	WOS:000270593800011
J	Doumanis, J; Wada, K; Kino, Y; Moore, AW; Nukina, N				Doumanis, Joanna; Wada, Koji; Kino, Yoshihiro; Moore, Adrian W.; Nukina, Nobuyuki			RNAi Screening in Drosophila Cells Identifies New Modifiers of Mutant Huntingtin Aggregation	PLOS ONE			English	Article								The fruitfly Drosophila melanogaster is well established as a model system in the study of human neurodegenerative diseases. Utilizing RNAi, we have carried out a high-throughput screen for modifiers of aggregate formation in Drosophila larval CNS-derived cells expressing mutant human Huntingtin exon 1 fused to EGFP with an expanded polyglutamine repeat (62Q). 7200 genes, encompassing around 50% of the Drosophila genome, were screened, resulting in the identification of 404 candidates that either suppress or enhance aggregation. These candidates were subjected to secondary screening in normal length (18Q)-expressing cells and pruned to remove dsRNAs with greater than 10 off-target effects (OTEs). De novo RNAi probes were designed and synthesized for the remaining 68 candidates. Following a tertiary round of screening, 21 high confidence candidates were analyzed in vivo for their ability to modify mutant Huntingtin-induced eye degeneration and brain aggregation. We have established useful models for the study of human HD using the fly, and through our RNAi screen, we have identified new modifiers of mutant human Huntingtin aggregation and aggregate formation in the brain. Newly identified modifiers including genes related to nuclear transport, nucleotide processes, and signaling, may be involved in polyglutamine aggregate formation and Huntington disease cascades.			Doumanis, J (corresponding author), RIKEN Brain Sci Inst, Lab Struct Neuropathol, Wako, Saitama, Japan.	nukina@brain.riken.jp	Moore, Adrian Walton/AAN-5656-2021; Nukina, Nobuyuki/GPP-6265-2022; Moore, Adrian W/A-3339-2013	Moore, Adrian Walton/0000-0002-8242-301X; Moore, Adrian W/0000-0002-8242-301X				Abramoff M.D., 2004, BIOPHOT INT, V11, P36, DOI DOI 10.1117/1.3589100; Arziman Z, 2005, NUCLEIC ACIDS RES, V33, pW582, DOI 10.1093/nar/gki468; Atwal RS, 2007, HUM MOL GENET, V16, P2600, DOI 10.1093/hmg/ddm217; Bai JW, 2008, DEVELOPMENT, V135, P1439, DOI 10.1242/dev.012849; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Bodner RA, 2006, P NATL ACAD SCI USA, V103, P4246, DOI 10.1073/pnas.0511256103; Celotto AM, 2005, MOL INTERV, V5, P292, DOI 10.1124/mi.5.5.9; Clemens JC, 2000, P NATL ACAD SCI USA, V97, P6499, DOI 10.1073/pnas.110149597; Cornett J, 2005, NAT GENET, V37, P198, DOI 10.1038/ng1503; Desai UA, 2006, HUM MOL GENET, V15, P2114, DOI 10.1093/hmg/ddl135; Dietzl G, 2007, NATURE, V448, P151, DOI 10.1038/nature05954; Doi H, 2008, J BIOL CHEM, V283, P6489, DOI 10.1074/jbc.M705306200; Gil JM, 2008, EUR J NEUROSCI, V27, P2803, DOI 10.1111/j.1460-9568.2008.06310.x; Jana NR, 2001, HUM MOL GENET, V10, P1049, DOI 10.1093/hmg/10.10.1049; Kazemi-Esfarjani P, 2000, SCIENCE, V287, P1837, DOI 10.1126/science.287.5459.1837; Kulkarni MM, 2006, NAT METHODS, V3, P833, DOI 10.1038/nmeth935; Ma Y, 2006, NATURE, V443, P359, DOI 10.1038/nature05179; Marsh JL, 2004, BIOESSAYS, V26, P485, DOI 10.1002/bies.20029; Murata T, 2008, BIOSCI BIOTECH BIOCH, V72, P2255, DOI 10.1271/bbb.70829; Ramadan N, 2007, NAT PROTOC, V2, P2245, DOI 10.1038/nprot.2007.250; Ravikumar B, 2004, NAT GENET, V36, P585, DOI 10.1038/ng1362; Sang Tzu-Kang, 2005, NeuroRx, V2, P438, DOI 10.1602/neurorx.2.3.438; Ui-Tei K, 2000, APOPTOSIS, V5, P133, DOI 10.1023/A:1009676528805; Yamamoto A, 2006, J CELL BIOL, V172, P719, DOI 10.1083/jcb.200510065; Zhang XQ, 2005, P NATL ACAD SCI USA, V102, P892, DOI 10.1073/pnas.0408936102	25	50	51	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7275	10.1371/journal.pone.0007275	http://dx.doi.org/10.1371/journal.pone.0007275			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789644	Green Submitted, Green Published, gold			2022-12-27	WOS:000270354100023
J	Ioset, JR; Kaur, H				Ioset, Jean-Robert; Kaur, Harparkash			Simple Field Assays to Check Quality of Current Artemisinin-Based Antimalarial Combination Formulations	PLOS ONE			English	Article								Introduction: Malaria continues to be one of the major public health problems in Africa, Asia and Latin America. Artemisinin derivatives (ARTs; artesunate, artemether, and dihydroartemisinin) derived from the herb, Artemisia annua, are the most effective antimalarial drugs available providing rapid cures. The World Health Organisation ( WHO) has recommended that all antimalarials must be combined with an artemisinin component (artemisinin-based combination therapy; ACT) for use as first line treatment against malaria. This class of drugs is now first-line policy in most malaria-endemic countries. Reports of ad hoc surveys from South East Asia show that up to 50% of the artesunate currently sold is counterfeit. Drug quality is rarely assessed in resource poor countries in part due to lack of dedicated laboratory facilities which are expensive to build, equip and maintain. With a view to address this unmet need we developed two novel colour reaction assays that can be used in the field to check the quality of ARTs. Methods and Findings: Our assays utilise thin layer chromatography silica gel sheets and 2, 4 dinitrophenylhydrazine or 4-Benzoylamino-2, 5-dimethoxybenzenediazonium chloride hemi (zinc chloride) salt as the reagents showing a pink or blue product respectively only in the presence ARTs. We are able to detect as low as 10% of ARTs in ACTs (WINTHROP artesunate/amodiaquine, Coartem (R)-artemether/lumefantrine and Duocortexcin - dihydroartemisinin/piperaquine). The assays have been validated extensively by testing eighty readily accessible and widely used drugs in malaria endemic countries. None of the other antimalarial drugs or a range of commonly used excipients, antiretroviral drugs or other frequently used drugs from the WHO essential drugs list such as analgesics or antibiotics are detected with our assays. Conclusions: Our two independent assays requiring no specialist training are specific, simple to use, rapid, robust, reproducible, inexpensive and, have successfully resulted in detecting two counterfeit drugs within a small scale screening survey of over 100 declared artemisinin-containing drugs collected from various Asian and African countries. These promising results indicate that the assays will provide a useful first test to assure the quality of the ACTs formulations in resource poor malaria endemic areas when there is an absence of dedicated medicines quality laboratory facilities.			Ioset, JR (corresponding author), DNDi, Geneva, Switzerland.	Harparkash.Kaur@lshtm.ac.uk						Aldhous P, 2005, NATURE, V434, P132, DOI 10.1038/434132a; Atemnkeng MA, 2007, TROP MED INT HEALTH, V12, P68, DOI 10.1111/j.1365-3156.2006.01769.x; Bate R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002132; Gabriels M, 2004, J CHROMATOGR SCI, V42, P341, DOI 10.1093/chromsci/42.7.341; Green MD, 2000, J PHARMACEUT BIOMED, V24, P65, DOI 10.1016/S0731-7085(00)00360-5; Green MD, 2001, TROP MED INT HEALTH, V6, P980, DOI 10.1046/j.1365-3156.2001.00793.x; Haynes RK, 2007, CHEMMEDCHEM, V2, P1448, DOI 10.1002/cmdc.200700064; Kaur H, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003403; KIBBE AH, HDB PHARM EXCIPIENTS; Lewison G, 2008, ACTA TROP, V106, P96, DOI 10.1016/j.actatropica.2008.01.009; Lon CT, 2006, T ROY SOC TROP MED H, V100, P1019, DOI 10.1016/j.trstmh.2006.01.003; Newton P, 2001, LANCET, V357, P1948, DOI 10.1016/S0140-6736(00)05085-6; Newton PN, 2006, PLOS MED, V3, P752, DOI 10.1371/journal.pmed.0030197; Newton PN, 2006, LANCET INFECT DIS, V6, P602, DOI 10.1016/S1473-3099(06)70581-3; Phanouvong S., 2005, 7 INT C AIDS AS PAC; Rozendaal J, 2001, LANCET, V357, P890, DOI 10.1016/S0140-6736(05)71830-4; SNOW RW, 2003, 11 NAT I HLTH FOG IN; THOMAS CG, 1992, J CHROMATOGR-BIOMED, V583, P131, DOI 10.1016/0378-4347(92)80355-T; WHO, 2006, GUID TREATM MAL; ZHAO S, 1986, ANAL CHEM, V58, P131; 2007, Patent No. 2007077444	21	29	29	1	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7270	10.1371/journal.pone.0007270	http://dx.doi.org/10.1371/journal.pone.0007270			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789707	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000270354100022
J	Kroger, B; Servais, T; Zhang, YB				Kroeger, Bjoern; Servais, Thomas; Zhang, Yunbai			The Origin and Initial Rise of Pelagic Cephalopods in the Ordovician	PLOS ONE			English	Article							MIDDLE ORDOVICIAN; SEQUENCE STRATIGRAPHY; BIODIVERSIFICATION; CLASSIFICATION; NAUTILOIDS; ECOLOGY	Background: During the Ordovician the global diversity increased dramatically at family, genus and species levels. Partially the diversification is explained by an increased nutrient, and phytoplankton availability in the open water. Cephalopods are among the top predators of todays open oceans. Their Ordovician occurrences, diversity evolution and abundance pattern potentially provides information on the evolution of the pelagic food chain. Methodology/Principal Findings: We reconstructed the cephalopod departure from originally exclusively neritic habitats into the pelagic zone by the compilation of occurrence data in offshore paleoenvironments from the Paleobiology Database, and from own data, by evidence of the functional morphology, and the taphonomy of selected cephalopod faunas. The occurrence data show, that cephalopod associations in offshore depositional settings and black shales are characterized by a specific composition, often dominated by orthocerids and lituitids. The siphuncle and conch form of these cephalopods indicate a dominant lifestyle as pelagic, vertical migrants. The frequency distribution of conch sizes and the pattern of epibionts indicate an autochthonous origin of the majority of orthocerid and lituitid shells. The consistent concentration of these cephalopods in deep subtidal sediments, starting from the middle Tremadocian indicates the occupation of the pelagic zone early in the Early Ordovician and a subsequent diversification which peaked during the Darriwilian. Conclusions/Significance: The exploitation of the pelagic realm started synchronously in several independent invertebrate clades during the latest Cambrian to Middle Ordovician. The initial rise and diversification of pelagic cephalopods during the Early and Middle Ordovician indicates the establishment of a pelagic food chain sustainable enough for the development of a diverse fauna of large predators. The earliest pelagic cephalopods were slowly swimming vertical migrants. The appearance and early diversification of pelagic cephalopods is interpreted as a consequence of the increased food availability in the open water since the latest Cambrian.			Kroger, B (corresponding author), Humboldt Univ, Museum Nat Kunde, Leibniz Inst Res Evolut & Biodivers, Berlin, Germany.	bjoekroe@gmx.de	Servais, Thomas/S-8045-2019	Servais, Thomas/0000-0002-4089-7874				Achab A, 2007, PALAEOGEOGR PALAEOCL, V245, P5, DOI 10.1016/j.palaeo.2006.02.030; Adrain JM, 2004, CRIT MOM PERSP EARTH, P231; Baird G.C., 1989, Senckenbergiana Lethaea, V69, P439; Bambach RK, 2007, PALAEONTOLOGY, V50, P1, DOI 10.1111/j.1475-4983.2006.00611.x; BAMBACH RK, 1983, BIOTIC INTERACTIONS, P719; BARRANDE J, 1867, CEPHALOPODES, P711; BARSKOV IS, 1966, CEPHALOPODS LATE ORD, P200; Bogolepova Olga K., 1999, Acta Universitatis Carolinae Geologica, V43, P409; BOLL E., 1857, ARCH VEREINS FREUNDE, V11, P58; Boucot A.J., 1975, EVOLUTION EXTINCTION, V1, DOI DOI 10.1016/0012-8252(75)90144-0; Brett CE, 2004, PALAEOGEOGR PALAEOCL, V210, P295, DOI 10.1016/j.palaeo.2004.02.038; BROGGER WC, 1882, SILURISCHEN ETAGEN 2, P376; BRUGUIERE JG, 1789, HIST NATURELLE VER 1, V1, P757; BURRETT CF, 1984, ASPECTS ORDOVICIAN S, P149; Chen J.-y., 1982, Acta Palaeontologica Sinica, V21, P392; Chen J.-y., 1991, Geologica et Palaeontologica, V25, P5; Chen J.Y., 1988, NEW MEXICO BUREAU MI, V44, P387; CHLUPAC I., 2003, B GEOSCI, V78, P91; Cocks LRM, 2004, CRIT MOM PERSP EARTH, P61; Conrad T.A., 1838, NEW YORK GEOLOGICAL, V2, P107; DZIK J, 1981, Acta Palaeontologica Polonica, V26, P161; Dzik J., 1984, PALAENTOL POL, V45, P1; Ebbestad Jan Ove Roysi, 1999, Fossils and Strata, V47, P1; EBBESTAD JOR, 2007, WOGOGOB 2007 9 M WOR, V128, P84; EICHWALD E, 1654, LETHAEA ROSSICA PALO; Engeser Theo, 1996, Topics in Geobiology, V13, P3; Evans D. H, 2005, MONOGRAPH PALAEONTOG, V628, P1; Evans DH, 2002, SPEC PAP PALAEONTOL, P77; Flower R. H., 1957, Memoirs Geological Society of America, V67, P829; FLOWER R. H., 1962, NEW MEXICO BUREAU MI, V10, P21; Foerste A. F., 1924, Journal Sci Nat Denison University Bul Granville, V20, P193; Foerste A. F., 1932, J SCI LAB DENISON U, V27, P47; FOERSTE AF, 1930, U MICHIGAN CONTRIBUT, V3, P109; FORTEY R A, 1985, Transactions of the Royal Society of Edinburgh Earth Sciences, V76, P219; Fortey Richard A., 2007, Memoir of the Association of Australasian Palaeontologists, V34, P391; Frey R.C, 1995, US GEOLOGICAL SURVEY, V1066P, P1, DOI [10.3133/pp1066P, DOI 10.3133/PP1066P]; Gabbott SE, 1999, PALAEONTOLOGY, V42, P123, DOI 10.1111/1475-4983.00065; GEG. Westermann, 1998, FUNCTIONAL MORPHOLOG, P263; Hall J., 1843, GEOLOGY NEW YORK 4, P683; Hall J., 1847, NATURAL HIST NEW YOR, V1, P338; HAVLICEK V, 1990, Vestnik Ustredniho Ustavu Geologickeho, V65, P223; HavlYek V., 1982, SB GEOL VED GEOL, V37, P103; Hewitt R.A., 1980, Neues Jahrbuch fuer Geologie und Palaeontologie Abhandlungen, V160, P96; HEWITT RA, 1985, ALCHERINGA, V9, P229, DOI 10.1080/03115518508618970; Hewitt Roger A., 1996, Palaeontologische Zeitschrift, V70, P405; Holm G, 1899, GEOLOGISKA FORENINGE, V20, P354; Hyatt A., 1884, P BOSTON SOC NAT HIS, V22, P253; JABLONSKI D, 1983, BIOL REV, V58, P21, DOI 10.1111/j.1469-185X.1983.tb00380.x; Kobayashi T, 1934, J FS IMPERIAL U TOKY, V3, P329; KOKELAAR BP, 1985, J GEOL SOC LONDON, V142, P591, DOI 10.1144/gsjgs.142.4.0591; KOLEBABA I, 1974, Vestnik Ustredniho Ustavu Geologickeho, V49, P293; Kroger B, 2008, SPEC PAP PALAEONTOL, P5, DOI 10.1111/j.1475-4983.2008.00764.x; Kroger B, 2007, J PALEONTOL, V81, P1266, DOI 10.1666/06-013.1; Kroger B, 2006, LETHAIA, V39, P129, DOI 10.1080/00241160600623749; Kroger B, 2009, GEOBIOS-LYON, V42, P273, DOI 10.1016/j.geobios.2008.09.006; Kroger B, 2008, ACTA PALAEONTOL POL, V53, P745, DOI 10.4202/app.2008.0417; Kroger B, 2004, J PALEONTOL, V78, P560, DOI 10.1666/0022-3360(2004)078<0560:LCCEON>2.0.CO;2; Kroger B, 2004, ACTA PALAEONTOL POL, V49, P57; KROGER B, 2009, PALAEOGEOGR PALAEOCL, V273, P74; Kroger B., 2006, FOSS REC, V9, P139; LANDING E, 2009, J PALEONTOL, V83, P89, DOI DOI 10.1666/08-078R.1; Landing E, 2007, GEOL MAG, V144, P909, DOI 10.1017/S0016756807003585; MAPES RH, 2008, LETHAIA; MAREK J, 2000, ARENIG CEPHALOPODS B, P56; Marek Jaroslav, 1999, Acta Universitatis Carolinae Geologica, V43, P413; Martin RE, 1996, PALAIOS, V11, P209, DOI 10.2307/3515230; Martin RE, 2008, PALAEOGEOGR PALAEOCL, V258, P277, DOI 10.1016/j.palaeo.2007.11.003; MURCHISON RI, 1859, SILURIA HIST OLDEST, pR9; Mutvei H, 2002, ACTA PALAEONTOL POL, V47, P157; Niko S, 2008, PALEONTOL RES, V12, P195, DOI 10.2517/1342-8144(2008)12[195:IWANLO]2.0.CO;2; Noble PJ, 2004, CRIT MOM PERSP EARTH, P97; Nutzel A, 2006, EVOL DEV, V8, P325, DOI 10.1111/j.1525-142X.2006.00105.x; Peterson KJ, 2005, GEOLOGY, V33, P929, DOI 10.1130/G21697.1; Reyment R. A., 1958, Stockholm Contributions in Geology, V1, P97; Reyment RA, 2008, PALAEONTOL ELECTRON, V11; Rudiger H, 1891, ARCH VEREINS FREUNDE, P1; Ruedemann R., 1912, NEW YORK STATE MUSEU, V162, P1; RUEDEMANN R, 1921, NEW YORK STATE MUSEU, V227, P79; Ruedemann R., 1926, NEW YORK STATE MUSEU, V227, P1; Schindewolf O. H., 1933, Abhandlungen der Preussischen Geologischen Landesanstalt, V148, P1; SCHOENEMANN B, 2008, ADV TRILOBITE RES, P361; Servais T, 2008, LETHAIA, V41, P99, DOI 10.1111/j.1502-3931.2008.00115.x; SHIMIZU S, 1935, SINOCERAS P IMPERIAL, V11, P324; SIGNOR PW, 1994, PALEOBIOLOGY, V20, P297, DOI 10.1017/S0094837300012793; Strand T., 1934, Norsk Geologisk Tidsskrift, V14, P1; THOMAS H, 2007, TRILOBITES FAUNAL DY, P466; Thoral M., 1935, CONTRIBUTION ETUDE P, P363; Tolmacheva TJ, 2001, GEOLOGY, V29, P755, DOI 10.1130/0091-7613(2001)029<0755:EFMYOC>2.0.CO;2; Vannier J, 2003, PALAEOGEOGR PALAEOCL, V195, P173, DOI 10.1016/S0031-0182(03)00307-9; Wani R, 2005, GEOLOGY, V33, P849, DOI 10.1130/G21712.1; Webby BD, 2004, CRIT MOM PERSP EARTH, P41; WESTERMA.GE, 1973, LETHAIA, V6, P383, DOI 10.1111/j.1502-3931.1973.tb01205.x; WESTERMANN G E G, 1977, Paleobiology, V3, P300; WESTERMANN G E G, 1985, Palaeontologische Zeitschrift, V59, P79; Xu C, 2006, GEOL J, V41, P289, DOI 10.1002/gj.1051; ZHAN R, 2004, P C FIELD EXC 10 INT, P169; Zou X.-P, 1987, B NANJING I GEOLOGY, V12, P231	97	60	63	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7262	10.1371/journal.pone.0007262	http://dx.doi.org/10.1371/journal.pone.0007262			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789709	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000270354100019
J	Chen, ZB; Feng, JN; Buzin, CH; Liu, Q; Weiss, L; Kernstine, K; Somlo, G; Sommer, SS				Chen, Zhenbin; Feng, Jinong; Buzin, Carolyn H.; Liu, Qiang; Weiss, Lawrence; Kernstine, Kemp; Somlo, George; Sommer, Steve S.			Analysis of Cancer Mutation Signatures in Blood by a Novel Ultra-Sensitive Assay: Monitoring of Therapy or Recurrence in Non-Metastatic Breast Cancer	PLOS ONE			English	Article							PYROPHOSPHOROLYSIS-ACTIVATED POLYMERIZATION; LUNG-CANCER; RARE ALLELES; TISSUE; GENE; DNA; OLIGONUCLEOTIDES; AMPLIFICATION; SURVIVAL; OCCUR	Tumor DNA has been shown to be present both in circulating tumor cells in blood and as fragments in the plasma of metastatic cancer patients. The identification of ultra-rare tumor-specific mutations in blood would be the ultimate marker to measure efficacy of cancer therapy and/orearly recurrence. Herein we present a method for detecting microinsertions/deletions/indels (MIDIs) at ultra-high analytical selectivity. MIDIs comprise about 15% of mutations. Methods and Findings: We describe MIDI-Activated Pyrophosphorolysis (MAP), a method of ultra-high analytical selectivity for detecting MIDIs. The high analytical selectivity of MAP is putatively due to serial coupling of two rare events: heteroduplex slippage and mis-pyrophosphorolysis. MAP generally has an analytical selectivity of one mutant molecule per 1 billion wild type molecules and an analytical sensitivity of one mutant molecule per reaction. The analytical selectivity of MAP is about 100,000-fold better than that of our previously described method of Pyrophosphorolysis Activated Polymerization-Allele specific amplification (PAP-A) for detecting MIDIs. The utility of this method is illustrated in two ways. 1) We demonstrate that two EGFR deletions commonly found in lung cancers are not present in tissue from four normal human lungs (10(7) copies of gDNA each) or in blood samples from 10 healthy individuals (10(7) copies of gDNA each). This is inconsistent, at least at an analytical sensitivity of 10(-7), with the hypotheses of (a) hypermutation or (b) strong selection of these growth factor-mutated cells during normal lung development leads to accumulation of pre-neoplastic cells with these EGFR mutations, which sometimes can lead to lung cancer in late adulthood. Moreover, MAP was used for large scale, high throughput "gene pool'' analysis. No germline or early embryonic somatic mosaic mutation was detected (at a frequency of > 0.3%) for the 15/18 bp EGFR deletion mutations in 6,400 individuals, suggesting that early embryonic EGFR somatic mutation is very rare, inconsistent with hypermutation or strong selection of these deletions in the embryo. 2) The second illustration of MAP utility is in personalized monitoring of therapy and early recurrence in cancer. Tumor-specific p53 mutations identified at diagnosis in the plasma of six patients with stage II and III breast cancer were undetectable after therapy in four women, consistent with clinical remission, and continued to be detected after treatment in two others, reflecting tumor progression. Conclusions: MAP has an analytical selectivity of one part per billion for detection of MIDIs and an analytical sensitivity of one molecule. MAP provides a general tool for monitoring ultra-rare mutations in tissues and blood. As an example, we show that the personalized cancer signature in six out of six patients with non-metastatic breast cancer can be detected and that levels over time are correlated with the clinical course of disease.			Chen, ZB (corresponding author), City Hope Natl Med Ctr, Dept Mol Genet, 1500 E Duarte Rd, Duarte, CA 91010 USA.	ssommer@medomics.com			NATIONAL CANCER INSTITUTE [R33CA094334] Funding Source: NIH RePORTER; NCI NIH HHS [1R33CA94334, R33 CA094334] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bell DW, 2005, NAT GENET, V37, P1315, DOI 10.1038/ng1671; BELLUS GA, 1995, AM J HUM GENET, V56, P368; Bielas JH, 2006, P NATL ACAD SCI USA, V103, P18238, DOI 10.1073/pnas.0607057103; Birim O, 2005, ANN THORAC SURG, V79, P1137, DOI 10.1016/j.athoracsur.2004.09.051; Buettner VL, 1999, ENVIRON MOL MUTAGEN, V33, P320, DOI 10.1002/(SICI)1098-2280(1999)33:4<320::AID-EM9>3.0.CO;2-S; Buzin CH, 2005, HUM MUTAT, V25, P177, DOI 10.1002/humu.20132; Chen Z, 2008, ONCOGENE, V27, P4336, DOI 10.1038/onc.2008.71; Diehl F, 2008, NAT MED, V14, P985, DOI 10.1038/nm.1789; Fleischhacker M, 2007, BBA-REV CANCER, V1775, P181, DOI 10.1016/j.bbcan.2006.10.001; Gormally E, 2007, MUTAT RES-REV MUTAT, V635, P105, DOI 10.1016/j.mrrev.2006.11.002; Greaves M, 2007, NAT REV CANCER, V7, P213, DOI 10.1038/nrc2071; Gu D, 2007, HUM MUTAT, V28, P760, DOI 10.1002/humu.20512; Halangoda A, 2001, ENVIRON MOL MUTAGEN, V37, P311, DOI 10.1002/em.1038; Hartmann A, 1997, TRENDS GENET, V13, P27, DOI 10.1016/S0168-9525(96)10043-3; Hill KA, 2003, MUTAT RES-GEN TOX EN, V534, P173, DOI 10.1016/S1383-5718(02)00277-2; Huse SM, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-7-r143; KOVACH JS, 1991, JNCI-J NATL CANCER I, V83, P1004, DOI 10.1093/jnci/83.14.1004; KWOK S, 1989, NATURE, V339, P237, DOI 10.1038/339237a0; Li M, 2006, NAT METHODS, V3, P95, DOI 10.1038/NMETH850; Liu Q, 2004, BIOTECHNIQUES, V36, P156, DOI 10.2144/04361DD03; Liu Q, 2004, HUM MUTAT, V23, P426, DOI 10.1002/humu.20036; Liu Q, 2002, NUCLEIC ACIDS RES, V30, P598, DOI 10.1093/nar/30.2.598; Liu Q, 2006, BIOTECHNIQUES, V40, P661, DOI 10.2144/000112164; MARTINI N, 1995, J THORAC CARDIOV SUR, V109, P120, DOI 10.1016/S0022-5223(95)70427-2; Mitani Y, 2007, NAT METHODS, V4, P257, DOI 10.1038/NMETH1007; Moloney DM, 1996, NAT GENET, V13, P48, DOI 10.1038/ng0596-48; Pao W, 2007, CLIN CANCER RES, V13, P4954, DOI 10.1158/1078-0432.CCR-07-1387; Parsons BL, 1998, ENVIRON MOL MUTAGEN, V32, P200, DOI 10.1002/(SICI)1098-2280(1998)32:3<200::AID-EM2>3.3.CO;2-F; Port JL, 2003, CHEST, V124, P1828, DOI 10.1378/chest.124.5.1828; SALDIVAR JS, 2006, EGF RECEPTOR TESTING; SARKAR G, 1990, NATURE, V343, P27, DOI 10.1038/343027a0; SARKAR G, 1990, BIOTECHNIQUES, V8, P404; Shi JX, 2007, HUM MUTAT, V28, P131, DOI 10.1002/humu.20423; Shigematsu H, 2006, INT J CANCER, V118, P257, DOI 10.1002/ijc.21496; SOMMER SS, 1994, HUM MUTAT, V3, P166, DOI 10.1002/humu.1380030214; Song WJ, 2008, BIOCHEM BIOPH RES CO, V367, P700, DOI 10.1016/j.bbrc.2007.12.117; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Vineis P, 2006, INT J EPIDEMIOL, V35, P1151, DOI 10.1093/ije/dyl185; Wang JC, 2007, P NATL ACAD SCI USA, V104, P8403, DOI 10.1073/pnas.0610902104; Zheng L, 2007, NAT MED, V13, P812, DOI 10.1038/nm1599	40	36	39	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 28	2009	4	9							e7220	10.1371/journal.pone.0007220	http://dx.doi.org/10.1371/journal.pone.0007220			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HQ	19789704	gold, Green Published, Green Submitted			2022-12-27	WOS:000270290000017
J	Middeldorp, J; van den Berge, SA; Aronica, E; Speijer, D; Hol, EM				Middeldorp, Jinte; van den Berge, Simone A.; Aronica, Eleonora; Speijer, Dave; Hol, Elly M.			Specific Human Astrocyte Subtype Revealed by Affinity Purified GFAP(+1) Antibody; Unpurified Serum CrossReacts with Neurofilament-L in Alzheimer	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; EXPRESSION; TANGLES; DISEASE	The human GFAP splice variants GF Delta PD164 and GF Delta PDexon6 both result in a GFAP protein isoform with a unique out-of-frame carboxy-terminus that can be detected by the GFAP(+1) antibody. We previously reported that GFAP(+1) was expressed in astrocytes and in degenerating neurons in Alzheimer's disease brains. In this study we aimed at further investigating the neuronal GFAP(+1) expression and we started by affinity purifying the GFAP(+1) antibody. The purified antibody resulted in a loss of neuronal GFAP(+1) signal, although other antibodies directed against the amino-and carboxy-terminus of GFAP alpha still revealed GFAP-immunopositive neurons, as described before. With an in-depth analysis of a western blot, followed by mass spectrometry we discovered that the previously detected neuronal GFAP(+1) expression was due to cross-reactivity of the antibody with neurofilament-L (NF-L). This was confirmed by double-label fluorescent immunohistochemistry and western blotting with the unpurified GFAP(+1) antibody and an antibody against NF-L. Our data imply that NF-L can accumulate in some tangle-like structures in Alzheimer brains. More importantly, the purified GFAP(+1) antibody clearly revealed a specific subtype of astrocytes in the adult human brain. These large astrocytes are present throughout the brain, e.g., along the subventricular zone, in the hippocampus, in the striatum and in the spinal cord of controls, Alzheimer, and Parkinson patients. The presence of a specific GFAP-isoform suggests a specialized function of these astrocytes.			Middeldorp, J (corresponding author), Inst Royal Netherlands Acad Arts & Sci, Dept Astrocyte Biol & Neurodegenerat, Netherlands Inst Neurosci, Amsterdam, Netherlands.	e.hol@nin.knaw.nl	Hol, Elly/J-2025-2019; Middeldorp, Jinte/M-2352-2016; Hol, Elly M/F-1891-2013; Speijer, Dave/AAE-4613-2019; , Jinte/AHA-6575-2022	Hol, Elly/0000-0001-5604-2603; Middeldorp, Jinte/0000-0002-9198-8020; Hol, Elly M/0000-0001-5604-2603; Speijer, Dave/0000-0002-2340-2753; , Jinte/0000-0002-9198-8020; van den Berge, Simone/0000-0003-2019-1812; Aronica, Eleonora/0000-0002-3542-3770				BEACH TG, 1989, GLIA, V2, P420, DOI 10.1002/glia.440020605; BIANCHINI D, 1992, BRAIN RES, V570, P209, DOI 10.1016/0006-8993(92)90583-U; Carotti S, 2008, LIVER TRANSPLANT, V14, P806, DOI 10.1002/lt.21436; Hainfellner JA, 2001, J NEUROPATH EXP NEUR, V60, P449, DOI 10.1093/jnen/60.5.449; Hol EM, 2003, MOL PSYCHIATR, V8, P786, DOI 10.1038/sj.mp.4001379; IKEDA K, 1992, J NEUROL, V239, P191, DOI 10.1007/BF00839138; Nakamura Y, 1997, NEUROSCI LETT, V225, P201, DOI 10.1016/S0304-3940(97)00223-1; Oberheim NA, 2006, TRENDS NEUROSCI, V29, P547, DOI 10.1016/j.tins.2006.08.004; Oberheim NA, 2009, J NEUROSCI, V29, P3276, DOI 10.1523/JNEUROSCI.4707-08.2009; OESTREICHER AB, 1983, J NEUROCHEM, V41, P331, DOI 10.1111/j.1471-4159.1983.tb04747.x; Perng MD, 2008, MOL BIOL CELL, V19, P4521, DOI 10.1091/mbc.E08-03-0284; Roelofs RF, 2005, GLIA, V52, P289, DOI 10.1002/glia.20243; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; YAMAGUCHI H, 1991, ACTA NEUROPATHOL, V81, P603, DOI 10.1007/BF00296369	14	20	20	2	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2009	4	11							e7663	10.1371/journal.pone.0007663	http://dx.doi.org/10.1371/journal.pone.0007663			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RZ	19888461	gold, Green Published, Green Submitted			2022-12-27	WOS:000271414600004
J	Gustafsson, A; Bostrom, AK; Ljungberg, B; Axelson, H; Dahlback, B				Gustafsson, Anna; Bostrom, Anna-Karin; Ljungberg, Borje; Axelson, Hakan; Dahlback, Bjorn			Gas6 and the Receptor Tyrosine Kinase Axl in Clear Cell Renal Cell Carcinoma	PLOS ONE			English	Article							ARREST-SPECIFIC GENE-6; K-DEPENDENT PROTEINS; GROWTH-ARREST; DIABETIC-NEPHROPATHY; BREAST-CANCER; EXPRESSION; LINES; HYPERTROPHY; PROGRESSION; FIBROBLASTS	Background: The molecular biology of renal cell carcinoma (RCC) is complex and not fully understood. We have recently found that the expression of the receptor tyrosine kinase Axl in the RCC tumors independently correlates with survival of the patients. Principal Findings: Here, we have investigated the role of Axl and its ligand Gas6, the vitamin-K dependent protein product of the growth arrest-specific gene 6, in clear cell RCC (ccRCC) derived cells. The Axl protein was highly expressed in ccRCC cells deficient in functional von Hippel-Lindau (VHL) protein, a tumor suppressor gene often inactivated in ccRCC. VHL reconstituted cells expressed decreased levels of Axl protein, but not Axl mRNA, suggesting VHL to regulate Axl expression. Gas6-mediated activation of Axl in ccRCC cells resulted in Axl phosphorylation, receptor down-regulation, decreased cell-viability and migratory capacity. No effects of the Gas6/Axl system could be detected on invasion. Moreover, in ccRCC tumor tissues, Axl was phosphorylated and Gas6 c-carboxylated, suggesting these molecules to be active in vivo. Significance: These results provide novel information regarding the complex function of the Gas6/Axl system in ccRCC.			Gustafsson, A (corresponding author), Lund Univ, Malmo Univ Hosp, Dept Lab Med, Sect Clin Chem, Malmo, Sweden.	bjorn.dahlback@med.lu.se		Dahlback, Bjorn/0000-0003-1546-0328; Ljungberg, Borje/0000-0002-4121-3753				Allen MP, 2002, MOL CELL BIOL, V22, P599, DOI 10.1128/MCB.22.2.599-613.2002; Angelillo-Scherrer A, 2001, NAT MED, V7, P215, DOI 10.1038/84667; Arai H, 2008, VITAM HORM, V78, P375, DOI 10.1016/S0083-6729(07)00015-5; Bellido-Martin L, 2008, VITAM HORM, V78, P185, DOI 10.1016/S0083-6729(07)00009-X; BELLOSTA P, 1995, MOL CELL BIOL, V15, P614; Berclaz G, 2001, ANN ONCOL, V12, P819, DOI 10.1023/A:1011126330233; Brown MA, 2000, J BIOL CHEM, V275, P19795, DOI 10.1074/jbc.M002298200; Budagian V, 2005, EMBO J, V24, P4260, DOI 10.1038/sj.emboj.7600874; Cohen HT, 2005, NEW ENGL J MED, V353, P2477, DOI 10.1056/NEJMra043172; CRAVEN RJ, 1995, INT J CANCER, V60, P791, DOI 10.1002/ijc.2910600611; EBERT T, 1990, CANCER RES, V50, P5531; Evenas P, 2000, THROMB HAEMOSTASIS, V84, P271, DOI 10.1055/s-0037-1614007; Fiebeler A, 2004, AM J KIDNEY DIS, V43, P286, DOI 10.1053/j.ajkd.2003.10.016; Fogh J, 1978, Natl Cancer Inst Monogr, P5; Fridell YWC, 1998, J BIOL CHEM, V273, P7123, DOI 10.1074/jbc.273.12.7123; Gallicchio M, 2005, BLOOD, V105, P1970, DOI 10.1182/blood-2004-04-1469; Goruppi S, 1996, ONCOGENE, V12, P471; GUSTAFSSON A, 2009, CLIN CANC RES, V15; Hafizi S, 2006, FEBS J, V273, P5231, DOI 10.1111/j.1742-4658.2006.05529.x; Hafizi S, 2006, CYTOKINE GROWTH F R, V17, P295, DOI 10.1016/j.cytogfr.2006.04.004; Hasanbasic I, 2005, J THROMB HAEMOST, V3, P2790, DOI 10.1111/j.1538-7836.2005.01662.x; Holland SJ, 2005, CANCER RES, V65, P9294, DOI 10.1158/0008-5472.CAN-05-0993; Hu CJ, 2003, MOL CELL BIOL, V23, P9361, DOI 10.1128/MCB.23.24.9361-9374.2003; Hutterer M, 2008, CLIN CANCER RES, V14, P130, DOI 10.1158/1078-0432.CCR-07-0862; ILIOPOULOS O, 1995, NAT MED, V1, P822, DOI 10.1038/nm0895-822; Ito T, 1999, THYROID, V9, P563, DOI 10.1089/thy.1999.9.563; JANSSEN JWG, 1991, ONCOGENE, V6, P2113; Linger RMA, 2008, ADV CANCER RES, V100, P35, DOI 10.1016/S0065-230X(08)00002-X; Ljungberg B, 2007, EUR UROL, V51, P1502, DOI 10.1016/j.eururo.2007.03.035; MANFIOLETTI G, 1993, MOL CELL BIOL, V13, P4976, DOI 10.1128/MCB.13.8.4976; Maxwell PH, 1999, NATURE, V399, P271, DOI 10.1038/20459; Mc Cormack O, 2008, BRIT J CANCER, V98, P1141, DOI 10.1038/sj.bjc.6604260; Nagai K, 2005, KIDNEY INT, V68, P552, DOI 10.1111/j.1523-1755.2005.00433.x; Nagai K, 2003, J BIOL CHEM, V278, P18229, DOI 10.1074/jbc.M213266200; Nielsen-Preiss SM, 2007, ENDOCRINOLOGY, V148, P2806, DOI 10.1210/en.2007-0039; OBRYAN JP, 1995, J BIOL CHEM, V270, P551, DOI 10.1074/jbc.270.2.551; OBRYAN JP, 1991, MOL CELL BIOL, V11, P5016, DOI 10.1128/MCB.11.10.5016; QUONG RYY, 1994, MELANOMA RES, V4, P313, DOI 10.1097/00008390-199410000-00008; Robinson DR, 2000, ONCOGENE, V19, P5548, DOI 10.1038/sj.onc.1203957; Sawabu T, 2007, MOL CARCINOGEN, V46, P155, DOI 10.1002/mc.20211; Schlessinger J, 2000, CELL, V103, P211, DOI 10.1016/j.cell.2010.06.011; Shieh YS, 2005, NEOPLASIA, V7, P1058, DOI 10.1593/neo.05640; SKINNER DG, 1971, CANCER-AM CANCER SOC, V28, P1165, DOI 10.1002/1097-0142(1971)28:5<1165::AID-CNCR2820280513>3.0.CO;2-G; Sobin LH, 2002, INT UNION CANC UICC, P193; Stenhoff J, 2004, BIOCHEM BIOPH RES CO, V319, P871, DOI 10.1016/j.bbrc.2004.05.070; Sun WS, 2004, ONCOLOGY-BASEL, V66, P450, DOI 10.1159/000079499; Tai KY, 2008, ONCOGENE, V27, P4044, DOI 10.1038/onc.2008.57; Vajkoczy P, 2006, P NATL ACAD SCI USA, V103, P5799, DOI 10.1073/pnas.0510923103; VARNUM BC, 1995, NATURE, V373, P623, DOI 10.1038/373623a0; WILLIAMS RD, 1978, IN VITRO CELL DEV B, V14, P779, DOI 10.1007/BF02617972; Wimmel A, 2001, EUR J CANCER, V37, P2264, DOI 10.1016/S0959-8049(01)00271-4; Yanagita M, 2002, J CLIN INVEST, V110, P239, DOI 10.1172/JCI200214861; Yanagita M, 2001, AM J PATHOL, V158, P1423, DOI 10.1016/S0002-9440(10)64093-X; Zhang YX, 2008, CANCER RES, V68, P1905, DOI 10.1158/0008-5472.CAN-07-2661	54	38	38	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2009	4	10							e7575	10.1371/journal.pone.0007575	http://dx.doi.org/10.1371/journal.pone.0007575			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RW	19888345	gold, Green Published, Green Submitted			2022-12-27	WOS:000271414300003
J	Lim, JH; Davis, GE; Wang, ZS; Li, V; Wu, YP; Rue, TC; Storm, DR				Lim, Jae H.; Davis, Greg E.; Wang, Zhenshan; Li, Vicky; Wu, Yuping; Rue, Tessa C.; Storm, Daniel R.			Zicam-Induced Damage to Mouse and Human Nasal Tissue	PLOS ONE			English	Article							OLFACTORY EPITHELIUM; INTRANASAL ZINC; NEURONAL DEATH; COMMON-COLD; ANOSMIA; IRRIGATION; ZNSO4; MICE	Intranasal medications are used to treat various nasal disorders. However, their effects on olfaction remain unknown. Zicam (zinc gluconate; Matrixx Initiatives, Inc), a homeopathic substance marketed to alleviate cold symptoms, has been implicated in olfactory dysfunction. Here, we investigated Zicam and several common intranasal agents for their effects on olfactory function. Zicam was the only substance that showed significant cytotoxicity in both mouse and human nasal tissue. Specifically, Zicam-treated mice had disrupted sensitivity of olfactory sensory neurons to odorant stimulation and were unable to detect novel odorants in behavioral testing. These findings were long-term as no recovery of function was observed after two months. Finally, human nasal explants treated with Zicam displayed significantly elevated extracellular lactate dehydrogenase levels compared to saline-treated controls, suggesting severe necrosis that was confirmed on histology. Our results demonstrate that Zicam use could irreversibly damage mouse and human nasal tissue and may lead to significant smell dysfunction.			Lim, JH (corresponding author), Univ Washington, Dept Otolaryngol Head & Neck Surg, Seattle, WA 98195 USA.	dstorm@u.washington.edu	wu, Yuping/B-5104-2012		NATIONAL CENTER FOR RESEARCH RESOURCES [KL2RR025015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS [R01DC004156, T32DC000018] Funding Source: NIH RePORTER	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DEAFNESS AND OTHER COMMUNICATION DISORDERS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD))		Alexander TH, 2006, LARYNGOSCOPE, V116, P217, DOI 10.1097/01.mlg.0000191549.17796.13; Angell M, 1998, NEW ENGL J MED, V339, P839, DOI 10.1056/NEJM199809173391210; BURD GD, 1993, MICROSC RES TECHNIQ, V24, P195, DOI 10.1002/jemt.1070240302; Calof AL, 1996, J NEUROBIOL, V30, P67; Capasso M, 2005, J ALZHEIMERS DIS, V8, P93; Chen CJ, 2003, J NEUROCHEM, V85, P443, DOI 10.1046/j.1471-4159.2003.01691.x; Doty RL, 2009, SEMIN NEUROL, V29, P74, DOI 10.1055/s-0028-1124025; Eby GA, 2006, ALTERN THER HEALTH M, V12, P34; Feron F, 1998, ARCH OTOLARYNGOL, V124, P861, DOI 10.1001/archotol.124.8.861; HARDING JW, 1978, BRAIN RES, V140, P271, DOI 10.1016/0006-8993(78)90460-2; Henion TR, 2007, J CELL PHYSIOL, V210, P290, DOI 10.1002/jcp.20888; Holbrook Eric H, 2006, Curr Opin Otolaryngol Head Neck Surg, V14, P23, DOI 10.1097/01.moo.0000193174.77321.39; Jafek BW, 2004, AM J RHINOL, V18, P137, DOI 10.1177/194589240401800302; Jones LM, 2006, CURR OPIN NEUROBIOL, V16, P420, DOI 10.1016/j.conb.2006.06.011; Kim EY, 1999, EUR J NEUROSCI, V11, P327, DOI 10.1046/j.1460-9568.1999.00437.x; Leopold Donald A, 2002, J Otolaryngol, V31 Suppl 1, pS18, DOI 10.2310/7070.2002.21263; Lund Valerie J., 1993, Rhinology (Utrecht), V31, P183; Manev H, 1997, EXP NEUROL, V146, P171, DOI 10.1006/exnr.1997.6510; MATULIONIS DH, 1975, AM J ANAT, V142, P67, DOI 10.1002/aja.1001420106; McBride K, 2003, CHEM SENSES, V28, P659, DOI 10.1093/chemse/bjg053; Mossad SB, 2003, QJM-INT J MED, V96, P35, DOI 10.1093/qjmed/hcg004; Pavlica S, 2009, TOXICOL IN VITRO, V23, P653, DOI 10.1016/j.tiv.2009.03.003; Piccirillo JF, 2002, OTOLARYNG HEAD NECK, V126, P41, DOI 10.1067/mhn.2002.121022; Sheline CT, 2000, J NEUROSCI, V20, P3139, DOI 10.1523/JNEUROSCI.20-09-03139.2000; Simon SA, 2006, NAT REV NEUROSCI, V7, P890, DOI 10.1038/nrn2006; Slotnick B, 2007, LARYNGOSCOPE, V117, P743, DOI 10.1097/MLG.0b013e318033006b; Trinh K, 2003, NAT NEUROSCI, V6, P519, DOI 10.1038/nn1039; Widdicombe J, 1997, ALLERGY, V52, P7, DOI 10.1111/j.1398-9995.1997.tb04877.x; WIDDICOMBE JG, 1986, CLIN CHEST MED, V7, P159; Wong ST, 2000, NEURON, V27, P487, DOI 10.1016/S0896-6273(00)00060-X	30	24	24	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2009	4	10							e7647	10.1371/journal.pone.0007647	http://dx.doi.org/10.1371/journal.pone.0007647			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RW	19876403	Green Submitted, Green Published, gold			2022-12-27	WOS:000271414300008
J	Lell, B; Agnandji, S; von Glasenapp, I; Haertle, S; Oyakhiromen, S; Issifou, S; Vekemans, J; Leach, A; Lievens, M; Dubois, MC; Demoitie, MA; Carter, T; Villafana, T; Ballou, WR; Cohen, J; Kremsner, PG				Lell, Bertrand; Agnandji, Selidji; von Glasenapp, Isabelle; Haertle, Sonja; Oyakhiromen, Sunny; Issifou, Saadou; Vekemans, Johan; Leach, Amanda; Lievens, Marc; Dubois, Marie-Claude; Demoitie, Marie-Ange; Carter, Terrell; Villafana, Tonya; Ballou, W. Ripley; Cohen, Joe; Kremsner, Peter G.			A Randomized Trial Assessing the Safety and Immunogenicity of AS01 and AS02 Adjuvanted RTS,S Malaria Vaccine Candidates in Children in Gabon	PLOS ONE			English	Article							PLASMODIUM-FALCIPARUM INFECTION; PHASE 2A TRIAL; DOUBLE-BLIND; NAIVE ADULTS; RTS,S/AS02A; EFFICACY; FORMULATIONS; IMMUNIZATION; MOZAMBIQUE; PROTECTION	Background: The malaria vaccine candidate antigen RTS, S includes parts of the pre-erythrocytic stage circumsporozoite protein fused to the Hepatitis B surface antigen. Two Adjuvant Systems are in development for this vaccine, an oil-in water emulsion - based formulation (AS02) and a formulation based on liposomes (AS01). Methods & Principal Findings: In this Phase II, double-blind study (NCT00307021), 180 healthy Gabonese children aged 18 months to 4 years were randomized to receive either RTS, S/AS01(E) or RTS, S/AS02(D), on a 0-1-2 month vaccination schedule. The children were followed-up daily for six days after each vaccination and monthly for 14 months. Blood samples were collected at 4 time-points. Both vaccines were well tolerated. Safety parameters were distributed similarly between the two groups. Both vaccines elicited a strong specific immune response after Doses 2 and 3 with a ratio of anti-CS GMT titers (AS02(D)/AS01(E)) of 0.88 (95% CI: 0.68-1.15) post-Dose 3. After Doses 2 and 3 of experimental vaccines, anti-CS and anti-HBs antibody GMTs were higher in children who had been previously vaccinated with at least one dose of hepatitis B vaccine compared to those not previously vaccinated. Conclusions: RTS, S/AS01(E) proved similarly as well tolerated and immunogenic as RTS, S/AS02(D), completing an essential step in the age de-escalation process within the RTS, S clinical development plan. Trial Registration: ClinicalTrials.gov.NCT00307021			Lell, B (corresponding author), Albert Schweitzer Hosp, Med Res Unit, Lambarene, Gabon.	bertrand.lell@uni-tuebingen.de	Leach, Amanda/AAS-1120-2020	Leach, Amanda/0000-0002-7114-9967				Alonso PL, 2005, LANCET, V366, P2012, DOI 10.1016/S0140-6736(05)67669-6; Alonso PL, 2004, LANCET, V364, P1411, DOI 10.1016/S0140-6736(04)17223-1; Aponte JJ, 2007, LANCET, V370, P1543, DOI 10.1016/S0140-6736(07)61542-6; Bojang KA, 2001, LANCET, V358, P1927, DOI 10.1016/S0140-6736(01)06957-4; Bonhoeffer J, 2004, VACCINE, V22, P557, DOI 10.1016/j.vaccine.2003.09.008; Breman JG, 2004, AM J TROP MED HYG, V71, P1; Doherty JF, 1999, AM J TROP MED HYG, V61, P865, DOI 10.4269/ajtmh.1999.61.865; Girard MP, 2007, VACCINE, V25, P1567, DOI 10.1016/j.vaccine.2006.09.074; Goesch JN, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-60; Grobusch MP, 2007, J INFECT DIS, V196, P1595, DOI 10.1086/522160; Kester KE, 2008, VACCINE, V26, P2191, DOI 10.1016/j.vaccine.2008.02.048; Kester KE, 2007, VACCINE, V25, P5359, DOI 10.1016/j.vaccine.2007.05.005; Kester KE, 2009, J INFECT DIS, V200, P337, DOI 10.1086/600120; Lell B, 1999, CLIN INFECT DIS, V28, P794, DOI 10.1086/515193; Macete E, 2007, TROP MED INT HEALTH, V12, P37, DOI 10.1111/j.1365-3156.2006.01754.x; Macete EV, 2007, TRIALS, V8, DOI 10.1186/1745-6215-8-11; Malkin E, 2006, TRENDS PARASITOL, V22, P292, DOI 10.1016/j.pt.2006.05.002; Pichichero ME, 1996, DRUG SAFETY, V15, P311, DOI 10.2165/00002018-199615050-00002; Polhemus ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006465; Sachs J, 2002, NATURE, V415, P680, DOI 10.1038/415680a; Stewart VA, 2006, VACCINE, V24, P6483, DOI 10.1016/j.vaccine.2006.06.033; Stoute JA, 1998, J INFECT DIS, V178, P1139, DOI 10.1086/515657; Sylla EHK, 2001, PARASITOL RES, V87, P530, DOI 10.1007/s004360100407; *UN POP FUND, 2001, ENQ DEM SANT GAB 200; WILDLING E, 1995, TROP MED PARASITOL, V46, P77	25	58	63	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7611	10.1371/journal.pone.0007611	http://dx.doi.org/10.1371/journal.pone.0007611			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859560	gold, Green Submitted, Green Published			2022-12-27	WOS:000271147400013
J	Sharma, AK; Ali, A; Gogna, R; Singh, AK; Pati, U				Sharma, Anuj Kumar; Ali, Amjad; Gogna, Rajan; Singh, Amir Kumar; Pati, Uttam			p53 Amino-Terminus Region (1-125) Stabilizes and Restores Heat Denatured p53 Wild Phenotype	PLOS ONE			English	Article							TUMOR-SUPPRESSOR PROTEIN; PROLINE-RICH DOMAIN; DNA-BINDING; MUTANT P53; TRANSACTIVATION DOMAIN; MOLECULAR CHAPERONE; CONFORMATIONAL PHENOTYPE; GROWTH SUPPRESSION; CANCER-CELLS; N-TERMINUS	Background: The intrinsically disordered N-ter domain (NTD) of p53 encompasses approximately hundred amino acids that contain a transactivation domain (1-73) and a proline-rich domain (64-92) and is responsible for transactivation function and apoptosis. It also possesses an auto-inhibitory function as its removal results in remarkable reduction in dissociation of p53 from DNA. Principal Findings/Methodology: In this report, we have discovered that p53-NTD spanning amino acid residues 1-125 (NTD125) interacted with WT p53 and stabilized its wild type conformation under physiological and elevated temperatures, both in vitro and in cellular systems. NTD125 prevented irreversible thermal aggregation of heat denatured p53, enhanced p21-5'-DBS binding and further restored DBS binding activity of heat-denatured p53, in vitro, in a dose-dependent manner. In vivo ELISA and immunoprecipitation analysis of NTD125-transfected cells revealed that NTD125 shifted equilibrium from p53 mutant to wild type under heat stress conditions. Further, NTD125 initiated nuclear translocation of cytoplasmic p53 in transcriptionally active state in order to activate p53 downstream genes such as p21, Bax, PUMA, Noxa and SUMO. Conclusion/Significance: Here, we showed that a novel chaperone-like activity resides in p53-N-ter region. This study might have significance in understanding the role of p53-NTD in p53 stabilization, conformational activation and apoptosis under heat-stress conditions.			Sharma, AK (corresponding author), Jawaharlal Nehru Univ, Transcript & Human Biol Lab, Sch Biotechnol, New Delhi 110067, India.	uttam@mail.jnu.ac.in	Sharma, Anuj/G-3043-2011; Pati, Uttam/L-9345-2019	Sharma, Anuj/0000-0001-5061-9731; GOGNA, RAJAN/0000-0001-7304-7692; SINGH, Amir/0000-0003-2814-2759				Baptiste N, 2002, ONCOGENE, V21, P9, DOI 10.1038/sj/onc/1205015; Bell S, 2002, J MOL BIOL, V322, P917, DOI 10.1016/S0022-2836(02)00848-3; Beretta GL, 2008, MINI-REV MED CHEM, V8, P856, DOI 10.2174/138955708785132774; Bhattacharyya J, 1999, J BIOL CHEM, V274, P15505, DOI 10.1074/jbc.274.22.15505; Bochkareva E, 2005, P NATL ACAD SCI USA, V102, P15412, DOI 10.1073/pnas.0504614102; Bykov VJN, 2005, J BIOL CHEM, V280, P30384, DOI 10.1074/jbc.M501664200; Bykov VJN, 2003, EUR J CANCER, V39, P1828, DOI 10.1016/S0959-8049(03)00454-4; Cain C, 2000, J BIOL CHEM, V275, P39944, DOI 10.1074/jbc.M002509200; Courtois S, 2002, ONCOGENE, V21, P6722, DOI 10.1038/sj.onc.1205874; Cregan SP, 2004, J NEUROSCI, V24, P10003, DOI 10.1523/JNEUROSCI.2114-04.2004; Dawson R, 2003, J MOL BIOL, V332, P1131, DOI 10.1016/j.jmb.2003.08.008; Di Lello P, 2006, MOL CELL, V22, P731, DOI 10.1016/j.molcel.2006.05.007; Dunker AK, 2007, STRUCTURE, V15, P1026, DOI 10.1016/j.str.2007.08.001; FIELDS S, 1990, SCIENCE, V249, P1046, DOI 10.1126/science.2144363; Friedler A, 2002, P NATL ACAD SCI USA, V99, P937, DOI 10.1073/pnas.241629998; Gaitonde SV, 2000, ONCOGENE, V19, P4042, DOI 10.1038/sj.onc.1203756; Greenfield NJ, 2006, NAT PROTOC, V1, P2876, DOI 10.1038/nprot.2006.202; Hansen S, 1996, J BIOL CHEM, V271, P3917; Hansen S, 1998, J MOL BIOL, V275, P575, DOI 10.1006/jmbi.1997.1507; Hegyi H, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000017; HUPP TR, 1992, CELL, V71, P875, DOI 10.1016/0092-8674(92)90562-Q; Issaeva N, 2003, P NATL ACAD SCI USA, V100, P13303, DOI 10.1073/pnas.1835733100; Joerger AC, 2008, ANNU REV BIOCHEM, V77, P557, DOI 10.1146/annurev.biochem.77.060806.091238; Kim AL, 1999, J BIOL CHEM, V274, P34924, DOI 10.1074/jbc.274.49.34924; Kussie PH, 1996, SCIENCE, V274, P948, DOI 10.1126/science.274.5289.948; Ma BY, 2000, PROTEIN ENG, V13, P617, DOI 10.1093/protein/13.9.617; Matas D, 2001, EMBO J, V20, P4163, DOI 10.1093/emboj/20.15.4163; Matsumoto S, 2002, J BIOL CHEM, V277, P34959, DOI 10.1074/jbc.M203038200; MILNER J, 1990, ONCOGENE, V5, P1683; Muller-Tiemann BF, 1998, P NATL ACAD SCI USA, V95, P6079, DOI 10.1073/pnas.95.11.6079; Okorokov AL, 2006, EMBO J, V25, P5191, DOI 10.1038/sj.emboj.7601382; Park SM, 2002, J BIOL CHEM, V277, P28512, DOI 10.1074/jbc.M111971200; Protopopova M, 2003, CELL CYCLE, V2, P592, DOI 10.4161/cc.2.6.501; Roth J, 2000, ONCOGENE, V19, P1834, DOI 10.1038/sj.onc.1203500; RYAN JJ, 1994, LEUKEMIA RES, V18, P617, DOI 10.1016/0145-2126(94)90043-4; Sabapathy K, 1997, EMBO J, V16, P6217, DOI 10.1093/emboj/16.20.6217; Sakamuro D, 1997, ONCOGENE, V15, P887, DOI 10.1038/sj.onc.1201263; Selivanova G, 1997, NAT MED, V3, P632, DOI 10.1038/nm0697-632; Seo YR, 2002, P NATL ACAD SCI USA, V99, P14548, DOI 10.1073/pnas.212319799; Toledo F, 2007, MOL CELL BIOL, V27, P1425, DOI 10.1128/MCB.00999-06; Tompa P, 2004, FASEB J, V18, P1169, DOI 10.1096/fj.04-1584rev; Tripathi V, 2007, J BIOL CHEM, V282, P28441, DOI 10.1074/jbc.M703698200; Uesugi M, 1999, P NATL ACAD SCI USA, V96, P14801, DOI 10.1073/pnas.96.26.14801; Walerych D, 2004, J BIOL CHEM, V279, P48836, DOI 10.1074/jbc.M407601200; Wawrzynow B, 2007, J BIOL CHEM, V282, P32603, DOI 10.1074/jbc.M702767200; Xirodimas DP, 1999, J BIOL CHEM, V274, P28042, DOI 10.1074/jbc.274.39.28042; ZERRAHN J, 1992, ONCOGENE, V7, P1371; Zhu JH, 2000, J BIOL CHEM, V275, P39927, DOI 10.1074/jbc.M005676200; Zylicz M, 2001, EMBO J, V20, P4634, DOI 10.1093/emboj/20.17.4634	49	11	11	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7159	10.1371/journal.pone.0007159	http://dx.doi.org/10.1371/journal.pone.0007159			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847292	gold, Green Submitted, Green Published			2022-12-27	WOS:000271022000003
J	Le Hellard, S; Havik, B; Espeseth, T; Breilid, H; Lovlie, R; Luciano, M; Gow, AJ; Harris, SE; Starr, JM; Wibrand, K; Lundervold, AJ; Porteous, DJ; Bramham, CR; Deary, IJ; Reinvang, I; Steen, VM				Le Hellard, Stephanie; Havik, Bjarte; Espeseth, Thomas; Breilid, Harald; Lovlie, Roger; Luciano, Michelle; Gow, Alan J.; Harris, Sarah E.; Starr, John M.; Wibrand, Karin; Lundervold, Astri J.; Porteous, David J.; Bramham, Clive R.; Deary, Ian J.; Reinvang, Ivar; Steen, Vidar M.			Variants in Doublecortin- and Calmodulin Kinase Like 1, a Gene Up-Regulated by BDNF, Are Associated with Memory and General Cognitive Abilities	PLOS ONE			English	Article							CONVERGENT FUNCTIONAL GENOMICS; LONG-TERM POTENTIATION; COPY-NUMBER VARIATION; BIPOLAR-DISORDER; HIPPOCAMPAL ACTIVITY; SYNAPTIC PLASTICITY; EPISODIC MEMORY; CANDIDATE GENES; PROTEIN-KINASE; IDENTIFICATION	Background: Human memory and general cognitive abilities are complex functions of high heritability and wide variability in the population. The brain-derived neurotrophic factor (BDNF) plays an important role in mammalian memory formation. Methodology / Principal Finding: Based on the identification of genes markedly up-regulated during BDNF-induced synaptic consolidation in the hippocampus, we selected genetic variants that were tested in three independent samples, from Norway and Scotland, of adult individuals examined for cognitive abilities. In all samples, we show that markers in the doublecortin-and calmodulin kinase like 1 (DCLK1) gene, are significantly associated with general cognition (IQ scores) and verbal memory function, resisting multiple testing. DCLK1 is a complex gene with multiple transcripts which vary in expression and function. We show that the short variants are all up-regulated after BDNF treatment in the rat hippocampus, and that they are expressed in the adult human brain (mostly in cortices and hippocampus). We demonstrate that several of the associated variants are located in potential alternative promoter-and cis-regulatory elements of the gene and that they affect BDNF-mediated expression of short DCLK1 transcripts in a reporter system. Conclusion: These data present DCLK1 as a functionally pertinent gene involved in human memory and cognitive functions.			Le Hellard, S (corresponding author), Univ Bergen, Dept Clin Med, Bergen Mental Hlth Res Ctr, Bergen, Norway.	stephanie.hellard@med.uib.no	Lundervold, Astri/AAH-9796-2021; Deary, Ian J/C-6297-2009; Gow, Alan J/A-6070-2009; Porteous, David J/C-7289-2013; Porteous, David/AAA-3446-2021; Starr, John/C-8951-2011; Luciano, Michelle/F-7277-2010; Bramham, Clive/Q-1854-2018	Lundervold, Astri/0000-0002-6819-6164; Deary, Ian J/0000-0002-1733-263X; Gow, Alan J/0000-0002-3320-4531; Porteous, David J/0000-0003-1249-6106; Porteous, David/0000-0003-1249-6106; Luciano, Michelle/0000-0003-0935-7682; Bramham, Clive/0000-0001-5958-7115; Le Hellard, Stephanie/0000-0002-8085-051X	Medical Research Council [G0700704B, G9900991B] Funding Source: researchfish; Medical Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline; Chief Scientist Office [CZB/4/505, ETM/55] Funding Source: Medline	Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust); Chief Scientist Office		Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Aukes MF, 2009, BIOL PSYCHIAT, V65, P527, DOI 10.1016/j.biopsych.2008.09.020; Bramham CR, 2008, J NEUROSCI, V28, P11760, DOI 10.1523/JNEUROSCI.3864-08.2008; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Burgess HA, 2002, J BIOL CHEM, V277, P17696, DOI 10.1074/jbc.M111981200; Christoforou A, 2007, MOL PSYCHIATR, V12, P1011, DOI 10.1038/sj.mp.4002003; Craddock N, 2009, TRENDS GENET, V25, P99, DOI 10.1016/j.tig.2008.12.002; de Quervain DJF, 2006, P NATL ACAD SCI USA, V103, P4270, DOI 10.1073/pnas.0510212103; de Smith AJ, 2007, HUM MOL GENET, V16, P2783, DOI 10.1093/hmg/ddm208; Deary Ian J, 2007, BMC Geriatr, V7, P28, DOI 10.1186/1471-2318-7-28; Deary IJ, 2004, J PERS SOC PSYCHOL, V86, P130, DOI 10.1037/0022-3514.86.1.130; Deary IJ, 2001, TRENDS COGN SCI, V5, P127, DOI 10.1016/S1364-6613(00)01621-1; Delis DC, 2000, CALIFORNIA VERBAL LE, DOI DOI 10.1016/j.schres.2003.09.011; Dempster E, 2005, AM J MED GENET B, V134B, P73, DOI 10.1002/ajmg.b.30150; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Engels BM, 2004, MOL BRAIN RES, V120, P103, DOI 10.1016/j.molbrainres.2003.10.006; Espeseth T, 2006, COGN AFFECT BEHAV NE, V6, P31, DOI 10.3758/CABN.6.1.31; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Glahn DC, 2004, BIPOLAR DISORD, V6, P171, DOI 10.1111/j.1399-5618.2004.00113.x; Goldberg TE, 2004, TRENDS COGN SCI, V8, P325, DOI 10.1016/j.tics.2004.05.011; GORDON D, 2004, CURRENT PROTOCOLS BI; Gottesman II, 2003, AM J PSYCHIAT, V160, P636, DOI 10.1176/appi.ajp.160.4.636; Green AE, 2008, NAT REV NEUROSCI, V9, P710, DOI 10.1038/nrn2461; Gur RE, 2007, SCHIZOPHRENIA BULL, V33, P49, DOI 10.1093/schbul/sbl055; Hariri AR, 2003, J NEUROSCI, V23, P6690, DOI 10.1523/jneurosci.23-17-06690.2003; Harris SE, 2006, MOL PSYCHIATR, V11, P505, DOI 10.1038/sj.mp.4001799; Hill SK, 2008, SCHIZOPHRENIA BULL, V34, P743, DOI 10.1093/schbul/sbn027; Holback S, 2005, J NEUROCHEM, V95, P1059, DOI 10.1111/j.1471-4159.2005.03440.x; Huentelman MJ, 2007, HUM MOL GENET, V16, P1469, DOI 10.1093/hmg/ddm097; Iafrate AJ, 2004, NAT GENET, V36, P949, DOI 10.1038/ng1416; Jakobsson M, 2008, NATURE, V451, P998, DOI 10.1038/nature06742; Kandel ER, 2007, SEARCH MEMORY EMERGE; Kovas Y, 2006, TRENDS COGN SCI, V10, P198, DOI 10.1016/j.tics.2006.03.001; Le Hellard S, 2009, MOL PSYCHIATR, V14, P308, DOI 10.1038/sj.mp.4002133; Le-Niculescu H, 2007, NEUROSCI BIOBEHAV R, V31, P897, DOI 10.1016/j.neubiorev.2007.05.008; Le-Niculescu H, 2007, AM J MED GENET B, V144B, P129, DOI 10.1002/ajmg.b.30481; Le-Niculescu H, 2009, AM J MED GENET B, V150B, P155, DOI 10.1002/ajmg.b.30887; LEHELLARD S, 2008, MOL PSYCHIATR, DOI DOI 10.1038/MP.2008.1110; Lezak MD, 1995, NEUROPSYCHOLOGICAL T; Lin PT, 2000, J NEUROSCI, V20, P9152; Messaoudi E, 2007, J NEUROSCI, V27, P10445, DOI 10.1523/JNEUROSCI.2883-07.2007; Ogden CA, 2004, MOL PSYCHIATR, V9, P1007, DOI 10.1038/sj.mp.4001547; PETRYSHEN TL, 2009, MOL PSYCHIATR, DOI DOI 10.1038/MP.2009.1024; Plath N, 2006, NEURON, V52, P437, DOI 10.1016/j.neuron.2006.08.024; Purcell S, 2003, BIOINFORMATICS, V19, P149, DOI 10.1093/bioinformatics/19.1.149; Raven JC, 1977, MANUAL RAVENS PROGR; Rozen S, 2000, Methods Mol Biol, V132, P365; Schenk GJ, 2007, EUR J NEUROSCI, V26, P3411, DOI 10.1111/j.1460-9568.2007.05956.x; Scottish Council for Research in Education, 1949, TREND SCOTT INT COMP; Silverman MA, 1999, J BIOL CHEM, V274, P2631, DOI 10.1074/jbc.274.5.2631; Sossey-Alaoui K, 1999, GENOMICS, V56, P121, DOI 10.1006/geno.1998.5718; Tan YL, 2005, SCHIZOPHR RES, V77, P355, DOI 10.1016/j.schres.2005.03.012; Tanaka T, 2006, CEREB CORTEX, V16, pI69, DOI 10.1093/cercor/bhk005; Terracciano A, 2010, MOL PSYCHIATR, V15, P647, DOI 10.1038/mp.2008.113; Vreugdenhil E, 2001, EUR NEUROPSYCHOPHARM, V11, P423, DOI 10.1016/S0924-977X(01)00119-5; Vreugdenhil E, 2007, EUR J NEUROSCI, V25, P635, DOI 10.1111/j.1460-9568.2007.05318.x; Weschler D., 1999, WESCHLER ABBREVIATED; Weschler D, 1987, WESCHLER MEMORY SCAL; WESCHLER D, 1998, WMS IIIUK ADM SCORIN; Wibrand K, 2006, EUR J NEUROSCI, V23, P1501, DOI 10.1111/j.1460-9568.2006.04687.x; ZIGMOND SH, 1993, CELL MOTIL CYTOSKEL, V25, P309, DOI 10.1002/cm.970250402	61	28	32	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7534	10.1371/journal.pone.0007534	http://dx.doi.org/10.1371/journal.pone.0007534			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844571	gold, Green Published, Green Submitted			2022-12-27	WOS:000271013000012
J	Rudi, K; Odegard, K; Lokken, TT; Wilson, R				Rudi, Knut; Odegard, Kristin; Lokken, Tine Therese; Wilson, Robert			A Feeding Induced Switch from a Variable to a Homogenous State of the Earthworm Gut Microbiota within a Host Population	PLOS ONE			English	Article							SOIL; COMMUNITIES; BACTERIA; LUMBRICIDAE; HABITAT; CASTS	Background: The distribution pattern of the earthworm gut microbiota at the host population level is of fundamental importance to understand host-microbiota interactions. Our current understanding of these interactions is very limited. Since feeding represents a main perturbation of the gut microbiota, we determined the effect of a single dose of feed on the microbiota associated with an earthworm population in a simulated microenvironment. Methodology: Earthworms were sampled 0, 1 and 7 days after feeding. We determined the overall composition of the earthworm-associated microbiota by 16S rRNA gene cloning and sequencing. Based on the 16S rRNA gene data we constructed quantitative PCR's (Q-PCR) for the seven most dominating bacterial groups. Principal Findings: Q-PCR revealed low density and highly variable microbiota among the earthworms before feeding, while a high-density homologous microbiota resulted from feeding. We found that the microbiota 1 day after feeding was more equal to the microbiota after 7 days than before feeding. Furthermore, we found that the gut microbiota was very distinct from that of the bedding and the feed. Significance: The homogenous population response represents fundamental new knowledge about earthworm gut associated bacteria.			Rudi, K (corresponding author), Hedmark Univ Coll, Hamar, Norway.	knut.rudi@hihm.no	Rudi, Knut/AAZ-9858-2020					Berget I, 2008, COMPUT STAT DATA AN, V52, P2403, DOI 10.1016/j.csda.2007.10.020; Bjornstad A, 2004, HEREDITAS, V141, P149, DOI 10.1111/j.1601-5223.2004.01816.x; BOUCHE MB, 1983, REV ECOL BIOL SOL, V20, P49; Cole JR, 2005, NUCLEIC ACIDS RES, V33, pD294, DOI 10.1093/nar/gki038; COOPER EL, 2005, IMMUNOL LETT; Curry JP, 2007, PEDOBIOLOGIA, V50, P463, DOI 10.1016/j.pedobi.2006.09.001; Darwin C, 1881, FORMATION VEGETABLE, DOI DOI 10.1017/CBO9780511703850; Davidson SK, 2008, ISME J, V2, P510, DOI 10.1038/ismej.2008.16; DEANGELIS DL, 1987, ECOL MONOGR, V57, P1, DOI 10.2307/1942636; Dethlefsen L, 2007, NATURE, V449, P811, DOI 10.1038/nature06245; Drake HL, 2007, ANNU REV MICROBIOL, V61, P169, DOI 10.1146/annurev.micro.61.080706.093139; Egert M, 2004, FEMS MICROBIOL ECOL, V48, P187, DOI 10.1016/j.femsec.2004.01.007; Furlong MA, 2002, APPL ENVIRON MICROB, V68, P1265, DOI 10.1128/AEM.68.3.1265-1279.2002; Horn MA, 2003, APPL ENVIRON MICROB, V69, P1662, DOI 10.1128/AEM.69.3.1662-1669.2003; Jimenez JJ, 2000, PEDOBIOLOGIA, V44, P677, DOI 10.1078/S0031-4056(04)70081-5; Khomyakov NV, 2007, MICROBIOLOGY+, V76, P45, DOI 10.1134/S0026261707010079; Knapp BA, 2008, B ENTOMOL RES, V98, P271, DOI 10.1017/S0007485308006056; Kvell K, 2007, CLIN DEV IMMUNOL, P1, DOI 10.1155/2007/83671; Lavelle P, 2006, EUR J SOIL BIOL, V42, pS3, DOI 10.1016/j.ejsobi.2006.10.002; Lepp PW, 2004, P NATL ACAD SCI USA, V101, P6176, DOI 10.1073/pnas.0308766101; Ley RE, 2006, CELL, V124, P837, DOI 10.1016/j.cell.2006.02.017; MacDonald TT, 2005, SCIENCE, V307, P1920, DOI 10.1126/science.1106442; Nadkarni MA, 2002, MICROBIOL-SGM, V148, P257, DOI 10.1099/00221287-148-1-257; NECHITAYLO T, 2006, THESIS TU CAROLOWILH; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Rastall RA, 2004, J NUTR, V134, p2022S, DOI 10.1093/jn/134.8.2022S; Rudi K, 2007, APPL ENVIRON MICROB, V73, P2727, DOI 10.1128/AEM.01205-06; Rudi K, 2006, INT J SYST EVOL MICR, V56, P1565, DOI 10.1099/ijs.0.63936-0; SantaLucia J, 2004, ANNU REV BIOPH BIOM, V33, P415, DOI 10.1146/annurev.biophys.32.110601.141800; Singleton DR, 2003, SOIL BIOL BIOCHEM, V35, P1547, DOI 10.1016/S0038-0717(03)00244-X; Stainier DYR, 2005, SCIENCE, V307, P1902, DOI 10.1126/science.1108709	31	15	17	1	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7528	10.1371/journal.pone.0007528	http://dx.doi.org/10.1371/journal.pone.0007528			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841743	gold, Green Published, Green Submitted			2022-12-27	WOS:000271012900017
J	Chatelain, FC; Gazzarrini, S; Fujiwara, Y; Arrigoni, C; Domigan, C; Ferrara, G; Pantoja, C; Thiel, G; Moroni, A; Minor, DL				Chatelain, Franck C.; Gazzarrini, Sabrina; Fujiwara, Yuichiro; Arrigoni, Cristina; Domigan, Courtney; Ferrara, Giuseppina; Pantoja, Carlos; Thiel, Gerhard; Moroni, Anna; Minor, Daniel L., Jr.			Selection of Inhibitor-Resistant Viral Potassium Channels Identifies a Selectivity Filter Site that Affects Barium and Amantadine Block	PLOS ONE			English	Article							KCSA K+ CHANNEL; PROTON CHANNEL; IN-VITRO; MOLECULAR EVOLUTION; STRUCTURAL BASIS; VOLTAGE SENSOR; ION CHANNELS; PORE HELIX; VIRUS; PROTEIN	Background: Understanding the interactions between ion channels and blockers remains an important goal that has implications for delineating the basic mechanisms of ion channel function and for the discovery and development of ion channel directed drugs. Methodology/Principal Findings: We used genetic selection methods to probe the interaction of two ion channel blockers, barium and amantadine, with the miniature viral potassium channel Kcv. Selection for Kcv mutants that were resistant to either blocker identified a mutant bearing multiple changes that was resistant to both. Implementation of a PCR shuffling and backcrossing procedure uncovered that the blocker resistance could be attributed to a single change, T63S, at a position that is likely to form the binding site for the inner ion in the selectivity filter (site 4). A combination of electrophysiological and biochemical assays revealed a distinct difference in the ability of the mutant channel to interact with the blockers. Studies of the analogous mutation in the mammalian inward rectifier Kir2.1 show that the T -> S mutation affects barium block as well as the stability of the conductive state. Comparison of the effects of similar barium resistant mutations in Kcv and Kir2.1 shows that neighboring amino acids in the Kcv selectivity filter affect blocker binding. Conclusions/Significance: The data support the idea that permeant ions have an integral role in stabilizing potassium channel structure, suggest that both barium and amantadine act at a similar site, and demonstrate how genetic selections can be used to map blocker binding sites and reveal mechanistic features.			Chatelain, FC (corresponding author), Univ Calif San Francisco, Cardiovasc Res Inst, San Francisco, CA 94143 USA.	daniel.minor@ucsf.edu	moroni, anna/H-2097-2014; Arrigoni, Cristina/AAG-8176-2020; Fujiwara, Yuichiro/GOP-2340-2022	moroni, anna/0000-0002-1860-406X; Fujiwara, Yuichiro/0000-0002-9628-4073; gazzarrini, sabrina/0000-0003-3062-7536; CHATELAIN, Franck C./0000-0002-8426-8893; Arrigoni, Cristina/0000-0003-1917-1750; Thiel, Gerhard/0000-0002-2335-1351				Abenavoli A, 2009, J GEN PHYSIOL, V134, P219, DOI 10.1085/jgp.200910266; Alagem N, 2003, BIOPHYS J, V85, P300, DOI 10.1016/S0006-3495(03)74475-0; ANDERSON JA, 1994, SYM SOC EXP BIOL, P85; ASHCROFT FM, 1991, BRIT J PHARMACOL, V104, P579, DOI 10.1111/j.1476-5381.1991.tb12472.x; Balss J, 2008, P NATL ACAD SCI USA, V105, P12313, DOI 10.1073/pnas.0805709105; Bichet D, 2004, P NATL ACAD SCI USA, V101, P4441, DOI 10.1073/pnas.0401195101; Bulaj G, 2008, CURR OPIN CHEM BIOL, V12, P441, DOI 10.1016/j.cbpa.2008.07.012; Burns AR, 2006, NAT PROTOC, V1, P1906, DOI 10.1038/nprot.2006.283; CARTER PJ, 1984, CELL, V38, P835, DOI 10.1016/0092-8674(84)90278-2; Chatelain FC, 2005, NEURON, V47, P833, DOI 10.1016/j.neuron.2005.08.022; Chen J, 2005, BIOCHEM BIOPH RES CO, V326, P887, DOI 10.1016/j.bbrc.2004.11.125; Cortes DM, 1997, BIOCHEMISTRY-US, V36, P10343, DOI 10.1021/bi971018y; DORNMAIR K, 1990, J BIOL CHEM, V265, P18907; Doyle DA, 1998, SCIENCE, V280, P69, DOI 10.1126/science.280.5360.69; DUFF KC, 1993, BIOCHIM BIOPHYS ACTA, V1145, P149, DOI 10.1016/0005-2736(93)90392-D; Dunlop J, 2008, NAT REV DRUG DISCOV, V7, P358, DOI 10.1038/nrd2552; Gazzarrini S, 2009, BIOCHEM J, V420, P295, DOI 10.1042/BJ20090095; Grabe M, 2007, NATURE, V445, P550, DOI 10.1038/nature05494; Guizouarn H, 2001, J PHYSIOL-LONDON, V535, P497, DOI 10.1111/j.1469-7793.2001.t01-1-00497.x; Heginbotham L, 1997, BIOCHEMISTRY-US, V36, P10335, DOI 10.1021/bi970988i; HEGINBOTHAM L, 1994, BIOPHYS J, V66, P1061, DOI 10.1016/S0006-3495(94)80887-2; HIDALGO P, 1995, SCIENCE, V268, P307, DOI 10.1126/science.7716527; Hille B., 2001, ION CHANNELS EXCITAB, V3rd Edn; Jiang YX, 2000, J GEN PHYSIOL, V115, P269, DOI 10.1085/jgp.115.3.269; Kaczorowski GJ, 2008, J GEN PHYSIOL, V131, P399, DOI 10.1085/jgp.200709946; Kang M, 2004, P NATL ACAD SCI USA, V101, P5318, DOI 10.1073/pnas.0307824100; Krishnan MN, 2008, BIOCHEMISTRY-US, V47, P5354, DOI 10.1021/bi702281p; Krishnan MN, 2005, J GEN PHYSIOL, V126, P271, DOI 10.1085/jgp.200509323; Kwok TCY, 2006, NATURE, V441, P91, DOI 10.1038/nature04657; Kwok TCY, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000067; Lai HC, 2005, NEURON, V47, P395, DOI 10.1016/j.neuron.2005.06.019; Lenaeus MJ, 2005, NAT STRUCT MOL BIOL, V12, P454, DOI 10.1038/nsmb929; Lockless SW, 2007, PLOS BIOL, V5, P1079, DOI 10.1371/journal.pbio.0050121; Long SB, 2005, SCIENCE, V309, P897, DOI 10.1126/science.1116269; Lu Q, 2008, COMB CHEM HIGH T SCR, V11, P185, DOI 10.2174/138620708783877735; Minor DL, 2009, MOL BIOSYST, V5, P802, DOI 10.1039/b901708a; Minor DL, 1999, CELL, V96, P879, DOI 10.1016/S0092-8674(00)80597-8; Nakamura RL, 1997, J BIOL CHEM, V272, P1011, DOI 10.1074/jbc.272.2.1011; Pagliuca C, 2007, BIOCHEMISTRY-US, V46, P1079, DOI 10.1021/bi061530w; Pinto LH, 2007, MOL BIOSYST, V3, P18, DOI 10.1039/b611613m; Plugge B, 2000, SCIENCE, V287, P1641, DOI 10.1126/science.287.5458.1641; Rath A, 2009, P NATL ACAD SCI USA, V106, P1760, DOI 10.1073/pnas.0813167106; Roux B, 2005, NEURON, V47, P777, DOI 10.1016/j.neuron.2005.08.031; Roux B, 2005, ANNU REV BIOPH BIOM, V34, P153, DOI 10.1146/annurev.biophys.34.040204.144655; Sadja R, 2001, NEURON, V29, P669, DOI 10.1016/S0896-6273(01)00242-2; Sanguinetti MC, 2006, NATURE, V440, P463, DOI 10.1038/nature04710; Sanguinetti MC, 2005, TRENDS PHARMACOL SCI, V26, P119, DOI 10.1016/j.tips.2005.01.003; Schnell JR, 2008, NATURE, V451, P591, DOI 10.1038/nature06531; Shim JW, 2007, FEBS LETT, V581, P1027, DOI 10.1016/j.febslet.2007.02.005; SIGWORTH FJ, 1987, BIOPHYS J, V52, P1047, DOI 10.1016/S0006-3495(87)83298-8; STEMMER WPC, 1994, NATURE, V370, P389, DOI 10.1038/370389a0; STEMMER WPC, 1994, P NATL ACAD SCI USA, V91, P10747, DOI 10.1073/pnas.91.22.10747; Stouffer AL, 2008, NATURE, V451, P596, DOI 10.1038/nature06528; Subczynski WK, 1998, J PHARM SCI-US, V87, P1249, DOI 10.1021/js970381n; Syeda R, 2008, J AM CHEM SOC, V130, P15543, DOI 10.1021/ja804968g; TANG WM, 1995, MOL BIOL CELL, V6, P1231, DOI 10.1091/mbc.6.9.1231; Wang JF, 2004, BIOCHEM BIOPH RES CO, V324, P212, DOI 10.1016/j.bbrc.2004.09.039; Wang S, 2009, J BIOL CHEM, V284, P2854, DOI 10.1074/jbc.M807474200; WOODHULL AM, 1973, J GEN PHYSIOL, V61, P687, DOI 10.1085/jgp.61.6.687; Yi BA, 2001, NEURON, V29, P657, DOI 10.1016/S0896-6273(01)00241-0; Yohannan S, 2007, J MOL BIOL, V366, P806, DOI 10.1016/j.jmb.2006.11.081; Zaks-Makhina E, 2004, MOL PHARMACOL, V65, P214, DOI 10.1124/mol.65.1.214; Zaks-Makhina E, 2009, J BIOL CHEM, V284, P15432, DOI 10.1074/jbc.M901586200; Zhou M, 2004, J MOL BIOL, V338, P839, DOI 10.1016/j.jmb.2004.03.020; Zhou YF, 2001, NATURE, V414, P43, DOI 10.1038/35102009	65	37	38	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7496	10.1371/journal.pone.0007496	http://dx.doi.org/10.1371/journal.pone.0007496			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834614	Green Submitted, Green Published, gold			2022-12-27	WOS:000270880700018
J	Linnertz, C; Saucier, L; Ge, DL; Cronin, KD; Burke, JR; Browndyke, JN; Hulette, CM; Welsh-Bohmer, KA; Chiba-Falek, O				Linnertz, Colton; Saucier, Laura; Ge, Dongliang; Cronin, Kenneth D.; Burke, James R.; Browndyke, Jeffrey N.; Hulette, Christine M.; Welsh-Bohmer, Kathleen A.; Chiba-Falek, Ornit			Genetic Regulation of alpha-Synuclein mRNA Expression in Various Human Brain Tissues	PLOS ONE			English	Article							SPORADIC PARKINSONS-DISEASE; LOCUS TRIPLICATION; SEQUENCE-ANALYSIS; ALLELIC VARIATION; SUBSTANTIA-NIGRA; SNCA GENE; NACP-REP1; MUTATION; DUPLICATION; SUSCEPTIBILITY	Genetic variability across the SNCA locus has been repeatedly associated with susceptibility to sporadic Parkinson's disease (PD). Accumulated evidence emphasizes the importance of SNCA dosage and expression levels in PD pathogenesis. However whether genetic variability in the SNCA gene modulates the risk to develop sporadic PD via regulation of SNCA expression remained elusive. We studied the effect of PD risk-associated variants at SNCA 5' and 3' regions on SNCA-mRNA levels in vivo in 228 human brain samples from three structures differentially vulnerable to PD pathology (substantia-nigra, temporal-and frontal-cortex) obtained from 144 neurologically normal cadavers. The extensively characterized PD-associated promoter polymorphism, Rep1, had an effect on SNCA-mRNA levels. Homozygous genotype of the 'protective', Rep1-259 bp allele, was associated with lower levels of SNCA-mRNA relative to individuals that carried at least one copy of the PD-risk associated alleles, amounting to an average decrease of similar to 40% and >50% in temporal-cortex and substantia-nigra, respectively. Furthermore, SNPs tagging the SNCA 3'-untranslated-region also showed effects on SNCA-mRNA levels in both the temporal-cortex and the substantia-nigra, although, in contrast to Rep1, the 'decreased-risk' alleles were correlated with increased SNCA-mRNA levels. Similar to Rep1 findings, no difference in SNCA-mRNA level was seen with different SNCA 3'SNP alleles in the frontal-cortex, indicating there is brain-region specificity of the genetic regulation of SNCA expression. We provide evidence for functional consequences of PD-associated SNCA gene variants in disease relevant brain tissues, suggesting that genetic regulation of SNCA expression plays an important role in the development of the disease.			Linnertz, C (corresponding author), Duke Univ, Med Ctr, Inst Genome Sci & Policy, Durham, NC 27710 USA.	o.chibafalek@duke.edu	Burke, James R/E-4245-2016; Browndyke, Jeffrey/AAE-7292-2021; Welsh-Bohmer, Kathleen/AAA-3178-2020	Burke, James R/0000-0002-3408-7787; Browndyke, Jeffrey/0000-0002-8573-7073	NIA NIH HHS [P30 AG028377] Funding Source: Medline	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Bengtsson M, 2005, GENOME RES, V15, P1388, DOI 10.1101/gr.3820805; Beyer K, 2006, ACTA NEUROPATHOL, V112, P237, DOI 10.1007/s00401-006-0104-6; Braak H, 2007, ACTA NEUROPATHOL, V114, P231, DOI 10.1007/s00401-007-0244-3; Chartier-Harlin MC, 2004, LANCET, V364, P1167, DOI 10.1016/S0140-6736(04)17103-1; Chiba-Falek O, 2005, AM J HUM GENET, V76, P478, DOI 10.1086/428655; Chiba-Falek O, 2003, HUM GENET, V113, P426, DOI 10.1007/s00439-003-1002-9; Chiba-Falek O, 2001, HUM MOL GENET, V10, P3101, DOI 10.1093/hmg/10.26.3101; Chiba-Falek O, 2006, MOVEMENT DISORD, V21, P1703, DOI 10.1002/mds.21007; CRONIN KD, 2009, HUM MOL GENET; Cullen V, 2009, MOL BRAIN, V2, DOI 10.1186/1756-6606-2-5; Dachsel JC, 2007, MOVEMENT DISORD, V22, P293, DOI 10.1002/mds.21223; Emilsson V, 2008, NATURE, V452, P423, DOI 10.1038/nature06758; Farrer M, 2004, ANN NEUROL, V55, P174, DOI 10.1002/ana.10846; Farrer M, 2001, HUM MOL GENET, V10, P1847, DOI 10.1093/hmg/10.17.1847; Fuchs J, 2007, NEUROLOGY, V68, P916, DOI 10.1212/01.wnl.0000254458.17630.c5; Fuchs J, 2008, FASEB J, V22, P1327, DOI 10.1096/fj.07-9348com; Grundemann J, 2008, NUCLEIC ACIDS RES, V36, DOI 10.1093/nar/gkn084; Ibanez P, 2004, LANCET, V364, P1169, DOI 10.1016/S0140-6736(04)17104-3; Kingsbury AE, 2004, MOVEMENT DISORD, V19, P162, DOI 10.1002/mds.10683; Kruger R, 1998, NAT GENET, V18, P106, DOI 10.1038/ng0298-106; Lee HJ, 2002, J BIOL CHEM, V277, P671, DOI 10.1074/jbc.M107045200; Lewis J, 2008, MOL NEURODEGENER, V3, DOI 10.1186/1750-1326-3-19; Maraganore DM, 2006, JAMA-J AM MED ASSOC, V296, P661, DOI 10.1001/jama.296.6.661; Mellick GD, 2005, NEUROSCI LETT, V375, P112, DOI 10.1016/j.neulet.2004.10.078; Miller DW, 2004, NEUROLOGY, V62, P1835, DOI 10.1212/01.WNL.0000127517.33208.F4; Mizuta I, 2006, HUM MOL GENET, V15, P1151, DOI 10.1093/hmg/ddl030; Mizuta I, 2002, J NEUROL NEUROSUR PS, V73, P350, DOI 10.1136/jnnp.73.3.350; Mueller JC, 2005, ANN NEUROL, V57, P535, DOI 10.1002/ana.20438; Myers AJ, 2007, NAT GENET, V39, P1494, DOI 10.1038/ng.2007.16; Myhre R, 2008, ACTA NEUROL SCAND, V118, P320, DOI 10.1111/j.1600-0404.2008.01019.x; Neystat M, 1999, MOVEMENT DISORD, V14, P417, DOI 10.1002/1531-8257(199905)14:3<417::AID-MDS1005>3.0.CO;2-X; Pals P, 2004, ANN NEUROL, V56, P591, DOI 10.1002/ana.20268; Parsian A, 1998, NEUROLOGY, V51, P1757, DOI 10.1212/WNL.51.6.1757; Polymeropoulos MH, 1997, SCIENCE, V276, P2045, DOI 10.1126/science.276.5321.2045; Qiao LY, 2008, MOL BRAIN, V1, DOI 10.1186/1756-6606-1-17; Ross OA, 2008, ANN NEUROL, V63, P743, DOI 10.1002/ana.21380; Singleton AB, 2003, SCIENCE, V302, P841, DOI 10.1126/science.1090278; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Touchman JW, 2001, GENOME RES, V11, P78, DOI 10.1101/gr.165801; Winkler S., 2007, NEUROLOGY; Xia Y, 1996, ANN NEUROL, V40, P207, DOI 10.1002/ana.410400212; Zarranz JJ, 2004, ANN NEUROL, V55, P164, DOI 10.1002/ana.10795	42	67	68	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7480	10.1371/journal.pone.0007480	http://dx.doi.org/10.1371/journal.pone.0007480			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834617	Green Published, Green Submitted, gold			2022-12-27	WOS:000270880700008
J	Martins, GG; Rifes, P; Amandio, R; Rodrigues, G; Palmeirim, I; Thorsteinsdottir, S				Martins, Gabriel G.; Rifes, Pedro; Amandio, Rita; Rodrigues, Gabriela; Palmeirim, Isabel; Thorsteinsdottir, Solveig			Dynamic 3D Cell Rearrangements Guided by a Fibronectin Matrix Underlie Somitogenesis	PLOS ONE			English	Article							PRESOMITIC MESODERM; CHICK-EMBRYO; GENE-EXPRESSION; MOUSE EMBRYOS; BRANCHING MORPHOGENESIS; VERTEBRATE SEGMENTATION; MORPHOLOGICAL BOUNDARY; SOMITIC SEGMENTATION; NOTOCHORD FORMATION; ADHESION MOLECULES	Somites are transient segments formed in a rostro-caudal progression during vertebrate development. In chick embryos, segmentation of a new pair of somites occurs every 90 minutes and involves a mesenchyme-to-epithelium transition of cells from the presomitic mesoderm. Little is known about the cellular rearrangements involved, and, although it is known that the fibronectin extracellular matrix is required, its actual role remains elusive. Using 3D and 4D imaging of somite formation we discovered that somitogenesis consists of a complex choreography of individual cell movements. Epithelialization starts medially with the formation of a transient epithelium of cuboidal cells, followed by cell elongation and reorganization into a pseudostratified epithelium of spindle-shaped epitheloid cells. Mesenchymal cells are then recruited to this medial epithelium through accretion, a phenomenon that spreads to all sides, except the lateral side of the forming somite, which epithelializes by cell elongation and intercalation. Surprisingly, an important contribution to the somite epithelium also comes from the continuous egression of mesenchymal cells from the core into the epithelium via its apical side. Inhibition of fibronectin matrix assembly first slows down the rate, and then halts somite formation, without affecting pseudopodial activity or cell body movements. Rather, cell elongation, centripetal alignment, N-cadherin polarization and egression are impaired, showing that the fibronectin matrix plays a role in polarizing and guiding the exploratory behavior of somitic cells. To our knowledge, this is the first 4D in vivo recording of a full mesenchyme-to-epithelium transition. This approach brought new insights into this event and highlighted the importance of the extracellular matrix as a guiding cue during morphogenesis.			Martins, GG (corresponding author), Univ Lisbon, Fac Ciencias, Dept Biol Anim, Ctr Biol Ambiental, Lisbon, Portugal.	gaby@fc.ul.pt; solveig@fc.ul.pt	Rodrigues, Gabriela/A-1909-2013; Martins, Gabriel G/AAG-4074-2020; Rodrigues, Gabriela/GQH-1711-2022; Palmeirim, Isabel/F-4522-2012; Thorsteinsdottir, Solveig/ABG-4504-2021; Martins, Gabriel G/A-1538-2012; Thorsteinsdottir, Solveig/M-3561-2013	Rodrigues, Gabriela/0000-0002-0598-4040; Martins, Gabriel G/0000-0002-6506-9776; Thorsteinsdottir, Solveig/0000-0002-9018-3431; Martins, Gabriel G/0000-0002-6506-9776; Thorsteinsdottir, Solveig/0000-0002-9018-3431; Palmeirim, Isabel/0000-0003-2282-7829; Rifes, Pedro/0000-0002-9963-3291	Fundação para a Ciência e a Tecnologia [POCI/BIA-BCM/59201/2004] Funding Source: FCT	Fundação para a Ciência e a Tecnologia		Andrade Raquel P., 2007, Birth Defects Research, V81, P65, DOI 10.1002/bdrc.20094; BELLAIRS R, 1979, J EMBRYOL EXP MORPH, V51, P227; BELLAIRS R, 1978, J EMBRYOL EXP MORPH, V46, P207; Chen X, 2006, CURR OPIN CELL BIOL, V18, P572, DOI 10.1016/j.ceb.2006.07.002; Daley WP, 2008, J CELL SCI, V121, P255, DOI 10.1242/jcs.006064; Danen EHJ, 2003, J PATHOL, V201, P632, DOI 10.1002/path.1472; Davidson LA, 2008, DEV DYNAM, V237, P2684, DOI 10.1002/dvdy.21600; Davidson LA, 2006, CURR BIOL, V16, P833, DOI 10.1016/j.cub.2006.03.038; Dequeant ML, 2008, NAT REV GENET, V9, P370, DOI 10.1038/nrg2320; DUBAND JL, 1987, J CELL BIOL, V104, P1361, DOI 10.1083/jcb.104.5.1361; Dubrulle J, 2004, DEVELOPMENT, V131, P5783, DOI 10.1242/dev.01519; Freitas C, 2001, DEVELOPMENT, V128, P5139; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; GeorgesLabouesse EN, 1996, DEV DYNAM, V207, P145, DOI 10.1002/(SICI)1097-0177(199610)207:2<145::AID-AJA3>3.0.CO;2-H; Ghajar CM, 2008, HISTOCHEM CELL BIOL, V130, P1105, DOI 10.1007/s00418-008-0537-1; Gossler A, 1998, CURR TOP DEV BIOL, V38, P225; Haas P, 2006, DEV CELL, V10, P673, DOI 10.1016/j.devcel.2006.02.019; HAMBURGER V, 1951, J MORPHOL, V88, P49, DOI 10.1002/jmor.1050880104; Harburger DS, 2009, J CELL SCI, V122, P159, DOI 10.1242/jcs.018093; Hay ED, 2005, DEV DYNAM, V233, P706, DOI 10.1002/dvdy.20345; Ingber DE, 2006, INT J DEV BIOL, V50, P255, DOI 10.1387/ijdb.052044di; Julich D, 2005, DEV CELL, V8, P575, DOI 10.1016/j.devcel.2005.01.016; Keller R, 2000, PHILOS T R SOC B, V355, P897, DOI 10.1098/rstb.2000.0626; Koshida S, 2005, DEV CELL, V8, P587, DOI 10.1016/j.devcel.2005.03.006; Kragtorp KA, 2006, DEVELOPMENT, V133, P685, DOI 10.1242/dev.02230; Kragtorp KA, 2007, DEV DYNAM, V236, P2713, DOI 10.1002/dvdy.21280; KUHL U, 1982, DEV BIOL, V93, P344, DOI 10.1016/0012-1606(82)90122-1; Kulesa PM, 2002, SCIENCE, V298, P991, DOI 10.1126/science.1075544; Larsen M, 2006, CURR OPIN CELL BIOL, V18, P463, DOI 10.1016/j.ceb.2006.08.009; Larsen M, 2006, J CELL SCI, V119, P3376, DOI 10.1242/jcs.03079; LASH JW, 1984, J EXP ZOOL, V232, P197, DOI 10.1002/jez.1402320207; LASH JW, 1986, SOMITES DEV EMBRYOS, P201; LIPTON BH, 1974, DEV BIOL, V38, P73, DOI 10.1016/0012-1606(74)90260-7; Mao Y, 2005, MATRIX BIOL, V24, P389, DOI 10.1016/j.matbio.2005.06.008; Marsden M, 2003, CURR BIOL, V13, P1182, DOI 10.1016/S0960-9822(03)00433-0; MCKEOWNLONGO PJ, 1985, J CELL BIOL, V100, P364, DOI 10.1083/jcb.100.2.364; McLaren A, 2005, DIFFERENTIATION, V73, P435, DOI 10.1111/j.1432-0436.2005.00049.x; Meyer S, 2005, INT J ONCOL, V27, P1197; Momose T, 1999, DEV GROWTH DIFFER, V41, P335; Montell DJ, 2008, SCIENCE, V322, P1502, DOI 10.1126/science.1164073; Nakaya Y, 2004, DEV CELL, V7, P425, DOI 10.1016/j.devcel.2004.08.003; Ohashi T, 2002, J CELL SCI, V115, P1221; OSTROVSKY D, 1983, CELL DIFFER DEV, V13, P217, DOI 10.1016/0045-6039(83)90092-1; PACKARD DS, 1976, DEV BIOL, V53, P36, DOI 10.1016/0012-1606(76)90207-4; Palmeirim I, 1997, CELL, V91, P639, DOI 10.1016/S0092-8674(00)80451-1; Palmeirim I, 1998, DEV GENET, V23, P77, DOI 10.1002/(SICI)1520-6408(1998)23:1<77::AID-DVG8>3.0.CO;2-3; Pourquie O, 2001, DEV CELL, V1, P619, DOI 10.1016/S1534-5807(01)00082-X; Psychoyos D, 1996, DEVELOPMENT, V122, P1523; Ribeiro C, 2004, CURR BIOL, V14, P2197, DOI 10.1016/j.cub.2004.11.056; Rifes P, 2007, DEVELOPMENT, V134, P3155, DOI 10.1242/dev.003665; Saga Y, 2001, NAT REV GENET, V2, P835, DOI 10.1038/35098552; Saga Y, 2007, DEV DYNAM, V236, P1450, DOI 10.1002/dvdy.21143; Sakai T, 2003, NATURE, V423, P876, DOI 10.1038/nature01712; Sato Y, 2002, DEVELOPMENT, V129, P3633; SAUSEDO RA, 1993, ANAT REC, V237, P58, DOI 10.1002/ar.1092370107; SAUSEDO RA, 1994, ANAT REC, V239, P103, DOI 10.1002/ar.1092390112; Schock F, 2002, ANNU REV CELL DEV BI, V18, P463, DOI 10.1146/annurev.cellbio.18.022602.131838; Shook DR, 2008, J EXP ZOOL PART B, V310B, P85, DOI 10.1002/jez.b.21198; Sottile J, 2002, MOL BIOL CELL, V13, P3546, DOI 10.1091/mbc.E02-01-0048; Stockdale FE, 2000, DEV DYNAM, V219, P304, DOI 10.1002/1097-0177(2000)9999:9999<::AID-DVDY1057>3.0.CO;2-5; THORSTEINSDOTTIR S, 1992, ANAT RECORD, V232, P141, DOI 10.1002/ar.1092320116; Trinh LA, 2004, DEV CELL, V6, P371; Uyen HD, 2002, J CELL SCI, V115, P3073; Vicente-Manzanares M, 2009, J CELL SCI, V122, P199, DOI 10.1242/jcs.018564; Voiculescu O, 2007, NATURE, V449, P1049, DOI 10.1038/nature06211; Watanabe T, 2009, P NATL ACAD SCI USA, V106, P7467, DOI 10.1073/pnas.0902859106; Wierzbicka-Patynowski I, 2003, J CELL SCI, V116, P3269, DOI 10.1242/jcs.00670; Williams LW, 1910, AM J ANAT, V11, P55, DOI 10.1002/aja.1000110103; Yurchenco PD, 2004, MATRIX BIOL, V22, P521, DOI 10.1016/j.matbio.2003.10.006; Zamir EA, 2008, PLOS BIOL, V6, P2163, DOI 10.1371/journal.pbio.0060247; Zhou XM, 2008, GENE DEV, V22, P1231, DOI 10.1101/gad.1643308	71	50	50	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7429	10.1371/journal.pone.0007429	http://dx.doi.org/10.1371/journal.pone.0007429			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829711	Green Published, gold			2022-12-27	WOS:000270847800001
J	Shi-wen, X; Liu, SX; Eastwood, M; Sonnylal, S; Denton, CP; Abraham, DJ; Leask, A				Shi-wen, Xu; Liu, Shangxi; Eastwood, Mark; Sonnylal, Sonali; Denton, Christopher P.; Abraham, David J.; Leask, Andrew			Rac Inhibition Reverses the Phenotype of Fibrotic Fibroblasts	PLOS ONE			English	Article							SMALL-MOLECULE INHIBITOR; FOCAL ADHESION KINASE; SCLERODERMA FIBROBLASTS; SYSTEMIC-SCLEROSIS; GROWTH-FACTOR; RHO GTPASES; TGF-BETA; IN-VIVO; LUNG FIBROBLASTS; RATIONAL DESIGN	Background: Fibrosis, the excessive deposition of scar tissue by fibroblasts, is one of the largest groups of diseases for which there is no therapy. Fibroblasts from lesional areas of scleroderma patients possess elevated abilities to contract matrix and produce alpha-smooth muscle actin (alpha-SMA), type I collagen and CCN2 (connective tissue growth factor, CTGF). The basis for this phenomenon is poorly understood, and is a necessary prerequisite for developing novel, rational anti-fibrotic strategies. Methods and Findings: Compared to healthy skin fibroblasts, dermal fibroblasts cultured from lesional areas of scleroderma (SSc) patients possess elevated Rac activity. NSC23766, a Rac inhibitor, suppressed the persistent fibrotic phenotype of lesional SSc fibroblasts. NSC23766 caused a decrease in migration on and contraction of matrix, and alpha-SMA, type I collagen and CCN2 mRNA and protein expression. SSc fibroblasts possessed elevated Akt phosphorylation, which was also blocked by NSC23766. Overexpression of rac1 in normal fibroblasts induced matrix contraction and alpha-SMA, type I collagen and CCN2 mRNA and protein expression. Rac1 activity was blocked by PI3kinase/Akt inhibition. Basal fibroblast activity was not affected by NSC23766. Conclusion: Rac inhibition may be considered as a novel treatment for the fibrosis observed in SSc.			Shi-wen, X (corresponding author), UCL, Dept Med, Ctr Rheumatol, Royal Free Campus, London, England.	Andrew.leask@schulich.uwo.ca	Leask, Andy/ABH-9433-2020; Leask, Andrew/G-5217-2015					Akbar H, 2006, METHOD ENZYMOL, V406, P554, DOI 10.1016/S0076-6879(06)06043-5; Anand-Apte B, 1997, J BIOL CHEM, V272, P30688, DOI 10.1074/jbc.272.49.30688; Banyard J, 2000, ONCOGENE, V19, P580, DOI 10.1038/sj.onc.1203338; Bosco EE, 2009, CELL MOL LIFE SCI, V66, P370, DOI 10.1007/s00018-008-8552-x; Burridge K, 1996, ANNU REV CELL DEV BI, V12, P463, DOI 10.1146/annurev.cellbio.12.1.463; Cain RJ, 2009, BIOL CELL, V101, P13, DOI 10.1042/BC20080079; Chen YL, 2006, ARTHRITIS RHEUM-US, V54, P1309, DOI 10.1002/art.21725; Chen YL, 2005, AM J PATHOL, V167, P1699, DOI 10.1016/S0002-9440(10)61252-7; Chen YL, 2008, ARTHRITIS RHEUM-US, V58, P577, DOI 10.1002/art.23146; Denton CP, 2007, ARTHRITIS RHEUM-US, V56, P323, DOI 10.1002/art.22289; Dugina V, 2001, J CELL SCI, V114, P3285; EASTWOOD M, 1994, BBA-GEN SUBJECTS, V1201, P186, DOI 10.1016/0304-4165(94)90040-X; Franke TF, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.124pe29; Fritz G, 2006, CURR CANCER DRUG TAR, V6, P1, DOI 10.2174/156800906775471752; Gabbiani G, 2003, J PATHOL, V200, P500, DOI 10.1002/path.1427; Gao Y, 2004, P NATL ACAD SCI USA, V101, P7618, DOI 10.1073/pnas.0307512101; Heasman SJ, 2008, NAT REV MOL CELL BIO, V9, P690, DOI 10.1038/nrm2476; Ishibe S, 2004, MOL CELL, V16, P257, DOI 10.1016/j.molcel.2004.10.006; Ishida W, 2006, J INVEST DERMATOL, V126, P1733, DOI 10.1038/sj.jid.5700303; Jun JB, 2005, J INVEST DERMATOL, V124, P298, DOI 10.1111/j.0022-202X.2004.23559.x; Leask A, 2008, J CELL SCI, V121, P3459, DOI 10.1242/jcs.029215; Leask A, 2008, CELL SIGNAL, V20, P1409, DOI 10.1016/j.cellsig.2008.01.006; Liu SX, 2008, ARTHRITIS RHEUM-US, V58, P2189, DOI 10.1002/art.23595; Liu SX, 2009, AM J PATHOL, V174, P1847, DOI 10.2353/ajpath.2009.080779; Matozaki T, 2000, CELL SIGNAL, V12, P515, DOI 10.1016/S0898-6568(00)00102-9; Nobes CD, 1999, J CELL BIOL, V144, P1235, DOI 10.1083/jcb.144.6.1235; Parsons JT, 2003, J CELL SCI, V116, P1409, DOI 10.1242/jcs.00373; Renzoni EA, 2004, RESP RES, V5, DOI 10.1186/1465-9921-5-24; Rockey DC, 2008, CLIN LIVER DIS, V12, P939, DOI 10.1016/j.cld.2008.07.011; Song G, 2005, J CELL MOL MED, V9, P59, DOI 10.1111/j.1582-4934.2005.tb00337.x; Trojanowska M, 2007, CURR OPIN RHEUMATOL, V19, P568, DOI 10.1097/BOR.0b013e3282e6f495; Turner CE, 2000, NAT CELL BIOL, V2, pE231, DOI 10.1038/35046659; van Nimwegen MJ, 2007, BIOCHEM PHARMACOL, V73, P597, DOI 10.1016/j.bcp.2006.08.011; Varga J, 2007, J CLIN INVEST, V117, P557, DOI 10.1172/JCI31139; Varga John, 2004, Curr Rheumatol Rep, V6, P164, DOI 10.1007/s11926-004-0062-8; Werner S, 2003, PHYSIOL REV, V83, P835, DOI 10.1152/physrev.2003.83.3.835; Wynn TA, 2008, J PATHOL, V214, P199, DOI 10.1002/path.2277; Wynn TA, 2004, NAT REV IMMUNOL, V4, P583, DOI 10.1038/nri1412; Xu SW, 2007, MATRIX BIOL, V26, P625, DOI 10.1016/j.matbio.2007.06.003; Xu SW, 2004, MOL BIOL CELL, V15, P2707, DOI 10.1091/mbc.E03-12-0902; Xu SW, 2004, J BIOL CHEM, V279, P23098, DOI 10.1074/jbc.M311430200; Xu SW, 1998, J CARDIOVASC PHARM, V31, pS360, DOI 10.1097/00005344-199800001-00101; Zamir E, 2001, J CELL SCI, V114, P3583	44	42	42	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7438	10.1371/journal.pone.0007438	http://dx.doi.org/10.1371/journal.pone.0007438			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823586	Green Published, gold, Green Submitted			2022-12-27	WOS:000270808300014
J	Scholl, HPN; Fleckenstein, M; Fritsche, LG; Schmitz-Valckenberg, S; Gobel, A; Adrion, C; Herold, C; Keilhauer, CN; Mackensen, F; Mossner, A; Pauleikhoff, D; Weinberger, AWA; Mansmann, U; Holz, FG; Becker, T; Weber, BHF				Scholl, Hendrik P. N.; Fleckenstein, Monika; Fritsche, Lars G.; Schmitz-Valckenberg, Steffen; Goebel, Arno; Adrion, Christine; Herold, Christine; Keilhauer, Claudia N.; Mackensen, Friederike; Moessner, Andreas; Pauleikhoff, Daniel; Weinberger, Andreas W. A.; Mansmann, Ulrich; Holz, Frank G.; Becker, Tim; Weber, Bernhard H. F.			CFH, C3 and ARMS2 Are Significant Risk Loci for Susceptibility but Not for Disease Progression of Geographic Atrophy Due to AMD	PLOS ONE			English	Article								Background: Age-related macular degeneration (AMD) is a prevalent cause of blindness in Western societies. Variants in the genes encoding complement factor H (CFH), complement component 3 (C3) and age-related maculopathy susceptibility 2 (ARMS2) have repeatedly been shown to confer significant risks for AMD; however, their role in disease progression and thus their potential relevance for interventional therapeutic approaches remains unknown. Methodology/Principal Findings: Here, we analyzed association between variants in CFH, C3 and ARMS2 and disease progression of geographic atrophy (GA) due to AMD. A quantitative phenotype of disease progression was computed based on longitudinal observations by fundus autofluorescence imaging. In a subset of 99 cases with pure bilateral GA, variants in CFH (Y402H), C3 (R102G), and ARMS2 (A69S) are associated with disease (P = 1.6 x 10(-9), 3.2 x 10(-3), and P = 2.6 x 10(-12), respectively) when compared to 612 unrelated healthy control individuals. In cases, median progression rate of GA over a mean follow-up period of 3.0 years was 1.61 mm(2)/year with high concordance between fellow eyes. No association between the progression rate and any of the genetic risk variants at the three loci was observed (P>0.13). Conclusions/Significance: This study confirms that variants at CFH, C3, and ARMS2 confer significant risks for GA due to AMD. In contrast, our data indicate no association of these variants with disease progression which may have important implications for future treatment strategies. Other, as yet unknown susceptibilities may influence disease progression.			Scholl, HPN (corresponding author), Univ Bonn, Dept Ophthalmol, D-5300 Bonn, Germany.	bweb@klinik.uni-regensburg.de	Adrion, Christine/AAB-7247-2020; Fritsche, Lars G/AAF-9387-2019	Adrion, Christine/0000-0003-2408-2533; Fritsche, Lars G/0000-0002-2110-1690; Weber, Bernhard H.F./0000-0002-8808-7723; Fleckenstein, Monika/0000-0001-8321-8037				Becker T, 2005, ANN HUM GENET, V69, P747, DOI 10.1111/j.1529-8817.2005.00198.x; Bergmann M, 2004, FASEB J, V18, P562, DOI 10.1096/fj.03-0289fje; Bindewald A, 2005, BRIT J OPHTHALMOL, V89, P874, DOI 10.1136/bjo.2004.057794; Brown DM, 2006, NEW ENGL J MED, V355, P1432, DOI 10.1056/NEJMoa062655; Congdon N, 2004, ARCH OPHTHALMOL-CHIC, V122, P477; Davis MD, 2005, ARCH OPHTHALMOL-CHIC, V123, P1484; de Jong PTVM, 2006, NEW ENGL J MED, V355, P1474, DOI 10.1056/NEJMra062326; Deckert A, 2005, BMC Ophthalmol, V5, P8, DOI 10.1186/1471-2415-5-8; Dewan A, 2006, SCIENCE, V314, P989, DOI 10.1126/science.1133807; Dreyhaupt J, 2007, METHOD INFORM MED, V46, P432, DOI 10.1160/ME0328; Dreyhaupt J, 2005, OPHTHAL EPIDEMIOL, V12, P353, DOI 10.1080/09286580591005723; Dudbridge F, 2008, HUM HERED, V66, P87, DOI 10.1159/000119108; Edwards AO, 2005, SCIENCE, V308, P421, DOI 10.1126/science.1110189; Friedman DS, 2004, ARCH OPHTHALMOL-CHIC, V122, P564; Fritsche LG, 2008, NAT GENET, V40, P892, DOI 10.1038/ng.170; Haddad S, 2006, SURV OPHTHALMOL, V51, P316, DOI 10.1016/j.survophthal.2006.05.001; Hageman GS, 2005, P NATL ACAD SCI USA, V102, P7227, DOI 10.1073/pnas.0501536102; Haines JL, 2005, SCIENCE, V308, P419, DOI 10.1126/science.1110359; Holz FG, 2001, INVEST OPHTH VIS SCI, V42, P1051; Holz FG, 2004, AM J OPHTHALMOL, V137, P504, DOI 10.1016/j.ajo.2003.11.026; Holz FG, 1998, AM J OPHTHALMOL, V125, P227, DOI 10.1016/S0002-9394(99)80095-6; Holz FG, 2007, AM J OPHTHALMOL, V143, P463, DOI 10.1016/j.ajo.2006.11.041; Jager RD, 2008, NEW ENGL J MED, V358, P2606, DOI 10.1056/NEJMra0801537; Jakobsdottir J, 2005, AM J HUM GENET, V77, P389, DOI 10.1086/444437; Kanda A, 2007, P NATL ACAD SCI USA, V104, P16227, DOI 10.1073/pnas.0703933104; Klein R, 2004, AM J OPHTHALMOL, V137, P486, DOI 10.1016/j.ajo.2003.11.069; Klein RJ, 2005, SCIENCE, V308, P385, DOI 10.1126/science.1109557; Klein R, 2007, OPHTHALMOLOGY, V114, P253, DOI 10.1016/j.ophtha.2006.10.040; LIN LI, 1989, BIOMETRICS, V45, P255, DOI 10.2307/2532051; Lindblad AS, 2009, ARCH OPHTHALMOL-CHIC, V127, P1168, DOI 10.1001/archophthalmol.2009.198; Magnusson KP, 2006, PLOS MED, V3, P109, DOI 10.1371/journal.pmed.0030005; Maller JB, 2007, NAT GENET, V39, P1200, DOI 10.1038/ng2131; Pirbhai A, 2005, AM J OPHTHALMOL, V139, P455, DOI 10.1016/j.ajo.2004.09.077; Rivera A, 2005, HUM MOL GENET, V14, P3227, DOI 10.1093/hmg/ddi353; Rosenfeld PJ, 2006, NEW ENGL J MED, V355, P1419, DOI 10.1056/NEJMoa054481; Schaumberg DA, 2007, ARCH OPHTHALMOL-CHIC, V125, P55, DOI 10.1001/archopht.125.1.55; Schmitz-Valckenberg S, 2004, INVEST OPHTH VIS SCI, V45, P4470, DOI 10.1167/iovs.03-1311; Scholl HPN, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002593; Scholl HPN, 2007, MOL VIS, V13, P196; Scholl HPN, 2003, GRAEF ARCH CLIN EXP, V241, P39, DOI 10.1007/s00417-002-0602-8; Seddon JM, 2007, JAMA-J AM MED ASSOC, V297, P1793, DOI 10.1001/jama.297.16.1793; Sunness JS, 1999, INVEST OPHTH VIS SCI, V40, P1761; Yang ZL, 2006, SCIENCE, V314, P992, DOI 10.1126/science.1133811; Yates JRW, 2007, NEW ENGL J MED, V357, P553, DOI 10.1056/NEJMoa072618; Zhou JL, 2006, P NATL ACAD SCI USA, V103, P16182, DOI 10.1073/pnas.0604255103	45	73	74	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7418	10.1371/journal.pone.0007418	http://dx.doi.org/10.1371/journal.pone.0007418			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823576	Green Published, gold, Green Submitted			2022-12-27	WOS:000270728500016
J	Bozek, K; Thielen, A; Sierra, S; Kaiser, R; Lengauer, T				Bozek, Katarzyna; Thielen, Alexander; Sierra, Saleta; Kaiser, Rolf; Lengauer, Thomas			V3 Loop Sequence Space Analysis Suggests Different Evolutionary Patterns of CCR5-and CXCR4-Tropic HIV	PLOS ONE			English	Article								The V3 loop of human immunodeficiency virus type 1 (HIV-1) is critical for coreceptor binding and is the main determinant of which of the cellular coreceptors, CCR5 or CXCR4, the virus uses for cell entry. The aim of this study is to provide a large-scale data driven analysis of HIV-1 coreceptor usage with respect to the V3 loop evolution and to characterize CCR5- and CXCR4-tropic viral phenotypes previously studied in small-and medium-scale settings. We use different sequence similarity measures, phylogenetic and clustering methods in order to analyze the distribution in sequence space of roughly 1000 V3 loop sequences and their tropism phenotypes. This analysis affords a means of characterizing those sequences that are misclassified by several sequence-based coreceptor prediction methods, as well as predicting the coreceptor using the location of the sequence in sequence space and of relating this location to the CD4(+) T-cell count of the patient. We support previous findings that the usage of CCR5 is correlated with relatively high sequence conservation whereas CXCR4-tropic viruses spread over larger regions in sequence space. The incorrectly predicted sequences are mostly located in regions in which their phenotype represents the minority or in close vicinity of regions dominated by the opposite phenotype. Nevertheless, the location of the sequence in sequence space can be used to improve the accuracy of the prediction of the coreceptor usage. Sequences from patients with high CD4+ T-cell counts are relatively highly conserved as compared to those of immunosuppressed patients. Our study thus supports hypotheses of an association of immune system depletion with an increase in V3 loop sequence variability and with the escape of the viral sequence to distant parts of the sequence space.			Bozek, K (corresponding author), Max Planck Inst Informat, Saarbrucken, Germany.	bozek@mpi-inf.mpg.de						Altmann A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003470; Bandelt HJ, 1992, MOL PHYLOGENET EVOL, V1, P242, DOI 10.1016/1055-7903(92)90021-8; Berger EA, 1999, ANNU REV IMMUNOL, V17, P657, DOI 10.1146/annurev.immunol.17.1.657; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; CHESEBRO B, 1992, J VIROL, V66, P6547, DOI 10.1128/JVI.66.11.6547-6554.1992; Chun TW, 2005, J CLIN INVEST, V115, P3250, DOI 10.1172/JCI26197; Deng HK, 1996, NATURE, V381, P661, DOI 10.1038/381661a0; FOUCHIER RAM, 1992, J VIROL, V66, P3183, DOI 10.1128/JVI.66.5.3183-3187.1992; Friedman J., 2001, ELEMENTS STAT LEARNI, DOI 10.1007/978-0-387-21606-5; HENIKOFF S, 1992, P NATL ACAD SCI USA, V89, P10915, DOI 10.1073/pnas.89.22.10915; Hoffman NG, 2002, J VIROL, V76, P3852, DOI 10.1128/JVI.76.8.3852-3864.2002; Huson DH, 1998, BIOINFORMATICS, V14, P68, DOI 10.1093/bioinformatics/14.1.68; Jensen Mark A., 2003, AIDS Reviews, V5, P104; Low AJ, 2008, AIDS RES HUM RETROV, V24, P219, DOI 10.1089/aid.2007.0140; MCNEARNEY T, 1992, P NATL ACAD SCI USA, V89, P10247, DOI 10.1073/pnas.89.21.10247; MIEDEMA F, 1994, IMMUNOL REV, V140, P35, DOI 10.1111/j.1600-065X.1994.tb00864.x; MILICH L, 1993, J VIROL, V67, P5623, DOI 10.1128/JVI.67.9.5623-5634.1993; Nelson JAE, 1997, J VIROL, V71, P8750, DOI 10.1128/JVI.71.11.8750-8758.1997; Pillai S, 2003, AIDS RES HUM RETROV, V19, P145, DOI 10.1089/088922203762688658; Resch W, 2001, VIROLOGY, V288, P51, DOI 10.1006/viro.2001.1087; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; SCHUITEMAKER H, 1991, J VIROL, V65, P356, DOI 10.1128/JVI.65.1.356-363.1991; Shankarappa R, 1999, J VIROL, V73, P10489, DOI 10.1128/JVI.73.12.10489-10502.1999; SHEPHERD J, 2008, J INFECT DIS, V198; Sing T, 2005, BIOINFORMATICS, V21, P3940, DOI 10.1093/bioinformatics/bti623; Sing T, 2007, ANTIVIR THER, V12, P1097; Van Rij RP, 2003, AIDS RES HUM RETROV, V19, P389, DOI 10.1089/088922203765551737; Waters L, 2008, CLIN INFECT DIS, V46, P1617, DOI 10.1086/587660; Yang ZH, 2000, MOL BIOL EVOL, V17, P32, DOI 10.1093/oxfordjournals.molbev.a026236; Yang ZH, 1997, COMPUT APPL BIOSCI, V13, P555; Zhang LQ, 1997, J VIROL, V71, P2555, DOI 10.1128/JVI.71.3.2555-2561.1997; LANL HIV SEQUENCE DA	32	10	10	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7387	10.1371/journal.pone.0007387	http://dx.doi.org/10.1371/journal.pone.0007387			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816596	Green Published, Green Submitted, gold			2022-12-27	WOS:000270594300009
J	Nuijten, E; van Treuren, R; Struik, PC; Mokuwa, A; Okry, F; Teeken, B; Richards, P				Nuijten, Edwin; van Treuren, Robbert; Struik, Paul C.; Mokuwa, Alfred; Okry, Florent; Teeken, Bela; Richards, Paul			Evidence for the Emergence of New Rice Types of Interspecific Hybrid Origin in West African Farmers' Fields	PLOS ONE			English	Article							ORYZA-SATIVA-L; CULTIVATED RICE; POPULATION-STRUCTURE; GENETIC DIVERSITY; CHLOROPLAST DNA; FOOD SECURITY; UPLAND RICE; GLABERRIMA; INFERENCE; PROGENIES	In West Africa two rice species (Oryza glaberrima Steud. and Oryza sativa L.) co-exist. Although originally it was thought that interspecific hybridization is impossible without biotechnological methods, progenies of hybridization appear to occur in farmer fields. AFLP analysis was used to assess genetic diversity in West Africa (including the countries The Gambia, Senegal, Guinea Bissau, Guinea Conakry, Sierra Leone, Ghana and Togo) using 315 rice samples morphologically classified prior to analysis. We show evidence for farmer interspecific hybrids of African and Asian rice, resulting in a group of novel genotypes, and identify possible mechanisms for in-field hybridization. Spontaneous back-crossing events play a crucial role, resulting in different groups of genetic diversity in different regions developed by natural and cultural selection, often under adverse conditions. These new groups of genotypes may have potential relevance for exploitation by plant breeders. Future advances in crop development could be achieved through co-operation between scientists and marginalized farmer groups in order to address challenges of rapid adaptation in a world of increasing socio-political and climatic uncertainty.			Nuijten, E (corresponding author), Wageningen Univ, Technol & Agr Dev Grp, Wageningen, Netherlands.	Edwin.Nuijten@wur.nl		Teeken, Bela/0000-0002-3150-1532; Richards, Paul/0000-0001-5813-0228				Barry MB, 2007, EUPHYTICA, V154, P127, DOI 10.1007/s10681-006-9278-1; BOUHARMONT J, 1985, EUPHYTICA, V34, P75, DOI 10.1007/BF00022865; BRYDON L, 1981, AFRICA, V51, P658, DOI 10.2307/1158831; CHANG TT, 1976, EUPHYTICA, V25, P425, DOI 10.1007/BF00041576; CHU YE, 1970, EVOLUTION, V24, P344, DOI 10.2307/2406809; DALLY AM, 1990, THEOR APPL GENET, V80, P209, DOI 10.1007/BF00224389; Falush D, 2007, MOL ECOL NOTES, V7, P574, DOI 10.1111/j.1471-8286.2007.01758.x; HARLAN JR, 1971, SCIENCE, V174, P468, DOI 10.1126/science.174.4008.468; Huson DH, 2006, MOL BIOL EVOL, V23, P254, DOI 10.1093/molbev/msj030; ISHII T, 1988, JPN J GENET, V63, P523, DOI 10.1266/jjg.63.523; JONES M, 2004, INT YEAR RIC WORLD F; Jones MP, 1997, EUPHYTICA, V94, P237, DOI 10.1023/A:1002969932224; Jusu Malcolm, 1999, THESIS WAGENINGEN U; LONGLEY C, 1993, CULTIVATING KNOWLEDG, P51; Nei M., 1987, MOL EVOLUTIONARY GEN; Nuijten E, 2007, GENET RESOUR CROP EV, V54, P989, DOI 10.1007/s10722-006-9191-4; Nuijten Edwin, 2005, THESIS WAGENINGEN U; PHAM JL, 1993, HEREDITY, V70, P466, DOI 10.1038/hdy.1993.68; Pham JL, 1996, HEREDITAS, V124, P179, DOI 10.1111/j.1601-5223.1996.00179.x; PORTERES R, 1962, J AFR HIST, V3, P195, DOI 10.1017/S0021853700003030; Pritchard JK, 2000, GENETICS, V155, P945; Richards P, 2006, AFR SPECTR, V41, P77; Richards P., 1997, The ecology of practice: studies of food crop production in Sub-Saharan West Africa., P201; Richards P., 1986, COPING HUNGER HAZARD; Richards P, 2009, INT J TECHNOL MANAGE, V45, P196, DOI 10.1504/IJTM.2009.021528; SANO Y, 1989, HEREDITY, V63, P353, DOI 10.1038/hdy.1989.109; SANO Y, 1980, JPN J GENET, V55, P19, DOI 10.1266/jjg.55.19; SECOND G, 1982, JPN J GENET, V57, P25, DOI 10.1266/jjg.57.25; Semon M, 2005, GENETICS, V169, P1639, DOI 10.1534/genetics.104.033175; Spillane C, 2001, BROADENING GENETIC B, P25, DOI DOI 10.1079/9780851994116.0025; Sweeney MT, 2007, PLOS GENET, V3, P1418, DOI 10.1371/journal.pgen.0030133; YABUNO T, 1977, EUPHYTICA, V26, P451, DOI 10.1007/BF00027007	32	45	45	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7335	10.1371/journal.pone.0007335	http://dx.doi.org/10.1371/journal.pone.0007335			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806197	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593800025
J	Zong, F; Fthenou, E; Wolmer, N; Hollosi, P; Kovalszky, I; Szilak, L; Mogler, C; Nilsonne, G; Tzanakakis, G; Dobra, K				Zong, Fang; Fthenou, Eleni; Wolmer, Nina; Hollosi, Peter; Kovalszky, Ilona; Szilak, Laszlo; Mogler, Carolin; Nilsonne, Gustav; Tzanakakis, Georgios; Dobra, Katalin			Syndecan-1 and FGF-2, but Not FGF Receptor-1, Share a Common Transport Route and Co-Localize with Heparanase in the Nuclei of Mesenchymal Tumor Cells	PLOS ONE			English	Article							FIBROBLAST-GROWTH-FACTOR; SULFATE PROTEOGLYCANS; SURFACE; HEPARIN; BINDING; TRANSLOCATION; BFGF; ACCUMULATION; TRAFFICKING; MOLECULES	Syndecan-1 forms complexes with growth factors and their cognate receptors in the cell membrane. We have previously reported a tubulin-mediated translocation of syndecan-1 to the nucleus. The transport route and functional significance of nuclear syndecan-1 is still incompletely understood. Here we investigate the sub-cellular distribution of syndecan-1, FGF-2, FGFR-1 and heparanase in malignant mesenchymal tumor cells, and explore the possibility of their coordinated translocation to the nucleus. To elucidate a structural requirement for this nuclear transport, we have transfected cells with a syndecan-1/EGFP construct or with a short truncated version containing only the tubulin binding RMKKK sequence. The sub-cellular distribution of the EGFP fusion proteins was monitored by fluorescence microscopy. Our data indicate that syndecan-1, FGF-2 and heparanase co-localize in the nucleus, whereas FGFR-1 is enriched mainly in the perinuclear area. Overexpression of syndecan-1 results in increased nuclear accumulation of FGF-2, demonstrating the functional importance of syndecan-1 for this nuclear transport. Interestingly, exogenously added FGF-2 does not follow the route taken by endogenous FGF-2. Furthermore, we prove that the RMKKK sequence of syndecan-1 is necessary and sufficient for nuclear translocation, acting as a nuclear localization signal, and the Arginine residue is vital for this localization. We conclude that syndecan-1 and FGF-2, but not FGFR-1 share a common transport route and co-localize with heparanase in the nucleus, and this transport is mediated by the RMKKK motif in syndecan-1. Our study opens a new perspective in the proteoglycan field and provides more evidence of nuclear interactions of syndecan-1.			Zong, F (corresponding author), Huddinge Univ Hosp, Karolinska Inst, Div Pathol, Dept Lab Med, Stockholm, Sweden.	fang.zong@ki.se	Kovalszky, Ilona/ABH-2832-2020; Nilsonne, Gustav/C-4579-2008; Tzanakakis, George N/F-6955-2010; Szilak, Laszlo/T-1426-2017; zong, fang/GQZ-6104-2022; Tzanakakis, George/ABH-7725-2020	Kovalszky, Ilona/0000-0002-0179-3378; Tzanakakis, George N/0000-0001-5276-4764; Szilak, Laszlo/0000-0003-0334-272X; Tzanakakis, George/0000-0001-5276-4764; Fthenou, Eleni/0000-0002-1178-6841; Nilsonne, Gustav/0000-0001-5273-0150				AKNER G, 1990, EUR J CELL BIOL, V53, P390; BALDIN V, 1990, EMBO J, V9, P1511, DOI 10.1002/j.1460-2075.1990.tb08269.x; Beauvais DeannaLee M, 2004, Reprod Biol Endocrinol, V2, P3, DOI 10.1186/1477-7827-2-3; Bernfield M, 1999, ANNU REV BIOCHEM, V68, P729, DOI 10.1146/annurev.biochem.68.1.729; Bonnet H, 1996, J BIOL CHEM, V271, P24781, DOI 10.1074/jbc.271.40.24781; BOULIKAS T, 1994, J CELL BIOCHEM, V55, P32, DOI 10.1002/jcb.240550106; Brockstedt U, 2002, EXP CELL RES, V274, P235, DOI 10.1006/excr.2002.5477; Chen H, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006918; Cheng F, 2001, J CELL BIOCHEM, V83, P597, DOI 10.1002/jcb.1254; Dobra K, 2000, EXP CELL RES, V258, P12, DOI 10.1006/excr.2000.4915; ELENIUS K, 1994, J CELL SCI, V107, P2975; FEDARKO NS, 1989, J CELL PHYSIOL, V139, P287, DOI 10.1002/jcp.1041390210; Gingis-Velitski S, 2004, J BIOL CHEM, V279, P44084, DOI 10.1074/jbc.M402131200; Hodel MR, 2001, J BIOL CHEM, V276, P1317, DOI 10.1074/jbc.M008522200; Hsia E, 2003, J CELL BIOCHEM, V88, P1214, DOI 10.1002/jcb.10470; Ilan N, 2006, INT J BIOCHEM CELL B, V38, P2018, DOI 10.1016/j.biocel.2006.06.004; ISHIHARA M, 1989, J CELL PHYSIOL, V138, P467, DOI 10.1002/jcp.1041380305; Jans DA, 1998, BIOESSAYS, V20, P400, DOI 10.1002/(SICI)1521-1878(199805)20:5<400::AID-BIES7>3.0.CO;2-R; Joy A, 1997, ONCOGENE, V14, P171, DOI 10.1038/sj.onc.1200823; Keresztes M, 1999, J CELL BIOL, V145, P421, DOI 10.1083/jcb.145.3.421; Kilkenny DM, 1996, ENDOCRINOLOGY, V137, P5078, DOI 10.1210/en.137.11.5078; KLOMINEK J, 1989, CANCER RES, V49, P6118; Kolset SO, 2004, BIOCHEM J, V379, P217, DOI 10.1042/BJ20031230; Leadbeater WE, 2006, J NEUROCHEM, V96, P1189, DOI 10.1111/j.1471-4159.2005.03632.x; Liang Y, 1997, J CELL BIOL, V139, P851, DOI 10.1083/jcb.139.4.851; Liu DF, 2002, P NATL ACAD SCI USA, V99, P568, DOI 10.1073/pnas.012578299; Maher PA, 1996, J CELL BIOL, V134, P529, DOI 10.1083/jcb.134.2.529; Malecki J, 2004, MOL BIOL CELL, V15, P801, DOI 10.1091/mbc.E03-08-0589; PILLAI S, 1994, J INVEST DERMATOL, V103, P647, DOI 10.1111/1523-1747.ep12398386; Rahmoune H, 1998, J BIOL CHEM, V273, P7303, DOI 10.1074/jbc.273.13.7303; RAPRAEGER AC, 1991, SCIENCE, V252, P1705, DOI 10.1126/science.1646484; Reiland J, 2004, J BIOL CHEM, V279, P8047, DOI 10.1074/jbc.M304872200; Richardson TP, 2001, J CELL SCI, V114, P1613; ROGHANI M, 1992, J BIOL CHEM, V267, P22156; Schlessinger J, 2000, MOL CELL, V6, P743, DOI 10.1016/S1097-2765(00)00073-3; Schrage YM, 2009, AM J PATHOL, V174, P979, DOI 10.2353/ajpath.2009.080623; Sperinde GV, 1998, BIOCHEMISTRY-US, V37, P13153, DOI 10.1021/bi980600z; SPIVAKKROIZMAN T, 1994, CELL, V79, P1015, DOI 10.1016/0092-8674(94)90032-9; Stachowiak EK, 1997, ONCOGENE, V14, P2201, DOI 10.1038/sj.onc.1201057; Stachowiak MK, 2003, J CELL BIOCHEM, V90, P662, DOI 10.1002/jcb.10606; THURZO V, 1976, NEOPLASMA, V23, P577; Tkachenko E, 2005, CIRC RES, V96, P488, DOI 10.1161/01.RES.0000159708.71142.c8; Tumova S, 2000, INT J BIOCHEM CELL B, V32, P269, DOI 10.1016/S1357-2725(99)00116-8; Wiedlocha A, 2004, CURR TOP MICROBIOL, V286, P45; Xiao Z, 2003, J BIOL CHEM, V278, P21767, DOI 10.1074/jbc.M300229200; YAYON A, 1991, CELL, V64, P841, DOI 10.1016/0092-8674(91)90512-W; ZONG F, 2009, CELL PROLIF IN PRESS	47	58	62	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7346	10.1371/journal.pone.0007346	http://dx.doi.org/10.1371/journal.pone.0007346			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802384	Green Published, Green Submitted, gold			2022-12-27	WOS:000270593600015
J	Sartore-Bianchi, A; Di Nicolantonio, F; Nichelatti, M; Molinari, F; De Dosso, S; Saletti, P; Martini, M; Cipani, T; Marrapese, G; Mazzucchelli, L; Lamba, S; Veronese, S; Frattini, M; Bardelli, A; Siena, S				Sartore-Bianchi, Andrea; Di Nicolantonio, Federica; Nichelatti, Michele; Molinari, Francesca; De Dosso, Sara; Saletti, Piercarlo; Martini, Miriam; Cipani, Tiziana; Marrapese, Giovanna; Mazzucchelli, Luca; Lamba, Simona; Veronese, Silvio; Frattini, Milo; Bardelli, Alberto; Siena, Salvatore			Multi-Determinants Analysis of Molecular Alterations for Predicting Clinical Benefit to EGFR-Targeted Monoclonal Antibodies in Colorectal Cancer	PLOS ONE			English	Article								Background: KRAS mutations occur in 35-45% of metastatic colorectal cancers (mCRC) and preclude responsiveness to EGFR-targeted therapy with cetuximab or panitumumab. However, less than 20% patients displaying wild-type KRAS tumors achieve objective response. Alterations in other effectors downstream of the EGFR, such as BRAF, and deregulation of the PIK3CA/PTEN pathway have independently been found to give rise to resistance. We present a comprehensive analysis of KRAS, BRAF, PIK3CA mutations, and PTEN expression in mCRC patients treated with cetuximab or panitumumab, with the aim of clarifying the relative contribution of these molecular alterations to resistance. Methodology/Principal Findings: We retrospectively analyzed objective tumor response, progression-free (PFS) and overall survival ( OS) together with the mutational status of KRAS, BRAF, PIK3CA and expression of PTEN in 132 tumors from cetuximab or panitumumab treated mCRC patients. Among the 106 non-responsive patients, 74 (70%) had tumors with at least one molecular alteration in the four markers. The probability of response was 51% (22/43) among patients with no alterations, 4% (2/47) among patients with 1 alteration, and 0% (0/24) for patients with >= 2 alterations (p<0.0001). Accordingly, PFS and OS were increasingly worse for patients with tumors harboring none, 1, or >= 2 molecular alteration(s) (p<0.001). Conclusions/Significance: When expression of PTEN and mutations of KRAS, BRAF and PIK3CA are concomitantly ascertained, up to 70% of mCRC patients unlikely to respond to anti-EGFR therapies can be identified. We propose to define as 'quadruple negative', the CRCs lacking alterations in KRAS, BRAF, PTEN and PIK3CA. Comprehensive molecular dissection of the EGFR signaling pathways should be considered to select mCRC patients for cetuximab- or panitumumab-based therapies.			Sartore-Bianchi, A (corresponding author), Osped Niguarda Ca Granda, Falck Div Med Oncol, Milan, Italy.	a.bardelli@unito.it; salvatore.siena@ospedaleniguarda.it	Di Nicolantonio, Federica/A-2503-2011; Sartore-Bianchi, Andrea/AAB-9848-2019; SIENA, SALVATORE/AAC-5806-2019; BARDELLI, Alberto/J-9721-2018; Martini, Miriam/K-3053-2016	Di Nicolantonio, Federica/0000-0001-9618-2010; Sartore-Bianchi, Andrea/0000-0003-0780-0409; SIENA, SALVATORE/0000-0002-2681-2846; Lamba, Simona Elena/0000-0003-3207-1594; BARDELLI, Alberto/0000-0003-1647-5070; Martini, Miriam/0000-0002-4262-946X; Veronese, Silvio Marco/0000-0002-5280-3740	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Allegra CJ, 2009, J CLIN ONCOL, V27, P2091, DOI 10.1200/JCO.2009.21.9170; Amado RG, 2008, J CLIN ONCOL, V26, P1626, DOI 10.1200/JCO.2007.14.7116; Andreyev HJN, 1998, J NATL CANCER I, V90, P675, DOI 10.1093/jnci/90.9.675; Barault L, 2008, INT J CANCER, V122, P2255, DOI 10.1002/ijc.23388; Benvenuti S, 2007, CANCER RES, V67, P2643, DOI 10.1158/0008-5472.CAN-06-4158; Bokemeyer C, 2009, J CLIN ONCOL, V27, P663, DOI 10.1200/JCO.2008.20.8397; Cappuzzo F, 2008, ANN ONCOL, V19, P717, DOI 10.1093/annonc/mdm492; Cunningham D, 2004, NEW ENGL J MED, V351, P337, DOI 10.1056/NEJMoa033025; Di Nicolantonio F, 2008, J CLIN ONCOL, V26, P5705, DOI 10.1200/JCO.2008.18.0786; European Medicines Agency, EUR PUBL ASS REP; Frattini M, 2007, BRIT J CANCER, V97, P1139, DOI 10.1038/sj.bjc.6604009; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Jhawer M, 2008, CANCER RES, V68, P1953, DOI 10.1158/0008-5472.CAN-07-5659; Jonker DJ, 2007, NEW ENGL J MED, V357, P2040, DOI 10.1056/NEJMoa071834; Karakas B, 2006, BRIT J CANCER, V94, P455, DOI 10.1038/sj.bjc.6602970; Karapetis CS, 2008, NEW ENGL J MED, V359, P1757, DOI 10.1056/NEJMoa0804385; Lievre A, 2006, CANCER RES, V66, P3992, DOI 10.1158/0008-5472.CAN-06-0191; Linardou H, 2008, LANCET ONCOL, V9, P962, DOI 10.1016/S1470-2045(08)70206-7; Marchetti A, 2009, NEW ENGL J MED, V360, P833, DOI 10.1056/NEJMc082346; Meyerhardt JA, 2005, NEW ENGL J MED, V352, P476, DOI 10.1056/NEJMra040958; Moroni M, 2005, LANCET ONCOL, V6, P279, DOI 10.1016/S1470-2045(05)70102-9; Moroni M, 2008, LANCET ONCOL, V9, P402, DOI 10.1016/S1470-2045(08)70109-8; Ogino S, 2009, J CLIN ONCOL, V27, P1477, DOI 10.1200/JCO.2008.18.6544; Perrone F, 2009, ANN ONCOL, V20, P84, DOI 10.1093/annonc/mdn541; Personeni N, 2008, CLIN CANCER RES, V14, P5869, DOI 10.1158/1078-0432.CCR-08-0449; Pessino A, 2008, ANN ONCOL, V19, P711, DOI 10.1093/annonc/mdm516; Rajagopalan H, 2002, NATURE, V418, P934, DOI 10.1038/418934a; RODRIGUEZVICIANA P, 1994, NATURE, V370, P527, DOI 10.1038/370527a0; Samuels Y, 2005, CANCER CELL, V7, P561, DOI 10.1016/j.ccr.2005.05.014; Sargent DJ, 2005, J CLIN ONCOL, V23, P8664, DOI 10.1200/JCO.2005.01.6071; Sartore-Bianchi A, 2007, J CLIN ONCOL, V25, P3238, DOI 10.1200/JCO.2007.11.5956; Sartore-Bianchi A, 2009, CANCER RES, V69, P1851, DOI 10.1158/0008-5472.CAN-08-2466; Therasse P, 2000, J NATL CANCER I, V92, P205, DOI 10.1093/jnci/92.3.205; Tol J, 2009, NEW ENGL J MED, V361, P98, DOI 10.1056/NEJMc0904160; Van Cutsem E, 2007, J CLIN ONCOL, V25, P1658, DOI 10.1200/JCO.2006.08.1620; Van Cutsem E, 2009, NEW ENGL J MED, V360, P1408, DOI 10.1056/NEJMoa0805019; Yan J, 1998, J BIOL CHEM, V273, P24052, DOI 10.1074/jbc.273.37.24052; Zhang BH, 2000, EMBO J, V19, P5429, DOI 10.1093/emboj/19.20.5429	38	212	215	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7287	10.1371/journal.pone.0007287	http://dx.doi.org/10.1371/journal.pone.0007287			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19806185	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593300007
J	Xu, XM; Lin, H; Latijnhouwers, M; Moller, SG				Xu, Xiang Ming; Lin, Hong; Latijnhouwers, Maita; Moller, Simon Geir			Dual Localized AtHscB Involved in Iron Sulfur Protein Biogenesis in Arabidopsis	PLOS ONE			English	Article							CLUSTER BIOSYNTHETIC SCAFFOLD; SACCHAROMYCES-CEREVISIAE; ESCHERICHIA-COLI; THALIANA; CHLOROPLASTS; MECHANISMS; EUKARYOTES; FERREDOXIN; BACTERIA; GENE	Background: Iron-sulfur clusters are ubiquitous structures which act as prosthetic groups for numerous proteins involved in several fundamental biological processes including respiration and photosynthesis. Although simple in structure both the assembly and insertion of clusters into apoproteins requires complex biochemical pathways involving a diverse set of proteins. In yeast, the J-type chaperone Jac1 plays a key role in the biogenesis of iron sulfur clusters in mitochondria. Methodology/Principal Findings: In this study we demonstrate that AtHscB from Arabidopsis can rescue the Jac1 yeast knockout mutant suggesting a role for AtHscB in iron sulfur protein biogenesis in plants. In contrast to mitochondrial Jac1, AtHscB localizes to both mitochondria and the cytosol. AtHscB interacts with AtIscU1, an Isu-like scaffold protein involved in iron-sulfur cluster biogenesis, and through this interaction AtIscU1 is most probably retained in the cytosol. The chaperone AtHscA can functionally complement the yeast Ssq1knockout mutant and its ATPase activity is enhanced by AtHscB and AtIscU1. Interestingly, AtHscA is also localized in both mitochondria and the cytosol. Furthermore, AtHscB is highly expressed in anthers and trichomes and an AtHscB T-DNA insertion mutant shows reduced seed set, a waxless phenotype and inappropriate trichome development as well as dramatically reduced activities of the iron-sulfur enzymes aconitase and succinate dehydrogenase. Conclusions: Our data suggest that AtHscB together with AtHscA and AtIscU1 plays an important role in the biogenesis of iron-sulfur proteins in both mitochondria and the cytosol.			Xu, XM (corresponding author), Univ Stavanger, Ctr Organelle Res, Fac Sci & Technol, Stavanger, Norway.	simon.g.moller@uis.no		Moller, Simon/0000-0002-0460-3592	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abdel-Ghany SE, 2005, PLANT PHYSIOL, V138, P161, DOI 10.1104/pp.104.058602; Alonso JM, 2003, SCIENCE, V301, P653, DOI 10.1126/science.1086391; Amann K, 2004, PLANT CELL, V16, P3084, DOI 10.1105/tpc.104.024935; Ayala-Castro C, 2008, MICROBIOL MOL BIOL R, V72, P110, DOI 10.1128/MMBR.00034-07; Balk J, 2005, TRENDS PLANT SCI, V10, P324, DOI 10.1016/j.tplants.2005.05.002; Bandyopadhyay S, 2008, EMBO J, V27, P1122, DOI 10.1038/emboj.2008.50; Bandyopadhyay S, 2008, BIOCHEM SOC T, V36, P1112, DOI 10.1042/BST0361112; Barras F, 2005, ADV MICROB PHYSIOL, V50, P41, DOI 10.1016/S0065-2911(05)50002-X; Beinert H, 1997, SCIENCE, V277, P653, DOI 10.1126/science.277.5326.653; Bych K, 2008, J BIOL CHEM, V283, P35797, DOI 10.1074/jbc.M807303200; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Craig EA, 2002, CELL MOL LIFE SCI, V59, P1658, DOI 10.1007/PL00012493; Dutkiewicz R, 2003, J BIOL CHEM, V278, P29719, DOI 10.1074/jbc.M303527200; Emanuelsson O, 2000, J MOL BIOL, V300, P1005, DOI 10.1006/jmbi.2000.3903; Fontecave M, 2005, J BIOL INORG CHEM, V10, P713, DOI 10.1007/s00775-005-0025-1; Fontecave M, 2008, ARCH BIOCHEM BIOPHYS, V474, P226, DOI 10.1016/j.abb.2007.12.014; Frazzon APG, 2007, PLANT MOL BIOL, V64, P225, DOI 10.1007/s11103-007-9147-x; Frazzon J, 2002, BIOCHEM SOC T, V30, P680, DOI 10.1042/BST0300680; Frazzon J, 2003, CURR OPIN CHEM BIOL, V7, P166, DOI 10.1016/S1367-5931(03)00021-8; Hjorth E, 2005, FEBS LETT, V579, P1129, DOI 10.1016/j.febslet.2004.12.084; Johnson DC, 2005, ANNU REV BIOCHEM, V74, P247, DOI 10.1146/annurev.biochem.74.082803.133518; Kessler D, 2005, PHOTOSYNTH RES, V86, P391, DOI 10.1007/s11120-005-5913-2; Kost B, 1998, PLANT J, V16, P393, DOI 10.1046/j.1365-313x.1998.00304.x; Kushnir S, 2001, PLANT CELL, V13, P89, DOI 10.1105/tpc.13.1.89; Leon G, 2007, PLANT PHYSIOL, V143, P1534, DOI 10.1104/pp.106.095158; Leon S, 2005, FEBS LETT, V579, P1930, DOI 10.1016/j.febslet.2005.02.038; Leon S, 2003, BIOCHEM J, V371, P823, DOI 10.1042/BJ20021946; Leon S, 2002, BIOCHEM J, V366, P557, DOI 10.1042/BJ20020322; Lezhneva L, 2004, PLANT J, V37, P174, DOI 10.1046/j.1365-313X.2003.01952.x; Lill R, 2005, TRENDS BIOCHEM SCI, V30, P133, DOI 10.1016/j.tibs.2005.01.006; Lill R, 2008, ANNU REV BIOCHEM, V77, P669, DOI 10.1146/annurev.biochem.76.052705.162653; Lill R, 2006, ANNU REV CELL DEV BI, V22, P457, DOI 10.1146/annurev.cellbio.22.010305.104538; Merchant S, 1998, ANNU REV PLANT PHYS, V49, P25, DOI 10.1146/annurev.arplant.49.1.25; Millar AA, 1999, PLANT CELL, V11, P825, DOI 10.1105/tpc.11.5.825; Muhlenhoff U, 2003, EMBO J, V22, P4815, DOI 10.1093/emboj/cdg446; Nielsen H, 1997, Int J Neural Syst, V8, P581, DOI 10.1142/S0129065797000537; Pilon Marinus, 2006, Genet Eng (N Y), V27, P101, DOI 10.1007/0-387-25856-6_7; Pilon-Smits EAH, 2002, PLANT PHYSIOL, V130, P1309, DOI 10.1104/pp.010280; Rouault TA, 2005, NAT REV MOL CELL BIO, V6, P345, DOI 10.1038/nrm1620; Rouault TA, 2008, TRENDS GENET, V24, P398, DOI 10.1016/j.tig.2008.05.008; Silberg JJ, 2000, J BIOL CHEM, V275, P7779, DOI 10.1074/jbc.275.11.7779; Stehling Oliver, 2007, Methods Mol Biol, V372, P325, DOI 10.1007/978-1-59745-365-3_24; Studier FW, 2005, PROTEIN EXPRES PURIF, V41, P207, DOI 10.1016/j.pep.2005.01.016; Touraine B, 2004, PLANT J, V40, P101, DOI 10.1111/j.1365-313X.2004.02189.x; TSUGAMA D, 2009, BIOTECHNOL LETT; Vickery LE, 2007, CRIT REV BIOCHEM MOL, V42, P95, DOI 10.1080/10409230701322298; Voisine C, 2001, P NATL ACAD SCI USA, V98, P1483, DOI 10.1073/pnas.98.4.1483; Xu XM, 2008, CHEMBIOCHEM, V9, P2355, DOI 10.1002/cbic.200800384; Xu XM, 2006, EMBO J, V25, P900, DOI 10.1038/sj.emboj.7600968; Xu XM, 2005, J BIOL CHEM, V280, P6648, DOI 10.1074/jbc.M413082200; Xu XM, 2004, P NATL ACAD SCI USA, V101, P9143, DOI 10.1073/pnas.0400799101; Yabe T, 2006, BIOCHEM BIOPH RES CO, V340, P1047, DOI 10.1016/j.bbrc.2005.12.104; Yabe T, 2004, PLANT CELL, V16, P993, DOI 10.1105/tpc.020511; Yabe T, 2008, J MOL BIOL, V381, P160, DOI 10.1016/j.jmb.2008.05.072; Ye H, 2006, J BIOL CHEM, V281, P8958, DOI 10.1074/jbc.M512737200; Ye H, 2005, PLANTA, V220, P602, DOI 10.1007/s00425-004-1388-1; Ye H, 2006, NEW PHYTOL, V171, P285, DOI 10.1111/j.1469-8137.2006.01751.x; 2007, J BIOL CHEM, V282, P18254	58	23	24	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 29	2009	4	10							e7662	10.1371/journal.pone.0007662	http://dx.doi.org/10.1371/journal.pone.0007662			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	512FP	19865480	Green Submitted, Green Published, gold			2022-12-27	WOS:000271232000016
J	Guillaume, M; El Helou, N; Nassif, H; Berthelot, G; Len, S; Thibault, V; Tafflet, M; Quinquis, L; Desgorces, F; Hermine, O; Toussaint, JF				Guillaume, Marion; El Helou, Nour; Nassif, Hala; Berthelot, Geoffroy; Len, Stephane; Thibault, Valerie; Tafflet, Muriel; Quinquis, Laurent; Desgorces, Francois; Hermine, Olivier; Toussaint, Jean-Francois			Success in Developing Regions: World Records Evolution through a Geopolitical Prism	PLOS ONE			English	Article							PROGRESSION; SPORT	A previous analysis of World Records (WR) has revealed the potential limits of human physiology through athletes' personal commitment. The impact of political factors on sports has only been studied through Olympic medals and results. Here we studied 2876 WR from 63 nations in four summer disciplines. We propose three new indicators and show the impact of historical, geographical and economical factors on the regional WR evolution. The south-eastward path of weighted annual barycenter (i.e. the average of country coordinates weighting by the WR number) shows the emergence of East Africa and China in WR archives. Home WR ratio decreased from 79.9% before the second World War to 23.3% in 2008, underlining sports globalization. Annual Cumulative Proportions (ACP, i.e. the cumulative sum of the WR annual rate) highlight the regional rates of progression. For all regions, the mean slope of ACP during the Olympic era is 0.0101, with a maximum between 1950 and 1989 (0.0156). For European countries, this indicator reflects major historical events (slowdown for western countries after 1945, slowdown for eastern countries after 1990). Mean North-American ACP slope is 0.0029 over the century with an acceleration between 1950 and 1989 at 0.0046. Russia takes off in 1935 and slows down in 1988 (0.0038). For Eastern Europe, maximal progression is seen between 1970 and 1989 (0.0045). China starts in 1979 with a maximum between 1990 and 2008 (0.0021), while other regions have largely declined ( mean ACP slope for all other countries = 0.0011). A similar trend is observed for the evolution of the 10 best performers. The national analysis of WR reveals a precise and quantifiable link between the sport performances of a country, its historical or geopolitical context, and its steps of development.			Guillaume, M (corresponding author), INSEP, IRMES, Paris, France.	irmes@insep.fr	Helou, Nour El/AAH-6490-2021; Hermine, Olivier/Q-7072-2018	Helou, Nour El/0000-0002-6012-0042; Hermine, Olivier/0000-0003-2574-3874				Andreff M, 2008, REV ECON POLIT, V118, P135, DOI 10.3917/redp.182.0135; ANDREFF W, 2001, EC SPORT, P118; AUGUSTIN J.P., 2004, OLYMPISME BILAN ENJE; Bernard AB, 2004, REV ECON STAT, V86, P413, DOI 10.1162/003465304774201824; Berthelot G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001552; BORDRY P, 2008, BEIJING 2008 INSIGHT, P179; DEROOY C, 2008, LIFE EXPECTANCY GOVT; Desgorces FD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003653; Franke WW, 1997, CLIN CHEM, V43, P1262; *GIO, 2002, RES OL GAM CONF SPEC; GOODGAME C, 2008, HIGH TECH SWIMSUITS; HURTEBIZE C, 1999, GEOPOLITIQUE, V66, P35; Hwang DJ, 2008, CHINA PERSPECT, V1, P4; LEN S, 2009, BEIJING 2008 INSIGHT, P259; Nevill AM, 1999, SPORTS MED, V28, P221, DOI 10.2165/00007256-199928040-00001; R Core Team, 2018, R LANG ENV STAT COMP; RIASANOVSKY NV, 1993, HIST RUSSIA; RIORDAN J, 1993, J SPORT HIST, V20, P247; RIORDAN J, 1999, ISCPES BOOK SERIES; Roberts Geoffrey., 2006, STALINS WARS WORLD W; Thibault V, 2009, FUND CLIN PHARMACOL, V23, P88; Toussaint Huub M, 2002, Sports Biomech, V1, P1, DOI 10.1080/14763140208522783; Zinn H., 2005, PEOPLES HIST US 1942; CHIDLOWSKI AR LIFT H	24	14	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7573	10.1371/journal.pone.0007573	http://dx.doi.org/10.1371/journal.pone.0007573			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862324	Green Published, gold, Green Submitted			2022-12-27	WOS:000271194600005
J	Strandberg, L; Verdrengh, M; Enge, M; Andersson, N; Amu, S; Onnheim, K; Benrick, A; Brisslert, M; Bylund, J; Bokarewa, M; Nilsson, S; Jansson, JO				Strandberg, Louise; Verdrengh, Margareta; Enge, Maria; Andersson, Niklas; Amu, Sylvie; Onnheim, Karin; Benrick, Anna; Brisslert, Mikael; Bylund, Johan; Bokarewa, Maria; Nilsson, Staffan; Jansson, John-Olov			Mice Chronically Fed High-Fat Diet Have Increased Mortality and Disturbed Immune Response in Sepsis	PLOS ONE			English	Article							CHRONIC GRANULOMATOUS-DISEASE; NECROSIS-FACTOR-ALPHA; INDUCED OBESITY; ADIPOSE-TISSUE; BONE-MARROW; IKK-BETA; INFLAMMATION; DEFICIENCY; ACTIVATION; LEPTIN	Background: Sepsis is a potentially deadly disease that often is caused by gram-positive bacteria, in particular Staphylococcus aureus ( S. aureus). As there are few effective therapies for sepsis, increased basic knowledge about factors predisposing is needed. Methodology/Principal Findings: The purpose of this study was to study the effect of Western diet on mortality induced by intravenous S. aureus inoculation and the immune functions before and after bacterial inoculation. Here we show that C57Bl/6 mice on high-fat diet (HFD) for 8 weeks, like genetically obese Ob/Ob mice on low-fat diet (LFD), have increased mortality during S. aureus-induced sepsis compared with LFD-fed C57Bl/6 controls. Bacterial load in the kidneys 5-7 days after inoculation was increased 10-fold in HFD-fed compared with LFD-fed mice. At that time, HFD-fed mice had increased serum levels and fat mRNA expression of the immune suppressing cytokines interleukin-1 receptor antagonist (IL-1Ra) and IL-10 compared with LFD-fed mice. In addition, HFD-fed mice had increased serum levels of the pro-inflammatory IL-1 beta. Also, HFD-fed mice with and without infection had increased levels of macrophages in fat. The proportion and function of phagocytosing granulocytes, and the production of reactive oxygen species (ROS) by peritoneal lavage cells were decreased in HFD-fed compared with LFD-fed mice. Conclusions: Our findings imply that chronic HFD disturb several innate immune functions in mice, and impairs the ability to clear S. aureus and survive sepsis.			Strandberg, L (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol Endocrinol, Sahlgrenska Acad, Gothenburg, Sweden.	JOJ@medic.gu.se	Bokarewa, Maria I/A-8114-2019; Grahnemo, Louise/H-9407-2017	Bokarewa, Maria I/0000-0001-9424-5145; Grahnemo, Louise/0000-0001-5276-6612; Brisslert, Mikael/0000-0002-1412-5600; Nilsson, Staffan/0000-0003-4748-0446; Andersson, Niklas/0000-0002-3493-7358; Amu, Sylvie/0000-0001-9593-7952; Granhagen Onnheim, Karin/0000-0001-5415-6842				Amar S, 2007, P NATL ACAD SCI USA, V104, P20466, DOI 10.1073/pnas.0710335105; Arkan MC, 2005, NAT MED, V11, P191, DOI 10.1038/nm1185; Ashare A, 2005, AM J PHYSIOL-LUNG C, V288, pL633, DOI 10.1152/ajplung.00231.2004; Benfield T, 2007, CLIN MICROBIOL INFEC, V13, P257, DOI 10.1111/j.1469-0691.2006.01589.x; Bjorkman L, 2008, ARTHRITIS RHEUM-US, V58, P2931, DOI 10.1002/art.23941; Boxio R, 2004, J LEUKOCYTE BIOL, V75, P604, DOI 10.1189/jlb.0703340; Cai DS, 2005, NAT MED, V11, P183, DOI 10.1038/nm1166; Carlsson G, 2006, ACTA PAEDIATR, V95, P1526, DOI 10.1080/08035250601087607; Chida D, 2006, DIABETES, V55, P971, DOI 10.2337/diabetes.55.04.06.db05-1250; Chonchol M, 2006, SEMIN DIALYSIS, V19, P291, DOI 10.1111/j.1525-139X.2006.00175.x; Clark SR, 2007, NAT MED, V13, P463, DOI 10.1038/nm1565; Collins S, 2004, PHYSIOL BEHAV, V81, P243, DOI 10.1016/j.physbeh.2004.02.006; Dahlgren Claes, 2007, V412, P349, DOI 10.1007/978-1-59745-467-4_23; Deitch EA, 1998, SHOCK, V9, P1, DOI 10.1097/00024382-199801000-00001; Dixon JB, 2006, OBES SURG, V16, P251, DOI 10.1381/096089206776116453; Faggioni R, 1999, AM J PHYSIOL-REG I, V276, pR136, DOI 10.1152/ajpregu.1999.276.1.R136; Falagas ME, 2006, LANCET INFECT DIS, V6, P438, DOI 10.1016/S1473-3099(06)70523-0; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fessler BJ, 2002, BEST PRACT RES CL RH, V16, P281, DOI 10.1053/berh.2001.0226; Garcia MC, 2006, DIABETES, V55, P1205, DOI 10.2337/db05-1304; HOTAMISLIGIL GS, 1993, SCIENCE, V259, P87, DOI 10.1126/science.7678183; Hotchkiss RS, 2003, NEW ENGL J MED, V348, P138, DOI 10.1056/NEJMra021333; Itou T, 2006, CLIN VACCINE IMMUNOL, V13, P575, DOI 10.1128/CVI.13.5.575-583.2006; James WPT, 2008, OBES REV, V9, P6, DOI 10.1111/j.1467-789X.2007.00432.x; Jiang T, 2005, J BIOL CHEM, V280, P32317, DOI 10.1074/jbc.M500801200; Juge-Aubry CE, 2004, J CLIN ENDOCR METAB, V89, P2652, DOI 10.1210/jc.2003-031219; Juge-Aubry CE, 2005, CYTOKINE, V29, P270, DOI 10.1016/j.cyto.2004.10.017; Levy SB, 2004, NAT MED, V10, pS122, DOI 10.1038/nm1145; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Martin GS, 2003, NEW ENGL J MED, V348, P1546, DOI 10.1056/NEJMoa022139; Mikuls TR, 2003, BEST PRACT RES CL RH, V17, P729, DOI 10.1016/S1521-6942(03)00041-X; Mohamed-Ali V, 1997, J CLIN ENDOCR METAB, V82, P4196, DOI 10.1210/jc.82.12.4196; Netea MG, 2006, NAT MED, V12, P650, DOI 10.1038/nm1415; Perfetto SP, 2004, NAT REV IMMUNOL, V4, P648, DOI 10.1038/nri1416; POLLOCK JD, 1995, NAT GENET, V9, P202, DOI 10.1038/ng0295-202; Reed JA, 2005, J CLIN INVEST, V115, P3035, DOI 10.1172/JCI25681; Robinson SW, 2000, ANNU REV GENET, V34, P687, DOI 10.1146/annurev.genet.34.1.687; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Saito T, 2001, J DENT RES, V80, P1631, DOI 10.1177/00220345010800070701; Scheel-Toellner D, 2004, BLOOD, V104, P2557, DOI 10.1182/blood-2004-01-0191; Serhan CN, 2005, NAT IMMUNOL, V6, P1191, DOI 10.1038/ni1276; Shamshiev AT, 2007, J EXP MED, V204, P441, DOI 10.1084/jem.20061737; Song GY, 1999, SURGERY, V126, P378, DOI 10.1016/S0039-6060(99)70180-7; STARKIE R, 2003, FASEB J; Strandberg L, 2006, J CLIN ENDOCR METAB, V91, P2749, DOI 10.1210/jc.2005-2786; Verdrengh M, 1997, INFECT IMMUN, V65, P2517, DOI 10.1128/IAI.65.7.2517-2521.1997; Wallenius V, 2002, NAT MED, V8, P75, DOI 10.1038/nm0102-75; Weisberg SP, 2003, J CLIN INVEST, V112, P1796, DOI 10.1172/JCI200319246; Wellen KE, 2005, J CLIN INVEST, V115, P1111, DOI 10.1172/JCI200525102; WHO, 2003, WHO TECH REP SER, V916, P1; Winkelstein JA, 2000, MEDICINE, V79, P155, DOI 10.1097/00005792-200005000-00003; Xing Z, 1998, J CLIN INVEST, V101, P311, DOI 10.1172/JCI1368; Xu HY, 2003, J CLIN INVEST, V112, P1821, DOI 10.1172/JCI200319451; Zorriila EP, 2007, P NATL ACAD SCI USA, V104, P11097, DOI 10.1073/pnas.0611523104	55	72	74	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7605	10.1371/journal.pone.0007605	http://dx.doi.org/10.1371/journal.pone.0007605			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19865485	Green Submitted, Green Published, gold			2022-12-27	WOS:000271194600009
J	Yu, SB; Franceschi, RT; Luo, M; Fan, J; Jiang, D; Cao, HL; Kwon, TG; Lai, YM; Zhang, J; Patrene, K; Hankenson, K; Roodman, GD; Xiao, GZ				Yu, Shibing; Franceschi, Renny T.; Luo, Min; Fan, Jie; Jiang, Di; Cao, Huiling; Kwon, Tae-Geon; Lai, Yumei; Zhang, Jian; Patrene, Kenneth; Hankenson, Kurt; Roodman, G. David; Xiao, Guozhi			Critical Role of Activating Transcription Factor 4 in the Anabolic Actions of Parathyroid Hormone in Bone	PLOS ONE			English	Article							OSTEOCALCIN GENE-EXPRESSION; MULTIPLE SIGNALING PATHWAYS; RAT OSTEOBLASTIC CELLS; PROTEIN-KINASE; C-FOS; MESSENGER-RNA; CLEIDOCRANIAL DYSPLASIA; TARGETED DISRUPTION; FACTOR OSTERIX; IN-VITRO	Parathyroid hormone (PTH) is a potent anabolic agent for the treatment of osteoporosis. However, its mechanism of action in osteoblast and bone is not well understood. In this study, we show that the anabolic actions of PTH in bone are severely impaired in both growing and adult ovariectomized mice lacking bone-related activating transcription factor 4 (ATF4). Our study demonstrates that ATF4 deficiency suppresses PTH-stimulated osteoblast proliferation and survival and abolishes PTH-induced osteoblast differentiation, which, together, compromise the anabolic response. We further demonstrate that the PTH-dependent increase in osteoblast differentiation is correlated with ATF4-dependent up-regulation of Osterix. This regulation involves interactions of ATF4 with a specific enhancer sequence in the Osterix promoter. Furthermore, actions of PTH on Osterix require this same element and are associated with increased binding of ATF4 to chromatin. Taken together these experiments establish a fundamental role for ATF4 in the anabolic actions of PTH on the skeleton.			Yu, SB (corresponding author), Univ Pittsburgh, Dept Med, Pittsburgh, PA 15260 USA.	xiaog@upmc.edu	Hankenson, Kurt/AFS-9417-2022; Hankenson, Kurt/ABI-1547-2020; ZHANG, JIAN/Q-6334-2018; YU, SHIBING/B-7648-2012	Hankenson, Kurt/0000-0001-6361-143X; Kwon, Tae-Geon/0000-0003-2799-0510	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [R01AR059647] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK072230] Funding Source: NIH RePORTER; NIAMS NIH HHS [R01 AR059647] Funding Source: Medline; NIDDK NIH HHS [R01 DK072230-02, R01 DK072230-04, R01 DK072230-03, R01 DK072230, R01 DK072230-01A2, DK072230, R01 DK072230-02S1] Funding Source: Medline	NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		Banerjee C, 1996, P NATL ACAD SCI USA, V93, P4968, DOI 10.1073/pnas.93.10.4968; Banerjee C, 1997, J CELL BIOCHEM, V66, P1, DOI 10.1002/(SICI)1097-4644(19970701)66:1<1::AID-JCB1>3.0.CO;2-V; Bellido T, 2003, J BIOL CHEM, V278, P50259, DOI 10.1074/jbc.M307444200; Boguslawski G, 2000, J BIOL CHEM, V275, P999, DOI 10.1074/jbc.275.2.999; Boudreaux JM, 1996, J BIOL CHEM, V271, P7508, DOI 10.1074/jbc.271.13.7508; Calvi LM, 2001, J CLIN INVEST, V107, P277, DOI 10.1172/JCI11296; Calvi LM, 2003, NATURE, V425, P841, DOI 10.1038/nature02040; Carpio L, 2001, AM J PHYSIOL-ENDOC M, V281, pE489, DOI 10.1152/ajpendo.2001.281.3.E489; Chen C, 2004, J BIOL CHEM, V279, P29121, DOI 10.1074/jbc.M313000200; Chen HL, 2002, J BIOL CHEM, V277, P19374, DOI 10.1074/jbc.M108913200; Cole JA, 1999, ENDOCRINOLOGY, V140, P5771, DOI 10.1210/en.140.12.5771; DALONZO RC, 2001, J BIOL CHEM, V18, P18; Datta NS, 2007, J BONE MINER RES, V22, P951, DOI 10.1359/JBMR.070328; Demiralp B, 2002, ENDOCRINOLOGY, V143, P4038, DOI 10.1210/en.2002-220221; DEMPSTER DW, 1993, ENDOCR REV, V14, P690, DOI 10.1210/er.14.6.690; Dobreva G, 2006, CELL, V125, P971, DOI 10.1016/j.cell.2006.05.012; DUCY P, 1995, MOL CELL BIOL, V15, P1858; Ducy P, 1997, CELL, V89, P747, DOI 10.1016/S0092-8674(00)80257-3; Ducy P, 1999, GENE DEV, V13, P1025, DOI 10.1101/gad.13.8.1025; Elefteriou F, 2005, NATURE, V434, P514, DOI 10.1038/nature03398; Elefteriou F, 2006, CELL METAB, V4, P441, DOI 10.1016/j.cmet.2006.10.010; GONZALEZ GA, 1989, CELL, V59, P675, DOI 10.1016/0092-8674(89)90013-5; Hess J, 2001, J BIOL CHEM, V276, P20029, DOI 10.1074/jbc.M010601200; Hettmann T, 2000, DEV BIOL, V222, P110, DOI 10.1006/dbio.2000.9699; HOCK JM, 1988, ENDOCRINOLOGY, V122, P2899, DOI 10.1210/endo-122-6-2899; Hurley MM, 2006, BIOCHEM BIOPH RES CO, V341, P989, DOI 10.1016/j.bbrc.2006.01.044; Iida-Klein A, 2005, J ENDOCRINOL, V186, P549, DOI 10.1677/joe.1.06270; Iida-Klein A, 2002, J BONE MINER RES, V17, P808, DOI 10.1359/jbmr.2002.17.5.808; Jiang D, 2004, J BIOL CHEM, V279, P5329, DOI 10.1074/jbc.M311547200; Jilka RL, 1999, J CLIN INVEST, V104, P439, DOI 10.1172/JCI6610; Jilka RL, 2007, BONE, V40, P1434, DOI 10.1016/j.bone.2007.03.017; Kaback LA, 2008, J CELL BIOCHEM, V105, P219, DOI 10.1002/jcb.21816; Karsenty G, 2000, SEMIN CELL DEV BIOL, V11, P343, DOI 10.1006/scdb.2000.0188; Koh AJ, 1999, ENDOCRINOLOGY, V140, P3154, DOI 10.1210/en.140.7.3154; Komori T, 1997, CELL, V89, P755, DOI 10.1016/S0092-8674(00)80258-5; Krishnan V, 2003, MOL ENDOCRINOL, V17, P423, DOI 10.1210/me.2002-0225; Liu F, 2007, BONE, V40, P1135, DOI 10.1016/j.bone.2006.12.003; McCauley LK, 1997, ENDOCRINOLOGY, V138, P5427, DOI 10.1210/en.138.12.5427; McCauley LK, 2001, ENDOCRINOLOGY, V142, P1975, DOI 10.1210/en.142.5.1975; MCCAULEY LK, 1995, J BONE MINER RES, V10, P1243, DOI 10.1002/jbmr.5650100815; Miao DS, 2002, J CLIN INVEST, V109, P1173, DOI 10.1172/JCI200214817; Miao DS, 2005, J CLIN INVEST, V115, P2402, DOI 10.1172/JCI24918; Miyakoshi N, 2001, ENDOCRINOLOGY, V142, P4349, DOI 10.1210/en.142.10.4349; MOSEKILDE L, 1995, BONE, V16, P223, DOI 10.1016/8756-3282(94)00033-V; Mundlos S, 1997, CELL, V89, P773, DOI 10.1016/S0092-8674(00)80260-3; Nakashima K, 2002, CELL, V108, P17, DOI 10.1016/S0092-8674(01)00622-5; Neer RM, 2001, NEW ENGL J MED, V344, P1434, DOI 10.1056/NEJM200105103441904; Ogata Y, 2000, MATRIX BIOL, V19, P395, DOI 10.1016/S0945-053X(00)00085-8; Otto F, 1997, CELL, V89, P765, DOI 10.1016/S0092-8674(00)80259-7; PARFITT AM, 1987, J BONE MINER RES, V2, P595, DOI 10.1002/jbmr.5650020617; PARTRIDGE NC, 1981, ENDOCRINOLOGY, V108, P213, DOI 10.1210/endo-108-1-213; Pearman AT, 1996, J BIOL CHEM, V271, P25715, DOI 10.1074/jbc.271.41.25715; SCHMIDT IU, 1995, ENDOCRINOLOGY, V136, P5127, DOI 10.1210/en.136.11.5127; Selvamurugan N, 1998, J BIOL CHEM, V273, P10647, DOI 10.1074/jbc.273.17.10647; Swarthout JT, 2002, GENE, V282, P1, DOI 10.1016/S0378-1119(01)00798-3; Swarthout JT, 2001, J BIOL CHEM, V276, P7586, DOI 10.1074/jbc.M007400200; Tanaka S, 2004, J BONE MINER RES, V19, P1813, DOI 10.1359/JBMR.040808; Tanaka T, 1998, GENES CELLS, V3, P801, DOI 10.1046/j.1365-2443.1998.00230.x; TOMINAGA H, 2008, MOL BIOL CELL; van der Horst G, 2005, J BONE MINER RES, V20, P2233, DOI 10.1359/JBMR.050821; Wan M, 2008, GENE DEV, V22, P2968, DOI 10.1101/gad.1702708; Wang BL, 2006, J ENDOCRINOL INVEST, V29, P101, DOI 10.1007/BF03344081; Wang YH, 2005, J BONE MINER RES, V20, P5, DOI 10.1359/JBMR.041016; Xiao GZ, 1997, MOL ENDOCRINOL, V11, P1103, DOI 10.1210/me.11.8.1103; Xiao GZ, 2005, J BIOL CHEM, V280, P30689, DOI 10.1074/jbc.M500750200; Yang XG, 2004, CELL, V117, P387, DOI 10.1016/S0092-8674(04)00344-7; Yang XL, 2004, J BIOL CHEM, V279, P47109, DOI 10.1074/jbc.M410010200; Yu SB, 2008, ENDOCRINOLOGY, V149, P1960, DOI 10.1210/en.2007-1573; Yu SB, 2008, J BIOL CHEM, V283, P5542, DOI 10.1074/jbc.M705653200; Yu XP, 1997, ENDOCRINOLOGY, V138, P3085, DOI 10.1210/en.138.8.3085; Zhang C, 2008, P NATL ACAD SCI USA, V105, P6936, DOI 10.1073/pnas.0710831105; Zhang XY, 2008, J CELL BIOCHEM, V105, P885, DOI 10.1002/jcb.21888; Zhao WG, 2000, J CLIN INVEST, V106, P941, DOI 10.1172/JCI10158	73	55	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7583	10.1371/journal.pone.0007583	http://dx.doi.org/10.1371/journal.pone.0007583			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851510	gold, Green Published			2022-12-27	WOS:000271022300014
J	Borot, F; Vieu, DL; Faure, G; Fritsch, J; Colas, J; Moriceau, S; Baudouin-Legros, M; Brouillard, F; Ayala-Sanmartin, J; Touqui, L; Chanson, M; Edelman, A; Ollero, M				Borot, Florence; Vieu, Diane-Lore; Faure, Grazyna; Fritsch, Janine; Colas, Julien; Moriceau, Sandra; Baudouin-Legros, Maryvonne; Brouillard, Franck; Ayala-Sanmartin, Jesus; Touqui, Lhousseine; Chanson, Marc; Edelman, Aleksander; Ollero, Mario			Eicosanoid Release Is Increased by Membrane Destabilization and CFTR Inhibition in Calu-3 Cells	PLOS ONE			English	Article							CYTOSOLIC PHOSPHOLIPASE A(2); TRANSMEMBRANE CONDUCTANCE REGULATOR; NECROSIS-FACTOR-RECEPTOR; INNATE IMMUNE-RESPONSE; CYSTIC-FIBROSIS; EPITHELIAL-CELLS; GENE-EXPRESSION; PULMONARY INFLAMMATION; COX-2 EXPRESSION; LIPID RAFTS	The antiinflammatory protein annexin-1 (ANXA1) and the adaptor S100A10 (p11), inhibit cytosolic phospholipase A2 (cPLA2 alpha) by direct interaction. Since the latter is responsible for the cleavage of arachidonic acid at membrane phospholipids, all three proteins modulate eicosanoid production. We have previously shown the association of ANXA1 expression with that of CFTR, the multifactorial protein mutated in cystic fibrosis. This could in part account for the abnormal inflammatory status characteristic of this disease. We postulated that CFTR participates in the regulation of eicosanoid release by direct interaction with a complex containing ANXA1, p11 and cPLA2 alpha. We first analyzed by plasmon surface resonance the in vitro binding of CFTR to the three proteins. A significant interaction between p11 and the NBD1 domain of CFTR was found. We observed in Calu-3 cells a rapid and partial redistribution of all four proteins in detergent resistant membranes (DRM) induced by TNF-alpha. This was concomitant with increased IL-8 synthesis and cPLA2 alpha activation, ultimately resulting in eicosanoid (PGE2 and LTB4) overproduction. DRM destabilizing agent methyl-beta-cyclodextrin induced further cPLA2 alpha activation and eicosanoid release, but inhibited IL-8 synthesis. We tested in parallel the effect of short exposure of cells to CFTR inhibitors Inh172 and Gly-101. Both inhibitors induced a rapid increase in eicosanoid production. Longer exposure to Inh172 did not increase further eicosanoid release, but inhibited TNF-alpha-induced relocalization to DRM. These results show that (i) CFTR may form a complex with cPLA2 alpha and ANXA1 via interaction with p11, (ii) CFTR inhibition and DRM disruption induce eicosanoid synthesis, and (iii) suggest that the putative cPLA2/ANXA1/p11/CFTR complex may participate in the modulation of the TNF-alpha-induced production of eicosanoids, pointing to the importance of membrane composition and CFTR function in the regulation of inflammation mediator synthesis.			Borot, F (corresponding author), Univ Paris 05, INSERM, U845, Fac Med Paris Descartes, Paris, France.	mario.ollero@inserm.fr	Ollero, Mario/AAJ-3545-2020; Ollero, Mario/Q-6147-2018	Chanson, Marc/0000-0001-8104-2090; Ollero, Mario/0000-0003-3590-706X				Ayala-Sanmartin J, 2000, BIOCHEMISTRY-US, V39, P15190, DOI 10.1021/bi000764r; Bailleux A, 2004, BIOCHEM J, V378, P307, DOI 10.1042/BJ20031014; BAJMOCZI M, 2009, AM J PHYSL CELL PHYS; BASTIAN BC, 1993, J INVEST DERMATOL, V101, P359, DOI 10.1111/1523-1747.ep12365541; Bensalem N, 2005, MOL CELL PROTEOMICS, V4, P1591, DOI 10.1074/mcp.M500019-MCP200; BESANCON F, 1994, AM J PHYSIOL-CELL PH, V267, pC1398, DOI 10.1152/ajpcell.1994.267.5.C1398; Borthwick LA, 2007, MOL BIOL CELL, V18, P3388, DOI 10.1091/mbc.E07-02-0126; Brouillard F, 2001, CANCER RES, V61, P1693; Brouillard F, 2001, J BIOL CHEM, V276, P9486, DOI 10.1074/jbc.M006636200; Brouillard F, 2008, PROTEOM CLIN APPL, V2, P264, DOI 10.1002/prca.200780018; Buckland AG, 1998, BIOCHEM J, V329, P369; Cabrera-Poch N, 2004, J BIOL CHEM, V279, P28592, DOI 10.1074/jbc.M312242200; CHAP H, 1991, M S-MED SCI, V7, P8, DOI 10.4267/10608/4270; Chmiel JF, 2002, CLIN REV ALLERG IMMU, V23, P5, DOI 10.1385/CRIAI:23:1:005; Choi YA, 2004, EXP MOL MED, V36, P78, DOI 10.1038/emm.2004.11; de Coupade C, 2001, AM J PATHOL, V159, P1435, DOI 10.1016/S0002-9440(10)62530-8; DEBBAGHI A, 1992, J IMMUNOL, V149, P1374; Di A, 2006, NAT CELL BIOL, V8, P933, DOI 10.1038/ncb1456; Dudez T, 2008, BBA-MOL CELL RES, V1783, P779, DOI 10.1016/j.bbamcr.2008.01.007; Ganster RW, 2005, J INTERF CYTOK RES, V25, P707, DOI 10.1089/jir.2005.25.707; Grassme H, 2003, NAT MED, V9, P322, DOI 10.1038/nm823; GRELL M, 1995, CELL, V83, P793, DOI 10.1016/0092-8674(95)90192-2; Habib A, 2007, FASEB J, V21, P1665, DOI 10.1096/fj.06-6766com; Haggie PM, 2007, J BIOL CHEM, V282, P31422, DOI 10.1074/jbc.M705296200; Harder T, 2007, CURR OPIN IMMUNOL, V19, P470, DOI 10.1016/j.coi.2007.05.002; Hsieh HL, 2008, BBA-MOL CELL RES, V1783, P1563, DOI 10.1016/j.bbamcr.2008.03.016; Hueber AO, 2003, CELL DEATH DIFFER, V10, P7, DOI 10.1038/sj.cdd.4401155; HUGHES LK, 2004, VIRTUAL REPOSITORY C; Jupp OJ, 2003, BIOCHEM J, V374, P453, DOI 10.1042/BJ20030705; KHAN TZ, 1995, AM J RESP CRIT CARE, V151, P1075; Kim SW, 2001, J BIOL CHEM, V276, P15712, DOI 10.1074/jbc.M009905200; Klapisz E, 2000, J LIPID RES, V41, P1680; Koehler DR, 2004, AM J RESP CELL MOL, V31, P377, DOI 10.1165/rcmb.2004-0124TR; KONSTAN MW, 1993, AM REV RESPIR DIS, V148, P896, DOI 10.1164/ajrccm/148.4_Pt_1.896; Koumanov KS, 2004, SUB CELL BIOCHEM, V37, P153; Kowalski MP, 2004, J IMMUNOL, V172, P418, DOI 10.4049/jimmunol.172.1.418; La M, 2001, FASEB J, V15, P2247, DOI 10.1096/fj.01-0196com; Lipecka J, 2006, J PHARMACOL EXP THER, V317, P500, DOI 10.1124/jpet.105.097667; Liu J, 2005, J ALLERGY CLIN IMMUN, V115, P493, DOI 10.1016/j.jaci.2004.11.010; Ma TH, 2002, J CLIN INVEST, V110, P1651, DOI 10.1172/JCI200216112; Machen TE, 2006, AM J PHYSIOL-CELL PH, V291, pC218, DOI 10.1152/ajpcell.00605.2005; Medjane S, 2005, AM J PHYSIOL-LUNG C, V289, pL816, DOI 10.1152/ajplung.00466.2004; Meli R, 2000, LIFE SCI, V67, P2845, DOI 10.1016/S0024-3205(00)00871-7; Moon S, 1997, AM J PHYSIOL-LUNG C, V273, pL1208, DOI 10.1152/ajplung.1997.273.6.L1208; Ollero M, 2006, PROTEOMICS, V6, P4084, DOI 10.1002/pmic.200600028; PEREZ A, 2007, CELL MOL PHYSL, V292, pL383; Rao S, 2006, ARCH DIS CHILD, V91, P786, DOI 10.1136/adc.2004.069419; Ratjen F, 2006, PAEDIATR RESPIR REV, V7, pS70, DOI 10.1016/j.prrv.2006.04.170; Rhen T, 2005, NEW ENGL J MED, V353, P1711, DOI 10.1056/NEJMra050541; Rosenstein BJ, 1998, LANCET, V351, P277, DOI 10.1016/S0140-6736(97)09174-5; Rubin BK, 2003, CHEST, V123, P1792, DOI 10.1378/chest.123.6.1792; SHEN RQ, 1994, AM J PHYSIOL, V266, pL493, DOI 10.1152/ajplung.1994.266.5.L493; Tirouvanziam R, 2000, AM J RESP CELL MOL, V23, P121, DOI 10.1165/ajrcmb.23.2.4214; TOUQUI L, 1986, NATURE, V321, P177, DOI 10.1038/321177a0; Vij N, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004664; WALLNER BP, 1986, NATURE, V320, P77, DOI 10.1038/320077a0; Wang D, 2008, PFLUG ARCH EUR J PHY, V456, P929, DOI 10.1007/s00424-008-0460-2; Wu T, 1997, J BIOL CHEM, V272, P17145, DOI 10.1074/jbc.272.27.17145; Yu H, 2000, INFECT IMMUN, V68, P2142, DOI 10.1128/IAI.68.4.2142-2147.2000	59	25	26	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7116	10.1371/journal.pone.0007116	http://dx.doi.org/10.1371/journal.pone.0007116			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847291	Green Published, gold, Green Submitted			2022-12-27	WOS:000271022000002
J	Kurth-Nelson, Z; Redish, AD				Kurth-Nelson, Zeb; Redish, A. David			Temporal-Difference Reinforcement Learning with Distributed Representations	PLOS ONE			English	Article							MIDBRAIN DOPAMINE NEURONS; BASAL GANGLIA; REWARD-PREDICTION; FUTURE REWARDS; MODELS; HIPPOCAMPUS; DELAY; UNCERTAINTY; SEROTONIN; ADDICTION	Temporal-difference (TD) algorithms have been proposed as models of reinforcement learning (RL). We examine two issues of distributed representation in these TD algorithms: distributed representations of belief and distributed discounting factors. Distributed representation of belief allows the believed state of the world to distribute across sets of equivalent states. Distributed exponential discounting factors produce hyperbolic discounting in the behavior of the agent itself. We examine these issues in the context of a TD RL model in which state-belief is distributed over a set of exponentially-discounting "micro-Agents", each of which has a separate discounting factor (gamma). Each mu Agent maintains an independent hypothesis about the state of the world, and a separate value-estimate of taking actions within that hypothesized state. The overall agent thus instantiates a flexible representation of an evolving world-state. As with other TD models, the value-error (delta) signal within the model matches dopamine signals recorded from animals in standard conditioning reward-paradigms. The distributed representation of belief provides an explanation for the decrease in dopamine at the conditioned stimulus seen in overtrained animals, for the differences between trace and delay conditioning, and for transient bursts of dopamine seen at movement initiation. Because each mAgent also includes its own exponential discounting factor, the overall agent shows hyperbolic discounting, consistent with behavioral experiments.			Kurth-Nelson, Z (corresponding author), Univ Minnesota, Dept Neurosci, Minneapolis, MN 55455 USA.	redish@umn.edu			NATIONAL INSTITUTE ON DRUG ABUSE [R01DA024080] Funding Source: NIH RePORTER; NEI NIH HHS [T32 EY007133] Funding Source: Medline; NIDA NIH HHS [DA024080, R01 DA024080] Funding Source: Medline	NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission); NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA))		Ainslie G, 2004, SCIENCE, V306, P421, DOI 10.1126/science.1104884; Ainslie G., 1992, PICOECONOMICS; Alessi SM, 2003, BEHAV PROCESS, V64, P345, DOI 10.1016/S0376-6357(03)00150-5; ALEXANDER GE, 1990, TRENDS NEUROSCI, V13, P266, DOI 10.1016/0166-2236(90)90107-L; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; BADTKE SJ, 1995, ADV NEURAL INFORM PR, V7; Bayer HM, 2007, J NEUROPHYSIOL, V98, P1428, DOI 10.1152/jn.01140.2006; Bayer HM, 2005, NEURON, V47, P129, DOI 10.1016/j.neuron.2005.05.020; Beiser, 1995, MODELS INFORM PROCES, P215; Bell M G H, 1997, Q APPL MATH, P17, DOI 10.1090/qam/102435; Bertin M, 2007, NEURAL NETWORKS, V20, P668, DOI 10.1016/j.neunet.2007.04.028; Beylin AV, 2001, NEUROBIOL LEARN MEM, V76, P447, DOI 10.1006/nlme.2001.4039; Bremaud P., 1975, MARKOV CHAINS GIBBS, V19, P91, DOI DOI 10.1007/978-1-4757-3124-8; Cardinal RN, 2001, SCIENCE, V292, P2499, DOI 10.1126/science.1060818; Cheer JF, 2007, NEURON, V54, P237, DOI 10.1016/j.neuron.2007.03.021; DAS T, 1999, MANAGE SCI, V45, P575; Daw N., 2003, THESIS CARNEGIE MELL; Daw ND, 2006, NEURAL COMPUT, V18, P1637, DOI 10.1162/neco.2006.18.7.1637; Daw ND, 2002, NEURAL NETWORKS, V15, P603, DOI 10.1016/S0893-6080(02)00052-7; DAW ND, 2002, P 2 INT C DEV LEARN; Day JJ, 2007, NAT NEUROSCI, V10, P1020, DOI 10.1038/nn1923; Dayan P, 2001, COMPUTATIONAL NEUROS; Doya K, 1999, NEURAL NETWORKS, V12, P961, DOI 10.1016/S0893-6080(99)00046-5; Doya K, 2000, CURR OPIN NEUROBIOL, V10, P732, DOI 10.1016/S0959-4388(00)00153-7; Doya K, 2002, NEURAL COMPUT, V14, P1347, DOI 10.1162/089976602753712972; Doya K, 2000, AFFECTIVE MINDS, P101; DYAN P, 2002, ADV NEURAL INFORM PR, V14; Fiorillo CD, 2003, SCIENCE, V299, P1898, DOI 10.1126/science.1077349; Fiorillo CD, 2008, NAT NEUROSCI, V11, P966, DOI 10.1038/nn.2159; Fiorillo CD, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-7; Gallistel CR, 2000, PSYCHOL REV, V107, P289, DOI 10.1037/0033-295X.107.2.289; GIBBON J, 1988, PSYCHOL REV, V95, P102, DOI 10.1037/0033-295X.95.1.102; GRAYBIEL AM, 1991, BASAL GANGLIA, V3; Haber SN, 2000, J NEUROSCI, V20, P2369; Herrnstein RJ., 1997, MATCHING LAW; Hollerman JR, 1998, NAT NEUROSCI, V1, P304, DOI 10.1038/1124; Jackson JC, 2003, NETWORK-COMP NEURAL, V14, P629, DOI 10.1088/0954-898X/14/4/302; Johnson A, 2008, MECH INFORM PROCESSI, P95; Johnson A, 2005, HIPPOCAMPUS, V15, P86, DOI 10.1002/hipo.20033; Kacelnik A, 1997, Ciba Found Symp, V208, P51; Kakade S, 2002, NEURAL NETWORKS, V15, P549, DOI 10.1016/S0893-6080(02)00048-5; Kalenscher T, 2008, PROG NEUROBIOL, V84, P284, DOI 10.1016/j.pneurobio.2007.11.004; KAPLAN PS, 1984, ANIM LEARN BEHAV, V12, P142, DOI 10.3758/BF03213133; Kawato M, 2007, CURR OPIN NEUROBIOL, V17, P205, DOI 10.1016/j.conb.2007.03.004; Laibson DI, 1996, BEHAV BRAIN SCI, V19, P583, DOI 10.1017/S0140525X00043119; Levy WB, 2005, BIOL CYBERN, V92, P409, DOI 10.1007/s00422-005-0568-9; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; LJUNGBERG T, 1992, J NEUROPHYSIOL, V67, P145, DOI 10.1152/jn.1992.67.1.145; Ludvig EA, 2009, ADV NEURAL INFORM PR, V21, P993; Ludvig EA, 2008, NEURAL COMPUT, V20, P3034, DOI 10.1162/neco.2008.11-07-654; Mackintosh N. J., 1974, PSYCHOL ANIMAL LEARN; MADDEN G, IMPULSIVITY THEORY S; Madden GJ, 1999, EXP CLIN PSYCHOPHARM, V7, P284, DOI 10.1037/1064-1297.7.3.284; Mazur JE, 1997, ANIM LEARN BEHAV, V25, P131, DOI 10.3758/BF03199051; Mazur JE, 2001, PSYCHOL REV, V108, P96, DOI 10.1037/0033-295X.108.1.96; McClure SM, 2004, SCIENCE, V306, P503, DOI 10.1126/science.1100907; Mirenowicz J, 1996, NATURE, V379, P449, DOI 10.1038/379449a0; MIRENOWICZ J, 1994, J NEUROPHYSIOL, V72, P1024, DOI 10.1152/jn.1994.72.2.1024; Mitchell SH, 1999, PSYCHOPHARMACOLOGY, V146, P455, DOI 10.1007/PL00005491; Montague PR, 1996, J NEUROSCI, V16, P1936, DOI 10.1523/jneurosci.16-05-01936.1996; Niv Y, 2005, BEHAV BRAIN FUNCT, V1, DOI 10.1186/1744-9081-1-6; O'Doherty JP, 2003, NEURON, V38, P329, DOI 10.1016/S0896-6273(03)00169-7; O'Doherty JP, 2004, CURR OPIN NEUROBIOL, V14, P769, DOI 10.1016/j.conb.2004.10.016; Odum Amy L, 2002, Nicotine Tob Res, V4, P295, DOI 10.1080/14622200210141257; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Pastalkova E, 2008, SCIENCE, V321, P1322, DOI 10.1126/science.1159775; Pavlov I.P., 1927, CONDITIONED REFLEXES; Petry NM, 1998, ADDICTION, V93, P321, DOI 10.1046/j.1360-0443.1998.9333212.x; Phillips PEM, 2003, NATURE, V422, P614, DOI 10.1038/nature01566; Read D, 2001, J RISK UNCERTAINTY, V23, P5, DOI 10.1023/A:1011198414683; Redish A. D., 2010, IMPULSIVITY BEHAV NE, P123; Redish AD, 2007, PSYCHOL REV, V114, P784, DOI 10.1037/0033-295X.114.3.784; Redish AD, 2004, SCIENCE, V306, P1944, DOI 10.1126/science.1102384; Rescorla, 1972, CLASSICAL CONDITION, P64, DOI DOI 10.1101/GR.110528.110; Reynolds B, 2006, BEHAV PHARMACOL, V17, P651, DOI 10.1097/FBP.0b013e3280115f99; Roitman MF, 2004, J NEUROSCI, V24, P1265, DOI 10.1523/JNEUROSCI.3823-03.2004; Rubin DC, 1999, J EXP PSYCHOL LEARN, V25, P1161, DOI 10.1037/0278-7393.25.5.1161; Rubin DC, 1996, PSYCHOL REV, V103, P734, DOI 10.1037/0033-295X.103.4.734; Samejima K, 2005, SCIENCE, V310, P1337, DOI 10.1126/science.1115270; Samejima K, 2003, NEURAL NETWORKS, V16, P985, DOI 10.1016/S0893-6080(02)00235-6; Sanfey AG, 2006, TRENDS COGN SCI, V10, P108, DOI 10.1016/j.tics.2006.01.009; Schultz W, 1997, SCIENCE, V275, P1593, DOI 10.1126/science.275.5306.1593; Schultz W, 2004, CURR OPIN NEUROBIOL, V14, P139, DOI 10.1016/j.conb.2004.03.017; Schultz W, 2002, NEURON, V36, P241, DOI 10.1016/S0896-6273(02)00967-4; Schultz W, 2000, ANNU REV NEUROSCI, V23, P473, DOI 10.1146/annurev.neuro.23.1.473; Schultz W, 1998, J NEUROPHYSIOL, V80, P1, DOI 10.1152/jn.1998.80.1.1; Schweighofer N, 2006, PLOS COMPUT BIOL, V2, P1349, DOI 10.1371/journal.pcbi.0020152; Schweighofer N, 2008, J NEUROSCI, V28, P4528, DOI 10.1523/JNEUROSCI.4982-07.2008; Schweighofer N, 2007, ANN NY ACAD SCI, V1104, P289, DOI 10.1196/annals.1390.011; Self D, 2003, NATURE, V422, P573, DOI 10.1038/422573a; Shors TJ, 2004, TRENDS NEUROSCI, V27, P250, DOI 10.1016/j.tins.2004.03.007; Si J., 2004, HDB LEARNING APPROXI; SOLOMON PR, 1986, BEHAV NEUROSCI, V100, P729, DOI 10.1037/0735-7044.100.5.729; Sozou PD, 1998, P ROY SOC B-BIOL SCI, V265, P2015, DOI 10.1098/rspb.1998.0534; Staddon JER, 2003, ANNU REV PSYCHOL, V54, P115, DOI 10.1146/annurev.psych.54.101601.145124; Stephens DW, 1987, FORAGING THEORY; Strick PL, 1995, MODELS INFORM PROCES, P117; Stuber GD, 2005, NEURON, V46, P661, DOI 10.1016/j.neuron.2005.04.036; Suri RE, 1999, NEUROSCIENCE, V91, P871, DOI 10.1016/S0306-4522(98)00697-6; Suri RE, 2001, NEURAL COMPUT, V13, P841, DOI 10.1162/089976601300014376; Sutton R. S., 1992, MACHINE LEARNING, V8; Sutton R.S., 2015, REINFORCEMENT LEARNI, V2nd ed.; SUTTON RS, 1981, PSYCHOL REV, V88, P135, DOI 10.1037/0033-295X.88.2.135; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; TANAKA SC, 2004, SOC NEUR ABSTR; Thibaudeau G, 2007, BEHAV BRAIN RES, V185, P9, DOI 10.1016/j.bbr.2007.07.004; Vuchinich RE, 1998, EXP CLIN PSYCHOPHARM, V6, P292, DOI 10.1037/1064-1297.6.3.292; Wightman RM, 2007, EUR J NEUROSCI, V26, P2046, DOI 10.1111/j.1460-9568.2007.05772.x; Worgotter F, 2005, NEURAL COMPUT, V17, P245, DOI 10.1162/0899766053011555; Zemel RS, 1998, NEURAL COMPUT, V10, P403, DOI 10.1162/089976698300017818; [No title captured]	113	33	33	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7362	10.1371/journal.pone.0007362	http://dx.doi.org/10.1371/journal.pone.0007362			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509JT	19841749	Green Published, Green Submitted, gold			2022-12-27	WOS:000271012900006
J	Gilmore, S; Hofmann-Wellenhof, R; Muir, J; Soyer, HP				Gilmore, Stephen; Hofmann-Wellenhof, Rainer; Muir, Jim; Soyer, H. Peter			Lacunarity Analysis: A Promising Method for the Automated Assessment of Melanocytic Naevi and Melanoma	PLOS ONE			English	Article							PIGMENTED SKIN-LESIONS; ARTIFICIAL NEURAL-NETWORK; DIGITAL DERMOSCOPY ANALYSIS; IMAGE-ANALYSIS; EPILUMINESCENCE MICROSCOPY; DIAGNOSIS; COMPUTER; DIFFERENTIATION; PATTERN; SYSTEM	The early diagnosis of melanoma is critical to achieving reduced mortality and increased survival. Although clinical examination is currently the method of choice for melanocytic lesion assessment, there is a growing interest among clinicians regarding the potential diagnostic utility of computerised image analysis. Recognising that there exist significant shortcomings in currently available algorithms, we are motivated to investigate the utility of lacunarity, a simple statistical measure previously used in geology and other fields for the analysis of fractal and multi-scaled images, in the automated assessment of melanocytic naevi and melanoma. Digitised dermoscopic images of 111 benign melanocytic naevi, 99 dysplastic naevi and 102 melanomas were obtained over the period 2003 to 2008, and subject to lacunarity analysis. We found the lacunarity algorithm could accurately distinguish melanoma from benign melanocytic naevi or non-melanoma without introducing many of the limitations associated with other previously reported diagnostic algorithms. Lacunarity analysis suggests an ordering of irregularity in melanocytic lesions, and we suggest the clinical application of this ordering may have utility in the naked-eye dermoscopic diagnosis of early melanoma.			Gilmore, S (corresponding author), Univ Queensland, Sch Med, Princess Alexandra Hosp, Dermatol Res Ctr, Brisbane, Qld, Australia.	s.gilmore1@uq.edu.au	Muir, James B/ABI-2711-2020; Soyer, H. Peter/W-3791-2017; Soyer, H. Peter/E-6000-2010	Soyer, H. Peter/0000-0002-4770-561X; Soyer, H. Peter/0000-0002-4770-561X; Muir, James/0000-0003-3791-161X				ALLAIN C, 1991, PHYS REV A, V44, P3552, DOI 10.1103/PhysRevA.44.3552; Andreassi L, 1999, ARCH DERMATOL, V135, P1459, DOI 10.1001/archderm.135.12.1459; Argenziano G, 2003, J AM ACAD DERMATOL, V48, P679, DOI 10.1067/mjd.2003.281; Argenziano G, 2001, LANCET ONCOL, V2, P443, DOI 10.1016/S1470-2045(00)00422-8; Bauer P, 2000, MELANOMA RES, V10, P345, DOI 10.1097/00008390-200008000-00005; Benvenuto-Andrade C, 2007, ARCH DERMATOL, V143, P329, DOI 10.1001/archderm.143.3.329; Binder M, 1998, MELANOMA RES, V8, P261, DOI 10.1097/00008390-199806000-00009; BINDER M, 1994, BRIT J DERMATOL, V130, P460, DOI 10.1111/j.1365-2133.1994.tb03378.x; Blum A, 2004, BRIT J DERMATOL, V151, P1029, DOI 10.1111/j.1365-2133.2004.06210.x; CASCINELLI N, 1987, J AM ACAD DERMATOL, V16, P361, DOI 10.1016/S0190-9622(87)70050-4; Dougherty G, 2002, MED ENG PHYS, V24, P129, DOI 10.1016/S1350-4533(01)00106-0; Elbaum M, 2001, J AM ACAD DERMATOL, V44, P207, DOI 10.1067/mjd.2001.110395; Ernstoff MS, 2000, CLIN PLAST SURG, V27, P317; Fikrle T, 2007, J EUR ACAD DERMATOL, V21, P48, DOI 10.1111/j.1468-3083.2006.01864.x; GEFEN Y, 1983, PHYS REV LETT, V50, P145, DOI 10.1103/PhysRevLett.50.145; GREEN A, 1994, J AM ACAD DERMATOL, V31, P958, DOI 10.1016/S0190-9622(94)70264-0; GUTKOWITZKRUSIN D, 2007, COLOR ATLAS MELANOCY, P52; Hoffmann K, 2003, BRIT J DERMATOL, V149, P801, DOI 10.1046/j.1365-2133.2003.05547.x; Kittler H, 2002, LANCET ONCOL, V3, P159, DOI 10.1016/S1470-2045(02)00679-4; LIN B, 1986, J PHYS A-MATH GEN, V19, pL49, DOI 10.1088/0305-4470/19/2/005; Mandelbrot B, 1983, FRACTAL GEOMETRY NAT; Manousaki AG, 2006, INT J DERMATOL, V45, P402, DOI 10.1111/j.1365-4632.2006.02726.x; Manousaki AG, 2006, COMPUT BIOL MED, V36, P419, DOI 10.1016/j.compbiomed.2005.01.004; Menzies SW, 2005, ARCH DERMATOL, V141, P1388, DOI 10.1001/archderm.141.11.1388; Piantanelli A, 2005, MED BIOL ENG COMPUT, V43, P436, DOI 10.1007/BF02344723; Piccolo D, 2002, BRIT J DERMATOL, V147, P481, DOI 10.1046/j.1365-2133.2002.04978.x; Plotnick RE, 1996, PHYS REV E, V53, P5461, DOI 10.1103/PhysRevE.53.5461; Rubegni P, 2002, J INVEST DERMATOL, V119, P471, DOI 10.1046/j.1523-1747.2002.01835.x; Rubegni P, 2002, INT J CANCER, V101, P576, DOI 10.1002/ijc.10620; SCHINDEWOLF T, 1994, J AM ACAD DERMATOL, V31, P33, DOI 10.1016/S0190-9622(94)70132-6; Soyer HP, 2004, DERMATOLOGY, V208, P27, DOI 10.1159/000075042; Weinstock MA, 1999, AM J PREV MED, V17, P169, DOI 10.1016/S0749-3797(99)00077-X; Weishampel JF, 1998, INT J REMOTE SENS, V19, P1007, DOI 10.1080/014311698215847; Zalaudek I, 2007, ARCH DERMATOL, V143, P351, DOI 10.1001/archderm.143.3.351	34	31	31	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7449	10.1371/journal.pone.0007449	http://dx.doi.org/10.1371/journal.pone.0007449			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823688	Green Published, gold			2022-12-27	WOS:000270808300020
J	Johnson, KJ; Griswold, IJ; O'Hare, T; Corbin, AS; Loriaux, M; Deininger, MW; Druker, BJ				Johnson, Kara J.; Griswold, Ian J.; O'Hare, Thomas; Corbin, Amie S.; Loriaux, Marc; Deininger, Michael W.; Druker, Brian J.			A BCR-ABL Mutant Lacking Direct Binding Sites for the GRB2, CBL and CRKL Adapter Proteins Fails to Induce Leukemia in Mice	PLOS ONE			English	Article							CHRONIC MYELOGENOUS LEUKEMIA; TYROSINE KINASE-ACTIVITY; POSITIVE HUMAN LEUKEMIAS; PHILADELPHIA-CHROMOSOME; HEMATOPOIETIC-CELLS; SH2 DOMAIN; MYELOPROLIFERATIVE DISEASE; SIGNAL-TRANSDUCTION; TRANSFORMATION; ONCOGENE	The BCR-ABL tyrosine kinase is the defining feature of chronic myeloid leukemia (CML) and its kinase activity is required for induction of this disease. Current thinking holds that BCR-ABL forms a multi-protein complex that incorporates several substrates and adaptor proteins and is stabilized by multiple direct and indirect interactions. Signaling output from this highly redundant network leads to cellular transformation. Proteins known to be associated with BCR-ABL in this complex include: GRB2, c-CBL, p62(DOK), and CRKL. These proteins in turn, link BCR-ABL to various signaling pathways indicated in cellular transformation. In this study we show that a triple mutant of BCR-ABL with mutations of the direct binding sites for GRB2, CBL, p62(DOK) and CRKL, is defective for transformation of primary hematopoietic cells in vitro and in a murine CML model, while it retains the capacity to induce IL-3 independence in 32D cells. Compared to BCR-ABL, the triple mutant's ability to activate the MAP kinase and PI3-kinase pathways is severely compromised, while STAT5 phosphorylation is maintained, suggesting that the former are crucial for the transformation of primary cells, but dispensable for transformation of factor dependent cell lines. Our data suggest that inhibition of BCR-ABL-induced leukemia by disrupting protein interactions could be possible, but would require blocking of multiple sites.			Johnson, KJ (corresponding author), Oregon Hlth & Sci Univ, Knight Canc Inst, Div Hematol & Med Oncol, Portland, OR 97201 USA.	johnskar@ohsu.edu		Druker, Brian/0000-0001-8331-8206	NATIONAL CANCER INSTITUTE [R01CA065823] Funding Source: NIH RePORTER; Howard Hughes Medical Institute Funding Source: Medline; NCI NIH HHS [R01 CA065823, R01 CA65823] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Howard Hughes Medical Institute(Howard Hughes Medical Institute); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Bhat A, 1997, J BIOL CHEM, V272, P16170, DOI 10.1074/jbc.272.26.16170; Bhat A, 1998, J BIOL CHEM, V273, P32360, DOI 10.1074/jbc.273.48.32360; Brasher BB, 2000, J BIOL CHEM, V275, P35631, DOI 10.1074/jbc.M005401200; Cheng AM, 1998, CELL, V95, P793, DOI 10.1016/S0092-8674(00)81702-X; CORTEZ D, 1995, MOL CELL BIOL, V15, P5531; Dai ZH, 2001, J BIOL CHEM, V276, P28954, DOI 10.1074/jbc.M101170200; DALEY GQ, 1988, P NATL ACAD SCI USA, V85, P9312, DOI 10.1073/pnas.85.23.9312; DALEY GQ, 1990, SCIENCE, V247, P824, DOI 10.1126/science.2406902; Dinulescu DM, 2003, ONCOGENE, V22, P8852, DOI 10.1038/sj.onc.1206892; Gaston I, 2004, EXP HEMATOL, V32, P113, DOI 10.1016/j.exphem.2003.09.018; GISHIZKY ML, 1993, P NATL ACAD SCI USA, V90, P3755, DOI 10.1073/pnas.90.8.3755; GOGA A, 1995, CELL, V82, P981, DOI 10.1016/0092-8674(95)90277-5; Gotoh A, 1997, Curr Opin Hematol, V4, P3; GREENBERGER JS, 1983, P NATL ACAD SCI-BIOL, V80, P2931, DOI 10.1073/pnas.80.10.2931; Heaney C, 1997, BLOOD, V89, P297, DOI 10.1182/blood.V89.1.297.297_297_306; ILARIA RL, 1995, BLOOD, V86, P3897, DOI 10.1182/blood.V86.10.3897.bloodjournal86103897; Kang JX, 2005, CARCINOGENESIS, V26, P1934, DOI 10.1093/carcin/bgi154; Kardinal C, 2001, BLOOD, V98, P1773, DOI 10.1182/blood.V98.6.1773; KELLIHER MA, 1990, P NATL ACAD SCI USA, V87, P6649, DOI 10.1073/pnas.87.17.6649; KOTANI H, 1994, HUM GENE THER, V5, P19, DOI 10.1089/hum.1994.5.1-19; LOZZIO CB, 1975, BLOOD, V45, P321, DOI 10.1182/blood.V45.3.321.321; LUGO TG, 1990, SCIENCE, V247, P1079, DOI 10.1126/science.2408149; LUGO TG, 1989, MOL CELL BIOL, V9, P1263, DOI 10.1128/MCB.9.3.1263; MCLAUGHLIN J, 1987, P NATL ACAD SCI USA, V84, P6558, DOI 10.1073/pnas.84.18.6558; MCWHIRTER JR, 1993, EMBO J, V12, P1533, DOI 10.1002/j.1460-2075.1993.tb05797.x; Million RP, 2002, BLOOD, V99, P4568, DOI 10.1182/blood-2001-12-0244; Million RP, 2000, BLOOD, V96, P664; MOSMANN T, 1983, J IMMUNOL METHODS, V65, P55, DOI 10.1016/0022-1759(83)90303-4; MULLER AJ, 1991, MOL CELL BIOL, V11, P1785, DOI 10.1128/MCB.11.4.1785; O'Hare T, 2005, CANCER RES, V65, P4500, DOI 10.1158/0008-5472.CAN-05-0259; ODA T, 1995, LEUKEMIA, V9, P295; Onishi M, 1998, MOL CELL BIOL, V18, P3871, DOI 10.1128/MCB.18.7.3871; PEAR WS, 1993, P NATL ACAD SCI USA, V90, P8392, DOI 10.1073/pnas.90.18.8392; PENDERGAST AM, 1993, CELL, V75, P175, DOI 10.1016/S0092-8674(05)80094-7; PUIL L, 1994, EMBO J, V13, P764, DOI 10.1002/j.1460-2075.1994.tb06319.x; Raitano AB, 1997, BBA-REV CANCER, V1333, pF201, DOI 10.1016/S0304-419X(97)00023-1; Roumiantsev S, 2001, BLOOD, V97, P4, DOI 10.1182/blood.V97.1.4; SALGIA R, 1995, J BIOL CHEM, V270, P5039, DOI 10.1074/jbc.270.10.5039; Sattler M, 2002, CANCER CELL, V1, P479, DOI 10.1016/S1535-6108(02)00074-0; Sattler M, 1996, ONCOGENE, V12, P839; Sattler Martin, 1997, Cytokine and Growth Factor Reviews, V8, P63, DOI 10.1016/S1359-6101(96)00047-0; Sawyers CL, 1997, BAILLIERE CLIN HAEM, V10, P223, DOI 10.1016/S0950-3536(97)80004-2; Senechal K, 1998, MOL CELL BIOL, V18, P5082, DOI 10.1128/MCB.18.9.5082; Senechal K, 1996, J BIOL CHEM, V271, P23255, DOI 10.1074/jbc.271.38.23255; Shah K, 2002, CHEM BIOL, V9, P35, DOI 10.1016/S1074-5521(02)00086-8; Skorski T, 1997, EMBO J, V16, P6151, DOI 10.1093/emboj/16.20.6151; Zhang XW, 1998, BLOOD, V92, P3829, DOI 10.1182/blood.V92.10.3829	47	20	20	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7439	10.1371/journal.pone.0007439	http://dx.doi.org/10.1371/journal.pone.0007439			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823681	gold, Green Submitted, Green Published			2022-12-27	WOS:000270808300015
J	Sumner, MD; Wotherspoon, SJ; Hindell, MA				Sumner, Michael D.; Wotherspoon, Simon J.; Hindell, Mark A.			Bayesian Estimation of Animal Movement from Archival and Satellite Tags	PLOS ONE			English	Article							SOUTHERN ELEPHANT SEALS; SURFACE TEMPERATURE; LOCATION ACCURACY; FORAGING ECOLOGY; GREY SEALS; GEOLOCATION; INFERENCE; MODEL; MIGRATIONS; SEABIRDS	The reliable estimation of animal location, and its associated error is fundamental to animal ecology. There are many existing techniques for handling location error, but these are often ad hoc or are used in isolation from each other. In this study we present a Bayesian framework for determining location that uses all the data available, is flexible to all tagging techniques, and provides location estimates with built-in measures of uncertainty. Bayesian methods allow the contributions of multiple data sources to be decomposed into manageable components. We illustrate with two examples for two different location methods: satellite tracking and light level geo-location. We show that many of the problems with uncertainty involved are reduced and quantified by our approach. This approach can use any available information, such as existing knowledge of the animal's potential range, light levels or direct location estimates, auxiliary data, and movement models. The approach provides a substantial contribution to the handling uncertainty in archival tag and satellite tracking data using readily available tools.			Sumner, MD (corresponding author), Univ Tasmania, Michael D Sumner Sch Math & Phys IASOS, Hobart, Tas, Australia.	mdsumner@utas.edu.au	Wotherspoon, Simon J/B-2390-2013; Hindell, Mark A/K-1131-2013; Hindell, Mark A/C-8368-2013	Wotherspoon, Simon J/0000-0002-6947-4445; Sumner, Michael/0000-0002-2471-7511; Hindell, Mark/0000-0002-7823-7185				Austin D, 2003, MAR MAMMAL SCI, V19, P371, DOI 10.1111/j.1748-7692.2003.tb01115.x; Best NG, 1995, CODA CONVERGENCE DIA; Block BA, 2002, OCEANOL ACTA, V25, P255, DOI 10.1016/S0399-1784(02)01212-4; Bradshaw CJA, 2002, ICES J MAR SCI, V59, P770, DOI 10.1006/jmsc.2002.1246; Bradshaw Corey J.A., 2006, P889; Brothers NP, 1997, EMU, V97, P231; CROXALL J, 2004, RES GLOB PROC TRACK; DELONG RL, 1992, MAR MAMMAL SCI, V8, P155, DOI 10.1111/j.1748-7692.1992.tb00375.x; Dixon P, 1996, ECOL APPL, V6, P1034, DOI 10.2307/2269587; DOMEIER ML, 2005, FISHERY B, V108, P292; Dorazio RM, 2003, ECOL APPL, V13, P556, DOI 10.1890/1051-0761(2003)013[0556:BIADTA]2.0.CO;2; EKSTROM P, 2002, P INT SOC OPTICAL EN, V4815; Ekstrom Philip A., 2004, Memoirs of National Institute of Polar Research Special Issue, V58, P210; Ellison AM, 2004, ECOL LETT, V7, P509, DOI 10.1111/j.1461-0248.2004.00603.x; Ellison AM, 1996, ECOL APPL, V6, P1036, DOI 10.2307/2269588; Gelman A., 2004, BAYESIAN DATA ANAL; Gilks W.R., 1995, MARKOV CHAIN MONTE C, P1; Gunn JS, 2003, MAR FRESHWATER RES, V54, P515, DOI 10.1071/MF03022; Halpin PN, 2006, MAR ECOL PROG SER, V316, P239, DOI 10.3354/meps316239; Hays GC, 2001, ANIM BEHAV, V61, P1035, DOI 10.1006/anbe.2001.1685; Hill C., 2001, ELECT TAGGING TRACKI, P315, DOI DOI 10.1007/978-94-017-1402-0_17; Hill Roger D., 1994, P227; HINDELL MA, 1991, AUST J MAR FRESH RES, V42, P115; Hindell MA, 2003, J APPL ECOL, V40, P703, DOI 10.1046/j.1365-2664.2003.00832.x; Hunter J. R., 1986, DYNAMICS TUNA MOVEME; Jonsen ID, 2005, ECOLOGY, V86, P2874, DOI 10.1890/04-1852; Jonsen ID, 2003, ECOLOGY, V84, P3055, DOI 10.1890/02-0670; Lake S, 2005, ECOGRAPHY, V28, P295, DOI 10.1111/j.0906-7590.2005.03949.x; Matthiopoulos J, 2005, J ANIM ECOL, V74, P716, DOI 10.1111/j.1365-2656.2005.00970.x; Matthiopoulos J, 2004, J APPL ECOL, V41, P476, DOI 10.1111/j.0021-8901.2004.00911.x; Matthiopoulos J, 2003, OIKOS, V102, P367, DOI 10.1034/j.1600-0706.2003.12528.x; MCCONNELL BJ, 1992, ANTARCT SCI, V4, P393, DOI 10.1017/S0954102092000580; MEEUS J, 1991, ASTRONOMICAL ALGORIT, V477; Nel DC, 2002, IBIS, V144, pE141, DOI 10.1046/j.1474-919X.2002.00092.x; Nielsen A, 2006, FISH OCEANOGR, V15, P314, DOI 10.1111/j.1365-2419.2005.00401.x; ORSI AH, 1995, DEEP-SEA RES PT I, V42, P641, DOI 10.1016/0967-0637(95)00021-W; Ovaskainen O, 2008, ECOLOGY, V89, P542, DOI 10.1890/07-0443.1; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Plummer M., 2006, R NEWS, V6, P7, DOI DOI 10.1159/000323281; Roberts S, 2004, J THEOR BIOL, V227, P39, DOI 10.1016/j.jtbi.2003.07.002; Royer F, 2005, OIKOS, V109, P473, DOI 10.1111/j.0030-1299.2005.13777.x; *SERV ARG, 2004, US MAN COLL LOC SAT; Smith Paul, 1986, DETERMINING FISH MOV; Sumner MD, 2003, REMOTE SENS ENVIRON, V84, P161, DOI 10.1016/S0034-4257(02)00103-7; Teo SLH, 2004, MAR ECOL PROG SER, V283, P81, DOI 10.3354/meps283081; Thompson D, 2003, MAR ECOL PROG SER, V260, P285, DOI 10.3354/meps260285; Tremblay Y, 2006, J EXP BIOL, V209, P128, DOI 10.1242/jeb.01970; Turchin Peter, 1998; van den Hoff J, 2002, ANTARCT SCI, V14, P134, DOI 10.1017/S095410200200069X; Vincent C, 2002, MAR MAMMAL SCI, V18, P156, DOI 10.1111/j.1748-7692.2002.tb01025.x; Viswanathan GM, 2000, PHYSICA A, V282, P1, DOI 10.1016/S0378-4371(00)00071-6; Wentz EA, 2003, INT J GEOGR INF SCI, V17, P623, DOI 10.1080/1365881031000135492; Wessel P, 1996, J GEOPHYS RES-SOL EA, V101, P8741, DOI 10.1029/96JB00104; White NA, 2002, POLAR BIOL, V25, P629, DOI 10.1007/s00300-002-0385-8; Wintle BA, 2003, CONSERV BIOL, V17, P1579, DOI 10.1111/j.1523-1739.2003.00614.x; Wood AG, 2000, J AVIAN BIOL, V31, P278, DOI 10.1034/j.1600-048X.2000.310302.x; Xavier JC, 2004, FISH OCEANOGR, V13, P324, DOI 10.1111/j.1365-2419.2004.00298.x	57	113	119	0	34	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7324	10.1371/journal.pone.0007324	http://dx.doi.org/10.1371/journal.pone.0007324			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823684	Green Published, gold, Green Accepted			2022-12-27	WOS:000270808300004
J	Singh, R; Lemire, J; Mailloux, RJ; Chenier, D; Hamel, R; Appanna, VD				Singh, Ranji; Lemire, Joseph; Mailloux, Ryan J.; Chenier, Daniel; Hamel, Robert; Appanna, Vasu D.			An ATP and Oxalate Generating Variant Tricarboxylic Acid Cycle Counters Aluminum Toxicity in Pseudomonas fluorescens	PLOS ONE			English	Article								Although the tricarboxylic acid (TCA) cycle is essential in almost all aerobic organisms, its precise modulation and integration in global cellular metabolism is not fully understood. Here, we report on an alternative TCA cycle uniquely aimed at generating ATP and oxalate, two metabolites critical for the survival of Pseudomonas fluorescens. The upregulation of isocitrate lyase (ICL) and acylating glyoxylate dehydrogenase (AGODH) led to the enhanced synthesis of oxalate, a dicarboxylic acid involved in the immobilization of aluminum (Al). The increased activity of succinyl-CoA synthetase (SCS) and oxalate CoA-transferase (OCT) in the Al-stressed cells afforded an effective route to ATP synthesis from oxalyl-CoA via substrate level phosphorylation. This modified TCA cycle with diminished efficacy in NADH production and decreased CO(2)-evolving capacity, orchestrates the synthesis of oxalate, NADPH, and ATP, ingredients pivotal to the survival of P. fluorescens in an Al environment. The channeling of succinyl-CoA towards ATP formation may be an important function of the TCA cycle during anaerobiosis, Fe starvation and O(2)-limited conditions.			Singh, R (corresponding author), Laurentian Univ, Dept Chem & Biochem, Sudbury, ON P3E 2C6, Canada.	vappanna@laurentian.ca		Appanna, Vasu/0000-0002-0138-5665; Mailloux, Ryan/0000-0003-3986-9830				ANDERSON S, 1992, FEBS LETT, V308, P94, DOI 10.1016/0014-5793(92)81059-U; Appanna VD, 2003, CURR MICROBIOL, V47, P521, DOI 10.1007/s00284-003-4100-y; Atamna H, 2002, P NATL ACAD SCI USA, V99, P14807, DOI 10.1073/pnas.192585799; Baysse C, 2001, FEMS MICROBIOL LETT, V205, P57, DOI 10.1016/S0378-1097(01)00441-4; Bochud-Allemann N, 2002, J BIOL CHEM, V277, P32849, DOI 10.1074/jbc.M205776200; Bott M, 2007, TRENDS MICROBIOL, V15, P417, DOI 10.1016/j.tim.2007.08.004; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Chenier D, 2008, APPL ENVIRON MICROB, V74, P3977, DOI 10.1128/AEM.02702-07; DIJKHUIZEN L, 1980, ARCH MICROBIOL, V124, P261, DOI 10.1007/BF00427736; Fernie AR, 2004, CURR OPIN PLANT BIOL, V7, P254, DOI 10.1016/j.pbi.2004.03.007; Fraser ME, 2006, J BIOL CHEM, V281, P11058, DOI 10.1074/jbc.M511785200; Gaballa A, 2008, P NATL ACAD SCI USA, V105, P11927, DOI 10.1073/pnas.0711752105; GUCHHAIT RB, 1974, J BIOL CHEM, V249, P6646; Hamel R, 2003, BBA-GEN SUBJECTS, V1619, P70, DOI 10.1016/S0304-4165(02)00444-0; Hamel R, 2004, BIOCHEM BIOPH RES CO, V317, P1189, DOI 10.1016/j.bbrc.2004.03.157; Hugler M, 2005, J BACTERIOL, V187, P3020, DOI 10.1128/JB.187.9.3020-3027.2005; HUNGERER C, 1995, J BACTERIOL, V177, P1435, DOI 10.1128/jb.177.6.1435-1443.1995; Kern A, 2007, J BIOTECHNOL, V129, P6, DOI 10.1016/j.jbiotec.2006.11.021; Kibbey RG, 2007, CELL METAB, V5, P253, DOI 10.1016/j.cmet.2007.02.008; KREBS A, 1974, CAN J BIOCHEM CELL B, V52, P594, DOI 10.1139/o74-086; Lambeth DO, 2004, J BIOL CHEM, V279, P36621, DOI 10.1074/jbc.M406884200; Lorenz MC, 2001, NATURE, V412, P83, DOI 10.1038/35083594; Mailloux RJ, 2008, ELECTROPHORESIS, V29, P1484, DOI 10.1002/elps.200700697; Mailloux RJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000690; Mailloux RJ, 2007, TOXICOL IN VITRO, V21, P16, DOI 10.1016/j.tiv.2006.07.013; Mailloux RJ, 2006, J BIOCHEM MOL TOXIC, V20, P198, DOI 10.1002/jbt.20137; Mailloux RJ, 2009, J BACTERIOL, V191, P3804, DOI 10.1128/JB.00046-09; Mailloux RJ, 2009, BIOCHIMIE, V91, P408, DOI 10.1016/j.biochi.2008.10.014; Mailloux RJ, 2006, ANAL BIOCHEM, V359, P210, DOI 10.1016/j.ab.2006.09.019; Maklashina E, 1999, ARCH BIOCHEM BIOPHYS, V369, P223, DOI 10.1006/abbi.1999.1359; Middaugh J, 2005, J BIOL CHEM, V280, P3159, DOI 10.1074/jbc.M411979200; Pandey AV, 1999, ANAL BIOCHEM, V268, P159, DOI 10.1006/abio.1998.2997; QUAYLE JR, 1961, BIOCHEM J, V78, P225, DOI 10.1042/bj0780225; Ricagno S, 2003, EMBO J, V22, P3210, DOI 10.1093/emboj/cdg333; Romanov V, 1999, ANAL BIOCHEM, V268, P49, DOI 10.1006/abio.1998.3033; Sadykov MR, 2008, J BACTERIOL, V190, P7621, DOI 10.1128/JB.00806-08; Schwimmer C, 2005, J BIOL CHEM, V280, P30751, DOI 10.1074/jbc.M501831200; Shoolingin-Jordan PM, 2003, BBA-PROTEINS PROTEOM, V1647, P361, DOI 10.1016/S1570-9639(03)00095-5; Singh R, 2005, EXTREMOPHILES, V9, P367, DOI 10.1007/s00792-005-0450-7; Singh R, 2007, J BACTERIOL, V189, P6665, DOI 10.1128/JB.00555-07; Singh R, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002682; Tian J, 2005, P NATL ACAD SCI USA, V102, P10670, DOI 10.1073/pnas.0501605102; van Weelden SWH, 2005, J BIOL CHEM, V280, P12451, DOI 10.1074/jbc.M412447200; Ward RJ, 2001, J INORG BIOCHEM, V87, P9, DOI 10.1016/S0162-0134(01)00308-7; Williams AW, 1998, BIOCHEMISTRY-US, V37, P7096, DOI 10.1021/bi972562+	45	46	47	1	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7344	10.1371/journal.pone.0007344	http://dx.doi.org/10.1371/journal.pone.0007344			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809498	Green Published, Green Submitted, gold			2022-12-27	WOS:000270594000010
J	Reinicke, AT; Omilusik, KD; Basha, G; Jefferies, WA				Reinicke, Anna T.; Omilusik, Kyla D.; Basha, Genc; Jefferies, Wilfred A.			Dendritic Cell Cross-Priming Is Essential for Immune Responses to Listeria monocytogenes	PLOS ONE			English	Article								Cross-presentation is now recognized as a major mechanism for initiating CD8 T cell responses to virus and tumor antigens in vivo. It provides an elegant mechanism that allows relatively few Dendritic cells (DCs) to initiate primary immune responses while avoiding the consumptive nature of pathogenic infection. CD8 T cells play a major role in anti-bacterial immune responses; however, the contribution of cross-presentation for priming CD8 T cell responses to bacteria, in vivo, is not well established. Listeria monocytogenes (Listeria) is the causative agent of Listeriosis, an opportunistic food-borne bacterial infection that poses a significant public health risk. Here, we employ a transgenic mouse model in which cross-presentation is uniquely inactivated, to investigate cross-priming during primary Listeria infection. We show that cross-priming deficient mice are severely compromised in their ability to generate antigen-specific T cells to stimulate MHC I-restricted CTL responses following Listeria infection. The defect in generation of Listeria-elicited CD8 T cell responses is also apparent in vitro. However, in this setting, the endogenous route of processing Listeria-derived antigens is predominant. This reveals a new experimental dichotomy whereby functional sampling of Listeria-derived antigens in vivo but not in vitro is dependent on cross-presentation of exogenously derived antigen. Thus, under normal physiological circumstances, cross-presentation is demonstrated to play an essential role in priming CD8 T cell responses to bacteria.			Reinicke, AT (corresponding author), Univ British Columbia, Biomed Res Ctr, Michael Smith Labs, Dept Med Genet, 2222 Hlth Sci Mall, Vancouver, BC, Canada.	wilf@brc.ubc.ca		Omilusik, Kyla/0000-0003-3675-048X; Basha, Genc/0000-0003-0471-2892				Ackerman AL, 2003, P NATL ACAD SCI USA, V100, P12889, DOI 10.1073/pnas.1735556100; Albert ML, 1998, NATURE, V392, P86, DOI 10.1038/32183; AlvarezDominguez C, 1997, J CELL SCI, V110, P731; Basha G, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003247; Basta S, 2003, VIRAL IMMUNOL, V16, P231, DOI 10.1089/088282403322396064; Beauregard KE, 1997, J EXP MED, V186, P1159, DOI 10.1084/jem.186.7.1159; Bevan MJ, 2006, NAT IMMUNOL, V7, P363, DOI 10.1038/ni0406-363; CHEERS C, 1978, INFECT IMMUN, V19, P755, DOI 10.1128/IAI.19.3.755-762.1978; Gagnon E, 2002, CELL, V110, P119, DOI 10.1016/S0092-8674(02)00797-3; Glomski IJ, 2002, J CELL BIOL, V156, P1029, DOI 10.1083/jcb.200201081; Gregory SH, 1997, INFECT IMMUN, V65, P5137, DOI 10.1128/IAI.65.12.5137-5141.1997; Guermonprez P, 2003, NATURE, V425, P397, DOI 10.1038/nature01911; Heath WR, 2004, IMMUNOL REV, V199, P9, DOI 10.1111/j.0105-2896.2004.00142.x; HOGQUIST KA, 1994, CELL, V76, P17, DOI 10.1016/0092-8674(94)90169-4; Houde M, 2003, NATURE, V425, P402, DOI 10.1038/nature01912; Hsing LC, 2005, IMMUNOL REV, V207, P229, DOI 10.1111/j.0105-2896.2005.00310.x; Jiang J, 2003, J IMMUNOL, V171, P4352, DOI 10.4049/jimmunol.171.8.4352; Jung S, 2002, IMMUNITY, V17, P211, DOI 10.1016/S1074-7613(02)00365-5; Kaufmann SHE, 2005, CURR OPIN IMMUNOL, V17, P79, DOI 10.1016/j.coi.2004.12.004; KOVACSOVICSBANKOWSKI M, 1995, SCIENCE, V267, P243, DOI 10.1126/science.7809629; LADEL CH, 1994, J IMMUNOL, V153, P3116; Lenz LL, 2000, J EXP MED, V192, P1135, DOI 10.1084/jem.192.8.1135; Lizee G, 2003, NAT IMMUNOL, V4, P1065, DOI 10.1038/ni989; Lutz MB, 1999, J IMMUNOL METHODS, V223, P77, DOI 10.1016/S0022-1759(98)00204-X; McElroy DS, 2009, MICROB PATHOGENESIS, V46, P214, DOI 10.1016/j.micpath.2009.01.003; MCGREGOR DD, 1970, NATURE, V228, P855, DOI 10.1038/228855a0; Merrick JC, 1997, AM J PATHOL, V151, P785; Pamer EG, 2004, NAT REV IMMUNOL, V4, P812, DOI 10.1038/nri1461; PFEIFER JD, 1993, NATURE, V361, P359, DOI 10.1038/361359a0; Porgador A, 1997, IMMUNITY, V6, P715, DOI 10.1016/S1074-7613(00)80447-1; ROCK KL, 1990, SCIENCE, V249, P918, DOI 10.1126/science.2392683; Rodriguez A, 1999, NAT CELL BIOL, V1, P362, DOI 10.1038/14058; Savina A, 2007, IMMUNOL REV, V219, P143, DOI 10.1111/j.1600-065X.2007.00552.x; Savina A, 2006, CELL, V126, P205, DOI 10.1016/j.cell.2006.05.035; Schaible UE, 2003, NAT MED, V9, P1039, DOI 10.1038/nm906; SHASTRI N, 1993, J IMMUNOL, V150, P2724; Shaughnessy LM, 2006, CELL MICROBIOL, V8, P781, DOI 10.1111/j.1462-5822.2005.00665.x; SHEN H, 1995, P NATL ACAD SCI USA, V92, P3987, DOI 10.1073/pnas.92.9.3987; Shen LJ, 2004, IMMUNITY, V21, P155, DOI 10.1016/j.immuni.2004.07.004; Sigal LJ, 1999, NATURE, V398, P77, DOI 10.1038/18038; Spiotto MT, 2004, NAT MED, V10, P294, DOI 10.1038/nm999; Stockinger B, 1996, J EXP MED, V183, P891, DOI 10.1084/jem.183.3.891; Unanue ER, 1997, IMMUNOL REV, V158, P11, DOI 10.1111/j.1600-065X.1997.tb00988.x; VILLANUEVA MS, 1995, J IMMUNOL, V155, P5227; Wilson NS, 2005, ADV IMMUNOL, V86, P241, DOI 10.1016/S0065-2776(04)86007-3; Winau F, 2006, IMMUNITY, V24, P105, DOI 10.1016/j.immuni.2005.12.001; Yewdell JW, 2007, CURR OPIN IMMUNOL, V19, P79, DOI 10.1016/j.coi.2006.11.010; Yrlid U, 2000, J EXP MED, V191, P613, DOI 10.1084/jem.191.4.613	48	29	29	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7210	10.1371/journal.pone.0007210	http://dx.doi.org/10.1371/journal.pone.0007210			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806187	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593800001
J	Johnson, MK; Clark, TD; Njama-Meya, D; Rosenthal, PJ; Parikh, S				Johnson, Marla K.; Clark, Tamara D.; Njama-Meya, Denise; Rosenthal, Philip J.; Parikh, Sunil			Impact of the Method of G6PD Deficiency Assessment on Genetic Association Studies of Malaria Susceptibility	PLOS ONE			English	Article								Background: Clinical association studies have yielded varied results regarding the impact of glucose-6-phosphate dehydrogenase (G6PD) deficiency upon susceptibility to malaria. Analyses have been complicated by varied methods used to diagnose G6PD deficiency. Methodology/Prinicipal Findings: We compared the association between uncomplicated malaria incidence and G6PD deficiency in a cohort of 601 Ugandan children using two different diagnostic methods, enzyme activity and G6PD genotype (G202A, the predominant East African allele). Although roughly the same percentage of males were identified as deficient using enzyme activity (12%) and genotype (14%), nearly 30% of males who were enzymatically deficient were wildtype at G202A. The number of deficient females was three-fold higher with assessment by genotype (21%) compared to enzyme activity (7%). Heterozygous females accounted for the majority (46/54) of children with a mutant genotype but normal enzyme activity. G6PD deficiency, as determined by G6PD enzyme activity, conferred a 52% (relative risk [RR] 0.48, 95% CI 0.31-0.75) reduced risk of uncomplicated malaria in females. In contrast, when G6PD deficiency was defined based on genotype, the protective association for females was no longer seen (RR=0.99, 95% CI 0.70-1.39). Notably, restricting the analysis to those females who were both genotypically and enzymatically deficient, the association of deficiency and protection from uncomplicated malaria was again demonstrated in females, but not in males (RR=0.57, 95% CI 0.37-0.88 for females). Conclusions/Significance: This study underscores the impact that the method of identifying G6PD deficient individuals has upon association studies of G6PD deficiency and uncomplicated malaria. We found that G6PD-deficient females were significantly protected against uncomplicated malaria, but this protection was only seen when G6PD deficiency is described using enzyme activity. These observations may help to explain the discrepancy in some published association studies involving G6PD deficiency and uncomplicated malaria.			Johnson, MK (corresponding author), Univ Calif San Francisco, San Francisco Gen Hosp, Dept Med, San Francisco, CA 94143 USA.	sparikh@medsfgh.ucsf.edu			NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U01AI052142, K23AI060681] Funding Source: NIH RePORTER; NIAID NIH HHS [AI060681, AI052142, U01 AI052142, K23 AI060681] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ainoon O., 2003, Southeast Asian Journal of Tropical Medicine and Public Health, V34, P405; ALLISON AC, 1960, NATURE, V186, P531, DOI 10.1038/186531a0; BEUTLER E, 1989, BLOOD, V74, P2550; Beutler E, 2002, BLOOD CELL MOL DIS, V28, P93, DOI 10.1006/bcmd.2002.0490; BEUTLER E, 1962, P NATL ACAD SCI USA, V48, P9, DOI 10.1073/pnas.48.1.9; Beutler E, 2001, BLOOD, V98, P2597, DOI 10.1182/blood.V98.9.2597; Beutler E, 2007, AM J TROP MED HYG, V77, P779, DOI 10.4269/ajtmh.2007.77.779; BIENZLE U, 1972, LANCET, V1, P107; BIENZLE U, 1979, AM J TROP MED HYG, V28, P619, DOI 10.4269/ajtmh.1979.28.619; Cappellini MD, 2008, LANCET, V371, P64, DOI 10.1016/S0140-6736(08)60073-2; CARSON PE, 1956, SCIENCE, V124, P484, DOI 10.1126/science.124.3220.484-a; Clark TG, 2009, EUR J HUM GENET, V17, P1080, DOI 10.1038/ejhg.2009.8; Clark TD, 2008, J INFECT DIS, V198, P393, DOI 10.1086/589778; Davis JC, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-18; Dorsey G, 2007, JAMA-J AM MED ASSOC, V297, P2210, DOI 10.1001/jama.297.20.2210; Drousiotou A, 2004, BLOOD CELL MOL DIS, V33, P25, DOI 10.1016/j.bcmd.2004.03.004; Enevold A, 2005, MALARIA J, V4, DOI 10.1186/1475-2875-4-61; Fanello CI, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004031; Greenhouse B, 2007, ANTIMICROB AGENTS CH, V51, P3096, DOI 10.1128/AAC.00159-07; Greenwood BM, 2008, J CLIN INVEST, V118, P1266, DOI 10.1172/JCI33996; Guindo A, 2007, PLOS MED, V4, P516, DOI 10.1371/journal.pmed.0040066; HIRONO A, 1988, P NATL ACAD SCI USA, V85, P3951, DOI 10.1073/pnas.85.11.3951; Hirono A, 2002, BLOOD, V99, P1498, DOI 10.1182/blood.V99.4.1498; Lell B, 1999, CLIN INFECT DIS, V28, P794, DOI 10.1086/515193; Mason PJ, 2007, BLOOD REV, V21, P267, DOI 10.1016/j.blre.2007.05.002; Minucci A, 2009, IUBMB LIFE, V61, P27, DOI 10.1002/iub.137; MOTULSKY ARNO G., 1960, HUMAN BIOL, V32, P28; Nkhoma ET, 2009, BLOOD CELL MOL DIS, V42, P267, DOI 10.1016/j.bcmd.2008.12.005; Parikh S, 2004, AM J TROP MED HYG, V71, P750, DOI 10.4269/ajtmh.2004.71.750; Reclos GJ, 2000, J MED SCREEN, V7, P46, DOI 10.1136/jms.7.1.46; RUWENDE C, 1995, NATURE, V376, P246, DOI 10.1038/376246a0; Samilchuk E, 2003, BLOOD CELL MOL DIS, V31, P201, DOI 10.1016/S1079-9796(03)00125-6; Snow RW, 2005, NATURE, V434, P214, DOI 10.1038/nature03342; Staedke SG, 2003, AM J TROP MED HYG, V69, P244, DOI 10.4269/ajtmh.2003.69.244; Tagarelli A, 2006, CLIN BIOCHEM, V39, P183, DOI 10.1016/j.clinbiochem.2005.10.015; Tishkoff SA, 2001, SCIENCE, V293, P455, DOI 10.1126/science.1061573; TOWN M, 1992, HUM MOL GENET, V1, P171, DOI 10.1093/hmg/1.3.171; USANGA EA, 1985, NATURE, V313, P793, DOI 10.1038/313793a0; [No title captured]	39	52	54	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7246	10.1371/journal.pone.0007246	http://dx.doi.org/10.1371/journal.pone.0007246			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789650	gold, Green Published, Green Submitted			2022-12-27	WOS:000270354100011
J	Wolff, EDS; Salisbury, SW; Horner, JR; Varricchio, DJ				Wolff, Ewan D. S.; Salisbury, Steven W.; Horner, John R.; Varricchio, David J.			Common Avian Infection Plagued the Tyrant Dinosaurs	PLOS ONE			English	Article							TRICHOMONAS-GALLINAE; CROCODILE; GOSHAWKS	Background: Tyrannosaurus rex and other tyrannosaurid fossils often display multiple, smooth-edged full-thickness erosive lesions on the mandible, either unilaterally or bilaterally. The cause of these lesions in the Tyrannosaurus rex specimen FMNH PR2081 (known informally by the name 'Sue') has previously been attributed to actinomycosis, a bacterial bone infection, or bite wounds from other tyrannosaurids. Methodology/Principal Findings: We conducted an extensive survey of tyrannosaurid specimens and identified ten individuals with full-thickness erosive lesions. These lesions were described, measured and photographed for comparison with one another. We also conducted an extensive survey of related archosaurs for similar lesions. We show here that these lesions are consistent with those caused by an avian parasitic infection called trichomonosis, which causes similar abnormalities on the mandible of modern birds, in particular raptors. Conclusions/ Significance: This finding represents the first evidence for the ancient evolutionary origin of an avian transmissible disease in non-avian theropod dinosaurs. It also provides a valuable insight into the palaeobiology of these now extinct animals. Based on the frequency with which these lesions occur, we hypothesize that tyrannosaurids were commonly infected by a Trichomonas gallinae-like protozoan. For tyrannosaurid populations, the only non-avian dinosaur group that show trichomonosis-type lesions, it is likely that the disease became endemic and spread as a result of antagonistic intraspecific behavior, consumption of prey infected by a Trichomonas gallinae-like protozoan and possibly even cannibalism. The severity of trichomonosis-related lesions in specimens such as Tyrannosaurus rex FMNH PR2081 and Tyrannosaurus rex MOR 980, strongly suggests that these animals died as a direct result of this disease, mostly likely through starvation.			Wolff, EDS (corresponding author), Univ Wisconsin, Sch Vet Med, Dept Pathobiol Sci, Madison, WI 53706 USA.	ewolff@wisc.edu; s.salisbury@uq.edu.au	Salisbury, Steven W./A-7518-2011	Salisbury, Steven W./0000-0003-4097-8567; Wolff, Ewan/0000-0002-5726-4766				BAKER J, 1981, ORAL PATHOLOGY ANIMA, P135; BRAZAITIS P, 1981, J HERPETOL, V15, P360, DOI 10.2307/1563441; Brochu CA, 2003, J VERTEBR PALEONTOL, V22, P1, DOI [10.1080/02724634.2003.10010947, DOI 10.1080/02724634.2003.10010947, 10.2307/3889334, DOI 10.2307/3889334]; Cooper J.E., 2002, BIRDS PREY HLTH DIS; COOPER JE, 1988, J WILDLIFE DIS, V24, P80, DOI 10.7589/0090-3558-24.1.80; COTT H. B., 1961, TRANS ZOOL SOC LONDON, V29, P211; ENSLEY PK, 1979, J AM VET MED ASSOC, V175, P978; Erickson GM, 1996, J VERTEBR PALEONTOL, V16, P175, DOI 10.1080/02724634.1996.10011297; Harmon BG, 1998, POULTRY SCI, V77, P972, DOI 10.1093/ps/77.7.972; Heidenreich M, 1997, BIRDS PREY MED MANAG; Hibberd E. M. A., 1993, Mycologist, V7, P32, DOI 10.1016/S0269-915X(09)80625-3; Huchzermeyer F. W., 2003, CROCODILES BIOL HUSB, P337; Huchzermeyer FW, 2000, VET REC, V147, P515, DOI 10.1136/vr.147.18.515; Jacobsen Aase Roland, 1998, Historical Biology, V13, P17; JACOBSEN ER, 2007, INFECT DIS PATHOLOGY; Kalin J.A., 1936, Z F R MORPHOLOGIE OE, V32, P327; KEYMER IF, 1972, VET REC, V90, P579, DOI 10.1136/vr.90.21.579; Krone O, 2005, J WILDLIFE DIS, V41, P304, DOI 10.7589/0090-3558-41.2.304; LEBNINSKY NG, 1920, VERHANDLUNGEN NATURF, V31, P39; Levinee ND, 1941, AM J HYG, V33, P23, DOI 10.1093/oxfordjournals.aje.a118708; Loh R, 2006, VET PATHOL, V43, P890, DOI 10.1354/vp.43-6-890; Real J, 2000, J WILDLIFE DIS, V36, P64, DOI 10.7589/0090-3558-36.1.64; Rega Elizabeth A., 2001, Journal of Vertebrate Paleontology, V21, p92A; Saif Y., 2003, DIS POULTRY, V11th; SCHULTZ CWN, 1994, AM BIRD BNDR, V19, P56; STABLER RM, 1954, EXP PARASITOL, V3, P368, DOI 10.1016/0014-4894(54)90035-1; STABLER RM, 1969, PEREGRINE FALCON POP; STONE W B, 1969, Bulletin of the Wildlife Disease Association, V5, P147; Tanke D.H., 2006, HORNS BEAKS CERATOPS, P319; Tanke Darren H., 2000, Gaia (Lisboa), V15, P167; VARRICCHIO DJ, 1995, PALAEOGEOGR PALAEOCL, V114, P297, DOI 10.1016/0031-0182(94)00084-L; Webb G., 1989, CROCODILES AUSTR; WEBB GJW, 1977, AUST WILDLIFE RES, V4, P311; WEISBRODE SE, 2001, THOMPSONS SPECIALIZE, P502; WOLFF EDS, 2005, WILDL DIS ASS INT C	35	31	31	1	31	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7288	10.1371/journal.pone.0007288	http://dx.doi.org/10.1371/journal.pone.0007288			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789646	Green Published, Green Submitted, gold			2022-12-27	WOS:000270354100032
J	Lee, WH; Atienza-Herrero, J; Abagyan, R; Marsden, BD				Lee, Wen Hwa; Atienza-Herrero, Julian; Abagyan, Ruben; Marsden, Brian D.			SGC - Structural Biology and Human Health: A New Approach to Publishing Structural Biology Results	PLOS ONE			English	Article							PROMOTE PROTEIN STABILITY; DRUG DISCOVERY; GENOMICS; DESIGN; CRYSTALLIZATION; VISUALIZATION; INHIBITORS; IMPACT; PROBES; TOOL				Lee, WH (corresponding author), Univ Oxford, SGC, Oxford, England.	wenhwa.lee@sgc.ox.ac.uk	Lee, Wen Hwa/GZA-8183-2022; Lee, Wen Hwa/G-1250-2013	Lee, Wen Hwa/0000-0002-4098-5225; Lee, Wen Hwa/0000-0002-4098-5225	CIHR Funding Source: Medline; Wellcome Trust Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)		Abagyan R, 2006, TRENDS BIOCHEM SCI, V31, P76, DOI 10.1016/j.tibs.2005.12.006; ABAGYAN R, 1994, J COMPUT CHEM, V15, P488, DOI 10.1002/jcc.540150503; [Anonymous], 2006, NAT STRUCT MOL BIOL, V13, P93, DOI 10.1038/nsmb0206-93; Autin L, 2007, NUCLEIC ACIDS RES, V35, pW483, DOI 10.1093/nar/gkm277; Chandonia JM, 2006, SCIENCE, V311, P347, DOI 10.1126/science.1121018; Chen V. B., 2009, PROTEIN SCI; Congreve M, 2005, DRUG DISCOV TODAY, V10, P895, DOI 10.1016/S1359-6446(05)03484-7; Dong AP, 2007, NAT METHODS, V4, P1019, DOI 10.1038/nmeth1118; Edwards A, 2008, DRUG DISCOV TODAY, V13, P731, DOI 10.1016/j.drudis.2008.04.011; Edwards A, 2009, ANNU REV BIOCHEM, V78, P541, DOI 10.1146/annurev.biochem.78.070907.103305; Edwards AM, 2009, NAT CHEM BIOL, V5, P436, DOI 10.1038/nchembio0709-436; Gileadi Opher, 2007, Journal of Structural and Functional Genomics, V8, P107, DOI 10.1007/s10969-007-9027-2; Graslund S, 2008, NAT METHODS, V5, P135, DOI 10.1038/nmeth.f.202; Hodis E, 2007, TRENDS BIOCHEM SCI, V32, P199, DOI 10.1016/j.tibs.2007.03.008; Hodis E, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-8-r121; Humphrey W, 1996, J MOL GRAPH MODEL, V14, P33, DOI 10.1016/0263-7855(96)00018-5; Janin J, 2007, STRUCTURE, V15, P1347, DOI 10.1016/j.str.2007.10.005; Kaplan W, 2001, Brief Bioinform, V2, P195, DOI 10.1093/bib/2.2.195; Kumar P, 2008, TRENDS BIOCHEM SCI, V33, P408, DOI 10.1016/j.tibs.2008.06.004; Maiti R, 2005, NUCLEIC ACIDS RES, V33, pW358, DOI 10.1093/nar/gki485; Moreland JL, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-21; Niesen FH, 2007, NAT PROTOC, V2, P2212, DOI 10.1038/nprot.2007.321; Oprea TI, 2009, NAT CHEM BIOL, V5, P441, DOI 10.1038/nchembio0709-441; Porollo A, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-316; RICHARDSON DC, 1992, PROTEIN SCI, V1, P3; Sali Andrej, 1998, Nature Structural Biology, V5, P1029, DOI 10.1038/4136; Terwilliger TC, 1998, PROTEIN SCI, V7, P1851, DOI 10.1002/pro.5560070901; Terwilliger TC, 2009, ANNU REV BIOPHYS, V38, P371, DOI 10.1146/annurev.biophys.050708.133740; THOMPSON WJ, 1992, J MED CHEM, V35, P1685, DOI 10.1021/jm00088a003; Vedadi M, 2006, P NATL ACAD SCI USA, V103, P15835, DOI 10.1073/pnas.0605224103; VONITZSTEIN M, 1993, NATURE, V363, P418, DOI 10.1038/363418a0; Weigelt J, 2009, EMBO REP, V10, P941, DOI 10.1038/embor.2009.193; Wlodawer A, 2002, ANNU REV MED, V53, P595, DOI 10.1146/annurev.med.53.052901.131947; 2009, J BIOL CHEM, V284, P21101	34	15	16	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7675	10.1371/journal.pone.0007675	http://dx.doi.org/10.1371/journal.pone.0007675			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19847312	Green Published, Green Submitted, gold			2022-12-27	WOS:000271012900018
J	Lin, YC; Schlievert, PM; Anderson, MJ; Fair, CL; Schaefers, MM; Muthyala, R; Peterson, ML				Lin, Ying-Chi; Schlievert, Patrick M.; Anderson, Michele J.; Fair, Christina L.; Schaefers, Matthew M.; Muthyala, Ramaiah; Peterson, Marnie L.			Glycerol Monolaurate and Dodecylglycerol Effects on Staphylococcus aureus and Toxic Shock Syndrome Toxin-1 In Vitro and In Vivo	PLOS ONE			English	Article							STREPTOCOCCUS-FAECIUM ATCC-9790; FATTY-ACIDS; SIGNAL-TRANSDUCTION; EXOTOXIN PRODUCTION; AUTOLYSIN ACTIVITY; GROWTH; AGENTS; BIOSYNTHESIS; PATHOGENESIS; ANTIBIOTICS	Background: Glycerol monolaurate (GML), a 12 carbon fatty acid monoester, inhibits Staphylococcus aureus growth and exotoxin production, but is degraded by S. aureus lipase. Therefore, dodecylglycerol (DDG), a 12 carbon fatty acid monoether, was compared in vitro and in vivo to GML for its effects on S. aureus growth, exotoxin production, and stability. Methodology/Principal Findings: Antimicrobial effects of GML and DDG (0 to 500 mg/ml) on 54 clinical isolates of S. aureus, including pulsed-field gel electrophoresis (PFGE) types USA200, USA300, and USA400, were determined in vitro. A rabbit Wiffle ball infection model assessed GML and DDG (1 mg/ml instilled into the Wiffle ball every other day) effects on S. aureus (MN8) growth (inoculum 3X10(8) CFU/ml), toxic shock syndrome toxin-1 (TSST-1) production, tumor necrosis factor-alpha (TNF-alpha) concentrations and mortality over 7 days. DDG (50 and 100 mg/ml) inhibited S. aureus growth in vitro more effectively than GML (p < 0.01) and was stable to lipase degradation. Unlike GML, DDG inhibition of TSST-1 was dependent on S. aureus growth. GML-treated (4 of 5; 80%) and DDG-treated rabbits (2 of 5; 40%) survived after 7 days. Control rabbits (5 of 5; 100%) succumbed by day 4. GML suppressed TNF-alpha at the infection site on day 7; however, DDG did not (< 10 ng/ml versus 80 ng/ml, respectively). Conclusions/Significance: These data suggest that DDG was stable to S. aureus lipase and inhibited S. aureus growth at lower concentrations than GML in vitro. However, in vivo GML was more effective than DDG by reducing mortality, and suppressing TNF-alpha, S. aureus growth and exotoxin production, which may reduce toxic shock syndrome. GML is proposed as a more effective anti-staphylococcal topical anti-infective candidate than DDG, despite its potential degradation by S. aureus lipase.			Lin, YC (corresponding author), Univ Minnesota, Coll Pharm, Dept Expt & Clin Pharmacol, Minneapolis, MN 55455 USA.	peter377@umn.edu	Lin, Ying-Chi/V-7851-2019; Schaefers, Matthew/AAU-8213-2021	Lin, Ying-Chi/0000-0003-0335-3402; Schaefers, Matthew/0000-0001-7454-4180; Schlievert, Patrick/0000-0001-8314-9369	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI073366, R01AI074283] Funding Source: NIH RePORTER; NIAID NIH HHS [AI-074283, R01 AI074283, R01 AI073366-01A2, R01 AI073366, R01 AI074283-21] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Boguniewicz M, 2006, J ALLERGY CLIN IMMUN, V118, P40, DOI 10.1016/j.jaci.2006.04.044; BRISSETTE JL, 1986, J BIOL CHEM, V261, P6338; Chuang Yu-Yu, 2005, Paediatr Drugs, V7, P11, DOI 10.2165/00148581-200507010-00002; De Bels D, 2005, J ANTIMICROB CHEMOTH, V55, P812, DOI 10.1093/jac/dki068; Fey PD, 2003, ANTIMICROB AGENTS CH, V47, P196, DOI 10.1128/AAC.47.1.196-203.2003; Gordon RJ, 2008, CLIN INFECT DIS, V46, pS350, DOI 10.1086/533591; HAYNES MP, 1994, ANTIMICROB AGENTS CH, V38, P1523, DOI 10.1128/AAC.38.7.1523; Hill DR, 2005, J APPL PHYSIOL, V99, P1582, DOI 10.1152/japplphysiol.01422.2004; HOLLAND KT, 1994, J ANTIMICROB CHEMOTH, V33, P41, DOI 10.1093/jac/33.1.41; Jarman A, 2007, BURNS, V33, P1051, DOI 10.1016/j.burns.2006.10.001; Johnson W, 2004, INT J TOXICOL, V23, P55, DOI 10.1080/10915810490499064; KABARA JJ, 1972, ANTIMICROB AGENTS CH, V2, P23, DOI 10.1128/AAC.2.1.23; Kelsey JA, 2006, LIPIDS, V41, P951, DOI 10.1007/s11745-006-5048-z; Kenny JG, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004344; Kitahara T, 2004, BIOL PHARM BULL, V27, P1321, DOI 10.1248/bpb.27.1321; Klevens RM, 2006, CLIN INFECT DIS, V42, P389, DOI 10.1086/499367; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Li QS, 2009, NATURE, V458, P1034, DOI 10.1038/nature07831; Limbago B, 2009, J CLIN MICROBIOL, V47, P1344, DOI 10.1128/JCM.02264-08; McCormick JK, 2001, ANNU REV MICROBIOL, V55, P77, DOI 10.1146/annurev.micro.55.1.77; McNamara PJ, 2009, ANTIMICROB AGENTS CH, V53, P1898, DOI 10.1128/AAC.01293-08; Moran GJ, 2006, NEW ENGL J MED, V355, P666, DOI 10.1056/NEJMoa055356; Pankey GA, 2004, CLIN INFECT DIS, V38, P864, DOI 10.1086/381972; Peterson ML, 2006, BIOCHEMISTRY-US, V45, P2387, DOI 10.1021/bi051992u; Preuss HG, 2005, MOL CELL BIOCHEM, V272, P29, DOI 10.1007/s11010-005-6604-1; PROJAN SJ, 1994, J BACTERIOL, V176, P4204, DOI 10.1128/jb.176.14.4204-4209.1994; Ruzin A, 2000, J BACTERIOL, V182, P2668, DOI 10.1128/JB.182.9.2668-2671.2000; Schlievert PM, 2008, ANTIMICROB AGENTS CH, V52, P4448, DOI 10.1128/AAC.00989-08; Schlievert PM, 2007, OBSTET GYNECOL, V109, p74S; Schlievert PM, 2007, ANTIMICROB AGENTS CH, V51, P3056, DOI 10.1128/AAC.01295-06; SCHLIEVERT PM, 1988, METHOD ENZYMOL, V165, P339; SCHLIEVERT PM, 1984, J INFECT DIS, V149, P471, DOI 10.1093/infdis/149.3.471; SCHLIEVERT PM, 1992, ANTIMICROB AGENTS CH, V36, P626, DOI 10.1128/AAC.36.3.626; SCHLIEVERT PM, 1983, J INFECT DIS, V147, P236, DOI 10.1093/infdis/147.2.236; SCOTT DF, 1983, INFECT IMMUN, V39, P383, DOI 10.1128/IAI.39.1.383-387.1983; Stevens DL, 2007, J INFECT DIS, V195, P202, DOI 10.1086/510396; Stevens DL, 2006, CLIN INFECT DIS, V42, P729, DOI 10.1086/500265; Tenover FC, 2008, J CLIN MICROBIOL, V46, P2837, DOI 10.1128/JCM.00480-08; TODD JK, 1987, J INFECT DIS, V155, P673, DOI 10.1093/infdis/155.4.673; Trop M, 2004, BURNS, V30, P176, DOI 10.1016/j.burns.2003.10.001; VED HS, 1984, J BIOL CHEM, V259, P8122; VED HS, 1990, LIPIDS, V25, P119, DOI 10.1007/BF02562216; VED HS, 1984, J BIOL CHEM, V259, P8115; WEBER N, 1985, J LIPID RES, V26, P1412; Yarwood JM, 2000, J CLIN MICROBIOL, V38, P1797, DOI 10.1128/JCM.38.5.1797-1803.2000; Yarwood JM, 2002, J BACTERIOL, V184, P1095, DOI 10.1128/jb.184.4.1095-1101.2002	46	33	35	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7499	10.1371/journal.pone.0007499	http://dx.doi.org/10.1371/journal.pone.0007499			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838303	Green Published, gold, Green Submitted			2022-12-27	WOS:000270880900005
J	Graves, N; Courtney, M; Edwards, H; Chang, A; Parker, A; Finlayson, K				Graves, Nicholas; Courtney, Mary; Edwards, Helen; Chang, Anne; Parker, Anthony; Finlayson, Kathleen			Cost-Effectiveness of an Intervention to Reduce Emergency Re-Admissions to Hospital among Older Patients	PLOS ONE			English	Article							RANDOMIZED CONTROLLED-TRIAL; CHRONIC HEART-FAILURE; EFFECTIVENESS ACCEPTABILITY CURVES; HEALTH-CARE; ECONOMIC-EVALUATION; TECHNOLOGY-ASSESSMENT; MANAGEMENT PROGRAM; EFFICIENCY; EQUITY; VALUES	Background: The objective is to estimate the cost-effectiveness of an intervention that reduces hospital re-admission among older people at high risk. A cost-effectiveness model to estimate the costs and health benefits of the intervention was implemented. Methodology/Principal Findings: The model used data from a randomised controlled trial conducted in an Australian tertiary metropolitan hospital. Participants were acute medical admissions aged >65 years with at least one risk factor for re-admission: multiple comorbidities,impaired functionality, aged >75 years, recent multiple admissions, poor social support, history of depression. The intervention was a comprehensive nursing and physiotherapy assessment and an individually tailored program of exercise strategies and nurse home visits with telephone follow-up; commencing in hospital and continuing following discharge for 24 weeks. The change to cost outcomes, including the costs of implementing the intervention and all subsequent use of health care services, and, the change to health benefits, represented by quality adjusted life years, were estimated for the intervention as compared to existing practice. The mean change to total costs and quality adjusted life years for an average individual over 24 weeks participating in the intervention were: cost savings of $333 (95% Bayesian credible interval $-1,932: 1,282) and 0.118 extra quality adjusted life years ( 95% Bayesian credible interval 0.1:0.136). The mean net-monetary-benefit per individual for the intervention group compared to the usual care condition was $7,907 (95% Bayesian credible interval $5,959:$9,995) for the 24 week period. Conclusions/Significance: The estimation model that describes this intervention predicts cost savings and improved health outcomes. A decision to remain with existing practices causes unnecessary costs and reduced health. Decision makers should consider adopting this program for elderly hospitalised patients.			Graves, N (corresponding author), Queensland Univ Technol, Inst Hlth & Biomed Innovat, Sch Publ Hlth, Brisbane, Qld 4001, Australia.	n.graves@qut.edu.au	Chang, Anne M/A-3425-2009; Edwards, Helen E/I-9554-2012; Finlayson, Kathleen/D-1108-2012; Edwards, Helen/GPX-3511-2022; Graves, Nicholas/A-3052-2011	Chang, Anne M/0000-0003-3409-874X; Finlayson, Kathleen/0000-0002-5743-2731; Edwards, Helen/0000-0002-4451-0577; Graves, Nicholas/0000-0002-5559-3267				*AIHW, 2004, RES AG CAR AUSTR 200; Australian Institute of Health and Welfare, 2006, AUSTR HOSP STAT 2004; Australian Institute of Health & Welfare, 2007, AUSTR HOSP STAT 2005; BIRCH S, 1992, J HEALTH ECON, V11, P279, DOI 10.1016/0167-6296(92)90004-K; Brazier J, 1999, HLTH TECHNOL ASSESS, V3; Briggs A, 1998, PHARMACOECONOMICS, V13, P397, DOI 10.2165/00019053-199813040-00003; Briggs AH, 2001, HEALTH ECON, V10, P179, DOI 10.1002/hec.584; Capomolla S, 2002, J AM COLL CARDIOL, V40, P1259, DOI 10.1016/S0735-1097(02)02140-X; Claxton K, 2005, HEALTH ECON, V14, P339, DOI 10.1002/hec.985; Coast J, 2004, BRIT MED J, V329, P1233, DOI 10.1136/bmj.329.7476.1233; Cookson R, 2003, HEALTH ECON, V12, P891, DOI 10.1002/hec.847; Courtney M, 2009, J AM GERIATR SOC, V57, P395, DOI 10.1111/j.1532-5415.2009.02138.x; Del Sindaco D, 2007, J CARDIOVASC MED, V8, P324, DOI 10.2459/JCM.0b013e32801164cb; *DEP HLTH AG, 2007, COMPL MED BEN SCHED; Donaldson C, 2002, BRIT MED J, V325, P891, DOI 10.1136/bmj.325.7369.891; Drummond MF., 2005, METHODS EC EVALUATIO, P55; Elixhauser A, 2000, AHRQ PUBLICATION; Epstein DM, 2007, MED DECIS MAKING, V27, P128, DOI 10.1177/0272989X06297396; Fenwick E, 2004, HEALTH ECON, V13, P405, DOI 10.1002/hec.903; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Gray AM, 2006, MED DECIS MAKING, V26, P18, DOI 10.1177/0272989X05284108; Ho YL, 2007, J FORMOS MED ASSOC, V106, P313, DOI 10.1016/S0929-6646(09)60258-8; Hoch JS, 2002, HEALTH ECON, V11, P415, DOI 10.1002/hec.678; Jackson TJ, 2007, MED J AUSTRALIA, V187, P262, DOI 10.5694/j.1326-5377.2007.tb01238.x; Karmel R., 2007, B AUSTR I HLTH WELFA, V53; Krupnick A.J., 2004, VALUING HLTH OUTCOME; Kwok T, 2008, J CLIN NURS, V17, P109, DOI 10.1111/j.1365-2702.2007.01978.x; Latour CHM, 2007, J PSYCHOSOM RES, V62, P363, DOI 10.1016/j.jpsychores.2006.10.016; Layard R., 1994, COST BENEFIT ANAL; Mistiaen P, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004510.pub3; *NAT HLTH SERV, 2006, HES ONL HOSP EP STAT; Naylor MD, 2004, J AM GERIATR SOC, V52, P675, DOI 10.1111/j.1532-5415.2004.52202.x; Parker S. G., 2005, DO CURRENT DISCHARGE; Phillips CO, 2004, JAMA-J AM MED ASSOC, V291, P1358, DOI 10.1001/jama.291.11.1358; Rawlins MD, 2004, BRIT MED J, V329, P224, DOI 10.1136/bmj.329.7459.224; Ryan M, 2001, Health Technol Assess, V5, P1; Sampietro-Colom L, 2004, INT J TECHNOL ASSESS, V20, P145, DOI 10.1017/S0266462304000923; Shepperd S, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000313.pub4; SHIROIWA T, 2009, HLTH EC; SONNENBERG FA, 1993, MED DECIS MAKING, V13, P322, DOI 10.1177/0272989X9301300409; Stinnett AA, 1996, J HEALTH ECON, V15, P641, DOI 10.1016/S0167-6296(96)00493-6; Sugden R., 1978, PRINCIPLES PRACTICAL; TORRANCE GW, 1986, J HEALTH ECON, V5, P1, DOI 10.1016/0167-6296(86)90020-2; Trueman P, 2001, PHARMACOECONOMICS, V19, P609, DOI 10.2165/00019053-200119060-00001; WAGSTAFF A, 1991, J HEALTH ECON, V10, P21, DOI 10.1016/0167-6296(91)90015-F	45	21	21	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7455	10.1371/journal.pone.0007455	http://dx.doi.org/10.1371/journal.pone.0007455			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	506WT	19829702	Green Published, gold, Green Submitted			2022-12-27	WOS:000270808700015
J	Yang, HY; Chen, CW				Yang, Han-Yu; Chen, Carton W.			Extracellular and Intracellular Polyphenol Oxidases Cause Opposite Effects on Sensitivity of Streptomyces to Phenolics: A Case of Double-Edged Sword	PLOS ONE			English	Article							ARGININE TRANSLOCATION PATHWAY; TYROSINASE GENE; CHROMOSOMAL DNA; MELC OPERON; EXPRESSION; COPPER; OXIDATION; CLONING; DIFFERENTIATION; ANTIBIOTICUS	Many but not all species of Streptomyces species harbour a bicistronic melC operon, in which melC2 encodes an extracellular tyrosinase (a polyphenol oxidase) and melC1 encodes a helper protein. On the other hand, a melC-homologous operon (melD) is present in all sequenced Streptomyces chromosomes and could be isolated by PCR from six other species tested. Bioinformatic analysis showed that melC and melD have divergently evolved toward different functions. MelD2, unlike tyrosinase (MelC2), is not secreted, and has a narrower substrate spectrum. Deletion of melD caused an increased sensitivity to several phenolics that are substrates of MelD2. Intracellularly, MelD2 presumably oxidizes the phenolics, thus bypassing spontaneous copper-dependent oxidation that generates DNA-damaging reactive oxygen species. Surprisingly, melC+ strains were more sensitive rather than less sensitive to phenolics than melC 2 strains. This appeared to be due to conversion of the phenolics by MelC2 to more hydrophobic and membrane-permeable quinones. We propose that the conserved melD operon is involved in defense against phenolics produced by plants, and the sporadically present melC operon probably plays an aggressive role in converting the phenolics to the more permeable quinones, thus fending off less tolerant competing microbes (lacking melD) in the phenolic-rich rhizosphere.			Yang, HY (corresponding author), Dept Life Sci, Taipei, Taiwan.	cwchen@ym.edu.tw	Chen, Carton W/GVS-7763-2022	Chen, Carton W/0000-0001-8891-1623				ARAI T, 1972, APPL MICROBIOL, V23, P402, DOI 10.1128/AEM.23.2.402-406.1972; Bendtsen JD, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-167; CHEN CW, 1992, J BACTERIOL, V174, P7762, DOI 10.1128/JB.174.23.7762-7769.1992; CHEN LY, 1992, J BIOL CHEM, V267, P20100; Claus H, 2006, SYST APPL MICROBIOL, V29, P3, DOI 10.1016/j.syapm.2005.07.012; Conant JB, 1924, J AM CHEM SOC, V46, P1858, DOI 10.1021/ja01673a014; CRAMERI R, 1984, CAN J MICROBIOL, V30, P1058, DOI 10.1139/m84-165; Endo K, 2001, J ANTIBIOT, V54, P789, DOI 10.7164/antibiotics.54.789; GREGORY KF, 1964, J BACTERIOL, V87, P1287, DOI 10.1128/JB.87.6.1287-1294.1964; Gust B, 2003, P NATL ACAD SCI USA, V100, P1541, DOI 10.1073/pnas.0337542100; HINTERMANN G, 1985, MOL GEN GENET, V200, P422, DOI 10.1007/BF00425726; Hirakawa K, 2002, CHEM RES TOXICOL, V15, P76, DOI 10.1021/tx010121s; HIROCHIKA H, 1984, EMBO J, V3, P761, DOI 10.1002/j.1460-2075.1984.tb01881.x; HOPWOOD DA, 1983, J GEN MICROBIOL, V129, P2257; Hsiao NH, 2008, ANTON LEEUW INT J G, V93, P1, DOI 10.1007/s10482-007-9175-1; Ikeda K, 1996, J BIOCHEM-TOKYO, V120, P1141; Kahn V, 1999, J FOOD BIOCHEM, V23, P263, DOI 10.1111/j.1745-4514.1999.tb00019.x; KATZ E, 1983, J GEN MICROBIOL, V129, P2703; KATZ E, 1988, CAN J MICROBIOL, V34, P1297, DOI 10.1139/m88-227; KAWAMOTO S, 1993, J FERMENT BIOENG, V76, P345, DOI 10.1016/0922-338X(93)90020-9; Keijser BJF, 2000, J MOL MICROB BIOTECH, V2, P565; KIESER HM, 1992, J BACTERIOL, V174, P5496, DOI 10.1128/JB.174.17.5496-5507.1992; Kieser T., 2000, PRACTICAL STREPTOMYC, V4362; Kirby R, 2006, ADV APPL MICROBIOL, V58, P125, DOI 10.1016/S0065-2164(05)58004-3; LEE YHW, 1988, GENE, V65, P71, DOI 10.1016/0378-1119(88)90418-0; LERCH K, 1972, PATHOL MICROBIOL, V38, P24, DOI 10.1159/000162371; LEU WM, 1989, GENE, V84, P267; LEU WM, 1992, J BIOL CHEM, V267, P20108; Li L, 2002, PLANTA, V215, P239, DOI 10.1007/s00425-002-0750-4; LI WH, 1985, MOL BIOL EVOL, V2, P150; LI YB, 1993, CARCINOGENESIS, V14, P1303, DOI 10.1093/carcin/14.7.1303; LI YB, 1995, CHEM-BIOL INTERACT, V94, P101, DOI 10.1016/0009-2797(94)03326-4; Lin YS, 1997, MOL MICROBIOL, V26, P709, DOI 10.1046/j.1365-2958.1997.5991975.x; LIN YS, 1993, MOL MICROBIOL, V10, P923, DOI 10.1111/j.1365-2958.1993.tb00964.x; LYR H, 1962, NATURE, V195, P289, DOI 10.1038/195289a0; Matoba Y, 2006, J BIOL CHEM, V281, P8981, DOI 10.1074/jbc.M509785200; Mayer AM, 2006, PHYTOCHEMISTRY, V67, P2318, DOI 10.1016/j.phytochem.2006.08.006; MERCADOBLANCO J, 1993, J BACTERIOL, V175, P5403, DOI 10.1128/JB.175.17.5403-5410.1993; Orenes-Pinero E, 2006, ENZYME MICROB TECH, V39, P158, DOI 10.1016/j.enzmictec.2006.03.001; Paget MSB, 1999, J BACTERIOL, V181, P204, DOI 10.1128/JB.181.1.204-211.1999; Pinero S, 2007, J MOL MICROB BIOTECH, V13, P35, DOI 10.1159/000103595; Rozas J, 2003, BIOINFORMATICS, V19, P2496, DOI 10.1093/bioinformatics/btg359; Sambrook J., 2001, MOL CLONING; Schaerlaekens K, 2001, J BACTERIOL, V183, P6727, DOI 10.1128/JB.183.23.6727-6732.2001; SCHREMPF H, 1982, J BACTERIOL, V151, P701, DOI 10.1128/JB.151.2.701-707.1982; SCHREMPF H, 1983, MOL GEN GENET, V189, P501, DOI 10.1007/BF00325917; SHIRLING EB, 1970, ACTINOMYCETALES, P79; Streffer K, 2001, ANAL CHIM ACTA, V427, P201, DOI 10.1016/S0003-2670(00)01040-0; Suzuki H, 2006, J BIOL CHEM, V281, P30251, DOI 10.1074/jbc.M605726200; Thipyapong P, 2004, PLANTA, V220, P105, DOI 10.1007/s00425-004-1330-6; Thipyapong P, 2007, MOLECULES, V12, P1569, DOI 10.3390/12081569; Thompson JD, 1997, NUCLEIC ACIDS RES, V25, P4876, DOI 10.1093/nar/25.24.4876; TOUSSAINT O, 1987, BIOCHEMISTRY-US, V26, P8567, DOI 10.1021/bi00400a011; Ueda K, 2000, ANTON LEEUW INT J G, V78, P263, DOI 10.1023/A:1010220614293; Ueda K, 1997, J ANTIBIOT, V50, P693, DOI 10.7164/antibiotics.50.693; WAKSMAN SA, 1948, BERGEYS MANUAL DETER, P892; Widdick DA, 2006, P NATL ACAD SCI USA, V103, P17927, DOI 10.1073/pnas.0607025103; WILLIAMS ST, 1983, J GEN MICROBIOL, V129, P1743; YU TW, 1993, J BACTERIOL, V175, P1847, DOI 10.1128/JB.175.6.1847-1852.1993; Zhu DQ, 2005, J BACTERIOL, V187, P3180, DOI 10.1128/JB.187.9.3180-3187.2005	60	17	17	1	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7462	10.1371/journal.pone.0007462	http://dx.doi.org/10.1371/journal.pone.0007462			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826489	gold, Green Published, Green Submitted			2022-12-27	WOS:000270808700021
J	Mileo, AM; Abbruzzese, C; Mattarocci, S; Bellacchio, E; Pisano, P; Federico, A; Maresca, V; Picardo, M; Giorgi, A; Maras, B; Schinina, ME; Paggi, MG				Mileo, Anna M.; Abbruzzese, Claudia; Mattarocci, Stefano; Bellacchio, Emanuele; Pisano, Paola; Federico, Antonio; Maresca, Vittoria; Picardo, Mauro; Giorgi, Alessandra; Maras, Bruno; Schinina, M. Eugenia; Paggi, Marco G.			Human Papillomavirus-16 E7 Interacts with Glutathione S-Transferase P1 and Enhances Its Role in Cell Survival	PLOS ONE			English	Article							PEPTIDE-SYNTHESIS; CANCER; IDENTIFICATION; APOPTOSIS; PROTEINS; VIRUSES; LINE; KERATINOCYTES; SENSITIVITY; MECHANISMS	Background: Human Papillomavirus (HPV)-16 is a paradigm for "high-risk'' HPVs, the causative agents of virtually all cervical carcinomas. HPV E6 and E7 viral genes are usually expressed in these tumors, suggesting key roles for their gene products, the E6 and E7 oncoproteins, in inducing malignant transformation. Methodology/Principal Findings: By protein-protein interaction analysis, using mass spectrometry, we identified glutathione S-transferase P1-1 (GSTP1) as a novel cellular partner of the HPV-16 E7 oncoprotein. Following mapping of the region in the HPV-16 E7 sequence that is involved in the interaction, we generated a three-dimensional molecular model of the complex between HPV-16 E7 and GSTP1, and used this to engineer a mutant molecule of HPV-16 E7 with strongly reduced affinity for GSTP1. When expressed in HaCaT human keratinocytes, HPV-16 E7 modified the equilibrium between the oxidized and reduced forms of GSTP1, thereby inhibiting JNK phosphorylation and its ability to induce apoptosis. Using GSTP1-deficient MCF-7 cancer cells and siRNA interference targeting GSTP1 in HaCaT keratinocytes expressing either wild-type or mutant HPV-16 E7, we uncovered a pivotal role for GSTP1 in the pro-survival program elicited by its binding with HPV-16 E7. Conclusions/Significance: This study provides further evidence of the transforming abilities of this oncoprotein, setting the groundwork for devising unique molecular tools that can both interfere with the interaction between HPV-16 E7 and GSTP1 and minimize the survival of HPV-16 E7-expressing cancer cells.			Mileo, AM (corresponding author), Regina Elena Inst Canc Res, CRS, Dept Dev, Therapeut Programs, Rome, Italy.	marco.paggi@gmail.com	Maras, Bruno/A-2020-2010; Bellacchio, Emanuele/AAH-9255-2019; Paggi, Marco G./K-3494-2018; maresca, vittoria/J-3272-2016; Abbruzzese, Claudia/U-7576-2017; Federico, Antonio/H-8871-2017; Picardo, Mauro/A-6978-2011; Mileo, Anna Maria/J-3667-2016	maresca, vittoria/0000-0001-9239-6978; Abbruzzese, Claudia/0000-0003-3301-9421; Federico, Antonio/0000-0001-9650-2256; Picardo, Mauro/0000-0003-4899-6639; Mileo, Anna Maria/0000-0002-1970-3297; Bellacchio, Emanuele/0000-0002-2757-849X	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Adler V, 1999, EMBO J, V18, P1321, DOI 10.1093/emboj/18.5.1321; AWASTHI S, 1993, BIOCHIM BIOPHYS ACTA, V1164, P173, DOI 10.1016/0167-4838(93)90245-M; BOUKAMP P, 1988, J CELL BIOL, V106, P761, DOI 10.1083/jcb.106.3.761; BROOKS SC, 1973, J BIOL CHEM, V248, P6251; Chen C, 1999, CARCINOGENESIS, V20, P699, DOI 10.1093/carcin/20.4.699; Claiborne A., 1985, CRC HDB METHODS OXYG, P283; Cumming RC, 2001, NAT MED, V7, P814, DOI 10.1038/89937; D'Souza G, 2007, NEW ENGL J MED, V356, P1944, DOI 10.1056/NEJMoa065497; Dang DT, 2005, CANCER RES, V65, P9485, DOI 10.1158/0008-5472.CAN-05-1930; De Luca A, 2003, CANCER RES, V63, P1430; Duensing S, 2000, P NATL ACAD SCI USA, V97, P10002, DOI 10.1073/pnas.170093297; Felsani A, 2006, ONCOGENE, V25, P5277, DOI 10.1038/sj.onc.1209621; FLOHE L, 1984, METHOD ENZYMOL, V105, P114; FRIEDL F, 1970, P SOC EXP BIOL MED, V135, P543; GEYSEN HM, 1984, P NATL ACAD SCI-BIOL, V81, P3998, DOI 10.1073/pnas.81.13.3998; Hayes JD, 2005, ANNU REV PHARMACOL, V45, P51, DOI 10.1146/annurev.pharmtox.45.120403.095857; Helt AM, 2003, CARCINOGENESIS, V24, P159, DOI 10.1093/carcin/24.2.159; Henderson CJ, 1998, CHEM-BIOL INTERACT, V112, P69, DOI 10.1016/S0009-2797(97)00176-2; Jentzsch AM, 1996, FREE RADICAL BIO MED, V20, P251, DOI 10.1016/0891-5849(95)02043-8; Kinsella TM, 1996, HUM GENE THER, V7, P1405, DOI 10.1089/hum.1996.7.12-1405; Lavia P, 2003, ONCOGENE, V22, P6508, DOI 10.1038/sj.onc.1206861; Lin XH, 2003, CANCER RES, V63, P498; LOBELLO M, 1990, FEBS LETT, V263, P389, DOI 10.1016/0014-5793(90)81421-J; MAEJI NJ, 1990, J IMMUNOL METHODS, V134, P23; Magal SS, 1998, INT J CANCER, V75, P96; Marchese C, 2003, ONCOGENE, V22, P2422, DOI 10.1038/sj.onc.1206301; McIlwain CC, 2006, ONCOGENE, V25, P1639, DOI 10.1038/sj.onc.1209373; McLaughlin-Drubin ME, 2008, BBA-MOL BASIS DIS, V1782, P127, DOI 10.1016/j.bbadis.2007.12.005; McLaughlin-Drubin ME, 2009, VIROLOGY, V384, P335, DOI 10.1016/j.virol.2008.10.006; Mignogna G, 2005, J PROTEOME RES, V4, P1361, DOI 10.1021/pr0500511; MOSCOW JA, 1989, MOL PHARMACOL, V36, P22; Mouret S, 2005, EXP DERMATOL, V14, P401, DOI 10.1111/j.0906-6705.2005.00296.x; Munger K, 2001, ONCOGENE, V20, P7888, DOI 10.1038/sj.onc.1204860; Munger K, 2004, J VIROL, V78, P11451, DOI 10.1128/JVI.78.21.11451-11460.2004; PASSI S, 1991, Journal of Dermatological Science, V2, P171, DOI 10.1016/0923-1811(91)90064-5; PATRICK DR, 1994, J BIOL CHEM, V269, P6842; PATTILLO R A, 1977, Science (Washington D C), V196, P1456, DOI 10.1126/science.867042; Pfister Herbert, 2003, J Natl Cancer Inst Monogr, P52; RICCI G, 1991, J BIOL CHEM, V266, P21409; SALI A, 1993, J MOL BIOL, V234, P779, DOI 10.1006/jmbi.1993.1626; SEEDORF K, 1987, EMBO J, V6, P139, DOI 10.1002/j.1460-2075.1987.tb04731.x; Severino A, 2007, J CELL PHYSIOL, V212, P118, DOI 10.1002/jcp.21011; Shim JH, 2005, PROTEOMICS, V5, P2112, DOI 10.1002/pmic.200401106; SMOTKIN D, 1986, P NATL ACAD SCI USA, V83, P4680, DOI 10.1073/pnas.83.13.4680; SPITZ DR, 1989, ANAL BIOCHEM, V179, P8, DOI 10.1016/0003-2697(89)90192-9; TEW KD, 1994, CANCER RES, V54, P4313; Wang T, 2001, J BIOL CHEM, V276, P20999, DOI 10.1074/jbc.M101355200; Whiteside MA, 2008, CANCER-AM CANCER SOC, V113, P2981, DOI 10.1002/cncr.23750; zur Hausen H, 2002, NAT REV CANCER, V2, P342, DOI 10.1038/nrc798	49	26	27	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7254	10.1371/journal.pone.0007254	http://dx.doi.org/10.1371/journal.pone.0007254			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19826491	gold, Green Published, Green Submitted			2022-12-27	WOS:000270808300001
J	Ding, XQ; Quiambao, AB; Fitzgerald, JB; Cooper, MJ; Conley, SM; Naash, MI				Ding, Xi-Qin; Quiambao, Alexander B.; Fitzgerald, J. Browning; Cooper, Mark J.; Conley, Shannon M.; Naash, Muna I.			Ocular Delivery of Compacted DNA-Nanoparticles Does Not Elicit Toxicity in the Mouse Retina	PLOS ONE			English	Article								Subretinal delivery of polyethylene glycol-substituted lysine peptide (CK30PEG)-compacted DNA nanoparticles results in efficient gene expression in retinal cells. This work evaluates the ocular safety of compacted DNA nanoparticles. CK30PEG-compacted nanoparticles containing an EGFP expression plasmid were subretinally injected in adult mice (1 mu l at 0.3, 1.0 and 3.0 mu g/mu l). Retinas were examined for signs of inflammation at 1, 2, 4 and 7 days post-injection. Neither infiltration of polymorphonuclear neutrophils or lymphocytes was detected in retinas. In addition, elevation of macrophage marker F4/80 or myeloid marker myeloperoxidase was not detected in the injected eyes. The chemokine KC mRNA increased 3-4 fold in eyes injected with either nanoparticles or saline at 1 day post-injection, but returned to control levels at 2 days post-injection. No elevation of KC protein was observed in these mice. The monocyte chemotactic protein-1, increased 3-4 fold at 1 day post-injection for both nanoparticle and saline injected eyes, but also returned to control levels at 2 days. No elevations of tumor necrosis factor alpha mRNA or protein were detected. These investigations show no signs of local inflammatory responses associated with subretinal injection of compacted DNA nanoparticles, indicating that the retina may be a suitable target for clinical nanoparticle-based interventions.			Ding, XQ (corresponding author), Univ Oklahoma, Hlth Sci Ctr, Dept Cell Biol, Oklahoma City, OK USA.	xi-qin-ding@ouhsc.edu			NEI NIH HHS [EY018656, R21 EY017031, R01 EY018656, EY-017031, R01 EY018656-01] Funding Source: Medline; NATIONAL EYE INSTITUTE [R21EY017031, R01EY018656] Funding Source: NIH RePORTER	NEI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI)); NATIONAL EYE INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI))		Acland GM, 2005, MOL THER, V12, P1072, DOI 10.1016/j.ymthe.2005.08.008; Acland GM, 2001, NAT GENET, V28, P92, DOI 10.1038/88327; Alexander JJ, 2007, NAT MED, V13, P685, DOI 10.1038/nm1596; Bainbridge JWB, 2008, NEW ENGL J MED, V358, P2231, DOI 10.1056/NEJMoa0802268; Bennett J, 1996, NAT MED, V2, P649, DOI 10.1038/nm0696-649; Cai X, 2008, VISION RES, V48, P319, DOI 10.1016/j.visres.2007.07.012; Cai X, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005290; Chen X, 2008, MOL THER, V16, P333, DOI 10.1038/sj.mt.6300365; Chintakuntlawar AV, 2007, INVEST OPHTH VIS SCI, V48, P781, DOI 10.1167/iovs.06-1036; Cideciyan AV, 2008, P NATL ACAD SCI USA, V105, P15112, DOI 10.1073/pnas.0807027105; Dai H, 2006, INT J NANOMED, V1, P507, DOI 10.2147/nano.2006.1.4.507; Davies M, 2006, MOL VIS, V12, P467; Dezawa M, 2002, MICRON, V33, P1, DOI 10.1016/S0968-4328(01)00002-6; Elner VM, 1997, EXP EYE RES, V65, P781, DOI 10.1006/exer.1997.0380; Espinosa-Heidmann DG, 2003, INVEST OPHTH VIS SCI, V44, P3586, DOI 10.1167/iovs.03-0038; Farjo R, 2006, J CELL BIOL, V173, P59, DOI 10.1083/jcb.200509036; Farjo R, 2006, PLOS ONE, V1, DOI 10.1371/journal.pone.0000038; Fink TL, 2006, GENE THER, V13, P1048, DOI 10.1038/sj.gt.3302761; Giese MJ, 1998, INVEST OPHTH VIS SCI, V39, P2785; Hantzschel N, 2007, LANGMUIR, V23, P10793, DOI 10.1021/la701691g; Halbert CL, 2006, HUM GENE THER, V17, P440, DOI 10.1089/hum.2006.17.440; Heinecke JW, 1997, BIOFACTORS, V6, P145, DOI 10.1002/biof.5520060208; Holtkamp GM, 1999, CLIN EXP IMMUNOL, V118, P35; Jan E, 2008, ACS NANO, V2, P928, DOI 10.1021/nn7004393; JO N, 2003, INVEST OPHTHALMOL VI, V44; Jun AS, 2003, EYE, V17, P906, DOI 10.1038/sj.eye.6700565; KLEBANOFF SJ, 1980, ANN INTERN MED, V93, P480, DOI 10.7326/0003-4819-93-3-480; Konstan MW, 2004, HUM GENE THER, V15, P1255, DOI 10.1089/hum.2004.15.1255; Kowalczyk TH, 2003, MOL THER, V7, pS375; Lee J, 2009, SMALL, V5, P1213, DOI 10.1002/smll.200801788; LEIBOVICH SJ, 1987, NATURE, V329, P630, DOI 10.1038/329630a0; Liaw J, 2001, GENE THER, V8, P999, DOI 10.1038/sj.gt.3301485; Limb GA, 1996, BRIT J OPHTHALMOL, V80, P168, DOI 10.1136/bjo.80.2.168; Limb GA, 2001, INVEST OPHTH VIS SCI, V42, P1586; Liu G, 2003, J BIOL CHEM, V278, P32578, DOI 10.1074/jbc.M305776200; Maguire AM, 2008, NEW ENGL J MED, V358, P2240, DOI 10.1056/NEJMoa0802315; Moyer AL, 2009, INVEST OPHTH VIS SCI, V50, P3783, DOI 10.1167/iovs.08-3051; Nakazawa T, 2006, MOL VIS, V12, P867; Nour M, 2003, INVEST OPHTH VIS SCI, V44, P4505, DOI 10.1167/iovs.03-0453; Oshitari T, 2006, DIABETES, V55, P86, DOI 10.2337/diabetes.55.1.86; Ott MG, 2006, NAT MED, V12, P401, DOI 10.1038/nm1393; Portillo JAC, 2008, J IMMUNOL, V181, P8719, DOI 10.4049/jimmunol.181.12.8719; Powers MR, 2005, CURR EYE RES, V30, P299, DOI 10.1080/02713680590923276; Ramadan RT, 2008, INVEST OPHTH VIS SCI, V49, P4482, DOI 10.1167/iovs.08-2085; Ramadan RT, 2006, CURR EYE RES, V31, P955, DOI 10.1080/02713680600976925; RAUSCH PG, 1978, NEW ENGL J MED, V298, P693, DOI 10.1056/NEJM197803302981301; Sieving PA, 2006, P NATL ACAD SCI USA, V103, P3896, DOI 10.1073/pnas.0600236103; Stieger K, 2008, MOL THER, V16, P916, DOI 10.1038/mt.2008.41; SUNDERKOTTER C, 1994, J LEUKOCYTE BIOL, V55, P410, DOI 10.1002/jlb.55.3.410; Thomas CE, 2003, NAT REV GENET, V4, P346, DOI 10.1038/nrg1066; Uchida E, 2002, BIOL PHARM BULL, V25, P891, DOI 10.1248/bpb.25.891; Yoshida S, 2003, J LEUKOCYTE BIOL, V73, P137, DOI 10.1189/jlb.0302117; Yurek DM, 2009, MOL THER, V17, P641, DOI 10.1038/mt.2009.2; Ziady AG, 2003, MOL THER, V8, P936, DOI 10.1016/j.ymthe.2003.07.007; Ziady AG, 2003, MOL THER, V8, P948, DOI 10.1016/j.ymthe.2003.09.002	55	56	59	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7410	10.1371/journal.pone.0007410	http://dx.doi.org/10.1371/journal.pone.0007410			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823583	Green Submitted, Green Published, gold			2022-12-27	WOS:000270728500011
J	Duan, ZF; Choy, E; Hornicek, FJ				Duan, Zhenfeng; Choy, Edwin; Hornicek, Francis J.			NSC23925, Identified in a High-Throughput Cell-Based Screen, Reverses Multidrug Resistance	PLOS ONE			English	Article								Background: Multidrug resistance (MDR) is a major factor which contributes to the failure of cancer chemotherapy, and numerous efforts have been attempted to overcome MDR. To date, none of these attempts have yielded a tolerable and effective therapy to reverse MDR; thus, identification of new agents would be useful both clinically and scientifically. Methodology/Principal Findings: To identify small molecule compounds that can reverse chemoresistance, we developed a 96-well plate high-throughput cell-based screening assay in a paclitaxel resistant ovarian cancer cell line. Coincubating cells with a sublethal concentration of paclitaxel in combination with each of 2,000 small molecule compounds from the National Cancer Institute Diversity Set Library, we identified a previously uncharacterized molecule, NSC23925, that inhibits Pgp1 and reverses MDR1 (Pgp1) but does not inhibit MRP or BCRP-mediated MDR. The cytotoxic activity of NSC23925 was further evaluated using a panel of cancer cell lines expressing Pgp1, MRP, and BCRP. We found that at a concentration of >10 mu M NSC23925 moderately inhibits the proliferation of both sensitive and resistant cell lines with almost equal activity, but its inhibitory effect was not altered by co-incubation with the Pgp1 inhibitor, verapamil, suggesting that NSC23925 itself is not a substrate of Pgp1. Additionally, NSC23925 increases the intracellular accumulation of Pgp1 substrates: calcein AM, Rhodamine-123, paclitaxel, mitoxantrone, and doxorubicin. Interestingly, we further observed that, although NSC23925 directly inhibits the function of Pgp1 in a dose-dependent manner without altering the total expression level of Pgp1, NSC23925 actually stimulates ATPase activity of Pgp, a phenomenon seen in other Pgp inhibitors. Conclusions/Significance: The ability of NSC23925 to restore sensitivity to the cytotoxic effects of chemotherapy or to prevent resistance could significantly benefit cancer patients.			Duan, ZF (corresponding author), Massachusetts Gen Hosp, Ctr Sarcoma & Connect Tissue Oncol, Sarcoma Biol Lab, Boston, MA 02114 USA.	zduan@partners.org		Duan, Zhenfeng/0000-0002-8543-083X; Choy, Edwin/0000-0001-9896-8084	NCI NIH HHS [R01 CA119617, R01-CA119617] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA119617] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ahmed-Belkacem A, 2005, CANCER RES, V65, P4852, DOI 10.1158/0008-5472.CAN-04-1817; Ambudkar SV, 1999, ANNU REV PHARMACOL, V39, P361, DOI 10.1146/annurev.pharmtox.39.1.361; AMBUDKAR SV, 1992, P NATL ACAD SCI USA, V89, P8472, DOI 10.1073/pnas.89.18.8472; Belpomme D, 2000, ANN ONCOL, V11, P1471, DOI 10.1023/A:1026556119020; Caldwell JS, 2007, ADV CANCER RES, V96, P145, DOI 10.1016/S0065-230X(06)96006-0; CARMICHAEL J, 1987, CANCER RES, V47, P936; Choi CH, 2004, BIOCHEM BIOPH RES CO, V320, P672, DOI 10.1016/j.bbrc.2004.06.020; Dai CL, 2007, CANCER CHEMOTH PHARM, V60, P741, DOI 10.1007/s00280-007-0420-0; Dantzig AH, 1996, CANCER RES, V56, P4171; Dean M, 2005, NAT REV CANCER, V5, P275, DOI 10.1038/nrc1590; Duan ZF, 2005, CANCER CHEMOTH PHARM, V55, P277, DOI 10.1007/s00280-004-0878-y; Duan ZF, 1999, GENE, V229, P75, DOI 10.1016/S0378-1119(99)00042-6; Duan Z, 2007, MOL PHARMACOL, V72, P1137, DOI 10.1124/mol.107.038117; Duan ZF, 2009, CANCER CHEMOTH PHARM, V63, P1121, DOI 10.1007/s00280-008-0843-2; Ferry DR, 1996, EUR J CANCER, V32A, P1070, DOI 10.1016/0959-8049(96)00091-3; Garrigues A, 2002, ANAL BIOCHEM, V305, P106, DOI 10.1006/abio.2002.5650; Gottesman MM, 2002, NAT REV CANCER, V2, P48, DOI 10.1038/nrc706; HAMADA H, 1988, CANCER RES, V48, P4926; Higgins CF, 2007, NATURE, V446, P749, DOI 10.1038/nature05630; Iorns E, 2009, BIOCHEM J, V417, P361, DOI 10.1042/BJ20081682; Kaye SB, 2008, J CLIN ONCOL, V26, P2616, DOI 10.1200/JCO.2008.16.2123; Kitazaki T, 2005, LUNG CANCER, V49, P337, DOI 10.1016/j.lungcan.2005.03.035; Kolitz JE, 2004, J CLIN ONCOL, V22, P4290, DOI 10.1200/JCO.2004.11.106; Krishna R, 2000, EUR J PHARM SCI, V11, P265, DOI 10.1016/S0928-0987(00)00114-7; Lamendola DE, 2003, CANCER RES, V63, P2200; Litman T, 2003, J PHARMACOL EXP THER, V307, P846, DOI 10.1124/jpet.103.056960; Lourda M, 2007, INT J CANCER, V120, P611, DOI 10.1002/ijc.22327; Mellor HR, 2008, PHARMACOLOGY, V81, P275, DOI 10.1159/000115967; MILLWARD MJ, 1993, BRIT J CANCER, V67, P1031, DOI 10.1038/bjc.1993.189; Mimeault M, 2006, CARCINOGENESIS, V27, P1, DOI 10.1093/carcin/bgi229; Rosenberg MF, 2001, EMBO J, V20, P5615, DOI 10.1093/emboj/20.20.5615; Scarborough GA, 2003, TRENDS BIOCHEM SCI, V28, P581, DOI 10.1016/j.tibs.2003.08.010; Scarborough GA, 2002, J BIOENERG BIOMEMBR, V34, P235, DOI 10.1023/A:1020211016696; Schwab D, 2003, J MED CHEM, V46, P1716, DOI 10.1021/jm021012t; Sikic BI, 1997, SEMIN HEMATOL, V34, P40; Sonneveld P, 2001, BRIT J HAEMATOL, V115, P895, DOI 10.1046/j.1365-2141.2001.03171.x; Szakacs G, 2004, CANCER CELL, V6, P129, DOI 10.1016/j.ccr.2004.06.026; Szakacs G, 2006, NAT REV DRUG DISCOV, V5, P219, DOI 10.1038/nrd1984; TEBOEKHORST PAW, 1992, CANCER CHEMOTH PHARM, V30, P238, DOI 10.1007/BF00686322; TWENTYMAN PR, 1991, EUR J CANCER, V27, P1639, DOI 10.1016/0277-5379(91)90435-G; Ulukaya E, 2004, CHEMOTHERAPY, V50, P43, DOI 10.1159/000077285; Wang EJ, 2000, DRUG METAB DISPOS, V28, P522; Yap TA, 2009, NAT REV CANCER, V9, P167, DOI 10.1038/nrc2583; Yusuf RZ, 2003, CURR CANCER DRUG TAR, V3, P1, DOI 10.2174/1568009033333754; Zhu XM, 2005, ANTICANCER RES, V25, P1953	45	41	42	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7415	10.1371/journal.pone.0007415	http://dx.doi.org/10.1371/journal.pone.0007415			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823672	gold, Green Published, Green Submitted			2022-12-27	WOS:000270728500014
J	Fleming-Waddell, JN; Olbricht, GR; Taxis, TM; White, JD; Vuocolo, T; Craig, BA; Tellam, RL; Neary, MK; Cockett, NE; Bidwell, CA				Fleming-Waddell, Jolena N.; Olbricht, Gayla R.; Taxis, Tasia M.; White, Jason D.; Vuocolo, Tony; Craig, Bruce A.; Tellam, Ross L.; Neary, Mike K.; Cockett, Noelle E.; Bidwell, Christopher A.			Effect of DLK1 and RTL1 but Not MEG3 or MEG8 on Muscle Gene Expression in Callipyge Lambs	PLOS ONE			English	Article							BETA-ADRENERGIC AGONIST; TUMOR-SUPPRESSOR PTEN; SKELETAL-MUSCLE; POLAR OVERDOMINANCE; E-BOX; PHENOTYPIC CHARACTERIZATION; PROTEINASE ACTIVITIES; NEGATIVE REGULATOR; TRANS-INTERACTION; FETAL ANTIGEN-1	Callipyge sheep exhibit extreme postnatal muscle hypertrophy in the loin and hindquarters as a result of a single nucleotide polymorphism (SNP) in the imprinted DLK1-DIO3 domain on ovine chromosome 18. The callipyge SNP up-regulates the expression of surrounding transcripts when inherited in cis without altering their allele-specific imprinting status. The callipyge phenotype exhibits polar overdominant inheritance since only paternal heterozygous animals have muscle hypertrophy. Two studies were conducted profiling gene expression in lamb muscles to determine the down-stream effects of over-expression of paternal allele-specific DLK1 and RTL1 as well as maternal allele-specific MEG3, RTL1AS and MEG8, using Affymetrix bovine expression arrays. A total of 375 transcripts were differentially expressed in callipyge muscle and 25 transcripts were subsequently validated by quantitative PCR. The muscle-specific expression patterns of most genes were similar to DLK1 and included genes that are transcriptional repressors or affect feedback mechanisms in beta-adrenergic and growth factor signaling pathways. One gene, phosphodiesterase 7A had an expression pattern similar to RTL1 expression indicating a biological activity for RTL1 in muscle. Only transcripts that localize to the DLK1-DIO3 domain were affected by inheritance of a maternal callipyge allele. Callipyge sheep are a unique model to study over expression of both paternal allele-specific genes and maternal allele-specific non-coding RNA with an accessible and nonlethal phenotype. This study has identified a number of genes that are regulated by DLK1 and RTL1 expression and exert control on postnatal skeletal muscle growth. The genes identified in this model are primary candidates for naturally regulating postnatal muscle growth in all meat animal species, and may serve as targets to ameliorate muscle atrophy conditions including myopathic diseases and age-related sarcopenia.			Fleming-Waddell, JN (corresponding author), Purdue Univ, Dept Anim Sci, W Lafayette, IN 47907 USA.	cbidwell@purdue.edu	Craig, Bruce A/D-5797-2017; Tellam, Ross/T-2423-2019; White, Jason/AAF-8712-2020; Tellam, Ross/H-2798-2013; Vuocolo, Tony/H-7533-2013	Craig, Bruce A/0000-0001-9346-467X; White, Jason/0000-0002-0557-392X; Tellam, Ross/0000-0003-2353-1640; Vuocolo, Tony/0000-0002-5574-8126				Azmi S, 2004, J BIOL CHEM, V279, P52643, DOI 10.1074/jbc.M409188200; Bachmann E, 1996, J REPROD FERTIL, V107, P279; Baillie GS, 2003, P NATL ACAD SCI USA, V100, P940, DOI 10.1073/pnas.262787199; Baladron V, 2005, EXP CELL RES, V303, P343, DOI 10.1016/j.yexcr.2004.10.001; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bidwell CA, 2001, ANIM GENET, V32, P248, DOI 10.1046/j.1365-2052.2001.00776.x; Bidwell CA, 2004, BMC BIOL, V2, DOI 10.1186/1741-7007-2-17; Bloom TJ, 1996, P NATL ACAD SCI USA, V93, P14188, DOI 10.1073/pnas.93.24.14188; Bodine SC, 2001, NAT CELL BIOL, V3, P1014, DOI 10.1038/ncb1101-1014; Bray SJ, 2008, BMC DEV BIOL, V8, DOI 10.1186/1471-213X-8-11; Butler MP, 2004, J BIOL RHYTHM, V19, P126, DOI 10.1177/0748730403262870; Carpenter CE, 2000, CAN J ANIM SCI, V80, P511, DOI 10.4141/A00-009; Carpenter CE, 2000, CAN J ANIM SCI, V80, P297, DOI 10.4141/A99-115; Carpenter E, 1996, J ANIM SCI, V74, P388; Cavaille J, 2002, HUM MOL GENET, V11, P1527, DOI 10.1093/hmg/11.13.1527; Charlier C, 2001, NAT GENET, V27, P367, DOI 10.1038/86856; Charlier C, 2001, GENOME RES, V11, P850, DOI 10.1101/gr.172701; CHIRGWIN JM, 1979, BIOCHEMISTRY-US, V18, P5294, DOI 10.1021/bi00591a005; Cockett NE, 1996, SCIENCE, V273, P236, DOI 10.1126/science.273.5272.236; Coutinho LL, 2007, PHYSIOL GENOMICS, V29, P35, DOI 10.1152/physiolgenomics.00081.2006; Croteau S, 2003, MAMM GENOME, V14, P231, DOI 10.1007/s00335-002-2244-x; da Rocha ST, 2007, DEV BIOL, V306, P810, DOI 10.1016/j.ydbio.2007.02.043; Davis E, 2005, CURR BIOL, V15, P743, DOI 10.1016/j.cub.2005.02.060; Davis E, 2004, CURR BIOL, V14, P1858, DOI 10.1016/j.cub.2004.09.079; De Arcangelis V, 2003, MOL BIOL CELL, V14, P1392, DOI 10.1091/mbc.E02-03-0156; Dennis G, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-9-r60; Duckett SK, 2000, J ANIM SCI, V78, P2836; Edwards CA, 2008, PLOS BIOL, V6, P1292, DOI 10.1371/journal.pbio.0060135; Enoksson S, 1998, DIABETOLOGIA, V41, P560, DOI 10.1007/s001250050947; Fleming-Waddell JN, 2007, ANIM GENET, V38, P28, DOI 10.1111/j.1365-2052.2006.01562.x; Freking BA, 1998, J ANIM SCI, V76, P2062; Freking BA, 1998, J ANIM SCI, V76, P2549; Freking BA, 2002, GENOME RES, V12, P1496, DOI 10.1101/gr.571002; Fujimoto K, 2007, INT J MOL MED, V19, P925; Garces C, 1999, DIFFERENTIATION, V64, P103, DOI 10.1007/s002580050265; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Georges M, 2003, TRENDS GENET, V19, P248, DOI 10.1016/S0168-9525(03)00082-9; Glass DJ, 2005, INT J BIOCHEM CELL B, V37, P1974, DOI 10.1016/j.biocel.2005.04.018; Glazov EA, 2008, MOL BIOL EVOL, V25, P939, DOI 10.1093/molbev/msn045; Haberland M, 2007, MOL CELL BIOL, V27, P518, DOI 10.1128/MCB.01415-06; Hagan JP, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004352; Han P, 1997, J BIOL CHEM, V272, P16152, DOI 10.1074/jbc.272.26.16152; HASTY P, 1993, NATURE, V364, P501, DOI 10.1038/364501a0; Honma S, 2002, NATURE, V419, P841, DOI 10.1038/nature01123; Huang DW, 2008, BIOINFORMATION, V2, P428; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Hui STY, 2008, P NATL ACAD SCI USA, V105, P3921, DOI 10.1073/pnas.0800293105; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Izumiya Y, 2008, CELL METAB, V7, P159, DOI 10.1016/j.cmet.2007.11.003; Jackson SP, 1997, J ANIM SCI, V75, P125; Jackson SP, 1997, J ANIM SCI, V75, P133; Jarriault S, 1998, MOL CELL BIOL, V18, P7423, DOI 10.1128/MCB.18.12.7423; JENSEN CH, 1994, EUR J BIOCHEM, V225, P83, DOI 10.1111/j.1432-1033.1994.00083.x; JENSEN CH, 1993, HUM REPROD, V8, P635, DOI 10.1093/oxfordjournals.humrep.a138110; Kaneta M, 2000, J IMMUNOL, V164, P256, DOI 10.4049/jimmunol.164.1.256; Kijas JW, 2006, ANIM GENET, V37, P171, DOI 10.1111/j.1365-2052.2005.01399.x; Kim KS, 2004, MAMM GENOME, V15, P552, DOI 10.1007/s00335-004-2341-0; Kim RH, 2005, CANCER CELL, V7, P263, DOI 10.1016/j.ccr.2005.02.010; Kircher M, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-346; Koohmaraie M, 1996, J ANIM SCI, V74, P70; KOOHMARAIE M, 1991, J ANIM SCI, V69, P4823, DOI 10.2527/1991.69124823x; Koohmaraie M, 1995, J ANIM SCI, V73, P3596; Kwon J, 2004, P NATL ACAD SCI USA, V101, P16419, DOI 10.1073/pnas.0407396101; Lai KMV, 2004, MOL CELL BIOL, V24, P9295, DOI 10.1128/MCB.24.21.9295-9304.2004; Lee SR, 2002, J BIOL CHEM, V277, P20336, DOI 10.1074/jbc.M111899200; Li XP, 2008, ANIM GENET, V39, P189, DOI 10.1111/j.1365-2052.2007.01693.x; Li YX, 2003, J BIOL CHEM, V278, P16899, DOI 10.1074/jbc.M300596200; Liu HG, 1999, J BIOL CHEM, V274, P10557, DOI 10.1074/jbc.274.15.10557; Lynch C, 2003, CURR BIOL, V13, P1518, DOI 10.1016/S0960-9822(03)00618-3; Murphy SK, 2005, MAMM GENOME, V16, P171, DOI 10.1007/s00335-004-2421-1; Nishiyama A, 1999, J BIOL CHEM, V274, P21645, DOI 10.1074/jbc.274.31.21645; Noshiro M, 2004, GENES CELLS, V9, P317, DOI 10.1111/j.1356-9597.2004.00722.x; Nueda ML, 2007, J MOL BIOL, V367, P1270, DOI 10.1016/j.jmb.2006.10.020; Perkins AC, 2006, ANIM GENET, V37, P535, DOI 10.1111/j.1365-2052.2006.01518.x; Polineni P, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-283; PRINGLE TD, 1993, J ANIM SCI, V71, P636, DOI 10.2527/1993.713636x; *R DCT, 2007, R LANG ENV STAT COMP; Richter W, 2008, EMBO J, V27, P384, DOI 10.1038/sj.emboj.7601968; Rommel C, 2001, NAT CELL BIOL, V3, P1009, DOI 10.1038/ncb1101-1009; Rommel C, 1999, SCIENCE, V286, P1738, DOI 10.1126/science.286.5445.1738; SASAI Y, 1992, GENE DEV, V6, P2620, DOI 10.1101/gad.6.12b.2620; Sato F, 2008, GENES CELLS, V13, P131, DOI 10.1111/j.1365-2443.2007.01153.x; Seitz H, 2004, GENOME RES, V14, P1741, DOI 10.1101/gr.2743304; Seitz H, 2003, NAT GENET, V34, P261, DOI 10.1038/ng1171; Sekita Y, 2008, NAT GENET, V40, P243, DOI 10.1038/ng.2007.51; SMAS CM, 1994, BIOCHEMISTRY-US, V33, P9257, DOI 10.1021/bi00197a029; Smit M, 2003, GENETICS, V163, P453; Smith TR, 2001, J ANIM SCI, V79, P781; Soderling SH, 1998, P NATL ACAD SCI USA, V95, P8991, DOI 10.1073/pnas.95.15.8991; St-Pierre B, 2002, J BIOL CHEM, V277, P46544, DOI 10.1074/jbc.M111652200; Tierling S, 2006, GENOMICS, V87, P225, DOI 10.1016/j.ygeno.2005.09.018; Vuocolo T, 2005, AUST J EXP AGR, V45, P879, DOI 10.1071/EA05049; Vuocolo T, 2007, PHYSIOL GENOMICS, V28, P253, DOI 10.1152/physiolgenomics.00121.2006; Wermter AK, 2008, EUR J HUM GENET, V16, P1126, DOI 10.1038/ejhg.2008.64; White JD, 2008, DIFFERENTIATION, V76, P283, DOI 10.1111/j.1432-0436.2007.00208.x; Wolfinger RD, 2001, J COMPUT BIOL, V8, P625, DOI 10.1089/106652701753307520; Xiang Y, 2005, P NATL ACAD SCI USA, V102, P909, DOI 10.1073/pnas.0405263102; Yevtodiyenko A, 2006, DEV DYNAM, V235, P1115, DOI 10.1002/dvdy.20705; Yu M, 2007, MAMM GENOME, V18, P197, DOI 10.1007/s00335-007-9006-8	99	37	44	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7399	10.1371/journal.pone.0007399	http://dx.doi.org/10.1371/journal.pone.0007399			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816583	gold, Green Published, Green Submitted			2022-12-27	WOS:000270594300015
J	Feng, YX; Wang, YM; Stock, O; Pfister, F; Tanimoto, N; Seeliger, MW; Hillebrands, JL; Hoffmann, S; Wolburg, H; Gretz, N; Hammes, HP				Feng, Yuxi; Wang, Yumei; Stock, Oliver; Pfister, Frederick; Tanimoto, Naoyuki; Seeliger, Mathias W.; Hillebrands, Jan-Luuk; Hoffmann, Sigrid; Wolburg, Hartwig; Gretz, Norbert; Hammes, Hans-Peter			Vasoregression Linked to Neuronal Damage in the Rat with Defect of Polycystin-2	PLOS ONE			English	Article								Background: Neuronal damage is correlated with vascular dysfunction in the diseased retina, but the underlying mechanisms remain controversial because of the lack of suitable models in which vasoregression related to neuronal damage initiates in the mature retinal vasculature. The aim of this study was to assess the temporal link between neuronal damage and vascular patency in a transgenic rat (TGR) with overexpression of a mutant cilia gene polycystin-2. Methods: Vasoregression, neuroglial changes and expression of neurotrophic factors were assessed in TGR and control rats in a time course. Determination of neuronal changes was performed by quantitative morphometry of paraffin-embedded vertical sections. Vascular cell composition and patency were assessed by quantitative retinal morphometry of digest preparations. Glial activation was assessed by western blot and immunofluorescence. Expression of neurotrophic factors was detected by quantitative PCR. Findings: At one month, number and thickness of the outer nuclear cell layers (ONL) in TGR rats were reduced by 31% (p<0.001) and 17% (p<0.05), respectively, compared to age-matched control rats. Furthermore, the reduction progressed from 1 to 7 months in TGR rats. Apoptosis was selectively detected in the photoreceptor in the ONL, starting after one month. Nevertheless, TGR and control rats showed normal responses in electroretinogram at one month. From the second month onwards, TGR retinas had significantly increased acellular capillaries (p<0.001), and a reduction of endothelial cells (p<0.01) and pericytes (p<0.01). Upregulation of GFAP was first detected in TGR retinas after 1 month in glial cells, in parallel with an increase of FGF2 (fourfold) and CNTF (60%), followed by upregulation of NGF (40%) at 3 months. Interpretation: Our data suggest that TGR is an appropriate animal model for vasoregression related to neuronal damage. Similarities to experimental diabetic retinopathy render this model suitable to understand general mechanisms of maturity-onset vasoregression.			Feng, YX (corresponding author), Univ Heidelberg, Dept Med 5, Med Fac Mannheim, D-6800 Mannheim, Germany.	hans-peter.hammes@med5.ma.uni-heidelberg.de	Hammes, Hans-Peter/S-3719-2019	Hillebrands, Jan-Luuk/0000-0003-3135-3274				Barber AJ, 2000, INVEST OPHTH VIS SCI, V41, P3561; BLANKS JC, 1986, J COMP NEUROL, V254, P543, DOI 10.1002/cne.902540407; Bringmann A, 2006, PROG RETIN EYE RES, V25, P397, DOI 10.1016/j.preteyeres.2006.05.003; Carmeliet P, 2003, NAT MED, V9, P653, DOI 10.1038/nm0603-653; Chaum E, 2003, J CELL BIOCHEM, V88, P57, DOI 10.1002/jcb.10354; COGAN DG, 1961, ARCH OPHTHALMOL-CHIC, V66, P366, DOI 10.1001/archopht.1961.00960010368014; de Gooyer TE, 2006, INVEST OPHTH VIS SCI, V47, P5553, DOI 10.1167/iovs.06-0646; DOWLING JE, 1962, J CELL BIOL, V14, P73, DOI 10.1083/jcb.14.1.73; Emanueli C, 2002, CIRCULATION, V106, P2257, DOI 10.1161/01.CIR.0000033971.56802.C5; FALSINI B, 1989, DOC OPHTHALMOL, V73, P193, DOI 10.1007/BF00155037; Fletcher EL, 2007, CURR PHARM DESIGN, V13, P2699, DOI 10.2174/138161207781662920; Gallagher AR, 2006, J AM SOC NEPHROL, V17, P2719, DOI 10.1681/ASN.2005090979; HAMMES HP, 1995, MOL MED, V1, P527, DOI 10.1007/BF03401589; Hammes HP, 2004, DIABETES, V53, P1104, DOI 10.2337/diabetes.53.4.1104; Hammes HP, 2002, DIABETES, V51, P3107, DOI 10.2337/diabetes.51.10.3107; Hammes HP, 1998, DIABETES, V47, P401, DOI 10.2337/diabetes.47.3.401; Harada T, 2002, J NEUROSCI, V22, P9228, DOI 10.1523/jneurosci.22-21-09228.2002; Hoffmann J, 2005, FASEB J, V19, P2035, DOI 10.1096/fj.04-2109fje; Holopigian K, 1997, INVEST OPHTH VIS SCI, V38, P2355; Joly S, 2007, INVEST OPHTH VIS SCI, V48, P2311, DOI 10.1167/iovs.06-1205; Kubota Y, 2008, J CLIN INVEST, V118, P2393, DOI 10.1172/JCI34882; Lambiase A, 1996, GRAEF ARCH CLIN EXP, V234, pS96, DOI 10.1007/BF02343055; Lenzi L, 2005, VISION RES, V45, P1491, DOI 10.1016/j.visres.2004.12.020; Lieth E, 1998, DIABETES, V47, P815, DOI 10.2337/diabetes.47.5.815; Luhmann UFO, 2005, INVEST OPHTH VIS SCI, V46, P3372, DOI 10.1167/iovs.05-0174; MASTRONARDE DN, 1984, J COMP NEUROL, V228, P598, DOI 10.1002/cne.902280410; Narendran N, 2004, AM J MED GENET A, V127A, P208, DOI 10.1002/ajmg.a.20673; Olbrich H, 2003, NAT GENET, V34, P455, DOI 10.1038/ng1216; Palmowski AM, 1997, INVEST OPHTH VIS SCI, V38, P2586; Phipps JA, 2004, INVEST OPHTH VIS SCI, V45, P4592, DOI 10.1167/iovs.04-0842; Roepman Ronald, 2007, V43, P209, DOI 10.1007/978-1-4020-5943-8_10; SAKAI H, 1995, OPHTHALMIC RES, V27, P57, DOI 10.1159/000267571; SEATON AD, 1994, INVEST OPHTH VIS SCI, V35, P162; SIDMAN RL, 1965, J HERED, V56, P23, DOI 10.1093/oxfordjournals.jhered.a107364; Vogel G, 2005, SCIENCE, V310, P216, DOI 10.1126/science.310.5746.216; Wang SM, 2000, INVEST OPHTH VIS SCI, V41, P537	36	54	54	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7328	10.1371/journal.pone.0007328	http://dx.doi.org/10.1371/journal.pone.0007328			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806208	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593800022
J	Wu, ZH; Wang, HW; Mu, WH; Ouyang, ZC; Nogales, E; Xing, JH				Wu, Zhanghan; Wang, Hong-Wei; Mu, Weihua; Ouyang, Zhongcan; Nogales, Eva; Xing, Jianhua			Simulations of Tubulin Sheet Polymers as Possible Structural Intermediates in Microtubule Assembly	PLOS ONE			English	Article							PROTEIN-PROTEIN ASSOCIATION; FORCE-VELOCITY RELATION; ELECTRON-MICROSCOPE; DYNAMICS; MODEL; POLYMERIZATION; FLUCTUATIONS; INSTABILITY; FIBRILS; LATTICE	The microtubule assembly process has been extensively studied, but the underlying molecular mechanism remains poorly understood. The structure of an artificially generated sheet polymer that alternates two types of lateral contacts and that directly converts into microtubules, has been proposed to correspond to the intermediate sheet structure observed during microtubule assembly. We have studied the self-assembly process of GMPCPP tubulins into sheet and microtubule structures using thermodynamic analysis and stochastic simulations. With the novel assumptions that tubulins can laterally interact in two different forms, and allosterically affect neighboring lateral interactions, we can explain existing experimental observations. At low temperature, the allosteric effect results in the observed sheet structure with alternating lateral interactions as the thermodynamically most stable form. At normal microtubule assembly temperature, our work indicates that a class of sheet structures resembling those observed at low temperature is transiently trapped as an intermediate during the assembly process. This work may shed light on the tubulin molecular interactions, and the role of sheet formation during microtubule assembly.			Wu, ZH (corresponding author), Virginia Polytech Inst & State Univ, Program Genet Bioinformat & Computat Biol, Blacksburg, VA 24061 USA.	xing@vt.edu	Xing, Jianhua/A-8101-2012; Mu, Weihua/AAG-6247-2020	Xing, Jianhua/0000-0002-3700-8765; Mu, Weihua/0000-0002-0338-7023				Aggeli A, 2001, P NATL ACAD SCI USA, V98, P11857, DOI 10.1073/pnas.191250198; AMOS LA, 1974, J CELL SCI, V14, P523; BAYLEY P, 1989, FEBS LETT, V259, P181, DOI 10.1016/0014-5793(89)81523-6; BERGEN LG, 1980, J CELL BIOL, V84, P141, DOI 10.1083/jcb.84.1.141; Brangwynne CP, 2007, P NATL ACAD SCI USA, V104, P16128, DOI 10.1073/pnas.0703094104; Bruce A., 2002, MOL BIOL CELL, V4th ed.; Buey RM, 2007, NAT CHEM BIOL, V3, P117, DOI 10.1038/nchembio853; BURTON PR, 1978, J CELL BIOL, V77, P120, DOI 10.1083/jcb.77.1.120; CHRETIEN D, 1995, J CELL BIOL, V129, P1311, DOI 10.1083/jcb.129.5.1311; de Pablo PJ, 2003, PHYS REV LETT, V91, DOI 10.1103/PhysRevLett.91.098101; Dogterom M, 1997, SCIENCE, V278, P856, DOI 10.1126/science.278.5339.856; ERICKSON HP, 1989, J MOL BIOL, V206, P465, DOI 10.1016/0022-2836(89)90494-4; ERICKSON HP, 1974, J CELL BIOL, V60, P153, DOI 10.1083/jcb.60.1.153; ERICKSON HP, 1981, BIOPHYS J, V34, P293, DOI 10.1016/S0006-3495(81)84850-3; Fygenson DK, 2004, PROTEIN SCI, V13, P25, DOI 10.1110/ps.03225304; Gardner MK, 2006, CURR OPIN CELL BIOL, V18, P639, DOI 10.1016/j.ceb.2006.10.006; GILLESPIE DT, 1977, J PHYS CHEM-US, V81, P2340, DOI 10.1021/j100540a008; HILL TL, 1985, P NATL ACAD SCI USA, V82, P4404, DOI 10.1073/pnas.82.13.4404; HILL TL, 1981, P NATL ACAD SCI-BIOL, V78, P5613, DOI 10.1073/pnas.78.9.5613; Howard J, 2001, MECH MOTOR PROTEINS; Kerssemakers JWJ, 2006, NATURE, V442, P709, DOI 10.1038/nature04928; KOREN R, 1976, BIOCHEMISTRY-US, V15, P1165, DOI 10.1021/bi00650a032; Li HL, 2002, STRUCTURE, V10, P1317, DOI 10.1016/S0969-2126(02)00827-4; MARTIN SR, 1993, BIOPHYS J, V65, P578, DOI 10.1016/S0006-3495(93)81091-9; McIntosh JR, 2008, CELL, V135, P322, DOI 10.1016/j.cell.2008.08.038; MILLER WH, 1980, J CHEM PHYS, V72, P99, DOI 10.1063/1.438959; Mogilner A, 1999, EUR BIOPHYS J BIOPHY, V28, P235, DOI 10.1007/s002490050204; Molodtsov MI, 2005, BIOPHYS J, V88, P3167, DOI 10.1529/biophysj.104.051789; Molodtsov MI, 2005, P NATL ACAD SCI USA, V102, P4353, DOI 10.1073/pnas.0501142102; Muller-Reichert T, 1998, P NATL ACAD SCI USA, V95, P3661, DOI 10.1073/pnas.95.7.3661; Nogales E, 1999, CELL, V96, P79, DOI 10.1016/S0092-8674(00)80961-7; Nogales E, 2006, CURR OPIN CELL BIOL, V18, P179, DOI 10.1016/j.ceb.2006.02.009; NORTHRUP SH, 1992, P NATL ACAD SCI USA, V89, P3338, DOI 10.1073/pnas.89.8.3338; O'Brien ET, 2008, P NATL ACAD SCI USA, V105, P19438, DOI 10.1073/pnas.0804865105; Odde DJ, 1999, J CELL SCI, V112, P3283; PESKIN CS, 1993, BIOPHYS J, V65, P316, DOI 10.1016/S0006-3495(93)81035-X; Rice LM, 2008, P NATL ACAD SCI USA, V105, P5378, DOI 10.1073/pnas.0801155105; Schaap IAT, 2006, BIOPHYS J, V91, P1521, DOI 10.1529/biophysj.105.077826; Schek HT, 2007, CURR BIOL, V17, P1445, DOI 10.1016/j.cub.2007.07.011; Sept D, 2003, PROTEIN SCI, V12, P2257, DOI 10.1110/ps.03187503; Shin JH, 2003, J CELL BIOL, V162, P1183, DOI 10.1083/jcb.200304006; Sui HX, 2006, NATURE, V442, P475, DOI 10.1038/nature04816; SUMMERS K, 1979, J CELL BIOL, V83, P205, DOI 10.1083/jcb.83.1.205; VanBuren V, 2005, BIOPHYS J, V89, P2911, DOI 10.1529/biophysj.105.060913; VanBuren V, 2002, P NATL ACAD SCI USA, V99, P6035, DOI 10.1073/pnas.092504999; Vitre B, 2008, NAT CELL BIOL, V10, P415, DOI 10.1038/ncb1703; Wang HW, 2005, CELL CYCLE, V4, P1157, DOI 10.4161/cc.4.9.2042; Wang HW, 2005, NATURE, V435, P911, DOI 10.1038/nature03606; Xu H, 2009, LANGMUIR, V25, P4115, DOI 10.1021/la802499n	49	18	18	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7291	10.1371/journal.pone.0007291	http://dx.doi.org/10.1371/journal.pone.0007291			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19806219	gold, Green Published, Green Submitted			2022-12-27	WOS:000270593300008
J	Hu, H; Wang, JQ; Bu, DP; Wei, HY; Zhou, LY; Li, FD; Loor, JJ				Hu, Han; Wang, Jiaqi; Bu, Dengpan; Wei, Hongyang; Zhou, Linyun; Li, Fadi; Loor, Juan J.			In Vitro Culture and Characterization of a Mammary Epithelial Cell Line from Chinese Holstein Dairy Cow	PLOS ONE			English	Article								Background: The objective of this study was to establish a culture system and elucidate the unique characteristics of a bovine mammary epithelial cell line in vitro. Methodology: Mammary tissue from a three year old lactating dairy cow (ca. 100 d relative to parturition) was used as a source of the epithelial cell line, which was cultured in collagen-coated tissue culture dishes. Fibroblasts and epithelial cells successively grew and extended from the culturing mammary tissue at the third day. Pure epithelial cells were obtained by passages culture. Principal Findings: The strong positive immunostaining to cytokeratin 18 suggested that the resulting cell line exhibited the specific character of epithelial cells. Epithelial cells cultured in the presence of 10% FBS, supraphysiologic concentrations of insulin, and hydrocortisone maintained a normal diploid chromosome modal number of 2n = 60. Furthermore, they were capable of synthesizing beta-casein (CSN2), acetyl-CoA carboxylase-alpha. (ACACA) and butyrophilin (BTN1A1). An important finding was that frozen preservation in a mixture of 90% FBS and 10% DMSO did not influence the growth characteristics, chromosome number, or protein secretion of the isolated epithelial cell line. Conclusions:The obtained mammary epithelial cell line had normal morphology, growth characteristics, cytogenetic and secretory characteristics, thus, it might represent an useful tool for studying the function of Chinese Holstein dairy cows mammary epithelial cell (CMECs).	[Hu, Han; Wang, Jiaqi; Bu, Dengpan; Wei, Hongyang; Zhou, Linyun] Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing, Peoples R China; [Hu, Han; Li, Fadi] Gansu Agr Univ, Fac Anim Sci & Technol, Lanzhou, Peoples R China; [Loor, Juan J.] Univ Illinois, Dept Anim Sci, Urbana, IL 61801 USA; [Loor, Juan J.] Univ Illinois, Div Nutr Sci, Urbana, IL 61801 USA	Chinese Academy of Agricultural Sciences; Institute of Animal Science, CAAS; Gansu Agricultural University; University of Illinois System; University of Illinois Urbana-Champaign; University of Illinois System; University of Illinois Urbana-Champaign	Hu, H (corresponding author), Chinese Acad Agr Sci, Inst Anim Sci, State Key Lab Anim Nutr, Beijing, Peoples R China.	wang-jia-qi@263.net; burdenpan@gmail.com	Loor, Juan J./H-3760-2012	Loor, Juan J./0000-0003-1586-4365	Ministry of Science and Technology of China [2006BAD04A03]; National Natural Science Foundation of China [30871837]	Ministry of Science and Technology of China(Ministry of Science and Technology, China); National Natural Science Foundation of China(National Natural Science Foundation of China (NSFC))	This work was financially supported by the Ministry of Science and Technology of China (2006BAD04A03) and the National Natural Science Foundation of China (30871837). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	CERIANI RI, 1979, IN VITRO, V135, P356; GILBOTT CA, 1991, IN VITRO CELL DEV, V27, P585; HUYNH HT, 1991, EXP CELL RES, V197, P191, DOI 10.1016/0014-4827(91)90422-Q; TAYLORPAPADIMIT.J, 1977, J NATL CANCER I, V586, P1563; ZAVIZION B, 1992, J DAIRY SCI, V75, P3367, DOI 10.3168/jds.S0022-0302(92)78113-2	5	73	97	0	26	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2009	4	11							e7636	10.1371/journal.pone.0007636	http://dx.doi.org/10.1371/journal.pone.0007636			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	V11YO	19888476	gold, Green Published, Green Submitted			2022-12-27	WOS:000207567100001
J	Walia, G; Kumar, P; Surolia, A				Walia, Guneet; Kumar, Parimal; Surolia, Avadhesha			The Role of UPF0157 in the Folding of M-tuberculosis Dephosphocoenzyme A Kinase and the Regulation of the Latter by CTP	PLOS ONE			English	Article							COENZYME-A BIOSYNTHESIS; ESCHERICHIA-COLI K-12; CRYSTAL-STRUCTURE; COA SYNTHASE; PANTOTHENATE KINASE; COMPLEX; ADENYLYLTRANSFERASE; IDENTIFICATION; CALORIMETRY; PROTEINS	Background: Targeting the biosynthetic pathway of Coenzyme A (CoA) for drug development will compromise multiple cellular functions of the tubercular pathogen simultaneously. Structural divergence in the organization of the penultimate and final enzymes of CoA biosynthesis in the host and pathogen and the differences in their regulation mark out the final enzyme, dephosphocoenzyme A kinase (CoaE) as a potential drug target. Methodology/Principal Findings: We report here a complete biochemical and biophysical characterization of the M. tuberculosis CoaE, an enzyme essential for the pathogen's survival, elucidating for the first time the interactions of a dephosphocoenzyme A kinase with its substrates, dephosphocoenzyme A and ATP; its product, CoA and an intrinsic yet novel inhibitor, CTP, which helps modulate the enzyme's kinetic capabilities providing interesting insights into the regulation of CoaE activity. We show that the mycobacterial enzyme is almost 21 times more catalytically proficient than its counterparts in other prokaryotes. ITC measurements illustrate that the enzyme follows an ordered mechanism of substrate addition with DCoA as the leading substrate and ATP following in tow. Kinetic and ITC experiments demonstrate that though CTP binds strongly to the enzyme, it is unable to participate in DCoA phosphorylation. We report that CTP actually inhibits the enzyme by decreasing its Vmax. Not surprisingly, a structural homology search for the modeled mycobacterial CoaE picks up cytidylmonophosphate kinases, deoxycytidine kinases, and cytidylate kinases as close homologs. Docking of DCoA and CTP to CoaE shows that both ligands bind at the same site, their interactions being stabilized by 26 and 28 hydrogen bonds respectively. We have also assigned a role for the universal Unknown Protein Family 0157 (UPF0157) domain in the mycobacterial CoaE in the proper folding of the full length enzyme. Conclusions/Significance: In view of the evidence presented, it is imperative to assign a greater role to the last enzyme of Coenzyme A biosynthesis in metabolite flow regulation through this critical biosynthetic pathway.			Walia, G (corresponding author), Indian Inst Sci, Mol Biophys Unit, Bangalore 560012, Karnataka, India.	surolia@nii.res.in	Kumar, Parimal/AAG-9653-2019					Aghajanian S, 2002, BIOCHEM J, V365, P13, DOI 10.1042/BJ20020569; Arnold K, 2006, BIOINFORMATICS, V22, P195, DOI 10.1093/bioinformatics/bti770; Begley TP, 2006, NAT PROD REP, V23, P15, DOI 10.1039/b207131m; Begley TP, 2001, VITAM HORM, V61, P157; Bucovaz ET, 1997, BIOCHIMIE, V79, P787, DOI 10.1016/S0300-9084(97)86938-6; *CHEM COMP GROUP I, 2001, MOL OP ENV MOE VERS; Chohnan S, 1998, BIOSCI BIOTECH BIOCH, V62, P1122, DOI 10.1271/bbb.62.1122; Cole ST, 1998, NATURE, V393, P537, DOI 10.1038/31159; CUFF ME, STRUCTURE C IN PRESS; Das S, 2006, ACTA CRYSTALLOGR D, V62, P628, DOI 10.1107/S0907444906012728; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Glickman MS, 2001, CELL, V104, P477, DOI 10.1016/S0092-8674(01)00236-7; Gu YJ, 2002, J MOL BIOL, V319, P779, DOI 10.1016/S0022-2836(02)00339-X; Hong BS, 2007, J BIOL CHEM, V282, P27984, DOI 10.1074/jbc.M701915200; JACKOWSKI S, 1981, J BACTERIOL, V148, P926, DOI 10.1128/JB.148.3.926-932.1981; Kraft L, 2002, J MOL BIOL, V318, P1057, DOI 10.1016/S0022-2836(02)00215-2; Kupke T, 2004, EUR J BIOCHEM, V271, P163, DOI 10.1046/j.1432-1033.2003.03916.x; Leavitt S, 2001, CURR OPIN STRUC BIOL, V11, P560, DOI 10.1016/S0959-440X(00)00248-7; Leonardi R, 2005, PROG LIPID RES, V44, P125, DOI 10.1016/j.plipres.2005.04.001; Manabe YC, 2000, NAT MED, V6, P1327, DOI 10.1038/82139; McKinney JD, 2000, NAT MED, V6, P1330, DOI 10.1038/82142; Mishra PK, 2001, J BACTERIOL, V183, P2774, DOI 10.1128/JB.183.9.2774-2778.2001; MURZIN AG, 1995, J MOL BIOL, V247, P536, DOI 10.1006/jmbi.1995.0159; Obmolova G, 2001, J STRUCT BIOL, V136, P119, DOI 10.1006/jsbi.2001.4428; Rock CO, 2003, J BACTERIOL, V185, P3410, DOI 10.1128/JB.185.11.3410-3415.2003; Sobolev V, 1999, BIOINFORMATICS, V15, P327, DOI 10.1093/bioinformatics/15.4.327; SONG WJ, 1994, J BIOL CHEM, V269, P27051; TAHILIANI AG, 1991, VITAM HORM, V46, P165; Todd MJ, 2001, ANAL BIOCHEM, V296, P179, DOI 10.1006/abio.2001.5218; WORRALL DM, 1985, FEBS LETT, V187, P277, DOI 10.1016/0014-5793(85)81258-8; WORRALL DM, 1983, BIOCHEM J, V215, P153, DOI 10.1042/bj2150153; Xing X, 2004, BIOCHEMISTRY-US, V43, P16142, DOI 10.1021/bi048165y; Zhyvoloup A, 2003, J BIOL CHEM, V278, P50316, DOI 10.1074/jbc.M307763200; Zhyvoloup A, 2002, J BIOL CHEM, V277, P22107, DOI 10.1074/jbc.C200195200	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2009	4	10							e7645	10.1371/journal.pone.0007645	http://dx.doi.org/10.1371/journal.pone.0007645			16	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RW	19876400	Green Submitted, gold, Green Published			2022-12-27	WOS:000271414300007
J	Torres, R; Ramirez, JC				Torres, Raul; Ramirez, Juan C.			A Chemokine Targets the Nucleus: Cxcl12-Gamma Isoform Localizes to the Nucleolus in Adult Mouse Heart	PLOS ONE			English	Article							CELL-DERIVED FACTOR-1; RECEPTOR CXCR4; MESSENGER-RNA; EXPRESSION; SDF-1; INTRACRINE; PROTEIN; TRANSLATION; SURVIVAL; AUG	Chemokines are extracellular mediators of complex regulatory circuits involved principally in cell-to-cell communication. Most studies to date of the essential chemokine Cxcl12 (Sdf-1) have focused on the ubiquitously expressed secreted isoforms alpha and beta. Here we show that, unlike these isoforms and all other known chemokines, the alternatively transcribed c isoform is an intracellular protein that localizes to the nucleolus in differentiated mouse Cardiac tissue. Our results demonstrate that nucleolar transportation is encoded by a nucleolar-localization signal in the unique carboxy-terminal region of Sdf-1 gamma, and is competent both in vivo and in vitro. The molecular mechanism underlying these unusual chemokine properties involves cardiac-specific transcription of an mRNA containing a unique short-leader sequence lacking the signal peptide and translation from a non-canonical CUG codon. Our results provide an example of genome economy even for essential and highly conserved genes such as Cxcl12, and suggest that chemokines can exert tissue specific functions unrelated to cell-to-cell communication.			Torres, R (corresponding author), Fdn CNIC Natl Ctr Cardiovasc Res, Tech Unit Gene Targeting, Viral Vector Facil, Madrid, Spain.	jcramirez@cnic.es	Ruiz, Raul Torres/J-1649-2018; Ramírez, Juan Carlos/B-7979-2015	Ruiz, Raul Torres/0000-0001-9606-0398; 				Altenburg JD, 2007, J VIROL, V81, P8140, DOI 10.1128/JVI.00268-07; Andersen JS, 2005, NATURE, V433, P77, DOI 10.1038/nature03207; Baggiolini M, 2000, IMMUNOL REV, V177, P5, DOI 10.1034/j.1600-065X.2000.17722.x; Bleul CC, 1996, NATURE, V382, P829, DOI 10.1038/382829a0; BORDO D, 1991, J MOL BIOL, V217, P721, DOI 10.1016/0022-2836(91)90528-E; Burns JM, 2006, J EXP MED, V203, P2201, DOI 10.1084/jem.20052144; Carriere V, 2007, P NATL ACAD SCI USA, V104, P282, DOI 10.1073/pnas.0606854104; Ceradini DJ, 2004, NAT MED, V10, P858, DOI 10.1038/nm1075; Delrieu I, 2000, FEBS LETT, V468, P6, DOI 10.1016/S0014-5793(00)01189-3; Emmott E, 2009, EMBO REP, V10, P231, DOI 10.1038/embor.2009.14; Fiaschi-Taesch NM, 2003, ENDOCRINOLOGY, V144, P407, DOI 10.1210/en.2002-220818; Gardner RG, 2005, CELL, V120, P803, DOI 10.1016/j.cell.2005.01.016; Gleichmann M, 2000, EUR J NEUROSCI, V12, P1857, DOI 10.1046/j.1460-9568.2000.00048.x; Gortz A, 2002, J IMMUNOL, V169, P1387, DOI 10.4049/jimmunol.169.3.1387; Gudlaugsdottir S, 2007, GENETICA, V131, P299, DOI 10.1007/s10709-007-9139-4; Huez I, 1998, MOL CELL BIOL, V18, P6178, DOI 10.1128/MCB.18.11.6178; Jans DA, 1998, BIOESSAYS, V20, P400, DOI 10.1002/(SICI)1521-1878(199805)20:5<400::AID-BIES7>3.0.CO;2-R; Kafri R, 2009, CELL, V136, P389, DOI 10.1016/j.cell.2009.01.027; KIEFER P, 1994, EMBO J, V13, P4126, DOI 10.1002/j.1460-2075.1994.tb06730.x; Kijowski J, 2001, STEM CELLS, V19, P453, DOI 10.1634/stemcells.19-5-453; Kozak M, 1997, EMBO J, V16, P2482, DOI 10.1093/emboj/16.9.2482; Laguri C, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001110; Lange A, 2007, J BIOL CHEM, V282, P5101, DOI 10.1074/jbc.R600026200; Levoye A, 2009, BLOOD, V113, P6085, DOI 10.1182/blood-2008-12-196618; Martindill DMJ, 2007, NAT CELL BIOL, V9, P1131, DOI 10.1038/ncb1633; McGrath KE, 1999, DEV BIOL, V213, P442, DOI 10.1006/dbio.1999.9405; Mekhail K, 2004, NAT CELL BIOL, V6, P642, DOI 10.1038/ncb1144; Nagasawa T, 1996, NATURE, V382, P635, DOI 10.1038/382635a0; Nguyen MTA, 2001, ENDOCRINOLOGY, V142, P694, DOI 10.1210/en.142.2.694; Ochs RL, 1998, METHOD CELL BIOL, V53, P303; Petit I, 2005, J CLIN INVEST, V115, P168, DOI 10.1172/JCI200521773; Pillarisetti K, 2001, INFLAMMATION, V25, P293, DOI 10.1023/A:1012808525370; Risebro CA, 2006, DEVELOPMENT, V133, P4595, DOI 10.1242/dev.02625; Rueda P, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002543; Segret A, 2007, J HISTOCHEM CYTOCHEM, V55, P141, DOI 10.1369/jhc.6A7050.2006; Shinohara ML, 2008, P NATL ACAD SCI USA, V105, P7235, DOI 10.1073/pnas.0802301105; Sierra MD, 2004, BLOOD, V103, P2452; Sierro F, 2007, P NATL ACAD SCI USA, V104, P14759, DOI 10.1073/pnas.0702229104; Tachibana K, 1998, NATURE, V393, P591, DOI 10.1038/31261; Touriol C, 2003, BIOL CELL, V95, P169, DOI 10.1016/S0248-4900(03)00033-9; Valentin G, 2007, CURR BIOL, V17, P1026, DOI 10.1016/j.cub.2007.05.020; von Mikecz A, 2006, J CELL SCI, V119, P1977, DOI 10.1242/jcs.03008; Werman A, 2004, P NATL ACAD SCI USA, V101, P2434, DOI 10.1073/pnas.0308705101; Yu L, 2006, GENE, V374, P174, DOI 10.1016/j.gene.2006.02.001; Zou YR, 1998, NATURE, V393, P595, DOI 10.1038/31269	45	19	19	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7570	10.1371/journal.pone.0007570	http://dx.doi.org/10.1371/journal.pone.0007570			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859557	gold, Green Published, Green Submitted			2022-12-27	WOS:000271147400003
J	Salminen, NH; May, PJC; Alku, P; Tiitinen, H				Salminen, Nelli H.; May, Patrick J. C.; Alku, Paavo; Tiitinen, Hannu			A Population Rate Code of Auditory Space in the Human Cortex	PLOS ONE			English	Article							INFERIOR COLLICULUS; SOUND LOCALIZATION; INTERAURAL TIME; STIMULUS AZIMUTH; SUPERIOR OLIVE; RECEPTIVE-FIELDS; SPATIAL LOCATION; CORTICAL-NEURONS; NEURAL CODE; CAT	Background: Previous work on the human auditory cortex has revealed areas specialized in spatial processing but how the neurons in these areas represent the location of a sound source remains unknown. Methodology/Principal Findings: Here, we performed a magnetoencephalography (MEG) experiment with the aim of revealing the neural code of auditory space implemented by the human cortex. In a stimulus-specific adaptation paradigm, realistic spatial sound stimuli were presented in pairs of adaptor and probe locations. We found that the attenuation of the N1m response depended strongly on the spatial arrangement of the two sound sources. These location-specific effects showed that sounds originating from locations within the same hemifield activated the same neuronal population regardless of the spatial separation between the sound sources. In contrast, sounds originating from opposite hemifields activated separate groups of neurons. Conclusions/Significance: These results are highly consistent with a rate code of spatial location formed by two opponent populations, one tuned to locations in the left and the other to those in the right. This indicates that the neuronal code of sound source location implemented by the human auditory cortex is similar to that previously found in other primates.			Salminen, NH (corresponding author), Aalto Univ, Dept Biomed Engn & Computat Sci, Helsinki, Finland.	nelli.salminen@tkk.fi	Alku, Paavo/E-2400-2012; May, Patrick JC/E-1786-2015	May, Patrick JC/0000-0002-3954-0421; Alku, Paavo/0000-0002-8173-9418				Ahveninen J, 2006, P NATL ACAD SCI USA, V103, P14608, DOI 10.1073/pnas.0510480103; AITKIN LM, 1987, J NEUROPHYSIOL, V57, P1185, DOI 10.1152/jn.1987.57.4.1185; AITKIN LM, 1985, J NEUROPHYSIOL, V53, P43, DOI 10.1152/jn.1985.53.1.43; Barone P, 1996, J NEUROPHYSIOL, V75, P1206, DOI 10.1152/jn.1996.75.3.1206; Baumgart F, 1999, NATURE, V400, P724, DOI 10.1038/23390; BENSON DA, 1981, BRAIN RES, V219, P249, DOI 10.1016/0006-8993(81)90290-0; BOUDREAU JC, 1968, J NEUROPHYSIOL, V31, P442, DOI 10.1152/jn.1968.31.3.442; Brand A, 2002, NATURE, V417, P543, DOI 10.1038/417543a; Brosch M, 1997, J NEUROPHYSIOL, V77, P923, DOI 10.1152/jn.1997.77.2.923; BRUGGE JF, 1973, J NEUROPHYSIOL, V36, P1138, DOI 10.1152/jn.1973.36.6.1138; BUTLER RA, 1972, NEUROPSYCHOLOGIA, V10, P219, DOI 10.1016/0028-3932(72)90063-2; BUTLER RA, 1968, J ACOUST SOC AM, V44, P945, DOI 10.1121/1.1911233; CHAN JCK, 1987, J NEUROPHYSIOL, V58, P543, DOI 10.1152/jn.1987.58.3.543; CLAREY JC, 1995, J NEUROPHYSIOL, V74, P961, DOI 10.1152/jn.1995.74.3.961; Delgutte B, 1999, J NEUROPHYSIOL, V81, P2833, DOI 10.1152/jn.1999.81.6.2833; Deouell LY, 2007, NEURON, V55, P985, DOI 10.1016/j.neuron.2007.08.019; EISENMAN LM, 1974, BRAIN RES, V75, P203, DOI 10.1016/0006-8993(74)90742-2; GOLDBERG JM, 1969, J NEUROPHYSIOL, V32, P613, DOI 10.1152/jn.1969.32.4.613; Griffiths TD, 1998, NAT NEUROSCI, V1, P74, DOI 10.1038/276; Groh JM, 2003, J COGNITIVE NEUROSCI, V15, P1217, DOI 10.1162/089892903322598166; Grothe B, 2003, NAT REV NEUROSCI, V4, P540, DOI 10.1038/nrn1136; Harper NS, 2004, NATURE, V430, P682, DOI 10.1038/nature02768; IVARSSON C, 1988, J NEUROPHYSIOL, V59, P586, DOI 10.1152/jn.1988.59.2.586; JEFFRESS LA, 1948, J COMP PHYSIOL PSYCH, V41, P35, DOI 10.1037/h0061495; Joris PX, 1998, NEURON, V21, P1235, DOI 10.1016/S0896-6273(00)80643-1; KING AJ, 1987, J NEUROPHYSIOL, V57, P596, DOI 10.1152/jn.1987.57.2.596; KNUDSEN EI, 1978, J NEUROPHYSIOL, V41, P870, DOI 10.1152/jn.1978.41.4.870; KNUDSEN EI, 1982, J NEUROSCI, V2, P1177; Krumbholz K, 2005, CEREB CORTEX, V15, P317, DOI 10.1093/cercor/bhh133; Krumbholz K, 2007, J NEUROPHYSIOL, V97, P1649, DOI 10.1152/jn.00560.2006; KUWADA S, 1987, J NEUROPHYSIOL, V57, P1338, DOI 10.1152/jn.1987.57.5.1338; LEIMAN AL, 1972, EXP NEUROL, V35, P431, DOI 10.1016/0014-4886(72)90114-8; LIEGEOISCHAUVEL C, 1994, ELECTROEN CLIN NEURO, V92, P204, DOI 10.1016/0168-5597(94)90064-7; Lutkenhoner B, 1998, AUDIOL NEURO-OTOL, V3, P191, DOI 10.1159/000013790; McAlpine D, 2003, TRENDS NEUROSCI, V26, P347, DOI 10.1016/S0166-2236(03)00140-1; McAlpine D, 2001, NAT NEUROSCI, V4, P396, DOI 10.1038/86049; Middlebrooks JC, 2002, NEUROSCIENTIST, V8, P73, DOI 10.1177/107385840200800112; MIDDLEBROOKS JC, 1981, J NEUROSCI, V1, P107, DOI 10.1523/JNEUROSCI.01-01-00107.1981; MIDDLEBROOKS JC, 1994, SCIENCE, V264, P842, DOI 10.1126/science.8171339; Middlebrooks JC, 1998, J NEUROPHYSIOL, V80, P863, DOI 10.1152/jn.1998.80.2.863; MIDDLEBROOKS JC, 1984, J NEUROSCI, V4, P2621; MIDDLEBROOKS JC, 1991, ANNU REV PSYCHOL, V42, P135, DOI 10.1146/annurev.ps.42.020191.001031; PALMER AR, 1982, NATURE, V299, P248, DOI 10.1038/299248a0; Palomaki K, 2000, NEUROREPORT, V11, P1535, DOI 10.1097/00001756-200005150-00033; Palomaki KJ, 2005, COGNITIVE BRAIN RES, V24, P364, DOI 10.1016/j.cogbrainres.2005.02.013; Palomaki KJ, 2002, COGNITIVE BRAIN RES, V14, P294, DOI 10.1016/S0926-6410(02)00132-5; REALE RA, 1990, J NEUROPHYSIOL, V64, P1247, DOI 10.1152/jn.1990.64.4.1247; Recanzone GH, 2000, P NATL ACAD SCI USA, V97, P11829, DOI 10.1073/pnas.97.22.11829; ROSE JE, 1966, J NEUROPHYSIOL, V29, P288, DOI 10.1152/jn.1966.29.2.288; Samson FK, 2000, J NEUROPHYSIOL, V84, P1330, DOI 10.1152/jn.2000.84.3.1330; SHAMMA SA, 1989, J ACOUST SOC AM, V86, P989, DOI 10.1121/1.398734; Stecker GC, 2005, PLOS BIOL, V3, P520, DOI 10.1371/journal.pbio.0030078; STILLMAN RD, 1971, EXP NEUROL, V32, P404, DOI 10.1016/0014-4886(71)90007-0; STUMPF E, 1992, EXP BRAIN RES, V88, P158, DOI 10.1007/BF02259137; SULLIVAN WE, 1986, P NATL ACAD SCI USA, V83, P8400, DOI 10.1073/pnas.83.21.8400; Tian B, 2001, SCIENCE, V292, P290, DOI 10.1126/science.1058911; Tiitinen H, 2006, NEUROSCI LETT, V396, P17, DOI 10.1016/j.neulet.2005.11.018; Tollin DJ, 2002, J NEUROSCI, V22, P1454, DOI 10.1523/JNEUROSCI.22-04-01454.2002; Ulanovsky N, 2004, J NEUROSCI, V24, P10440, DOI 10.1523/JNEUROSCI.1905-04.2004; Ulanovsky N, 2003, NAT NEUROSCI, V6, P391, DOI 10.1038/nn1032; Ungan P, 2001, CLIN NEUROPHYSIOL, V112, P485, DOI 10.1016/S1388-2457(00)00550-2; Uutela K, 1999, NEUROIMAGE, V10, P173, DOI 10.1006/nimg.1999.0454; van BERGEIJK WILLEM A., 1962, JOUR ACOUSTICAL SOC AMER, V34, P1431, DOI 10.1121/1.1918364; von Bekesy G, 1930, PHYS Z, V31, P824; VONBEKESY, 1960, EXPT HERARING; Warren JD, 2003, J NEUROSCI, V23, P5799; Werner-Reiss U, 2008, J NEUROSCI, V28, P3747, DOI 10.1523/JNEUROSCI.5044-07.2008; Woods TM, 2006, J NEUROPHYSIOL, V96, P3323, DOI 10.1152/jn.00392.2006; Xu L, 1998, J NEUROPHYSIOL, V80, P882, DOI 10.1152/jn.1998.80.2.882; YIN TCT, 1990, J NEUROPHYSIOL, V64, P465, DOI 10.1152/jn.1990.64.2.465; Zatorre RJ, 2002, NAT NEUROSCI, V5, P905, DOI 10.1038/nn904	71	64	65	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7600	10.1371/journal.pone.0007600	http://dx.doi.org/10.1371/journal.pone.0007600			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855836	Green Submitted, Green Published, gold			2022-12-27	WOS:000271147200016
J	Sato, N; Yamaguchi, Y				Sato, Naoyuki; Yamaguchi, Yoko			A Computational Predictor of Human Episodic Memory Based on a Theta Phase Precession Network	PLOS ONE			English	Article							HIERARCHICAL COGNITIVE MAP; HIPPOCAMPAL NETWORK; SPATIAL MEMORY; PLACE; EEG; DEPENDENCE; SEQUENCES; CELLS; TASK; REPRESENTATION	In the rodent hippocampus, a phase precession phenomena of place cell firing with the local field potential (LFP) theta is called "theta phase precession'' and is considered to contribute to memory formation with spike time dependent plasticity (STDP). On the other hand, in the primate hippocampus, the existence of theta phase precession is unclear. Our computational studies have demonstrated that theta phase precession dynamics could contribute to primate-hippocampal dependent memory formation, such as object-place association memory. In this paper, we evaluate human theta phase precession by using a theory-experiment combined analysis. Human memory recall of object-place associations was analyzed by an individual hippocampal network simulated by theta phase precession dynamics of human eye movement and EEG data during memory encoding. It was found that the computational recall of the resultant network is significantly correlated with human memory recall performance, while other computational predictors without theta phase precession are not significantly correlated with subsequent memory recall. Moreover the correlation is larger than the correlation between human recall and traditional experimental predictors. These results indicate that theta phase precession dynamics are necessary for the better prediction of human recall performance with eye movement and EEG data. In this analysis, theta phase precession dynamics appear useful for the extraction of memory-dependent components from the spatio-temporal pattern of eye movement and EEG data as an associative network. Theta phase precession may be a common neural dynamic between rodents and humans for the formation of environmental memories.			Sato, N (corresponding author), Future Univ Hakodate, Sch Syst Informat Sci, Dept Complex Syst, Hakodate, Hokkaido, Japan.	satonao@fun.ac.jp						Bi GQ, 1998, J NEUROSCI, V18, P10464, DOI 10.1523/jneurosci.18-24-10464.1998; BURGESS N, 1994, NEURAL NETWORKS, V7, P1065, DOI 10.1016/S0893-6080(05)80159-5; Cave C B, 1991, Hippocampus, V1, P329, DOI 10.1002/hipo.450010323; Croft RJ, 2000, NEUROPHYSIOL CLIN, V30, P5, DOI 10.1016/S0987-7053(00)00055-1; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Ekstrom AD, 2005, HIPPOCAMPUS, V15, P881, DOI 10.1002/hipo.20109; Engbert R, 2003, VISION RES, V43, P1035, DOI 10.1016/S0042-6989(03)00084-1; Everitt B. S., 2001, CLUSTER ANAL; Fyhn M, 2004, SCIENCE, V305, P1258, DOI 10.1126/science.1099901; Hafting T, 2008, NATURE, V453, P1248, DOI 10.1038/nature06957; Jensen O, 1996, LEARN MEMORY, V3, P279, DOI 10.1101/lm.3.2-3.279; Kahana MJ, 1999, NATURE, V399, P781, DOI 10.1038/21645; Kerr KM, 2007, HIPPOCAMPUS, V17, P697, DOI 10.1002/hipo.20315; King JA, 2002, HIPPOCAMPUS, V12, P811, DOI 10.1002/hipo.10070; Klimesch W, 1996, NEUROREPORT, V7, P1235, DOI 10.1097/00001756-199605170-00002; Levy WB, 1996, HIPPOCAMPUS, V6, P579, DOI 10.1002/(SICI)1098-1063(1996)6:6<579::AID-HIPO3>3.0.CO;2-C; Matsumura N, 1999, J NEUROSCI, V19, P2381; MCNAMARA TP, 1989, J EXP PSYCHOL LEARN, V15, P211, DOI 10.1037/0278-7393.15.2.211; Mishkin M, 1997, PHILOS T R SOC B, V352, P1461, DOI 10.1098/rstb.1997.0132; Molter C, 2008, HIPPOCAMPUS, V18, P919, DOI 10.1002/hipo.20450; OKEEFE J, 1993, HIPPOCAMPUS, V3, P317, DOI 10.1002/hipo.450030307; Petitti D. B., 2000, METAANALYSIS DECISIO, P94; Rolls ET, 1999, HIPPOCAMPUS, V9, P467; Sato N, 2005, HIPPOCAMPUS, V15, P963, DOI 10.1002/hipo.20110; Sato N, 2003, NEURAL COMPUT, V15, P2379, DOI 10.1162/089976603322362400; SATO N, NEUROREPORT IN PRESS; Sato N, 2007, NEUROREPORT, V18, P419, DOI 10.1097/WNR.0b013e3280586760; Sato N, 2009, COGN NEURODYNAMICS, V3, P131, DOI 10.1007/s11571-008-9074-9; Sato N, 2008, ADVANCES IN COGNITIVE NEURODYNAMICS, PROCEEDINGS, P429, DOI 10.1007/978-1-4020-8387-7_73; Skaggs WE, 1996, HIPPOCAMPUS, V6, P149, DOI 10.1002/(SICI)1098-1063(1996)6:2<149::AID-HIPO6>3.0.CO;2-K; SMITH ML, 1981, NEUROPSYCHOLOGIA, V19, P781, DOI 10.1016/0028-3932(81)90090-7; Stepankova K, 2004, NEUROPSYCHOLOGIA, V42, P1017, DOI 10.1016/j.neuropsychologia.2004.01.002; STEWART M, 1991, BRAIN RES, V538, P59, DOI 10.1016/0006-8993(91)90376-7; Summerfield C, 2005, NEUROIMAGE, V24, P692, DOI 10.1016/j.neuroimage.2004.09.012; TallonBaudry C, 1997, J NEUROSCI, V17, P722; Tanaka SC, 2004, NAT NEUROSCI, V7, P887, DOI 10.1038/nn1279; Ulanovsky N, 2007, NAT NEUROSCI, V10, P224, DOI 10.1038/nn1829; Wagatsuma H, 2004, NEURAL COMPUT, V16, P2665, DOI 10.1162/0899766042321742; Wu ZH, 2004, BIOL CYBERN, V90, P113, DOI 10.1007/s00422-003-0454-2; Yamaguchi Y, 2003, BIOL CYBERN, V89, P1, DOI 10.1007/s00422-003-0415-9	40	3	3	1	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7536	10.1371/journal.pone.0007536	http://dx.doi.org/10.1371/journal.pone.0007536			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851508	Green Published, gold, Green Submitted			2022-12-27	WOS:000271022300004
J	Broderick, T; MacKay, DJC				Broderick, Tamara; MacKay, David J. C.			Fast and Flexible Selection with a Single Switch	PLOS ONE			English	Article							COMMUNICATION	Selection methods that require only a single-switch input, such as a button click or blink, are potentially useful for individuals with motor impairments, mobile technology users, and individuals wishing to transmit information securely. We present a single-switch selection method, "Nomon,'' that is general and efficient. Existing single-switch selection methods require selectable options to be arranged in ways that limit potential applications. By contrast, traditional operating systems, web browsers, and free-form applications (such as drawing) place options at arbitrary points on the screen. Nomon, however, has the flexibility to select any point on a screen. Nomon adapts automatically to an individual's clicking ability; it allows a person who clicks precisely to make a selection quickly and allows a person who clicks imprecisely more time to make a selection without error. Nomon reaps gains in information rate by allowing the specification of beliefs (priors) about option selection probabilities and by avoiding tree-based selection schemes in favor of direct (posterior) inference. We have developed both a Nomon-based writing application and a drawing application. To evaluate Nomon's performance, we compared the writing application with a popular existing method for single-switch writing (row-column scanning). Novice users wrote 35% faster with the Nomon interface than with the scanning interface. An experienced user (author TB, with > 10 hours practice) wrote at speeds of 9.3 words per minute with Nomon, using 1.2 clicks per character and making no errors in the final text.			Broderick, T (corresponding author), Univ Calif Berkeley, Dept Stat, Berkeley, CA 94720 USA.	tab@stat.berkeley.edu						Baljko M., 2006, P ASSETS 2006, P18; DAMPER RI, 1984, APPL ERGON, V15, P289, DOI 10.1016/0003-6870(84)90201-1; Esser J., 1994, AAC, V10, P237, DOI [DOI 10.1080/07434619412331276940, 10.1080/07434619412331276940]; Evreinov G, 2004, LECT NOTES COMPUT SC, V3118, P836; HORN EM, 1996, AUGMENTATIVE ALTERNA, V12, P23, DOI DOI 10.1080/07434619612331277448; *ITU, 2004, M1677 ITUR; Kilgarriff Adam, 1998, BNC DATABASE WORD FR; Koester H H, 1994, Assist Technol, V6, P42; KOESTER HH, 1996, AUGMENTATIVE ALTERNA, V12, P155, DOI DOI 10.1080/07434619612331277608; Kristensson PO, 2009, CHI2009: PROCEEDINGS OF THE 27TH ANNUAL CHI CONFERENCE ON HUMAN FACTORS IN COMPUTING SYSTEMS, VOLS 1-4, P567; Lesher G W, 1998, IEEE Trans Rehabil Eng, V6, P415, DOI 10.1109/86.736156; MACKAY DJ, 2007, ANOTHER ONE BUTTON D; MACKAY DJ, 2006, DASHERS ONE BUTTON D; MacKay DJC, 2004, AIP CONF PROC, V735, P207, DOI 10.1063/1.1835215; MacKenzie IS, 2002, LECT NOTES COMPUT SC, V2411, P195; MACKENZIE IS, 2003, CHI 03 HUM FACT COMP, P00754, DOI DOI 10.1145/765891.765971; MEAD JMG, 2009, EFFICIENT COMMUNICAT; MIZUKO M, 1991, J SPEECH HEAR RES, V34, P43, DOI 10.1044/jshr.3401.43; PETERSEN K, 2000, AUGMENTATIVE ALTERNA, V16, P27, DOI DOI 10.1080/07434610012331278884; Ratcliff A., 1994, AAC, V10, P67, DOI [DOI 10.1080/07434619412331276770, 10.1080/07434619412331276770]; *SENS SOFTW INT LT, 2008, GRID 2 VERS 2 4; Silverman B.W., 1986, DENSITY ESTIMATION S; Simpson R C, 1999, IEEE Trans Rehabil Eng, V7, P464, DOI 10.1109/86.808950; *SUN JAV DESKT SYS, 2004, GOK MAN V 2 3; Szeto A., 1993, AUGMENTATIVE ALTERNA, V9, P229; Venkatagiri Horabail, 1999, AUGMENT ALTERN COMM, V15, P126; Wagner BT, 2006, J SPEECH LANG HEAR R, V49, P113, DOI 10.1044/1092-4388(2006/009); WAGNER RA, 1974, J ACM, V21, P168, DOI 10.1145/321796.321811; Wand MP., 1994, KERNEL SMOOTHING; Ward D. J., 2000, UIST. Proceedings of the 13th Annual ACM Symposium on User Interface Software and Technology, P129, DOI 10.1145/354401.354427; Ward DJ, 2002, NATURE, V418, P838, DOI 10.1038/418838a; *WORDS INC, 2004, EZ KEYS XP PROD SPEC; *WORDS INC, 2000, EZ KEYS US MAN	33	10	11	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7481	10.1371/journal.pone.0007481	http://dx.doi.org/10.1371/journal.pone.0007481			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847300	Green Published, gold, Green Submitted			2022-12-27	WOS:000271022000006
J	Jimenez-Dalmaroni, MJ; Xiao, NM; Corper, AL; Verdino, P; Ainge, GD; Larsen, DS; Painter, GF; Rudd, PM; Dwek, RA; Hoebe, K; Beutler, B; Wilson, IA				Jimenez-Dalmaroni, Maximiliano J.; Xiao, Nengming; Corper, Adam L.; Verdino, Petra; Ainge, Gary D.; Larsen, Dave S.; Painter, Gavin F.; Rudd, Pauline M.; Dwek, Raymond A.; Hoebe, Kasper; Beutler, Bruce; Wilson, Ian A.			Soluble CD36 Ectodomain Binds Negatively Charged Diacylglycerol Ligands and Acts as a Co-Receptor for TLR2	PLOS ONE			English	Article							B SCAVENGER RECEPTOR; MYCOBACTERIAL PHOSPHATIDYLINOSITOL MANNOSIDE; CRYSTAL-STRUCTURE; LIPOPOLYSACCHARIDE LPS; LIPOTEICHOIC ACID; CD14; CELLS; ATHEROSCLEROSIS; PROTEIN; IDENTIFICATION	Background: Cluster of differentiation 36 (CD36) is a transmembrane glycoprotein involved in many biological processes, such as platelet biology, angiogenesis and in the aetiopathology of atherosclerosis and cardiovascular diseases. Toll-like receptors (TLRs) are one of the most important receptors of the innate immune system. Their main function is the recognition of conserved structure of microorganisms. This recognition triggers signaling pathways that activate transcription of cytokines and co-stimulatory molecules which participate in the generation of an immune response against microbes. In particular, TLR2 has been shown to recognize a broad range of ligands. Recently, we showed that CD36 serves as a co-receptor for TLR2 and enhances recognition of specific diacylglycerides derived from bacteria. Methodology/Principal Findings: Here, we investigate the mechanism by which CD36 contributes to ligand recognition and activation of TLR2 signaling pathway. We show that the ectodomain of murine CD36 (mCD36ED) directly interacts with negatively charged diacylglycerol ligands, which explains the specificity and selectivity of CD36 as a TLR2 co-receptor. We also show that mCD36ED amplifies the pro-inflammatory response to lipoteichoic acid in macrophages of wild-type mice and restores the pro-inflammatory response of macrophages from mice deficient in CD36 (oblivious), but not from mice deficient in cluster of differentiation 14 (CD14) (heedless). Conclusion/Significance: These data indicate that the CD36 ectodomain is the only relevant domain for activation of TLR2 signaling pathway and that CD36 and CD14 have a non-redundant role for loading ligands onto TLR2 in the plasma-membrane. The pro-inflammatory role of soluble CD36 can be relevant in the activation of the immune response against pathogens, as well as in the progression of chronic diseases. Therefore, an increased level of soluble forms of CD36, which has been reported to be increased in type II diabetic patients, could accelerate atherosclerosis by increasing the pro-inflammatory response to diacylglycerol ligands.			Jimenez-Dalmaroni, MJ (corresponding author), Cincinnati Childrens Hosp Res Fdn, Div Dev Biol, Cincinnati, OH USA.	kasper.hoebe@cchmc.org; bruce@scripps.edu; wilson@scripps.edu	Eckhardt, Erik/G-1567-2010; Larsen, David S/A-6367-2014	Larsen, David S/0000-0002-3563-1086; Hoebe, Kasper/0000-0002-3626-8098; Jimenez-Dalmaroni, Maximiliano Javier/0000-0001-5468-6982	NATIONAL CANCER INSTITUTE [R01CA058896] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R37AI042266, P01AI070167, R01AI042266] Funding Source: NIH RePORTER; NCI NIH HHS [CA58896, R01 CA058896] Funding Source: Medline; NIAID NIH HHS [AI42266, R37 AI042266, AI070167-01, R01 AI042266, P01 AI070167] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ainge GD, 2006, BIOORGAN MED CHEM, V14, P7615, DOI 10.1016/j.bmc.2006.07.003; Altmann F, 1999, GLYCOCONJUGATE J, V16, P109, DOI 10.1023/A:1026488408951; Basu D, 2000, J IMMUNOL, V164, P5788, DOI 10.4049/jimmunol.164.11.5788; Benton R, 2007, NATURE, V450, P289, DOI 10.1038/nature06328; Bodart V, 2002, CIRC RES, V90, P844, DOI 10.1161/01.RES.0000016164.02525.B4; Boullier A, 2005, J LIPID RES, V46, P969, DOI 10.1194/jlr.M400496-JLR200; Collot-Teixeira S, 2007, CARDIOVASC RES, V75, P468, DOI 10.1016/j.cardiores.2007.03.010; Doz E, 2007, J BIOL CHEM, V282, P26014, DOI 10.1074/jbc.M702690200; ENDEMANN G, 1993, J BIOL CHEM, V268, P11811; Febbraio M, 2000, J CLIN INVEST, V105, P1049, DOI 10.1172/JCI9259; Febbraio M, 2001, J CLIN INVEST, V108, P785, DOI 10.1172/JCI200114006; Fischer K, 2004, P NATL ACAD SCI USA, V101, P10685, DOI 10.1073/pnas.0403787101; FREY EA, 1992, J EXP MED, V176, P1665, DOI 10.1084/jem.176.6.1665; Gajhede M, 1996, NAT STRUCT BIOL, V3, P1040, DOI 10.1038/nsb1296-1040; Garcia KC, 1997, P NATL ACAD SCI USA, V94, P13838, DOI 10.1073/pnas.94.25.13838; Glintborg D, 2008, DIABETES CARE, V31, P328, DOI 10.2337/dc07-1424; Greenfield NJ, 1996, ANAL BIOCHEM, V235, P1, DOI 10.1006/abio.1996.0084; HAILMAN E, 1994, J EXP MED, V179, P269, DOI 10.1084/jem.179.1.269; Hancock K, 2008, J IMMUNOL METHODS, V330, P130, DOI 10.1016/j.jim.2007.08.002; Handberg A, 2006, CIRCULATION, V114, P1169, DOI 10.1161/CIRCULATIONAHA.106.626135; Hoebe K, 2005, NATURE, V433, P523, DOI 10.1038/nature03253; Jiang ZF, 2005, NAT IMMUNOL, V6, P565, DOI 10.1038/ni1207; Jiang ZF, 2006, P NATL ACAD SCI USA, V103, P10961, DOI 10.1073/pnas.0603804103; Jimenez B, 2000, NAT MED, V6, P41, DOI 10.1038/71517; Jin MS, 2007, CELL, V130, P1071, DOI 10.1016/j.cell.2007.09.008; Kagan JC, 2008, NAT IMMUNOL, V9, P361, DOI 10.1038/ni1569; Kim HM, 2007, CELL, V130, P906, DOI 10.1016/j.cell.2007.08.002; Kim JI, 2005, J BIOL CHEM, V280, P11347, DOI 10.1074/jbc.M414607200; Krutzik SR, 2003, NAT MED, V9, P525, DOI 10.1038/nm864; Latz E, 2003, J ENDOTOXIN RES, V9, P375, DOI 10.1179/096805103225003303; Martin CA, 2007, PROTEIN SCI, V16, P2531, DOI 10.1110/ps.073007207; Means TK, 1999, J IMMUNOL, V163, P3920; NICHOLSON AC, 1995, ARTERIOSCL THROM VAS, V15, P269, DOI 10.1161/01.ATV.15.2.269; Nicholson AC, 2000, ANN NY ACAD SCI, V902, P128; Nilsen NJ, 2008, J LEUKOCYTE BIOL, V84, P280, DOI 10.1189/jlb.0907656; Ohgami N, 2001, ANN NY ACAD SCI, V947, P350; Ohgami N, 2002, J DIABETES COMPLICAT, V16, P56, DOI 10.1016/S1056-8727(01)00208-2; Patel SN, 2007, J IMMUNOL, V178, P3954, DOI 10.4049/jimmunol.178.6.3954; Philips JA, 2005, SCIENCE, V309, P1251, DOI 10.1126/science.1116006; Platt N, 1998, CHEM BIOL, V5, pR193, DOI 10.1016/S1074-5521(98)90156-9; Pohl J, 2005, MOL BIOL CELL, V16, P24, DOI 10.1091/mbc.E04-07-0616; Prigozy TI, 1997, IMMUNITY, V6, P187, DOI 10.1016/S1074-7613(00)80425-2; Rahaman SO, 2006, CELL METAB, V4, P211, DOI 10.1016/j.cmet.2006.06.007; Rasmussen JT, 1998, EUR J BIOCHEM, V257, P488, DOI 10.1046/j.1432-1327.1998.2570488.x; Reiher FK, 2002, INT J CANCER, V98, P682, DOI 10.1002/ijc.10247; Schroder NWJ, 2003, J BIOL CHEM, V278, P15587, DOI 10.1074/jbc.M212829200; Silverstein RL, 2000, CURR OPIN LIPIDOL, V11, P483, DOI 10.1097/00041433-200010000-00006; Stevens J, 2006, SCIENCE, V312, P404, DOI 10.1126/science.1124513; Stuart LM, 2005, J CELL BIOL, V170, P477, DOI 10.1083/jcb.200501113; TANDON NN, 1989, J BIOL CHEM, V264, P7576; Tapping RI, 2003, J ENDOTOXIN RES, V9, P264, DOI 10.1179/096805103225001477; Triantafilou M, 2006, J BIOL CHEM, V281, P31002, DOI 10.1074/jbc.M602794200; Verdino P, 2008, J IMMUNOL, V180, P2313, DOI 10.4049/jimmunol.180.4.2313; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311; WURFEL MM, 1995, J EXP MED, V181, P1743, DOI 10.1084/jem.181.5.1743; Zajonc DM, 2006, J IMMUNOL, V177, P4577, DOI 10.4049/jimmunol.177.7.4577	56	68	72	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7411	10.1371/journal.pone.0007411	http://dx.doi.org/10.1371/journal.pone.0007411			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847289	Green Submitted, Green Published, gold			2022-12-27	WOS:000271022000004
J	Lee, MY; Huang, JP; Chen, YY; Aplin, JD; Wu, YH; Chen, CY; Chen, PC; Chen, CP				Lee, Ming-Yi; Huang, Jian-Pei; Chen, Yi-Yung; Aplin, John D.; Wu, Yi-Hsin; Chen, Chia-Yu; Chen, Pei-Chun; Chen, Chie-Pein			Angiogenesis in Differentiated Placental Multipotent Mesenchymal Stromal Cells Is Dependent on Integrin alpha(5)beta(1)	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; HUMAN FETOPLACENTAL VASCULOGENESIS; STEM-CELLS; EXTRACELLULAR-MATRIX; HEMATOPOIETIC STEM; FUNCTIONAL EXPRESSION; VASCULAR DEVELOPMENT; GENE-EXPRESSION; MOUSE EMBRYOS; MICE LACKING	Human placental multipotent mesenchymal stromal cells (hPMSCs) can be isolated from term placenta, but their angiogenic ability and the regulatory pathways involved are not known. hPMSCs were shown to express integrins alpha(v), alpha(4), alpha(5), beta(1), beta(3), and beta(5) and could be induced to differentiate into cells expressing endothelial markers. Increases in cell surface integrins a(5) and beta(1), but not alpha(4), alpha(v)beta(3), or alpha(v)beta(5), accompanied endothelial differentiation. Vascular endothelial growth factor-A augmented the effect of fibronectin in enhancing adhesion and migration of differentiated hPMSC through integrin alpha(5)beta(1), but not alpha(v)beta(3) or alpha(v)beta(5). Formation of capillary-like structures in vitro from differentiated cells was inhibited by pre-treatment with function-blocking antibodies to integrins alpha(5) and beta(1). When hPMSCs were seeded onto chick chorioallantoic membranes (CAM), human von Willebrand factor-positive cells were observed to engraft in the chick endothelium. CAMs transplanted with differentiated hPMSCs had a greater number of vessels containing human cells and more incorporated cells per vessel compared to CAMs transplanted with undifferentiated hPMSCs, and overall angiogenesis was enhanced more by the differentiated cells. Function-blocking antibodies to integrins alpha(5) and beta(1) inhibited angiogenesis in the CAM assay. These results suggest that differentiated hPMSCs may contribute to blood vessel formation, and this activity depends on integrin alpha(5)beta(1).			Lee, MY (corresponding author), Mackay Mem Hosp, Dept Med Res, Taipei, Taiwan.	cpchen@ms2.mmh.org.tw	CHEN, CHEN/HDM-6657-2022; Aplin, John/AET-4363-2022	Lee, Ming-Yi/0000-0001-7742-9508; Aplin, John/0000-0001-8777-9261				Alviano F, 2007, BMC DEV BIOL, V7, DOI 10.1186/1471-213X-7-11; Astrof S, 2007, DEV BIOL, V311, P11, DOI 10.1016/j.ydbio.2007.07.005; Bader BL, 1998, CELL, V95, P507, DOI 10.1016/S0092-8674(00)81618-9; Barry F, 2001, BIOCHEM BIOPH RES CO, V289, P519, DOI 10.1006/bbrc.2001.6013; Barry FP, 1999, BIOCHEM BIOPH RES CO, V265, P134, DOI 10.1006/bbrc.1999.1620; Battula VL, 2008, DIFFERENTIATION, V76, P326, DOI 10.1111/j.1432-0436.2007.00225.x; Beltrami AR, 2007, BLOOD, V110, P3438, DOI 10.1182/blood-2006-11-055566; Bloch W, 1997, J CELL BIOL, V139, P265, DOI 10.1083/jcb.139.1.265; Bortoloso E, 2004, EUR J ENDOCRINOL, V150, P799, DOI 10.1530/eje.0.1500799; Breier G, 1996, TRENDS CELL BIOL, V6, P454, DOI 10.1016/0962-8924(96)84935-X; BROOKS PC, 1994, SCIENCE, V264, P569, DOI 10.1126/science.7512751; CHALLIER JC, 2001, CELL MOL BIOL, V47; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Charnock-Jones DS, 2004, PLACENTA, V25, P103, DOI 10.1016/j.placenta.2003.10.004; Chen CP, 2009, HUM REPROD, V24, P154, DOI 10.1093/humrep/den356; Chen CP, 2003, PLACENTA, V24, P316, DOI 10.1053/plac.2002.0904; Chen CP, 2002, AM J OBSTET GYNECOL, V187, P764, DOI 10.1067/mob.2002.125243; Clark RAF, 1996, AM J PATHOL, V148, P1407; Dao MA, 1998, BLOOD, V92, P4612, DOI 10.1182/blood.V92.12.4612.424k04_4612_4621; Demir R, 2007, ACTA HISTOCHEM, V109, P257, DOI 10.1016/j.acthis.2007.02.008; Dvorak HF, 2005, J THROMB HAEMOST, V3, P1835, DOI 10.1111/j.1538-7836.2005.01361.x; Dye JF, 2004, ENDOTHELIUM-J ENDOTH, V11, P151, DOI 10.1080/10623320490512093; Eghbali-Fatourechi G, 2003, J CLIN INVEST, V111, P1221, DOI 10.1172/JCI200317215; Eliceiri BP, 2001, CURR OPIN CELL BIOL, V13, P563, DOI 10.1016/S0955-0674(00)00252-0; ELICES MJ, 1994, J CLIN INVEST, V93, P405, DOI 10.1172/JCI116975; Feistritzer C, 2004, AM J RESP CELL MOL, V30, P729, DOI 10.1165/rcmb.2003-0314OC; Feng L, 1999, RADIOLOGY, V212, P655, DOI 10.1148/radiology.212.3.r99au28655; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Francis SE, 2002, ARTERIOSCL THROM VAS, V22, P927, DOI 10.1161/01.ATV.0000016045.93313.F2; Fukuchi Y, 2004, STEM CELLS, V22, P649, DOI 10.1634/stemcells.22-5-649; Gang EJ, 2006, CYTOTHERAPY, V8, P215, DOI 10.1080/14653240600735933; Gang EJ, 2007, BLOOD, V109, P1743, DOI 10.1182/blood-2005-11-010504; George EL, 1997, BLOOD, V90, P3073, DOI 10.1182/blood.V90.8.3073; GEORGE EL, 1993, DEVELOPMENT, V119, P1079; Hodivala-Dilke KM, 1999, J CLIN INVEST, V103, P229, DOI 10.1172/JCI5487; Huang XZ, 2000, MOL CELL BIOL, V20, P755, DOI 10.1128/MCB.20.3.755-759.2000; HURLEY RW, 1995, J CLIN INVEST, V96, P511, DOI 10.1172/JCI118063; Hynes RO, 2007, J THROMB HAEMOST, V5, P32, DOI 10.1111/j.1538-7836.2007.02569.x; Hynes RO, 2002, NAT MED, V8, P918, DOI 10.1038/nm0902-918; Ishikane S, 2008, STEM CELLS, V26, P2625, DOI 10.1634/stemcells.2008-0236; Jiang WG, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-16; Kale S, 2004, FASEB J, V18, P270, DOI 10.1096/fj.04-1604fje; Kaufmann P, 2004, PLACENTA, V25, P114, DOI 10.1016/j.placenta.2003.10.009; Kim S, 2000, J BIOL CHEM, V275, P33920, DOI 10.1074/jbc.M003668200; Kim S, 2000, AM J PATHOL, V156, P1345, DOI 10.1016/S0002-9440(10)65005-5; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Liao WB, 2009, TRANSPLANTATION, V87, P350, DOI 10.1097/TP.0b013e318195742e; Magnussen A, 2005, CANCER RES, V65, P2712, DOI 10.1158/0008-5472.CAN-04-2691; Mayhew TM, 2004, PLACENTA, V25, P127, DOI 10.1016/j.placenta.2003.10.010; Milner R, 2002, MOL CELL NEUROSCI, V20, P616, DOI 10.1006/mcne.2002.1151; Muether PS, 2007, EXP EYE RES, V85, P356, DOI 10.1016/j.exer.2007.06.004; Nishishita T, 2004, BIOCHEM BIOPH RES CO, V325, P24, DOI 10.1016/j.bbrc.2004.10.003; Niwa H, 2002, MOL CELL BIOL, V22, P1526, DOI 10.1128/MCB.22.5.1526-1536.2002; Orlic D, 2001, NATURE, V410, P701, DOI 10.1038/35070587; Oswald J, 2004, STEM CELLS, V22, P377, DOI 10.1634/stemcells.22-3-377; Parsons-Wingerter P, 2005, AM J PATHOL, V167, P193, DOI 10.1016/S0002-9440(10)62965-3; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Portmann-Lanz CB, 2006, AM J OBSTET GYNECOL, V194, P664, DOI 10.1016/j.ajog.2006.01.101; Reynolds LE, 2002, NAT MED, V8, P27, DOI 10.1038/nm0102-27; Richards M, 2004, STEM CELLS, V22, P51, DOI 10.1634/stemcells.22-1-51; Romanov YA, 2003, STEM CELLS, V21, P105, DOI 10.1634/stemcells.21-1-105; Senger DR, 1996, AM J PATHOL, V149, P293; Silva GV, 2005, CIRCULATION, V111, P150, DOI 10.1161/01.CIR.0000151812.86142.45; Stupack DG, 2002, J CELL SCI, V115, P3729, DOI 10.1242/jcs.00071; Taverna D, 2001, CANCER RES, V61, P5255; Umeda N, 2006, MOL PHARMACOL, V69, P1820, DOI 10.1124/mol.105.020941; van der Loo JCM, 1998, J CLIN INVEST, V102, P1051, DOI 10.1172/JCI3687; Wijelath ES, 2004, J VASC SURG, V39, P655, DOI 10.1016/j.jvs.2003.10.042; Wijelath ES, 2002, CIRC RES, V91, P25, DOI 10.1161/01.RES.0000026420.22406.79; WILLIAMS DA, 1991, NATURE, V352, P438, DOI 10.1038/352438a0; Wu CC, 2008, J BIOMECH, V41, P813, DOI 10.1016/j.jbiomech.2007.11.008; YANG JT, 1993, DEVELOPMENT, V119, P1093; Yang S, 1999, AM J PATHOL, V155, P887, DOI 10.1016/S0002-9440(10)65188-7; Yen BL, 2005, STEM CELLS, V23, P3, DOI 10.1634/stemcells.2004-0098; YODER MC, 1995, EXP HEMATOL, V23, P961; Zhang Y, 2004, EXP HEMATOL, V32, P657, DOI 10.1016/j.exphem.2004.04.001	76	42	44	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e6913	10.1371/journal.pone.0006913	http://dx.doi.org/10.1371/journal.pone.0006913			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847290	Green Published, gold, Green Submitted			2022-12-27	WOS:000271022000001
J	Plaskon, NE; Adelman, ZN; Myles, KM				Plaskon, Nicole E.; Adelman, Zach N.; Myles, Kevin M.			Accurate Strand-Specific Quantification of Viral RNA	PLOS ONE			English	Article							REAL-TIME PCR; HEPATITIS-C; VIRUS-RNA; RT-PCR; REPLICATION; QUANTITATION; POLYMERASE; CELLS; LIVER	The presence of full-length complements of viral genomic RNA is a hallmark of RNA virus replication within an infected cell. As such, methods for detecting and measuring specific strands of viral RNA in infected cells and tissues are important in the study of RNA viruses. Strand-specific quantitative real-time PCR (ssqPCR) assays are increasingly being used for this purpose, but the accuracy of these assays depends on the assumption that the amount of cDNA measured during the quantitative PCR (qPCR) step accurately reflects amounts of a specific viral RNA strand present in the RT reaction. To specifically test this assumption, we developed multiple ssqPCR assays for the positive-strand RNA virus o'nyong-nyong (ONNV) that were based upon the most prevalent ssqPCR assay design types in the literature. We then compared various parameters of the ONNV-specific assays. We found that an assay employing standard unmodified virus-specific primers failed to discern the difference between cDNAs generated from virus specific primers and those generated through false priming. Further, we were unable to accurately measure levels of ONNV (-) strand RNA with this assay when higher levels of cDNA generated from the (+) strand were present. Taken together, these results suggest that assays of this type do not accurately quantify levels of the anti-genomic strand present during RNA virus infectious cycles. However, an assay permitting the use of a tag-specific primer was able to distinguish cDNAs transcribed from ONNV (-) strand RNA from other cDNAs present, thus allowing accurate quantification of the anti-genomic strand. We also report the sensitivities of two different detection strategies and chemistries, SYBR(R) Green and DNA hydrolysis probes, used with our tagged ONNV-specific ssqPCR assays. Finally, we describe development, design and validation of ssqPCR assays for chikungunya virus (CHIKV), the recent cause of large outbreaks of disease in the Indian Ocean region.			Plaskon, NE (corresponding author), Virginia Tech, Fralin Life Sci Inst, Dept Entomol, Blacksburg, VA 24061 USA.	mylesk@vt.edu		Adelman, Zach/0000-0001-5901-7171	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI077726] Funding Source: NIH RePORTER; NIAID NIH HHS [R01 AI077726-02, AI077726, R01 AI077726] Funding Source: Medline	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Afonina I, 2007, BIOTECHNIQUES, V43, P770, DOI 10.2144/000112631; Anderson JR, 2006, AM J TROP MED HYG, V75, P886, DOI 10.4269/ajtmh.2006.75.886; Anwar A, 2006, ANAL BIOCHEM, V352, P120, DOI 10.1016/j.ab.2006.01.046; Bartolome J, 2007, J VIROL, V81, P7710, DOI 10.1128/JVI.02750-06; Campbell CL, 2008, BMC MICROBIOL, V8, DOI 10.1186/1471-2180-8-47; Castillo I, 2006, CLIN INFECT DIS, V43, P1277, DOI 10.1086/508198; Enserink M, 2008, SCIENCE, V320, P864, DOI 10.1126/science.320.5878.864; Gu CJ, 2007, VIRUS GENES, V34, P289, DOI 10.1007/s11262-006-0019-2; GUNJI T, 1994, ARCH VIROL, V134, P293, DOI 10.1007/BF01310568; Hashimoto Y, 2008, J INVERTEBR PATHOL, V98, P243, DOI 10.1016/j.jip.2008.02.002; HIGUCHI R, 1993, BIO-TECHNOL, V11, P1026, DOI 10.1038/nbt0993-1026; HOLLAND PM, 1991, P NATL ACAD SCI USA, V88, P7276, DOI 10.1073/pnas.88.16.7276; Kim KH, 2004, VIROLOGY, V323, P153, DOI 10.1016/j.virol.2004.03.009; Komurian-Pradel F, 2004, J VIROL METHODS, V116, P103, DOI 10.1016/j.jviromet.2003.10.004; Lin L, 2002, J VIROL METHODS, V100, P97, DOI 10.1016/S0166-0934(01)00399-8; Peyrefitte CN, 2003, J VIROL METHODS, V113, P19, DOI 10.1016/S0166-0934(03)00218-0; Powers AM, 2007, J GEN VIROL, V88, P2363, DOI 10.1099/vir.0.82858-0; Purcell MK, 2006, J VIROL METHODS, V132, P18, DOI 10.1016/j.jviromet.2005.08.017; Richardson J, 2006, AM J TROP MED HYG, V74, P132, DOI 10.4269/ajtmh.2006.74.132; SAWICKI DL, 1980, J VIROL, V34, P108, DOI 10.1128/JVI.34.1.108-118.1980; SHIRAKO Y, 1994, J VIROL, V68, P1874, DOI 10.1128/JVI.68.3.1874-1885.1994; STRAUSS JH, 1994, MICROBIOL REV, V58, P491, DOI 10.1128/MMBR.58.3.491-562.1994; Timofeeva AV, 2001, BIOTECHNIQUES, V30, P22, DOI 10.2144/01301bm02; Wang WK, 2002, J CLIN MICROBIOL, V40, P4472, DOI 10.1128/JCM.40.12.4472-4478.2002; Wittwer CT, 1997, BIOTECHNIQUES, V22, P130, DOI 10.2144/97221bi01; Yuki N, 2006, J HEPATOL, V44, P302, DOI 10.1016/j.jhep.2005.10.014	26	73	75	1	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7468	10.1371/journal.pone.0007468	http://dx.doi.org/10.1371/journal.pone.0007468			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847293	Green Published, Green Submitted, gold			2022-12-27	WOS:000271022000005
J	Simon-Sanchez, J; Seelaar, H; Bochdanovits, Z; Deeg, DJH; van Swieten, JC; Heutink, P				Simon-Sanchez, Javier; Seelaar, Harro; Bochdanovits, Zoltan; Deeg, Dorly J. H.; van Swieten, John C.; Heutink, Peter			Variation at GRN 3 '-UTR rs5848 Is Not Associated with a Risk of Frontotemporal Lobar Degeneration in Dutch Population	PLOS ONE			English	Article							DEMENTIA; MUTATIONS; PROGRANULIN; PREVALENCE; PATHOLOGY; TDP-43	Background: A single nucleotide polymorphism (rs5848) located in the 3'- untranslated region of GRN has recently been associated with a risk of frontotemporal lobar degeneration (FTLD) in North American population particularly in pathologically confirmed cases with neural inclusions immunoreactive for ubiquitin and TAR DNA-binding protein 43 (TDP-43), but negative for tau and alpha-synuclein (FTLD-TDP). Methodology/Principal Findings: In an effort to replicate these results in a different population, rs5848 was genotyped in 256 FTLD cases and 1695 controls from the Netherlands. Single SNP gender-adjusted logistic regression analysis revealed no significant association between variation at rs5848 and FTLD. Fisher's exact test, failed to find any significant association between rs5848 and a subset of 23 pathology confirmed FTLD-TDP cases. Conclusions/Significance: The evidence presented here suggests that variation at rs5848 does not contribute to the etiology of FTLD in the Dutch population.			Simon-Sanchez, J (corresponding author), Vrije Univ Amsterdam Med Ctr, Dept Clin Genet, Sect Med Genom, Amsterdam, Netherlands.	p.heutink@vumc.nl		van Swieten, John/0000-0001-6278-6844; Heutink, Peter/0000-0001-5218-1737; Simon Sanchez, Javier/0000-0001-5141-5829				Baker M, 2006, NATURE, V442, P916, DOI 10.1038/nature05016; Bergmann M, 1996, ACTA NEUROPATHOL, V92, P170, DOI 10.1007/s004010050505; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Cruts M, 2006, NATURE, V442, P920, DOI 10.1038/nature05017; Deeg DJH, 2002, J CLIN EPIDEMIOL, V55, P319, DOI 10.1016/S0895-4356(01)00475-9; Gass J, 2006, HUM MOL GENET, V15, P2988, DOI 10.1093/hmg/ddl241; Gijselinck I, 2008, HUM MUTAT, V29, P1373, DOI 10.1002/humu.20785; Graff-Radford NR, 2007, SEMIN NEUROL, V27, P48, DOI 10.1055/s-2006-956755; Mackenzie IRA, 2006, ACTA NEUROPATHOL, V112, P539, DOI 10.1007/s00401-006-0138-9; Neumann M, 2006, SCIENCE, V314, P130, DOI 10.1126/science.1134108; Pickering-Brown SM, 2002, BRAIN, V125, P732, DOI 10.1093/brain/awf069; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Rademakers R, 2008, HUM MOL GENET, V17, P3631, DOI 10.1093/hmg/ddn257; Ratnavalli E, 2002, NEUROLOGY, V58, P1615, DOI 10.1212/WNL.58.11.1615; ROLLINSON S, 2009, NEUROBIOL AGING; Rollinson S, 2009, NEUROBIOL AGING, V30, P656, DOI 10.1016/j.neurobiolaging.2009.01.009; Rosso SM, 2003, BRAIN, V126, P2016, DOI 10.1093/brain/awg204; Seelaar H, 2008, NEUROLOGY, V71, P1220, DOI 10.1212/01.wnl.0000319702.37497.72; Seelaar H, 2007, BRAIN, V130, P1375, DOI 10.1093/brain/awm024; Snowden JS, 2002, BRIT J PSYCHIAT, V180, P140, DOI 10.1192/bjp.180.2.140; Stevens M, 1998, NEUROLOGY, V50, P1541, DOI 10.1212/WNL.50.6.1541; VISWANATHAN J, 2008, AM J MED GENET B	22	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7494	10.1371/journal.pone.0007494	http://dx.doi.org/10.1371/journal.pone.0007494			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847305	Green Published, gold			2022-12-27	WOS:000271022000008
J	Milton, JG; Ohira, T; Cabrera, JL; Fraiser, RM; Gyorffy, JB; Ruiz, FK; Strauss, MA; Balch, EC; Marin, PJ; Alexander, JL				Milton, John G.; Ohira, Toru; Luis Cabrera, Juan; Fraiser, Ryan M.; Gyorffy, Janelle B.; Ruiz, Ferrin K.; Strauss, Meredith A.; Balch, Elizabeth C.; Marin, Pedro J.; Alexander, Jeffrey L.			Balancing with Vibration: A Prelude for "Drift and Act" Balance Control	PLOS ONE			English	Article							HUMAN POSTURAL SWAY; DELAYED FEEDBACK-CONTROL; MOTOR-EVOKED-POTENTIALS; INVERTED PENDULUM; PARAMETRIC-EXCITATION; AMPLITUDE CONTROL; MUSCLE VIBRATION; NOISE; SYSTEMS; MODEL	Stick balancing at the fingertip is a powerful paradigm for the study of the control of human balance. Here we show that the mean stick balancing time is increased by about two-fold when a subject stands on a vibrating platform that produces vertical vibrations at the fingertip (0.001 m, 15-50 Hz). High speed motion capture measurements in three dimensions demonstrate that vibration does not shorten the neural latency for stick balancing or change the distribution of the changes in speed made by the fingertip during stick balancing, but does decrease the amplitude of the fluctuations in the relative positions of the fingertip and the tip of the stick in the horizontal plane, A(x, y). The findings are interpreted in terms of a time-delayed "drift and act" control mechanism in which controlling movements are made only when controlled variables exceed a threshold, i.e. the stick survival time measures the time to cross a threshold. The amplitude of the oscillations produced by this mechanism can be decreased by parametric excitation. It is shown that a plot of the logarithm of the vibration-induced increase in stick balancing skill, a measure of the mean first passage time, versus the standard deviation of the A(x, y) fluctuations, a measure of the distance to the threshold, is linear as expected for the times to cross a threshold in a stochastic dynamical system. These observations suggest that the balanced state represents a complex time-dependent state which is situated in a basin of attraction that is of the same order of size. The fact that vibration amplitude can benefit balance control raises the possibility of minimizing risk of falling through appropriate changes in the design of footwear and roughness of the walking surfaces.			Milton, JG (corresponding author), Claremont Coll, Joint Sci Dept, Claremont, CA USA.	jmilton@jsd.claremont.edu	CABRERA, Juan Luis/B-5442-2009; Milton, John G/H-7320-2012	CABRERA, Juan Luis/0000-0003-4523-8373; MARIN, PEDRO J/0000-0001-7536-6005				ACHESON D, 1998, CALCULUS CHAOS INTRO; [Anonymous], 1983, J ACOUST SOC AM; Asai Y, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006169; Atay FM, 1998, J SOUND VIB, V218, P333, DOI 10.1006/jsvi.1998.1843; Bormann R, 2004, NEUROCOMPUTING, V58, P517, DOI 10.1016/j.neucom.2004.01.089; Bottaro A, 2008, HUM MOVEMENT SCI, V27, P473, DOI 10.1016/j.humov.2007.11.005; Cabrera JL, 2006, CONDENS MATTER PHYS, V9, P373, DOI 10.5488/CMP.9.2.373; Cabrera J. L., 2004, NONLINEAR STUDIES, V11, P305; Cabrera JL, 2004, CHAOS, V14, P691, DOI 10.1063/1.1785453; Cabrera JL, 2004, FLUCT NOISE LETT, V4, pL107, DOI 10.1142/S0219477504001719; Cabrera JL, 2002, PHYS REV LETT, V89, DOI 10.1103/PhysRevLett.89.158702; CHIN C, 1995, INT J BIFURCAT CHAOS, V5, P971, DOI 10.1142/S0218127495000739; Cluff T, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005998; COLLINS JJ, 1993, EXP BRAIN RES, V95, P308, DOI 10.1007/BF00229788; COLLINS JJ, 1994, PHYS REV LETT, V73, P764, DOI 10.1103/PhysRevLett.73.764; Ermentrout B., 2002, SIMULATING ANAL ANIM, V14; Eurich CW, 1996, PHYS REV E, V54, P6681, DOI 10.1103/PhysRevE.54.6681; Foss J, 1997, PHYS REV E, V55, P4536, DOI 10.1103/PhysRevE.55.4536; Gawthrop P, 2009, BIOL CYBERN, V101, P131, DOI 10.1007/s00422-009-0325-6; Griffin M.J., 1998, FUNDAMENTALS NOISE V, P179; GUCKENHEIMER J, 1995, IEEE T AUTOMAT CONTR, V40, P321, DOI 10.1109/9.341802; Hijmans JM, 2008, J REHABIL RES DEV, V45, P1441, DOI 10.1682/JRRD.2008.02.0023; HOFFMANN ER, 1992, ERGONOMICS, V35, P37, DOI 10.1080/00140139208967796; Ibrahim RA, 2006, NONLINEAR DYNAM, V46, P387, DOI 10.1007/s11071-006-9031-2; Insperger T, 2006, IEEE T CONTR SYST T, V14, P974, DOI 10.1109/TCST.2006.876938; Jenkins G., 1968, SPECTRAL ANAL ITS AP; Jordan MJ, 2005, J STRENGTH COND RES, V19, P459, DOI 10.1519/13293.1; Kawazoe Y., 2008, J SYSTEM DESIGN DYNA, V2, P1351; Kossev A, 2001, CLIN NEUROPHYSIOL, V112, P453, DOI 10.1016/S1388-2457(01)00473-4; Kramers HA, 1940, PHYSICA, V7, P284, DOI 10.1016/S0031-8914(40)90098-2; Landry M, 2005, SIAM J APPL DYN SYST, V4, P333, DOI 10.1137/030600461; Loram ID, 2005, J PHYSIOL-LONDON, V564, P281, DOI 10.1113/jphysiol.2004.073437; Loram ID, 2005, J PHYSIOL-LONDON, V564, P295, DOI 10.1113/jphysiol.2004.076307; Loram ID, 2001, J PHYSIOL-LONDON, V532, P879, DOI 10.1111/j.1469-7793.2001.0879e.x; Lumbantobing H, 2004, J FLUID STRUCT, V19, P221, DOI 10.1016/j.jfluidstructs.2003.12.006; Luo J, 2005, SPORTS MED, V35, P23, DOI 10.2165/00007256-200535010-00003; Maccari A, 2008, J SOUND VIB, V317, P20, DOI 10.1016/j.jsv.2008.03.029; Masani K, 2008, J NEUROPHYSIOL, V100, P1465, DOI 10.1152/jn.00801.2007; Milton JG, 2008, EPL-EUROPHYS LETT, V83, DOI 10.1209/0295-5075/83/48001; Milton JG, 2004, J CLIN NEUROPHYSIOL, V21, P134, DOI 10.1097/00004691-200405000-00002; Milton J, 2009, CHAOS, V19, DOI 10.1063/1.3141429; Milton J, 2009, PHILOS T R SOC A, V367, P1181, DOI 10.1098/rsta.2008.0257; Morris K.A., 2001, INTRO FEEDBACK CONTR; Moss F, 2003, NATURE, V425, P911, DOI 10.1038/425911a; Newell KM, 1997, EXP BRAIN RES, V113, P158, DOI 10.1007/BF02454152; Peli E, 2003, EXP BRAIN RES, V149, P431, DOI 10.1007/s00221-003-1383-y; Pippard A. B., 1987, European Journal of Physics, V8, P203, DOI 10.1088/0143-0807/8/3/012; Priplata AA, 2006, ANN NEUROL, V59, P4, DOI 10.1002/ana.20670; Priplata AA, 2003, LANCET, V362, P1123, DOI 10.1016/S0140-6736(03)14470-4; PROSKE U, 1993, PROG NEUROBIOL, V41, P705, DOI 10.1016/0301-0082(93)90032-N; ROLL JP, 1988, INT CONGR SER, V812, P155; Shumway-Cook A., 2001, MOTOR CONTROL THEORY, V2nd; Sieber J, 2004, PHYSICA D, V197, P332, DOI 10.1016/j.physd.2004.07.007; SIEBER J, 2004, BIFURCATION ANAL INV, P85; Siggelkow S, 1999, MUSCLE NERVE, V22, P1544, DOI 10.1002/(SICI)1097-4598(199911)22:11<1544::AID-MUS9>3.3.CO;2-#; Stepan G., 1989, PITMAN RESEARCHNOTES, V210; Stepan G, 2006, ANNU REV CONTROL, V30, P159, DOI 10.1016/j.arcontrol.2006.08.002; Stepan G, 2009, PHILOS T R SOC A, V367, P1195, DOI 10.1098/rsta.2008.0278; Straw A., 2008, FRONTIERS NEUROINFOR, V11, DOI 10.3389.neuro.11.004:2008; Tang JS, 2009, NONLINEAR ANAL-THEOR, V71, P2491, DOI 10.1016/j.na.2009.01.130; Winter DA, 1998, J NEUROPHYSIOL, V80, P1211, DOI 10.1152/jn.1998.80.3.1211; Yamada N, 1995, HUM MOVEMENT SCI, V14, P711, DOI 10.1016/0167-9457(95)00032-1; [No title captured]	64	57	57	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7427	10.1371/journal.pone.0007427	http://dx.doi.org/10.1371/journal.pone.0007427			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841741	gold, Green Published, Green Submitted			2022-12-27	WOS:000271012900010
J	Dixit, A; Yi, L; Gowthaman, R; Torkamani, A; Schork, NJ; Verkhivker, GM				Dixit, Anshuman; Yi, Lin; Gowthaman, Ragul; Torkamani, Ali; Schork, Nicholas J.; Verkhivker, Gennady M.			Sequence and Structure Signatures of Cancer Mutation Hotspots in Protein Kinases	PLOS ONE			English	Article							GROWTH-FACTOR RECEPTOR; CELL LUNG-CANCER; C-KIT; SOMATIC MUTATIONS; ACTIVATION LOOP; CRYSTAL-STRUCTURE; CONFORMATIONAL TRANSITIONS; NUCLEOTIDE POLYMORPHISMS; MOLECULAR-MECHANISMS; CATALYTIC DOMAIN	Protein kinases are the most common protein domains implicated in cancer, where somatically acquired mutations are known to be functionally linked to a variety of cancers. Resequencing studies of protein kinase coding regions have emphasized the importance of sequence and structure determinants of cancer-causing kinase mutations in understanding of the mutation-dependent activation process. We have developed an integrated bioinformatics resource, which consolidated and mapped all currently available information on genetic modifications in protein kinase genes with sequence, structure and functional data. The integration of diverse data types provided a convenient framework for kinome-wide study of sequence-based and structure-based signatures of cancer mutations. The database-driven analysis has revealed a differential enrichment of SNPs categories in functional regions of the kinase domain, demonstrating that a significant number of cancer mutations could fall at structurally equivalent positions (mutational hotspots) within the catalytic core. We have also found that structurally conserved mutational hotspots can be shared by multiple kinase genes and are often enriched by cancer driver mutations with high oncogenic activity. Structural modeling and energetic analysis of the mutational hotspots have suggested a common molecular mechanism of kinase activation by cancer mutations, and have allowed to reconcile the experimental data. According to a proposed mechanism, structural effect of kinase mutations with a high oncogenic potential may manifest in a significant destabilization of the autoinhibited kinase form, which is likely to drive tumorigenesis at some level. Structure-based functional annotation and prediction of cancer mutation effects in protein kinases can facilitate an understanding of the mutation-dependent activation process and inform experimental studies exploring molecular pathology of tumorigenesis.			Dixit, A (corresponding author), Univ Kansas, Ctr Bioinformat, Grad Program Bioinformat, Lawrence, KS 66045 USA.	verk@ku.edu	Verkhivker, Gennady/V-9404-2018	Verkhivker, Gennady/0000-0002-4507-4471; Gowthaman, Ragul/0000-0002-0008-6401; Schork, Nicholas/0000-0003-0920-5013	NATIONAL CENTER FOR RESEARCH RESOURCES [UL1RR025774] Funding Source: NIH RePORTER; NCRR NIH HHS [UL1 RR025774] Funding Source: Medline	NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR))		Abu-Duhier FM, 2001, BRIT J HAEMATOL, V113, P983, DOI 10.1046/j.1365-2141.2001.02850.x; Altshuler D, 2005, NATURE, V437, P1299, DOI 10.1038/nature04226; Arora K, 2007, P NATL ACAD SCI USA, V104, P18496, DOI 10.1073/pnas.0706443104; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; Bamford S, 2004, BRIT J CANCER, V91, P355, DOI 10.1038/sj.bjc.6601894; Banavali NK, 2007, PROTEINS, V67, P1096, DOI 10.1002/prot.21334; Banavali NK, 2009, PROTEINS, V74, P378, DOI 10.1002/prot.22153; Bardelli A, 1998, P NATL ACAD SCI USA, V95, P14379, DOI 10.1073/pnas.95.24.14379; Berteotti A, 2009, J AM CHEM SOC, V131, P244, DOI 10.1021/ja806846q; Berthou S, 2004, ONCOGENE, V23, P5387, DOI 10.1038/sj.onc.1207691; Boeckmann B, 2003, NUCLEIC ACIDS RES, V31, P365, DOI 10.1093/nar/gkg095; Boutet Emmanuel, 2007, V406, P89; Canutescu AA, 2003, PROTEIN SCI, V12, P2001, DOI 10.1110/ps.03154503; Cheetham GMT, 2004, CURR OPIN STRUC BIOL, V14, P700, DOI 10.1016/j.sbi.2004.10.011; Cherry M, 2004, CURR MED CHEM, V11, P663, DOI 10.2174/0929867043455792; Chiara F, 2003, J BIOL CHEM, V278, P29352, DOI 10.1074/jbc.M302404200; Collins FS, 2007, SCI AM, V296, P50, DOI 10.1038/scientificamerican0307-50; Conde L, 2004, NUCLEIC ACIDS RES, V32, pW242, DOI 10.1093/nar/gkh438; Corbin AS, 2003, BLOOD, V101, P4611, DOI 10.1182/blood-2002-12-3659; Cranston AN, 2006, CANCER RES, V66, P10179, DOI 10.1158/0008-5472.CAN-06-0884; Davies H, 2005, CANCER RES, V65, P7591, DOI 10.1158/0008-5472.CAN-05-1855; Dixit A, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000487; Dixit A, 2009, BIOPHYS J, V96, P858, DOI 10.1016/j.bpj.2008.10.041; Eichler EE, 2007, NATURE, V447, P161, DOI 10.1038/447161a; Ferrao PT, 2003, LEUKEMIA RES, V27, P547, DOI 10.1016/S0145-2126(02)00272-2; Fiser A, 2000, PROTEIN SCI, V9, P1753, DOI 10.1110/ps.9.9.1753; Foster R, 2004, J MOL GRAPH MODEL, V23, P139, DOI 10.1016/j.jmgm.2004.04.003; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Frohling S, 2007, CANCER CELL, V12, P501, DOI 10.1016/j.ccr.2007.11.005; Fu YN, 2008, ONCOGENE, V27, P957, DOI 10.1038/sj.onc.1210684; FURITSU T, 1993, J CLIN INVEST, V92, P1736, DOI 10.1172/JCI116761; Greenman C, 2007, NATURE, V446, P153, DOI 10.1038/nature05610; Griffith J, 2004, MOL CELL, V13, P169, DOI 10.1016/S1097-2765(03)00505-7; Guerois R, 2002, J MOL BIOL, V320, P369, DOI 10.1016/S0022-2836(02)00442-4; Gujral TS, 2006, ANN NY ACAD SCI, V1073, P234, DOI 10.1196/annals.1353.025; Gujral TS, 2006, CANCER RES, V66, P10741, DOI 10.1158/0008-5472.CAN-06-3329; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; HANKS SK, 1995, FASEB J, V9, P576, DOI 10.1096/fasebj.9.8.7768349; Hunter T, 1997, TRENDS BIOCHEM SCI, V22, P18, DOI 10.1016/S0968-0004(96)10068-2; Hunter T, 2000, CELL, V100, P113, DOI 10.1016/S0092-8674(00)81688-8; Huse M, 2002, CELL, V109, P275, DOI 10.1016/S0092-8674(02)00741-9; IZARZUGAZA JM, 2009, PROTEINS IN PRESS; Jeffers M, 1997, P NATL ACAD SCI USA, V94, P11445, DOI 10.1073/pnas.94.21.11445; Jones S, 2008, SCIENCE, V321, P1801, DOI 10.1126/science.1164368; JORGENSEN WL, 1983, J CHEM PHYS, V79, P926, DOI 10.1063/1.445869; Kaminker JS, 2007, NUCLEIC ACIDS RES, V35, pW595, DOI 10.1093/nar/gkm405; Kaminker JS, 2007, CANCER RES, V67, P465, DOI 10.1158/0008-5472.CAN-06-1736; Kannan N, 2005, J MOL BIOL, V351, P956, DOI 10.1016/j.jmb.2005.06.057; Kannan N, 2007, PLOS BIOL, V5, P467, DOI 10.1371/journal.pbio.0050017; Kiemeney LA, 2008, NAT GENET, V40, P1307, DOI 10.1038/ng.229; Knight ZA, 2005, CHEM BIOL, V12, P621, DOI 10.1016/j.chembiol.2005.04.011; Knowles PP, 2006, J BIOL CHEM, V281, P33577, DOI 10.1074/jbc.M605604200; Kornev AP, 2008, P NATL ACAD SCI USA, V105, P14377, DOI 10.1073/pnas.0807988105; Kornev AP, 2006, P NATL ACAD SCI USA, V103, P17783, DOI 10.1073/pnas.0607656103; Kouranov A, 2006, NUCLEIC ACIDS RES, V34, pD302, DOI 10.1093/nar/gkj120; Krallinger M, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-S8-S1; Krawczak M, 2000, HUM MUTAT, V15, P45, DOI 10.1002/(SICI)1098-1004(200001)15:1<45::AID-HUMU10>3.0.CO;2-T; Kumar A, 2008, J CLIN ONCOL, V26, P1742, DOI 10.1200/JCO.2007.12.1178; Lai AZ, 2007, ENDOCR PATHOL, V18, P57, DOI 10.1007/s12022-007-0009-5; Lander ES, 2000, SCIENCE, V287, P1777, DOI 10.1126/science.287.5459.1777; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Lorenzato A, 2002, CANCER RES, V62, P7025; Loriaux MM, 2008, BLOOD, V111, P4788, DOI 10.1182/blood-2007-07-101394; Lynch TJ, 2004, NEW ENGL J MED, V350, P2129, DOI 10.1056/NEJMoa040938; MacKerell AD, 2001, BIOPOLYMERS, V56, P257; MacKerell AD, 1998, J PHYS CHEM B, V102, P3586, DOI 10.1021/jp973084f; Madhusudan S, 2004, CLIN BIOCHEM, V37, P618, DOI 10.1016/j.clinbiochem.2004.05.006; Manning G, 2002, SCIENCE, V298, P1912, DOI 10.1126/science.1075762; Manning G, 2002, TRENDS BIOCHEM SCI, V27, P514, DOI 10.1016/S0968-0004(02)02179-5; Maritano D, 2000, ONCOGENE, V19, P1354, DOI 10.1038/sj.onc.1203431; Marti-Renom MA, 2000, ANNU REV BIOPH BIOM, V29, P291, DOI 10.1146/annurev.biophys.29.1.291; Masterson LR, 2008, P NATL ACAD SCI USA, V105, P506, DOI 10.1073/pnas.0709214104; Miller M, 2001, PROTEINS, V44, P32, DOI 10.1002/prot.1069; Modugno M, 2007, CANCER RES, V67, P7987, DOI 10.1158/0008-5472.CAN-07-1825; Mol CD, 2004, J BIOL CHEM, V279, P31655, DOI 10.1074/jbc.M403319200; Morotti A, 2002, ONCOGENE, V21, P4885, DOI 10.1038/sj.onc.1205622; Nakaigawa N, 2000, ONCOGENE, V19, P2996, DOI 10.1038/sj.onc.1203628; Neuwald AF, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-157; NEUWALD AF, 1995, PROTEIN SCI, V4, P1618, DOI 10.1002/pro.5560040820; Niedner RH, 2006, PROTEINS, V63, P78, DOI 10.1002/prot.20825; Noble MEM, 2004, SCIENCE, V303, P1800, DOI 10.1126/science.1095920; Nolen B, 2004, MOL CELL, V15, P661, DOI 10.1016/j.molcel.2004.08.024; Ortutay C, 2005, HUM MUTAT, V25, P435, DOI 10.1002/humu.20166; Ozkirimli E, 2006, PROTEIN SCI, V15, P1051, DOI 10.1110/ps.051999206; Ozkirimli E, 2008, PROTEIN SCI, V17, P1871, DOI 10.1110/ps.037457.108; Paez JG, 2004, SCIENCE, V304, P1497, DOI 10.1126/science.1099314; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Papakyriakou A, 2009, PROTEINS, V76, P375, DOI 10.1002/prot.22353; Parmigiani G, 2009, GENOMICS, V93, P17, DOI 10.1016/j.ygeno.2008.07.005; Parsons DW, 2008, SCIENCE, V321, P1807, DOI 10.1126/science.1164382; Parthiban V, 2006, NUCLEIC ACIDS RES, V34, pW239, DOI 10.1093/nar/gkl190; Parthiban V, 2007, BMC STRUCT BIOL, V7, DOI 10.1186/1472-6807-7-54; Pei JM, 2008, NUCLEIC ACIDS RES, V36, pW30, DOI 10.1093/nar/gkn322; Pellicena P, 2006, CURR OPIN STRUC BIOL, V16, P702, DOI 10.1016/j.sbi.2006.10.007; Phillips JC, 2005, J COMPUT CHEM, V26, P1781, DOI 10.1002/jcc.20289; Rebholz-Schuhmann D, 2004, NUCLEIC ACIDS RES, V32, P135, DOI 10.1093/nar/gkh162; Richardson CJ, 2009, NUCLEIC ACIDS RES, V37, pD824, DOI 10.1093/nar/gkn832; Sawyer Tomi K., 2004, Current Medicinal Chemistry - Anti-Cancer Agents, V4, P449, DOI 10.2174/1568011043352830; Sawyers CL, 2003, GENE DEV, V17, P2998, DOI 10.1101/gad.1152403; Scheeff ED, 2005, PLOS COMPUT BIOL, V1, P359, DOI 10.1371/journal.pcbi.0010049; Schiering N, 2003, P NATL ACAD SCI USA, V100, P12654, DOI 10.1073/pnas.1734128100; Schymkowitz J, 2005, NUCLEIC ACIDS RES, V33, pW382, DOI 10.1093/nar/gki387; Sensi M, 2006, ONCOGENE, V25, P3357, DOI 10.1038/sj.onc.1209379; Shan YB, 2009, P NATL ACAD SCI USA, V106, P139, DOI 10.1073/pnas.0811223106; Sharma SV, 2007, GENE DEV, V21, P3214, DOI 10.1101/gad.1609907; Sherry ST, 1999, GENOME RES, V9, P677; Sjoblom T, 2006, SCIENCE, V314, P268, DOI 10.1126/science.1133427; Sridhar R, 2000, PHARM RES-DORDR, V17, P1345, DOI 10.1023/A:1007507224529; Stenberg KAE, 2000, NUCLEIC ACIDS RES, V28, P369, DOI 10.1093/nar/28.1.369; Stenson PD, 2003, HUM MUTAT, V21, P577, DOI 10.1002/humu.10212; Stephens P, 2005, NAT GENET, V37, P590, DOI 10.1038/ng1571; Tan A, 2006, CLIN CHEM, V52, P2250, DOI 10.1373/clinchem.2006.068205; Thomas PD, 2004, P NATL ACAD SCI USA, V101, P15398, DOI 10.1073/pnas.0404380101; Thomas PD, 2003, GENOME RES, V13, P2129, DOI 10.1101/gr.772403; Thomas RK, 2007, NAT GENET, V39, P347, DOI 10.1038/ng1975; Tomasson MH, 2008, BLOOD, V111, P4797, DOI 10.1182/blood-2007-09-113027; Torkamani A, 2008, P NATL ACAD SCI USA, V105, P9011, DOI 10.1073/pnas.0802403105; Torkamani A, 2008, CANCER RES, V68, P1675, DOI 10.1158/0008-5472.CAN-07-5283; Torkamani A, 2007, BIOINFORMATICS, V23, P2918, DOI 10.1093/bioinformatics/btm437; Torkamani A, 2009, CANCER LETT, V281, P117, DOI 10.1016/j.canlet.2008.11.008; Torrent M, 2004, J MOL GRAPH MODEL, V23, P153, DOI 10.1016/j.jmgm.2004.05.002; Tyner JW, 2009, LEUKEMIA, V23, P406, DOI 10.1038/leu.2008.187; Valiaho J, 2006, HUM MUTAT, V27, P1209, DOI 10.1002/humu.20410; Vendome J, 2005, J MED CHEM, V48, P6194, DOI 10.1021/jm050231m; Wan PTC, 2004, CELL, V116, P855, DOI 10.1016/S0092-8674(04)00215-6; Wang WR, 2006, P NATL ACAD SCI USA, V103, P3563, DOI 10.1073/pnas.0600048103; Weinstein IB, 2002, SCIENCE, V297, P63, DOI 10.1126/science.1073096; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000; Wood LD, 2007, SCIENCE, V318, P1108, DOI 10.1126/science.1145720; Yamamoto Y, 2001, BLOOD, V97, P2434, DOI 10.1182/blood.V97.8.2434; Yang S, 2009, P NATL ACAD SCI USA, V106, P3776, DOI 10.1073/pnas.0808261106; Yang S, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000047; Young MA, 2001, CELL, V105, P115, DOI 10.1016/S0092-8674(01)00301-4; Yun CH, 2008, P NATL ACAD SCI USA, V105, P2070, DOI 10.1073/pnas.0709662105; Yun CH, 2007, CANCER CELL, V11, P217, DOI 10.1016/j.ccr.2006.12.017; Zhang XW, 2006, CELL, V125, P1137, DOI 10.1016/j.cell.2006.05.013; Zhang Y, 2005, NUCLEIC ACIDS RES, V33, P2302, DOI 10.1093/nar/gki524; Zheng W, 2009, NAT GENET, V41, P324, DOI 10.1038/ng.318; Zhou TJ, 2007, CHEM BIOL DRUG DES, V70, P171, DOI 10.1111/j.1747-0285.2007.00556.x; Zou J, 2008, PROTEINS, V72, P323, DOI 10.1002/prot.21928	140	57	58	0	14	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7485	10.1371/journal.pone.0007485	http://dx.doi.org/10.1371/journal.pone.0007485			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834613	Green Published, Green Submitted, gold			2022-12-27	WOS:000270880700010
J	da Silva, ANMR; Nascimento, EJM; Cordeiro, MT; Gil, LHVG; Abath, FGC; Montenegro, SML; Marques, ETA				Rangel da Silva, Andrea N. M.; Nascimento, Eduardo J. M.; Cordeiro, Marli Tenorio; Gil, Laura H. V. G.; Abath, Frederico G. C.; Montenegro, Silvia M. L.; Marques, Ernesto T. A., Jr.			Identification of Continuous Human B-Cell Epitopes in the Envelope Glycoprotein of Dengue Virus Type 3 (DENV-3)	PLOS ONE			English	Article							MONOCLONAL-ANTIBODIES; SYNTHETIC PEPTIDE; NEUTRALIZING ANTIBODY; REACTIVE EPITOPES; SWISS-MODEL; DOMAIN-III; PROTEIN; DETERMINANTS; RECOGNITION; PREDICTION	Background: Dengue virus infection is a growing global public health concern in tropical and subtropical regions of the world. Dengue vaccine development has been hampered by concerns that cross-reactive immunological memory elicited by a candidate vaccine could increase the risk of development of more severe clinical forms. One possible strategy to reduce risks associated with a dengue vaccine is the development of a vaccine composed of selected critical epitopes of each of the serotypes. Methodology/Principal Findings: Synthetic peptides were used to identify B-cell epitopes in the envelope (E) glycoprotein of dengue virus type 3 (DENV-3). Eleven linear, immunodominant epitopes distributed in five regions at amino acid (aa) positions: 51-65, 71-90, 131-170, 196-210 and 246-260 were identified by employing an enzyme-linked immunosorbent assay (ELISA), using a pool of human sera from dengue type 3 infected individuals. Peptides 11 (aa51-65), 27 and 28 (aa131-150) also reacted with dengue 1 (DENV-1) and dengue 2 (DENV-2) patient sera as analyzed through the ROC curves generated for each peptide by ELISA and might have serotype specific diagnostic potential. Mice immunized against each one of the five immunogenic regions showed epitopes 51-65, 131-170, 196-210 and 246-260 elicited the highest antibody response and epitopes 131-170, 196-210 and 246-260, elicited IFN-gamma production and T CD4+ cell response, as evaluated by ELISA and ELISPOT assays respectively. Conclusions/Significance: Our study identified several useful immunodominant IgG-specific epitopes on the envelope of DENV-3. They are important tools for understanding the mechanisms involved in antibody dependent enhancement and immunity. If proven protective and safe, in conjunction with others well-documented epitopes, they might be included into a candidate epitope-based vaccine.			da Silva, ANMR (corresponding author), Fiocruz MS, Aggeu Magalhaes Res Ctr, Virol & Expt Therapy Lab, Recife, PE, Brazil.	marques@pitt.edu	Gil, Laura Helena Vega Gonzales/AAX-5319-2021; Marques, Ernesto T. A/L-4967-2013; Publica, Inct Saude/J-9544-2013; montenegro, silvia/AAD-9090-2020; Nascimento, Eduardo/J-4590-2014; Marques, Ernesto/L-4514-2013	Gil, Laura Helena Vega Gonzales/0000-0002-8796-6080; Marques, Ernesto T. A/0000-0003-3826-9358; Nascimento, Eduardo/0000-0002-9851-2332; Marques, Ernesto/0000-0003-3826-9358	NIAID NIH HHS [U19 AI05641] Funding Source: Medline	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		AnandaRao R, 2005, VIRUS RES, V112, P60, DOI 10.1016/j.virusres.2005.03.022; Apt D, 2006, VACCINE, V24, P335, DOI 10.1016/j.vaccine.2005.07.100; Beasley DWC, 2001, VIROLOGY, V279, P447, DOI 10.1006/viro.2000.0721; Berman HM, 2000, NUCLEIC ACIDS RES, V28, P235, DOI 10.1093/nar/28.1.235; Cordeiro MT, 2007, AM J TROP MED HYG, V77, P1128, DOI 10.4269/ajtmh.2007.77.1128; Crill WD, 2001, J VIROL, V75, P7769, DOI 10.1128/JVI.75.16.7769-7773.2001; Crill WD, 2004, J VIROL, V78, P13975, DOI 10.1128/JVI.78.24.13975-13986.2004; EMINI EA, 1985, J VIROL, V55, P836, DOI 10.1128/JVI.55.3.836-839.1985; Guex N, 1997, ELECTROPHORESIS, V18, P2714, DOI 10.1002/elps.1150181505; Guirakhoo F, 2004, J VIROL, V78, P4761, DOI 10.1128/JVI.78.9.4761-4775.2004; Guzman MG, 2004, INT J INFECT DIS, V8, P69, DOI 10.1016/j.ijid.2003.03.003; HECHAVARRIA A, 2002, MANUAL PROCEDIMIENTO; Hombach J, 2005, VACCINE, V23, P5205, DOI 10.1016/j.vaccine.2004.11.040; Huang JH, 1999, J MED VIROL, V57, P1, DOI 10.1002/(SICI)1096-9071(199901)57:1&lt;1::AID-JMV1&gt;3.0.CO;2-T; KABSCH W, 1983, BIOPOLYMERS, V22, P2577, DOI 10.1002/bip.360221211; KOLASKAR AS, 1990, FEBS LETT, V276, P172, DOI 10.1016/0014-5793(90)80535-Q; KYTE J, 1982, J MOL BIOL, V157, P105, DOI 10.1016/0022-2836(82)90515-0; Leitmeyer KC, 1999, J VIROL, V73, P4738, DOI 10.1128/JVI.73.6.4738-4747.1999; MATHEWS JH, 1991, J VIROL, V65, P5141, DOI 10.1128/JVI.65.10.5141-5148.1991; Matsui K, 2009, VIROLOGY, V384, P16, DOI 10.1016/j.virol.2008.11.013; Miagostovich MP, 2002, BRAZ J MED BIOL RES, V35, P869, DOI 10.1590/S0100-879X2002000800002; Modis Y, 2005, J VIROL, V79, P1223, DOI 10.1128/JVI.79.2.1223-1231.2005; Modis Y, 2004, NATURE, V427, P313, DOI 10.1038/nature02165; Oliphant T, 2006, J VIROL, V80, P12149, DOI 10.1128/JVI.01732-06; Reynolds J, 2009, CLIN EXP IMMUNOL, V155, P311, DOI 10.1111/j.1365-2249.2008.03833.x; Roehrig JT, 1998, VIROLOGY, V246, P317, DOI 10.1006/viro.1998.9200; ROEHRIG JT, 1992, J VIROL, V66, P3385, DOI 10.1128/JVI.66.6.3385-3390.1992; Schwede T, 2003, NUCLEIC ACIDS RES, V31, P3381, DOI 10.1093/nar/gkg520; Serafin IL, 2001, ARCH VIROL, V146, P2469, DOI 10.1007/s007050170017; SINGH B, 1980, J IMMUNOL, V124, P1336; Thullier P, 2001, J GEN VIROL, V82, P1885, DOI 10.1099/0022-1317-82-8-1885; Wu HC, 2003, J GEN VIROL, V84, P2771, DOI 10.1099/vir.0.19228-0; Wu HC, 2001, J CLIN MICROBIOL, V39, P977, DOI 10.1128/JCM.39.3.977-982.2001; Yamada KI, 2002, J CLIN VIROL, V24, P203, DOI 10.1016/S1386-6532(01)00250-5; Zhang GL, 2005, NUCLEIC ACIDS RES, V33, pW172, DOI 10.1093/nar/gki452; Zhang W, 2003, NAT STRUCT BIOL, V10, P907, DOI 10.1038/nsb990; Zhang Y, 2004, STRUCTURE, V12, P1607, DOI 10.1016/j.str.2004.06.019	37	22	24	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7425	10.1371/journal.pone.0007425	http://dx.doi.org/10.1371/journal.pone.0007425			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19826631	Green Published, gold, Green Submitted			2022-12-27	WOS:000270808300008
J	Shi, WF; Leong, M; Cho, E; Farrell, J; Chen, HC; Tian, J; Zhang, DZ				Shi, Wen-feng; Leong, Melanie; Cho, Ellen; Farrell, Joseph; Chen, Han-chun; Tian, Jun; Zhang, Dianzheng			Repressive Effects of Resveratrol on Androgen Receptor Transcriptional Activity	PLOS ONE			English	Article							PROSTATE-CANCER CELLS; RED WINE; CHEMOPREVENTIVE AGENT; TRANS-RESVERATROL; LNCAP CELLS; EXPRESSION; GROWTH; MODULATION; APOPTOSIS; GRAPE	Background: The chemopreventive effects of resveratrol (RSV) on prostate cancer have been well established; the androgen receptor (AR) plays pivotal roles in prostatic tumorigenesis. However, the exact underlying molecular mechanisms about the effects of RSV on AR have not been fully elucidated. A model system is needed to determine whether and how RSV represses AR transcriptional activity. Methodology: The AR cDNA was first cloned into the retroviral vector pOZ-N and then integrated into the genome of AR-negative HeLa cells to generate the AR(+) cells. The constitutively expressed AR was characterized by monitoring hormone-stimulated nuclear translocation, DNA binding, and transcriptional activation, with the AR(-) cells serving as controls. AR(+) cells were treated with RSV, and both AR protein levels and AR transcriptional activity were measured simultaneously. Chromatin immunoprecipitation (ChIP) assays were used to detect the effects of RSV on the recruitment of AR to its cognate element (ARE). Results: AR in the AR (+) stable cell line functions in a manner similar to that of endogenously expressed AR. Using this model system we clearly demonstrated that RSV represses AR transcriptional activity independently of any effects on AR protein levels. However, neither the hormone-mediated nucleus translocation nor the AR/ARE interaction was affected by RSV treatment. Conclusion: We demonstrated unambiguously that RSV regulates AR target gene expression, at least in part, by repressing AR transcriptional activity. Repressive effects of RSV on AR activity result from mechanisms other than the affects of AR nuclear translocation or DNA binding.			Shi, WF (corresponding author), Shandong Univ, Dept Blood Purificat, Qilu Hosp, Jinan 250100, Shandong, Peoples R China.	dianzhengzh@pcom.edu		Chen, Han-chun/0000-0003-2528-3492				Agoulnik IU, 2008, ADV EXP MED BIOL, V617, P245, DOI 10.1007/978-0-387-69080-3_23; Agoulnik IU, 2006, J CELL BIOCHEM, V99, P362, DOI 10.1002/jcb.20811; Agoulnik IU, 2005, CANCER RES, V65, P7959, DOI 10.1158/0008-5472.CAN-04-3541; Ajmo JM, 2008, AM J PHYSIOL-GASTR L, V295, pG833, DOI 10.1152/ajpgi.90358.2008; Aziz MH, 2006, MOL CANCER THER, V5, P1335, DOI 10.1158/1535-7163.MCT-05-0526; Beck C, 2004, CURR GENE THER, V4, P457; Benitez DA, 2007, BRIT J CANCER, V96, P1595, DOI 10.1038/sj.bjc.6603755; Bertelli AAE, 1996, INT J CLIN PHARM RES, V16, P77; Bertelli AAE, 1998, DRUG EXP CLIN RES, V24, P51; Bertelli AAE, 1996, INT J TISSUE REACT, V18, P67; BOSTWICK DG, 1992, J CELL BIOCHEM, P10; Burd CJ, 2006, P NATL ACAD SCI USA, V103, P2190, DOI 10.1073/pnas.0506281103; Careri M, 2003, J AGR FOOD CHEM, V51, P5226, DOI 10.1021/jf034149g; CHANG CS, 1988, SCIENCE, V240, P324, DOI 10.1126/science.3353726; Denis LJ, 2000, SEMIN SURG ONCOL, V18, P52, DOI 10.1002/(SICI)1098-2388(200001/02)18:1<52::AID-SSU8>3.0.CO;2-6; DePrimo SE, 2001, HEMATOL ONCOL CLIN N, V15, P445, DOI 10.1016/S0889-8588(05)70225-2; Faus H, 2008, J CELL BIOCHEM, V104, P511, DOI 10.1002/jcb.21640; Fletterick RJ, 2005, BJU INT, V96, P2, DOI 10.1111/j.1464-410X.2005.05940.x; Fu MF, 2006, MOL CELL BIOL, V26, P8122, DOI 10.1128/MCB.00289-06; Gao S, 2004, PROSTATE, V59, P214, DOI 10.1002/pros.10375; Harada N, 2007, J NUTR SCI VITAMINOL, V53, P556, DOI 10.3177/jnsv.53.556; Hsieh TC, 2000, ANTICANCER RES, V20, P225; Hsieh TC, 1999, EXP CELL RES, V249, P109, DOI 10.1006/excr.1999.4471; Jang MS, 1997, SCIENCE, V275, P218, DOI 10.1126/science.275.5297.218; Jemal A, 2004, CA-CANCER J CLIN, V54, P8, DOI 10.3322/canjclin.54.1.8; Jemal A, 2005, CA-CANCER J CLIN, V55, P10, DOI 10.3322/canjclin.55.1.10; Jones SB, 2005, CANCER EPIDEM BIOMAR, V14, P596, DOI 10.1158/1055-9965.EPI-04-0398; Kageyama Y, 2007, RECENT PAT ANTI-CANC, V2, P203, DOI 10.2174/157489207782497172; Kong ANT, 2001, MUTAT RES-FUND MOL M, V480, P231, DOI 10.1016/S0027-5107(01)00182-8; Meeran SM, 2008, TOXICOL APPL PHARM, V229, P33, DOI 10.1016/j.taap.2007.12.027; Meeran SM, 2008, FRONT BIOSCI-LANDMRK, V13, P2191, DOI 10.2741/2834; Mitchell SH, 1999, CANCER RES, V59, P5892; Miyamoto H, 2005, MOL CARCINOGEN, V44, P1, DOI 10.1002/mc.20121; Ogryzko VV, 1998, CELL, V94, P35, DOI 10.1016/S0092-8674(00)81219-2; PARNES HL, 2004, J UROL 2, V171, P74; PARNES HL, 2004, J UROLOGY, V171, pS75; Parnes Howard L., 2004, Journal of Urology, V171, pS68, DOI 10.1097/01.ju.0000107220.64675.74; Ratan HL, 2002, UROL ONCOL, V7, P223, DOI 10.1016/S1078-1439(02)00194-1; Sartor O, 2002, UROLOGY, V60, P93; SCHERER WF, 1953, J EXP MED, V97, P695, DOI 10.1084/jem.97.5.695; Schoonen WM, 2005, INT J CANCER, V113, P133, DOI 10.1002/ijc.20528; Seeni A, 2008, ASIAN PAC J CANCER P, V9, P7; Shih HM, 2007, BIOCHEM SOC T, V35, P1397, DOI 10.1042/BST0351397; Signorelli P, 2005, J NUTR BIOCHEM, V16, P449, DOI 10.1016/j.jnutbio.2005.01.017; Thorne J, 2008, P NUTR SOC, V67, P115, DOI 10.1017/S0029665108006964; Wang TTY, 2008, CARCINOGENESIS, V29, P2001, DOI 10.1093/carcin/bgn131; Wang Y, 2002, J AGR FOOD CHEM, V50, P431, DOI 10.1021/jf010812u; WHITTEMORE AS, 1995, JNCI-J NATL CANCER I, V87, P652, DOI 10.1093/jnci/87.9.652; Yoon HG, 2006, MOL ENDOCRINOL, V20, P1048, DOI 10.1210/me.2005-0324; You M, 2008, AM J PHYSIOL-GASTR L, V294, pG892, DOI 10.1152/ajpgi.00575.2007; Yuan HQ, 2004, CANCER LETT, V213, P155, DOI 10.1016/j.canlet.2004.04.003; Zhang DZ, 2007, CELL RES, V17, P804, DOI 10.1038/cr.2007.72; Zhang DZ, 2005, MOL CELL BIOL, V25, P6404, DOI 10.1128/MCB.25.15.6404-6414.2005	53	30	30	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7398	10.1371/journal.pone.0007398	http://dx.doi.org/10.1371/journal.pone.0007398			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816598	Green Published, gold, Green Submitted			2022-12-27	WOS:000270594300014
J	Fort, A; Cordaillat, M; Thollon, C; Salazar, G; Mechaly, I; Villeneuve, N; Vilaine, JP; Richard, S; Virsolvy, A				Fort, Aurelie; Cordaillat, Magali; Thollon, Catherine; Salazar, Guillermo; Mechaly, Ilana; Villeneuve, Nicole; Vilaine, Jean-Paul; Richard, Sylvain; Virsolvy, Anne			New Insights in the Contribution of Voltage-Gated Na-v Channels to Rat Aorta Contraction	PLOS ONE			English	Article								Background: Despite increasing evidence for the presence of voltage-gated Na+ channels (Na-v) isoforms and measurements of Na-v channel currents with the patch-clamp technique in arterial myocytes, no information is available to date as to whether or not Na-v channels play a functional role in arteries. The aim of the present work was to look for a physiological role of Na-v channels in the control of rat aortic contraction. Methodology/Principal Findings: Na-v channels were detected in the aortic media by Western blot analysis and double immunofluorescence labeling for Na-v channels and smooth muscle a-actin using specific antibodies. In parallel, using real time RT-PCR, we identified three Na-v transcripts: Na(v)1.2, Na(v)1.3, and Na(v)1.5. Only the Na(v)1.2 isoform was found in the intact media and in freshly isolated myocytes excluding contamination by other cell types. Using the specific Na-v channel agonist veratridine and antagonist tetrodotoxin (TTX), we unmasked a contribution of these channels in the response to the depolarizing agent KCl on rat aortic isometric tension recorded from endothelium-denuded aortic rings. Experimental conditions excluded a contribution of Na-v channels from the perivascular sympathetic nerve terminals. Addition of low concentrations of KCl (2-10 mM), which induced moderate membrane depolarization (e. g., from -55.9 +/- 1.4 mV to -45.9 +/- 1.2 mV at 10 mmol/L as measured with microelectrodes), triggered a contraction potentiated by veratridine (100 mu M) and blocked by TTX (1 mu M). KB-R7943, an inhibitor of the reverse mode of the Na+/Ca2+ exchanger, mimicked the effect of TTX and had no additive effect in presence of TTX. Conclusions/Significance: These results define a new role for Na-v channels in arterial physiology, and suggest that the TTX-sensitive Na(v)1.2 isoform, together with the Na+/Ca2+ exchanger, contributes to the contractile response of aortic myocytes at physiological range of membrane depolarization.			Fort, A (corresponding author), Univ Montpellier 1 & 2, INSERM, U637, Montpellier, France.	sylvain.richard@inserm.fr	Petit, Aurelie/O-1731-2018; Richard, Sylvain/C-9695-2016; VIRSOLVY, Anne/E-4964-2016	Petit, Aurelie/0000-0002-9069-9868; VIRSOLVY, Anne/0000-0002-5819-3306; Richard, Sylvain/0000-0001-9460-6705				Baluchnejadmojarad T, 2004, VASC PHARMACOL, V40, P301, DOI 10.1016/j.vph.2004.02.003; Barger G, 1910, J PHYSIOL-LONDON, V41, P19; Berra-Romani R, 2005, AM J PHYSIOL-HEART C, V289, pH137, DOI 10.1152/ajpheart.01156.2004; Blaustein MP, 2009, HYPERTENSION, V53, P291, DOI 10.1161/HYPERTENSIONAHA.108.119974; Boccara G, 1999, CIRC RES, V85, P606, DOI 10.1161/01.RES.85.7.606; BODIN P, 1991, AM J PHYSIOL, V260, pC151, DOI 10.1152/ajpcell.1991.260.1.C151; Carrithers MD, 2009, J BIOL CHEM, V284, P8114, DOI 10.1074/jbc.M801892200; Catterall WA, 2003, PHARMACOL REV, V55, P575, DOI 10.1124/pr.55.4.7; Catterall WA, 1995, CARDIAC ELECTROPHYSI, P1; Choby C, 2000, PFLUG ARCH EUR J PHY, V440, P149, DOI 10.1007/s004240051032; Cordaillat M, 2007, AM J PHYSIOL-REG I, V292, pR1557, DOI 10.1152/ajpregu.00624.2006; Cox RH, 1998, J VASC RES, V35, P310, DOI 10.1159/000025600; DECKER N, 1984, N-S ARCH PHARMACOL, V326, P1, DOI 10.1007/BF00518771; DIGGES KG, 1983, EUR J PHARMACOL, V96, P95, DOI 10.1016/0014-2999(83)90533-2; Eatman D, 1998, EUR J PHARMACOL, V361, P207, DOI 10.1016/S0014-2999(98)00700-6; Fauaz G, 2000, BRIT J PHARMACOL, V131, P788, DOI 10.1038/sj.bjp.0703630; Hille B., 1992, IONIC CHANNELS EXCIT; Iwamoto T, 2004, NAT MED, V10, P1193, DOI 10.1038/nm1118; Iwamoto T, 2004, J PHARMACOL SCI, V96, P27, DOI 10.1254/jphs.FMJ04002X6; JAMES AF, 1995, AM J PHYSIOL-HEART C, V268, pH2358, DOI 10.1152/ajpheart.1995.268.6.H2358; Jo T, 2005, BIOCHEM BIOPH RES CO, V331, P1452, DOI 10.1016/j.bbrc.2005.04.062; Jo T, 2004, FEBS LETT, V567, P339, DOI 10.1016/j.febslet.2004.04.092; Krzemien DM, 2000, J COMP NEUROL, V420, P70; LEENEN FHH, 1992, J HYPERTENS, V10, P929; MACIA RA, 1984, N-S ARCH PHARMACOL, V325, P306, DOI 10.1007/BF00504373; Misra SN, 2008, EPILEPSIA, V49, P1535, DOI 10.1111/j.1528-1167.2008.01619.x; MURAMATSU I, 1987, BRIT J PHARMACOL, V91, P467, DOI 10.1111/j.1476-5381.1987.tb11238.x; Platoshyn O, 2005, PFLUG ARCH EUR J PHY, V451, P380, DOI 10.1007/s00424-005-1478-3; Quignard JF, 1997, CIRC RES, V80, P377, DOI 10.1161/01.res.0000435853.85322.af; Raina H, 2008, J PHYSIOL-LONDON, V586, P1669, DOI 10.1113/jphysiol.2007.150268; RICHARD S, 1992, BIOCHIM BIOPHYS ACTA, V1160, P95, DOI 10.1016/0167-4838(92)90042-C; Rush AM, 2005, J PHYSIOL-LONDON, V564, P803, DOI 10.1113/jphysiol.2005.083089; SHINJOH M, 1991, EUR J PHARMACOL, V205, P199; SHINJOH M, 1992, JPN J PHARM S2, V58; Thollon C, 1999, CIRC RES, V84, P371, DOI 10.1161/01.RES.84.4.371; VANHEEL B, 1994, J PHYSIOL-LONDON, V475, P277, DOI 10.1113/jphysiol.1994.sp020068; Vasconcelos F, 2005, COMP BIOCHEM PHYS C, V141, P85, DOI 10.1016/j.cca.2005.05.012; Vassort G, 2001, PHYSIOL REV, V81, P767, DOI 10.1152/physrev.2001.81.2.767; Zhang XF, 1999, BRIT J PHARMACOL, V127, P1388, DOI 10.1038/sj.bjp.0702661	39	15	15	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7360	10.1371/journal.pone.0007360	http://dx.doi.org/10.1371/journal.pone.0007360			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809503	Green Published, Green Submitted, gold			2022-12-27	WOS:000270594000014
J	Garren, M; Raymundo, L; Guest, J; Harvell, CD; Azam, F				Garren, Melissa; Raymundo, Laurie; Guest, James; Harvell, C. Drew; Azam, Farooq			Resilience of Coral-Associated Bacterial Communities Exposed to Fish Farm Effluent	PLOS ONE			English	Article							BLACK BAND DISEASE; RIBOSOMAL-RNA SEQUENCES; MICROBIAL-POPULATIONS; DIVIDING CELLS; ECOLOGY; REEFS; DIVERSITY; FREQUENCY; IMPACTS; TISSUES	Background: The coral holobiont includes the coral animal, algal symbionts, and associated microbial community. These microbes help maintain the holobiont homeostasis; thus, sustaining robust mutualistic microbial communities is a fundamental part of long-term coral reef survival. Coastal pollution is one major threat to reefs, and intensive fish farming is a rapidly growing source of this pollution. Methodology & Principal Findings: We investigated the susceptibility and resilience of the bacterial communities associated with a common reef-building coral, Porites cylindrica, to coastal pollution by performing a clonally replicated transplantation experiment in Bolinao, Philippines adjacent to intensive fish farming. Ten fragments from each of four colonies (total of 40 fragments) were followed for 22 days across five sites: a well-flushed reference site (the original fragment source); two sites with low exposure to milkfish (Chanos chanos) aquaculture effluent; and two sites with high exposure. Elevated levels of dissolved organic carbon (DOC), chlorophyll a, total heterotrophic and autotrophic bacteria abundance, virus like particle (VLP) abundances, and culturable Vibrio abundance characterized the high effluent sites. Based on 16S rRNA clone libraries and denaturing gradient gel electrophoresis (DGGE) analysis, we observed rapid, dramatic changes in the coral-associated bacterial communities within five days of high effluent exposure. The community composition on fragments at these high effluent sites shifted towards known human and coral pathogens (i.e. Arcobacter, Fusobacterium, and Desulfovibrio) without the host corals showing signs of disease. The communities shifted back towards their original composition by day 22 without reduction in effluent levels. Significance: This study reveals fish farms as a likely source of pathogens with the potential to proliferate on corals and an unexpected short-term resilience of coral-associated bacterial communities to eutrophication pressure. These data highlight a need for improved aquaculture practices that can achieve both sustainable industry goals and long-term coral reef survival.			Garren, M (corresponding author), Univ Calif San Diego, Scripps Inst Oceanog, Div Marine Biol Res, La Jolla, CA 92093 USA.	mgarren@ucsd.edu	Raymundo, Laurie/AAE-5230-2020; Guest, James/D-5179-2011; Bossier, Peter GM/A-8118-2008; Azam, Farooq/A-2306-2012	Guest, James/0000-0002-9714-9009; Bossier, Peter GM/0000-0002-6165-9111; 				Acinas SG, 2005, APPL ENVIRON MICROB, V71, P8966, DOI 10.1128/AEM.71.12.8966-8969.2005; Berkelmans R, 2006, P ROY SOC B-BIOL SCI, V273, P2305, DOI 10.1098/rspb.2006.3567; BIDLE KD, 1995, APPL ENVIRON MICROB, V61, P944, DOI 10.1128/AEM.61.3.944-952.1995; Bourne D, 2008, ISME J, V2, P350, DOI 10.1038/ismej.2007.112; Carpenter KE, 2008, SCIENCE, V321, P560, DOI 10.1126/science.1159196; Cooney RP, 2002, ENVIRON MICROBIOL, V4, P401, DOI 10.1046/j.1462-2920.2002.00308.x; Crump BC, 1999, APPL ENVIRON MICROB, V65, P3192; Fabricius KE, 2005, MAR POLLUT BULL, V50, P125, DOI 10.1016/j.marpolbul.2004.11.028; Frias-Lopez J, 2002, APPL ENVIRON MICROB, V68, P2214, DOI 10.1128/AEM.68.5.2214-2228.2002; Garren M, 2008, ENVIRON MICROBIOL, V10, P2299, DOI 10.1111/j.1462-2920.2008.01654.x; Geffen Y, 2005, MAR BIOL, V146, P931, DOI 10.1007/s00227-004-1505-5; Gochfeld DJ, 2008, MAR ECOL PROG SER, V362, P119, DOI 10.3354/meps07418; Graham NAJ, 2007, CONSERV BIOL, V21, P1291, DOI 10.1111/j.1523-1739.2007.00754.x; HAGSTROM A, 1979, APPL ENVIRON MICROB, V37, P805; Harvell D, 2007, OCEANOGRAPHY, V20, P172, DOI 10.5670/oceanog.2007.91; Holmer M, 2002, MAR POLLUT BULL, V44, P685, DOI 10.1016/S0025-326X(02)00048-6; Knowlton N, 2003, AM NAT, V162, pS51, DOI 10.1086/378684; Koren O, 2006, APPL ENVIRON MICROB, V72, P5254, DOI 10.1128/AEM.00554-06; Kvennefors ECE, 2008, DEV COMP IMMUNOL, V32, P1582, DOI 10.1016/j.dci.2008.05.010; LANE DJ, 1985, P NATL ACAD SCI USA, V82, P6955, DOI 10.1073/pnas.82.20.6955; Long RA, 2001, AQUAT MICROB ECOL, V26, P103, DOI 10.3354/ame026103; Mumby PJ, 2008, J APPL ECOL, V45, P854, DOI 10.1111/j.1365-2664.2008.01459.x; MUYZER G, 1993, APPL ENVIRON MICROB, V59, P695, DOI 10.1128/AEM.59.3.695-700.1993; Mydlarz LD, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001811; Nystrom M, 2008, CORAL REEFS, V27, P795, DOI 10.1007/s00338-008-0426-z; Palmer CV, 2008, P ROY SOC B-BIOL SCI, V275, P2687, DOI 10.1098/rspb.2008.0335; Pantos O, 2003, ENVIRON MICROBIOL, V5, P370, DOI 10.1046/j.1462-2920.2003.00427.x; Raymundo LJ, 2002, CORAL REEFS, V21, P260, DOI 10.1007/s00338-002-0237-6; Remily ER, 2006, MICROB ECOL, V51, P345, DOI 10.1007/s00248-006-9029-9; Richardson LL, 1998, TRENDS ECOL EVOL, V13, P438, DOI 10.1016/S0169-5347(98)01460-8; Ritchie KB, 1995, MOL MAR BIOL BIOTECH, V4, P345; Ritchie KB, 2006, MAR ECOL PROG SER, V322, P1, DOI 10.3354/meps322001; Rohwer F, 2001, CORAL REEFS, V20, P85; Rohwer F, 2002, MAR ECOL PROG SER, V243, P1, DOI 10.3354/meps243001; Rosenberg E, 2007, NAT REV MICROBIOL, V5, P355, DOI 10.1038/nrmicro1635; Rosenberg E, 2007, OCEANOGRAPHY, V20, P146, DOI 10.5670/oceanog.2007.60; Rowan R, 1997, NATURE, V388, P265, DOI 10.1038/40843; RYPIEN KL, ENV MICROBI IN PRESS; Sekar R, 2008, MAR ECOL PROG SER, V362, P85, DOI 10.3354/meps07496; Torreton JP, 1996, MICROB ECOL, V32, P185; Viehman S, 2006, DIS AQUAT ORGAN, V69, P119, DOI 10.3354/dao069119; Villanueva RD, 2005, MAR POLLUT BULL, V51, P580, DOI 10.1016/j.marpolbul.2005.04.033; Wang Q, 2007, APPL ENVIRON MICROB, V73, P5261, DOI 10.1128/AEM.00062-07; WEISBURG WG, 1991, J BACTERIOL, V173, P697, DOI 10.1128/JB.173.2.697-703.1991; Yu YN, 2006, BMC BIOINFORMATICS, V7, DOI 10.1186/1471-2105-7-57	45	84	84	2	37	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7319	10.1371/journal.pone.0007319	http://dx.doi.org/10.1371/journal.pone.0007319			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806190	Green Submitted, Green Published, gold			2022-12-27	WOS:000270593800020
J	Sissoko, MS; Dabo, A; Traore, H; Diallo, M; Traore, B; Konate, D; Niare, B; Diakite, M; Kamate, B; Traore, A; Bathily, A; Tapily, A; Toure, OB; Cauwenbergh, S; Jansen, HF; Doumbo, OK				Sissoko, Mahamadou S.; Dabo, Abdoulaye; Traore, Hamidou; Diallo, Mouctar; Traore, Boubacar; Konate, Drissa; Niare, Boubacar; Diakite, Moussa; Kamate, Bourama; Traore, Abdrahamane; Bathily, Aboudramane; Tapily, Amadou; Toure, Ousmane B.; Cauwenbergh, Sarah; Jansen, Herwig F.; Doumbo, Ogobara K.			Efficacy of Artesunate plus Sulfamethoxypyrazine/Pyrimethamine versus Praziquantel in the Treatment of Schistosoma haematobium in Children	PLOS ONE			English	Article							ARTEMETHER-LUMEFANTRINE; FALCIPARUM-MALARIA; MANSONI FOCUS; PYRIMETHAMINE; COMBINATION; INFECTION; COMMUNITY; PATHOLOGY; BLADDER; KIDNEY	Background: This study was conducted to determine the efficacy of the antimalarial artemisinin-based combination therapy (ACT) artesunate + sulfamethoxypyrazine/pyrimethamine (As+SMP), administered in doses used for malaria, to treat Schistosoma haematobium in school aged children. Methodology/Principal Findings: The study was conducted in Djalakorodji, a peri-urban area of Bamako, Mali, using a double blind setup in which As+SMP was compared with praziquantel (PZQ). Urine samples were examined for Schistosoma haematobium on days -1, 0, 28 and 29. Detection of haematuria, and haematological and biochemical exams were conducted on day 0 and day 28. Clinical exams were performed on days 0, 1, 2, and 28. A total of 800 children were included in the trial. The cure rate obtained without viability testing was 43.9% in the As+SMP group versus 53% in the PZQ group (Chi(2) = 6.44, p = 0.011). Egg reduction rates were 95.6% with PZQ in comparison with 92.8% with As+SMP, p = 0.096. The proportion of participants who experienced adverse events related to the medication was 0.5% (2/400) in As+SMP treated children compared to 2.3% (9/399) in the PZQ group (p = 0.033). Abdominal pain and vomiting were the most frequent adverse events in both treatment arms. All adverse events were categorized as mild. Conclusions/Significance: The study demonstrates that PZQ was more effective than As+SMP for treating Schistosoma haematobium. However, the safety and tolerability profile of As+SMP was similar to that seen with PZQ. Our findings suggest that further investigations seem justifiable to determine the dose/efficacy/safety pattern of As+SMP in the treatment of Schistosoma infections.			Sissoko, MS (corresponding author), Univ Bamako, Malaria Res & Training Ctr, Fac Med Pharm & Odontostomatol, Dept Epidemiol Parasit Dis, Bamako, Mali.	mssissoko@mrtcbko.org						Adam I, 2008, ANN TROP MED PARASIT, V102, P39, DOI 10.1179/136485908X252214; BERTE N, 1999, ACTA TROP, V72, P53; Boulanger D, 2007, T ROY SOC TROP MED H, V101, P113, DOI 10.1016/j.trstmh.2006.03.003; Brouwer KC, 2003, ACTA TROP, V85, P339, DOI 10.1016/S0001-706X(02)00262-0; CLERCQ D, 2002, ACTA TROP, V82, P61; Danso-Appiah A, 2009, PARASITOLOGY, V136, P1837, DOI 10.1017/S0031182009005939; DANSOAPPIAH A, 2008, COCHRANE DB SYST REV, V16; DOUMENGUE JP, 1987, ATLAS GLOBAL DISTRIB; Gryseels B, 2001, TROP MED INT HEALTH, V6, P864, DOI 10.1046/j.1365-3156.2001.00811.x; GRYSEELS B, 1987, T ROY SOC TROP MED H, V81, P641, DOI 10.1016/0035-9203(87)90439-1; Guisse F, 1997, AM J TROP MED HYG, V56, P511, DOI 10.4269/ajtmh.1997.56.511; Inyang-Etoh PC, 2004, ANN TROP MED PARASIT, V98, P491, DOI 10.1179/000349804225003460; Jaoko WG, 1996, E AFR MED J, V73, P499; Kabatereine NB, 2003, T ROY SOC TROP MED H, V97, P599, DOI 10.1016/S0035-9203(03)80044-5; Kimura Eisaku, 1992, Tropical Medicine, V34, P91; KIRSTEN E, 2005, AM J TROP MED HYG, V73, P1124; KLAYMAN DL, 1985, SCIENCE, V228, P1049, DOI 10.1126/science.3887571; Kouriba B, 2005, J INFECT DIS, V192, P2152, DOI 10.1086/498214; MCCARTHY JJ, 2001, INTERGOVERNMENTAL PA; Midzi N, 2008, T ROY SOC TROP MED H, V102, P759, DOI 10.1016/j.trstmh.2008.03.010; Nmorsi O. P. G., 2007, Southeast Asian Journal of Tropical Medicine and Public Health, V38, P32; Raso G, 2004, T ROY SOC TROP MED H, V98, P18, DOI 10.1016/S0035-9203(03)00003-8; Sagara I, 2006, AM J TROP MED HYG, V75, P630, DOI 10.4269/ajtmh.2006.75.630; Sagara I, 2009, MALARIA J, V8, DOI 10.1186/1475-2875-8-63; SHUHUA X, 1989, ANTIMICROB AGENTS CH, V33, P1557, DOI 10.1128/AAC.33.9.1557; SISSOKO K, 2005, THESIS; STELMA FF, 1995, AM J TROP MED HYG, V53, P167, DOI 10.4269/ajtmh.1995.53.167; Utzinger J, 2003, ANTIMICROB AGENTS CH, V47, P1487, DOI 10.1128/AAC.47.5.1487-1495.2003; Utzinger J, 2001, ACTA TROP, V80, P9, DOI 10.1016/S0001-706X(01)00138-3; Utzinger J, 2007, CURR OPIN INVEST DR, V8, P105; WEGNER DHG, 1984, ARZNEIMITTEL-FORSCH, V34-2, P1132; *WHO, 2005, WHOTDRSWG07; *WHO, 2002, WHOCDCCPEPVC20024; World Health Organization, 1993, WHO TECHN REP SER; Xiao SH, 2006, INT J PARASITOL, V36, P957, DOI 10.1016/j.ijpara.2006.03.007	35	33	38	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e6732	10.1371/journal.pone.0006732	http://dx.doi.org/10.1371/journal.pone.0006732			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802383	Green Published, Green Submitted, gold			2022-12-27	WOS:000270593600001
J	Roland, CL; Lynn, KD; Toombs, JE; Dineen, SP; Udugamasooriya, DG; Brekken, RA				Roland, Christina L.; Lynn, Kristi D.; Toombs, Jason E.; Dineen, Sean P.; Udugamasooriya, D. Gomika; Brekken, Rolf A.			Cytokine Levels Correlate with Immune Cell Infiltration after Anti-VEGF Therapy in Preclinical Mouse Models of Breast Cancer	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; REGULATORY T-CELLS; MAMMARY-CARCINOMA 4T1; TUMOR MICROENVIRONMENT; SUPPRESSOR-CELLS; INFLAMMATION; ANGIOGENESIS; EXPRESSION; MACROPHAGES; ANTAGONIST	The effect of blocking VEGF activity in solid tumors extends beyond inhibition of angiogenesis. However, no studies have compared the effectiveness of mechanistically different anti-VEGF inhibitors with respect to changes in tumor growth and alterations in the tumor microenvironment. In this study we use three distinct breast cancer models, a MDA-MB-231 xenograft model, a 4T1 syngenic model, and a transgenic model using MMTV-PyMT mice, to explore the effects of various anti-VEGF therapies on tumor vasculature, immune cell infiltration, and cytokine levels. Tumor vasculature and immune cell infiltration were evaluated using immunohistochemistry. Cytokine levels were evaluated using ELISA and electrochemiluminescence. We found that blocking the activation of VEGF receptor resulted in changes in intra-tumoral cytokine levels, specifically IL-1 beta, IL-6 and CXCL1. Modulation of the level these cytokines is important for controlling immune cell infiltration and ultimately tumor growth. Furthermore, we demonstrate that selective inhibition of VEGF binding to VEGFR2 with r84 is more effective at controlling tumor growth and inhibiting the infiltration of suppressive immune cells (MDSC, Treg, macrophages) while increasing the mature dendritic cell fraction than other anti-VEGF strategies. In addition, we found that changes in serum IL-1 beta and IL-6 levels correlated with response to therapy, identifying two possible biomarkers for assessing the effectiveness of anti-VEGF therapy in breast cancer patients.			Roland, CL (corresponding author), Univ Texas SW Med Ctr Dallas, Hamon Ctr Therapeut Oncol Res, Dept Surg, Div Surg Oncol, Dallas, TX 75390 USA.	rolf.brekken@utsouthwestern.edu	Dineen, Sean/M-3741-2013; Dineen, Sean/B-6222-2013; Dineen, Sean/K-1471-2015	Dineen, Sean/0000-0002-2012-2238	NCI NIH HHS [T32CA12433401] Funding Source: Medline	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Achen MG, 1998, P NATL ACAD SCI USA, V95, P548, DOI 10.1073/pnas.95.2.548; Amano K, 2004, J MOL CELL CARDIOL, V36, P469, DOI 10.1016/j.yjmcc.2004.01.006; Ancelin M, 2004, LAB INVEST, V84, P502, DOI 10.1038/labinvest.3700053; Aoki Y, 1999, BLOOD, V93, P4034, DOI 10.1182/blood.V93.12.4034.412k38_4034_4043; Armstrong DA, 2004, J LEUKOCYTE BIOL, V75, P641, DOI 10.1189/jlb.0803370; Astle JM, 2008, INT J PEPT RES THER, V14, P223, DOI 10.1007/s10989-008-9136-1; Balkwill F, 2001, LANCET, V357, P539, DOI 10.1016/S0140-6736(00)04046-0; Bingle L, 2002, J PATHOL, V196, P254, DOI 10.1002/path.1027; Bunt SK, 2006, J IMMUNOL, V176, P284, DOI 10.4049/jimmunol.176.1.284; Bunt SK, 2007, CANCER RES, V67, P10019, DOI 10.1158/0008-5472.CAN-07-2354; Cao YH, 1998, P NATL ACAD SCI USA, V95, P14389, DOI 10.1073/pnas.95.24.14389; Chen X, 2007, J IMMUNOL, V179, P154, DOI 10.4049/jimmunol.179.1.154; Clauss M, 1996, J BIOL CHEM, V271, P17629, DOI 10.1074/jbc.271.30.17629; Coussens LM, 2002, NATURE, V420, P860, DOI 10.1038/nature01322; Dikov MM, 2005, J IMMUNOL, V174, P215, DOI 10.4049/jimmunol.174.1.215; Dineen SP, 2008, CANCER RES, V68, P4340, DOI 10.1158/0008-5472.CAN-07-6705; Dupre SA, 2007, INT J EXP PATHOL, V88, P351, DOI 10.1111/j.1365-2613.2007.00539.x; duPre' SA, 2007, EXP MOL PATHOL, V82, P12, DOI 10.1016/j.yexmp.2006.06.007; Dvorak HF, 2002, J CLIN ONCOL, V20, P4368, DOI 10.1200/JCO.2002.10.088; Ellis LM, 2008, NAT REV CANCER, V8, P579, DOI 10.1038/nrc2403; Feng G, 2008, TRANSPLANTATION, V86, P578, DOI 10.1097/TP.0b013e3181806a60; FOLKMAN J, 1995, NAT MED, V1, P27, DOI 10.1038/nm0195-27; Folkman J, 2007, NAT REV DRUG DISCOV, V6, P273, DOI 10.1038/nrd2115; Gabrilovich DI, 2001, J IMMUNOL, V166, P5398, DOI 10.4049/jimmunol.166.9.5398; Gabrilovich DI, 2009, NAT REV IMMUNOL, V9, P162, DOI 10.1038/nri2506; GUY CT, 1992, MOL CELL BIOL, V12, P954, DOI 10.1128/MCB.12.3.954; Hanahan D, 2000, CELL, V100, P57, DOI 10.1016/S0092-8674(00)81683-9; Huang YH, 2007, BLOOD, V110, P624, DOI 10.1182/blood-2007-01-065714; Hurwitz H, 2004, NEW ENGL J MED, V350, P2335, DOI 10.1056/NEJMoa032691; Iwamoto M, 2003, INT J CANCER, V104, P92, DOI 10.1002/ijc.10915; Karlen Y, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-131; Ko JS, 2009, CLIN CANCER RES, V15, P2148, DOI 10.1158/1078-0432.CCR-08-1332; Konecny GE, 2004, CLIN CANCER RES, V10, P1706, DOI 10.1158/1078-0432.CCR-0951-3; Lacouture ME, 2008, ONCOLOGIST, V13, P1001, DOI 10.1634/theoncologist.2008-0131; Linehan DC, 2005, IMMUNOL RES, V32, P155, DOI 10.1385/IR:32:1-3:155; Liyanage UK, 2002, J IMMUNOL, V169, P2756, DOI 10.4049/jimmunol.169.5.2756; MANTOVANI A, 1992, FASEB J, V6, P2591, DOI 10.1096/fasebj.6.8.1592209; Maruyama K, 1999, J MOL CELL CARDIOL, V31, P607, DOI 10.1006/jmcc.1998.0895; Miller K, 2007, NEW ENGL J MED, V357, P2666, DOI 10.1056/NEJMoa072113; Murdoch C, 2008, NAT REV CANCER, V8, P618, DOI 10.1038/nrc2444; Nakao S, 2005, J CLIN INVEST, V115, P2979, DOI 10.1172/JCI23298; Ozao-Choy J, 2009, CANCER RES, V69, P2514, DOI 10.1158/0008-5472.CAN-08-4709; Pahler J, 2008, NEOPLASIA, V10, P329, DOI 10.1593/neo.07871; Pollard JW, 2004, NAT REV CANCER, V4, P71, DOI 10.1038/nrc1256; Ran S, 2003, NEOPLASIA, V5, P297, DOI 10.1016/S1476-5586(03)80023-4; Roland CL, 2009, MOL CANCER THER, V8, P1761, DOI 10.1158/1535-7163.MCT-09-0280; Roskoski R, 2007, CRIT REV ONCOL HEMAT, V62, P179, DOI 10.1016/j.critrevonc.2007.01.006; Salnikov AV, 2006, INT J CANCER, V119, P2795, DOI 10.1002/ijc.22217; Serafini P, 2004, CANCER IMMUNOL IMMUN, V53, P64, DOI 10.1007/s00262-003-0443-2; Shin JY, 2009, CELL IMMUNOL, V256, P72, DOI 10.1016/j.cellimm.2009.01.006; Tsakiri N, 2008, MOL CELL NEUROSCI, V38, P259, DOI 10.1016/j.mcn.2008.02.015; Udugamasooriya DG, 2008, BIOORG MED CHEM LETT, V18, P5892, DOI 10.1016/j.bmcl.2008.07.023; Udugamasooriya DG, 2008, J AM CHEM SOC, V130, P5744, DOI 10.1021/ja711193x; Udugamasooriya DG, 2008, BIOORGAN MED CHEM, V16, P6338, DOI 10.1016/j.bmc.2008.05.015; Vakkila J, 2004, NAT REV IMMUNOL, V4, P641, DOI 10.1038/nri1415; Whitehurst B, 2007, INT J CANCER, V121, P2181, DOI 10.1002/ijc.22937; Wilhelm SM, 2008, MOL CANCER THER, V7, P3129, DOI 10.1158/1535-7163.MCT-08-0013; Zhang Wei, 2002, Angiogenesis, V5, P35, DOI 10.1023/A:1021540120521; Zheng SG, 2007, J IMMUNOL, V178, P2018, DOI 10.4049/jimmunol.178.4.2018	59	143	150	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2009	4	11							e7669	10.1371/journal.pone.0007669	http://dx.doi.org/10.1371/journal.pone.0007669			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RY	19888452	gold, Green Submitted, Green Published			2022-12-27	WOS:000271414500005
J	Zhu, DM; Fang, JS; Li, YX; Zhang, J				Zhu, Dongmei; Fang, Junshun; Li, Yanxin; Zhang, Jian			Mbd3, a Component of NuRD/Mi-2 Complex, Helps Maintain Pluripotency of Mouse Embryonic Stem Cells by Repressing Trophectoderm Differentiation	PLOS ONE			English	Article							CPG-BINDING DOMAINS; HISTONE DEACETYLASE; TRANSCRIPTIONAL REGULATION; DEVELOPMENTAL REGULATORS; CHROMATIN-STRUCTURE; GENE-EXPRESSION; SELF-RENEWAL; NANOG; NURD; ACETYLATION	Embryonic stem cells (ES cells) can differentiate into cells derived from all three germ layers and extraembryonic tissues. While transcription factors such as, Oct4 and Nanog are well known for their requirements for undifferentiated ES cell growth, mechanisms of epigenetic repression of germ layer specific differentiation in ES cells are not well understood. Here, we investigate functions of Mbd3, a component of nucleosome remodeling and histone deacetylation complex (NuRD/Mi-2) in mouse ES cells. We find that compared to wild type ES cells, Mbd3 knockdown cells show elevated RNA expression of trophectoderm markers, including Cdx2, Eomesodermin, and Hand1. In parallel, these cells show an increased acetylation level of histone 3 in promoters of the respective genes, suggesting Mbd3 plays a role in repression of these genes in undifferentiated ES cells. However, these changes are not sufficient for definitive differentiation to trophectoderm (TE) in chimeric embryos. When further cultured in ES medium without LIF or in trophoblast stem (TS) cell medium, Mbd3 knockdown cells differentiate into TE cells, which express Cdx2 and, at later stages, trophoblast lineage specific marker Cadherin 3. These results suggest that Mbd3 helps restrict ES cells from differentiating towards the trophectoderm lineage and is an important epigenetic player in maintaining full pluripotency of mouse ES cells.			Zhu, DM (corresponding author), Chinese Acad Sci, Inst Genet & Dev Biol, Lab Mol & Dev Biol, Beijing, Peoples R China.	jianzhang84@genetics.ac.cn						BEDDINGTON RSP, 1989, DEVELOPMENT, V105, P733; Bernstein BE, 2006, CELL, V125, P315, DOI 10.1016/j.cell.2006.02.041; Bird AP, 1999, CELL, V99, P451, DOI 10.1016/S0092-8674(00)81532-9; Boyer LA, 2006, NATURE, V441, P349, DOI 10.1038/nature04733; Chambers I, 2003, CELL, V113, P643, DOI 10.1016/S0092-8674(03)00392-1; Chambers I, 2007, NATURE, V450, P1230, DOI 10.1038/nature06403; Chew JL, 2005, MOL CELL BIOL, V25, P6031, DOI 10.1128/MCB.25.14.6031-6046.2005; Grunstein M, 1997, NATURE, V389, P349, DOI 10.1038/38664; Gu PL, 2006, MOL CELL BIOL, V26, P9471, DOI 10.1128/MCB.00898-06; Hattori N, 2004, J BIOL CHEM, V279, P17063, DOI 10.1074/jbc.M309002200; Hendrich B, 1998, MOL CELL BIOL, V18, P6538, DOI 10.1128/MCB.18.11.6538; Hendrich B, 2001, GENE DEV, V15, P710, DOI 10.1101/gad.194101; Hendrich B, 2000, CURR TOP MICROBIOL, V249, P55; HOGAN B, 1996, MANIPULATING MOUSE E; Ivanova N, 2006, NATURE, V442, P533, DOI 10.1038/nature04915; Kaji K, 2006, NAT CELL BIOL, V8, P285, DOI 10.1038/ncb1372; Kaji K, 2007, DEVELOPMENT, V134, P1123, DOI 10.1242/dev.02802; Keller G, 2005, GENE DEV, V19, P1129, DOI 10.1101/gad.1303605; KELLER GM, 1995, CURR OPIN CELL BIOL, V7, P862, DOI 10.1016/0955-0674(95)80071-9; Koutsourakis M, 1999, DEVELOPMENT, V126, P723; Kouzarides T, 1999, CURR OPIN GENET DEV, V9, P40, DOI 10.1016/S0959-437X(99)80006-9; Lee TI, 2006, CELL, V125, P301, DOI 10.1016/j.cell.2006.02.043; Li E, 2002, NAT REV GENET, V3, P662, DOI 10.1038/nrg887; Li JW, 2002, GENE DEV, V16, P687, DOI 10.1101/gad.962502; Loh YH, 2006, NAT GENET, V38, P431, DOI 10.1038/ng1760; Mitsui K, 2003, CELL, V113, P631, DOI 10.1016/S0092-8674(03)00393-3; Nichols J, 1998, CELL, V95, P379, DOI 10.1016/S0092-8674(00)81769-9; Nightingale KP, 2006, CURR OPIN GENET DEV, V16, P125, DOI 10.1016/j.gde.2006.02.015; Niwa H, 2000, NAT GENET, V24, P372, DOI 10.1038/74199; Niwa H, 2005, CELL, V123, P917, DOI 10.1016/j.cell.2005.08.040; Niwa H, 2007, DEVELOPMENT, V134, P635, DOI 10.1242/dev.02787; Saburi S, 1997, DIFFERENTIATION, V62, P1, DOI 10.1046/j.1432-0436.1997.6210001.x; Sambrook J., 2001, MOL CLONING LAB MANU; Santos F, 2002, DEV BIOL, V241, P172, DOI 10.1006/dbio.2001.0501; SCHALL TJ, 1990, CELL, V61, P361, DOI 10.1016/0092-8674(90)90816-W; SMITH AG, 1988, NATURE, V336, P688, DOI 10.1038/336688a0; Soprano DR, 2007, VITAM HORM, V75, P69, DOI 10.1016/S0083-6729(06)75003-8; Spivakov M, 2007, NAT REV GENET, V8, P263, DOI 10.1038/nrg2046; Struhl K, 1998, GENE DEV, V12, P599, DOI 10.1101/gad.12.5.599; Strumpf D, 2005, DEVELOPMENT, V132, P2093, DOI 10.1242/dev.01801; Surani MA, 2007, CELL, V128, P747, DOI 10.1016/j.cell.2007.02.010; Tanaka S, 1998, SCIENCE, V282, P2072, DOI 10.1126/science.282.5396.2072; Tolkunova E, 2006, STEM CELLS, V24, P139, DOI 10.1634/stemcells.2005-0240; Tong JK, 1998, NATURE, V395, P917, DOI 10.1038/27699; TURNER BM, 1991, J CELL SCI, V99, P13; Velkey JM, 2003, GENESIS, V37, P18, DOI 10.1002/gene.10218; Wade PA, 1998, CURR BIOL, V8, P843, DOI 10.1016/S0960-9822(98)70328-8; Wang JL, 2006, NATURE, V444, P364, DOI 10.1038/nature05284; Wang XW, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng154; Wobus AM, 2005, PHYSIOL REV, V85, P635, DOI 10.1152/physrev.00054.2003; Xue YT, 1998, MOL CELL, V2, P851, DOI 10.1016/S1097-2765(00)80299-3; Zhang JQ, 2006, NAT CELL BIOL, V8, P1114, DOI 10.1038/ncb1481; Zhang Y, 1999, GENE DEV, V13, P1924, DOI 10.1101/gad.13.15.1924; Zhang Y, 1998, CELL, V95, P279, DOI 10.1016/S0092-8674(00)81758-4	54	38	44	1	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2009	4	11							e7684	10.1371/journal.pone.0007684	http://dx.doi.org/10.1371/journal.pone.0007684			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RY	19888462	gold, Green Published, Green Submitted			2022-12-27	WOS:000271414500007
J	Grimaldi, A; Banfi, S; Gerosa, L; Tettamanti, G; Noonan, DM; Valvassori, R; de Eguileor, M				Grimaldi, Annalisa; Banfi, Serena; Gerosa, Laura; Tettamanti, Gianluca; Noonan, Douglas M.; Valvassori, Roberto; de Eguileor, Magda			Identification, Isolation and Expansion of Myoendothelial Cells Involved in Leech Muscle Regeneration	PLOS ONE			English	Article							ENDOTHELIAL GROWTH-FACTOR; STEM-CELLS; PROGENITOR CELLS; VEGF; DIFFERENTIATION	Adult skeletal muscle in vertebrates contains myoendothelial cells that express both myogenic and endothelial markers, and which are able to differentiate into myogenic cells to contribute to muscle regeneration. In spite of intensive research efforts, numerous questions remain regarding the role of cytokine signalling on myoendothelial cell differentiation and muscle regeneration. Here we used Hirudo medicinalis (Annelid, leech) as an emerging new model to study myoendothelial cells and muscle regeneration. Although the leech has relative anatomical simplicity, it shows a striking similarity with vertebrate responses and is a reliable model for studying a variety of basic events, such as tissue repair. Double immunohistochemical analysis were used to characterize myoendothelial cells in leeches and, by injecting in vivo the matrigel biopolymer supplemented with the cytokine Vascular Endothelial Growth Factor (VEGF), we were able to isolate this specific cell population expressing myogenic and endothelial markers. We then evaluated the effect of VEGF on these cells in vitro. Our data indicate that, similar to that proposed for vertebrates, myoendothelial cells of the leech directly participate in myogenesis both in vivo and in vitro, and that VEGF secretion is involved in the recruitment and expansion of these muscle progenitor cells.			Grimaldi, A (corresponding author), Univ Insubria, Dept Biotechnol & Mol Sci, Varese, Italy.	annalisa.grimaldi@uninsubria.it	Noonan, Douglas M/A-8620-2010; Tettamanti, Gianluca/E-5465-2012; Tettamanti, Gianluca/L-8748-2019	Noonan, Douglas M/0000-0001-8058-0719; Tettamanti, Gianluca/0000-0002-0665-828X; Tettamanti, Gianluca/0000-0002-0665-828X; Grimaldi, Annalisa/0000-0002-9258-7595	Associazione Italiana per la Ricerca sul Cancro Funding Source: Custom	Associazione Italiana per la Ricerca sul Cancro(Fondazione AIRC per la ricerca sul cancro)		Arsic N, 2004, MOL THER, V10, P844, DOI 10.1016/j.ymthe.2004.08.007; Asakura A, 2003, TRENDS CARDIOVAS MED, V13, P123, DOI 10.1016/S1050-1738(03)00024-0; Beauchamp JR, 2000, J CELL BIOL, V151, P1221, DOI 10.1083/jcb.151.6.1221; CHOI J, 1990, P NATL ACAD SCI USA, V87, P7988, DOI 10.1073/pnas.87.20.7988; de Eguileor M, 2000, TISSUE CELL, V32, P437; De Eguileor M., 2001, Angiogenesis, V4, P299, DOI 10.1023/A:1016025803370; De Eguileor M, 1999, J MICROSC-OXFORD, V196, P6, DOI 10.1046/j.1365-2818.1999.00600.x; De Eguileor M, 1998, J EXP ZOOL, V281, P171, DOI 10.1002/(SICI)1097-010X(19980615)281:3&lt;171::AID-JEZ3&gt;3.0.CO;2-K; FALINI B, 1993, AM J PATHOL, V142, P1359; Gerber HP, 2003, J MOL MED, V81, P20, DOI 10.1007/s00109-002-0397-4; Germani A, 2003, AM J PATHOL, V163, P1417, DOI 10.1016/S0002-9440(10)63499-2; Grimaldi A., 2004, ISJ, V1, P38; Grimaldi A, 2006, CURR PHARM DESIGN, V12, P3033, DOI 10.2174/138161206777947443; Grimaldi A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001910; Hatzopoulos AK, 1998, DEVELOPMENT, V125, P1457; HUGUET G, 1994, J EXP ZOOL, V269, P23, DOI 10.1002/jez.1402690104; Huguet G, 1996, J EXP ZOOL, V275, P308, DOI 10.1002/(SICI)1097-010X(19960701)275:4&lt;308::AID-JEZ9&gt;3.0.CO;2-T; HYNES RO, 1987, CELL, V48, P549, DOI 10.1016/0092-8674(87)90233-9; Jackson KA, 1999, P NATL ACAD SCI USA, V96, P14482, DOI 10.1073/pnas.96.25.14482; Kalka C, 2000, CIRC RES, V86, P1198, DOI 10.1161/01.RES.86.12.1198; KLEINMAN HK, 1986, BIOCHEMISTRY-US, V25, P312, DOI 10.1021/bi00350a005; KOCH AE, 1994, J IMMUNOL, V152, P4149; Krause DS, 2001, CELL, V105, P369, DOI 10.1016/S0092-8674(01)00328-2; LAEMMLI UK, 1970, NATURE, V227, P680, DOI 10.1038/227680a0; Lagasse E, 2001, IMMUNITY, V14, P425, DOI 10.1016/S1074-7613(01)00123-6; Le Grand F, 2004, EXP CELL RES, V301, P232, DOI 10.1016/j.yexcr.2004.07.028; Lee TH, 2006, INT J CANCER, V119, P839, DOI 10.1002/ijc.21916; LEGORE RS, 1971, J INVERTEBR PATHOL, V18, P40, DOI 10.1016/0022-2011(91)90006-C; MAURO A, 1961, J BIOPHYS BIOCHEM CY, V9, P493, DOI 10.1083/jcb.9.2.493; Neufeld G, 1999, FASEB J, V13, P9, DOI 10.1096/fasebj.13.1.9; Pesce M, 2003, CIRC RES, V93, pE51, DOI 10.1161/01.RES.0000090624.04507.45; SCHULTZ E, 1994, REV PHYSIOL BIOCH P, V123, P213, DOI 10.1007/BFb0030904; Seale P, 2001, DEV CELL, V1, P333, DOI 10.1016/S1534-5807(01)00049-1; Tamaki T, 2002, J CELL BIOL, V157, P571, DOI 10.1083/jcb.200112106; Tettamanti G, 2003, CYTOKINE, V22, P168, DOI 10.1016/S1043-4666(03)00176-5; Tettamanti G, 2003, TISSUE CELL, V35, P199, DOI 10.1016/S0040-8166(03)00027-2; Towbin H, 1992, Biotechnology, V24, P145; VOYTA JC, 1984, J CELL BIOL, V99, P2034, DOI 10.1083/jcb.99.6.2034; Wang SS, 2008, P NATL ACAD SCI USA, V105, P7738, DOI 10.1073/pnas.0802857105; Zhang SJ, 2006, CELL RES, V16, P577, DOI 10.1038/sj.cr.7310075; Zheng B, 2007, NAT BIOTECHNOL, V25, P1025, DOI 10.1038/nbt1334	41	12	12	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2009	4	10							e7652	10.1371/journal.pone.0007652	http://dx.doi.org/10.1371/journal.pone.0007652			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RW	19876402	gold, Green Submitted, Green Published			2022-12-27	WOS:000271414300010
J	Chapron, G; Wielgus, R; Quenette, PY; Camarra, JJ				Chapron, Guillaume; Wielgus, Robert; Quenette, Pierre-Yves; Camarra, Jean-Jacques			Diagnosing Mechanisms of Decline and Planning for Recovery of an Endangered Brown Bear (Ursus arctos) Population	PLOS ONE			English	Article							SEXUALLY SELECTED INFANTICIDE; ADULT MALE MORTALITY; GRIZZLY BEARS; REINTRODUCTION; CONSERVATION; SEGREGATION; STRATEGIES; TELEMETRY; CARNIVORE; SURVIVAL	Background: The usual paradigm for translocations is that they should not take place in declining populations until the causes(s) of the decline has been reversed. This approach sounds intuitive, but may not apply in cases where population decline is caused by behavioral or demographic mechanisms that could only be reversed by translocation itself. Methodology/Principal Findings: We analyzed a decade of field data for Pyrenean brown bears (Ursus arctos) from two small populations: the growing Central population - created from a previous translocation and the endemic Western population - believed to be declining because of excessive human-caused mortality. We found that adult survival rates for both populations were as high as those observed for most other protected brown bear populations. However, the Western population had much lower reproductive success than the Central population. Adult breeding sex ratio was male-biased in the Western population and female-biased in the Central population. Our results exclude high anthropogenic mortality as a cause for population decline in the West but support low reproductive success, which could result from sexually selected infanticide induced by a male-biased adult sex ratio or inbreeding depression. Using a stochastic demographic model to compute how many bears should be released to ensure viability, we show that the Western population could recover provided adequate numbers of new females are translocated. Conclusions/Significance: We suggest that a translocation could take place, even if the decline has not yet been reversed, if the translocation itself removes the biological mechanisms behind the decline. In our case, the ultimate cause of low reproductive success remained unknown ( infanticide or inbreeding), but our proposed translocation strategies should eliminate the proximate cause ( low reproductive success) of the decline and ensure population recovery and viability.			Chapron, G (corresponding author), Swedish Univ Agr Sci, Grimso Wildlife Res Stn, Dept Ecol, Riddarhyttan, Sweden.	gchapron@carnivoreconservation.org						Arquilliere A, 1998, ORYX, V32, P8, DOI 10.1046/j.1365-3008.1998.00007.x; Barnes VG, 1998, URSUS-SERIES, V10, P1; Bellemain E, 2006, P ROY SOC B-BIOL SCI, V273, P283, DOI 10.1098/rspb.2005.3331; Bellemain E, 2006, ETHOLOGY, V112, P238, DOI 10.1111/j.1439-0310.2006.01152.x; Breitenmoser U, 2001, CONSERV BIOL SER, V5, P241; CAMARRA JJ, 1995, M BROWN BEAR EC LIFE; CAMARRA JJ, 1992, 9 INT BEAR C GREN; CAMARRA JJ, 1992, MONITORING TECHNIQUE; CAMARRA JJ, 1999, B MENSUEL ONCFS, V249, P24; CASE JT, 2000, ILLUSTRATED GUIDE TH; Caswell, 2000, MATRIX POPULATION MO; CAUSSIMONT G, 2002, ETUDE CONSERVATION C, P30; CETTO E, 2005, 16 INT C BEAR RES MA; Chapron G, 2003, CR BIOL, V326, pS174, DOI 10.1016/S1631-0691(03)00055-6; CHASSIN N, 2003, ASPECTS JURIDIQUES C; Couturier M.A.J., 1954, OURS BRUN; *DIREN MID PYR, 2001, B4320096518 DIREN MI; Garshelis DL, 2005, J WILDLIFE MANAGE, V69, P277, DOI 10.2193/0022-541X(2005)069<0277:GBDIAA>2.0.CO;2; Graf JA, 2006, ANIM CONSERV, V9, P398, DOI 10.1111/j.1469-1795.2006.00048.x; HEISEY DM, 1985, J WILDLIFE MANAGE, V49, P668, DOI 10.2307/3801692; ILANY G, 1991, MASA ACHER, V20, P54; ILANY G, 1991, MASA ACHER, V19, P45; IUCN/SSC Re-introduction Specialist Group, 1998, IUCN GUID RE INTR; KAPLAN EL, 1958, J AM STAT ASSOC, V53, P457, DOI 10.2307/2281868; Laikre L, 1996, BIOL CONSERV, V76, P69, DOI 10.1016/0006-3207(95)00084-4; Lande R., 2003, OXFORD SERIES ECOLOG; Legendre S, 1995, J APPL STAT, V22, P817, DOI 10.1080/02664769524649; LEPELTIER S, 2005, COMMUNICATION OFFICI; McCallum H., 2000, METH ECOL; McLellan BN, 2005, URSUS, V16, P141, DOI 10.2192/1537-6176(2005)016[0141:SSIIGB]2.0.CO;2; *MEDD, 2005, RENF POP OURS BRUNS; Miller B, 1999, ANIM CONSERV, V2, P59, DOI 10.1111/j.1469-1795.1999.tb00049.x; Morris WF, 2002, QUANTITATIVE CONSERV; Paetkau D, 1998, MOL ECOL, V7, P1283, DOI 10.1046/j.1365-294x.1998.00440.x; POLLOCK KH, 1989, J WILDLIFE MANAGE, V53, P7, DOI 10.2307/3801296; Quenette PY, 2001, URSUS-SERIES, V12, P115; QUENETTE PY, 2000, BILAN SCI TECHNIQUE; REICHMANN A, 1990, MORTALITY 5 CUBS BOR; Saether BE, 1998, OIKOS, V83, P403, DOI 10.2307/3546856; Schwartz Charles C., 2003, Ursus (Knoxville), V14, P109; Seddon PJ, 2007, CONSERV BIOL, V21, P303, DOI 10.1111/j.1523-1739.2006.00627.x; SKALSKI RJ, 2005, WILDLIFE DEMOGRAPHY; Stoen OG, 2006, OECOLOGIA, V148, P356, DOI 10.1007/s00442-006-0384-5; Swenson JE, 2001, URSUS-SERIES, V12, P81; Swenson JE, 2001, URSUS-SERIES, V12, P69; Swenson JE, 2003, ANIMAL BEHAVIOR AND WILDLIFE CONSERVATION, P171; Swenson JE, 1998, J ANIM ECOL, V67, P819, DOI 10.1046/j.1365-2656.1998.00248.x; Swenson JE, 1997, NATURE, V386, P450, DOI 10.1038/386450a0; Taberlet P, 1997, MOL ECOL, V6, P869, DOI 10.1111/j.1365-294X.1997.tb00141.x; Tufto J, 1999, P ROY SOC B-BIOL SCI, V266, P961, DOI 10.1098/rspb.1999.0730; Wielgus RB, 2001, BIOL CONSERV, V98, P293, DOI 10.1016/S0006-3207(00)00168-3; Wielgus RB, 2000, BIOL CONSERV, V93, P145, DOI 10.1016/S0006-3207(99)00152-4; Wielgus RB, 2002, BIOL CONSERV, V106, P381, DOI 10.1016/S0006-3207(01)00265-8; WIELGUS RB, 1994, BIOL CONSERV, V67, P161, DOI 10.1016/0006-3207(94)90362-X; WIELGUS RB, 1995, J WILDLIFE MANAGE, V59, P552, DOI 10.2307/3802462; WIELGUS RB, 1994, J WILDLIFE MANAGE, V58, P405, DOI 10.2307/3809310	56	19	20	0	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7568	10.1371/journal.pone.0007568	http://dx.doi.org/10.1371/journal.pone.0007568			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862319	gold, Green Published			2022-12-27	WOS:000271194600004
J	Young, LC; Vanderlip, C; Duffy, DC; Afanasyev, V; Shaffer, SA				Young, Lindsay C.; Vanderlip, Cynthia; Duffy, David C.; Afanasyev, Vsevolod; Shaffer, Scott A.			Bringing Home the Trash: Do Colony-Based Differences in Foraging Distribution Lead to Increased Plastic Ingestion in Laysan Albatrosses?	PLOS ONE			English	Article							DEBRIS; ACCUMULATION; NORTH; SHEARWATERS; GEOLOCATION; STRATEGY	When searching for prey, animals should maximize energetic gain, while minimizing energy expenditure by altering their movements relative to prey availability. However, with increasing amounts of marine debris, what once may have been 'optimal' foraging strategies for top marine predators, are leading to sub-optimal diets comprised in large part of plastic. Indeed, the highly vagile Laysan albatross (Phoebastria immutabilis) which forages throughout the North Pacific, are well known for their tendency to ingest plastic. Here we examine whether Laysan albatrosses nesting on Kure Atoll and Oahu Island, 2,150 km apart, experience different levels of plastic ingestion. Twenty two geolocators were deployed on breeding adults for up to two years. Regurgitated boluses of undigestable material were also collected from chicks at each site to compare the amount of plastic vs. natural foods. Chicks from Kure Atoll were fed almost ten times the amount of plastic compared to chicks from Oahu despite boluses from both colonies having similar amounts of natural food. Tracking data indicated that adults from either colony did not have core overlapping distributions during the early half of the breeding period and that adults from Kure had a greater overlap with the putative range of the Western Garbage Patch corroborating our observation of higher plastic loads at this colony. At-sea distributions also varied throughout the year suggesting that Laysan albatrosses either adjusted their foraging behavior according to constraints on time away from the nest or to variation in resources. However, in the non-breeding season, distributional overlap was greater indicating that the energy required to reach the foraging grounds was less important than the total energy available. These results demonstrate how a marine predator that is not dispersal limited alters its foraging strategy throughout the reproductive cycle to maximize energetic gain and how this has led to differences in plastic ingestion.			Young, LC (corresponding author), Univ Hawaii, Dept Zool, Ecol Evolut & Conservat Biol Program, Honolulu, HI 96822 USA.	lindsay@pacificrimconservation.com	Shaffer, Scott A/D-5015-2009	Shaffer, Scott A/0000-0002-7751-5059; Duffy, David/0000-0002-0498-9632	NERC [bas010011] Funding Source: UKRI; Natural Environment Research Council [bas010011] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		ASHMOLE N. P., 1963, IBIS, V103b, P458, DOI 10.1111/j.1474-919X.1963.tb06766.x; Auman HJ, 1998, ALBATROSS: BIOLOGY AND CONSERVATION, P239; Barnes DKA, 2009, PHILOS T R SOC B, V364, P1985, DOI 10.1098/rstb.2008.0205; Dameron OJ, 2007, MAR POLLUT BULL, V54, P423, DOI 10.1016/j.marpolbul.2006.11.019; Fernandez P, 2001, J ZOOL, V254, P391, DOI 10.1017/S0952836901000899; Fritz H, 2003, P ROY SOC B-BIOL SCI, V270, P1143, DOI 10.1098/rspb.2003.2350; FRY DM, 1987, MAR POLLUT BULL, V18, P339, DOI 10.1016/S0025-326X(87)80022-X; Harrison CS., 1990, SEABIRDS HAWAII; Hasunuma K., 1978, J OCEANOGR, V34, P160, DOI DOI 10.1007/BF02108654; Hill Roger D., 1994, P227; Hyrenbach KD, 2002, MAR ECOL PROG SER, V233, P283, DOI 10.3354/meps233283; KAPPES M, 2009, THESIS U CALIFORNIA; KAPPES MA, 2009, PROG OCEANO IN PRESS; KUBOTA M, 1994, J PHYS OCEANOGR, V24, P1059, DOI 10.1175/1520-0485(1994)024<1059:AMFTAO>2.0.CO;2; Matsumura S., 1997, MARINE DEBRIS SOURCE, P15, DOI [10.1007/978-1-4613-8486-1_3, DOI 10.1007/978-1-4613-8486-1_3]; Naughton MB, 2007, CONSERVATION ACTION; Orians G.H., 1979, P155; Phillips RA, 2004, MAR ECOL PROG SER, V266, P265, DOI 10.3354/meps266265; Pichel WG, 2007, MAR POLLUT BULL, V54, P1207, DOI 10.1016/j.marpolbul.2007.04.010; Pinaud D, 2005, J ANIM ECOL, V74, P852, DOI 10.1111/j.1365-2656.2005.00984.x; Pinaud D, 2007, J ANIM ECOL, V76, P9, DOI 10.1111/j.1365-2656.2006.01186.x; Polovina JJ, 2001, PROG OCEANOGR, V49, P469, DOI 10.1016/S0079-6611(01)00036-2; Robards Martin D., 1997, P71; Ryan PG, 2009, PHILOS T R SOC B, V364, P1999, DOI 10.1098/rstb.2008.0207; SCHOENER TW, 1979, AM NAT, V114, P902, DOI 10.1086/283537; SCHREIBER BA, 2001, BIOL MARINE BIRDS; Shaffer SA, 2005, MAR BIOL, V147, P833, DOI 10.1007/s00227-005-1631-8; Shaffer SA, 2003, FUNCT ECOL, V17, P66, DOI 10.1046/j.1365-2435.2003.00705.x; Shaffer SA, 2006, P NATL ACAD SCI USA, V103, P12799, DOI 10.1073/pnas.0603715103; Shaffer SA, 2009, MAR ECOL PROG SER, V391, P209, DOI 10.3354/meps07932; SHEATHER SJ, 1991, J ROY STAT SOC B MET, V53, P683; Sievert P.R., 1993, STATUS ECOLOGY CONSE, P212; Stephens D.W., 1986, pi; Weimerskirch H, 1997, ECOLOGY, V78, P2051; WEIMERSKIRCH H, 1993, AUK, V110, P325; Weimerskirch H, 2008, MAR ECOL PROG SER, V362, P291, DOI 10.3354/meps07424; Wilson R.P., 1992, P131; WORTON BJ, 1989, ECOLOGY, V70, P164, DOI 10.2307/1938423; Young LC, 2008, BIOL LETTERS, V4, P323, DOI 10.1098/rsbl.2008.0191; Young LC, 2009, WILSON J ORNITHOL, V121, P722, DOI 10.1676/08-150.1; [No title captured]	41	69	70	1	154	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7623	10.1371/journal.pone.0007623	http://dx.doi.org/10.1371/journal.pone.0007623			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862322	Green Published, Green Accepted, gold			2022-12-27	WOS:000271194600012
J	Joo, J; Christensen, L; Warner, K; States, L; Kang, HG; Vo, K; Lawlor, ER; May, WA				Joo, Jay; Christensen, Laura; Warner, Kegan; States, Leith; Kang, Hyung-Gyoo; Vo, Kieuhoa; Lawlor, Elizabeth R.; May, William A.			GLI1 Is a Central Mediator of EWS/FLI1 Signaling in Ewing Tumors	PLOS ONE			English	Article							SONIC HEDGEHOG; TRANSCRIPTION FACTORS; INHIBITION; GROWTH; GENE; SUPPRESSOR; TARGET; CANCER; CELLS; REVEALS	The Ewing Sarcoma Family Tumors (ESFT) consist of the classical pathologic entities of Ewing Sarcoma and peripheral Primitive Neuroectodermal Tumor. Occurring largely in the childhood through young adult years, these tumors have an unsurpassed propensity for metastasis and have no defined cell of origin. The biology of these aggressive malignancies centers around EWS/FLI1 and related EWS/ETS chimeric transcription factors, which are largely limited to this tumor class. Much progress has been made in the identification of a network of loci whose expression is modulated by EWS/FLI1 and its congeners. To date, little progress has been made in reconstructing the sequence of direct and indirect events that produce this network of modulated loci. The recent identification of GLI1 as an upregulated target of EWS/ETS transcription factors suggests a target which may be a more central mediator in the ESFT signaling network. In this paper, we further define the relationship of EWS/FLI1 expression and GLI1 upregulation in ESFT. This relationship is supported with data from primary tumor specimens. It is consistently observed across multiple ESFT cell lines and with multiple means of EWS/FLI1 inhibition. GLI1 inhibition affects tumor cell line phenotype whether shRNA or endogenous or pharmacologic inhibitors are employed. As is seen in model transformation systems, GLI1 upregulation by EWS/FLI1 appears to be independent of Hedgehog stimulation. Consistent with a more central role in ESFT pathogenesis, several known EWS/FLI1 targets appear to be targeted through GLI1. These findings further establish a central role for GLI1 in the pathogenesis of Ewing Tumors.			Joo, J (corresponding author), Childrens Hosp Los Angeles, Dept Pediat, Div Hematol Oncol, Los Angeles, CA 90027 USA.	wmay@chla.usc.edu			NCI NIH HHS [R01 CA090666, CA90666] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA090666] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Altaba AR, 2002, NAT REV CANCER, V2, P361, DOI 10.1038/nrc796; Arvand A, 2001, ONCOGENE, V20, P5747, DOI 10.1038/sj.onc.1204598; Beauchamp E, 2009, J BIOL CHEM, V284, P9074, DOI 10.1074/jbc.M806233200; Berman DM, 2002, SCIENCE, V297, P1559, DOI 10.1126/science.1073733; Callahan CA, 2004, GENE DEV, V18, P2724, DOI 10.1101/gad.1221804; Chen JK, 2002, GENE DEV, V16, P2743, DOI 10.1101/gad.1025302; Cheng SY, 2002, P NATL ACAD SCI USA, V99, P5442, DOI 10.1073/pnas.082096999; Clement V, 2007, CURR BIOL, V17, P165, DOI 10.1016/j.cub.2006.11.033; FAN CM, 1995, CELL, V81, P457, DOI 10.1016/0092-8674(95)90398-4; Gangwal K, 2008, P NATL ACAD SCI USA, V105, P10149, DOI 10.1073/pnas.0801073105; Gustafsson MK, 2002, GENE DEV, V16, P114, DOI 10.1101/gad.940702; Hancock JD, 2008, CELL CYCLE, V7, P250, DOI 10.4161/cc.7.2.5229; Janknecht R, 2005, GENE, V363, P1, DOI 10.1016/j.gene.2005.08.007; Jiang J, 2008, DEV CELL, V15, P801, DOI 10.1016/j.devcel.2008.11.010; Kang J.-S., 2007, SCI STKE, V2007, DOI [DOI 10.1126/STKE.4032007PE50, 10.1126/stke.4032007pe50]; Kasper M, 2006, EUR J CANCER, V42, P437, DOI 10.1016/j.ejca.2005.08.039; LAUTH M, 2007, ONCOGENE; Lauth M, 2007, CELL CYCLE, V6, P2458, DOI 10.4161/cc.6.20.4808; Lauth M, 2007, P NATL ACAD SCI USA, V104, P8455, DOI 10.1073/pnas.0609699104; Lei QB, 2006, DEV CELL, V11, P325, DOI 10.1016/j.devcel.2006.06.013; MAY WA, 1993, P NATL ACAD SCI USA, V90, P5752, DOI 10.1073/pnas.90.12.5752; Murone M, 2000, NAT CELL BIOL, V2, P310, DOI 10.1038/35010610; Potikyan G, 2007, CANCER RES, V67, P6675, DOI 10.1158/0008-5472.CAN-06-4140; Prieur A, 2004, MOL CELL BIOL, V24, P7275, DOI 10.1128/MCB.24.16.7275-7283.2004; Ruiz i Altaba A, 2007, TRENDS CELL BIOL, V17, P438, DOI 10.1016/j.tcb.2007.06.007; Sanchez P, 2004, P NATL ACAD SCI USA, V101, P12561, DOI 10.1073/pnas.0404956101; Sasai K, 2006, CANCER RES, V66, P4215, DOI 10.1158/0008-5472.CAN-05-4505; Smith R, 2006, CANCER CELL, V9, P405, DOI 10.1016/j.ccr.2006.04.004; Stecca B, 2007, P NATL ACAD SCI USA, V104, P5895, DOI 10.1073/pnas.0700776104; Svard J, 2006, DEV CELL, V10, P187, DOI 10.1016/j.devcel.2005.12.013; Testaz S, 2001, P NATL ACAD SCI USA, V98, P12521, DOI 10.1073/pnas.221108698; Vokes SA, 2007, DEVELOPMENT, V134, P1977, DOI 10.1242/dev.001966; Zhang JS, 2004, CANCER RES, V64, P6026, DOI 10.1158/0008-5472.CAN-03-2594; Zwerner JP, 2008, ONCOGENE, V27, P3282, DOI 10.1038/sj.onc.1210991	34	54	59	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 27	2009	4	10							e7608	10.1371/journal.pone.0007608	http://dx.doi.org/10.1371/journal.pone.0007608			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ET	19859563	Green Published, Green Submitted, gold			2022-12-27	WOS:000271147400012
J	Stanton, SJ; Beehner, JC; Saini, EK; Kuhn, CM; LaBar, KS				Stanton, Steven J.; Beehner, Jacinta C.; Saini, Ekjyot K.; Kuhn, Cynthia M.; LaBar, Kevin S.			Dominance, Politics, and Physiology: Voters' Testosterone Changes on the Night of the 2008 United States Presidential Election	PLOS ONE			English	Article							IMPLICIT POWER MOTIVATION; SALIVARY TESTOSTERONE; HUMAN MALES; COMPETITION; AGGRESSION; CORTISOL; HORMONES; ABILITY; WOMEN; SERUM	Background: Political elections are dominance competitions. When men win a dominance competition, their testosterone levels rise or remain stable to resist a circadian decline; and when they lose, their testosterone levels fall. However, it is unknown whether this pattern of testosterone change extends beyond interpersonal competitions to the vicarious experience of winning or losing in the context of political elections. Women's testosterone responses to dominance competition outcomes are understudied, and to date, a clear pattern of testosterone changes in response to winning and losing dominance competitions has not emerged. Methodology/Principal Findings: The present study investigated voters' testosterone responses to the outcome of the 2008 United States Presidential election. 183 participants provided multiple saliva samples before and after the winner was announced on Election Night. The results show that male Barack Obama voters (winners) had stable post-outcome testosterone levels, whereas testosterone levels dropped in male John McCain and Robert Barr voters (losers). There were no significant effects in female voters. Conclusions/Significance: The findings indicate that male voters exhibit biological responses to the realignment of a country's dominance hierarchy as if they participated in an interpersonal dominance contest.			Stanton, SJ (corresponding author), Duke Univ, Ctr Cognit Neurosci, Durham, NC 27706 USA.	klabar@duke.edu	Beehner, Jacinta/E-8467-2012	Beehner, Jacinta/0000-0001-6566-6872; Saini, Ekjyot/0000-0002-5254-6422				Altemeyer, 1996, AUTHORITARIAN SPECTE; Altemeyer B, 2004, J SOC PSYCHOL, V144, P421, DOI 10.3200/SOCP.144.4.421-448; ALTEMEYER B, 1998, 20 ITEM RWA SC UNPUB; Archer J, 2006, NEUROSCI BIOBEHAV R, V30, P319, DOI 10.1016/j.neubiorev.2004.12.007; Archer J, 2004, REV GEN PSYCHOL, V8, P291, DOI 10.1037/1089-2680.8.4.291; Bateup HS, 2002, EVOL HUM BEHAV, V23, P181, DOI 10.1016/S1090-5138(01)00100-3; Bernhardt PC, 1998, PHYSIOL BEHAV, V65, P59, DOI 10.1016/S0031-9384(98)00147-4; BOOTH A, 1989, HORM BEHAV, V23, P556, DOI 10.1016/0018-506X(89)90042-1; DABBS JM, 1991, PHYSIOL BEHAV, V49, P815, DOI 10.1016/0031-9384(91)90323-G; Daly M, 2001, Nebr Symp Motiv, V47, P1; DEWAAL F, 1982, CHIMPANZEE POLITICS; Edwards DA, 2006, PHYSIOL BEHAV, V87, P135, DOI 10.1016/j.physbeh.2005.09.007; Fodor EM, 2008, J APPL SOC PSYCHOL, V38, P215; Granger DA, 2004, PSYCHONEUROENDOCRINO, V29, P1229, DOI 10.1016/j.psyneuen.2004.02.005; KHANDAWOOD FS, 1984, AM J OBSTET GYNECOL, V148, P441; MAZUR A, 1992, SOC PSYCHOL QUART, V55, P70, DOI 10.2307/2786687; MAZUR A, 1980, HORM BEHAV, V14, P236, DOI 10.1016/0018-506X(80)90032-X; Mazur A, 1997, EVOL HUM BEHAV, V18, P317, DOI 10.1016/S1090-5138(97)00013-5; Mazur A, 1998, BEHAV BRAIN SCI, V21, P353, DOI 10.1017/S0140525X98001228; MAZUR A, 1985, SOC FORCES, V64, P377; Mehta PH, 2006, HORM BEHAV, V50, P684, DOI 10.1016/j.yhbeh.2006.07.001; MENDELSON JH, 1977, J PHARMACOL EXP THER, V202, P676; NAVARRO MA, 1986, CLIN CHEM, V32, P231; Nisbett Richard E., 1996, CULTURE HONOR PSYCHO; Oliveira T, 2009, PSYCHONEUROENDOCRINO, V34, P1056, DOI 10.1016/j.psyneuen.2009.02.006; Oyegbile TO, 2005, HORM BEHAV, V48, P259, DOI 10.1016/j.yhbeh.2005.04.007; Sapolsky RM, 2005, SCIENCE, V308, P648, DOI 10.1126/science.1106477; SAPOLSKY RM, 1991, PSYCHONEUROENDOCRINO, V16, P281, DOI 10.1016/0306-4530(91)90015-L; Schultheiss O.C., 2009, METHODS NEUROBIOLOGY, P17; Schultheiss OC, 2004, HORM BEHAV, V46, P592, DOI 10.1016/j.yhbeh.2004.07.005; Schultheiss OC, 2003, HORM BEHAV, V43, P293, DOI 10.1016/S0018-506X(03)00003-5; Schultheiss OC, 2005, J PERS SOC PSYCHOL, V88, P174, DOI 10.1037/0022-3514.88.1.174; SMITH RG, 1979, FERTIL STERIL, V31, P513; Stanton SJ, 2007, HORM BEHAV, V52, P571, DOI 10.1016/j.yhbeh.2007.07.002; Stanton SJ, 2009, J RES PERS, V43, P942, DOI 10.1016/j.jrp.2009.04.001; van Anders SM, 2007, PHYSIOL BEHAV, V90, P634, DOI 10.1016/j.physbeh.2006.11.017; Wirth MM, 2007, PHYSIOL BEHAV, V90, P496, DOI 10.1016/j.physbeh.2006.10.016	37	73	73	0	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7543	10.1371/journal.pone.0007543	http://dx.doi.org/10.1371/journal.pone.0007543			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509JU	19844583	Green Submitted, Green Published, gold			2022-12-27	WOS:000271013000017
J	Banerji, A; Ghosh, I				Banerji, Anirban; Ghosh, Indira			Revisiting the Myths of Protein Interior: Studying Proteins with Mass-Fractal Hydrophobicity-Fractal and Polarizability-Fractal Dimensions	PLOS ONE			English	Article							SELF-ORGANIZED CRITICALITY; MOLECULAR-DYNAMICS; RIBONUCLEASE-A; BETA-HAIRPIN; SIDE-CHAIN; PACKING; STABILITY; CORE; SEQUENCES; MODEL	A robust marker to describe mass, hydrophobicity and polarizability distribution holds the key to deciphering structural and folding constraints within proteins. Since each of these distributions is inhomogeneous in nature, the construct should be sensitive in describing the patterns therein. We show, for the first time, that the hydrophobicity and polarizability distributions in protein interior follow fractal scaling. It is found that (barring 'all-alpha') all the major structural classes of proteins have an amount of unused hydrophobicity left in them. This amount of untapped hydrophobicity is observed to be greater in thermophilic proteins, than that in their (structurally aligned) mesophilic counterparts. 'All-beta'(thermophilic, mesophilic alike) proteins are found to have maximum amount of unused hydrophobicity, while 'all-alpha' proteins have been found to have minimum polarizability. A non-trivial dependency is observed between dielectric constant and hydrophobicity distributions within (alpha+beta) and 'all-alpha' proteins, whereas absolutely no dependency is found between them in the 'all-beta' class. This study proves that proteins are not as optimally packed as they are supposed to be. It is also proved that origin of alpha-helices are possibly not hydrophobic but electrostatic; whereas beta-sheets are predominantly hydrophobic in nature. Significance of this study lies in protein engineering studies; because it quantifies the extent of packing that ensures protein functionality. It shows that myths regarding protein interior organization might obfuscate our knowledge of actual reality. However, if the later is studied with a robust marker of strong mathematical basis, unknown correlations can still be unearthed; which help us to understand the nature of hydrophobicity, causality behind protein folding, and the importance of anisotropic electrostatics in stabilizing a highly complex structure named 'proteins'.			Banerji, A (corresponding author), Univ Pune, Bioinformat Ctr, Pune, Maharashtra, India.	indirag@mail.jnu.ac.in	ghosh, indira/H-5008-2019					Akasaka K, 2001, BIOCHEMISTRY-US, V40, P8665, DOI 10.1021/bi010312u; ALLEN JP, 1982, BIOPHYS J, V38, P299, DOI 10.1016/S0006-3495(82)84562-1; Andreeva A, 2008, NUCLEIC ACIDS RES, V36, pD419, DOI 10.1093/nar/gkm993; ARTECA GA, 1995, CAN J CHEM, V73, P241, DOI 10.1139/v95-033; Ba XW, 2002, MACROMOLECULES, V35, P4193, DOI 10.1021/ma011436h; Bachmann M, 2004, J CHEM PHYS, V120, P6779, DOI 10.1063/1.1651055; Banerji A, 2009, EUR BIOPHYS J BIOPHY, V38, P577, DOI 10.1007/s00249-009-0409-1; BARRETT AJ, 1988, MACROMOLECULES, V21, P1141, DOI 10.1021/ma00182a048; BEHE MJ, 1991, P NATL ACAD SCI USA, V88, P4195, DOI 10.1073/pnas.88.10.4195; Berman H, 2003, NAT STRUCT BIOL, V10, P980, DOI 10.1038/nsb1203-980; Bonvin AMJJ, 2000, J MOL BIOL, V296, P255, DOI 10.1006/jmbi.1999.3446; BOWIE JU, 1990, SCIENCE, V247, P1306, DOI 10.1126/science.2315699; Bullock AN, 2001, NAT REV CANCER, V1, P68, DOI 10.1038/35094077; Burke HB, 2005, CANCER INFORM, V1, P15; Carter CW, 2001, J MOL BIOL, V311, P625, DOI 10.1006/jmbi.2001.4906; Chakrabarti P, 2001, PROG BIOPHYS MOL BIO, V76, P1, DOI 10.1016/S0079-6107(01)00005-0; Dabora JM, 1996, BIOCHEMISTRY-US, V35, P11951, DOI 10.1021/bi9611671; DAYANTIS J, 1994, PHYS REV B, V49, P3217, DOI 10.1103/PhysRevB.49.3217; DEWEY TG, 1994, P NATL ACAD SCI USA, V91, P12101, DOI 10.1073/pnas.91.25.12101; Dewey TG, 1999, PHYS REV E, V60, P4652, DOI 10.1103/PhysRevE.60.4652; Dokholyan NV, 1998, FOLD DES, V3, P577, DOI 10.1016/S1359-0278(98)00072-8; Dwyer Donard S, 2005, BMC Chem Biol, V5, P2, DOI 10.1186/1472-6769-5-2; Elking D, 2007, J COMPUT CHEM, V28, P1261, DOI 10.1002/jcc.20574; ENGLANDER SW, 1983, Q REV BIOPHYS, V16, P521, DOI 10.1017/S0033583500005217; Enright MB, 2005, PHYS REV E, V71, DOI 10.1103/PhysRevE.71.011912; Finucane MD, 1999, BIOCHEMISTRY-US, V38, P11613, DOI 10.1021/bi990766f; Fitzkee NC, 2005, TRENDS BIOCHEM SCI, V30, P73, DOI 10.1016/j.tibs.2004.12.005; Flory P. J., 1953, PRINCIPLES POLYM CHE, P428; Galzitskaya OV, 2008, PROTEINS, V70, P329, DOI 10.1002/prot.21619; Gao J, 2008, BIOPOLYMERS, V89, P1174, DOI 10.1002/bip.21072; GLYAKINA A, 2007, MOL BIOL J, V41, P4; GOLDSTEIN H, 1962, CLASSICAL MECHANICS, P149; Guo HH, 2004, P NATL ACAD SCI USA, V101, P9205, DOI 10.1073/pnas.0403255101; Haney PJ, 1999, P NATL ACAD SCI USA, V96, P3578, DOI 10.1073/pnas.96.7.3578; Havranek JJ, 2003, NAT STRUCT BIOL, V10, P45, DOI 10.1038/nsb877; Hecht MH, 2004, PROTEIN SCI, V13, P1711, DOI 10.1110/ps.04690804; HECHT MH, 1983, P NATL ACAD SCI-BIOL, V80, P2676, DOI 10.1073/pnas.80.9.2676; HELMAN JS, 1984, PHYS REV LETT, V53, P1195, DOI 10.1103/PhysRevLett.53.1195; Higo J, 1997, PROTEIN ENG, V10, P373, DOI 10.1093/protein/10.4.373; Hildebrand PW, 2005, BIOPHYS J, V88, P1970, DOI 10.1529/biophysj.104.049585; HUBBARD SJ, 1995, CURR OPIN BIOTECH, V6, P375, DOI 10.1016/0958-1669(95)80065-4; Irback A, 2001, J BIOL PHYS, V27, P169, DOI 10.1023/A:1013155018382; Jaenicke R, 1998, CURR OPIN STRUC BIOL, V8, P738, DOI 10.1016/S0959-440X(98)80094-8; Jefferson ER, 2006, J MOL BIOL, V364, P1118, DOI 10.1016/j.jmb.2006.09.042; Kajander T, 2003, PROTEIN SCI, V12, P1855, DOI 10.1110/ps.0388503; Karplus M, 2000, J PHYS CHEM B, V104, P11, DOI 10.1021/jp993555t; KARPUSAS M, 1989, P NATL ACAD SCI USA, V86, P8237, DOI 10.1073/pnas.86.21.8237; Kaya H, 2000, PHYS REV LETT, V85, P4823, DOI 10.1103/PhysRevLett.85.4823; Koshi JM, 1997, PROTEINS, V27, P336, DOI 10.1002/(SICI)1097-0134(199703)27:3<336::AID-PROT2>3.0.CO;2-B; Kuhn LA, 1995, PROTEINS, V23, P536, DOI 10.1002/prot.340230408; Lee CY, 2006, PHYS REV E, V73, DOI 10.1103/PhysRevE.73.042901; LEWIS M, 1985, SCIENCE, V230, P1163, DOI 10.1126/science.4071040; Liang J, 2001, BIOPHYS J, V81, P751, DOI 10.1016/S0006-3495(01)75739-6; LIM WA, 1989, NATURE, V339, P31, DOI 10.1038/339031a0; Lumry R., 1975, C INT CNRS EAU SYST, V246, P55; MACDONALD M, 1986, CAN J PHYS, V64, P1353, DOI 10.1139/p86-239; MCCAMMON JA, 1983, J AM CHEM SOC, V105, P2232, DOI 10.1021/ja00346a022; Medini D, 2003, J CHEM PHYS, V118, P2405, DOI 10.1063/1.1533785; MILLHAUSER GL, 1988, P NATL ACAD SCI USA, V85, P1503, DOI 10.1073/pnas.85.5.1503; Munson M, 1996, PROTEIN SCI, V5, P1584, DOI 10.1002/pro.5560050813; Olumee Z, 1998, J PHYS CHEM B, V102, P6118, DOI 10.1021/jp981123x; Pande VS, 1999, P NATL ACAD SCI USA, V96, P9062, DOI 10.1073/pnas.96.16.9062; PERUTZ MF, 1978, SCIENCE, V201, P1187, DOI 10.1126/science.694508; Phillips JC, 2009, P NATL ACAD SCI USA, V106, P3113, DOI 10.1073/pnas.0811308105; Phillips JC, 2009, P NATL ACAD SCI USA, V106, P3107, DOI 10.1073/pnas.0811262106; PRIVALOV PL, 1974, J MOL BIOL, V86, P665, DOI 10.1016/0022-2836(74)90188-0; RASMUSSEN BF, 1992, NATURE, V357, P423, DOI 10.1038/357423a0; REIDHAAROLSON JF, 1988, SCIENCE, V241, P53, DOI 10.1126/science.3388019; Reuveni S, 2008, PHYS REV LETT, V100, DOI 10.1103/PhysRevLett.100.208101; Richards FM, 1997, CELL MOL LIFE SCI, V53, P790, DOI 10.1007/s000180050100; Rother K, 2003, BIOINFORMATICS, V19, P2112, DOI 10.1093/bioinformatics/btg292; Russo D, 2002, BIOPHYS J, V83, P2792, DOI 10.1016/S0006-3495(02)75288-0; Samuel D, 2000, J BIOL CHEM, V275, P34968, DOI 10.1074/jbc.M005147200; SHUDE Y, 2007, J MOL BIOL, V368, P230; Sivaraman T, 1997, BIOCHEM J, V321, P457, DOI 10.1042/bj3210457; Song XY, 2002, J CHEM PHYS, V116, P9359, DOI 10.1063/1.1474582; SOSNICK TR, 1992, BIOCHEMISTRY-US, V31, P8329, DOI 10.1021/bi00150a029; STEINBACH PJ, 1991, BIOCHEMISTRY-US, V30, P3988, DOI 10.1021/bi00230a026; Taverna DM, 2002, PROTEINS, V46, P105, DOI 10.1002/prot.10016; TISSEN JTWM, 1994, ACTA CRYSTALLOGR D, V50, P569, DOI 10.1107/S0907444993013332; Vendruscolo M, 2002, PHYS REV E, V65, DOI 10.1103/PhysRevE.65.061910; Voges D, 1998, J CHEM PHYS, V108, P2219, DOI 10.1063/1.475602; Vogl T, 1997, BIOCHEMISTRY-US, V36, P1657, DOI 10.1021/bi962163z; WEST MW, 1995, PROTEIN SCI, V4, P2032, DOI 10.1002/pro.5560041008; Xiao M, 1998, BIOPHYS J, V74, pA131; Zhang JF, 2003, J CHEM PHYS, V118, P6102, DOI 10.1063/1.1554395; ZYDNEY AL, 2001, MEMBRANE SEPARATIONS, P280	87	21	21	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7361	10.1371/journal.pone.0007361	http://dx.doi.org/10.1371/journal.pone.0007361			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834622	gold, Green Submitted, Green Published			2022-12-27	WOS:000270880700002
J	Bachmann, A; Esser, C; Petter, M; Predehl, S; von Kalckreuth, V; Schmiedel, S; Bruchhaus, I; Tannich, E				Bachmann, Anna; Esser, Claudia; Petter, Michaela; Predehl, Sabine; von Kalckreuth, Vera; Schmiedel, Stefan; Bruchhaus, Iris; Tannich, Egbert			Absence of Erythrocyte Sequestration and Lack of Multicopy Gene Family Expression in Plasmodium falciparum from a Splenectomized Malaria Patient	PLOS ONE			English	Article							RED-BLOOD-CELLS; INFECTED ERYTHROCYTES; PFMC-2TM SUPERFAMILIES; ADHESION MOLECULE-1; SPLENIC LYMPHOMA; STEVOR PROTEINS; ANTIGENS; CYTOADHERENCE; RECEPTOR; SURFACE	Background: To avoid spleen-dependent killing mechanisms parasite-infected erythrocytes (IE) of Plasmodium falciparum malaria patients have the capacity to bind to endothelial receptors. This binding also known as sequestration, is mediated by parasite proteins, which are targeted to the erythrocyte surface. Candidate proteins are those encoded by P. falciparum multicopy gene families, such as var, rif, stevor or PfMC-2TM. However, a direct in vivo proof of IE sequestration and expression of multicopy gene families is still lacking. Here, we report on the analysis of IE from a black African immigrant, who received the diagnosis of a malignant lymphoproliferative disorder and subsequently underwent splenectomy. Three weeks after surgery, the patient experienced clinical falciparum malaria with high parasitemia and circulating developmental parasite stages usually sequestered to the vascular endothelium such as late trophozoites, schizonts or immature gametocytes. Methodology/Principal Findings: Initially, when isolated from the patient, the infected erythrocytes were incapable to bind to various endothelial receptors in vitro. Moreover, the parasites failed to express the multicopy gene families var, A-type rif and stevor but expression of B-type rif and PfMC-2TM genes were detected. In the course of in vitro cultivation, the parasites started to express all investigated multicopy gene families and concomitantly developed the ability to adhere to endothelial receptors such as CD36 and ICAM-1, respectively. Conclusion/Significance: This case strongly supports the hypothesis that parasite surface proteins such as PfEMP1, A-type RIFIN or STEVOR are involved in interactions of infected erythrocytes with endothelial receptors mediating sequestration of mature asexual and immature sexual stages of P. falciparum. In contrast, multicopy gene families coding for B-type RIFIN and PfMC-2TM proteins may not be involved in sequestration, as these genes were transcribed in infected but not sequestered erythrocytes.			Bachmann, A (corresponding author), Bernhard Nocht Inst Trop Med, Hamburg, Germany.	tannich@bni-hamburg.de	Bachmann, Anna/GRO-1087-2022; Petter, Michaela/N-9876-2017	Petter, Michaela/0000-0002-1837-2756; Bachmann, Anna/0000-0001-8397-7308				Abdel-Latif MS, 2002, INFECT IMMUN, V70, P7013, DOI 10.1128/IAI.70.12.7013-7021.2002; Anyona SB, 2006, MALARIA J, V5, DOI 10.1186/1475-2875-5-64; Bach O, 2005, T ROY SOC TROP MED H, V99, P861, DOI 10.1016/j.trstmh.2005.03.008; BARNWELL JW, 1989, J CLIN INVEST, V84, P765, DOI 10.1172/JCI114234; Bates I, 1997, LANCET, V349, P1178, DOI 10.1016/S0140-6736(05)63061-9; BERENDT AR, 1989, NATURE, V341, P57, DOI 10.1038/341057a0; BHATTACHARYA DN, 1983, T ROY SOC TROP MED H, V77, P221, DOI 10.1016/0035-9203(83)90077-9; Bidegain F, 2005, CLIN INFECT DIS, V40, pE97, DOI 10.1086/430061; Blythe JE, 2008, INFECT IMMUN, V76, P3329, DOI 10.1128/IAI.01460-07; Cheng Q, 1998, MOL BIOCHEM PARASIT, V97, P161, DOI 10.1016/S0166-6851(98)00144-3; DAVID PH, 1983, P NATL ACAD SCI-BIOL, V80, P5075, DOI 10.1073/pnas.80.16.5075; Demar M, 2004, AM J TROP MED HYG, V71, P290, DOI 10.4269/ajtmh.2004.71.290; FAKUNLE YM, 1981, CLIN HAEMATOL, V10, P963; Fleming AF, 2009, MANSONS TROPICAL DIS; Gardner MJ, 2002, NATURE, V419, P498, DOI 10.1038/nature01097; HO M, 1992, INFECT IMMUN, V60, P2225, DOI 10.1128/IAI.60.6.2225-2228.1992; HO M, 1990, J INFECT DIS, V161, P555, DOI 10.1093/infdis/161.3.555; ISRAELI A, 1987, T ROY SOC TROP MED H, V81, P233, DOI 10.1016/0035-9203(87)90224-0; Jimmy EO, 1996, T ROY SOC TROP MED H, V90, P37, DOI 10.1016/S0035-9203(96)90472-1; Kaestli M, 2006, J INFECT DIS, V193, P1567, DOI 10.1086/503776; Kaestli M, 2004, J INFECT DIS, V189, P1942, DOI 10.1086/383250; Khattab A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-137; Kraemer SM, 2003, MOL MICROBIOL, V50, P1527, DOI 10.1046/j.1365-2958.2003.03814.x; Kyes S, 2000, MOL BIOCHEM PARASIT, V105, P311, DOI 10.1016/S0166-6851(99)00193-0; LAMBROS C, 1979, J PARASITOL, V65, P418, DOI 10.2307/3280287; Lavazec C, 2007, MOL MICROBIOL, V64, P1621, DOI 10.1111/j.1365-2958.2007.05767.x; Lavazec C, 2006, NUCLEIC ACIDS RES, V34, P6696, DOI 10.1093/nar/gkl942; LAVSTSEN T, 2003, MALARIA J, V27, P3; LEECH JH, 1984, J EXP MED, V159, P1567, DOI 10.1084/jem.159.6.1567; LOOAREESUWAN S, 1987, NEW ENGL J MED, V317, P675, DOI 10.1056/NEJM198709103171105; LOOAREESUWAN S, 1993, CLIN INFECT DIS, V16, P361, DOI 10.1093/clind/16.3.361; Niang M, 2009, PLOS PATHOG, V5, DOI 10.1371/journal.ppat.1000307; OCKENHOUSE CF, 1992, J EXP MED, V176, P1183, DOI 10.1084/jem.176.4.1183; Petter M, 2007, MOL BIOCHEM PARASIT, V156, P51, DOI 10.1016/j.molbiopara.2007.07.011; Pongponratn E, 2000, Southeast Asian J Trop Med Public Health, V31, P829; Przyborski JM, 2005, EMBO J, V24, P2306, DOI 10.1038/sj.emboj.7600720; Robert F, 1996, T ROY SOC TROP MED H, V90, P704, DOI 10.1016/S0035-9203(96)90446-0; Salanti A, 2003, MOL MICROBIOL, V49, P179, DOI 10.1046/j.1365-2958.2003.03570.x; Sam-Yellowe TY, 2004, GENOME RES, V14, P1052, DOI 10.1101/gr.2126104; Saul A, 1999, PARASITOL TODAY, V15, P455, DOI 10.1016/S0169-4758(99)01534-3; SCHNITZER B, 1972, SCIENCE, V177, P175, DOI 10.1126/science.177.4044.175; Schreiber N, 2008, PARASITOLOGY, V135, P155, DOI 10.1017/S0031182007003794; Trager W, 2005, J PARASITOL, V91, P484, DOI 10.1645/0022-3395(2005)091[0484:HMPICC]2.0.CO;2; Udomsangpetch R, 1997, J IMMUNOL, V158, P4358; Wallace S, 1998, T ROY SOC TROP MED H, V92, P463, DOI 10.1016/S0035-9203(98)91095-1; WALZER PD, 1974, AM J TROP MED HYG, V23, P328, DOI 10.4269/ajtmh.1974.23.328; WHITE JW, 2009, MANSONS TROPICAL DIE	47	69	70	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7459	10.1371/journal.pone.0007459	http://dx.doi.org/10.1371/journal.pone.0007459			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826486	Green Published, gold			2022-12-27	WOS:000270808700018
J	Keller, A; Leidinger, P; Lange, J; Borries, A; Schroers, H; Scheffler, M; Lenhof, HP; Ruprecht, K; Meese, E				Keller, Andreas; Leidinger, Petra; Lange, Julia; Borries, Anne; Schroers, Hannah; Scheffler, Matthias; Lenhof, Hans-Peter; Ruprecht, Klemens; Meese, Eckart			Multiple Sclerosis: MicroRNA Expression Profiles Accurately Differentiate Patients with Relapsing-Remitting Disease from Healthy Controls	PLOS ONE			English	Article							CANCER; BIOMARKERS; CELLS	Multiple sclerosis (MS) is a chronic inflammatory demyelinating disease of the central nervous system, which is heterogenous with respect to clinical manifestations and response to therapy. Identification of biomarkers appears desirable for an improved diagnosis of MS as well as for monitoring of disease activity and treatment response. MicroRNAs (miRNAs) are short non-coding RNAs, which have been shown to have the potential to serve as biomarkers for different human diseases, most notably cancer. Here, we analyzed the expression profiles of 866 human miRNAs. In detail, we investigated the miRNA expression in blood cells of 20 patients with relapsing-remitting MS (RRMS) and 19 healthy controls using a human miRNA microarray and the Geniom Real Time Analyzer (GRTA) platform. We identified 165 miRNAs that were significantly up- or downregulated in patients with RRMS as compared to healthy controls. The best single miRNA marker, hsa-miR-145, allowed discriminating MS from controls with a specificity of 89.5%, a sensitivity of 90.0%, and an accuracy of 89.7%. A set of 48 miRNAs that was evaluated by radial basis function kernel support vector machines and 10-fold cross validation yielded a specificity of 95%, a sensitivity of 97.6%, and an accuracy of 96.3%. While 43 of the 165 miRNAs deregulated in patients with MS have previously been related to other human diseases, the remaining 122 miRNAs are so far exclusively associated with MS. The implications of our study are twofold. The miRNA expression profiles in blood cells may serve as a biomarker for MS, and deregulation of miRNA expression may play a role in the pathogenesis of MS.			Keller, A (corresponding author), Febit Biomed Gmbh, Heidelberg, Germany.	andreas.keller@febit.de	Meese, Eckart Ulrich/ABD-1983-2021; Keller, Andreas/ABB-6412-2021	Keller, Andreas/0000-0002-5361-0895				Bielekova B, 2004, BRAIN, V127, P1463, DOI 10.1093/brain/awh176; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Esquela-Kerscher A, 2006, NAT REV CANCER, V6, P259, DOI 10.1038/nrc1840; Griffiths-Jones Sam, 2006, V342, P129, DOI 10.1385/1-59745-123-1:129; Guo JM, 2009, J GASTROEN HEPATOL, V24, P652, DOI 10.1111/j.1440-1746.2008.05666.x; Hunter MP, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003694; Lu M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003420; Merkerova M, 2008, EUR J HAEMATOL, V81, P304, DOI 10.1111/j.1600-0609.2008.01111.x; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Otaegui D, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0006309; Pauley KM, 2008, ARTHRITIS RES THER, V10, DOI 10.1186/ar2493; Polman CH, 2005, ANN NEUROL, V58, P840, DOI 10.1002/ana.20703; Sassen S, 2008, VIRCHOWS ARCH, V452, P1, DOI 10.1007/s00428-007-0532-2; SCHAFER A, 2009, INT J CANC; Vorwerk S, 2008, NEW BIOTECHNOL, V25, P142, DOI 10.1016/j.nbt.2008.08.005; Wu HQ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001020; Xiao CC, 2009, CELL, V136, P26, DOI 10.1016/j.cell.2008.12.027; Zhang YQ, 2009, WORLD J SURG, V33, P698, DOI 10.1007/s00268-008-9833-0	19	280	311	0	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7440	10.1371/journal.pone.0007440	http://dx.doi.org/10.1371/journal.pone.0007440			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823682	gold, Green Submitted, Green Published			2022-12-27	WOS:000270808300016
J	Le Naour, F; Bralet, MP; Debois, D; Sandt, C; Guettier, C; Dumas, P; Brunelle, A; Laprevote, O				Le Naour, Francois; Bralet, Marie-Pierre; Debois, Delphine; Sandt, Christophe; Guettier, Catherine; Dumas, Paul; Brunelle, Alain; Laprevote, Olivier			Chemical Imaging on Liver Steatosis Using Synchrotron Infrared and ToF-SIMS Microspectroscopies	PLOS ONE			English	Article								Fatty liver or steatosis is a frequent histopathological change. It is a precursor for steatohepatitis that may progress to cirrhosis and in some cases to hepatocellular carcinoma. In this study we addressed the in situ composition and distribution of biochemical compounds on tissue sections of steatotic liver using both synchrotron FTIR (Fourier transform infrared) and ToF-SIMS (time of flight secondary ion mass spectrometry) microspectroscopies. FTIR is a vibrational spectroscopy that allows investigating the global biochemical composition and ToF-SIMS lead to identify molecular species in particular lipids. Synchrotron FTIR microspectroscopy demonstrated that bands linked to lipid contribution such as -CH(3) and -CH(2) as well as esters were highly intense in steatotic vesicles. Moreover, a careful analysis of the -CH(2) symmetric and anti- symmetric stretching modes revealed a slight downward shift in spectra recorded inside steatotic vesicles when compared to spectra recorded outside, suggesting a different lipid environment inside the steatotic vesicles. ToF-SIMS analysis of such steatotic vesicles disclosed a selective enrichment in cholesterol as well as in diacylglycerol (DAG) species carrying long alkyl chains. Indeed, DAG C36 species were selectively localized inside the steatotic vesicles whereas DAG C30 species were detected mostly outside. Furthermore, FTIR detected a signal corresponding to olefin (C = C, 3000- 3060 cm(-1)) and revealed a selective localization of unsaturated lipids inside the steatotic vesicles. ToF-SIMS analysis definitely demonstrated that DAG species C30, C32, C34 and C36 carrying at least one unsaturated alkyl chain were selectively concentrated into the steatotic vesicles. On the other hand, investigations performed on the non-steatotic part of the fatty livers have revealed important changes when compared to the normal liver. Although the non-steatotic regions of fatty livers exhibited normal histological aspect, IR spectra demonstrated an increase in the lipid content and ToF-SIMS detected small lipid droplets corresponding most likely to the first steps of lipid accretion.			Le Naour, F (corresponding author), INSERM, U602, Villejuif, France.	francois.le-naour@inserm.fr	Soleil, SMIS/I-3166-2014; Sandt, Christophe/M-9806-2014; Sandt, Christophe/ABE-6818-2020; Brunelle, Alain/L-3889-2013	Sandt, Christophe/0000-0002-6432-2004; Sandt, Christophe/0000-0002-6432-2004; Brunelle, Alain/0000-0001-6526-6481				Albano E, 2005, ALIMENT PHARM THER, V22, P71, DOI 10.1111/j.1365-2036.2005.02601.x; Albano E, 2008, MOL ASPECTS MED, V29, P9, DOI 10.1016/j.mam.2007.09.004; Banyay M, 2003, BIOPHYS CHEM, V104, P477, DOI 10.1016/S0301-4622(03)00035-8; Brunelle A, 2005, J MASS SPECTROM, V40, P985, DOI 10.1002/jms.902; Brunelle A, 2007, CURR PHARM DESIGN, V13, P3335, DOI 10.2174/138161207782360618; Brunelle A, 2009, ANAL BIOANAL CHEM, V393, P31, DOI 10.1007/s00216-008-2367-3; Debois D, 2009, ANAL CHEM, V81, P2823, DOI 10.1021/ac900045m; Diem M, 2000, BIOPOLYMERS, V57, P282, DOI 10.1002/1097-0282(2000)57:5<282::AID-BIP50>3.0.CO;2-R; Dreissig I, 2009, SPECTROCHIM ACTA A, V71, P2069, DOI 10.1016/j.saa.2008.08.008; Dumas P, 2003, VIB SPECTROSC, V32, P3, DOI 10.1016/S0924-2031(03)00043-2; Dumas P, 2007, TRENDS BIOTECHNOL, V25, P40, DOI 10.1016/j.tibtech.2006.11.002; Ginsberg HN, 2006, CELL METAB, V4, P179, DOI 10.1016/j.cmet.2006.08.010; Goldberg IJ, 2006, GASTROENTEROLOGY, V130, P1343, DOI 10.1053/j.gastro.2006.02.040; Jackson M, 1998, CELL MOL BIOL, V44, P89; Liu KZ, 2006, BBA-BIOMEMBRANES, V1758, P960, DOI 10.1016/j.bbamem.2006.05.006; Miller LM, 2006, BBA-BIOMEMBRANES, V1758, P846, DOI 10.1016/j.bbamem.2006.04.010; Nagata Kiyoshi, 2007, Journal of Toxicological Sciences, V32, P453, DOI 10.2131/jts.32.453; Oleszczuk A, 2007, EXP TOXICOL PATHOL, V59, P205, DOI 10.1016/j.etp.2007.05.009; Tahallah N, 2008, J LIPID RES, V49, P438, DOI 10.1194/jlr.M700421-JLR200; Torres DM, 2008, GASTROENTEROLOGY, V134, P1682, DOI 10.1053/j.gastro.2008.02.077	20	65	67	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7408	10.1371/journal.pone.0007408	http://dx.doi.org/10.1371/journal.pone.0007408			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823674	Green Submitted, Green Published, gold			2022-12-27	WOS:000270728500009
J	Wayengera, M				Wayengera, Misaki			Searching for New Clues about the Molecular Cause of Endomyocardial Fibrosis by Way of In Silico Proteomics and Analytical Chemistry	PLOS ONE			English	Article								Background: Endomyocardial Fibrosis (EMF) -is a chronic inflammatory disease of the heart with related pathology to that of late stage Chaga's disease. Indeed, both diseases are thought to result from auto-immune responses against myocardial tissue. As is the case that molecular mimicry between the acidic termini of Trypanosoma cruzi ribosomal P0, P1 and P2 beta (or simply TcP0, TcP1, and TcP2 beta) proteins and myocardial tissue causes Chaga's disease, excessive exposure to certain infections, toxins including cassava ones, allergy and malnutrition has been suggested as the possible cause for EMF. Recent studies have defined the proteomic characteristics of the T. cruzi ribosomal P protein-C-termini involved in mediating auto-immunity against Beta1-adrenergic receptors of the heart in Chaga's disease. This study aimed to investigate the similarity of C-termini of TcP0/TcP2 beta to sequences and molecules of several plants, microbial, viral and chemical elements-most prior thought to be possible causative agents for EMF. Methods and Principal Findings: Comparative Sequence alignments and phylogeny using the BLAST-P tool at the Swiss Institute of Biotechnology (SIB) revealed homologs of C-termini of TcP0 and TcP2b among related proteins from several eukaryotes including the animals (Homo sapiens, C. elegans, D. melanogaster), plants (Arabidopsis thaliana, Zea mays, Glycina Max, Oryza sativa, Rhizopus oryzae) and protozoa (P. falciparum, T. gondii, Leishmania spp). The chemical formulae of the two T. cruzi ribosomal protein C-terminal peptides were found to be C(61)H(83)N(13)O(26)S(1)and C(64)H(87)N(13)O(28)S(1) respectively by Protparam. Both peptides are heavily negatively charged. Constitutively, both auto-antigens predominantly contain Asparagine (D), Glycine (G) and Phenylamine (F), with a balanced Leucine (L) and Methionine (M) percent composition of 7.7%. The afore going composition, found to be non-homologous to all molecules of chemical species in the databases searched, suggests the possible role of a metabolic pathway in the pathogenesis of EMF if aligned with our "molecular mimicry'' hypothesis. Conclusions: Our findings provide a "window'' to suggest that cross reactivity of antibodies against C-terminal sequences of several animal, plant and protozoal ribosomal P proteins with heart tissue may mediate EMF in a similar manner as C-termini of T. cruzi do for Chaga's disease.			Wayengera, M (corresponding author), Makerere Univ, Coll Hlth Sci, Sch Biomed Sci, Dept Pathol,Div Mol Pathol, Kampala, Uganda.	wmisaki@yahoo.com		Wayengera, Misaki/0000-0001-7239-8079				Altschul SF, 2005, FEBS J, V272, P5101, DOI 10.1111/j.1742-4658.2005.04945.x; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Andy JJ, 1998, ACTA TROP, V69, P127, DOI 10.1016/S0001-706X(97)00125-3; Bassett DE, 1997, NAT GENET, V15, P339, DOI 10.1038/ng0497-339; BEISEL WR, 1995, AM J CLIN NUTR, V62, P813, DOI 10.1093/ajcn/62.4.813; Boehme SA, 2004, J IMMUNOL, V173, P3599, DOI 10.4049/jimmunol.173.6.3599; Bukhman G, 2008, PLOS NEGLECT TROP D, V2, DOI 10.1371/journal.pntd.0000097; Byarugaba W, 2009, THEOR BIOL MED MODEL, V6, DOI 10.1186/1742-4682-6-14; CONNOR DH, 1967, AM HEART J, V74, P687, DOI 10.1016/0002-8703(67)90509-1; Cools J, 2003, NEW ENGL J MED, V348, P1201, DOI 10.1056/NEJMoa025217; CRAWFORD MA, 1962, LANCET, V1, P352; DAVIES JNP, 1948, E AFR MED J, V25, P10; EDGE J, 1946, LANCET, V248, P675; El-Sayed NM, 2005, SCIENCE, V309, P409, DOI 10.1126/science.1112631; Feng DF, 1997, P NATL ACAD SCI USA, V94, P13028, DOI 10.1073/pnas.94.24.13028; Freers J, 1996, LANCET, V347, P197, DOI 10.1016/S0140-6736(96)90383-9; Gagou ME, 2000, NUCLEIC ACIDS RES, V28, P736, DOI 10.1093/nar/28.3.736; Gasteiger E., 2005, PROTEOMICS PROTOC HD, P571, DOI [10.1385/1-59259-890-0:571, DOI 10.1385/1-59259-890-0:571]; Grela P, 2008, J MOL EVOL, V67, P154, DOI 10.1007/s00239-008-9132-2; HASLER P, 1991, J BIOL CHEM, V266, P13815; Iglezias SD, 2008, VIRCHOWS ARCH, V453, P233, DOI 10.1007/s00428-008-0652-3; LEWIS CE, 1958, P SOC EXP BIOL MED, V99, P523; Martin Osvaldo A, 2009, PMC Biophys, V2, P4, DOI 10.1186/1757-5036-2-4; Mocumbi AO, 2008, NEW ENGL J MED, V359, P43, DOI 10.1056/NEJMoa0708629; Ntusi Ntobeko B A, 2009, Expert Rev Cardiovasc Ther, V7, P169, DOI 10.1586/14779072.7.2.169; OJO GO, 1970, BRIT HEART J, V32, P671; OSAMU G, 2008, NUCLEIC ACIDS RES, V36, P2630; PARRY EHO, 1965, Q J MED, V34, P383; Rutakingirwa M, 1999, TROP MED INT HEALTH, V4, P229, DOI 10.1046/j.1365-3156.1999.43376.x; SCHIJMAN AG, 1992, IMMUNOL LETT, V33, P15, DOI 10.1016/0165-2478(92)90087-5; SCHIJMAN AG, 1992, NUCLEIC ACIDS RES, V20, P2894, DOI 10.1093/nar/20.11.2894; SCHIJMAN AG, 1990, NUCLEIC ACIDS RES, V18, P3399, DOI 10.1093/nar/18.11.3399; Sepulveda P, 2000, INFECT IMMUN, V68, P5114, DOI 10.1128/IAI.68.9.5114-5119.2000; Sivasankaran S, 2009, HEART, V95, P9, DOI 10.1136/hrt.2008.148437; SKEIKY YAW, 1992, J EXP MED, V176, P201, DOI 10.1084/jem.176.1.201; Spry C J, 1985, Heart Vessels Suppl, V1, P240, DOI 10.1007/BF02072402; Turan AA, 2008, AM J FOREN MED PATH, V29, P354, DOI 10.1097/PAF.0b013e3181859fe3; WAYENGERA M, 2008, SCI RES ESSAYS, V3, P125; Zanettini R, 2007, NEW ENGL J MED, V356, P39, DOI 10.1056/NEJMoa054830	39	9	10	0	16	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7420	10.1371/journal.pone.0007420	http://dx.doi.org/10.1371/journal.pone.0007420			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823676	Green Published, Green Submitted, gold			2022-12-27	WOS:000270728500018
J	Lao, NT; Maloney, AP; Atkins, JF; Kavanagh, TA				Lao, Nga T.; Maloney, Alan P.; Atkins, John F.; Kavanagh, Tony A.			Versatile Dual Reporter Gene Systems for Investigating Stop Codon Readthrough in Plants	PLOS ONE			English	Article								Background: Translation is most often terminated when a ribosome encounters the first in-frame stop codon (UAA, UAG or UGA) in an mRNA. However, many viruses (and some cellular mRNAs) contain "stop" codons that cause a proportion of ribosomes to terminate and others to incorporate an amino acid and continue to synthesize a "readthrough", or C-terminally extended, protein. This dynamic redefinition of codon meaning is dependent on specific sequence context. Methodology: We describe two versatile dual reporter systems which facilitate investigation of stop codon readthrough in vivo in intact plants, and identification of the amino acid incorporated at the decoded stop codon. The first is based on the reporter enzymes NAN and GUS for which sensitive fluorogenic and histochemical substrates are available; the second on GST and GFP. Conclusions: We show that the NAN-GUS system can be used for direct in planta measurements of readthrough efficiency following transient expression of reporter constructs in leaves, and moreover, that the system is sufficiently sensitive to permit measurement of readthrough in stably transformed plants. We further show that the GST-GFP system can be used to affinity purify readthrough products for mass spectrometric analysis and provide the first definitive evidence that tyrosine alone is specified in vivo by a 'leaky' UAG codon, and tyrosine and tryptophan, respectively, at decoded UAA, and UGA codons in the Tobacco mosaic virus (TMV) readthrough context.			Lao, NT (corresponding author), Trinity Coll Dublin, Smurfit Inst Genet, Plant Mol Genet Lab, Dublin, Ireland.	tkvanagh@mail.tcd.ie		Atkins, John/0000-0001-7933-0165	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM079523] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM079523, GM079523] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Bedwell DM, 1997, NAT MED, V3, P1280, DOI 10.1038/nm1197-1280; BEIER H, 1984, EMBO J, V3, P351, DOI 10.1002/j.1460-2075.1984.tb01810.x; Beier H, 2001, NUCLEIC ACIDS RES, V29, P4767, DOI 10.1093/nar/29.23.4767; BERGSTROM DE, 1995, GENETICS, V139, P1331; BRAULT V, 1995, EMBO J, V14, P650, DOI 10.1002/j.1460-2075.1995.tb07043.x; Brown CM, 1996, J VIROL, V70, P5884, DOI 10.1128/JVI.70.9.5884-5892.1996; Cardno TS, 2009, RNA, V15, P1614, DOI 10.1261/rna.1586709; Cazzonelli CI, 2005, TRANSGENIC RES, V14, P941, DOI 10.1007/s11248-005-2539-2; CHALFIE M, 1994, SCIENCE, V263, P802, DOI 10.1126/science.8303295; Clough SJ, 1998, PLANT J, V16, P735, DOI 10.1046/j.1365-313x.1998.00343.x; Dreher TW, 2006, VIROLOGY, V344, P185, DOI 10.1016/j.virol.2005.09.031; Fabret C, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-22; FENG YX, 1992, J VIROL, V66, P5127, DOI 10.1128/JVI.66.8.5127-5132.1992; Grentzmann G, 1998, RNA, V4, P479; Grimm M, 1998, PLANT MOL BIOL, V38, P689, DOI 10.1023/A:1006068303683; Herr AJ, 2004, J BIOL CHEM, V279, P11081, DOI 10.1074/jbc.M311491200; Hirosawa-Takamori M, 2009, FASEB J, V23, P107, DOI 10.1096/fj.08-116640; ISHIKAWA M, 1986, NUCLEIC ACIDS RES, V14, P8291, DOI 10.1093/nar/14.21.8291; ISHIKAWA M, 1991, J VIROL, V65, P861, DOI 10.1128/JVI.65.2.861-868.1991; JEFFERSON RA, 1987, EMBO J, V6, P3901; Kirby J, 2002, PLANT J, V32, P391, DOI 10.1046/j.1365-313X.2002.01422.x; Lewandowski DJ, 2000, VIROLOGY, V271, P90, DOI 10.1006/viro.2000.0313; Lin MF, 2007, GENOME RES, V17, P1823, DOI 10.1101/gr.6679507; Liu QP, 2004, BIOSYSTEMS, V77, P33, DOI 10.1016/j.biosystems.2004.03.005; Marillonnet S, 2004, P NATL ACAD SCI USA, V101, P6852, DOI 10.1073/pnas.0400149101; NAMY O, 2009, RECODING EXPANSION D; Ohtsubo H, 1999, GENES GENET SYST, V74, P83, DOI 10.1266/ggs.74.83; PELHAM HRB, 1978, NATURE, V272, P469, DOI 10.1038/272469a0; Robinson DN, 1997, DEVELOPMENT, V124, P1405; Salas-Marco J, 2004, MOL CELL BIOL, V24, P7769, DOI 10.1128/MCB.24.17.7769-7778.2004; Schmidt TGM, 2007, NAT PROTOC, V2, P1528, DOI 10.1038/nprot.2007.209; SKUZESKI JM, 1990, PLANT MOL BIOL, V15, P65, DOI 10.1007/BF00017725; SKUZESKI JM, 1991, J MOL BIOL, V218, P365, DOI 10.1016/0022-2836(91)90718-L; SMITH DB, 1988, GENE, V67, P31, DOI 10.1016/0378-1119(88)90005-4; STAHL G, 1995, NUCLEIC ACIDS RES, V23, P1557, DOI 10.1093/nar/23.9.1557; STANSFIELD I, 1994, CURR GENET, V25, P385, DOI 10.1007/BF00351776; Steneberg P, 1998, GENE DEV, V12, P956, DOI 10.1101/gad.12.7.956; Steneberg P, 2001, EMBO REP, V2, P593, DOI 10.1093/embo-reports/kve128; Tate WP, 1996, BIOCHIMIE, V78, P945, DOI 10.1016/S0300-9084(97)86716-8; Urban C, 1996, NUCLEIC ACIDS RES, V24, P3424, DOI 10.1093/nar/24.17.3424; VALLE RPC, 1987, EMBO J, V6, P3049, DOI 10.1002/j.1460-2075.1987.tb02611.x; von der Haar T, 2007, TRENDS MICROBIOL, V15, P78, DOI 10.1016/j.tim.2006.12.002; WILLS NM, 1991, P NATL ACAD SCI USA, V88, P6991, DOI 10.1073/pnas.88.16.6991; ZERFASS K, 1992, NUCLEIC ACIDS RES, V20, P5911, DOI 10.1093/nar/20.22.5911; ZHOURAVLEVA G, 1995, EMBO J, V14, P4065, DOI 10.1002/j.1460-2075.1995.tb00078.x	45	8	10	1	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7354	10.1371/journal.pone.0007354	http://dx.doi.org/10.1371/journal.pone.0007354			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816579	gold, Green Published, Green Submitted			2022-12-27	WOS:000270594300005
J	Sakamoto, KQ; Takahashi, A; Iwata, T; Trathan, PN				Sakamoto, Kentaro Q.; Takahashi, Akinori; Iwata, Takashi; Trathan, Philip N.			From the Eye of the Albatrosses: A Bird-Borne Camera Shows an Association between Albatrosses and a Killer Whale in the Southern Ocean	PLOS ONE			English	Article								Albatrosses fly many hundreds of kilometers across the open ocean to find and feed upon their prey. Despite the growing number of studies concerning their foraging behaviour, relatively little is known about how albatrosses actually locate their prey. Here, we present our results from the first deployments of a combined animal-borne camera and depth data logger on free-ranging black-browed albatrosses (Thalassarche melanophrys). The still images recorded from these cameras showed that some albatrosses actively followed a killer whale (Orcinus orca), possibly to feed on food scraps left by this diving predator. The camera images together with the depth profiles showed that the birds dived only occasionally, but that they actively dived when other birds or the killer whale were present. This association with diving predators or other birds may partially explain how albatrosses find their prey more efficiently in the apparently 'featureless' ocean, with a minimal requirement for energetically costly diving or landing activities.	[Sakamoto, Kentaro Q.] Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido, Japan; [Takahashi, Akinori; Iwata, Takashi] Natl Inst Polar Res, Dept Polar Sci, Grad Univ Adv Studies, Tachikawa, Tokyo, Japan; [Trathan, Philip N.] NERC, British Antarctic Survey, Cambridge, England	Hokkaido University; Graduate University for Advanced Studies - Japan; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan; UK Research & Innovation (UKRI); Natural Environment Research Council (NERC); NERC British Antarctic Survey	Sakamoto, KQ (corresponding author), Hokkaido Univ, Grad Sch Vet Med, Sapporo, Hokkaido, Japan.	atak@nipr.ac.jp	Sakamoto, Kentaro/N-7424-2019; Sakamoto, Kentaro/A-4843-2012	Sakamoto, Kentaro/0000-0002-8499-799X; Sakamoto, Kentaro/0000-0002-8499-799X	NERC [bas0100025] Funding Source: UKRI; Natural Environment Research Council [bas0100025] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Anderson EM, 2008, MAR ECOL PROG SER, V360, P291, DOI 10.3354/meps07359; Au D.W., 1988, P174; Bluff LA, 2008, BIOL LETTERS, V4, P319, DOI 10.1098/rsbl.2008.0075; Brooke M, 2004, ALBATROSSES PETRELS; Cherel Y, 2000, MAR ECOL PROG SER, V207, P183, DOI 10.3354/meps207183; CROXALL JP, 1994, ANTARCT SCI, V6, P155, DOI 10.1017/S0954102094000246; Croxall JP, 1999, MAR ECOL PROG SER, V177, P115, DOI 10.3354/meps177115; EVANS PGH, 1982, MAMMAL REV, V12, P187, DOI 10.1111/j.1365-2907.1982.tb00015.x; Ford JKB, 2006, MAR ECOL PROG SER, V316, P185, DOI 10.3354/meps316185; GON O, 1990, FISHES SO OCEAN; Grunbaum D, 2003, ECOLOGY, V84, P3265, DOI 10.1890/01-4098; Hedd A, 1997, IBIS, V139, P452, DOI 10.1111/j.1474-919X.1997.tb04658.x; Hodges C. L., 1994, Marine Ornithology, V22, P205; Huin N, 1997, ANTARCT SCI, V9, P243, DOI 10.1017/S0954102097000321; Huin N, 2000, IBIS, V142, P550, DOI 10.1111/j.1474-919X.2000.tb04456.x; Kock KH, 2006, POLAR BIOL, V29, P379, DOI 10.1007/s00300-005-0067-4; Moil RJ, 2007, TRENDS ECOL EVOL, V22, P660, DOI 10.1016/j.tree.2007.09.007; Nevitt G, 2004, J EXP BIOL, V207, P3537, DOI 10.1242/jeb.01198; Nevitt GA, 2008, P NATL ACAD SCI USA, V105, P4576, DOI 10.1073/pnas.0709047105; Pierotti R., 1988, P31; PRINCE PA, 1994, ANTARCT SCI, V6, P353, DOI 10.1017/S0954102094000532; RIDOUX V, 1987, CAN J ZOOL, V65, P2113, DOI 10.1139/z87-324; Rutz C, 2007, SCIENCE, V318, P765, DOI 10.1126/science.1146788; SAFINA C, 2002, EYE ALBATROSSES; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; Silverman ED, 2004, MAR ECOL PROG SER, V277, P25, DOI 10.3354/meps277025; Takahashi A, 2004, P ROY SOC B-BIOL SCI, V271, pS281, DOI 10.1098/rsbl.2004.0182; Weimerskirch H, 2000, P ROY SOC B-BIOL SCI, V267, P1869, DOI 10.1098/rspb.2000.1223; Xavier JC, 2003, IBIS, V145, P593, DOI 10.1046/j.1474-919X.2003.00196.x	29	39	40	0	27	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7322	10.1371/journal.pone.0007322	http://dx.doi.org/10.1371/journal.pone.0007322			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809497	Green Published, Green Accepted, gold			2022-12-27	WOS:000270594000006
J	Shortreed, KE; Krause, MP; Huang, JH; Dhanani, D; Moradi, J; Ceddia, RB; Hawke, TJ				Shortreed, Karin E.; Krause, Matthew P.; Huang, Julianna H.; Dhanani, Dili; Moradi, Jasmin; Ceddia, Rolando B.; Hawke, Thomas J.			Muscle-Specific Adaptations, Impaired Oxidative Capacity and Maintenance of Contractile Function Characterize Diet-Induced Obese Mouse Skeletal Muscle	PLOS ONE			English	Article								Background: The effects of diet-induced obesity on skeletal muscle function are largely unknown, particularly as it relates to changes in oxidative metabolism and morphology. Principal Findings: Compared to control fed mice, mice fed a high fat diet (HFD; 60% kcal: fat) for 8 weeks displayed increased body mass and insulin resistance without overt fasting hyperglycemia (i.e. pre-diabetic). Histological analysis revealed a greater oxidative potential in the HFD gastrocnemius/plantaris (increased IIA, reduced IIB fiber-type percentages) and soleus (increased I, IIA cross-sectional areas) muscles, but no change in fiber type percentages in tibialis anterior muscles compared to controls. Intramyocellular lipid levels were significantly increased relative to control in HFD gastrocnemius/plantaris, but were similar to control values in the HFD soleus. Using a novel, single muscle fiber approach, impairments in complete palmitate and glucose oxidation (72.8 +/- 6.6% and 61.8 +/- 9.1% of control, respectively; p<0.05) with HFD were detected. These reductions were consistent with measures made using intact extensor digitorum longus and soleus muscles. Compared to controls, no difference in succinate dehydrogenase or citrate synthase enzyme activities were observed between groups in any muscle studied, however, short-chain fatty acyl CoA dehydrogenase (SCHAD) activity was elevated in the HFD soleus, but not tibialis anterior muscles. Despite these morphological and metabolic alterations, no significant difference in peak tetanic force or low-frequency fatigue rates were observed between groups. Conclusions: These findings indicate that HFD induces early adaptive responses that occur in a muscle-specific pattern, but are insufficient to prevent impairments in oxidative metabolism with continued high-fat feeding. Moreover, the morphological and metabolic changes which occur with 8 weeks of HFD do not significantly impact muscle contractile properties.			Shortreed, KE (corresponding author), McMaster Univ, Dept Pathol & Mol Med, Hamilton, ON, Canada.	hawke@mcmaster.ca		Hawke, Thomas/0000-0003-4974-4820				Bonnard C, 2008, J CLIN INVEST, V118, P789, DOI 10.1172/JCI32601; BURKHOLDER TJ, 1994, J MORPHOL, V221, P177, DOI 10.1002/jmor.1052210207; Carter SL, 2001, CAN J PHYSIOL PHARM, V79, P386, DOI 10.1139/cjpp-79-5-386; Ceddia RB, 2004, J PHYSIOL-LONDON, V555, P409, DOI 10.1113/jphysiol.2003.056291; Ceddia RB, 1999, INT J OBESITY, V23, P75, DOI 10.1038/sj.ijo.0800762; Chanseaume E, 2006, J NUTR, V136, P2194, DOI 10.1093/jn/136.8.2194; de Wilde J, 2008, PHYSIOL GENOMICS, V32, P360, DOI 10.1152/physiolgenomics.00219.2007; FARKAS GA, 1994, J APPL PHYSIOL, V77, P2250, DOI 10.1152/jappl.1994.77.5.2250; Fediuc S, 2006, J LIPID RES, V47, P412, DOI 10.1194/jlr.M500438-JLR200; HAMALAINEN N, 1993, J HISTOCHEM CYTOCHEM, V41, P733, DOI 10.1177/41.5.8468455; Hawke TJ, 2003, J BIOL CHEM, V278, P4015, DOI 10.1074/jbc.M209200200; Kemp JG, 2009, INT J OBESITY, V33, P831, DOI 10.1038/ijo.2009.100; Koopman R, 2001, HISTOCHEM CELL BIOL, V116, P63; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Krause MP, 2008, AM J PHYSIOL-CELL PH, V295, pC203, DOI 10.1152/ajpcell.00030.2008; Krause MP, 2009, J APPL PHYSIOL, V106, P1650, DOI 10.1152/japplphysiol.91565.2008; Lee JS, 2006, J APPL PHYSIOL, V100, P1467, DOI 10.1152/japplphysiol.01438.2005; Lionetti L, 2007, INT J OBESITY, V31, P1596, DOI 10.1038/sj.ijo.0803636; MARIN P, 1994, DIABETES CARE, V17, P382, DOI 10.2337/diacare.17.5.382; OGILVIE RW, 1990, STAIN TECHNOL, V65, P231, DOI 10.3109/10520299009105613; Pimenta AS, 2008, J CELL PHYSIOL, V217, P478, DOI 10.1002/jcp.21520; Sayer AA, 2005, DIABETES CARE, V28, P2541, DOI 10.2337/diacare.28.10.2541; Sciacco M, 1996, Methods Enzymol, V264, P509, DOI 10.1016/S0076-6879(96)64045-2; Silveira LR, 2008, J CELL PHYSIOL, V217, P1, DOI 10.1002/jcp.21514; Smith AC, 2007, AM J PHYSIOL-ENDOC M, V293, pE172, DOI 10.1152/ajpendo.00677.2006; Sparks LM, 2005, DIABETES, V54, P1926, DOI 10.2337/diabetes.54.7.1926; Tanji K, 2008, METHODS, V46, P274, DOI 10.1016/j.ymeth.2008.09.027; Turner N, 2007, DIABETES, V56, P2085, DOI 10.2337/db07-0093; Turpin SM, 2009, J PHYSIOL-LONDON, V587, P1593, DOI 10.1113/jphysiol.2008.166033	29	86	89	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7293	10.1371/journal.pone.0007293	http://dx.doi.org/10.1371/journal.pone.0007293			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806198	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593800008
J	Wei, BR; Hoover, SB; Ross, MM; Zhou, WD; Meani, F; Edwards, JB; Spehalski, EI; Risinger, JI; Alvord, WG; Quinones, OA; Belluco, C; Martella, L; Campagnutta, E; Ravaggi, A; Dai, RM; Goldsmith, PK; Woolard, KD; Pecorelli, S; Liotta, LA; Petricoin, EF; Simpson, RM				Wei, Bih-Rong; Hoover, Shelley B.; Ross, Mark M.; Zhou, Weidong; Meani, Francesco; Edwards, Jennifer B.; Spehalski, Elizabeth I.; Risinger, John I.; Alvord, W. Gregory; Quinones, Octavio A.; Belluco, Claudio; Martella, Luca; Campagnutta, Elio; Ravaggi, Antonella; Dai, Ren-Ming; Goldsmith, Paul K.; Woolard, Kevin D.; Pecorelli, Sergio; Liotta, Lance A.; Petricoin, Emanuel F., III; Simpson, R. Mark			Serum S100A6 Concentration Predicts Peritoneal Tumor Burden in Mice with Epithelial Ovarian Cancer and Is Associated with Advanced Stage in Patients	PLOS ONE			English	Article							PHASE PROTEIN MICROARRAYS; CALCIUM-BINDING PROTEINS; ALBUMIN-BINDING; INCREASED EXPRESSION; SAMPLE PREPARATION; MODEL; METASTASIS; BIOMARKERS; SURVIVAL; MOUSE	Background: Ovarian cancer is the 5th leading cause of cancer related deaths in women. Five-year survival rates for early stage disease are greater than 94%, however most women are diagnosed in advanced stage with 5 year survival less than 28%. Improved means for early detection and reliable patient monitoring are needed to increase survival. Methodology and Principal Findings: Applying mass spectrometry-based proteomics, we sought to elucidate an unanswered biomarker research question regarding ability to determine tumor burden detectable by an ovarian cancer biomarker protein emanating directly from the tumor cells. Since aggressive serous epithelial ovarian cancers account for most mortality, a xenograft model using human SKOV-3 serous ovarian cancer cells was established to model progression to disseminated carcinomatosis. Using a method for low molecular weight protein enrichment, followed by liquid chromatography and mass spectrometry analysis, a human-specific peptide sequence of S100A6 was identified in sera from mice with advanced-stage experimental ovarian carcinoma. S100A6 expression was documented in cancer xenografts as well as from ovarian cancer patient tissues. Longitudinal study revealed that serum S100A6 concentration is directly related to tumor burden predictions from an inverse regression calibration analysis of data obtained from a detergent-supplemented antigen capture immunoassay and whole-animal bioluminescent optical imaging. The result from the animal model was confirmed in human clinical material as S100A6 was found to be significantly elevated in the sera from women with advanced stage ovarian cancer compared to those with early stage disease. Conclusions: S100A6 is expressed in ovarian and other cancer tissues, but has not been documented previously in ovarian cancer disease sera. S100A6 is found in serum in concentrations that correlate with experimental tumor burden and with clinical disease stage. The data signify that S100A6 may prove useful in detecting and/or monitoring ovarian cancer, when used in concert with other biomarkers.			Wei, BR (corresponding author), NCI, Mol Pathol Unit, Lab Canc Biol & Genet, Ctr Canc Res, Bethesda, MD 20892 USA.	ms43b@nih.gov	Martella, Luca/ABD-8896-2020; Ravaggi, Antonella/K-5585-2016; Meani, Francesco/GWZ-1745-2022; belluco, claudio/J-1339-2018	Martella, Luca/0000-0002-2058-1469; Ravaggi, Antonella/0000-0003-4661-9979; belluco, claudio/0000-0001-5972-9574	NATIONAL CANCER INSTITUTE [ZICBC010953] Funding Source: NIH RePORTER; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [N01-CO-12400, N01CO12400] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Aguilar-Mahecha A, 2009, PROTEOME SCI, V7, DOI 10.1186/1477-5956-7-15; Ahmed FE, 2009, J SEP SCI, V32, P771, DOI 10.1002/jssc.200800622; ALVORD WG, 1993, J IMMUNOL METHODS, V157, P155; BAST RC, 1985, GYNECOL ONCOL, V22, P115, DOI 10.1016/0090-8258(85)90015-0; BAST RC, 1985, EUR J OBSTET GYN R B, V19, P354, DOI 10.1016/0028-2243(85)90130-3; Bast RC., 2003, J CLIN ONCOL, V21, P200, DOI [10.1200/JCO.2003.01.068, DOI 10.1200/JCO.2003.01.068]; Besada V, 2006, PROTEOMICS, V6, P1038, DOI 10.1002/pmic.200500151; Brown LM, 2006, MOL CARCINOGEN, V45, P613, DOI 10.1002/mc.20193; Camerini S, 2007, PROTEOM CLIN APPL, V1, P176, DOI 10.1002/prca.200600618; Cannistra SA, 2004, NEW ENGL J MED, V351, P2519, DOI 10.1056/NEJMra041842; Crnogorac-Jurcevic T, 2003, J PATHOL, V201, P63, DOI 10.1002/path.1418; Cross SS, 2005, HISTOPATHOLOGY, V46, P256, DOI 10.1111/j.1365-2559.2005.02097.x; Custer MC, 2006, PROSTATE, V66, P567, DOI 10.1002/pros.20386; De Petris L, 2009, LUNG CANCER, V63, P410, DOI 10.1016/j.lungcan.2008.06.003; DELEAN A, 1978, AM J PHYSIOL, V235, pE97, DOI 10.1152/ajpendo.1978.235.2.E97; Dennis MS, 2002, J BIOL CHEM, V277, P35035, DOI 10.1074/jbc.M205854200; Donato R, 1999, BBA-MOL CELL RES, V1450, P191, DOI 10.1016/S0167-4889(99)00058-0; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Draper N.R, 1998, WILEY SERIES PROBABI, Vthird; Faca Vitor, 2009, V492, P309, DOI 10.1007/978-1-59745-493-3_19; Filipek A, 2006, CHEMOTHERAPY, V52, P32, DOI 10.1159/000090240; Grote T, 2008, PROTEOMICS, V8, P3051, DOI 10.1002/pmic.200700951; Hood BL, 2005, J AM SOC MASS SPECTR, V16, P1221, DOI 10.1016/j.jasms.2005.02.005; *INS CORP, 2005, S PLUS 7 0 WIND; Ito Y, 2005, HISTOPATHOLOGY, V46, P569, DOI 10.1111/j.1365-2559.2005.02137.x; Jemal A, 2008, CA-CANCER J CLIN, V58, P71, DOI 10.3322/CA.2007.0010; Juan HF, 2004, PROTEOMICS, V4, P2766, DOI 10.1002/pmic.200400785; Kelly-Spratt KS, 2008, J PROTEOME RES, V7, P3613, DOI 10.1021/pr800210b; Komatsu K, 2000, BRIT J CANCER, V83, P769, DOI 10.1054/bjoc.2000.1356; Kurtzhals P, 1995, BIOCHEM J, V312, P725, DOI 10.1042/bj3120725; KUZNICKI J, 1992, EXP CELL RES, V200, P425, DOI 10.1016/0014-4827(92)90191-A; Littell R. C., 2006, SAS SYSTEMS MIXED MO, V2nd; Luque-Garcia JL, 2007, J CHROMATOGR A, V1153, P259, DOI 10.1016/j.chroma.2006.11.054; Luu HH, 2005, CANCER LETT, V229, P135, DOI 10.1016/j.canlet.2005.02.015; Makrides SC, 1996, J PHARMACOL EXP THER, V277, P534; Milliken G. A., 2009, ANAL MESSY DATA DESI, V2nd; Nossov V, 2008, AM J OBSTET GYNECOL, V199, P215, DOI 10.1016/j.ajog.2008.04.009; Ohuchida K, 2005, CLIN CANCER RES, V11, P7785, DOI 10.1158/1078-0432.CCR-05-0714; Ohuchida K, 2007, CANCER EPIDEM BIOMAR, V16, P649, DOI 10.1158/1055-9965.EPI-06-0157; Paweletz CP, 2001, ONCOGENE, V20, P1981, DOI 10.1038/sj.onc.1204265; Petricoin EF, 2002, LANCET, V359, P572, DOI 10.1016/S0140-6736(02)07746-2; Petricoin EF, 2006, NAT REV CANCER, V6, P961, DOI 10.1038/nrc2011; Rantalainen M, 2006, J PROTEOME RES, V5, P2642, DOI 10.1021/pr060124w; Rapkiewicz AV, 2004, EUR J CANCER, V40, P2604, DOI 10.1016/j.ejca.2004.05.021; Rosen DG, 2009, FRONT BIOSCI-LANDMRK, V14, P2089, DOI 10.2741/3364; SAS Institute, 2002, SAS STAT SOFTW; Schafer BW, 1996, TRENDS BIOCHEM SCI, V21, P134, DOI 10.1016/S0968-0004(96)80167-8; Schaub MC, 2008, BIOCHEM BIOPH RES CO, V369, P247, DOI 10.1016/j.bbrc.2007.10.082; Shan WW, 2009, CELL CYCLE, V8, P731, DOI 10.4161/cc.8.5.7848; Shih IM, 2004, AM J PATHOL, V164, P1511, DOI 10.1016/S0002-9440(10)63708-X; Team RDC, 2019, R LANG ENV STAT COMP; Vimalachandran D, 2005, CANCER RES, V65, P3218, DOI 10.1158/0008-5472.CAN-04-4311; Wei BR, 2008, TOXICOL PATHOL, V36, P972, DOI 10.1177/0192623308327120; Williams TI, 2007, J PROTEOME RES, V6, P2936, DOI 10.1021/pr070041v; Young RC, 2003, JNCI-J NATL CANCER I, V95, P94, DOI 10.1093/jnci/95.2.94; Zietarska M, 2007, MOL CARCINOGEN, V46, P872, DOI 10.1002/mc.20315	56	33	37	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2009	4	10							e7670	10.1371/journal.pone.0007670	http://dx.doi.org/10.1371/journal.pone.0007670			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RW	19888321	Green Submitted, Green Published, gold			2022-12-27	WOS:000271414300015
J	Matsuda, F; Shinbo, Y; Oikawa, A; Hirai, MY; Fiehn, O; Kanaya, S; Saito, K				Matsuda, Fumio; Shinbo, Yoko; Oikawa, Akira; Hirai, Masami Yokota; Fiehn, Oliver; Kanaya, Shigehiko; Saito, Kazuki			Assessment of Metabolome Annotation Quality: A Method for Evaluating the False Discovery Rate of Elemental Composition Searches	PLOS ONE			English	Article							NEUTRAL LOSS COMPOSITIONS; TANDEM MASS-SPECTROMETRY; LIQUID-CHROMATOGRAPHY; PRODUCT IONS; IDENTIFICATION; DECONVOLUTION; INTEGRATION; LIPIDOMICS; DIVERSITY; REVEALS	Background: In metabolomics researches using mass spectrometry (MS), systematic searching of high-resolution mass data against compound databases is often the first step of metabolite annotation to determine elemental compositions possessing similar theoretical mass numbers. However, incorrect hits derived from errors in mass analyses will be included in the results of elemental composition searches. To assess the quality of peak annotation information, a novel methodology for false discovery rates (FDR) evaluation is presented in this study. Based on the FDR analyses, several aspects of an elemental composition search, including setting a threshold, estimating FDR, and the types of elemental composition databases most reliable for searching are discussed. Methodology/Principal Findings: The FDR can be determined from one measured value (i.e., the hit rate for search queries) and four parameters determined by Monte Carlo simulation. The results indicate that relatively high FDR values (30-50%) were obtained when searching time-of-flight (TOF)/MS data using the KNApSAcK and KEGG databases. In addition, searches against large all-in-one databases (e. g., PubChem) always produced unacceptable results (FDR>70%). The estimated FDRs suggest that the quality of search results can be improved not only by performing more accurate mass analysis but also by modifying the properties of the compound database. A theoretical analysis indicates that FDR could be improved by using compound database with smaller but higher completeness entries. Conclusions/Significance: High accuracy mass analysis, such as Fourier transform (FT)-MS, is needed for reliable annotation (FDR<10%). In addition, a small, customized compound database is preferable for high-quality annotation of metabolome data.			Matsuda, F (corresponding author), RIKEN, Plant Sci Ctr, Metabolome Res Grp, Kanagawa, Japan.	ksaito@psc.riken.jp	Oikawa, Akira/D-2715-2017; Hirai, Masami Y/D-5319-2009; Saito, Kazuki/D-2670-2009	Hirai, Masami Y/0000-0003-0802-6208; Saito, Kazuki/0000-0001-6310-5342				Abate-Shen C, 2009, NATURE, V457, P799, DOI 10.1038/457799a; Bino RJ, 2004, TRENDS PLANT SCI, V9, P418, DOI 10.1016/j.tplants.2004.07.004; Bocker S, 2008, BIOINFORMATICS, V24, pI49, DOI 10.1093/bioinformatics/btn270; Bottcher C, 2008, PLANT PHYSIOL, V147, P2107, DOI 10.1104/pp.108.117754; Choi H, 2008, J PROTEOME RES, V7, P47, DOI 10.1021/pr700747q; De Vos RCH, 2007, NAT PROTOC, V2, P778, DOI 10.1038/nprot.2007.95; Dettmer K, 2007, MASS SPECTROM REV, V26, P51, DOI 10.1002/mas.20108; Dixon RA, 2003, PHYTOCHEMISTRY, V62, P815, DOI 10.1016/S0031-9422(02)00712-4; Dunn WB, 2008, PHYS BIOL, V5, DOI 10.1088/1478-3975/5/1/011001; Elias JE, 2007, NAT METHODS, V4, P207, DOI 10.1038/nmeth1019; GIAVALISCO P, 2009, ANAL CHEM IN PRESS; Grange AH, 2006, RAPID COMMUN MASS SP, V20, P89, DOI 10.1002/rcm.2277; Grange AH, 2008, RAPID COMMUN MASS SP, V22, P2375, DOI 10.1002/rcm.3619; Hegeman AD, 2007, ANAL CHEM, V79, P6912, DOI 10.1021/ac070346t; Hirai MY, 2004, P NATL ACAD SCI USA, V101, P10205, DOI 10.1073/pnas.0403218101; Iijima Y, 2008, PLANT J, V54, P949, DOI 10.1111/j.1365-313X.2008.03434.x; Kall L, 2008, J PROTEOME RES, V7, P29, DOI 10.1021/pr700600n; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Kaufmann A, 2007, RAPID COMMUN MASS SP, V21, P2003, DOI 10.1002/rcm.3035; Kiefer P, 2008, ANAL BIOCHEM, V382, P94, DOI 10.1016/j.ab.2008.07.010; Kind T, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-105; Kind T, 2007, ANAL BIOCHEM, V363, P185, DOI 10.1016/j.ab.2007.01.028; Koulman A, 2009, RAPID COMMUN MASS SP, V23, P1411, DOI 10.1002/rcm.4015; Madalinski G, 2008, ANAL CHEM, V80, P3291, DOI 10.1021/ac7024915; Matsuda F, 2009, PLANT J, V57, P555, DOI 10.1111/j.1365-313X.2008.03705.x; Moco S, 2007, TRAC-TREND ANAL CHEM, V26, P855, DOI 10.1016/j.trac.2007.08.003; Oikawa A, 2006, PLANT PHYSIOL, V142, P398, DOI 10.1104/pp.106.080317; Ojanpera S, 2006, RAPID COMMUN MASS SP, V20, P1161, DOI 10.1002/rcm.2429; Scheltema RA, 2008, PROTEOMICS, V8, P4647, DOI 10.1002/pmic.200800314; Schmidt J, 2007, PHYTOCHEMISTRY, V68, P189, DOI 10.1016/j.phytochem.2006.10.003; Schwab W, 2003, PHYTOCHEMISTRY, V62, P837, DOI 10.1016/S0031-9422(02)00723-9; Shinbo Y, 2006, BIOTECH AGR FOREST, V57, P165; Soga T, 2006, J BIOL CHEM, V281, P16768, DOI 10.1074/jbc.M601876200; Sumner LW, 2007, METABOLOMICS, V3, P211, DOI 10.1007/s11306-007-0082-2; Suzuki H, 2008, PHYTOCHEMISTRY, V69, P99, DOI 10.1016/j.phytochem.2007.06.017; Suzuki S, 2005, RAPID COMMUN MASS SP, V19, P3500, DOI 10.1002/rcm.2220; Tabb DL, 2008, J PROTEOME RES, V7, P45, DOI 10.1021/pr700728t; Takahashi H, 2008, ANAL BIOANAL CHEM, V391, P2769, DOI 10.1007/s00216-008-2195-5; Watanabe M, 2008, PLANT PHYSIOL, V146, P310, DOI 10.1104/pp.107.106831; Werner E, 2008, J CHROMATOGR B, V871, P143, DOI 10.1016/j.jchromb.2008.07.004; Wheeler DL, 2008, NUCLEIC ACIDS RES, V36, pD13, DOI 10.1093/nar/gkm1000	42	49	50	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7490	10.1371/journal.pone.0007490	http://dx.doi.org/10.1371/journal.pone.0007490			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19847304	gold, Green Published, Green Submitted			2022-12-27	WOS:000270880700014
J	Masson, O; Chavey, C; Dray, C; Meulle, A; Daviaud, D; Quilliot, D; Muller, C; Valet, P; Liaudet-Coopman, E				Masson, Olivier; Chavey, Carine; Dray, Cedric; Meulle, Aline; Daviaud, Danielle; Quilliot, Didier; Muller, Catherine; Valet, Philippe; Liaudet-Coopman, Emmanuelle			LRP1 Receptor Controls Adipogenesis and Is Up-Regulated In Human and Mouse Obese Adipose Tissue	PLOS ONE			English	Article								The cell surface low-density lipoprotein receptor-related protein 1, LRP1, plays a major role in lipid metabolism. The question that remains open concerns the function of LRP1 in adipogenesis. Here, we show that LRP1 is highly expressed in murine preadipocytes as well as in primary culture of human adipocytes. Moreover, LRP1 remains abundantly synthesised during mouse and human adipocyte differentiation. We demonstrate that LRP1 silencing in 3T3F442A murine preadipocytes significantly inhibits the expression of PPAR gamma, HSL and aP2 adipocyte differentiation markers after adipogenesis induction, and leads to lipid-depleted cells. We further show that the absence of lipids in LRP1-silenced preadipocytes is not caused by lipolysis induction. In addition, we provide the first evidences that LRP1 is significantly up-regulated in obese C57BI6/J mouse adipocytes and obese human adipose tissues. Interestingly, silencing of LRP1 in fully-differentiated adipocytes also reduces cellular lipid level and is associated with an increase of basal lipolysis. However, the ability of mature adipocytes to induce lipolysis is independent of LRP1 expression. Altogether, our findings highlight the dual role of LRP1 in the control of adipogenesis and lipid homeostasis, and suggest that LRP1 may be an important therapeutic target in obesity.			Masson, O (corresponding author), Univ Montpellier 1, INSERM, IRCM,U896, CRLC Val Aurelle Paul Lamarque, Montpellier, France.	e.liaudet@valdorel.fnclcc.fr	Meulle, Aline/M-6370-2014; MULLER, Catherine/M-2185-2018; Liaudet-Coopman, Emmanuelle/N-4744-2017; Valet, Philippe/N-7472-2017; MULLER, Catherine/E-2060-2011; Quillot, Didier/ABB-5326-2021; dray, cedric/N-7440-2017	Liaudet-Coopman, Emmanuelle/0000-0001-9313-9690; Valet, Philippe/0000-0001-6520-7393; DRAY, Cedric/0000-0002-4712-791X; Chavey, Carine/0000-0002-5267-5638				BEISIEGEL U, 1989, NATURE, V341, P162, DOI 10.1038/341162a0; BEISIEGEL U, 1991, P NATL ACAD SCI USA, V88, P8342, DOI 10.1073/pnas.88.19.8342; Bour S, 2007, BIOCHIMIE, V89, P916, DOI 10.1016/j.biochi.2007.02.013; CHAPPELL DA, 1992, J BIOL CHEM, V267, P25764; CHAPPELL DA, 1993, J BIOL CHEM, V268, P14168; CHAPPELL DA, 1994, J BIOL CHEM, V269, P18001; Daviaud D, 2006, FASEB J, V20, P1528, DOI 10.1096/fj.05-5243fje; DESCAMPS O, 1993, J BIOL CHEM, V268, P974; Fears CY, 2005, CANCER RES, V65, P9338, DOI 10.1158/0008-5472.CAN-05-1560; Gao JH, 2007, DIABETES, V56, P24, DOI 10.2337/db06-0144; Gauthier A, 2003, J BIOL CHEM, V278, P11945, DOI 10.1074/jbc.M212989200; He WM, 2003, P NATL ACAD SCI USA, V100, P15712, DOI 10.1073/pnas.2536828100; Heeren J, 2002, J MOL MED-JMM, V80, P576, DOI 10.1007/s00109-002-0351-5; Hofmann SM, 2007, J CLIN INVEST, V117, P3271, DOI 10.1172/JCI31929; Huang ZH, 2006, DIABETES, V55, P3394, DOI 10.2337/db06-0354; JI ZS, 1993, J BIOL CHEM, V268, P10160; Kahn SE, 2006, NATURE, V444, P840, DOI 10.1038/nature05482; KOUNNAS MZ, 1995, J BIOL CHEM, V270, P9307, DOI 10.1074/jbc.270.16.9307; KOWAL RC, 1989, P NATL ACAD SCI USA, V86, P5810, DOI 10.1073/pnas.86.15.5810; Lillis AP, 2008, PHYSIOL REV, V88, P887, DOI 10.1152/physrev.00033.2007; Neese RA, 2002, P NATL ACAD SCI USA, V99, P15345, DOI 10.1073/pnas.232551499; NYKJAER A, 1993, J BIOL CHEM, V268, P15048; Prawitt J, 2008, EXP CELL RES, V314, P814, DOI 10.1016/j.yexcr.2007.11.011; RAMIREZZACARIAS JL, 1992, HISTOCHEMISTRY, V97, P493, DOI 10.1007/BF00316069; SPIEGELMAN BM, 1982, CELL, V29, P53, DOI 10.1016/0092-8674(82)90089-7; Terrand J, 2009, J BIOL CHEM, V284, P381, DOI 10.1074/jbc.M806538200; TONTONOZ P, 1994, GENE DEV, V8, P1224, DOI 10.1101/gad.8.10.1224; Vassiliou G, 2001, J BIOL CHEM, V276, P48823, DOI 10.1074/jbc.M103954200; VIGNON F, 1986, ENDOCRINOLOGY, V118, P1537, DOI 10.1210/endo-118-4-1537; WILLNOW TE, 1994, J CELL SCI, V107, P719; WILLNOW TE, 1992, J BIOL CHEM, V267, P26172; Yue LL, 2004, J BIOL CHEM, V279, P47626, DOI 10.1074/jbc.M408461200; Zhang HY, 2004, J BIOL CHEM, V279, P2221, DOI 10.1074/jbc.M310679200; Zurhove K, 2008, SCI SIGNAL, V1, DOI 10.1126/scisignal.1164263	34	44	46	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7422	10.1371/journal.pone.0007422	http://dx.doi.org/10.1371/journal.pone.0007422			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823686	Green Published, gold, Green Submitted			2022-12-27	WOS:000270728500020
J	Ropert-Coudert, Y; Brooks, L; Yamamoto, M; Kato, A				Ropert-Coudert, Yan; Brooks, Lisa; Yamamoto, Maki; Kato, Akiko			ECG Response of Koalas to Tourists Proximity: A Preliminary Study	PLOS ONE			English	Article								Koalas operate on a tight energy budget and, thus, may not always display behavioral avoidance reaction when placed in a stressful condition. We investigated the physiological response of captive koalas Phascolarctos cinereus in a conservation centre to the presence of tourists walking through their habitat. We compared, using animal-attached data-recorders, the electrocardiogram activity of female koalas in contact with tourists and in a human-free area. One of the koalas in the tourist zone presented elevated heart rate values and variability throughout the recording period. The remaining female in the exhibit area showed a higher field resting heart rates during the daytime than that in the isolated area. In the evening, heart rate profiles changed drastically and both the koalas in the exhibit and in the tourist-free zones displayed similar field resting heart rates, which were lower than those during the day. In parallel, the autonomic nervous systems of these two individuals evolved from sympathetic-dominant during the day to parasympathetic-dominant in the evening. Our results report ECG of free-living koalas for the first time. Although they are preliminary due to the difficulty of having sufficient samples of animals of the same sex and age, our results stress out the importance of studies investigating the physiological reaction of animals to tourists.	[Ropert-Coudert, Yan] Inst Pluridisciplinaire Hubert Curien, UMR7178, Strasbourg, France; [Brooks, Lisa] Phillip Isl Nat Pk, Koala Conservat Ctr, Cowes, Vic, Australia; [Yamamoto, Maki] Nagaoka Univ Technol, Dept Bioengn, Nagaoka, Niigata, Japan; [Kato, Akiko] Natl Inst Polar Res, Tachikawa, Tokyo 1908518, Japan	Centre National de la Recherche Scientifique (CNRS); CNRS - National Institute of Nuclear and Particle Physics (IN2P3); Nagaoka University of Technology; Research Organization of Information & Systems (ROIS); National Institute of Polar Research (NIPR) - Japan	Ropert-Coudert, Y (corresponding author), Inst Pluridisciplinaire Hubert Curien, UMR7178, Strasbourg, France.	yan.ropert-coudert@c-strasbourg.fr	Kato, Akiko/W-2447-2019	Kato, Akiko/0000-0002-8947-3634				Accorsi PA, 2008, GEN COMP ENDOCR, V155, P398, DOI 10.1016/j.ygcen.2007.07.002; BLANSHARD W, 1994, WILDLIFE, P547; Culik B., 1990, P177; De Villiers M, 2006, POLAR BIOL, V29, P717, DOI 10.1007/s00300-006-0137-2; Eckert R, 1978, ANIMAL PHYSL; FISHER LA, 1983, REGUL PEPTIDES, V5, P153, DOI 10.1016/0167-0115(83)90123-4; Froget G, 2002, J EXP BIOL, V205, P2511; Handasyde, 1999, KOALA NATURAL HIST C; Hume I.D., 1999, MARSUPIAL NUTR; JACKSON SM, 2003, AUSTR MAMMALS BIOL C, P163; KINNEAR JE, 1967, NATURE, V215, P1501, DOI 10.1038/2151501a0; Krockenberger AK, 2007, FUNCT ECOL, V21, P748, DOI 10.1111/j.1365-2435.2007.01279.x; Kuwahara M, 1999, LAB ANIM SCI, V49, P202; Kuwahara M, 1996, J AUTONOM NERV SYST, V60, P43, DOI 10.1016/0165-1838(96)00028-8; McPhee JM, 2003, J EXP BIOL, V206, P1941, DOI 10.1242/jeb.00369; NAGY KA, 1985, AUST J ZOOL, V33, P655, DOI 10.1071/ZO9850655; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Ropert-Coudert Y, 2004, ANIM BEHAV, V67, P985, DOI 10.1016/j.anbehav.2003.09.010; Ropert-Coudert Y, 2006, MAR ECOL PROG SER, V328, P275, DOI 10.3354/meps328275; Sakamoto KQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005379; von Borell E, 2007, PHYSIOL BEHAV, V92, P293, DOI 10.1016/j.physbeh.2007.01.007; Ward S, 2002, J EXP BIOL, V205, P3347; Wilson RP, 2006, J ANIM ECOL, V75, P1081, DOI 10.1111/j.1365-2656.2006.01127.x; YAMAMOTO M, 2001, THESIS GRADUATE U AD	24	12	14	0	17	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7378	10.1371/journal.pone.0007378	http://dx.doi.org/10.1371/journal.pone.0007378			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823679	gold, Green Submitted, Green Published			2022-12-27	WOS:000270728500004
J	Bhagavatula, P; Claudianos, C; Ibbotson, M; Srinivasan, M				Bhagavatula, Partha; Claudianos, Charles; Ibbotson, Michael; Srinivasan, Mandyam			Edge Detection in Landing Budgerigars (Melopsittacus undulatus)	PLOS ONE			English	Article								Background: While considerable scientific effort has been devoted to studying how birds navigate over long distances, relatively little is known about how targets are detected, obstacles are avoided and smooth landings are orchestrated. Here we examine how visual features in the environment, such as contrasting edges, determine where a bird will land. Methodology/Principal Findings: Landing in budgerigars (Melopsittacus undulatus) was investigated by training them to fly from a perch to a feeder, and video-filming their landings. The feeder was placed on a grey disc that produced a contrasting edge against a uniformly blue background. We found that the birds tended to land primarily at the edge of the disc and walk to the feeder, even though the feeder was in the middle of the disc. This suggests that the birds were using the visual contrast at the boundary of the disc to target their landings. When the grey level of the disc was varied systematically, whilst keeping the blue background constant, there was one intermediate grey level at which the budgerigar's preference for the disc boundary disappeared. The budgerigars then landed randomly all over the test surface. Even though this disc is (for humans) clearly distinguishable from the blue background, it offers very little contrast against the background, in the red and green regions of the spectrum. Conclusions: We conclude that budgerigars use visual edges to target and guide landings. Calculations of photoreceptor excitation reveal that edge detection in landing budgerigars is performed by a color-blind luminance channel that sums the signals from the red and green photoreceptors, or, alternatively, receives input from the red double-cones. This finding has close parallels to vision in honeybees and primates, where edge detection and motion perception are also largely color-blind.			Bhagavatula, P (corresponding author), Australian Natl Univ, ARC Ctr Excellence Vis Sci, Canberra, ACT, Australia.	m.srinivasan@uq.edu.au	Ibbotson, Michael R/C-9305-2009	Ibbotson, Michael R/0000-0002-3803-6653; Claudianos, Charles/0000-0002-9799-9572; Muthukumarasamy, Srinivasan/0000-0002-2948-6206; BHAGAVATULA, PARTHA/0000-0003-0942-2974				CARON R, 2009, BEHAV PROCESS, V80, P196; D'eath RB, 1998, BIOL REV, V73, P267, DOI 10.1017/S0006323198005179; DAVIES MNO, 1988, J EXP BIOL, V138, P71; DAVIES MNO, 1991, ZOOL JAHRB ALLG ZOOL, V95, P331; DAVIES MNO, 1990, NATURWISSENSCHAFTEN, V77, P142, DOI 10.1007/BF01134481; Egelhaaf M, 2002, CURR OPIN NEUROBIOL, V12, P699, DOI 10.1016/S0959-4388(02)00390-2; Gibson JJ, 1950, PERCEPTION VISUAL WO; GINSBURG N, 1971, J EXP ANAL BEHAV, V15, P189, DOI 10.1901/jeab.1971.15-189; Goldsmith TH, 2003, J COMP PHYSIOL A, V189, P135, DOI 10.1007/s00359-002-0385-8; Goldsmith TH, 2005, J COMP PHYSIOL A, V191, P933, DOI 10.1007/s00359-005-0024-2; HATEREN JH, 1990, J COMP PHYSIOL A, V167, P649; IBBOTSON MR, 1991, J EXP BIOL, V157, P573; Ibbotson MR, 2001, P ROY SOC B-BIOL SCI, V268, P2195, DOI 10.1098/rspb.2001.1770; Lau KK, 2006, J THEOR BIOL, V239, P71, DOI 10.1016/j.jtbi.2005.07.013; LEE DN, 1981, NATURE, V293, P293, DOI 10.1038/293293a0; LEE DN, 1993, J EXP BIOL, V180, P85; LEHRER M, 1990, PROC R SOC SER B-BIO, V238, P321, DOI 10.1098/rspb.1990.0002; LEHRER M, 1987, Israel Journal of Entomology, V21, P51; LIVINGSTONE MS, 1987, J NEUROSCI, V7, P3416; Plath M., 1935, Zeitschrift fuer Vergleichende Physiologie, V22, P691; SCHEFLER WC, 1979, STAT BIOL SCI, P48; Srinivasan M V, 2000, Int Rev Neurobiol, V44, P67; TROJE NF, 2001, 6 INT C NEUROETHOLOG; YATES D, 1999, PRACTICE STAT, P678	24	16	16	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7301	10.1371/journal.pone.0007301	http://dx.doi.org/10.1371/journal.pone.0007301			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809500	gold, Green Published			2022-12-27	WOS:000270594000002
J	Green, JA; Tran, CTH; Farrar, JJ; Nguyen, MTH; Nguyen, PH; Dinh, SX; Ho, NDT; Ly, CV; Tran, HT; Friedland, JS; Thwaites, GE				Green, Justin A.; Tran, Chau T. H.; Farrar, Jeremy J.; Nguyen, Mai T. H.; Nguyen, Phu H.; Dinh, Sinh X.; Ho, Nghia D. T.; Ly, Chuong V.; Tran, Hien T.; Friedland, Jon S.; Thwaites, Guy E.			Dexamethasone, Cerebrospinal Fluid Matrix Metalloproteinase Concentrations and Clinical Outcomes in Tuberculous Meningitis	PLOS ONE			English	Article								Background: Adjunctive dexamethasone reduces mortality from tuberculous meningitis, but how it produces this effect is not known. Matrix metalloproteinases (MMPs) are important in the immunopathology of many inflammatory CNS diseases thus we hypothesized that that their secretion is important in TBM and might be influenced by dexamethasone. Methodology/Principal Findings: The kinetics of cerebrospinal fluid (CSF) MMP and tissue inhibitors of MMPs (TIMPs) concentrations were studied in a subset of HIV uninfected adults (n=37) with TBM recruited to a randomized, placebocontrolled trial of adjuvant dexamethasone. Analysis followed a pre-defined plan. Dexamethasone significantly reduced CSF MMP-9 concentrations in early follow up samples (median 5 days (range 3-8) of treatment), but had no significant influence on other MMPs/TIMPs. Additionally CSF MMP-9 concentration was strongly correlated to concomitant CSF neutrophil count. Conclusions/Significance: Dexamethasone decreased CSF MMP-9 concentrations early in treatment and this may represent one mechanism by which corticosteroids improve outcome in TBM. The strong correlation between CSF MMP-9 and neutrophil count suggests that polymorphonuclear leukocytes may play a central role in the early pathogenesis of TBM.			Green, JA (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Infect Dis & Immun, London, England.	j.friedland@imperial.ac.uk	Farrar, Jeremy J./HGA-7610-2022; Thwaites, Guy E/R-4993-2019; Tran, Chau/GRX-4633-2022	Thwaites, Guy E/0000-0002-2858-2087; Farrar, Jeremy/0000-0002-2700-623X; Friedland, Jonathan S/0000-0001-7789-9649	MRC [G0500385] Funding Source: UKRI; Medical Research Council [G0500385] Funding Source: Medline; Wellcome Trust Funding Source: Medline	MRC(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)); Wellcome Trust(Wellcome Trust)		Bottcher T, 2003, NEUROSCI LETT, V338, P201, DOI 10.1016/S0304-3940(02)01406-4; Chang JC, 1996, THORAX, V51, P306, DOI 10.1136/thx.51.3.306; Cuadrado E, 2008, J LEUKOCYTE BIOL, V84, P207, DOI 10.1189/jlb.0907606; Elkington PTG, 2005, AM J RESP CRIT CARE, V172, P1596, DOI 10.1164/rccm.200505-753OC; Harris JE, 2007, FASEB J, V21, P356, DOI 10.1096/fj.06-6925com; Harris JE, 2007, J IMMUNOL, V178, P1199, DOI 10.4049/jimmunol.178.2.1199; Hoheisel G, 2001, TUBERCULOSIS, V81, P203, DOI 10.1054/tube.2000.0276; Hrabec E, 2002, INT J TUBERC LUNG D, V6, P713; Keller C, 2004, TUBERCULOSIS, V84, P144, DOI 10.1016/j.tube.2003.12.003; Lee KY, 2004, J NEUROL SCI, V220, P73, DOI 10.1016/j.jns.2004.02.008; Leppert D, 2000, CLIN INFECT DIS, V31, P80, DOI 10.1086/313922; Liu L, 2005, INFLAMM RES, V54, P37, DOI 10.1007/s00011-004-1320-y; Liu XJ, 2008, BRAIN RES, V1207, P237, DOI 10.1016/j.brainres.2008.01.106; Martineau AR, 2007, J CLIN INVEST, V117, P1988, DOI 10.1172/JCI31097; Matsuura E, 2000, J NEUROL SCI, V173, P45, DOI 10.1016/S0022-510X(99)00303-2; McGeer PL, 1999, J LEUKOCYTE BIOL, V65, P409, DOI 10.1002/jlb.65.4.409; Okada S, 1997, AM J RESP CELL MOL, V17, P519, DOI 10.1165/ajrcmb.17.4.2877; Opdenakker G, 2001, J LEUKOCYTE BIOL, V69, P851; Price NM, 2001, J IMMUNOL, V166, P4223, DOI 10.4049/jimmunol.166.6.4223; Rivera-Marrero CA, 2000, MICROB PATHOGENESIS, V29, P231, DOI 10.1006/mpat.2000.0383; Rosenberg GA, 2002, GLIA, V39, P279, DOI 10.1002/glia.10108; Rosenberg GA, 2005, LANCET, V365, P1291, DOI 10.1016/S0140-6736(05)61008-2; Schoeman JF, 2001, ANN TROP PAEDIATR, V21, P299, DOI 10.1080/07430170120093481; Sellner J, 2006, NEUROBIOL DIS, V21, P647, DOI 10.1016/j.nbd.2005.09.007; Simmons CP, 2005, J IMMUNOL, V175, P579, DOI 10.4049/jimmunol.175.1.579; Snoek-van Beurden PAM, 2005, BIOTECHNIQUES, V38, P73, DOI 10.2144/05381RV01; Sulik A, 2008, SCAND J IMMUNOL, V68, P323, DOI 10.1111/j.1365-3083.2008.02137.x; Taylor JL, 2006, INFECT IMMUN, V74, P6135, DOI 10.1128/IAI.02048-05; TEASDALE G, 1974, LANCET, V2, P81; Thwaites GE, 2004, NEW ENGL J MED, V351, P1741, DOI 10.1056/NEJMoa040573; Thwaites GE, 2003, J INFECT DIS, V188, P1105, DOI 10.1086/378642; Thwaites GE, 2007, LANCET NEUROL, V6, P230, DOI 10.1016/S1474-4422(07)70034-0; van Horssen J, 2005, J NEUROPATH EXP NEUR, V64, P722, DOI 10.1097/01.jnen.0000173894.09553.13; Zhang KY, 2003, NAT NEUROSCI, V6, P1064, DOI 10.1038/nn1127	34	51	53	2	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7277	10.1371/journal.pone.0007277	http://dx.doi.org/10.1371/journal.pone.0007277			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789647	Green Published, gold, Green Submitted, Green Accepted			2022-12-27	WOS:000270354100025
J	Kweku, M; Webster, J; Adjuik, M; Abudey, S; Greenwood, B; Chandramohan, D				Kweku, Margaret; Webster, Jayne; Adjuik, Martin; Abudey, Samuel; Greenwood, Brian; Chandramohan, Daniel			Options for the Delivery of Intermittent Preventive Treatment for Malaria to Children: A Community Randomised Trial	PLOS ONE			English	Article							SULFADOXINE-PYRIMETHAMINE; PREGNANCY; IMPACT; CARE	Background: Intermittent preventive treatment for malaria in children (IPTc) is a promising new intervention for the prevention of malaria but its delivery is a challenge. We have evaluated the coverage of IPTc that can be achieved by two different delivery systems in Ghana. Methods: IPTc was delivered by volunteers in six villages (community-based arm) and by health workers at health centres or at Expanded Programme on Immunisation outreach clinics (facility based) in another six communities. The villages were selected randomly and drugs were administered in May, June, September and October 2006. The first dose of a three-dose regimen of amodiaquine plus sulphadoxine-pyrimethamine was administered under supervision to 3-59 month-old children (n=964) in the 12 study villages; doses for days 2 and 3 were given to parents/guardians to administer at home. Results: The proportion of children who received at least the first dose of 3 or more courses of IPTc was slightly higher in the community based arm (90.5% vs 86.6%; p=0.059). Completion of the three dose regimen was high and similar with both delivery systems (91.6% and 91.7% respectively). Conclusion: Seasonal IPTc delivered through community-based or facility-based systems can achieve a high coverage rate with the support and supervision of the district health management team. However, in order to maximise the impact of IPTc, both delivery systems may be needed in some settings.			Kweku, M (corresponding author), London Sch Hyg & Trop Med, London WC1, England.	Daniel.chandramohan@lshtm.ac.uk		Webster, Jayne/0000-0002-0498-8883				Chinbuah AM, 2006, TROP MED INT HEALTH, V11, P1003, DOI 10.1111/j.1365-3156.2006.01654.x; Cisse B, 2006, LANCET, V367, P659, DOI 10.1016/S0140-6736(06)68264-0; Dicko A, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-123; Hill J, 2006, TROP MED INT HEALTH, V11, P409, DOI 10.1111/j.1365-3156.2006.01585.x; Katabarwa MN, 2005, TROP MED INT HEALTH, V10, P312, DOI 10.1111/j.1365-3156.2005.01396.x; Katabarwa MN, 2001, ANN TROP MED PARASIT, V95, P275, DOI 10.1080/00034983.2001.11813639; Kidane G, 2000, LANCET, V356, P550, DOI 10.1016/S0140-6736(00)02580-0; Kweku M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004000; Mbonye AK, 2007, T ROY SOC TROP MED H, V101, P1088, DOI 10.1016/j.trstmh.2007.06.017; Msyamboza KP, 2009, TROP MED INT HEALTH, V14, P183, DOI 10.1111/j.1365-3156.2008.02197.x; NDYOMUGYENYI R, 2009, T ROYAL SOC IN PRESS; Pagnoni F, 1997, T ROY SOC TROP MED H, V91, P512, DOI 10.1016/S0035-9203(97)90006-7; Ramaiah KD, 2001, TROP MED INT HEALTH, V6, P1062, DOI 10.1046/j.1365-3156.2001.00813.x; Sirima SB, 2003, TROP MED INT HEALTH, V8, P133, DOI 10.1046/j.1365-3156.2003.00997.x; Smith P. G., 1996, FIELD TRIALS HLTH IN; Sokhna C, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001471	16	29	29	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7256	10.1371/journal.pone.0007256	http://dx.doi.org/10.1371/journal.pone.0007256			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789648	Green Published, Green Submitted, gold, Green Accepted			2022-12-27	WOS:000270354100015
J	Johnson, BF; Wilson, LE; Ellis, J; Elliot, AJ; Barclay, WS; Pebody, RG; McMenamin, J; Fleming, DM; Zambon, MC				Johnson, Benjamin F.; Wilson, Louise E.; Ellis, Joanna; Elliot, Alex J.; Barclay, Wendy S.; Pebody, Richard G.; McMenamin, Jim; Fleming, Douglas M.; Zambon, Maria C.			Fatal Cases of Influenza A in Childhood	PLOS ONE			English	Article							VIRUS; HEMAGGLUTININ; CHILDREN	Background: In the northern hemisphere winter of 2003-04 antigenic variant strains (A/Fujian/411/02 -like) of influenza A H3N2 emerged. Circulation of these strains in the UK was accompanied by an unusually high number of laboratory confirmed influenza associated fatalities in children. This study was carried out to better understand risk factors associated with fatal cases of influenza in children. Methodology/Principal Findings: Case histories, autopsy reports and death registration certificates for seventeen fatal cases of laboratory confirmed influenza in children were analyzed. None had a recognized pre-existing risk factor for severe influenza and none had been vaccinated. Three cases had evidence of significant bacterial co-infection. Influenza strains recovered from fatal cases were antigenically similar to those circulating in the community. A comparison of protective antibody titres in age stratified cohort sera taken before and after winter 2003-04 showed that young children had the highest attack rate during this season (21% difference, 95% confidence interval from 0.09 to 0.33, p = 0.0009). Clinical incidences of influenza-like illness (ILI) in young age groups were shown to be highest only in the years when novel antigenic drift variants emerged. Conclusions/Significance: This work presents a rare insight into fatal influenza H3N2 in healthy children. It confirms that circulating seasonal influenza A H3N2 strains can cause severe disease and death in children in the apparent absence of associated bacterial infection or predisposing risk factors. This adds to the body of evidence demonstrating the burden of severe illness due to seasonal influenza A in childhood.			Johnson, BF (corresponding author), Hlth Protect Agcy, Ctr Infect, London, England.	maria.zambon@hpa.org.uk		Elliot, Alex/0000-0002-6414-3065; Johnson, Benjamin/0000-0001-5991-7612; Barclay, Wendy/0000-0002-3948-0895; Pebody, Richard/0000-0002-9069-2885				Bhat N, 2005, NEW ENGL J MED, V353, P2559, DOI 10.1056/NEJMoa051721; *CDC, 2009, N ENGL J MED; *CDC, 2009, TALK POINTS DEATHS C; COOKE MC, 2005, CDR SUPPLEMENT; de Jong J C, 2003, Dev Biol (Basel), V115, P63; Donaldson L, 2008, INFLUENZA IMMUNISATI; Fleming DM, 2008, EPIDEMIOL INFECT, V136, P866, DOI 10.1017/S0950268807009910; Fleming DM, 2007, EPIDEMIOL INFECT, V135, P1099, DOI 10.1017/S0950268807007881; Fleming D M, 2000, Commun Dis Public Health, V3, P32; Hackett S, 2009, LANCET, V374, P605, DOI 10.1016/S0140-6736(09)61511-7; Jin H, 2005, VIROLOGY, V336, P113, DOI 10.1016/j.virol.2005.03.010; Matrosovich M, 2003, J VIROL, V77, P8418, DOI 10.1128/JVI.77.15.8418-8425.2003; Morens DM, 2008, J INFECT DIS, V198, P962, DOI 10.1086/591708; Poehling KA, 2006, NEW ENGL J MED, V355, P31, DOI 10.1056/NEJMoa054869; Taubenberger JK, 2008, ANNU REV PATHOL-MECH, V3, P499, DOI 10.1146/annurev.pathmechdis.3.121806.154316; WILSON IA, 1990, ANNU REV IMMUNOL, V8, P737, DOI 10.1146/annurev.iy.08.040190.003513; ZAMBON M, 1998, TXB INFLUENZA	17	20	20	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2009	4	10							e7671	10.1371/journal.pone.0007671	http://dx.doi.org/10.1371/journal.pone.0007671			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RW	19876396	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414300016
J	Hu, C; Zhang, R; Wang, CR; Wang, J; Ma, XJ; Lu, JY; Qin, W; Hou, XH; Wang, C; Bao, YQ; Xiang, KS; Jia, WP				Hu, Cheng; Zhang, Rong; Wang, Congrong; Wang, Jie; Ma, Xiaojing; Lu, Jingyi; Qin, Wen; Hou, Xuhong; Wang, Chen; Bao, Yuqian; Xiang, Kunsan; Jia, Weiping			PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 Are Associated with Type 2 Diabetes in a Chinese Population	PLOS ONE			English	Article							GENOME-WIDE ASSOCIATION; COMMON VARIANTS; EUROPEAN POPULATIONS; GENETIC-VARIANTS; INSULIN-RELEASE; RISK LOCI; SUSCEPTIBILITY; REPLICATION; GLUCOSE; MELLITUS	Background: Recent advance in genetic studies added the confirmed susceptible loci for type 2 diabetes to eighteen. In this study, we attempt to analyze the independent and joint effect of variants from these loci on type 2 diabetes and clinical phenotypes related to glucose metabolism. Methods/Principal Findings: Twenty-one single nucleotide polymorphisms ( SNPs) from fourteen loci were successfully genotyped in 1,849 subjects with type 2 diabetes and 1,785 subjects with normal glucose regulation. We analyzed the allele and genotype distribution between the cases and controls of these SNPs as well as the joint effects of the susceptible loci on type 2 diabetes risk. The associations between SNPs and type 2 diabetes were examined by logistic regression. The associations between SNPs and quantitative traits were examined by linear regression. The discriminative accuracy of the prediction models was assessed by area under the receiver operating characteristic curves. We confirmed the effects of SNPs from PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 on risk for type 2 diabetes, with odds ratios ranging from 1.114 to 1.406 ( P value range from 0.0335 to 1.37E-12). But no significant association was detected between SNPs from WFS1, FTO, JAZF1, TSPAN8-LGR5, THADA, ADAMTS9, NOTCH2-ADAM30 and type 2 diabetes. Analyses on the quantitative traits in the control subjects showed that THADA SNP rs7578597 was association with 2-h insulin during oral glucose tolerance tests (P = 0.0005, empirical P = 0.0090). The joint effect analysis of SNPs from eleven loci showed the individual carrying more risk alleles had a significantly higher risk for type 2 diabetes. And the type 2 diabetes patients with more risk allele tended to have earlier diagnostic ages (P = 0.0006). Conclusions/Significance: The current study confirmed the association between PPARG, KCNJ11, CDKAL1, CDKN2A-CDKN2B, IDE-KIF11-HHEX, IGF2BP2 and SLC30A8 and type 2 diabetes. These type 2 diabetes risk loci contributed to the disease additively.			Hu, C (corresponding author), Shanghai Jiao Tong Univ, Dept Endocrinol & Metab, Affiliated Peoples Hosp 6, Shanghai 200030, Peoples R China.	wpjia@sjtu.edu.cn	Hu, Cheng/C-3346-2008; 王, 从容/HDM-0959-2022; Wang, Congrong/AAL-8178-2020; Jia, Weiping/B-7483-2012	Hu, Cheng/0000-0003-4314-2386; 王, 从容/0000-0002-8645-1114; 				Alberti KGMM, 1998, DIABETIC MED, V15, P539, DOI 10.1002/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S; Drieschner N, 2007, GENE, V403, P110, DOI 10.1016/j.gene.2007.06.029; Franks PW, 2008, DIABETOLOGIA, V51, P458, DOI 10.1007/s00125-007-0887-6; Frayling TM, 2007, SCIENCE, V316, P889, DOI 10.1126/science.1141634; Gloyn AL, 2001, BEST PRACT RES CL EN, V15, P293, DOI 10.1053/beem.2001.0147; Grarup N, 2008, DIABETES, V57, P2534, DOI 10.2337/db08-0436; Grarup N, 2007, DIABETES, V56, P3105, DOI 10.2337/db07-0856; Horikawa Y, 2008, J CLIN ENDOCR METAB, V93, P3136, DOI 10.1210/jc.2008-0452; HU C, 2009, DIABETOLOGIA; Jia WP, 2007, DIABETOLOGIA, V50, P286, DOI 10.1007/s00125-006-0503-1; Lango H, 2008, DIABETES, V57, P3129, DOI 10.2337/db08-0504; MATTHEWS DR, 1985, DIABETOLOGIA, V28, P412, DOI 10.1007/BF00280883; Ng MCY, 2008, DIABETES, V57, P2226, DOI 10.2337/db07-1583; Purcell S, 2007, AM J HUM GENET, V81, P559, DOI 10.1086/519795; Saxena R, 2007, SCIENCE, V316, P1331, DOI 10.1126/science.1142358; Scott LJ, 2007, SCIENCE, V316, P1341, DOI 10.1126/science.1142382; Sladek R, 2007, NATURE, V445, P881, DOI 10.1038/nature05616; Unoki H, 2008, NAT GENET, V40, P1098, DOI 10.1038/ng.208; van Hoek M, 2008, DIABETES, V57, P3122, DOI 10.2337/db08-0425; Wang CR, 2009, DIABETES, V58, P1023, DOI 10.2337/db08-1064; Wasson J, 2008, DIABETOLOGIA, V51, P391, DOI 10.1007/s00125-007-0920-9; Winckler W, 2007, DIABETES, V56, P685, DOI 10.2337/db06-0202; Wu Y, 2008, DIABETES, V57, P2834, DOI 10.2337/db08-0047; Yasuda K, 2008, NAT GENET, V40, P1092, DOI 10.1038/ng.207; Zeggini E, 2008, NAT GENET, V40, P638, DOI 10.1038/ng.120; Zeggini E, 2007, SCIENCE, V316, P1336, DOI 10.1126/science.1142364	26	134	146	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 28	2009	4	10							e7643	10.1371/journal.pone.0007643	http://dx.doi.org/10.1371/journal.pone.0007643			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511UJ	19862325	gold, Green Submitted, Green Published			2022-12-27	WOS:000271194600020
J	Schulze, SR; Curio-Penny, B; Speese, S; Dialynas, G; Cryderman, DE; McDonough, CW; Nalbant, D; Petersen, M; Budnik, V; Geyer, PK; Wallrath, LL				Schulze, Sandra R.; Curio-Penny, Beatrice; Speese, Sean; Dialynas, George; Cryderman, Diane E.; McDonough, Caitrin W.; Nalbant, Demet; Petersen, Melissa; Budnik, Vivian; Geyer, Pamela K.; Wallrath, Lori L.			A Comparative Study of Drosophila and Human A-Type Lamins	PLOS ONE			English	Article							DREIFUSS MUSCULAR-DYSTROPHY; TO-AUTOINTEGRATION FACTOR; LEM-DOMAIN PROTEINS; NUCLEAR LAMIN; DILATED CARDIOMYOPATHY; PARTIAL LIPODYSTROPHY; IN-VITRO; GENE; ENVELOPE; ORGANIZATION	Nuclear intermediate filament proteins, called lamins, form a meshwork that lines the inner surface of the nuclear envelope. Lamins contain three domains: an N-terminal head, a central rod and a C-terminal tail domain possessing an Ig-fold structural motif. Lamins are classified as either A-or B-type based on structure and expression pattern. The Drosophila genome possesses two genes encoding lamins, Lamin C and lamin Dm(0), which have been designated A-and B-type, respectively, based on their expression profile and structural features. In humans, mutations in the gene encoding A-type lamins are associated with a spectrum of predominantly tissue-specific diseases known as laminopathies. Linking the disease phenotypes to cellular functions of lamins has been a major challenge. Drosophila is being used as a model system to identify the roles of lamins in development. Towards this end, we performed a comparative study of Drosophila and human A-type lamins. Analysis of transgenic flies showed that human lamins localize predictably within the Drosophila nucleus. Consistent with this finding, yeast two-hybrid data demonstrated conservation of partner-protein interactions. Drosophila lacking A-type lamin show nuclear envelope defects similar to those observed with human laminopathies. Expression of mutant forms of the A-type Drosophila lamin modeled after human disease-causing amino acid substitutions revealed an essential role for the N-terminal head and the Ig-fold in larval muscle tissue. This tissue-restricted sensitivity suggests a conserved role for lamins in muscle biology. In conclusion, we show that (1) localization of A-type lamins and protein-partner interactions are conserved between Drosophila and humans, (2) loss of the Drosophila A-type lamin causes nuclear defects and (3) muscle tissue is sensitive to the expression of mutant forms of A-type lamin modeled after those causing disease in humans. These studies provide new insights on the role of lamins in nuclear biology and support Drosophila as a model for studies of human laminopathies involving muscle dysfunction.			Schulze, SR (corresponding author), Western Washington Univ, Dept Biol, Bellingham, WA 98225 USA.	lori-wallrath@uiowa.edu		Wallrath, Lori/0000-0002-4391-7199; McDonough, Caitrin/0000-0001-6393-7288; Geyer, Pamela/0000-0001-9275-1407	NIMH NIH HHS [R01 MH070000] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH070000] Funding Source: NIH RePORTER	NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH))		AKAI H, 1967, SCIENCE, V157, P810, DOI 10.1126/science.157.3790.810; Beard GS, 2008, BIOCHEM SOC T, V36, P1389, DOI 10.1042/BST0361389; Bier E, 2005, NAT REV GENET, V6, P9, DOI 10.1038/nrg1503; Brandt A, 2008, AGING CELL, V7, P541, DOI 10.1111/j.1474-9726.2008.00406.x; BUDNIK V, 1990, J NEUROSCI, V10, P3754; Cai ML, 2001, EMBO J, V20, P4399, DOI 10.1093/emboj/20.16.4399; Crisp M, 2006, J CELL BIOL, V172, P41, DOI 10.1083/jcb.200509124; Duffy JB, 2002, GENESIS, V34, P1, DOI 10.1002/gene.10150; Emery AEH, 2000, NEUROMUSCULAR DISORD, V10, P228, DOI 10.1016/S0960-8966(00)00105-X; Erber A, 1999, J MOL EVOL, V49, P260, DOI 10.1007/PL00006548; Fanti L, 1998, MOL CELL, V2, P527, DOI 10.1016/S1097-2765(00)80152-5; Fidzianska A, 2003, J NEUROL SCI, V210, P47, DOI 10.1016/S0022-510X(03)00012-1; Fidzianska A, 1998, J NEUROL SCI, V159, P88, DOI 10.1016/S0022-510X(98)00130-0; FILSHIE B, 1999, J INVERTEBR PATHOL, V9; Fischer JA, 2004, GENETICS, V168, P1385, DOI 10.1534/genetics.104.028662; Foster HA, 2007, CHROMOSOME RES, V15, P163, DOI 10.1007/s10577-006-1088-8; FRIEDMAN TB, 1992, J MOL EVOL, V34, P62, DOI 10.1007/BF00163853; Furukawa K, 2003, J CELL SCI, V116, P3811, DOI 10.1242/jcs.00682; Guillemin K, 2001, NAT CELL BIOL, V3, P848, DOI 10.1038/ncb0901-848; Haque F, 2006, MOL CELL BIOL, V26, P3738, DOI 10.1128/MCB.26.10.3738-3751.2006; Harborth J, 2001, J CELL SCI, V114, P4557; Herrmann H, 2003, CELL MOL LIFE SCI, V60, P1607, DOI 10.1007/s00018-003-3004-0; Holt I, 2003, J CELL SCI, V116, P3027, DOI 10.1242/jcs.00599; Hutchison CJ, 2001, J CELL SCI, V114, P9; Isobe K, 2007, BIOSCI BIOTECH BIOCH, V71, P1252, DOI 10.1271/bbb.60674; Jacob KN, 2006, MOL GENET METAB, V87, P289, DOI 10.1016/j.ymgme.2005.10.018; JAMES TC, 1989, EUR J CELL BIOL, V50, P170; Krimm I, 2002, STRUCTURE, V10, P811, DOI 10.1016/S0969-2126(02)00777-3; Laguri C, 2001, STRUCTURE, V9, P503, DOI 10.1016/S0969-2126(01)00611-6; LenzBohme B, 1997, J CELL BIOL, V137, P1001, DOI 10.1083/jcb.137.5.1001; LIN DM, 1994, NEURON, V13, P507, DOI 10.1016/0896-6273(94)90022-1; Mattout A, 2006, CURR OPIN CELL BIOL, V18, P335, DOI 10.1016/j.ceb.2006.03.007; Mejat A, 2009, J CELL BIOL, V184, P31, DOI 10.1083/jcb.200811035; Melcer S, 2007, EXP CELL RES, V313, P2157, DOI 10.1016/j.yexcr.2007.03.004; Misteli T, 2005, NAT MED, V11, P718, DOI 10.1038/nm0705-718; Moir RD, 2000, J CELL BIOL, V149, P1179, DOI 10.1083/jcb.149.6.1179; Mosley-Bishop KL, 1999, CURR BIOL, V9, P1211, DOI 10.1016/S0960-9822(99)80501-6; Muchir A, 2003, EXP CELL RES, V291, P352, DOI 10.1016/j.yexcr.2003.07.002; Munoz-Alarcon A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000532; Nikolova V, 2004, J CLIN INVEST, V113, P357, DOI 10.1172/JCI200419448; Osouda S, 2005, DEV BIOL, V284, P219, DOI 10.1016/j.ydbio.2005.05.022; Ostlund C, 2001, J CELL SCI, V114, P4435; Patterson K, 2004, MOL BIOL CELL, V15, P600, DOI 10.1091/mbc.E03-06-0374; Pickersgill H, 2006, NAT GENET, V38, P1005, DOI 10.1038/ng1852; Pinto BS, 2008, GENETICS, V180, P133, DOI 10.1534/genetics.108.091371; Raharjo WH, 2001, J CELL SCI, V114, P4447; RIEMER D, 1995, J CELL SCI, V108, P3189; RIZKI TM, 1970, GENETICS, V64, P459; ROBER RA, 1989, DEVELOPMENT, V105, P365; Sameshima M, 2001, J STRUCT BIOL, V136, P7, DOI 10.1006/jsbi.2001.4424; Schulze SR, 2005, GENETICS, V171, P185, DOI 10.1534/genetics.105.043208; Segura-Totten M, 2002, J CELL BIOL, V158, P475, DOI 10.1083/jcb.200202019; Shumaker DK, 2005, P NATL ACAD SCI USA, V102, P15494, DOI 10.1073/pnas.0507612102; Spann TP, 1997, J CELL BIOL, V136, P1201, DOI 10.1083/jcb.136.6.1201; Spann TP, 2002, J CELL BIOL, V156, P603, DOI 10.1083/jcb.200112047; Stewart CL, 2007, SCIENCE, V318, P1408, DOI 10.1126/science.1142034; Stierle VN, 2003, BIOCHEMISTRY-US, V42, P4819, DOI 10.1021/bi020704g; Strelkov SV, 2004, J MOL BIOL, V343, P1067, DOI 10.1016/j.jmb.2004.08.093; Sullivan T, 1999, J CELL BIOL, V147, P913, DOI 10.1083/jcb.147.5.913; Sylvius N, 2005, J MED GENET, V42, P639, DOI 10.1136/jmg.2004.023283; Vlcek S, 2007, BBA-MOL CELL RES, V1773, P661, DOI 10.1016/j.bbamcr.2006.07.002; Wagner N, 2004, EUR J CELL BIOL, V82, P605, DOI 10.1078/0171-9335-00350; Wagner N, 2007, INT REV CYTOL, V261, P1, DOI 10.1016/S0074-7696(07)61001-8; Walter MC, 2005, NEUROMUSCULAR DISORD, V15, P40, DOI 10.1016/j.nmd.2004.09.007; WILDER EL, 1995, DEVELOPMENT, V121, P477; Worman HJ, 2004, J CLIN INVEST, V113, P349, DOI 10.1172/JCI200420832; Worman HJ, 2007, EXP CELL RES, V313, P2121, DOI 10.1016/j.yexcr.2007.03.028; Zastrow MS, 2004, J CELL SCI, V117, P979, DOI 10.1242/jcs.01102; Zhang HG, 2002, GENETICS, V162, P1283; Zhang QP, 2002, GENOMICS, V80, P473, DOI 10.1006/geno.2002.6859	70	36	37	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7564	10.1371/journal.pone.0007564	http://dx.doi.org/10.1371/journal.pone.0007564			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855837	gold, Green Published			2022-12-27	WOS:000271147200007
J	Davies, P; Brown, DR				Davies, Paul; Brown, David R.			Manganese Enhances Prion Protein Survival in Model Soils and Increases Prion Infectivity to Cells	PLOS ONE			English	Article							METAL-BINDING; SCRAPIE VIRUS; FATE; ADSORPTION; DISEASE; COPPER; MONTMORILLONITE; PATHOGENESIS; INITIATE; TSES	Prion diseases are considered to be transmissible. The existence of sporadic forms of prion diseases such as scrapie implies an environmental source for the infectious agent. This would suggest that under certain conditions the prion protein, the accepted agent of transmission, can survive in the environment. We have developed a novel technique to extract the prion protein from soil matrices. Previous studies have suggested that environmental manganese is a possible risk factor for prion diseases. We have shown that exposure to manganese is a soil matrix causes a dramatic increase in prion protein survival (similar to 10 fold) over a two year period. We have also shown that manganese increases infectivity of mouse passaged scrapie to culture cells by 2 logs. These results clearly verify that manganese is a risk factor for both the survival of the infectious agent in the environment and its transmissibility.			Davies, P (corresponding author), Univ Bath, Dept Biol & Biochem, Bath BA2 7AY, Avon, England.	bssdrb@bath.ac.uk		Davies, Paul/0000-0001-8022-2719	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Abollino O, 2008, APPL CLAY SCI, V38, P227, DOI 10.1016/j.clay.2007.04.002; Birkett CR, 2001, EMBO J, V20, P3351, DOI 10.1093/emboj/20.13.3351; BOST M, 2002, PRION DIS COPPER MET, P119; Brazier MW, 2008, J BIOL CHEM, V283, P12831, DOI 10.1074/jbc.M709820200; Brown DR, 2000, EMBO J, V19, P1180, DOI 10.1093/emboj/19.6.1180; Brown DR, 1997, NATURE, V390, P684, DOI 10.1038/37733; BROWN P, 1991, LANCET, V337, P269, DOI 10.1016/0140-6736(91)90873-N; Chihota CM, 2004, VET REC, V154, P809, DOI 10.1136/vr.154.26.809; Cooke CM, 2007, ENVIRON SCI TECHNOL, V41, P811, DOI 10.1021/es0618189; Davies P, 2009, BIOCHEMISTRY-US, V48, P2610, DOI 10.1021/bi900170n; Deer W. A., 1992, INTRO ROCK FORMING M; Fischer M, 1996, EMBO J, V15, P1255, DOI 10.1002/j.1460-2075.1996.tb00467.x; Gale P, 2001, J APPL MICROBIOL, V91, P563, DOI 10.1046/j.1365-2672.2001.01466.x; HADLOW WJ, 1982, J INFECT DIS, V146, P657, DOI 10.1093/infdis/146.5.657; Hesketh S, 2007, J ANIM SCI, V85, P1596, DOI 10.2527/jas.2006-714; Hesketh S, 2008, MOL CELL NEUROSCI, V37, P590, DOI 10.1016/j.mcn.2007.12.008; Imrie CE, 2009, ENVIRON GEOCHEM HLTH, V31, P133, DOI 10.1007/s10653-008-9172-y; Johnson CJ, 2007, PLOS PATHOG, V3, P874, DOI 10.1371/journal.ppat.0030093; Johnson CJ, 2006, PLOS PATHOG, V2, P296, DOI 10.1371/journal.ppat.0020032; Kralovicova S, 2009, MOL CELL NEUROSCI, V41, P135, DOI 10.1016/j.mcn.2009.02.002; Leita L, 2006, SOIL BIOL BIOCHEM, V38, P1638, DOI 10.1016/j.soilbio.2005.11.018; Miller MW, 2004, EMERG INFECT DIS, V10, P1003, DOI 10.3201/eid1006.040010; Nishida Y, 2003, Z NATURFORSCH C, V58, P752; Norde W, 2000, J BIOTECHNOL, V79, P259, DOI 10.1016/S0168-1656(00)00242-X; PENNINGTON JAT, 1991, J AM DIET ASSOC, V91, P179; Polano M, 2008, BIOCHEM BIOPH RES CO, V367, P323, DOI 10.1016/j.bbrc.2007.12.143; Prusiner SB, 1996, TRENDS BIOCHEM SCI, V21, P482, DOI 10.1016/S0968-0004(96)10063-3; Prusiner SB, 1998, P NATL ACAD SCI USA, V95, P13363, DOI 10.1073/pnas.95.23.13363; Purdey M, 2005, MED HYPOTHESES, V65, P448, DOI 10.1016/j.mehy.2005.03.018; Purdey M, 2004, MED HYPOTHESES, V63, P211, DOI 10.1016/j.mehy.2004.02.041; Purdey M, 2001, MED HYPOTHESES, V57, P29, DOI 10.1054/mehy.2001.1305; Purdey M, 2000, MED HYPOTHESES, V54, P278, DOI 10.1054/mehy.1999.0836; Ragnarsdottir KV, 2006, J GEOCHEM EXPLOR, V88, P228, DOI 10.1016/j.gexplo.2005.08.046; Revault M, 2005, BBA-GEN SUBJECTS, V1724, P367, DOI 10.1016/j.bbagen.2005.05.005; Rigou P, 2006, ENVIRON SCI TECHNOL, V40, P1497, DOI 10.1021/es0516965; Roy G, 2000, CLAY MINER, V35, P335, DOI 10.1180/000985500546800; Russo F, 2009, J GEN VIROL, V90, P275, DOI 10.1099/vir.0.003251-0; Saunders SE, 2008, PRION, V2, P162, DOI 10.4161/pri.2.4.7951; Servagent-Noinville S, 2000, J COLLOID INTERF SCI, V221, P273, DOI 10.1006/jcis.1999.6576; Stumm W., CHEM SOLID WATER INT; Thackray AM, 2002, BIOCHEM J, V362, P253, DOI 10.1042/0264-6021:3620253; Thompsett AR, 2005, J BIOL CHEM, V280, P42750, DOI 10.1074/jbc.M506521200; Vasina EN, 2005, BIOMACROMOLECULES, V6, P3425, DOI 10.1021/bm050492d; Wiggins RC, 2009, NEUROCHEM RES, V34, P158, DOI 10.1007/s11064-008-9741-6; Wong BS, 2001, J NEUROCHEM, V78, P1400, DOI 10.1046/j.1471-4159.2001.00522.x; Wong BS, 2001, PANMINERVA MED, V43, P283	47	38	38	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7518	10.1371/journal.pone.0007518	http://dx.doi.org/10.1371/journal.pone.0007518			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844576	Green Published, gold, Green Submitted			2022-12-27	WOS:000271013000006
J	Di Serio, F; Gisel, A; Navarro, B; Delgado, S; Martinez de Alba, AE; Donvito, G; Flores, R				Di Serio, Francesco; Gisel, Andreas; Navarro, Beatriz; Delgado, Sonia; Martinez de Alba, Angel-Emilio; Donvito, Giacinto; Flores, Ricardo			Deep Sequencing of the Small RNAs Derived from Two Symptomatic Variants of a Chloroplastic Viroid: Implications for Their Genesis and for Pathogenesis	PLOS ONE			English	Article							IN-VITRO; INFECTED PLANTS; ROLLING CIRCLE; SELF-CLEAVAGE; PEACH CALICO; REPLICATION; PATHWAY; VIVO; HETEROGENEITY; PATHOGENICITY	Northern-blot hybridization and low-scale sequencing have revealed that plants infected by viroids, non-protein-coding RNA replicons, accumulate 21-24 nt viroid-derived small RNAs (vd-sRNAs) similar to the small interfering RNAs, the hallmarks of RNA silencing. These results strongly support that viroids are elicitors and targets of the RNA silencing machinery of their hosts. Low-scale sequencing, however, retrieves partial datasets and may lead to biased interpretations. To overcome this restraint we have examined by deep sequencing (Solexa-Illumina) and computational approaches the vd-sRNAs accumulating in GF-305 peach seedlings infected by two molecular variants of Peach latent mosaic viroid (PLMVd) inciting peach calico (albinism) and peach mosaic. Our results show in both samples multiple PLMVd-sRNAs, with prevalent 21-nt (+) and (2) RNAs presenting a biased distribution of their 5' nucleotide, and adopting a hotspot profile along the genomic (+) and (2) RNAs. Dicer-like 4 and 2 (DCL4 and DCL2, respectively), which act hierarchically in antiviral defense, likely also mediate the genesis of the 21- and 22-nt PLMVd-sRNAs. More specifically, because PLMVd replicates in plastids wherein RNA silencing has not been reported, DCL4 and DCL2 should dice the PLMVd genomic RNAs during their cytoplasmic movement or the PLMVd-dsRNAs generated by a cytoplasmic RNA-dependent RNA polymerase (RDR), like RDR6, acting in concert with DCL4 processing. Furthermore, given that vd-sRNAs derived from the 12-14-nt insertion containing the pathogenicity determinant of peach calico are underrepresented, it is unlikely that symptoms may result from the accidental targeting of host mRNAs by vd-sRNAs from this determinant guiding the RNA silencing machinery.			Di Serio, F (corresponding author), CNR, Ist Virol Vegetale, I-70126 Bari, Italy.	rflores@ibmcp.upv.es	Martínez de Alba, Ángel Emilio/B-1935-2013; Donvito, Giacinto/AAC-9872-2020; Flores, Ricardo/K-2788-2014; Navarro, Beatriz/B-9128-2015; Gisel, Andreas/AAW-2335-2020; Di Serio, Francesco/I-5191-2012	Martínez de Alba, Ángel Emilio/0000-0002-1198-3415; Donvito, Giacinto/0000-0002-0628-1080; Flores, Ricardo/0000-0002-3033-5077; Navarro, Beatriz/0000-0001-8981-1018; Di Serio, Francesco/0000-0003-2822-704X; GISEL, ANDREAS/0000-0001-7218-9488				ALTSCHUL SF, 1990, J MOL BIOL, V215, P403, DOI 10.1016/S0022-2836(05)80360-2; Ambros S, 1999, J GEN VIROL, V80, P2239, DOI 10.1099/0022-1317-80-8-2239; Ambros S, 1998, J VIROL, V72, P7397; Barba M, 2009, J PLANT PATHOL, V91, P243; Bouche N, 2006, EMBO J, V25, P3347, DOI 10.1038/sj.emboj.7601217; BRANCH AD, 1988, P NATL ACAD SCI USA, V85, P9128, DOI 10.1073/pnas.85.23.9128; Brodersen P, 2006, TRENDS GENET, V22, P268, DOI 10.1016/j.tig.2006.03.003; Bussiere F, 1999, J VIROL, V73, P6353; Bussiere F, 2000, J VIROL, V74, P2647, DOI 10.1128/JVI.74.6.2647-2654.2000; Carbonell A, 2008, VIROLOGY, V371, P44, DOI 10.1016/j.virol.2007.09.031; DAROS JA, 1994, P NATL ACAD SCI USA, V91, P12813, DOI 10.1073/pnas.91.26.12813; Daros JA, 2002, EMBO J, V21, P749, DOI 10.1093/emboj/21.4.749; Deleris A, 2006, SCIENCE, V313, P68, DOI 10.1126/science.1128214; Delgado S, 2005, J VIROL, V79, P12934, DOI 10.1128/JVI.79.20.12934-12943.2005; Diaz-Pendon JA, 2008, ANNU REV PHYTOPATHOL, V46, P303, DOI 10.1146/annurev.phyto.46.081407.104746; Diener TO, 2003, NAT REV MICROBIOL, V1, P75, DOI 10.1038/nrmicro736; Ding B, 2007, MOL PLANT MICROBE IN, V20, P7, DOI 10.1094/MPMI-20-0007; Ding B, 2009, ANNU REV PHYTOPATHOL, V47, P105, DOI 10.1146/annurev-phyto-080508-081927; Ding SW, 2007, CELL, V130, P413, DOI 10.1016/j.cell.2007.07.039; Eamens A, 2008, PLANT PHYSIOL, V147, P456, DOI 10.1104/pp.108.117275; Flores R, 2000, ADV VIRUS RES, V55, P271, DOI 10.1016/S0065-3527(00)55006-4; Flores R, 2005, ANNU REV PHYTOPATHOL, V43, P117, DOI 10.1146/annurev.phyto.43.040204.140243; Flores R, 2006, MOL PLANT PATHOL, V7, P209, DOI [10.1111/j.1364-3703.2006.00332.x, 10.1111/J.1364-3703.2006.00332.X]; Fusaro AF, 2006, EMBO REP, V7, P1168, DOI 10.1038/sj.embor.7400837; Gago S, 2005, RNA, V11, P1073, DOI 10.1261/rna.2230605; Gago S, 2009, SCIENCE, V323, P1308, DOI 10.1126/science.1169202; Gas ME, 2007, PLOS PATHOG, V3, P1813, DOI 10.1371/journal.ppat.0030182; Gomez G, 2007, PLANT J, V51, P1041, DOI 10.1111/j.1365-313X.2007.03203.x; Gomez G, 2009, TRENDS PLANT SCI, V14, P264, DOI 10.1016/j.tplants.2009.03.002; GROSS HJ, 1978, NATURE, V273, P203, DOI 10.1038/273203a0; HERNANDEZ C, 1992, P NATL ACAD SCI USA, V89, P3711, DOI 10.1073/pnas.89.9.3711; Herr AJ, 2006, P NATL ACAD SCI USA, V103, P14994, DOI 10.1073/pnas.0606536103; Ho T, 2007, FEBS LETT, V581, P3267, DOI 10.1016/j.febslet.2007.06.022; Howell MD, 2007, PLANT CELL, V19, P926, DOI 10.1105/tpc.107.050062; HUTCHINS CJ, 1986, NUCLEIC ACIDS RES, V14, P3627, DOI 10.1093/nar/14.9.3627; Itaya A, 2001, MOL PLANT MICROBE IN, V14, P1332, DOI 10.1094/MPMI.2001.14.11.1332; Itaya A, 2007, J VIROL, V81, P2980, DOI 10.1128/JVI.02339-06; Kasschau KD, 2003, DEV CELL, V4, P205, DOI 10.1016/S1534-5807(03)00025-X; Kim VN, 2008, CELL, V133, P25, DOI 10.1016/j.cell.2008.03.015; Landry P, 2005, J VIROL, V79, P6540, DOI 10.1128/JVI.79.10.6540-6543.2005; Luo ZH, 2007, PLANT CELL, V19, P943, DOI 10.1105/tpc.106.045724; Machida S, 2007, J GEN VIROL, V88, P3452, DOI 10.1099/vir.0.83228-0; Malfitano M, 2003, VIROLOGY, V313, P492, DOI 10.1016/S0042-6822(03)00315-5; Margis R, 2006, FEBS LETT, V580, P2442, DOI 10.1016/j.febslet.2006.03.072; Markarian N, 2004, ARCH VIROL, V149, P397, DOI 10.1007/s00705-003-0215-5; Martin R, 2007, VIROLOGY, V367, P135, DOI 10.1016/j.virol.2007.05.011; Martinez de Alba AE, 2003, J VIROL, V77, P9685, DOI 10.1128/JVI.77.17.9685-9694.2003; Martinez de Alba AE, 2002, J VIROL, V76, P13094, DOI 10.1128/JVI.76.24.13094-13096.2002; Morel JB, 2002, PLANT CELL, V14, P629, DOI 10.1105/tpc.010358; Navarro B, 1997, P NATL ACAD SCI USA, V94, P11262, DOI 10.1073/pnas.94.21.11262; Omarov RT, 2007, P NATL ACAD SCI USA, V104, P1714, DOI 10.1073/pnas.0608117104; Pak J, 2007, SCIENCE, V315, P241, DOI 10.1126/science.1132839; Pantaleo V, 2007, J VIROL, V81, P3797, DOI 10.1128/JVI.02383-06; Papaefthimiou I, 2001, NUCLEIC ACIDS RES, V29, P2395, DOI 10.1093/nar/29.11.2395; Qi Y, 2005, MOL CELL, V19, P421, DOI 10.1016/j.molcel.2005.06.014; Qu F, 2005, FEBS LETT, V579, P5958, DOI 10.1016/j.febslet.2005.08.041; Qu F, 2008, P NATL ACAD SCI USA, V105, P14732, DOI 10.1073/pnas.0805760105; Ramachandran V, 2008, SCIENCE, V321, P1490, DOI 10.1126/science.1163728; Ramachandran V, 2008, TRENDS PLANT SCI, V13, P368, DOI 10.1016/j.tplants.2008.03.008; Rodio ME, 2007, PLANT CELL, V19, P3610, DOI 10.1105/tpc.106.049775; Rodio ME, 2006, J GEN VIROL, V87, P231, DOI 10.1099/vir.0.81356-0; Schwach F, 2005, PLANT PHYSIOL, V138, P1842, DOI 10.1104/pp.105.063537; Schwind N, 2009, MOL PLANT PATHOL, V10, P459, DOI [10.1111/j.1364-3703.2009.00546.x, 10.1111/J.1364-3703.2009.00546.X]; Sijen T, 2007, SCIENCE, V315, P244, DOI 10.1126/science.1136699; St-Pierre P, 2009, VIROLOGY, V383, P178, DOI 10.1016/j.virol.2008.11.008; Takeda A, 2005, EMBO J, V24, P3147, DOI 10.1038/sj.emboj.7600776; Takeda A, 2008, PLANT CELL PHYSIOL, V49, P493, DOI 10.1093/pcp/pcn043; Tsagris EM, 2008, CELL MICROBIOL, V10, P2168, DOI 10.1111/j.1462-5822.2008.01231.x; Vaucheret H, 2008, TRENDS PLANT SCI, V13, P350, DOI 10.1016/j.tplants.2008.04.007; Wang MB, 2004, P NATL ACAD SCI USA, V101, P3275, DOI 10.1073/pnas.0400104101; Yang ZY, 2006, NUCLEIC ACIDS RES, V34, P667, DOI 10.1093/nar/gkj474	71	59	62	1	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7539	10.1371/journal.pone.0007539	http://dx.doi.org/10.1371/journal.pone.0007539			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19847296	Green Published, gold, Green Submitted			2022-12-27	WOS:000271013000015
J	Salomon, R; Malach, R; Lamy, D				Salomon, Roy; Malach, Rafael; Lamy, Dominique			Involvement of the Intrinsic/Default System in Movement-Related Self Recognition	PLOS ONE			English	Article							PERSPECTIVE-TAKING; FACE RECOGNITION; FUNCTIONAL NEUROANATOMY; PARIETAL CORTEX; DEFAULT MODE; HUMAN BRAIN; MOTOR; FMRI; AWARENESS; EMOTION	The question of how people recognize themselves and separate themselves from the environment and others has long intrigued philosophers and scientists. Recent findings have linked regions of the 'default brain' or 'intrinsic system' to self-related processing. We used a paradigm in which subjects had to rely on subtle sensory-motor synchronization differences to determine whether a viewed movement belonged to them or to another person, while stimuli and task demands associated with the "responded self" and "responded other" conditions were precisely matched. Self recognition was associated with enhanced brain activity in several ROIs of the intrinsic system, whereas no differences emerged within the extrinsic system. This self-related effect was found even in cases where the sensory-motor aspects were precisely matched. Control conditions ruled out task difficulty as the source of the differential self-related effects. The findings shed light on the neural systems underlying bodily self recognition.			Salomon, R (corresponding author), Tel Aviv Univ, Dept Psychol, IL-69978 Tel Aviv, Israel.	royesal@gmail.com	Salomon, Roy/N-8249-2015	Salomon, Roy/0000-0002-6688-617X				AMSTERDAM B, 1972, DEV PSYCHOBIOL, V5, P297, DOI 10.1002/dev.420050403; Balslev D, 2006, NEUROIMAGE, V31, P308, DOI 10.1016/j.neuroimage.2005.11.037; Bermudez S.I., 2020, 10 HL LHC COLL M CER; Binder JR, 1999, J COGNITIVE NEUROSCI, V11, P80, DOI 10.1162/089892999563265; Blanke O, 2002, NATURE, V419, P269, DOI 10.1038/419269a; Bundick T, 2000, J NEUROL NEUROSUR PS, V68, P83, DOI 10.1136/jnnp.68.1.83; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Christensen MS, 2007, CEREB CORTEX, V17, P1906, DOI 10.1093/cercor/bhl101; Culham JC, 1998, J NEUROPHYSIOL, V80, P2657, DOI 10.1152/jn.1998.80.5.2657; Damasio A, 2003, ANN NY ACAD SCI, V1001, P253, DOI 10.1196/annals.1279.014; Damasio A.R., 2000, FEELING WHAT HAPPENS; Damasio AR, 2000, NAT NEUROSCI, V3, P1049, DOI 10.1038/79871; Daprati E, 2000, NEUROCASE, V6, P477, DOI 10.1080/13554790008402718; David N, 2006, J COGNITIVE NEUROSCI, V18, P898, DOI 10.1162/jocn.2006.18.6.898; Decety J, 2003, TRENDS COGN SCI, V7, P527, DOI 10.1016/j.tics.2003.10.004; Decety J, 2003, CONSCIOUS COGN, V12, P577, DOI 10.1016/S1053-8100(03)00076-X; Dennett D.C., 1991, CONSCIOUSNESS EXPLAI; Farrer C, 2003, NEUROIMAGE, V18, P324, DOI 10.1016/S1053-8119(02)00041-1; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; FARRER C, 2007, CEREBRAL CORTEX; Fink GR, 1999, BRAIN, V122, P497, DOI 10.1093/brain/122.3.497; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI DOI 10.1002/HBM.460020402; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gallagher HL, 2003, TRENDS COGN SCI, V7, P77, DOI 10.1016/S1364-6613(02)00025-6; Gallagher S, 2000, TRENDS COGN SCI, V4, P14, DOI 10.1016/S1364-6613(99)01417-5; Gilboa A, 2004, CEREB CORTEX, V14, P1214, DOI 10.1093/cercor/bhh082; GOLDBERG I, CONSCIOUSNE IN PRESS; Goldberg II, 2006, NEURON, V50, P329, DOI 10.1016/j.neuron.2006.03.015; Goldberg I, 2008, CONSCIOUS COGN, V17, P587, DOI 10.1016/j.concog.2007.10.003; GOLLAND Y, NEUROPSYCHOLOGIA; Golland Y, 2007, CEREB CORTEX, V17, P766, DOI 10.1093/cercor/bhk030; Green DM, 1966, SIGNAL DETECTION THE; Gusnard DA, 2001, P NATL ACAD SCI USA, V98, P4259, DOI 10.1073/pnas.071043098; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hanakawa T, 2003, J NEUROPHYSIOL, V89, P989, DOI 10.1152/jn.00132.2002; Hasson U, 2004, SCIENCE, V303, P1634, DOI 10.1126/science.1089506; Heller R, 2007, NEUROIMAGE, V37, P1178, DOI 10.1016/j.neuroimage.2007.05.051; HUME D, 1978, 1739 TREATISE HUMAN; Jackson PL, 2004, CURR OPIN NEUROBIOL, V14, P259, DOI 10.1016/j.conb.2004.01.020; James W., 1890, PRINCIPLES PSYCHOL; Keenan JP, 1999, NEUROPSYCHOLOGIA, V37, P1421, DOI 10.1016/S0028-3932(99)00025-1; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kircher TTJ, 2003, CONSCIOUS COGN, V12, P656, DOI 10.1016/S1053-8100(03)00071-0; Kircher TTJ, 2002, NEUROPSYCHOLOGIA, V40, P683, DOI 10.1016/S0028-3932(01)00138-5; Kircher TTJ, 2001, COGNITION, V78, pB1, DOI 10.1016/S0010-0277(00)00104-9; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Lane RD, 1997, NEUROREPORT, V8, P3969, DOI 10.1097/00001756-199712220-00024; LEIGUARDA R, 1993, J NEUROL NEUROSUR PS, V56, P788, DOI 10.1136/jnnp.56.7.788; Leube DT, 2003, CONSCIOUS COGN, V12, P597, DOI 10.1016/S1053-8100(03)00079-5; Lou HC, 2004, P NATL ACAD SCI USA, V101, P6827, DOI 10.1073/pnas.0400049101; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; MacDonald PA, 2003, CEREB CORTEX, V13, P962, DOI 10.1093/cercor/13.9.962; Macrae CN, 2004, CEREB CORTEX, V14, P647, DOI 10.1093/cercor/bhh025; Maddock RJ, 1999, TRENDS NEUROSCI, V22, P310, DOI 10.1016/S0166-2236(98)01374-5; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; MARKUS HR, 1991, PSYCHOL REV, V98, P224, DOI 10.1037/0033-295X.98.2.224; McKiernan KA, 2006, NEUROIMAGE, V29, P1185, DOI 10.1016/j.neuroimage.2005.09.030; McKiernan KA, 2003, J COGNITIVE NEUROSCI, V15, P394, DOI 10.1162/089892903321593117; Northoff G, 2004, TRENDS COGN SCI, V8, P102, DOI 10.1016/j.tics.2004.01.004; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Panksepp J, 2003, BRAIN COGNITION, V52, P4, DOI 10.1016/S0278-2626(03)00003-4; Platek SA, 2002, SCHIZOPHR RES, V57, P81, DOI 10.1016/S0920-9964(01)00310-3; Platek SM, 2004, COGNITIVE BRAIN RES, V19, P114, DOI 10.1016/j.cogbrainres.2003.11.014; POPE KS, 1976, REGULATION STREAM CO, P101; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ruby P, 2004, J COGNITIVE NEUROSCI, V16, P988, DOI 10.1162/0898929041502661; Ruby P, 2001, NAT NEUROSCI, V4, P546, DOI 10.1038/87510; Sala CMSD., 1998, COGN NEUROPSYCHIATRY, V3, P191, DOI [DOI 10.1080/135468098396143, 10.1080/135468098396143]; Schmitz TW, 2004, NEUROIMAGE, V22, P941, DOI 10.1016/j.neuroimage.2004.02.018; Schubert T, 1998, NEUROREPORT, V9, P3171, DOI 10.1097/00001756-199810050-00009; Sirigu A, 1999, BRAIN, V122, P1867, DOI 10.1093/brain/122.10.1867; Sirigu A, 2004, NAT NEUROSCI, V7, P80, DOI 10.1038/nn1160; Spence SA, 2002, COGN NEUROPSYCHIATRY, P211, DOI 10.1080/13546800244000094; Spence SA, 1997, BRAIN, V120, P1997, DOI 10.1093/brain/120.11.1997; TEASDALE JD, 1995, MEM COGNITION, V23, P551, DOI 10.3758/BF03197257; Tournoux P., 1988, COPLANAR STEREOTAXIC; Tsakiris M, 2005, COGNITION, V96, P215, DOI 10.1016/j.cognition.2004.08.002; Turk DJ, 2003, ANN NY ACAD SCI, V1001, P65, DOI 10.1196/annals.1279.005; Uddin LQ, 2005, NEUROIMAGE, V25, P926, DOI 10.1016/j.neuroimage.2004.12.018; Uddin LQ, 2006, SOC COGN AFFECT NEUR, V1, P65, DOI 10.1093/scan/nsl003; Vogeley K, 2001, NEUROIMAGE, V14, P170, DOI 10.1006/nimg.2001.0789; Vogeley K, 2004, J COGNITIVE NEUROSCI, V16, P817, DOI 10.1162/089892904970799	85	25	25	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7527	10.1371/journal.pone.0007527	http://dx.doi.org/10.1371/journal.pone.0007527			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509JU	19844584	Green Published, gold			2022-12-27	WOS:000271013000010
J	Schwabe, L; Wolf, OT				Schwabe, Lars; Wolf, Oliver T.			New Episodic Learning Interferes with the Reconsolidation of Autobiographical Memories	PLOS ONE			English	Article							RETROACTIVE INTERFERENCE; PROTEIN-SYNTHESIS; FEAR MEMORIES; CONSOLIDATION; RETRIEVAL; REACTIVATION; NEUROSCIENCE; ATTENUATION; AMYGDALA; CONTEXT	It is commonly assumed that, with time, an initially labile memory is transformed into a permanent one via a process of consolidation. Yet, recent evidence indicates that memories can return to a fragile state again when reactivated, requiring a period of reconsolidation. In the study described here, we found that participants who memorized a story immediately after they had recalled neutral and emotional experiences from their past were impaired in their memory for the neutral (but not for the emotional) experiences one week later. The effect of learning the story depended critically on the preceding reactivation of the autobiographical memories since learning without reactivation had no effect. These results suggest that new learning impedes the reconsolidation of neutral autobiographical memories.			Schwabe, L (corresponding author), Ruhr Univ Bochum, Dept Cognit Psychol, Bochum, Germany.	Lars.Schwabe@rub.de		Wolf, Oliver T./0000-0002-9320-2124				Bartlett FC., 1995, REMEMBERING STUDY EX, V2nd edn; Bauml KH, 1996, PSYCHON B REV, V3, P380, DOI 10.3758/BF03210765; BLANEY PH, 1986, PSYCHOL BULL, V99, P229, DOI 10.1037/0033-2909.99.2.229; Brunet A, 2008, J PSYCHIATR RES, V42, P503, DOI 10.1016/j.jpsychires.2007.05.006; Buss C, 2004, PSYCHONEUROENDOCRINO, V29, P1093, DOI 10.1016/j.psyneuen.2003.09.006; Debiec J, 2002, NEURON, V36, P527, DOI 10.1016/S0896-6273(02)01001-2; EICH E, 1995, PSYCHOL SCI, V6, P67, DOI 10.1111/j.1467-9280.1995.tb00309.x; Galluccio L, 2005, DEV PSYCHOBIOL, V47, P1, DOI 10.1002/dev.20073; GOELET P, 1986, NATURE, V322, P419, DOI 10.1038/322419a0; Hupbach A, 2008, LEARN MEMORY, V15, P574, DOI 10.1101/lm.1022308; Hupbach A, 2007, LEARN MEMORY, V14, P47, DOI 10.1101/lm.365707; KINDT M, 2009, NAT NEUROSCI; Marsh RL, 1998, AM J PSYCHOL, V111, P175, DOI 10.2307/1423485; McGaugh JL, 2000, SCIENCE, V287, P248, DOI 10.1126/science.287.5451.248; Milekic MH, 2002, NEURON, V36, P521, DOI 10.1016/S0896-6273(02)00976-5; Monfils MH, 2009, SCIENCE, V324, P951, DOI 10.1126/science.1167975; Moscovitch M, 1998, CURR OPIN NEUROBIOL, V8, P297, DOI 10.1016/S0959-4388(98)80155-4; Nader K, 2003, NATURE, V425, P571, DOI 10.1038/425571a; Nader K, 2003, TRENDS NEUROSCI, V26, P65, DOI 10.1016/S0166-2236(02)00042-5; Nader K, 2000, NATURE, V406, P722, DOI 10.1038/35021052; Nader K, 2009, NAT REV NEUROSCI, V10, P224, DOI 10.1038/nrn2590; POSTMAN L, 1973, MEM COGNITION, V1, P19, DOI 10.3758/BF03198064; Przybyslawski J, 1999, J NEUROSCI, V19, P6623; Roozendaal B, 2009, NAT REV NEUROSCI, V10, P423, DOI 10.1038/nrn2651; Sara SJ, 2000, LEARN MEMORY, V7, P73, DOI 10.1101/lm.7.2.73; Steyer R., 1994, DIAGNOSTICA, V40, P320; Suzuki A, 2004, J NEUROSCI, V24, P4787, DOI 10.1523/JNEUROSCI.5491-03.2004; Walker MP, 2003, NATURE, V425, P616, DOI 10.1038/nature01930; Westermann R, 1996, EUR J SOC PSYCHOL, V26, P557, DOI 10.1002/(SICI)1099-0992(199607)26:4<557::AID-EJSP769>3.0.CO;2-4; WILLIAMS JMG, 1986, J ABNORM PSYCHOL, V95, P144, DOI 10.1037/0021-843X.95.2.144; Wiltgen BJ, 2007, LEARN MEMORY, V14, P313, DOI 10.1101/lm.430907	31	66	67	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7519	10.1371/journal.pone.0007519	http://dx.doi.org/10.1371/journal.pone.0007519			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509JU	19844577	Green Published, gold			2022-12-27	WOS:000271013000007
J	Eryilmaz, J; Pan, P; Amaya, MF; Allali-Hassani, A; Dong, AP; Adams-Cioaba, MA; MacKenzie, F; Vedadi, M; Min, JR				Eryilmaz, Jitka; Pan, Patricia; Amaya, Maria F.; Allali-Hassani, Abdellah; Dong, Aiping; Adams-Cioaba, Melanie A.; MacKenzie, Farrell; Vedadi, Masoud; Min, Jinrong			Structural Studies of a Four-MBT Repeat Protein MBTD1	PLOS ONE			English	Article							POLYCOMB GROUP PROTEIN; METHYL-LYSINE-BINDING; HISTONE H3; TRANSCRIPTIONAL REPRESSOR; ZINC-FINGER; CHROMODOMAIN; RECOGNITION; L3MBTL1; DOMAINS; TUDOR	Background: The Polycomb group (PcG) of proteins is a family of important developmental regulators. The respective members function as large protein complexes involved in establishment and maintenance of transcriptional repression of developmental control genes. MBTD1, Malignant Brain Tumor domain-containing protein 1, is one such PcG protein. MBTD1 contains four MBT repeats. Methodology/Principal Findings: We have determined the crystal structure of MBTD1 (residues 130-566aa covering the 4 MBT repeats) at 2.5 angstrom resolution by X-ray crystallography. The crystal structure of MBTD1 reveals its similarity to another four-MBT-repeat protein L3MBTL2, which binds lower methylated lysine histones. Fluorescence polarization experiments confirmed that MBTD1 preferentially binds mono- and di-methyllysine histone peptides, like L3MBTL1 and L3MBTL2. All known MBT-peptide complex structures characterized to date do not exhibit strong histone peptide sequence selectivity, and use a "cavity insertion recognition mode" to recognize the methylated lysine with the deeply buried methyl-lysine forming extensive interactions with the protein while the peptide residues flanking methyl-lysine forming very few contacts [1]. Nevertheless, our mutagenesis data based on L3MBTL1 suggested that the histone peptides could not bind to MBT repeats in any orientation. Conclusions: The four MBT repeats in MBTD1 exhibits an asymmetric rhomboid architecture. Like other MBT repeat proteins characterized so far, MBTD1 binds mono- or dimethylated lysine histones through one of its four MBT repeats utilizing a semi-aromatic cage.			Eryilmaz, J (corresponding author), Univ Toronto, Struct Genom Consortium, Toronto, ON, Canada.	jr.min@utoronto.ca	Min, Jinrong/G-3449-2011	Min, Jinrong/0000-0001-5210-3130	CIHR Funding Source: Medline; Wellcome Trust Funding Source: Medline	CIHR(Canadian Institutes of Health Research (CIHR)); Wellcome Trust(Wellcome TrustEuropean Commission)		Adams-Cioaba MA, 2009, BIOCHEM CELL BIOL, V87, P93, DOI 10.1139/O08-129; Boccuni P, 2003, J BIOL CHEM, V278, P15412, DOI 10.1074/jbc.M300592200; Emsley P, 2004, ACTA CRYSTALLOGR D, V60, P2126, DOI 10.1107/S0907444904019158; Fischle W, 2003, GENE DEV, V17, P1870, DOI 10.1101/gad.1110503; Grimm C, 2007, EMBO REP, V8, P1031, DOI 10.1038/sj.embor.7401085; Guo YH, 2009, NUCLEIC ACIDS RES, V37, P2204, DOI 10.1093/nar/gkp086; Jacobs SA, 2002, SCIENCE, V295, P2080, DOI 10.1126/science.1069473; KALAKONDA N, 2008, ONCOGENE; Kim J, 2006, EMBO REP, V7, P397, DOI 10.1038/sj.embor.7400625; Klymenko T, 2006, GENE DEV, V20, P1110, DOI 10.1101/gad.377406; Kouzarides T, 2007, CELL, V128, P693, DOI 10.1016/j.cell.2007.02.005; Lechtenberg BC, 2009, PROTEIN SCI, V18, P657, DOI 10.1002/pro.51; Li H, 2007, MOL CELL, V28, P677, DOI 10.1016/j.molcel.2007.10.023; Martin C, 2005, NAT REV MOL CELL BIO, V6, P838, DOI 10.1038/nrm1761; Maurer-Stroh S, 2003, TRENDS BIOCHEM SCI, V28, P69, DOI 10.1016/S0968-0004(03)00004-5; Min JR, 2007, NAT STRUCT MOL BIOL, V14, P1229, DOI 10.1038/nsmb1340; Min JR, 2003, GENE DEV, V17, P1823, DOI 10.1101/gad.269603; Murshudov GN, 1997, ACTA CRYSTALLOGR D, V53, P240, DOI 10.1107/S0907444996012255; NADY N, 2008, TRENDS BIOCH SCI; Nielsen PR, 2002, NATURE, V416, P103, DOI 10.1038/nature722; Perrakis A, 2001, ACTA CRYSTALLOGR D, V57, P1445, DOI 10.1107/S0907444901014007; Santiveri CM, 2008, J MOL BIOL, V382, P1107, DOI 10.1016/j.jmb.2008.07.081; Schuetz A, 2006, EMBO J, V25, P4245, DOI 10.1038/sj.emboj.7601316; Trojer P, 2007, CELL, V129, P915, DOI 10.1016/j.cell.2007.03.048; Trojer P, 2009, J BIOL CHEM, V284, P8395, DOI 10.1074/jbc.M807818200; WISMAR J, 1995, MECH DEVELOP, V53, P141, DOI 10.1016/0925-4773(95)00431-9; Wismar J, 2001, FEBS LETT, V507, P119, DOI 10.1016/S0014-5793(01)02959-3; Wu SM, 2007, FEBS LETT, V581, P3289, DOI 10.1016/j.febslet.2007.06.025	28	45	46	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7274	10.1371/journal.pone.0007274	http://dx.doi.org/10.1371/journal.pone.0007274			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JT	19841675	Green Published, Green Submitted, gold			2022-12-27	WOS:000271012900005
J	Yuen, RKC; Avila, L; Penaherrera, MS; von Dadelszen, P; Lefebvre, L; Kobor, MS; Robinson, WP				Yuen, Ryan K. C.; Avila, Luana; Penaherrera, Maria S.; von Dadelszen, Peter; Lefebvre, Louis; Kobor, Michael S.; Robinson, Wendy P.			Human Placental-Specific Epipolymorphism and its Association with Adverse Pregnancy Outcomes	PLOS ONE			English	Article							HUMAN GENE-EXPRESSION; DNA METHYLATION; HUMAN GENOME; GERMLINE EPIMUTATION; EPIGENETIC VARIATION; COLORECTAL-CANCER; ALLELIC VARIATION; PATTERNS; CELLS; VARIABILITY	Interindividual variation in DNA-methylation level is widespread in the human genome, despite its critical role in regulating gene expression. The nature of this variation, including its tissue-specific nature, and the role it may play in human phenotypic variation and disease is still poorly characterized. The placenta plays a critical role in regulating fetal growth and development in ways that have lifelong effects on health. To identify genes with a high degree of interindividual DNA methylation variation in the human placenta, we surveyed the human genome using the Illumina GoldenGate Methylation Cancer panel targeting 1505 CpG sites of 807 genes. While many sites show a continuous pattern of methylation levels, WNT2, TUSC3 and EPHB4 were identified to have a polymorphic "on-or-off'' pattern of DNA methylation variation at their promoter region which was confirmed by pyrosequencing. Methylation of these genes can be found in 7%-25% of over 100 placentas tested. The methylation state at the promoter of these genes is concordant with mRNA allelic expression. In three informative cases TUSC3 was observed to be methylated on the maternal allele, and it is thus possible this represents a polymorphically imprinted gene. Furthermore, TUSC3 promoter methylation showed evidence for association with preeclampsia. A biological significance of these methylation allelic polymorphisms (MAPs) to human placental diversity is further implied by their placental specificity and absence in mouse. An extended study of blood suggests that MAPs may also be found in other tissues, implicating their utility for tissue-specific association with complex disorders. The identification of such "epipolymorphism'' in other tissues and their use in association studies, should improve our understanding of interindividual phenotypic variability and complex disease susceptibility.			Yuen, RKC (corresponding author), Univ British Columbia, Dept Med Genet, Vancouver, BC, Canada.	wprobins@interchange.ubc.ca	Robinson, Wendy/AAB-6420-2020; von Dadelszen, Peter/AAP-7480-2021; Yuen, Ryan K. C./J-4876-2012; Robinson, Wendy P/I-9590-2014; Lefebvre, Louis/O-9309-2016	Robinson, Wendy/0000-0002-2010-6174; Yuen, Ryan K. C./0000-0001-7273-4968; Robinson, Wendy P/0000-0002-2010-6174; Lefebvre, Louis/0000-0001-5664-9480; von Dadelszen, Peter/0000-0003-4136-3070; Kobor, Michael/0000-0003-4140-1743	Canadian Institutes of Health Research [GMH-79041] Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		Bird A, 2002, GENE DEV, V16, P6, DOI 10.1101/gad.947102; Bjornsson HT, 2004, TRENDS GENET, V20, P350, DOI 10.1016/j.tig.2004.06.009; Busque L, 1996, BLOOD, V88, P59; Carrel L, 2005, NATURE, V434, P400, DOI 10.1038/nature03479; Chan TL, 2006, NAT GENET, V38, P1178, DOI 10.1038/ng1866; Cheung VG, 2003, NAT GENET, V33, P422, DOI 10.1038/ng1094; Cheung VG, 2008, AM J HUM GENET, V82, P1357, DOI 10.1016/j.ajhg.2008.05.003; Chiu RWK, 2007, AM J PATHOL, V170, P941, DOI 10.2353/ajpath.2007.060641; Constancia M, 2004, NATURE, V432, P53, DOI 10.1038/432053a; Cui HM, 2003, SCIENCE, V299, P1753, DOI 10.1126/science.1080902; Flanagan JM, 2006, AM J HUM GENET, V79, P67, DOI 10.1086/504729; Gerety SS, 1999, MOL CELL, V4, P403, DOI 10.1016/S1097-2765(00)80342-1; Godfrey KM, 2002, PLACENTA, V23, pS20, DOI 10.1053/plac.2002.0773; Hachwell E, 2007, TRENDS GENET, V23, P588, DOI 10.1016/j.tig.2007.08.010; Houseman EA, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-365; Illingworth R, 2008, PLOS BIOL, V6, P37, DOI 10.1371/journal.pbio.0060022; Inoki I, 2001, FASEB J, V15, P219, DOI 10.1096/fj.01-0332fje; JINNO Y, 1994, NAT GENET, V6, P305, DOI 10.1038/ng0394-305; Kelleher DJ, 2006, GLYCOBIOLOGY, V16, p47R, DOI 10.1093/glycob/cwj066; Kerkel K, 2008, NAT GENET, V40, P904, DOI 10.1038/ng.174; Lo HS, 2003, GENOME RES, V13, P1855, DOI 10.1101/gr.1006603; McMinn J, 2006, PLACENTA, V27, P119, DOI 10.1016/j.placenta.2004.12.003; Monkley SJ, 1996, DEVELOPMENT, V122, P3343; Morison IM, 2005, TRENDS GENET, V21, P457, DOI 10.1016/j.tig.2005.06.008; Morley M, 2004, NATURE, V430, P743, DOI 10.1038/nature02797; Novakovic B, 2008, MOL HUM REPROD, V14, P547, DOI 10.1093/molehr/gan046; Pak BJ, 1998, PLACENTA, V19, P483, DOI 10.1016/S0143-4004(98)91041-4; Pastinen T, 2004, PHYSIOL GENOMICS, V16, P184, DOI 10.1152/physiolgenomics.00163.2003; Pastinen T, 2004, SCIENCE, V306, P647, DOI 10.1126/science.1101659; Rakyan VK, 2004, PLOS BIOL, V2, P2170, DOI 10.1371/journal.pbio.0020405; Red-Horse K, 2005, DEVELOPMENT, V132, P4097, DOI 10.1242/dev.01971; Sandovici I, 2003, HUM MOL GENET, V12, P1569, DOI 10.1093/hmg/ddg167; Sandovici I, 2005, HUM MOL GENET, V14, P2135, DOI 10.1093/hmg/ddi218; Serre D, 2008, PLOS GENET, V4, DOI 10.1371/journal.pgen.1000006; Sontia Bruno, 2007, Pathophysiology, V14, P205, DOI 10.1016/j.pathophys.2007.09.005; Sood R, 2006, P NATL ACAD SCI USA, V103, P5478, DOI 10.1073/pnas.0508035103; Spencer HG, 2000, ANNU REV GENET, V34, P457, DOI 10.1146/annurev.genet.34.1.457; Su AI, 2002, P NATL ACAD SCI USA, V99, P4465, DOI 10.1073/pnas.012025199; Suter CM, 2004, NAT GENET, V36, P497, DOI 10.1038/ng1342; Walsh CP, 1999, GENE DEV, V13, P26, DOI 10.1101/gad.13.1.26; Weber M, 2007, NAT GENET, V39, P457, DOI 10.1038/ng1990; Whitney AR, 2003, P NATL ACAD SCI USA, V100, P1896, DOI 10.1073/pnas.252784499; XU YQ, 1993, BIOCHEM BIOPH RES CO, V197, P747, DOI 10.1006/bbrc.1993.2542; Yan H, 2004, CURR OPIN ONCOL, V16, P39, DOI 10.1097/00001622-200401000-00008; Yan H, 2002, SCIENCE, V297, P1143, DOI 10.1126/science.1072545	45	57	60	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7389	10.1371/journal.pone.0007389	http://dx.doi.org/10.1371/journal.pone.0007389			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838307	Green Accepted, Green Published, gold, Green Submitted			2022-12-27	WOS:000270880900001
J	Gonzalez, MA; Baraloto, C; Engel, J; Mori, SA; Petronelli, P; Riera, B; Roger, A; Thebaud, C; Chave, J				Gonzalez, Mailyn Adriana; Baraloto, Christopher; Engel, Julien; Mori, Scott A.; Petronelli, Pascal; Riera, Bernard; Roger, Aurelien; Thebaud, Christophe; Chave, Jerome			Identification of Amazonian Trees with DNA Barcodes	PLOS ONE			English	Article							LAND PLANTS; FOREST; COMMUNITY; DIVERSITY; EVOLUTION; REGIONS; LIFE; CHLOROPLAST; ACCURATE; TAXONOMY	Background: Large-scale plant diversity inventories are critical to develop informed conservation strategies. However, the workload required for classic taxonomic surveys remains high and is particularly problematic for megadiverse tropical forests. Methodology/Principal Findings: Based on a comprehensive census of all trees in two hectares of a tropical forest in French Guiana, we examined whether plant DNA barcoding could contribute to increasing the quality and the pace of tropical plant biodiversity surveys. Of the eight plant DNA markers we tested (rbcLa, rpoC1, rpoB, matK, ycf5, trnL, psbA-trnH, ITS), matK and ITS had a low rate of sequencing success. More critically, none of the plastid markers achieved a rate of correct plant identification greater than 70%, either alone or combined. The performance of all barcoding markers was noticeably low in few species-rich clades, such as the Laureae, and the Sapotaceae. A field test of the approach enabled us to detect 130 molecular operational taxonomic units in a sample of 252 juvenile trees. Including molecular markers increased the identification rate of juveniles from 72% (morphology alone) to 96% (morphology and molecular) of the individuals assigned to a known tree taxon. Conclusion/Significance: We conclude that while DNA barcoding is an invaluable tool for detecting errors in identifications and for identifying plants at juvenile stages, its limited ability to identify collections will constrain the practical implementation of DNA-based tropical plant biodiversity programs.			Gonzalez, MA (corresponding author), Univ Toulouse 3, Lab Evolut & Divers Biol, F-31062 Toulouse, France.	chave@cict.fr	Thébaud, Christophe/N-3916-2016; 赵, 鹏/B-8401-2009; Baraloto, Christopher/ABG-2500-2020; RIERA, Bernard/ABG-1318-2020	Thébaud, Christophe/0000-0002-8586-1234; Baraloto, Christopher/0000-0001-7322-8581; RIERA, Bernard/0000-0002-5320-9671; Engel, Julien/0000-0002-8078-9309				Abdo Z, 2007, SYST BIOL, V56, P44, DOI 10.1080/10635150601167005; Anisimova M, 2006, SYST BIOL, V55, P539, DOI 10.1080/10635150600755453; Awano T, 2009, P NATL ACAD SCI USA, V106, P2794, DOI [10.1073/pnas.0905845106, 10.1073/pnas.0812297106]; Balmford A, 2002, SCIENCE, V297, P950, DOI 10.1126/science.1073947; Blaxter M, 2005, PHILOS T R SOC B, V360, P1935, DOI 10.1098/rstb.2005.1725; BONGERS F, 2001, NOURAGUES DYNAMICS P; Brooks TM, 2006, SCIENCE, V313, P58, DOI 10.1126/science.1127609; Chanderbali AS, 2001, ANN MO BOT GARD, V88, P104, DOI 10.2307/2666133; Chase MW, 2007, TAXON, V56, P295, DOI 10.1002/tax.562004; Chase MW, 2009, SCIENCE, V325, P682, DOI 10.1126/science.1176906; Chase MW, 2005, PHILOS T R SOC B, V360, P1889, DOI 10.1098/rstb.2005.1720; Coley PD, 1996, ANNU REV ECOL SYST, V27, P305, DOI 10.1146/annurev.ecolsys.27.1.305; Condit R, 2002, SCIENCE, V295, P666, DOI 10.1126/science.1066854; Couvreur TLP, 2008, BMC BIOL, V6, DOI 10.1186/1741-7007-6-54; de Castilho CV, 2006, BIOTROPICA, V38, P555, DOI 10.1111/j.1744-7429.2006.00172.x; Deguilloux MF, 2002, P ROY SOC B-BIOL SCI, V269, P1039, DOI 10.1098/rspb.2002.1982; Devey DS, 2009, TAXON, V58, P7, DOI 10.1002/tax.581003; Dick C. W., 2008, Tropical Plant Biology, V1, P20, DOI 10.1007/s12042-007-9006-6; Elias M, 2007, P ROY SOC B-BIOL SCI, V274, P2881, DOI 10.1098/rspb.2007.1035; Fazekas AJ, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002802; Floyd R, 2002, MOL ECOL, V11, P839, DOI 10.1046/j.1365-294X.2002.01485.x; Ford CS, 2009, BOT J LINN SOC, V159, P1, DOI 10.1111/j.1095-8339.2008.00938.x; Friar EA, 2005, METHOD ENZYMOL, V395, P3; GENTRY AH, 1982, ANN MO BOT GARD, V69, P557, DOI 10.2307/2399084; Guindon S, 2003, SYST BIOL, V52, P696, DOI 10.1080/10635150390235520; Hebert PDN, 2004, PLOS BIOL, V2, P1657, DOI 10.1371/journal.pbio.0020312; Hebert PDN, 2003, P ROY SOC B-BIOL SCI, V270, pS96, DOI 10.1098/rsbl.2003.0025; Hickerson MJ, 2006, SYST BIOL, V55, P729, DOI 10.1080/10635150600969898; Hollingsworth ML, 2009, MOL ECOL RESOUR, V9, P439, DOI 10.1111/j.1755-0998.2008.02439.x; Hubbell SP, 2008, P NATL ACAD SCI USA, V105, P11498, DOI 10.1073/pnas.0801915105; Jurado-Rivera JA, 2009, P ROY SOC B-BIOL SCI, V276, P639, DOI 10.1098/rspb.2008.1264; KIMURA M, 1980, J MOL EVOL, V16, P111, DOI 10.1007/BF01731581; Kress WJ, 2008, BIOTROPICA, V40, P405, DOI 10.1111/j.1744-7429.2008.00426.x; Kress WJ, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000508; Kress WJ, 2005, P NATL ACAD SCI USA, V102, P8369, DOI 10.1073/pnas.0503123102; Lahaye R, 2008, P NATL ACAD SCI USA, V105, P2923, DOI 10.1073/pnas.0709936105; Larkin MA, 2007, BIOINFORMATICS, V23, P2947, DOI 10.1093/bioinformatics/btm404; Laurance WF, 2006, P NATL ACAD SCI USA, V103, P19010, DOI 10.1073/pnas.0609048103; Linder HP, 2008, PHILOS T R SOC B, V363, P3097, DOI 10.1098/rstb.2008.0075; Little DP, 2007, CLADISTICS, V23, P1, DOI 10.1111/j.1096-0031.2006.00126.x; Malhi Y, 2008, SCIENCE, V319, P169, DOI 10.1126/science.1146961; Margulies M, 2005, NATURE, V437, P376, DOI 10.1038/nature03959; Meier R, 2006, SYST BIOL, V55, P715, DOI 10.1080/10635150600969864; MORI SA, 1987, ANN MO BOT GARD, V74, P321, DOI 10.2307/2399402; Mori SA, 2007, AM J BOT, V94, P289, DOI 10.3732/ajb.94.3.289; Moritz C, 2004, PLOS BIOL, V2, P1529, DOI 10.1371/journal.pbio.0020354; Munch K, 2008, PHILOS T R SOC B, V363, P3997, DOI 10.1098/rstb.2008.0169; Newmaster SG, 2008, MOL ECOL RESOUR, V8, P480, DOI 10.1111/j.1471-8286.2007.02002.x; Petit RJ, 2005, MOL ECOL, V14, P689, DOI 10.1111/j.1365-294X.2004.02410.x; Pitman NCA, 2001, ECOLOGY, V82, P2101, DOI 10.1890/0012-9658(2001)082[2101:DADOTS]2.0.CO;2; Pitman NCA, 2008, BIOTROPICA, V40, P525, DOI 10.1111/j.1744-7429.2008.00424.x; Pons J, 2006, SYST BIOL, V55, P595, DOI 10.1080/10635150600852011; Richardson JE, 2001, SCIENCE, V293, P2242, DOI 10.1126/science.1061421; Ronaghi M, 1998, SCIENCE, V281, P363, DOI 10.1126/science.281.5375.363; Savolainen V, 2005, PHILOS T R SOC B, V360, P1805, DOI 10.1098/rstb.2005.1730; Shaw J, 2007, AM J BOT, V94, P275, DOI 10.3732/ajb.94.3.275; SMITH N, 2004, FLOWERING PLANTS NEO; Smith SA, 2008, SCIENCE, V322, P86, DOI 10.1126/science.1163197; Starr JR, 2009, MOL ECOL RESOUR, V9, P151, DOI 10.1111/j.1755-0998.2009.02640.x; Swenson U, 2005, CLADISTICS, V21, P101, DOI 10.1111/j.1096-0031.2005.00056.x; Taberlet P, 2007, NUCLEIC ACIDS RES, V35, DOI 10.1093/nar/gkl938; Tamura K, 2007, MOL BIOL EVOL, V24, P1596, DOI 10.1093/molbev/msm092; ter Steege H, 2006, NATURE, V443, P444, DOI 10.1038/nature05134; Tuomisto H, 2003, SCIENCE, V299, P241, DOI 10.1126/science.1078037; Valentini A, 2009, TRENDS ECOL EVOL, V24, P110, DOI 10.1016/j.tree.2008.09.011	65	160	180	2	59	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7483	10.1371/journal.pone.0007483	http://dx.doi.org/10.1371/journal.pone.0007483			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834612	Green Published, gold			2022-12-27	WOS:000270880700009
J	Canessa, N; Motterlini, M; Di Dio, C; Perani, D; Scifo, P; Cappa, SF; Rizzolatti, G				Canessa, Nicola; Motterlini, Matteo; Di Dio, Cinzia; Perani, Daniela; Scifo, Paola; Cappa, Stefano F.; Rizzolatti, Giacomo			Understanding Others' Regret: A fMRI Study	PLOS ONE			English	Article							ORBITOFRONTAL CORTEX; EXPERIENCE; EMPATHY; BRAIN; PAIN	Previous studies showed that the understanding of others' basic emotional experiences is based on a "resonant'' mechanism, i.e., on the reactivation, in the observer's brain, of the cerebral areas associated with those experiences. The present study aimed to investigate whether the same neural mechanism is activated both when experiencing and attending complex, cognitively-generated, emotions. A gambling task and functional-Magnetic-Resonance-Imaging (fMRI) were used to test this hypothesis using regret, the negative cognitively-based emotion resulting from an unfavorable counterfactual comparison between the outcomes of chosen and discarded options. Do the same brain structures that mediate the experience of regret become active in the observation of situations eliciting regret in another individual? Here we show that observing the regretful outcomes of someone else's choices activates the same regions that are activated during a first-person experience of regret, i.e. the ventromedial prefrontal cortex, anterior cingulate cortex and hippocampus. These results extend the possible role of a mirror like mechanism beyond basic emotions.			Canessa, N (corresponding author), Univ Vita Salute San Raffaele, CRESA, Milan, Italy.	cappa.stefano@hsr.it	Perani, Daniela/AAN-3221-2020; scifo, paola/J-4410-2016; Di Dio, Cinzia/HGB-3168-2022; Cappa, Stefano/B-1874-2014; Canessa, Nicola/K-3223-2016	scifo, paola/0000-0001-5135-8086; Cappa, Stefano/0000-0003-1003-3925; Canessa, Nicola/0000-0002-0179-6384; MOTTERLINI, Matteo Mario Pietro/0000-0002-4915-4524				Andersson JLR, 2001, NEUROIMAGE, V13, P903, DOI 10.1006/nimg.2001.0746; Ashburner J, 1999, HUM BRAIN MAPP, V7, P254, DOI 10.1002/(SICI)1097-0193(1999)7:4<254::AID-HBM4>3.0.CO;2-G; Baron-Cohen S, 2005, SCIENCE, V310, P819, DOI 10.1126/science.1115455; Bault N, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003477; Bush G, 2000, TRENDS COGN SCI, V4, P215, DOI 10.1016/S1364-6613(00)01483-2; BYRNE RM, 2008, HDB IMAGINATION MENT; Camille N, 2004, SCIENCE, V304, P1167, DOI 10.1126/science.1094550; Carr L, 2003, P NATL ACAD SCI USA, V100, P5497, DOI 10.1073/pnas.0935845100; Coricelli G, 2005, NAT NEUROSCI, V8, P1255, DOI 10.1038/nn1514; Coricelli G, 2007, TRENDS COGN SCI, V11, P258, DOI 10.1016/j.tics.2007.04.003; Dale AM, 1999, HUM BRAIN MAPP, V8, P109, DOI 10.1002/(SICI)1097-0193(1999)8:2/3<109::AID-HBM7>3.0.CO;2-W; Eickhoff SB, 2005, NEUROIMAGE, V25, P1325, DOI 10.1016/j.neuroimage.2004.12.034; Friston KJ, 2002, NEUROIMAGE, V16, P484, DOI 10.1006/nimg.2002.1091; Friston KJ, 1996, MAGNET RESON MED, V35, P346, DOI 10.1002/mrm.1910350312; Friston KJ, 1999, NEUROIMAGE, V10, P1, DOI 10.1006/nimg.1999.0439; Fukushima H, 2006, SOC COGN AFFECT NEUR, V1, P149, DOI 10.1093/scan/nsl020; Gallese V, 2004, TRENDS COGN SCI, V8, P396, DOI 10.1016/j.tics.2004.07.002; Gallese V, 1996, BRAIN, V119, P593, DOI 10.1093/brain/119.2.593; Girotto V, 2007, PSYCHOL SCI, V18, P510, DOI 10.1111/j.1467-9280.2007.01931.x; Gottfried JA, 2004, NAT NEUROSCI, V7, P1145, DOI 10.1038/nn1314; KAHNEMAN D, 1982, COGNITION, V11, P143, DOI 10.1016/0010-0277(82)90023-3; Keysers C, 2004, NEURON, V42, P335, DOI 10.1016/S0896-6273(04)00156-4; Kringelbach ML, 2005, NAT REV NEUROSCI, V6, P691, DOI 10.1038/nrn1747; Marchiori D, 2008, SCIENCE, V319, P1111, DOI 10.1126/science.1151185; MEHRABIAN A, 1972, J PERSONALITY, V40; Mellers B, 1999, J EXP PSYCHOL GEN, V128, P332, DOI 10.1037/0096-3445.128.3.332; Meneghini AM, 2006, RICERCHE PSICOLOGIA, V29, P123; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Onishi KH, 2005, SCIENCE, V308, P255, DOI 10.1126/science.1107621; Rizzolatti G, 1996, COGNITIVE BRAIN RES, V3, P131, DOI 10.1016/0926-6410(95)00038-0; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Singer T, 2006, NATURE, V439, P466, DOI 10.1038/nature04271; Takahashi H, 2009, SCIENCE, V323, P937, DOI 10.1126/science.1165604; Talairach I., 1988, COPLANAR STEREOTACTI; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; WORSLEY KJ, 1995, NEUROIMAGE, V2, P173, DOI 10.1006/nimg.1995.1023	36	30	30	2	18	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7402	10.1371/journal.pone.0007402	http://dx.doi.org/10.1371/journal.pone.0007402			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826471	gold, Green Submitted, Green Published			2022-12-27	WOS:000270808700003
J	Rhodes, P; Craigon, J; Gray, C; Rhind, SM; Loughna, PT; Gardner, DS				Rhodes, Philip; Craigon, Jim; Gray, Clint; Rhind, Stuart M.; Loughna, Paul T.; Gardner, David S.			Adult-Onset Obesity Reveals Prenatal Programming of Glucose-Insulin Sensitivity in Male Sheep Nutrient Restricted during Late Gestation	PLOS ONE			English	Article							LOW-BIRTH-WEIGHT; CATCH-UP GROWTH; DUTCH FAMINE; MATERNAL UNDERNUTRITION; DIETARY RESTRICTION; METABOLIC SYNDROME; SKELETAL-MUSCLE; BLOOD-PRESSURE; LATER LIFE; EXPOSURE	Background: Obesity invokes a range of metabolic disturbances, but the transition from a poor to excessive nutritional environment may exacerbate adult metabolic dysfunction. The current study investigated global maternal nutrient restriction during early or late gestation on glucose tolerance and insulin sensitivity in the adult offspring when lean and obese. Methods/Principal Findings: Pregnant sheep received adequate (1.0M; CE, n = 6) or energy restricted (0.7M) diet during early (1-65 days; LEE, n = 6) or late (65-128 days; LEL, n = 7) gestation ( term,147 days). Subsequent offspring remained on pasture until 1.5 years when all received glucose and insulin tolerance tests (GTT & ITT) and body composition determination by dual energy x-ray absorptiometry (DXA). All animals were then exposed to an obesogenic environment for 6-7 months and all protocols repeated. Prenatal dietary treatment had no effect on birth weight or on metabolic endpoints when animals were 'lean' ( 1.5 years). Obesity revealed generalised metabolic 'inflexibility' and insulin resistance; characterised by blunted excursions of plasma NEFA and increased insulin(AUC) ( from 133 to 341 [s.e.d. 26] ng.ml(-1).120 mins) during a GTT, respectively. For LEL vs. CE, the peak in plasma insulin when obese was greater (7.8 vs. 4.7 [s.e.d.1.1] ng.ml(-1)) and was exacerbated by offspring sex (i.e. 9.8 vs. 4.4 [s.e.d. 1.16] ng. ml(-1); LEL male vs. CE male, respectively). Acquisition of obesity also significantly influenced the plasma lipid and protein profile to suggest, overall, greater net lipogenesis and reduced protein metabolism. Conclusions: This study indicates generalised metabolic dysfunction with adult-onset obesity which also exacerbates and 'reveals' programming of glucose-insulin sensitivity in male offspring prenatally exposed to maternal undernutrition during late gestation. Taken together, the data suggest that metabolic function appears little compromised in young prenatally 'programmed' animals so long as weight is adequately controlled. Nutritional excess in adulthood exacerbates any programmed phenotype, indicating greater vigilance over weight control is required for those individuals exposed to nutritional thrift during gestation.			Rhodes, P (corresponding author), Univ Nottingham, Sch Vet Med & Sci, Loughborough, England.	david.gardner@nottingham.ac.uk	Loughna, Paul/B-7918-2012; Biguzzi, Felipe A/E-4724-2015; Gardner, David S/A-7484-2010	Gardner, David S/0000-0002-6490-2412; Loughna, Paul/0000-0002-5162-9613; Craigon, Jim/0000-0003-4570-5138				Alderman G., 1993, EN PROT REQ RUM ADV; Allender S, 2007, OBES REV, V8, P467, DOI 10.1111/j.1467-789X.2007.00394.x; Armitage JA, 2004, J PHYSIOL-LONDON, V561, P355, DOI 10.1113/jphysiol.2004.072009; Barker DJP, 2005, NEW ENGL J MED, V353, P1802, DOI 10.1056/NEJMoa044160; BERGMAN EN, 1989, AM J PHYSIOL, V257, pE772, DOI 10.1152/ajpendo.1989.257.5.E772; BONORA E, 1989, J CLIN ENDOCR METAB, V68, P374, DOI 10.1210/jcem-68-2-374; BROCKMAN RP, 1975, AM J PHYSIOL, V229, P1338, DOI 10.1152/ajplegacy.1975.229.5.1338; Budge H, 2008, FASEB J, V22; Chevalier S, 2006, DIABETES, V55, P675, DOI 10.2337/diabetes.55.03.06.db05-1117; Cleal JK, 2007, P NATL ACAD SCI USA, V104, P9529, DOI 10.1073/pnas.0610373104; Daar AS, 2007, NATURE, V450, P494, DOI 10.1038/450494a; Daniel ZCTR, 2007, J ANIM SCI, V85, P1565, DOI 10.2527/jas.2006-743; Delavaud C, 2000, J ENDOCRINOL, V165, P519, DOI 10.1677/joe.0.1650519; Demetrius L, 2004, J GERONTOL A-BIOL, V59, P902, DOI 10.1093/gerona/59.9.B902; DIETZ WH, 1994, AM J CLIN NUTR, V59, P955, DOI 10.1093/ajcn/59.5.955; Dodic M, 2001, CIRC RES, V89, P623, DOI 10.1161/hh1901.097086; Dulloo AG, 2008, BEST PRACT RES CL EN, V22, P155, DOI 10.1016/j.beem.2007.08.001; ELMES MJ, 2008, BR J NUTR, P1; Fahey AJ, 2005, J ANIM SCI, V83, P2330; Fahey AJ, 2005, J ANIM SCI, V83, P2564; FESTING MFW, 2004, DESIGN ANIMAL EXPT R; Galgani JE, 2008, AM J PHYSIOL-ENDOC M, V295, pE1009, DOI 10.1152/ajpendo.90558.2008; Gardner DS, 2007, CURR DRUG TARGETS, V8, P894; Gardner DS, 2005, AM J PHYSIOL-REG I, V289, pR947, DOI 10.1152/ajpregu.00120.2005; Gillooly JF, 2001, SCIENCE, V293, P2248, DOI 10.1126/science.1061967; Gluckman PD, 2004, SCIENCE, V305, P1733, DOI 10.1126/science.1095292; Gopalakrishnan GS, 2004, AM J PHYSIOL-REG I, V287, pR12, DOI 10.1152/ajpregu.00687.2003; Gower BA, 2002, J CLIN ENDOCR METAB, V87, P2218, DOI 10.1210/jc.87.5.2218; Grigore D, 2008, GENDER MED, V5, pS121, DOI 10.1016/j.genm.2008.03.012; Hales CN, 2001, BRIT MED BULL, V60, P5, DOI 10.1093/bmb/60.1.5; HAMMOND JJ, 1976, HAMMONDS FARM ANIMAL; Hattersley AT, 1999, LANCET, V353, P1789, DOI 10.1016/S0140-6736(98)07546-1; Khan I, 2004, CIRCULATION, V110, P1097, DOI 10.1161/01.CIR.0000139843.05436.A0; Kim SP, 2007, AM J PHYSIOL-ENDOC M, V292, pE1581, DOI 10.1152/ajpendo.00351.2006; Koves TR, 2008, CELL METAB, V7, P45, DOI 10.1016/j.cmet.2007.10.013; Lillycrop KA, 2005, J NUTR, V135, P1382, DOI 10.1093/jn/135.6.1382; McMillen IC, 2005, PHYSIOL REV, V85, P571, DOI 10.1152/physrev.00053.2003; McMullen S, 2005, HYPERTENSION, V46, P1374, DOI 10.1161/01.HYP.0000188702.96256.46; Norton L, 2007, ACTA PHYSIOL, V189, P233, DOI 10.1111/j.1748-1716.2006.01639.x; Ojeda NB, 2007, HYPERTENSION, V50, P679, DOI 10.1161/HYPERTENSIONAHA.107.091785; Owens JA, 2007, AM J PHYSIOL-ENDOC M, V292, pE1879, DOI 10.1152/ajpendo.00706.2006; Ozanne SE, 2004, NATURE, V427, P411, DOI 10.1038/427411b; Ozanne SE, 2005, DIABETOLOGIA, V48, P547, DOI 10.1007/s00125-005-1669-7; Painter RC, 2005, REPROD TOXICOL, V20, P345, DOI 10.1016/j.reprotox.2005.04.005; Phelan JP, 2005, AGEING RES REV, V4, P339, DOI 10.1016/j.arr.2005.06.001; Poore KR, 2007, AM J PHYSIOL-ENDOC M, V292, pE32, DOI 10.1152/ajpendo.00253.2006; Poore KR, 2002, DIABETOLOGIA, V45, P1247, DOI 10.1007/s00125-002-0849-y; Popkin BM, 2006, AM J CLIN NUTR, V84, P289, DOI 10.1093/ajcn/84.2.289; ROBINSON JJ, 1983, FEEDING EWE MILTON K; Roseboom TJ, 2001, MOL CELL ENDOCRINOL, V185, P93, DOI 10.1016/S0303-7207(01)00721-3; Roseboom TJ, 2000, HEART, V84, P595, DOI 10.1136/heart.84.6.595; RUSSEL AJF, 1969, J AGR SCI, V72, P451, DOI 10.1017/S0021859600024874; Sasaki S., 2002, Animal Science Journal, V73, P423, DOI 10.1046/j.1344-3941.2002.00059.x; Saver AA, 2004, AM J CLIN NUTR, V80, P199; Sebert SP, 2009, ENDOCRINOLOGY, V150, P634, DOI 10.1210/en.2008-0542; SEBERT SP, 2008, ENDOCRINOLOGY; Sinclair KD, 2008, REPROD BIOMED ONLINE, V16, P859, DOI 10.1016/S1472-6483(10)60153-8; Sinclair KD, 2007, P NATL ACAD SCI USA, V104, P19351, DOI 10.1073/pnas.0707258104; Singhal A, 2004, LANCET, V363, P1642, DOI 10.1016/S0140-6736(04)16210-7; Storlien L, 2004, P NUTR SOC, V63, P363, DOI 10.1079/PNS2004349; Vickers MH, 2000, AM J PHYSIOL-ENDOC M, V279, pE83; Wells JCK, 2006, INT J OBESITY, V30, P1506, DOI 10.1038/sj.ijo.0803402; Williams PJ, 2007, KIDNEY INT, V72, P279, DOI 10.1038/sj.ki.5002276	63	21	21	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7393	10.1371/journal.pone.0007393	http://dx.doi.org/10.1371/journal.pone.0007393			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826474	Green Published, gold			2022-12-27	WOS:000270808700001
J	Kurki, I; Peromaa, T; Hyvarinen, A; Saarinen, J				Kurki, Ilmari; Peromaa, Tarja; Hyvarinen, Aapo; Saarinen, Jussi			Visual Features Underlying Perceived Brightness as Revealed by Classification Images	PLOS ONE			English	Article							LETTER IDENTIFICATION; RECEPTIVE-FIELDS; PERCEPTION; CONTRAST; MODEL; LIGHTNESS	Along with physical luminance, the perceived brightness is known to depend on the spatial structure of the stimulus. Often it is assumed that neural computation of the brightness is based on the analysis of luminance borders of the stimulus. However, this has not been tested directly. We introduce a new variant of the psychophysical reverse-correlation or classification image method to estimate and localize the physical features of the stimuli which correlate with the perceived brightness, using a brightness-matching task. We derive classification images for the illusory Craik-O'Brien-Cornsweet stimulus and a "real'' uniform step stimulus. For both stimuli, classification images reveal a positive peak at the stimulus border, along with a negative peak at the background, but are flat at the center of the stimulus, suggesting that brightness is determined solely by the border information. Features in the perceptually completed area in the Craik-O'Brien-Cornsweet do not contribute to its brightness, nor could we see low-frequency boosting, which has been offered as an explanation for the illusion. Tuning of the classification image profiles changes remarkably little with stimulus size. This supports the idea that only certain spatial scales are used for computing the brightness of a surface.			Kurki, I (corresponding author), Univ Helsinki, Dept Psychol, Fabianinkatu 28, SF-00100 Helsinki, Finland.	ilmari.kurki@helsinki.fi		Peromaa, Tarja/0000-0001-6290-111X; Hyvarinen, Aapo/0000-0002-5806-4432				AREND LE, 1993, PERCEPT PSYCHOPHYS, V54, P446, DOI 10.3758/BF03211767; AREND LE, 1993, PERCEPT PSYCHOPHYS, V54, P457, DOI 10.3758/BF03211768; BEARD B, 1998, SPIE P, P79; BURR DC, 1987, VISION RES, V27, P1903, DOI 10.1016/0042-6989(87)90056-3; CAMPBELL FW, 1965, J PHYSIOL-LONDON, V181, P576, DOI 10.1113/jphysiol.1965.sp007784; Dakin SC, 2003, P ROY SOC B-BIOL SCI, V270, P2341, DOI 10.1098/rspb.2003.2528; Eckstein MP, 2002, J VISION, V2, pI, DOI 10.1167/2.1.i; Efron Bradley, 1993, INTRO BOOTSTRAP, V57; Gold JM, 2000, CURR BIOL, V10, P663, DOI 10.1016/S0960-9822(00)00523-6; Graham N.V.S, 1989, VISUAL PATTERN ANAL; GROSSBERG S, 1988, PERCEPT PSYCHOPHYS, V43, P241, DOI 10.3758/BF03207869; HUBEL DH, 1962, J PHYSIOL-LONDON, V160, P106, DOI 10.1113/jphysiol.1962.sp006837; Kontsevich LL, 2004, VISION RES, V44, P1493, DOI 10.1016/j.visres.2003.11.027; Majaj NJ, 2002, VISION RES, V42, P1165, DOI 10.1016/S0042-6989(02)00045-7; Mangini MC, 2004, COGNITIVE SCI, V28, P209, DOI 10.1016/j.cogsci.2003.11.004; MORRONE MC, 1988, PROC R SOC SER B-BIO, V235, P221, DOI 10.1098/rspb.1988.0073; Nasanen R, 1999, VISION RES, V39, P3824, DOI 10.1016/S0042-6989(99)00096-6; Pelli DG, 1999, SCIENCE, V285, P844, DOI 10.1126/science.285.5429.844; Perna A, 2007, VISION RES, V47, P1282, DOI 10.1016/j.visres.2007.01.011; Peromaa TL, 2004, VISION RES, V44, P1919, DOI 10.1016/j.visres.2004.03.005; PESSOA L, 1995, VISION RES, V35, P2201, DOI 10.1016/0042-6989(94)00313-0; Salmela VR, 2005, J OPT SOC AM A, V22, P2239, DOI 10.1364/JOSAA.22.002239; Shimozaki SS, 2005, J VISION, V5, P45, DOI 10.1167/5.1.5; SOLOMON JA, 1994, NATURE, V369, P395, DOI 10.1038/369395a0; Tjan BS, 2006, J VISION, V6, P387, DOI 10.1167/6.4.8; WHITTLE P, 1994, LIGHTNESS BRIGHTNESS, P111; Whittle P., 1994, BRIGHTNESS LIGHTNESS, P35	27	8	8	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 13	2009	4	10							e7432	10.1371/journal.pone.0007432	http://dx.doi.org/10.1371/journal.pone.0007432			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WQ	19823590	gold, Green Published, Green Submitted			2022-12-27	WOS:000270808300010
J	Chan, ACH; Borts, RH; Hoffmann, E				Chan, Andrew Chi-Ho; Borts, Rhona H.; Hoffmann, Eva			Temperature-Dependent Modulation of Chromosome Segregation in msh4 Mutants of Budding Yeast	PLOS ONE			English	Article								Background: In many organisms, homologous chromosomes rely upon recombination-mediated linkages, termed crossovers, to promote their accurate segregation at meiosis I. In budding yeast, the evolutionarily conserved mismatch-repair paralogues, Msh4 and Msh5, promote crossover formation in conjunction with several other proteins, collectively termed the Synapsis Initiation Complex (SIC) proteins or 'ZMM's (Zip1-Zip2-Zip3-Zip4-Spo16, Msh4-Msh5, Mer3). zmm mutants show decreased levels of crossovers and increased chromosome missegregation, which is thought to cause decreased spore viability. Principal Findings: In contrast to other ZMM mutants, msh4 and msh5 mutants show improved spore viability and chromosome segregation in response to elevated temperature (23 degrees C versus 33 degrees C). Crossover frequencies in the population of viable spores in msh4 and msh5 mutants are similar at both temperatures, suggesting that temperature-mediated chromosome segregation does not occur by increasing crossover frequencies. Furthermore, meiotic progression defects at elevated temperature do not select for a subpopulation of cells with improved segregation. Instead, another ZMM protein, Zip1, is important for the temperature-dependent improvement in spore viability. Conclusions: Our data demonstrate interactions between genetic (zmm status) and environmental factors in determining chromosome segregation.			Chan, ACH (corresponding author), Univ Sussex, MRC, Genome Damage & Stabil Ctr, Falmer, England.	eh58@sussex.ac.uk	hoffmann, eva/AAM-6594-2020	hoffmann, eva/0000-0002-2588-0652	Biotechnology and Biological Sciences Research Council Funding Source: Medline; Wellcome Trust Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC)); Wellcome Trust(Wellcome TrustEuropean Commission)		Allers T, 2001, CELL, V106, P47, DOI 10.1016/S0092-8674(01)00416-0; Argueso JL, 2004, GENETICS, V168, P1805, DOI 10.1534/genetics.104.032912; Borner GV, 2004, CELL, V117, P29, DOI 10.1016/S0092-8674(04)00292-2; Chambers SR, 1996, MOL CELL BIOL, V16, P6110; Chen SY, 2008, DEV CELL, V15, P401, DOI 10.1016/j.devcel.2008.07.006; Cheslock PS, 2005, NAT GENET, V37, P756, DOI 10.1038/ng1588; Chua PR, 1998, CELL, V93, P349, DOI 10.1016/S0092-8674(00)81164-2; DAWSON DS, 1986, SCIENCE, V234, P713, DOI 10.1126/science.3535068; Hoffmann ER, 2004, CYTOGENET GENOME RES, V107, P232, DOI 10.1159/000080601; HOLLINGSWORTH NM, 1995, GENE DEV, V9, P1728, DOI 10.1101/gad.9.14.1728; Hunter N, 2001, CELL, V106, P59, DOI 10.1016/S0092-8674(01)00430-5; Jessop L, 2006, PLOS GENET, V2, P1402, DOI 10.1371/journal.pgen.0020155; Kellis M, 2003, NATURE, V423, P241, DOI 10.1038/nature01644; Kemp B, 2004, GENE DEV, V18, P1946, DOI 10.1101/gad.1227304; Lacefield S, 2007, NAT GENET, V39, P1273, DOI 10.1038/ng2120; Lamers MH, 2000, NATURE, V407, P711, DOI 10.1038/35037523; Liti G, 2009, NATURE, V458, P337, DOI 10.1038/nature07743; LOIDL J, 1994, P NATL ACAD SCI USA, V91, P331, DOI 10.1073/pnas.91.1.331; Mancera E, 2008, NATURE, V454, P479, DOI 10.1038/nature07135; Martini E, 2006, CELL, V126, P285, DOI 10.1016/j.cell.2006.05.044; Monje-Casas F, 2007, CELL, V128, P477, DOI 10.1016/j.cell.2006.12.040; Novak JE, 2001, GENETICS, V158, P1013; OBLOMOVA G, 2000, NATURE, V407, P703; Oh SD, 2007, CELL, V130, P259, DOI 10.1016/j.cell.2007.05.035; Peoples-Holst TL, 2005, GENE DEV, V19, P863, DOI 10.1101/gad.1293605; PERKINS DD, 1949, GENETICS, V34, P607; Petronczki M, 2003, CELL, V112, P423, DOI 10.1016/S0092-8674(03)00083-7; Pochart P, 1997, J BIOL CHEM, V272, P30345, DOI 10.1074/jbc.272.48.30345; RESNICK MA, 1989, P NATL ACAD SCI USA, V86, P2276, DOI 10.1073/pnas.86.7.2276; ROSSMACDONALD P, 1994, CELL, V79, P1069, DOI 10.1016/0092-8674(94)90037-X; SCHWACHA A, 1994, CELL, V76, P51, DOI 10.1016/0092-8674(94)90172-4; SCHWACHA A, 1995, CELL, V83, P738; Snowden T, 2004, MOL CELL, V15, P437, DOI 10.1016/j.molcel.2004.06.040; WOLF KW, 1994, BIOESSAYS, V16, P107, DOI 10.1002/bies.950160207	34	13	14	0	15	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7284	10.1371/journal.pone.0007284	http://dx.doi.org/10.1371/journal.pone.0007284			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816584	Green Accepted, Green Submitted, Green Published, gold			2022-12-27	WOS:000270594300002
J	Chattopadhyay, S; Bhattacharyya, S; Saha, B; Chakraborty, J; Mohanty, S; Hossain, DMS; Banerjee, S; Das, K; Sa, G; Das, T				Chattopadhyay, Sreya; Bhattacharyya, Sankar; Saha, Baisakhi; Chakraborty, Juni; Mohanty, Suchismita; Hossain, Dewan Md. Sakib; Banerjee, Shuvomoy; Das, Kaushik; Sa, Gaurisankar; Das, Tanya			Tumor-Shed PGE(2) Impairs IL2R gamma c-Signaling to Inhibit CD4(+) T Cell Survival: Regulation by Theaflavins	PLOS ONE			English	Article							NECROSIS-FACTOR-ALPHA; DENDRITIC CELLS; BLACK TEA; PROSTAGLANDIN E-2; ELEVATING AGENTS; CUTTING EDGE; EXPRESSION; RECEPTOR; APOPTOSIS; LYMPHOCYTES	Background: Many tumors are associated with decreased cellular immunity and elevated levels of prostaglandin E2 (PGE2), a known inhibitor of CD4+ T cell activation and inducer of type-2 cytokine bias. However, the role of this immunomodulator in the survival of T helper cells remained unclear. Since CD4+ T cells play critical roles in cell-mediated immunity, detail knowledge of the effect tumor-derived PGE2 might have on CD4+ T cell survival and the underlying mechanism may, therefore, help to overcome the overall immune deviation in cancer. Methodology/Principal Findings: By culturing purified human peripheral CD4+ T cells or Jurkat cells with spent media of theaflavin- or celecoxib-pre-treated MCF-7 cells, we show that tumor-shed PGE2 severely impairs interleukin 2 receptor cc (IL2R gamma c)-mediated survival signaling in CD4+ T cells. Indeed, tumor-shed PGE2 down-regulates IL2R gamma c expression, reduces phosphorylation as well as activation of Janus kinase 3 (Jak-3)/signal transducer and activator of transcription 5 (Stat-5) and decreases Bcl-2/Bax ratio thereby leading to activation of intrinsic apoptotic pathway. Constitutively active Stat-5A (Stat5A1*6) over-expression efficiently elevates Bcl-2 levels in CD4+ T cells and protects them from tumor-induced death while dominant-negative Stat-5A over-expression fails to do so, indicating the importance of Stat-5A-signaling in CD4+ T cell survival. Further support towards the involvement of PGE2 comes from the results that (a) purified synthetic PGE2 induces CD4+ T cell apoptosis, and (b) when knocked out by small interfering RNA, cyclooxygenase-2 (Cox-2)-defective tumor cells fail to initiate death. Interestingly, the entire phenomena could be reverted back by theaflavins that restore cytokine-dependent IL2Rcc/Jak-3/Stat-5A signaling in CD4+ T cells thereby protecting them from tumor-shed PGE2-induced apoptosis. Conclusions/Significance: These data strongly suggest that tumor-shed PGE2 is an important factor leading to CD4+ T cell apoptosis during cancer and raise the possibility that theaflavins may have the potential as an effective immunorestorer in cancer-bearer.			Chattopadhyay, S (corresponding author), Bose Inst, Div Mol Med, P-1-12 CIT Scheme VIIM, Kolkata, India.	tanya@bic.boseinst.ernet.in	Bhattacharyya, Sankar/AAK-2204-2020; Bhattacharyya, Sankar/GZH-3091-2022; Banerjee, Shuvomoy/AAZ-2479-2021	Bhattacharyya, Sankar/0000-0002-3235-4220; Banerjee, Shuvomoy/0000-0002-6936-1950				ALAVA MA, 1992, BIOCHEM J, V284, P189, DOI 10.1042/bj2840189; Alves NL, 2007, IMMUNOL LETT, V108, P113, DOI 10.1016/j.imlet.2006.11.006; ANASTASSIOU ED, 1992, J IMMUNOL, V148, P2845; Astoul E, 2001, TRENDS IMMUNOL, V22, P490, DOI 10.1016/S1471-4906(01)01973-1; Baird AM, 1998, J LEUKOCYTE BIOL, V63, P669, DOI 10.1002/jlb.63.6.669; Bennett SRM, 1998, NATURE, V393, P478, DOI 10.1038/30996; Bevan MJ, 2004, NAT REV IMMUNOL, V4, P595, DOI 10.1038/nri1413; Bhattacharyya A, 2005, INT J CANCER, V117, P308, DOI 10.1002/ijc.21075; Bhattacharyya S, 2007, J BIOL CHEM, V282, P15954, DOI 10.1074/jbc.M608189200; Bhattacharyya S, 2007, CANCER RES, V67, P362, DOI 10.1158/0008-5472.CAN-06-2583; CAYEUX SJ, 1993, BONE MARROW TRANSPL, V12, P603; Chemnitz JM, 2006, CANCER RES, V66, P1114, DOI 10.1158/0008-5472.CAN-05-3252; Choudhuri T, 2005, J BIOL CHEM, V280, P20059, DOI 10.1074/jbc.M410670200; Das T, 2008, J IMMUNOL, V180, P4687, DOI 10.4049/jimmunol.180.7.4687; Das T, 2008, CANCER RES, V68, P2014, DOI 10.1158/0008-5472.CAN-07-6037; Dreger H, 2008, EXP BIOL MED, V233, P427, DOI 10.3181/0710-RM-292; Finke J, 1999, IMMUNOL TODAY, V20, P158, DOI 10.1016/S0167-5699(98)01435-2; GOEDEGEBUURE PS, 1995, IMMUNOL RES, V14, P119, DOI 10.1007/BF02918172; GOETZL EJ, 1995, FASEB J, V9, P1051, DOI 10.1096/fasebj.9.11.7649404; GOODWIN JS, 1977, J EXP MED, V146, P1719, DOI 10.1084/jem.146.6.1719; Harris SG, 2002, TRENDS IMMUNOL, V23, P144, DOI 10.1016/S1471-4906(01)02154-8; Hengartner MO, 2000, NATURE, V407, P770, DOI 10.1038/35037710; HILKENS CMU, 1995, EUR J IMMUNOL, V25, P59, DOI 10.1002/eji.1830250112; Huang H, 2007, IMMUNOLOGY, V120, P148, DOI 10.1111/j.1365-2567.2006.02452.x; Kennedy R, 2008, IMMUNOL REV, V222, P129, DOI 10.1111/j.1600-065X.2008.00616.x; Kolenko V, 1999, BLOOD, V93, P2308, DOI 10.1182/blood.V93.7.2308.407k16_2308_2318; Kolenko V, 1997, J IMMUNOL, V159, P3057; Lahiry L, 2008, APOPTOSIS, V13, P771, DOI 10.1007/s10495-008-0213-x; Li CQ, 2008, PROTEIN SCI, V17, P1624, DOI 10.1110/ps.036145.108; Luczaj W, 2005, PREV MED, V40, P910, DOI 10.1016/j.ypmed.2004.10.014; Mandal D, 2006, INT IMMUNOPHARMACOL, V6, P433, DOI 10.1016/j.intimp.2005.09.005; Mandal D, 2007, NUTR CANCER, V58, P213, DOI 10.1080/01635580701328503; Marzo AL, 1999, CANCER RES, V59, P1071; Mastino A, 1992, Dev Immunol, V2, P263, DOI 10.1155/1992/80863; Micallef MJ, 1997, CANCER IMMUNOL IMMUN, V43, P361, DOI 10.1007/s002620050345; MINAKUCHI R, 1990, J IMMUNOL, V145, P2616; Nakajima H, 1997, J EXP MED, V185, P189, DOI 10.1084/jem.185.2.189; Oakes SA, 1996, IMMUNITY, V5, P605, DOI 10.1016/S1074-7613(00)80274-5; Pardoll DM, 1998, CURR OPIN IMMUNOL, V10, P588, DOI 10.1016/S0952-7915(98)80228-8; PASSWELL J, 1983, CLIN EXP IMMUNOL, V51, P61; PHIPPS RP, 1991, IMMUNOL TODAY, V12, P349, DOI 10.1016/0167-5699(91)90064-Z; Pockaj BA, 2004, ANN SURG ONCOL, V11, P328, DOI 10.1245/ASO.2004.05.027; Prasad S, 2007, LIFE SCI, V81, P1323, DOI 10.1016/j.lfs.2007.07.033; Rabinowich H, 1998, J CLIN INVEST, V101, P2579, DOI 10.1172/JCI1518; Reichert TE, 1998, J IMMUNOTHER, V21, P295, DOI 10.1097/00002371-199807000-00007; Sa G, 2009, CANCER RES, V69, P3095, DOI 10.1158/0008-5472.CAN-08-3776; Saas P, 1997, J CLIN INVEST, V99, P1173, DOI 10.1172/JCI119273; SAIAGH S, 1994, INT J IMMUNOPHARMACO, V16, P775, DOI 10.1016/0192-0561(94)90098-1; Saito T, 2000, CLIN CANCER RES, V6, P1351; Schoenberger SP, 1998, NATURE, V393, P480, DOI 10.1038/31002; Sharma S, 2005, CANCER RES, V65, P5211, DOI 10.1158/0008-5472.CAN-05-0141; Shreedhar V, 1999, IMMUNITY, V11, P625, DOI 10.1016/S1074-7613(00)80137-5; Smith CM, 2004, NAT IMMUNOL, V5, P1143, DOI 10.1038/ni1129; Spierings DCJ, 2006, EUR J IMMUNOL, V36, P1707, DOI 10.1002/eji.200635929; TANIGUCHI T, 1993, CELL, V73, P5, DOI 10.1016/0092-8674(93)90152-G; Thomis DC, 1997, J EXP MED, V185, P197, DOI 10.1084/jem.185.2.197; Toes REM, 1999, J EXP MED, V189, P753, DOI 10.1084/jem.189.5.753; Vermeer MA, 2008, J AGR FOOD CHEM, V56, P12031, DOI 10.1021/jf8022035; Wang JCE, 2003, J IMMUNOL, V171, P6339, DOI 10.4049/jimmunol.171.12.6339; Watanabe S, 2003, J IMMUNOL, V171, P5828, DOI 10.4049/jimmunol.171.11.5828; Webb LMC, 2005, J IMMUNOL, V175, P2783, DOI 10.4049/jimmunol.175.5.2783; Wen RR, 2001, MOL CELL BIOL, V21, P678, DOI 10.1128/MCB.21.2.678-689.2001; WITTHUHN BA, 1994, NATURE, V370, P153, DOI 10.1038/370153a0; Yang CS, 2005, EXP LUNG RES, V31, P135, DOI 10.1080/01902140490495525; Yang E, 1996, BLOOD, V88, P386, DOI 10.1182/blood.V88.2.386.bloodjournal882386; Yang L, 2003, J CLIN INVEST, V111, P727, DOI 10.1172/JCI200316492; Zhang Q, 1996, P NATL ACAD SCI USA, V93, P9148, DOI 10.1073/pnas.93.17.9148	67	25	27	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7382	10.1371/journal.pone.0007382	http://dx.doi.org/10.1371/journal.pone.0007382			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812686	Green Published, gold, Green Submitted			2022-12-27	WOS:000270594200008
J	Biebl, A; Muendlein, A; Kazakbaeva, Z; Heuberger, S; Sonderegger, G; Drexel, H; Lau, S; Nickel, R; Kabesch, M; Simma, B				Biebl, Ariane; Muendlein, Axel; Kazakbaeva, Zhyrgal; Heuberger, Sigrid; Sonderegger, Gudrun; Drexel, Heinz; Lau, Susanne; Nickel, Renate; Kabesch, Michael; Simma, Burkhard			CD14 C-159T and Toll-Like Receptor 4 Asp299Gly Polymorphisms in Surviving Meningococcal Disease Patients	PLOS ONE			English	Article							SOLUBLE CD14; SUSCEPTIBILITY; MUTATIONS; PROMOTER; BINDING; INFECTION; SEVERITY; RISK; GENE	Background: Carriage of Neisseria meningitidis occurs approximately in 10% of the population, onset of invasive meningococcal disease (IMD) cannot be predicted and differs between ages. It remains unclear, which host factors determine invasion of the bloodstream by the bacteria. Innate immunity has a very important role in the first recognition of invading pathogens. The functional single nucleotide polymorphisms (SNPs) CD14 C-159T and toll-like receptor 4 (TLR4) Asp299Gly have been associated with the risk of gram-negative infections. However, their role in development of IMD still remains unclear. Our aim was to investigate the influence of CD14 C-159T and TLR4 Asp299Gly polymorphisms on the risk of IMD. Methodology/Principal Findings: It was a retrospective case control study. Surviving Austrian meningococcal disease patients were enrolled by sending buccal swabs for DNA analysis. 185 cases with a proven meningococcal infection and 770 healthy controls were enrolled. In surviving meningococcal disease patients DNA analysis of CD14 C-159T and TLR 4 Asp299Gly polymorphisms was performed, as they are part of the innate immune response to bacterial determinants. CD14 C-159T and TLR4 Asp299Gly SNPs were not significantly associated with the presence of IMD when compared to healthy controls. The odds ratio for CD14 C-159T SNP was 1.14 (95% confidence interval (CI) 0.91-1.43; p = 0.266). In TLR4 Asp 299 Gly SNP the odds ratio was 0.78 (CI 0.47-1.43; p = 0.359). Conclusion/Significance: We could not observe a significant influence of CD14 C-159T and TLR4 Asp299Gly polymorphisms on the risk of developing IMD in surviving meningococcal disease patients. To our knowledge, this is the first study investigating the influence of the CD14 C-159T SNP on the susceptibility to IMD.			Biebl, A (corresponding author), Univ Teaching Hosp, Dept Pediat, Feldkirch, Austria.	ariane.biebl@gespag.at	Muendlein, Axel/AAS-5313-2021; Kabesch, Michael/AAB-5701-2020; Kabesch, Michael/GZM-1583-2022	Muendlein, Axel/0000-0002-5582-4125				*ACIP, 2005, MMWR-MORBID MORTAL W, V7, P1; Agnese DM, 2002, J INFECT DIS, V186, P1522, DOI 10.1086/344893; Baldini M, 1999, AM J RESP CELL MOL, V20, P976, DOI 10.1165/ajrcmb.20.5.3494; Bunker-Wiersma HE, 2008, PEDIATR CRIT CARE ME, V9, P517, DOI 10.1097/PCC.0b013e318184985b; Burgmann H, 1996, CLIN IMMUNOL IMMUNOP, V80, P307, DOI 10.1006/clin.1996.0128; Caroff M, 2002, MICROBES INFECT, V4, P915, DOI 10.1016/S1286-4579(02)01612-X; Emonts M, 2003, LANCET INFECT DIS, V3, P565, DOI 10.1016/S1473-3099(03)00740-0; Faber J, 2006, PEDIATR INFECT DIS J, V25, P80, DOI 10.1097/01.inf.0000195595.22547.fe; Gardner P, 2006, NEW ENGL J MED, V355, P1466, DOI 10.1056/NEJMcp063561; Hubacek JA, 1999, CIRCULATION, V99, P3218, DOI 10.1161/01.CIR.99.25.3218; Illi S, 2001, BMJ-BRIT MED J, V322, P390, DOI 10.1136/bmj.322.7283.390; Jessen KM, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-108; LABETA MO, 1993, EUR J IMMUNOL, V23, P2144, DOI 10.1002/eji.1830230915; LeVan TD, 2001, J IMMUNOL, V167, P5838, DOI 10.4049/jimmunol.167.10.5838; PUGIN J, 1994, IMMUNITY, V1, P509, DOI 10.1016/1074-7613(94)90093-0; Read RC, 2001, J INFECT DIS, V184, P640, DOI 10.1086/322798; Read RC, 2009, CRIT CARE MED, V37, P1237, DOI 10.1097/CCM.0b013e31819c39bc; Rupp J, 2004, GENES IMMUN, V5, P435, DOI 10.1038/sj.gene.6364112; Sengler C, 2003, CLIN EXP ALLERGY, V33, P166, DOI 10.1046/j.1365-2222.2003.01549.x; Smirnova I, 2003, P NATL ACAD SCI USA, V100, P6075, DOI 10.1073/pnas.1031605100; Sutherland AM, 2005, CRIT CARE MED, V33, P638, DOI [10.1097/01.CCM.0000156242.44356.C5, 10.1097/01.ccm.0000156242.44356.c5]; Trotter CL, 2006, EPIDEMIOL INFECT, V134, P556, DOI 10.1017/S0950268805005339; WRIGHT SD, 1990, SCIENCE, V249, P1431, DOI 10.1126/science.1698311	23	19	21	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7374	10.1371/journal.pone.0007374	http://dx.doi.org/10.1371/journal.pone.0007374			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809507	Green Submitted, Green Published, gold			2022-12-27	WOS:000270594000021
J	Li, GR; Sun, HY; Chen, JB; Zhou, Y; Tse, HF; Lau, CP				Li, Gui-Rong; Sun, Hai-Ying; Chen, Jing-Bo; Zhou, Yuan; Tse, Hung-Fat; Lau, Chu-Pak			Characterization of Multiple Ion Channels in Cultured Human Cardiac Fibroblasts	PLOS ONE			English	Article							MESENCHYMAL STEM-CELLS; HUMAN ATRIAL; CHLORIDE CHANNELS; SODIUM CURRENT; ACTION-POTENTIALS; SINOATRIAL NODE; K+ CURRENTS; POTASSIUM CHANNELS; TRANSIENT OUTWARD; MYOCYTES	Background: Although fibroblast-to-myocyte electrical coupling is experimentally suggested, electrophysiology of cardiac fibroblasts is not as well established as contractile cardiac myocytes. The present study was therefore designed to characterize ion channels in cultured human cardiac fibroblasts. Methods and Findings: A whole-cell patch voltage clamp technique and RT-PCR were employed to determine ion channels expression and their molecular identities. We found that multiple ion channels were heterogeneously expressed in human cardiac fibroblasts. These include a big conductance Ca2+-activated K+ current (BKCa) in most (88%) human cardiac fibroblasts, a delayed rectifier K+ current (IKDR) and a transient outward K+ current (I-to) in a small population (15 and 14%, respectively) of cells, an inwardly-rectifying K+ current (I-Kir) in 24% of cells, and a chloride current (I-Cl) in 7% of cells under isotonic conditions. In addition, two types of voltage-gated Na+ currents (I-Na) with distinct properties were present in most (61%) human cardiac fibroblasts. One was a slowly inactivated current with a persistent component, sensitive to tetrodotoxin (TTX) inhibition (I-Na.TTX, IC50 = 7.8 nM), the other was a rapidly inactivated current, relatively resistant to TTX (I-Na.TTXR, IC50 = 1.8 mu M). RT-PCR revealed the molecular identities (mRNAs) of these ion channels in human cardiac fibroblasts, including KCa.1.1 (responsible for BKCa), Kv1.5, Kv1.6 (responsible for IKDR), Kv4.2, Kv4.3 (responsible for I-to), Kir2.1, Kir2.3 (for I-Kir), Clnc3 (for I-Cl), NaV1.2, NaV1.3, NaV1.6, NaV1.7 (for I-Na.TTX), and NaV1.5 (for I-Na.TTXR). Conclusions: These results provide the first information that multiple ion channels are present in cultured human cardiac fibroblasts, and suggest the potential contribution of these ion channels to fibroblast-myocytes electrical coupling.			Li, GR (corresponding author), Univ Hong Kong, Li Ka Shing Fac Med, Dept Med, Pokfulam, Hong Kong, Peoples R China.	grli@hkucc.hku.hk	Tse, Hung-Fat/C-4426-2009; Li, Gui-Rong/C-4341-2009; , 李贵荣（沧海一粟）/AAZ-4335-2020	Tse, Hung-Fat/0000-0002-9578-7808; , 李贵荣（沧海一粟）/0000-0002-9437-2280				Baumgarten CM, 2003, PROG BIOPHYS MOL BIO, V82, P25, DOI 10.1016/S0079-6107(03)00003-8; BEUCKELMANN DJ, 1993, CIRC RES, V73, P379, DOI 10.1161/01.RES.73.2.379; Brown RD, 2005, ANNU REV PHARMACOL, V45, P657, DOI 10.1146/annurev.pharmtox.45.120403.095802; Camelliti P, 2005, MICROSC MICROANAL, V11, P249, DOI [10.1017/S1431927605050506, 10.1017/S143927605050506]; Camelliti P, 2004, CARDIOVASC RES, V62, P415, DOI 10.1016/j.cardiores.2004.01.027; Camelliti P, 2004, CIRC RES, V94, P828, DOI 10.1161/01.RES.0000122382.19400.14; Camelliti P, 2006, ADV CARDIOL, V42, P132, DOI 10.1159/000092566; Chilton L, 2005, AM J PHYSIOL-HEART C, V288, pH2931, DOI 10.1152/ajpheart.01220.2004; Coiret G, 2007, MOL PHARMACOL, V71, P843, DOI 10.1124/mol.106.028290; Du XL, 2004, J GEN PHYSIOL, V123, P427, DOI 10.1085/jgp.200409013; FEDIDA D, 1993, CIRC RES, V73, P210, DOI 10.1161/01.RES.73.1.210; Feng JL, 1996, AM J PHYSIOL-HEART C, V270, pH1676, DOI 10.1152/ajpheart.1996.270.5.H1676; Flack EC, 2006, J MOL CELL CARDIOL, V40, P474, DOI 10.1016/j.yjmcc.2006.01.019; FURUKAWA T, 1995, J MOL CELL CARDIOL, V27, P831, DOI 10.1016/0022-2828(95)90090-X; Gaborit N, 2007, J PHYSIOL-LONDON, V582, P675, DOI 10.1113/jphysiol.2006.126714; Gao Z, 2005, BRIT J PHARMACOL, V144, P595, DOI 10.1038/sj.bjp.0706113; Gao Z, 2007, J MOL CELL CARDIOL, V42, P98, DOI 10.1016/j.yjmcc.2006.10.002; Gaudesius G, 2003, CIRC RES, V93, P421, DOI 10.1161/01.RES.0000089258.40661.0C; Goldin AL, 2001, ANNU REV PHYSIOL, V63, P871, DOI 10.1146/annurev.physiol.63.1.871; Hammarstrom AKM, 1999, J PHYSIOL-LONDON, V520, P451, DOI 10.1111/j.1469-7793.1999.t01-1-00451.x; Hu H, 2009, J CELL PHYSIOL, V218, P427, DOI 10.1002/jcp.21617; Kohl P, 2005, J ELECTROCARDIOL, V38, P45, DOI 10.1016/j.jelectrocard.2005.06.096; Kohl P, 2003, CIRC RES, V93, P381, DOI 10.1161/01.RES.0000091364.90121.0C; KOHL P, 1994, EXP PHYSIOL, V79, P943, DOI 10.1113/expphysiol.1994.sp003819; Kohl P, 2007, HEART RHYTHM, V4, P233, DOI 10.1016/j.hrthm.2006.10.014; Kuhlmann CRW, 2005, ACTA PHYSIOL SCAND, V183, P161, DOI 10.1111/j.1365-201X.2004.01378.x; Lei M, 2007, CARDIOVASC RES, V74, P356, DOI 10.1016/j.cardiores.2007.01.009; LI GR, 1995, AM J PHYSIOL-HEART C, V269, pH463, DOI 10.1152/ajpheart.1995.269.2.H463; Li GR, 2005, STEM CELLS, V23, P371, DOI 10.1634/stemcells.2004-0213; Li GR, 2004, HEART RHYTHM, V1, P460, DOI 10.1016/j.hrthm.2004.06.003; Li GR, 1998, AM J PHYSIOL-CELL PH, V274, pC577, DOI 10.1152/ajpcell.1998.274.3.C577; Li GR, 1999, AM J PHYSIOL-HEART C, V276, pH98, DOI 10.1152/ajpheart.1999.276.1.H98; Li GR, 1998, AM J PHYSIOL-HEART C, V275, pH369, DOI 10.1152/ajpheart.1998.275.2.H369; Li GR, 1996, CIRC RES, V78, P689, DOI 10.1161/01.RES.78.4.689; Li GR, 1996, AM J PHYSIOL-CELL PH, V270, pC500; Li GR, 2006, STEM CELLS, V24, P1519, DOI 10.1634/stemcells.2005-0307; Liu H, 2007, J MOL CELL CARDIOL, V42, P760, DOI 10.1016/j.yjmcc.2006.10.013; Masur SK, 1996, P NATL ACAD SCI USA, V93, P4219, DOI 10.1073/pnas.93.9.4219; Miragoli M, 2006, CIRC RES, V98, P801, DOI 10.1161/01.RES.0000214537.44195.a3; Nilius B, 2001, J PHYSIOL-LONDON, V532, P581, DOI 10.1111/j.1469-7793.2001.0581e.x; Pardo LA, 2004, PHYSIOLOGY, V19, P285, DOI 10.1152/physiol.00011.2004; ROOK MB, 1992, AM J PHYSIOL, V263, pC959, DOI 10.1152/ajpcell.1992.263.5.C959; Rose RA, 2007, J PHYSIOL-LONDON, V580, P255, DOI 10.1113/jphysiol.2006.120832; Sachse FB, 2008, ANN BIOMED ENG, V36, P41, DOI 10.1007/s10439-007-9405-8; SAKAKIBARA Y, 1992, CIRC RES, V71, P535, DOI 10.1161/01.RES.71.3.535; Shibukawa Y, 2005, BIOPHYS J, V88, P3924, DOI 10.1529/biophysj.104.054429; Shirihai O, 1998, J CELL PHYSIOL, V177, P197; Tao R, 2008, AM J PHYSIOL-CELL PH, V295, pC1409, DOI 10.1152/ajpcell.00268.2008; Wang GL, 2002, CIRC RES, V91, pE28, DOI 10.1161/01.RES.0000042062.69653.E4; Wang YJ, 2006, J MEMBRANE BIOL, V213, P175, DOI 10.1007/s00232-007-0027-8; Wu WKK, 2006, J CELL PHYSIOL, V207, P437, DOI 10.1002/jcp.20576	51	94	96	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7307	10.1371/journal.pone.0007307	http://dx.doi.org/10.1371/journal.pone.0007307			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806193	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593800015
J	Jaiswal, S; Pearson, T; Friberg, H; Shultz, LD; Greiner, DL; Rothman, AL; Mathew, A				Jaiswal, Smita; Pearson, Todd; Friberg, Heather; Shultz, Leonard D.; Greiner, Dale L.; Rothman, Alan L.; Mathew, Anuja			Dengue Virus Infection and Virus-Specific HLA-A2 Restricted Immune Responses in Humanized NOD-scid IL2r gamma(null) Mice	PLOS ONE			English	Article								Background: The lack of a suitable animal model to study viral and immunological mechanisms of human dengue disease has been a deterrent to dengue research. Methodology/Principal Findings: We sought to establish an animal model for dengue virus (DENV) infection and immunity using non-obese diabetic/severe combined immunodeficiency interleukin-2 receptor gamma-chain knockout (NOD-scid IL2r gamma(null)) mice engrafted with human hematopoietic stem cells. Human CD45(+) cells in the bone marrow of engrafted mice were susceptible to in vitro infection using low passage clinical and established strains of DENV. Engrafted mice were infected with DENV type 2 by different routes and at multiple time points post infection, we detected DENV antigen and RNA in the sera, bone marrow, spleen and liver of infected engrafted mice. Anti-dengue IgM antibodies directed against the envelope protein of DENV peaked in the sera of mice at 1 week post infection. Human T cells that developed following engraftment of HLA-A2 transgenic NOD-scid IL2r gamma(null) mice with HLA-A2(+) human cord blood hematopoietic stem cells, were able to secrete IFN-gamma, IL-2 and TNF-alpha in response to stimulation with three previously identified A2 restricted dengue peptides NS4b 2353((111-119)), NS4b 2423((181-189)), and NS4a 2148((56-64)). Conclusions/Significance: This is the first study to demonstrate infection of human cells and functional DENV-specific T cell responses in DENV-infected humanized mice. Overall, these mice should be a valuable tool to study the role of prior immunity on subsequent DENV infections.			Jaiswal, S (corresponding author), Univ Massachusetts, Sch Med, Ctr Infect Dis & Vaccine Res, Worcester, MA 01605 USA.	anuja.mathew@umassmed.edu	Mathew, Anuja/V-6711-2019	Mathew, Anuja/0000-0002-6752-009X; Rothman, Alan/0000-0002-4064-6848	NCI NIH HHS [CA34196, P30 CA034196] Funding Source: Medline; NIAID NIH HHS [U19 AI057319] Funding Source: Medline; NIDDK NIH HHS [DK52530] Funding Source: Medline; NATIONAL CANCER INSTITUTE [P30CA034196] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [U19AI057319] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK052530] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		An J, 1999, VIROLOGY, V263, P70, DOI 10.1006/viro.1999.9887; Armstrong PM, 2003, AM J TROP MED HYG, V68, P539, DOI 10.4269/ajtmh.2003.68.539; Bashyam HS, 2006, J IMMUNOL, V176, P2817, DOI 10.4049/jimmunol.176.5.2817; Bente DA, 2005, J VIROL, V79, P13797, DOI 10.1128/JVI.79.21.13797-13799.2005; Bray M, 1998, J VIROL, V72, P1647, DOI 10.1128/JVI.72.2.1647-1651.1998; BURKE DS, 1988, AM J TROP MED HYG, V38, P172, DOI 10.4269/ajtmh.1988.38.172; Chen HC, 2007, J VIROL, V81, P5518, DOI 10.1128/JVI.02575-06; Cologna R, 2005, J VIROL, V79, P853, DOI 10.1128/JVI.79.2.853-859.2005; Diamond MS, 2000, J VIROL, V74, P4957, DOI 10.1128/JVI.74.11.4957-4966.2000; Diamond MS, 2001, VIROLOGY, V289, P297, DOI 10.1006/viro.2001.1114; ECKELS KH, 1994, AM J TROP MED HYG, V50, P472, DOI 10.4269/ajtmh.1994.50.472; Greiner DL, 1998, STEM CELLS, V16, P166, DOI 10.1002/stem.160166; GUBLER DJ, 1995, EMERG INFECT DIS, V1, P55; Gubler DJ, 1998, CLIN MICROBIOL REV, V11, P480, DOI 10.1128/CMR.11.3.480; HALSTEAD SB, 1989, REV INFECT DIS, V11, pS830; HALSTEAD SB, 1973, J INFECT DIS, V128, P7, DOI 10.1093/infdis/128.1.7; Ishikawa F, 2002, EXP HEMATOL, V30, P488, DOI 10.1016/S0301-472X(02)00784-1; Ishikawa F, 2005, BLOOD, V106, P1565, DOI 10.1182/blood-2005-02-0516; Jarchum I, 2007, DIABETES, V56, P2551, DOI 10.2337/db07-0332; Johnson AJ, 1999, J VIROL, V73, P783, DOI 10.1128/JVI.73.1.783-786.1999; Kalayanarooj S, 1997, J INFECT DIS, V176, P313, DOI 10.1086/514047; KURANE I, 1990, ARCH VIROL, V110, P91, DOI 10.1007/BF01310705; KURANE I, 1994, ARCH VIROL, P59; Kurane I, 1998, VIROLOGY, V240, P169, DOI 10.1006/viro.1997.8925; Kuruvilla JG, 2007, VIROLOGY, V369, P143, DOI 10.1016/j.virol.2007.06.005; LANCIOTTI RS, 1992, J CLIN MICROBIOL, V30, P545, DOI 10.1128/JCM.30.3.545-551.1992; Lin YL, 1998, J VIROL, V72, P9729, DOI 10.1128/JVI.72.12.9729-9737.1998; Lin YW, 2002, J VIROL, V76, P12242, DOI 10.1128/JVI.76.23.12242-12249.2002; Macchiarini Francesca, 2005, J Exp Med, V202, P1307, DOI 10.1084/jem.20051547; Melkus MW, 2006, NAT MED, V12, P1316, DOI 10.1038/nm1431; MOTA J, 2009, J VIROL; Pearson T, 2008, CURR TOP MICROBIOL, V324, P25; Sanchez V, 2006, FEMS IMMUNOL MED MIC, V46, P113, DOI 10.1111/j.1574-695X.2005.00008.x; Shresta S, 2005, J IMMUNOL, V175, P3946, DOI 10.4049/jimmunol.175.6.3946; Shresta S, 2004, J VIROL, V78, P2701, DOI 10.1128/JVI.78.6.2701-2710.2004; Shresta S, 2006, J VIROL, V80, P10208, DOI 10.1128/JVI.00062-06; Shultz LD, 2005, J IMMUNOL, V174, P6477, DOI 10.4049/jimmunol.174.10.6477; Shultz LD, 2007, NAT REV IMMUNOL, V7, P118, DOI 10.1038/nri2017; Takaki T, 2006, J IMMUNOL, V176, P3257, DOI 10.4049/jimmunol.176.5.3257; Tassaneetrithep B, 2003, J EXP MED, V197, P823, DOI 10.1084/jem.20021840; Traggiai E, 2004, SCIENCE, V304, P104, DOI 10.1126/science.1093933; Vaughn DW, 1997, J INFECT DIS, V176, P322, DOI 10.1086/514048; Watanabe S, 2007, BLOOD, V109, P212, DOI 10.1182/blood-2006-04-017681; Woodland RT, 2006, SEMIN IMMUNOL, V18, P318, DOI 10.1016/j.smim.2006.06.001; WOODLAND RT, 2007, BLOOD; WU SJL, 1995, AM J TROP MED HYG, V52, P468, DOI 10.4269/ajtmh.1995.52.468	46	102	106	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7251	10.1371/journal.pone.0007251	http://dx.doi.org/10.1371/journal.pone.0007251			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802382	gold, Green Published, Green Submitted			2022-12-27	WOS:000270593600003
J	Maisonneuve, E; Ducret, A; Khoueiry, P; Lignon, S; Longhi, S; Talla, E; Dukan, S				Maisonneuve, Etienne; Ducret, Adrien; Khoueiry, Pierre; Lignon, Sabrina; Longhi, Sonia; Talla, Emmanuel; Dukan, Sam			Rules Governing Selective Protein Carbonylation	PLOS ONE			English	Article							OXIDATIVE STRESS; GLUTAMINE-SYNTHETASE; CATALYZED OXIDATION; DISORDERED REGIONS; COG DATABASE; WEB SERVER; PREDICTION; DAMAGE; SEQUENCE; SITES	Background: Carbonyl derivatives are mainly formed by direct metal-catalysed oxidation (MCO) attacks on the amino-acid side chains of proline, arginine, lysine and threonine residues. For reasons unknown, only some proteins are prone to carbonylation. Methodology/Principal Findings: We used mass spectrometry analysis to identify carbonylated sites in: BSA that had undergone in vitro MCO, and 23 carbonylated proteins in Escherichia coli. The presence of a carbonylated site rendered the neighbouring carbonylatable site more prone to carbonylation. Most carbonylated sites were present within hot spots of carbonylation. These observations led us to suggest rules for identifying sites more prone to carbonylation. We used these rules to design an in silico model (available at http://www.lcb.cnrs-mrs.fr/CSPD/), allowing an effective and accurate prediction of sites and of proteins more prone to carbonylation in the E. coli proteome. Conclusions/Significance: We observed that proteins evolve to either selectively maintain or lose predicted hot spots of carbonylation depending on their biological function. As our predictive model also allows efficient detection of carbonylated proteins in Bacillus subtilis, we believe that our model may be extended to direct MCO attacks in all organisms.			Maisonneuve, E (corresponding author), Aix Marseille Univ, CNRS, Chim Bacterienne Lab, UPR 9043, 31 Chemin Joseph Aiguier, Marseille, France.	talla@ifr88.cnrs-mrs.fr; sdukan@ifr88.cnrs-mrs.fr	Khoueiry, Pierre/F-2130-2017; LONGHI, Sonia/M-5305-2014	Khoueiry, Pierre/0000-0001-7643-3310; LONGHI, Sonia/0000-0002-6829-6771; TALLA, Emmanuel/0000-0002-7775-8296; maisonneuve, Etienne/0000-0003-3451-1223				Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Berlett BS, 1997, J BIOL CHEM, V272, P20313, DOI 10.1074/jbc.272.33.20313; Bota DA, 2002, NAT CELL BIOL, V4, P674, DOI 10.1038/ncb836; BOURHIS J, 2007, CURRENT PRO IN PRESS; Bucciantini M, 2002, NATURE, V416, P507, DOI 10.1038/416507a; Cabiscol E, 2000, J BIOL CHEM, V275, P27393; Callebaut I, 1997, CELL MOL LIFE SCI, V53, P621, DOI 10.1007/s000180050082; Chandonia JM, 1999, PROTEINS, V35, P293; Coeytaux K, 2005, BIOINFORMATICS, V21, P1891, DOI 10.1093/bioinformatics/bti266; Dalle-Donne I, 2006, J CELL MOL MED, V10, P389, DOI 10.1111/j.1582-4934.2006.tb00407.x; Desnues B, 2003, EMBO REP, V4, P400, DOI 10.1038/sj.embor.embor799; Dosztanyi Z, 2005, BIOINFORMATICS, V21, P3433, DOI 10.1093/bioinformatics/bti541; Dukan S, 2000, P NATL ACAD SCI USA, V97, P5746, DOI 10.1073/pnas.100422497; Dukan S, 1999, J BIOL CHEM, V274, P26027, DOI 10.1074/jbc.274.37.26027; Dukan S, 1998, GENE DEV, V12, P3431, DOI 10.1101/gad.12.21.3431; Ferron F, 2006, PROTEINS, V65, P1, DOI 10.1002/prot.21075; Fredriksson A, 2006, MOL MICROBIOL, V59, P350, DOI 10.1111/j.1365-2958.2005.04947.x; Galzitskaya OV, 2006, BIOINFORMATICS, V22, P2948, DOI 10.1093/bioinformatics/btl504; Garbuzynskiy SO, 2004, PROTEIN SCI, V13, P2871, DOI 10.1110/ps.04881304; Grune T, 2003, BIOCHEM BIOPH RES CO, V305, P709, DOI 10.1016/S0006-291X(03)00809-X; Job C, 2005, PLANT PHYSIOL, V138, P790, DOI 10.1104/pp.105.062778; Lee S, 2006, J PROTEOME RES, V5, P539, DOI 10.1021/pr050299q; Levine RL, 2002, FREE RADICAL BIO MED, V32, P790, DOI 10.1016/S0891-5849(02)00765-7; LEVINE RL, 1983, J BIOL CHEM, V258, P1823; Lieutaud P, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-S2-S25; Linding R, 2003, NUCLEIC ACIDS RES, V31, P3701, DOI 10.1093/nar/gkg519; Liu JF, 2003, NUCLEIC ACIDS RES, V31, P3833, DOI 10.1093/nar/gkg515; Maisonneuve E, 2008, J BACTERIOL, V190, P6609, DOI 10.1128/JB.00588-08; Mirzaei H, 2006, ANAL CHEM, V78, P770, DOI 10.1021/ac0514220; Mirzaei H, 2005, ANAL CHEM, V77, P2386, DOI 10.1021/ac0484373; Mirzaei H, 2006, J PROTEOME RES, V5, P2159, DOI 10.1021/pr060021d; Mostertz J, 2003, MOL GENET GENOMICS, V269, P640, DOI 10.1007/s00438-003-0877-4; Nystrom T, 2005, EMBO J, V24, P1311, DOI 10.1038/sj.emboj.7600599; Obradovic Z, 2003, PROTEINS, V53, P566, DOI 10.1002/prot.10532; OBRADOVIC Z, 2005, PROTEINS; OLIVER CN, 1990, P NATL ACAD SCI USA, V87, P5144, DOI 10.1073/pnas.87.13.5144; Prilusky J, 2005, BIOINFORMATICS, V21, P3435, DOI 10.1093/bioinformatics/bti537; Requena JR, 2001, P NATL ACAD SCI USA, V98, P69, DOI 10.1073/pnas.011526698; Reverter-Branchat G, 2004, J BIOL CHEM, V279, P31983, DOI 10.1074/jbc.M404849200; Selkoe DJ, 2003, NATURE, V426, P900, DOI 10.1038/nature02264; Shastry BS, 2003, NEUROCHEM INT, V43, P1, DOI 10.1016/S0197-0186(02)00196-1; Shevchenko A, 1996, ANAL CHEM, V68, P850, DOI 10.1021/ac950914h; Sohal RS, 2002, FREE RADICAL BIO MED, V33, P37, DOI 10.1016/S0891-5849(02)00856-0; STADTMAN ER, 1990, FREE RADICAL BIO MED, V9, P315, DOI 10.1016/0891-5849(90)90006-5; Tatusov RL, 2001, NUCLEIC ACIDS RES, V29, P22, DOI 10.1093/nar/29.1.22; Tatusov RL, 2000, NUCLEIC ACIDS RES, V28, P33, DOI 10.1093/nar/28.1.33; Temple A, 2006, J AM SOC MASS SPECTR, V17, P1172, DOI 10.1016/j.jasms.2006.04.030; Wolf E, 1997, PROTEIN SCI, V6, P1179, DOI 10.1002/pro.5560060606; Yang ZR, 2005, BIOINFORMATICS, V21, P3369, DOI 10.1093/bioinformatics/bti534	49	95	97	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 5	2009	4	10							e7269	10.1371/journal.pone.0007269	http://dx.doi.org/10.1371/journal.pone.0007269			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DG	19802390	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593600004
J	Tang, KH; Feng, XY; Tang, YJJ; Blankenship, RE				Tang, Kuo-Hsiang; Feng, Xueyang; Tang, Yinjie J.; Blankenship, Robert E.			Carbohydrate Metabolism and Carbon Fixation in Roseobacter denitrificans OCh114	PLOS ONE			English	Article								The Roseobacter clade of aerobic marine proteobacteria, which compose 10-25% of the total marine bacterial community, has been reported to fix CO2, although it has not been determined what pathway is involved. In this study, we report the first metabolic studies on carbohydrate utilization, CO2 assimilation, and amino acid biosynthesis in the phototrophic Roseobacter clade bacterium Roseobacter denitrificans OCh114. We develop a new minimal medium containing defined carbon source(s), in which the requirements of yeast extract reported previously for the growth of R. denitrificans can be replaced by vitamin B-12 (cyanocobalamin). Tracer experiments were carried out in R. denitrificans grown in a newly developed minimal medium containing isotopically labeled pyruvate, glucose or bicarbonate as a single carbon source or in combination. Through measurements of C-13-isotopomer labeling patterns in protein-derived amino acids, gene expression profiles, and enzymatic activity assays, we report that: (1) R. denitrificans uses the anaplerotic pathways mainly via the malic enzyme to fix 10-15% of protein carbon from CO2; (2) R. denitrificans employs the Entner-Doudoroff (ED) pathway for carbohydrate metabolism and the non-oxidative pentose phosphate pathway for the biosynthesis of histidine, ATP, and coenzymes; (3) the Embden-Meyerhof-Parnas (EMP, glycolysis) pathway is not active and the enzymatic activity of 6-phosphofructokinase (PFK) cannot be detected in R. denitrificans; and (4) isoleucine can be synthesized from both threonine-dependent (20% total flux) and citramalate-dependent (80% total flux) pathways using pyruvate as the sole carbon source.			Tang, KH (corresponding author), Washington Univ, Dept Biol, Campus Box 1137, St Louis, MO 63130 USA.	blankenship@wustl.edu	Feng, Xueyang/G-1295-2015; Tang, Yinjie/AAI-5584-2020	Feng, Xueyang/0000-0003-4426-5732				Allard J, 2001, P NATL ACAD SCI USA, V98, P3679, DOI 10.1073/pnas.071380898; Beja O, 2002, NATURE, V415, P630, DOI 10.1038/415630a; Biebl H, 2005, INT J SYST EVOL MICR, V55, P2377, DOI 10.1099/ijs.0.63832-0; Biebl H, 2005, INT J SYST EVOL MICR, V55, P1089, DOI 10.1099/ijs.0.63511-0; BRADFORD MM, 1976, ANAL BIOCHEM, V72, P248, DOI 10.1016/0003-2697(76)90527-3; Brinkhoff T, 2008, ARCH MICROBIOL, V189, P531, DOI 10.1007/s00203-008-0353-y; Buchan A, 2005, APPL ENVIRON MICROB, V71, P5665, DOI 10.1128/AEM.71.10.5665-5677.2005; Case RJ, 2007, APPL ENVIRON MICROB, V73, P278, DOI 10.1128/AEM.01177-06; CONRAD R, 1977, J GEN MICROBIOL, V101, P277, DOI 10.1099/00221287-101-2-277; CONRAD R, 1977, ARCH MICROBIOL, V112, P39, DOI 10.1007/BF00446652; ENTNER N, 1952, J BIOL CHEM, V196, P853; Griffiths JS, 2002, BIOORGAN MED CHEM, V10, P545, DOI 10.1016/S0968-0896(01)00307-8; Guillouet S, 1999, APPL ENVIRON MICROB, V65, P3100; HATFIELD GW, 1970, J BIOL CHEM, V245, P1742; Holmes DE, 2004, INT J SYST EVOL MICR, V54, P1591, DOI 10.1099/ijs.0.02958-0; Howell DM, 1999, J BACTERIOL, V181, P331, DOI 10.1128/JB.181.1.331-333.1999; KISHIMOTO N, 1995, FEMS MICROBIOL ECOL, V16, P291, DOI 10.1111/j.1574-6941.1995.tb00293.x; Koblizek M, 2003, ARCH MICROBIOL, V180, P327, DOI 10.1007/s00203-003-0596-6; Kolber ZS, 2001, SCIENCE, V292, P2492, DOI 10.1126/science.1059707; Kortluke C, 1997, J BACTERIOL, V179, P5247, DOI 10.1128/jb.179.17.5247-5258.1997; Kruger NJ, 2003, CURR OPIN PLANT BIOL, V6, P236, DOI 10.1016/S1369-5266(03)00039-6; Lin H, 2005, APPL MICROBIOL BIOT, V67, P515, DOI 10.1007/s00253-004-1789-x; MELOCHE HP, 1964, J BIOL CHEM, V239, P3511; MELOCHE HP, 1964, J BIOL CHEM, V239, P3505; MEYER CR, 1988, PLANT PHYSIOL, V86, P325, DOI 10.1104/pp.86.2.325; Moran MA, 2007, APPL ENVIRON MICROB, V73, P4559, DOI 10.1128/AEM.02580-06; Moran MA, 2004, NATURE, V432, P910, DOI 10.1038/nature03170; Moran MA, 2007, NAT REV MICROBIOL, V5, P792, DOI 10.1038/nrmicro1746; Motter AE, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.1; Mukhopadhyay B, 1998, J BIOL CHEM, V273, P5155, DOI 10.1074/jbc.273.9.5155; Pavlekovic M, 2009, J MICROBIOL METH, V78, P119, DOI 10.1016/j.mimet.2009.04.003; Pingitore F, 2007, ANAL CHEM, V79, P2483, DOI 10.1021/ac061906b; RAY TB, 1976, PLANT PHYSIOL, V58, P603, DOI 10.1104/pp.58.5.603; Risso C, 2008, J BACTERIOL, V190, P2266, DOI 10.1128/JB.01841-07; Selje N, 2004, NATURE, V427, P445, DOI 10.1038/nature02272; SHIBA T, 1991, SYST APPL MICROBIOL, V14, P140, DOI 10.1016/S0723-2020(11)80292-4; SHIBA T, 1979, APPL ENVIRON MICROB, V38, P43, DOI 10.1128/AEM.38.1.43-45.1979; SHIBA T, 1986, MICROBIOL SCI, V3, P376; Swingley WD, 2007, J BACTERIOL, V189, P683, DOI 10.1128/JB.01390-06; Tang KH, 2009, J BACTERIOL, V191, P3580, DOI 10.1128/JB.00110-09; Tang Y, 2007, J BACTERIOL, V189, P940, DOI 10.1128/JB.00948-06; Tang YJ, 2009, BIOTECHNOL BIOENG, V102, P1377, DOI 10.1002/bit.22181; THOMPSON JS, 1968, ANAL BIOCHEM, V24, P197, DOI 10.1016/0003-2697(68)90170-X; UMBARGER HE, 1978, ANNU REV BIOCHEM, V47, P533, DOI 10.1146/annurev.bi.47.070178.002533; VANSCHAFTINGEN E, 1981, P NATL ACAD SCI-BIOL, V78, P3483; Wagner-Dobler I, 2006, ANNU REV MICROBIOL, V60, P255, DOI 10.1146/annurev.micro.60.080805.142115; Wahl SA, 2004, BIOTECHNOL BIOENG, V85, P259, DOI 10.1002/bit.10909; Xu H, 2004, J BACTERIOL, V186, P5400, DOI 10.1128/JB.186.16.5400-5409.2004; Yurkov VV, 1998, MICROBIOL MOL BIOL R, V62, P695, DOI 10.1128/MMBR.62.3.695-724.1998	49	53	54	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2009	4	10							e7233	10.1371/journal.pone.0007233	http://dx.doi.org/10.1371/journal.pone.0007233			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BP	19794911	gold, Green Published, Green Submitted			2022-12-27	WOS:000270354200001
J	Paun, BC; Cheng, YL; Leggett, BA; Young, J; Meltzer, SJ; Mori, Y				Paun, Bogdan C.; Cheng, Yulan; Leggett, Barbara A.; Young, Joanne; Meltzer, Stephen J.; Mori, Yuriko			Screening for Microsatellite Instability Identifies Frequent 3 '-Untranslated Region Mutation of the RB1-Inducible Coiled-Coil 1 Gene in Colon Tumors	PLOS ONE			English	Article							MISMATCH REPAIR DEFICIENCY; HUMAN BREAST-CANCER; COLORECTAL-CANCER; FIP200; EXPRESSION; CELL; MICRORNA; YEAST; PATHOGENESIS; DEPENDENCE	Background: Coding region microsatellite instability (MSI) results in loss of gene products and promotion of microsatellite-unstable (MSI-H) carcinogenesis. Recent studies have indicated that MSI within 3'-untranslated regions (3'UTRs) may post-transcriptionally dysregulate gene products. Within this context, we conducted a broad mutational survey of 42 short 3'UTR microsatellites (MSs) in 45 MSI-H colorectal tumors and their corresponding normal colonic mucosae. Methodology/Principal Findings: In order to estimate the overall susceptibility of MSs to MSI in MSI-H tumors, the observed MSI frequency of each MS was correlated with its length, interspecies sequence conservation level, and distance from some genetic elements (i.e., stop codon, polyA signal, and microRNA binding sites). All MSs were stable in normal colonic mucosae. The MSI frequency at each MS in MSI-H tumors was independent of sequence conservation level and distance from other genetic elements. In contrast, MS length correlated significantly with MSI frequency in MSI-H tumors (r = 0.86, p = 7.2x10(-13)). 3'UTR MSs demonstrated MSI frequencies in MSI-H tumors higher than the 99% upper limit predicted by MS length for RB1-inducible coiled-coil 1(RB1CC1, mutation frequency 68.4%), NUAK family SNF1-like kinase 1(NUAK1, 31.0%), and Rtf1, Paf1/RNA polymerase II complex component, homolog (RTF1, 25.0%). An in silico prediction of RNA structure alterations was conducted for these MSI events to gauge their likelihood of affecting post-transcriptional regulation. RB1CC1 mutant was predicted to lose a microRNA-accessible loop structure at a putative binding site for the tumor-suppressive microRNA, miR-138. In contrast, the predicted 3'UTR structural change was minimal for NUAK1- and RTF1 mutants. Notably, real-time quantitative RT-PCR analysis revealed significant RB1CC1 mRNA overexpression vs. normal colonic mucosae in MSI-H cancers manifesting RB1CC1 3'UTR MSI (9.0-fold; p = 3.6x10(-4)). Conclusions: This mutational survey of well-characterized short 3'UTR MSs confirms that MSI incidence in MSI-H colorectal tumors correlates with MS length, but not with sequence conservation level or distance from other genetic elements. This study also identifies RB1CC1 as a novel target of frequent mutation and aberrant upregulation in MSI-H colorectal tumors. The predicted loss of a microRNA-accessible structure in mutant RB1CC1 RNA fits the hypothesis that 3'UTR MSI involves in aberrant RB1CC1 posttranscriptional upregulation. Further direct assessments are indicated to investigate this possibility.			Paun, BC (corresponding author), Johns Hopkins Univ, Sch Med, Dept Med, Div Gastroenterol, Baltimore, MD 21205 USA.	ymori3@jhmi.edu	Young, Joanne P/H-7774-2014; Young, Joanne P/B-9981-2011; Leggett, Barbara A/D-3579-2011	Leggett, Barbara/0000-0003-2062-7380; Young, Joanne/0000-0002-1514-1522	NATIONAL CANCER INSTITUTE [R01CA077057] Funding Source: NIH RePORTER; NCI NIH HHS [R01 CA077057, CA077057] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abbi S, 2002, MOL BIOL CELL, V13, P3178, DOI 10.1091/mbc.E02-05-0295; Ariza M, 2004, CANCER-AM CANCER SOC, V100, P335, DOI 10.1002/cncr.11931; Boland CR, 1998, CANCER RES, V58, P5248; Chano T, 2002, NAT GENET, V31, P285, DOI 10.1038/ng911; Chano T, 2002, ONCOGENE, V21, P1295, DOI 10.1038/sj.onc.1205178; de Silanes IL, 2007, CELL ONCOL, V29, P1; Duval A, 2002, CANCER RES, V62, P1609; Gan B, 2008, CELL SIGNAL, V20, P787, DOI 10.1016/j.cellsig.2007.10.021; Gan BY, 2006, J CELL BIOL, V175, P121, DOI 10.1083/jcb.200604129; Grady WM, 2008, GASTROENTEROLOGY, V135, P1079, DOI 10.1053/j.gastro.2008.07.076; Halees AS, 2008, NUCLEIC ACIDS RES, V36, pD137, DOI 10.1093/nar/gkm959; Heinimann K, 2001, CANCER RES, V61, P7616; John B, 2004, PLOS BIOL, V2, P1862, DOI 10.1371/journal.pbio.0020363; Karolchik D, 2004, NUCLEIC ACIDS RES, V32, pD493, DOI 10.1093/nar/gkh103; Kertesz M, 2007, NAT GENET, V39, P1278, DOI 10.1038/ng2135; Leedham SJ, 2008, J CLIN PATHOL, V61, P164, DOI 10.1136/jcp.2006.044610; Levenberg K., 1944, Q APPL MATH, V2, P164, DOI [10.1090/qam/10666, DOI 10.1090/QAM/10666]; Lewis BP, 2005, CELL, V120, P15, DOI 10.1016/j.cell.2004.12.035; Mao G, 2008, J BIOL CHEM, V283, P3211, DOI 10.1074/jbc.M709276200; Martin N, 2008, MOL CELL BIOL, V28, P2771, DOI 10.1128/MCB.01210-07; Melkoumian ZK, 2005, CANCER RES, V65, P6676, DOI 10.1158/0008-5472.CAN-04-4142; Mitomo S, 2008, CANCER SCI, V99, P280, DOI 10.1111/j.1349-7006.2007.00666.x; Mori Y, 2001, CANCER RES, V61, P6046; Mori Y, 2006, GASTROENTEROLOGY, V131, P797, DOI 10.1053/j.gastro.2006.06.006; Pietschmann A, 2005, J CANCER RES CLIN, V131, P552, DOI 10.1007/s00432-005-0678-8; Reeder J, 2007, NUCLEIC ACIDS RES, V35, pW320, DOI 10.1093/nar/gkm258; Ruggiero T, 2003, NUCLEIC ACIDS RES, V31, P6561, DOI 10.1093/nar/gkg858; Shin JG, 2007, SURGERY, V142, P222, DOI 10.1016/j.surg.2007.04.002; Shiomi K, 2005, MOL BRAIN RES, V135, P169, DOI 10.1016/j.molbrainres.2004.12.002; Sia EA, 1997, MOL CELL BIOL, V17, P2851, DOI 10.1128/MCB.17.5.2851; Siepel A, 2005, GENOME RES, V15, P1034, DOI 10.1101/gr.3715005; Strauss BS, 1999, MUTAT RES-REV MUTAT, V437, P195, DOI 10.1016/S1383-5742(99)00066-6; Suraweera N, 2001, ONCOGENE, V20, P7472, DOI 10.1038/sj.onc.1204952; Suzuki A, 2004, MOL CELL BIOL, V24, P3526, DOI 10.1128/MCB.24.8.3526-3535.2004; Tenney K, 2006, P NATL ACAD SCI USA, V103, P11970, DOI 10.1073/pnas.0603620103; Ueda H, 2000, J CELL BIOL, V149, P423, DOI 10.1083/jcb.149.2.423; Wei HJ, 2009, J BIOL CHEM, V284, P6004, DOI 10.1074/jbc.M806375200; Wierdl M, 1997, GENETICS, V146, P769; Woerner SM, 2003, ONCOGENE, V22, P2226, DOI 10.1038/sj.onc.1206421; Woerner SM, 2001, INT J CANCER, V93, P12, DOI 10.1002/ijc.1299; Wong TS, 2008, CLIN CANCER RES, V14, P2588, DOI 10.1158/1078-0432.CCR-07-0666; Wu L, 2008, MOL CELL, V29, P1, DOI 10.1016/j.molcel.2007.12.010; Zhang HB, 2005, NUCLEIC ACIDS RES, V33, pD116, DOI 10.1093/nar/gki055	43	11	12	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2009	4	11							e7715	10.1371/journal.pone.0007715	http://dx.doi.org/10.1371/journal.pone.0007715			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RX	19888451	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414400015
J	Tortiglione, C; Quarta, A; Malvindi, MA; Tino, A; Pellegrino, T				Tortiglione, Claudia; Quarta, Alessandra; Malvindi, Maria Ada; Tino, Angela; Pellegrino, Teresa			Fluorescent Nanocrystals Reveal Regulated Portals of Entry into and Between the Cells of Hydra	PLOS ONE			English	Article							QUANTUM DOTS; IN-VIVO; SEMICONDUCTOR NANOCRYSTALS; HYDROPHOBIC NANOCRYSTALS; BIOLOGICAL LABELS; CRYSTAL-STRUCTURE; TARGETED PROBES; MODEL SYSTEM; LIVE CELLS; ACIDIC PH	Initially viewed as innovative carriers for biomedical applications, with unique photophysical properties and great versatility to be decorated at their surface with suitable molecules, nanoparticles can also play active roles in mediating biological effects, suggesting the need to deeply investigate the mechanisms underlying cell-nanoparticle interaction and to identify the molecular players. Here we show that the cell uptake of fluorescent CdSe/CdS quantum rods (QRs) by Hydra vulgaris, a simple model organism at the base of metazoan evolution, can be tuned by modifying nanoparticle surface charge. At acidic pH, amino-PEG coated QRs, showing positive surface charge, are actively internalized by tentacle and body ectodermal cells, while negatively charged nanoparticles are not uptaken. In order to identify the molecular factors underlying QR uptake at acidic pH, we provide functional evidence of annexins involvement and explain the QR uptake as the combined result of QR positive charge and annexin membrane insertion. Moreover, tracking QR labelled cells during development and regeneration allowed us to uncover novel intercellular trafficking and cell dynamics underlying the remarkable plasticity of this ancient organism.			Tortiglione, C (corresponding author), CNR, Ist Cibernet E Caianiello, Pozzuoli, Italy.	c.tortiglione@cib.na.cnr.it	QUARTA, ALESSANDRA/AAL-9175-2020; Tortiglione, Claudia/K-5200-2014; Pellegrino, teresa/G-6417-2010; Quarta, Alessandra/AAD-4326-2020; Tino, Angela/E-8425-2014; Tortiglione, Claudia/N-3290-2019	QUARTA, ALESSANDRA/0000-0003-1911-9864; Tortiglione, Claudia/0000-0003-1447-7611; Tino, Angela/0000-0002-9673-1064; Tortiglione, Claudia/0000-0003-1447-7611; Pellegrino, Teresa/0000-0001-5518-1134				Alivisatos P, 2004, NAT BIOTECHNOL, V22, P47, DOI 10.1038/nbt927; BARTON GJ, 1991, EUR J BIOCHEM, V198, P749, DOI 10.1111/j.1432-1033.1991.tb16076.x; Bottger A, 2007, SEMIN CANCER BIOL, V17, P134, DOI 10.1016/j.semcancer.2006.11.008; BOSCH TCG, 1984, DEV BIOL, V104, P161, DOI 10.1016/0012-1606(84)90045-9; Bruchez M, 1998, SCIENCE, V281, P2013, DOI 10.1126/science.281.5385.2013; Buzgariu W, 2008, METHOD ENZYMOL, V451, P409, DOI 10.1016/S0076-6879(08)03226-6; CAMPBELL RD, 1973, J CELL SCI, V13, P651; CAMPBELL RD, 1976, J CELL SCI, V21; Carbone L, 2007, NANO LETT, V7, P2942, DOI 10.1021/nl0717661; Carlson C, 2008, J PHYS CHEM B, V112, P13608, DOI 10.1021/jp712087m; Cartailler JP, 2000, BIOCHEMISTRY-US, V39, P2475, DOI 10.1021/bi992278d; Chera S, 2009, BBA-MOL CELL RES, V1793, P1432, DOI 10.1016/j.bbamcr.2009.03.010; Chithrani BD, 2007, NANO LETT, V7, P1542, DOI 10.1021/nl070363y; Cho SJ, 2007, LANGMUIR, V23, P1974, DOI 10.1021/la060093j; Conner SD, 2003, NATURE, V422, P37, DOI 10.1038/nature01451; Dahan M, 2003, SCIENCE, V302, P442, DOI 10.1126/science.1088525; DAVID CN, 1973, ENTW MECH ORG, P259; Deka S, 2009, J AM CHEM SOC, V131, P2948, DOI 10.1021/ja808369e; Delehanty JB, 2009, ANAL BIOANAL CHEM, V393, P1091, DOI 10.1007/s00216-008-2410-4; Di Corato R, 2008, J MATER CHEM, V18, P1991, DOI 10.1039/b717801h; Dobrovolskaia MA, 2007, NAT NANOTECHNOL, V2, P469, DOI 10.1038/nnano.2007.223; Figuerola A, 2008, J AM CHEM SOC, V130, P1477, DOI 10.1021/ja078034v; Flick K.M., 1983, P251; Fu AH, 2005, CURR OPIN NEUROBIOL, V15, P568, DOI 10.1016/j.conb.2005.08.004; Fu AH, 2007, NANO LETT, V7, P179, DOI 10.1021/nl0626434; FUJISAWA T, 1984, J CELL SCI, V68, P243; Galliot B, 2006, SEMIN CELL DEV BIOL, V17, P492, DOI 10.1016/j.semcdb.2006.05.005; Gerke V, 2005, NAT REV MOL CELL BIO, V6, P449, DOI 10.1038/nrm1661; Gerke V, 2002, PHYSIOL REV, V82, P331, DOI 10.1152/physrev.00030.2001; Hager G, 1997, DEVELOPMENT, V124, P569; Hegde BG, 2006, BIOCHEMISTRY-US, V45, P934, DOI 10.1021/bi052143+; Holdway DA, 2001, ENVIRON TOXICOL, V16, P557, DOI 10.1002/tox.10017.abs; Holstein TW, 2003, DEV DYNAM, V226, P257, DOI 10.1002/dvdy.10227; Howarth M, 2005, P NATL ACAD SCI USA, V102, P7583, DOI 10.1073/pnas.0503125102; Hunter R. J., 1988, ZETA POTENTIAL COLLO; Isas JM, 2003, J BIOL CHEM, V278, P30227, DOI 10.1074/jbc.M301228200; Isas JM, 2000, BIOCHEMISTRY-US, V39, P3015, DOI 10.1021/bi9922401; Jiang W, 2008, NAT NANOTECHNOL, V3, P145, DOI 10.1038/nnano.2008.30; Karntanut W, 2002, CHEMOSPHERE, V47, P1059, DOI 10.1016/S0045-6535(02)00050-4; Kirchner C, 2005, NANO LETT, V5, P331, DOI 10.1021/nl047996m; Kuznetsov SG, 2002, J EXP BIOL, V205, P3809; Ladokhin AS, 2005, BIOCHEMISTRY-US, V44, P3402, DOI 10.1021/bi047805u; Langen R, 1998, P NATL ACAD SCI USA, V95, P14060, DOI 10.1073/pnas.95.24.14060; Lewinski N, 2008, SMALL, V4, P26, DOI 10.1002/smll.200700595; LOOMIS WF, 1956, J EXP ZOOL, V132, P555, DOI 10.1002/jez.1401320309; LUECKE H, 1995, NATURE, V378, P512, DOI 10.1038/378512a0; Malvindi MA, 2008, SMALL, V4, P1747, DOI 10.1002/smll.200800413; Maynard AD, 2006, NATURE, V444, P267, DOI 10.1038/444267a; Maysinger D, 2007, NANO LETT, V7, P2513, DOI 10.1021/nl071611t; MCNEIL PL, 1981, J CELL SCI, V49, P311; Medintz IL, 2005, NAT MATER, V4, P435, DOI 10.1038/nmat1390; Michalet X, 2005, SCIENCE, V307, P538, DOI 10.1126/science.1104274; Mok H, 2008, BIOCONJUGATE CHEM, V19, P797, DOI 10.1021/bc700464m; Moss SE, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-4-219; Murate M, 1997, J CELL SCI, V110, P1919; Nabiev I, 2007, NANO LETT, V7, P3452, DOI 10.1021/nl0719832; Pellegrino T, 2004, NANO LETT, V4, P703, DOI 10.1021/nl035172j; PRASAD K, 1988, BIOCHEMISTRY-US, V27, P6098, DOI 10.1021/bi00416a040; PRENCIPE G, 2009, J AM CHEM SOC; Quarta A, 2008, J AM CHEM SOC, V130, P10545, DOI 10.1021/ja800102v; Rescher U, 2004, J CELL SCI, V117, P2631, DOI 10.1242/jcs.01245; SCHLAEPFER DD, 1992, J CELL BIOL, V118, P911, DOI 10.1083/jcb.118.4.911; Sheng Y, 2009, BIOMATERIALS, V30, P2340, DOI 10.1016/j.biomaterials.2008.12.070; Sperling RA, 2006, ADV FUNCT MATER, V16, P943, DOI 10.1002/adfm.200500589; TECHNAU U, 1992, DEV BIOL, V151, P117, DOI 10.1016/0012-1606(92)90219-7; Tortiglione C, 2007, BIOCONJUGATE CHEM, V18, P829, DOI 10.1021/bc060355t; WILLIAMS A, 1981, CHEM REV, V81, P589, DOI 10.1021/cr00046a004; Xu G, 2008, BIOCONJUGATE CHEM, V19, P1179, DOI 10.1021/bc700477u; Yong KT, 2007, NANO LETT, V7, P761, DOI 10.1021/nl063031m	69	41	42	0	24	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2009	4	11							e7698	10.1371/journal.pone.0007698	http://dx.doi.org/10.1371/journal.pone.0007698			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RX	19888325	Green Published, Green Submitted, gold			2022-12-27	WOS:000271414400010
J	Jeru, I; Hayrapetyan, H; Duquesnoy, P; Cochet, E; Serre, JL; Feingold, J; Grateau, G; Sarkisian, T; Jeanpierre, M; Amselem, S				Jeru, Isabelle; Hayrapetyan, Hasmik; Duquesnoy, Philippe; Cochet, Emmanuelle; Serre, Jean-Louis; Feingold, Josue; Grateau, Gilles; Sarkisian, Tamara; Jeanpierre, Marc; Amselem, Serge			Involvement of the Modifier Gene of a Human Mendelian Disorder in a Negative Selection Process	PLOS ONE			English	Article							FAMILIAL-MEDITERRANEAN-FEVER; DIAGNOSTIC-VALUE; AMYLOIDOSIS; MEFV; ARMENIANS; ALLELES; SAA1	Background: Identification of modifier genes and characterization of their effects represent major challenges in human genetics. SAA1 is one of the few modifiers identified in humans: this gene influences the risk of renal amyloidosis (RA) in patients with familial Mediterranean fever (FMF), a Mendelian autoinflammatory disorder associated with mutations in MEFV. Indeed, the SAA1 alpha homozygous genotype and the p.Met694Val homozygous genotype at the MEFV locus are two main risk factors for RA. Methodology/Principal Findings: Here, we investigated Armenian FMF patients and controls from two neighboring countries: Armenia, where RA is frequent (24%), and Karabakh, where RA is rare (2.5%). Sequencing of MEFV revealed similar frequencies of p.Met694Val homozygotes in the two groups of patients. However, a major deficit of SAA1 alpha homozygotes was found among Karabakhian patients (4%) as compared to Armenian patients (24%) (p = 5.10(-5)). Most importantly, we observed deviations from Hardy-Weinberg equilibrium (HWE) in the two groups of patients, and unexpectedly, in opposite directions, whereas, in the two control populations, genotype distributions at this locus were similar and complied with (HWE). Conclusions/Significance: The excess of SAA1 alpha homozygotes among Armenian patients could be explained by the recruitment of patients with severe phenotypes. In contrast, a population-based study revealed that the deficit of alpha/alpha among Karabakhian patients would result from a negative selection against carriers of this genotype. This study, which provides new insights into the role of SAA1 in the pathophysiology of FMF, represents the first example of deviations from HWE and selection involving the modifier gene of a Mendelian disorder.			Jeru, I (corresponding author), INSERM, U933, Paris, France.	serge.amselem@trs.aphp.fr		Sarkisian, Tamara/0000-0002-4767-7567				AIVAZYAN AA, 1982, KLIN MED MOSCOW+, V60, P65; Akar N, 2003, AMYLOID, V10, P12, DOI 10.3109/13506120308995251; Aksentijevich I, 1997, CELL, V90, P797; ARMENIAN HK, 1973, LEBAN MED J, V26, P605; Bakkaloglu A, 2004, J RHEUMATOL, V31, P1139; Bernot A, 1997, NAT GENET, V17, P25; Cazeneuve C, 2000, AM J HUM GENET, V67, P1136, DOI 10.1016/S0002-9297(07)62944-9; Cazeneuve C, 1999, AM J HUM GENET, V65, P88, DOI 10.1086/302459; Cazeneuve C, 2003, ARTHRITIS RHEUM-US, V48, P2324, DOI 10.1002/art.11102; DeVry CG, 1999, J HUM GENET, V44, P275, DOI 10.1007/s100380050161; DONABEDIAN P, 1991, ARTSAKH HIST KARABAK; Gershoni-Baruch R, 2003, ARTHRITIS RHEUM, V48, P1149, DOI 10.1002/art.10944; Hartl D.L., 1997, PRINCIPLES POPULATIO, V3rd ed.; Huber M, 2006, BIOMETRICS, V62, P49, DOI 10.1111/j.1541-0420.2005.00418.x; Kang SH, 2004, HUM HERED, V58, P10, DOI 10.1159/000081452; Livneh A, 1997, ARTHRITIS RHEUM-US, V40, P1879, DOI 10.1002/art.1780401023; Luo XG, 2007, HUM MOL GENET, V16, P380, DOI 10.1093/hmg/ddl460; Medlej-Hashim Myrna, 2004, BMC Med Genet, V5, P4, DOI 10.1186/1471-2350-5-4; Nadeau JH, 2003, CURR OPIN GENET DEV, V13, P290, DOI 10.1016/S0959-437X(03)00061-3; Nadeau JH, 2001, NAT REV GENET, V2, P165, DOI 10.1038/35056009; ROGERS DB, 1989, AM J MED GENET, V34, P168, DOI 10.1002/ajmg.1320340206; Schollen E, 2000, EUR J HUM GENET, V8, P367, DOI 10.1038/sj.ejhg.5200470; SCHWABE AD, 1974, MEDICINE, V53, P453, DOI 10.1097/00005792-197411000-00005; Wahlund S, 1928, HEREDITAS, V11, P65, DOI 10.1111/j.1601-5223.1928.tb02483.x; ZEMER D, 1986, NEW ENGL J MED, V314, P1001, DOI 10.1056/NEJM198604173141601; Zuniga J, 1999, GENES IMMUN, V1, P66, DOI 10.1038/sj.gene.6363633	26	5	7	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2009	4	10							e7676	10.1371/journal.pone.0007676	http://dx.doi.org/10.1371/journal.pone.0007676			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RW	19888326	Green Published, Green Submitted, gold			2022-12-27	WOS:000271414300018
J	Zheng, XM; Oancea, C; Henschler, R; Moore, MAS; Ruthardt, M				Zheng, Xiaomin; Oancea, Claudia; Henschler, Reinhard; Moore, Malcolm A. S.; Ruthardt, Martin			Reciprocal t(9;22) ABL/BCR Fusion Proteins: Leukemogenic Potential and Effects on B Cell Commitment	PLOS ONE			English	Article							CHRONIC MYELOID-LEUKEMIA; DERIVATIVE CHROMOSOME-9; SELF-RENEWAL; BCR-ABL; STEM-CELLS; EXPRESSION; GENE; DELETIONS; TRANSFORMATION; TRANSLOCATION	Background: t(9;22) is a balanced translocation, and the chromosome 22 breakpoints (Philadelphia chromosome - Ph+) determine formation of different fusion genes that are associated with either Ph+ acute lymphatic leukemia (Ph+ ALL) or chronic myeloid leukemia (CML). The "minor'' breakpoint in Ph+ ALL encodes p185(BCR/ABL) from der22 and p96(ABL/BCR) from der9. The "major'' breakpoint in CML encodes p210(BCR/ABL) and p40(ABL/BCR). Herein, we investigated the leukemogenic potential of the der9-associated p96(ABL/BCR) and p40(ABL/BCR) fusion proteins and their roles in the lineage commitment of hematopoietic stem cells in comparison to BCR/ABL. Methodology: All t(9; 22) derived proteins were retrovirally expressed in murine hematopoietic stem cells (SL cells) and human umbilical cord blood cells (UCBC). Stem cell potential was determined by replating efficiency, colony forming spleen and competitive repopulating assays. The leukemic potential of the ABL/BCR fusion proteins was assessed by in a transduction/transplantation model. Effects on the lineage commitment and differentiation were investigated by culturing the cells under conditions driving either myeloid or lymphoid commitment. Expression of key factors of the B-cell differentiation and components of the preB-cell receptor were determined by qRT-PCR. Principal Findings: Both p96(ABL/BCR) and p40(ABL/BCR) increased proliferation of early progenitors and the short term stem cell capacity of SL-cells and exhibited own leukemogenic potential. Interestingly, BCR/ABL gave origin exclusively to a myeloid phenotype independently from the culture conditions whereas p96(ABL/BCR) and to a minor extent p40(ABL/BCR) forced the B-cell commitment of SL-cells and UCBC. Conclusions/Significance: Our here presented data establish the reciprocal ABL/BCR fusion proteins as second oncogenes encoded by the t(9;22) in addition to BCR/ABL and suggest that ABL/BCR contribute to the determination of the leukemic phenotype through their influence on the lineage commitment.			Zheng, XM (corresponding author), Goethe Univ Frankfurt, Dept Hematol, Lab Tumor Stem Cell Biol, Frankfurt, Germany.	ruthardt@em.uni-frankfurt.de		Ruthardt, Martin/0000-0003-1021-3811; Chiriches, Claudia/0000-0003-3758-1892				Alberts AS, 1998, EMBO J, V17, P4075, DOI 10.1093/emboj/17.14.4075; Barnes DJ, 2006, CELL CYCLE, V5, P2862, DOI 10.4161/cc.5.24.3573; Barnes DJ, 2002, ACTA HAEMATOL-BASEL, V108, P180, DOI 10.1159/000065655; Beissert T, 2008, INT J CANCER, V122, P2744, DOI 10.1002/ijc.23467; Bug G, 2005, CANCER RES, V65, P2537, DOI 10.1158/0008-5472.CAN-04-3011; Cobaleda C, 2007, NAT IMMUNOL, V8, P463, DOI 10.1038/ni1454; de la Fuente J, 2001, BLOOD, V98, P2879, DOI 10.1182/blood.V98.9.2879; Era T, 2000, P NATL ACAD SCI USA, V97, P1737, DOI 10.1073/pnas.97.4.1737; ETTEN RAV, 2002, ONCOGENE, V21, P8643; Faderl S, 1999, NEW ENGL J MED, V341, P164, DOI 10.1056/NEJM199907153410306; Feldhahn N, 2007, J EXP MED, V204, P1157, DOI 10.1084/jem.20062662; Fu C, 1998, IMMUNITY, V9, P93, DOI 10.1016/S1074-7613(00)80591-9; Gokbuget Nicola, 2006, Hematology Am Soc Hematol Educ Program, P133; Gonda H, 2003, J EXP MED, V198, P1427, DOI 10.1084/jem.20030802; Griswold IJ, 2006, MOL CELL BIOL, V26, P6082, DOI 10.1128/MCB.02202-05; Hagman J, 2006, CURR OPIN IMMUNOL, V18, P127, DOI 10.1016/j.coi.2006.01.007; HEISTERKAMP N, 1990, NATURE, V344, P251, DOI 10.1038/344251a0; Huettner CS, 2000, NAT GENET, V24, P57, DOI 10.1038/71691; Huntly BJP, 2004, CANCER CELL, V6, P587, DOI 10.1016/j.ccr.2004.10.015; Huntly BJP, 2001, BLOOD, V98, P1732, DOI 10.1182/blood.V98.6.1732; Johnson JJ, 2003, BLOOD, V101, P3229, DOI 10.1182/blood-2002-05-1515; Jumaa H, 2005, ANNU REV IMMUNOL, V23, P415, DOI 10.1146/annurev.immunol.23.021704.115606; Kantarjian H, 2006, NEW ENGL J MED, V354, P2542, DOI 10.1056/NEJMoa055104; Klein F, 2004, J EXP MED, V199, P673, DOI 10.1084/jem.20031637; Kogan SC, 2002, BLOOD, V100, P238, DOI 10.1182/blood.V100.1.238; Kreil S, 2007, BLOOD, V110, P1283, DOI 10.1182/blood-2007-02-074252; Lavau C, 1997, EMBO J, V16, P4226, DOI 10.1093/emboj/16.14.4226; Mathas S, 2006, NAT IMMUNOL, V7, P207, DOI 10.1038/ni1285; Melo JV, 2007, NAT REV CANCER, V7, P441, DOI 10.1038/nrc2147; MELO JV, 1993, BLOOD, V81, P2488; MELO JV, 1993, BLOOD, V81, P158; Michor F, 2006, P NATL ACAD SCI USA, V103, P14931, DOI 10.1073/pnas.0607006103; Ohkawara JI, 1998, LEUKEMIA, V12, P764, DOI 10.1038/sj.leu.2401004; Orkin SH, 2008, CELL, V132, P631, DOI 10.1016/j.cell.2008.01.025; Puccetti E, 2004, LEUKEMIA, V18, P1169, DOI 10.1038/sj.leu.2403367; Radich JP., 2007, HEMATOL AM SOC HEMAT, V2007, P384, DOI [10.1182/asheducation-2007.1.384, DOI 10.1182/ASHEDUCATION-2007.1.384]; Radziwill G, 2003, MOL CELL BIOL, V23, P4663, DOI 10.1128/MCB.23.13.4663-4672.2003; Ress A, 2006, FEBS LETT, V580, P1227, DOI 10.1016/j.febslet.2006.01.034; Tokarski JS, 2006, CANCER RES, V66, P5790, DOI 10.1158/0008-5472.CAN-05-4187; VanAelst L, 1997, GENE DEV, V11, P2295, DOI 10.1101/gad.11.18.2295; Whitehead IP, 1997, BBA-REV CANCER, V1332, pF1, DOI 10.1016/S0304-419X(96)00040-6; Wilson A, 2004, GENE DEV, V18, P2747, DOI 10.1101/gad.313104; YIN JL, 1995, BRIT J HAEMATOL, V89, P539, DOI 10.1111/j.1365-2141.1995.tb08361.x; Zheng X, 2006, BMC CANCER, V6, DOI 10.1186/1471-2407-6-262; Zheng XM, 2004, BLOOD, V103, P3535, DOI 10.1182/blood-2003-09-3335	45	20	22	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 30	2009	4	10							e7661	10.1371/journal.pone.0007661	http://dx.doi.org/10.1371/journal.pone.0007661			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RW	19876398	Green Published, gold, Green Submitted			2022-12-27	WOS:000271414300013
J	Chang, SH; Jobling, S; Brennan, K; Headon, DJ				Chang, Shie Hong; Jobling, Stephanie; Brennan, Keith; Headon, Denis J.			Enhanced Edar Signalling Has Pleiotropic Effects on Craniofacial and Cutaneous Glands	PLOS ONE			English	Article							HYPOHIDROTIC ECTODERMAL DYSPLASIA; POSITIVE SELECTION; HAIR THICKNESS; POPULATION DIFFERENTIATION; RELATIVE-HUMIDITY; SUBMUCOSAL GLANDS; SEBACEOUS GLANDS; GENOMIC REGIONS; ECTODYSPLASIN-A; LIPID LAYER	The skin carries a number of appendages, including hair follicles and a range of glands, which develop under the influence of EDAR signalling. A gain of function allele of EDAR is found at high frequency in human populations of East Asia, with genetic evidence suggesting recent positive selection at this locus. The derived EDAR allele, estimated to have reached fixation more than 10,000 years ago, causes thickening of hair fibres, but the full spectrum of phenotypic changes induced by this allele is unknown. We have examined the changes in glandular structure caused by elevation of Edar signalling in a transgenic mouse model. We find that sebaceous and Meibomian glands are enlarged and that salivary and mammary glands are more elaborately branched with increased Edar activity, while the morphology of eccrine sweat and tracheal submucosal glands appears to be unaffected. Similar changes to gland sizes and structures may occur in human populations carrying the derived East Asian EDAR allele. As this allele attained high frequency in an environment that was notably cold and dry, increased glandular secretions could represent a trait that was positively selected to achieve increased lubrication and reduced evaporation from exposed facial structures and upper airways.			Chang, SH (corresponding author), Univ Manchester, Fac Life Sci, Manchester, Lancs, England.	keith.brennan@manchester.ac.uk; denis.headon@roslin.ed.ac.uk		Brennan, Keith/0000-0002-9384-125X	Biotechnology and Biological Sciences Research Council Funding Source: Medline	Biotechnology and Biological Sciences Research Council(UK Research & Innovation (UKRI)Biotechnology and Biological Sciences Research Council (BBSRC))		Ballard ST, 2004, J PHYSIOL-LONDON, V556, P1, DOI 10.1113/jphysiol.2003.052779; Binczek E, 2007, BIOL CHEM, V388, P405, DOI 10.1515/BC.2007.046; BLECHER SR, 1982, ANAT REC, V202, pA17; BLECHER SR, 1986, J INVEST DERMATOL, V87, P720, DOI 10.1111/1523-1747.ep12456718; Bron AJ, 2004, EXP EYE RES, V78, P347, DOI 10.1016/j.exer.2003.09.019; Bryk J, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002209; Carlson CS, 2005, GENOME RES, V15, P1553, DOI 10.1101/gr.4326505; CLARKE A, 1987, J MED GENET, V24, P659, DOI 10.1136/jmg.24.11.659; CLARKE A, 1987, ARCH DIS CHILD, V62, P989, DOI 10.1136/adc.62.10.989; Cohn BA, 1998, INT J DERMATOL, V37, P821, DOI 10.1046/j.1365-4362.1998.00575.x; Coon C., 1950, RACES STUDY PROBLEMS; Cui CY, 2003, HUM MOL GENET, V12, P2931, DOI 10.1093/hmg/ddg325; Daniel E, 2002, LARYNGOSCOPE, V112, P962, DOI 10.1097/00005537-200206000-00005; Fluhr JW, 2008, BRIT J DERMATOL, V159, P23, DOI 10.1111/j.1365-2133.2008.08643.x; Fluhr JW, 2003, J INVEST DERMATOL, V120, P728, DOI 10.1046/j.1523-1747.2003.12134.x; Fujimoto A, 2008, HUM GENET, V124, P179, DOI 10.1007/s00439-008-0537-1; Fujimoto A, 2008, HUM MOL GENET, V17, P835, DOI 10.1093/hmg/ddm355; Fujimoto A, 2009, J HUM GENET, V54, P461, DOI 10.1038/jhg.2009.61; Haubrich Kathleen A, 2003, AACN Clin Issues, V14, P457, DOI 10.1097/00044067-200311000-00006; Headon DJ, 1999, NAT GENET, V22, P370, DOI 10.1038/11943; Hofer T, 2009, ANN HUM GENET, V73, P95, DOI 10.1111/j.1469-1809.2008.00489.x; Jakobsson J, 2006, J CLIN ENDOCR METAB, V91, P687, DOI 10.1210/jc.2005-1643; Jaskoll T, 2003, ANAT REC PART A, V271A, P322, DOI 10.1002/ar.a.10045; Jiang DB, 2003, J GEOPHYS RES-ATMOS, V108, DOI 10.1029/2002JD002167; Kaercher T, 2004, GRAEF ARCH CLIN EXP, V242, P495, DOI 10.1007/s00417-004-0868-0; Kelley JL, 2006, GENOME RES, V16, P980, DOI 10.1101/gr.5157306; Lamartine J, 2003, CLIN EXP DERMATOL, V28, P351, DOI 10.1046/j.1365-2230.2003.01319.x; Lee HJ, 2002, J AM ACAD DERMATOL, V46, P218, DOI 10.1067/mjd.2002.119558; Lexner MO, 2007, INT J PAEDIATR DENT, V17, P155, DOI 10.1111/j.1365-263X.2006.00812.x; Loussouarn G, 2005, INT J DERMATOL, V44, P6, DOI 10.1111/j.1365-4632.2005.02800.x; Majumder K, 1998, MAMM GENOME, V9, P863, DOI 10.1007/s003359900884; Maskarinec G, 2001, INT J EPIDEMIOL, V30, P959, DOI 10.1093/ije/30.5.959; McCulley JP, 2006, AM J OPHTHALMOL, V141, P758, DOI 10.1016/j.ajo.2005.10.057; McCulley JP, 2004, EXP EYE RES, V78, P361, DOI 10.1016/S0014-4835(03)00203-3; Mehta U, 2007, AM J RHINOL, V21, P55, DOI 10.2500/ajr.2007.21.2989; Melnik BC, 2009, J INVEST DERMATOL, V129, P1868, DOI 10.1038/jid.2009.8; Mese H, 2007, J ORAL REHABIL, V34, P711, DOI 10.1111/j.1365-2842.2007.01794.x; Miura K, 2007, HUM GENET, V121, P631, DOI 10.1007/s00439-007-0356-9; Monreal AW, 1999, NAT GENET, V22, P366, DOI 10.1038/11937; Mou C, 2008, HUM MUTAT, V29, P1405, DOI 10.1002/humu.20795; MURRILL RUPERT IVAN, 1960, TRANS KANSAS ACAD SCI, V63, P194, DOI 10.2307/3626638; Mustonen T, 2003, DEV BIOL, V259, P123, DOI 10.1016/S0012-1606(03)00157-X; Myles S, 2008, ANN HUM GENET, V72, P99, DOI 10.1111/j.1469-1809.2007.00390.x; Nagda NL, 2001, INDOOR AIR, V11, P200, DOI 10.1034/j.1600-0668.2001.011003200.x; NEWMAN MT, 1956, EVOLUTION, V10, P101, DOI 10.1111/j.1558-5646.1956.tb02835.x; Nielsen R, 2007, NAT REV GENET, V8, P857, DOI 10.1038/nrg2187; Pantalacci S, 2008, MOL BIOL EVOL, V25, P912, DOI 10.1093/molbev/msn038; Porter AMW, 2001, J ROY SOC MED, V94, P236, DOI 10.1177/014107680109400509; Rawlins EL, 2005, DEV DYNAM, V233, P1378, DOI 10.1002/dvdy.20461; Ray N, 2001, INTERNET ARCHAEOLOGY, V11; REED WB, 1970, ARCH DERMATOL, V102, P134, DOI 10.1001/archderm.102.2.134; ROLANDO M, 1983, EXP EYE RES, V36, P25, DOI 10.1016/0014-4835(83)90086-6; Sabeti PC, 2007, NATURE, V449, P913, DOI 10.1038/nature06250; Sampath H, 2009, J BIOL CHEM, V284, P19961, DOI 10.1074/jbc.M109.014225; Srivastava AK, 1997, P NATL ACAD SCI USA, V94, P13069, DOI 10.1073/pnas.94.24.13069; STEVENS A, 1996, HUMAN HISTOLOGY; Sunwoo Yujin, 2006, Journal of Physiological Anthropology and Applied Human Science, V25, P7, DOI 10.2114/jpa2.25.7; Tang K, 2007, PLOS BIOL, V5, P1587, DOI 10.1371/journal.pbio.0050171; THODY AJ, 1989, PHYSIOL REV, V69, P383, DOI 10.1152/physrev.1989.69.2.383; Toyoda Y, 2009, FASEB J, V23, P2001, DOI 10.1096/fj.09-129098; Tsai RY, 2002, DERMATOL SURG, V28, P500, DOI 10.1046/j.1524-4725.2002.01194.x; Tucker AS, 2007, SEMIN CELL DEV BIOL, V18, P237, DOI 10.1016/j.semcdb.2007.01.006; Voight BF, 2006, PLOS BIOL, V4, P446, DOI 10.1371/journal.pbio.0040072; Watson CJ, 2008, DEVELOPMENT, V135, P995, DOI 10.1242/dev.005439; Xue YL, 2008, AM J HUM GENET, V83, P337, DOI 10.1016/j.ajhg.2008.08.004; Zhou WJ, 1999, PALAEOGEOGR PALAEOCL, V152, P163, DOI 10.1016/S0031-0182(99)00041-3; Zouboulis CC, 2007, HORM METAB RES, V39, P85, DOI 10.1055/s-2007-961807	67	46	47	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7591	10.1371/journal.pone.0007591	http://dx.doi.org/10.1371/journal.pone.0007591			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855838	Green Submitted, Green Published, gold			2022-12-27	WOS:000271147200012
J	Djagaeva, I; Doronkin, S				Djagaeva, Inna; Doronkin, Sergey			Dual Regulation of Dendritic Morphogenesis in Drosophila by the COP9 Signalosome	PLOS ONE			English	Article							SMITH-MAGENIS-SYNDROME; CUBITUS INTERRUPTUS PROTEIN; LINKED MENTAL-RETARDATION; HEDGEHOG TARGET GENES; UBIQUITIN LIGASES; HUNTINGTONS-DISEASE; ALZHEIMERS-DISEASE; BETA-CATENIN; SCF; DEGRADATION	Altered dendritic arborization contributes to numerous physiological processes including synaptic plasticity, behavior, learning and memory, and is one of the most consistent neuropathologic conditions found in a number of mental retardation disorders, schizophrenia, and neurodegenerative disease. COP9 signalosome (CSN), an evolutionarily conserved regulator of the Cullin-based ubiquitin ligases that act in the proteasome pathway, has been found associated with diverse debilitating syndromes, suggesting that CSN may be involved in regulation of dendritic arborization. However, the mechanism of this control, if it exists, is unknown. To address whether the CSN pathway plays a role in dendrites, we used a simple and genetically tractable model, Drosophila larval peripheral nervous system. Our model study identified the COP9 signalosome as the key and multilayer regulator of dendritic arborization. CSN is responsible for shaping the entire dendritic tree through both stimulating and then repressing dendritic branching. We identified that CSN exerts its dualistic function via control of different Cullins. In particular, CSN stimulates dendritic branching through Cullin1, and inhibits it via control of Cullin3 function. We also identified that Cullin1 acts in neurons with the substrate-specific F-box protein Slimb to target the Cubitus interruptus protein for degradation.			Djagaeva, I (corresponding author), Univ Tennessee, Hlth Sci Ctr, Dept Anat & Neurobiol, Memphis, TN USA.	sdoronki@utmem.edu						Akiyama H, 2003, DEV BRAIN RES, V140, P45, DOI 10.1016/S0165-3806(02)00574-6; Alexandre C, 1996, GENE DEV, V10, P2003, DOI 10.1101/gad.10.16.2003; Bilen J, 2005, ANNU REV GENET, V39, P153, DOI 10.1146/annurev.genet.39.110304.095804; Cope GA, 2003, CELL, V114, P663, DOI 10.1016/S0092-8674(03)00722-0; Cope GA, 2002, SCIENCE, V298, P608, DOI 10.1126/science.1075901; Deshaies RJ, 1999, ANNU REV CELL DEV BI, V15, P435, DOI 10.1146/annurev.cellbio.15.1.435; Dierssen M, 2006, GENES BRAIN BEHAV, V5, P48, DOI 10.1111/j.1601-183X.2006.00224.x; DJAGAEVA I, 2009, PLOS ONE IN PRESS; Dominguez M, 1996, SCIENCE, V272, P1621, DOI 10.1126/science.272.5268.1621; Doronkin S, 2002, DEVELOPMENT, V129, P5053; Doronkin S, 2003, DEV CELL, V4, P699, DOI 10.1016/S1534-5807(03)00121-7; Doronkin S, 2008, PROG NUCLEIC ACID RE, V82, P1, DOI 10.1016/S0079-6603(08)00001-9; Elsea SH, 1999, AM J MED GENET, V87, P342, DOI 10.1002/(SICI)1096-8628(19991203)87:4<342::AID-AJMG12>3.3.CO;2-1; FERRANTE RJ, 1991, J NEUROSCI, V11, P3877; FORBES AJ, 1993, DEVELOPMENT, P115; Fuchs SY, 1999, ONCOGENE, V18, P2039, DOI 10.1038/sj.onc.1202760; Glickman MH, 2002, PHYSIOL REV, V82, P373, DOI 10.1152/physrev.00027.2001; Grueber WB, 2002, DEVELOPMENT, V129, P2867; Harari-Steinberg O, 2007, GENES CELLS, V12, P183, DOI 10.1111/j.1365-2443.2007.01049.x; Hepker J, 1997, DEVELOPMENT, V124, P549; Hershko A, 1998, ANNU REV BIOCHEM, V67, P425, DOI 10.1146/annurev.biochem.67.1.425; Jiang J, 1998, NATURE, V391, P493, DOI 10.1038/35154; Kalderon D, 2005, BIOCHEM SOC T, V33, P1509, DOI 10.1042/BST0331509; Kaufmann WE, 2000, CEREB CORTEX, V10, P981, DOI 10.1093/cercor/10.10.981; Kelleher RJ, 2008, CELL, V135, P401, DOI 10.1016/j.cell.2008.10.017; Kennedy MB, 2005, NAT REV NEUROSCI, V6, P423, DOI 10.1038/nrn1685; Knobloch M, 2008, MOL NEUROBIOL, V37, P73, DOI 10.1007/s12035-008-8018-z; Knowles A, 2009, J NEUROSCI, V29, P1152, DOI 10.1523/JNEUROSCI.0429-08.2009; Kuazi AD, 2003, J PATHOL, V199, P259, DOI 10.1002/path.1283; Lee T, 1999, NEURON, V22, P451, DOI 10.1016/S0896-6273(00)80701-1; Lum L, 2004, SCIENCE, V304, P1755, DOI 10.1126/science.1098020; Lyapina S, 2001, SCIENCE, V292, P1382, DOI 10.1126/science.1059780; Mikus P, 2005, SEMIN CELL DEV BIOL, V16, P462, DOI 10.1016/j.semcdb.2005.03.002; Mori F, 2005, NEUROPATH APPL NEURO, V31, P53, DOI 10.1111/j.1365-2990.2004.00603.x; Oono K, 2004, NEUROCHEM INT, V45, P765, DOI 10.1016/j.neuint.2004.01.003; Parrish JZ, 2007, ANNU REV NEUROSCI, V30, P399, DOI 10.1146/annurev.neuro.29.051605.112907; Parrish JZ, 2006, GENE DEV, V20, P820, DOI 10.1101/gad.1391006; Penzes P, 2008, TRENDS NEUROSCI, V31, P419, DOI 10.1016/j.tins.2008.06.001; Petroski MD, 2005, NAT REV MOL CELL BIO, V6, P9, DOI 10.1038/nrm1547; Peyrl A, 2002, ELECTROPHORESIS, V23, P152, DOI 10.1002/1522-2683(200201)23:1<152::AID-ELPS152>3.0.CO;2-T; Potocki L, 1999, GENOMICS, V57, P180, DOI 10.1006/geno.1998.5748; Potocki L, 2000, J MED GENET, V37, P428, DOI 10.1136/jmg.37.6.428; Richardson KS, 2005, MOL CANCER RES, V3, P645, DOI 10.1158/1541-7786.MCR-05-0233; Schubert V, 2007, J CELL SCI, V120, P205, DOI 10.1242/jcs.03337; Schwechheimer C, 2004, BBA-MOL CELL RES, V1695, P45, DOI 10.1016/j.bbamcr.2004.09.023; Schwechheimer C, 2001, SCIENCE, V292, P1379, DOI 10.1126/science.1059776; Shin SH, 1999, P NATL ACAD SCI USA, V96, P2880, DOI 10.1073/pnas.96.6.2880; SHOLL DA, 1953, J ANAT, V87, P387; Smelkinson MG, 2006, CURR BIOL, V16, P110, DOI 10.1016/j.cub.2005.12.012; Spires TL, 2004, EUR J NEUROSCI, V19, P2799, DOI 10.1111/j.0953-816X.2004.03374.x; Suh GSB, 2002, NEURON, V33, P35, DOI 10.1016/S0896-6273(01)00576-1; Tarpey PS, 2007, AM J HUM GENET, V80, P345, DOI 10.1086/511134; Walsh DM, 2004, NEURON, V44, P181, DOI 10.1016/j.neuron.2004.09.010; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Wolf DA, 2003, NAT CELL BIOL, V5, P1029, DOI 10.1038/ncb1203-1029; Yan J, 2003, MOL CELL BIOL, V23, P6798, DOI 10.1128/MCB.23.19.6798-6808.2003; Yu X, 2003, NAT NEUROSCI, V6, P1169, DOI 10.1038/nn1132; Zhou CS, 2001, BMC BIOCHEM, V2, DOI 10.1186/1471-2091-2-7; Zou YX, 2007, AM J HUM GENET, V80, P561, DOI 10.1086/512489	59	9	9	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7577	10.1371/journal.pone.0007577	http://dx.doi.org/10.1371/journal.pone.0007577			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855832	gold, Green Published, Green Submitted			2022-12-27	WOS:000271147200009
J	Hill, ER; Tian, JB; Tilley, MR; Zhu, MX; Gu, HH				Hill, Erik R.; Tian, Jinbin; Tilley, Michael R.; Zhu, Michael X.; Gu, Howard H.			Potencies of Cocaine Methiodide on Major Cocaine Targets in Mice	PLOS ONE			English	Article							INHIBITION; DOPAMINE; CHANNELS; SODIUM; NOREPINEPHRINE; TRANSPORTERS; SENSITIVITY; ADDICTION; ANALOG	Cocaine methiodide (CM), a charged cocaine analog, cannot pass the blood brain barrier. It has been assumed the effects of systemic CM represent cocaine actions in peripheral tissues. However, the IC50 values of CM have not been clearly determined for the major cocaine targets: dopamine, norepinephrine, and serotonin transporters, and sodium channels. Using cells transfected with individual transporters from mice and synaptosomes from mouse striatum tissues, we observed that the inhibition IC50 values for monoamine uptake by CM were 31-fold to 184-fold higher compared to cocaine at each of the transporters. In dorsal root ganglion neurons, cocaine inhibited sodium channels with an apparent IC50 of 75 mu M, while CM showed no observable effect at concentrations up to 3 mM. These results indicate that an equal dose of CM will not produce an equivalent peripheral effect of cocaine.			Hill, ER (corresponding author), Ohio State Univ, Ohio State Biochem Program, Columbus, OH 43210 USA.	gu.37@osu.edu	Tian, JinBin/B-7001-2019; tian, jinbin/L-6006-2019	Tian, JinBin/0000-0002-5516-7778; 	NIDA NIH HHS [R01 DA014610, R01DA020124, R01DA014610, R01 DA020124] Funding Source: Medline; NATIONAL INSTITUTE ON DRUG ABUSE [R01DA014610, R01DA020124] Funding Source: NIH RePORTER	NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		AMARA SG, 1993, ANNU REV NEUROSCI, V16, P73, DOI 10.1146/annurev.ne.16.030193.000445; BILLMAN GE, 1995, CRIT REV TOXICOL, V25, P113, DOI 10.3109/10408449509021610; Brown PL, 2006, EUR J NEUROSCI, V24, P1182, DOI 10.1111/j.1460-9568.2006.05001.x; Chen R, 2005, J NEUROCHEM, V94, P352, DOI 10.1111/j.1471-4159.2005.03199.x; Dickerson LW, 1999, J CARDIOVASC PHARM, V33, P36, DOI 10.1097/00005344-199901000-00006; Espana RA, 2008, NEUROSCIENCE, V155, P250, DOI 10.1016/j.neuroscience.2008.05.022; Francis MM, 2001, MOL PHARMACOL, V60, P71, DOI 10.1124/mol.60.1.71; Freeman KB, 2005, PHARMACOL BIOCHEM BE, V80, P281, DOI 10.1016/j.pbb.2004.11.009; Han Dawn D., 2006, BMC Pharmacology, V6, P6, DOI 10.1186/1471-2210-6-6; Kalivas PW, 2007, AM J ADDICTION, V16, P71, DOI 10.1080/10550490601184142; Koob G, 2007, AM J PSYCHIAT, V164, P1149, DOI 10.1176/appi.ajp.2007.05030503; Ma YL, 2006, TOXICOLOGY, V220, P46, DOI 10.1016/j.tox.2005.11.025; Malin SA, 2007, NAT PROTOC, V2, P152, DOI 10.1038/nprot.2006.461; RITZ MC, 1990, LIFE SCI, V46, P635, DOI 10.1016/0024-3205(90)90132-B; Rush AM, 2007, J PHYSIOL-LONDON, V579, P1, DOI 10.1113/jphysiol.2006.121483; SCHINDLER CW, 1992, EUR J PHARMACOL, V213, P99, DOI 10.1016/0014-2999(92)90238-Y; Scholz A, 2002, BRIT J ANAESTH, V89, P52, DOI 10.1093/bja/aef163; SHRIVER DA, 1971, ARCH INT PHARMACOD T, V189, P198; STRYCKER SJ, 1968, J PHARM SCI, V57, P1822, DOI 10.1002/jps.2600571051; Tessel R E, 1978, J Pharmacol Exp Ther, V205, P568; TUFARIELLO JJ, 1979, J AM CHEM SOC, V101, P2435, DOI 10.1021/ja00503a033; Uhl GR, 1996, CURR BIOL, V6, P935, DOI 10.1016/S0960-9822(02)00630-9; Wei H, 2009, NEUROPHARMACOLOGY, V56, P399, DOI 10.1016/j.neuropharm.2008.09.008; Wise RA, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002846; WITKIN JM, 1991, J PHARMACOL EXP THER, V257, P706; WITKIN JM, 1993, J PHARMACOL EXP THER, V267, P266	26	9	9	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7578	10.1371/journal.pone.0007578	http://dx.doi.org/10.1371/journal.pone.0007578			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855831	Green Submitted, gold, Green Published			2022-12-27	WOS:000271147200010
J	Elefsinioti, A; Ackermann, M; Beyer, A				Elefsinioti, Antigoni; Ackermann, Marit; Beyer, Andreas			Accounting for Redundancy when Integrating Gene Interaction Databases	PLOS ONE			English	Article							PROTEIN-PROTEIN INTERACTIONS; INTERACTION NETWORKS; YEAST; SCALE; RESOURCE; MAP; IDENTIFICATION; FRAMEWORK; BIOVERSE; GENOMES	During the last years gene interaction networks are increasingly being used for the assessment and interpretation of biological measurements. Knowledge of the interaction partners of an unknown protein allows scientists to understand the complex relationships between genetic products, helps to reveal unknown biological functions and pathways, and get a more detailed picture of an organism's complexity. Being able to measure all protein interactions under all relevant conditions is virtually impossible. Hence, computational methods integrating different datasets for predicting gene interactions are needed. However, when integrating different sources one has to account for the fact that some parts of the information may be redundant, which may lead to an overestimation of the true likelihood of an interaction. Our method integrates information derived from three different databases (Bioverse, HiMAP and STRING) for predicting human gene interactions. A Bayesian approach was implemented in order to integrate the different data sources on a common quantitative scale. An important assumption of the Bayesian integration is independence of the input data (features). Our study shows that the conditional dependency cannot be ignored when combining gene interaction databases that rely on partially overlapping input data. In addition, we show how the correlation structure between the databases can be detected and we propose a linear model to correct for this bias. Benchmarking the results against two independent reference data sets shows that the integrated model outperforms the individual datasets. Our method provides an intuitive strategy for weighting the different features while accounting for their conditional dependencies.			Elefsinioti, A (corresponding author), Tech Univ Dresden, Ctr Biotechnol, Dresden, Germany.	andreas.beyer@biotec.tu-dresden.de	Beyer, Andreas/A-3352-2009; Beyer, Andreas/AAQ-5519-2020	Beyer, Andreas/0000-0002-3891-2123; Beyer, Andreas/0000-0002-3891-2123				Albert J., 2007, BAYESIAN COMPUTATION; Bader GD, 2002, NAT BIOTECHNOL, V20, P991, DOI 10.1038/nbt1002-991; Beyer A, 2007, NAT REV GENET, V8, P699, DOI 10.1038/nrg2144; Bork P, 2004, CURR OPIN STRUC BIOL, V14, P292, DOI 10.1016/j.sbi.2004.05.003; Ewing RM, 2007, MOL SYST BIOL, V3, DOI 10.1038/msb4100134; Friedman J, 2000, ANN STAT, V28, P400; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Giot L, 2003, SCIENCE, V302, P1727, DOI 10.1126/science.1090289; Guerquin Michal, 2009, V541, P511, DOI 10.1007/978-1-59745-243-4_22; Harris MA, 2004, NUCLEIC ACIDS RES, V32, pD258, DOI 10.1093/nar/gkh036; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Ito T, 2001, P NATL ACAD SCI USA, V98, P4569, DOI 10.1073/pnas.061034498; Jansen R, 2004, CURR OPIN MICROBIOL, V7, P535, DOI 10.1016/j.mib.2004.08.012; Jansen R, 2003, SCIENCE, V302, P449, DOI 10.1126/science.1087361; Jensen LJ, 2009, NUCLEIC ACIDS RES, V37, pD412, DOI 10.1093/nar/gkn760; Kerrien S, 2007, NUCLEIC ACIDS RES, V35, pD561, DOI 10.1093/nar/gkl958; Lee I, 2004, SCIENCE, V306, P1555, DOI 10.1126/science.1099511; Lee I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000988; Li SM, 2004, SCIENCE, V303, P540, DOI 10.1126/science.1091403; Lu LJ, 2005, GENOME RES, V15, P945, DOI 10.1101/gr.3610305; Marcotte EM, 1999, NATURE, V402, P83, DOI 10.1038/47048; Matthews LR, 2001, GENOME RES, V11, P2120, DOI 10.1101/gr.205301; McDermott J, 2005, NUCLEIC ACIDS RES, V33, pW324, DOI 10.1093/nar/gki401; Mulder NJ, 2003, NUCLEIC ACIDS RES, V31, P315, DOI 10.1093/nar/gkg046; Ramirez F, 2007, PROTEOMICS, V7, P2541, DOI 10.1002/pmic.200600924; Rhodes DR, 2005, NAT BIOTECHNOL, V23, P951, DOI 10.1038/nbt1103; Rhodes DR, 2004, P NATL ACAD SCI USA, V101, P9309, DOI 10.1073/pnas.0401994101; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; Rual JF, 2005, NATURE, V437, P1173, DOI 10.1038/nature04209; Ruepp A, 2008, NUCLEIC ACIDS RES, V36, pD646, DOI 10.1093/nar/gkm936; SCHAPIRE RE, 1990, MACH LEARN, V5, P197, DOI 10.1023/A:1022648800760; Snel B, 2000, NUCLEIC ACIDS RES, V28, P3442, DOI 10.1093/nar/28.18.3442; Stelzl U, 2005, CELL, V122, P957, DOI 10.1016/j.cell.2005.08.029; Stumpf MPH, 2008, P NATL ACAD SCI USA, V105, P6959, DOI 10.1073/pnas.0708078105; Uetz P, 2000, NATURE, V403, P623, DOI 10.1038/35001009; Venkatesan K, 2009, NAT METHODS, V6, P83, DOI 10.1038/NMETH.1280; Walhout AJM, 2000, SCIENCE, V287, P116, DOI 10.1126/science.287.5450.116; Yu HY, 2004, GENOME RES, V14, P1107, DOI 10.1101/gr.1774904	38	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7492	10.1371/journal.pone.0007492	http://dx.doi.org/10.1371/journal.pone.0007492			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847299	Green Published, gold, Green Submitted			2022-12-27	WOS:000271022000007
J	Shiao, YH; Lupascu, ST; Gu, YD; Kasprzak, W; Hwang, CJ; Fields, JR; Leighty, RM; Quinones, O; Shapiro, BA; Alvord, WG; Anderson, LM				Shiao, Yih-Horng; Lupascu, Sorin T.; Gu, Yuhan D.; Kasprzak, Wojciech; Hwang, Christopher J.; Fields, Janet R.; Leighty, Robert M.; Quinones, Octavio; Shapiro, Bruce A.; Alvord, W. Gregory; Anderson, Lucy M.			An Intergenic Non-Coding rRNA Correlated with Expression of the rRNA and Frequency of an rRNA Single Nucleotide Polymorphism in Lung Cancer Cells	PLOS ONE			English	Article							EXTERNAL TRANSCRIBED SPACER; PARALLEL GENETIC ALGORITHM; SECONDARY STRUCTURE; IN-VIVO; SEQUENCE; PROMOTER; DNA; INITIATION; PREDICTION; MECHANISM	Background: Ribosomal RNA (rRNA) is a central regulator of cell growth and may control cancer development. A cis noncoding rRNA (nc-rRNA) upstream from the 45S rRNA transcription start site has recently been implicated in control of rRNA transcription in mouse fibroblasts. We investigated whether a similar nc-rRNA might be expressed in human cancer epithelial cells, and related to any genomic characteristics. Methodology/Principal Findings: Using quantitative rRNA measurement, we demonstrated that a nc-rRNA is transcribed in human lung epithelial and lung cancer cells, starting from approximately -1000 nucleotides upstream of the rRNA transcription start site (+1) and extending at least to +203. This nc-rRNA was significantly more abundant in the majority of lung cancer cell lines, relative to a nontransformed lung epithelial cell line. Its abundance correlated negatively with total 45S rRNA in 12 of 13 cell lines (P = 0.014). During sequence analysis from -388 to +306, we observed diverse, frequent intercopy single nucleotide polymorphisms (SNPs) in rRNA, with a frequency greater than predicted by chance at 12 sites. A SNP at +139 (U/C) in the 59 leader sequence varied among the cell lines and correlated negatively with level of the nc-rRNA (P = 0.014). Modelling of the secondary structure of the rRNA 5'-leader sequence indicated a small increase in structural stability due to the +139 U/C SNP and a minor shift in local configuration occurrences. Conclusions/Significance: The results demonstrate occurrence of a sense nc-rRNA in human lung epithelial and cancer cells, and imply a role in regulation of the rRNA gene, which may be affected by a +139 SNP in the 5' leader sequence of the primary rRNA transcript.			Shiao, YH (corresponding author), Natl Canc Inst Frederick, Comparat Carcinogenesis Lab, Frederick, MD USA.	shiaoy@mail.nih.gov	Wang, Weili/D-1546-2011; Shiao, Yih-Horng/ABC-7262-2021	Shiao, Yih-Horng/0000-0001-9841-7784	CCR NIH HHS [HHSN261200800001C] Funding Source: Medline; Intramural NIH HHS Funding Source: Medline; NCI NIH HHS [HHSN261200800001E] Funding Source: Medline; NATIONAL CANCER INSTITUTE [ZIABC008382, ZIABC005399] Funding Source: NIH RePORTER	CCR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); Intramural NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Ayrault O, 2006, ONCOGENE, V25, P7577, DOI 10.1038/sj.onc.1209743; Ayrault O, 2006, EXP CELL RES, V312, P1185, DOI 10.1016/j.yexcr.2006.01.027; Barrandon C, 2008, BIOL CELL, V100, P83, DOI 10.1042/BC20070090; BELL SP, 1988, SCIENCE, V241, P1192, DOI 10.1126/science.3413483; Brown SE, 2007, MOL CELL BIOL, V27, P4938, DOI 10.1128/MCB.01880-06; Cui CH, 2004, CANCER RES, V64, P5651, DOI 10.1158/0008-5472.CAN-04-0801; DECAPOA A, 1985, HUM GENET, V69, P212, DOI 10.1007/BF00293027; DECAPOA A, 1985, J CELL SCI, V74, P21; DEHNE N, 2002, HEARING RES, V16, P947; Demirtas H, 2009, MICRON, V40, P511, DOI 10.1016/j.micron.2009.02.014; Drygin Denis, 2008, Proceedings of the American Association for Cancer Research Annual Meeting, V49, P784; Gee AH, 2006, J BIOMOL STRUCT DYN, V23, P417, DOI 10.1080/07391102.2006.10531236; Ghoshal K, 2004, J BIOL CHEM, V279, P6783, DOI 10.1074/jbc.M309393200; Hirota K, 2008, NATURE, V456, P130, DOI 10.1038/nature07348; HUTCHIN T, 1994, ANTIMICROB AGENTS CH, V38, P2517, DOI 10.1128/AAC.38.11.2517; JONES MH, 1988, P NATL ACAD SCI USA, V85, P669, DOI 10.1073/pnas.85.3.669; Kasprzak W, 1999, BIOINFORMATICS, V15, P16, DOI 10.1093/bioinformatics/15.1.16; Kasprzak W, 2005, NUCLEIC ACIDS RES, V33, P7151, DOI 10.1093/nar/gki1015; KASS S, 1987, MOL CELL BIOL, V7, P2891, DOI 10.1128/MCB.7.8.2891; Kriegova E, 2008, BMC MOL BIOL, V9, DOI 10.1186/1471-2199-9-69; Kuo BA, 1996, NUCLEIC ACIDS RES, V24, P4817, DOI 10.1093/nar/24.23.4817; LEFFERS H, 1993, NUCLEIC ACIDS RES, V21, P1449, DOI 10.1093/nar/21.6.1449; Liao DQ, 1999, AM J HUM GENET, V64, P24, DOI 10.1086/302221; Linnstaedt SD, 2006, RNA, V12, P1521, DOI 10.1261/rna.89306; Linnstaedt SD, 2009, RNA, V15, P1177, DOI 10.1261/rna.1504009; MADEN BEH, 1987, BIOCHEM J, V246, P519, DOI 10.1042/bj2460519; Martianov I, 2007, NATURE, V445, P666, DOI 10.1038/nature05519; MASER RL, 1989, P NATL ACAD SCI USA, V86, P6523, DOI 10.1073/pnas.86.17.6523; Masuda A, 1997, CANCER RES, V57, P4898; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; Mattick JS, 2006, HUM MOL GENET, V15, pR17, DOI 10.1093/hmg/ddl046; Mayer C, 2008, EMBO REP, V9, P774, DOI 10.1038/embor.2008.109; Mayer C, 2006, MOL CELL, V22, P351, DOI 10.1016/j.molcel.2006.03.028; MCGOWAN PO, 2008, PLOS ONE, V3, DOI DOI 10.1371/JOURNAL/PONE.0002085; McStay B, 2008, ANNU REV CELL DEV BI, V24, P131, DOI 10.1146/annurev.cellbio.24.110707.175259; MICHOT B, 1991, EUR J BIOCHEM, V195, P601, DOI 10.1111/j.1432-1033.1991.tb15743.x; Montanaro L, 2008, AM J PATHOL, V173, P301, DOI 10.2353/ajpath.2008.070752; Moss T, 2007, CELL MOL LIFE SCI, V64, P29, DOI 10.1007/s00018-006-6278-1; O'Brien Sean E., 2008, Proceedings of the American Association for Cancer Research Annual Meeting, V49, P556; O'Sullivan AC, 2002, MOL CELL BIOL, V22, P657, DOI 10.1128/MCB.22.2.657-668.2002; QU LH, 1991, NUCLEIC ACIDS RES, V19, P1015, DOI 10.1093/nar/19.5.1015; RENALIER MH, 1989, FEBS LETT, V249, P279, DOI 10.1016/0014-5793(89)80641-6; RENALIER MH, 1989, FEBS LETT, V247, P298, DOI 10.1016/0014-5793(89)81356-0; Ruggero D, 2003, NAT REV CANCER, V3, P179, DOI 10.1038/nrc1015; Serin G, 1996, BIOCHIMIE, V78, P530, DOI 10.1016/0300-9084(96)84759-6; Shapiro BA, 1996, J MOL GRAPH MODEL, V14, P194, DOI 10.1016/S0263-7855(96)00063-X; Shapiro BA, 1996, COMPUT APPL BIOSCI, V12, P171; SHAPIRO BA, 1994, J SUPERCOMPUT, V8, P195, DOI 10.1007/BF01204728; Shapiro BA, 2001, J MOL BIOL, V312, P27, DOI 10.1006/jmbi.2001.4931; Shapiro BA, 2001, BIOINFORMATICS, V17, P137, DOI 10.1093/bioinformatics/17.2.137; SHAPIRO BA, 1996, J MOL GRAPHICS, V14, P222; Shapiro BA, 2006, J MOL GRAPH MODEL, V25, P514, DOI 10.1016/j.jmgm.2006.04.004; Srivastava M, 1999, FASEB J, V13, P1911, DOI 10.1096/fasebj.13.14.1911; TRUSS M, 1992, NUCLEIC ACIDS RES, V20, P1483, DOI 10.1093/nar/20.7.1483; Tseng H, 1998, Front Biosci, V3, pD985; TSENG H, 2008, PLOS ONE, V3, DOI DOI 10.1371/JOURNAL.PONE.00001834; Umlauf D, 2008, BIOL CHEM, V389, P323, DOI 10.1515/BC.2008.047; Van Camp G, 2000, CLIN GENET, V57, P409, DOI 10.1034/j.1399-0004.2000.570601.x; WORTON RG, 1988, SCIENCE, V239, P64, DOI 10.1126/science.3336775; Zhang SL, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000902; Zuker M, 2003, NUCLEIC ACIDS RES, V31, P3406, DOI 10.1093/nar/gkg595	61	17	18	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7505	10.1371/journal.pone.0007505	http://dx.doi.org/10.1371/journal.pone.0007505			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838300	gold, Green Published, Green Submitted			2022-12-27	WOS:000270880900009
J	Costa, A; Jan, E; Sarnow, P; Schneider, D				Costa, Alexandre; Jan, Eric; Sarnow, Peter; Schneider, David			The Imd Pathway Is Involved in Antiviral Immune Responses in Drosophila	PLOS ONE			English	Article							CRICKET PARALYSIS VIRUS; NF-KAPPA-B; HOST-DEFENSE; PGRP-LC; MELANOGASTER; ACTIVATION; INFECTION; PROTEIN; TOLL; BACTERIAL	Cricket Paralysis virus (CrPV) is a member of the Dicistroviridae family of RNA viruses, which infect a broad range of insect hosts, including the fruit fly Drosophila melanogaster. Drosophila has emerged as an effective system for studying innate immunity because of its powerful genetic techniques and the high degree of gene and pathway conservation. Intra-abdominal injection of CrPV into adult flies causes a lethal infection that provides a robust assay for the identification of mutants with altered sensitivity to viral infection. To gain insight into the interactions between viruses and the innate immune system, we injected wild type flies with CrPV and observed that antimicrobial peptides (AMPs) were not induced and hemocytes were depleted in the course of infection. To investigate the contribution of conserved immune signaling pathways to antiviral innate immune responses, CrPV was injected into isogenic mutants of the Immune Deficiency (Imd) pathway, which resembles the mammalian Tumor Necrosis Factor Receptor (TNFR) pathway. Loss-of-function mutations in several Imd pathway genes displayed increased sensitivity to CrPV infection and higher CrPV loads. Our data show that antiviral innate immune responses in flies infected with CrPV depend upon hemocytes and signaling through the Imd pathway.			Costa, A (corresponding author), Univ Calif Berkeley, Sch Publ Hlth, Berkeley, CA 94720 USA.	dschneider@stanford.edu	Jan, Eric/O-1923-2019	Sarnow, Peter/0000-0002-2043-2770	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI069164] Funding Source: NIH RePORTER	NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Ayres JS, 2008, GENETICS, V178, P1807, DOI 10.1534/genetics.107.083782; Bangham J, 2008, GENETICS, V178, P2191, DOI 10.1534/genetics.107.085449; Basset A, 2000, P NATL ACAD SCI USA, V97, P3376, DOI 10.1073/pnas.070357597; Benedict CA, 2003, CURR OPIN IMMUNOL, V15, P59, DOI 10.1016/S0952-7915(02)00018-3; Braun A, 1997, GENETICS, V147, P623; Braun A, 1998, P NATL ACAD SCI USA, V95, P14337, DOI 10.1073/pnas.95.24.14337; Brennan CA, 2007, CURR BIOL, V17, P67, DOI 10.1016/j.cub.2006.11.026; Cherry S, 2004, NAT IMMUNOL, V5, P81, DOI 10.1038/ni1019; Cherry S, 2006, NAT IMMUNOL, V7, P911, DOI 10.1038/ni1388; Choe KM, 2005, P NATL ACAD SCI USA, V102, P1122, DOI 10.1073/pnas.0404952102; Choe KM, 2002, SCIENCE, V296, P359, DOI 10.1126/science.1070216; Chotkowski HL, 2008, VIROLOGY, V377, P197, DOI 10.1016/j.virol.2008.04.021; Chung HK, 1996, VIROLOGY, V225, P359, DOI 10.1006/viro.1996.0610; Corby-Harris V, 2007, J EVOLUTION BIOL, V20, P526, DOI 10.1111/j.1420-9101.2006.01267.x; De Gregorio E, 2002, EMBO J, V21, P2568, DOI 10.1093/emboj/21.11.2568; Deddouche S, 2008, NAT IMMUNOL, V9, P1425, DOI 10.1038/ni.1664; Dionne MS, 2008, DIS MODEL MECH, V1, P43, DOI 10.1242/dmm.000307; Dionne MS, 2006, CURR BIOL, V16, P1977, DOI 10.1016/j.cub.2006.08.052; Dostert C, 2005, NAT IMMUNOL, V6, P946, DOI 10.1038/ni1237; Elrod-Erickson M, 2000, CURR BIOL, V10, P781, DOI 10.1016/S0960-9822(00)00569-8; Ferrandon D, 2007, NAT REV IMMUNOL, V7, P862, DOI 10.1038/nri2194; Fields B. N., 2007, FIELDS VIROLOGY; Galiana-Arnoux D, 2006, NAT IMMUNOL, V7, P590, DOI 10.1038/ni1335; Georgel P, 2001, DEV CELL, V1, P503, DOI 10.1016/S1534-5807(01)00059-4; Goto A, 2001, BIOCHEM J, V359, P99, DOI 10.1042/0264-6021:3590099; Gottar M, 2002, NATURE, V416, P640, DOI 10.1038/nature734; Hedengren M, 1999, MOL CELL, V4, P827, DOI 10.1016/S1097-2765(00)80392-5; Hedengren-Olcott M, 2004, J BIOL CHEM, V279, P21121, DOI 10.1074/jbc.M313856200; Hedges LM, 2008, SCIENCE, V322, P702, DOI 10.1126/science.1162418; Hedges LM, 2008, J GEN VIROL, V89, P1497, DOI 10.1099/vir.0.83684-0; Herbein G, 2000, P SOC EXP BIOL MED, V223, P241, DOI 10.1046/j.1525-1373.2000.22335.x; Kaneko T, 2006, NAT IMMUNOL, V7, P715, DOI 10.1038/ni1356; Lazzaro BP, 2004, SCIENCE, V303, P1873, DOI 10.1126/science.1092447; Lemaitre B, 1996, CELL, V86, P973, DOI 10.1016/S0092-8674(00)80172-5; Leulier F, 2000, EMBO REP, V1, P353, DOI 10.1093/embo-reports/kvd073; Leulier F, 2002, CURR BIOL, V12, P996, DOI 10.1016/S0960-9822(02)00873-4; Lu YR, 2001, GENE DEV, V15, P104, DOI 10.1101/gad.856901; Medzhitov R, 1997, NATURE, V388, P394, DOI 10.1038/41131; MOORE N, 1991, VIRUSES INVERTEBRATE, P287; Pham LN, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030026; Ramet M, 2002, NATURE, V416, P644, DOI 10.1038/nature735; Reed L.J., 1938, SIMPLE METHOD ESTIMA, V27, P493, DOI [10.1093/oxfordjournals.aje.a118408, DOI 10.1093/OXFORDJOURNALS.AJE.A118408]; REINGANUM C, 1975, INTERVIROLOGY, V5, P97, DOI 10.1159/000149886; REINGANUM C, 1970, J INVERTEBR PATHOL, V16, P214, DOI 10.1016/0022-2011(70)90062-5; ROSETTO M, 1995, BIOCHEM BIOPH RES CO, V209, P111, DOI 10.1006/bbrc.1995.1477; Roxstrom-Lindquist K, 2004, EMBO REP, V5, P207, DOI 10.1038/sj.embor.7400073; Rutschmann S, 2000, NAT IMMUNOL, V1, P342, DOI 10.1038/79801; Sabatier L, 2003, EUR J BIOCHEM, V270, P3398, DOI 10.1046/j.1432-1033.2003.03725.x; Saleh MC, 2009, NATURE, V458, P346, DOI 10.1038/nature07712; Schmidt RL, 2008, FASEB J, V22, P918, DOI 10.1096/fj.06-7907com; Schneider D, 2000, SCIENCE, V288, P2376, DOI 10.1126/science.288.5475.2376; Schneider DS, 2007, PLOS PATHOG, V3, DOI 10.1371/journal.ppat.0030041; SCHNEIDER I, 1964, J EXP ZOOL, V156, P91, DOI 10.1002/jez.1401560107; SCHNEIDER I, 1972, J EMBRYOL EXP MORPH, V27, P353; SCOTTI PD, 1976, INTERVIROLOGY, V6, P333, DOI 10.1159/000149489; SCOTTI PD, 1977, J GEN VIROL, V35, P393, DOI 10.1099/0022-1317-35-2-393; Silverman N, 2003, J BIOL CHEM, V278, P48928, DOI 10.1074/jbc.M304802200; Sinenko SA, 2004, ONCOGENE, V23, P9120, DOI 10.1038/sj.onc.1208156; Stoven S, 2003, P NATL ACAD SCI USA, V100, P5991, DOI 10.1073/pnas.1035902100; Strand MR, 2008, INSECT IMMUNOLOGY, P25, DOI 10.1016/S0965-1748(02)00092-9; Tate J, 1999, NAT STRUCT BIOL, V6, P765, DOI 10.1038/11543; Teixeira L, 2008, PLOS BIOL, V6, P2753, DOI 10.1371/journal.pbio.1000002; Thibault ST, 2004, NAT GENET, V36, P283, DOI 10.1038/ng1314; Trudeau D, 2001, J VIROL, V75, P996, DOI 10.1128/JVI.75.2.996-1003.2001; Tsai CW, 2008, APPL ENVIRON MICROB, V74, P3251, DOI 10.1128/AEM.02248-07; van Rij RP, 2006, GENE DEV, V20, P2985, DOI 10.1101/gad.1482006; Vidal S, 2001, GENE DEV, V15, P1900, DOI 10.1101/gad.203301; Wang XH, 2006, SCIENCE, V312, P452, DOI 10.1126/science.1125694; Zambon RA, 2006, CELL MICROBIOL, V8, P880, DOI 10.1111/j.1462-5822.2006.00688.x; Zambon RA, 2005, P NATL ACAD SCI USA, V102, P7257, DOI 10.1073/pnas.0409181102; Zhou WG, 1998, P ROY SOC B-BIOL SCI, V265, P509, DOI 10.1098/rspb.1998.0324	72	171	181	4	38	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7436	10.1371/journal.pone.0007436	http://dx.doi.org/10.1371/journal.pone.0007436			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829691	Green Submitted, Green Published, gold			2022-12-27	WOS:000270847800002
J	Saxena, S; Bottle, A; Gilbert, R; Sharland, M				Saxena, Sonia; Bottle, Alex; Gilbert, Ruth; Sharland, Mike			Increasing Short-Stay Unplanned Hospital Admissions among Children in England; Time Trends Analysis '97-'06	PLOS ONE			English	Article							PRESCHOOL-CHILDREN; HEALTH-SERVICES; UNITED-STATES; ACUTELY ILL; CARE; CONTINUITY; PARENTS; CHILDHOOD; PROVIDER; QUALITY	Background: Timely care by general practitioners in the community keeps children out of hospital and provides better continuity of care. Yet in the UK, access to primary care has diminished since 2004 when changes in general practitioners' contracts enabled them to 'opt out' of providing out-of-hours care and since then unplanned pediatric hospital admission rates have escalated, particularly through emergency departments. We hypothesised that any increase in isolated short stay admissions for childhood illness might reflect failure to manage these cases in the community over a 10 year period spanning these changes. Methods and Findings: We conducted a population based time trends study of major causes of hospital admission in children <10 years using the Hospital Episode Statistics database, which records all admissions to all NHS hospitals in England using ICD10 codes. Outcomes measures were total and isolated short stay unplanned hospital admissions (lasting less than 2 days without readmission within 28 days) from 1997 to 2006. Over the period annual unplanned admission rates in children aged <10 years rose by 22% (from 73.6/1000 to 89.5/1000 child years) with larger increases of 41% in isolated short stay admissions (from 42.7/1000 to 60.2/1000 child years). There was a smaller fall of 12% in admissions with length of stay of >2 days. By 2006, 67.3% of all unplanned admissions were isolated short stays,2 days. The increases in admission rates were greater for common non-infectious than infectious causes of admissions. Conclusions: Short stay unplanned hospital admission rates in young children in England have increased substantially in recent years and are not accounted for by reductions in length of in-hospital stay. The majority are isolated short stay admissions for minor illness episodes that could be better managed by primary care in the community and may be evidence of a failure of primary care services.			Saxena, S (corresponding author), Univ London Imperial Coll Sci Technol & Med, Dept Primary Care & Social Med, London, England.	s.saxena@imperial.ac.uk	Saxena, Sonia K/G-4821-2013; Saxena, Sonia/ABD-7737-2021	Saxena, Sonia K/0000-0003-3787-2083; Saxena, Sonia/0000-0003-3787-2083; sharland, mike/0000-0001-8626-8291; Bottle, Alex/0000-0001-9978-2011; Gilbert, Ruth/0000-0001-9347-2709	Department of Health [PDA/02/06/076] Funding Source: Medline; Medical Research Council [G0400546B] Funding Source: researchfish; National Institute for Health Research [PDA/02/06/076] Funding Source: researchfish	Department of Health; Medical Research Council(UK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission); National Institute for Health Research(National Institute for Health Research (NIHR))		Agency for Healthcare Research and Quality, 2008, CLIN CLASS SOFTW CCS; Chief Nursing Officer's Directorate Children Families and Maternity Analysis, 2008, TRENDS CHILDR YOUNG; Christakis DA, 2001, PEDIATRICS, V107, P524, DOI 10.1542/peds.107.3.524; *DEP HLTH, 2008, EV CHILD MATT; *DEP HLTH, 2009, HLTH LIV BRIGH FUT S; *DEP HLTH, 1998, HES BOOK; Dixon J, 1998, J PUBLIC HEALTH MED, V20, P63, DOI 10.1093/oxfordjournals.pubmed.a024721; Flores G, 2003, PEDIATRICS, V112, P1021, DOI 10.1542/peds.112.5.1021; Gadomski A, 1998, PEDIATRICS, V101, DOI 10.1542/peds.101.3.e1; Gill JM, 1998, ARCH FAM MED, V7, P352, DOI 10.1001/archfami.7.4.352; Hargreaves S, 2006, BMC HEALTH SERV RES, V6, DOI 10.1186/1472-6963-6-153; *HEALTHC COMM, 2005, NHS PERF RAT 2004 20; Hippisley-Cox J, 2007, TRENDS CONSULTATION; Horton R, 2008, LANCET, V372, P3, DOI 10.1016/S0140-6736(08)60963-0; Inkelas M, 2004, PEDIATRICS, V113, P1917; Kai J, 1996, BRIT MED J, V313, P987; Kai J, 1996, BRIT MED J, V313, P983; Kmietowicz Z, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1207; Lachman P, 2004, BRIT MED J, V329, P693, DOI 10.1136/bmj.329.7468.693; Leibowitz R, 2003, FAM PRACT, V20, P311, DOI 10.1093/fampra/cmg313; MacFaul R, 2001, ARCH DIS CHILD, V85, P203, DOI 10.1136/adc.85.3.203; McDonald KM, 2008, PEDIATRICS, V122, pE416, DOI 10.1542/peds.2007-2477; National Collaborating Centre for Women's and Children's Health, 2007, FEV ILLN CHILDR ASS; *NHS CONF, 2003, INV GEN PRACT NEW GE; NHS Institute for Innovation and Improvement, 2008, FOC EM URG CAR PATHW; *OFF NAT STAT, 2009, MID 1997 POP EST ENG; Ogilvie D, 2005, ARCH DIS CHILD, V90, P138, DOI 10.1136/adc.2003.035543; *ORG EC COOP DEV, 2001, HLTH GLANC; Roland M, 2008, NEW ENGL J MED, V359, P2087, DOI 10.1056/NEJMp0805633; Royal College of Paediatrics and Child Health, 2008, MOD FUT; Salisbury C, 2000, BRIT MED J, V320, P618, DOI 10.1136/bmj.320.7235.618; Saxena S, 1999, BRIT MED J, V318, P642, DOI 10.1136/bmj.318.7184.642; Saxena S, 2002, BMJ-BRIT MED J, V325, P520, DOI 10.1136/bmj.325.7363.520; Starfield B., 1992, PRIMARY CARE CONCEPT; Stephenson T, 2009, BRIT MED J, V338, DOI 10.1136/bmj.b1783; Stewart M, 1998, ARCH DIS CHILD, V79, P219, DOI 10.1136/adc.79.3.219; Wise PH, 2007, J PEDIATR-US, V151, pS6, DOI 10.1016/j.jpeds.2007.08.013; Wise PH, 2004, HEALTH AFFAIR, V23, P9, DOI 10.1377/hlthaff.23.5.9	38	68	68	0	10	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7484	10.1371/journal.pone.0007484	http://dx.doi.org/10.1371/journal.pone.0007484			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829695	Green Submitted, Green Published, Green Accepted, gold			2022-12-27	WOS:000270847800017
J	Stomel, JM; Wilson, JW; Leon, MA; Stafford, P; Chaput, JC				Stomel, Joshua M.; Wilson, James W.; Leon, Megan A.; Stafford, Phillip; Chaput, John C.			A Man-Made ATP-Binding Protein Evolved Independent of Nature Causes Abnormal Growth in Bacterial Cells	PLOS ONE			English	Article							ESCHERICHIA-COLI; DIVISION; DNA; EXPRESSION; INSIGHTS; REGULON; FOLD	Recent advances in de novo protein evolution have made it possible to create synthetic proteins from unbiased libraries that fold into stable tertiary structures with predefined functions. However, it is not known whether such proteins will be functional when expressed inside living cells or how a host organism would respond to an encounter with a non-biological protein. Here, we examine the physiology and morphology of Escherichia coli cells engineered to express a synthetic ATP-binding protein evolved entirely from non-biological origins. We show that this man-made protein disrupts the normal energetic balance of the cell by altering the levels of intracellular ATP. This disruption cascades into a series of events that ultimately limit reproductive competency by inhibiting cell division. We now describe a detailed investigation into the synthetic biology of this man-made protein in a living bacterial organism, and the effect that this protein has on normal cell physiology.			Stomel, JM (corresponding author), Arizona State Univ, Ctr BioOpt Nanotechnol, Tempe, AZ 85287 USA.	john.chaput@asu.edu		Stafford, Phillip/0000-0001-7989-9036				Arends SJR, 2004, J BACTERIOL, V186, P880, DOI 10.1128/JB.186.3.880-884.2004; Balagadde FK, 2008, MOL SYST BIOL, V4, DOI 10.1038/msb.2008.24; Benner SA, 2005, NAT REV GENET, V6, P533, DOI 10.1038/nrg1637; Benner SA, 2004, SCIENCE, V306, P625, DOI 10.1126/science.1101104; Brakmann S, 2001, CHEMBIOCHEM, V2, P865, DOI 10.1002/1439-7633(20011203)2:12<865::AID-CBIC865>3.0.CO;2-6; Chaput JC, 2004, CHEM BIOL, V11, P865, DOI 10.1016/j.chembiol.2004.04.006; Chaput JC, 2008, EXPERT OPIN BIOL TH, V8, P1087, DOI 10.1517/14712598.8.8.1087 ; Chen GZ, 2003, CAN J MICROBIOL, V49, P733, DOI 10.1139/W03-096; Chung HJ, 2000, LETT APPL MICROBIOL, V31, P416, DOI 10.1046/j.1472-765X.2000.00840.x; Delaney JC, 2003, P NATL ACAD SCI USA, V100, P4469, DOI 10.1073/pnas.0837277100; DHAR PK, 2009, J BIOL ENG, V3, P1; Elbeik T, 2004, J CLIN MICROBIOL, V42, P3120, DOI 10.1128/JCM.42.7.3120-3127.2004; Elbeik T, 2004, J CLIN MICROBIOL, V42, P563, DOI 10.1128/JCM.42.2.563-569.2004; Elowitz MB, 2000, NATURE, V403, P335, DOI 10.1038/35002125; Endy D, 2005, NATURE, V438, P449, DOI 10.1038/nature04342; Filipovska A, 2008, ACS CHEM BIOL, V3, P51, DOI 10.1021/cb700185e; Gardner TS, 2000, NATURE, V403, P339, DOI 10.1038/35002131; Gibson DG, 2008, SCIENCE, V319, P1215, DOI 10.1126/science.1151721; Goehring NW, 2005, CURR BIOL, V15, pR514, DOI 10.1016/j.cub.2005.06.038; GUZMAN LM, 1995, J BACTERIOL, V177, P4121, DOI 10.1128/jb.177.14.4121-4130.1995; Hanczyc MM, 2003, SCIENCE, V302, P618, DOI 10.1126/science.1089904; Harry E., 2006, INT REV CYTOL, V253, P27; Henry AA, 2003, CURR OPIN CHEM BIOL, V7, P727, DOI 10.1016/j.cbpa.2003.10.011; Huang DW, 2009, NAT PROTOC, V4, P44, DOI 10.1038/nprot.2008.211; Isalan M, 2008, NATURE, V452, P840, DOI 10.1038/nature06847; Justice SS, 2006, P NATL ACAD SCI USA, V103, P19884, DOI 10.1073/pnas.0606329104; Keefe AD, 2001, NATURE, V410, P715, DOI 10.1038/35070613; Kuhlman B, 2003, SCIENCE, V302, P1364, DOI 10.1126/science.1089427; Lartigue C, 2007, SCIENCE, V317, P632, DOI 10.1126/science.1144622; Leonard E, 2008, TRENDS BIOTECHNOL, V26, P674, DOI 10.1016/j.tibtech.2008.08.003; Lock RL, 2008, NAT REV DRUG DISCOV, V7, P324, DOI 10.1038/nrd2510; Macnab RM, 2003, ANNU REV MICROBIOL, V57, P77, DOI 10.1146/annurev.micro.57.030502.090832; Mansy SS, 2007, J MOL BIOL, V371, P501, DOI 10.1016/j.jmb.2007.05.062; McBroom AJ, 2007, MOL MICROBIOL, V63, P545, DOI 10.1111/j.1365-2958.2006.05522.x; Pruss BM, 1996, J BACTERIOL, V178, P668; Pryciak PM, 2009, CHEM BIOL, V16, P249, DOI 10.1016/j.chembiol.2009.01.011; Scheffers DJ, 2008, FEBS LETT, V582, P2601, DOI 10.1016/j.febslet.2008.06.038; SCHENA M, 1995, SCIENCE, V270, P467, DOI 10.1126/science.270.5235.467; Schmid A, 2001, NATURE, V409, P258, DOI 10.1038/35051736; Sismour AM, 2004, NUCLEIC ACIDS RES, V32, P728, DOI 10.1093/nar/gkh241; Smith MD, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000467; Suefuji K, 2002, P NATL ACAD SCI USA, V99, P16776, DOI 10.1073/pnas.262671699; Szostak JW, 2001, NATURE, V409, P387, DOI 10.1038/35053176; Vetter IR, 1999, Q REV BIOPHYS, V32, P1, DOI 10.1017/S0033583599003480; Walsh C, 2003, NAT REV MICROBIOL, V1, P65, DOI 10.1038/nrmicro727; Watkins JL, 2008, CHEMBIOCHEM, V9, P1361, DOI 10.1002/cbic.200800147; Wei YN, 2003, P NATL ACAD SCI USA, V100, P13270, DOI 10.1073/pnas.1835644100; Yim L, 2000, J BACTERIOL, V182, P6366, DOI 10.1128/JB.182.22.6366-6373.2000	48	5	5	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7385	10.1371/journal.pone.0007385	http://dx.doi.org/10.1371/journal.pone.0007385			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812699	Green Published, gold, Green Submitted			2022-12-27	WOS:000270594200010
J	Sun, Y; Liou, B; Quinn, B; Ran, HM; Xu, YH; Grabowski, GA				Sun, Ying; Liou, Benjamin; Quinn, Brian; Ran, Huimin; Xu, You-Hai; Grabowski, Gregory A.			In Vivo and Ex Vivo Evaluation of L-Type Calcium Channel Blockers on Acid beta-Glucosidase in Gaucher Disease Mouse Models	PLOS ONE			English	Article							SAPOSIN-C; DILTIAZEM; MICE; GLUCOCEREBROSIDASE; FIBROBLASTS; MUTATIONS; PHENOTYPE; REGISTRY; THERAPY; PLACE	Gaucher disease is a lysosomal storage disease caused by mutations in acid beta-glucosidase (GCase) leading to defective hydrolysis and accumulation of its substrates. Two L-type calcium channel (LTCC) blockers-verapamil and diltiazem-have been reported to modulate endoplasmic reticulum (ER) folding, trafficking, and activity of GCase in human Gaucher disease fibroblasts. Similarly, these LTCC blockers were tested with cultured skin fibroblasts from homozygous point-mutated GCase mice (V394L, D409H, D409V, and N370S) with the effect of enhancing of GCase activity. Correspondingly, diltiazem increased GCase protein and facilitated GCase trafficking to the lysosomes of these cells. The in vivo effects of diltiazem on GCase were evaluated in mice homozygous wild-type (WT), V394L and D409H. In D409H homozygotes diltiazem (10 mg/kg/d via drinking water or 50-200 mg/kg/d intraperitoneally) had minor effects on increasing GCase activity in brain and liver (1.2-fold). Diltiazem treatment (10 mg/kg/d) had essentially no effect on WT and V394L GCase protein or activity levels (, 1.2-fold) in liver. These results show that LTCC blockers had the ex vivo effects of increasing GCase activity and protein in the mouse fibroblasts, but these effects did not translate into similar changes in vivo even at very high drug doses.			Sun, Y (corresponding author), Univ Cincinnati, Med Ctr, Coll Med, Cincinnati Childrens Hosp,Div Human Genet, Cincinnati, OH 45267 USA.	ying.sun@cchmc.org			NIDDK NIH HHS [R01 NS/DK36729, R01 NS/DK36681, R01 DK036729] Funding Source: Medline; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [R01DK036729] Funding Source: NIH RePORTER	NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK))		BEUTLER E, 2001, METABOLIC MOL BASES, P3635; Biala G, 2003, POL J PHARMACOL, V55, P327; Butters TD, 2005, GLYCOBIOLOGY, V15, pR43, DOI 10.1093/glycob/cwi076; Charrow J, 2000, ARCH INTERN MED, V160, P2835, DOI 10.1001/archinte.160.18.2835; Eder C, 1998, AM J PHYSIOL-CELL PH, V275, pC327, DOI 10.1152/ajpcell.1998.275.2.C327; Enquist IB, 2007, P NATL ACAD SCI USA, V104, P17483, DOI 10.1073/pnas.0708086104; EYAL N, 1990, GENE, V96, P277, DOI 10.1016/0378-1119(90)90264-R; Flynn JT, 2000, PEDIATR NEPHROL, V15, P302, DOI 10.1007/s004670000480; Grabowski GA, 2006, METABOLIC MOL BASES; Kornhaber GJ, 2008, CHEMBIOCHEM, V9, P2643, DOI 10.1002/cbic.200800249; Lieberman RL, 2007, NAT CHEM BIOL, V3, P101, DOI 10.1038/nchembio850; Liu YJ, 1998, P NATL ACAD SCI USA, V95, P2503, DOI 10.1073/pnas.95.5.2503; Luszczki JJ, 2007, PHARMACOL REP, V59, P672; Mu TW, 2008, PLOS BIOL, V6, P253, DOI 10.1371/journal.pbio.0060026; NAITO K, 1986, ARZNEIMITTEL-FORSCH, V36-1, P25; Nunia V, 2007, J ENVIRON PATHOL TOX, V26, P185, DOI 10.1615/JEnvironPatholToxicolOncol.v26.i3.30; PasmanikChor M, 1996, BIOCHEM MOL MED, V59, P125, DOI 10.1006/bmme.1996.0077; Rigat B, 2009, MOL GENET METAB, V96, P225, DOI 10.1016/j.ymgme.2008.12.008; Sawkar AR, 2002, P NATL ACAD SCI USA, V99, P15428, DOI 10.1073/pnas.192582899; Sinclair GB, 2007, MOL GENET METAB, V90, P148, DOI 10.1016/j.ymgme.2006.09.008; Steet RA, 2006, P NATL ACAD SCI USA, V103, P13813, DOI 10.1073/pnas.0605928103; Sun Y, 2003, J BIOL CHEM, V278, P31918, DOI 10.1074/jbc.M302752200; Sun Y, 2007, HUM MOL GENET, V16, P957, DOI 10.1093/hmg/ddm040; THEOPHILUS B, 1989, AM J HUM GENET, V45, P212; TSUJI A, 1988, J BIOCHEM-TOKYO, V104, P276, DOI 10.1093/oxfordjournals.jbchem.a122457; Weinreb NJ, 2005, AM J HEMATOL, V80, P223, DOI 10.1002/ajh.20504; Weinreb NJ, 2002, AM J MED, V113, P112, DOI 10.1016/S0002-9343(02)01150-6; Westermann D, 2006, EUR J HEART FAIL, V8, P115, DOI 10.1016/j.ejheart.2005.07.012; Xu YH, 2003, AM J PATHOL, V163, P2093, DOI 10.1016/S0002-9440(10)63566-3; Zhang F, 2007, J BIOL CHEM, V282, P25259, DOI 10.1074/jbc.M701614200; Zinchuk V, 2007, ACTA HISTOCHEM CYTOC, V40, P101, DOI 10.1267/ahc.07002	31	14	14	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7320	10.1371/journal.pone.0007320	http://dx.doi.org/10.1371/journal.pone.0007320			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809509	Green Published, Green Submitted, gold			2022-12-27	WOS:000270594000005
J	Franz, CK; Quach, ET; Krudy, CA; Federici, T; Kliem, MA; Snyder, BR; Raore, B; Boulis, NM				Franz, Colin K.; Quach, Eric T.; Krudy, Christina A.; Federici, Thais; Kliem, Michele A.; Snyder, Brooke R.; Raore, Bethwei; Boulis, Nicholas M.			A Conditioning Lesion Provides Selective Protection in a Rat Model of Amyotrophic Lateral Sclerosis	PLOS ONE			English	Article								Background: Amyotrophic Lateral Sclerosis (ALS) is neurodegenerative disease characterized by muscle weakness and atrophy due to progressive motoneuron loss. The death of motoneuron is preceded by the failure of neuromuscular junctions (NMJs) and axonal retraction. Thus, to develop an effective ALS therapy you must simultaneously preserve motoneuron somas, motor axons and NMJs. A conditioning lesion has the potential to accomplish this since it has been shown to enhance neuronal survival and recovery from trauma in a variety of contexts. Methodology/Principal Findings: To test the effects of a conditioning lesion in a model of familial ALS we administered a tibial nerve crush injury to presymptomatic fALS(G93A) rats. We examined its effects on motor function, motoneuron somas, motor axons, and NMJs. Our experiments revealed a novel paradigm for the conditioning lesion effect. Specifically we found that the motor functional decline in fALS(G93A) rats that received a conditioning lesion was delayed and less severe. These improvements in motor function corresponded to greater motoneuron survival, reduced motor axonopathy, and enhanced NMJ maintenance at disease end-stage. Furthermore, the increased NMJ maintenance was selective for muscle compartments innervated by the most resilient (slow) motoneuron subtypes, but was absent in muscle compartments innervated by the most vulnerable (fast fatigable) motoneuron subtypes. Conclusions/Significance: These findings support the development of strategies aimed at mimicking the conditioning lesion effect to treat ALS as well as underlined the importance of considering the heterogeneity of motoneuron sub-types when evaluating prospective ALS therapeutics.			Franz, CK (corresponding author), Univ Calgary, Fac Med, Calgary, AB, Canada.	nboulis@emory.edu	Franz, Colin/A-2513-2012	Franz, Colin K./0000-0003-4546-8638				Armon C, 2007, J NEUROL SCI, V262, P45, DOI 10.1016/j.jns.2007.06.021; Atkin JD, 2005, NEUROMUSCULAR DISORD, V15, P377, DOI 10.1016/j.nmd.2005.02.005; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Beck M, 2001, AMYOTROPH LATERAL SC, V2, pS55, DOI 10.1080/146608201300079454; Chio A, 2005, BRAIN, V128, P472, DOI 10.1093/brain/awh373; Chong MS, 1996, J COMP NEUROL, V370, P97, DOI 10.1002/(SICI)1096-9861(19960617)370:1<97::AID-CNE9>3.0.CO;2-G; Dal Bello-Haas V, 2007, NEUROLOGY, V68, P2003, DOI 10.1212/01.wnl.0000264418.92308.a4; DENGLER R, 1990, MUSCLE NERVE, V13, P545, DOI 10.1002/mus.880130612; Drory VE, 2001, J NEUROL SCI, V191, P133, DOI 10.1016/S0022-510X(01)00610-4; EDSTROM L, 1986, MUSCLE NERVE, V9, P104, DOI 10.1002/mus.880090203; Federici T, 2006, MUSCLE NERVE, V33, P302, DOI 10.1002/mus.20439; Fischer LR, 2004, EXP NEUROL, V185, P232, DOI 10.1016/j.expneurol.2003.10.004; FORMAN DS, 1980, BRAIN RES, V182, P180, DOI 10.1016/0006-8993(80)90842-2; Franz CK, 2009, NEUROBIOL DIS, V33, P473, DOI 10.1016/j.nbd.2008.12.003; Frey D, 2000, J NEUROSCI, V20, P2534; Gordon Tessa, 2009, Neurosurg Focus, V26, pE3, DOI 10.3171/FOC.2009.26.2.E3; Gould TW, 2007, NEUROSCI BIOBEHAV R, V31, P1073, DOI 10.1016/j.neubiorev.2007.04.015; Gould TW, 2009, NEUROSCIENTIST, V15, P105, DOI 10.1177/1073858408324787; Hegedus J, 2008, J PHYSIOL-LONDON, V586, P3337, DOI 10.1113/jphysiol.2007.149286; Hegedus J, 2007, NEUROBIOL DIS, V28, P154, DOI 10.1016/j.nbd.2007.07.003; HENNEMAN E, 1981, HDB PHYSL NERVOUS SY, P345; Howland DS, 2002, P NATL ACAD SCI USA, V99, P1604, DOI 10.1073/pnas.032539299; Ikeda K, 2005, J NEUROSCI RES, V82, P63, DOI 10.1002/jnr.20621; JENQ CB, 1988, BRAIN RES, V457, P63, DOI 10.1016/0006-8993(88)90057-1; Kaspar BK, 2005, ANN NEUROL, V57, P649, DOI 10.1002/ana.20451; Kernell D., 2006, MOTONEURONE ITS MUSC; KIERNAN JA, 1991, BRAIN, V114, P843, DOI 10.1093/brain/114.2.843; Kirkinezos IG, 2003, ANN NEUROL, V53, P804, DOI 10.1002/ana.10597; Kong JM, 1998, J NEUROSCI, V18, P3241; Kong JM, 1999, J COMP NEUROL, V412, P373, DOI 10.1002/(SICI)1096-9861(19990920)412:2<373::AID-CNE13>3.0.CO;2-N; Lambrechts D, 2007, TRENDS NEUROSCI, V30, P536, DOI 10.1016/j.tins.2007.07.002; Longstreth WT, 1998, ARCH NEUROL-CHICAGO, V55, P201, DOI 10.1001/archneur.55.2.201; Mariotti R, 2002, NEUROSCIENCE, V115, P331, DOI 10.1016/S0306-4522(02)00448-7; Matsumoto A, 2006, J NEUROSCI RES, V83, P119, DOI 10.1002/jnr.20708; MCQUARRIE IG, 1973, ARCH NEUROL-CHICAGO, V29, P53, DOI 10.1001/archneur.1973.00490250071008; MCQUARRIE IG, 1985, J COMP NEUROL, V231, P239, DOI 10.1002/cne.902310211; MULDER DW, 1986, NEUROLOGY, V36, P511, DOI 10.1212/WNL.36.4.511; Nguyen MD, 2000, P NATL ACAD SCI USA, V97, P12306, DOI 10.1073/pnas.97.22.12306; NIETOSAMPEDRO M, 1987, ANN NY ACAD SCI, V495, P108, DOI 10.1111/j.1749-6632.1987.tb23670.x; OUDEGA M, 1994, EXP NEUROL, V129, P194, DOI 10.1006/exnr.1994.1161; PETTE D, 1992, REV PHYSIOL BIOCH P, V120, P115, DOI 10.1007/BFb0036123; Pinto AC, 1999, J NEUROL SCI, V169, P69, DOI 10.1016/S0022-510X(99)00218-X; Pun S, 2006, NAT NEUROSCI, V9, P408, DOI 10.1038/nn1653; Qureshi MM, 2006, AMYOTROPH LATERAL SC, V7, P173, DOI 10.1080/14660820600640596; RICHARDSON PM, 1984, NATURE, V309, P791, DOI 10.1038/309791a0; Sakuma K, 2001, BRAIN RES, V907, P1, DOI 10.1016/S0006-8993(01)02288-0; Scarmeas N, 2002, NEUROLOGY, V59, P773, DOI 10.1212/WNL.59.5.773; Sharp PS, 2005, NEUROSCIENCE, V130, P897, DOI 10.1016/j.neuroscience.2004.09.069; Simon M, 2003, EUR J NEUROSCI, V18, P2460, DOI 10.1046/j.1460-9568.2003.02978.x; Simon M, 2002, NEUROSCI LETT, V320, P9, DOI 10.1016/S0304-3940(02)00007-1; Simon M, 2000, EUR J NEUROSCI, V12, P863, DOI 10.1046/j.1460-9568.2000.00975.x; SNIDER WD, 1992, J NEUROBIOL, V23, P1231, DOI 10.1002/neu.480230913; Sterne GD, 1997, J CELL BIOL, V139, P709, DOI 10.1083/jcb.139.3.709; Strickland D, 1996, ACTA NEUROL SCAND, V94, P45, DOI 10.1111/j.1600-0404.1996.tb00038.x; ULFHAKE B, 1982, BRAIN RES, V251, P201, DOI 10.1016/0006-8993(82)90738-7; Veldink JH, 2005, NEUROLOGY, V64, P241, DOI 10.1212/01.WNL.0000149513.82332.5C; Veldink JH, 2003, NEUROMUSCULAR DISORD, V13, P737, DOI 10.1016/S0960-8966(03)00104-4	57	10	11	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7357	10.1371/journal.pone.0007357	http://dx.doi.org/10.1371/journal.pone.0007357			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806196	Green Submitted, gold, Green Published			2022-12-27	WOS:000270593800030
J	Gong, YX; Yao, E; Shen, RL; Goel, A; Arcila, M; Teruya-Feldstein, J; Zakowski, MF; Frankel, S; Peifer, M; Thomas, RK; Ladanyi, M; Pao, W				Gong, Yixuan; Yao, Evelyn; Shen, Ronglai; Goel, Aviva; Arcila, Maria; Teruya-Feldstein, Julie; Zakowski, Maureen F.; Frankel, Stanley; Peifer, Martin; Thomas, Roman K.; Ladanyi, Marc; Pao, William			High Expression Levels of Total IGF-1R and Sensitivity of NSCLC Cells In Vitro to an Anti-IGF-1R Antibody (R1507)	PLOS ONE			English	Article								Background: The IGF receptor type 1 (IGF-1R) pathway is frequently deregulated in human tumors and has become a target of interest for anti-cancer therapy. Methodology/Principal Findings: We used a panel of 22 non-small cell lung cancer (NSCLC) cell lines to investigate predictive biomarkers of response to R1507, a fully-humanized anti-IGF-1R monoclonal antibody (Ab; Roche). 5 lines were moderately sensitive (25-50% growth inhibition) to R1507 alone. While levels of phospho-IGF-1R did not correlate with drug sensitivity, 4 out of 5 sensitive lines displayed high levels of total IGF-1R versus 1 out of 17 resistant lines (p = 0.003, Fisher's Exact). Sensitive lines also harbored higher copy numbers of IGF-1R as assessed by independent SNP array analysis. Addition of erlotinib or paclitaxel to R1507 led to further growth inhibition in sensitive but not resistant lines. In one EGFR mutant lung adenocarcinoma cell line (11-18), R1507 and erlotinib co-treatment induced apoptosis, whereas treatment with either drug alone induced only cell cycle arrest. Apoptosis was mediated, in part, by the survival-related AKT pathway. Additionally, immunohistochemical (IHC) staining of total IGF-1R with an anti-total IGF-1R Ab (G11; Ventana) was performed on tissue microarrays (TMAs) containing 270 independent NSCLC tumor samples. Staining intensity was scored on a scale of 0 to 3+. 39.3% of tumors showed medium to high IGF-1R IHC staining (scores of 2+ or 3+, respectively), while 16.7% had scores of 3+. Conclusions/Significance: In NSCLC cell lines, high levels of total IGF-1R are associated with moderate sensitivity to R1507. These results suggest a possible enrichment strategy for clinical trials with anti-IGF-1R therapy.			Gong, YX (corresponding author), Mem Sloan Kettering Canc Ctr, Pao Lab, Human Oncol & Pathogenesis Program, 1275 York Ave, New York, NY 10021 USA.	william.pao@vanderbilt.edu	Ladanyi, Marc/AAG-8585-2019; Arcila, Maria/ABE-2235-2021	Peifer, Martin/0000-0002-5243-5503; Beckmann, Aviva/0000-0002-5739-5512; Beckmann, Aviva/0000-0001-6099-6135	NATIONAL CANCER INSTITUTE [P01CA129243, K08CA097980, R01CA121210] Funding Source: NIH RePORTER; NCI NIH HHS [P01 CA129243, R01 CA121210, K08 CA097980] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Adams TE, 2000, CELL MOL LIFE SCI, V57, P1050, DOI 10.1007/PL00000744; Cao L, 2008, CANCER RES, V68, P8039, DOI 10.1158/0008-5472.CAN-08-1712; Derrane M, 1998, J NATL CANCER I, V90, P1770, DOI 10.1093/jnci/90.23.1770; Engelman JA, 2005, P NATL ACAD SCI USA, V102, P3788, DOI 10.1073/pnas.0409773102; Gong YX, 2007, PLOS MED, V4, P1655, DOI 10.1371/journal.pmed.0040294; Jemal A, 2006, CA-CANCER J CLIN, V56, P106, DOI 10.3322/canjclin.56.2.106; Karp DD, 2007, J CLIN ONCOL, V25; Karp DD, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.8015; London SJ, 2002, JNCI-J NATL CANCER I, V94, P749, DOI 10.1093/jnci/94.10.749; Ludovini V, 2009, ANN ONCOL, V20, P842, DOI 10.1093/annonc/mdn727; Merrick DT, 2007, J CLIN ONCOL, V25; MYERS MG, 1992, P NATL ACAD SCI USA, V89, P10350, DOI 10.1073/pnas.89.21.10350; Pao W, 2004, P NATL ACAD SCI USA, V101, P13306, DOI 10.1073/pnas.0405220101; Paz K, 2008, COMB CHEM HIGH T SCR, V11, P62, DOI 10.2174/138620708783398313; Pollak M, 2008, NAT REV CANCER, V8, P915, DOI 10.1038/nrc2536; Riedemann J, 2006, ENDOCR-RELAT CANCER, V13, pS33, DOI 10.1677/erc.1.01280; Rodon J, 2008, MOL CANCER THER, V7, P2575, DOI 10.1158/1535-7163.MCT-08-0265; Sos ML, 2009, J CLIN INVEST, V119, P1727, DOI 10.1172/JCI37127; Travis WD, 1999, HISTOLOGICAL TYPING; Weir BA, 2007, NATURE, V450, P893, DOI 10.1038/nature06358; Yee D, 2006, BRIT J CANCER, V94, P465, DOI 10.1038/sj.bjc.6602963; Yu H, 1999, JNCI-J NATL CANCER I, V91, P151, DOI 10.1093/jnci/91.2.151	22	111	116	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7273	10.1371/journal.pone.0007273	http://dx.doi.org/10.1371/journal.pone.0007273			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806209	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593800006
J	Mesoudi, A				Mesoudi, Alex			The Cultural Dynamics of Copycat Suicide	PLOS ONE			English	Article							TRANSMISSION; CONTAGION; EVOLUTION; CLUSTERS; BEHAVIOR	The observation that suicides sometimes cluster in space and/or time has led to suggestions that these clusters are caused by the social learning of suicide-related behaviours, or "copycat suicides". Point clusters are clusters of suicides localised in both time and space, and have been attributed to direct social learning from nearby individuals. Mass clusters are clusters of suicides localised in time but not space, and have been attributed to the dissemination of information concerning celebrity suicides via the mass media. Here, agent-based simulations, in combination with scan statistic methods for detecting clusters of rare events, were used to clarify the social learning processes underlying point and mass clusters. It was found that social learning between neighbouring agents did generate point clusters as predicted, although this effect was partially mimicked by homophily (individuals preferentially assorting with similar others). The one-to-many transmission dynamics characterised by the mass media were shown to generate mass clusters, but only where social learning was weak, perhaps due to prestige bias (only copying prestigious celebrities) and similarity bias (only copying similar models) acting to reduce the subset of available models. These findings can help to clarify and formalise existing hypotheses and to guide future empirical work relating to real-life copycat suicides.			Mesoudi, A (corresponding author), Univ London, Biol & Expt Psychol Grp, Sch Biol & Chem Sci, London, England.	a.mesoudi@qmul.ac.uk	Mesoudi, Alex/K-4410-2012	Mesoudi, Alex/0000-0002-7740-1625				Aamodt Geir, 2006, Int J Health Geogr, V5, P15, DOI 10.1186/1476-072X-5-15; Axelrod R, 1997, J CONFLICT RESOLUT, V41, P203, DOI 10.1177/0022002797041002001; Bakker MI, 2004, INT J EPIDEMIOL, V33, P1329, DOI 10.1093/ije/dyh266; Boyd R., 1985, CULTURE EVOLUTIONARY; BRENT DA, 1989, J AM ACAD CHILD PSY, V28, P918, DOI 10.1097/00004583-198911000-00017; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Cheng ATA, 2007, J AFFECT DISORDERS, V103, P69, DOI 10.1016/j.jad.2007.01.021; Cutler David, 2001, RISKY BEHAV YOUTHS E, P219; Durrett R, 2005, J ECON BEHAV ORGAN, V57, P267, DOI 10.1016/j.jebo.2003.09.017; EPSTEIN J, 2007, STUDIES AGENT BASED; Gilbert N., 2007, AGENT BASED MODELS Q; Gould M, 2003, AM BEHAV SCI, V46, P1269, DOI 10.1177/0002764202250670; GOULD MS, 1990, AM J EPIDEMIOL, V131, P71, DOI 10.1093/oxfordjournals.aje.a115487; GOULD MS, 1989, SUICIDE LIFE-THREAT, V19, P17; HAW CM, 1994, SUICIDE LIFE-THREAT, V24, P256; Henrich J, 2001, EVOL HUM BEHAV, V22, P165, DOI 10.1016/S1090-5138(00)00071-4; Henrich J., 2007, OXFORD HDB EVOLUTION; ISHII K, 1991, SOC SCI RES, V20, P188, DOI 10.1016/0049-089X(91)90016-V; Jennings JM, 2005, AM J EPIDEMIOL, V161, P73, DOI 10.1093/aje/kwi012; Joiner TE, 1999, CURR DIR PSYCHOL SCI, V8, P89, DOI 10.1111/1467-8721.00021; JONAS K, 1992, BRIT J SOC PSYCHOL, V31, P295, DOI 10.1111/j.2044-8309.1992.tb00974.x; Kulldorff M, 1997, COMMUN STAT-THEOR M, V26, P1481, DOI 10.1080/03610929708831995; Kulldorff M, 2006, SATSCAN SOFTWARE SPA; KUNG HC, 2008, NATL VITAL STAT REPO, V56, P9; McElreath R, 2003, CURR ANTHROPOL, V44, P122, DOI 10.1086/345689; McPherson M, 2001, ANNU REV SOCIOL, V27, P415, DOI 10.1146/annurev.soc.27.1.415; Mostashari F, 2003, EMERG INFECT DIS, V9, P641; PHILLIPS DP, 1974, AM SOCIOL REV, V39, P340, DOI 10.2307/2094294; SONNECK G, 1994, SOC SCI MED, V38, P453, DOI 10.1016/0277-9536(94)90447-2; Stack S, 2003, J EPIDEMIOL COMMUN H, V57, P238, DOI 10.1136/jech.57.4.238; STACK S, 1987, AM SOCIOL REV, V52, P401, DOI 10.2307/2095359; Stack S, 2000, SOC SCI QUART, V81, P957; Stack S, 2000, SUICIDE LIFE-THREAT, V30, P145; Stack S, 2000, SUICIDE LIFE-THREAT, V30, P163	34	61	61	0	23	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7252	10.1371/journal.pone.0007252	http://dx.doi.org/10.1371/journal.pone.0007252			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	501BO	19789643	Green Accepted, Green Published, gold			2022-12-27	WOS:000270354100014
J	Roos, AK; Eriksson, F; Timmons, JA; Gerhardt, J; Nyman, U; Gudmundsdotter, L; Brave, A; Wahren, B; Pisa, P				Roos, Anna-Karin; Eriksson, Fredrik; Timmons, James A.; Gerhardt, Josefine; Nyman, Ulrika; Gudmundsdotter, Lindvi; Brave, Andreas; Wahren, Britta; Pisa, Pavel			Skin Electroporation: Effects on Transgene Expression, DNA Persistence and Local Tissue Environment	PLOS ONE			English	Article							IN-VIVO ELECTROPORATION; GENE-EXPRESSION; PLASMID DNA; SKELETAL-MUSCLE; IMMUNE-RESPONSES; VACCINE DELIVERY; INTRAMUSCULAR INJECTION; FIREFLY LUCIFERASE; NAKED DNA; IMMUNOGENICITY	Background: Electrical pulses have been used to enhance uptake of molecules into living cells for decades. This technique, often referred to as electroporation, has become an increasingly popular method to enhance in vivo DNA delivery for both gene therapy applications as well as for delivery of vaccines against both infectious diseases and cancer. In vivo electrovaccination (gene delivery followed by electroporation) is currently being investigated in several clinical trials, including DNA delivery to healthy volunteers. However, the mode of action at molecular level is not yet fully understood. Methodology/Principal Findings: This study investigates intradermal DNA electrovaccination in detail and describes the effects on expression of the vaccine antigen, plasmid persistence and the local tissue environment. Gene profiling of the vaccination site showed that the combination of DNA and electroporation induced a significant up-regulation of proinflammatory genes. In vivo imaging of luciferase activity after electrovaccination demonstrated a rapid onset (minutes) and a long duration (months) of transgene expression. However, when the more immunogenic prostate specific antigen (PSA) was co-administered, PSA-specific T cells were induced and concurrently the luciferase expression became undetectable. Electroporation did not affect the long-term persistence of the PSA-expressing plasmid. Conclusions/Significance: This study provides important insights to how DNA delivery by intradermal electrovaccination affects the local immunological responses of the skin, transgene expression and clearance of the plasmid. As the described vaccination approach is currently being evaluated in clinical trials, the data provided will be of high significance.			Roos, AK (corresponding author), Karolinska Inst, Sci Pk, Solna, Sweden.	roos.anki@gmail.com	Timmons, James A/J-4698-2014; Timmons, James A/M-6350-2019; Nyman, Ulrika/D-3708-2013	Timmons, James A/0000-0002-2255-1220; Timmons, James A/0000-0002-2255-1220; Eriksson, Fredrik/0000-0001-9548-3276				Ahlen G, 2007, J IMMUNOL, V179, P4741, DOI 10.4049/jimmunol.179.7.4741; Babiuk S, 2004, J BIOTECHNOL, V110, P1, DOI 10.1016/j.jbiotec.2004.01.015; Babiuk S, 2003, MOL THER, V8, P992, DOI 10.1016/j.ymthe.2003.09.008; Babiuk S, 2002, VACCINE, V20, P3399, DOI 10.1016/S0264-410X(02)00269-4; Barouch DH, 2004, IMMUNOL REV, V202, P266, DOI 10.1111/j.0105-2896.2004.00200.x; Bergman PJ, 2003, CLIN CANCER RES, V9, P1284; Bins AD, 2005, NAT MED, V11, P899, DOI 10.1038/nm1264; Borish Larry C., 2003, Journal of Allergy and Clinical Immunology, V111, pS460; Chen Z, 2002, BIOCHEM BIOPH RES CO, V290, P66, DOI 10.1006/bbrc.2001.6147; Chiarella P, 2008, EXPERT OPIN BIOL TH, V8, P1645, DOI 10.1517/14712598.8.11.1645 ; Contag CH, 2000, NEOPLASIA, V2, P41, DOI 10.1038/sj.neo.7900079; Daud AI, 2008, J CLIN ONCOL, V26, P3235, DOI 10.1200/JCO.2007.13.9048; Doh SG, 1997, GENE THER, V4, P648, DOI 10.1038/sj.gt.3300460; Drabick JJ, 2001, MOL THER, V3, P249, DOI 10.1006/mthe.2000.0257; Dupuis M, 2000, J IMMUNOL, V165, P2850, DOI 10.4049/jimmunol.165.5.2850; Durieux AC, 2004, J GENE MED, V6, P809, DOI 10.1002/jgm.534; Foell D, 2007, J LEUKOCYTE BIOL, V81, P28, DOI 10.1189/jlb.0306170; Greenland JR, 2007, J IMMUNOL, V178, P5652, DOI 10.4049/jimmunol.178.9.5652; Greenland JR, 2007, VACCINE, V25, P3731, DOI 10.1016/j.vaccine.2007.01.120; Gronevik E, 2005, J GENE MED, V7, P1246, DOI 10.1002/jgm.760; Guevara-Patino JA, 2003, ADV CANCER RES, V90, P157, DOI 10.1016/S0065-230X(03)90005-4; Hakamata Y, 2006, TRANSPLANTATION, V81, P1179, DOI 10.1097/01.tp.0000203137.06587.4a; Hirao LA, 2008, VACCINE, V26, P440, DOI 10.1016/j.vaccine.2007.10.041; Hooper JW, 2007, VACCINE, V25, P1814, DOI 10.1016/j.vaccine.2006.11.017; Jeon YH, 2006, VACCINE, V24, P3057, DOI 10.1016/j.vaccine.2006.01.033; Kutzler MA, 2008, NAT REV GENET, V9, P776, DOI 10.1038/nrg2432; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Luckay A, 2007, J VIROL, V81, P5257, DOI 10.1128/JVI.00055-07; Luxembourg A, 2007, EXPERT OPIN BIOL TH, V7, P1647, DOI 10.1517/14712598.7.11.1647; Maruyama H, 2001, GENE THER, V8, P1808, DOI 10.1038/sj.gt.3301604; Medi BM, 2005, INT J PHARMACEUT, V294, P53, DOI 10.1016/j.ijpharm.2004.12.014; Mir LM, 1999, P NATL ACAD SCI USA, V96, P4262, DOI 10.1073/pnas.96.8.4262; Prud'homme GJ, 2006, CURR GENE THER, V6, P243, DOI 10.2174/156652306776359504; Rice J, 2008, NAT REV CANCER, V8, P108, DOI 10.1038/nrc2326; Rizzuto G, 1999, P NATL ACAD SCI USA, V96, P6417, DOI 10.1073/pnas.96.11.6417; Roos AK, 2006, MOL THER, V13, P320, DOI 10.1016/j.ymthe.2005.08.005; Sandstrom E, 2008, J INFECT DIS, V198, P1482, DOI 10.1086/592507; SCHIRRMACHER V, 2008, 2 INT C CANC VACC AD; Sweeney TJ, 1999, P NATL ACAD SCI USA, V96, P12044, DOI 10.1073/pnas.96.21.12044; THOMPSON JF, 1991, GENE, V103, P171, DOI 10.1016/0378-1119(91)90270-L; Tollefsen S, 2003, SCAND J IMMUNOL, V57, P229, DOI 10.1046/j.1365-3083.2003.01218.x; Tusher VG, 2001, P NATL ACAD SCI USA, V98, P5116, DOI 10.1073/pnas.091062498; Ulmer JB, 2006, TRENDS MOL MED, V12, P216, DOI 10.1016/j.molmed.2006.03.007; Wang Z, 2004, GENE THER, V11, P711, DOI 10.1038/sj.gt.3302213; Widera G, 2000, J IMMUNOL, V164, P4635, DOI 10.4049/jimmunol.164.9.4635; Wolff Jon A., 1992, Human Molecular Genetics, V1, P363, DOI 10.1093/hmg/1.6.363; Zhang L, 2002, BBA-GEN SUBJECTS, V1572, P1, DOI 10.1016/S0304-4165(02)00270-2; Zhu DL, 2002, CURR OPIN MOL THER, V4, P41	48	112	118	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7226	10.1371/journal.pone.0007226	http://dx.doi.org/10.1371/journal.pone.0007226			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789652	gold, Green Published, Green Submitted			2022-12-27	WOS:000270354100002
J	Gilbert, MM; Robinson, BS; Moberg, KH				Gilbert, M. Melissa; Robinson, Brian S.; Moberg, Kenneth H.			Functional Interactions between the erupted/tsg101 Growth Suppressor Gene and the DaPKC and rbf1 Genes in Drosophila Imaginal Disc Tumors	PLOS ONE			English	Article							NEUROBLAST SELF-RENEWAL; CELL POLARITY; FOLLICLE CELLS; NOTCH PATHWAY; CYCLIN-E; PROTEIN; PROLIFERATION; APOPTOSIS; COMPLEX; EYE	Background: The Drosophila gene erupted (ept) encodes the fly homolog of human Tumor Susceptibility Gene-101 (TSG101), which functions as part of the conserved ESCRT-1 complex to facilitate the movement of cargoes through the endolysosomal pathway. Loss of ept or other genes that encode components of the endocytic machinery (e. g. synatxin7/avalanche, rab5, and vps25) produces disorganized overgrowth of imaginal disc tissue. Excess cell division is postulated to be a primary cause of these 'neoplastic' phenotypes, but the autonomous effect of these mutations on cell cycle control has not been examined. Principal Findings: Here we show that disc cells lacking ept function display an altered cell cycle profile indicative of deregulated progression through the G1-to-S phase transition and express reduced levels of the tumor suppressor ortholog and G1/S inhibitor Rbf1. Genetic reductions of the Drosophila aPKC kinase (DaPKC), which has been shown to promote tumor growth in other fly tumor models, prevent both the ept neoplastic phenotype and the reduction in Rbf1 levels that otherwise occurs in clones of ept mutant cells; this effect is coincident with changes in localization of Notch and Crumbs, two proteins whose sorting is altered in ept mutant cells. The effect on Rbf1 can also be blocked by removal of the gamma-secretase component presenilin, suggesting that cleavage of a gamma-secretase target influences Rbf1 levels in ept mutant cells. Expression of exogenous rbf1 completely ablates ept mutant eye tissues but only mildly affects the development of discs composed of cells with wild type ept. Conclusions: Together, these data show that loss of ept alters nuclear cell cycle control in developing imaginal discs and identify the DaPKC, presenilin, and rbf1 genes as modifiers of molecular and cellular phenotypes that result from loss of ept.			Gilbert, MM (corresponding author), Emory Univ, Sch Med, Dept Cell Biol, Atlanta, GA 30322 USA.	kmoberg@cellbio.emory.edu	Moberg, Ken/J-4849-2017	Moberg, Ken/0000-0002-9820-5543; Gilbert-Ross, Melissa/0000-0002-1960-8302	NCI NIH HHS [R01 CA123368-01, R01 CA123368-03, R01 CA123368-04, R01 CA123368-05, R01 CA123368, R01 CA123368-02] Funding Source: Medline; NIGMS NIH HHS [F32 GM077898, T32 GM008169, F32-GM077898] Funding Source: Medline; NATIONAL CANCER INSTITUTE [R01CA123368] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [F32GM077898, T32GM008169] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Assemat E, 2008, BBA-BIOMEMBRANES, V1778, P614, DOI 10.1016/j.bbamem.2007.08.029; Balklava Z, 2007, NAT CELL BIOL, V9, P1066, DOI 10.1038/ncb1627; Baonza A, 2005, DEV CELL, V8, P529, DOI 10.1016/j.devcel.2005.01.019; Bilder D, 2004, GENE DEV, V18, P1909, DOI 10.1101/gad.1211604; Bishop N, 2001, J BIOL CHEM, V276, P11735, DOI 10.1074/jbc.M009863200; Childress JL, 2006, CURR BIOL, V16, P2228, DOI 10.1016/j.cub.2006.09.031; Du W, 1996, GENE DEV, V10, P1206, DOI 10.1101/gad.10.10.1206; Dyson N, 1998, GENE DEV, V12, P2245, DOI 10.1101/gad.12.15.2245; Ferres-Marco D, 2006, NATURE, V439, P430, DOI 10.1038/nature04376; Firth LC, 2005, DEV CELL, V8, P541, DOI 10.1016/j.devcel.2005.01.017; Goyal L, 2000, EMBO J, V19, P589, DOI 10.1093/emboj/19.4.589; Hariharan IK, 2006, ANNU REV GENET, V40, P335, DOI 10.1146/annurev.genet.39.073003.100738; Henrique D, 2003, CURR OPIN GENET DEV, V13, P341, DOI 10.1016/S0959-437X(03)00077-7; Herranz H, 2006, EMBO REP, V7, P297, DOI 10.1038/sj.embor.7400617; Herz HM, 2006, DEVELOPMENT, V133, P1871, DOI 10.1242/dev.02356; HOLLEY CL, 2002, NAT CELL BIOL, V14, P14; Hou XS, 1996, CELL, V84, P411, DOI 10.1016/S0092-8674(00)81286-6; Jekely G, 2003, EMBO REP, V4, P1163, DOI 10.1038/sj.embor.7400019; Katzmann DJ, 2001, CELL, V106, P145, DOI 10.1016/S0092-8674(01)00434-2; Lai EC, 2002, CURR BIOL, V12, pR74, DOI 10.1016/S0960-9822(01)00679-0; Lee CY, 2006, GENE DEV, V20, P3464, DOI 10.1101/gad.1489406; Lee CY, 2006, NATURE, V439, P594, DOI 10.1038/nature04299; Lee TM, 2001, TRENDS NEUROSCI, V24, P251, DOI 10.1016/S0166-2236(00)01791-4; Lisi S, 2000, GENETICS, V154, P669; Lloyd TE, 2002, CELL, V108, P261, DOI 10.1016/S0092-8674(02)00611-6; Lu H, 2005, NAT CELL BIOL, V7, P1232, DOI 10.1038/ncb1324; Mahoney MB, 2006, GENETICS, V172, P2309, DOI 10.1534/genetics.104.035170; Moberg KH, 2005, DEV CELL, V9, P699, DOI 10.1016/j.devcel.2005.09.018; Moberg KH, 2001, NATURE, V413, P311, DOI 10.1038/35095068; Pellock BJ, 2007, DEV BIOL, V304, P102, DOI 10.1016/j.ydbio.2006.12.021; Pignoni F, 1997, DEVELOPMENT, V124, P271; Rolls MM, 2003, J CELL BIOL, V163, P1089, DOI 10.1083/jcb.200306079; RYOO HD, 2002, NAT CELL BIOL, V20, P20; Schaeffer V, 2004, CURR BIOL, V14, P630, DOI 10.1016/j.cub.2004.03.040; Shcherbata HR, 2004, DEVELOPMENT, V131, P3169, DOI 10.1242/dev.01172; Smith CA, 2007, EMBO J, V26, P468, DOI 10.1038/sj.emboj.7601495; Sotillos S, 2004, J CELL BIOL, V166, P549, DOI 10.1083/jcb.200311031; Spradling AC, 1999, GENETICS, V153, P135; Struhl G, 2000, MOL CELL, V6, P625, DOI 10.1016/S1097-2765(00)00061-7; Struhl G, 2001, P NATL ACAD SCI USA, V98, P229, DOI 10.1073/pnas.011530298; Suzuki A, 2006, J CELL SCI, V119, P979, DOI 10.1242/jcs.02898; Thompson BJ, 2005, DEV CELL, V9, P711, DOI 10.1016/j.devcel.2005.09.020; Vaccari T, 2005, DEV CELL, V9, P687, DOI 10.1016/j.devcel.2005.09.019; Vaccari T, 2008, J CELL BIOL, V180, P755, DOI 10.1083/jcb.200708127; van den Heuvel S, 2008, NAT REV MOL CELL BIO, V9, P713, DOI 10.1038/nrm2469; Wang H, 2006, GENE DEV, V20, P3453, DOI 10.1101/gad.1487506; Wang SL, 1999, CELL, V98, P453, DOI 10.1016/S0092-8674(00)81974-1; WHITE K, 1994, SCIENCE, V264, P677, DOI 10.1126/science.8171319; WOLFF T, 1991, DEVELOPMENT, V113, P841; Yan RQ, 1996, CELL, V84, P421, DOI 10.1016/S0092-8674(00)81287-8; Yoo SJ, 2002, NAT CELL BIOL, V4, P416, DOI 10.1038/ncb793	51	7	8	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 29	2009	4	9							e7039	10.1371/journal.pone.0007039	http://dx.doi.org/10.1371/journal.pone.0007039			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	500HR	19855819	gold, Green Published			2022-12-27	WOS:000270290100001
J	Du, YCN; Klimstra, DS; Varmus, H				Du, Yi-Chieh Nancy; Klimstra, David S.; Varmus, Harold			Activation of PyMT in beta Cells Induces Irreversible Hyperplasia, but Oncogene-Dependent Acinar Cell Carcinomas When Activated in Pancreatic Progenitors	PLOS ONE			English	Article							SOMATIC MOUSE MODEL; IN-VIVO; MICE; EXPRESSION; APOPTOSIS; ANTIGEN; BIOLOGY; GROWTH; CANCER; PDX-1	It is unclear whether the cellular origin of various forms of pancreatic cancer involves transformation or transdifferentiation of different target cells or whether tumors arise from common precursors, with tumor types determined by the specific genetic alterations. Previous studies suggested that pancreatic ductal carcinomas might be induced by polyoma middle T antigen (PyMT) expressed in non-ductal cells. To ask whether PyMT transforms and transdifferentiates endocrine cells toward exocrine tumor phenotypes, we generated transgenic mice that carry tetracycline-inducible PyMT and a linked luciferase reporter. Induction of PyMT in beta cells causes beta-cell hyperplastic lesions that do not progress to malignant neoplasms. When PyMT is de-induced, beta cell proliferation and growth cease; however, regression does not occur, suggesting that continued production of PyMT is not required to maintain the viable expanded beta cell population. In contrast, induction of PyMT in early pancreatic progenitor cells under the control of Pdx1 produces acinar cell carcinomas and beta-cell hyperplasia. The survival of acinar tumor cells is dependent on continued expression of PyMT. Our findings indicate that PyMT can induce exocrine tumors from pancreatic progenitor cells, but cells in the beta cell lineage are not transdifferentiated toward exocrine cell types by PyMT; instead, they undergo oncogene-dependent hyperplastic growth, but do not require PyMT for survival.			Du, YCN (corresponding author), Mem Sloan Kettering Canc Ctr, Cell Biol & Genet Program, New York, NY 10021 USA.	duy@mskcc.org			NCI NIH HHS [P30 CA08748, P30-CA 08748, P01 CA94060, R24 CA083084, P30 CA008748, P01 CA094060, U01 CA105492, 5U01CA105492, R24 CA83084] Funding Source: Medline; NATIONAL CANCER INSTITUTE [U01CA105492, P30CA008748, P01CA094060, R24CA083084] Funding Source: NIH RePORTER	NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Berkovich I, 2001, DIABETES, V50, P2260, DOI 10.2337/diabetes.50.10.2260; Bernal-Mizrachi E, 2001, J CLIN INVEST, V108, P1631, DOI 10.1172/JCI13785; Collombat P, 2007, J CLIN INVEST, V117, P961, DOI 10.1172/JCI29115; Dilworth SM, 2002, NAT REV CANCER, V2, P951, DOI 10.1038/nrc946; Dor Y, 2004, NATURE, V429, P41, DOI 10.1038/nature02520; Edlund H, 2002, NAT REV GENET, V3, P524, DOI 10.1038/nrg841; GITTES GK, 1992, P NATL ACAD SCI USA, V89, P1128, DOI 10.1073/pnas.89.3.1128; Gottlieb KA, 2001, MICROBIOL MOL BIOL R, V65, P288, DOI 10.1128/MMBR.65.2.288-318.2001; Gunther EJ, 2003, GENE DEV, V17, P488, DOI 10.1101/gad.1051603; HANAHAN D, 1985, NATURE, V315, P115, DOI 10.1038/315115a0; Hezel AF, 2006, GENE DEV, V20, P1218, DOI 10.1101/gad.1415606; Hingorani SR, 2003, CANCER CELL, V4, P437, DOI 10.1016/S1535-6108(03)00309-X; Holland AM, 2002, P NATL ACAD SCI USA, V99, P12236, DOI 10.1073/pnas.192255099; JONSSON J, 1994, NATURE, V371, P606, DOI 10.1038/371606a0; Klimstra DS, 2007, MODERN PATHOL, V20, pS94, DOI 10.1038/modpathol.3800686; KLIMSTRA DS, 1992, AM J SURG PATHOL, V16, P815, DOI 10.1097/00000478-199209000-00001; Lewis BC, 2005, MOL CELL BIOL, V25, P1228, DOI 10.1128/MCB.25.4.1228-1237.2005; Lewis BC, 2003, GENE DEV, V17, P3127, DOI 10.1101/gad.1140403; LUDLOW JW, 1993, FASEB J, V7, P866, DOI 10.1096/fasebj.7.10.8344486; Milo-Landesman D, 2001, CELL TRANSPLANT, V10, P645; Naik P, 1996, GENE DEV, V10, P2105, DOI 10.1101/gad.10.17.2105; Nguyen KTT, 2006, MOL CELL BIOL, V26, P4511, DOI 10.1128/MCB.00238-06; PASSMAN RS, 1994, J CLIN INVEST, V94, P2421, DOI 10.1172/JCI117609; Pelengaris S, 2002, CELL, V109, P321, DOI 10.1016/S0092-8674(02)00738-9; Podsypanina K, 2008, SCIENCE, V321, P1841, DOI 10.1126/science.1161621; Shih DQ, 2002, P NATL ACAD SCI USA, V99, P3818, DOI 10.1073/pnas.062605899; Stiles BL, 2006, MOL CELL BIOL, V26, P2772, DOI 10.1128/MCB.26.7.2772-2781.2006; Tuttle RL, 2001, NAT MED, V7, P1133, DOI 10.1038/nm1001-1133; Varmus H, 2005, COLD SH Q B, V70, P1, DOI 10.1101/sqb.2005.70.039; Weinstein IB, 2008, CANCER RES, V68, P3077, DOI 10.1158/0008-5472.CAN-07-3293; Weinstein IB, 2008, CANCER RES, V68, P3086; Wu KL, 1997, MOL CELL BIOL, V17, P6002, DOI 10.1128/MCB.17.10.6002; YOSHIDA T, 1994, AM J PATHOL, V145, P671; Zhou Q, 2008, NATURE, V455, P627, DOI 10.1038/nature07314	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 7	2009	4	9							e6932	10.1371/journal.pone.0006932	http://dx.doi.org/10.1371/journal.pone.0006932			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	491ZH	19812721	gold, Green Published, Green Submitted			2022-12-27	WOS:000269622300015
J	Girasol, A; Albuquerque, GG; Mansour, E; Araujo, EP; Degasperi, G; Denis, RG; Carvalheira, JB; Saad, MJ; Velloso, LA				Girasol, Alessandra; Albuquerque, Gabriela G.; Mansour, Eli; Araujo, Eliana P.; Degasperi, Giovanna; Denis, Raphael G.; Carvalheira, Jose B.; Saad, Mario J.; Velloso, Licio A.			Fyn Mediates Leptin Actions in the Thymus of Rodents	PLOS ONE			English	Article							PERIPHERAL T-CELLS; IMMUNE-RESPONSE; RECEPTOR; ACTIVATION; HYPOTHALAMUS; IMMUNOLOGY; RESISTANCE; NUTRITION; PATHWAYS; P59(FYN)	Background: Several effects of leptin in the immune system rely on its capacity to modulate cytokine expression and apoptosis in the thymus. Surprisingly, some of these effects are dependent on signal transduction through the IRS1/PI3-kinase, but not on the activation of JAK2. Since all the well known effects of leptin in different cell types and tissues seem to be dependent on JAK2 activation, we hypothesized that, at least for the control of thymic function, another, unknown kinase could mediate the transduction of the leptin signal from the ObR towards the IRS1/PI3-kinase signaling cascade. Methodology/Principal Findings: Here, by employing immunoblot, real-time PCR and flow citometry we show that the tyrosine kinase, Fyn, is constitutively associated with the ObR in thymic cells. Following a leptin stimulus, Fyn undergoes an activating tyrosine phosphorylation and a transient association with IRS1. All these effects are independent of JAK2 activation and, upon Fyn inhibition, the signal transduction towards IRS1/PI3-kinase is abolished. In addition, the inhibition of Fyn significantly modifies the effects of leptin on thymic cytokine expression. Conclusion /Significance: Therefore, in the thymus, Fyn acts as a tyrosine kinase that transduces the leptin signal independently of JAK2 activation, and mediates some of the immunomodulatory effects of leptin in this tissue.			Girasol, A (corresponding author), Univ Estadual Campinas, Dept Internal Med, Campinas, SP, Brazil.	lavelloso@fcm.unicamp.br	Araujo, EP/D-9231-2013; Carvalheira, Jose B/H-8405-2012; Carvalheira, Jose Barreto Campello/E-8562-2013; Saad, Mario/ABD-8262-2020; Velloso, Licio/AAJ-3778-2020; Mansour, Eli/AAD-2841-2019; Vercesi, Aníbal E/C-8767-2012; Degasperi, G/V-3451-2018; Denis, Raphael/ABE-1758-2020	Araujo, EP/0000-0002-7539-8477; Carvalheira, Jose Barreto Campello/0000-0002-0136-0943; Mansour, Eli/0000-0001-6450-6930; Degasperi, G/0000-0002-0317-2532; Denis, Raphael/0000-0002-7677-7460				Ahluwalia N, 2004, J Nutr Health Aging, V8, P2; Banks AS, 2000, J BIOL CHEM, V275, P14563, DOI 10.1074/jbc.275.19.14563; BOYUM A, 1976, SCAND J IMMUNOL, P9, DOI 10.1111/j.1365-3083.1976.tb03851.x; Brumatti G, 2003, FEBS LETT, V541, P57, DOI 10.1016/S0014-5793(03)00299-0; Carvalheira JBC, 2001, FEBS LETT, V500, P119, DOI 10.1016/S0014-5793(01)02591-1; Chung WK, 1996, GENOME RES, V6, P431, DOI 10.1101/gr.6.5.431; Degasperi GR, 2006, EUR J PHARMACOL, V549, P179, DOI 10.1016/j.ejphar.2006.08.027; Farooqi IS, 2002, J CLIN INVEST, V110, P1093, DOI 10.1172/JCI200215693; Fernandes G, 2008, IMMUNOL RES, V40, P244, DOI 10.1007/s12026-007-0021-3; Flier JS, 1998, NAT MED, V4, P1124, DOI 10.1038/2619; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Gasparetti AL, 2003, J PHYSIOL-LONDON, V552, P149, DOI 10.1113/jphysiol.2003.050369; Howard JK, 1999, J CLIN INVEST, V104, P1051, DOI 10.1172/JCI6762; Jiang L, 2008, J BIOL CHEM, V283, P28066, DOI 10.1074/jbc.M805545200; Kellerer M, 1997, DIABETOLOGIA, V40, P1358, DOI 10.1007/s001250050832; Kloek C, 2002, J BIOL CHEM, V277, P41547, DOI 10.1074/jbc.M205148200; La Cava A, 2004, NAT REV IMMUNOL, V4, P371, DOI 10.1038/nri1350; Lesourd BM, 1998, NUTR REV, V56, pS113; Lord GM, 1998, NATURE, V394, P897, DOI 10.1038/29795; Mansour E, 2006, ENDOCRINOLOGY, V147, P5470, DOI 10.1210/en.2006-0223; Matarese G, 2005, J IMMUNOL, V174, P3137, DOI 10.4049/jimmunol.174.6.3137; Matarese G, 2001, J IMMUNOL, V166, P5909, DOI 10.4049/jimmunol.166.10.5909; Munzberg H, 2005, NAT NEUROSCI, V8, P566, DOI 10.1038/nn1454; Myers MG, 2008, ANNU REV PHYSIOL, V70, P537, DOI 10.1146/annurev.physiol.70.113006.100707; OLSZOWY MW, 1995, J IMMUNOL, V155, P4236; Salmond RJ, 2009, IMMUNOL REV, V228, P9, DOI 10.1111/j.1600-065X.2008.00745.x; Savino W, 2007, BRIT J NUTR, V98, pS11, DOI 10.1017/S0007114507832880; STEIN PL, 1992, CELL, V70, P741, DOI 10.1016/0092-8674(92)90308-Y; Taga T, 1997, ANNU REV IMMUNOL, V15, P797, DOI 10.1146/annurev.immunol.15.1.797; Tartaglia LA, 1997, J BIOL CHEM, V272, P6093, DOI 10.1074/jbc.272.10.6093; Utting O, 1998, J IMMUNOL, V160, P5410; Valdes-Ramos R, 2007, BRIT J NUTR, V98, pS127, DOI 10.1017/S0007114507833009; Velloso LA, 2008, NEUROIMMUNOMODULAT, V15, P189, DOI 10.1159/000153423; Velloso LA, 2009, ANN NY ACAD SCI, V1153, P29, DOI 10.1111/j.1749-6632.2008.03973.x	34	10	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2009	4	11							e7707	10.1371/journal.pone.0007707	http://dx.doi.org/10.1371/journal.pone.0007707			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RY	19888448	Green Submitted, Green Published, gold			2022-12-27	WOS:000271414500009
J	Meybohm, P; Gruenewald, M; Albrecht, M; Zacharowski, KD; Lucius, R; Zitta, K; Koch, A; Tran, N; Scholz, J; Bein, B				Meybohm, Patrick; Gruenewald, Matthias; Albrecht, Martin; Zacharowski, Kai D.; Lucius, Ralph; Zitta, Karina; Koch, Alexander; Tran, Nguyen; Scholz, Jens; Bein, Berthold			Hypothermia and Postconditioning after Cardiopulmonary Resuscitation Reduce Cardiac Dysfunction by Modulating Inflammation, Apoptosis and Remodeling	PLOS ONE			English	Article							PERCUTANEOUS CORONARY INTERVENTION; MYOCARDIAL ISCHEMIA-REPERFUSION; AMERICAN-HEART-ASSOCIATION; COMATOSE SURVIVORS; STROKE FOUNDATION; CRITICAL-CARE; ARREST; INFARCTION; MODEL; CARDIOLOGY	Background: Mild therapeutic hypothermia following cardiac arrest is neuroprotective, but its effect on myocardial dysfunction that is a critical issue following resuscitation is not clear. This study sought to examine whether hypothermia and the combination of hypothermia and pharmacological postconditioning are cardioprotective in a model of cardiopulmonary resuscitation following acute myocardial ischemia. Methodology/Principal Findings: Thirty pigs (28-34 kg) were subjected to cardiac arrest following left anterior descending coronary artery ischemia. After 7 minutes of ventricular fibrillation and 2 minutes of basic life support, advanced cardiac life support was started according to the current AHA guidelines. After successful return of spontaneous circulation (n = 21), coronary perfusion was reestablished after 60 minutes of occlusion, and animals were randomized to either normothermia at 38 degrees C, hypothermia at 33 degrees C or hypothermia at 33 degrees C combined with sevoflurane (each group n = 7) for 24 hours. The effects on cardiac damage especially on inflammation, apoptosis, and remodeling were studied using cellular and molecular approaches. Five animals were sham operated. Animals treated with hypothermia had lower troponin T levels (p<0.01), reduced infarct size (34 +/- 7 versus 57 +/- 12%; p<0.05) and improved left ventricular function compared to normothermia (p<0.05). Hypothermia was associated with a reduction in: (i) immune cell infiltration, (ii) apoptosis, (iii) IL-1 beta and IL-6 mRNA up-regulation, and (iv) IL-1 beta protein expression (p<0.05). Moreover, decreased matrix metalloproteinase-9 activity was detected in the ischemic myocardium after treatment with mild hypothermia. Sevoflurane conferred additional protective effects although statistic significance was not reached. Conclusions/Significance: Hypothermia reduced myocardial damage and dysfunction after cardiopulmonary resuscitation possible via a reduced rate of apoptosis and pro-inflammatory cytokine expression.			Meybohm, P (corresponding author), Univ Hosp Schleswig Holstein, Dept Anaesthesiol & Intens Care Med, Kiel, Germany.	meybohm@anaesthesie.uni-kiel.de	Albrecht, Martin/AAW-9303-2021; Lucius, Ralph/B-1614-2010; Meybohm, Patrick/K-4066-2017; Gruenewald, Matthias/F-9485-2012	Albrecht, Martin/0000-0003-2580-768X; Meybohm, Patrick/0000-0002-2666-8696; 				Abbate A, 2002, J CELL PHYSIOL, V193, P145, DOI 10.1002/jcp.10174; Abbate A, 2008, CIRCULATION, V117, P2670, DOI 10.1161/CIRCULATIONAHA.107.740233; Adrie C, 2002, CIRCULATION, V106, P562, DOI 10.1161/01.CIR.0000023891.80661.AD; Bein B, 2005, ANESTH ANALG, V100, P610, DOI 10.1213/01.ANE.0000145012.27484.A7; Bernard SA, 2002, NEW ENGL J MED, V346, P557, DOI 10.1056/NEJMoa003289; Bolli R, 2004, CIRC RES, V95, P125, DOI 10.1161/01.RES.0000137171.97172.d7; Bujak M, 2008, AM J PATHOL, V173, P57, DOI 10.2353/ajpath.2008.070974; deVreedeSwagemakers JJM, 1997, J AM COLL CARDIOL, V30, P1500, DOI 10.1016/S0735-1097(97)00355-0; Dixon SR, 2002, J AM COLL CARDIOL, V40, P1928, DOI 10.1016/S0735-1097(02)02567-6; Hale SL, 1997, BASIC RES CARDIOL, V92, P351, DOI 10.1007/BF00788947; Holzer M, 2005, CRIT CARE MED, V33, P414, DOI 10.1097/01.CCM.0000153410.87750.53; Holzer M, 2008, BEST PRACT RES-CLIN, V22, P711, DOI 10.1016/j.bpa.2008.02.001; Idris AH, 1996, CIRCULATION, V94, P2324, DOI 10.1161/01.CIR.94.9.2324; KELLEY KW, 1973, J ANIM SCI, V36, P927; KERN KB, 1990, AM HEART J, V120, P324, DOI 10.1016/0002-8703(90)90076-A; KLEINER DE, 1994, ANAL BIOCHEM, V218, P325, DOI 10.1006/abio.1994.1186; Koreny M, 2009, RESUSCITATION, V80, P56, DOI 10.1016/j.resuscitation.2008.08.019; Lange M, 2009, ANESTHESIOLOGY, V110, P516, DOI 10.1097/ALN.0b013e318197ff62; Laurent I, 2002, J AM COLL CARDIOL, V40, P2110, DOI 10.1016/S0735-1097(02)02594-9; Ly HQ, 2005, AM HEART J, V150, DOI 10.1016/j.ahj.200502.049; Neumar RW, 2008, CIRCULATION, V118, P2452, DOI 10.1161/CIRCULATIONAHA.108.190652; Oddo M, 2008, CRIT CARE MED, V36, P2296, DOI 10.1097/CCM.0b013e3181802599; Pell JP, 2003, HEART, V89, P839, DOI 10.1136/heart.89.8.839; RASHEED S, 1974, CANCER, V33, P1027, DOI 10.1002/1097-0142(197404)33:4<1027::AID-CNCR2820330419>3.0.CO;2-Z; Ren Guofeng, 2003, Current Drug Targets - Inflammation and Allergy, V2, P242, DOI 10.2174/1568010033484098; Riess ML, 2002, ANESTH ANALG, V95, P1540, DOI 10.1097/00000539-200212000-00013; Roesner JP, 2007, CRIT CARE MED, V35, P1730, DOI 10.1097/01.CCM.0000269035.30231.76; Spinale FG, 2007, PHYSIOL REV, V87, P1285, DOI 10.1152/physrev.00012.2007; Stangl V, 2002, CARDIOVASC RES, V53, P12, DOI 10.1016/S0008-6363(01)00420-5; Tortorici MA, 2007, CRIT CARE MED, V35, P2196, DOI 10.1097/01.CCM.0000281517.97507.6E; Tsai MS, 2008, J AM COLL CARDIOL, V51, P1988, DOI 10.1016/j.jacc.2007.12.057; von Bismarck P, 2007, CRIT CARE MED, V35, P2309, DOI 10.1097/01.CCM.0000281472.47067.45; Weber NC, 2005, BEST PRACT RES-CLIN, V19, P429, DOI 10.1016/j.bpa.2005.02.003; Wolfrum S, 2008, CRIT CARE MED, V36, P1780, DOI 10.1097/CCM.0b013e31817437ca; Xu TY, 2008, RESUSCITATION, V76, P103, DOI 10.1016/j.resuscitation.2007.06.004; Zhao ZQ, 2003, AM J PHYSIOL-HEART C, V285, pH579, DOI 10.1152/ajpheart.01064.2002	36	59	68	0	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7588	10.1371/journal.pone.0007588	http://dx.doi.org/10.1371/journal.pone.0007588			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855846	Green Published, gold, Green Submitted			2022-12-27	WOS:000271147200011
J	Gobeske, KT; Das, S; Bonaguidi, MA; Weiss, C; Radulovic, J; Disterhoft, JF; Kessler, JA				Gobeske, Kevin T.; Das, Sunit; Bonaguidi, Michael A.; Weiss, Craig; Radulovic, Jelena; Disterhoft, John F.; Kessler, John A.			BMP Signaling Mediates Effects of Exercise on Hippocampal Neurogenesis and Cognition in Mice	PLOS ONE			English	Article							BONE MORPHOGENETIC PROTEINS; ENDOTHELIAL GROWTH-FACTOR; NEWLY GENERATED NEURONS; LONG-TERM POTENTIATION; NEURAL STEM-CELLS; RAT DENTATE GYRUS; ENHANCED SYNAPTIC PLASTICITY; SPATIAL WORKING-MEMORY; ANXIETY-LIKE BEHAVIOR; MORRIS WATER MAZE	Exposure to exercise or to environmental enrichment increases the generation of new neurons in the adult hippocampus and promotes certain kinds of learning and memory. While the precise role of neurogenesis in cognition has been debated intensely, comparatively few studies have addressed the mechanisms linking environmental exposures to cellular and behavioral outcomes. Here we show that bone morphogenetic protein (BMP) signaling mediates the effects of exercise on neurogenesis and cognition in the adult hippocampus. Elective exercise reduces levels of hippocampal BMP signaling before and during its promotion of neurogenesis and learning. Transgenic mice with decreased BMP signaling or wild type mice infused with a BMP inhibitor both exhibit remarkable gains in hippocampal cognitive performance and neurogenesis, mirroring the effects of exercise. Conversely, transgenic mice with increased BMP signaling have diminished hippocampal neurogenesis and impaired cognition. Exercise exposure does not rescue these deficits, suggesting that reduced BMP signaling is required for environmental effects on neurogenesis and learning. Together, these observations show that BMP signaling is a fundamental mechanism linking environmental exposure with changes in cognitive function and cellular properties in the hippocampus.			Gobeske, KT (corresponding author), Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA.	kgobeske@md.northwestern.edu	Weiss, Craig/K-8910-2018; Das, Sunit/J-3903-2015	Das, Sunit/0000-0002-2146-4168; Radulovic, Jelena/0000-0002-0268-2426; Disterhoft, John/0000-0002-8817-7913	NIA NIH HHS [R01 AG017139, R37 AG008796] Funding Source: Medline; NIMH NIH HHS [R01 MH047340, R01 MH078064] Funding Source: Medline; NINDS NIH HHS [R01 NS020013-26, R01 NS020778-26, R01 NS020778, R01 NS020013] Funding Source: Medline; NATIONAL INSTITUTE OF MENTAL HEALTH [R01MH047340, R01MH078064] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE [R01NS020013, R01NS020778] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGING [R37AG008796, R01AG017139] Funding Source: NIH RePORTER	NIA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)); NIMH NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NINDS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE OF MENTAL HEALTH(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH)); NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS)); NATIONAL INSTITUTE ON AGING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA))		Aberg MAI, 2003, MOL CELL NEUROSCI, V24, P23, DOI 10.1016/S1044-7431(03)00082-4; Adlard PA, 2005, NEUROBIOL AGING, V26, P511, DOI 10.1016/j.neurobiolaging.2004.05.006; Aimone JB, 2009, NEURON, V61, P187, DOI 10.1016/j.neuron.2008.11.026; Baines RA, 2004, J NEUROSCI, V24, P6904, DOI 10.1523/JNEUROSCI.1978-04.2004; Bakker A, 2008, SCIENCE, V319, P1640, DOI 10.1126/science.1152882; Bartkowska K, 2007, DEVELOPMENT, V134, P4369, DOI 10.1242/dev.008227; Baruch DE, 2004, BEHAV NEUROSCI, V118, P1123, DOI 10.1037/0735-7044.118.5.1123; Bauer S, 2006, J NEUROSCI, V26, P12089, DOI 10.1523/JNEUROSCI.3047-06.2006; Becker S, 2005, HIPPOCAMPUS, V15, P722, DOI 10.1002/hipo.20095; Becker S, 2007, TRENDS COGN SCI, V11, P70, DOI 10.1016/j.tics.2006.10.013; Bergami M, 2008, P NATL ACAD SCI USA, V105, P15570, DOI 10.1073/pnas.0803702105; Bonaguidi MA, 2005, DEVELOPMENT, V132, P5503, DOI 10.1242/dev.02166; Bonaguidi MA, 2008, J NEUROSCI, V28, P9194, DOI 10.1523/JNEUROSCI.3314-07.2008; Branchi Igor, 2004, Ann Ist Super Sanita, V40, P231; Brown J, 2003, EUR J NEUROSCI, V17, P2042, DOI 10.1046/j.1460-9568.2003.02647.x; Bruel-Jungerman E, 2005, EUR J NEUROSCI, V21, P513, DOI 10.1111/j.1460-9568.2005.03875.x; Burghardt PR, 2006, PHARMACOL BIOCHEM BE, V84, P306, DOI 10.1016/j.pbb.2006.05.015; Cao L, 2004, NAT GENET, V36, P827, DOI 10.1038/ng1395; Carro E, 2000, J NEUROSCI, V20, P2926; Chambers RA, 2007, J COGNITIVE NEUROSCI, V19, P1, DOI 10.1162/jocn.2007.19.1.1; Chmielnicki E, 2004, J NEUROSCI, V24, P2133, DOI 10.1523/JNEUROSCI.1554-03.2004; Clark PJ, 2008, NEUROSCIENCE, V155, P1048, DOI 10.1016/j.neuroscience.2008.06.051; Colak D, 2008, J NEUROSCI, V28, P434, DOI 10.1523/JNEUROSCI.4374-07.2008; Crandall J, 2004, P NATL ACAD SCI USA, V101, P5111, DOI 10.1073/pnas.0306336101; Deisseroth K, 2004, NEURON, V42, P535, DOI 10.1016/S0896-6273(04)00266-1; Denise A, 2004, NAT NEUROSCI, V7, P1233, DOI 10.1038/nn1340; Derynck R, 2003, NATURE, V425, P577, DOI 10.1038/nature02006; Ding Q, 2006, NEUROSCIENCE, V140, P823, DOI 10.1016/j.neuroscience.2006.02.084; Doetsch F, 1997, J NEUROSCI, V17, P5046; Drapeau E, 2003, P NATL ACAD SCI USA, V100, P14385, DOI 10.1073/pnas.2334169100; Dupret D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001959; Ehninger D, 2006, GENES BRAIN BEHAV, V5, P29, DOI 10.1111/j.1601-183X.2005.00129.x; Esposito MS, 2005, J NEUROSCI, V25, P10074, DOI 10.1523/JNEUROSCI.3114-05.2005; Fabel K, 2003, EUR J NEUROSCI, V18, P2803, DOI 10.1111/j.1460-9568.2003.03041.x; Fabel K, 2008, NEUROMOL MED, V10, P59, DOI 10.1007/s12017-008-8031-4; FAN X, 2003, BRAIN RES BRAIN RES, V13, P99; Fan XT, 2004, BRAIN RES PROTOC, V13, P99, DOI 10.1016/j.brainresprot.2004.01.005; Fan Y, 2007, EUR J NEUROSCI, V25, P38, DOI 10.1111/j.1460-9568.2006.05269.x; Farioli-Vecchioli S, 2008, PLOS BIOL, V6, P2188, DOI 10.1371/journal.pbio.0060246; FORSSPETTER S, 1990, NEURON, V5, P187, DOI 10.1016/0896-6273(90)90308-3; Galvao RP, 2008, J NEUROSCI, V28, P13368, DOI 10.1523/JNEUROSCI.2918-08.2008; Ge SY, 2007, NEURON, V54, P559, DOI 10.1016/j.neuron.2007.05.002; Ge SY, 2006, NATURE, V439, P589, DOI 10.1038/nature04404; Gerlai R, 2001, BEHAV BRAIN RES, V125, P269, DOI 10.1016/S0166-4328(01)00296-0; Gomes WA, 2003, DEV BIOL, V255, P164, DOI 10.1016/S0012-1606(02)00037-4; Goodrich-Hunsaker NJ, 2008, BEHAV NEUROSCI, V122, P16, DOI 10.1037/0735-7044.122.1.16; Gorski JA, 2003, NEUROSCIENCE, V121, P341, DOI 10.1016/S0306-4522(03)00426-3; Gross RE, 1996, NEURON, V17, P595, DOI 10.1016/S0896-6273(00)80193-2; Guha U, 2004, AM J PATHOL, V165, P729, DOI 10.1016/S0002-9440(10)63336-6; Gutierrez R, 2003, J NEUROSCI, V23, P5594; Hastings NB, 1999, J COMP NEUROL, V413, P146, DOI 10.1002/(SICI)1096-9861(19991011)413:1<146::AID-CNE10>3.0.CO;2-B; Heldt SA, 2007, MOL PSYCHIATR, V12, P656, DOI 10.1038/sj.mp.4001957; Hernandez-Rabaza V, 2009, NEUROSCIENCE, V159, P59, DOI 10.1016/j.neuroscience.2008.11.054; Holick KA, 2008, NEUROPSYCHOPHARMACOL, V33, P406, DOI 10.1038/sj.npp.1301399; Hsieh J, 2004, J CELL BIOL, V164, P111, DOI 10.1083/jcb.200308101; Hunsaker MR, 2008, HIPPOCAMPUS, V18, P1064, DOI 10.1002/hipo.20464; Ide Y, 2008, EUR J NEUROSCI, V28, P2381, DOI 10.1111/j.1460-9568.2008.06548.x; Imayoshi I, 2008, NAT NEUROSCI, V11, P1153, DOI 10.1038/nn.2185; JACKSON WJ, 1969, J COMP PHYSIOL PSYCH, V68, P442, DOI 10.1037/h0027502; Jessberger S, 2009, LEARN MEMORY, V16, P147, DOI 10.1101/lm.1172609; Jin KL, 2002, P NATL ACAD SCI USA, V99, P11946, DOI 10.1073/pnas.182296499; Jones SP, 2003, HIPPOCAMPUS, V13, P413, DOI 10.1002/hipo.10121; Kempermann G, 1998, J NEUROSCI, V18, P3206; Kempermann G, 2003, DEVELOPMENT, V130, P391, DOI 10.1242/dev.00203; Kempermann G, 1997, NATURE, V386, P493, DOI 10.1038/386493a0; Kempermann G, 2002, EUR J NEUROSCI, V16, P129, DOI 10.1046/j.1460-9568.2002.02042.x; Kim BW, 2008, CELL SIGNAL, V20, P714, DOI 10.1016/j.cellsig.2007.12.009; Kovalchuk Y, 2002, SCIENCE, V295, P1729, DOI 10.1126/science.1067766; Kronenberg G, 2003, J COMP NEUROL, V467, P455, DOI 10.1002/cne.10945; Kuhn HG, 1996, J NEUROSCI, V16, P2027; Laplagne DA, 2006, PLOS BIOL, V4, P2349, DOI 10.1371/journal.pbio.0040409; Laplagne DA, 2007, EUR J NEUROSCI, V25, P2973, DOI 10.1111/j.1460-9568.2007.05549.x; Lee I, 2005, BEHAV NEUROSCI, V119, P145, DOI 10.1037/0735-7044.119.1.145; Lee I, 2004, HIPPOCAMPUS, V14, P66, DOI 10.1002/hipo.10167; Leutgeb JK, 2007, SCIENCE, V315, P961, DOI 10.1126/science.1135801; Leutgeb S, 2005, SCIENCE, V309, P619, DOI 10.1126/science.1114037; Li Y, 2008, NEURON, V59, P399, DOI 10.1016/j.neuron.2008.06.023; Lichtenwalner RJ, 2001, NEUROSCIENCE, V107, P603, DOI 10.1016/S0306-4522(01)00378-5; Lim DA, 2000, NEURON, V28, P713, DOI 10.1016/S0896-6273(00)00148-3; Madsen TM, 2003, NEUROSCIENCE, V119, P635, DOI 10.1016/S0306-4522(03)00199-4; Massague J, 2000, GENE DEV, V14, P627; McCloskey DP, 2005, J NEUROSCI, V25, P8889, DOI 10.1523/JNEUROSCI.2577-05.2005; McHugh TJ, 2007, SCIENCE, V317, P94, DOI 10.1126/science.1140263; Mehler MF, 2000, DEV NEUROSCI-BASEL, V22, P74, DOI 10.1159/000017429; Meltzer LA, 2005, TRENDS NEUROSCI, V28, P653, DOI 10.1016/j.tins.2005.09.007; Meshi D, 2006, NAT NEUROSCI, V9, P729, DOI 10.1038/nn1696; Messaoudi E, 2002, J NEUROSCI, V22, P7453; Minichiello L, 1999, NEURON, V24, P401, DOI 10.1016/S0896-6273(00)80853-3; Nakashiba T, 2008, SCIENCE, V319, P1260, DOI 10.1126/science.1151120; Niewoehner B, 2007, EUR J NEUROSCI, V25, P837, DOI 10.1111/j.1460-9568.2007.05312.x; Nilsson M, 1999, J NEUROBIOL, V39, P569, DOI 10.1002/(SICI)1097-4695(19990615)39:4<569::AID-NEU10>3.0.CO;2-F; Nohe A, 2002, J BIOL CHEM, V277, P5330, DOI 10.1074/jbc.M102750200; NOHNO T, 1995, J BIOL CHEM, V270, P22522, DOI 10.1074/jbc.270.38.22522; O'Callaghan RM, 2007, BEHAV BRAIN RES, V176, P362, DOI 10.1016/j.bbr.2006.10.018; Peretto P, 2004, NEUROSCIENCE, V128, P685, DOI 10.1016/j.neuroscience.2004.06.053; Raber J, 2004, RADIAT RES, V162, P39, DOI 10.1667/RR3206; Rossi C, 2006, EUR J NEUROSCI, V24, P1850, DOI 10.1111/j.1460-9568.2006.05059.x; Samanta J, 2004, DEVELOPMENT, V131, P4131, DOI 10.1242/dev.01273; Saxe MD, 2007, P NATL ACAD SCI USA, V104, P4642, DOI 10.1073/pnas.0611718104; Saxe MD, 2006, P NATL ACAD SCI USA, V103, P17501, DOI 10.1073/pnas.0607207103; Scharfman HE., 2007, DENTATE GYRUS COMPRE; Schmidt-Hieber C, 2004, NATURE, V429, P184, DOI 10.1038/nature02553; Seidenbecher T, 2003, SCIENCE, V301, P846, DOI 10.1126/science.1085818; Seri B, 2004, J COMP NEUROL, V478, P359, DOI 10.1002/cne.20288; Shaw KN, 2003, EUR J NEUROSCI, V17, P2438, DOI 10.1046/j.1460-9568.2003.02643.x; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Singer BH, 2009, J COMP NEUROL, V514, P567, DOI 10.1002/cne.22052; Sirn FJ, 2006, ANN NEUROL, V59, P763, DOI 10.1002/ana.20812; Snyder JS, 2001, J NEUROPHYSIOL, V85, P2423, DOI 10.1152/jn.2001.85.6.2423; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Steiner B, 2006, GLIA, V54, P805, DOI 10.1002/glia.20407; Suh H, 2007, CELL STEM CELL, V1, P515, DOI 10.1016/j.stem.2007.09.002; Sun M, 2007, J NEUROSCI, V27, P7740, DOI 10.1523/JNEUROSCI.1604-07.2007; Suzuki S, 2007, J NEUROSCI, V27, P6417, DOI 10.1523/JNEUROSCI.0690-07.2007; THURET S, 2009, HIPPOCAMPUS DEPENDEN; Trejo JL, 2008, MOL CELL NEUROSCI, V37, P402, DOI 10.1016/j.mcn.2007.10.016; Trejo JL, 2001, J NEUROSCI, V21, P1628, DOI 10.1523/JNEUROSCI.21-05-01628.2001; Trouche S, 2009, P NATL ACAD SCI USA, V106, P5919, DOI 10.1073/pnas.0811054106; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Van Dam D, 2006, NEUROBIOL LEARN MEM, V85, P164, DOI 10.1016/j.nlm.2005.09.006; Van der Borght K, 2007, BEHAV NEUROSCI, V121, P324, DOI 10.1037/0735-7044.121.2.324; van Praag H, 1999, P NATL ACAD SCI USA, V96, P13427, DOI 10.1073/pnas.96.23.13427; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Vaynman S, 2004, EUR J NEUROSCI, V20, P2580, DOI 10.1111/j.1460-9568.2004.03720.x; Vaynman S, 2003, NEUROSCIENCE, V122, P647, DOI 10.1016/j.neuroscience.2003.08.001; Vega CJ, 2005, NAT METHODS, V2, P167, DOI 10.1038/NMETH741; Wadiche LO, 2005, J NEUROPHYSIOL, V94, P4528, DOI 10.1152/jn.00633.2005; Walker TL, 2008, J NEUROSCI, V28, P5240, DOI 10.1523/JNEUROSCI.0344-08.2008; Wang LP, 2005, MOL CELL NEUROSCI, V29, P181, DOI 10.1016/j.mcn.2005.02.002; Wiskott L, 2006, HIPPOCAMPUS, V16, P329, DOI 10.1002/hipo.20167; Zhang CL, 2008, NATURE, V451, P1004, DOI 10.1038/nature06562; Zhao CM, 2008, CELL, V132, P645, DOI 10.1016/j.cell.2008.01.033; Zigova T, 1998, MOL CELL NEUROSCI, V11, P234, DOI 10.1006/mcne.1998.0684	134	79	80	1	13	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 20	2009	4	10							e7506	10.1371/journal.pone.0007506	http://dx.doi.org/10.1371/journal.pone.0007506			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	509JT	19841742	gold, Green Submitted, Green Published			2022-12-27	WOS:000271012900011
J	De la Fuente, IM; Vadillo, F; Perez-Pinilla, MB; Vera-Lopez, A; Veguillas, J				De la Fuente, Ildefonso M.; Vadillo, Fernando; Perez-Pinilla, Martin-Blas; Vera-Lopez, Antonio; Veguillas, Juan			The Number of Catalytic Elements Is Crucial for the Emergence of Metabolic Cores	PLOS ONE			English	Article							PANCREATIC BETA-CELL; SACCHAROMYCES-CEREVISIAE; AUTONOMOUS OSCILLATIONS; YEAST; EXPRESSION; CYCLE; CA2+; MITOCHONDRIA; ORGANIZATION; GLYCOLYSIS	Background: Different studies show evidence that several unicellular organisms display a cellular metabolic structure characterized by a set of enzymes which are always in an active state (metabolic core), while the rest of the molecular catalytic reactions exhibit on-off changing states. This self-organized enzymatic configuration seems to be an intrinsic characteristic of metabolism, common to all living cellular organisms. In a recent analysis performed with dissipative metabolic networks (DMNs) we have shown that this global functional structure emerges in metabolic networks with a relatively high number of catalytic elements, under particular conditions of enzymatic covalent regulatory activity. Methodology/Principal Findings: Here, to investigate the mechanism behind the emergence of this supramolecular organization of enzymes, we have performed extensive DMNs simulations (around 15,210,000 networks) taking into account the proportion of the allosterically regulated enzymes and covalent enzymes present in the networks, the variation in the number of substrate fluxes and regulatory signals per catalytic element, as well as the random selection of the catalytic elements that receive substrate fluxes from the exterior. The numerical approximations obtained show that the percentages of DMNs with metabolic cores grow with the number of catalytic elements, converging to 100% for all cases. Conclusions/Significance: The results show evidence that the fundamental factor for the spontaneous emergence of this global self-organized enzymatic structure is the number of catalytic elements in the metabolic networks. Our analysis corroborates and expands on our previous studies illustrating a crucial property of the global structure of the cellular metabolism. These results also offer important insights into the mechanisms which ensure the robustness and stability of living cells.			De la Fuente, IM (corresponding author), Univ Basque Country, Fac Sci & Technol, Dept Math, Vizcaya, Spain.	mtpmadei@ehu.es	Vera-López, Antonio/P-3022-2016; Pérez-Pinillla, Martín-Blas/K-9042-2017; Vadillo, Fernando/AAW-5629-2021	Pérez-Pinillla, Martín-Blas/0000-0002-3461-9990; Vadillo, Fernando/0000-0001-6524-360X; De la Fuente, Ildefonso/0000-0001-6548-7583; Vera-Lopez, Antonio/0000-0002-0351-2701				Ainscow EK, 2002, J PHYSIOL-LONDON, V544, P429, DOI 10.1113/jphysiol.2002.022434; Almaas E, 2007, J EXP BIOL, V210, P1548, DOI 10.1242/jeb.003731; Almaas E, 2005, PLOS COMPUT BIOL, V1, P557, DOI 10.1371/journal.pcbi.0010068; Chabot JR, 2007, NATURE, V450, P1249, DOI 10.1038/nature06395; Chiam KH, 2007, PHYS REV E, V75, DOI 10.1103/PhysRevE.75.061901; De La Fuente IM, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003100; De La Fuente IM, 1999, B MATH BIOL, V61, P573, DOI 10.1006/bulm.1999.0103; DIXON CJ, 1995, BIOCHEM J, V309, P145, DOI 10.1042/bj3090145; Dyachok O, 2006, NATURE, V439, P349, DOI 10.1038/nature04410; FUENTES JM, 1994, ARCH INT PHYSIOL BIO, V102, P237, DOI 10.3109/13813459409003936; Futcher B, 2006, GENOME BIOL, V7, DOI 10.1186/gb-2006-7-4-107; Garmendia-Torres C, 2007, CURR BIOL, V17, P1044, DOI 10.1016/j.cub.2007.05.032; Gavin AC, 2002, NATURE, V415, P141, DOI 10.1038/415141a; Getty L, 2000, J CLIN INVEST, V106, P421, DOI 10.1172/JCI7815; Gillette MU, 2005, SCIENCE, V309, P1196, DOI 10.1126/science.1111420; GOLDBETER A, 1972, BIOPHYS J, V12, P1302, DOI 10.1016/S0006-3495(72)86164-2; Goldbeter A, 2002, NATURE, V420, P238, DOI 10.1038/nature01259; Goldbeter A, 2007, ADV CHEM PHYS, V135, P253; Hans MA, 2003, BIOTECHNOL BIOENG, V82, P143, DOI 10.1002/bit.10553; Hartig K, 2005, PLANT BIOLOGY, V7, P33, DOI 10.1055/s-2004-830474; HEINZLE E, 1983, P 1 IFAC WORKSH MOD, P57; Hess B, 2000, NATURWISSENSCHAFTEN, V87, P199, DOI 10.1007/s001140050704; Ho Y, 2002, NATURE, V415, P180, DOI 10.1038/415180a; Holz GG, 2008, AM J PHYSIOL-CELL PH, V294, pC4, DOI 10.1152/ajpcell.00522.2007; Hungerbuehler AK, 2007, EUKARYOT CELL, V6, P473, DOI 10.1128/EC.00273-06; Ishii K, 2006, EMBO REP, V7, P390, DOI 10.1038/sj.embor.7400620; Jules M, 2005, FEBS J, V272, P1490, DOI 10.1111/j.1742-4658.2005.04588.x; Karp PD, 2001, SCIENCE, V293, P2040, DOI 10.1126/science.1064621; Kindzelskii AL, 1998, BIOPHYS J, V74, P90, DOI 10.1016/S0006-3495(98)77770-7; Kitano H, 2004, NAT REV GENET, V5, P826, DOI 10.1038/nrg1471; Klevecz RR, 2004, P NATL ACAD SCI USA, V101, P1200, DOI 10.1073/pnas.0306490101; Klevecz RR, 2001, MOL BIOL REP, V28, P73, DOI 10.1023/A:1017909012215; LANGE G, 2004, FEBS, V178, P61; LEBRUN P, 1985, BIOPHYS J, V48, P529, DOI 10.1016/S0006-3495(85)83809-1; Lloyd D, 2002, FEBS LETT, V519, P41, DOI 10.1016/S0014-5793(02)02704-7; MacDonald MJ, 2003, J BIOL CHEM, V278, P51894, DOI 10.1074/jbc.M309038200; Marquez S, 2004, FASEB J, V18, P519, DOI 10.1096/fj.03-0417fje; Mellon D, 1999, J NEUROPHYSIOL, V81, P1231, DOI 10.1152/jn.1999.81.3.1231; Moller AC, 1998, BIOPHYS CHEM, V72, P63, DOI 10.1016/S0301-4622(98)00123-9; Nielsen K, 1998, BIOPHYS CHEM, V72, P49, DOI 10.1016/S0301-4622(98)00122-7; OVADI J, 2005, CELL BIOCH, V256, P5; Pal C, 2006, NATURE, V440, P667, DOI 10.1038/nature04568; Placantonakis DG, 2001, J PHYSIOL-LONDON, V534, P123, DOI 10.1111/j.1469-7793.2001.t01-1-00123.x; Ramanujan VK, 2006, BIOPHYS J, V90, pL70, DOI 10.1529/biophysj.106.083501; Rosenspire AJ, 2001, J CELL SCI, V114, P1515; Sanchez-Armass S, 2006, AM J PHYSIOL-CELL PH, V290, pC524, DOI 10.1152/ajpcell.00290.2005; Shaul O, 1996, P NATL ACAD SCI USA, V93, P4868, DOI 10.1073/pnas.93.10.4868; Smrcinova M, 1998, INT J BIFURCAT CHAOS, V8, P2467, DOI 10.1142/S0218127498001984; Tian B, 2005, BMC GENOMICS, V6, DOI 10.1186/1471-2164-6-137; Tonozuka H, 2001, J BIOCHEM-TOKYO, V130, P589, DOI 10.1093/oxfordjournals.jbchem.a003023; Wittmann C, 2005, BIOTECHNOL BIOENG, V89, P839, DOI 10.1002/bit.20408; CYBER CELL DATABASE	54	11	11	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7510	10.1371/journal.pone.0007510	http://dx.doi.org/10.1371/journal.pone.0007510			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19888419	Green Published, gold, Green Submitted			2022-12-27	WOS:000270880900012
J	Webster, DR; Hekele, AG; Lauring, AS; Fischer, KF; Li, H; Andino, R; DeRisi, JL				Webster, Dale R.; Hekele, Armin G.; Lauring, Adam S.; Fischer, Kael F.; Li, Hao; Andino, Raul; DeRisi, Joseph L.			An Enhanced Single Base Extension Technique for the Analysis of Complex Viral Populations	PLOS ONE			English	Article							IN-VIVO; RNA; DNA; MUTATION; POLYMORPHISMS; PATHOGENESIS; MECHANISMS; DIVERSITY; RATES	Many techniques for the study of complex populations provide either specific information on a small number of variants or general information on the entire population. Here we describe a powerful new technique for elucidating mutation frequencies at each genomic position in a complex population. This single base extension (SBE) based microarray platform was designed and optimized using poliovirus as the target genotype, but can be easily adapted to assay populations derived from any organism. The sensitivity of the method was demonstrated by accurate and consistent readouts from a controlled population of mutant genotypes. We subsequently deployed the technique to investigate the effects of the nucleotide analog ribavirin on a typical poliovirus population through two rounds of passage. Our results show that this economical platform can be used to investigate dynamic changes occurring at frequencies below 1% within a complex nucleic acid population. Given that many key aspects of the study and treatment of disease are intimately linked to population-level genomic diversity, our SBE-based technique provides a scalable and cost-effective complement to both traditional and next generation sequencing methodologies.			Webster, DR (corresponding author), Pacific Biosci, Menlo Pk, CA USA.	raul.andino@ucsf.edu; joe@derisilab.ucsf.edu	Fischer, Kael/F-7756-2015	Fischer, Kael/0000-0002-7547-330X	Howard Hughes Medical Institute Funding Source: Medline; NIAID NIH HHS [K08 AI081754, N01AI40085, AI36178, R01 AI036178, R21 AI036178, R56 AI036178, K08 AI081754-03] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI036178, K08AI081754, R21AI040085, R56AI036178, R21AI036178, R01AI040085] Funding Source: NIH RePORTER	Howard Hughes Medical Institute(Howard Hughes Medical Institute); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Agol VI, 2006, CURR TOP MICROBIOL, V299, P211; Amexis G, 2001, P NATL ACAD SCI USA, V98, P12097, DOI 10.1073/pnas.211423298; Arnold JJ, 2005, J BIOL CHEM, V280, P25706, DOI 10.1074/jbc.M503444200; Berger J, 2001, NAT GENET, V29, P475, DOI 10.1038/ng773; BOYER JC, 1992, P NATL ACAD SCI USA, V89, P6919, DOI 10.1073/pnas.89.15.6919; Bozdech Z, 2003, GENOME BIOL, V4, DOI 10.1186/gb-2003-4-2-r9; Brakmann S, 2001, CHEMBIOCHEM, V2, P212, DOI 10.1002/1439-7633(20010302)2:3<212::AID-CBIC212>3.3.CO;2-I; Chee M, 1996, SCIENCE, V274, P610, DOI 10.1126/science.274.5287.610; COFFIN JM, 1995, SCIENCE, V267, P483, DOI 10.1126/science.7824947; Crotty S, 2000, NAT MED, V6, P1375, DOI 10.1038/82191; Crotty S, 2002, MICROBES INFECT, V4, P1301, DOI 10.1016/S1286-4579(02)00008-4; Crotty S, 2001, P NATL ACAD SCI USA, V98, P6895, DOI 10.1073/pnas.111085598; DAVIS MM, 1988, NATURE, V334, P395, DOI 10.1038/334395a0; DELWART EL, 1994, J VIROL, V68, P6672, DOI 10.1128/JVI.68.10.6672-6683.1994; Elena SF, 2006, EMBO REP, V7, P168, DOI 10.1038/sj.embor.7400636; Frazer KA, 2007, NATURE, V449, P851, DOI 10.1038/nature06258; Hacia JG, 1999, NAT GENET, V21, P42, DOI 10.1038/4469; Hacia JG, 1999, J MED GENET, V36, P730, DOI 10.1136/jmg.36.10.730; Holt RA, 2008, GENOME RES, V18, P839, DOI 10.1101/gr.073262.107; Hughes TR, 2001, NAT BIOTECHNOL, V19, P342, DOI 10.1038/86730; Jones E., 2001, SCIPY OPEN SOURCE SC; KIM S, 1981, CELL, V27, P573, DOI 10.1016/0092-8674(81)90399-8; Kruglyak L, 2008, NAT REV GENET, V9, P314, DOI 10.1038/nrg2316; Martin V, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-117; Mathews DH, 1999, J MOL BIOL, V288, P911, DOI 10.1006/jmbi.1999.2700; ORITA M, 1989, P NATL ACAD SCI USA, V86, P2766, DOI 10.1073/pnas.86.8.2766; Pfeiffer JK, 2003, P NATL ACAD SCI USA, V100, P7289, DOI 10.1073/pnas.1232294100; Shen R, 2005, MUTAT RES-FUND MOL M, V573, P70, DOI 10.1016/j.mrfmmm.2004.07.022; Steemers FJ, 2006, NAT METHODS, V3, P31, DOI 10.1038/NMETH842; TONEGAWA S, 1983, NATURE, V302, P575, DOI 10.1038/302575a0; Vignuzzi M, 2006, NATURE, V439, P344, DOI 10.1038/nature04388; Villa-Angulo R, 2009, BMC GENET, V10, DOI 10.1186/1471-2156-10-19; Wang HY, 2005, GENOME RES, V15, P276, DOI 10.1101/gr.2885205	33	9	10	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7453	10.1371/journal.pone.0007453	http://dx.doi.org/10.1371/journal.pone.0007453			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834618	gold, Green Submitted, Green Published			2022-12-27	WOS:000270880700005
J	Copeland, HE; Doherty, KE; Naugle, DE; Pocewicz, A; Kiesecker, JM				Copeland, Holly E.; Doherty, Kevin E.; Naugle, David E.; Pocewicz, Amy; Kiesecker, Joseph M.			Mapping Oil and Gas Development Potential in the US Intermountain West and Estimating Impacts to Species	PLOS ONE			English	Article							WINTER HABITAT SELECTION; MULE DEER; BIODIVERSITY; CLASSIFICATION; MODELS	Background: Many studies have quantified the indirect effect of hydrocarbon-based economies on climate change and biodiversity, concluding that a significant proportion of species will be threatened with extinction. However, few studies have measured the direct effect of new energy production infrastructure on species persistence. Methodology/Principal Findings: We propose a systematic way to forecast patterns of future energy development and calculate impacts to species using spatially-explicit predictive modeling techniques to estimate oil and gas potential and create development build-out scenarios by seeding the landscape with oil and gas wells based on underlying potential. We illustrate our approach for the greater sage-grouse (Centrocercus urophasianus) in the western US and translate the build-out scenarios into estimated impacts on sage-grouse. We project that future oil and gas development will cause a 7-19 percent decline from 2007 sage-grouse lek population counts and impact 3.7 million ha of sagebrush shrublands and 1.1 million ha of grasslands in the study area. Conclusions/Significance: Maps of where oil and gas development is anticipated in the US Intermountain West can be used by decision-makers intent on minimizing impacts to sage-grouse. This analysis also provides a general framework for using predictive models and build-out scenarios to anticipate impacts to species. These predictive models and build-out scenarios allow tradeoffs to be considered between species conservation and energy development prior to implementation.			Copeland, HE (corresponding author), Nature Conservancy, Lander, WY USA.	hcopeland@tnc.org						Aldridge CL, 2007, ECOL APPL, V17, P508, DOI 10.1890/05-1871; [Anonymous], 1998, GEOGRAPHICAL ENV MOD; Aydemir A, 2008, J PETROL SCI ENG, V61, P33, DOI 10.1016/j.petrol.2007.10.004; Breiman L., 2001, Machine Learning, V45, P5, DOI 10.1023/A:1010933404324; Chapin FS, 2000, NATURE, V405, P234, DOI 10.1038/35012241; Chen ZH, 2000, B CAN PETROL GEOL, V48, P150, DOI 10.2113/48.2.150; Chow J, 2003, SCIENCE, V302, P1528, DOI 10.1126/science.1091939; Clark WC, 2007, P NATL ACAD SCI USA, V104, P1737, DOI 10.1073/pnas.0611291104; COHEN J, 1960, EDUC PSYCHOL MEAS, V20, P37, DOI 10.1177/001316446002000104; Connelly JW, 1997, WILDLIFE BIOL, V3, P229, DOI 10.2981/wlb.1997.028; Cutler DR, 2007, ECOLOGY, V88, P2783, DOI 10.1890/07-0539.1; De'ath G, 2000, ECOLOGY, V81, P3178, DOI 10.2307/177409; DOHERTY K, 2009, STUD AVIAN IN PRESS; DOHERTY KE, 2008, THESIS MONTANA MISSO; Ehrlich PR, 2008, P NATL ACAD SCI USA, V105, P11579, DOI 10.1073/pnas.0801911105; Evans JS, 2009, LANDSCAPE ECOL, V24, P673, DOI 10.1007/s10980-009-9341-0; Fenneman N.M., 1946, PHYSIOGRAPHIC DIVISI; Groom MJ, 2008, CONSERV BIOL, V22, P602, DOI 10.1111/j.1523-1739.2007.00879.x; GUISAN A, 2000, ECOLOGICAL MODELLING, V186, P135; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Holloran M., 2005, THESIS U WYOMING LAR; HULSE D, 2009, LANDSCAPE E IN PRESS; Ingelfinger F, 2004, WEST N AM NATURALIST, V64, P385; International Energy Agency, 2007, WORLD EN OUTL 2007; IVANOV VL, 1985, POLAR GEOGRAPHY, V9, P116; Kiesecker JM, 2001, NATURE, V410, P681, DOI 10.1038/35070552; KIESECKER JM, 2009, FRONT ECOL ENV; Kiesecker JM, 2009, BIOSCIENCE, V59, P77, DOI 10.1525/bio.2009.59.1.11; KUCKS RP, 2000, WYOMING AEROMAGNETIC; McDaniel CN, 2002, BIOSCIENCE, V52, P929, DOI 10.1641/0006-3568(2002)052[0929:IHEUCB]2.0.CO;2; *MEDIAS FRANC POST, 2004, ESA ESA GLOBC PROJ; Nassauer JI, 2004, LANDSCAPE ECOL, V19, P343, DOI 10.1023/B:LAND.0000030666.55372.ae; *NAT ATL US, 2006, FED LANDS US; NAUGLE D, 2009, STUDIES AVI IN PRESS; NAUGLE DE, 2009, STUD AVIAN IN PRESS; NEWSON AC, 2001, LEADING EDGE, V20, P74, DOI DOI 10.1190/1.1438884; PHILLIPS JD, 1993, NATL GEOPHYS DATA GR; Phillips SJ, 2006, ECOL MODEL, V190, P231, DOI 10.1016/j.ecolmodel.2005.03.026; Pitman JC, 2005, J WILDLIFE MANAGE, V69, P1259, DOI 10.2193/0022-541X(2005)069[1259:LASOLP]2.0.CO;2; Pocewicz A, 2008, LANDSCAPE ECOL, V23, P195, DOI 10.1007/s10980-007-9159-6; Polasky S, 2008, P NATL ACAD SCI USA, V105, P6505, DOI 10.1073/pnas.0802815105; Pontius GR, 2005, INT J GEOGR INF SCI, V19, P243, DOI 10.1080/13658810410001713434; REED JC, 2007, GEOLOGIC MAP NATL AT; Rykiel EJ, 1996, ECOL MODEL, V90, P229, DOI 10.1016/0304-3800(95)00152-2; Sawyer H, 2005, WILDLIFE SOC B, V33, P1266, DOI 10.2193/0091-7648(2005)33[1266:MDAPMI]2.0.CO;2; Sawyer H, 2006, J WILDLIFE MANAGE, V70, P396, DOI 10.2193/0022-541X(2006)70[396:WHSOMD]2.0.CO;2; Sawyer H, 2009, J WILDLIFE MANAGE, V73, P1052, DOI 10.2193/2008-478; Solomon S, 2007, AR4 CLIMATE CHANGE 2007: THE PHYSICAL SCIENCE BASIS, P1; Sorensen T, 2008, J WILDLIFE MANAGE, V72, P900, DOI 10.2193/2007-079; Stiver S., 2006, GREATER SAGE GROUSE; *US BUR LAND MAN, 2008, NAT INT LANDS SYST N; *US BUR LAND MAN, 1997, WHIT RIV RES AR APPR; *US DOE, 2008, 20 EN 2030 INCR WIND; *US FISH WILDL SER, 2008, IN STAT REV GREAT SA; *US GOV ACC OFF, 2006, END SPEC REC; Walker BL, 2007, J WILDLIFE MANAGE, V71, P2644, DOI 10.2193/2006-529	56	110	111	1	55	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7400	10.1371/journal.pone.0007400	http://dx.doi.org/10.1371/journal.pone.0007400			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826472	Green Published, gold, Green Submitted			2022-12-27	WOS:000270808700002
J	Doncaster, CP				Doncaster, C. Patrick			Ecological Equivalence: A Realistic Assumption for Niche Theory as a Testable Alternative to Neutral Theory	PLOS ONE			English	Article							COMMUNITY ECOLOGY; SPECIES ABUNDANCE; COEXISTENCE; COMPETITION; MODEL; HYPOTHESIS; BIODIVERSITY; POPULATION; DIVERSITY; DYNAMICS	Background: Hubbell's 2001 neutral theory unifies biodiversity and biogeography by modelling steady-state distributions of species richness and abundances across spatio-temporal scales. Accurate predictions have issued from its core premise that all species have identical vital rates. Yet no ecologist believes that species are identical in reality. Here I explain this paradox in terms of the ecological equivalence that species must achieve at their coexistence equilibrium, defined by zero net fitness for all regardless of intrinsic differences between them. I show that the distinction of realised from intrinsic vital rates is crucial to evaluating community resilience. Principal Findings: An analysis of competitive interactions reveals how zero-sum patterns of abundance emerge for species with contrasting life-history traits as for identical species. I develop a stochastic model to simulate community assembly from a random drift of invasions sustaining the dynamics of recruitment following deaths and extinctions. Species are allocated identical intrinsic vital rates for neutral dynamics, or random intrinsic vital rates and competitive abilities for niche dynamics either on a continuous scale or between dominant-fugitive extremes. Resulting communities have steady-state distributions of the same type for more or less extremely differentiated species as for identical species. All produce negatively skewed log-normal distributions of species abundance, zero-sum relationships of total abundance to area, and Arrhenius relationships of species to area. Intrinsically identical species nevertheless support fewer total individuals, because their densities impact as strongly on each other as on themselves. Truly neutral communities have measurably lower abundance/area and higher species/abundance ratios. Conclusions: Neutral scenarios can be parameterized as null hypotheses for testing competitive release, which is a sure signal of niche dynamics. Ignoring the true strength of interactions between and within species risks a substantial misrepresentation of community resilience to habitat loss.			Doncaster, CP (corresponding author), Univ Southampton, Sch Biol Sci, Southampton, Hants, England.	cpd@soton.ac.uk	Doncaster, C. Patrick/AAT-7621-2020	Doncaster, C. Patrick/0000-0001-9406-0693	NERC [NE/C003705/1] Funding Source: UKRI; Natural Environment Research Council [NE/C003705/1] Funding Source: researchfish	NERC(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC)); Natural Environment Research Council(UK Research & Innovation (UKRI)Natural Environment Research Council (NERC))		Adler PB, 2007, ECOL LETT, V10, P95, DOI 10.1111/j.1461-0248.2006.00996.x; Allouche O, 2009, J THEOR BIOL, V258, P274, DOI 10.1016/j.jtbi.2008.12.024; Alonso D, 2006, TRENDS ECOL EVOL, V21, P451, DOI 10.1016/j.tree.2006.03.019; Calcagno V, 2006, ECOL LETT, V9, P897, DOI 10.1111/j.1461-0248.2006.00930.x; CASWELL H, 1976, ECOL MONOGR, V46, P327, DOI 10.2307/1942257; Chave J, 2002, AM NAT, V159, P1, DOI 10.1086/324112; CHAVE J, 2006, SCIENCE, V441, pE1; Doncaster CP, 2003, J ANIM ECOL, V72, P116, DOI 10.1046/j.1365-2656.2003.00687.x; Doncaster CP, 2000, NATURE, V404, P281, DOI 10.1038/35005078; GILPIN ME, 1976, NATURE, V261, P40, DOI 10.1038/261040a0; Gravel D, 2006, ECOL LETT, V9, P399, DOI 10.1111/j.1461-0248.2006.00884.x; Hanski I, 1996, AM NAT, V147, P527, DOI 10.1086/285864; Holt RD, 2006, TRENDS ECOL EVOL, V21, P531, DOI 10.1016/j.tree.2006.08.003; Holyoak M, 2006, ECOLOGY, V87, P1368; Hubbell SP, 2005, FUNCT ECOL, V19, P166, DOI 10.1111/j.0269-8463.2005.00965.x; Hubbell SP, 2006, ECOLOGY, V87, P1387, DOI 10.1890/0012-9658(2006)87[1387:NTATEO]2.0.CO;2; Hubbell Stephen P., 2001, V32, pi; Leibold MA, 2006, ECOLOGY, V87, P1399, DOI 10.1890/0012-9658(2006)87[1399:COTNAN]2.0.CO;2; Maurer BA, 2004, BASIC APPL ECOL, V5, P413, DOI 10.1016/j.baae.2004.08.006; McGill BJ, 2006, ECOLOGY, V87, P1411, DOI 10.1890/0012-9658(2006)87[1411:EEONT]2.0.CO;2; NEE S, 1992, J ANIM ECOL, V61, P37, DOI 10.2307/5506; NEE S, 1994, NATURE, V367, P123, DOI 10.1038/367123b0; Pound GE, 2004, J EVOLUTION BIOL, V17, P651, DOI 10.1111/j.1420-9101.2003.00690.x; Pound GE, 2002, J THEOR BIOL, V217, P535, DOI 10.1006/jtbi.2002.3040; PULLIAM HR, 1988, AM NAT, V132, P652, DOI 10.1086/284880; Purves Drew W., 2005, P107, DOI 10.1017/CBO9780511541971.006; Rosindell J, 2007, ECOL LETT, V10, P586, DOI 10.1111/j.1461-0248.2007.01050.x; Scheffer M, 2006, P NATL ACAD SCI USA, V103, P6230, DOI 10.1073/pnas.0508024103; Sokal R. H., 1995, BIOMETRY PRINCIPLES; Sole RV, 2004, ECOL COMPLEX, V1, P65, DOI 10.1016/j.ecocom.2003.12.003; TILMAN D, 1994, ECOLOGY, V75, P2, DOI 10.2307/1939377; Tilman D, 2004, P NATL ACAD SCI USA, V101, P10854, DOI 10.1073/pnas.0403458101; Volkov I, 2005, NATURE, V438, P658, DOI 10.1038/nature04030; VOLKOV I, 2005, SCIENCE, V441, pE1; Volkov I, 2007, NATURE, V450, P45, DOI 10.1038/nature06197; Zhou SR, 2008, ECOLOGY, V89, P248, DOI 10.1890/06-1817.1	36	16	16	0	54	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7460	10.1371/journal.pone.0007460	http://dx.doi.org/10.1371/journal.pone.0007460			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19829714	Green Published, Green Submitted, Green Accepted, gold			2022-12-27	WOS:000270808700019
J	Paumet, F; Wesolowski, J; Garcia-Diaz, A; Delevoye, C; Aulner, N; Shuman, HA; Subtil, A; Rothman, JE				Paumet, Fabienne; Wesolowski, Jordan; Garcia-Diaz, Alejandro; Delevoye, Cedric; Aulner, Nathalie; Shuman, Howard A.; Subtil, Agathe; Rothman, James E.			Intracellular Bacteria Encode Inhibitory SNARE-Like Proteins	PLOS ONE			English	Article								Pathogens use diverse molecular machines to penetrate host cells and manipulate intracellular vesicular trafficking. Viruses employ glycoproteins, functionally and structurally similar to the SNARE proteins, to induce eukaryotic membrane fusion. Intracellular pathogens, on the other hand, need to block fusion of their infectious phagosomes with various endocytic compartments to escape from the degradative pathway. The molecular details concerning the mechanisms underlying this process are lacking. Using both an in vitro liposome fusion assay and a cellular assay, we showed that SNARE-like bacterial proteins block membrane fusion in eukaryotic cells by directly inhibiting SNARE-mediated membrane fusion. More specifically, we showed that IncA and icmG/DotF, two SNARE-like proteins respectively expressed by Chlamydia and Legionella, inhibit the endocytic SNARE machinery. Furthermore, we identified that the SNARE-like motif present in these bacterial proteins encodes the inhibitory function. This finding suggests that SNARE-like motifs are capable of specifically manipulating membrane fusion in a wide variety of biological environments. Ultimately, this motif may have been selected during evolution because it is an efficient structural motif for modifying eukaryotic membrane fusion and thus contribute to pathogen survival.			Paumet, F (corresponding author), Thomas Jefferson Univ, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA.	fabienne.paumet@jefferson.edu	; Subtil, Agathe/C-7464-2017	Delevoye, Cedric/0000-0002-3835-6649; Subtil, Agathe/0000-0002-7481-4846; Paumet, Fabienne/0000-0003-4466-6966; Wesolowski, Jordan/0000-0002-4439-385X	NIAID NIH HHS [AI064481, AI23549, R01 AI064481, R01 AI023549, R01 AI073486] Funding Source: Medline; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI023549, R01AI073486, R01AI064481] Funding Source: NIH RePORTER	NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Barocchi MA, 2005, NAT REV MICROBIOL, V3, P349, DOI 10.1038/nrmicro1131; Belland RJ, 2003, P NATL ACAD SCI USA, V100, P8478, DOI 10.1073/pnas.1331135100; Dautry-Varsat A, 2004, TRAFFIC, V5, P561, DOI 10.1111/j.1398-9219.2004.00207.x; de Felipe KS, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000117; Delevoye C, 2004, J BIOL CHEM, V279, P46896, DOI 10.1074/jbc.M407227200; Delevoye C, 2008, PLOS PATHOG, V4, DOI 10.1371/journal.ppat.1000022; Duclos S, 2000, CELL MICROBIOL, V2, P365, DOI 10.1046/j.1462-5822.2000.00066.x; EISSENBERG LG, 1983, INFECT IMMUN, V40, P741, DOI 10.1128/IAI.40.2.741-751.1983; Fasshauer D, 1998, P NATL ACAD SCI USA, V95, P15781, DOI 10.1073/pnas.95.26.15781; Fasshauer D, 1998, BIOCHEMISTRY-US, V37, P10354, DOI 10.1021/bi980542h; Fields KA, 2002, INFECT IMMUN, V70, P3816, DOI 10.1128/IAI.70.7.3816-3823.2002; Fields KA, 2002, ANNU REV CELL DEV BI, V18, P221, DOI 10.1146/annurev.cellbio.18.012502.105845; Geisler WM, 2001, J INFECT DIS, V184, P879, DOI 10.1086/323340; Hackstadt T, 1999, CELL MICROBIOL, V1, P119, DOI 10.1046/j.1462-5822.1999.00012.x; Hackstadt T, 2000, TRAFFIC, V1, P93, DOI 10.1034/j.1600-0854.2000.010201.x; Hashim S, 2000, J BIOL CHEM, V275, P16281, DOI 10.1074/jbc.275.21.16281; Low SH, 1998, J CELL BIOL, V141, P1503, DOI 10.1083/jcb.141.7.1503; Lutz-Wohlgroth L, 2006, J VET MED A, V53, P185, DOI 10.1111/j.1439-0442.2006.00819.x; McNew JA, 2000, NATURE, V407, P153, DOI 10.1038/35025000; Meresse S, 1999, NAT CELL BIOL, V1, pE183, DOI 10.1038/15620; Morozova I, 2004, PLASMID, V51, P127, DOI 10.1016/j.plasmid.2003.12.004; Mullock BM, 2000, MOL BIOL CELL, V11, P3137, DOI 10.1091/mbc.11.9.3137; Nakamura N, 2000, J BIOL CHEM, V275, P6523, DOI 10.1074/jbc.275.9.6523; Nickel W, 1999, P NATL ACAD SCI USA, V96, P12571, DOI 10.1073/pnas.96.22.12571; Oh YK, 1996, INFECT IMMUN, V64, P319, DOI 10.1128/IAI.64.1.319-325.1996; Parlati F, 1999, P NATL ACAD SCI USA, V96, P12565, DOI 10.1073/pnas.96.22.12565; Parlati F, 2002, P NATL ACAD SCI USA, V99, P5424, DOI 10.1073/pnas.082100899; Paumet F, 2000, J IMMUNOL, V164, P5850, DOI 10.4049/jimmunol.164.11.5850; Paumet F, 2005, J BIOL CHEM, V280, P21137, DOI 10.1074/jbc.M500841200; Paumet F, 2004, P NATL ACAD SCI USA, V101, P3376, DOI 10.1073/pnas.0400271101; Paumet F, 2001, J CELL BIOL, V155, P961, DOI 10.1083/jcb.200104092; Pryor PR, 2004, EMBO REP, V5, P590, DOI 10.1038/sj.embor.7400150; Puri N, 2008, P NATL ACAD SCI USA, V105, P2580, DOI 10.1073/pnas.0707854105; Roa M, 1997, J IMMUNOL, V159, P2815; Rockey DD, 2002, MICROBES INFECT, V4, P333, DOI 10.1016/S1286-4579(02)01546-0; Rockey DD, 2002, MICROBIOL-SGM, V148, P2497, DOI 10.1099/00221287-148-8-2497; Rockey DD, 1997, MOL MICROBIOL, V24, P217, DOI 10.1046/j.1365-2958.1997.3371700.x; Roy CR, 1998, MOL MICROBIOL, V28, P663, DOI 10.1046/j.1365-2958.1998.00841.x; Sagi-Eisenberg R, 2007, IMMUNOL REV, V217, P292, DOI 10.1111/j.1600-065X.2007.00516.x; Schuette CG, 2004, P NATL ACAD SCI USA, V101, P2858, DOI 10.1073/pnas.0400044101; SCHWARTZ LB, 1979, J IMMUNOL, V123, P1445; Scidmore MA, 2003, INFECT IMMUN, V71, P973, DOI 10.1128/IAI.71.2.973-984.2003; Skehel JJ, 1998, CELL, V95, P871, DOI 10.1016/S0092-8674(00)81710-9; Sollner TH, 2004, CURR OPIN CELL BIOL, V16, P429, DOI 10.1016/j.ceb.2004.06.015; Stebbins CE, 2001, NATURE, V412, P701, DOI 10.1038/35089000; Varlamov O, 2004, J CELL BIOL, V164, P79, DOI 10.1083/jcb.200307066; Weber T, 2000, J CELL BIOL, V149, P1063, DOI 10.1083/jcb.149.5.1063; Weber T, 1998, CELL, V92, P759, DOI 10.1016/S0092-8674(00)81404-X; Weimbs T, 1997, P NATL ACAD SCI USA, V94, P3046, DOI 10.1073/pnas.94.7.3046; Wu M, 2007, J CELL SCI, V120, P3147, DOI 10.1242/jcs.007260; Xia MS, 2005, J INFECT DIS, V192, P1229, DOI 10.1086/444394	51	64	66	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 12	2009	4	10							e7375	10.1371/journal.pone.0007375	http://dx.doi.org/10.1371/journal.pone.0007375			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	505VX	19823575	Green Published, gold			2022-12-27	WOS:000270728500003
J	Stone, GW; Barzee, S; Snarsky, V; Santucci, C; Tran, B; Langer, R; Zugates, GT; Anderson, DG; Kornbluth, RS				Stone, Geoffrey W.; Barzee, Suzanne; Snarsky, Victoria; Santucci, Camila; Tran, Brian; Langer, Robert; Zugates, Gregory T.; Anderson, Daniel G.; Kornbluth, Richard S.			Nanoparticle-Delivered Multimeric Soluble CD40L DNA Combined with Toll-Like Receptor Agonists as a Treatment for Melanoma	PLOS ONE			English	Article								Stimulation of CD40 or Toll-Like Receptors (TLR) has potential for tumor immunotherapy. Combinations of CD40 and TLR stimulation can be synergistic, resulting in even stronger dendritic cell (DC) and CD8+ T cell responses. To evaluate such combinations, established B16F10 melanoma tumors were injected every other day X 5 with plasmid DNA encoding a multimeric, soluble form of CD40L (pSP-D-CD40L) either alone or combined with an agonist for TLR1/2 (Pam(3)CSK(4)), TLR2/6 (FSL-1 and MALP2), TLR3 (polyinosinic-polycytidylic acid, poly(I:C)), TLR4 (monophosphoryl lipid A, MPL), TLR7 (imiquimod), or TLR9 (Class B CpG phosphorothioate oligodeoxynucleotide, CpG). When used by itself, pSP-D-CD40L slowed tumor growth and prolonged survival, but did not lead to cure. Of the TLR agonists, CpG and poly(I:C) also slowed tumor growth, and the combination of these two TLR agonists was more effective than either agent alone. The triple combination of intratumoral pSP-D-CD40L + CpG + poly(I:C) markedly slowed tumor growth and prolonged survival. This treatment was associated with a reduction in intratumoral CD11c+ dendritic cells and an influx of CD8+ T cells. Since intratumoral injection of plasmid DNA does not lead to efficient transgene expression, pSP-D-CD40L was also tested with cationic polymers that form DNA-containing nanoparticles which lead to enhanced intratumoral gene expression. Intratumoral injections of pSP-D-CD40L-containing nanoparticles formed from polyethylenimine (PEI) or C32 (a novel biodegradable poly(B-amino esters) polymer) in combination with CpG + poly(I:C) had dramatic antitumor effects and frequently cured mice of B16F10 tumors. These data confirm and extend previous reports that CD40 and TLR agonists are synergistic and demonstrate that this combination of immunostimulants can significantly suppress tumor growth in mice. In addition, the enhanced effectiveness of nanoparticle formulations of DNA encoding immunostimulatory molecules such as multimeric, soluble CD40L supports the further study of this technology for tumor immunotherapy.			Stone, GW (corresponding author), Univ Miami, Miller Sch Med, Miami, FL 33136 USA.	rkornbluth@ucsd.edu		Kornbluth, Richard/0000-0002-0218-2026	NATIONAL CANCER INSTITUTE [R01CA132091, U54CA119349] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R21AI073240, P30AI036214, T32AI007384, K22AI068489, R21AI078834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING [R37EB000244] Funding Source: NIH RePORTER; NCI NIH HHS [U54 CA119349, R01CA132091, R01 CA132091, U54CA119349] Funding Source: Medline; NIAID NIH HHS [R21AI078834, T32 AI007384, T32AI007384, P30AI036214, K22AI068489, 5R21AI073240, P30 AI036214, R21 AI078834, R21 AI073240, K22 AI068489] Funding Source: Medline; NIBIB NIH HHS [R37 EB000244, R37EB000244] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERING(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIBIB NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB))		Ahonen CL, 2004, J EXP MED, V199, P775, DOI 10.1084/jem.20031591; Ahonen CL, 2008, BLOOD, V111, P3116, DOI 10.1182/blood-2007-09-114371; Anderson DG, 2004, P NATL ACAD SCI USA, V101, P16028, DOI 10.1073/pnas.0407218101; Barr TA, 2003, IMMUNOLOGY, V109, P87, DOI 10.1046/j.1365-2567.2003.01634.x; Barrat FJ, 2005, J EXP MED, V202, P1131, DOI 10.1084/jem.20050914; BOUSSIF O, 1995, P NATL ACAD SCI USA, V92, P7297, DOI 10.1073/pnas.92.16.7297; Broomfield SA, 2009, J IMMUNOL, V182, P5217, DOI 10.4049/jimmunol.0803826; Buhtoiarov IN, 2007, IMMUNOLOGY, V120, P412, DOI 10.1111/j.1365-2567.2006.02517.x; COTTEN M, 1994, GENE THER, V1, P239; Cubillos-Ruiz JR, 2009, J CLIN INVEST, V119, P2231, DOI 10.1172/JCI37716; Currie AJ, 2008, J IMMUNOL, V180, P1535, DOI 10.4049/jimmunol.180.3.1535; de Herve MGD, 2005, BLOOD, V106, P2806, DOI 10.1182/blood-2004-12-4678; Edwards AD, 2002, J IMMUNOL, V169, P3652, DOI 10.4049/jimmunol.169.7.3652; FIDLER IJ, 1975, CANCER RES, V35, P218; FIDLER IJ, 1976, JNCI-J NATL CANCER I, V57, P1199, DOI 10.1093/jnci/57.5.1199; Finkelstein SE, 2004, J LEUKOCYTE BIOL, V76, P333, DOI 10.1189/jlb.0304120; Fuse S, 2009, J IMMUNOL, V182, P4244, DOI 10.4049/jimmunol.0802041; Gabrilovich D, 2004, NAT REV IMMUNOL, V4, P941, DOI 10.1038/nri1498; Gambotto A, 2000, GENE THER, V7, P2036, DOI 10.1038/sj.gt.3301335; Gautier G, 2005, J EXP MED, V201, P1435, DOI 10.1084/jem.20041964; Gerosa F, 2005, J IMMUNOL, V174, P727, DOI 10.4049/jimmunol.174.2.727; Ghiringhelli F, 2005, J EXP MED, V202, P919, DOI 10.1084/jem.20050463; Greenland JR, 2005, MOL THER, V12, P164, DOI 10.1016/j.ymthe.2005.01.021; GUARDA G, 2009, NATURE; Guiducci C, 2005, CANCER RES, V65, P3437, DOI 10.1158/0008-5472.CAN-04-4262; Hanks BA, 2005, NAT MED, V11, P130, DOI 10.1038/nm1183; Haswell LE, 2001, EUR J IMMUNOL, V31, P3094, DOI 10.1002/1521-4141(2001010)31:10<3094::AID-IMMU3094>3.0.CO;2-F; Hiura T, 2005, J IMMUNOL, V175, P5058, DOI 10.4049/jimmunol.175.8.5058; Hodge JW, 2003, CLIN CANCER RES, V9, P1837; Hoebe K, 2003, NAT IMMUNOL, V4, P1223, DOI 10.1038/ni1010; Holler N, 2003, MOL CELL BIOL, V23, P1428, DOI 10.1128/MCB.23.4.1428-1440.2003; Kadowaki N, 2001, J EXP MED, V194, P863, DOI 10.1084/jem.194.6.863; Kato H, 2006, NATURE, V441, P101, DOI 10.1038/nature04734; Kikuchi T, 2000, CANCER RES, V60, P6391; Kochenderfer JN, 2007, EXP BIOL MED, V232, P1128, DOI 10.3181/0702-MR-42; Kornbluth RS, 1998, P NATL ACAD SCI USA, V95, P5205, DOI 10.1073/pnas.95.9.5205; Kornbluth RS, 2002, J HEMATOTH STEM CELL, V11, P787, DOI 10.1089/152581602760404595; Krieg AM, 2002, ANNU REV IMMUNOL, V20, P709, DOI 10.1146/annurev.immunol.20.100301.064842; Krug A, 2001, EUR J IMMUNOL, V31, P3026, DOI 10.1002/1521-4141(2001010)31:10<3026::AID-IMMU3026>3.0.CO;2-H; Lapteva N, 2007, CANCER RES, V67, P10528, DOI 10.1158/0008-5472.CAN-07-0833; LEVY HB, 1969, P NATL ACAD SCI USA, V62, P357, DOI 10.1073/pnas.62.2.357; Liu K, 2005, J EXP MED, V202, P1507, DOI 10.1084/jem.20050956; Marzo AL, 1999, J IMMUNOL, V162, P5838; McCutcheon B, 2005, AM SURGEON, V71, P662; McWilliams JA, 2006, J IMMUNOL, V177, P155, DOI 10.4049/jimmunol.177.1.155; Meunier MC, 2005, NAT MED, V11, P1222, DOI 10.1038/nm1311; Moodycliffe AM, 2000, J EXP MED, V191, P2011, DOI 10.1084/jem.191.11.2011; Morris AE, 1999, J BIOL CHEM, V274, P418, DOI 10.1074/jbc.274.1.418; Muranski P, 2008, BLOOD, V112, P362, DOI 10.1182/blood-2007-11-120998; Napolitani G, 2005, NAT IMMUNOL, V6, P769, DOI 10.1038/ni1223; Okano F, 2005, J IMMUNOL, V174, P2645, DOI 10.4049/jimmunol.174.5.2645; Perona-Wright G, 2009, J IMMUNOL, V182, P2808, DOI 10.4049/jimmunol.0803553; Phan GQ, 2003, P NATL ACAD SCI USA, V100, P8372, DOI 10.1073/pnas.1533209100; Powell AM, 2004, CLIN EXP DERMATOL, V29, P15, DOI 10.1111/j.1365-2230.2004.01452.x; Riddell SR, 1996, NAT MED, V2, P216, DOI 10.1038/nm0296-216; Roman M, 1997, NAT MED, V3, P849, DOI 10.1038/nm0897-849; Scarlett UK, 2009, CANCER RES, V69, P7329, DOI 10.1158/0008-5472.CAN-09-0835; Schreurs MWJ, 2000, CANCER RES, V60, P6995; Schulz O, 2000, IMMUNITY, V13, P453, DOI 10.1016/S1074-7613(00)00045-5; Seliger B, 2001, CANCER RES, V61, P1095; Sharp FA, 2009, P NATL ACAD SCI USA, V106, P870, DOI 10.1073/pnas.0804897106; Sotomayor EM, 1999, NAT MED, V5, P780, DOI 10.1038/10503; Sparwasser T, 1999, J IMMUNOL, V162, P2368; Stone GW, 2006, CLIN VACCINE IMMUNOL, V13, P1223, DOI 10.1128/CVI.00198-06; Stone GW, 2009, J THORAC ONCOL, V4, P802, DOI 10.1097/JTO.0b013e3181a8634d; Stone GW, 2006, J VIROL, V80, P1762, DOI 10.1128/JVI.80.4.1762-1772.2006; Stumbles PA, 2004, J IMMUNOL, V173, P5923, DOI 10.4049/jimmunol.173.10.5923; Tamada K, 2006, CANCER IMMUNOL IMMUN, V55, P355, DOI 10.1007/s00262-005-0081-y; Thomas M, 2002, P NATL ACAD SCI USA, V99, P14640, DOI 10.1073/pnas.192581499; Thomsen LL, 2004, VACCINE, V22, P1799, DOI 10.1016/j.vaccine.2003.09.052; Toso JF, 2002, J IMMUNOL METHODS, V259, P181, DOI 10.1016/S0022-1759(01)00513-0; Turner JG, 2001, J IMMUNOL, V166, P89, DOI 10.4049/jimmunol.166.1.89; van Elsas A, 1999, J EXP MED, V190, P355, DOI 10.1084/jem.190.3.355; van Mierlo GJD, 2002, P NATL ACAD SCI USA, V99, P5561, DOI 10.1073/pnas.082107699; van Mierlo GJD, 2004, J IMMUNOL, V173, P6753, DOI 10.4049/jimmunol.173.11.6753; Vicari AP, 2002, J EXP MED, V196, P541, DOI 10.1084/jem.20020732; Vicari AP, 2002, SEMIN CANCER BIOL, V12, P33, DOI 10.1006/scbi.2001.0400; Vonderheide RH, 2001, J CLIN ONCOL, V19, P3280, DOI 10.1200/JCO.2001.19.13.3280; Vonderheide RH, 2007, J CLIN ONCOL, V25, P876, DOI 10.1200/JCO.2006.08.3311; Walsh P, 2000, HUM GENE THER, V11, P1355, DOI 10.1089/10430340050032447; Wells JW, 2008, J IMMUNOL, V181, P3422, DOI 10.4049/jimmunol.181.5.3422; Welters MJP, 2007, VACCINE, V25, P1379, DOI 10.1016/j.vaccine.2006.10.049; Whitmore MM, 2004, CANCER RES, V64, P5850, DOI 10.1158/0008-5472.CAN-04-0063; Wierda WG, 2000, BLOOD, V96, P2917; Xiang R, 2001, J IMMUNOL, V167, P4560, DOI 10.4049/jimmunol.167.8.4560; Yang YP, 2004, NAT IMMUNOL, V5, P508, DOI 10.1038/ni1059; Zhang LX, 2003, P NATL ACAD SCI USA, V100, P15101, DOI 10.1073/pnas.2135379100; Zheng RX, 2008, CANCER RES, V68, P4045, DOI 10.1158/0008-5472.CAN-07-6669; Zhu Q, 2008, P NATL ACAD SCI USA, V105, P16260, DOI 10.1073/pnas.0805325105	90	53	63	0	29	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 8	2009	4	10							e7334	10.1371/journal.pone.0007334	http://dx.doi.org/10.1371/journal.pone.0007334			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DL	19812695	Green Published, Green Submitted, gold			2022-12-27	WOS:000270594200002
J	McGregor, SJ; Busa, MA; Yaggie, JA; Bollt, EM				McGregor, Stephen J.; Busa, Michael A.; Yaggie, James A.; Bollt, Erik M.			High Resolution MEMS Accelerometers to Estimate VO2 and Compare Running Mechanics between Highly Trained Inter-Collegiate and Untrained Runners	PLOS ONE			English	Article								Background: The purposes of this study were to determine the validity and reliability of high resolution accelerometers (HRA) relative to VO2 and speed, and compare putative differences in HRA signal between trained (T) and untrained (UT) runners during treadmill locomotion. Methodology: Runners performed 2 incremental VO2max trials while wearing HRA. RMS of high frequency signal from three axes (VT, ML, AP) and the Euclidean resultant (RES) were compared to VO2 to determine validity and reliability. Additionally, axial rms relative to speed, and ratio of axial accelerations to RES were compared between T and UT to determine if differences in running mechanics could be identified between the two groups. Principal Findings: Regression of RES was strongly related to VO2, but T was different than UT (r = 0.96 vs 0.92; p <.001) for walking and running. During walking, only the ratio of ML and AP to RES were different between groups. For running, nearly all acceleration parameters were lower for T than UT, the exception being ratio of VT to RES, which was higher in T than UT. All of these differences during running were despite higher VO2, O-2 cost, and lower RER in T vs UT, which resulted in no significant difference in energy expenditure between groups. Conclusions/Signficance: These results indicate that HRA can accurately and reliably estimate VO2 during treadmill locomotion, but differences exist between T and UT that should be considered when estimating energy expenditure. Differences in running mechanics between T and UT were identified, yet the importance of these differences remains to be determined.			McGregor, SJ (corresponding author), Eastern Michigan Univ, Appl Physiol Lab, Ypsilanti, MI 48197 USA.	smcgregor@emich.edu						Achten J, 2003, SPORTS MED, V33, P517, DOI 10.2165/00007256-200333070-00004; Banister E W, 1980, Can J Appl Sport Sci, V5, P170; Billat VL, 2006, J PHYSIOL SCI, V56, P103, DOI 10.2170/physiolsci.R2028; Buzzi UH, 2003, CLIN BIOMECH, V18, P435, DOI 10.1016/S0268-0033(03)00029-9; CAVAGNA G, 1961, J APPL PHYSIOL, V16, P191, DOI 10.1152/jappl.1961.16.1.191; Chen KY, 2005, MED SCI SPORT EXER, V37, pS490, DOI 10.1249/01.mss.0000185571.49104.82; Corder K, 2008, J APPL PHYSIOL, V105, P977, DOI 10.1152/japplphysiol.00094.2008; COUTTS AJ, 2008, J SCI MED SPORT; DANIELS J, 1992, MED SCI SPORT EXER, V24, P483; DANIELS JT, 1985, MED SCI SPORT EXER, V17, P332; Foster C, 2005, MED SCI SPORT EXER, V37, P670, DOI 10.1249/01.MSS.0000158183.64465.BF; Foster C, 2007, SPORTS MED, V37, P316, DOI 10.2165/00007256-200737040-00011; Fudge BW, 2007, MED SCI SPORT EXER, V39, P192, DOI 10.1249/01.mss.0000235884.71487.21; Georgoulis Anastasios D, 2006, J Clin Monit Comput, V20, P11, DOI 10.1007/s10877-006-1032-7; Gibson AS, 2004, BRIT J SPORT MED, V38, P797, DOI 10.1136/bjsm.2003.009852; Halsey LG, 2008, ZOOLOGY, V111, P231, DOI 10.1016/j.zool.2007.07.011; Henriksen M, 2004, GAIT POSTURE, V19, P288, DOI 10.1016/S0966-6362(03)00069-9; Kurz MJ, 2007, J BIOMECH ENG-T ASME, V129, P216, DOI 10.1115/1.2486008; Kurz MJ, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-30; Lambert EV, 2005, BRIT J SPORT MED, V39, P52, DOI 10.1136/bjsm.2003.011247; Lucia A, 2006, APPL PHYSIOL NUTR ME, V31, P530, DOI 10.1139/H06-029; MARTIN PE, 1992, MED SCI SPORT EXER, V24, P467; Masse LC, 2005, MED SCI SPORT EXER, V37, pS544, DOI 10.1249/01.mss.0000185674.09066.8a; MCGREGOR SJ, 2007, MED SCI SPORTS EXERC, V39, pS35; MCGREGOR SJ, 2008, J STRENGTH IN PRESS; McGregor SJ, 2009, CHAOS, V19, DOI 10.1063/1.3147423; Messier SP, 2008, MED SCI SPORT EXER, V40, P1873, DOI 10.1249/MSS.0b013e31817ed272; Miller DJ, 2006, J BIOMECH, V39, P2873, DOI 10.1016/j.jbiomech.2005.10.019; Moe-Nilssen R, 1998, CLIN BIOMECH, V13, P328, DOI 10.1016/S0268-0033(98)00090-4; Moe-Nilssen R, 1998, ARCH PHYS MED REHAB, V79, P1377, DOI 10.1016/S0003-9993(98)90231-3; Moraiti C, 2007, KNEE SURG SPORT TR A, V15, P1406, DOI 10.1007/s00167-007-0373-1; MORGAN DW, 1995, MED SCI SPORT EXER, V27, P404; MORTON RH, 1990, J APPL PHYSIOL, V69, P1171, DOI 10.1152/jappl.1990.69.3.1171; Slawinski JS, 2004, MED SCI SPORT EXER, V36, P1440, DOI 10.1249/01.MSS.0000135785.68760.96; Stagno KM, 2007, J SPORT SCI, V25, P629, DOI 10.1080/02640410600811817; Terrier Philippe, 2005, J Neuroeng Rehabil, V2, P28, DOI 10.1186/1743-0003-2-28; Troiano RP, 2008, MED SCI SPORT EXER, V40, P181, DOI 10.1249/mss.0b013e31815a51b3; Troiano RP, 2007, MED SCI SPORT EXER, V39, P1501, DOI 10.1097/mss.0b013e318150d42e; Trost SG, 2006, MED SCI SPORT EXER, V38, P380, DOI 10.1249/01.mss.0000183848.25845.e0; Ward DS, 2005, MED SCI SPORT EXER, V37, pS582, DOI 10.1249/01.mss.0000185292.71933.91; Welk GJ, 2005, MED SCI SPORT EXER, V37, pS501, DOI 10.1249/01.mss.0000185660.38335.de; WILLIAMS KR, 1987, J APPL PHYSIOL, V63, P1236, DOI 10.1152/jappl.1987.63.3.1236	42	61	61	1	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 6	2009	4	10							e7355	10.1371/journal.pone.0007355	http://dx.doi.org/10.1371/journal.pone.0007355			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DI	19806216	Green Published, gold, Green Submitted			2022-12-27	WOS:000270593800029
J	Quaranta, A; Bellantuono, V; Cassano, G; Lippe, C				Quaranta, Angelo; Bellantuono, Vito; Cassano, Giuseppe; Lippe, Claudio			Why Amphibians Are More Sensitive than Mammals to Xenobiotics	PLOS ONE			English	Article							PIG EAR SKIN; ANURAN AMPHIBIANS; ATRAZINE; EXTINCTION; ABSORPTION; EXPOSURE; PENETRATION; HERBICIDE; TRANSPORT; JUNCTIONS	Dramatic declines in amphibian populations have been described all over the world since the 1980s. The evidence that the sensitivity to environmental threats is greater in amphibians than in mammals has been generally linked to the observation that amphibians are characterized by a rather permeable skin. Nevertheless, a numerical comparison of data of percutaneous (through the skin) passage between amphibians and mammals is lacking. Therefore, in this investigation we have measured the percutaneous passage of two test molecules (mannitol and antipyrine) and three heavily used herbicides (atrazine, paraquat and glyphosate) in the skin of the frog Rana esculenta ( amphibians) and of the pig ear (mammals), by using the same experimental protocol and a simple apparatus which minimizes the edge effect, occurring when the tissue is clamped in the usually used experimental device. The percutaneous passage (P) of each substance is much greater in frog than in pig. LogP is linearly related to logK(ow) (logarithm of the octanol-water partition coefficient). The measured P value of atrazine was about 134 times larger than that of glyphosate in frog skin, but only 12 times in pig ear skin. The FoD value (P(frog)/P(pig)) was 302 for atrazine, 120 for antipyrine, 66 for mannitol, 29 for paraquat, and 26 for glyphosate. The differences in structure and composition of the skin between amphibians and mammals are discussed.			Quaranta, A (corresponding author), Univ Bari, Dept Anim Prod, I-70121 Bari, Italy.	a.quaranta@veterinaria.uniba.it		Quaranta, Angelo/0000-0001-7835-2485; CASSANO, Giuseppe/0000-0003-3698-3355				Anderson JM, 2001, NEWS PHYSIOL SCI, V16, P126; BirdLife International, 2004, STAT WORLDS BIRDS IN; BLAUSTEIN AR, 1990, TRENDS ECOL EVOL, V5, P203, DOI 10.1016/0169-5347(90)90129-2; Boone MD, 2003, ENVIRON TOXICOL CHEM, V22, P2695, DOI 10.1897/02-401; Carrer DC, 2008, J CONTROL RELEASE, V132, P12, DOI 10.1016/j.jconrel.2008.08.006; Cassano G, 2006, ENVIRON TOXICOL CHEM, V25, P509, DOI 10.1897/05-141R.1; Dalton R, 2002, NATURE, V416, P665, DOI 10.1038/416665a; DICK IP, 1992, J PHARM PHARMACOL, V44, P640, DOI 10.1111/j.2042-7158.1992.tb05485.x; FARQUHAR MG, 1965, J CELL BIOL, V26, P263, DOI 10.1083/jcb.26.1.263; HADLEY NF, 1991, ADV LIPID RES, V24, P303; Hansch C., 1995, EXPLORING QSAR HYDRO; HELMAN SI, 1974, AM J PHYSIOL, V226, P1198, DOI 10.1152/ajplegacy.1974.226.5.1198; Herkenne C, 2006, PHARM RES-DORDR, V23, P1850, DOI 10.1007/s11095-006-9011-8; IUCN - The World Conservation Union, 2001, IUCN RED LIST CAT CR; IUCN - World Conservation Union, 2003, IUCN RED LIST THREAT; Langerveld AJ, 2009, ENVIRON RES, V109, P379, DOI 10.1016/j.envres.2009.01.006; Lillywhite HB, 2006, J EXP BIOL, V209, P202, DOI 10.1242/jeb.02007; LILLYWHITE HB, 2007, KOSMETISCHE MED, V5, P220; Moody RP, 2000, TOXICOL IN VITRO, V14, P467, DOI 10.1016/S0887-2333(00)00038-2; Nemes Z, 1999, EXP MOL MED, V31, P5, DOI 10.1038/emm.1999.2; Nielsen JB, 2000, OCCUP ENVIRON MED, V57, P734, DOI 10.1136/oem.57.11.734; OECD, 2004, OECD GUID TEST CHEM; Pimm SL, 2000, NATURE, V403, P843, DOI 10.1038/35002708; Rowe CL, 2003, AMPHIBIAN DECLINE: AN INTEGRATED ANALYSIS OF MULTIPLE STRESSOR EFFECTS, P9; Sangster J, 2006, LOGKOW DATABANK EVAL; Schaefer H., 1996, SKIN BARRIER PRINCIP, P118; Sodhi NS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001636; Stuart SN, 2004, SCIENCE, V306, P1783, DOI 10.1126/science.1103538; Suzawa M, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002117; Thomas CD, 2004, NATURE, V427, P145, DOI 10.1038/nature02121; Uchiyama M, 2006, GEN COMP ENDOCR, V147, P54, DOI 10.1016/j.ygcen.2005.12.018; Vallet V, 2007, TOXICOL IN VITRO, V21, P1182, DOI 10.1016/j.tiv.2007.03.007; Willens S, 2006, ENVIRON TOXICOL PHAR, V22, P255, DOI 10.1016/j.etap.2006.04.010; WITHERS PC, 1984, J EXP ZOOL, V232, P11, DOI 10.1002/jez.1402320103; Young BE, 2001, CONSERV BIOL, V15, P1213, DOI 10.1046/j.1523-1739.2001.00218.x	35	85	89	7	64	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 4	2009	4	11							e7699	10.1371/journal.pone.0007699	http://dx.doi.org/10.1371/journal.pone.0007699			4	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RZ	19888346	gold, Green Published, Green Submitted			2022-12-27	WOS:000271414600007
J	Jonsdottir, IH; Hagg, DA; Glise, K; Ekman, R				Jonsdottir, Ingibjorg H.; Hagg, Daniel A.; Glise, Kristina; Ekman, Rolf			Monocyte Chemotactic Protein-1 (MCP-1) and Growth Factors Called into Question as Markers of Prolonged Psychosocial Stress	PLOS ONE			English	Article							C-REACTIVE PROTEIN; TERM SICKNESS ABSENCE; CARDIOVASCULAR-DISEASE; RHEUMATOID-ARTHRITIS; GENERAL-POPULATION; DEPRESSION SCALE; HOSPITAL ANXIETY; BURNOUT; WOMEN; INFLAMMATION	Background: Psychosocial stress is becoming a major contributor to increased mental ill-health and sick leave in many countries. Valid markers of chronic stress would be valuable for diagnostic and prognostic purposes. A recent study suggested monocyte chemotactic protein-1 (MCP-1), epidermal growth factor (EGF) and vascular endothelial growth factor (VEGF) as markers of chronic stress. We aimed to confirm these potential biomarkers of prolonged psychosocial stress in female patients. Methodology/Principal Findings: Circulating levels of MCP-1, EGF and VEGF, along with several other cytokines, were measured in plasma from 42 female patients suffering from exhaustion due to prolonged psychosocial stress and 42 control subjects, using a protein biochip immunoassay. There were no significant differences between patients and controls in any of the cytokines or growth factors analyzed. Furthermore, when using a different protein bioassay and reanalyzing MCP-1 and VEGF in the same samples, markedly different levels were obtained. To further explore if inflammation is present in patients with exhaustion, the classical inflammatory marker C-reactive protein (CRP) was measured in another group of patients (n = 89) and controls (n = 88) showing a small but significant increase of CRP levels in the patients. Conclusions/Significance: MCP-1, EGF and VEGF may not be suitable markers of prolonged psychosocial stress as previously suggested. Furthermore, significant differences were obtained when using two different protein assays measuring the same samples, indicating that comparing studies where different analytic techniques have been used might be difficult. Increased levels of CRP indicate that low-grade inflammation might be present in patients with exhaustion due to prolonged stress exposure but this inflammation does not seem to be reflected by increase in circulating MCP-1 or other cytokines measured.			Jonsdottir, IH (corresponding author), Inst Stress Med, Gothenburg, Sweden.	inga.jonsdottir@stressmedicin.com	Hägg, Daniel/K-8027-2019					[Anonymous], 2005, FAC CHALL BUILD SOL; Asberg M, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0003590; Bellingrath S, 2009, STRESS, V12, P37, DOI 10.1080/10253890802042041; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Black PH, 2002, J PSYCHOSOM RES, V52, P1, DOI 10.1016/S0022-3999(01)00302-6; BLAND JM, 1986, LANCET, V1, P307, DOI 10.1016/s0140-6736(86)90837-8; Bultmann U, 2005, J OCCUP ENVIRON MED, V47, P941; CUSHING SD, 1990, P NATL ACAD SCI USA, V87, P5134, DOI 10.1073/pnas.87.13.5134; FitzGerald SP, 2005, CLIN CHEM, V51, P1165, DOI 10.1373/clinchem.2005.049429; Grossi G, 2003, J PSYCHOSOM RES, V55, P309, DOI 10.1016/S0022-3999(02)00633-5; Haus E, 2001, CHRONOBIOL INT, V18, P709, DOI 10.1081/CBI-100106083; Hayashi M, 2007, BIOL PHARM BULL, V30, P621, DOI 10.1248/bpb.30.621; Henderson M, 2005, BMJ-BRIT MED J, V330, P802, DOI 10.1136/bmj.330.7495.802; Henningsson S, 2008, BEHAV BRAIN FUNCT, V4, DOI 10.1186/1744-9081-4-16; Hetland ML, 2008, DIS MARKERS, V24, P1; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; KOCH AE, 1992, J CLIN INVEST, V90, P772, DOI 10.1172/JCI115950; Kudielka B M, 2006, G Ital Med Lav Ergon, V28, P34; Kuo HK, 2005, LANCET NEUROL, V4, P371, DOI 10.1016/S1474-4422(05)70099-5; Maslach C, 2001, ANNU REV PSYCHOL, V52, P397, DOI 10.1146/annurev.psych.52.1.397; MELAMED S, 1992, BEHAV MED, V18, P53, DOI 10.1080/08964289.1992.9935172; Melamed S, 2006, PSYCHOL BULL, V132, P327, DOI 10.1037/0033-2909.132.3.327; Panagiotakos DB, 2004, EUR HEART J, V25, P492, DOI 10.1016/j.ehj.2004.01.018; Rajagopalan S, 2001, AM J CARDIOL, V88, P196, DOI 10.1016/S0002-9149(01)01623-X; Ranjit N, 2007, ARCH INTERN MED, V167, P174, DOI 10.1001/archinte.167.2.174; Rink L, 1998, MECH AGEING DEV, V102, P199, DOI 10.1016/S0047-6374(97)00153-X; Rovin BH, 1999, BIOCHEM BIOPH RES CO, V259, P344, DOI 10.1006/bbrc.1999.0796; Stansfeld S, 2006, SCAND J WORK ENV HEA, V32, P443, DOI 10.5271/sjweh.1050; Stenlund T, 2007, SCAND J PUBLIC HEALT, V35, P516, DOI 10.1080/14034940701271874; Sutcigil L, 2007, CLIN DEV IMMUNOL, DOI 10.1155/2007/76396; Toker S, 2005, J OCCUP HEALTH PSYCH, V10, P344, DOI 10.1037/1076-8998.10.4.344; Wener MH, 2000, J RHEUMATOL, V27, P2351; Zhang ZF, 2008, EXP BIOL MED, V233, P1171, DOI 10.3181/0712-RM-328; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	34	37	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	NOV 3	2009	4	11							e7659	10.1371/journal.pone.0007659	http://dx.doi.org/10.1371/journal.pone.0007659			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	514RY	19888340	Green Published, Green Submitted, gold			2022-12-27	WOS:000271414500003
J	Hirsch, ML; Storici, F; Li, CW; Choi, VW; Samulski, J				Hirsch, Matthew L.; Storici, Francesca; Li, Chengwen; Choi, Vivian W.; Samulski, Jude			AAV Recombineering with Single Strand Oligonucleotides	PLOS ONE			English	Article							RECOMBINANT ADENOASSOCIATED VIRUS; PACKAGING CAPACITY; GENE-THERAPY; DNA-DAMAGE; REPAIR; TRANSDUCTION; REPLICATION; VECTORS; CELLS; GENOMES	Adeno-associated virus (AAV) transduction initiates a signaling cascade that culminates in a transient DNA damage response. During this time, host DNA repair proteins convert the linear single-strand AAV genomes to double-strand circular monomers and concatemers in processes stimulated by the AAV inverted terminal repeats (ITRs). As the orientation of AAV genome concatemerization appears unbiased, the likelihood of concatemerization in a desired orientation is low (less than 1 in 6). Using a novel recombineering method, Oligo-Assisted AAV Genome Recombination (OAGR), this work demonstrates the ability to direct concatemerization specifically to a desired orientation in human cells. This was achieved by a single-strand DNA oligonucleotide (oligo) displaying homology to distinct AAV genomes capable of forming an intermolecular bridge for recombination. This DNA repair process results in concatemers with genomic junctions corresponding to the sequence of oligo homology. Furthermore, OAGR was restricted to single-strand, not duplexed, AAV genomes suggestive of replication-dependent recombination. Consistent with this process, OAGR demonstrated oligo polarity biases in all tested configurations except when a portion of the oligo targeted the ITR. This approach, in addition to being useful for the elucidation of intermolecular homologous recombination, may find eventual relevance for AAV mediated large gene therapy.			Hirsch, ML (corresponding author), Univ N Carolina, UNC Gene Therapy Ctr, Chapel Hill, NC 27599 USA.	RJS@med.unc.edu	Xue, Fu-Shan/ADO-0664-2022	Choi, Vivian/0000-0003-4787-0735	NHLBI NIH HHS [P01 HL051818, HL066973, HL051818, P01 HL066973] Funding Source: Medline; NIAID NIH HHS [R01 AI072176, AI072176] Funding Source: Medline; NIGMS NIH HHS [GM0529299] Funding Source: Medline; NATIONAL HEART, LUNG, AND BLOOD INSTITUTE [P01HL051818, P01HL066973] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES [R01AI072176] Funding Source: NIH RePORTER	NHLBI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NIAID NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NATIONAL HEART, LUNG, AND BLOOD INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI)); NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID))		Choi VW, 2006, J VIROL, V80, P10346, DOI 10.1128/JVI.00841-06; Choi VW, 2005, J VIROL, V79, P6801, DOI 10.1128/JVI.79.11.6801-6807.2005; Duan DS, 1998, J VIROL, V72, P8568, DOI 10.1128/JVI.72.11.8568-8577.1998; Duan DS, 2001, MOL THER, V4, P383, DOI 10.1006/mthe.2001.0456; Ellis HM, 2001, P NATL ACAD SCI USA, V98, P6742, DOI 10.1073/pnas.121164898; Ferrari FK, 1996, J VIROL, V70, P3227, DOI 10.1128/JVI.70.5.3227-3234.1996; Ghosh A, 2008, MOL THER, V16, P124, DOI 10.1038/sj.mt.6300322; Grieger JC, 2006, NAT PROTOC, V1, P1412, DOI 10.1038/nprot.2006.207; Halbert CL, 2002, NAT BIOTECHNOL, V20, P697, DOI 10.1038/nbt0702-697; Hermanns J, 1997, J VIROL, V71, P6020, DOI 10.1128/JVI.71.8.6020-6027.1997; Huen MSY, 2006, NUCLEIC ACIDS RES, V34, P6183, DOI 10.1093/nar/gkl852; Inagaki K, 2007, J VIROL, V81, P11304, DOI 10.1128/JVI.01225-07; Jasin M, 1996, TRENDS GENET, V12, P224, DOI 10.1016/0168-9525(96)10019-6; Jurvansuu J, 2005, J VIROL, V79, P569, DOI 10.1128/JVI.79.1.569-580.2005; Jurvansuu J, 2007, J MOL BIOL, V372, P397, DOI 10.1016/j.jmb.2007.06.077; King JA, 2001, EMBO J, V20, P3282, DOI 10.1093/emboj/20.12.3282; Kreuzer KN, 2005, ANNU REV MICROBIOL, V59, P43, DOI 10.1146/annurev.micro.59.030804.121255; Liu L, 2002, MOL CELL BIOL, V22, P3852, DOI 10.1128/MCB.22.11.3852-3863.2002; Nakai H, 2000, J VIROL, V74, P9451, DOI 10.1128/JVI.74.20.9451-9463.2000; Radecke F, 2006, MOL THER, V14, P798, DOI 10.1016/j.ymthe.2006.06.008; Radecke S, 2006, J GENE MED, V8, P217, DOI 10.1002/jgm.828; Raj K, 2001, NATURE, V412, P914, DOI 10.1038/35091082; SAMULSKI RJ, 1989, J VIROL, V63, P3822, DOI 10.1128/JVI.63.9.3822-3828.1989; SAMULSKI RJ, 1983, CELL, V33, P135, DOI 10.1016/0092-8674(83)90342-2; Schwartz RA, 2007, J VIROL, V81, P12936, DOI 10.1128/JVI.01523-07; SRIVASTAVA A, 1983, J VIROL, V45, P555, DOI 10.1128/JVI.45.2.555-564.1983; Storici F, 2003, P NATL ACAD SCI USA, V100, P14994, DOI 10.1073/pnas.2036296100; Storici F, 2006, MOL CELL BIOL, V26, P7645, DOI 10.1128/MCB.00672-06; Wu ZJ, 2006, MOL THER, V14, P316, DOI 10.1016/j.ymthe.2006.05.009; Xu ZP, 2004, HUM GENE THER, V15, P896, DOI 10.1089/1043034041839253; YAMAMOTO T, 1992, GENETICS, V131, P811; Zolotukhin S, 1999, GENE THER, V6, P973, DOI 10.1038/sj.gt.3300938	32	22	22	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 2	2009	4	11							e7705	10.1371/journal.pone.0007705	http://dx.doi.org/10.1371/journal.pone.0007705			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	514RX	19888330	Green Published, gold			2022-12-27	WOS:000271414400013
J	Yasrebi, H; Sperisen, P; Praz, V; Bucher, P				Yasrebi, Haleh; Sperisen, Peter; Praz, Viviane; Bucher, Philipp			Can Survival Prediction Be Improved By Merging Gene Expression Data Sets?	PLOS ONE			English	Article							BREAST-CANCER; MICROARRAY DATA; ESTROGEN-RECEPTOR; HISTOLOGIC GRADE; MARKER GENES; SIGNATURE; PLATFORM; CLASSIFICATION; CARCINOMAS; SUBTYPES	Background: High-throughput gene expression profiling technologies generating a wealth of data, are increasingly used for characterization of tumor biopsies for clinical trials. By applying machine learning algorithms to such clinically documented data sets, one hopes to improve tumor diagnosis, prognosis, as well as prediction of treatment response. However, the limited number of patients enrolled in a single trial study limits the power of machine learning approaches due to over-fitting. One could partially overcome this limitation by merging data from different studies. Nevertheless, such data sets differ from each other with regard to technical biases, patient selection criteria and follow-up treatment. It is therefore not clear at all whether the advantage of increased sample size outweighs the disadvantage of higher heterogeneity of merged data sets. Here, we present a systematic study to answer this question specifically for breast cancer data sets. We use survival prediction based on Cox regression as an assay to measure the added value of merged data sets. Results: Using time-dependent Receiver Operating Characteristic-Area Under the Curve (ROC-AUC) and hazard ratio as performance measures, we see in overall no significant improvement or deterioration of survival prediction with merged data sets as compared to individual data sets. This apparently was due to the fact that a few genes with strong prognostic power were not available on all microarray platforms and thus were not retained in the merged data sets. Surprisingly, we found that the overall best performance was achieved with a single-gene predictor consisting of CYB5D1. Conclusions: Merging did not deteriorate performance on average despite (a) The diversity of microarray platforms used. (b) The heterogeneity of patients cohorts. (c) The heterogeneity of breast cancer disease. (d) Substantial variation of time to death or relapse. (e) The reduced number of genes in the merged data sets. Predictors derived from the merged data sets were more robust, consistent and reproducible across microarray platforms. Moreover, merging data sets from different studies helps to better understand the biases of individual studies and can lead to the identification of strong survival factors like CYB5D1 expression.			Yasrebi, H (corresponding author), Swiss Fed Inst Technol EPFL, Swiss Inst Expt Canc Res ISREC, Sch Life Sci, EPFL SV ISREC, Lausanne, Switzerland.	Haleh.Yasrebi@epfl.ch						Ach RA, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-148; Acharya CR, 2008, JAMA-J AM MED ASSOC, V299, P1574, DOI 10.1001/jama.299.13.1574; Benito M, 2004, BIOINFORMATICS, V20, P105, DOI 10.1093/bioinformatics/btg385; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Bild AH, 2006, NATURE, V439, P353, DOI 10.1038/nature04296; Bloom G, 2004, AM J PATHOL, V164, P9, DOI 10.1016/S0002-9440(10)63090-8; Boutros PC, 2009, P NATL ACAD SCI USA, V106, P2824, DOI 10.1073/pnas.0809444106; BURKE HB, 1993, CANCER, V72, P3131, DOI 10.1002/1097-0142(19931115)72:10<3131::AID-CNCR2820721039>3.0.CO;2-J; Buyse M, 2006, JNCI-J NATL CANCER I, V98, P1183, DOI 10.1093/jnci/djj329; Calza S, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1517; Chang HY, 2005, P NATL ACAD SCI USA, V102, P3738, DOI 10.1073/pnas.0409462102; Chen QR, 2008, GENOMICS, V92, P195, DOI 10.1016/j.ygeno.2008.05.014; Craven RJ, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2191; Dan L, 2008, J CLIN ONCOL, V26, DOI 10.1200/jco.2008.26.15_suppl.7580; Ein-Dor L, 2005, BIOINFORMATICS, V21, P171, DOI 10.1093/bioinformatics/bth469; Ein-Dor L, 2006, P NATL ACAD SCI USA, V103, P5923, DOI 10.1073/pnas.0601231103; Fan C, 2006, NEW ENGL J MED, V355, P560, DOI 10.1056/NEJMoa052933; Gentleman RC, 2004, GENOME BIOL, V5, DOI 10.1186/gb-2004-5-10-r80; Grade M, 2006, CANCER RES, V66, P267, DOI 10.1158/0008-5472.CAN-05-2533; Grade M, 2007, CANCER RES, V67, P41, DOI 10.1158/0008-5472.CAN-06-1514; Haibe-Kains B, 2008, BIOINFORMATICS, V24, P2200, DOI 10.1093/bioinformatics/btn374; Heagerty PJ, 2000, BIOMETRICS, V56, P337, DOI 10.1111/j.0006-341X.2000.00337.x; Hu ZY, 2006, BMC GENOMICS, V7, DOI 10.1186/1471-2164-7-96; Ivshina AV, 2006, CANCER RES, V66, P10292, DOI 10.1158/0008-5472.CAN-05-4414; Jenssen TK, 2002, HUM GENET, V111, P411, DOI 10.1007/s00439-002-0804-5; Jiang HY, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-81; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; LIN X, 2003, MAKING SENSE HUMAN L; Loi S, 2007, J CLIN ONCOL, V25, P1239, DOI 10.1200/JCO.2006.07.1522; Lu Y, 2006, PLOS MED, V3, P2229, DOI 10.1371/journal.pmed.0030467; Lyman GH, 2006, CLIN BREAST CANCER, V7, P372, DOI 10.3816/CBC.2006.n.053; Mackay A, 2007, BREAST CANCER RES, V9, DOI 10.1186/bcr1732; Mullins M, 2007, CLIN CHEM, V53, P1273, DOI 10.1373/clinchem.2006.083725; Pawitan Y, 2005, BREAST CANCER RES, V7, pR953, DOI 10.1186/bcr1325; Pepe MS, 2004, AM J EPIDEMIOL, V159, P882, DOI 10.1093/aje/kwh101; Perreard L, 2006, BREAST CANCER RES, V8, DOI 10.1186/bcr1399; Praz V, 2004, NUCLEIC ACIDS RES, V32, pD542, DOI 10.1093/nar/gkh107; Pruitt KD, 2001, NUCLEIC ACIDS RES, V29, P137, DOI 10.1093/nar/29.1.137; R Development Core Team, 2007, R LANG ENV STAT COMP; Reyal F, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2192; Rhodes DR, 2004, NEOPLASIA, V6, P1, DOI 10.1016/S1476-5586(04)80047-2; SCHULER GD, 1996, SCIENCE, V274; Shen RL, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-94; Sohal D, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002965; Sorlie T, 2003, P NATL ACAD SCI USA, V100, P8418, DOI 10.1073/pnas.0932692100; Sorlie T, 2001, P NATL ACAD SCI USA, V98, P10869, DOI 10.1073/pnas.191367098; Sotiriou C, 2006, JNCI-J NATL CANCER I, V98, P262, DOI 10.1093/jnci/djj052; Stec J, 2005, J MOL DIAGN, V7, P357, DOI 10.1016/S1525-1578(10)60565-X; Troyanskaya O, 2001, BIOINFORMATICS, V17, P520, DOI 10.1093/bioinformatics/17.6.520; Vachani A, 2007, CLIN CANCER RES, V13, P2905, DOI 10.1158/1078-0432.CCR-06-1670; van de Vijver MJ, 2002, NEW ENGL J MED, V347, P1999, DOI 10.1056/NEJMoa021967; van Vliet MH, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-375; Wain HM, 2002, GENOMICS, V79, P464, DOI 10.1006/geno.2002.6748; Wang YX, 2005, LANCET, V365, P671, DOI 10.1016/S0140-6736(05)17947-1; Warnat P, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-265; Wirapati P, 2008, BREAST CANCER RES, V10, DOI 10.1186/bcr2124; Xu L, 2005, BIOINFORMATICS, V21, P3905, DOI 10.1093/bioinformatics/bti647; Xu L, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-125	58	36	37	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 23	2009	4	10							e7431	10.1371/journal.pone.0007431	http://dx.doi.org/10.1371/journal.pone.0007431			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MQ	19851466	Green Submitted, Green Published, gold			2022-12-27	WOS:000271022300002
J	Hall, JS; Ip, HS; Franson, JC; Meteyer, C; Nashold, S; TeSlaa, JL; French, J; Redig, P; Brand, C				Hall, Jeffrey S.; Ip, Hon S.; Franson, J. Christian; Meteyer, Carol; Nashold, Sean; TeSlaa, Joshua L.; French, John; Redig, Patrick; Brand, Christopher			Experimental Infection of a North American Raptor, American Kestrel (Falco sparverius), with Highly Pathogenic Avian Influenza Virus (H5N1)	PLOS ONE			English	Article							DUCKS; SUSCEPTIBILITY; GULLS	Several species of wild raptors have been found in Eurasia infected with highly pathogenic avian influenza virus (HPAIV) subtype H5N1. Should HPAIV (H5N1) reach North America in migratory birds, species of raptors are at risk not only from environmental exposure, but also from consuming infected birds and carcasses. In this study we used American kestrels as a representative species of a North American raptor to examine the effects of HPAIV (H5N1) infection in terms of dose response, viral shedding, pathology, and survival. Our data showed that kestrels are highly susceptible to HPAIV (H5N1). All birds typically died or were euthanized due to severe neurologic disease within 4-5 days of inoculation and shed significant amounts of virus both orally and cloacally, regardless of dose administered. The most consistent microscopic lesions were necrosis in the brain and pancreas. This is the first experimental study of HPAIV infection in a North American raptor and highlights the potential risks to birds of prey if HPAIV (H5N1) is introduced into North America.			Hall, JS (corresponding author), USGS Natl Wildlife Hlth Ctr, Madison, WI USA.	jshall@usgs.gov		Ip, Hon/0000-0003-4844-7533; TeSlaa, Joshua/0000-0001-7802-3454; Franson, J/0000-0002-0251-4238; Hall, Jeffrey/0000-0001-5599-2826; Meteyer, Carol/0000-0002-4007-3410; Nashold, Sean/0000-0002-8869-6633	PHS HHS [HHSN266200700007C] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Alexander DJ, 2007, AVIAN DIS, V51, P161, DOI 10.1637/7602-041306R.1; Beaty B.J., 1995, DIAGNOSTIC PROCEDURE, P189; Brown JD, 2008, AVIAN PATHOL, V37, P393, DOI 10.1080/03079450802216595; Brown JD, 2008, EMERG INFECT DIS, V14, P136, DOI 10.3201/eid1401.070740; Brown JD, 2007, J WILDLIFE DIS, V43, P660, DOI 10.7589/0090-3558-43.4.660; Brown JD, 2006, EMERG INFECT DIS, V12, P1663, DOI 10.3201/eid1211.060652; Clark L, 2006, ORNITHOL MONOGR, P3; COUACYHYMANN E, 2008, 1 SPECIFIC DETECTION, P1; Keawcharoen J, 2008, EMERG INFECT DIS, V14, P600, DOI 10.3201/eid1404.071016; Lierz M, 2007, EMERG INFECT DIS, V13, P1667, DOI 10.3201/eid1311.070705; Medica DL, 2007, J WILDLIFE DIS, V43, P538, DOI 10.7589/0090-3558-43.3.538; REED L. J., 1938, AMER JOUR HYG, V27, P493; SAMOUR J, 2006, FALCO NEWSLETTER, V27, P21; Spackman E, 2002, J CLIN MICROBIOL, V40, P3256, DOI 10.1128/JCM.40.9.3256-3260.2002; SWAYNE D., 1998, LAB MANUAL ISOLATION, P150; Van Borm S, 2005, EMERG INFECT DIS, V11, P702, DOI 10.3201/eid1105.050211	16	27	27	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 22	2009	4	10							e7555	10.1371/journal.pone.0007555	http://dx.doi.org/10.1371/journal.pone.0007555			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509MN	19847294	Green Published, Green Submitted, gold			2022-12-27	WOS:000271022000017
J	Louie, B; Higdon, R; Kolker, E				Louie, Brenton; Higdon, Roger; Kolker, Eugene			A Statistical Model of Protein Sequence Similarity and Function Similarity Reveals Overly-Specific Function Predictions	PLOS ONE			English	Article							GENE ONTOLOGY; SEMANTIC SIMILARITY; ANNOTATION TRANSFER; HYPOTHETICAL GENES; DATABASE; GENOMICS; ERRORS; BLAST; IDENTIFICATION; EXPRESSION	Background: Predicting protein function from primary sequence is an important open problem in modern biology. Not only are there many thousands of proteins of unknown function, current approaches for predicting function must be improved upon. One problem in particular is overly-specific function predictions which we address here with a new statistical model of the relationship between protein sequence similarity and protein function similarity. Methodology: Our statistical model is based on sets of proteins with experimentally validated functions and numeric measures of function specificity and function similarity derived from the Gene Ontology. The model predicts the similarity of function between two proteins given their amino acid sequence similarity measured by statistics from the BLAST sequence alignment algorithm. A novel aspect of our model is that it predicts the degree of function similarity shared between two proteins over a continuous range of sequence similarity, facilitating prediction of function with an appropriate level of specificity. Significance: Our model shows nearly exact function similarity for proteins with high sequence similarity (bit score > 244.7, e-value > 1e(-62), non-redundant NCBI protein database (NRDB)) and only small likelihood of specific function match for proteins with low sequence similarity (bit score < 54.6, e-value < 1e(-05), NRDB). For sequence similarity ranges in between our annotation model shows an increasing relationship between function similarity and sequence similarity, but with considerable variability. We applied the model to a large set of proteins of unknown function, and predicted functions for thousands of these proteins ranging from general to very specific. We also applied the model to a data set of proteins with previously assigned, specific functions that were electronically based. We show that, on average, these prior function predictions are more specific (quite possibly overly-specific) compared to predictions from our model that is based on proteins with experimentally determined function.			Louie, B (corresponding author), Seattle Childrens Res Inst, Bioinformat & High Throughput Anal Lab, Seattle, WA USA.	eugene.kolker@seattlechildrens.org	Kolker, Eugene/C-6711-2008		NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES [U01DK072473] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM076680] Funding Source: NIH RePORTER; NIDDK NIH HHS [UO1 DK072473, U01 DK072473] Funding Source: Medline; NIGMS NIH HHS [R01 GM076680, 5R01 GM076680-02] Funding Source: Medline	NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIDDK NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Addou S, 2009, J MOL BIOL, V387, P416, DOI 10.1016/j.jmb.2008.12.045; AKAIKE H, 1974, IEEE T AUTOMAT CONTR, VAC19, P716, DOI 10.1109/TAC.1974.1100705; Altschul SF, 1997, NUCLEIC ACIDS RES, V25, P3389, DOI 10.1093/nar/25.17.3389; Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bork P, 2000, GENOME RES, V10, P398, DOI 10.1101/gr.10.4.398; Brenner SE, 1999, TRENDS GENET, V15, P132, DOI 10.1016/S0168-9525(99)01706-0; Camon E, 2004, NUCLEIC ACIDS RES, V32, pD262, DOI 10.1093/nar/gkh021; Deonier R.C., 2005, COMPUTATIONAL GENOME; Devos D, 2000, PROTEINS, V41, P98, DOI 10.1002/1097-0134(20001001)41:1<98::AID-PROT120>3.3.CO;2-J; Devos D, 2001, TRENDS GENET, V17, P429, DOI 10.1016/S0168-9525(01)02348-4; Frishman D, 2001, BIOINFORMATICS, V17, P44, DOI 10.1093/bioinformatics/17.1.44; FRISHMAN D, 2008, MODERN GENOME ANNOTA; Frishman D, 2007, CHEM REV, V107, P3448, DOI 10.1021/cr068303k; Galperin M Y, 1998, In Silico Biol, V1, P55; Galperin MY, 2006, CURR OPIN BIOTECH, V17, P440, DOI 10.1016/j.copbio.2006.08.007; Galperin MY, 2004, NUCLEIC ACIDS RES, V32, P5452, DOI 10.1093/nar/gkh885; Gilks WR, 2002, BIOINFORMATICS, V18, P1641, DOI 10.1093/bioinformatics/18.12.1641; Gough J, 2001, J MOL BIOL, V313, P903, DOI 10.1006/jmbi.2001.5080; Hastie T., 2007, ELEMENTS STAT LEARNI; Hegyi H, 2001, GENOME RES, V11, P1632, DOI 10.1101/gr. 183801; HENIKOFF S, 1994, GENOMICS, V19, P97, DOI 10.1006/geno.1994.1018; Hunter S, 2009, NUCLEIC ACIDS RES, V37, pD211, DOI 10.1093/nar/gkn785; Iliopoulos I, 2003, BIOINFORMATICS, V19, P717, DOI 10.1093/bioinformatics/btg077; Jones CE, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-170; Joshi T, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-222; Karp PD, 1998, BIOINFORMATICS, V14, P753, DOI 10.1093/bioinformatics/14.9.753; Karp PD, 2001, BIOINFORMATICS, V17, P526, DOI 10.1093/bioinformatics/17.6.526; Kolker E, 2005, P NATL ACAD SCI USA, V102, P2099, DOI 10.1073/pnas.0409111102; Kolker E, 2004, NUCLEIC ACIDS RES, V32, P2353, DOI 10.1093/nar/gkh555; Kolker E, 2003, J BACTERIOL, V185, P4593, DOI 10.1128/JB.185.15.4593-4602.2003; Koonin EV, 2003, SEQUENCE EVOLUTION F; Lee TJ, 2008, BIOINFORMATICS, V24, pI259, DOI 10.1093/bioinformatics/btn180; Lin D, 1998, P INT C MACH LEARN; Lord PW, 2003, BIOINFORMATICS, V19, P1275, DOI 10.1093/bioinformatics/btg153; Louie B, 2008, OMICS, V12, P211, DOI 10.1089/omi.2008.0051; Maglott D, 2005, NUCLEIC ACIDS RES, V33, pD54, DOI 10.1093/nar/gki031; Marchler-Bauer A, 2009, NUCLEIC ACIDS RES, V37, pD205, DOI 10.1093/nar/gkn845; Martin DMA, 2004, BMC BIOINFORMATICS, V5, DOI 10.1186/1471-2105-5-178; McCullagh P, 1989, GEN LINEAR MODELS; McGinnis S, 2004, NUCLEIC ACIDS RES, V32, pW20, DOI 10.1093/nar/gkh435; Ouzounis CA, 2002, GENOME BIOL, V3; Pesquita C, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S5-S4; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Raghunathan A, 2004, OMICS, V8, P25, DOI 10.1089/153623104773547471; Roberts RJ, 2004, PLOS BIOL, V2, P293, DOI 10.1371/journal.pbio.0020042; Rost B, 1999, PROTEIN ENG, V12, P85, DOI 10.1093/protein/12.2.85; Sangar V, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-294; SMITH TF, 1981, J MOL BIOL, V147, P195, DOI 10.1016/0022-2836(81)90087-5; Thomas GH, 1999, BIOINFORMATICS, V15, P860, DOI 10.1093/bioinformatics/15.10.860; Valencia A, 2005, CURR OPIN STRUC BIOL, V15, P267, DOI 10.1016/j.sbi.2005.05.010; Wilson CA, 2000, J MOL BIOL, V297, P233, DOI 10.1006/jmbi.2000.3550; Ye J, 2006, NUCLEIC ACIDS RES, V34, pW6, DOI 10.1093/nar/gkl164	52	23	24	0	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7546	10.1371/journal.pone.0007546	http://dx.doi.org/10.1371/journal.pone.0007546			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844580	gold, Green Published, Green Submitted			2022-12-27	WOS:000271013000019
J	Gershon, TR; Shirazi, A; Qin, LX; Gerald, WL; Kenney, AM; Cheung, NK				Gershon, Timothy R.; Shirazi, Arash; Qin, Li-Xuan; Gerald, William L.; Kenney, Anna M.; Cheung, Nai-Kong			Enteric Neural Crest Differentiation in Ganglioneuromas Implicates Hedgehog Signaling in Peripheral Neuroblastic Tumor Pathogenesis	PLOS ONE			English	Article							FIBRILLARY ACIDIC PROTEIN; B RECEPTOR GENE; SONIC HEDGEHOG; HIRSCHSPRUNGS-DISEASE; NEURONAL PRECURSORS; DESERT HEDGEHOG; MOUSE MODEL; CELLS; EXPRESSION; ZEBRAFISH	Peripheral neuroblastic tumors (PNTs) share a common origin in the sympathetic nervous system, but manifest variable differentiation and growth potential. Malignant neuroblastoma (NB) and benign ganglioneuroma (GN) stand at opposite ends of the clinical spectrum. We hypothesize that a common PNT progenitor is driven to variable differentiation by specific developmental signaling pathways. To elucidate developmental pathways that direct PNTs along the differentiation spectrum, we compared the expression of genes related to neural crest development in GN and NB. In GNs, we found relatively low expression of sympathetic markers including adrenergic biosynthesis enzymes, indicating divergence from sympathetic fate. In contrast, GNs expressed relatively high levels of enteric neuropeptides and key constituents of the Hedgehog (HH) signaling pathway, including Dhh, Gli1 and Gli3. Predicted HH targets were also differentially expressed in GN, consistent with transcriptional response to HH signaling. These findings indicate that HH signaling is specifically active in GN. Together with the known role of HH activity in enteric neural development, these findings further suggested a role for HH activity in directing PNTs away from the sympathetic lineage toward a benign GN phenotype resembling enteric ganglia. We tested the potential for HH signaling to advance differentiation in PNTs by transducing NB cell lines with Gli1 and determining phenotypic and transcriptional response. Gli1 inhibited proliferation of NB cells, and induced a pattern of gene expression that resembled the differential pattern of gene expression of GN, compared to NB (p<0.00001). Moreover, the transcriptional response of SY5Y cells to Gli1 transduction closely resembled the transcriptional response to the differentiation agent retinoic acid (p<0.00001). Notably, Gli1 did not induce N-MYC expression in neuroblastoma cells, but strongly induced RET, a known mediator of RA effect. The decrease in NB cell proliferation induced by Gli1, and the similarity in the patterns of gene expression induced by Gli1 and by RA, corroborated by closely matched gene sets in GN tumors, all support a model in which HH signaling suppresses PNT growth by promoting differentiation along alternative neural crest pathways.			Gershon, TR (corresponding author), Mem Sloan Kettering Canc Ctr, Dept Pediat, 1275 York Ave, New York, NY 10021 USA.	gershont@neurology.unc.edu	Gershon, Timothy/H-5398-2019	Gershon, Timothy/0000-0001-7034-6400	NATIONAL CANCER INSTITUTE [P01CA106450] Funding Source: NIH RePORTER; NCI NIH HHS [CA106450, P01 CA106450] Funding Source: Medline	NATIONAL CANCER INSTITUTE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI)); NCI NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI))		Abe M, 2007, INT J DEV BIOL, V51, P97, DOI 10.1387/ijdb.062237ma; Alaminos M, 2003, CANCER RES, V63, P4538; Barrallo-Gimeno A, 2004, DEVELOPMENT, V131, P1463, DOI 10.1242/dev.01033; Cariboni A, 2004, HUM MOL GENET, V13, P2781, DOI 10.1093/hmg/ddh309; Chamberlain CE, 2008, DEVELOPMENT, V135, P1097, DOI 10.1242/dev.013086; EDERY P, 1994, NATURE, V367, P378, DOI 10.1038/367378a0; Eggert A, 2008, PEDIATR CLIN N AM, V55, px; ELFVIN LG, 1987, CELL TISSUE RES, V250, P79, DOI 10.1007/BF00214657; Fu M, 2004, J CELL BIOL, V166, P673, DOI 10.1083/jcb.200401077; Galvin KE, 2008, STEM CELLS, V26, P1027, DOI 10.1634/stemcells.2007-0879; Gershon TR, 2005, NEOPLASIA, V7, P575, DOI 10.1593/neo.04637; Goodrich LV, 1997, SCIENCE, V277, P1109, DOI 10.1126/science.277.5329.1109; GRIFFIN ME, 1969, PEDIATRICS, V43, P377; Hallahan AR, 2004, CANCER RES, V64, P7794, DOI 10.1158/0008-5472.CAN-04-1813; Han J, 2007, MECH DEVELOP, V124, P729, DOI 10.1016/j.mod.2007.06.006; Hong SJ, 2008, J BIOL CHEM, V283, P16860, DOI 10.1074/jbc.M709106200; HOSODA K, 1994, CELL, V79, P1267, DOI 10.1016/0092-8674(94)90017-5; Ingram WJ, 2002, ONCOGENE, V21, P8196, DOI 10.1038/sj.onc.1205975; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Jeong JH, 2004, GENE DEV, V18, P937, DOI 10.1101/gad.1190304; JESSEN KR, 1984, J NEUROCYTOL, V13, P187, DOI 10.1007/BF01148114; Kenney AM, 2000, MOL CELL BIOL, V20, P9055, DOI 10.1128/MCB.20.23.9055-9067.2000; KIRCHGESSNER AL, 1988, J COMP NEUROL, V276, P607, DOI 10.1002/cne.902760412; Kwiatkowski JL, 1998, CANCER RES, V58, P4602; Lee J, 1997, DEVELOPMENT, V124, P2537; LINDH B, 1989, CELL TISSUE RES, V256, P259; Lipinski RJ, 2005, DEV DYNAM, V233, P829, DOI 10.1002/dvdy.20414; Liu SQ, 2005, CANCER LETT, V228, P125, DOI 10.1016/j.canlet.2005.01.056; Mao J, 2006, CANCER RES, V66, P10171, DOI 10.1158/0008-5472.CAN-06-0657; Matthay KK, 1999, NEW ENGL J MED, V341, P1165, DOI 10.1056/NEJM199910143411601; Nair S, 2007, DEVELOPMENT, V134, P335, DOI 10.1242/dev.02704; Oliver TG, 2003, P NATL ACAD SCI USA, V100, P7331, DOI 10.1073/pnas.0832317100; Oppenheimer O, 2007, MOL CANCER THER, V6, P1300, DOI 10.1158/1535-7163.MCT-06-0587; Palma V, 2005, DEVELOPMENT, V132, P335, DOI 10.1242/dev.01567; Park JR, 2008, PEDIATR CLIN N AM, V55, P97, DOI 10.1016/j.pcl.2007.10.014; Parmantier E, 1999, NEURON, V23, P713, DOI 10.1016/S0896-6273(01)80030-1; PUFFENBERGER EG, 1994, CELL, V79, P1257, DOI 10.1016/0092-8674(94)90016-7; QUAK SH, 1988, AUST PAEDIATR J, V24, P55; Raffel C, 1997, CANCER RES, V57, P842; Rossi J, 2003, J CLIN INVEST, V112, P707, DOI 10.1172/JCI200317995; Sharghi-Namini S, 2006, J NEUROSCI, V26, P6364, DOI 10.1523/JNEUROSCI.0157-06.2006; Shkumatava A, 2005, EMBO REP, V6, P563, DOI 10.1038/sj.embor.7400416; Smyth G.K., 2004, STAT APPL GENET MOL, V3, P3, DOI [DOI 10.2202/1544-6115.1027, 10.2202/1544-6115.1027]; Sukegawa A, 2000, DEVELOPMENT, V127, P1971; Tischler AS, 2000, SEMIN DIAGN PATHOL, V17, P120; Weiss WA, 1997, EMBO J, V16, P2985, DOI 10.1093/emboj/16.11.2985; Whitlock KE, 2003, DEV BIOL, V257, P140, DOI 10.1016/S0012-1606(03)00039-3; Yoon JW, 2002, J BIOL CHEM, V277, P5548, DOI 10.1074/jbc.M105708200; Zigmond RE, 1997, ANN NY ACAD SCI, V814, P181, DOI 10.1111/j.1749-6632.1997.tb46157.x	49	19	19	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7491	10.1371/journal.pone.0007491	http://dx.doi.org/10.1371/journal.pone.0007491			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834598	gold, Green Published, Green Submitted			2022-12-27	WOS:000270880700015
J	Salisbury, J; Hutchison, KW; Wigglesworth, K; Eppig, JJ; Graber, JH				Salisbury, Jesse; Hutchison, Keith W.; Wigglesworth, Karen; Eppig, John J.; Graber, Joel H.			Probe-Level Analysis of Expression Microarrays Characterizes Isoform-Specific Degradation during Mouse Oocyte Maturation	PLOS ONE			English	Article							3' UNTRANSLATED REGIONS; GENOME-WIDE ANALYSIS; GENE-EXPRESSION; MESSENGER-RNAS; ALTERNATIVE POLYADENYLATION; DATABASE; TRANSCRIPTOME; SEQUENCES; CLEAVAGE; IMPROVES	Background: Gene expression microarrays have provided many insights into changes in gene expression patterns between different tissue types, developmental stages, and disease states. Analyses of these data focused primarily measuring the relative abundance of transcripts of a gene, while treating most or all transcript isoforms as equivalent. Differences in the selection between transcript isoforms can, however, represent critical changes to either the protein product or the posttranscriptional regulation of the transcript. Novel analyses on existing microarray data provide fresh insights and new interpretations into transcriptome-wide changes in expression. Methodology: A probe-level analysis of existing gene expression arrays revealed differences in mRNA processing, primarily affecting the 39-untranslated region. Working with the example of microarrays drawn from a transcriptionally silent period of mouse oocyte development, probe-level analysis (implemented here as rmodel) identified genes whose transcript isoforms have differing stabilities. Comparison of micorarrays measuring cDNA generated from oligo-dT and random primers revealed further differences in the polyadenylation status of some transcripts. Additional analysis provided evidence for sequence-targeted cleavage, including putative targeting sequences, as one mechanism of degradation for several hundred transcripts in the maturing oocyte. Conclusions: The capability of probe-level analysis to elicit novel findings from existing expression microarray data was demonstrated. The characterization of differences in stability between transcript isoforms in maturing mouse oocytes provided some mechanistic details of degradation. Similar analysis of existing archives of expression microarray data will likely provide similar discoveries.			Salisbury, J (corresponding author), Univ Maine, Funct Genom PhD Program, Orono, ME 04469 USA.	joel.graber@jax.org		Graber, Joel/0000-0001-5137-4553	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [U01HD021970] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR016463] Funding Source: NIH RePORTER; NCRR NIH HHS [2 P20 RR16463-04, P20 RR016463] Funding Source: Medline; NICHD NIH HHS [1R01HD21970, U01 HD021970] Funding Source: Medline; NIGMS NIH HHS [1R01GM077206] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Affymetrix, 2005, GUID PROB LOG INT ER; Bemmo A, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-529; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Benson DA, 2011, NUCLEIC ACIDS RES, V39, pD32, DOI [10.1093/nar/gkw1070, 10.1093/nar/gks1195, 10.1093/nar/gkq1079, 10.1093/nar/gkt1030, 10.1093/nar/gkx1094, 10.1093/nar/gkn723, 10.1093/nar/gkp1024, 10.1093/nar/gkr1202]; Bouniol-Baly C, 1999, BIOL REPROD, V60, P580, DOI 10.1095/biolreprod60.3.580; Brockman JM, 2005, BIOINFORMATICS, V21, P3691, DOI 10.1093/bioinformatics/bti589; Bult CJ, 2008, NUCLEIC ACIDS RES, V36, pD724, DOI 10.1093/nar/gkm961; Campagna D, 2009, BIOINFORMATICS, V25, P967, DOI 10.1093/bioinformatics/btp087; Carninci P, 2006, NAT GENET, V38, P626, DOI 10.1038/ng1789; Comander J, 2004, BMC GENOMICS, V5, DOI 10.1186/1471-2164-5-17; Cui XQ, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004229; D'mello Veera, 2006, Appl Bioinformatics, V5, P249, DOI 10.2165/00822942-200605040-00007; Dai MH, 2005, NUCLEIC ACIDS RES, V33, DOI 10.1093/nar/gni179; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Enright Anton J, 2003, Genome Biol, V5, pR1, DOI 10.1186/gb-2003-5-1-r1; Eulalio A, 2009, RNA, V15, P21, DOI 10.1261/rna.1399509; Evsikov AV, 2006, GENE DEV, V20, P2713, DOI 10.1101/gad.1471006; Gerhard DS, 2004, GENOME RES, V14, P2121, DOI 10.1101/gr.2596504; Griffiths-Jones S, 2006, NUCLEIC ACIDS RES, V34, pD140, DOI 10.1093/nar/gkj112; Grimson A, 2007, MOL CELL, V27, P91, DOI 10.1016/j.molcel.2007.06.017; Hsu F, 2006, BIOINFORMATICS, V22, P1036, DOI 10.1093/bioinformatics/btl048; Hubbell E, 2002, BIOINFORMATICS, V18, P1585, DOI 10.1093/bioinformatics/18.12.1585; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Ji Z, 2009, P NATL ACAD SCI USA, V106, P7028, DOI 10.1073/pnas.0900028106; Kawaji H, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-4-r40; Kent WJ, 2002, GENOME RES, V12, P996, DOI 10.1101/gr.229102; Kuhn RM, 2009, NUCLEIC ACIDS RES, V37, pD755, DOI 10.1093/nar/gkn875; Kwan T, 2008, NAT GENET, V40, P225, DOI 10.1038/ng.2007.57; Laajala E, 2009, GENOME BIOL, V10, DOI 10.1186/gb-2009-10-7-r77; LAWRENCE CE, 1993, SCIENCE, V262, P208, DOI 10.1126/science.8211139; Liu DL, 2007, NUCLEIC ACIDS RES, V35, P234, DOI 10.1093/nar/gkl919; Majoros WH, 2007, BMC GENOMICS, V8, DOI 10.1186/1471-2164-8-152; Mayr C, 2009, CELL, V138, P673, DOI 10.1016/j.cell.2009.06.016; Murchison EP, 2007, GENE DEV, V21, P682, DOI 10.1101/gad.1521307; Pan Q, 2008, NAT GENET, V40, P1413, DOI 10.1038/ng.259; PAYNTON BV, 1988, DEV BIOL, V129, P304, DOI 10.1016/0012-1606(88)90377-6; Pruitt KD, 2007, NUCLEIC ACIDS RES, V35, pD61, DOI 10.1093/nar/gkl842; Pullmann R, 2007, MOL CELL BIOL, V27, P6265, DOI 10.1128/MCB.00500-07; Richter JD, 1999, MICROBIOL MOL BIOL R, V63, P446, DOI 10.1128/MMBR.63.2.446-456.1999; Robinson MD, 2009, BMC BIOINFORMATICS, V10, DOI 10.1186/1471-2105-10-156; Sandberg R, 2008, SCIENCE, V320, P1643, DOI 10.1126/science.1155390; Sandberg R, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-48; SCHNEIDER TD, 1990, NUCLEIC ACIDS RES, V18, P6097, DOI 10.1093/nar/18.20.6097; Shen BZ, 2004, SCIENCE, V306, P997, DOI 10.1126/science.1103521; Su YQ, 2007, DEV BIOL, V302, P104, DOI 10.1016/j.ydbio.2006.09.008; Tang F, 2007, GENE DEV, V21, P644, DOI 10.1101/gad.418707; Tang FC, 2009, NAT METHODS, V6, P377, DOI [10.1038/NMETH.1315, 10.1038/nmeth.1315]; Thompson W, 2003, NUCLEIC ACIDS RES, V31, P3580, DOI 10.1093/nar/gkg608; Wang ET, 2008, NATURE; Yu H, 2007, BMC BIOINFORMATICS, V8, DOI 10.1186/1471-2105-8-194; Zhang HB, 2005, GENOME BIOL, V6, DOI 10.1186/gb-2005-6-12-r100	51	23	23	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7479	10.1371/journal.pone.0007479	http://dx.doi.org/10.1371/journal.pone.0007479			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834616	Green Published, Green Submitted, gold			2022-12-27	WOS:000270880700007
J	Yasukochi, Y; Tanaka-Okuyama, M; Shibata, F; Yoshido, A; Marec, F; Wu, CC; Zhang, HB; Goldsmith, MR; Sahara, K				Yasukochi, Yuji; Tanaka-Okuyama, Makiko; Shibata, Fukashi; Yoshido, Atsuo; Marec, Frantisek; Wu, Chengcang; Zhang, Hongbin; Goldsmith, Marian R.; Sahara, Ken			Extensive Conserved Synteny of Genes between the Karyotypes of Manduca sexta and Bombyx mori Revealed by BAC-FISH Mapping	PLOS ONE			English	Article							GENOME SEQUENCE; LINKAGE MAP; CHROMOSOME EVOLUTION; LEPIDOPTERA; SILKWORM; REGIONS; ORDER; KINETOCHORE; EXPRESSION; LOCATION	Background: Genome sequencing projects have been completed for several species representing four highly diverged holometabolous insect orders, Diptera, Hymenoptera, Coleoptera, and Lepidoptera. The striking evolutionary diversity of insects argues a need for efficient methods to apply genome information from such models to genetically uncharacterized species. Constructing conserved synteny maps plays a crucial role in this task. Here, we demonstrate the use of fluorescence in situ hybridization with bacterial artificial chromosome probes as a powerful tool for physical mapping of genes and comparative genome analysis in Lepidoptera, which have numerous and morphologically uniform holokinetic chromosomes. Methodology/Principal Findings: We isolated 214 clones containing 159 orthologs of well conserved single-copy genes of a sequenced lepidopteran model, the silkworm, Bombyx mori, from a BAC library of a sphingid with an unexplored genome, the tobacco hornworm, Manduca sexta. We then constructed a BAC-FISH karyotype identifying all 28 chromosomes of M. sexta by mapping 124 loci using the corresponding BAC clones. BAC probes from three M. sexta chromosomes also generated clear signals on the corresponding chromosomes of the convolvulus hawk moth, Agrius convolvuli, which belongs to the same subfamily, Sphinginae, as M. sexta. Conclusions/Significance: Comparison of the M. sexta BAC physical map with the linkage map and genome sequence of B. mori pointed to extensive conserved synteny including conserved gene order in most chromosomes. Only a few rearrangements, including three inversions, three translocations, and two fission/fusion events were estimated to have occurred after the divergence of Bombycidae and Sphingidae. These results add to accumulating evidence for the stability of lepidopteran genomes. Generating signals on A. convolvuli chromosomes using heterologous M. sexta probes demonstrated that BAC-FISH with orthologous sequences can be used for karyotyping a wide range of related and genetically uncharacterized species, significantly extending the ability to develop synteny maps for comparative and functional genomics.			Yasukochi, Y (corresponding author), Natl Inst Agrobiol Sci, Insect Genome Res Unit, Tsukuba, Ibaraki, Japan.	yaskoch@affrc.go.jp	Marec, Frantisek/G-7943-2014; Yoshido, Atsuo/K-6437-2015; SHIBATA, Fukashi/B-2534-2011; Sahara, Ken/A-4266-2012	Marec, Frantisek/0000-0002-6745-5603; Yoshido, Atsuo/0000-0003-0343-2709; 				Adams MD, 2000, SCIENCE, V287, P2185, DOI 10.1126/science.287.5461.2185; Beldade P, 2009, PLOS GENET, V5, DOI 10.1371/journal.pgen.1000366; Cabrero J, 2008, CHROMOSOME RES, V16, P595, DOI 10.1007/s10577-008-1214-x; Cameron SL, 2008, GENE, V408, P112, DOI 10.1016/j.gene.2007.10.023; CARPENTER JE, 2005, PRINCIPLES PRACTICE, P115; Clark AG, 2007, NATURE, V450, P203, DOI 10.1038/nature06341; Davis BW, 2009, GENOMICS, V93, P299, DOI 10.1016/j.ygeno.2008.09.010; Dernburg AF, 2001, J CELL BIOL, V153, pF33, DOI 10.1083/jcb.153.6.F33; Dopman EB, 2004, GENETICS, V167, P301, DOI 10.1534/genetics.167.1.301; DUBCOVSKY J, 1995, GENETICS, V140, P1367; Duch C, 2003, EUR J NEUROSCI, V17, P945, DOI 10.1046/j.1460-9568.2003.02523.x; Eleftherianos I, 2006, DEV COMP IMMUNOL, V30, P1099, DOI 10.1016/j.dci.2006.02.008; Engstrom PG, 2007, GENOME RES, V17, P1898, DOI 10.1101/gr.6669607; Furusawa T, 2008, J PROTEOME RES, V7, P938, DOI 10.1021/pr070405j; Holt RA, 2002, SCIENCE, V298, P129, DOI 10.1126/science.1076181; HUGHESSCHRADER S, 1961, CHROMOSOMA, V12, P327, DOI 10.1007/BF00328928; Jiggins CD, 2005, GENETICS, V171, P557, DOI 10.1534/genetics.104.034686; Kawahara AY, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005719; Keshan B, 2006, DEV BIOL, V295, P623, DOI 10.1016/j.ydbio.2006.03.049; Maddox PS, 2004, CHROMOSOME RES, V12, P641, DOI 10.1023/B:CHRO.0000036588.42225.2f; MALHEIROS NYDIA, 1947, AGRONOMIA LUSITANA, V9, P51; Marec F., 1995, Chromosome Research, V3, P117; MINET J, 1994, ENTOMOL SCAND, V25, P63, DOI 10.1163/187631294X00045; Mita K, 2004, DNA RES, V11, P27, DOI 10.1093/dnares/11.1.27; Nagaki K, 2005, PLANT CELL, V17, P1886, DOI 10.1105/tpc.105.032961; Papa R, 2008, BMC GENOMICS, V9, DOI 10.1186/1471-2164-9-345; Papanicolaou A, 2008, NUCLEIC ACIDS RES, V36, pD582, DOI 10.1093/nar/gkm853; Pop M, 2008, TRENDS GENET, V24, P142, DOI 10.1016/j.tig.2007.12.006; Pringle EG, 2007, GENETICS, V177, P417, DOI 10.1534/genetics.107.073122; Raudsepp T, 2001, CYTOGENET CELL GENET, V94, P180, DOI 10.1159/000048812; Regier JC, 2008, SYST ENTOMOL, V33, P175, DOI 10.1111/j.1365-3113.2007.00409.x; Richards S, 2008, NATURE, V452, P949, DOI 10.1038/nature06784; Roberto R, 2007, GENOME RES, V17, P249, DOI 10.1101/gr.6052507; Robertson HM, 1999, INSECT MOL BIOL, V8, P501, DOI 10.1046/j.1365-2583.1999.00146.x; Robinson R, 1971, LEPIDOPTERA GENETICS; Roy V, 2005, HEREDITY, V94, P388, DOI 10.1038/sj.hdy.6800612; Sahara K, 2003, CHROMOSOMA, V112, P48, DOI 10.1007/s00412-003-0245-5; Sahara K, 2007, GENOME, V50, P1061, DOI 10.1139/G07-082; SCHUBERT I, 1985, CHROMOSOMA, V92, P143, DOI 10.1007/BF00328466; Shibata F, 2009, ZOOL SCI, V26, P187, DOI 10.2108/zsj.26.187; Stanyon R, 2008, CHROMOSOME RES, V16, P17, DOI 10.1007/s10577-007-1209-z; Sundquist A, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000484; Tobler A, 2005, HEREDITY, V94, P408, DOI 10.1038/sj.hdy.6800619; Traut W, 2007, SEX DEV, V1, P332, DOI 10.1159/000111765; Van't Hof AE, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003882; Wang BQ, 2004, GENETICS, V168, P215, DOI 10.1534/genetics.104.028118; Weinstock GM, 2006, NATURE, V443, P931, DOI 10.1038/nature05260; WHALLEY P, 1986, BIOL J LINN SOC, V28, P253, DOI 10.1111/j.1095-8312.1986.tb01756.x; Willis Judith H., 1995, P1; Wrensch Dana L., 1994, P282; Wu CC, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-283; Wyder S, 2007, GENOME BIOL, V8, DOI 10.1186/gb-2007-8-11-r242; Xia QY, 2008, INSECT BIOCHEM MOLEC, V38, P1036, DOI [10.1016/j.ibmb.2009.01.004, 10.1016/j.ibmb.2008.11.004]; Xia QY, 2004, SCIENCE, V306, P1937, DOI 10.1126/science.1102210; Yasukochi Y, 1998, GENETICS, V150, P1513; Yasukochi Y, 2006, GENETICS, V173, P1319, DOI 10.1534/genetics.106.055541; Yasukochi Yuji, 2002, Methods Mol Biol, V192, P401; Yoshido A, 2005, GENETICS, V170, P675, DOI 10.1534/genetics.104.040352; Young ND, 2009, CURR OPIN PLANT BIOL, V12, P193, DOI 10.1016/j.pbi.2008.11.005; Zdobnov EM, 2007, TRENDS GENET, V23, P16, DOI 10.1016/j.tig.2006.10.004; Zou Z, 2008, INSECT BIOCHEM MOLEC, V38, P677, DOI 10.1016/j.ibmb.2008.03.009	61	33	36	1	12	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 15	2009	4	10							e7465	10.1371/journal.pone.0007465	http://dx.doi.org/10.1371/journal.pone.0007465			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507JB	19829706	gold, Green Published, Green Submitted			2022-12-27	WOS:000270847800007
J	Boily-Larouche, G; Iscache, AL; Zijenah, LS; Humphrey, JH; Mouland, AJ; Ward, BJ; Roger, M				Boily-Larouche, Genevieve; Iscache, Anne-Laure; Zijenah, Lynn S.; Humphrey, Jean H.; Mouland, Andrew J.; Ward, Brian J.; Roger, Michel			Functional Genetic Variants in DC-SIGNR Are Associated with Mother-to-Child Transmission of HIV-1	PLOS ONE			English	Article							ENDOTHELIAL-CELLS; VERTICAL TRANSMISSION; EXPRESSION; INFECTION; ADHESION; CCR5; POLYMORPHISMS; DIVERSITY; INFANTS; ANTIGEN	Background: Mother-to-child transmission (MTCT) is the main cause of HIV-1 infection in children worldwide. Given that the C-type lectin receptor, dendritic cell-specific ICAM-grabbing non-integrin-related (DC-SIGNR, also known as CD209L or liver/lymph node-specific ICAM-grabbing non-integrin (L-SIGN)), can interact with pathogens including HIV-1 and is expressed at the maternal-fetal interface, we hypothesized that it could influence MTCT of HIV-1. Methods and Findings: To investigate the potential role of DC-SIGNR in MTCT of HIV-1, we carried out a genetic association study of DC-SIGNR in a well-characterized cohort of 197 HIV-infected mothers and their infants recruited in Harare, Zimbabwe. Infants harbouring two copies of DC-SIGNR H1 and/or H3 haplotypes (H1-H1, H1-H3, H3-H3) had a 3.6-fold increased risk of in utero (IU) (P = 0.013) HIV-1 infection and a 5.7-fold increased risk of intrapartum (IP) (P = 0.025) HIV-1 infection after adjusting for a number of maternal factors. The implicated H1 and H3 haplotypes share two single nucleotide polymorphisms (SNPs) in promoter region (p-198A) and intron 2 (int2-180A) that were associated with increased risk of both IU (P = 0.045 and P = 0.003, respectively) and IP (P = 0.025, for int2-180A) HIV-1 infection. The promoter variant reduced transcriptional activity in vitro. In homozygous H1 infants bearing both the p-198A and int2-180A mutations, we observed a 4-fold decrease in the level of placental DC-SIGNR transcripts, disproportionately affecting the expression of membrane-bound isoforms compared to infant noncarriers (P = 0.011). Conclusion: These results suggest that DC-SIGNR plays a crucial role in MTCT of HIV-1 and that impaired placental DC-SIGNR expression increases risk of transmission.			Boily-Larouche, G (corresponding author), CHU Montreal, Ctr Rech, Immunogenet Lab, Montreal, PQ, Canada.	michel.roger.chum@ssss.gouv.qc.ca						Bashirova AA, 2001, J EXP MED, V193, P671, DOI 10.1084/jem.193.6.671; Boily-Larouche G, 2007, HUM IMMUNOL, V68, P523, DOI 10.1016/j.humimm.2007.02.002; Boniotto M, 2000, GENES IMMUN, V1, P346, DOI 10.1038/sj.gene.6363685; BRYSON YJ, 1992, NEW ENGL J MED, V327, P1246, DOI 10.1056/NEJM199210223271718; Chan VSF, 2006, NAT GENET, V38, P38, DOI 10.1038/ng1698; D Kanmogne G, 2007, J CEREBR BLOOD F MET, V27, P123, DOI 10.1038/sj.jcbfm.9600330; Humphrey JH, 2006, J INFECT DIS, V193, P960; Kourtis AP, 2006, LANCET INFECT DIS, V6, P726, DOI 10.1016/S1473-3099(06)70629-6; Kuhn L, 2007, AIDS, V21, P1753, DOI 10.1097/QAD.0b013e3282ba553a; Kwiek JJ, 2008, J INFECT DIS, V197, P1378, DOI 10.1086/587646; Kwiek JJ, 2006, PLOS MED, V3, P70, DOI 10.1371/journal.pmed.0030010; Limmer A, 2000, NAT MED, V6, P1348, DOI 10.1038/82161; Liu HL, 2005, EUR J HUM GENET, V13, P707, DOI 10.1038/sj.ejhg.5201409; Luzuriaga Katherine, 2007, Curr Infect Dis Rep, V9, P511, DOI 10.1007/s11908-007-0076-2; Mangano A, 2008, J INFECT DIS, V198, P694, DOI 10.1086/590498; Martinson JJ, 1997, NAT GENET, V16, P100, DOI 10.1038/ng0597-100; Meddows-Taylor S, 2006, J GEN VIROL, V87, P2055, DOI 10.1099/vir.0.81709-0; Mukhtar M, 2002, VIROLOGY, V297, P78, DOI 10.1006/viro.2002.1376; Mummidi S, 2001, J BIOL CHEM, V276, P33196, DOI 10.1074/jbc.M009807200; Pedersen BR, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000838; Pober JS, 2007, NAT REV IMMUNOL, V7, P803, DOI 10.1038/nri2171; Pohlmann S, 2001, P NATL ACAD SCI USA, V98, P2670, DOI 10.1073/pnas.051631398; Singh KK, 2003, J INFECT DIS, V188, P1461, DOI 10.1086/379038; SINGH KK, 2009, PEDIAT RES; Singh KK, 2008, JAIDS-J ACQ IMM DEF, V49, P259, DOI 10.1097/QAI.0b013e318186eaa4; Snyder GA, 2005, J VIROL, V79, P4589, DOI 10.1128/JVI.79.8.4589-4598.2005; Soilleux EJ, 2002, HUM PATHOL, V33, P652, DOI 10.1053/hupa.2002.124036; Stephens M, 2001, AM J HUM GENET, V68, P978, DOI 10.1086/319501; Turville SG, 2002, NAT IMMUNOL, V3, P975, DOI 10.1038/ni841; Wiley RD, 2006, P NATL ACAD SCI USA, V103, P738, DOI 10.1073/pnas.0507995103; Yang B, 2009, MICROVASC RES, V77, P212, DOI 10.1016/j.mvr.2008.11.003; Zhang K, 2003, BIOINFORMATICS, V19, P1300, DOI 10.1093/bioinformatics/btg142	32	22	22	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7211	10.1371/journal.pone.0007211	http://dx.doi.org/10.1371/journal.pone.0007211			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809496	Green Published, Green Submitted, gold			2022-12-27	WOS:000270594000001
J	Salama, SA; Kamel, MW; Botting, S; Salih, SM; Borahay, MA; Hamed, AA; Kilic, GS; Saeed, M; Williams, MY; Diaz-Arrastia, CR				Salama, Salama A.; Kamel, Marwa W.; Botting, Shaleen; Salih, Sana M.; Borahay, Mostafa A.; Hamed, Ahmed A.; Kilic, Gokhan S.; Saeed, Muhammad; Williams, Marian Y.; Diaz-Arrastia, Concepcion R.			Catechol-O-Methyltransferase Expression and 2-Methoxyestradiol Affect Microtubule Dynamics and Modify Steroid Receptor Signaling in Leiomyoma Cells	PLOS ONE			English	Article							GONADOTROPIN-RELEASING-HORMONE; HUMAN UTERINE LEIOMYOMA; NECROSIS-FACTOR-ALPHA; NF-KAPPA-B; AROMATASE EXPRESSION; MENSTRUAL-CYCLE; FIBROIDS; GROWTH; COMPLEX; GENE	Context: Development of optimal medicinal treatments of uterine leiomyomas represents a significant challenge. 2-Methoxyestradiol (2ME) is an endogenous estrogen metabolite formed by sequential action of CYP450s and catechol-O-methyltransferase (COMT). Our previous study demonstrated that 2ME is a potent antiproliferative, proapoptotic, antiangiogenic, and collagen synthesis inhibitor in human leiomyomas cells (huLM). Objectives: Our objectives were to investigate whether COMT expression, by the virtue of 2ME formation, affects the growth of huLM, and to explore the cellular and molecular mechanisms whereby COMT expression or treatment with 2ME affect these cells. Results: Our data demonstrated that E-2-induced proliferation was less pronounced in cells over-expressing COMT or treated with 2ME (500 nM). This effect on cell proliferation was associated with microtubules stabilization and diminution of estrogen receptor alpha (ER alpha) and progesterone receptor (PR) transcriptional activities, due to shifts in their subcellular localization and sequestration in the cytoplasm. In addition, COMT over expression or treatment with 2ME reduced the expression of hypoxia-inducible factor-1 alpha (HIF-1 alpha) and the basal level as well as TNF-alpha-induced aromatase (CYP19) expression. Conclusions: COMT over expression or treatment with 2ME stabilize microtubules, ameliorates E-2-induced proliferation, inhibits ER alpha and PR signaling, and reduces HIF-1 alpha and CYP19 expression in human uterine leiomyoma cells. Thus, microtubules are a candidate target for treatment of uterine leiomyomas. In addition, the naturally occurring microtubule-targeting agent 2ME represents a potential new therapeutic for uterine leiomyomas.			Salama, SA (corresponding author), Baylor Coll Med, Dept Obstet & Gynecol, Div Gynecol Oncol, Houston, TX 77030 USA.	salama@bcm.tmc.edu	Borahay, Mostafa/AAJ-6582-2020	Borahay, Mostafa/0000-0002-0554-132X; Williams-Brown, Marian/0000-0001-5034-5152; theiler, shaleen/0000-0002-6881-6319; Kilic, Gokhan/0000-0002-7926-7458				Al-Hendy A, 2004, AM J OBSTET GYNECOL, V191, P1621, DOI 10.1016/j.ajog.2004.04.022; Azuma K, 2004, FEBS LETT, V577, P339, DOI 10.1016/j.febslet.2004.10.025; BULUN SE, 1994, J CLIN ENDOCR METAB, V78, P736, DOI 10.1210/jc.78.3.736; Carney SA, 2002, LAB INVEST, V82, P719, DOI 10.1097/01.LAB.0000017499.51216.3E; DAMATO RJ, 1994, P NATL ACAD SCI USA, V91, P3964, DOI 10.1073/pnas.91.9.3964; Ding L, 2004, J CLIN ENDOCR METAB, V89, P5549, DOI 10.1210/jc.2004-0161; Edwards RD, 2007, NEW ENGL J MED, V356, P360; Englund K, 1998, J CLIN ENDOCR METAB, V83, P4092, DOI 10.1210/jc.83.11.4092; Escuin D, 2005, CANCER RES, V65, P9021, DOI 10.1158/0008-5472.CAN-04-4095; Farquhar CM, 2002, OBSTET GYNECOL, V99, P229, DOI 10.1016/S0029-7844(01)01723-9; Hassan MH, 2007, J CLIN ENDOCR METAB, V92, P3949, DOI 10.1210/jc.2007-0823; Hoekstra AV, 2009, J CLIN ENDOCR METAB, V94, P1768, DOI 10.1210/jc.2008-2093; Hwu YM, 2008, FERTIL STERIL, V89, P468, DOI 10.1016/j.fertnstert.2007.02.031; Imir AG, 2007, J CLIN ENDOCR METAB, V92, P1979, DOI 10.1210/jc.2006-2482; Ishikawa H, 2009, J CLIN ENDOCR METAB, V94, P1752, DOI 10.1210/jc.2008-2327; Jordan MA, 2004, NAT REV CANCER, V4, P253, DOI 10.1038/nrc1317; LaVallee TM, 2008, MOL CANCER THER, V7, P1472, DOI 10.1158/1535-7163.MCT-08-0107; Lee SJ, 2009, MOL ENDOCRINOL, V23, P620, DOI 10.1210/me.2007-0477; Lombardi M, 2008, J CELL BIOL, V182, P327, DOI 10.1083/jcb.200712125; Manavathi B, 2006, P NATL ACAD SCI USA, V103, P15981, DOI 10.1073/pnas.0607445103; Mikenberg I, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000589; MITCHISON T, 1984, NATURE, V312, P237, DOI 10.1038/312237a0; Moon JO, 2009, AM J PHYSIOL-GASTR L, V296, pG582, DOI 10.1152/ajpgi.90368.2008; Nisolle M, 1999, HUM REPROD, V14, P2844, DOI 10.1093/humrep/14.11.2844; Nogales E, 2006, CURR OPIN STRUC BIOL, V16, P221, DOI 10.1016/j.sbi.2006.03.005; Okolo S, 2008, BEST PRACT RES CL OB, V22, P571, DOI 10.1016/j.bpobgyn.2008.04.002; Purohit A, 1999, BIOCHEM BIOPH RES CO, V261, P214, DOI 10.1006/bbrc.1999.1010; Reiter-Funk CK, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-16; Salama SA, 2008, INT J CANCER, V123, P1246, DOI 10.1002/ijc.23653; Salama SA, 2006, J SOC GYNECOL INVEST, V13, P542, DOI 10.1016/j.jsgi.2006.09.003; Salama SA, 2009, J CLIN ENDOCR METAB, V94, P285, DOI 10.1210/jc.2008-1389; Shrum CK, 2009, P NATL ACAD SCI USA, V106, P2647, DOI 10.1073/pnas.0806677106; Sourla A, 1996, CANCER RES, V56, P3123; Stewart EA, 2001, LANCET, V357, P293, DOI 10.1016/S0140-6736(00)03622-9; Sumitani H, 2000, ENDOCRINOLOGY, V141, P3852, DOI 10.1210/en.141.10.3852; Vrzal R, 2008, EUR J PHARMACOL, V581, P244, DOI 10.1016/j.ejphar.2007.11.059; Xue Q, 2007, J CLIN ENDOCR METAB, V92, P3261, DOI 10.1210/jc.2007-0494; Yu LD, 2008, MOL MED, V14, P264, DOI 10.2119/2007-00101.Yu	38	32	35	0	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7356	10.1371/journal.pone.0007356	http://dx.doi.org/10.1371/journal.pone.0007356			8	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809499	Green Published, gold, Green Submitted			2022-12-27	WOS:000270594000012
J	Jarve, M; Zhivotovsky, LA; Rootsi, S; Help, H; Rogaev, EI; Khusnutdinova, EK; Kivisild, T; Sanchez, JJ				Jarve, Mari; Zhivotovsky, Lev A.; Rootsi, Siiri; Help, Hela; Rogaev, Evgeny I.; Khusnutdinova, Elza K.; Kivisild, Toomas; Sanchez, Juan J.			Decreased Rate of Evolution in Y Chromosome STR Loci of Increased Size of the Repeat Unit	PLOS ONE			English	Article							GENETIC LEGACY; MUTATION-RATE; EUROPE; POPULATIONS; MARKERS; SPREAD	Background: Polymorphic Y chromosome short tandem repeats (STRs) have been widely used in population genetic and evolutionary studies. Compared to di-, tri-, and tetranucleotide repeats, STRs with longer repeat units occur more rarely and are far less commonly used. Principal Findings: In order to study the evolutionary dynamics of STRs according to repeat unit size, we analysed variation at 24 Y chromosome repeat loci: 1 tri-, 14 tetra-, 7 penta-, and 2 hexanucleotide loci. According to our results, penta- and hexanucleotide repeats have approximately two times lower repeat variance and diversity than tri- and tetranucleotide repeats, indicating that their mutation rate is about half of that of tri- and tetranucleotide repeats. Thus, STR markers with longer repeat units are more robust in distinguishing Y chromosome haplogroups and, in some cases, phylogenetic splits within established haplogroups. Conclusions: Our findings suggest that Y chromosome STRs of increased repeat unit size have a lower rate of evolution, which has significant relevance in population genetic and evolutionary studies.			Jarve, M (corresponding author), Univ Tartu, Dept Evolutionary Biol, Ulikooli 18, EE-50090 Tartu, Estonia.	mari.jarve@ut.ee	Kivisild, Toomas/P-5889-2017; Khusnutdinova, Elza Kamilevna/A-4810-2013; Rogaev, Evgeny/AAN-7662-2020; Zhivotovsky, Lev A/A-1351-2012	Kivisild, Toomas/0000-0002-6297-7808; Khusnutdinova, Elza Kamilevna/0000-0003-2987-3334; 				de Knijff P, 2000, AM J HUM GENET, V67, P1055; Forster P, 2000, AM J HUM GENET, V67, P182, DOI 10.1086/302953; Ge JY, 2009, FORENSIC SCI INT-GEN, V3, P179, DOI 10.1016/j.fsigen.2009.01.007; Goedbloed M, 2009, INT J LEGAL MED, V123, P471, DOI 10.1007/s00414-009-0342-y; Hanson Erin K., 2006, Legal Medicine, V8, P110, DOI 10.1016/j.legalmed.2005.10.001; Hanson EK, 2006, J FORENSIC SCI, V51, P1298, DOI 10.1111/j.1556-4029.2006.00263.x; Heyer E, 1997, HUM MOL GENET, V6, P799, DOI 10.1093/hmg/6.5.799; Jobling MA, 2003, NAT REV GENET, V4, P598, DOI 10.1038/nrg1124; Karafet TM, 2008, GENOME RES, V18, P830, DOI 10.1101/gr.7172008; Kayser M, 2004, AM J HUM GENET, V74, P1183, DOI 10.1086/421531; Kayser M, 2001, AM J HUM GENET, V68, P990, DOI 10.1086/319510; Kivisild T, 2003, AM J HUM GENET, V72, P313, DOI 10.1086/346068; Nei M., 1987, MOL EVOLUTIONARY GEN; Reidla M, 2003, AM J HUM GENET, V73, P1178, DOI 10.1086/379380; Rootsi S, 2004, AM J HUM GENET, V75, P128, DOI 10.1086/422196; Rootsi S, 2007, EUR J HUM GENET, V15, P204, DOI 10.1038/sj.ejhg.5201748; Rosser ZH, 2000, AM J HUM GENET, V67, P1526, DOI 10.1086/316890; Schlecht J, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000093; Semino O, 2000, SCIENCE, V290, P1155, DOI 10.1126/science.290.5494.1155; Tambets K, 2004, AM J HUM GENET, V74, P661, DOI 10.1086/383203; Tamm E, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000829; XUE Y, 2009, CURR BIOL; Xue YL, 2005, AM J HUM GENET, V77, P1112, DOI 10.1086/498583; Zerjal T, 2003, AM J HUM GENET, V72, P717, DOI 10.1086/367774; Zhivotovsky LA, 2004, AM J HUM GENET, V74, P50, DOI 10.1086/380911; Zhivotovsky LA, 2000, MOL BIOL EVOL, V17, P757, DOI 10.1093/oxfordjournals.molbev.a026354; Zhivotovsky LA, 2006, MOL BIOL EVOL, V23, P2268, DOI 10.1093/molbev/msl105	27	9	9	0	5	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7276	10.1371/journal.pone.0007276	http://dx.doi.org/10.1371/journal.pone.0007276			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789645	Green Published, gold, Green Submitted			2022-12-27	WOS:000270354100024
J	Mo, JR; Mathur, A; Angagaw, M; Zhao, SX; Wang, YX; Gargano, D; DiBacco, A; Bachman, ES				Mo, Jan-Rung; Mathur, Anjili; Angagaw, Minilik; Zhao, Shuxia; Wang, Yuxun; Gargano, Diana; DiBacco, Alessandra; Bachman, Eric S.			Splenectomy Normalizes Hematocrit in Murine Polycythemia Vera	PLOS ONE			English	Article								Splenic enlargement (splenomegaly) develops in numerous disease states, although a specific pathogenic role for the spleen has rarely been described. In polycythemia vera (PV), an activating mutation in Janus kinase 2 (JAK2(V617)) induces splenomegaly and an increase in hematocrit. Splenectomy is sparingly performed in patients with PV, however, due to surgical complications. Thus, the role of the spleen in the pathogenesis of human PV remains unknown. We specifically tested the role of the spleen in the pathogenesis of PV by performing either sham (SH) or splenectomy (SPL) surgeries in a murine model of JAK2(V617F)-driven PV. Compared to SH-operated mice, which rapidly develop high hematocrits after JAK2(V617F) transplantation, SPL mice completely fail to develop this phenotype. Disease burden (JAK2(V617)) is equivalent in the bone marrow of SH and SPL mice, however, and both groups develop fibrosis and osteosclerosis. If SPL is performed after PV is established, hematocrit rapidly declines to normal even though myelofibrosis and osteosclerosis again develop independently in the bone marrow. In contrast, SPL only blunts hematocrit elevation in secondary, erythropoietin-induced polycythemia. We conclude that the spleen is required for an elevated hematocrit in murine, JAK2(V617F)-driven PV, and propose that this phenotype of PV may require a specific interaction between mutant cells and the spleen.			Mo, JR (corresponding author), Merck Res Labs, Dept Oncol Pharmacol, Lab Anim Res & Pharmacol, Boston, MA USA.	eric.bachman@bmc.org		Wang, Yuxun/0000-0002-4252-6102				Agool A, 2006, J NUCL MED, V47, P1592; Baxter EJ, 2005, LANCET, V365, P1054, DOI 10.1016/S0140-6736(05)71142-9; Cadili A, 2008, AM J MED, V121, P371, DOI 10.1016/j.amjmed.2008.02.014; Cunningham SC, 2004, AM J SURG, V188, P94, DOI 10.1016/j.amjsurg.2003.11.040; DEHAAN G, 1994, BLOOD, V84, P4157, DOI 10.1182/blood.V84.12.4157.bloodjournal84124157; Gilbert HS, 2003, SEMIN HEMATOL, V40, P26, DOI 10.1053/shem.2003.50031; Hsieh PP, 2007, MODERN PATHOL, V20, P929, DOI 10.1038/modpathol.3800826; James C, 2005, NATURE, V434, P1144, DOI 10.1038/nature03546; Kralovics R, 2005, NEW ENGL J MED, V352, P1779, DOI 10.1056/NEJMoa051113; Lacout C, 2006, BLOOD, V108, P1652, DOI 10.1182/blood-2006-02-002030; Larsen TS, 2007, EUR J HAEMATOL, V79, P508, DOI 10.1111/j.1600-0609.2007.00960.x; Levine RL, 2005, CANCER CELL, V7, P387, DOI 10.1016/j.ccr.2005.03.023; Liu Y, 2006, BLOOD, V108, P123, DOI 10.1182/blood-2005-11-4458; Mathur A, 2009, BIOCHEM PHARMACOL, V78, P382, DOI 10.1016/j.bcp.2009.04.025; MCDONALD TP, 1992, BLOOD, V80, P352; Mesa RA, 2000, BLOOD REV, V14, P121, DOI 10.1054/blre.2000.0132; Messinezy M, 1997, BRIT J HAEMATOL, V98, P103, DOI 10.1046/j.1365-2141.1997.1552969.x; MORGAN KJ, 2008, ANNU REV MED, V59, P371; Pardanani A, 2007, LEUKEMIA, V21, P1658, DOI 10.1038/sj.leu.2404750; RAFF RF, 1993, EXP HEMATOL, V21, P385; Scott LM, 2007, NEW ENGL J MED, V356, P459, DOI 10.1056/NEJMoa065202; Tefferi A, 2003, MAYO CLIN PROC, V78, P174, DOI 10.4065/78.2.174; WASSERMAN LR, 1963, NEW ENGL J MED, V269, P1226, DOI 10.1056/NEJM196312052692302; Wernig G, 2006, BLOOD, V107, P4274, DOI 10.1182/blood-2005-12-4824; Xing S, 2008, BLOOD, V111, P5109, DOI 10.1182/blood-2007-05-091579; Zhao RX, 2005, J BIOL CHEM, V280, P22788, DOI 10.1074/jbc.C500138200; 1984, CANCER, V54, P333	27	4	4	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	SEP 30	2009	4	9							e7286	10.1371/journal.pone.0007286	http://dx.doi.org/10.1371/journal.pone.0007286			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	501BO	19789710	Green Submitted, Green Published, gold			2022-12-27	WOS:000270354100031
J	Shahine, LK; Lamb, JD; Lathi, RB; Milki, AA; Langen, E; Westphal, LM				Shahine, Lora K.; Lamb, Julie D.; Lathi, Ruth B.; Milki, Amin A.; Langen, Elizabeth; Westphal, Lynn M.			Poor Prognosis with In Vitro Fertilization in Indian Women Compared to Caucasian Women Despite Similar Embryo Quality	PLOS ONE			English	Article							OVARY-SYNDROME PCOS; SOUTH ASIANS; ENDOMETRIOSIS; ORIGIN; IVF	Background: Disease prevalence and response to medical therapy may differ among patients of diverse ethnicities. Poor outcomes with in vitro fertilization (IVF) treatment have been previously shown in Indian women compared to Caucasian women, and some evidence suggests that poor embryo quality may be a cause for the discrepancy. In our center, only patients with the highest quality cleavage stage embryos are considered eligible for extending embryo culture to the blastocyst stage. We compared live birth rates (LBR) between Indian and Caucasian women after blastocyst transfer to investigate whether differences in IVF outcomes between these ethnicities would persist in patients who transferred similar quality embryos. Methodology/Principal Findings: In this retrospective cohort analysis, we compared IVF outcome between 145 Caucasians and 80 Indians who had a blastocyst transfer between January 1, 2005 and June 31, 2007 in our university center. Indians were younger than Caucasians by 2.7 years (34.03 vs. 36.71, P = 0.03), were more likely to have an agonist down regulation protocol (68% vs. 43%, P < 0.01), and were more likely to have polycystic ovarian syndrome (PCOS), although not significant, (24% vs. 14%, P = 0.06). Sixty eight percent of Indian patients had the highest quality embryos (4AB blastocyst or better) transferred compared to 71% of the Caucasians (P = 0.2). LBR was significantly lower in the Indians compared to the Caucasians (24% vs. 41%, P < 0.01) with an odds ratio of 0.63, (95% CI 0.46-0.86). Controlling for age, stimulation protocol and PCOS showed persistently lower LBR with an adjusted odds ratio of 0.56, (95% CI 0.40-0.79) in the multivariate analysis. Conclusions/Significance: Despite younger age and similar embryo quality, Indians had a significantly lower LBR than Caucasians. In this preliminary study, poor prognosis after IVF for Indian ethnicity persisted despite limiting analysis to patients with high quality embryos transferred. Further investigation into explanations for ethnic differences in reproduction is needed.			Shahine, LK (corresponding author), Stanford Univ, Dept Obstet & Gynecol, Div Reprod Med, Stanford, CA 94305 USA.	lora@shahine.com		Lathi, Ruth/0000-0003-2159-2714				Allahbadia Gautam N, 2008, Semin Reprod Med, V26, P22, DOI 10.1055/s-2007-992921; ARUMUGAM K, 1992, AUST NZ J OBSTET GYN, V32, P164, DOI 10.1111/j.1479-828X.1992.tb01932.x; Behr B, 2002, FERTIL STERIL, V77, P697, DOI 10.1016/S0015-0282(01)03267-8; Bhopal R, 2000, J PUBLIC HEALTH MED, V22, P375, DOI 10.1093/pubmed/22.3.375; Dam P, 2006, GYNECOL OBSTET INVES, V61, P223, DOI 10.1159/000091498; della Ragione T, 2007, REPROD BIOL ENDOCRIN, V5, DOI 10.1186/1477-7827-5-2; Gardner D, 1999, REPROD CERTAINTY FER; Heijnen EMEW, 2006, HUM REPROD UPDATE, V12, P13, DOI 10.1093/humupd/dmi036; Jun SH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0002562; Kumar AV, 2004, FERTIL STERIL, V82, pS298, DOI 10.1016/j.fertnstert.2004.07.804; Lashen H, 1999, BRIT J OBSTET GYNAEC, V106, P407, DOI 10.1111/j.1471-0528.1999.tb08291.x; MAHMUD G, 1995, FERTIL STERIL, V64, P103, DOI 10.1016/S0015-0282(16)57663-8; Missmer SA, 2003, OBSTET GYN CLIN N AM, V30, P3; MIYAZAWA K, 1976, OBSTET GYNECOL, V48, P407; Palep-Singh A, 2007, EUR J OBSTET GYN R B, V134, P202, DOI 10.1016/j.ejogrb.2007.02.005; Rodin DA, 1998, CLIN ENDOCRINOL, V49, P91, DOI 10.1046/j.1365-2265.1998.00492.x; SANGIHAGHPEYKAR H, 1995, OBSTET GYNECOL, V85, P983, DOI 10.1016/0029-7844(95)00074-2; Sheth T, 1999, CAN MED ASSOC J, V161, P132; SUTHERLAND A, 1993, ARCH GYNECOL OBSTET, V234, P95; Veeck LL., 1999, ATLAS HUMAN GAMETES; Wijeyaratne CN, 2002, CLIN ENDOCRINOL, V57, P343, DOI 10.1046/j.1365-2265.2002.01603.x	21	30	31	0	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 26	2009	4	10							e7599	10.1371/journal.pone.0007599	http://dx.doi.org/10.1371/journal.pone.0007599			5	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	511ER	19855835	gold, Green Published, Green Submitted			2022-12-27	WOS:000271147200015
J	Bisson, IA; Safi, K; Holland, RA				Bisson, Isabelle-Anne; Safi, Kamran; Holland, Richard A.			Evidence for Repeated Independent Evolution of Migration in the Largest Family of Bats	PLOS ONE			English	Article							LONG-DISTANCE MIGRATION; AVIAN MIGRATION; CHIROPTERA; PATTERNS	Background: How migration evolved represents one of the most poignant questions in evolutionary biology. While studies on the evolution of migration in birds are well represented in the literature, migration in bats has received relatively little attention. Yet, more than 30 species of bats are known to migrate annually from breeding to non-breeding locations. Our study is the first to test hypotheses on the evolutionary history of migration in bats using a phylogenetic framework. Methods and Principal Findings: In addition to providing a review of bat migration in relation to existing hypotheses on the evolution of migration in birds, we use a previously published supertree to formulate and test hypotheses on the evolutionary history of migration in bats. Our results suggest that migration in bats has evolved independently in several lineages potentially as the need arises to track resources (food, roosting site) but not through a series of steps from short-to long-distance migrants, as has been suggested for birds. Moreover, our analyses do not indicate that migration is an ancestral state but has relatively recently evolved in bats. Our results also show that migration is significantly less likely to evolve in cave roosting bats than in tree roosting species. Conclusions and Significance: This is the first study to provide evidence that migration has evolved independently in bat lineages that are not closely related. If migration evolved as a need to track seasonal resources or seek adequate roosting sites, climate change may have a pivotal impact on bat migratory habits. Our study provides a strong framework for future research on the evolution of migration in chiropterans.			Bisson, IA (corresponding author), Princeton Univ, Dept Ecol & Evolutionary Biol, Princeton, NJ 08544 USA.	ibisson@princeton.edu	Safi, Kamran/B-2079-2008; Holland, Richard A/A-6107-2010	Safi, Kamran/0000-0002-8418-6759; Holland, Richard A/0000-0003-4495-8061				ADRIAENSEN F, 1990, J ANIM ECOL, V59, P1077, DOI 10.2307/5033; [Anonymous], 2020, ECONOMIST 0326; BERTHOLD P, 2001, BIRD MIGRATION GEN S, P253; Blomberg SP, 2003, EVOLUTION, V57, P717, DOI 10.1111/j.0014-3820.2003.tb00285.x; COX GW, 1985, AM NAT, V126, P451, DOI 10.1086/284432; Cryan PM, 2004, J MAMMAL, V85, P995, DOI 10.1644/BRG-202; Cryan PM, 2003, J MAMMAL, V84, P579, DOI 10.1644/1545-1542(2003)084<0579:SDOMTB>2.0.CO;2; Desdevises Y, 2003, EVOLUTION, V57, P2647; Diniz JAF, 1998, EVOLUTION, V52, P1247, DOI 10.1111/j.1558-5646.1998.tb02006.x; Diniz JAF, 2001, EVOLUTION, V55, P1104, DOI 10.1111/j.0014-3820.2001.tb00630.x; Fleming TH, 2003, BAT ECOLOGY, P156; GITTLEMAN JL, 1990, SYST ZOOL, V39, P227, DOI 10.2307/2992183; GRZIMEK B, 1989, GRZIMEKS ENCY MAMMAL; HARMON L, 2008, GEIGER ANAL EVOLUTIO, P2; Helm B, 2006, PLOS BIOL, V4, P611, DOI 10.1371/journal.pbio.0040110; Hutterer R., 2005, BAT MIGRATIONS EUROP; Jones KE, 2005, EVOLUTION, V59, P2243, DOI 10.1111/j.0014-3820.2005.tb00932.x; Jones KE, 2002, BIOL REV, V77, P223, DOI 10.1017/S1464793101005899; LEVEY DJ, 1992, AM NAT, V140, P447, DOI 10.1086/285421; MitchellJones A.J., 1999, ATLAS EUROPEAN MAMMA; Musser G G, 1993, MAMMAL SPECIES WORLD; PAGEL M, 1994, P ROY SOC B-BIOL SCI, V255, P37, DOI 10.1098/rspb.1994.0006; Paradis E, 2004, BIOINFORMATICS, V20, P289, DOI 10.1093/bioinformatics/btg412; Paradis E, 2006, ANAL PHYLOGENETICS E; Pierson E.D., 1986, THESIS U CALIF; Pulido F, 1996, P NATL ACAD SCI USA, V93, P14642, DOI 10.1073/pnas.93.25.14642; Pulido F, 2007, BIOSCIENCE, V57, P165, DOI 10.1641/B570211; R Core Team, 2018, R LANG ENV STAT COMP; Ransome R., 1990, NATURAL HIST HIBERNA; Rappole JH., 1995, ECOLOGY MIGRANT BIRD; ROER H, 1995, MYOTIS, V32, P251; Schwabl H., 1990, P144; Simmons NB, 1998, B AM MUS NAT HIST, P1; Teeling EC, 2005, SCIENCE, V307, P580, DOI 10.1126/science.1105113; Yang Z., 2006, COMPUTATIONAL MOL EV, DOI DOI 10.1093/ACPROF:OSO/9780198567028.001.0001	35	36	37	7	39	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 21	2009	4	10							e7504	10.1371/journal.pone.0007504	http://dx.doi.org/10.1371/journal.pone.0007504			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	509JU	19844569	Green Published, Green Submitted, gold			2022-12-27	WOS:000271013000004
J	Abrahao, JS; Guedes, MIM; Trindade, GS; Fonseca, FG; Campos, RK; Mota, BF; Lobato, ZIP; Silva-Fernandes, AT; Rodrigues, GOL; Lima, LS; Ferreira, PCP; Bonjardim, CA; Kroon, EG				Abrahao, Jonatas S.; Guedes, Maria Isabel M.; Trindade, Giliane S.; Fonseca, Flavio G.; Campos, Rafael K.; Mota, Bruno F.; Lobato, Zelia I. P.; Silva-Fernandes, Andre T.; Rodrigues, Gisele O. L.; Lima, Larissa S.; Ferreira, Paulo C. P.; Bonjardim, Claudio A.; Kroon, Erna G.			One More Piece in the VACV Ecological Puzzle: Could Peridomestic Rodents Be the Link between Wildlife and Bovine Vaccinia Outbreaks in Brazil?	PLOS ONE			English	Article							VIRUS-STRAINS; TRANSMISSION; INFECTION; SMALLPOX; HUMANS; POXVIRUS; CATTLE; MODEL; RATS; MICE	Background: Despite the fact that smallpox eradication was declared by the World Health Organization (WHO) in 1980, other poxviruses have emerged and re-emerged, with significant public health and economic impacts. Vaccinia virus (VACV), a poxvirus used during the WHO smallpox vaccination campaign, has been involved in zoonotic infections in Brazilian rural areas (Bovine Vaccinia outbreaks - BV), affecting dairy cattle and milkers. Little is known about VACV's natural hosts and its epidemiological and ecological characteristics. Although VACV was isolated and/or serologically detected in Brazilian wild animals, the link between wildlife and farms has not yet been elucidated. Methodology/Principal Findings: In this study, we describe for the first time, to our knowledge, the isolation of a VACV (Mariana virus - MARV) from a mouse during a BV outbreak. Genetic data, in association with biological assays, showed that this isolate was the same etiological agent causing exanthematic lesions observed in the cattle and human inhabitants of a particular BV-affected area. Phylogenetic analysis grouped MARV with other VACV isolated during BV outbreaks. Conclusion/Significance: These data provide new biological and epidemiological information on VACV and lead to an interesting question: could peridomestic rodents be the link between wildlife and BV outbreaks?			Abrahao, JS (corresponding author), Univ Fed Minas Gerais, Inst Ciencias Biol, Virus Lab, Belo Horizonte, MG, Brazil.	kroone@icb.ufmg.br	Abrahão, Jônatas/B-3895-2015; Bonjardim, Claudio A/J-2601-2014; Campos, Rafael Kroon/AAB-5135-2020; Kroon, Erna Geessien/B-3631-2015; Kroon, Erna/V-5444-2019	Abrahão, Jônatas/0000-0001-9420-1791; Campos, Rafael Kroon/0000-0002-4852-0449; Kroon, Erna Geessien/0000-0003-2721-3826; Lobato, Zelia/0000-0002-9399-3691; Mota, Bruno/0000-0003-0348-4875				Abdalrhman I, 2006, VACCINE, V24, P4152, DOI 10.1016/j.vaccine.2006.02.012; da Fonseca FG, 2002, J GEN VIROL, V83, P223, DOI 10.1099/0022-1317-83-1-223; Damaso CRA, 2000, VIROLOGY, V277, P439, DOI 10.1006/viro.2000.0603; DAMON I, 2007, FIELDS VIROLOGY, P2079; Drumond BP, 2008, MICROBES INFECT, V10, P185, DOI 10.1016/j.micinf.2007.11.005; Fenner F., 1989, MONKEYPOX VIRUS ORTH, P227; Fonseca FG, 1998, ARCH VIROL, V143, P1171, DOI 10.1007/s007050050365; GUEDES MIM, 2005, BRAZ SOC VIR C; Haenssle HA, 2006, J AM ACAD DERMATOL, V54, pS1, DOI 10.1016/j.jaad.2005.09.040; Heymann DL, 2006, CURR TOP MICROBIOL, V304, P1; Hutson CL, 2009, J GEN VIROL, V90, P323, DOI 10.1099/vir.0.005108-0; Jezek Z, 1988, HUMAN MONKEYPOX; JOKLIK WK, 1962, VIROLOGY, V18, P9, DOI 10.1016/0042-6822(62)90172-1; Kurth A, 2008, EMERG INFECT DIS, V14, P670, DOI 10.3201/eid1404.070817; Leite JA, 2005, EMERG INFECT DIS, V11, P1935, DOI 10.3201/eid1112.050773; Leite JA, 2007, VIRUS GENES, V35, P531, DOI 10.1007/s11262-007-0133-9; Lobato ZIP, 2005, ARQ BRAS MED VET ZOO, V57, P423, DOI 10.1590/S0102-09352005000400001; LOPES ODS, 1965, AM J TROP MED HYG, V14, P156; MADUREIRA M, 2009, THESIS U FEDERAL MIN; MAIBORODA AD, 1982, ACTA VIROL, V26, P288; Ninove L, 2009, EMERG INFECT DIS, V15, P781, DOI 10.3201/eid1505.090235; OVERMAN JR, 1957, VIROLOGY, V3, P173, DOI 10.1016/0042-6822(57)90031-4; Parrino J, 2006, J ALLERGY CLIN IMMUN, V118, P1320, DOI 10.1016/j.jaci.2006.09.037; Posada D, 1998, BIOINFORMATICS, V14, P817, DOI 10.1093/bioinformatics/14.9.817; Reynolds MG, 2006, J INFECT DIS, V194, P773, DOI 10.1086/505880; ROPP SL, 1995, J CLIN MICROBIOL, V33, P2069, DOI 10.1128/JCM.33.8.2069-2076.1995; Silva-Fernandes AT, 2009, J CLIN VIROL, V44, P308, DOI 10.1016/j.jcv.2009.01.007; SILVAFERNANDES AT, 2008, THESIS U FEDERAL NOR; SIMONETTI BR, 2007, VIRUS REV RES, V12, P1; Singh R. K., 2007, Animal Health Research Reviews, V8, P105, DOI 10.1017/S1466252307001259; Ferreira JMS, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003043; Ferreira JMS, 2008, J GEN VIROL, V89, P2986, DOI 10.1099/vir.0.2008/003947-0; Trindade GD, 2003, EMERG INFECT DIS, V9, P155; Trindade GS, 2007, EMERG INFECT DIS, V13, P965, DOI 10.3201/eid1307.061404; Trindade GS, 2006, AM J TROP MED HYG, V75, P486, DOI 10.4269/ajtmh.2006.75.486	35	82	85	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 19	2009	4	10							e7428	10.1371/journal.pone.0007428	http://dx.doi.org/10.1371/journal.pone.0007428			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UP	19838293	Green Published, gold, Green Submitted			2022-12-27	WOS:000270880900002
J	Manthey, GM; Naik, N; Bailis, AM				Manthey, Glenn M.; Naik, Nilan; Bailis, Adam M.			Msh2 Blocks an Alternative Mechanism for Non-Homologous Tail Removal during Single-Strand Annealing in Saccharomyces cerevisiae	PLOS ONE			English	Article							MISMATCH REPAIR PROTEINS; INDUCED CHROMOSOMAL REARRANGEMENTS; BREAK-INDUCED RECOMBINATION; DIRECT-REPEAT RECOMBINATION; HOMOLOGOUS RECOMBINATION; MITOTIC RECOMBINATION; GENETIC-CONTROL; DNA-REPAIR; RECIPROCAL TRANSLOCATIONS; HETERODUPLEX REJECTION	Chromosomal translocations are frequently observed in cells exposed to agents that cause DNA double-strand breaks (DSBs), such as ionizing radiation and chemotherapeutic drugs, and are often associated with tumors in mammals. Recently, translocation formation in the budding yeast, Saccharomyces cerevisiae, has been found to occur at high frequencies following the creation of multiple DSBs adjacent to repetitive sequences on non-homologous chromosomes. The genetic control of translocation formation and the chromosome complements of the clones that contain translocations suggest that translocation formation occurs by single-strand annealing (SSA). Among the factors important for translocation formation by SSA is the central mismatch repair (MMR) and homologous recombination (HR) factor, Msh2. Here we describe the effects of several msh2 missense mutations on translocation formation that suggest that Msh2 has separable functions in stabilizing annealed single strands, and removing non-homologous sequences from their ends. Additionally, interactions between the msh2 alleles and a null allele of RAD1, which encodes a subunit of a nuclease critical for the removal of non-homologous tails suggest that Msh2 blocks an alternative mechanism for removing these sequences. These results suggest that Msh2 plays multiple roles in the formation of chromosomal translocations following acute levels of DNA damage.			Manthey, GM (corresponding author), City Hope Natl Med Ctr, Beckman Res Inst, Div Mol Biol, Duarte, CA 91010 USA.	abailis@coh.org		Bailis, Adam/0000-0001-5628-0468	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES [R01GM057484] Funding Source: NIH RePORTER; NIGMS NIH HHS [R01 GM057484, GM057484] Funding Source: Medline	NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS)); NIGMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS))		Alani E, 1997, MOL CELL BIOL, V17, P2436, DOI 10.1128/MCB.17.5.2436; Alani E, 1997, J MOL BIOL, V265, P289, DOI 10.1006/jmbi.1996.0743; Argueso JL, 2008, P NATL ACAD SCI USA, V105, P11845, DOI 10.1073/pnas.0804529105; BARDWELL AJ, 1994, SCIENCE, V265, P2082, DOI 10.1126/science.8091230; BOEKE JD, 1984, MOL GEN GENET, V197, P345, DOI 10.1007/BF00330984; Deininger PL, 1999, MOL GENET METAB, V67, P183, DOI 10.1006/mgme.1999.2864; Evans E, 2000, MOL CELL, V5, P789, DOI 10.1016/S1097-2765(00)80319-6; Fasullo M, 2005, MUTAT RES-FUND MOL M, V578, P158, DOI 10.1016/j.mrfmmm.2005.05.003; Fasullo M, 1998, MOL CELL BIOL, V18, P1190, DOI 10.1128/MCB.18.3.1190; FASULLO M, 1994, MUTAT RES, V314, P121, DOI 10.1016/0921-8777(94)90076-0; FASULLO MT, 1988, MOL CELL BIOL, V8, P4370, DOI 10.1128/MCB.8.10.4370; FASULLO MT, 1987, P NATL ACAD SCI USA, V84, P6215, DOI 10.1073/pnas.84.17.6215; Featherstone C, 1999, MUTAT RES-DNA REPAIR, V434, P3, DOI 10.1016/S0921-8777(99)00006-3; FISHMANLOBELL J, 1992, SCIENCE, V258, P480, DOI 10.1126/science.1411547; Flott S, 2005, BIOCHEM J, V391, P325, DOI 10.1042/BJ20050768; Flott S, 2007, MOL CELL BIOL, V27, P6433, DOI 10.1128/MCB.00135-07; Forrester HB, 2004, INT J RADIAT BIOL, V80, P757, DOI 10.1080/09553000400017952; Forrester HB, 1999, INT J RADIAT BIOL, V75, P543, DOI 10.1080/095530099140186; GAME JC, 1974, MUTAT RES, V24, P281, DOI 10.1016/0027-5107(74)90176-6; Goldfarb T, 2005, GENETICS, V169, P563, DOI 10.1534/genetics.104.035204; Grawunder U, 1998, MOL CELL, V2, P477, DOI 10.1016/S1097-2765(00)80147-1; GROSOVSKY AJ, 1986, GENETICS, V113, P405; Haber JE, 1996, P NATL ACAD SCI USA, V93, P13949, DOI 10.1073/pnas.93.24.13949; HABER LT, 1991, EMBO J, V10, P2707, DOI 10.1002/j.1460-2075.1991.tb07815.x; Iadonato S P, 1996, Methods Mol Biol, V54, P75; Ivanov EL, 1996, GENETICS, V142, P693; KANO Y, 1984, CANCER RES, V44, P3706; Klymenko S V, 2005, Tsitol Genet, V39, P55; Knight W., 2006, CONFIDENCE INTERVALS; Kolodner RD, 1999, CURR OPIN GENET DEV, V9, P89, DOI 10.1016/S0959-437X(99)80013-6; Lambert V, 2001, INT J RADIAT BIOL, V77, P679, DOI 10.1080/09553000110042127; Lewis LK, 2000, MUTAT RES-FUND MOL M, V451, P71, DOI 10.1016/S0027-5107(00)00041-5; Li FY, 2008, MOL CELL, V30, P325, DOI 10.1016/j.molcel.2008.02.028; Liang F, 1998, P NATL ACAD SCI USA, V95, P5172, DOI 10.1073/pnas.95.9.5172; Liang F, 1996, P NATL ACAD SCI USA, V93, P8929, DOI 10.1073/pnas.93.17.8929; LIN FLM, 1990, MOL CELL BIOL, V10, P103, DOI 10.1128/MCB.10.1.103; LUKACSOVICH T, 1994, NUCLEIC ACIDS RES, V22, P5649, DOI 10.1093/nar/22.25.5649; Lyndaker AM, 2009, BIOESSAYS, V31, P315, DOI 10.1002/bies.200800195; Maines S, 1998, GENETICS, V150, P963; Maniatis T., 1989, MOL CLONING LAB MANU; Manthey GM, 2002, MOL CELL BIOL, V22, P5347, DOI 10.1128/MCB.22.15.5347-5356.2002; Marsischky GT, 1996, GENE DEV, V10, P407, DOI 10.1101/gad.10.4.407; Meyer DH, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0003318; Moore JK, 1996, NATURE, V383, P644, DOI 10.1038/383644a0; Mullen JR, 2001, GENETICS, V157, P103; Muller I, 2005, INT J RADIAT ONCOL, V63, P1214, DOI 10.1016/j.ijrobp.2005.03.056; NEW L, 1993, MOL GEN GENET, V239, P97, DOI 10.1007/BF00281607; NICKOLOFF JA, 1986, P NATL ACAD SCI USA, V83, P7831, DOI 10.1073/pnas.83.20.7831; Nikiforov YE, 1999, ONCOGENE, V18, P6330, DOI 10.1038/sj.onc.1203019; OZENBERGER BA, 1991, MOL CELL BIOL, V11, P1222, DOI 10.1128/MCB.11.3.1222; Pannunzio NR, 2008, DNA REPAIR, V7, P788, DOI 10.1016/j.dnarep.2008.02.003; Paques F, 1999, MICROBIOL MOL BIOL R, V63, P349; Paques F, 1997, MOL CELL BIOL, V17, P6765, DOI 10.1128/MCB.17.11.6765; PLESSIS A, 1992, GENETICS, V130, P451; REENAN RAG, 1992, GENETICS, V132, P963; RESNICK MA, 1976, MOL GEN GENET, V143, P119, DOI 10.1007/BF00266917; Richardson C, 2000, NATURE, V405, P697, DOI 10.1038/35015097; RONNE H, 1988, P NATL ACAD SCI USA, V85, P2696, DOI 10.1073/pnas.85.8.2696; ROUET P, 1994, MOL CELL BIOL, V14, P8096, DOI 10.1128/MCB.14.12.8096; RUDIN N, 1988, MOL CELL BIOL, V8, P3918, DOI 10.1128/MCB.8.9.3918; SAEKI T, 1980, MUTAT RES, V73, P251, DOI 10.1016/0027-5107(80)90192-X; Saparbaev M, 1996, GENETICS, V142, P727; SCHIESTL RH, 1990, MOL CELL BIOL, V10, P2485, DOI 10.1128/MCB.10.6.2485; SCHIESTL RH, 1988, MOL CELL BIOL, V8, P3619, DOI 10.1128/MCB.8.9.3619; Sherman F., 1986, METHODS YEAST GENETI; SIKORSKI RS, 1989, GENETICS, V122, P19; STRUHL K, 1979, P NATL ACAD SCI USA, V76, P1035, DOI 10.1073/pnas.76.3.1035; Studamire B, 1999, MOL CELL BIOL, V19, P7558; Studamire B, 1998, MOL CELL BIOL, V18, P7590, DOI 10.1128/MCB.18.12.7590; Sugawara N, 2004, P NATL ACAD SCI USA, V101, P9315, DOI 10.1073/pnas.0305749101; Sugawara N, 1997, P NATL ACAD SCI USA, V94, P9214, DOI 10.1073/pnas.94.17.9214; SUGAWARA N, 1992, MOL CELL BIOL, V12, P563, DOI 10.1128/MCB.12.2.563; Sugawara N, 2000, MOL CELL BIOL, V20, P5300, DOI 10.1128/MCB.20.14.5300-5309.2000; SUNG P, 1993, J BIOL CHEM, V268, P26391; Surtees JA, 2006, J MOL BIOL, V360, P523, DOI 10.1016/j.jmb.2006.05.032; Symington LS, 2002, MICROBIOL MOL BIOL R, V66, P630, DOI 10.1128/MMBR.66.4.630-670.2002; Teng SC, 1996, NATURE, V383, P641, DOI 10.1038/383641a0; THOMAS BJ, 1989, GENETICS, V123, P725; TOMKINSON AE, 1994, BIOCHEMISTRY-US, V33, P5305, DOI 10.1021/bi00183a038; TOMKINSON AE, 1993, NATURE, V362, P860, DOI 10.1038/362860a0; Weinstock DM, 2006, DNA REPAIR, V5, P1065, DOI 10.1016/j.dnarep.2006.05.028; WINEGAR RA, 1994, MUTAT RES, V307, P479, DOI 10.1016/0027-5107(94)90258-5; Yu X, 2004, GENETICS, V166, P741, DOI 10.1534/genetics.166.2.741	83	7	8	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7488	10.1371/journal.pone.0007488	http://dx.doi.org/10.1371/journal.pone.0007488			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	507UN	19834615	Green Published, Green Submitted, gold			2022-12-27	WOS:000270880700012
J	Salimpoor, VN; Benovoy, M; Longo, G; Cooperstock, JR; Zatorre, RJ				Salimpoor, Valorie N.; Benovoy, Mitchel; Longo, Gregory; Cooperstock, Jeremy R.; Zatorre, Robert J.			The Rewarding Aspects of Music Listening Are Related to Degree of Emotional Arousal	PLOS ONE			English	Article							GALVANIC SKIN-RESPONSES; DOPAMINE RELEASE; COLLEGE-STUDENTS; CHILLS; BRAIN; CORRELATE; EXPOSURE; PLEASANT; STIMULI; BIOLOGY	Background: Listening to music is amongst the most rewarding experiences for humans. Music has no functional resemblance to other rewarding stimuli, and has no demonstrated biological value, yet individuals continue listening to music for pleasure. It has been suggested that the pleasurable aspects of music listening are related to a change in emotional arousal, although this link has not been directly investigated. In this study, using methods of high temporal sensitivity we investigated whether there is a systematic relationship between dynamic increases in pleasure states and physiological indicators of emotional arousal, including changes in heart rate, respiration, electrodermal activity, body temperature, and blood volume pulse. Methodology: Twenty-six participants listened to self-selected intensely pleasurable music and "neutral'' music that was individually selected for them based on low pleasure ratings they provided on other participants' music. The "chills'' phenomenon was used to index intensely pleasurable responses to music. During music listening, continuous real-time recordings of subjective pleasure states and simultaneous recordings of sympathetic nervous system activity, an objective measure of emotional arousal, were obtained. Principal Findings: Results revealed a strong positive correlation between ratings of pleasure and emotional arousal. Importantly, a dissociation was revealed as individuals who did not experience pleasure also showed no significant increases in emotional arousal. Conclusions/Significance: These results have broader implications by demonstrating that strongly felt emotions could be rewarding in themselves in the absence of a physically tangible reward or a specific functional goal.			Salimpoor, VN (corresponding author), McGill Univ, Montreal Neurol Inst, Montreal, PQ, Canada.	valorie.salimpoor@mail.mcgill.ca	Cooperstock, Jeremy/AAU-1549-2020	Lauwereyns, Jan/0000-0003-0551-2550	Canadian Institutes of Health Research Funding Source: Medline	Canadian Institutes of Health Research(Canadian Institutes of Health Research (CIHR))		BARTLETT DL, 1996, HDB MUSIC PSYCHOL, P343; Baumgartner T, 2006, INT J PSYCHOPHYSIOL, V60, P34, DOI 10.1016/j.ijpsycho.2005.04.007; Blood AJ, 2001, P NATL ACAD SCI USA, V98, P11818, DOI 10.1073/pnas.191355898; Bradley MM., 2000, SER AFFECTIVE SCI, P242; Brown S, 2004, NEUROREPORT, V15, P2033, DOI 10.1097/00001756-200409150-00008; Camara E, 2009, FRONT HUM NEUROSCI, V2, DOI 10.3389/neuro.09.019.2008; Carter FA, 1995, BEHAV CHANGE, V12, P159, DOI 10.1017/S0813483900006021; Damasio A.R., 2005, DESCARTES ERROR EMOT; Damasio A.R., 2000, FEELING WHAT HAPPENS; Dube L, 2003, COGNITION EMOTION, V17, P263, DOI 10.1080/02699930302295; EKMAN P, 1983, SCIENCE, V221, P1208, DOI 10.1126/science.6612338; Etzel JA, 2006, INT J PSYCHOPHYSIOL, V61, P57, DOI 10.1016/j.ijpsycho.2005.10.025; Fitch WT, 2005, ANN NY ACAD SCI, V1060, P29, DOI 10.1196/annals.1360.004; Gabrielsson A., 2001, MUSIC EMOTION THEORY, P431; Gabrielsson A, 2001, MUSIC SCI, V5, P123, DOI 10.1177/10298649020050S105; GOLDSTEIN A, 1980, PHYSIOL PSYCHOL, V8, P126; Grewe O, 2005, ANN NY ACAD SCI, V1060, P446, DOI 10.1196/annals.1360.041; Grewe O, 2007, EMOTION, V7, P774, DOI 10.1037/1528-3542.7.4.774; Grewe O, 2009, ANN NY ACAD SCI, V1169, P351, DOI 10.1111/j.1749-6632.2009.04783.x; Guhn M, 2007, MUSIC PERCEPT, V24, P473, DOI 10.1525/MP.2007.24.5.473; Harrer G., 1977, MUSIC BRAIN STUDIES, P202; Huron D.B., 2006, SWEET ANTICIPATION M; Iwanaga M, 2005, BIOL PSYCHOL, V70, P61, DOI 10.1016/j.biopsycho.2004.11.015; James W., 1884, MIND, V9, P34, DOI [10.1093/mind/os-IX.34.188, DOI 10.1093/MIND/OS-IX.34.188]; Johnsen EL, 2009, INT J PSYCHOPHYSIOL, V72, P24, DOI 10.1016/j.ijpsycho.2008.03.011; Juslin PN, 2001, MUSIC EMOTION THEORY; Khalfa S, 2005, NEUROREPORT, V16, P1981, DOI 10.1097/00001756-200512190-00002; Khalfa S, 2002, NEUROSCI LETT, V328, P145, DOI 10.1016/S0304-3940(02)00462-7; Khalfa S, 2008, INT J PSYCHOPHYSIOL, V68, P17, DOI 10.1016/j.ijpsycho.2007.12.001; Koelsch S, 2006, HUM BRAIN MAPP, V27, P239, DOI 10.1002/hbm.20180; Koepp MJ, 1998, NATURE, V393, P266, DOI 10.1038/30498; Krumhansl CL, 1997, CAN J EXP PSYCHOL, V51, P336, DOI 10.1037/1196-1961.51.4.336; LeDoux J. E., 1996, EMOTIONAL BRAIN; Leyton M, 2002, NEUROPSYCHOPHARMACOL, V27, P1027, DOI 10.1016/S0893-133X(02)00366-4; Menon V, 2005, NEUROIMAGE, V28, P175, DOI 10.1016/j.neuroimage.2005.05.053; Meyer L., 1956, EMOTION MEANING MUSI; Nater UM, 2006, INT J PSYCHOPHYSIOL, V62, P300, DOI 10.1016/j.ijpsycho.2006.05.011; North AC, 1997, SCAND J PSYCHOL, V38, P45, DOI 10.1111/1467-9450.00008; Nyklicek I, 1997, J PSYCHOPHYSIOL, V11, P304; Panksepp J, 2002, BEHAV PROCESS, V60, P133, DOI 10.1016/S0376-6357(02)00080-3; Panksepp J, 1995, MUSIC PERCEPT, V13, P171; PINKER S, 1997, HOW MIND WORKS; Rickard N.S., 2004, PSYCHOL MUSIC, V32, P371, DOI [DOI 10.1177/0305735604046096, 10.1177%2F0305735604046096]; Rickard Nikki S, 2005, Behav Cogn Neurosci Rev, V4, P235, DOI 10.1177/1534582305285869; ROLLS ET, 1975, BRAIN REWARD; Roy M, 2009, INT J PSYCHOPHYSIOL, V71, P37, DOI 10.1016/j.ijpsycho.2008.07.010; Sammler D, 2007, PSYCHOPHYSIOLOGY, V44, P293, DOI 10.1111/j.1469-8986.2007.00497.x; SCHACHTER S, 1962, PSYCHOL REV, V69, P379, DOI 10.1037/h0046234; Schlaepfer TE, 1997, AM J PSYCHIAT, V154, P1209; Schott BH, 2008, J NEUROSCI, V28, P14311, DOI 10.1523/JNEUROSCI.2058-08.2008; Sequeira H, 2009, INT J PSYCHOPHYSIOL, V71, P50, DOI 10.1016/j.ijpsycho.2008.07.009; Sloboda JA., 2001, MUSIC EMOTION THEORY; Sloboda JohnA., 1991, PSYCHOL MUSIC, V19, P110, DOI [10.1177/0305735691192002, DOI 10.1177/0305735691192002]; Small DM, 2003, NEUROIMAGE, V19, P1709, DOI 10.1016/S1053-8119(03)00253-2; Steinbeis N, 2006, J COGNITIVE NEUROSCI, V18, P1380, DOI 10.1162/jocn.2006.18.8.1380; THAUT MH, 1993, J MUSIC THER, V30, P210, DOI 10.1093/jmt/30.4.210; VANDERARK SD, 1992, PERCEPT MOTOR SKILL, V74, P1079, DOI 10.2466/PMS.74.4.1079-1090; VANDERARK SD, 1993, PERCEPT MOTOR SKILL, V77, P227, DOI 10.2466/pms.1993.77.1.227; Witvliet CVO, 2007, COGNITION EMOTION, V21, P3, DOI 10.1080/02699930601000672; ZIMNY GH, 1963, AM J PSYCHOL, V76, P311, DOI 10.2307/1419170	60	312	317	1	76	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 16	2009	4	10							e7487	10.1371/journal.pone.0007487	http://dx.doi.org/10.1371/journal.pone.0007487			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	507UN	19834599	Green Published, gold, Green Submitted			2022-12-27	WOS:000270880700011
J	Juncker, AS; Larsen, MV; Weinhold, N; Nielsen, M; Brunak, S; Lund, O				Juncker, Agnieszka S.; Larsen, Mette V.; Weinhold, Nils; Nielsen, Morten; Brunak, Soren; Lund, Ole			Systematic Characterisation of Cellular Localisation and Expression Profiles of Proteins Containing MHC Ligands	PLOS ONE			English	Article							PEPTIDE BINDING; GENE ONTOLOGY; RECOGNITION; PREDICTIONS; MOLECULES; MECHANISM; DENSITY; EPITOPE; DRIP	Background: Presentation of peptides on Major Histocompatibility Complex (MHC) molecules is the cornerstone in immune system activation and increased knowledge of the characteristics of MHC ligands and their source proteins is highly desirable. Methodology/Principal Finding: In the present large-scale study, we used a large data set of proteins containing experimentally identified MHC class I or II ligands and examined the proteins according to their expression profiles at the mRNA level and their Gene Ontology (GO) classification within the cellular component ontology. Proteins encoded by highly abundant mRNA were found to be much more likely to be the source of MHC ligands. Of the 2.5% most abundant mRNAs as much as 41% of the proteins encoded by these mRNAs contained MHC class I ligands. For proteins containing MHC class II ligands, the corresponding percentage was 11%. Furthermore, we found that most proteins containing MHC class I ligands were localised to the intracellular parts of the cell including the cytoplasm and nucleus. MHC class II ligand donors were, on the other hand, mostly membrane proteins. Conclusions/Significance: The results contribute to the ongoing debate concerning the nature of MHC ligand-containing proteins and can be used to extend the existing methods for MHC ligand predictions by including the source protein's localisation and expression profile. Improving the current methods is important in the growing quest for epitopes that can be used for vaccine or diagnostic purposes, especially when it comes to large DNA viruses and cancer.			Juncker, AS (corresponding author), Tech Univ Denmark, Dept Syst Biol, Ctr Biol Sequence Anal, DK-2800 Lyngby, Denmark.	metteb@cbs.dtu.dk	Lund, Ole/F-4437-2014; Nielsen, Morten/AAL-8700-2020; Nielsen, Morten/E-7754-2011; Brunak, Soren/O-6621-2016	Lund, Ole/0000-0003-1108-0491; Nielsen, Morten/0000-0001-7885-4311; Nielsen, Morten/0000-0001-7885-4311; Brunak, Soren/0000-0003-0316-5866	PHS HHS [HHSN266200400083C] Funding Source: Medline	PHS HHS(United States Department of Health & Human ServicesUnited States Public Health Service)		Ashburner M, 2000, NAT GENET, V25, P25, DOI 10.1038/75556; Bairoch A, 2008, NUCLEIC ACIDS RES, V36, pD190, DOI 10.1093/nar/gkm895; CHICZ RM, 1993, J EXP MED, V178, P27, DOI 10.1084/jem.178.1.27; CHICZ RM, 1992, NATURE, V358, P764, DOI 10.1038/358764a0; Eklund AC, 2008, GENOME BIOL, V9, DOI 10.1186/gb-2008-9-2-r26; Engelhard VH, 2002, MOL IMMUNOL, V39, P127, DOI 10.1016/S0161-5890(02)00096-2; Ferris RL, 1996, J IMMUNOL, V156, P834; Fortier MH, 2008, J EXP MED, V205, P595, DOI 10.1084/jem.20071985; HAMMOND SA, 1995, J IMMUNOL, V154, P6140; Hickman HD, 2004, J IMMUNOL, V172, P2944, DOI 10.4049/jimmunol.172.5.2944; Hiller MM, 1996, SCIENCE, V273, P1725, DOI 10.1126/science.273.5282.1725; Irizarry RA, 2003, BIOSTATISTICS, V4, P249, DOI 10.1093/biostatistics/4.2.249; Irvine DJ, 2002, NATURE, V419, P845, DOI 10.1038/nature01076; Jerzak G, 2005, J GEN VIROL, V86, P2175, DOI 10.1099/vir.0.81015-0; Krogsgaard M, 2005, NATURE, V434, P238, DOI 10.1038/nature03391; Larsen Mette Voldby, 2006, Current Immunology Reviews, V2, P233; Lin HH, 2008, BMC IMMUNOL, V9, DOI 10.1186/1471-2172-9-8; LODISH H, 1998, MOL CELL BIOL; Lundegaard C, 2007, BIOINFORMATICS, V23, P3265, DOI 10.1093/bioinformatics/btm471; Maere S, 2005, BIOINFORMATICS, V21, P3448, DOI 10.1093/bioinformatics/bti551; Milner E, 2006, MOL CELL PROTEOMICS, V5, P357, DOI 10.1074/mcp.M500241-MCP200; Nielsen M, 2008, PLOS COMPUT BIOL, V4, DOI 10.1371/journal.pcbi.1000107; Peters B, 2006, PLOS COMPUT BIOL, V2, P574, DOI 10.1371/journal.pcbi.0020065; Purbhoo MA, 2004, NAT IMMUNOL, V5, P524, DOI 10.1038/ni1058; Rammensee HG, 1999, IMMUNOGENETICS, V50, P213, DOI 10.1007/s002510050595; ROTZSCHKE O, 1994, CURR OPIN IMMUNOL, V6, P45, DOI 10.1016/0952-7915(94)90032-9; RUDENSKY AY, 1991, NATURE, V353, P622, DOI 10.1038/353622a0; SILICIANO RF, 1995, J IMMUNOL, V155, P2; Su AI, 2004, P NATL ACAD SCI USA, V101, P6062, DOI 10.1073/pnas.0400782101; Tscharke DC, 2005, J EXP MED, V201, P95, DOI 10.1084/jem.20041912; Weinzierl AO, 2007, MOL CELL PROTEOMICS, V6, P102, DOI 10.1074/mcp.M600310-MCP200; Yewdell J, 2002, MOL IMMUNOL, V39, P139, DOI 10.1016/S0161-5890(02)00097-4; Yewdell JW, 2006, TRENDS IMMUNOL, V27, P368, DOI 10.1016/j.it.2006.06.008; Yewdell JW, 1996, J IMMUNOL, V157, P1823	34	25	25	0	1	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7448	10.1371/journal.pone.0007448	http://dx.doi.org/10.1371/journal.pone.0007448			7	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	506WT	19826487	Green Published, gold, Green Submitted			2022-12-27	WOS:000270808700010
J	Lycett, SJ				Lycett, Stephen J.			Understanding Ancient Hominin Dispersals Using Artefactual Data: A Phylogeographic Analysis of Acheulean Handaxes	PLOS ONE			English	Article							PHYLOGENETIC ANALYSES; LOS HUESOS; EVOLUTION; CHARACTERS; BEHAVIOR; CULTURE; AFRICA; DISTANCE; SUPPORT; MODEL	Background: Reconstructing the dispersal patterns of extinct hominins remains a challenging but essential goal. One means of supplementing fossil evidence is to utilize archaeological evidence in the form of stone tools. Based on broad dating patterns, it has long been thought that the appearance of Acheulean handaxe technologies outside of Africa was the result of hominin dispersals, yet independent tests of this hypothesis remain rare. Cultural transmission theory leads to a prediction of a strong African versus non-African phylogeographic pattern in handaxe datasets, if the African Acheulean hypothesis is to be supported. Methodology/Principal Findings: Here, this prediction is tested using an intercontinental dataset of Acheulean handaxes and a biological phylogenetic method ( maximum parsimony). The analyses produce a tree consistent with the phylogeographic prediction. Moreover, a bootstrap analysis provides evidence that this pattern is robust, and the maximum parsimony tree is also shown to be statistically different from a tree constrained by stone raw materials. Conclusions/Significance: These results demonstrate that nested analyses of behavioural data, utilizing methods drawn from biology, have the potential to shed light on ancient hominin dispersals. This is an encouraging prospect for human palaeobiology since sample sizes for lithic artefacts are many orders of magnitude higher than those of fossil data. These analyses also suggest that the sustained occurrence of Acheulean handaxe technologies in regions such as Europe and the Indian subcontinent resulted from dispersals by African hominin populations.			Lycett, SJ (corresponding author), Univ Kent, Dept Anthropol, Canterbury, Kent, England.	S.J.Lycett@kent.ac.uk						Anton SC, 2004, ANNU REV ANTHROPOL, V33, P271, DOI 10.1146/annurev.anthro.33.070203.144024; ASFAW B, 1992, NATURE, V360, P732, DOI 10.1038/360732a0; Bar-Yosef O, 2001, QUATERN INT, V75, P19, DOI 10.1016/S1040-6182(00)00074-4; BARYOSEF O, 1994, J WORLD PREHIST, V8, P211, DOI 10.1007/BF02221050; Bentley RA, 2004, P ROY SOC B-BIOL SCI, V271, P1443, DOI 10.1098/rspb.2004.2746; Bischoff JL, 2007, J ARCHAEOL SCI, V34, P763, DOI 10.1016/j.jas.2006.08.003; Boyd R., 1985, CULTURE EVOLUTIONARY; Buchanan B, 2008, J ARCHAEOL SCI, V35, P1683, DOI 10.1016/j.jas.2007.11.009; Buchanan B, 2007, J ANTHROPOL ARCHAEOL, V26, P366, DOI 10.1016/j.jaa.2007.02.005; Cap H, 2008, CLADISTICS, V24, P917, DOI 10.1111/j.1096-0031.2008.00223.x; Carbonell E, 2006, CR PALEVOL, V5, P155, DOI 10.1016/j.crpv.2005.11.010; Carbonell E, 1999, J ANTHROPOL ARCHAEOL, V18, P119, DOI 10.1006/jaar.1998.0331; Cavalli-Sforza LL., 1981, CULTURAL TRANSMISSIO; Chauhan PR, 2009, EVOL ANTHROPOL, V18, P62, DOI 10.1002/evan.20199; Christiansen P, 2008, CLADISTICS, V24, P977, DOI 10.1111/j.1096-0031.2008.00226.x; Clark J. D., 1994, INTEGRATIVE PATHS PA, P451; Collard M, 2006, EVOL HUM BEHAV, V27, P169, DOI 10.1016/j.evolhumbehav.2005.07.003; Dennell R, 2005, NATURE, V438, P1099, DOI 10.1038/nature04259; Dennell R, 2003, J HUM EVOL, V45, P421, DOI 10.1016/j.jhevol.2003.09.006; Dennell RW, 2009, PALAEOLITHIC SETTLEM; Dohrmann M, 2008, SYST BIOL, V57, P388, DOI 10.1080/10635150802161088; DURHAM WH, 1992, ANNU REV ANTHROPOL, V21, P331, DOI 10.1146/annurev.an.21.100192.001555; FALSETTI AB, 1993, INT J PRIMATOL, V14, P551, DOI 10.1007/BF02215447; Farris J.S., 1983, Advances in Cladistics, V2, P7; FELSENSTEIN J, 1985, EVOLUTION, V39, P783, DOI 10.1111/j.1558-5646.1985.tb00420.x; Finlayson C, 2005, TRENDS ECOL EVOL, V20, P457, DOI 10.1016/j.tree.2005.05.019; Gamble C., 1993, TIMEWALKERS PREHISTO; Gibbon RJ, 2009, J HUM EVOL, V56, P152, DOI 10.1016/j.jhevol.2008.09.006; Gibbs S, 2000, P NATL ACAD SCI USA, V97, P11130, DOI 10.1073/pnas.190252697; Goodman ME, 1944, AM ANTIQUITY, V9, P415, DOI 10.2307/275093; Goren-Inbar N, 2000, SCIENCE, V289, P944, DOI 10.1126/science.289.5481.944; Hamilton MJ, 2009, J ANTHROPOL ARCHAEOL, V28, P55, DOI 10.1016/j.jaa.2008.10.005; HAY RL, 1990, GEOLOGICAL SOC AM SP, V242, P23; HENNIG W, 1999, PHYLOGENETIC SYSTEMA; Holmes KM, 2007, PALAEOGEOGR PALAEOCL, V248, P96, DOI 10.1016/j.palaeo.2006.11.012; Hublin JJ, 2009, P NATL ACAD SCI USA, V106, P16022, DOI 10.1073/pnas.0904119106; Humphries C.J., 1988, P371; Jordan P, 2003, J ANTHROPOL ARCHAEOL, V22, P42, DOI 10.1016/S0278-4165(03)00004-7; Jungers WL, 1995, YEARB PHYS ANTHROPOL, V38, P137; KISHINO H, 1989, J MOL EVOL, V29, P170, DOI 10.1007/BF02100115; Kitching I. J., 1998, CLADISTICS THEORY PR; Klein R., 2005, HUMAN WORLD PREHISTO, P84; Klein R.G., 2009, HUMAN CAREER HUMAN B, V3rd; KLUGE AG, 1989, SYST ZOOL, V38, P7, DOI 10.2307/2992432; Kroken S, 2003, P NATL ACAD SCI USA, V100, P15670, DOI 10.1073/pnas.2532165100; Leakey M.D., 1971, OLDUVAI GORGE EXCAVA, V3; Li JZ, 2008, SCIENCE, V319, P1100, DOI 10.1126/science.1153717; LIPO CP, 2006, CULTURAL PHYLOGENIES, P3; Lycett SJ, 2006, J ARCHAEOL SCI, V33, P847, DOI 10.1016/j.jas.2005.10.014; Lycett SJ, 2008, WORLD ARCHAEOL, V40, P295, DOI 10.1080/00438240802260970; Lycett SJ, 2007, J ANTHROPOL ARCHAEOL, V26, P541, DOI 10.1016/j.jaa.2007.07.003; Lycett SJ, 2008, J ARCHAEOL SCI, V35, P553, DOI 10.1016/j.jas.2007.05.003; Lycett SJ, 2007, P NATL ACAD SCI USA, V104, P17588, DOI 10.1073/pnas.0707930104; Lycett SJ, 2007, J ARCHAEOL SCI, V34, P1434, DOI 10.1016/j.jas.2006.11.001; Lycett SJ, 2009, J HUM EVOL, V56, P175, DOI 10.1016/j.jhevol.2008.10.001; MADDISON DR, 2001, MACCLADE 4 ANAL PHYL; Mallegni F, 2007, HUMAN EVOLUTION, V21, P261; Manica A, 2007, NATURE, V448, P346, DOI 10.1038/nature05951; Mesoudi A, 2006, BEHAV BRAIN SCI, V29, P329, DOI 10.1017/S0140525X06009083; Mithen S, 2002, J HUM EVOL, V43, P433, DOI 10.1006/jhev.2002.0584; Mithen S, 1999, MAMMALIAN SOCIAL LEA, P389; Nadal-Roberts M, 2005, FOLIA PRIMATOL, V76, P207, DOI 10.1159/000086022; Nelson G., 1981, SYSTEMATICS BIOGEORA; O'Brien MJ, 2001, J ARCHAEOL SCI, V28, P1115, DOI 10.1006/jasc.2001.0681; O'Brien MJ., 2008, CULTURAL TRANSMISSIO, P39; O'Donnell K, 1998, P NATL ACAD SCI USA, V95, P2044, DOI 10.1073/pnas.95.5.2044; O'Leary MA, 2008, CLADISTICS, V24, P397, DOI 10.1111/j.1096-0031.2007.00187.x; OBrien M.J., 2003, CLADISTICS ARCHAEOLO; Prugnolle F, 2005, CURR BIOL, V15, pR159, DOI 10.1016/j.cub.2005.02.038; Rae Todd C., 1997, P59; Ramachandran S, 2005, P NATL ACAD SCI USA, V102, P15942, DOI 10.1073/pnas.0507611102; Richerson PJ., 2005, NOT GENES ALONE CULT; Roberts MB., 1999, BOXGROVE MIDDLE PLEI; Rogers DS, 2008, P NATL ACAD SCI USA, V105, P3416, DOI 10.1073/pnas.0711802105; Rogers DS, 2009, P ROY SOC B-BIOL SCI, V276, P3835, DOI 10.1098/rspb.2009.1088; Scott GR, 2009, NATURE, V461, P82, DOI 10.1038/nature08214; Semaw S, 2003, J HUM EVOL, V45, P169, DOI 10.1016/S0047-2484(03)00093-9; Shennan SJ., 1999, MAMMALIAN SOCIAL LEA, P367; Shennan Stephen, 2006, SOCIAL INFORM TRANSM, P173; SLOWINSKI JB, 1993, SYST BIOL, V42, P155, DOI 10.2307/2992538; SMITH AB, 1994, SYSTEMATICS FOSSIL R; Smith HF, 2008, J HUM EVOL, V54, P684, DOI 10.1016/j.jhevol.2007.10.012; Stout D, 2002, CURR ANTHROPOL, V43, P693, DOI 10.1086/342638; Strait DS, 2004, J HUM EVOL, V47, P399, DOI 10.1016/j.jhevol.2004.08.008; Swofford D.L, 1998, PAUP 4 0 PHYLOGENETI; Tehrani J, 2002, J ANTHROPOL ARCHAEOL, V21, P443, DOI 10.1016/S0278-4165(02)00002-8; Tehrani JJ, 2009, EVOL HUM BEHAV, V30, P286, DOI 10.1016/j.evolhumbehav.2009.03.002; THORPE RS, 1984, EVOLUTION, V38, P244, DOI 10.1111/j.1558-5646.1984.tb00282.x; von Cramon-Taubadel N, 2008, AM J PHYS ANTHROPOL, V136, P108, DOI 10.1002/ajpa.20775; Wills MA, 2008, SYST BIOL, V57, P891, DOI 10.1080/10635150802570809; Wood B, 1997, NATURE, V385, P292, DOI 10.1038/385292a0	91	44	44	0	22	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 14	2009	4	10							e7404	10.1371/journal.pone.0007404	http://dx.doi.org/10.1371/journal.pone.0007404			6	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	506WT	19826473	Green Published, Green Submitted, gold			2022-12-27	WOS:000270808700004
J	Jimenez, RH; Boylan, JM; Lee, JS; Francesconi, M; Castellani, G; Sanders, JA; Gruppuso, PA				Jimenez, Rosa H.; Boylan, Joan M.; Lee, Ju-Seog; Francesconi, Mirko; Castellani, Gastone; Sanders, Jennifer A.; Gruppuso, Philip A.			Rapamycin Response in Tumorigenic and Non-Tumorigenic Hepatic Cell Lines	PLOS ONE			English	Article							RAT-LIVER; HEPATOCELLULAR CANCER; MTOR; GROWTH; TRANSCRIPTION; TARGET; PHOSPHORYLATION; PROLIFERATION; TRANSLATION; DOWNSTREAM	Background: The mTOR inhibitor rapamycin has anti-tumor activity across a variety of human cancers, including hepatocellular carcinoma. However, resistance to its growth inhibitory effects is common. We hypothesized that hepatic cell lines with varying rapamycin responsiveness would show common characteristics accounting for resistance to the drug. Methodology/Principal Findings: We profiled a total of 13 cell lines for rapamycin-induced growth inhibition. The non-tumorigenic rat liver epithelial cell line WB-F344 was highly sensitive while the tumorigenic WB311 cell line, originally derived from the WB-F344 line, was highly resistant. The other 11 cell lines showed a wide range of sensitivities. Rapamycin induced inhibition of cyclin E-dependent kinase activity in some cell lines, but the ability to do so did not correlate with sensitivity. Inhibition of cyclin E-dependent kinase activity was related to incorporation of p27(Kip1) into cyclin E-containing complexes in some but not all cell lines. Similarly, sensitivity of global protein synthesis to rapamycin did not correlate with its anti-proliferative effect. However, rapamycin potently inhibited phosphorylation of two key substrates, ribosomal protein S6 and 4E-BP1, in all cases, indicating that the locus of rapamycin resistance was downstream from inhibition of mTOR Complex 1. Microarray analysis did not disclose a unifying mechanism for rapamycin resistance, although the glycolytic pathway was downregulated in all four cell lines studied. Conclusions/Significance: We conclude that the mechanisms of rapamycin resistance in hepatic cells involve alterations of signaling downstream from mTOR and that the mechanisms are highly heterogeneous, thus predicting that maintaining or promoting sensitivity will be highly challenging.			Jimenez, RH (corresponding author), Brown Univ, Rhode Isl Hosp, Dept Pediat, Providence, RI 02903 USA.	Philip_Gruppuso@brown.edu	francesconi, mirko/O-8080-2015; Castellani, Gastone c/L-3333-2017; Lee, Ju-Seog/X-1786-2018	francesconi, mirko/0000-0002-8702-0877; Castellani, Gastone c/0000-0003-4892-925X; Lee, Ju-Seog/0000-0002-5666-9753; Sanders, Jennifer/0000-0002-4714-5114	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT [R01HD024455] Funding Source: NIH RePORTER; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT [R01HD035831] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCES [P20RR017695] Funding Source: NIH RePORTER; NCRR NIH HHS [P20RR017695, P20 RR017695] Funding Source: Medline; NICHD NIH HHS [R01HD24455, R01 HD024455, R01HD35831, R01 HD035831, F31 HD041893] Funding Source: Medline	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH &HUMAN DEVELOPMENT(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NICHD NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD))		Abraham RT, 1996, ANNU REV IMMUNOL, V14, P483, DOI 10.1146/annurev.immunol.14.1.483; Anand P, 2006, J NUTR, V136, P27, DOI 10.1093/jn/136.1.27; Baba HA, 2009, LIVER INT, V29, P399, DOI 10.1111/j.1478-3231.2008.01798.x; Benjamini Y, 2001, BEHAV BRAIN RES, V125, P279, DOI 10.1016/S0166-4328(01)00297-2; Boylan JM, 2005, BIOCHEM BIOPH RES CO, V330, P722, DOI 10.1016/j.bbrc.2005.03.042; Boylan JM, 2001, J BIOL CHEM, V276, P44457, DOI 10.1074/jbc.M103457200; Campbell WA, 2000, J BIOL CHEM, V275, P5347, DOI 10.1074/jbc.275.8.5347; Chiang GG, 2007, TRENDS MOL MED, V13, P433, DOI 10.1016/j.molmed.2007.08.001; Choo AY, 2009, CELL CYCLE, V8, P567, DOI 10.4161/cc.8.4.7659; CURRAN TR, 1993, EXP CELL RES, V209, P53, DOI 10.1006/excr.1993.1284; Dever TE, 2002, CELL, V108, P545, DOI 10.1016/S0092-8674(02)00642-6; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Erbay E, 2003, J CELL BIOL, V163, P931, DOI 10.1083/jcb.200307158; Fingar DC, 2002, GENE DEV, V16, P1472, DOI 10.1101/gad.995802; Francesconi M, 2008, BMC BIOINFORMATICS, V9, DOI 10.1186/1471-2105-9-S4-S9; Gingras AC, 2003, CURR TOP MICROBIOL, V279, P169; Gruppuso PA, 2005, PEDIATR RES, V57, P185, DOI 10.1203/01.PDR.0000151646.55587.0F; Guertin DA, 2005, TRENDS MOL MED, V11, P353, DOI 10.1016/j.molmed.2005.06.007; Guertin DA, 2007, CANCER CELL, V12, P9, DOI 10.1016/j.ccr.2007.05.008; Hay N, 2004, GENE DEV, V18, P1926, DOI 10.1101/gad.1212704; Heuer M, 2009, TRANSPL P, V41, P359, DOI 10.1016/j.transproceed.2008.10.090; Hixson DC, 2000, EXP MOL PATHOL, V68, P152, DOI 10.1006/exmp.2000.2302; HIXSON DC, 1985, CANCER RES, V45, P3742; Hosoi H, 1998, MOL PHARMACOL, V54, P815, DOI 10.1124/mol.54.5.815; Huang SL, 2003, CANCER BIOL THER, V2, P222, DOI 10.4161/cbt.2.3.360; Inoki K, 2005, MICROBIOL MOL BIOL R, V69, P79, DOI 10.1128/MMBR.69.1.79-100.2005; Irizarry RA, 2003, NUCLEIC ACIDS RES, V31, DOI 10.1093/nar/gng015; Jiang YP, 2001, J BIOL CHEM, V276, P10943, DOI 10.1074/jbc.M007758200; KUNZ J, 1993, CELL, V73, P585, DOI 10.1016/0092-8674(93)90144-F; LEE LW, 1989, AM J PATHOL, V135, P63; Mayer C, 2006, ONCOGENE, V25, P6384, DOI 10.1038/sj.onc.1209883; Mayer C, 2004, GENE DEV, V18, P423, DOI 10.1101/gad.285504; Oldham S, 2000, GENE DEV, V14, P2689, DOI 10.1101/gad.845700; PANASYUK G, 2009, J BIOL CHEM; PITOT H. C., 1964, NAT CANCER INST MONOGR, V13, P229; Riemenschneider MJ, 2006, CANCER RES, V66, P5618, DOI 10.1158/0008-5472.CAN-06-0364; Sabatini DM, 2006, NAT REV CANCER, V6, P729, DOI 10.1038/nrc1974; Sarsour EH, 2005, J BIOL CHEM, V280, P18033, DOI 10.1074/jbc.M501939200; Thoreen CC, 2009, J BIOL CHEM, V284, P8023, DOI 10.1074/jbc.M900301200; Treiber G, 2009, EXPERT REV ANTICANC, V9, P247, DOI 10.1586/14737140.9.2.247; TSAO MS, 1985, CANCER RES, V45, P5139; TSAO MS, 1984, EXP CELL RES, V154, P38, DOI 10.1016/0014-4827(84)90666-9; Villanueva A, 2008, GASTROENTEROLOGY, V135, P1972, DOI 10.1053/j.gastro.2008.08.008; Wang W, 2009, DIGEST DIS SCI, V54, P2128, DOI 10.1007/s10620-008-0605-3; Wang Z, 2009, J CANCER RES CLIN, V135, P715, DOI 10.1007/s00432-008-0506-z; Wullschleger S, 2006, CELL, V124, P471, DOI 10.1016/j.cell.2006.01.016; Xie MW, 2005, P NATL ACAD SCI USA, V102, P7215, DOI 10.1073/pnas.0500297102; ZHOU L, 2009, MED ONCOL	48	19	20	0	0	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 9	2009	4	10							e7373	10.1371/journal.pone.0007373	http://dx.doi.org/10.1371/journal.pone.0007373			11	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DM	19816606	Green Published, gold, Green Submitted			2022-12-27	WOS:000270594300007
J	Das, H; George, JC; Joseph, M; Das, M; Abdulhameed, N; Blitz, A; Khan, M; Sakthivel, R; Mao, HQ; Hoit, BD; Kuppusamy, P; Pompili, VJ				Das, Hiranmoy; George, Jon C.; Joseph, Matthew; Das, Manjusri; Abdulhameed, Nasreen; Blitz, Anna; Khan, Mahmood; Sakthivel, Ramasamy; Mao, Hai-Quan; Hoit, Brian D.; Kuppusamy, Periannan; Pompili, Vincent J.			Stem Cell Therapy with Overexpressed VEGF and PDGF Genes Improves Cardiac Function in a Rat Infarct Model	PLOS ONE			English	Article							ENDOTHELIAL PROGENITOR CELLS; REDUCED NEOVASCULARIZATION CAPACITY; CORONARY-ARTERY; ISCHEMIC-HEART; GROWTH-FACTOR; BLOOD; ANGIOGENESIS; TRANSPLANTATION; EXPANSION; CONTRIBUTES	Background: Therapeutic potential was evaluated in a rat model of myocardial infarction using nanofiber-expanded human cord blood derived hematopoietic stem cells (CD133+/CD34+) genetically modified with VEGF plus PDGF genes (VIP). Methods and Findings: Myocardial function was monitored every two weeks up to six weeks after therapy. Echocardiography revealed time dependent improvement of left ventricular function evaluated by M-mode, fractional shortening, anterior wall tissue velocity, wall motion score index, strain and strain rate in animals treated with VEGF plus PDGF overexpressed stem cells (VIP) compared to nanofiber expanded cells (Exp), freshly isolated cells (FCB) or media control (Media). Improvement observed was as follows: VIP. Exp. FCB. media. Similar trend was noticed in the exercise capacity of rats on a treadmill. These findings correlated with significantly increased neovascularization in ischemic tissue and markedly reduced infarct area in animals in the VIP group. Stem cells in addition to their usual homing sites such as lung, spleen, bone marrow and liver, also migrated to sites of myocardial ischemia. The improvement of cardiac function correlated with expression of heart tissue connexin 43, a gap junctional protein, and heart tissue angiogenesis related protein molecules like VEGF, pNOS3, NOS2 and GSK3. There was no evidence of upregulation in the molecules of oncogenic potential in genetically modified or other stem cell therapy groups. Conclusion: Regenerative therapy using nanofiber-expanded hematopoietic stem cells with overexpression of VEGF and PDGF has a favorable impact on the improvement of rat myocardial function accompanied by upregulation of tissue connexin 43 and pro-angiogenic molecules after infarction.			Das, H (corresponding author), Ohio State Univ, Dorothy M Davis Heart & Lung Res Inst, Columbus, OH 43210 USA.	hiranmoy.das@osumc.edu	Das, Hiranmoy/R-7452-2019	Khan, Mahmood/0000-0003-3430-374X; Das, Hiranmoy/0000-0002-3343-0096; Mao, Hai-Quan/0000-0002-4262-9988	NIAMS NIH HHS [K01 AR054114] Funding Source: Medline; NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES [K01AR054114] Funding Source: NIH RePORTER	NIAMS NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS)); NATIONAL INSTITUTE OF ARTHRITIS AND MUSCULOSKELETAL AND SKIN DISEASES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Arthritis & Musculoskeletal & Skin Diseases (NIAMS))		Asahara T, 1997, SCIENCE, V275, P964, DOI 10.1126/science.275.5302.964; Asahara T, 1999, CIRC RES, V85, P221, DOI 10.1161/01.RES.85.3.221; Asahara T, 1999, EMBO J, V18, P3964, DOI 10.1093/emboj/18.14.3964; Bartunek J, 2005, CIRCULATION, V112, pI178, DOI 10.1161/CIRCULATIONAHA.104.522292; Brown JA, 2008, CLIN IMMUNOL, V127, P286, DOI 10.1016/j.clim.2008.02.008; Cao RH, 2004, CANCER CELL, V6, P333, DOI 10.1016/j.ccr.2004.08.034; Chua KN, 2006, BIOMATERIALS, V27, P6043, DOI 10.1016/j.biomaterials.2006.06.017; Daley GQ, 2008, CELL, V132, P544, DOI 10.1016/j.cell.2008.02.009; Das H, 2004, J IMMUNOL, V172, P6578, DOI 10.4049/jimmunol.172.11.6578; Das H, 2009, CELL TRANSPLANT, V18, P305, DOI 10.3727/096368909788534870; Erbs S, 2005, CIRC RES, V97, P756, DOI 10.1161/01.RES.0000185811.71306.8b; Fadini GP, 2006, ARTERIOSCL THROM VAS, V26, P2140, DOI 10.1161/01.ATV.0000237750.44469.88; Feigenbaum H, 1993, Int J Card Imaging, V9 Suppl 2, P55, DOI 10.1007/BF01143180; Giordano FJ, 1996, NAT MED, V2, P534, DOI 10.1038/nm0596-534; Gluckman, 1997, Oncologist, V2, P340; Hackney JA, 2002, P NATL ACAD SCI USA, V99, P13061, DOI 10.1073/pnas.192124499; Hao XJ, 2004, BIOCHEM BIOPH RES CO, V322, P292, DOI 10.1016/j.bbrc.2004.07.101; Heeschen C, 2004, CIRCULATION, V109, P1615, DOI 10.1161/01.CIR.0000124476.32871.E3; HOCHMAN JS, 1987, CIRCULATION, V75, P299, DOI 10.1161/01.CIR.75.1.299; Ibukiyama C, 1996, JPN HEART J, V37, P285; Kalka C, 2000, CIRC RES, V86, P1198, DOI 10.1161/01.RES.86.12.1198; Kano MR, 2005, J CELL SCI, V118, P3759, DOI 10.1242/jcs.02483; Kawamoto A, 2001, CIRCULATION, V103, P634; Kinnaird T, 2004, CIRCULATION, V109, P1543, DOI 10.1161/01.CIR.0000124062.31102.57; Kinnunen K, 2006, ACTA PHYSIOL, V187, P447, DOI 10.1111/j.1748-1716.2006.01588.x; Kobayashi T, 2000, J SURG RES, V89, P189, DOI 10.1006/jsre.2000.5828; KRAUSGRILL B, 2009, CELL TRANSP IN PRESS; Lahteenvuo JE, 2009, CIRCULATION, V119, P845, DOI 10.1161/CIRCULATIONAHA.108.816454; Laflamme MA, 2007, ANNU REV PATHOL-MECH, V2, P307, DOI 10.1146/annurev.pathol.2.010506.092038; Leor J, 2006, STEM CELLS, V24, P772, DOI 10.1634/stemcells.2005-0212; Li ML, 2007, RADIAT ONCOL, V2, DOI 10.1186/1748-717X-2-5; Lin Y, 2000, J CLIN INVEST, V105, P71, DOI 10.1172/JCI8071; Morgan EE, 2004, AM J PHYSIOL-HEART C, V287, pH2049, DOI 10.1152/ajpheart.00393.2004; Passier R, 2008, NATURE, V453, P322, DOI 10.1038/nature07040; Peled A, 1999, SCIENCE, V283, P845, DOI 10.1126/science.283.5403.845; Reffelmann T, 2009, J AM COLL CARDIOL, V53, P305, DOI 10.1016/j.jacc.2008.10.018; Segers VFM, 2008, NATURE, V451, P937, DOI 10.1038/nature06800; Shi Q, 1998, BLOOD, V92, P362, DOI 10.1182/blood.V92.2.362.414k38_362_367; Singh S, 2009, CLIN CARDIOL, V32, P176, DOI 10.1002/clc.20470; Stamm C, 2004, THORAC CARDIOV SURG, V52, P127, DOI 10.1055/s-2004-817978; Stevens MM, 2005, SCIENCE, V310, P1135, DOI 10.1126/science.1106587; Symes JF, 1999, ANN THORAC SURG, V68, P830, DOI 10.1016/S0003-4975(99)00807-3; Tomita S, 1999, CIRCULATION, V100, P247, DOI 10.1161/01.cir.100.suppl_2.ii-247; Tse W, 2008, CURR OPIN HEMATOL, V15, P279, DOI 10.1097/MOH.0b013e328304ae2c; Uemura R, 2006, CIRC RES, V98, P1414, DOI 10.1161/01.RES.0000225952.61196.39; Vale PR, 2000, CIRCULATION, V102, P965, DOI 10.1161/01.CIR.102.9.965; Van Zant G, 2003, EXP HEMATOL, V31, P659, DOI 10.1016/S0301-472X(03)00088-2; Walter DH, 2005, CIRC RES, V97, P1142, DOI 10.1161/01.RES.0000193596.94936.2c; WHITE HD, 1994, CIRCULATION, V89, P61, DOI 10.1161/01.CIR.89.1.61; Wu KH, 2009, J CELL BIOCHEM, V107, P926, DOI 10.1002/jcb.22193	50	80	87	0	8	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 7	2009	4	10							e7325	10.1371/journal.pone.0007325	http://dx.doi.org/10.1371/journal.pone.0007325			10	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DJ	19809493	Green Published, gold, Green Submitted			2022-12-27	WOS:000270594000007
J	Lindfors, E; Gopalacharyulu, PV; Halperin, E; Oresic, M				Lindfors, Erno; Gopalacharyulu, Peddinti V.; Halperin, Eran; Oresic, Matej			Detection of Molecular Paths Associated with Insulitis and Type 1 Diabetes in Non-Obese Diabetic Mouse	PLOS ONE			English	Article								Recent clinical evidence suggests important role of lipid and amino acid metabolism in early pre-autoimmune stages of type 1 diabetes pathogenesis. We study the molecular paths associated with the incidence of insulitis and type 1 diabetes in the Non-Obese Diabetic (NOD) mouse model using available gene expression data from the pancreatic tissue from young prediabetic mice. We apply a graph-theoretic approach by using a modified color coding algorithm to detect optimal molecular paths associated with specific phenotypes in an integrated biological network encompassing heterogeneous interaction data types. In agreement with our recent clinical findings, we identified a path downregulated in early insulitis involving dihydroxyacetone phosphate acyltransferase (DHAPAT), a key regulator of ether phospholipid synthesis. The pathway involving serine/threonine-protein phosphatase (PP2A), an upstream regulator of lipid metabolism and insulin secretion, was found upregulated in early insulitis. Our findings provide further evidence for an important role of lipid metabolism in early stages of type 1 diabetes pathogenesis, as well as suggest that such dysregulation of lipids and related increased oxidative stress can be tracked to beta cells.			Lindfors, E (corresponding author), VTT Tech Res Ctr Finland, Espoo, Finland.	matej.oresic@vtt.fi	Peddinti, Gopal/G-4872-2016; Oresic, Matej/K-7673-2016; Oresic, Matej/AAV-3978-2020	Peddinti, Gopal/0000-0002-8767-968X; Oresic, Matej/0000-0002-2856-9165; 				Achenbach P, 2005, DIABETES, V54, pS25, DOI 10.2337/diabetes.54.suppl_2.S25; ALON N, 1995, J ASSOC COMPUT MACH, V42, P844, DOI 10.1145/210332.210337; Anderson MS, 2005, ANNU REV IMMUNOL, V23, P447, DOI 10.1146/annurev.immunol.23.021704.115643; Atkinson MA, 1999, NAT MED, V5, P601, DOI 10.1038/9442; Bader GD, 2003, NUCLEIC ACIDS RES, V31, P248, DOI 10.1093/nar/gkg056; BARRETT T, 2008, NUCLEIC ACIDS RES, DOI DOI 10.1093/NAR/GKN1764; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Brindley DN, 1998, J BIOL CHEM, V273, P24281, DOI 10.1074/jbc.273.38.24281; Bukrinsky MI, 2002, TRENDS IMMUNOL, V23, P323, DOI 10.1016/S1471-4906(02)02237-8; Chaparro RJ, 2006, P NATL ACAD SCI USA, V103, P12475, DOI 10.1073/pnas.0604317103; Chatr-Aryamontri A, 2007, NUCLEIC ACIDS RES, V35, pD572, DOI 10.1093/nar/gkl950; Cnop M, 2005, DIABETES, V54, pS97, DOI 10.2337/diabetes.54.suppl_2.S97; Crispin JC, 2008, TRENDS IMMUNOL, V29, P110, DOI 10.1016/j.it.2007.12.003; Ewens KG, 2002, DIABETES, V51, P3318, DOI 10.2337/diabetes.51.11.3318; Futschik ME, 2007, BIOINFORMATICS, V23, P605, DOI 10.1093/bioinformatics/btl683; Gopalacharyulu PV, 2008, INT J DATA MIN BIOIN, V2, P54, DOI 10.1504/IJDMB.2008.016756; Gopalacharyulu PV, 2005, BIOINFORMATICS, V21, pI177, DOI 10.1093/bioinformatics/bti1015; Gorgas K, 2006, BBA-MOL CELL RES, V1763, P1511, DOI 10.1016/j.bbamcr.2006.08.038; Hulbert EM, 2007, NUCLEIC ACIDS RES, V35, pD742, DOI 10.1093/nar/gkl933; Jansen R, 2002, GENOME RES, V12, P37, DOI 10.1101/gr.205602; Kanehisa M, 2008, NUCLEIC ACIDS RES, V36, pD480, DOI 10.1093/nar/gkm882; Krull M, 2006, NUCLEIC ACIDS RES, V34, pD546, DOI 10.1093/nar/gkj107; Lantz KA, 2004, J CLIN INVEST, V114, P512, DOI 10.1172/JCI200421149; Lee TC, 1998, BBA-LIPID LIPID MET, V1394, P129, DOI 10.1016/S0005-2760(98)00107-6; Lenzen S, 1996, FREE RADICAL BIO MED, V20, P463, DOI 10.1016/0891-5849(96)02051-5; Lubert EJ, 2001, J BIOL CHEM, V276, P38582, DOI 10.1074/jbc.M106906200; Nagan N, 2001, PROG LIPID RES, V40, P199, DOI 10.1016/S0163-7827(01)00003-0; Notkins AL, 2001, J CLIN INVEST, V108, P1247, DOI 10.1172/JCI200114257; Oresic M, 2008, J EXP MED, V205, P2975, DOI 10.1084/jem.20081800; PARAMESWARA VK, 2005, JOP, V8, P303; Puigserver P, 2006, NAT MED, V12, P38, DOI 10.1038/nm0106-38; R Core Team, 2018, R LANG ENV STAT COMP; Ravnskjaer K, 2006, J MOL ENDOCRINOL, V36, P289, DOI 10.1677/jme.1.01965; Salwinski L, 2004, NUCLEIC ACIDS RES, V32, pD449, DOI 10.1093/nar/gkh086; Scott J, 2006, J COMPUT BIOL, V13, P133, DOI 10.1089/cmb.2006.13.133; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Thai TP, 2001, HUM MOL GENET, V10, P127, DOI 10.1093/hmg/10.2.127; Vukkadapu SS, 2005, PHYSIOL GENOMICS, V21, P201, DOI 10.1152/physiolgenomics.00173.2004; Wilson ME, 2005, DIABETES, V54, P3402, DOI 10.2337/diabetes.54.12.3402; Zoeller RA, 1999, BIOCHEM J, V338, P769, DOI 10.1042/0264-6021:3380769; Zoeller RA, 2002, AM J PHYSIOL-HEART C, V283, pH671, DOI 10.1152/ajpheart.00524.2001	41	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	OCT 2	2009	4	10							e7323	10.1371/journal.pone.0007323	http://dx.doi.org/10.1371/journal.pone.0007323			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	504DD	19798418	Green Published, gold			2022-12-27	WOS:000270593300014
J	Harris, S; Kaplan, JT; Curiel, A; Bookheimer, SY; Iacoboni, M; Cohen, MS				Harris, Sam; Kaplan, Jonas T.; Curiel, Ashley; Bookheimer, Susan Y.; Iacoboni, Marco; Cohen, Mark S.			The Neural Correlates of Religious and Nonreligious Belief	PLOS ONE			English	Article							CEREBRAL-BLOOD-FLOW; CORTICAL MIDLINE STRUCTURES; ORBITOFRONTAL CORTEX; PREFRONTAL CORTEX; PRELIMINARY SPECT; BRAIN-FUNCTION; SELF; FMRI; MEDITATION; OPTIMIZATION	Background: While religious faith remains one of the most significant features of human life, little is known about its relationship to ordinary belief at the level of the brain. Nor is it known whether religious believers and nonbelievers differ in how they evaluate statements of fact. Our lab previously has used functional neuroimaging to study belief as a general mode of cognition [1], and others have looked specifically at religious belief [2]. However, no research has compared these two states of mind directly. Methodology/Principal Findings: We used functional magnetic resonance imaging (fMRI) to measure signal changes in the brains of thirty subjects-fifteen committed Christians and fifteen nonbelievers-as they evaluated the truth and falsity of religious and nonreligious propositions. For both groups, and in both categories of stimuli, belief (judgments of "true'' vs judgments of "false'') was associated with greater signal in the ventromedial prefrontal cortex, an area important for self-representation [3,4,5,6], emotional associations [7], reward [8,9,10], and goal-driven behavior [11]. This region showed greater signal whether subjects believed statements about God, the Virgin Birth, etc. or statements about ordinary facts. A comparison of both stimulus categories suggests that religious thinking is more associated with brain regions that govern emotion, self-representation, and cognitive conflict, while thinking about ordinary facts is more reliant upon memory retrieval networks. Conclusions/Significance: While religious and nonreligious thinking differentially engage broad regions of the frontal, parietal, and medial temporal lobes, the difference between belief and disbelief appears to be content-independent. Our study compares religious thinking with ordinary cognition and, as such, constitutes a step toward developing a neuropsychology of religion. However, these findings may also further our understanding of how the brain accepts statements of all kinds to be valid descriptions of the world.			Harris, S (corresponding author), Univ Calif Los Angeles, David Geffen Sch Med, UCLA Ahmanson Lovelace Brain Mapping Ctr, Los Angeles, CA 90095 USA.	mscohen@ucla.edu	Cohen, Mark S/C-6610-2011	Cohen, Mark S/0000-0001-6731-4053; Bookheimer, Susan/0000-0002-3417-5891	NCRR NIH HHS [P41 RR013642, RR00865, M01 RR000865, RR13642, C06 RR012169] Funding Source: Medline; NIDA NIH HHS [R90 DA023422] Funding Source: Medline; NATIONAL CENTER FOR RESEARCH RESOURCES [P41RR013642, C06RR012169, M01RR000865] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSE [R90DA023422] Funding Source: NIH RePORTER	NCRR NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NIDA NIH HHS(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)); NATIONAL CENTER FOR RESEARCH RESOURCES(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR)); NATIONAL INSTITUTE ON DRUG ABUSE(United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission)		Anastasi MW, 2008, J ALTERN COMPLEM MED, V14, P163, DOI 10.1089/acm.2007.0675; Andersson J.L.R., 2007, TR07JA1 FMRIB; Andersson J.L.R, 2007, TR07JA2 FMRIB; Azari NP, 2001, EUR J NEUROSCI, V13, P1649, DOI 10.1046/j.0953-816x.2001.01527.x; Barrett JL, 2000, TRENDS COGN SCI, V4, P29, DOI 10.1016/S1364-6613(99)01419-9; Bechara A, 2000, CEREB CORTEX, V10, P295, DOI 10.1093/cercor/10.3.295; BLOOM P, 2004, DESCARTES BABY SCI C, pR15; Borg J, 2003, AM J PSYCHIAT, V160, P1965, DOI 10.1176/appi.ajp.160.11.1965; Boyer P, 2003, TRENDS COGN SCI, V7, P119, DOI 10.1016/S1364-6613(03)00031-7; Boyer Pascal, 2001, RELIG EXPLAINED EVOL; Brefczynski-Lewis JA, 2007, P NATL ACAD SCI USA, V104, P11483, DOI 10.1073/pnas.0606552104; BROOKS M, 2009, BORN BELIEVERS YOUR; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Carter CS, 1998, SCIENCE, V280, P747, DOI 10.1126/science.280.5364.747; D'Argembeau A, 2008, SOC COGN AFFECT NEUR, V3, P244, DOI 10.1093/scan/nsn020; DENNETT DC, 2006, BREAKING SPELL RELIG, pR14; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; DURKHEIM E, 2001, ELEMENTARY FORMS REL, pR41; Evans EM, 2001, COGNITIVE PSYCHOL, V42, P217, DOI 10.1006/cogp.2001.0749; Freud S., 1975, FUTURE ILLUSION; Freud Sigmund, 1994, CIVILIZ ITS DISCONT; Harris S, 2008, ANN NEUROL, V63, P141, DOI 10.1002/ana.21301; HOOD BM, 2009, SUPERSENSE WE BELIEV; Hornak J, 2004, J COGNITIVE NEUROSCI, V16, P463, DOI 10.1162/089892904322926791; Inzlicht M, 2009, PSYCHOL SCI, V20, P385, DOI 10.1111/j.1467-9280.2009.02305.x; Izuma K, 2008, NEURON, V58, P284, DOI 10.1016/j.neuron.2008.03.020; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Kapogiannis D, 2009, P NATL ACAD SCI USA, V106, P4876, DOI 10.1073/pnas.0811717106; Kelley WM, 2002, J COGNITIVE NEUROSCI, V14, P785, DOI 10.1162/08989290260138672; Lutz A, 2004, P NATL ACAD SCI USA, V101, P16369, DOI 10.1073/pnas.0407401101; Lutz A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001897; Lutz A, 2008, TRENDS COGN SCI, V12, P163, DOI 10.1016/j.tics.2008.01.005; MARX K, 1971, CRITIQUE HEGELS PHIL; Matsumoto K, 2004, CURR OPIN NEUROBIOL, V14, P178, DOI 10.1016/j.conb.2004.03.005; Monchi O, 2006, ANN NEUROL, V59, P257, DOI 10.1002/ana.20742; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Newberg A, 2003, PERCEPT MOTOR SKILL, V97, P625, DOI 10.2466/PMS.97.6.625-630; Newberg A, 2001, PSYCHIAT RES-NEUROIM, V106, P113, DOI 10.1016/S0925-4927(01)00074-9; Newberg AB, 2006, PSYCHIAT RES-NEUROIM, V148, P67, DOI 10.1016/j.pscychresns.2006.07.001; NORRIS P, 2004, SACRED SECULAR RELIG, pR15; Northoff G, 2006, NEUROIMAGE, V31, P440, DOI 10.1016/j.neuroimage.2005.12.002; O'Doherty J, 2001, NAT NEUROSCI, V4, P95, DOI 10.1038/82959; O'Doherty J, 2003, NEUROPSYCHOLOGIA, V41, P147, DOI 10.1016/S0028-3932(02)00145-8; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Poldrack RA, 2006, TRENDS COGN SCI, V10, P59, DOI 10.1016/j.tics.2005.12.004; Previc FH, 2006, CONSCIOUS COGN, V15, P500, DOI 10.1016/j.concog.2005.09.009; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rolls ET, 2008, NEUROIMAGE, V41, P1504, DOI 10.1016/j.neuroimage.2008.03.005; Royet JP, 2003, NEUROIMAGE, V20, P713, DOI 10.1016/S1053-8119(03)00388-4; Schjodt U, 2008, NEUROSCI LETT, V443, P165, DOI 10.1016/j.neulet.2008.07.068; Schjoedt U, 2009, SOC COGN AFFECT NEUR, V4, P199, DOI 10.1093/scan/nsn050; Schneider F, 2008, NEUROSCIENCE, V157, P120, DOI 10.1016/j.neuroscience.2008.08.014; Singer T, 2004, SCIENCE, V303, P1157, DOI 10.1126/science.1093535; Wager TD, 2004, SCIENCE, V303, P1162, DOI 10.1126/science.1093065; Wager TD, 2003, NEUROIMAGE, V18, P293, DOI 10.1016/S1053-8119(02)00046-0; Weber Max., 1993, SOCIOL RELIG; Wicker B, 2003, NEURON, V40, P655, DOI 10.1016/S0896-6273(03)00679-2; Woolrich MW, 2001, NEUROIMAGE, V14, P1370, DOI 10.1006/nimg.2001.0931; Zuckerman P., 2008, SOC GOD	60	76	78	0	68	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	185 BERRY ST, STE 1300, SAN FRANCISCO, CA 94107 USA	1932-6203			PLOS ONE	PLoS One	OCT 1	2009	4	10							e0007272	10.1371/journal.pone.0007272	http://dx.doi.org/10.1371/journal.pone.0007272			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	501BP	19794914	Green Published, gold			2022-12-27	WOS:000270354200005
J	Wang, YF; Chen, ZL; Qiao, F; Ying, TY; Yuan, J; Zhong, ZJ; Zhou, L; Du, XY; Wang, ZJ; Zhao, J; Dong, SC; Jia, LL; Yuan, XT; Yang, RF; Sun, YS; Huang, LY				Wang, Yufei; Chen, Zeliang; Qiao, Feng; Ying, Tianyi; Yuan, Jing; Zhong, Zhijun; Zhou, Lei; Du, Xinying; Wang, Zhoujia; Zhao, Jin; Dong, Shicun; Jia, Leili; Yuan, Xitong; Yang, Ruifu; Sun, Yansong; Huang, Liuyu			Comparative Proteomics Analyses Reveal the virB of B-melitensis Affects Expression of Intracellular Survival Related Proteins	PLOS ONE			English	Article							HIGH-TEMPERATURE-REQUIREMENT; OUTER-MEMBRANE PROTEIN; BRUCELLA-ABORTUS; ESCHERICHIA-COLI; TRIGGER FACTOR; HEAT-SHOCK; IN-VIVO; HTRA; SUIS; IDENTIFICATION	Backgound: Brucella melitensis is a facultative, intracellular, pathogenic bacterium that replicates within macrophages. The type IV secretion system encoded by the virB operon (virB) is involved in Brucella intracellular survival. However, the underlying molecular mechanisms, especially the target proteins affected by the virB, remain largely unclear. Methodology/Principal Findings: In order to define the proteins affected by virB, the proteomes of wild-type and the virB mutant were compared under in vitro conditions where virB was highly activated. The differentially expressed proteins were identified by MALDI-TOF-MS. Forty-four down-regulated and eighteen up-regulated proteins which exhibited a 2-fold or greater change were identified. These proteins included those involved in amino acid transport and metabolism, lipid metabolism, energy production, cell membrane biogenesis, translation, post-translational modifications and protein turnover, as well as unknown proteins. Interestingly, several important virulence related proteins involved in intracellular survival, including VjbR, DnaK, HtrA, Omp25, and GntR, were down-regulated in the virB mutant. Transcription analysis of virB and vjbR at different growth phase showed that virB positively affect transcription of vjbR in a growth phase dependent manner. Quantitative RT-PCR showed that transcription of these genes was also affected by virB during macrophage cell infection, consistent with the observed decreased survival of the virB mutant in macrophage. Conclusions/Significance: These data indicated that the virB operon may control the intracellular survival of Brucella by affecting the expression of relevant proteins.			Wang, YF (corresponding author), Acad Mil Med Sci, Inst Dis Control & Prevent, Beijing, Peoples R China.	Zeliangchen@yahoo.com; Huangly@nic.bmi.ac.cn		Qian, Pei-Yuan/0000-0003-4074-9078; wang, yong/0000-0003-3595-3867				Billard E, 2005, INFECT IMMUN, V73, P8418, DOI 10.1128/IAI.73.12.8418-8424.2005; Boschiroli ML, 2001, CURR OPIN MICROBIOL, V4, P58, DOI 10.1016/S1369-5274(00)00165-X; Celli J, 2003, J EXP MED, V198, P545, DOI 10.1084/jem.20030088; CLOECKAERT A, 1992, J GEN MICROBIOL, V138, P1543, DOI 10.1099/00221287-138-7-1543; Comerci DJ, 2001, CELL MICROBIOL, V3, P159, DOI 10.1046/j.1462-5822.2001.00102.x; de Jong MF, 2008, MOL MICROBIOL, V70, P1378, DOI 10.1111/j.1365-2958.2008.06487.x; Delrue RM, 2005, CELL MICROBIOL, V7, P1151, DOI 10.1111/j.1462-5822.2005.00543.x; Edmonds MD, 2002, RES VET SCI, V72, P235, DOI 10.1053/rvsc.2002.0555; Edmonds MD, 2002, VET MICROBIOL, V88, P205, DOI 10.1016/S0378-1135(02)00110-4; Edmonds MD, 2001, AM J VET RES, V62, P1461, DOI 10.2460/ajvr.2001.62.1461; ELZER PH, 1994, INFECT IMMUN, V62, P4135, DOI 10.1128/IAI.62.10.4135-4139.1994; ELZER PH, 1995, PLASMID, V33, P51, DOI 10.1006/plas.1995.1006; Elzer PH, 1996, INFECT IMMUN, V64, P4838, DOI 10.1128/IAI.64.11.4838-4841.1996; GEISOW MJ, 1981, J CELL BIOL, V89, P645, DOI 10.1083/jcb.89.3.645; Haine V, 2005, INFECT IMMUN, V73, P5578, DOI 10.1128/IAI.73.9.5578-5586.2005; Jubier-Maurin V, 2001, INFECT IMMUN, V69, P4823, DOI 10.1128/IAI.69.8.4823-4830.2001; Ko JY, 2003, CLIN MICROBIOL REV, V16, P65, DOI 10.1128/CMR.16.1.65-78.2003; Kohler S, 1996, MOL MICROBIOL, V20, P701, DOI 10.1111/j.1365-2958.1996.tb02510.x; Kohler S, 2002, INFECT IMMUN, V70, P1631, DOI 10.1128/IAI.70.3.1631-1634.2002; Kulakov YK, 1997, RES MICROBIOL, V148, P145, DOI 10.1016/S0923-2508(97)87645-0; Laskowska E, 1996, MOL MICROBIOL, V22, P555, DOI 10.1046/j.1365-2958.1996.1231493.x; Li SR, 1996, INFECT IMMUN, V64, P2088, DOI 10.1128/IAI.64.6.2088-2094.1996; LIN JS, 1995, INFECT IMMUN, V63, P1409, DOI 10.1128/IAI.63.4.1409-1414.1995; LIPINSKA B, 1990, J BACTERIOL, V172, P1791, DOI 10.1128/jb.172.4.1791-1797.1990; Livak KJ, 2001, METHODS, V25, P402, DOI 10.1006/meth.2001.1262; Maeda H, 1996, BIOL CHEM H-S, V377, P217; Nijskens C, 2008, MICROB PATHOGENESIS, V45, P134, DOI 10.1016/j.micpath.2008.04.005; O'Callaghan D, 1999, MOL MICROBIOL, V33, P1210, DOI 10.1046/j.1365-2958.1999.01569.x; Phillips RW, 1997, RES VET SCI, V63, P165, DOI 10.1016/S0034-5288(97)90012-6; PITT A, 1992, J CLIN INVEST, V90, P1978, DOI 10.1172/JCI116077; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P5711; Pizarro-Cerda J, 1998, INFECT IMMUN, V66, P2387; Porte F, 1999, INFECT IMMUN, V67, P4041, DOI 10.1128/IAI.67.8.4041-4047.1999; STRAUCH KL, 1988, P NATL ACAD SCI USA, V85, P1576, DOI 10.1073/pnas.85.5.1576; Taminiau B, 2002, INFECT IMMUN, V70, P3004, DOI 10.1128/IAI.70.6.3004-3011.2002; Teixeira-Gomes AP, 2000, INFECT IMMUN, V68, P2954, DOI 10.1128/IAI.68.5.2954-2961.2000; Uzureau S, 2007, J BACTERIOL, V189, P6035, DOI 10.1128/JB.00265-07; VALENT QA, 1995, EMBO J, V14, P5494, DOI 10.1002/j.1460-2075.1995.tb00236.x; Yamamoto T, 1996, INFECT IMMUN, V64, P2980, DOI 10.1128/IAI.64.8.2980-2987.1996; Yang XH, 2007, VACCINE, V25, P2261, DOI 10.1016/j.vaccine.2006.12.004	40	243	259	0	9	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 29	2009	4	4							e5368	10.1371/journal.pone.0005368	http://dx.doi.org/10.1371/journal.pone.0005368			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	439BG	19401764	gold, Green Published, Green Submitted			2022-12-27	WOS:000265601100011
